[1]	A. N. S. Gondim et al., “(-)-Terpinen-4-ol changes intracellular Ca2+ handling and induces pacing disturbance in rat hearts,” Eur. J. Pharmacol., vol. 807, pp. 56–63, Jul. 2017, doi: 10.1016/j.ejphar.2017.04.022.
[2]	K. Rutschky, “["Dear Papa!"--"My dear Anna": exchange of letters between Freud and his youngest daughter],” Luzif Amor, vol. 19, no. 38, pp. 149–152, 2006.
[3]	S. Gonzalez-Monge, “["Dys" or ‘not dys’? Challenges for both diagnosis and public health issues],” Arch Pediatr, vol. 20, no. 3, pp. 219–222, Mar. 2013, doi: 10.1016/j.arcped.2012.12.015.
[4]	F. Condrau, “["Economization": The Perspective of the History of Medicine],” Praxis (Bern 1994), vol. 109, no. 3, pp. 179–180, 2020, doi: 10.1024/1661-8157/a003402.
[5]	J. P. Levy and J. Peries, “["IN VITRO" CULTIVATION OF LEUKEMOGENIC VIRUSES],” Pathol Biol, vol. 12, pp. 1158–1162, Nov. 1964.
[6]	N. Biard, “["The eco-nurse is an expert in environmental health"],” Soins, vol. 63, no. 823, pp. 47–49, Mar. 2018, doi: 10.1016/j.soin.2018.01.012.
[7]	G. G. Ambrosini, C. Cammarota, M. Di Luozzo, R. Rotunno, C. Nesta, and A. Sette, “["The memory effect" in healthy heart and transplanted heart. ‘Cor se ipse alit, se ipse movet, se ipse reget’],” Recenti Prog Med, vol. 91, no. 9, pp. 430–435, Sep. 2000.
[8]	Y. L. Takeuchi, C. Veys, and O. Sanchez, “[« Let’s talk about sex » : adolescent boys’ sexual health in the primary care setting],” Rev Med Suisse, vol. 16, no. 691, pp. 765–768, Apr. 2020.
[9]	J. L. Fleckenstein, “(Dys-)functional MR imaging of skeletal muscle: a cautionary note,” Radiology, vol. 206, no. 2, pp. 305–307, Feb. 1998, doi: 10.1148/radiology.206.2.9457178.
[10]	H.-D. Ju, X.-T. Tao, S.-Q. Xu, and W.-T. Yu, “(E)-2-{3-[4-(Diphenyl-amino)styr-yl]-5,5-dimethyl-cyclo-hex-2-enyl-idene}-malono-nitrile,” Acta Crystallogr Sect E Struct Rep Online, vol. 65, no. Pt 5, p. o1135, Apr. 2009, doi: 10.1107/S1600536809014378.
[11]	B. Neumüller et al., “(Ph(4)P)S(6)-A Compound Containing the Cyclic Radical Anion S(6)(.-) We thank the Deutsche Forschungsgemeinschaft (DFG) and the Fonds der Chemischen Industrie (FCI) for financial support. A.D. thanks the FCI for a doctoral stipendium. F.M.B. thanks the DFG for a Habilitation fellowship.,” Angew. Chem. Int. Ed. Engl., vol. 39, no. 24, pp. 4580–4582, Dec. 2000.
[12]	T. Steinbach, S. Gad-McDonald, N. Kruhlak, M. Powley, and N. Greene, “(Q)SAR: A Tool for the Toxicologist,” Int. J. Toxicol., vol. 34, no. 4, pp. 352–354, Aug. 2015, doi: 10.1177/1091581815584914.
[13]	A. Peppuy et al., “(Z)-dodec-3-en-1-ol, a novel termite trail pheromone identified after solid phase microextraction from Macrotermes annandalei,” J. Insect Physiol., vol. 47, no. 4–5, pp. 445–453, Apr. 2001, doi: 10.1016/s0022-1910(00)00135-9.
[14]	K. Modi et al., “1-Chromonyl-5-Imidazolylpentadienone Demonstrates Anti-Cancer Action against TNBC and Exhibits Synergism with Paclitaxel,” Int J Mol Sci, vol. 21, no. 16, Aug. 2020, doi: 10.3390/ijms21165777.
[15]	P. Xu, F. Zhu, G. K. Buss, and W. S. Leal, “1-Octen-3-ol - the attractant that repels,” F1000Res, vol. 4, p. 156, 2015, doi: 10.12688/f1000research.6646.1.
[16]	G. S. Chitarra, T. Abee, F. M. Rombouts, and J. Dijksterhuis, “1-Octen-3-ol inhibits conidia germination of Penicillium paneum despite of mild effects on membrane permeability, respiration, intracellular pH, and changes the protein composition,” FEMS Microbiol. Ecol., vol. 54, no. 1, pp. 67–75, Sep. 2005, doi: 10.1016/j.femsec.2005.02.013.
[17]	K. Matsui, H. Takemoto, T. Koeduka, and T. Ohnishi, “1-Octen-3-ol Is Formed from Its Glycoside during Processing of Soybean [ Glycine max (L.) Merr.] Seeds,” J. Agric. Food Chem., vol. 66, no. 28, pp. 7409–7416, Jul. 2018, doi: 10.1021/acs.jafc.8b01950.
[18]	L. Kong, Y. Qiao, Z. Gao, and X. Ju, “1,5-Bis(1-phenyl-ethyl-idene)carbonohydrazide,” Acta Crystallogr Sect E Struct Rep Online, vol. 66, no. Pt 11, p. o2901, Oct. 2010, doi: 10.1107/S1600536810042121.
[19]	E. G. Z. Centeno, H. Cimarosti, and A. Bithell, “2D versus 3D human induced pluripotent stem cell-derived cultures for neurodegenerative disease modelling,” Mol Neurodegener, vol. 13, no. 1, p. 27, 22 2018, doi: 10.1186/s13024-018-0258-4.
[20]	S. H. Choi, Y. H. Kim, L. Quinti, R. E. Tanzi, and D. Y. Kim, “3D culture models of Alzheimer’s disease: a road map to a ‘cure-in-a-dish,’” Mol Neurodegener, vol. 11, no. 1, p. 75, 09 2016, doi: 10.1186/s13024-016-0139-7.
[21]	X. Lu et al., “3D microstructure design of lithium-ion battery electrodes assisted by X-ray nano-computed tomography and modelling,” Nat Commun, vol. 11, no. 1, p. 2079, Apr. 2020, doi: 10.1038/s41467-020-15811-x.
[22]	P. Mills and J. Zara, “3D simulation of an audible ultrasonic electrolarynx using difference waves,” PLoS ONE, vol. 9, no. 11, p. e113339, 2014, doi: 10.1371/journal.pone.0113339.
[23]	W.-S. Liu, R.-P. Wei, X.-L. Tang, W.-H. Wang, and Z.-H. Ju, “4-(Hydroxy-meth-yl)phenol,” Acta Crystallogr Sect E Struct Rep Online, vol. 65, no. Pt 7, p. o1689, Jun. 2009, doi: 10.1107/S1600536809022466.
[24]	P. Gonzalez, M. Cascales, F. Mayor, and A. Santos Ruiz, “4-AMINOBUTYRATE 1-C14 METABOLISM IN HELIANTHUS TUBEROSUS TISSUES GROWN IN VITRO,” Nature, vol. 201, p. 300, Jan. 1964, doi: 10.1038/201300a0.
[25]	R. Martin et al., “4Alpha-bromo-5alpha-cholestan-3beta-ol and nor-5alpha-cholestan-3beta-ol derivatives-stereoselective synthesis and hormonal activity in Caenorhabditis elegans,” Org. Biomol. Chem., vol. 7, no. 11, pp. 2303–2309, Jun. 2009, doi: 10.1039/b904001c.
[26]	R. A. Dombroski, M. L. Casey, and P. C. MacDonald, “5-Alpha-dihydroprogesterone formation in human placenta from 5alpha-pregnan-3beta/alpha-ol-20-ones and 5-pregnan-3beta-yl-20-one sulfate,” J. Steroid Biochem. Mol. Biol., vol. 63, no. 1–3, pp. 155–163, Oct. 1997, doi: 10.1016/s0960-0760(97)00058-7.
[27]	R. Buckstein, K. Yee, R. A. Wells, and Canadian Consortium on Evidence-based Care in MDS, “5-Azacytidine in myelodysplastic syndromes: a clinical practice guideline,” Cancer Treat. Rev., vol. 37, no. 2, pp. 160–167, Apr. 2011, doi: 10.1016/j.ctrv.2010.05.006.
[28]	M. L. Pascu, M. Brezeanu, L. Voicu, A. Staicu, B. Carstocea, and R. A. Pascu, “5-fluorouracil as a phosensitiser,” In Vivo, vol. 19, no. 1, pp. 215–220, Feb. 2005.
[29]	M. D. Gershon, “5-HT (serotonin) physiology and related drugs,” Curr. Opin. Gastroenterol., vol. 16, no. 2, pp. 113–120, Mar. 2000, doi: 10.1097/00001574-200003000-00004.
[30]	P. J. Pauwels, “5-HT 1B/D receptor antagonists,” Gen. Pharmacol., vol. 29, no. 3, pp. 293–303, Sep. 1997, doi: 10.1016/s0306-3623(96)00460-0.
[31]	X. Li et al., “5-HT 2 receptor mediates high-fat diet-induced hepatic steatosis and very low density lipoprotein overproduction in rats,” Obes Res Clin Pract, vol. 12, no. Suppl 2, pp. 16–28, Feb. 2018, doi: 10.1016/j.orcp.2016.03.015.
[32]	B.-G. Tuo, Z. Sellers, P. Paulus, K. E. Barrett, and J. I. Isenberg, “5-HT induces duodenal mucosal bicarbonate secretion via cAMP- and Ca2+-dependent signaling pathways and 5-HT4 receptors in mice,” Am. J. Physiol. Gastrointest. Liver Physiol., vol. 286, no. 3, pp. G444-451, Mar. 2004, doi: 10.1152/ajpgi.00105.2003.
[33]	K. B. Fink and M. Göthert, “5-HT receptor regulation of neurotransmitter release,” Pharmacol. Rev., vol. 59, no. 4, pp. 360–417, Dec. 2007, doi: 10.1124/pr.107.07103.
[34]	M. M. Wouters, G. Farrugia, and M. Schemann, “5-HT receptors on interstitial cells of Cajal, smooth muscle and enteric nerves,” Neurogastroenterol. Motil., vol. 19 Suppl 2, pp. 5–12, Aug. 2007, doi: 10.1111/j.1365-2982.2007.00963.x.
[35]	A. Meneses, “5-HT system and cognition,” Neurosci Biobehav Rev, vol. 23, no. 8, pp. 1111–1125, Dec. 1999, doi: 10.1016/s0149-7634(99)00067-6.
[36]	G. Luscombe, P. Jenner, and C. D. Marsden, “5-HT-mediated myoclonus in the guinea pig as a model of brainstem 5-HT and tryptamine receptor action,” Adv Neurol, vol. 43, pp. 529–543, 1986.
[37]	C. H. Vinkers, L. Groenink, T. Pattij, B. Olivier, and J. A. Bouwknecht, “5-HT(1A) receptor sensitivity in 5-HT(1B) receptor KO mice is unaffected by chronic fluvoxamine treatment,” Eur. J. Pharmacol., vol. 667, no. 1–3, pp. 250–257, Sep. 2011, doi: 10.1016/j.ejphar.2011.06.018.
[38]	C. Stein, H. Davidowa, and D. Albrecht, “5-HT(1A) receptor-mediated inhibition and 5-HT(2) as well as 5-HT(3) receptor-mediated excitation in different subdivisions of the rat amygdala,” Synapse, vol. 38, no. 3, pp. 328–337, Dec. 2000, doi: 10.1002/1098-2396(20001201)38:3<328::AID-SYN12>3.0.CO;2-T.
[39]	A. Meneses and G. Perez-Garcia, “5-HT(1A) receptors and memory,” Neurosci Biobehav Rev, vol. 31, no. 5, pp. 705–727, 2007, doi: 10.1016/j.neubiorev.2007.02.001.
[40]	G. Hedo and J. A. Lopez-Garcia, “5-HT(1B) but not 5-HT(6) or 5-HT(7) receptors mediate depression of spinal nociceptive reflexes in vitro,” Br. J. Pharmacol., vol. 135, no. 4, pp. 935–942, Feb. 2002, doi: 10.1038/sj.bjp.0704526.
[41]	S. Threlfell, S. A. Greenfield, and S. J. Cragg, “5-HT(1B) receptor regulation of serotonin (5-HT) release by endogenous 5-HT in the substantia nigra,” Neuroscience, vol. 165, no. 1, pp. 212–220, Jan. 2010, doi: 10.1016/j.neuroscience.2009.10.005.
[42]	M. Huang, J. Dai, and H. Y. Meltzer, “5-HT(2A) and 5-HT(2C) receptor stimulation are differentially involved in the cortical dopamine efflux-Studied in 5-HT(2A) and 5-HT(2C) genetic mutant mice,” Eur. J. Pharmacol., vol. 652, no. 1–3, pp. 40–45, Feb. 2011, doi: 10.1016/j.ejphar.2010.10.094.
[43]	M. Morales, N. McCollum, and E. F. Kirkness, “5-HT(3)-receptor subunits A and B are co-expressed in neurons of the dorsal root ganglion,” J. Comp. Neurol., vol. 438, no. 2, pp. 163–172, Sep. 2001, doi: 10.1002/cne.1307.
[44]	C. Moro, L. Edwards, and R. Chess-Williams, “5-HT2A receptor enhancement of contractile activity of the porcine urothelium and lamina propria,” Int. J. Urol., vol. 23, no. 11, pp. 946–951, 2016, doi: 10.1111/iju.13172.
[45]	I. Lim, R. Chess-Williams, and D. Sellers, “5-HT2A receptor is the predominant receptor mediating contraction of the isolated porcine distal ureter to 5-HT in young and old animals,” Eur. J. Pharmacol., vol. 818, pp. 328–334, Jan. 2018, doi: 10.1016/j.ejphar.2017.11.001.
[46]	D. L. Nelson, “5-HT5 receptors,” Curr Drug Targets CNS Neurol Disord, vol. 3, no. 1, pp. 53–58, Feb. 2004, doi: 10.2174/1568007043482606.
[47]	G. Luscombe, P. Jenner, and C. D. Marsden, “5-Hydroxytryptamine (5-HT)-dependent myoclonus in guinea pigs is induced through brainstem 5-HT-1 receptors,” Neurosci. Lett., vol. 44, no. 3, pp. 241–246, Feb. 1984, doi: 10.1016/0304-3940(84)90029-6.
[48]	M. Rekik, P. Lluel, and S. Palea, “5-Hydroxytryptamine potentiates neurogenic contractions of rat isolated urinary bladder through both 5-HT(7) and 5-HT(2C) receptors,” Eur. J. Pharmacol., vol. 650, no. 1, pp. 403–410, Jan. 2011, doi: 10.1016/j.ejphar.2010.10.027.
[49]	B. M. Svedenstål and K. J. Johanson, “5-Iododeoxyuridine-125I incorporation in vivo after exposure to a 50 Hz magnetic field,” In Vivo, vol. 12, no. 5, pp. 531–534, Oct. 1998.
[50]	A. S. Fischer et al., “5-Lipoxygenase inhibitors induce potent anti-proliferative and cytotoxic effects in human tumour cells independently of suppression of 5-lipoxygenase activity,” Br. J. Pharmacol., vol. 161, no. 4, pp. 936–949, Oct. 2010, doi: 10.1111/j.1476-5381.2010.00915.x.
[51]	C. Pergola and O. Werz, “5-Lipoxygenase inhibitors: a review of recent developments and patents,” Expert Opin Ther Pat, vol. 20, no. 3, pp. 355–375, Mar. 2010, doi: 10.1517/13543771003602012.
[52]	K. Ishii, M. Zaitsu, N. Yonemitsu, Y. Kan, Y. Hamasaki, and M. Matsuo, “5-lipoxygenase pathway promotes cell proliferation in human glioma cell lines,” Clin. Neuropathol., vol. 28, no. 6, pp. 445–452, Dec. 2009, doi: 10.5414/npp28445.
[53]	S. J. Lee et al., “5-Lipoxygenase plays a pivotal role in endothelial adhesion of monocytes via an increased expression of Mac-1,” Cardiovasc. Res., vol. 99, no. 4, pp. 724–733, Sep. 2013, doi: 10.1093/cvr/cvt135.
[54]	V. A. Blaho, Y. Zhang, J. M. Hughes-Hanks, and C. R. Brown, “5-Lipoxygenase-deficient mice infected with Borrelia burgdorferi develop persistent arthritis,” J. Immunol., vol. 186, no. 5, pp. 3076–3084, Mar. 2011, doi: 10.4049/jimmunol.1003473.
[55]	D. Steinhilber et al., “5-lipoxygenase: underappreciated role of a pro-inflammatory enzyme in tumorigenesis,” Front Pharmacol, vol. 1, p. 143, 2010, doi: 10.3389/fphar.2010.00143.
[56]	N. Horlock, A. O. Grobbelaar, and D. T. Gault, “5-year series of constricted (lop and cup) ear corrections: development of the mastoid hitch as an adjunctive technique,” Plast. Reconstr. Surg., vol. 102, no. 7, pp. 2325–2332; discussion 2333-2335, Dec. 1998, doi: 10.1097/00006534-199812000-00008.
[57]	Z.-Y. Ju, G.-C. Li, C. Li, J. Wang, and F.-L. Yang, “6-Benz-yloxy-2-phenyl-pyridazin-3(2H)-one,” Acta Crystallogr Sect E Struct Rep Online, vol. 68, no. Pt 6, p. o1646, Jun. 2012, doi: 10.1107/S1600536812018776.
[58]	F. Xue and S.-G. Ju, “6-Bromo-pyridine-2-carboxamide,” Acta Crystallogr Sect E Struct Rep Online, vol. 65, no. Pt 12, p. o3161, Nov. 2009, doi: 10.1107/S1600536809047114.
[59]	“10 facts on rabies,” Wkly. Epidemiol. Rec., vol. 91, no. 43, pp. 515–516, Oct. 2016.
[60]	C. D. Hatch and V. H. Grassian, “10th Anniversary review: applications of analytical techniques in laboratory studies of the chemical and climatic impacts of mineral dust aerosol in the Earth’s atmosphere,” J Environ Monit, vol. 10, no. 8, pp. 919–934, Aug. 2008, doi: 10.1039/b805153d.
[61]	H. Miwa et al., “[13C]-urea breath test for assessment of cure of Helicobacter pylori infection at 1 month after treatment,” J. Clin. Gastroenterol., vol. 27 Suppl 1, pp. S150-153, 1998, doi: 10.1097/00004836-199800001-00024.
[62]	N. Kanda and S. Watanabe, “17beta-estradiol enhances the production of granulocyte-macrophage colony-stimulating factor in human keratinocytes,” J. Invest. Dermatol., vol. 123, no. 2, pp. 329–337, Aug. 2004, doi: 10.1111/j.0022-202X.2004.23231.x.
[63]	N. Kanda and S. Watanabe, “17Beta-estradiol enhances the production of nerve growth factor in THP-1-derived macrophages or peripheral blood monocyte-derived macrophages,” J. Invest. Dermatol., vol. 121, no. 4, pp. 771–780, Oct. 2003, doi: 10.1046/j.1523-1747.2003.12487.x.
[64]	N. Kanda and S. Watanabe, “17beta-estradiol enhances vascular endothelial growth factor production and dihydrotestosterone antagonizes the enhancement via the regulation of adenylate cyclase in differentiated THP-1 cells,” J. Invest. Dermatol., vol. 118, no. 3, pp. 519–529, Mar. 2002, doi: 10.1046/j.0022-202x.2002.01672.x.
[65]	N. Kanda and S. Watanabe, “17Beta-estradiol inhibits MCP-1 production in human keratinocytes,” J. Invest. Dermatol., vol. 120, no. 6, pp. 1058–1066, Jun. 2003, doi: 10.1046/j.1523-1747.2003.12255.x.
[66]	N. Kanda and S. Watanabe, “17beta-estradiol inhibits oxidative stress-induced apoptosis in keratinocytes by promoting Bcl-2 expression,” J. Invest. Dermatol., vol. 121, no. 6, pp. 1500–1509, Dec. 2003, doi: 10.1111/j.1523-1747.2003.12617.x.
[67]	N. Kanda and S. Watanabe, “17beta-estradiol inhibits the production of interferon-induced protein of 10 kDa by human keratinocytes,” J. Invest. Dermatol., vol. 120, no. 3, pp. 411–419, Mar. 2003, doi: 10.1046/j.1523-1747.2003.12066.x.
[68]	N. Kanda and S. Watanabe, “17beta-estradiol inhibits the production of RANTES in human keratinocytes,” J. Invest. Dermatol., vol. 120, no. 3, pp. 420–427, Mar. 2003, doi: 10.1046/j.1523-1747.2003.12067.x.
[69]	N. Kanda and S. Watanabe, “17beta-estradiol stimulates the growth of human keratinocytes by inducing cyclin D2 expression,” J. Invest. Dermatol., vol. 123, no. 2, pp. 319–328, Aug. 2004, doi: 10.1111/j.0022-202X.2004.12645.x.
[70]	N. Kanda and S. Watanabe, “17beta-estradiol, progesterone, and dihydrotestosterone suppress the growth of human melanoma by inhibiting interleukin-8 production,” J. Invest. Dermatol., vol. 117, no. 2, pp. 274–283, Aug. 2001, doi: 10.1046/j.1523-1747.2001.01422.x.
[71]	S. Maio et al., “18-yr cumulative incidence of respiratory/allergic symptoms/diseases and risk factors in the Pisa epidemiological study,” Respir Med, vol. 158, pp. 33–41, Nov. 2019, doi: 10.1016/j.rmed.2019.09.013.
[72]	L. Rozenblum et al., “18F-FDOPA PET/CT Findings in a Patient With Primary Cerebral Amyloidoma,” Clin Nucl Med, vol. 45, no. 4, pp. e206–e207, Apr. 2020, doi: 10.1097/RLU.0000000000002959.
[73]	M. A. Mortensen, M. H. Poulsen, O. Gerke, J. S. Jakobsen, P. F. Høilund-Carlsen, and L. Lund, “18F-Fluoromethylcholine-positron emission tomography/computed tomography for diagnosing bone and lymph node metastases in patients with intermediate- or high-risk prostate cancer,” Prostate Int, vol. 7, no. 3, pp. 119–123, Sep. 2019, doi: 10.1016/j.prnil.2019.01.002.
[74]	A. AlBarrak, S. Khan, and M. Al-Zawahmah, “20 years of continuous publication in the neurosciences field,” Neurosciences (Riyadh), vol. 20, no. 1, pp. 1–3, Jan. 2015.
[75]	I. C. D. Y. M. Wolf-de Jonge, J. F. Beek, and R. Balm, “25 years of laser assisted vascular anastomosis (LAVA): what have we learned?,” Eur J Vasc Endovasc Surg, vol. 27, no. 5, pp. 466–476, May 2004, doi: 10.1016/j.ejvs.2004.02.021.
[76]	F. Patelli, P. Radice, G. Zumbo, G. Frisone, and G. Fasolino, “25-gauge macular surgery: results and complications,” Retina (Philadelphia, Pa.), vol. 27, no. 6, pp. 750–754, Aug. 2007, doi: 10.1097/IAE.0b013e31802c5125.
[77]	V. M. Petriev, A. E. Vatin, R. M. Prusova, P. P. Filatov, and D. G. Khachirov, “[57Co-bleomycetin pharmacokinetics in the body of mice with LIO-1 lymphosarcoma],” Antibiotiki, vol. 27, no. 8, pp. 623–626, Aug. 1982.
[78]	C. Udovicich et al., “68Ga-prostate-specific membrane antigen-positron emission tomography/computed tomography in advanced prostate cancer: Current state and future trends,” Prostate Int, vol. 5, no. 4, pp. 125–129, Dec. 2017, doi: 10.1016/j.prnil.2017.02.003.
[79]	L. Rozenblum-Beddok et al., “99mTc-HMPAO-leukocyte scintigraphy for diagnosis and therapy monitoring of skull base osteomyelitis,” Laryngoscope Investig Otolaryngol, vol. 3, no. 3, pp. 218–224, Jun. 2018, doi: 10.1002/lio2.159.
[80]	N. Rosen, E. Pearlman, D. Ruff, K. Day, and A. Jim Nagy, “100% Response Rate to Galcanezumab in Patients With Episodic Migraine: A Post Hoc Analysis of the Results From Phase 3, Randomized, Double-Blind, Placebo-Controlled EVOLVE-1 and EVOLVE-2 Studies,” Headache, vol. 58, no. 9, pp. 1347–1357, Oct. 2018, doi: 10.1111/head.13427.
[81]	P. Yi, G. Possnert, A. Aldahan, X. L. Hou, A. C. Bryhn, and P. He, “129I in the Baltic Proper and Bothnian Sea: application for estimation of water exchange and environmental impact,” J Environ Radioact, vol. 120, pp. 64–72, Jun. 2013, doi: 10.1016/j.jenvrad.2013.01.009.
[82]	“175 Performance of acute flaccid paralysis (AFP) surveillance and incidence of poliomyelitis, 2017,” Wkly. Epidemiol. Rec., vol. 92, no. 14, pp. 175–179, 07 2017.
[83]	“681 Progress report on the elimination of human onchocerciasis, 2016–2017,” Wkly. Epidemiol. Rec., vol. 92, no. 45, pp. 681–694, 10 2017.
[84]	Y. Zhao, C. M. Wen, N. N. Zhou, Q. Feng, and P. Tu, “1064-nm Q-switched Nd:YAG laser is an effective and safe approach to treat xanthelasma palpebrarum in Asian population,” J Eur Acad Dermatol Venereol, vol. 29, no. 11, pp. 2263–2265, Nov. 2015, doi: 10.1111/jdv.12568.
[85]	A. P. Hull, “1962 ENVIRONMENTAL RADIATION LEVELS AT BROOKHAVEN NATIONAL LABORATORY. BNL 807 (T-310),” Tech Rep Brookhaven Natl Lab, vol. 86, pp. 1–12, May 1963.
[86]	A. P. Hull, “1963 environmental radiation levels at Brookhaven National Laboratory. BNL 915 (T-376),” Tech Rep Brookhaven Natl Lab, pp. 1–16, 1965.
[87]	A. P. Hull, “1964 environmental monitoring radiation levels at Brookhaven National Laboratory. June 1966. BNL 50001 (T-427),” Tech Rep Brookhaven Natl Lab, pp. 1–31, Apr. 1964.
[88]	N. S. Vaage, “2016 World Congress on In Vitro Biology, June 11-15, San Diego, California : Late Submission Abstracts,” In Vitro Cell. Dev. Biol. Anim., vol. 52, no. 7, pp. 789–797, Aug. 2016, doi: 10.1007/s11626-016-0064-7.
[89]	“2017 In Vitro Biology Meeting, June 10-14, Raleigh, North Carolina : Late Submission Abstracts,” In Vitro Cell. Dev. Biol. Anim., vol. 53, no. 7, pp. 659–668, Aug. 2017, doi: 10.1007/s11626-017-0173-y.
[90]	C. Li, C. Chen, B. Qiu, and G. Yang, “A 2-year follow-up study of discharged psychiatric patients with bipolar disorder,” Psychiatry Res, vol. 218, no. 1–2, pp. 75–78, Aug. 2014, doi: 10.1016/j.psychres.2014.04.029.
[91]	D. F. Maciejewski, P. A. C. van Lier, S. J. T. Branje, W. H. J. Meeus, and H. M. Koot, “A 5-Year Longitudinal Study on Mood Variability Across Adolescence Using Daily Diaries,” Child Dev, vol. 86, no. 6, pp. 1908–1921, Dec. 2015, doi: 10.1111/cdev.12420.
[92]	L. Mansfield, G. Yiu, A. Sakov, S. Liu, and C. Caracta, “A 6-month safety and efficacy study of fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers in persistent asthma,” Allergy Asthma Proc, vol. 38, no. 4, pp. 264–276, Jul. 2017, doi: 10.2500/aap.2017.38.4061.
[93]	R. Tominaga et al., “A 10-year experience with the Carbomedics cardiac prosthesis,” Ann. Thorac. Surg., vol. 79, no. 3, pp. 784–789, Mar. 2005, doi: 10.1016/j.athoracsur.2004.08.067.
[94]	S. Knipper et al., “A 25-year Period Analysis of Other-cause Mortality in Localized Prostate Cancer,” Clin Genitourin Cancer, vol. 17, no. 5, pp. 395–401, 2019, doi: 10.1016/j.clgc.2019.07.008.
[95]	H. Iwata et al., “A Back-to-Front Fragment-Based Drug Design Search Strategy Targeting the DFG-Out Pocket of Protein Tyrosine Kinases,” ACS Med Chem Lett, vol. 3, no. 4, pp. 342–346, Apr. 2012, doi: 10.1021/ml3000403.
[96]	M. Rew and T. Ferns, “A balanced approach to dealing with violence and aggression at work,” Br J Nurs, vol. 14, no. 4, pp. 227–232, Mar. 2005, doi: 10.12968/bjon.2005.14.4.17609.
[97]	A. Kleidon, “A basic introduction to the thermodynamics of the Earth system far from equilibrium and maximum entropy production,” Philos. Trans. R. Soc. Lond., B, Biol. Sci., vol. 365, no. 1545, pp. 1303–1315, May 2010, doi: 10.1098/rstb.2009.0310.
[98]	J. M. Johanson, P. J. Berger, S. Tsuruta, and I. Misztal, “A Bayesian threshold-linear model evaluation of perinatal mortality, dystocia, birth weight, and gestation length in a Holstein herd,” J. Dairy Sci., vol. 94, no. 1, pp. 450–460, Jan. 2011, doi: 10.3168/jds.2009-2992.
[99]	R. Paulose, K. Jegatheesan, and G. S. Balakrishnan, “A big data approach with artificial neural network and molecular similarity for chemical data mining and endocrine disruption prediction,” Indian J Pharmacol, vol. 50, no. 4, pp. 169–176, Aug. 2018, doi: 10.4103/ijp.IJP_304_17.
[100]	M. T. Wolf et al., “A biologic scaffold-associated type 2 immune microenvironment inhibits tumor formation and synergizes with checkpoint immunotherapy,” Sci Transl Med, vol. 11, no. 477, 30 2019, doi: 10.1126/scitranslmed.aat7973.
[101]	N. Gravenstein and M. J. Rice, “A bit confused,” Anesth. Analg., vol. 112, no. 6, pp. 1509; author reply 1509-1510, Jun. 2011, doi: 10.1213/ANE.0b013e31821d121c.
[102]	X. Zhai and D. P. Chakraborty, “A bivariate contaminated binormal model for robust fitting of proper ROC curves to a pair of correlated, possibly degenerate, ROC datasets,” Med Phys, vol. 44, no. 6, pp. 2207–2222, Jun. 2017, doi: 10.1002/mp.12263.
[103]	S. Devarajan, R. Singh, B. Chatterjee, B. Zhang, and A. Ali, “A blend of sesame oil and rice bran oil lowers blood pressure and improves the lipid profile in mild-to-moderate hypertensive patients,” J Clin Lipidol, vol. 10, no. 2, pp. 339–349, Apr. 2016, doi: 10.1016/j.jacl.2015.12.011.
[104]	M. Kichelmacher and I. Magli, “A brief anthropological analysis of connections between ‘impurity’, ‘zara’at’ and slander in Jewish culture,” Korot, vol. 9, no. 1–2, pp. 136–143, 1985.
[105]	M. S. Carvalho, C. M. Coeli, and C. Travassos, “A brief history of cadernos de Saúde Pública/reports in Public Health,” Cien Saude Colet, vol. 20, no. 7, pp. 2007–2012, Jul. 2015, doi: 10.1590/1413-81232015207.05882015.
[106]	P. R. Chai et al., “A Brief Music App to Address Pain in the Emergency Department: Prospective Study,” J. Med. Internet Res., vol. 22, no. 5, p. e18537, May 2020, doi: 10.2196/18537.
[107]	S. Lazarus, P. Moffatt, E. L. Duncan, and G. P. Thomas, “A brilliant breakthrough in OI type V,” Osteoporos Int, vol. 25, no. 2, pp. 399–405, Feb. 2014, doi: 10.1007/s00198-013-2465-8.
[108]	S. Gruskin and E. Kismödi, “A Call for (Renewed) Commitment to Sexual Health, Sexual Rights, and Sexual Pleasure: A Matter of Health and Well-Being,” Am J Public Health, vol. 110, no. 2, pp. 159–160, 2020, doi: 10.2105/AJPH.2019.305497.
[109]	T. S. Horowitz, J. Suls, and M. Treviño, “A Call for a Neuroscience Approach to Cancer-Related Cognitive Impairment,” Trends Neurosci., vol. 41, no. 8, pp. 493–496, 2018, doi: 10.1016/j.tins.2018.05.001.
[110]	O. Henning, K. A. Alfstad, K. O. Nakken, and M. I. Lossius, “A call for better information about epilepsy: The patients’ perspective-An online survey,” Seizure, vol. 69, pp. 173–179, Jul. 2019, doi: 10.1016/j.seizure.2019.04.015.
[111]	K. Tanaka, S. Shiotani, K. Fukuda, N. Morioka, Y. Yokoi, and O. Fujimura, “A case of an incision-related single-loop intra-atrial reentrant tachycardia showing an eccentric atrial activation sequence and widely separate potentials resembling a double-loop reentry; its mechanism and analysis,” HeartRhythm Case Rep, vol. 3, no. 8, pp. 402–406, Aug. 2017, doi: 10.1016/j.hrcr.2017.06.002.
[112]	L. Benato, M. R. Stoeckli, S. H. Smith, S. Dickson, K. L. Thoday, and A. Meredith, “A case of antibacterial-responsive mucocutaneous disease in a seven-year-old dwarf lop rabbit (Oryctolagus cuniculus) resembling mucocutaneous pyoderma of dogs,” J Small Anim Pract, vol. 54, no. 4, pp. 209–212, Apr. 2013, doi: 10.1111/jsap.12007.
[113]	S. H. Kim et al., “A case of ascending colonic xanthoma presenting as a lateral spreading tumor,” Intest Res, vol. 12, no. 2, pp. 162–165, Apr. 2014, doi: 10.5217/ir.2014.12.2.162.
[114]	S. Tanaka et al., “A case of Jackhammer esophagus caused by eosinophilic esophagitis in which per-oral endoscopic myotomy resulted in symptom improvement,” Clin J Gastroenterol, vol. 11, no. 5, pp. 377–381, Oct. 2018, doi: 10.1007/s12328-018-0868-y.
[115]	M. A. Eid and E. Sutton, “A Case of Non-Obstructive Afferent Loop Syndrome after Roux-en-Y Gastric Bypass,” Am Surg, vol. 84, no. 2, pp. 318–319, Feb. 2018.
[116]	K. Kano et al., “[A Case of Roux-en-Y Loop Reconstruction Using a Modified Aboral Pouch Technique for Y-Limb Obstruction Following Distal Gastrectomy],” Gan To Kagaku Ryoho, vol. 44, no. 10, pp. 929–931, Oct. 2017.
[117]	M. Maeda et al., “[A case of rupture of post-gastrectomy afferent loop obstruction due to invasion by pancreatic cancer],” Gan To Kagaku Ryoho, vol. 37, no. 12, pp. 2364–2366, Nov. 2010.
[118]	J. Liu et al., “A Case of Ruptured Aneurysm of the Proper Esophageal Artery with Symptomatic Mediastinal Hematoma,” Cardiovasc Intervent Radiol, vol. 39, no. 8, pp. 1199–1202, Aug. 2016, doi: 10.1007/s00270-016-1349-7.
[119]	J. M. Unrine et al., “A case-control study of trace-element status and lung cancer in Appalachian Kentucky,” PLoS ONE, vol. 14, no. 2, p. e0212340, 2019, doi: 10.1371/journal.pone.0212340.
[120]	L. S. Seidman, “A cash-equivalent option under ‘major-risk’ national health insurance,” Policy Anal, vol. 4, no. 1, pp. 123–127, 1978.
[121]	P. Bech and A. Allerup, “A categorical approach to depression by a three-dimensional system,” Psychopathology, vol. 19, no. 6, pp. 327–339, 1986, doi: 10.1159/000284457.
[122]	R. Admon, M. R. Milad, and T. Hendler, “A causal model of post-traumatic stress disorder: disentangling predisposed from acquired neural abnormalities,” Trends Cogn. Sci. (Regul. Ed.), vol. 17, no. 7, pp. 337–347, Jul. 2013, doi: 10.1016/j.tics.2013.05.005.
[123]	E. N. Naumova, “A cautionary note for population health: disproportionate emphasis on personal responsibility for health and wellbeing,” J Public Health Policy, vol. 35, no. 3, pp. 397–400, Aug. 2014, doi: 10.1057/jphp.2014.23.
[124]	F. L. Mayer, E. Sánchez-León, and J. W. Kronstad, “A chemical genetic screen reveals a role for proteostasis in capsule and biofilm formation by Cryptococcus neoformans,” Microb Cell, vol. 5, no. 11, pp. 495–510, Oct. 2018, doi: 10.15698/mic2018.11.656.
[125]	J. H. Erasmus et al., “A chikungunya fever vaccine utilizing an insect-specific virus platform,” Nat. Med., vol. 23, no. 2, pp. 192–199, Feb. 2017, doi: 10.1038/nm.4253.
[126]	W. Kerstens and P. Van Dijck, “A Cinderella story: how the vacuolar proteases Pep4 and Prb1 do more than cleaning up the cell’s mass degradation processes,” Microb Cell, vol. 5, no. 10, pp. 438–443, 18 2018, doi: 10.15698/mic2018.10.650.
[127]	D. Yu, H. Yan, J. Zhou, X. Yang, Y. Lu, and Y. Han, “A circuit view of deep brain stimulation in Alzheimer’s disease and the possible mechanisms,” Mol Neurodegener, vol. 14, no. 1, p. 33, 08 2019, doi: 10.1186/s13024-019-0334-4.
[128]	D. Krishnakumar, J. Mahendra, G. Ari, and R. Perumalsamy, “A clinical and histological evaluation of platelet-rich fibrin and CGF for root coverage procedure using coronally advanced flap: A split-mouth design,” Indian J Dent Res, vol. 30, no. 6, pp. 970–974, Dec. 2019, doi: 10.4103/ijdr.IJDR_16_18.
[129]	M. Zhang et al., “A clinical objective IMRT QA method based on portal dosimetry and electronic portal imager device (EPID) measurement,” Technol. Cancer Res. Treat., vol. 12, no. 2, pp. 145–150, Apr. 2013, doi: 10.7785/tcrt.2012.500314.
[130]	A. Piwowarczyk, P. Ottl, H.-C. Lauer, and T. Kuretzky, “A clinical report and overview of scientific studies and clinical procedures conducted on the 3M ESPE Lava All-Ceramic System,” J Prosthodont, vol. 14, no. 1, pp. 39–45, Mar. 2005, doi: 10.1111/j.1532-849X.2005.00003.x.
[131]	J. H. Estepp et al., “A clinically meaningful fetal hemoglobin threshold for children with sickle cell anemia during hydroxyurea therapy,” Am. J. Hematol., vol. 92, no. 12, pp. 1333–1339, Dec. 2017, doi: 10.1002/ajh.24906.
[132]	M. Bar, “A cognitive neuroscience hypothesis of mood and depression,” Trends Cogn. Sci. (Regul. Ed.), vol. 13, no. 11, pp. 456–463, Nov. 2009, doi: 10.1016/j.tics.2009.08.009.
[133]	S. Songkro, S. Pengmak, P. Seajung, D. Maneenuan, and N. Kaewnopparat, “A Cold Process Preparation of Vetiveria zizanioides (L.) Nash Oil Lotions using Simulgel FL as an Emulsifier,” Int J Pharm Compd, vol. 22, no. 5, pp. 424–432, Oct. 2018.
[134]	S. Chattopadhyaya, D. Chakravorty, and G. Basu, “A collective motion description of tubulin βT7 loop dynamics,” Biophys Physicobiol, vol. 16, pp. 264–273, 2019, doi: 10.2142/biophysico.16.0_264.
[135]	S.-H. Jwa, Y.-A. Kim, V.-B. Hoa, and I.-H. Hwang, “A combination of postmortem ageing and sous vide cooking following by blowtorching and oven roasting for improving the eating quality and acceptance of low quality grade Hanwoo striploin,” Asian-australas. J. Anim. Sci., vol. 33, no. 8, pp. 1339–1351, Aug. 2020, doi: 10.5713/ajas.19.0667.
[136]	J. C. Tan, C.-H. Chuah, and S.-F. Cheng, “A combined microwave pretreatment/solvent extraction process for the production of oil from palm fruit: optimisation, oil quality and effect of prolonged exposure,” J. Sci. Food Agric., vol. 97, no. 6, pp. 1784–1789, Apr. 2017, doi: 10.1002/jsfa.7975.
[137]	L. Huang and O. Jolliet, “A combined quantitative property-property relationship (QPPR) for estimating packaging-food and solid material-water partition coefficients of organic compounds,” Sci. Total Environ., vol. 658, pp. 493–500, Mar. 2019, doi: 10.1016/j.scitotenv.2018.12.062.
[138]	M. F. McDermott, “A common pathway in periodic fever syndromes,” Trends Immunol., vol. 25, no. 9, pp. 457–460, Sep. 2004, doi: 10.1016/j.it.2004.07.007.
[139]	C. Gu et al., “A comparable method to Gd-contrast enhancement in the preoperative evaluation of anal fistula,” Medicine (Baltimore), vol. 98, no. 44, p. e17807, Nov. 2019, doi: 10.1097/MD.0000000000017807.
[140]	T. M. Khlebodarova et al., “A comparative analysis of juvenile hormone metabolyzing enzymes in two species of Drosophila during development,” Insect Biochem. Mol. Biol., vol. 26, no. 8–9, pp. 829–835, Oct. 1996, doi: 10.1016/s0965-1748(96)00043-4.
[141]	K. Nakashima, “A comparative approach to decipher intestinal animal-microbe associations,” Microb Cell, vol. 5, no. 11, pp. 522–524, Oct. 2018, doi: 10.15698/mic2018.11.658.
[142]	M. Malkoun, J. Huber, and D. Huber, “A comparative assessment of interface pressures generated by four surgical theatre heel pressure ulcer prophylactics,” Int Wound J, vol. 9, no. 3, pp. 259–263, Jun. 2012, doi: 10.1111/j.1742-481X.2011.00865.x.
[143]	J. M. Bennett, “A comparative review of classification systems in myelodysplastic syndromes (MDS),” Semin. Oncol., vol. 32, no. 4 Suppl 5, pp. S3-10, Aug. 2005, doi: 10.1053/j.seminoncol.2005.06.021.
[144]	R. Chen et al., “A Comparative Review of Electrolytes for Organic-Material-Based Energy-Storage Devices Employing Solid Electrodes and Redox Fluids,” ChemSusChem, vol. 13, no. 9, pp. 2205–2219, May 2020, doi: 10.1002/cssc.201903382.
[145]	B. Kargul, I. Tanboga, and N. Gulman, “A comparative study of fissure sealants Helioseal Clear Chroma and Delton FS(+): 3 year results,” Eur Arch Paediatr Dent, vol. 10, no. 4, pp. 218–222, Dec. 2009, doi: 10.1007/BF03262685.
[146]	S. Chompootaweep, D. Reinprayoon, P. Virutamasen, A. Somboonsuk, and N. Dusitsin, “A comparative study of Lippes loop and Delta loop intrauterine devices in early postpartum,” Contraception, vol. 28, no. 5, pp. 399–404, Nov. 1983, doi: 10.1016/0010-7824(83)90072-0.
[147]	E. Liu and J. Shen, “A comparative study of metal pollution and potential eco-risk in the sediment of Chaohu Lake (China) based on total concentration and chemical speciation,” Environ Sci Pollut Res Int, vol. 21, no. 12, pp. 7285–7295, Jun. 2014, doi: 10.1007/s11356-014-2639-8.
[148]	A. Harris, H. Gundersen, P. M. Andreassen, E. Thun, B. Bjorvatn, and S. Pallesen, “A Comparative Study of Sleep and Mood Between Young Elite Athletes and Age-Matched Controls,” J Phys Act Health, vol. 14, no. 6, pp. 465–473, 2017, doi: 10.1123/jpah.2016-0513.
[149]	K. S. Ramulu, “A comparison of mutagenic effectiveness and efficiency of NMU and MNG in Sorghum,” Theor. Appl. Genet., vol. 42, no. 3, pp. 101–106, Jan. 1972, doi: 10.1007/BF00583410.
[150]	C. M. Houghton, A. A. Woodcock, and D. Singh, “A comparison of plethysmography, spirometry and oscillometry for assessing the pulmonary effects of inhaled ipratropium bromide in healthy subjects and patients with asthma,” Br J Clin Pharmacol, vol. 59, no. 2, pp. 152–159, Feb. 2005, doi: 10.1111/j.1365-2125.2004.2262.x.
[151]	P. Kourtesis, E. Margioti, C. Demenega, F. Christidi, and S. Abrahams, “A Comparison of the Greek ACE-III, M-ACE, ACE-R, MMSE, and ECAS in the Assessment and Identification of Alzheimer’s Disease,” J Int Neuropsychol Soc, pp. 1–10, Apr. 2020, doi: 10.1017/S1355617720000314.
[152]	D. E. Mayer and T. W. Purdue, “A compilation of Good Laboratory Practice questions and (where to get the) answers,” Qual Assur, vol. 4, no. 4, pp. 252–270, Dec. 1995.
[153]	Y. H. Park, C. W. Jeong, and S. E. Lee, “A comprehensive review of neuroanatomy of the prostate,” Prostate Int, vol. 1, no. 4, pp. 139–145, 2013, doi: 10.12954/PI.13020.
[154]	E. J. Stanford and M. F. R. Paraiso, “A comprehensive review of suburethral sling procedure complications,” J Minim Invasive Gynecol, vol. 15, no. 2, pp. 132–145, Apr. 2008, doi: 10.1016/j.jmig.2007.11.004.
[155]	B. Wahlang, J. T. Perkins, M. C. Petriello, J. B. Hoffman, A. J. Stromberg, and B. Hennig, “A compromised liver alters polychlorinated biphenyl-mediated toxicity,” Toxicology, vol. 380, pp. 11–22, 01 2017, doi: 10.1016/j.tox.2017.02.001.
[156]	S. Bernini et al., “A computer-based cognitive training in Mild Cognitive Impairment in Parkinson’s Disease,” NeuroRehabilitation, vol. 44, no. 4, pp. 555–567, 2019, doi: 10.3233/NRE-192714.
[157]	J. Zhang, L. Zhang, C. Lei, X. Huang, Y. Yang, and C. Yu, “A Concentration-Dependent Insulin Immobilization Behavior of Alkyl-Modified Silica Vesicles: The Impact of Alkyl Chain Length,” Langmuir, vol. 34, no. 17, pp. 5011–5019, 01 2018, doi: 10.1021/acs.langmuir.8b00377.
[158]	M. I. Liontiris and E. E. Mazokopakis, “A concise review of Hashimoto thyroiditis (HT) and the importance of iodine, selenium, vitamin D and gluten on the autoimmunity and dietary management of HT patients.Points that need more investigation,” Hell J Nucl Med, vol. 20, no. 1, pp. 51–56, Apr. 2017, doi: 10.1967/s002449910507.
[159]	Y. Xu, K. K. Lai, and W. K. J. Leung, “A consensus-based decision model for assessing the health systems,” PLoS ONE, vol. 15, no. 8, p. e0237892, Aug. 2020, doi: 10.1371/journal.pone.0237892.
[160]	Y. Shan et al., “A conserved protonation-dependent switch controls drug binding in the Abl kinase,” Proc. Natl. Acad. Sci. U.S.A., vol. 106, no. 1, pp. 139–144, Jan. 2009, doi: 10.1073/pnas.0811223106.
[161]	J. Bomyea, V. Risbrough, and A. J. Lang, “A consideration of select pre-trauma factors as key vulnerabilities in PTSD,” Clin Psychol Rev, vol. 32, no. 7, pp. 630–641, Nov. 2012, doi: 10.1016/j.cpr.2012.06.008.
[162]	M. H. Wahdan, C. Sérié, Y. Cerisier, S. Sallam, and R. Germanier, “A controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against typhoid: three-year results,” J. Infect. Dis., vol. 145, no. 3, pp. 292–295, Mar. 1982, doi: 10.1093/infdis/145.3.292.
[163]	“A controlled trial of 2-month, 3-month, and 12-month regimens of chemotherapy for sputum-smear-negative pulmonary tuberculosis. Results at 60 months,” Am. Rev. Respir. Dis., vol. 130, no. 1, pp. 23–28, Jul. 1984, doi: 10.1164/arrd.1984.130.1.23.
[164]	I. Cortés, T. S. Kaufman, and A. B. J. Bracca, “A convenient and eco-friendly cerium(III) chloride-catalysed synthesis of methoxime derivatives of aromatic aldehydes and ketones,” R Soc Open Sci, vol. 5, no. 5, p. 180279, May 2018, doi: 10.1098/rsos.180279.
[165]	S. Weidinger, H. Baurecht, and J. Schmitt, “A Critical Appraisal of the PETITE Study Report: Topical Corticosteroids Are Safe and Effective in the Long-term Treatment of Infantile Atopic Dermatitis,” Pediatrics, vol. 136, no. 5, p. e1485, Nov. 2015, doi: 10.1542/peds.2015-2785A.
[166]	B. Sørensen and D. Bevan, “A critical evaluation of cryoprecipitate for replacement of fibrinogen,” Br. J. Haematol., vol. 149, no. 6, pp. 834–843, Jun. 2010, doi: 10.1111/j.1365-2141.2010.08208.x.
[167]	M. Banovic, M. J. Reinders, A. Claret, L. Guerrero, and A. Krystallis, “A cross-cultural perspective on impact of health and nutrition claims, country-of-origin and eco-label on consumer choice of new aquaculture products,” Food Res. Int., vol. 123, pp. 36–47, 2019, doi: 10.1016/j.foodres.2019.04.031.
[168]	H. Aust et al., “A cross-sectional study on preoperative anxiety in adults,” J Psychosom Res, vol. 111, pp. 133–139, 2018, doi: 10.1016/j.jpsychores.2018.05.012.
[169]	L. G. Chepenik, T. T. Have, D. Oslin, C. Datto, C. Zubritsky, and I. R. Katz, “A daily diary study of late-life depression,” Am J Geriatr Psychiatry, vol. 14, no. 3, pp. 270–279, Mar. 2006, doi: 10.1097/01.JGP.0000194644.63245.42.
[170]	A. Coppola et al., “A de novo 11p12-p15.4 duplication in a patient with pharmacoresistant epilepsy, mental retardation, and dysmorphisms,” Brain Dev., vol. 32, no. 3, pp. 248–252, Mar. 2010, doi: 10.1016/j.braindev.2009.01.003.
[171]	J. Mitchell et al., “A decision analytic approach to exposure-based chemical prioritization,” PLoS ONE, vol. 8, no. 8, p. e70911, 2013, doi: 10.1371/journal.pone.0070911.
[172]	R. C. McIlroy and N. A. Stanton, “A decision ladder analysis of eco-driving: the first step towards fuel-efficient driving behaviour,” Ergonomics, vol. 58, no. 6, pp. 866–882, 2015, doi: 10.1080/00140139.2014.997807.
[173]	K. G. White and R. J. Sargisson, “A delay-specific differential outcomes effect in delayed matching to sample,” Learn Behav, vol. 43, no. 3, pp. 217–227, Sep. 2015, doi: 10.3758/s13420-015-0174-1.
[174]	G. S. Raynor and M. E. Smith, “A DIFFUSION-DEPOSITION TRACER SYSTEM. BNL 859 (T-343),” Tech Rep Brookhaven Natl Lab, vol. 23, pp. 1–17, Apr. 1964.
[175]	G. Narayanasamy, D. Desai, S. Maraboyina, J. Penagaricano, R. Zwicker, and E. L. Johnson, “A Dose Falloff Gradient Study in RapidArc Planning of Lung Stereotactic Body Radiation Therapy,” J Med Phys, vol. 43, no. 3, pp. 147–154, Sep. 2018, doi: 10.4103/jmp.JMP_38_18.
[176]	Y. Kawai et al., “A double blind randomized clinical trial comparing lingualized and fully bilateral balanced posterior occlusion for conventional complete dentures,” J Prosthodont Res, vol. 61, no. 2, pp. 113–122, Apr. 2017, doi: 10.1016/j.jpor.2016.07.003.
[177]	T. Burki, “A dusty business,” Lancet Infect Dis, vol. 12, no. 6, pp. 434–435, Jun. 2012, doi: 10.1016/s1473-3099(12)70127-5.
[178]	A. L. Richards, R. C. Cook, G. Bolotin, and G. D. Buckner, “A dynamic heart system to facilitate the development of mitral valve repair techniques,” Ann Biomed Eng, vol. 37, no. 4, pp. 651–660, Apr. 2009, doi: 10.1007/s10439-009-9653-x.
[179]	M. A. Smith, W. K. Phillips, P. L. Rabin, and R. J. Johnson, “A dynamic loop provides dual control over the catalytic and membrane binding activity of a bacterial serine hydrolase,” Biochim Biophys Acta Proteins Proteom, vol. 1866, no. 9, pp. 925–932, 2018, doi: 10.1016/j.bbapap.2018.05.012.
[180]	M. E. Halse and P. T. Callaghan, “A dynamic nuclear polarization strategy for multi-dimensional Earth’s field NMR spectroscopy,” J. Magn. Reson., vol. 195, no. 2, pp. 162–168, Dec. 2008, doi: 10.1016/j.jmr.2008.09.007.
[181]	A. Katz and L. McGee, “A Fall From Grace?,” Oncol Nurs Forum, vol. 46, no. 1, pp. 9–10, 13 2019, doi: 10.1188/19.ONF.9-10.
[182]	N. J. Keuthen, E. M. Altenburger, and D. Pauls, “A family study of trichotillomania and chronic hair pulling,” Am. J. Med. Genet. B Neuropsychiatr. Genet., vol. 165B, no. 2, pp. 167–174, Mar. 2014, doi: 10.1002/ajmg.b.32218.
[183]	A. Bentley et al., “A feed restriction milieu for Pekin meat ducks that may improve gait characteristics but also affects gut leakiness,” Poult. Sci., vol. 99, no. 1, pp. 39–47, Jan. 2020, doi: 10.3382/ps/pez551.
[184]	C.-C. Li and L. Rew, “A feminist perspective on sexuality and body image in females with colorectal cancer: an integrative review,” J Wound Ostomy Continence Nurs, vol. 37, no. 5, pp. 519–525, Oct. 2010, doi: 10.1097/WON.0b013e3181edac2c.
[185]	A. Rajgopal, K. Aggarwal, and S. Kumar, “A Five-Year Comparative Functional and Clinical Evaluation of Two Contemporary Cruciate-Retaining Knee Implants,” Arthroplast Today, vol. 6, no. 3, pp. 369–377, Sep. 2020, doi: 10.1016/j.artd.2020.05.009.
[186]	S. Kita et al., “A Follow-Up Study on the Continuity and Spillover Effects of Intimate Partner Violence During Pregnancy on Postnatal Child Abuse,” J Interpers Violence, p. 886260518821460, Jan. 2019, doi: 10.1177/0886260518821460.
[187]	I. Acharya, J. Van Tuyl, J. de Lange, and C. Quenneville, “A Force-Sensing Insole to Quantify Impact Loading to the Foot,” J Biomech Eng, Nov. 2018, doi: 10.1115/1.4041902.
[188]	W. Wu, M. R. Long, X. Zhang, J. L. Reed, and C. T. Maravelias, “A framework for the identification of promising bio-based chemicals,” Biotechnol. Bioeng., vol. 115, no. 9, pp. 2328–2340, 2018, doi: 10.1002/bit.26779.
[189]	C. Massari, “A general guide for conducting in-process inspections,” Qual Assur, vol. 6, no. 2, pp. 97–105, Jun. 1998, doi: 10.1080/105294199277897.
[190]	K. E. Emblem et al., “A generic support vector machine model for preoperative glioma survival associations,” Radiology, vol. 275, no. 1, pp. 228–234, Apr. 2015, doi: 10.1148/radiol.14140770.
[191]	H. K. Hamdi and R. Castellon, “A genetic variant of ACE increases cell survival: a new paradigm for biology and disease,” Biochem. Biophys. Res. Commun., vol. 318, no. 1, pp. 187–191, May 2004, doi: 10.1016/j.bbrc.2004.04.004.
[192]	C. A. McKenzie et al., “A genome-wide search replicates evidence of a quantitative trait locus for circulating angiotensin I-converting enzyme (ACE) unlinked to the ACE gene,” BMC Med Genomics, vol. 1, p. 23, Jun. 2008, doi: 10.1186/1755-8794-1-23.
[193]	G. Zara, “A giant spinal cord cavity,” Arch. Neurol., vol. 66, no. 10, pp. 1294–1295, Oct. 2009, doi: 10.1001/archneurol.2009.220.
[194]	S. A. Touati and F. Uhlmann, “A global view of substrate phosphorylation and dephosphorylation during budding yeast mitotic exit,” Microb Cell, vol. 5, no. 8, pp. 389–392, Jul. 2018, doi: 10.15698/mic2018.08.644.
[195]	D. Yuan, X. Yang, and J.-C. Guo, “A great honor and a huge challenge for China: You-you TU getting the Nobel Prize in Physiology or Medicine,” J Zhejiang Univ Sci B, vol. 17, no. 5, pp. 405–408, May 2016, doi: 10.1631/jzus.B1600094.
[196]	M. Moayeri et al., “A heterodimer of a VHH (variable domains of camelid heavy chain-only) antibody that inhibits anthrax toxin cell binding linked to a VHH antibody that blocks oligomer formation is highly protective in an anthrax spore challenge model,” J. Biol. Chem., vol. 290, no. 10, pp. 6584–6595, Mar. 2015, doi: 10.1074/jbc.M114.627943.
[197]	J. König and M. Köckerling, “A Hexanuclear Niobium Cluster Compound Crystallizing as Macroscopic Tubes,” Chemistry, vol. 25, no. 61, pp. 13905–13910, Nov. 2019, doi: 10.1002/chem.201902481.
[198]	V. C. Sandulache, D. C. Wilde, E. M. Sturgis, E. Y. Chiao, and A. G. Sikora, “A Hidden Epidemic of ‘Intermediate Risk’ Oropharynx Cancer,” Laryngoscope Investig Otolaryngol, vol. 4, no. 6, pp. 617–623, Dec. 2019, doi: 10.1002/lio2.316.
[199]	E. K. Hanson and J. Ballantyne, “A highly discriminating 21 locus Y-STR ‘megaplex’ system designed to augment the minimal haplotype loci for forensic casework,” J. Forensic Sci., vol. 49, no. 1, pp. 40–51, Jan. 2004.
[200]	M.-A. Crocq, “A history of anxiety: from Hippocrates to DSM,” Dialogues Clin Neurosci, vol. 17, no. 3, pp. 319–325, Sep. 2015.
[201]	W. K. Saadawi, T. Shaibi, and B. B. Annajar, “A human case of urogenital myiasis caused by Psychoda sp. larvae in Tripoli, Libya,” Ann Parasitol, vol. 63, no. 1, pp. 69–71, 2017, doi: 10.17420/ap6301.88.
[202]	J. M. Coronas-Serna, T. Fernández-Acero, M. Molina, and V. J. Cid, “A humanized yeast-based toolkit for monitoring phosphatidylinositol 3-kinase activity at both single cell and population levels,” Microb Cell, vol. 5, no. 12, pp. 545–554, Nov. 2018, doi: 10.15698/mic2018.12.660.
[203]	H. J. Faust et al., “A hyaluronic acid binding peptide-polymer system for treating osteoarthritis,” Biomaterials, vol. 183, pp. 93–101, 2018, doi: 10.1016/j.biomaterials.2018.08.045.
[204]	A. Singh, P. Li, V. Beachley, P. McDonnell, and J. H. Elisseeff, “A hyaluronic acid-binding contact lens with enhanced water retention,” Cont Lens Anterior Eye, vol. 38, no. 2, pp. 79–84, Apr. 2015, doi: 10.1016/j.clae.2014.09.002.
[205]	“A journey through 90 years of the Weekly Epidemiological Record,” Wkly. Epidemiol. Rec., vol. 91, no. 13, pp. 169–176, Apr. 2016.
[206]	A. Kushki, A. Khan, J. Brian, and E. Anagnostou, “A Kalman filtering framework for physiological detection of anxiety-related arousal in children with autism spectrum disorder,” IEEE Trans Biomed Eng, vol. 62, no. 3, pp. 990–1000, Mar. 2015, doi: 10.1109/TBME.2014.2377555.
[207]	R. F. Díaz, “A key piece in the exoplanet puzzle,” Nature, vol. 563, no. 7731, pp. 329–330, 2018, doi: 10.1038/d41586-018-07328-7.
[208]	E. A. Coutsias, C. Seok, M. P. Jacobson, and K. A. Dill, “A kinematic view of loop closure,” J Comput Chem, vol. 25, no. 4, pp. 510–528, Mar. 2004, doi: 10.1002/jcc.10416.
[209]	A. Ferramosca, L. Conte, and V. Zara, “A krill oil supplemented diet reduces the activities of the mitochondrial tricarboxylate carrier and of the cytosolic lipogenic enzymes in rats,” J Anim Physiol Anim Nutr (Berl), vol. 96, no. 2, pp. 295–306, Apr. 2012, doi: 10.1111/j.1439-0396.2011.01135.x.
[210]	J. Ju, W. Zhang, Y. Zhou, and J. Zhang, “A large-size horn antenna for X-band high power microwave radiations,” Rev Sci Instrum, vol. 90, no. 2, p. 026101, Feb. 2019, doi: 10.1063/1.5082213.
[211]	B. M. Langolf and G. T. Kleinheinz, “A lava rock-based biofilter for the treatment of alpha-pinene,” Bioresour. Technol., vol. 97, no. 15, pp. 1951–1958, Oct. 2006, doi: 10.1016/j.biortech.2005.08.006.
[212]	U. Kipka and D. M. Di Toro, “A linear solvation energy relationship model of organic chemical partitioning to dissolved organic carbon,” Environ. Toxicol. Chem., vol. 30, no. 9, pp. 2023–2029, Sep. 2011, doi: 10.1002/etc.610.
[213]	U. Kipka and D. M. Di Toro, “A linear solvation energy relationship model of organic chemical partitioning to particulate organic carbon in soils and sediments,” Environ. Toxicol. Chem., vol. 30, no. 9, pp. 2013–2022, Sep. 2011, doi: 10.1002/etc.611.
[214]	G. Thanassoulis, A. D. Sniderman, and M. J. Pencina, “A Long-term Benefit Approach vs Standard Risk-Based Approaches for Statin Eligibility in Primary Prevention,” JAMA Cardiol, vol. 3, no. 11, pp. 1090–1095, 01 2018, doi: 10.1001/jamacardio.2018.3476.
[215]	G. Zara and D. P. Farrington, “A longitudinal analysis of early risk factors for adult-onset offending: What predicts a delayed criminal career?,” Crim Behav Ment Health, vol. 20, no. 4, pp. 257–273, Oct. 2010, doi: 10.1002/cbm.763.
[216]	M. J. Gray, E. E. Bolton, and B. T. Litz, “A longitudinal analysis of PTSD symptom course: delayed-onset PTSD in Somalia peacekeepers,” J Consult Clin Psychol, vol. 72, no. 5, pp. 909–913, Oct. 2004, doi: 10.1037/0022-006X.72.5.909.
[217]	S. T. Silverstein and D. Kritz-Silverstein, “A longitudinal study of stress in first-year dental students,” J Dent Educ, vol. 74, no. 8, pp. 836–848, Aug. 2010.
[218]	W. O. Gross and C. Müller, “A mechanical momentum in ultrastructural development of the heart,” Cell Tissue Res., vol. 178, no. 4, pp. 483–494, Mar. 1977, doi: 10.1007/BF00219570.
[219]	J. L. Vardy et al., “A mechanistic cohort study evaluating cognitive impairment in women treated for breast cancer,” Brain Imaging Behav, vol. 13, no. 1, pp. 15–26, Feb. 2019, doi: 10.1007/s11682-017-9728-5.
[220]	D. Ben Amara and H. Chen, “A mediation-moderation model of environmental and eco-innovation orientation for sustainable business growth,” Environ Sci Pollut Res Int, vol. 27, no. 14, pp. 16916–16928, May 2020, doi: 10.1007/s11356-020-08206-4.
[221]	R. D. Cohen, D. M. Woseth, R. A. Thisted, and S. B. Hanauer, “A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis,” Am. J. Gastroenterol., vol. 95, no. 5, pp. 1263–1276, May 2000, doi: 10.1111/j.1572-0241.2000.01940.x.
[222]	A. J. Larner and A. J. Mitchell, “A meta-analysis of the accuracy of the Addenbrooke’s Cognitive Examination (ACE) and the Addenbrooke’s Cognitive Examination-Revised (ACE-R) in the detection of dementia,” Int Psychogeriatr, vol. 26, no. 4, pp. 555–563, Apr. 2014, doi: 10.1017/S1041610213002329.
[223]	N. Abraham et al., “A Meta-Analysis of the Rates of Suicide Ideation, Attempts and Deaths in People with Epilepsy,” Int J Environ Res Public Health, vol. 16, no. 8, 24 2019, doi: 10.3390/ijerph16081451.
[224]	D. C. Walker, E. K. White, and V. J. Srinivasan, “A meta-analysis of the relationships between body checking, body image avoidance, body image dissatisfaction, mood, and disordered eating,” Int J Eat Disord, vol. 51, no. 8, pp. 745–770, 2018, doi: 10.1002/eat.22867.
[225]	K. Byron and S. Khazanchi, “A meta-analytic investigation of the relationship of state and trait anxiety to performance on figural and verbal creative tasks,” Pers Soc Psychol Bull, vol. 37, no. 2, pp. 269–283, Feb. 2011, doi: 10.1177/0146167210392788.
[226]	M. A. Gaddy and R. E. Ingram, “A meta-analytic review of mood-congruent implicit memory in depressed mood,” Clin Psychol Rev, vol. 34, no. 5, pp. 402–416, Jul. 2014, doi: 10.1016/j.cpr.2014.06.001.
[227]	A. D. Tagalakis et al., “A method for concentrating lipid peptide DNA and siRNA nanocomplexes that retains their structure and transfection efficiency,” Int J Nanomedicine, vol. 10, pp. 2673–2683, 2015, doi: 10.2147/IJN.S78935.
[228]	P. Lalezari, R. Lekhraj, and D. Casper, “A method for concentrating organic dyes: colorimetric measurements of nitric oxides and sialic acids,” Anal. Biochem., vol. 416, no. 1, pp. 92–99, Sep. 2011, doi: 10.1016/j.ab.2011.04.042.
[229]	R. L. Brinster, “A METHOD FOR IN VITRO CULTIVATION OF MOUSE OVA FROM TWO-CELL TO BLASTOCYST,” Exp. Cell Res., vol. 32, pp. 205–208, Oct. 1963, doi: 10.1016/0014-4827(63)90093-4.
[230]	M. Leißing, M. Winter, S. Wiemers-Meyer, and S. Nowak, “A method for quantitative analysis of gases evolving during formation applied on LiNi0.6Mn0.2Co0.2O2 ∣∣ natural graphite lithium ion battery cells using gas chromatography - barrier discharge ionization detector,” J Chromatogr A, vol. 1622, p. 461122, Jul. 2020, doi: 10.1016/j.chroma.2020.461122.
[231]	P. L. Davis, G. L. Raff, and S. A. Glantz, “A method to identify implanted radiopaque markers despite rotation of the heart,” Am. J. Physiol., vol. 239, no. 4, pp. H573–H580, Oct. 1980, doi: 10.1152/ajpheart.1980.239.4.H573.
[232]	M. S. Swanson, E. Fernandez-Moreira, and E. Fernandez-Moreia, “A microbial strategy to multiply in macrophages: the pregnant pause,” Traffic, vol. 3, no. 3, pp. 170–177, Mar. 2002, doi: 10.1034/j.1600-0854.2002.030302.x.
[233]	C. Drögemüller et al., “A missense mutation in the SERPINH1 gene in Dachshunds with osteogenesis imperfecta,” PLoS Genet., vol. 5, no. 7, p. e1000579, Jul. 2009, doi: 10.1371/journal.pgen.1000579.
[234]	M. González-Forero, T. Faulwasser, and L. Lehmann, “A model for brain life history evolution,” PLoS Comput. Biol., vol. 13, no. 3, p. e1005380, 2017, doi: 10.1371/journal.pcbi.1005380.
[235]	D. J. Pender, “A model of viscoelastoplasticity in the cochleo-saccular membranes,” Laryngoscope Investig Otolaryngol, vol. 4, no. 6, pp. 659–662, Dec. 2019, doi: 10.1002/lio2.318.
[236]	A. A. Inamdar, J. C. Moore, R. I. Cohen, and J. W. Bennett, “A model to evaluate the cytotoxicity of the fungal volatile organic compound 1-octen-3-ol in human embryonic stem cells,” Mycopathologia, vol. 173, no. 1, pp. 13–20, Jan. 2012, doi: 10.1007/s11046-011-9457-z.
[237]	O. A. Trowell, “A modified technique for organ culture in vitro,” Exp. Cell Res., vol. 6, no. 1, pp. 246–248, Feb. 1954, doi: 10.1016/0014-4827(54)90169-x.
[238]	G. Windisch, H. Clement, W. Grechenig, N. P. Tesch, and W. Pichler, “A morphometrical study of the medullary cavity of the ulna referred to intramedullary nailing,” Surg Radiol Anat, vol. 29, no. 1, pp. 47–53, Feb. 2007, doi: 10.1007/s00276-006-0170-4.
[239]	G. Zhao, L. Xie, Y. Xu, and Q. Cheng, “A Multicenter Cross-sectional Study on the Prevalence and Impact Factors of Hysteria Tendency in the Eastern Chinese Adolescents,” Iran. J. Public Health, vol. 47, no. 12, pp. 1854–1864, Dec. 2018.
[240]	A. Carlin, “A multidisciplinary, science-based approach to the economics of climate change,” Int J Environ Res Public Health, vol. 8, no. 4, pp. 985–1031, 2011, doi: 10.3390/ijerph8040985.
[241]	T. Qarni and A. Salardini, “A Multifactor Approach to Mild Cognitive Impairment,” Semin Neurol, vol. 39, no. 2, pp. 179–187, Apr. 2019, doi: 10.1055/s-0039-1678585.
[242]	M. Thonnus, A. Guérin, and L. Rivière, “A multigene family encoding surface glycoproteins in Trypanosoma congolense,” Microb Cell, vol. 4, no. 3, pp. 90–97, Mar. 2017, doi: 10.15698/mic2017.03.562.
[243]	T. Yonekawa et al., “A nationwide survey of hypertrophic pachymeningitis in Japan,” J. Neurol. Neurosurg. Psychiatry, vol. 85, no. 7, pp. 732–739, Jul. 2014, doi: 10.1136/jnnp-2013-306410.
[244]	P. J. Jones, P. Mair, B. C. Riemann, B. L. Mugno, and R. J. McNally, “A network perspective on comorbid depression in adolescents with obsessive-compulsive disorder,” J Anxiety Disord, vol. 53, pp. 1–8, 2018, doi: 10.1016/j.janxdis.2017.09.008.
[245]	S. Tanskul, K. Amornthatree, and N. Jaturonlak, “A new cellulose-producing bacterium, Rhodococcus sp. MI 2: screening and optimization of culture conditions,” Carbohydr Polym, vol. 92, no. 1, pp. 421–428, Jan. 2013, doi: 10.1016/j.carbpol.2012.09.017.
[246]	E. Frank, “A new chapter in the history of depression,” Eur Neuropsychopharmacol, vol. 22 Suppl 3, p. S475, 2012, doi: 10.1016/j.euroneuro.2012.06.017.
[247]	“A new definition for oral health developed by the FDI World Dental Federation opens the door to a universal definition of oral health,” Br Dent J, vol. 223, no. 3, p. 203, 11 2017, doi: 10.1038/sj.bdj.2017.670.
[248]	S. Wang, Z. Peng, D. Fang, and S. Chen, “A new Dirac nodal-ring semimetal made of 3D cross-linked graphene networks as lithium ion battery anode materials,” Nanoscale, vol. 12, no. 24, pp. 12985–12992, Jun. 2020, doi: 10.1039/d0nr01674h.
[249]	C. Hedberg-Oldfors et al., “A new early-onset neuromuscular disorder associated with kyphoscoliosis peptidase (KY) deficiency,” Eur. J. Hum. Genet., vol. 24, no. 12, pp. 1771–1777, 2016, doi: 10.1038/ejhg.2016.98.
[250]	S. McMahon and M. Ivarsson, “A New Frontier for Palaeobiology: Earth’s Vast Deep Biosphere,” Bioessays, vol. 41, no. 8, p. e1900052, 2019, doi: 10.1002/bies.201900052.
[251]	J. Obergasteiger, G. Frapporti, P. P. Pramstaller, A. A. Hicks, and M. Volta, “A new hypothesis for Parkinson’s disease pathogenesis: GTPase-p38 MAPK signaling and autophagy as convergence points of etiology and genomics,” Mol Neurodegener, vol. 13, no. 1, p. 40, 02 2018, doi: 10.1186/s13024-018-0273-5.
[252]	P. Liu, Z. Mu, W. Li, Y. Wu, and X. Li, “A new mathematical model and experimental validation on foamy-oil flow in developing heavy oil reservoirs,” Sci Rep, vol. 7, no. 1, p. 8534, 17 2017, doi: 10.1038/s41598-017-08882-2.
[253]	H. Xiaogeng, Z. Hongxing, Y. Qinghua, J. Haiyue, and Z. Yanyong, “A new method for correcting type I and type II constricted (cup and lop) ears,” Aesthetic Plast Surg, vol. 30, no. 4, pp. 449–454, Aug. 2006, doi: 10.1007/s00266-005-0011-6.
[254]	P. K. Eide, “A new method for processing of continuous intracranial pressure signals,” Med Eng Phys, vol. 28, no. 6, pp. 579–587, Jul. 2006, doi: 10.1016/j.medengphy.2005.09.008.
[255]	X. Wang, Y. Cao, X. Zhong, and P. Gao, “A new method of regional eco-environmental quality assessment and its application,” J. Environ. Qual., vol. 41, no. 5, pp. 1393–1401, Oct. 2012, doi: 10.2134/jeq2011.0390.
[256]	T. Kawada, M. Nakazawa, and T. Toyo-oka, “[A new paradigm for the progression of advanced heart failure],” Nippon Yakurigaku Zasshi, vol. 123, no. 2, pp. 55–62, Feb. 2004, doi: 10.1254/fpj.123.55.
[257]	A. Stigebrandt, L. Rahm, L. Viktorsson, M. Odalen, P. O. J. Hall, and B. Liljebladh, “A new phosphorus paradigm for the Baltic proper,” Ambio, vol. 43, no. 5, pp. 634–643, Sep. 2014, doi: 10.1007/s13280-013-0441-3.
[258]	P. Gallardo, S. Salas-Pino, and R. R. Daga, “A new role for the nuclear basket network,” Microb Cell, vol. 4, no. 12, pp. 423–425, Nov. 2017, doi: 10.15698/mic2017.12.604.
[259]	H. Broström, U. Hellström, S. Hammarström, N. Obel, and P. Perlmann, “A new surface marker on equine peripheral blood lymphocytes. I. Subpopulations of lymphocytes with receptors for Helix pomatia A hemagglutinin (HP),” Vet. Immunol. Immunopathol., vol. 8, no. 1–2, pp. 35–46, Jan. 1985, doi: 10.1016/0165-2427(85)90108-4.
[260]	H. Broström, U. Hellström, I. Ziverts, N. Obel, and P. Perlmann, “A new surface marker on equine peripheral blood lymphocytes. II. Characterization and separation of purified blood lymphocytes with receptors for Helix pomatia A hemagglutinin (HP),” Vet. Immunol. Immunopathol., vol. 8, no. 1–2, pp. 47–61, Jan. 1985, doi: 10.1016/0165-2427(85)90109-6.
[261]	W. van de Meugheuvel, G. van Seventer, and P. Demant, “A new Tla region antigen Qa-11, similar to Qa-2 and associated with B-type beta 2-microglobulin,” J. Immunol., vol. 134, no. 4, pp. 2507–2512, Apr. 1985.
[262]	G. Guglielmi, “A new way to capture the brain’s electrical symphony,” Nature, vol. 561, no. 7723, pp. 300–302, 2018, doi: 10.1038/d41586-018-06694-6.
[263]	S. Bayram, L. Mert, F. B. Anarat, M. Chodza, and Ö. N. Ergin, “A Newborn with Multiple Fractures in Osteogenesis Imperfecta: A Case Report,” J Orthop Case Rep, vol. 8, no. 3, pp. 71–73, Jun. 2018, doi: 10.13107/jocr.2250-0685.1116.
[264]	M. Danis and D. Richard-Lenoble, “[A Nobel Prize in Medicine 2015 for tropical countries: ivermectin, an antiparasitic drug undeniable against filariasis],” Med Sci (Paris), vol. 32, no. 1, pp. 110–115, Jan. 2016, doi: 10.1051/medsci/20163201018.
[265]	K. Gong, L. Zhao, J. Guo, and Z. Wang, “A nomogram to predict cognitive impairment after supratentorial spontaneous intracranial hematoma in adult patients: A retrospective cohort study,” Medicine (Baltimore), vol. 98, no. 42, p. e17626, Oct. 2019, doi: 10.1097/MD.0000000000017626.
[266]	T. Masuda, Y. Ito, T. Terada, T. Shibata, and T. Mikawa, “A non-canonical DNA structure enables homologous recombination in various genetic systems,” J. Biol. Chem., vol. 284, no. 44, pp. 30230–30239, Oct. 2009, doi: 10.1074/jbc.M109.043810.
[267]	M. Weill, P. Fort, A. Berthomieu, M. P. Dubois, N. Pasteur, and M. Raymond, “A novel acetylcholinesterase gene in mosquitoes codes for the insecticide target and is non-homologous to the ace gene in Drosophila,” Proc. Biol. Sci., vol. 269, no. 1504, pp. 2007–2016, Oct. 2002, doi: 10.1098/rspb.2002.2122.
[268]	K. Timberlake, A. Roubal, K. Hatchell, B. Catlin, and P. Remington, “A Novel Approach for Measuring and Communicating State Health Trends Over Time,” WMJ, vol. 114, no. 6, pp. 240–246, Dec. 2015.
[269]	G. Åvall and P. Johansson, “A novel approach to ligand-exchange rates applied to lithium-ion battery and sodium-ion battery electrolytes,” J Chem Phys, vol. 152, no. 23, p. 234104, Jun. 2020, doi: 10.1063/5.0005397.
[270]	N. Totani, A. Morita, M. Nishinaka, S. Tateishi, and H. Kida, “A novel body weight-loss promoting oil prepared with vegetable protein,” J Oleo Sci, vol. 59, no. 1, pp. 41–48, 2010, doi: 10.5650/jos.59.41.
[271]	X. Ding et al., “A novel daily QA system for proton therapy,” J Appl Clin Med Phys, vol. 14, no. 2, p. 4058, Mar. 2013, doi: 10.1120/jacmp.v14i2.4058.
[272]	B. M. Fathalla, A. M. Al-Wahadneh, M. Al-Mutawa, M. Kambouris, and H. El-Shanti, “A novel de novo PSTPIP1 mutation in a boy with pyogenic arthritis, pyoderma gangrenosum, acne (PAPA) syndrome,” Clin. Exp. Rheumatol., vol. 32, no. 6, pp. 956–958, Dec. 2014.
[273]	S. Trova et al., “A Novel Heme Pocket Hemoglobin Variant Associated with Normal Hematology: Hb Zara or α91(FG3)Leu→Ile (α2) (HBA2: c.274C > A),” Hemoglobin, vol. 39, no. 6, pp. 427–429, 2015, doi: 10.3109/03630269.2015.1071270.
[274]	B. Arif et al., “A novel homozygous KY variant causing a complex neurological disorder,” Eur J Med Genet, p. 104031, Aug. 2020, doi: 10.1016/j.ejmg.2020.104031.
[275]	M. P. Martin et al., “A novel mechanism by which small molecule inhibitors induce the DFG flip in Aurora A,” ACS Chem. Biol., vol. 7, no. 4, pp. 698–706, Apr. 2012, doi: 10.1021/cb200508b.
[276]	S. Gupta, P. Ylä-Anttila, and M. G. Masucci, “A novel mechanism for regulation of the type I IFN response by herpesvirus deconjugases,” Microb Cell, vol. 5, no. 5, pp. 259–261, Apr. 2018, doi: 10.15698/mic2018.05.633.
[277]	J. E. Gilmour et al., “A novel method for the purification of HIV-1 p24 protein from hybrid Ty virus-like particles (Ty-VLPs),” AIDS, vol. 3, no. 11, pp. 717–723, Nov. 1989, doi: 10.1097/00002030-198911000-00005.
[278]	T. Budsamongkol, N. Intarak, T. Theerapanon, S. Yodsanga, T. Porntaveetus, and V. Shotelersuk, “A novel mutation in COL1A2 leads to osteogenesis imperfecta/Ehlers-Danlos overlap syndrome with brachydactyly,” Genes Dis, vol. 6, no. 2, pp. 138–146, Jun. 2019, doi: 10.1016/j.gendis.2019.03.001.
[279]	T. S. Kuroda et al., “A novel nucleolar protein, PAPA-1, induces growth arrest as a result of cell cycle arrest at the G1 phase,” Gene, vol. 340, no. 1, pp. 83–98, Sep. 2004, doi: 10.1016/j.gene.2004.05.025.
[280]	T. Kawada, F. Masui, H. Kumagai, M. Koshimizu, M. Nakazawa, and T. Toyo-Oka, “A novel paradigm for therapeutic basis of advanced heart failure--assessment by gene therapy,” Pharmacol. Ther., vol. 107, no. 1, pp. 31–43, Jul. 2005, doi: 10.1016/j.pharmthera.2004.12.006.
[281]	T. Kanda et al., “A novel predictor of clinical outcomes in patients with heart failure with preserved left-ventricular ejection fraction: a pilot study,” Heart Vessels, vol. 33, no. 12, pp. 1490–1495, Dec. 2018, doi: 10.1007/s00380-018-1211-8.
[282]	H. P. Too, J. L. Cordova, and J. E. Maggio, “A novel radioimmunoassay for neuromedin K. I. Absence of neuromedin K-like immunoreactivity in guinea pig ileum and urinary bladder. II. Heterogeneity of tachykinins in guinea pig tissues,” Regul. Pept., vol. 26, no. 2, pp. 93–105, Oct. 1989, doi: 10.1016/0167-0115(89)90001-3.
[283]	T. Sawabe, T. Chiba, A. Kobayashi, K. Nagasaka, K. Aihara, and A. Takaya, “A novel soluble guanylate cyclase activator with reduced risk of hypotension by short-acting vasodilation,” Pharmacol Res Perspect, vol. 7, no. 2, p. e00463, 2019, doi: 10.1002/prp2.463.
[284]	A. Giannakas, A. Patsaoura, N.-M. Barkoula, and A. Ladavos, “A novel solution blending method for using olive oil and corn oil as plasticizers in chitosan based organoclay nanocomposites,” Carbohydr Polym, vol. 157, pp. 550–557, Feb. 2017, doi: 10.1016/j.carbpol.2016.10.020.
[285]	T. Suhm et al., “A novel system to monitor mitochondrial translation in yeast,” Microb Cell, vol. 5, no. 3, pp. 158–164, Jan. 2018, doi: 10.15698/mic2018.03.621.
[286]	A. Das et al., “A novel triazole, NMK-T-057, induces autophagic cell death in breast cancer cells by inhibiting γ-secretase-mediated activation of Notch signaling,” J. Biol. Chem., vol. 294, no. 17, pp. 6733–6750, 26 2019, doi: 10.1074/jbc.RA119.007671.
[287]	A. S. Yu, T. L. Fowler, and P. Dubrowski, “A novel-integrated quality assurance phantom for radiographic and nonradiographic radiotherapy localization and positioning systems,” Med Phys, vol. 45, no. 7, pp. 2857–2863, Jul. 2018, doi: 10.1002/mp.12950.
[288]	C. Burkhardt, L. E. Borg, G. A. Brennecka, Q. R. Shollenberger, N. Dauphas, and T. Kleine, “A nucleosynthetic origin for the Earth’s anomalous (142)Nd composition,” Nature, vol. 537, no. 7620, pp. 394–398, 15 2016, doi: 10.1038/nature18956.
[289]	J. B. Cooper-Sood, C. Chan, and C. S. Cho, “A Paper-Based Car Seat Safety Educational Intervention in the Pediatric Emergency Department,” Pediatr Emerg Care, Apr. 2019, doi: 10.1097/PEC.0000000000001808.
[290]	E. G. Lakatta, “A paradigm shift for the heart’s pacemaker,” Heart Rhythm, vol. 7, no. 4, pp. 559–564, Apr. 2010, doi: 10.1016/j.hrthm.2009.12.013.
[291]	J. C. Denneny, D. D. Cyr, D. L. Witsell, J. Brereton, and K. Schulz, “A pathway to value-based care of chronic rhinosinusitis using a claims database,” Laryngoscope Investig Otolaryngol, vol. 4, no. 1, pp. 193–206, Feb. 2019, doi: 10.1002/lio2.232.
[292]	H. Inooka et al., “A PEGylated analog of short-length Neuromedin U with potent anorectic and anti-obesity effects,” Bioorg. Med. Chem., vol. 25, no. 8, pp. 2307–2312, 15 2017, doi: 10.1016/j.bmc.2017.02.023.
[293]	L. L. Eggink, G. A. Spyroulias, N. G. Jones, C. V. Hanson, and J. K. Hoober, “A Peptide Mimetic of 5-Acetylneuraminic Acid-Galactose Binds with High Avidity to Siglecs and NKG2D,” PLoS ONE, vol. 10, no. 6, p. e0130532, 2015, doi: 10.1371/journal.pone.0130532.
[294]	Y. Morita et al., “A perforin/granzyme-positive MDS-derived T cell line, K2-MDS, induces apoptosis in CD34+ cells through the fractalkine-CX3CR1 system,” Clin. Immunol., vol. 113, no. 1, pp. 109–116, Oct. 2004, doi: 10.1016/j.clim.2004.05.005.
[295]	T. Neumann, H. E. Kaiser, and F. W. Rath, “A permanent cell line of the crayfish Orconectes limosus as a potential model in comparative oncology,” In Vivo, vol. 14, no. 5, pp. 691–698, Oct. 2000.
[296]	K. Zeiler, “A phenomenological analysis of bodily self-awareness in the experience of pain and pleasure: on dys-appearance and eu-appearance,” Med Health Care Philos, vol. 13, no. 4, pp. 333–342, Nov. 2010, doi: 10.1007/s11019-010-9237-4.
[297]	J. B. Allendorfer et al., “A pilot study of combined endurance and resistance exercise rehabilitation for verbal memory and functional connectivity improvement in epilepsy,” Epilepsy Behav, vol. 96, pp. 44–56, 2019, doi: 10.1016/j.yebeh.2019.04.020.
[298]	A. Aires et al., “A pilot study on the usefulness of peripheral blood flow cytometry for the diagnosis of lower risk myelodysplastic syndromes: the ‘MDS thermometer,’” BMC Hematol, vol. 18, p. 6, 2018, doi: 10.1186/s12878-018-0101-8.
[299]	A. J. De Roos, H. J. Deeg, and S. Davis, “A population-based study of survival in patients with secondary myelodysplastic syndromes (MDS): impact of type and treatment of primary cancers,” Cancer Causes Control, vol. 18, no. 10, pp. 1199–1208, Dec. 2007, doi: 10.1007/s10552-007-9060-2.
[300]	R. Pascal, “A possible non-biological reaction framework for metabolic processes on early Earth,” Nature, vol. 569, no. 7754, pp. 47–49, 2019, doi: 10.1038/d41586-019-01322-3.
[301]	Z. Zhang, L. Gao, C. Shen, M. Rong, X. Yan, and R. Lai, “A potent anti-thrombosis peptide (vasotab TY) from horsefly salivary glands,” Int. J. Biochem. Cell Biol., vol. 54, pp. 83–88, Sep. 2014, doi: 10.1016/j.biocel.2014.07.004.
[302]	E. R. Weyer, W. H. Park, and E. J. Banzhaf, “A POTENT ANTIPOLIOMYELITIC HORSE SERUM CONCENTRATE AND ITS EXPERIMENTAL USE IN INFECTED MONKEYS,” J. Exp. Med., vol. 53, no. 4, pp. 553–566, Mar. 1931, doi: 10.1084/jem.53.4.553.
[303]	N. Nishizawa et al., “A potent neuromedin U receptor 2-selective alkylated peptide,” Bioorg. Med. Chem. Lett., vol. 27, no. 20, pp. 4626–4629, 15 2017, doi: 10.1016/j.bmcl.2017.09.019.
[304]	I. Horiuchi et al., “A pregnancy-associated nonfamilial case of PAPA (pyogenic sterile arthritis, pyoderma gangrenosum, acne) syndrome,” Clin Case Rep, vol. 4, no. 10, pp. 989–991, 2016, doi: 10.1002/ccr3.662.
[305]	N. Walker, J. Thatcher, and D. Lavallee, “A preliminary development of the Re-Injury Anxiety Inventory (RIAI),” Phys Ther Sport, vol. 11, no. 1, pp. 23–29, Feb. 2010, doi: 10.1016/j.ptsp.2009.09.003.
[306]	L. R. Rutledge, C. D. M. Churchill, and S. D. Wetmore, “A preliminary investigation of the additivity of pi-pi or pi+-pi stacking and T-shaped interactions between natural or damaged DNA nucleobases and histidine,” J Phys Chem B, vol. 114, no. 9, pp. 3355–3367, Mar. 2010, doi: 10.1021/jp911990g.
[307]	C. Q. Cao, X. H. Yu, A. Dray, A. Filosa, and M. N. Perkins, “A pro-nociceptive role of neuromedin U in adult mice,” Pain, vol. 104, no. 3, pp. 609–616, Aug. 2003, doi: 10.1016/s0304-3959(03)00118-0.
[308]	M. M. Twitty, S. A. Martin, J. L. Henry, L. J. Nowicki, M. J. Dabrowski, and L. M. Veresh, “A procedure for assessing a contract testing facility: one sponsor’s perspective,” Qual Assur, vol. 5, no. 1, pp. 61–68, Mar. 1997.
[309]	S. L. Miller, “A production of amino acids under possible primitive earth conditions,” Science, vol. 117, no. 3046, pp. 528–529, May 1953, doi: 10.1126/science.117.3046.528.
[310]	L. Errichiello et al., “A proof-of-concept trial of the whey protein alfa-lactalbumin in chronic cortical myoclonus,” Mov. Disord., vol. 26, no. 14, pp. 2573–2575, Dec. 2011, doi: 10.1002/mds.23908.
[311]	B. M. Stern and E. K. O’Shea, “A proposal for the future of scientific publishing in the life sciences,” PLoS Biol., vol. 17, no. 2, p. e3000116, 2019, doi: 10.1371/journal.pbio.3000116.
[312]	E. L. Schneider et al., “A Prospective 12-Month Study of Prescriptions in Long-Term Care Nursing Facility Residents,” Sr Care Pharm, vol. 34, no. 3, pp. 206–214, Mar. 2019.
[313]	E. I. E. Abdelgadir et al., “A prospective multi-country observational trial to compare the incidences of diabetic ketoacidosis in the month of Ramadan, the preceding month, and the following month (DKAR international),” J Diabetes Metab Disord, vol. 15, p. 50, 2016, doi: 10.1186/s40200-016-0272-4.
[314]	S. Sivakumaran et al., “A prospective randomized comparison of loop recorders versus Holter monitors in patients with syncope or presyncope,” Am. J. Med., vol. 115, no. 1, pp. 1–5, Jul. 2003, doi: 10.1016/s0002-9343(03)00233-x.
[315]	A. Sato and S. Fukuda, “A prospective study of frequency and characteristics of cough during ACE inhibitor treatment,” Clin. Exp. Hypertens., vol. 37, no. 7, pp. 563–568, 2015, doi: 10.3109/10641963.2015.1026040.
[316]	S. M. Meffert et al., “A prospective study of trait anger and PTSD symptoms in police,” J Trauma Stress, vol. 21, no. 4, pp. 410–416, Aug. 2008, doi: 10.1002/jts.20350.
[317]	C. A. Blair et al., “A Protocol for Collecting Human Cardiac Tissue for Research,” VAD J, vol. 2, no. 1, 2016, doi: 10.13023/VAD.2016.12.
[318]	A. Roniger, C. Späth, U. Schweiger, and J. P. Klein, “A Psychometric Evaluation of the German Version of the Quick Inventory of Depressive Symptomatology (QIDS-SR16) in Outpatients with Depression,” Fortschr Neurol Psychiatr, vol. 83, no. 12, pp. e17-22, Dec. 2015, doi: 10.1055/s-0041-110203.
[319]	C. Zlotnick, “A public health quality assurance system,” Public Health Nurs, vol. 9, no. 2, pp. 133–137, Jun. 1992, doi: 10.1111/j.1525-1446.1992.tb00088.x.
[320]	J. H. Trevino, K. R. Gorny, A. Gomez-Cintron, C. Zhao, and H. Giambini, “A quantitative alternative to the Goutallier classification system using Lava Flex and Ideal MRI techniques: volumetric intramuscular fatty infiltration of the supraspinatus muscle, a cadaveric study,” MAGMA, vol. 32, no. 6, pp. 607–615, Dec. 2019, doi: 10.1007/s10334-019-00774-y.
[321]	L. M. Rinaldini, “A quantitative method for growing animal cells in vitro,” Nature, vol. 173, no. 4415, pp. 1134–1135, Jun. 1954, doi: 10.1038/1731134a0.
[322]	L. Huang and O. Jolliet, “A quantitative structure-property relationship (QSPR) for estimating solid material-air partition coefficients of organic compounds,” Indoor Air, vol. 29, no. 1, pp. 79–88, 2019, doi: 10.1111/ina.12510.
[323]	M. A. Cole, J. A. Rafael, D. J. Taylor, R. Lodi, K. E. Davies, and P. Styles, “A quantitative study of bioenergetics in skeletal muscle lacking utrophin and dystrophin,” Neuromuscul. Disord., vol. 12, no. 3, pp. 247–257, Mar. 2002, doi: 10.1016/s0960-8966(01)00278-4.
[324]	B. Penders, R. Vos, and K. Horstman, “A question of style: method, integrity and the meaning of proper science,” Endeavour, vol. 33, no. 3, pp. 93–98, Sep. 2009, doi: 10.1016/j.endeavour.2009.07.001.
[325]	K. Fauziah, K. W. Go, A. Ghazali, M. Zaki, and T. O. Lim, “A randomized cross-over study comparing the performance of HD integraTM central concentrate system versus pre-produced concentrate in hemodialysis,” BMC Nephrol, vol. 18, no. 1, p. 123, 03 2017, doi: 10.1186/s12882-017-0537-2.
[326]	R. D. Wasnich, J. W. Davis, Y. F. He, H. Petrovich, and P. D. Ross, “A randomized, double-masked, placebo-controlled trial of chlorthalidone and bone loss in elderly women,” Osteoporos Int, vol. 5, no. 4, pp. 247–251, 1995, doi: 10.1007/BF01774014.
[327]	E. Cho et al., “A rare case of pericarditis and pleural empyema secondary to transdiaphragmatic extension of pyogenic liver abscess,” BMC Infect. Dis., vol. 18, no. 1, p. 40, 15 2018, doi: 10.1186/s12879-018-2953-8.
[328]	E. Cho et al., “A Rare Case of Portal Biliopathy and Pylephlebitis Following the Injection of Cyanoacrylate into the Duodenal Varix,” J. Clin. Gastroenterol., vol. 50, no. 10, p. 897, Dec. 2016, doi: 10.1097/MCG.0000000000000601.
[329]	C. Monarca, M. Maruccia, F. Palumbo, P. Parisi, and N. Scuderi, “A rare case of postauricular spontaneous keloid in an elderly patient,” In Vivo, vol. 26, no. 1, pp. 173–175, Feb. 2012.
[330]	R. Khateeb, T. Gandhi, and G. Dhaliwal, “A raw deal,” J Hosp Med, vol. 8, no. 8, pp. 464–467, Aug. 2013, doi: 10.1002/jhm.2055.
[331]	D. A. Apatzidou and A. Papa, “A real-time PCR probe for the quantitative detection of Porphyromonas gingivalis,” Oral Dis, vol. 15, no. 1, p. 119, Jan. 2009, doi: 10.1111/j.1601-0825.2008.01470.x.
[332]	D. Rabinowitz, E. Helin, K. Lawrence, and S. Pravdo, “A reduced estimate of the number of kilometre-sized near-Earth asteroids,” Nature, vol. 403, no. 6766, pp. 165–166, Jan. 2000, doi: 10.1038/35003128.
[333]	Y. Shen, H. Huang, L. Zhu, M. Luo, and D. Chen, “A regulatory gene (ECO-orf4) required for ECO-0501 biosynthesis in Amycolatopsis orientalis,” J. Basic Microbiol., vol. 54, no. 2, pp. 104–110, Feb. 2014, doi: 10.1002/jobm.201200314.
[334]	S. Villiere et al., “A Resuscitation Option for Upper Airway Occlusion Based on Bolus Transtracheal Lung Inflation,” Laryngoscope Investig Otolaryngol, vol. 3, no. 4, pp. 296–303, Aug. 2018, doi: 10.1002/lio2.173.
[335]	R. J. Petrella and E. Merikle, “A retrospective analysis of the prevalence and treatment of hypertension and dyslipidemia in Southwestern Ontario, Canada,” Clin Ther, vol. 30, no. 6, pp. 1145–1154, Jun. 2008, doi: 10.1016/j.clinthera.2008.06.004.
[336]	F. Ozer, F. K. Mante, G. Chiche, N. Saleh, T. Takeichi, and M. B. Blatz, “A retrospective survey on long-term survival of posterior zirconia and porcelain-fused-to-metal crowns in private practice,” Quintessence Int, vol. 45, no. 1, pp. 31–38, Jan. 2014, doi: 10.3290/j.qi.a30768.
[337]	L. Rew, W. Thurman, and K. McDonald, “A Review and Critique of Advances in Nursing Science Articles That Focus on Sexual Health and Sexual Rights: A Call to Leadership and Policy Development,” ANS Adv Nurs Sci, vol. 40, no. 1, pp. 64–84, Mar. 2017, doi: 10.1097/ANS.0000000000000158.
[338]	R. Pelton, “A review of antifoam mechanisms in fermentation,” J. Ind. Microbiol. Biotechnol., vol. 29, no. 4, pp. 149–154, Oct. 2002, doi: 10.1038/sj.jim.7000293.
[339]	S. K. Dennis, K. Lam, and A. Luong, “A Review of Classification Schemes for Chronic Rhinosinusitis with Nasal Polyposis Endotypes,” Laryngoscope Investig Otolaryngol, vol. 1, no. 5, pp. 130–134, Oct. 2016, doi: 10.1002/lio2.32.
[340]	D. Timms, “A review of clinical ventricular assist devices,” Med Eng Phys, vol. 33, no. 9, pp. 1041–1047, Nov. 2011, doi: 10.1016/j.medengphy.2011.04.010.
[341]	C. R. Brewin et al., “A review of current evidence regarding the ICD-11 proposals for diagnosing PTSD and complex PTSD,” Clin Psychol Rev, vol. 58, pp. 1–15, Dec. 2017, doi: 10.1016/j.cpr.2017.09.001.
[342]	W. M. Lydiatt, J. Moran, and W. J. Burke, “A review of depression in the head and neck cancer patient,” Clin Adv Hematol Oncol, vol. 7, no. 6, pp. 397–403, Jun. 2009.
[343]	H. Zhou, A. Meng, Y. Long, Q. Li, and Y. Zhang, “A review of dioxin-related substances during municipal solid waste incineration,” Waste Manag, vol. 36, pp. 106–118, Feb. 2015, doi: 10.1016/j.wasman.2014.11.011.
[344]	R. Ponnampalam, N. I. Mondy, and J. G. Babish, “A review of environmental and health risks of maleic hydrazide,” Regul. Toxicol. Pharmacol., vol. 3, no. 1, pp. 38–47, Mar. 1983, doi: 10.1016/0273-2300(83)90048-x.
[345]	M. J. Norvell, “A review of fundamentals of EPA’s baseline human health risk assessment processes and associated QA needs,” Qual Assur, vol. 2, no. 1–2, pp. 67–70, Jun. 1993.
[346]	N. Malek, C. A. Heath, and J. Greene, “A review of medication adherence in people with epilepsy,” Acta Neurol. Scand., vol. 135, no. 5, pp. 507–515, May 2017, doi: 10.1111/ane.12703.
[347]	Y. Gong, X. Zhao, Z. Cai, S. E. O’Reilly, X. Hao, and D. Zhao, “A review of oil, dispersed oil and sediment interactions in the aquatic environment: influence on the fate, transport and remediation of oil spills,” Mar. Pollut. Bull., vol. 79, no. 1–2, pp. 16–33, Feb. 2014, doi: 10.1016/j.marpolbul.2013.12.024.
[348]	P. Fontelo and F. Liu, “A review of recent publication trends from top publishing countries,” Syst Rev, vol. 7, no. 1, p. 147, 27 2018, doi: 10.1186/s13643-018-0819-1.
[349]	T. S. Kashikar, T. F. Kerwin, A. C. Moberly, and G. J. Wiet, “A review of simulation applications in temporal bone surgery,” Laryngoscope Investig Otolaryngol, vol. 4, no. 4, pp. 420–424, Aug. 2019, doi: 10.1002/lio2.277.
[350]	S. S. Coughlin, “A review of social determinants of prostate cancer risk, stage, and survival,” Prostate Int, vol. 8, no. 2, pp. 49–54, Jun. 2020, doi: 10.1016/j.prnil.2019.08.001.
[351]	K. L. Keatley, “A review of the FDA draft guidance document for software validation: guidance for industry,” Qual Assur, vol. 7, no. 1, pp. 49–55, 1999, doi: 10.1080/105294100277723.
[352]	D. Nechita, F. Nechita, and R. Motorga, “A review of the influence the anxiety exerts on human life,” Rom J Morphol Embryol, vol. 59, no. 4, pp. 1045–1051, 2018.
[353]	A. Rehemtulla and B. D. Ross, “A review of the past, present, and future directions of neoplasia,” Neoplasia, vol. 7, no. 12, pp. 1039–1046, Dec. 2005, doi: 10.1593/neo.05793.
[354]	K. M. Pedersen, A. Alban, and B. Danneskiold-Samsøe, “[A review of the types of economic analyses of the health economy],” Ugeskr. Laeg., vol. 152, no. 3, pp. 144–148, Jan. 1990.
[355]	Y. Kase, H. Yamashita, M. Numano, H. Fuji, and S. Murayama, “A revision of proton machine quality assurance for wobbled-proton-beam therapy,” Radiol Phys Technol, vol. 6, no. 2, pp. 444–452, Jul. 2013, doi: 10.1007/s12194-013-0217-2.
[356]	J. M. Witkin, E. T. Tzavara, and G. G. Nomikos, “A role for cannabinoid CB1 receptors in mood and anxiety disorders,” Behav Pharmacol, vol. 16, no. 5–6, pp. 315–331, Sep. 2005, doi: 10.1097/00008877-200509000-00005.
[357]	C. Maitra, A. Hodge, and E. Jimenez Soto, “A scoping review of cost benefit analysis in reproductive, maternal, newborn and child health: What we know and what are the gaps?,” Health Policy Plan, vol. 31, no. 10, pp. 1530–1547, Dec. 2016, doi: 10.1093/heapol/czw078.
[358]	T. L. Luo et al., “A Sensitive Thresholding Method for Confocal Laser Scanning Microscope Image Stacks of Microbial Biofilms,” Sci Rep, vol. 8, no. 1, p. 13013, 29 2018, doi: 10.1038/s41598-018-31012-5.
[359]	J. M. Wright and T. F. Bateson, “A sensitivity analysis of bias in relative risk estimates due to disinfection by-product exposure misclassification,” J Expo Anal Environ Epidemiol, vol. 15, no. 3, pp. 212–216, May 2005, doi: 10.1038/sj.jea.7500389.
[360]	Y.-H. Su, T.-Y. Lin, H.-J. Liu, and C.-K. Chuang, “A set of cancer stem cell homing peptides associating with the glycan moieties of glycosphingolipids,” Oncotarget, vol. 9, no. 29, pp. 20490–20507, Apr. 2018, doi: 10.18632/oncotarget.24960.
[361]	T. W. W. Pace and C. M. Heim, “A short review on the psychoneuroimmunology of posttraumatic stress disorder: from risk factors to medical comorbidities,” Brain Behav. Immun., vol. 25, no. 1, pp. 6–13, Jan. 2011, doi: 10.1016/j.bbi.2010.10.003.
[362]	Y. Nishikawa and T. Sugiyama, “A shRNA library constructed through the generation of loop-stem-loop DNA,” J Gene Med, vol. 12, no. 11, pp. 927–933, Nov. 2010, doi: 10.1002/jgm.1513.
[363]	D. J. Haakinson et al., “A significant number of women present with palpable breast cancer even with a normal mammogram within 1 year,” Am. J. Surg., vol. 200, no. 6, pp. 712–717; discussion 717-718, Dec. 2010, doi: 10.1016/j.amjsurg.2010.08.005.
[364]	Y. Jin, H. Yu, and X. Liang, “A Simple Approach: Heat Treatment to Improve the Electrochemical Performance of Commonly Used Anode Electrodes for Lithium-Ion Batteries,” ACS Appl Mater Interfaces, Aug. 2020, doi: 10.1021/acsami.0c10823.
[365]	J. M. Warrender, “A Simple Framework for Evaluating Authorial Contributions for Scientific Publications,” Sci Eng Ethics, vol. 22, no. 5, pp. 1419–1430, 2016, doi: 10.1007/s11948-015-9719-0.
[366]	S. Warwood and J. Antony, “A simple, semi-prescriptive self-assessment model for TQM,” Qual Assur, vol. 10, no. 2, pp. 67–81, Jun. 2003, doi: 10.1080/10529410390262718.
[367]	B. L. Kaye and G. G. Lotuaco, “A simplified technique for correction of the congenital lop ear,” Plast. Reconstr. Surg., vol. 54, no. 6, pp. 667–670, Dec. 1974, doi: 10.1097/00006534-197412000-00008.
[368]	A. Filla and G. Campanella, “A six-month phosphatidylcholine trial in Friedreich’s ataxia,” Can J Neurol Sci, vol. 9, no. 2, pp. 147–150, May 1982, doi: 10.1017/s0317167100043857.
[369]	K. Ozaki, C. T. Reinhard, and E. Tajika, “A sluggish mid-Proterozoic biosphere and its effect on Earth’s redox balance,” Geobiology, vol. 17, no. 1, pp. 3–11, 2019, doi: 10.1111/gbi.12317.
[370]	M. Roscigno et al., “A Snapshot from the Department of Urology in Bergamo Evaluating the Timeline of the SARS-CoV-2 Outbreak: Which Patients Are We Missing?,” Eur Urol Focus, vol. 6, no. 5, pp. 1120–1123, Sep. 2020, doi: 10.1016/j.euf.2020.05.022.
[371]	P. Jennings, R. Corvi, and M. Culot, “A snapshot on the progress of in vitro toxicology for safety assessment,” Toxicol In Vitro, vol. 45, no. Pt 3, pp. 269–271, 2017, doi: 10.1016/j.tiv.2017.10.024.
[372]	S. Hoogland, V. Sukhovatkin, I. Howard, S. Cauchi, L. Levina, and E. H. Sargent, “A solution-processed 1.53 mum quantum dot laser with temperature-invariant emission wavelength,” Opt Express, vol. 14, no. 8, pp. 3273–3281, Apr. 2006, doi: 10.1364/oe.14.003273.
[373]	M. Seghezzi, B. Manenti, G. Previtali, A. Gianatti, P. Dominoni, and S. Buoro, “A specific abnormal scattergram of peripheral blood leukocytes that may suggest hairy cell leukemia,” Clin. Chem. Lab. Med., vol. 56, no. 5, pp. e108–e111, 25 2018, doi: 10.1515/cclm-2017-0763.
[374]	R. Caruso et al., “A specific gene-microbe interaction drives the development of Crohn’s disease-like colitis in mice,” Sci Immunol, vol. 4, no. 34, 19 2019, doi: 10.1126/sciimmunol.aaw4341.
[375]	M. Blanco, I. Casasús, and D. Villalba, “A spline polynomial model to describe serum IGF-I concentration from birth to slaughter in calves: effects of weaning age, pre-weaning concentrate feeding and breed,” Domest. Anim. Endocrinol., vol. 38, no. 3, pp. 157–167, Apr. 2010, doi: 10.1016/j.domaniend.2009.09.003.
[376]	J. Leighton, “A sponge matrix method for tissue culture; formation of organized aggregates of cells in vitro,” J. Natl. Cancer Inst., vol. 12, no. 3, pp. 545–561, Dec. 1951.
[377]	G. Palaniswaamy, R. Scott Brame, S. Yaddanapudi, D. Rangaraj, and S. Mutic, “A statistical approach to IMRT patient-specific QA,” Med Phys, vol. 39, no. 12, pp. 7560–7570, Dec. 2012, doi: 10.1118/1.4768161.
[378]	X. Niu, K. Deng, L. Liu, K. Yang, and X. Hu, “A statistical framework for predicting critical regions of p53-dependent enhancers,” Brief. Bioinformatics, May 2020, doi: 10.1093/bib/bbaa053.
[379]	S.-J. Kwag et al., “A stercoral perforation of the rectum,” Ann Coloproctol, vol. 29, no. 2, pp. 77–79, Apr. 2013, doi: 10.3393/ac.2013.29.2.77.
[380]	Y. Habara et al., “A strong exonic splicing enhancer in dystrophin exon 19 achieve proper splicing without an upstream polypyrimidine tract,” J. Biochem., vol. 143, no. 3, pp. 303–310, Mar. 2008, doi: 10.1093/jb/mvm227.
[381]	G. Blanco, A. Nikitopoulou, M. Kraus, R. M. Mason, G. R. Coulton, and S. D. Brown, “A STS content physical and transcription map across the ky, kyphoscoliosis, nonrecombinant region,” Genomics, vol. 54, no. 3, pp. 415–423, Dec. 1998, doi: 10.1006/geno.1998.5614.
[382]	J. V. Nani et al., “A study in first-episode psychosis patients: does angiotensin I-converting enzyme (ACE) activity associated with genotype predict symptoms severity reductions after treatment with the atypical antipsychotic risperidone?,” Int. J. Neuropsychopharmacol., Jul. 2020, doi: 10.1093/ijnp/pyaa050.
[383]	V. B. S. Gowda, B. H. Nagaiah, and B. Sengodan, “A study of the competency of third year medical students to interpret biochemically based clinical scenarios using knowledge and skills gained in year 1 and 2,” Biochem Mol Biol Educ, vol. 44, no. 2, pp. 202–207, Apr. 2016, doi: 10.1002/bmb.20936.
[384]	A. Yamada, “[A study of the relationship between the capacity of oral cavity proper and skeletal malocclusions],” Aichi Gakuin Daigaku Shigakkai Shi, vol. 28, no. 1 Pt 1, pp. 203–223, Mar. 1990.
[385]	P. Jahan, G. Deepthi, P. L. Komaravalli, and V. Usha Rani, “A study on the role of HLA-G 14bp and ACE IN/DEL polymorphisms in pre-eclamptic South Indian women,” Pregnancy Hypertens, vol. 4, no. 2, pp. 164–169, Apr. 2014, doi: 10.1016/j.preghy.2014.03.002.
[386]	H. Huang et al., “A study on the roles of Helicobacter pylori in bile reflux gastritis and gastric cancer,” J BUON, vol. 23, no. 3, pp. 659–664, Jun. 2018.
[387]	B. X. Li and X. Xiao, “A suite of bioassays to evaluate CREB inhibitors,” Meth. Enzymol., vol. 633, pp. 169–184, 2020, doi: 10.1016/bs.mie.2019.11.002.
[388]	Y. Nishina and S.-I. Yoshioka, “A Survey of Epilepsy-related Knowledge, Attitudes and Practices of Home Healthcare Nurses in the San-in Region of Japan,” Yonago Acta Med, vol. 61, no. 1, pp. 19–26, Mar. 2018.
[389]	R. W. Evans and K. Ghosh, “A Survey of Headache Medicine Physicians on the Likeability of Headaches and Their Personal Headache History,” Headache, vol. 56, no. 3, pp. 540–546, Mar. 2016, doi: 10.1111/head.12782.
[390]	M. Rew and H. Lake, “A survey of short- and long-term pre-lubricated intermittent catheters,” Br J Nurs, vol. 22, no. 18, pp. S12, S14-18, Oct. 2013, doi: 10.12968/bjon.2013.22.Sup18.S12.
[391]	S. Kun, G. Placencia, S. D. Ward, and T. Keens, “A System Analysis of Delay in Outpatient Respiratory Equipment Delivery,” Care Manag J, vol. 17, no. 4, pp. 161–169, Dec. 2016, doi: 10.1891/1521-0987.17.4.161.
[392]	D. M. Bryant, C. C. O’Meara, N. N. Ho, J. Gannon, L. Cai, and R. T. Lee, “A systematic analysis of neonatal mouse heart regeneration after apical resection,” J. Mol. Cell. Cardiol., vol. 79, pp. 315–318, Feb. 2015, doi: 10.1016/j.yjmcc.2014.12.011.
[393]	L. Rew, A. Saenz, and L. O. Walker, “A systematic method for reviewing and analysing health information on consumer-oriented websites,” J Adv Nurs, May 2018, doi: 10.1111/jan.13726.
[394]	C. M. Faggion, S. Listl, N. Frühauf, H.-J. Chang, and Y.-K. Tu, “A systematic review and Bayesian network meta-analysis of randomized clinical trials on non-surgical treatments for peri-implantitis,” J. Clin. Periodontol., vol. 41, no. 10, pp. 1015–1025, Oct. 2014, doi: 10.1111/jcpe.12292.
[395]	L. Zhuang, X. Zeng, and Z. Meng, “[A systematic review and meta-analysis of randomized controlled trails : adjuvant interferon therapy for hepatocellular carcinoma],” Zhonghua Gan Zang Bing Za Zhi, vol. 20, no. 5, pp. 363–367, May 2012, doi: 10.3760/cma.j.issn.1007-3418.2012.05.012.
[396]	V. Machado, J. Botelho, P. Mascarenhas, J. J. Mendes, and A. Delgado, “A systematic review and meta-analysis on Bolton’s ratios: Normal occlusion and malocclusion,” J Orthod, vol. 47, no. 1, pp. 7–29, 2020, doi: 10.1177/1465312519886322.
[397]	L. Rew and Y. J. Wong, “A systematic review of associations among religiosity/spirituality and adolescent health attitudes and behaviors,” J Adolesc Health, vol. 38, no. 4, pp. 433–442, Apr. 2006, doi: 10.1016/j.jadohealth.2005.02.004.
[398]	J. Choi, M. Kwon, and S. C. Jun, “A Systematic Review of Closed-Loop Feedback Techniques in Sleep Studies-Related Issues and Future Directions,” Sensors (Basel), vol. 20, no. 10, May 2020, doi: 10.3390/s20102770.
[399]	R. S. Lee, B. E. Hagel, M. Karkhaneh, and B. H. Rowe, “A systematic review of correct bicycle helmet use: how varying definitions and study quality influence the results,” Inj. Prev., vol. 15, no. 2, pp. 125–131, Apr. 2009, doi: 10.1136/ip.2008.019695.
[400]	L. Rew, K. Johnson, and C. Young, “A systematic review of interventions to reduce stress in adolescence,” Issues Ment Health Nurs, vol. 35, no. 11, pp. 851–863, Nov. 2014, doi: 10.3109/01612840.2014.924044.
[401]	L. Rew, M. Mackert, and D. Bonevac, “A systematic review of literature about the genetic testing of adolescents,” J Spec Pediatr Nurs, vol. 14, no. 4, pp. 284–294, Oct. 2009, doi: 10.1111/j.1744-6155.2009.00210.x.
[402]	L. Rew, C. Young, T. Harrison, and R. Caridi, “A systematic review of literature on psychosocial aspects of gynecomastia in adolescents and young men,” J Adolesc, vol. 43, pp. 206–212, Aug. 2015, doi: 10.1016/j.adolescence.2015.06.007.
[403]	Y. J. Wong, L. Rew, and K. D. Slaikeu, “A systematic review of recent research on adolescent religiosity/spirituality and mental health,” Issues Ment Health Nurs, vol. 27, no. 2, pp. 161–183, Mar. 2006, doi: 10.1080/01612840500436941.
[404]	K. Siewers, V. Backer, and E. S. Walsted, “A systematic review of surgical treatment for supraglottic exercise-induced laryngeal obstruction,” Laryngoscope Investig Otolaryngol, vol. 4, no. 2, pp. 227–233, Apr. 2019, doi: 10.1002/lio2.257.
[405]	P. C. Ndimubanzi et al., “A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy,” PLoS Negl Trop Dis, vol. 4, no. 11, p. e870, Nov. 2010, doi: 10.1371/journal.pntd.0000870.
[406]	J. L. Taylor and L. Rew, “A systematic review of the literature: workplace violence in the emergency department,” J Clin Nurs, vol. 20, no. 7–8, pp. 1072–1085, Apr. 2011, doi: 10.1111/j.1365-2702.2010.03342.x.
[407]	J. M. Converse, A. Nigro, F. A. Wilson, and N. Johnson, “A technique for surgical correction of lop ears,” Plast Reconstr Surg (1946), vol. 15, no. 5, pp. 411–418, May 1955, doi: 10.1097/00006534-195505000-00004.
[408]	N. Cofnas, “A teleofunctional account of evolutionary mismatch,” Biol Philos, vol. 31, pp. 507–525, 2016, doi: 10.1007/s10539-016-9527-1.
[409]	G. A. Cordero and C. M. Berns, “A test of Darwin’s ‘lop-eared’ rabbit hypothesis,” J. Evol. Biol., vol. 29, no. 11, pp. 2102–2110, 2016, doi: 10.1111/jeb.12938.
[410]	C. C. Young, A. O. Sagna, M. Monge, and L. Rew, “A Theoretically Grounded Exploration of Individual and Family Self-Management of Polycystic Ovary Syndrome in Adolescents,” Compr Child Adolesc Nurs, pp. 1–15, Oct. 2019, doi: 10.1080/24694193.2019.1679278.
[411]	M. Virk, K. Xiong, M. Svedendahl, M. Käll, and A. B. Dahlin, “A thermal plasmonic sensor platform: resistive heating of nanohole arrays,” Nano Lett., vol. 14, no. 6, pp. 3544–3549, Jun. 2014, doi: 10.1021/nl5011542.
[412]	S. Witman, A. Gefen, and O. Barnea, “A three dimensional heart model based on anatomically aligned trusses,” Conf Proc IEEE Eng Med Biol Soc, vol. 2007, pp. 2697–2700, 2007, doi: 10.1109/IEMBS.2007.4352885.
[413]	A. Clerkin, “A three-wave longitudinal assessment of socioemotional development in a year-long school-based ‘gap year,’” Br J Educ Psychol, vol. 90, no. 1, pp. 109–129, Mar. 2020, doi: 10.1111/bjep.12267.
[414]	H. Zhang, M. R. Razeghifard, G. Fischer, and T. Wydrzynski, “A time-resolved FTIR difference study of the plastoquinone QA and redox-active tyrosine YZ interactions in photosystem II,” Biochemistry, vol. 36, no. 39, pp. 11762–11768, Sep. 1997, doi: 10.1021/bi970815t.
[415]	F. A. P. C. Gobas, Y.-S. Lee, J. C. Lo, T. F. Parkerton, and D. J. Letinski, “A Toxicokinetic Framework and Analysis Tool for Interpreting Organisation for Economic Co-operation and Development Guideline 305 Dietary Bioaccumulation Tests,” Environ. Toxicol. Chem., vol. 39, no. 1, pp. 171–188, 2020, doi: 10.1002/etc.4599.
[416]	M. R. Montgomery and M. J. Reasor, “A toxicologic approach for evaluating cases of sick building syndrome or multiple chemical sensitivity,” J. Allergy Clin. Immunol., vol. 94, no. 2 Pt 2, pp. 371–375, Aug. 1994.
[417]	M. Kretzler and W. Ju, “A Transcriptional Map of the Renal Tubule: Linking Structure to Function,” J. Am. Soc. Nephrol., vol. 26, no. 11, pp. 2603–2605, Nov. 2015, doi: 10.1681/ASN.2015030242.
[418]	P. J. Tuchin, “A twelve month clinical trial of chiropractic spinal manipulative therapy for migraine,” Australas Chiropr Osteopathy, vol. 8, no. 2, pp. 61–65, Jul. 1999.
[419]	A. Y. Katukiza, M. Ronteltap, C. B. Niwagaba, F. Kansiime, and P. N. L. Lens, “A two-step crushed lava rock filter unit for grey water treatment at household level in an urban slum,” J. Environ. Manage., vol. 133, pp. 258–267, Jan. 2014, doi: 10.1016/j.jenvman.2013.12.003.
[420]	I. Nassar et al., “A twofold genetic increase of ACE expression has no effect on the development of spontaneous hypertension,” Am. J. Hypertens., vol. 21, no. 2, pp. 200–205, Feb. 2008, doi: 10.1038/ajh.2007.38.
[421]	K. M. Huntoon et al., “A unique form of haptoglobin produced by murine hematopoietic cells supports B-cell survival, differentiation and immune response,” Mol. Immunol., vol. 55, no. 3–4, pp. 345–354, Oct. 2013, doi: 10.1016/j.molimm.2013.03.008.
[422]	I. H. Lai et al., “A unique tetrameric structure of deer plasma haptoglobin--an evolutionary advantage in the Hp 2-2 phenotype with homogeneous structure,” FEBS J., vol. 275, no. 5, pp. 981–993, Mar. 2008, doi: 10.1111/j.1742-4658.2008.06267.x.
[423]	F. Ju et al., “A Variable-Impedance Tactile Sensor With Online Performance Tuning for Tissue Hardness Palpation in Robot-Assisted Minimally Invasive Surgery,” Conf Proc IEEE Eng Med Biol Soc, vol. 2018, pp. 2142–2145, 2018, doi: 10.1109/EMBC.2018.8512717.
[424]	R. H. Musgrave, “A variation on the correction of the congenital lop ear,” Plast. Reconstr. Surg., vol. 37, no. 5, pp. 394–398, May 1966, doi: 10.1097/00006534-196605000-00002.
[425]	P. Comba, H. Pritzkow, and W. Schiek, “A Very Rigid Bis-bispidine Tetraazamacrocycle and Its Unusual Copper(II) Complex This work was supported by the Deutsche Forschungsgemeinschaft (DFG). Bispidine=3,7-diazabicyclo,” Angew. Chem. Int. Ed. Engl., vol. 40, no. 13, pp. 2465–2468, Jul. 2001.
[426]	R. Zhou et al., “A Voxel-based Fully Convolution Network and Continuous Max-flow for Carotid Vessel-wall-volume Segmentation from 3D Ultrasound Images,” IEEE Trans Med Imaging, Feb. 2020, doi: 10.1109/TMI.2020.2975231.
[427]	C. D. Larson, E. A. Lehnhoff, and L. J. Rew, “A warmer and drier climate in the northern sagebrush biome does not promote cheatgrass invasion or change its response to fire,” Oecologia, vol. 185, no. 4, pp. 763–774, 2017, doi: 10.1007/s00442-017-3976-3.
[428]	S. Tamara, V. Franc, and A. J. R. Heck, “A wealth of genotype-specific proteoforms fine-tunes hemoglobin scavenging by haptoglobin,” Proc. Natl. Acad. Sci. U.S.A., vol. 117, no. 27, pp. 15554–15564, 07 2020, doi: 10.1073/pnas.2002483117.
[429]	X. Gu, S. Kumar, E. Kim, and Y. Kim, “A whole genome screening and RNA interference identify a juvenile hormone esterase-like gene of the diamondback moth, Plutella xylostella,” J. Insect Physiol., vol. 80, pp. 81–87, Sep. 2015, doi: 10.1016/j.jinsphys.2015.02.001.
[430]	J. L. Leslie and V. B. Young, “A whole new ball game: Stem cell-derived epithelia in the study of host-microbe interactions,” Anaerobe, vol. 37, pp. 25–28, Feb. 2016, doi: 10.1016/j.anaerobe.2015.10.016.
[431]	A. N. Halliday, “A young Moon-forming giant impact at 70-110 million years accompanied by late-stage mixing, core formation and degassing of the Earth,” Philos Trans A Math Phys Eng Sci, vol. 366, no. 1883, pp. 4163–4181, Nov. 2008, doi: 10.1098/rsta.2008.0209.
[432]	C. N. Chiu et al., “A Zebrafish Genetic Screen Identifies Neuromedin U as a Regulator of Sleep/Wake States,” Neuron, vol. 89, no. 4, pp. 842–856, Feb. 2016, doi: 10.1016/j.neuron.2016.01.007.
[433]	L. He, C. Tan, C. Sheng, Y. Chen, F. Yu, and Y. Chen, “A β-FeOOH/MXene sandwich for high-performance anodes in lithium-ion batteries,” Dalton Trans, vol. 49, no. 27, pp. 9268–9273, Jul. 2020, doi: 10.1039/d0dt01531h.
[434]	L. Zhao et al., “A-DROP: A predictive model for the formation of oil particle aggregates (OPAs),” Mar. Pollut. Bull., vol. 106, no. 1–2, pp. 245–259, May 2016, doi: 10.1016/j.marpolbul.2016.02.057.
[435]	T.-W. Tan et al., “A. cantoniensis inhibits the proliferation of murine leukemia WEHI-3 cells in vivo and promotes immunoresponses in vivo,” In Vivo, vol. 23, no. 4, pp. 561–566, Aug. 2009.
[436]	A. Vambutas and S. Pathak, “AAO: Autoimmune and Autoinflammatory (Disease) in Otology: What is New in Immune-Mediated Hearing Loss,” Laryngoscope Investig Otolaryngol, vol. 1, no. 5, pp. 110–115, 2016, doi: 10.1002/lio2.28.
[437]	K. Odai, T. Sugimoto, and E. Ito, “Ab-initio study of pyrrole ring deformation in the indole group of 5-HT interacting with water molecules,” Biophys Physicobiol, vol. 16, pp. 127–131, 2019, doi: 10.2142/biophysico.16.0_127.
[438]	A. S. Hale, “ABC of mental health. Anxiety,” BMJ, vol. 314, no. 7098, pp. 1886–1889, Jun. 1997, doi: 10.1136/bmj.314.7098.1886.
[439]	A. S. Hale, “ABC of mental health. Depression,” BMJ, vol. 315, no. 7099, pp. 43–46, Jul. 1997, doi: 10.1136/bmj.315.7099.43.
[440]	C. Y. Wang, N. Patel, W.-Y. Wholey, and S. Dawid, “ABC transporter content diversity in Streptococcus pneumoniae impacts competence regulation and bacteriocin production,” Proc. Natl. Acad. Sci. U.S.A., vol. 115, no. 25, pp. E5776–E5785, 19 2018, doi: 10.1073/pnas.1804668115.
[441]	X. H. Li et al., “Abdominal MRI at 3.0 T: LAVA-Flex compared with conventional fat suppression T1-weighted images,” J Magn Reson Imaging, vol. 40, no. 1, pp. 58–66, Jul. 2014, doi: 10.1002/jmri.24329.
[442]	E. Ibekwe et al., “Abducens Nerve Palsy as Initial Presentation of Multiple Myeloma and Intracranial Plasmacytoma,” J Clin Med, vol. 7, no. 9, Sep. 2018, doi: 10.3390/jcm7090253.
[443]	J. Chew et al., “Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy,” Mol Neurodegener, vol. 14, no. 1, p. 9, 15 2019, doi: 10.1186/s13024-019-0310-z.
[444]	J. Nijkamp, R. B. J. Jaafar, L. Postma, M. Snoeijs, S. S. Qiu Shao, and B. Tan, “Aberrant innominate artery: A possible hazard during total laryngectomy,” Laryngoscope Investig Otolaryngol, vol. 4, no. 3, pp. 307–309, Jun. 2019, doi: 10.1002/lio2.263.
[445]	T. A. LeGates et al., “Aberrant light directly impairs mood and learning through melanopsin-expressing neurons,” Nature, vol. 491, no. 7425, pp. 594–598, Nov. 2012, doi: 10.1038/nature11673.
[446]	G. Ju, H. Ma, and C. Yan, “Aberration fields of off-axis astronomical telescopes induced by rotational misalignments,” Opt Express, vol. 26, no. 19, pp. 24816–24834, Sep. 2018, doi: 10.1364/OE.26.024816.
[447]	M. A. Mittelman-Smith, S. J. Krajewski-Hall, N. T. McMullen, and N. E. Rance, “Ablation of KNDy Neurons Results in Hypogonadotropic Hypogonadism and Amplifies the Steroid-Induced LH Surge in Female Rats,” Endocrinology, vol. 157, no. 5, pp. 2015–2027, 2016, doi: 10.1210/en.2015-1740.
[448]	P. E. Garraghty, T. P. Pons, and J. H. Kaas, “Ablations of areas 3b (SI proper) and 3a of somatosensory cortex in marmosets deactivate the second and parietal ventral somatosensory areas,” Somatosens Mot Res, vol. 7, no. 2, pp. 125–135, 1990, doi: 10.3109/08990229009144703.
[449]	S. Gao et al., “Abnormal changes in the quantity and function of osteoblasts cultured in vitro in patients with myelodysplastic syndrome,” Oncol Lett, vol. 16, no. 4, pp. 4384–4390, Oct. 2018, doi: 10.3892/ol.2018.9206.
[450]	C. Wan et al., “Abnormal changes of plasma acute phase proteins in schizophrenia and the relation between schizophrenia and haptoglobin (Hp) gene,” Amino Acids, vol. 32, no. 1, pp. 101–108, Jan. 2007, doi: 10.1007/s00726-005-0292-8.
[451]	Z. Zhu et al., “Abnormal glucose regulation, hypoglycemic treatment during hospitalization and prognosis of acute ischemic stroke,” J. Neurol. Sci., vol. 379, pp. 177–182, Aug. 2017, doi: 10.1016/j.jns.2017.06.014.
[452]	S. Buoro et al., “Abnormal leukocyte scattergrams and immature platelet fraction on Sysmex XN-9000 analyzer: a new diagnostic tool for altered megakaryopoiesis?,” Scand. J. Clin. Lab. Invest., vol. 77, no. 1, pp. 73–75, Feb. 2017, doi: 10.1080/00365513.2016.1262057.
[453]	L. French, J. Horton, and M. Matousek, “Abnormal vaginal discharge: using office diagnostic testing more effectively,” J Fam Pract, vol. 53, no. 10, pp. 805–814, Oct. 2004.
[454]	B. Falkenberg-Jensen, K. R. Heimdal, H. E. Høgevold, G. E. Jablonski, B. J. Due-Tønnessen, and E. Hopp, “Abnormally wide eustachian tubes involving the sphenoid bone: A collection,” Laryngoscope Investig Otolaryngol, vol. 3, no. 3, pp. 214–217, Jun. 2018, doi: 10.1002/lio2.158.
[455]	M. Bolós et al., “Absence of CX3CR1 impairs the internalization of Tau by microglia,” Mol Neurodegener, vol. 12, no. 1, p. 59, 15 2017, doi: 10.1186/s13024-017-0200-1.
[456]	J. Huff, “Absence of morphologic correlation between chemical toxicity and chemical carcinogenesis,” Environ. Health Perspect., vol. 101 Suppl 5, pp. 45–53, Dec. 1993, doi: 10.1289/ehp.93101s545.
[457]	“Abstracts of the 3rd International Symposium on Silica, Silicosis, Cancer and other Diseases. S Margherita Ligure, Italy, 21-25 October 2002,” Med Lav, vol. 93 Suppl, pp. S1-73, 2002.
[458]	A. Shade and N. Stopnisek, “Abundance-occupancy distributions to prioritize plant core microbiome membership,” Curr. Opin. Microbiol., vol. 49, pp. 50–58, 2019, doi: 10.1016/j.mib.2019.09.008.
[459]	M. B. Manigrasso and J. P. O’Connor, “Accelerated fracture healing in mice lacking the 5-lipoxygenase gene,” Acta Orthop, vol. 81, no. 6, pp. 748–755, Dec. 2010, doi: 10.3109/17453674.2010.533931.
[460]	Y. Li, H. Matsuda, J. Yamahara, and M. Yoshikawa, “Acceleration of gastrointestinal transit by momordin Ic in mice: possible involvement of 5-hydroxytryptamine, 5-HT(2) receptors and prostaglandins,” Eur. J. Pharmacol., vol. 392, no. 1–2, pp. 71–77, Mar. 2000, doi: 10.1016/s0014-2999(00)00121-7.
[461]	S. Veldheer et al., “Acceptability of SPECTRUM Research Cigarettes among Participants in Trials of Reduced Nicotine Content Cigarettes,” Tob Regul Sci, vol. 4, no. 1, pp. 573–585, Jan. 2018, doi: 10.18001/TRS.4.1.4.
[462]	G. Paz-Y-Miño C and A. Espinosa, “Acceptance of Evolution Increases with Student Academic Level: A Comparison Between a Secular and a Religious College,” Evolution (N Y), vol. 2, no. 4, pp. 655–675, Dec. 2009, doi: 10.1007/s12052-009-0175-7.
[463]	L. Hanf, M. Diehl, L.-S. Kemper, M. Winter, and S. Nowak, “Accessing copper oxidation states of dissolved negative electrode current collectors in lithium ion batteries,” Electrophoresis, Jul. 2020, doi: 10.1002/elps.202000155.
[464]	C. R. Gong, D. Troilo, and K. Richdale, “Accommodation and Phoria in Children Wearing Multifocal Contact Lenses,” Optom Vis Sci, vol. 94, no. 3, pp. 353–360, 2017, doi: 10.1097/OPX.0000000000001044.
[465]	G. Arrhenius and A. Lepland, “Accretion of Moon and Earth and the emergence of life,” Chem. Geol., vol. 169, no. 1–2, pp. 69–82, Aug. 2000, doi: 10.1016/s0009-2541(00)00333-8.
[466]	R. M. Canup, “Accretion of the Earth,” Philos Trans A Math Phys Eng Sci, vol. 366, no. 1883, pp. 4061–4075, Nov. 2008, doi: 10.1098/rsta.2008.0101.
[467]	J. Guo, K. Simon, K. Romanak, W. Bowerman, and M. Venier, “Accumulation of flame retardants in paired eggs and plasma of bald eagles,” Environ. Pollut., vol. 237, pp. 499–507, Jun. 2018, doi: 10.1016/j.envpol.2018.02.056.
[468]	W. D. Paulson, S. J. Ram, C. G. Birk, M. Zapczynski, S. R. Martin, and J. Work, “Accuracy of decrease in blood flow in predicting hemodialysis graft thrombosis,” Am. J. Kidney Dis., vol. 35, no. 6, pp. 1089–1095, Jun. 2000, doi: 10.1016/s0272-6386(00)70045-x.
[469]	P. Seelbach, C. Brueckel, and B. Wöstmann, “Accuracy of digital and conventional impression techniques and workflow,” Clin Oral Investig, vol. 17, no. 7, pp. 1759–1764, Sep. 2013, doi: 10.1007/s00784-012-0864-4.
[470]	S. Vandeweghe, V. Vervack, M. Dierens, and H. De Bruyn, “Accuracy of digital impressions of multiple dental implants: an in vitro study,” Clin Oral Implants Res, vol. 28, no. 6, pp. 648–653, Jun. 2017, doi: 10.1111/clr.12853.
[471]	S. B. M. Patzelt, A. Emmanouilidi, S. Stampf, J. R. Strub, and W. Att, “Accuracy of full-arch scans using intraoral scanners,” Clin Oral Investig, vol. 18, no. 6, pp. 1687–1694, Jul. 2014, doi: 10.1007/s00784-013-1132-y.
[472]	Y. Haddadi, G. Bahrami, and F. Isidor, “Accuracy of Intra-Oral Scans Compared to Conventional Impression in Vitro,” Prim Dent J, vol. 8, no. 3, pp. 34–39, Nov. 2019, doi: 10.1308/205016819827601491.
[473]	L. Praça, F. C. Pekam, R. O. Rego, K. Radermacher, S. Wolfart, and J. Marotti, “Accuracy of single crowns fabricated from ultrasound digital impressions,” Dent Mater, vol. 34, no. 11, pp. e280–e288, 2018, doi: 10.1016/j.dental.2018.08.301.
[474]	J. Y. Leong and J. E. Wong, “Accuracy of three Android-based pedometer applications in laboratory and free-living settings,” J Sports Sci, vol. 35, no. 1, pp. 14–21, Jan. 2017, doi: 10.1080/02640414.2016.1154592.
[475]	M. Kates et al., “Accuracy of urethral frozen section during radical cystectomy for bladder cancer,” Urol. Oncol., vol. 34, no. 12, p. 532.e1-532.e6, 2016, doi: 10.1016/j.urolonc.2016.06.014.
[476]	V. G. Barauna, L. C. G. Campos, A. A. Miyakawa, and J. E. Krieger, “ACE as a mechanosensor to shear stress influences the control of its own regulation via phosphorylation of cytoplasmic Ser(1270),” PLoS ONE, vol. 6, no. 8, p. e22803, 2011, doi: 10.1371/journal.pone.0022803.
[477]	C. Harrison and K. R. Acharya, “ACE for all - a molecular perspective,” J Cell Commun Signal, vol. 8, no. 3, pp. 195–210, Sep. 2014, doi: 10.1007/s12079-014-0236-8.
[478]	B. Kennon and J. M. Connell, “ACE gene polymorphism and diabetic complications: is there a connection?,” BioDrugs, vol. 14, no. 2, pp. 73–81, Aug. 2000, doi: 10.2165/00063030-200014020-00001.
[479]	G. Mayer, “ACE genotype and ACE inhibitor response in kidney disease: a perspective,” Am. J. Kidney Dis., vol. 40, no. 2, pp. 227–235, Aug. 2002, doi: 10.1053/ajkd.2002.34489.
[480]	L. H. Færch, A.-S. Sejling, M. Lajer, L. Tarnow, B. Thorsteinsson, and U. Pedersen-Bjergaard, “ACE genotype, phenotype and all-cause mortality in different cohorts of patients with type 1 diabetes,” J Renin Angiotensin Aldosterone Syst, vol. 16, no. 2, pp. 374–381, Jun. 2015, doi: 10.1177/1470320313494431.
[481]	Z. Rahimi, H. Abdi, M. Tanhapoor, Z. Rahimi, A. Vaisi-Raygani, and H. Nomani, “ACE I/D and MMP-7 A-181G variants and the risk of end stage renal disease,” Mol Biol Res Commun, vol. 6, no. 1, pp. 41–44, Mar. 2017.
[482]	X. Yan et al., “ACE I/D gene variant predicts ACE enzyme content in blood but not the ACE, UCP2, and UCP3 protein content in human skeletal muscle in the Gene SMART study,” J. Appl. Physiol., vol. 125, no. 3, pp. 923–930, 01 2018, doi: 10.1152/japplphysiol.00344.2018.
[483]	A. Gadelha et al., “ACE I/D genotype-related increase in ACE plasma activity is a better predictor for schizophrenia diagnosis than the genotype alone,” Schizophr. Res., vol. 164, no. 1–3, pp. 109–114, May 2015, doi: 10.1016/j.schres.2015.01.044.
[484]	A. Kruit et al., “ACE I/D-corrected Z-scores to identify normal and elevated ACE activity in sarcoidosis,” Respir Med, vol. 101, no. 3, pp. 510–515, Mar. 2007, doi: 10.1016/j.rmed.2006.06.025.
[485]	B. A. Schölkens and W. Landgraf, “ACE inhibition and atherogenesis,” Can. J. Physiol. Pharmacol., vol. 80, no. 4, pp. 354–359, Apr. 2002, doi: 10.1139/y02-038.
[486]	L. Tang, K. Both, and R. Taylor, “ACE inhibition and fibroblast growth factor in cultured human vascular smooth muscle,” Vasc Med, vol. 4, no. 3, pp. 129–134, 1999, doi: 10.1177/1358836X9900400302.
[487]	M. J. Porritt, M. Chen, S. S. J. Rewell, R. G. Dean, L. M. Burrell, and D. W. Howells, “ACE inhibition reduces infarction in normotensive but not hypertensive rats: correlation with cortical ACE activity,” J. Cereb. Blood Flow Metab., vol. 30, no. 8, pp. 1520–1526, Aug. 2010, doi: 10.1038/jcbfm.2010.57.
[488]	B. Bian, C. M. L. Kelton, J. J. Guo, and P. R. Wigle, “ACE Inhibitor and ARB utilization and expenditures in the Medicaid fee-for-service program from 1991 to 2008,” J Manag Care Pharm, vol. 16, no. 9, pp. 671–679, Dec. 2010, doi: 10.18553/jmcp.2010.16.9.671.
[489]	D. S. Weisman et al., “ACE inhibitor angioedema: characterization and treatment versus non-ACE angioedema in acute hospitalized patients,” J Community Hosp Intern Med Perspect, vol. 10, no. 1, pp. 16–18, 2020, doi: 10.1080/20009666.2020.1711641.
[490]	A. Overlack, “ACE inhibitor-induced cough and bronchospasm. Incidence, mechanisms and management,” Drug Saf, vol. 15, no. 1, pp. 72–78, Jul. 1996, doi: 10.2165/00002018-199615010-00006.
[491]	W. Lear, M. Ruzicka, and F. H. Leenen, “ACE inhibitors and cardiac ACE mRNA in volume overload-induced cardiac hypertrophy,” Am. J. Physiol., vol. 273, no. 2 Pt 2, pp. H641-646, Aug. 1997, doi: 10.1152/ajpheart.1997.273.2.H641.
[492]	T. Miki, H. Kita, and T. Miura, “[ACE inhibitors use in patients with acute coronary syndrome],” Nippon Rinsho, vol. 56, no. 10, pp. 2601–2606, Oct. 1998.
[493]	E. V. Kugaevskaia and I. E. Eliseeva, “[ACE inhibitors--activators of kinin receptors],” Biomed Khim, vol. 57, no. 3, pp. 282–299, Jun. 2011.
[494]	Z. Rahimi, “ACE insertion/deletion (I/D) polymorphism and diabetic nephropathy,” J Nephropathol, vol. 1, no. 3, pp. 143–151, Oct. 2012, doi: 10.5812/nephropathol.8109.
[495]	A. H. J. Danser, W. W. Batenburg, A. H. van den Meiracker, and S. M. Danilov, “ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE inhibition?,” Pharmacol. Ther., vol. 113, no. 3, pp. 607–618, Mar. 2007, doi: 10.1016/j.pharmthera.2006.12.001.
[496]	S. M. Danilov, S. I. Tovsky, D. E. Schwartz, and R. O. Dull, “ACE Phenotyping as a Guide Toward Personalized Therapy With ACE Inhibitors,” J. Cardiovasc. Pharmacol. Ther., vol. 22, no. 4, pp. 374–386, 2017, doi: 10.1177/1074248416686188.
[497]	S. M. Danilov et al., “ACE phenotyping in Gaucher disease,” Mol. Genet. Metab., vol. 123, no. 4, pp. 501–510, 2018, doi: 10.1016/j.ymgme.2018.02.007.
[498]	V. E. Tikhomirova et al., “ACE phenotyping in human heart,” PLoS ONE, vol. 12, no. 8, p. e0181976, 2017, doi: 10.1371/journal.pone.0181976.
[499]	J. B. Schuch et al., “ACE polymorphism and use of ACE inhibitors: effects on memory performance,” Age (Dordr), vol. 36, no. 3, p. 9646, Jun. 2014, doi: 10.1007/s11357-014-9646-z.
[500]	J. S. Miners, Z. van Helmond, M. Raiker, S. Love, and P. G. Kehoe, “ACE variants and association with brain Aβ levels in Alzheimer’s disease,” Am J Transl Res, vol. 3, no. 1, pp. 73–80, Oct. 2010.
[501]	T. S. Ahluwalia et al., “ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy,” DNA Cell Biol., vol. 28, no. 3, pp. 141–150, Mar. 2009, doi: 10.1089/dna.2008.0810.
[502]	M. Vogt, W. Motz, and B. E. Strauer, “ACE-inhibitors in coronary artery disease?,” Basic Res. Cardiol., vol. 88 Suppl 1, pp. 43–64, 1993, doi: 10.1007/978-3-642-72497-8_4.
[503]	A. Pihlanto, S. Akkanen, and H. J. Korhonen, “ACE-inhibitory and antioxidant properties of potato (Solanum tuberosum),” Food Chem, vol. 109, no. 1, pp. 104–112, Jul. 2008, doi: 10.1016/j.foodchem.2007.12.023.
[504]	S. K. Trehan, E. Morakis, C. L. Raggio, K. D. Twomey, and D. W. Green, “Acetabular Protrusio and Proximal Femur Fractures in Patients With Osteogenesis Imperfecta,” J Pediatr Orthop, vol. 35, no. 6, pp. 645–649, Sep. 2015, doi: 10.1097/BPO.0000000000000343.
[505]	J. Ahn, E. Carter, C. L. Raggio, and D. W. Green, “Acetabular Protrusio in Patients With Osteogenesis Imperfecta: Risk Factors and Progression,” J Pediatr Orthop, vol. 39, no. 10, pp. e750–e754, Dec. 2019, doi: 10.1097/BPO.0000000000001051.
[506]	A. W. Rodriguez, D. Woolf, A. P. McCauley, F. Capasso, J. D. Joannopoulos, and S. G. Johnson, “Achieving a strongly temperature-dependent Casimir effect,” Phys. Rev. Lett., vol. 105, no. 6, p. 060401, Aug. 2010, doi: 10.1103/PhysRevLett.105.060401.
[507]	S. M. Rosen, “Achieving and sustaining full employment,” J Public Health Policy, vol. 16, no. 3, pp. 286–303, 1995.
[508]	Y. Tatara, T. Namba, Y. Yamagata, T. Yoshida, T. Uchida, and E. Ichishima, “Acid activation of protyrosinase from Aspergillus oryzae: homo-tetrameric protyrosinase is converted to active dimers with an essential intersubunit disulfide bond at acidic pH,” Pigment Cell Melanoma Res, vol. 21, no. 1, pp. 89–96, Feb. 2008, doi: 10.1111/j.1755-148X.2007.00422.x.
[509]	J. J. Baker, S. J. Dechow, and R. B. Abramovitch, “Acid Fasting: Modulation of Mycobacterium tuberculosis Metabolism at Acidic pH,” Trends Microbiol., vol. 27, no. 11, pp. 942–953, 2019, doi: 10.1016/j.tim.2019.06.005.
[510]	S. R. Martha, J. F. Fraser, and K. R. Pennypacker, “Acid-Base and Electrolyte Changes Drive Early Pathology in Ischemic Stroke,” Neuromolecular Med., vol. 21, no. 4, pp. 540–545, 2019, doi: 10.1007/s12017-019-08555-5.
[511]	L. Rew, “Acknowledging intuition in clinical decision making,” J Holist Nurs, vol. 18, no. 2, pp. 94–108, 109–113, Jun. 2000, doi: 10.1177/089801010001800202.
[512]	R. Patel and P. Campellone, “Acoustic and perceptual cues to contrastive stress in dysarthria,” J. Speech Lang. Hear. Res., vol. 52, no. 1, pp. 206–222, Feb. 2009, doi: 10.1044/1092-4388(2008/07-0078).
[513]	R. Patel, “Acoustic characteristics of the question-statement contrast in severe dysarthria due to cerebral palsy,” J. Speech Lang. Hear. Res., vol. 46, no. 6, pp. 1401–1415, Dec. 2003, doi: 10.1044/1092-4388(2003/109).
[514]	L. Tonetti, A. Scher, O. Atun-Einy, M. Samuel, M. Boreggiani, and V. Natale, “Actigraphic motor activity during sleep from infancy to adulthood,” Chronobiol. Int., vol. 34, no. 2, pp. 246–253, 2017, doi: 10.1080/07420528.2016.1219362.
[515]	M. Aires, C. M. Roos, A. V. F. Gonçalves, J. F. Schneider, and A. Olschowsky, “[Action in mental health to families in different contexts of work: integrative review],” Rev Gaucha Enferm, vol. 31, no. 3, pp. 567–574, Sep. 2010, doi: 10.1590/s1983-14472010000300023.
[516]	C. M. Inácio et al., “Action of tacrolimus on Wistar rat kidneys implanted with Walker 256 carcinosarcoma,” Acta Cir Bras, vol. 25, no. 1, pp. 98–104, Feb. 2010, doi: 10.1590/s0102-86502010000100020.
[517]	D. B. Iverson, Y. Xiao, D. N. Jones, E. Z. Eisenmesser, and N. G. Ahn, “Activation Loop Dynamics Are Coupled to Core Motions in Extracellular Signal-Regulated Kinase-2,” Biochemistry, vol. 59, no. 29, pp. 2698–2706, Jul. 2020, doi: 10.1021/acs.biochem.0c00485.
[518]	M. Fang, T. F. Webster, and H. M. Stapleton, “Activation of Human Peroxisome Proliferator-Activated Nuclear Receptors (PPARγ1) by Semi-Volatile Compounds (SVOCs) and Chemical Mixtures in Indoor Dust,” Environ. Sci. Technol., vol. 49, no. 16, pp. 10057–10064, Aug. 2015, doi: 10.1021/acs.est.5b01523.
[519]	Y. Zhang, D. Jiang, J. Zhang, F. Wang, X. Jiang, and J. Tao, “Activation of neuromedin U type 1 receptor inhibits L-type Ca2+ channel currents via phosphatidylinositol 3-kinase-dependent protein kinase C epsilon pathway in mouse hippocampal neurons,” Cell. Signal., vol. 22, no. 11, pp. 1660–1668, Nov. 2010, doi: 10.1016/j.cellsig.2010.06.006.
[520]	P. F. Abaurre, I. Stefanon, J. G. Mill, and D. V. Vassallo, “Activation of the Langendorff perfused rat heart depolarized by increased external potassium concentration,” Pharmacol. Res., vol. 25, no. 4, pp. 363–372, Jun. 1992, doi: 10.1016/1043-6618(92)90673-y.
[521]	S. Lohia, M. Hanson, R. M. Tuttle, and L. G. T. Morris, “Active surveillance for patients with very low-risk thyroid cancer,” Laryngoscope Investig Otolaryngol, vol. 5, no. 1, pp. 175–182, Feb. 2020, doi: 10.1002/lio2.356.
[522]	K. Montpetit, N. Dahan-Oliel, J. Ruck-Gibis, F. Fassier, F. Rauch, and F. Glorieux, “Activities and participation in young adults with osteogenesis imperfecta,” J Pediatr Rehabil Med, vol. 4, no. 1, pp. 13–22, 2011, doi: 10.3233/PRM-2011-0149.
[523]	H. Shibahara et al., “Activity of testis angiotensin converting enzyme (ACE) in ejaculated human spermatozoa,” Int. J. Androl., vol. 24, no. 5, pp. 295–299, Oct. 2001, doi: 10.1046/j.1365-2605.2001.00301.x.
[524]	J. M. Wheeler et al., “Activity of the poly(A) binding protein MSUT2 determines susceptibility to pathological tau in the mammalian brain,” Sci Transl Med, vol. 11, no. 523, 18 2019, doi: 10.1126/scitranslmed.aao6545.
[525]	X. Mao, Y. Wang, Y. Hou, and M. Zhou, “Activity of the Succinate Dehydrogenase Inhibitor Fungicide Penthiopyrad Against Sclerotinia sclerotiorum,” Plant Dis., p. PDIS10192253RE, Jul. 2020, doi: 10.1094/PDIS-10-19-2253-RE.
[526]	M. Mastrangelo, F. Midulla, and C. Moretti, “Actual insights into the clinical management of febrile seizures,” Eur. J. Pediatr., vol. 173, no. 8, pp. 977–982, Aug. 2014, doi: 10.1007/s00431-014-2269-7.
[527]	N. Errington-Evans, “Acupuncture for anxiety,” CNS Neurosci Ther, vol. 18, no. 4, pp. 277–284, Apr. 2012, doi: 10.1111/j.1755-5949.2011.00254.x.
[528]	M. Hollifield, “Acupuncture for posttraumatic stress disorder: conceptual, clinical, and biological data support further research,” CNS Neurosci Ther, vol. 17, no. 6, pp. 769–779, Dec. 2011, doi: 10.1111/j.1755-5949.2011.00241.x.
[529]	M. Akira and N. Suganuma, “Acute and subacute chemical-induced lung injuries: HRCT findings,” Eur J Radiol, vol. 83, no. 8, pp. 1461–1469, Aug. 2014, doi: 10.1016/j.ejrad.2014.04.024.
[530]	P. C. Pelikan, M. L. Weisfeldt, W. E. Jacobus, M. V. Miceli, B. H. Bulkley, and G. Gerstenblith, “Acute doxorubicin cardiotoxicity: functional, metabolic, and morphologic alterations in the isolated, perfused rat heart,” J. Cardiovasc. Pharmacol., vol. 8, no. 5, pp. 1058–1066, Oct. 1986.
[531]	H. E. Schlagintweit, R. F. Tyndale, and C. S. Hendershot, “Acute effects of a very low nicotine content cigarette on laboratory smoking lapse: Impacts of nicotine metabolism and nicotine dependence,” Addict Biol, p. e12930, Jun. 2020, doi: 10.1111/adb.12930.
[532]	A. Ushiyama and C. Ohkubo, “Acute effects of low-frequency electromagnetic fields on leukocyte-endothelial interactions in vivo,” In Vivo, vol. 18, no. 2, pp. 125–132, Apr. 2004.
[533]	M. E. Hoffer, B. E. Levin, H. Snapp, J. Buskirk, and C. Balaban, “Acute findings in an acquired neurosensory dysfunction,” Laryngoscope Investig Otolaryngol, vol. 4, no. 1, pp. 124–131, Feb. 2019, doi: 10.1002/lio2.231.
[534]	A. Minucci et al., “Acute haemolytic crisis due to concomitant presence of infection and possible altered acetaminophen catabolism in a Philipino child carrying the G6PD-Vanua Lava mutation,” Ann. Clin. Biochem., vol. 48, no. Pt 3, pp. 282–285, May 2011, doi: 10.1258/acb.2010.010163.
[535]	A. Ferrarini, G. P. Milani, M. G. Bianchetti, and S. a. G. Lava, “Acute hemorrhagic edema of infancy associated with Coxsackie virus infection,” Arch Pediatr, vol. 25, no. 3, p. 244, 2018, doi: 10.1016/j.arcped.2018.01.006.
[536]	R. R. Blush and M. Matzo, “Acute infectious diarrhea,” Am J Nurs, vol. 112, no. 8, pp. 65–68, Aug. 2012, doi: 10.1097/01.NAJ.0000418105.99929.4f.
[537]	M. Hamood, F. Corazza, P. F. Bluche, H. el-Teraifi, and P. Fondu, “Acute inflammation effects on in vivo granulopoiesis: comparative studies in healthy and leukaemic mice,” In Vivo, vol. 6, no. 1, pp. 45–48, Feb. 1992.
[538]	R. G. Kowalski et al., “Acute Ischemic Stroke After Moderate to Severe Traumatic Brain Injury: Incidence and Impact on Outcome,” Stroke, vol. 48, no. 7, pp. 1802–1809, 2017, doi: 10.1161/STROKEAHA.117.017327.
[539]	T. Yoshida, H. Tsujimoto, T. Ichikawa, S. Kounami, and H. Suzuki, “Acute Lymphoblastic Leukemia Presenting as Fanconi Syndrome,” Case Rep Oncol, vol. 11, no. 1, pp. 63–67, Apr. 2018, doi: 10.1159/000486364.
[540]	J.-Y. Yeh, K.-Y. Tu, P.-T. Tseng, Y. Lee, and P.-Y. Lin, “Acute Onset of Abdominal Muscle Dyskinesia ('Belly Dancer Syndrome’) From Quetiapine Exposure: A Case Report,” Clin Neuropharmacol, vol. 41, no. 2, pp. 73–74, Apr. 2018, doi: 10.1097/WNF.0000000000000271.
[541]	E. M. Barajas-Fregoso, T. Romero-Hernández, and M. D. Macías-Amezcua, “[Acute pancreatitis and afferent loop syndrome. Case report],” Cir Cir, vol. 81, no. 5, pp. 441–444, Oct. 2013.
[542]	E. Kaya, G. Senyürek, A. Dervisoglu, M. Danaci, and M. Kesim, “Acute pancreatitis caused by afferent loop herniation after Billroth II gastrectomy: report of a case and review of the literature,” Hepatogastroenterology, vol. 51, no. 56, pp. 606–608, Apr. 2004.
[543]	Z.-P. Guo, Y.-H. Tan, J.-L. Li, Z.-F. Xu, X.-H. Chen, and L.-R. Xu, “Acute pro-B-Cell lymphoblastic leukemia transformed from myelodysplastic syndrome with an ASXL1 missense mutation: A case report with literature review,” Oncol Lett, vol. 15, no. 6, pp. 9745–9750, Jun. 2018, doi: 10.3892/ol.2018.8546.
[544]	Y.-T. Zhao and It. Tu, “Acute pulmonary embolism with precordial T-wave inversion and negative D-dimer,” Am J Emerg Med, vol. 35, no. 3, p. 520.e3, 2017, doi: 10.1016/j.ajem.2016.09.061.
[545]	T. B. Erickson, S. E. Aks, R. Zabaneh, and R. Reid, “Acute renal toxicity after ingestion of Lava light liquid,” Ann Emerg Med, vol. 27, no. 6, pp. 781–784, Jun. 1996, doi: 10.1016/s0196-0644(96)70202-0.
[546]	Z. Brzoza et al., “Adaptation and initial results of the Polish version of the GA(2)LEN chronic urticaria quality of life questionnaire (CU-Q(2)oL),” J. Dermatol. Sci., vol. 62, no. 1, pp. 36–41, Apr. 2011, doi: 10.1016/j.jdermsci.2011.01.010.
[547]	J. Jeong and S. C. Chong, “Adaptation to mean and variance: Interrelationships between mean and variance representations in orientation perception,” Vision Res., vol. 167, pp. 46–53, 2020, doi: 10.1016/j.visres.2020.01.002.
[548]	G. Kampf, “Adaptive bacterial response to low level chlorhexidine exposure and its implications for hand hygiene,” Microb Cell, vol. 6, no. 7, pp. 307–320, Mar. 2019, doi: 10.15698/mic2019.07.683.
[549]	G. Conductier et al., “Adaptive changes in serotonin neurons of the raphe nuclei in 5-HT(4) receptor knock-out mouse,” Eur. J. Neurosci., vol. 24, no. 4, pp. 1053–1062, Aug. 2006, doi: 10.1111/j.1460-9568.2006.04943.x.
[550]	M. Diego, G. Carlos, and A. Jose, “Adaptive learning objects in the context of eco-connectivist communities using learning analytics,” Heliyon, vol. 5, no. 11, p. e02722, Nov. 2019, doi: 10.1016/j.heliyon.2019.e02722.
[551]	M. So et al., “Addenbrooke’s Cognitive Examination III: Psychometric Characteristics and Relations to Functional Ability in Dementia,” J Int Neuropsychol Soc, vol. 24, no. 8, pp. 854–863, 2018, doi: 10.1017/S1355617718000541.
[552]	J. M. Farber and M. H. Tang, “Addendum: Mood and affect disorders,” Pediatr Rev, vol. 36, no. 4, p. 180, Apr. 2015, doi: 10.1542/pir.36-4-180.
[553]	G. Lehnerdt, O. Schöffski, S. Mattheis, T. K. Hoffmann, and S. Lang, “[Additional qualification in health economics--a pre-condition for ENT leadership positions?],” Laryngorhinootologie, vol. 92, no. 11, pp. 746–755, Nov. 2013, doi: 10.1055/s-0032-1333264.
[554]	Y. Hen et al., “Additive prognostic significance of ejection fraction for ESC risk model in hypertrophic cardiomyopathy patients,” Heart Vessels, vol. 35, no. 3, pp. 391–398, Mar. 2020, doi: 10.1007/s00380-019-01496-w.
[555]	N. A. Merriman et al., “Addressing cognitive impairment following stroke: systematic review and meta-analysis of non-randomised controlled studies of psychological interventions,” BMJ Open, vol. 9, no. 2, p. e024429, 27 2019, doi: 10.1136/bmjopen-2018-024429.
[556]	Y. Dagan and J. Yager, “Addressing Loneliness in Complex PTSD,” J. Nerv. Ment. Dis., vol. 207, no. 6, pp. 433–439, Jun. 2019, doi: 10.1097/NMD.0000000000000992.
[557]	“Addressing the social determinants of health in young people,” Lancet, vol. 387, no. 10024, p. 1134, Mar. 2016, doi: 10.1016/S0140-6736(16)30004-6.
[558]	S. Aizawa et al., “Adenosine stimulates neuromedin U mRNA expression in the rat pars tuberalis,” Mol. Cell. Endocrinol., vol. 496, p. 110518, 01 2019, doi: 10.1016/j.mce.2019.110518.
[559]	F. Rahman, I. B. Putra, C. A. Mochtar, and N. Rasyid, “Adherence of Indonesian urologists to practice guidelines for the management of benign prostatic hyperplasia,” Prostate Int, vol. 7, no. 1, pp. 35–40, Mar. 2019, doi: 10.1016/j.prnil.2018.01.003.
[560]	U. Schepke, U. Lohbauer, H. J. Meijer, and M. S. Cune, “Adhesive Failure of Lava Ultimate and Lithium Disilicate Crowns Bonded to Zirconia Abutments: A Prospective Within-Patient Comparison,” Int J Prosthodont, vol. 31, no. 3, pp. 208–210, Jun. 2018, doi: 10.11607/ijp.5617.
[561]	S. Kwon, B. Kim, S. An, W. Lee, H.-Y. Kwak, and W. Jhe, “Adhesive force measurement of steady-state water nano-meniscus: Effective surface tension at nanoscale,” Sci Rep, vol. 8, no. 1, p. 8462, 31 2018, doi: 10.1038/s41598-018-26893-5.
[562]	K. Kohlstedt, C. Trouvain, D. Namgaladze, and I. Fleming, “Adipocyte-derived lipids increase angiotensin-converting enzyme (ACE) expression and modulate macrophage phenotype,” Basic Res. Cardiol., vol. 106, no. 2, pp. 205–215, Mar. 2011, doi: 10.1007/s00395-010-0137-9.
[563]	P. A. Smith, M. Piepenbrink, S. K. Smith, S. Bachmaier, A. Bedi, and C. A. Wijdicks, “Adjustable- Versus Fixed-Loop Devices for Femoral Fixation in ACL Reconstruction: An In Vitro Full-Construct Biomechanical Study of Surgical Technique-Based Tibial Fixation and Graft Preparation,” Orthop J Sports Med, vol. 6, no. 4, p. 2325967118768743, Apr. 2018, doi: 10.1177/2325967118768743.
[564]	L. Oddershede and K. D. Petersen, “Adjustment of foreign EQ-5D-3L utilities can increase their transferability,” Clinicoecon Outcomes Res, vol. 7, pp. 629–636, 2015, doi: 10.2147/CEOR.S93280.
[565]	E. Y. Tu and P. A. Majmudar, “Adjuvant Stromal Amphotericin B Injection for Late-Onset DMEK Infection,” Cornea, vol. 36, no. 12, pp. 1556–1558, Dec. 2017, doi: 10.1097/ICO.0000000000001398.
[566]	H. Lamouliatte, “Adjuvant therapy for Helicobacter pylori eradication: role of lansoprazole in clinical studies,” J. Clin. Gastroenterol., vol. 20 Suppl 1, pp. S28-31, 1995, doi: 10.1097/00004836-199506001-00007.
[567]	N. W. Harper et al., “Adjuvant Treatment of Triple-Negative Metaplastic Breast Cancer With Weekly Paclitaxel and Platinum Chemotherapy: Retrospective Case Review From a Single Institution,” Clin. Breast Cancer, vol. 19, no. 4, pp. e495–e500, 2019, doi: 10.1016/j.clbc.2019.05.009.
[568]	C. H. Hodgman and E. R. McAnarney, “Adolescent depression and suicide: rising problems,” Hosp. Pract. (Off. Ed.), vol. 27, no. 4, pp. 73–76, 81, 84-85 passim, Apr. 1992, doi: 10.1080/21548331.1992.11705400.
[569]	“Adolescent health: boys matter too,” Lancet, vol. 386, no. 10010, p. 2227, Dec. 2015, doi: 10.1016/S0140-6736(15)01160-5.
[570]	M. A. Short and M. W. L. Chee, “Adolescent sleep restriction effects on cognition and mood,” Prog. Brain Res., vol. 246, pp. 55–71, 2019, doi: 10.1016/bs.pbr.2019.02.008.
[571]	L. Rew, D. Tyler, N. Fredland, and D. Hannah, “Adolescents’ concerns as they transition through High School,” ANS Adv Nurs Sci, vol. 35, no. 3, pp. 205–221, Sep. 2012, doi: 10.1097/ANS.0b013e318261a7d7.
[572]	A. G. S. Prado et al., “Adsorption and preconcentration of divalent metal ions in fossil fuels and biofuels: gasoline, diesel, biodiesel, diesel-like and ethanol by using chitosan microspheres and thermodynamic approach,” Talanta, vol. 84, no. 3, pp. 759–765, May 2011, doi: 10.1016/j.talanta.2011.02.003.
[573]	J. K. Hacker and J. L. Hardy, “Adsorptive endocytosis of California encephalitis virus into mosquito and mammalian cells: a role for G1,” Virology, vol. 235, no. 1, pp. 40–47, Aug. 1997, doi: 10.1006/viro.1997.8675.
[574]	A. Castillo and J. W. Gilger, “Adult perceptions of children with dyslexia in the USA,” Ann Dyslexia, vol. 68, no. 3, pp. 203–217, 2018, doi: 10.1007/s11881-018-0163-0.
[575]	K. Geurtzen and F. Knopf, “Adult Zebrafish Injury Models to Study the Effects of Prednisolone in Regenerating Bone Tissue,” J Vis Exp, no. 140, 18 2018, doi: 10.3791/58429.
[576]	N. Maeda, K. Ikeda, M. Matsumoto, and Y. Namba, “Advanced lipid technology,” J Liposome Res, vol. 27, no. 3, pp. 221–227, Sep. 2017, doi: 10.1080/08982104.2016.1224898.
[577]	L. Zhang et al., “Advanced Matrixes for Binder-Free Nanostructured Electrodes in Lithium-Ion Batteries,” Adv. Mater. Weinheim, vol. 32, no. 24, p. e1908445, Jun. 2020, doi: 10.1002/adma.201908445.
[578]	J. Ge, H.-Y. Zhao, H.-W. Zhu, J. Huang, L.-A. Shi, and S.-H. Yu, “Advanced Sorbents for Oil-Spill Cleanup: Recent Advances and Future Perspectives,” Adv. Mater. Weinheim, vol. 28, no. 47, pp. 10459–10490, Dec. 2016, doi: 10.1002/adma.201601812.
[579]	D. Ockert, M. Schmitz, M. Hampl, and E. P. Rieber, “Advances in cancer immunotherapy,” Immunol. Today, vol. 20, no. 2, pp. 63–65, Feb. 1999, doi: 10.1016/s0167-5699(98)01388-7.
[580]	M. Parastarfeizabadi and A. Z. Kouzani, “Advances in closed-loop deep brain stimulation devices,” J Neuroeng Rehabil, vol. 14, no. 1, p. 79, 11 2017, doi: 10.1186/s12984-017-0295-1.
[581]	J. Cao, J. Hou, J. Ping, and D. Cai, “Advances in developing novel therapeutic strategies for Alzheimer’s disease,” Mol Neurodegener, vol. 13, no. 1, p. 64, 12 2018, doi: 10.1186/s13024-018-0299-8.
[582]	M. N. Jha, J. Levy, and Y. Gao, “Advances in Remote Sensing for Oil Spill Disaster Management: State-of-the-Art Sensors Technology for Oil Spill Surveillance,” Sensors (Basel), vol. 8, no. 1, pp. 236–255, 21 2008, doi: 10.3390/s8010236.
[583]	J. Elisseeff, C. Puleo, F. Yang, and B. Sharma, “Advances in skeletal tissue engineering with hydrogels,” Orthod Craniofac Res, vol. 8, no. 3, pp. 150–161, Aug. 2005, doi: 10.1111/j.1601-6343.2005.00335.x.
[584]	M. Polakovičová and J. Jampílek, “Advances in Structural Biology of ACE and Development of Domain Selective ACE-inhibitors,” Med Chem, vol. 15, no. 6, pp. 574–587, 2019, doi: 10.2174/1573406415666190514081132.
[585]	Z. Wang, R. Fang, and H. Guo, “Advances in ultrasonic production units for enhanced oil recovery in China,” Ultrason Sonochem, vol. 60, p. 104791, Jan. 2020, doi: 10.1016/j.ultsonch.2019.104791.
[586]	J. Liese et al., “Advances toward fully automated in vivo assessment of oral epithelial dysplasia by nuclear endomicroscopy-A pilot study,” J. Oral Pathol. Med., vol. 46, no. 10, pp. 911–920, Nov. 2017, doi: 10.1111/jop.12613.
[587]	Y. Ciervo, K. Ning, X. Jun, P. J. Shaw, and R. J. Mead, “Advances, challenges and future directions for stem cell therapy in amyotrophic lateral sclerosis,” Mol Neurodegener, vol. 12, no. 1, p. 85, Nov. 2017, doi: 10.1186/s13024-017-0227-3.
[588]	C.-S. Yang, “Advancing host-directed therapy for tuberculosis,” Microb Cell, vol. 4, no. 3, pp. 105–107, Mar. 2017, doi: 10.15698/mic2017.03.565.
[589]	K. A. Ports, D. C. Ford, and M. T. Merrick, “Adverse childhood experiences and sexual victimization in adulthood,” Child Abuse Negl, vol. 51, pp. 313–322, Jan. 2016, doi: 10.1016/j.chiabu.2015.08.017.
[590]	T. F. Dardas et al., “Adverse Effects of Delayed Transplant Listing Among Patients With Implantable Left Ventricular Assist Devices,” J. Card. Fail., vol. 24, no. 4, pp. 243–248, Apr. 2018, doi: 10.1016/j.cardfail.2018.01.003.
[591]	A. Budikayanti, L. M. Qadri, Z. Syeban, L. A. Indrawati, and F. Octaviana, “Adverse Events of Antiepileptic Drugs Using Indonesian Version of Liverpool Adverse Events Profile,” Neurol Res Int, vol. 2018, p. 8490639, 2018, doi: 10.1155/2018/8490639.
[592]	T. Horvat, B. Landesmann, A. Lostia, M. Vinken, S. Munn, and M. Whelan, “Adverse outcome pathway development from protein alkylation to liver fibrosis,” Arch. Toxicol., vol. 91, no. 4, pp. 1523–1543, Apr. 2017, doi: 10.1007/s00204-016-1814-8.
[593]	A. L. de S. A. Zara, S. M. D. Santos, E. S. Fernandes-Oliveira, R. G. Carvalho, and G. E. Coelho, “[Aedes aegypti control strategies: a review],” Epidemiol Serv Saude, vol. 25, no. 2, pp. 391–404, Jun. 2016, doi: 10.5123/S1679-49742016000200017.
[594]	E. I. Lee, “Aesthetic alteration of the chin,” Semin Plast Surg, vol. 27, no. 3, pp. 155–160, Aug. 2013, doi: 10.1055/s-0033-1357113.
[595]	J. K. Larsen and P. Bech, “[Affective disorders--depression diagnosis and prognosis],” Ugeskr. Laeg., vol. 169, no. 16, pp. 1427–1431, Apr. 2007.
[596]	M. Aoki, M. Saka, S. Morita, T. Fukagawa, and H. Katai, “Afferent loop obstruction after distal gastrectomy with Roux-en-Y reconstruction,” World J Surg, vol. 34, no. 10, pp. 2389–2392, Oct. 2010, doi: 10.1007/s00268-010-0602-5.
[597]	D. J. Kim, J. H. Lee, and W. Kim, “Afferent loop obstruction following laparoscopic distal gastrectomy with Billroth-II gastrojejunostomy,” J Korean Surg Soc, vol. 84, no. 5, pp. 281–286, May 2013, doi: 10.4174/jkss.2013.84.5.281.
[598]	R. K. Warrier and F. U. Steinheber, “Afferent loop obstruction presenting as obstructive jaundice,” Dig. Dis. Sci., vol. 24, no. 1, pp. 74–76, Jan. 1979, doi: 10.1007/BF01297242.
[599]	S. Bamba, H. Shiomi, and Y. Fujiyama, “Afferent loop syndrome successfully treated by endoscopic ultrasound-guided transgastric drainage,” Dig Endosc, vol. 25, no. 6, pp. 632–633, Nov. 2013, doi: 10.1111/den.12168.
[600]	W. G. Everett and D. Sampson, “Afferent-loop obstruction mimicking acute pancreatitis,” Br J Surg, vol. 56, no. 11, pp. 843–844, Nov. 1969, doi: 10.1002/bjs.1800561113.
[601]	M. Olabi, M. Stein, and H. Wätzig, “Affinity capillary electrophoresis for studying interactions in life sciences,” Methods, vol. 146, pp. 76–92, 15 2018, doi: 10.1016/j.ymeth.2018.05.006.
[602]	C. Megías et al., “Affinity purification of angiotensin converting enzyme inhibitory peptides using immobilized ACE,” J. Agric. Food Chem., vol. 54, no. 19, pp. 7120–7124, Sep. 2006, doi: 10.1021/jf061488b.
[603]	“African Programme for Onchocerciasis Control: progress report, 2014–2015,” Wkly. Epidemiol. Rec., vol. 90, no. 49, pp. 661–674, Dec. 2015.
[604]	J. H. Wallace and J. H. Hanks, “Agar substrates for study of microepidemiology and physiology in cells in vitro,” Science, vol. 128, no. 3325, pp. 658–659, Sep. 1958, doi: 10.1126/science.128.3325.658.
[605]	C. A. Brown, Y. Jiang, C. D. Smith, and B. T. Gold, “Age and Alzheimer’s pathology disrupt default mode network functioning via alterations in white matter microstructure but not hyperintensities,” Cortex, vol. 104, pp. 58–74, 2018, doi: 10.1016/j.cortex.2018.04.006.
[606]	M. Hamad and S. Awadallah, “Age group-associated variations in the pattern of Hp type distribution in Jordanians,” Clin. Chim. Acta, vol. 300, no. 1–2, pp. 75–81, Oct. 2000, doi: 10.1016/s0009-8981(00)00301-6.
[607]	K. E. Schenk and G. Heinze, “Age-dependent changes of heart valves and heart size,” Recent Adv Stud Cardiac Struct Metab, vol. 10, pp. 617–624, 1975.
[608]	O. J. Ungar, U. Amit, O. Cavel, Y. Oron, and O. Handzel, “Age-dependent variations of scalp thickness in the area designated for a cochlear implant receiver stimulator,” Laryngoscope Investig Otolaryngol, vol. 3, no. 6, pp. 496–499, Dec. 2018, doi: 10.1002/lio2.218.
[609]	 null Kumar,  null Houtz, and  null Knowles, “Age-induced protein modifications and increased proteolysis in potato seed-tubers,” Plant Physiol., vol. 119, no. 1, pp. 89–100, Jan. 1999, doi: 10.1104/pp.119.1.89.
[610]	R. Otsuka et al., “Age-Related 12-Year Changes in Dietary Diversity and Food Intakes among Community-Dwelling Japanese Aged 40 to 79 Years,” J Nutr Health Aging, vol. 22, no. 5, pp. 594–600, 2018, doi: 10.1007/s12603-018-0999-3.
[611]	S. Isoyama, “Age-related changes before and after imposition of hemodynamic stress in the mammalian heart,” Life Sci., vol. 58, no. 19, pp. 1601–1614, 1996, doi: 10.1016/0024-3205(96)00041-0.
[612]	D. G. Scholz, D. W. Kitzman, P. T. Hagen, D. M. Ilstrup, and W. D. Edwards, “Age-related changes in normal human hearts during the first 10 decades of life. Part I (Growth): A quantitative anatomic study of 200 specimens from subjects from birth to 19 years old,” Mayo Clin. Proc., vol. 63, no. 2, pp. 126–136, Feb. 1988, doi: 10.1016/s0025-6196(12)64945-3.
[613]	R. I. Abraĭtis, V. S. Vaĭchekauskas, R. A. Stropus, and K. A. Tamashauskas, “[Age-related changes in the cholin- and adrenergic innervation of the human heart],” Kardiologiia, vol. 21, no. 9, pp. 106–108, Sep. 1981.
[614]	N. C. Tu and R. A. Friedman, “Age-related hearing loss: Unraveling the pieces,” Laryngoscope Investig Otolaryngol, vol. 3, no. 2, pp. 68–72, Apr. 2018, doi: 10.1002/lio2.134.
[615]	M. Evrard, “Ageing and lexical access to common and proper names in picture naming,” Brain Lang, vol. 81, no. 1–3, pp. 174–179, Jun. 2002, doi: 10.1006/brln.2001.2515.
[616]	J. A. Smith, “Agenda driven publications,” J. Urol., vol. 188, no. 5, pp. 1656–1657, Nov. 2012, doi: 10.1016/j.juro.2012.08.140.
[617]	S. L. Smith and M. A. Rodriguez, “Agenda setting for maternal survival: the power of global health networks and norms,” Health Policy Plan, vol. 31 Suppl 1, pp. i48-59, Apr. 2016, doi: 10.1093/heapol/czu114.
[618]	K. S. Kaye, J. M. Pogue, T. B. Tran, R. L. Nation, and J. Li, “Agents of Last Resort: Polymyxin Resistance,” Infect. Dis. Clin. North Am., vol. 30, no. 2, pp. 391–414, 2016, doi: 10.1016/j.idc.2016.02.005.
[619]	S.-Y. Park et al., “Aggravation of Dysphagia aortica after wearing the abdominal binder,” J Neurogastroenterol Motil, vol. 16, no. 3, pp. 323–326, Jul. 2010, doi: 10.5056/jnm.2010.16.3.323.
[620]	N. Jollands, J. Lermit, and M. Patterson, “Aggregate eco-efficiency indices for New Zealand--a principal components analysis,” J. Environ. Manage., vol. 73, no. 4, pp. 293–305, Dec. 2004, doi: 10.1016/j.jenvman.2004.07.002.
[621]	M. Evans, “Aggressive cost-cutting. Maryland wants to tie spending increases to economic growth,” Mod Healthc, vol. 43, no. 15, p. 16, Apr. 2013.
[622]	A. Krolo et al., “Agility Testing in Youth Football (Soccer)Players; Evaluating Reliability, Validity, and Correlates of Newly Developed Testing Protocols,” Int J Environ Res Public Health, vol. 17, no. 1, 01 2020, doi: 10.3390/ijerph17010294.
[623]	H. E. Kaiser, “Aging and neoplastic progression,” In Vivo, vol. 12, no. 6, pp. 691–693, Dec. 1998.
[624]	J. L. McDermott and D. E. Dluzen, “Aging and sex differences in striatal dopaminergic function,” Neuroscience, vol. 149, no. 2, pp. 401–408, Oct. 2007, doi: 10.1016/j.neuroscience.2007.06.058.
[625]	J. F. Norman, K. N. Sanders, H. K. Shapiro, and A. E. Peterson, “Aging and the Perception of Motion-Defined Form,” Perception, vol. 49, no. 1, pp. 52–60, Jan. 2020, doi: 10.1177/0301006619887331.
[626]	R. E. Nappi, A. Costa, A. Poma, C. Farina, C. Zara, and S. Rivest, “Aging female brain: is there a change of adaptive stress?,” Aging (Milano), vol. 9, no. 4 Suppl, pp. 64–65, 1997, doi: 10.1007/BF03339711.
[627]	V. J. Coppola and V. P. Bingman, “Aging is associated with larger brain mass and volume in homing pigeons (Columba livia),” Neurosci. Lett., vol. 698, pp. 39–43, 17 2019, doi: 10.1016/j.neulet.2019.01.007.
[628]	G. A. Aguayo et al., “Agreement Between 35 Published Frailty Scores in the General Population,” Am. J. Epidemiol., vol. 186, no. 4, pp. 420–434, Aug. 2017, doi: 10.1093/aje/kwx061.
[629]	M. J. Postma, J. J. Kwik, W. J. M. J. Rutten, L. T. W. de Jong-van den Berg, and J. R. B. J. Brouwers, “[Agreement between guidelines for pharmaco-economic research and never-before-published health-economics evaluations],” Ned Tijdschr Geneeskd, vol. 146, no. 23, pp. 1082–1087, Jun. 2002.
[630]	M. Liu, C. Chen, L. Yang, Q. Min, and Y. Xiong, “Agricultural eco-compensation may not necessarily reduce chemical inputs,” Sci. Total Environ., vol. 741, p. 139847, May 2020, doi: 10.1016/j.scitotenv.2020.139847.
[631]	A. B. Cecílio, M. S. Bianco, C. F. Tardivo, and G. C. M. Pugina, “Agronomic viability of New Zealand spinach and kale intercropping,” An. Acad. Bras. Cienc., vol. 89, no. 4, pp. 2975–2986, Dec. 2017, doi: 10.1590/0001-3765201720160906.
[632]	P. P. Sengupta and D. A. Adjeroh, “AI tracks a beating heart’s function over time,” Nature, vol. 580, no. 7802, pp. 192–194, 2020, doi: 10.1038/d41586-020-00819-6.
[633]	S. Shang, W. Li, X. Qin, S. Zhang, and Y. Liu, “Aided Diagnosis of Hepatocellular Carcinoma Using Serum Fucosylated Haptoglobin Ratios,” J Cancer, vol. 8, no. 5, pp. 887–893, 2017, doi: 10.7150/jca.17747.
[634]	R. Biancheri, A. Rossi, F. Zara, and M. Filocamo, “AIMP1/p43 mutation and PMLD,” Am. J. Hum. Genet., vol. 88, no. 3, pp. 391; author reply 393-395, Mar. 2011, doi: 10.1016/j.ajhg.2011.02.003.
[635]	G. Zara, M. Budroni, I. Mannazzu, and S. Zara, “Air-liquid biofilm formation is dependent on ammonium depletion in a Saccharomyces cerevisiae flor strain,” Yeast, vol. 28, no. 12, pp. 809–814, Dec. 2011, doi: 10.1002/yea.1907.
[636]	T. A. Laguna et al., “Airway Microbiota in Bronchoalveolar Lavage Fluid from Clinically Well Infants with Cystic Fibrosis,” PLoS ONE, vol. 11, no. 12, p. e0167649, 2016, doi: 10.1371/journal.pone.0167649.
[637]	C. Cuvelier, M. Tintillier, G. Migali, C. Van Ende, and J.-M. Pochet, “Albumin losses during hemodiafiltration: all dialyzers are not created equal - a case report,” BMC Nephrol, vol. 20, no. 1, p. 392, 28 2019, doi: 10.1186/s12882-019-1567-8.
[638]	P. Bogowicz, J. Ferguson, E. Gilvarry, F. Kamali, E. Kaner, and D. Newbury-Birch, “Alcohol and other substance use among medical and law students at a UK university: a cross-sectional questionnaire survey,” Postgrad Med J, vol. 94, no. 1109, pp. 131–136, Mar. 2018, doi: 10.1136/postgradmedj-2017-135136.
[639]	K. Yoneyama and J. A. C. Lima, “Alcohol consumption and myocardial remodeling in elderly women and men,” Circ Cardiovasc Imaging, vol. 8, no. 6, Jun. 2015, doi: 10.1161/CIRCIMAGING.115.003523.
[640]	R. Marten, G. G. H. Amul, and S. Casswell, “Alcohol: global health’s blind spot,” Lancet Glob Health, vol. 8, no. 3, pp. e329–e330, 2020, doi: 10.1016/S2214-109X(20)30008-5.
[641]	R. A. Petrella, C. C. Fesmire, J. D. Kaufman, N. Topasna, and M. B. Sano, “Algorithmically Controlled Electroporation: A Technique for Closed Loop Temperature Regulated Pulsed Electric Field Cancer Ablation,” IEEE Trans Biomed Eng, vol. 67, no. 8, pp. 2176–2186, Aug. 2020, doi: 10.1109/TBME.2019.2956537.
[642]	C. Mirabelli and C. E. Wobus, “All Aboard! Enteric Viruses Travel Together,” Cell Host Microbe, vol. 24, no. 2, pp. 183–185, 08 2018, doi: 10.1016/j.chom.2018.07.012.
[643]	A. Papa and C. Lefton, “All in the Family Presence,” J Emerg Nurs, vol. 41, no. 5, pp. 434–437, Sep. 2015, doi: 10.1016/j.jen.2015.05.012.
[644]	W. H. Saris and S. B. Heymsfield, “All metabolic roads lead to mitochondrial (dys)-function,” Curr Opin Clin Nutr Metab Care, vol. 10, no. 6, pp. 661–663, Nov. 2007, doi: 10.1097/MCO.0b013e3282f161cb.
[645]	E. De la Rosa, L. A. Zenteno, A. N. Starodumov, and D. Monzon, “All-fiber absolute temperature sensor using an unbalanced high-birefringence Sagnac loop,” Opt Lett, vol. 22, no. 7, pp. 481–483, Apr. 1997, doi: 10.1364/ol.22.000481.
[646]	J. Sotor, T. Martynkien, P. G. Schunemann, P. Mergo, L. Rutkowski, and G. Soboń, “All-fiber mid-infrared source tunable from 6 to 9 μm based on difference frequency generation in OP-GaP crystal,” Opt Express, vol. 26, no. 9, pp. 11756–11763, Apr. 2018, doi: 10.1364/OE.26.011756.
[647]	M. Kupiec and T. D. Petes, “Allelic and ectopic recombination between Ty elements in yeast,” Genetics, vol. 119, no. 3, pp. 549–559, Jul. 1988.
[648]	K. T. Rew, “Allergy and Asthma: Foreword,” FP Essent, vol. 472, p. 2, Sep. 2018.
[649]	D. Rusinaru et al., “Allometric versus ratiometric normalization of left ventricular stroke volume by Doppler-echocardiography for outcome prediction in severe aortic stenosis with preserved ejection fraction,” Int. J. Cardiol., vol. 301, pp. 235–241, 15 2020, doi: 10.1016/j.ijcard.2019.09.056.
[650]	M. Yan, H. Wang, Q. Wang, Z. Zhang, and C. Zhang, “Allosteric inhibition of c-Met kinase in sub-microsecond molecular dynamics simulations induced by its inhibitor, tivantinib,” Phys Chem Chem Phys, vol. 18, no. 15, pp. 10367–10374, Apr. 2016, doi: 10.1039/c5cp07001e.
[651]	Z. Jelić-Ivanović, V. Spasojević-Kalimanovska, A. Topić, S. Spasić, and V. Petrović, “alpha-1-Antitrypsin (Pi) polymorphism in Serbia: deviation of Pi M subtype distribution from the Hardy-Weinberg equilibrium,” Gene Geogr, vol. 8, no. 2, pp. 129–135, Aug. 1994.
[652]	H. O. Otero, R. D. Wangler, H. V. Sparks, and J. E. Chimoskey, “Alpha-human atrial natriuretic peptide is a coronary vasodilator in the Langendorff-perfused guinea pig heart,” Life Sci., vol. 42, no. 6, pp. 695–700, 1988, doi: 10.1016/0024-3205(88)90461-4.
[653]	R. M. Meade, D. P. Fairlie, and J. M. Mason, “Alpha-synuclein structure and Parkinson’s disease - lessons and emerging principles,” Mol Neurodegener, vol. 14, no. 1, p. 29, 22 2019, doi: 10.1186/s13024-019-0329-1.
[654]	C. R. Camara-Lemarroy, D. Ortiz-Zacarías, J. J. Peña-Avendaño, I. Estrada-Bellmann, H. J. Villarreal-Velázquez, and M. A. Díaz-Torres, “Alterations in balance and mobility in people with epilepsy,” Epilepsy Behav, vol. 66, pp. 53–56, 2017, doi: 10.1016/j.yebeh.2016.10.021.
[655]	P. N. Jha et al., “Alterations in the Endophyte-Enriched Root-Associated Microbiome of Rice Receiving Growth-Promoting Treatments of Urea Fertilizer and Rhizobium Biofertilizer,” Microb. Ecol., vol. 79, no. 2, pp. 367–382, Feb. 2020, doi: 10.1007/s00248-019-01406-7.
[656]	L. M. Lagrou et al., “Altered corneal biomechanical properties in children with osteogenesis imperfecta,” J AAPOS, vol. 22, no. 3, pp. 183-187.e1, 2018, doi: 10.1016/j.jaapos.2017.12.015.
[657]	M. Radenković, N. Radunović, P. Momcilov, and L. Grbović, “Altered response of human umbilical artery to 5-HT in gestational diabetic pregnancy,” Pharmacol Rep, vol. 61, no. 3, pp. 520–528, Jun. 2009, doi: 10.1016/s1734-1140(09)70095-7.
[658]	G. Kullman and R. Pineda, “Alternative applications of the femtosecond laser in ophthalmology,” Semin Ophthalmol, vol. 25, no. 5–6, pp. 256–264, Nov. 2010, doi: 10.3109/08820538.2010.518507.
[659]	“Alternatives to animal experimentation,” ALTEX, vol. 30, no. 4, p. 409, 2013.
[660]	F. M. Kluxen and L. A. Hothorn, “Alternatives to statistical decision trees in regulatory (eco-)toxicological bioassays,” Arch. Toxicol., vol. 94, no. 4, pp. 1135–1149, 2020, doi: 10.1007/s00204-020-02690-w.
[661]	M. I. Yousef, A. M. A. El-Morsy, and M. S. Hassan, “Aluminium-induced deterioration in reproductive performance and seminal plasma biochemistry of male rabbits: protective role of ascorbic acid,” Toxicology, vol. 215, no. 1–2, pp. 97–107, Nov. 2005, doi: 10.1016/j.tox.2005.06.025.
[662]	“Ambassador for Earth,” Nature, vol. 443, no. 7112, p. 606, Oct. 2006, doi: 10.1038/443606a.
[663]	E. Wolff, “[Amelioration of chick embryo extracts by synthetic solutions in the in vitro culture of the syrinx of birds],” C. R. Hebd. Seances Acad. Sci., vol. 243, no. 25, pp. 2154–2156, Dec. 1956.
[664]	M. Shinderman, “American pika in a low-elevation lava landscape: expanding the known distribution of a temperature-sensitive species,” Ecol Evol, vol. 5, no. 17, pp. 3666–3676, Sep. 2015, doi: 10.1002/ece3.1626.
[665]	W. Lu, T. Rades, J. Rantanen, H.-K. Chan, and M. Yang, “Amino acids as stabilizers for spray-dried simvastatin powder for inhalation,” Int J Pharm, vol. 572, p. 118724, Dec. 2019, doi: 10.1016/j.ijpharm.2019.118724.
[666]	N. Nandwani, P. Surana, J. B. Udgaonkar, R. Das, and S. Gosavi, “Amino-acid composition after loop deletion drives domain swapping,” Protein Sci., vol. 26, no. 10, pp. 1994–2002, Oct. 2017, doi: 10.1002/pro.3237.
[667]	N. Albrecht, N. Tegtmeyer, H. Sticht, J. Skórko-Glonek, and S. Backert, “Amino-Terminal Processing of Helicobacter pylori Serine Protease HtrA: Role in Oligomerization and Activity Regulation,” Front Microbiol, vol. 9, p. 642, 2018, doi: 10.3389/fmicb.2018.00642.
[668]	E. Drouin, G. Lande, and F. Charpentier, “Amiodarone reduces transmural heterogeneity of repolarization in the human heart,” J. Am. Coll. Cardiol., vol. 32, no. 4, pp. 1063–1067, Oct. 1998, doi: 10.1016/s0735-1097(98)00330-1.
[669]	H. R. Omar, “Amiodarone-induced T-U fusion,” Am J Emerg Med, vol. 30, no. 9, p. 2081.e1–2, Nov. 2012, doi: 10.1016/j.ajem.2011.10.024.
[670]	G. Flaker et al., “Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trial,” J. Am. Coll. Cardiol., vol. 64, no. 15, pp. 1541–1550, Oct. 2014, doi: 10.1016/j.jacc.2014.07.967.
[671]	N. Watanabe-Okochi et al., “AML1 mutations induced MDS and MDS/AML in a mouse BMT model,” Blood, vol. 111, no. 8, pp. 4297–4308, Apr. 2008, doi: 10.1182/blood-2007-01-068346.
[672]	W. D. Mansilla et al., “Ammonia Nitrogen Added to Diets Deficient in Dispensable Amino Acid Nitrogen Is Poorly Utilized for Urea Production in Growing Pigs,” J. Nutr., vol. 147, no. 12, pp. 2228–2234, 2017, doi: 10.3945/jn.117.251314.
[673]	J. C. Hettinger, H. Lee, G. Bu, D. M. Holtzman, and J. R. Cirrito, “AMPA-ergic regulation of amyloid-β levels in an Alzheimer’s disease mouse model,” Mol Neurodegener, vol. 13, no. 1, p. 22, 15 2018, doi: 10.1186/s13024-018-0256-6.
[674]	A. C. Harvey, A. Vrij, S. Leal, L. Hope, and S. Mann, “Amplifying deceivers’ flawed metacognition: Encouraging disclosures after delays with a model statement,” Acta Psychol (Amst), vol. 200, p. 102935, Sep. 2019, doi: 10.1016/j.actpsy.2019.102935.
[675]	M. L. Hemming and D. J. Selkoe, “Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor,” J. Biol. Chem., vol. 280, no. 45, pp. 37644–37650, Nov. 2005, doi: 10.1074/jbc.M508460200.
[676]	L. Mendoza, R. Vilela, and R. Mani, “An accurate identification of Pythium insidiosum complex using MALDI-TOF, requires representative spectra of each of its four phylogenetic clusters,” Int. J. Infect. Dis., vol. 87, p. 193, 2019, doi: 10.1016/j.ijid.2019.07.025.
[677]	O. N. Atta, H. H. Alhawari, M. M. Murshidi, E. Tarawneh, and M. M. Murshidi, “An adult ureterocele complicated by a large stone: A case report,” Int J Surg Case Rep, vol. 44, pp. 166–171, 2018, doi: 10.1016/j.ijscr.2018.02.035.
[678]	A. L. Counts, L. A. Kochis, J. Buschman, and T. D. Savant, “An aggressive dentigerous cyst in a seven-year-old child,” ASDC J Dent Child, vol. 68, no. 4, pp. 268–271, Aug. 2001.
[679]	S. Nesnow and H. Bergman, “An analysis of the Gene-Tox Carcinogen Data Base,” Mutat. Res., vol. 205, no. 1–4, pp. 237–253, Aug. 1988, doi: 10.1016/0165-1218(88)90020-1.
[680]	X. Han, H. Yu, and Q. Zhang, “[An analysis of the medical administration pattern of the Yuan Dynasty as interpreted from the Guan yi ti ju si (Department of Official Medical Administration)],” Zhonghua Yi Shi Za Zhi, vol. 45, no. 4, pp. 202–205, Jul. 2015.
[681]	T.-C. Tsai, H.-P. Huang, Y.-C. Chang, and C.-J. Wang, “An anthocyanin-rich extract from Hibiscus sabdariffa linnaeus inhibits N-nitrosomethylurea-induced leukemia in rats,” J. Agric. Food Chem., vol. 62, no. 7, pp. 1572–1580, Feb. 2014, doi: 10.1021/jf405235j.
[682]	P. T. Brooks, J. A. Bell, C. E. Bejcek, A. Malik, and L. S. Mansfield, “An antibiotic depleted microbiome drives severe Campylobacter jejuni-mediated Type 1/17 colitis, Type 2 autoimmunity and neurologic sequelae in a mouse model,” J. Neuroimmunol., vol. 337, p. 577048, 15 2019, doi: 10.1016/j.jneuroim.2019.577048.
[683]	H. Kuribara et al., “An antidepressant effect of Sho-ju-sen, a Japanese herbal medicine, assessed by learned helplessness model in mice,” Phytother Res, vol. 18, no. 2, pp. 173–176, Feb. 2004, doi: 10.1002/ptr.1412.
[684]	R. C. Thurston, M. Rewak, and L. D. Kubzansky, “An anxious heart: anxiety and the onset of cardiovascular diseases,” Prog Cardiovasc Dis, vol. 55, no. 6, pp. 524–537, Jun. 2013, doi: 10.1016/j.pcad.2013.03.007.
[685]	A. D. Soteriades, P. Faverdin, S. Moreau, T. Charroin, M. Blanchard, and A. W. Stott, “An approach to holistically assess (dairy) farm eco-efficiency by combining Life Cycle Analysis with Data Envelopment Analysis models and methodologies,” Animal, vol. 10, no. 11, pp. 1899–1910, Nov. 2016, doi: 10.1017/S1751731116000707.
[686]	M. C. Feres et al., “An assessment of oxidized LDL in the lipid profiles of patients with obstructive sleep apnea and its association with both hypertension and dyslipidemia, and the impact of treatment with CPAP,” Atherosclerosis, vol. 241, no. 2, pp. 342–349, Aug. 2015, doi: 10.1016/j.atherosclerosis.2015.05.008.
[687]	S. L. Handley and J. W. McBlane, “An assessment of the elevated X-maze for studying anxiety and anxiety-modulating drugs,” J Pharmacol Toxicol Methods, vol. 29, no. 3, pp. 129–138, Jun. 1993, doi: 10.1016/1056-8719(93)90063-k.
[688]	E. M. Clerkin, C. Beard, C. R. Fisher, and C. A. Schofield, “An attempt to target anxiety sensitivity via cognitive bias modification,” PLoS ONE, vol. 10, no. 2, p. e0114578, 2015, doi: 10.1371/journal.pone.0114578.
[689]	J. Li, X. Liu, J. Zhuo, R. P. Gullapalli, and J. M. Zara, “An automatic rat brain extraction method based on a deformable surface model,” J. Neurosci. Methods, vol. 218, no. 1, pp. 72–82, Aug. 2013, doi: 10.1016/j.jneumeth.2013.04.011.
[690]	J. C. Croll, M. Egas, and I. M. Smallegange, “An eco-evolutionary feedback loop between population dynamics and fighter expression affects the evolution of alternative reproductive tactics,” J Anim Ecol, vol. 88, no. 1, pp. 11–23, 2019, doi: 10.1111/1365-2656.12899.
[691]	G. Hilt, F.-X. du Mesnil, and S. Lüers, “An Efficient Cobalt(I) Catalyst System for the Selective 1,4-Hydrovinylation of 1,3-Dienes This work was supported by the Deutche Forschungsgemeinschaft (DFG).,” Angew. Chem. Int. Ed. Engl., vol. 40, no. 2, pp. 387–389, Jan. 2001.
[692]	G. Zanette, M. F. Lauriola, and S. Tamburin, “An electrodiagnostic technique for assessing palmar proper digital nerves of the hand: Normative data and clinical application,” Muscle Nerve, vol. 52, no. 6, pp. 972–980, Dec. 2015, doi: 10.1002/mus.24668.
[693]	F. J. Papa, “An emergency medicine clinical problem-solving system,” Ann Emerg Med, vol. 14, no. 7, pp. 660–663, Jul. 1985, doi: 10.1016/s0196-0644(85)80883-0.
[694]	M. Hashimoto, I. Andersson, and L. Pettersson, “An equilibrium analysis of the aqueous H+-MoO4(2-)-(HP)O(3)2- and H+-MoO4(2-)-(HP)O(3)2--HPO4(2-) systems,” Dalton Trans, no. 1, pp. 124–132, Jan. 2007, doi: 10.1039/b613214f.
[695]	J. B. Nelson and A. Mital, “An ergonomic evaluation of dexterity and tactility with increase in examination/surgical glove thickness,” Ergonomics, vol. 38, no. 4, pp. 723–733, Apr. 1995, doi: 10.1080/00140139508925144.
[696]	R. E. Subramanian, D. G. Herrera, and P. M. Kelly, “An evaluation of the global network of field epidemiology and laboratory training programmes: a resource for improving public health capacity and increasing the number of public health professionals worldwide,” Hum Resour Health, vol. 11, p. 45, Sep. 2013, doi: 10.1186/1478-4491-11-45.
[697]	A. Deli et al., “An evaluation of the psychosocial impact of epilepsy on marriage in the United Kingdom,” Epilepsy Behav, vol. 94, pp. 204–208, 2019, doi: 10.1016/j.yebeh.2019.03.012.
[698]	G. M. Walker and D. J. Beebe, “An evaporation-based microfluidic sample concentration method,” Lab Chip, vol. 2, no. 2, pp. 57–61, May 2002, doi: 10.1039/b202473j.
[699]	F. Brigo, “An evidence-based approach to proper diagnostic use of the electroencephalogram for suspected seizures,” Epilepsy Behav, vol. 21, no. 3, pp. 219–222, Jul. 2011, doi: 10.1016/j.yebeh.2011.04.004.
[700]	B. Birur, N. C. Moore, and L. L. Davis, “An Evidence-Based Review of Early Intervention and Prevention of Posttraumatic Stress Disorder,” Community Ment Health J, vol. 53, no. 2, pp. 183–201, 2017, doi: 10.1007/s10597-016-0047-x.
[701]	Q.-M. Wang and L. Wang, “An evolutionary view of plant tissue culture: somaclonal variation and selection,” Plant Cell Rep., vol. 31, no. 9, pp. 1535–1547, Sep. 2012, doi: 10.1007/s00299-012-1281-5.
[702]	S. C. Barker and P. M. Altman, “An ex vivo, assessor blind, randomised, parallel group, comparative efficacy trial of the ovicidal activity of three pediculicides after a single application--melaleuca oil and lavender oil, eucalyptus oil and lemon tea tree oil, and a ‘suffocation’ pediculicide,” BMC Dermatol., vol. 11, p. 14, Aug. 2011, doi: 10.1186/1471-5945-11-14.
[703]	D. Kemmerer, D. Tranel, and K. Manzel, “An exaggerated effect for proper nouns in a case of superior written over spoken word production,” Cogn Neuropsychol, vol. 22, no. 1, pp. 3–27, Feb. 2005, doi: 10.1080/02643290442000013.
[704]	L. E. Gibson, J. C. Holt, K. M. Fondacaro, T. S. Tang, T. A. Powell, and E. L. Turbitt, “An examination of antecedent traumas and psychiatric comorbidity among male inmates with PTSD,” J Trauma Stress, vol. 12, no. 3, pp. 473–484, Jul. 1999, doi: 10.1023/A:1024767020280.
[705]	C. S. Black, D. J. Lehane, C. Burns, and B. D. O’Donnell, “An examination of the effect of open versus paywalled access publication on the disseminative impact and citation count of publications in intensive care medicine and anesthesia,” J Crit Care, vol. 46, pp. 88–93, 2018, doi: 10.1016/j.jcrc.2018.05.008.
[706]	Y. Rino et al., “An experimental assessment of suture techniques using Lapra-ty clips through the laparoscope and a case report: laparoscopic closure using Lapra-ty for a perforation of the sigmoid colon,” Hepatogastroenterology, vol. 49, no. 47, pp. 1281–1283, Oct. 2002.
[707]	J. Gerstmeier, C. Weinigel, D. Barz, O. Werz, and U. Garscha, “An experimental cell-based model for studying the cell biology and molecular pharmacology of 5-lipoxygenase-activating protein in leukotriene biosynthesis,” Biochim. Biophys. Acta, vol. 1840, no. 9, pp. 2961–2969, Sep. 2014, doi: 10.1016/j.bbagen.2014.05.016.
[708]	E. R. Whitmer, B. A. Elias, D. J. Harvey, and M. H. Ziccardi, “AN EXPERIMENTAL STUDY OF THE EFFECTS OF CHEMICALLY DISPERSED OIL ON FEATHER STRUCTURE AND WATERPROOFING IN COMMON MURRES ( URIA AALGE),” J. Wildl. Dis., vol. 54, no. 2, pp. 315–328, 2018, doi: 10.7589/2017-01-016.
[709]	A. K. Höffmann, P. Lakshmanan, C. Hollmann, and T. Ostermann, “An experimental study on oil-dispersion baths generated by the Jungebad apparatus,” Complement Ther Med, vol. 41, pp. 147–153, Dec. 2018, doi: 10.1016/j.ctim.2018.09.014.
[710]	J. K. Hoang et al., “An exponential growth in incidence of thyroid cancer: trends and impact of CT imaging,” AJNR Am J Neuroradiol, vol. 35, no. 4, pp. 778–783, Apr. 2014, doi: 10.3174/ajnr.A3743.
[711]	A. Aiswarya, R. Suresh, M. Janardhanan, V. Savithri, T. Aravind, and L. Mathew, “An immunohistochemical evaluation of podoplanin expression in oral leukoplakia and oral squamous cell carcinoma to explore its potential to be used as a predictor for malignant transformation,” J Oral Maxillofac Pathol, vol. 23, no. 1, p. 159, Apr. 2019, doi: 10.4103/jomfp.JOMFP_272_17.
[712]	N. H. Prins et al., “An improved in vitro bioassay for the study of 5-HT(4) receptors in the human isolated large intestinal circular muscle,” Br. J. Pharmacol., vol. 129, no. 8, pp. 1601–1608, Apr. 2000, doi: 10.1038/sj.bjp.0703254.
[713]	K. L. Cupo and R. B. Beckstead, “An In Vitro Assay of Disinfectants on the Viability of Heterakis gallinarum Eggs,” Avian Dis., vol. 63, no. 3, pp. 511–513, 01 2019, doi: 10.1637/11952-081418-ResNote.1.
[714]	S. Hugar, P. M Patel, J. Nagmoti, C. Uppin, L. Mistry, and N. Dhariwal, “An in vitro Comparative Evaluation of Efficacy of Disinfecting Ability of Garlic Oil, Neem Oil, Clove Oil, and Tulsi Oil with autoclaving on Endodontic K Files tested against Enterococcus faecalis,” Int J Clin Pediatr Dent, vol. 10, no. 3, pp. 283–288, Sep. 2017, doi: 10.5005/jp-journals-10005-1451.
[715]	A. Meirowitz, Y. Bitterman, S. Levy, E. Mijiritsky, and E. Dolev, “An in vitro evaluation of marginal fit zirconia crowns fabricated by a CAD-CAM dental laboratory and a milling center,” BMC Oral Health, vol. 19, no. 1, p. 103, 13 2019, doi: 10.1186/s12903-019-0810-9.
[716]	Q. Lu, H. Yin, M. P. Grant, and J. H. Elisseeff, “An In Vitro Model for the Ocular Surface and Tear Film System,” Sci Rep, vol. 7, no. 1, p. 6163, 21 2017, doi: 10.1038/s41598-017-06369-8.
[717]	W. C. Rose and G. A. Basler, “An in vivo human tumor xenograft model of etoposide resistance,” In Vivo, vol. 3, no. 4, pp. 249–253, Aug. 1989.
[718]	C. Varga, K. Szendi, and I. Ember, “An in vivo model for testing genotoxicity of environmental fibre-associated nitroarenes,” In Vivo, vol. 20, no. 4, pp. 539–541, Aug. 2006.
[719]	L. L. Eggink, K. F. Roby, R. Cote, and J. Kenneth Hoober, “An innovative immunotherapeutic strategy for ovarian cancer: CLEC10A and glycomimetic peptides,” J Immunother Cancer, vol. 6, no. 1, p. 28, 17 2018, doi: 10.1186/s40425-018-0339-5.
[720]	B. Rigat, C. Hubert, F. Alhenc-Gelas, F. Cambien, P. Corvol, and F. Soubrier, “An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels,” J. Clin. Invest., vol. 86, no. 4, pp. 1343–1346, Oct. 1990, doi: 10.1172/JCI114844.
[721]	J. K. Heard, P. O’Sullivan, C. E. Smith, R. A. Harper, and S. M. Schexnayder, “An institutional system to monitor and improve the quality of residency education,” Acad Med, vol. 79, no. 9, pp. 858–864, Sep. 2004, doi: 10.1097/00001888-200409000-00011.
[722]	R. T. Luo et al., “An Integrated Analysis of Risk Factors of Cognitive Impairment in Patients with Severe Carotid Artery Stenosis,” Biomed. Environ. Sci., vol. 31, no. 11, pp. 797–804, Nov. 2018, doi: 10.3967/bes2018.107.
[723]	S. Iyer, N. Pham, M. Marty, M. Sandy, G. Solomon, and L. Zeise, “An Integrated Approach Using Publicly Available Resources for Identifying and Characterizing Chemicals of Potential Toxicity Concern: Proof-of-Concept With Chemicals That Affect Cancer Pathways,” Toxicol. Sci., vol. 169, no. 1, pp. 14–24, 01 2019, doi: 10.1093/toxsci/kfz017.
[724]	E. Hulzebos, S. Gunnarsdottir, J.-P. Rila, Z. Dang, and E. Rorije, “An Integrated Assessment Scheme for assessing the adequacy of (eco)toxicological data under REACH,” Toxicol. Lett., vol. 198, no. 2, pp. 255–262, Oct. 2010, doi: 10.1016/j.toxlet.2010.07.004.
[725]	E. M. Myers, C. W. Bartlett, R. Machiraju, and J. W. Bohland, “An integrative analysis of regional gene expression profiles in the human brain,” Methods, vol. 73, pp. 54–70, Feb. 2015, doi: 10.1016/j.ymeth.2014.12.010.
[726]	D. C. Dorman, “An integrative approach to neurotoxicology,” Toxicol Pathol, vol. 28, no. 1, pp. 37–42, Feb. 2000, doi: 10.1177/019262330002800106.
[727]	A. P. Cyrino, E. A. Lima, V. L. Garcia, R. R. Teixeira, M. C. P. P. Foresti, and L. B. Schraiber, “An interdisciplinary space of scientific communication in Collective (Public) Health: the journal interface--Communication, Health, Education,” Cien Saude Colet, vol. 20, no. 7, pp. 2059–2068, Jul. 2015, doi: 10.1590/1413-81232015207.05942015.
[728]	R. A. Newham, “An internal morality of nursing: what it can and cannot do,” Nurs Philos, vol. 14, no. 2, pp. 109–116, Apr. 2013, doi: 10.1111/j.1466-769X.2012.00554.x.
[729]	L. Rew, T. Powell, A. Brown, H. Becker, and N. Slesnick, “An Intervention to Enhance Psychological Capital and Health Outcomes in Homeless Female Youths,” West J Nurs Res, vol. 39, no. 3, pp. 356–373, Mar. 2017, doi: 10.1177/0193945916658861.
[730]	I. Labuschagne, C. Grace, P. Rendell, G. Terrett, and M. Heinrichs, “An introductory guide to conducting the Trier Social Stress Test,” Neurosci Biobehav Rev, vol. 107, pp. 686–695, 2019, doi: 10.1016/j.neubiorev.2019.09.032.
[731]	S. Shimotsu et al., “An investigation of anxiety about radiotherapy deploying the Radiotherapy Categorical Anxiety Scale,” Int. J. Clin. Oncol., vol. 15, no. 5, pp. 457–461, Oct. 2010, doi: 10.1007/s10147-010-0088-z.
[732]	L. Chen, J. He, S. Sazzed, and R. Walker, “An Investigation of Atomic Structures Derived from X-ray Crystallography and Cryo-Electron Microscopy Using Distal Blocks of Side-Chains,” Molecules, vol. 23, no. 3, Mar. 2018, doi: 10.3390/molecules23030610.
[733]	H. Yamaguchi et al., “An NB-LRR gene, TYNBS1, is responsible for resistance mediated by the Ty-2 Begomovirus resistance locus of tomato,” Theor. Appl. Genet., vol. 131, no. 6, pp. 1345–1362, Jun. 2018, doi: 10.1007/s00122-018-3082-x.
[734]	A. Gröbe, H. Hanken, M. Blessmann, J. Zustin, M. Heiland, and A. Al-Dam, “An odontogenic keratocystic tumor in the buccal space: an unusual site of origin and a review of the literature,” In Vivo, vol. 26, no. 5, pp. 847–851, Oct. 2012.
[735]	T.-J. Lin and P. J. O’Malley, “An ONIOM study of the spin density distribution of the QA site plastosemiquinone in the photosystem II reaction center,” J Phys Chem B, vol. 115, no. 14, pp. 4227–4233, Apr. 2011, doi: 10.1021/jp112163w.
[736]	F. Maleki and A. Becskei, “An open-loop approach to calculate noise-induced transitions,” J. Theor. Biol., vol. 415, pp. 145–157, 21 2017, doi: 10.1016/j.jtbi.2016.12.012.
[737]	J. E. Morley, “An Overview of Cognitive Impairment,” Clin. Geriatr. Med., vol. 34, no. 4, pp. 505–513, 2018, doi: 10.1016/j.cger.2018.06.003.
[738]	M. Kapadiya and M. Tarabichi, “An overview of endoscopic ear surgery in 2018,” Laryngoscope Investig Otolaryngol, vol. 4, no. 3, pp. 365–373, Jun. 2019, doi: 10.1002/lio2.276.
[739]	J. Drazkowski, “An overview of epilepsy and driving,” Epilepsia, vol. 48 Suppl 9, pp. 10–12, 2007, doi: 10.1111/j.1528-1167.2007.01392.x.
[740]	V. Ferencz, Z. S Nagy, and M. Tóth, “[An overview of the research of cancer-related cognitive impairment],” Orv Hetil, vol. 160, no. 38, pp. 1495–1502, Sep. 2019, doi: 10.1556/650.2019.31516.
[741]	A. K. Sewell, M. Han, and B. Qi, “An unexpected benefit from E. coli: how enterobactin benefits host health,” Microb Cell, vol. 5, no. 10, pp. 469–471, Sep. 2018, doi: 10.15698/mic2018.10.653.
[742]	G. Skopp, I. Gutmann, C.-S. Schwarz, and G. Schmitt, “An unnatural death by propan-1-ol and propan-2-ol,” Int. J. Legal Med., vol. 130, no. 4, pp. 975–980, Jul. 2016, doi: 10.1007/s00414-015-1302-3.
[743]	E. A. Cho et al., “An unusual case of duodenal perforation caused by a lollipop stick: a case report,” Clin Endosc, vol. 47, no. 2, pp. 188–191, Mar. 2014, doi: 10.5946/ce.2014.47.2.188.
[744]	A. Rebel, S. G. Gambrel, N. Linville, and A. Kejner, “An unusual complication associated with use of transdermal scopolamine,” J Clin Anesth, vol. 54, pp. 81–82, May 2019, doi: 10.1016/j.jclinane.2018.10.034.
[745]	S. Greco, A. Sonzogni, and P. Ravelli, “An unusual onset of a rare disease,” Dig Liver Dis, vol. 47, no. 11, p. 987, Nov. 2015, doi: 10.1016/j.dld.2015.07.002.
[746]	R. A. Vasa and M. O. Mazurek, “An update on anxiety in youth with autism spectrum disorders,” Curr Opin Psychiatry, vol. 28, no. 2, pp. 83–90, Mar. 2015, doi: 10.1097/YCO.0000000000000133.
[747]	L. J. Wilcox, M. Bergeron, S. Reghunathan, and S. L. Ishman, “An updated review of pediatric drug-induced sleep endoscopy,” Laryngoscope Investig Otolaryngol, vol. 2, no. 6, pp. 423–431, 2017, doi: 10.1002/lio2.118.
[748]	D. Fehlings, J. Vajsar, B. Wilk, D. Stephens, and B.-O. Oded, “Anaerobic muscle performance of children after long-term recovery from Guillain-Barré syndrome,” Dev Med Child Neurol, vol. 46, no. 10, pp. 689–693, Oct. 2004, doi: 10.1017/s001216220400115x.
[749]	A. Bonabello, M. R. Galmozzi, T. Bruzzese, and G. P. Zara, “Analgesic effect of bisphosphonates in mice,” Pain, vol. 91, no. 3, pp. 269–275, Apr. 2001, doi: 10.1016/s0304-3959(00)00447-4.
[750]	K. Vredenburg, G. L. Flett, and L. Krames, “Analogue versus clinical depression: a critical reappraisal,” Psychol Bull, vol. 113, no. 2, pp. 327–344, Mar. 1993, doi: 10.1037/0033-2909.113.2.327.
[751]	B. Anderson, D. Scotchlas, D. Jones, A. Johnson, T. Tzianabos, and B. Baumstark, “Analysis of 36-kilodalton protein (PapA) associated with the bacteriophage particle of Bartonella henselae,” DNA Cell Biol., vol. 16, no. 10, pp. 1223–1229, Oct. 1997, doi: 10.1089/dna.1997.16.1223.
[752]	W. Hao, H. Xu, X. Chen, Q. Zhou, P. Zhang, and M. Qin, “[Analysis of caries susceptibility factors during transition from caries-free to caries in three-year-old children],” Zhonghua Kou Qiang Yi Xue Za Zhi, vol. 49, no. 4, pp. 193–198, Apr. 2014.
[753]	Y. Jiao, “[Analysis of clinical features of patients with de novo primary acute myeloid leukemia and various chromosomal karyotypes],” Zhonghua Yi Xue Yi Chuan Xue Za Zhi, vol. 35, no. 5, pp. 727–732, Oct. 2018, doi: 10.3760/cma.j.issn.1003-9406.2018.05.025.
[754]	A.-M. Turcotte, P. M. Scott, and B. Tague, “Analysis of cocoa products for ochratoxin A and aflatoxins,” Mycotoxin Res, vol. 29, no. 3, pp. 193–201, Aug. 2013, doi: 10.1007/s12550-013-0167-x.
[755]	Y.-Q. Xu, S.-Q. Chen, H.-B. Yuan, P. Tang, and J.-F. Yin, “Analysis of cream formation in green tea concentrates with different solid concentrations,” J Food Sci Technol, vol. 49, no. 3, pp. 362–367, Jun. 2012, doi: 10.1007/s13197-011-0281-8.
[756]	S. Charvet-Protat and F. Thoral, “[Analysis of economic data and elaboration of professional guidelines],” Gastroenterol. Clin. Biol., vol. 23, no. 1, pp. 19–23, Jan. 1999.
[757]	C. Ruiz-Ruiz, L. Fradua, A. Fernández-García, and A. Zubillaga, “Analysis of entries into the penalty area as a performance indicator in soccer,” Eur J Sport Sci, vol. 13, no. 3, pp. 241–248, 2013, doi: 10.1080/17461391.2011.606834.
[758]	P. D. Cebrián and O. Cauli, “Analysis of Functional and Cognitive Impairment in Institutionalized Individuals with Movement Disorders,” Endocr Metab Immune Disord Drug Targets, vol. 19, no. 7, pp. 1022–1031, 2019, doi: 10.2174/1871530319666190311104247.
[759]	S.-H. Sohn et al., “Analysis of Gastric Body Microbiota by Pyrosequencing: Possible Role of Bacteria Other Than Helicobacter pylori in the Gastric Carcinogenesis,” J Cancer Prev, vol. 22, no. 2, pp. 115–125, Jun. 2017, doi: 10.15430/JCP.2017.22.2.115.
[760]	E. Pathak, N. Atri, and R. Mishra, “Analysis of P-Loop and its Flanking Region Subsequence of Diverse NTPases Reveals Evolutionary Selected Residues,” Bioinformation, vol. 10, no. 4, pp. 216–220, 2014, doi: 10.6026/97320630010216.
[761]	M. C. Turcotte, E. G. Herzberg, M. Balou, and S. M. Molfenter, “Analysis of pharyngeal edema post-chemoradiation for head and neck cancer: Impact on swallow function,” Laryngoscope Investig Otolaryngol, vol. 3, no. 5, pp. 377–383, Oct. 2018, doi: 10.1002/lio2.203.
[762]	C.-L. Chang and J. Liou, “Analysis of Phosphatidylinositol Transfer at ER-PM Junctions in Receptor-Stimulated Live Cells,” Methods Mol. Biol., vol. 1949, pp. 1–11, 2019, doi: 10.1007/978-1-4939-9136-5_1.
[763]	C. M. Warner, S. O. Gollnick, L. Flaherty, and S. B. Goldbard, “Analysis of Qa-2 antigen expression by preimplantation mouse embryos: possible relationship to the preimplantation-embryo-development (Ped) gene product,” Biol. Reprod., vol. 36, no. 3, pp. 611–616, Apr. 1987, doi: 10.1095/biolreprod36.3.611.
[764]	M. L. Li et al., “[Analysis of silicosis surveillance data in Tianjin in 2017],” Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, vol. 37, no. 11, pp. 842–845, Nov. 2019, doi: 10.3760/cma.j.issn.1001-9391.2019.11.011.
[765]	V. K. Ward, B. C. Bonning, T. Huang, T. Shiotsuki, V. N. Griffeth, and B. D. Hammock, “Analysis of the catalytic mechanism of juvenile hormone esterase by site-directed mutagenesis,” Int. J. Biochem., vol. 24, no. 12, pp. 1933–1941, Dec. 1992, doi: 10.1016/0020-711x(92)90289-d.
[766]	H. Huang, Y. Sun, W. Yu, Z. Ma, and K. Tang, “Analysis of the characteristics of Eco-Exergy-based indices and diversity indices in the Zhoushan archipelago, China,” Environ Sci Pollut Res Int, Jan. 2020, doi: 10.1007/s11356-019-07544-2.
[767]	A. M. Delgado, A. da B. Freire, E. L. S. Wanderley, and A. Lemos, “Analysis of the Construct Validity and Internal Consistency of the State-Trait Anxiety Inventory (STAI) State-Anxiety (S-Anxiety) Scale for Pregnant Women during Labor,” Rev Bras Ginecol Obstet, vol. 38, no. 11, pp. 531–537, Nov. 2016, doi: 10.1055/s-0036-1593894.
[768]	A. Gawlikowska-Sroka, D. Miklaszewska, and F. Czerwiński, “Analysis of the correlation between aortic diameter, heart size, and type of coronary circulation,” Folia Morphol. (Warsz), vol. 69, no. 1, pp. 30–34, Feb. 2010.
[769]	L. Kämppi, H. Mustonen, and S. Soinila, “Analysis of the delay components in the treatment of status epilepticus,” Neurocrit Care, vol. 19, no. 1, pp. 10–18, Aug. 2013, doi: 10.1007/s12028-013-9862-x.
[770]	J. R. Johnson et al., “Analysis of the F antigen-specific papA alleles of extraintestinal pathogenic Escherichia coli using a novel multiplex PCR-based assay,” Infect. Immun., vol. 68, no. 3, pp. 1587–1599, Mar. 2000, doi: 10.1128/iai.68.3.1587-1599.2000.
[771]	J. Ohnishi, H. Yamaguchi, and A. Saito, “Analysis of the Mild strain of tomato yellow leaf curl virus, which overcomes Ty-2 gene-mediated resistance in tomato line H24,” Arch. Virol., vol. 161, no. 8, pp. 2207–2217, Aug. 2016, doi: 10.1007/s00705-016-2898-4.
[772]	J. Ni et al., “Analysis of the Relationship Between the Degree of Dysbiosis in Gut Microbiota and Prognosis at Different Stages of Primary Hepatocellular Carcinoma,” Front Microbiol, vol. 10, p. 1458, 2019, doi: 10.3389/fmicb.2019.01458.
[773]	L. Q. Liu, Y. P. Ma, and H. M. Ju, “[Analysis of the results of audiological examination of 2200 seamen],” Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, vol. 36, no. 11, pp. 858–859, Nov. 2018, doi: 10.3760/cma.j.issn.1001-9391.2018.11.017.
[774]	P. Bolshete, “Analysis of thirteen predatory publishers: a trap for eager-to-publish researchers,” Curr Med Res Opin, vol. 34, no. 1, pp. 157–162, 2018, doi: 10.1080/03007995.2017.1358160.
[775]	C. M. Wilke, S. H. Heidler, N. Brown, and S. W. Liebman, “Analysis of yeast retrotransposon Ty insertions at the CAN1 locus,” Genetics, vol. 123, no. 4, pp. 655–665, Dec. 1989.
[776]	Z. Ge, H. Du, Y. Gao, and W. Qiu, “Analysis on Metabolic Functions of Stored Rice Microbial Communities by BIOLOG ECO Microplates,” Front Microbiol, vol. 9, p. 1375, 2018, doi: 10.3389/fmicb.2018.01375.
[777]	K. Sadtler and J. H. Elisseeff, “Analyzing the scaffold immune microenvironment using flow cytometry: practices, methods and considerations for immune analysis of biomaterials,” Biomater Sci, vol. 7, no. 11, pp. 4472–4481, Nov. 2019, doi: 10.1039/c9bm00349e.
[778]	J. Ring, A. Weins, M. Grosber, and K. Brockow, “[Anaphylaxis - how to act fast and sustainable],” MMW Fortschr Med, vol. 161, no. 15, pp. 54–65, Sep. 2019, doi: 10.1007/s15006-019-0024-8.
[779]	D. M. Brown, L. Tuomi, H. Shapiro, and Pier Study Group, “Anatomical measures as predictors of visual outcomes in ranibizumab-treated eyes with neovascular age-related macular degeneration,” Retina (Philadelphia, Pa.), vol. 33, no. 1, pp. 23–34, Jan. 2013, doi: 10.1097/IAE.0b013e318263cedf.
[780]	M. Loukas et al., “Anatomical observations of the moderator band,” Clin Anat, vol. 23, no. 4, pp. 443–450, May 2010, doi: 10.1002/ca.20968.
[781]	J. Kim, Y. H. Lee, M. B. Kim, S. H. Rhee, and G. H. Baek, “Anatomy of the direct small branches of the proper digital nerve of the fingers: a cadaveric study,” J Plast Reconstr Aesthet Surg, vol. 67, no. 8, pp. 1129–1135, Aug. 2014, doi: 10.1016/j.bjps.2014.04.026.
[782]	S. J. Crick, M. N. Sheppard, S. Y. Ho, L. Gebstein, and R. H. Anderson, “Anatomy of the pig heart: comparisons with normal human cardiac structure,” J. Anat., vol. 193 ( Pt 1), pp. 105–119, Jul. 1998, doi: 10.1046/j.1469-7580.1998.19310105.x.
[783]	B. Jensen, J. R. Nyengaard, M. Pedersen, and T. Wang, “Anatomy of the python heart,” Anat Sci Int, vol. 85, no. 4, pp. 194–203, Dec. 2010, doi: 10.1007/s12565-010-0079-1.
[784]	K. R. Bermingham, “Ancient rock bears isotopic fingerprints of Earth’s origins,” Nature, vol. 579, no. 7798, pp. 195–196, 2020, doi: 10.1038/d41586-020-00605-4.
[785]	S. Rajender, N. J. Gupta, B. Chakravarty, L. Singh, and K. Thangaraj, “Androgen insensitivity syndrome: do trinucleotide repeats in androgen receptor gene have any role?,” Asian J. Androl., vol. 10, no. 4, pp. 616–624, Jul. 2008, doi: 10.1111/j.1745-7262.2007.00337.x.
[786]	V. Santini, “Anemia as the Main Manifestation of Myelodysplastic Syndromes,” Semin. Hematol., vol. 52, no. 4, pp. 348–356, Oct. 2015, doi: 10.1053/j.seminhematol.2015.06.002.
[787]	A. J. Rosenspire and K. Chen, “Anergic B Cells: Precarious On-Call Warriors at the Nexus of Autoimmunity and False-Flagged Pathogens,” Front Immunol, vol. 6, p. 580, 2015, doi: 10.3389/fimmu.2015.00580.
[788]	M. Kulkarni, K. E. Porter, and S. A. M. Rauch, “Anger, dissociation, and PTSD among male veterans entering into PTSD treatment,” J Anxiety Disord, vol. 26, no. 2, pp. 271–278, Mar. 2012, doi: 10.1016/j.janxdis.2011.12.005.
[789]	L. Davin, P. Marechal, P. Lancellotti, C. Martinez, L. Pierard, and R. Radermecker, “Angioedema: a rare and sometimes delayed side effect of angiotensin-converting enzyme inhibitors,” Acta Cardiol, vol. 74, no. 4, pp. 277–281, Aug. 2019, doi: 10.1080/00015385.2018.1507477.
[790]	A. B. Ingason et al., “Angiogenesis precedes cardiomyocyte migration in regenerating mammalian hearts,” J. Thorac. Cardiovasc. Surg., vol. 155, no. 3, pp. 1118-1127.e1, 2018, doi: 10.1016/j.jtcvs.2017.08.127.
[791]	R. Ceballos, B. Soto, and L. M. Bargeron, “Angiographic anatomy of the normal heart through axial angiography,” Circulation, vol. 64, no. 2, pp. 351–359, Aug. 1981, doi: 10.1161/01.cir.64.2.351.
[792]	L. Geng, K. Persson, and S. F. E. Nilsson, “Angiotensin converting anzyme (ACE) activity in porcine ocular tissue: effects of diet and ACE inhibitors,” J Ocul Pharmacol Ther, vol. 19, no. 6, pp. 589–598, Dec. 2003, doi: 10.1089/108076803322660503.
[793]	R. A. Skidgel and E. G. Erdös, “Angiotensin converting enzyme (ACE) and neprilysin hydrolyze neuropeptides: a brief history, the beginning and follow-ups to early studies,” Peptides, vol. 25, no. 3, pp. 521–525, Mar. 2004, doi: 10.1016/j.peptides.2003.12.010.
[794]	F. Ikemoto et al., “Angiotensin converting enzyme (ACE) in the kidney: contribution to blood pressure regulation and possible role of brush-border ACE,” J. Cardiovasc. Pharmacol., vol. 8 Suppl 10, pp. S69-74, 1986.
[795]	D. J. Campbell, “Angiotensin converting enzyme (ACE) inhibitors and kinin metabolism: evidence that ACE inhibitors may inhibit a kininase other than ACE,” Clin. Exp. Pharmacol. Physiol., vol. 22, no. 12, pp. 903–911, Dec. 1995, doi: 10.1111/j.1440-1681.1995.tb02325.x.
[796]	A. Tsantes et al., “Angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism and circulating ACE levels are not associated with outcome in critically ill septic patients,” Clin. Chem. Lab. Med., vol. 50, no. 2, pp. 293–299, Oct. 2011, doi: 10.1515/CCLM.2011.752.
[797]	S. Tejpal, N. Sanghera, V. Manoharan, J. Planas-Iglesias, C. C. Bastie, and J. Klein-Seetharaman, “Angiotensin Converting Enzyme (ACE): A Marker for Personalized Feedback on Dieting,” Nutrients, vol. 12, no. 3, Feb. 2020, doi: 10.3390/nu12030660.
[798]	S. S. Narayan, K. Lorenz, J. Ukkat, C. Hoang-Vu, and B. Trojanowicz, “Angiotensin converting enzymes ACE and ACE2 in thyroid cancer progression,” Neoplasma, vol. 67, no. 2, pp. 402–409, Mar. 2020, doi: 10.4149/neo_2019_190506N405.
[799]	B. Baudin, “[Angiotensin I-converting enzyme (ACE) for sarcoidosis diagnosis],” Pathol. Biol., vol. 53, no. 3, pp. 183–188, Apr. 2005, doi: 10.1016/j.patbio.2004.09.003.
[800]	Y.-Y. Hsieh, C.-C. Chang, F.-J. Tsai, C.-M. Hsu, C.-C. Lin, and C.-H. Tsai, “Angiotensin I-converting enzyme ACE 2350*G and ACE-240*T-related genotypes and alleles are associated with higher susceptibility to endometriosis,” Mol. Hum. Reprod., vol. 11, no. 1, pp. 11–14, Jan. 2005, doi: 10.1093/molehr/gah131.
[801]	S. Kim et al., “Angiotensin II Regulation of Proliferation, Differentiation, and Engraftment of Hematopoietic Stem Cells,” Hypertension, vol. 67, no. 3, pp. 574–584, Mar. 2016, doi: 10.1161/HYPERTENSIONAHA.115.06474.
[802]	D. K. Nagi, C. A. Foy, V. Mohamed-Ali, J. S. Yudkin, P. J. Grant, and W. C. Knowler, “Angiotensin-1-converting enzyme (ACE) gene polymorphism, plasma ACE levels, and their association with the metabolic syndrome and electrocardiographic coronary artery disease in Pima Indians,” Metab. Clin. Exp., vol. 47, no. 5, pp. 622–626, May 1998, doi: 10.1016/s0026-0495(98)90250-5.
[803]	K. Kohlstedt et al., “Angiotensin-converting enzyme (ACE) dimerization is the initial step in the ACE inhibitor-induced ACE signaling cascade in endothelial cells,” Mol. Pharmacol., vol. 69, no. 5, pp. 1725–1732, May 2006, doi: 10.1124/mol.105.020636.
[804]	E. M. W. van de Garde et al., “Angiotensin-converting enzyme (ACE) I/D corrected serum ACE activity and severity assessment of community-acquired pneumonia,” Clin. Chem. Lab. Med., vol. 45, no. 10, pp. 1326–1331, 2007, doi: 10.1515/CCLM.2007.268.
[805]	S. Mizuiri et al., “Angiotensin-converting enzyme (ACE) I/D genotype and renal ACE gene expression,” Kidney Int., vol. 60, no. 3, pp. 1124–1130, Sep. 2001, doi: 10.1046/j.1523-1755.2001.0600031124.x.
[806]	C. Ceconi, G. Francolini, A. Olivares, L. Comini, T. Bachetti, and R. Ferrari, “Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE,” Eur. J. Pharmacol., vol. 577, no. 1–3, pp. 1–6, Dec. 2007, doi: 10.1016/j.ejphar.2007.07.061.
[807]	J. S. Miners et al., “Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer’s disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy,” Neuropathol. Appl. Neurobiol., vol. 34, no. 2, pp. 181–193, Apr. 2008, doi: 10.1111/j.1365-2990.2007.00885.x.
[808]	K. M. Meurs et al., “Angiotensin-converting enzyme activity in Cavalier King Charles Spaniels with an ACE gene polymorphism and myxomatous mitral valve disease,” Pharmacogenet. Genomics, vol. 28, no. 2, pp. 37–40, 2018, doi: 10.1097/FPC.0000000000000322.
[809]	L. J. Baumgartner, A. A. Morris, and S. A. Chapman, “Angiotensin-converting enzyme inhibitor induced angioedema: predictors of mechanical ventilation and treatment approaches,” Intensive Care Med, vol. 41, no. 12, pp. 2233–2234, Dec. 2015, doi: 10.1007/s00134-015-4065-x.
[810]	K. Shuler, J. F. Sucic, S. A. Talley, and A. Goldberg, “Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism, Lower Extremity Strength, and Physical Performance in Older Adults,” Phys Ther, vol. 99, no. 8, pp. 998–1009, 01 2019, doi: 10.1093/ptj/pzz073.
[811]	S. Miners et al., “Angiotensin-converting enzyme levels and activity in Alzheimer’s disease: differences in brain and CSF ACE and association with ACE1 genotypes,” Am J Transl Res, vol. 1, no. 2, pp. 163–177, Jan. 2009.
[812]	J. F. Riordan, “Angiotensin-I-converting enzyme and its relatives,” Genome Biol., vol. 4, no. 8, p. 225, 2003, doi: 10.1186/gb-2003-4-8-225.
[813]	A. Erler, “[Anifrolumab in systemic lupus erythematosus],” Z Rheumatol, vol. 77, no. 2, pp. 175–176, 2018, doi: 10.1007/s00393-018-0420-y.
[814]	“Animal Contributed Papers,” In Vitro Cell. Dev. Biol. Anim., vol. 53, no. Suppl 1, pp. 25–29, Jun. 2017, doi: 10.1007/s11626-017-0159-9.
[815]	“Animal Contributed Papers,” In Vitro Cell. Dev. Biol. Anim., vol. 54, no. Suppl 1, pp. 24–27, Jun. 2018, doi: 10.1007/s11626-018-0246-6.
[816]	I. S. Blagbrough and C. Zara, “Animal models for target diseases in gene therapy--using DNA and siRNA delivery strategies,” Pharm. Res., vol. 26, no. 1, pp. 1–18, Jan. 2009, doi: 10.1007/s11095-008-9646-8.
[817]	H.-W. Shin, “Animal Models in CRS and Pathophysiologic Insights Gained: A Systematic Review,” Laryngoscope Investig Otolaryngol, vol. 1, no. 5, pp. 116–123, 2016, doi: 10.1002/lio2.29.
[818]	F. Ohl, “Animal models of anxiety,” Handb Exp Pharmacol, no. 169, pp. 35–69, 2005, doi: 10.1007/3-540-28082-0_2.
[819]	V. Lampis, M. Maziade, and M. Battaglia, “Animal models of human anxiety disorders: reappraisal from a developmental psychopathology vantage point,” Pediatr. Res., vol. 69, no. 5 Pt 2, pp. 77R-84R, May 2011, doi: 10.1203/PDR.0b013e318212b42e.
[820]	T. A. Enderli, S. R. Burtch, J. N. Templet, and A. Carriero, “Animal models of osteogenesis imperfecta: applications in clinical research,” Orthop Res Rev, vol. 8, pp. 41–55, 2016, doi: 10.2147/ORR.S85198.
[821]	J. Rew, S. Park, Y. Cho, S. Jung, and E. Hwang, “Animal Movement Prediction Based on Predictive Recurrent Neural Network,” Sensors (Basel), vol. 19, no. 20, Oct. 2019, doi: 10.3390/s19204411.
[822]	M. Baltazar-Soares and C. Eizaguirre, “Animal Navigation: The Eel’s Magnetic Guide to the Gulf Stream,” Curr. Biol., vol. 27, no. 12, pp. R604–R606, 19 2017, doi: 10.1016/j.cub.2017.04.042.
[823]	“Animal Posters,” In Vitro Cell. Dev. Biol. Anim., vol. 53, no. Suppl 1, pp. 39–44, Jun. 2017, doi: 10.1007/s11626-017-0154-1.
[824]	“Animal Posters,” In Vitro Cell. Dev. Biol. Anim., vol. 54, no. Suppl 1, pp. 36–38, Jun. 2018, doi: 10.1007/s11626-018-0247-5.
[825]	A. Salimi and J. Pourahmad, “Animal Tests for Evaluation of Cognitive Impairment in Neonatal Mouse,” Methods Mol. Biol., vol. 1797, pp. 545–554, 2018, doi: 10.1007/978-1-4939-7883-0_32.
[826]	H. L. Eisthen and K. R. Theis, “Animal-microbe interactions and the evolution of nervous systems,” Philos. Trans. R. Soc. Lond., B, Biol. Sci., vol. 371, no. 1685, p. 20150052, Jan. 2016, doi: 10.1098/rstb.2015.0052.
[827]	E. Papa, “Ankle brachial index in coronary artery disease - author’s reply,” Clinics (Sao Paulo), vol. 69, no. 9, p. 654, Sep. 2014, doi: 10.6061/clinics/2014(09)14.
[828]	R. S. Wright, J. S. Nichol, M. L. Papp, P. W. Groff, and M. W. Tufts, “Annual recertification program for audit standards used in the EPA PM2.5 Performance Evaluation Program,” Qual Assur, vol. 9, no. 3–4, pp. 129–135, Dec. 2001.
[829]	“Annual report, July 1, 1968. Brookhaven National Laboratory. BNL 50106 (AS-22),” Tech Rep Brookhaven Natl Lab, pp. 1–224, Jul. 1968.
[830]	J. Y. F. Lau and A. M. Waters, “Annual Research Review: An expanded account of information-processing mechanisms in risk for child and adolescent anxiety and depression,” J Child Psychol Psychiatry, vol. 58, no. 4, pp. 387–407, Apr. 2017, doi: 10.1111/jcpp.12653.
[831]	S. Bailey, F. Hoeft, K. Aboud, and L. Cutting, “Anomalous gray matter patterns in specific reading comprehension deficit are independent of dyslexia,” Ann Dyslexia, vol. 66, no. 3, pp. 256–274, 2016, doi: 10.1007/s11881-015-0114-y.
[832]	T. Torigoe, S. Sato, C. Kikuchi, and H. Kanazawa, “Anomalous origin of the left coronary artery from the proper sinus with acute angulation and an intramural segment,” Congenit Heart Dis, vol. 9, no. 1, pp. E1-5, Feb. 2014, doi: 10.1111/chd.12045.
[833]	D. Schulze-Makuch and E. Guinan, “Another Earth 2.0? Not So Fast,” Astrobiology, vol. 16, no. 11, pp. 817–821, 2016, doi: 10.1089/ast.2016.1584.
[834]	H. B. Waldman, A. Wong, and S. P. Perlman, “Another perspective on concerns regarding dental economics,” J Mass Dent Soc, vol. 63, no. 3, pp. 30–32, 2014.
[835]	M. D. Baroni, S. Colombo, and E. Martegani, “Antagonism between salicylate and the cAMP signal controls yeast cell survival and growth recovery from quiescence,” Microb Cell, vol. 5, no. 7, pp. 344–356, Mar. 2018, doi: 10.15698/mic2018.07.640.
[836]	F. J. Bosker et al., “Antagonism of 5-HT(1A) receptors uncovers an excitatory effect of SSRIs on 5-HT neuronal activity, an action probably mediated by 5-HT(7) receptors,” J. Neurochem., vol. 108, no. 5, pp. 1126–1135, Mar. 2009, doi: 10.1111/j.1471-4159.2008.05850.x.
[837]	O. Hartkamp, U. Lohbauer, and S. Reich, “Antagonist wear by polished zirconia crowns,” Int J Comput Dent, vol. 20, no. 3, pp. 263–274, 2017.
[838]	U. Lohbauer and S. Reich, “Antagonist wear of monolithic zirconia crowns after 2 years,” Clin Oral Investig, vol. 21, no. 4, pp. 1165–1172, May 2017, doi: 10.1007/s00784-016-1872-6.
[839]	J. O. Russell et al., “Anterior cervical incision-sparing thyroidectomy: Comparing retroauricular and transoral approaches,” Laryngoscope Investig Otolaryngol, vol. 3, no. 5, pp. 409–414, Oct. 2018, doi: 10.1002/lio2.200.
[840]	J. Nyland, A. Mattocks, S. Kibbe, A. Kalloub, J. W. Greene, and D. N. M. Caborn, “Anterior cruciate ligament reconstruction, rehabilitation, and return to play: 2015 update,” Open Access J Sports Med, vol. 7, pp. 21–32, 2016, doi: 10.2147/OAJSM.S72332.
[841]	N. S. Perera, J. Joel, and J. A. Bunola, “Anterior cruciate ligament rupture: Delay to diagnosis,” Injury, vol. 44, no. 12, pp. 1862–1865, Dec. 2013, doi: 10.1016/j.injury.2013.07.024.
[842]	R. E. Friedrich, H. A. Scheuer, and A. Gröbe, “Anterior lingual mandibular bone depression in an 11-year-old child,” In Vivo, vol. 26, no. 6, pp. 1103–1107, Dec. 2012.
[843]	H. Sahman and Y. Sisman, “Anterior Loop of the Inferior Alveolar Canal: A Cone-Beam Computerized Tomography Study of 494 Cases,” J Oral Implantol, vol. 42, no. 4, pp. 333–336, Aug. 2016, doi: 10.1563/aaid-joi-D-15-00038.
[844]	O. Mardinger, G. Chaushu, B. Arensburg, S. Taicher, and I. Kaffe, “Anterior loop of the mental canal: an anatomical-radiologic study,” Implant Dent, vol. 9, no. 2, pp. 120–125, 2000, doi: 10.1097/00008505-200009020-00003.
[845]	I. S. Sen and B. Peucker-Ehrenbrink, “Anthropogenic disturbance of element cycles at the Earth’s surface,” Environ. Sci. Technol., vol. 46, no. 16, pp. 8601–8609, Aug. 2012, doi: 10.1021/es301261x.
[846]	R. T. Hamza, T. H. Abdelaziz, and M. Elakkad, “Anthropometric and nutritional parameters in Egyptian children and adolescents with osteogenesis imperfecta,” Horm Res Paediatr, vol. 83, no. 5, pp. 311–320, 2015, doi: 10.1159/000374111.
[847]	M. Sett and S. Sahu, “Anthropometric characteristics and evaluation of nutritional status amongst female brick field workers of the unorganized sectors of West Bengal, India,” Homo, vol. 67, no. 3, pp. 235–244, Jun. 2016, doi: 10.1016/j.jchb.2015.10.003.
[848]	M. S. Aglan, M. E. Zaki, L. Hosny, R. El-Houssini, G. Oteify, and S. A. Temtamy, “Anthropometric measurements in Egyptian patients with osteogenesis imperfecta,” Am. J. Med. Genet. A, vol. 158A, no. 11, pp. 2714–2718, Nov. 2012, doi: 10.1002/ajmg.a.35529.
[849]	M. B. Zambrano, E. S. Brizola, L. Refosco, R. Giugliani, and T. M. Félix, “Anthropometry, nutritional status, and dietary intake in pediatric patients with osteogenesis imperfecta,” J Am Coll Nutr, vol. 33, no. 1, pp. 18–25, 2014, doi: 10.1080/07315724.2013.827065.
[850]	S. Zara, M. Di Giulio, S. D’Ercole, L. Cellini, and A. Cataldi, “Anti-adhesive and pro-apoptotic effects of 2-hydroxyethyl methacrylate on human gingival fibroblasts co-cultured with Streptococcus mitis strains,” Int Endod J, vol. 44, no. 12, pp. 1145–1154, Dec. 2011, doi: 10.1111/j.1365-2591.2011.01935.x.
[851]	L. Ma et al., “Anti-cancer Effects of Curcumin on Myelodysplastic Syndrome through the Inhibition of Enhancer of Zeste Homolog-2 (EZH2),” Curr Cancer Drug Targets, vol. 19, no. 9, pp. 729–741, 2019, doi: 10.2174/1568009619666190212121735.
[852]	P. F. Bolis and C. Zara, “[Anti-D antibodies after spontaneous abortion],” Arch Ostet Ginecol, vol. 78, no. 1–3, pp. 12–17, Jun. 1973.
[853]	N. Del Papa, D. Gambini, and P. L. Meroni, “Anti-endothelial cell antibodies and autoimmune diseases,” Clin Rev Allergy, vol. 12, no. 3, pp. 275–286, 1994, doi: 10.1007/BF02802322.
[854]	C. Rosette et al., “Anti-inflammatory and immunomodulatory activities of rifamycin SV,” Int. J. Antimicrob. Agents, vol. 42, no. 2, pp. 182–186, Aug. 2013, doi: 10.1016/j.ijantimicag.2013.04.020.
[855]	T.-K. Lin, L. Zhong, and J. L. Santiago, “Anti-Inflammatory and Skin Barrier Repair Effects of Topical Application of Some Plant Oils,” Int J Mol Sci, vol. 19, no. 1, Dec. 2017, doi: 10.3390/ijms19010070.
[856]	S. B. Park et al., “Anti-inflammatory effect of the extracts from the branch of Taxillus yadoriki being parasitic in Neolitsea sericea in LPS-stimulated RAW264.7 cells,” Biomed. Pharmacother., vol. 104, pp. 1–7, Aug. 2018, doi: 10.1016/j.biopha.2018.05.034.
[857]	V. P. Hiremath, C. B. Rao, V. Naiak, and K. V. V. Prasad, “Anti-inflammatory effect of vitamin D on gingivitis: a dose response randomised controlled trial,” Indian J Public Health, vol. 57, no. 1, pp. 29–32, Mar. 2013, doi: 10.4103/0019-557X.111365.
[858]	W. Jia, W. Gao, N. Cui, and P. Xiao, “Anti-inflammatory effects of an herbal medicine (Xuan-Ju agent) on carrageenan- and adjuvant-induced paw edema in rats,” J Ethnopharmacol, vol. 89, no. 1, pp. 139–141, Nov. 2003, doi: 10.1016/s0378-8741(03)00272-1.
[859]	G. Varga and D. Foell, “Anti-inflammatory monocytes-interplay of innate and adaptive immunity,” Mol Cell Pediatr, vol. 5, no. 1, p. 5, Apr. 2018, doi: 10.1186/s40348-018-0083-4.
[860]	N. Kanda, U. Enomoto, and S. Watanabe, “Anti-mycotics suppress interleukin-4 and interleukin-5 production in anti-CD3 plus anti-CD28-stimulated T cells from patients with atopic dermatitis,” J. Invest. Dermatol., vol. 117, no. 6, pp. 1635–1646, Dec. 2001, doi: 10.1046/j.0022-202x.2001.01566.x.
[861]	Y. Sheng et al., “Anti-obesity and hypolipidemic effect of water extract from Pleurotus citrinopileatus in C57BL/6J mice,” Food Sci Nutr, vol. 7, no. 4, pp. 1295–1301, Apr. 2019, doi: 10.1002/fsn3.962.
[862]	H. Obata, S. Saito, M. Sasaki, K. Ishizaki, and F. Goto, “Antiallodynic effect of intrathecally administered 5-HT(2) agonists in rats with nerve ligation,” Pain, vol. 90, no. 1–2, pp. 173–179, Feb. 2001, doi: 10.1016/s0304-3959(00)00401-2.
[863]	J. M. J. Favela-Hernández, A. García, E. Garza-González, V. M. Rivas-Galindo, and M. R. Camacho-Corona, “Antibacterial and antimycobacterial lignans and flavonoids from Larrea tridentata,” Phytother Res, vol. 26, no. 12, pp. 1957–1960, Dec. 2012, doi: 10.1002/ptr.4660.
[864]	K. W. Neuhaus, M. Liebi, S. Stauffacher, S. Eick, and A. Lussi, “Antibacterial Efficacy of a New Sonic Irrigation Device for Root Canal Disinfection,” J Endod, vol. 42, no. 12, pp. 1799–1803, Dec. 2016, doi: 10.1016/j.joen.2016.08.024.
[865]	J. Ho, J. C. Jolliff, and A. Heidari, “Antibiotic Lock Therapy for Leuconostoc pseudomesenteroides Catheter-Related Bacteremia,” Am. J. Med. Sci., vol. 352, no. 2, pp. 229–230, Aug. 2016, doi: 10.1016/j.amjms.2016.05.015.
[866]	D. L. Carter, K. M. Docherty, S. A. Gill, K. Baker, J. Teachout, and M. J. Vonhof, “Antibiotic resistant bacteria are widespread in songbirds across rural and urban environments,” Sci. Total Environ., vol. 627, pp. 1234–1241, Jun. 2018, doi: 10.1016/j.scitotenv.2018.01.343.
[867]	M. Dec, A. Wernicki, A. Puchalski, and R. Urban-Chmiel, “Antibiotic susceptibility of Lactobacillus strains isolated from domestic geese,” Br. Poult. Sci., vol. 56, no. 4, pp. 416–424, 2015, doi: 10.1080/00071668.2015.1058919.
[868]	P. Brassard et al., “Antibiotics in primary prevention of myocardial infarction among elderly patients with hypertension,” Am. Heart J., vol. 145, no. 5, p. E20, May 2003, doi: 10.1016/S0002-8703(03)00087-5.
[869]	C. T. Ambrose, “Antibody production in organ cultures of lymph-node fragments following in vitro secondary antigenic stimulation,” Natl Cancer Inst Monogr, vol. 11, pp. 117–126, Mar. 1963.
[870]	C. Ariyasriwatana, S. Kalayanarooj, and S. Pattamadilok, “Antibody response after measles immunization,” J Med Assoc Thai, vol. 86 Suppl 3, pp. S701-706, Aug. 2003.
[871]	M. Conti, V. Tazzari, C. Baccini, G. Pertici, L. P. Serino, and U. De Giorgi, “Anticancer drug delivery with nanoparticles,” In Vivo, vol. 20, no. 6A, pp. 697–701, Dec. 2006.
[872]	M. Zhang, K. T. Ma, J. H. Lim, Q. Zhao, and J. Feng, “Anticipating Where People will Look Using Adversarial Networks,” IEEE Trans Pattern Anal Mach Intell, vol. 41, no. 8, pp. 1783–1796, 2019, doi: 10.1109/TPAMI.2018.2871688.
[873]	H. Eberle, S. J. Nasuto, and Y. Hayashi, “Anticipation from sensation: using anticipating synchronization to stabilize a system with inherent sensory delay,” R Soc Open Sci, vol. 5, no. 3, p. 171314, Mar. 2018, doi: 10.1098/rsos.171314.
[874]	A. K. Sinha and P. K. Khan, “Anticlastogenicity of vitamin C in vivo against the cytogenetic toxicity of muriate of potash in murine bone marrow cells,” In Vivo, vol. 10, no. 1, pp. 111–112, Feb. 1996.
[875]	J. Meltzer and J. R. Guenzer, “Anticoagulant Reversal and Anesthetic Considerations,” Anesthesiol Clin, vol. 35, no. 2, pp. 191–205, Jun. 2017, doi: 10.1016/j.anclin.2017.01.005.
[876]	P. J. Evans et al., “Anticonvulsant therapy and cortisol elimination,” Br J Clin Pharmacol, vol. 20, no. 2, pp. 129–132, Aug. 1985, doi: 10.1111/j.1365-2125.1985.tb05042.x.
[877]	H. Förstl, “[Antidementia drugs--response or non-response?],” Internist (Berl), vol. 49, no. 3, pp. 353–359, Mar. 2008, doi: 10.1007/s00108-007-1990-y.
[878]	L. Cardamone, M. R. Salzberg, T. J. O’Brien, and N. C. Jones, “Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?,” Br. J. Pharmacol., vol. 168, no. 7, pp. 1531–1554, Apr. 2013, doi: 10.1111/bph.12052.
[879]	N. Górska, J. Słupski, W. J. Cubała, M. S. Wiglusz, and M. Gałuszko-Węgielnik, “Antidepressants in epilepsy,” Neurol. Neurochir. Pol., vol. 52, no. 6, pp. 657–661, Dec. 2018, doi: 10.1016/j.pjnns.2018.07.005.
[880]	Z. G. Laoutidis and K. Mathiak, “Antidepressants in the treatment of depression/depressive symptoms in cancer patients: a systematic review and meta-analysis,” BMC Psychiatry, vol. 13, p. 140, May 2013, doi: 10.1186/1471-244X-13-140.
[881]	K. R. Kaufman, “Antiepileptic drugs in the treatment of psychiatric disorders,” Epilepsy Behav, vol. 21, no. 1, pp. 1–11, May 2011, doi: 10.1016/j.yebeh.2011.03.011.
[882]	D. O. Okull, R. B. Beelman, and H. Gourama, “Antifungal activity of 10-oxo-trans-8-decenoic acid and 1-octen-3-ol against Penicillium expansum in potato dextrose agar medium,” J. Food Prot., vol. 66, no. 8, pp. 1503–1505, Aug. 2003, doi: 10.4315/0362-028x-66.8.1503.
[883]	“Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness,” Wkly. Epidemiol. Rec., vol. 93, no. 12, pp. 142–152, Mar. 2018.
[884]	L. K. D. Chaudhari, B. A. Jawale, S. Sharma, H. Sharma, C. D. M. Kumar, and P. A. Kulkarni, “Antimicrobial activity of commercially available essential oils against Streptococcus mutans,” J Contemp Dent Pract, vol. 13, no. 1, pp. 71–74, Jan. 2012, doi: 10.5005/jp-journals-10024-1098.
[885]	F. Fancello et al., “Antimicrobial activity of gaseous Citrus limon var pompia leaf essential oil against Listeria monocytogenes on ricotta salata cheese,” Food Microbiol., vol. 87, p. 103386, May 2020, doi: 10.1016/j.fm.2019.103386.
[886]	S.-Y. Yang, K.-Y. Lee, S.-E. Beak, H. Kim, and K. B. Song, “Antimicrobial activity of gelatin films based on duck feet containing cinnamon leaf oil and their applications in packaging of cherry tomatoes,” Food Sci. Biotechnol., vol. 26, no. 5, pp. 1429–1435, 2017, doi: 10.1007/s10068-017-0175-2.
[887]	T. M. Vieira, I. A. Dos Santos, T. S. Silva, C. H. G. Martins, and A. E. M. Crotti, “Antimicrobial Activity of Monoketone Curcuminoids Against Cariogenic Bacteria,” Chem. Biodivers., vol. 15, no. 8, p. e1800216, Aug. 2018, doi: 10.1002/cbdv.201800216.
[888]	S. G. Dastidar, S. K. Mahapatra, K. Ganguly, A. N. Chakrabarty, Y. Shirataki, and N. Motohashi, “Antimicrobial activity of prenylflavanones,” In Vivo, vol. 15, no. 6, pp. 519–523, Dec. 2001.
[889]	J. C. Onishi et al., “Antimicrobial activity of viridiofungins,” J. Antibiot., vol. 50, no. 4, pp. 334–338, Apr. 1997, doi: 10.7164/antibiotics.50.334.
[890]	R. L. Pizzey, R. E. Marquis, and D. J. Bradshaw, “Antimicrobial effects of o-cymen-5-ol and zinc, alone & in combination in simple solutions and toothpaste formulations,” Int Dent J, vol. 61 Suppl 3, pp. 33–40, Aug. 2011, doi: 10.1111/j.1875-595X.2011.00047.x.
[891]	J. Seddon and S. Bhagani, “Antimicrobial therapy for the treatment of opportunistic infections in HIV/AIDS patients: a critical appraisal,” HIV AIDS (Auckl), vol. 3, pp. 19–33, 2011, doi: 10.2147/HIV.S9274.
[892]	J.-K. Moon and T. Shibamoto, “Antioxidant assays for plant and food components,” J. Agric. Food Chem., vol. 57, no. 5, pp. 1655–1666, Mar. 2009, doi: 10.1021/jf803537k.
[893]	A. Ferramosca, M. Di Giacomo, and V. Zara, “Antioxidant dietary approach in treatment of fatty liver: New insights and updates,” World J. Gastroenterol., vol. 23, no. 23, pp. 4146–4157, Jun. 2017, doi: 10.3748/wjg.v23.i23.4146.
[894]	C. F. Tseng, C. C. Lin, H. Y. Huang, H. C. Liu, and S. J. T. Mao, “Antioxidant role of human haptoglobin,” Proteomics, vol. 4, no. 8, pp. 2221–2228, Aug. 2004, doi: 10.1002/pmic.200300787.
[895]	X. Bu et al., “Antiphosphatidylserine Antibodies and Clinical Outcomes in Patients With Acute Ischemic Stroke,” Stroke, vol. 47, no. 11, pp. 2742–2748, 2016, doi: 10.1161/STROKEAHA.116.013827.
[896]	R. Narayanan, “Antisense therapy of cancer,” In Vivo, vol. 8, no. 5, pp. 787–793, Dec. 1994.
[897]	E. Alt and C. Seliger, “Antithrombotic stent coatings: hirudin/iloprost combination,” Semin Interv Cardiol, vol. 3, no. 3–4, pp. 177–183, Dec. 1998.
[898]	T. Jiang et al., “Antitumor activity of a novel Aurora A/B kinases inhibitor TY-011 against gastric cancer by inducing DNA damage,” Anticancer Drugs, vol. 31, no. 5, pp. 440–451, 2020, doi: 10.1097/CAD.0000000000000928.
[899]	H. Thadepalli, F. Salem, S. K. Chuah, and S. Gollapudi, “Antitumor activity of trovafloxacin in an animal model,” In Vivo, vol. 19, no. 1, pp. 269–276, Feb. 2005.
[900]	W. Liu et al., “Antitumor activity of TY-011 against gastric cancer by inhibiting Aurora A, Aurora B and VEGFR2 kinases,” J. Exp. Clin. Cancer Res., vol. 35, no. 1, p. 183, 25 2016, doi: 10.1186/s13046-016-0464-2.
[901]	C. Socaciu, A. Bara, C. Silvestru, and I. Haiduc, “Antitumor organometallics. II. Inhibitory effects of two diphenyl-antimony (III) dithiophosphorus derivatives on in vitro and in vivo Ehrlich ascites tumor,” In Vivo, vol. 5, no. 4, pp. 425–428, Aug. 1991.
[902]	S. Sigurdsson, H. M. Ogmundsdottir, J. Hallgrimsson, and S. Gudbjarnason, “Antitumour activity of Angelica archangelica leaf extract,” In Vivo, vol. 19, no. 1, pp. 191–194, Feb. 2005.
[903]	E. Dean, “Anxiety,” Nurs Stand, vol. 30, no. 46, p. 15, Jul. 2016, doi: 10.7748/ns.30.46.15.s17.
[904]	A. K. Dutta, “Anxiety,” J Indian Med Assoc, vol. 55, no. 3, pp. 98–101, Aug. 1970.
[905]	D. Schuyler, “Anxiety,” Prim Care Companion CNS Disord, vol. 18, no. 5, Oct. 2016, doi: 10.4088/PCC.16f02039.
[906]	I. Cabrera and I. Montorio, “[Anxiety and ageing],” Rev Esp Geriatr Gerontol, vol. 44, no. 2, pp. 106–111, Apr. 2009, doi: 10.1016/j.regg.2009.01.001.
[907]	P. J. Tully, N. J. Harrison, P. Cheung, and S. Cosh, “Anxiety and Cardiovascular Disease Risk: a Review,” Curr Cardiol Rep, vol. 18, no. 12, p. 120, 2016, doi: 10.1007/s11886-016-0800-3.
[908]	A. M. Yohannes, A. Kaplan, and N. A. Hanania, “Anxiety and Depression in Chronic Obstructive Pulmonary Disease: Recognition and Management,” Cleve Clin J Med, vol. 85, no. 2 Suppl 1, pp. S11–S18, Feb. 2018, doi: 10.3949/ccjm.85.s1.03.
[909]	T. Knight and P. Thomas, “Anxiety and depression in the age of austerity: public health’s problems with IAPT,” Perspect Public Health, vol. 139, no. 3, pp. 128–130, 2019, doi: 10.1177/1757913919839004.
[910]	I. Bjelland and A. A. Dahl, “[Anxiety and depression--a common mixture],” Tidsskr. Nor. Laegeforen., vol. 119, no. 22, pp. 3277–3280, Sep. 1999.
[911]	C. J. Beuke, R. Fischer, and J. McDowall, “Anxiety and depression: why and how to measure their separate effects,” Clin Psychol Rev, vol. 23, no. 6, pp. 831–848, Nov. 2003, doi: 10.1016/s0272-7358(03)00074-6.
[912]	A. J. Scott, L. Sharpe, C. Hunt, and M. Gandy, “Anxiety and depressive disorders in people with epilepsy: A meta-analysis,” Epilepsia, vol. 58, no. 6, pp. 973–982, 2017, doi: 10.1111/epi.13769.
[913]	D. J. Kupfer, “Anxiety and DSM-5,” Dialogues Clin Neurosci, vol. 17, no. 3, pp. 245–246, Sep. 2015.
[914]	H. M. Munger Clary, “Anxiety and epilepsy: what neurologists and epileptologists should know,” Curr Neurol Neurosci Rep, vol. 14, no. 5, p. 445, May 2014, doi: 10.1007/s11910-014-0445-9.
[915]	T. Stompe et al., “Anxiety and hostility in the manifest dreams of schizophrenic patients,” J. Nerv. Ment. Dis., vol. 191, no. 12, pp. 806–812, Dec. 2003, doi: 10.1097/01.nmd.0000100924.73596.b8.
[916]	D. Nutt and A. Malizia, “Anxiety and OCD - the chicken or the egg?,” J. Psychopharmacol. (Oxford), vol. 20, no. 6, pp. 729–731, Nov. 2006, doi: 10.1177/0269881106068424.
[917]	M. G. Fraire and T. H. Ollendick, “Anxiety and oppositional defiant disorder: a transdiagnostic conceptualization,” Clin Psychol Rev, vol. 33, no. 2, pp. 229–240, Mar. 2013, doi: 10.1016/j.cpr.2012.11.004.
[918]	Z. B. Al-Bitar and H. T. Al-Ahmad, “Anxiety and post-traumatic stress symptoms in orthognathic surgery patients,” Eur J Orthod, vol. 39, no. 1, pp. 92–97, Feb. 2017, doi: 10.1093/ejo/cjw029.
[919]	E. V. Verbitskiĭ, “[Anxiety and sleep],” Zh Vyssh Nerv Deiat Im I P Pavlova, vol. 63, no. 1, pp. 6–12, Feb. 2013, doi: 10.7868/s0044467713010152.
[920]	W. Maier, “[Anxiety and somatoform disorders. Their diagnosis, epidemiology, biological causes and therapy],” Fortschr Neurol Psychiatr, vol. 66 Suppl 1, pp. S3-8, Dec. 1998, doi: 10.1055/s-2007-1001156.
[921]	A. Bottomley, “Anxiety and the adult cancer patient,” Eur J Cancer Care (Engl), vol. 7, no. 4, pp. 217–224, Dec. 1998, doi: 10.1046/j.1365-2354.1998.00101.x.
[922]	Z. Chmielnicki, “[Anxiety as a anesthesiological problem],” Wiad. Lek., vol. 52, no. 3–4, pp. 174–177, 1999.
[923]	S. Kraemer, “[Anxiety disorders and anxiety attacks: diagnosis and treatment from the viewpoint of behavior therapy],” Z Klin Psychol Psychopathol Psychother, vol. 39, no. 2, pp. 125–147, 1991.
[924]	D. Castellanos and T. Hunter, “Anxiety disorders in children and adolescents,” South. Med. J., vol. 92, no. 10, pp. 946–954, Oct. 1999.
[925]	T.-W. Yang, D.-H. Kim, Y.-S. Kim, J. Kim, and O.-Y. Kwon, “Anxiety disorders in outpatient clinics of epilepsy in tertiary care hospitals: A meta-analysis,” Seizure, vol. 75, pp. 34–42, Feb. 2020, doi: 10.1016/j.seizure.2019.12.011.
[926]	C. Andreescu and S. Lee, “Anxiety Disorders in the Elderly,” Adv. Exp. Med. Biol., vol. 1191, pp. 561–576, 2020, doi: 10.1007/978-981-32-9705-0_28.
[927]	C. A. Essau, “Anxiety in children: when is it classed as a disorder that should be treated?,” Expert Rev Neurother, vol. 7, no. 8, pp. 909–911, Aug. 2007, doi: 10.1586/14737175.7.8.909.
[928]	R. J. Boerner, “[Anxiety in elderly people -- epidemiology, diagnostic features and therapeutic options],” Fortschr Neurol Psychiatr, vol. 72, no. 10, pp. 564–573, Oct. 2004, doi: 10.1055/s-2004-818530.
[929]	R. Pary, S. K. Sarai, R. Sumner, and S. Lippmann, “Anxiety in geriatrics,” Postgrad Med, vol. 131, no. 5, pp. 330–332, 2019, doi: 10.1080/00325481.2019.1624583.
[930]	R. Mago, J.-P. Gomez, N. Gupta, and E. J. S. Kunhel, “Anxiety in medically ill patients,” Curr Psychiatry Rep, vol. 8, no. 3, pp. 228–233, Jun. 2006, doi: 10.1007/s11920-006-0028-9.
[931]	I. Koychev and K. P. Ebmeier, “Anxiety in older adults often goes undiagnosed,” Practitioner, vol. 260, no. 1789, pp. 17–20, 2–3, Jan. 2016.
[932]	S. Pautex et al., “[Anxiety in palliative care],” Rev Med Suisse, vol. 2, no. 85, pp. 2478–2482, 2484–2487, Nov. 2006.
[933]	S. D. Cohen, D. Cukor, and P. L. Kimmel, “Anxiety in Patients Treated with Hemodialysis,” Clin J Am Soc Nephrol, vol. 11, no. 12, pp. 2250–2255, 07 2016, doi: 10.2215/CJN.02590316.
[934]	M. E. Quirk, A. J. Letendre, R. A. Ciottone, and J. F. Lingley, “Anxiety in patients undergoing MR imaging,” Radiology, vol. 170, no. 2, pp. 463–466, Feb. 1989, doi: 10.1148/radiology.170.2.2911670.
[935]	J. W. Smoller, N. M. Simon, M. H. Pollack, R. Kradin, and T. Stern, “Anxiety in patients with pulmonary disease: comorbidity and treatment,” Semin Clin Neuropsychiatry, vol. 4, no. 2, pp. 84–97, Apr. 1999, doi: 10.1053/SCNP00400084.
[936]	J. C. H. van Bussel, B. Spitz, and K. Demyttenaere, “Anxiety in pregnant and postpartum women. An exploratory study of the role of maternal orientations,” J Affect Disord, vol. 114, no. 1–3, pp. 232–242, Apr. 2009, doi: 10.1016/j.jad.2008.07.018.
[937]	J. B. Byrd and R. D. Brook, “Anxiety in the ‘age of hypertension,’” Curr. Hypertens. Rep., vol. 16, no. 10, p. 486, Oct. 2014, doi: 10.1007/s11906-014-0486-0.
[938]	J. Anderson et al., “Anxiety in the management of localised prostate cancer by active surveillance,” BJU Int., vol. 114 Suppl 1, pp. 55–61, Nov. 2014, doi: 10.1111/bju.12765.
[939]	A. E. Skodol, “Anxiety in the medically ill: nosology and principles of differential diagnosis,” Semin Clin Neuropsychiatry, vol. 4, no. 2, pp. 64–71, Apr. 1999, doi: 10.1053/SCNP00400064.
[940]	S. Karande, N. Kumbhare, M. Kulkarni, and N. Shah, “Anxiety levels in mothers of children with specific learning disability,” J Postgrad Med, vol. 55, no. 3, pp. 165–170, Sep. 2009, doi: 10.4103/0022-3859.57388.
[941]	M. Mitchell, “Anxiety management in minimal stay surgery,” Nurs Times, vol. 108, no. 48, pp. 14–16, Dec. 2012.
[942]	C. Kılıç, S. Ak, and H. B. Ak, “Anxiety sensitivity: another reason to separate dental fears from blood-injury fears?,” J Anxiety Disord, vol. 28, no. 2, pp. 280–282, Mar. 2014, doi: 10.1016/j.janxdis.2014.01.001.
[943]	J. Zhang, X. Jin, X. Zhou, L. Shen, H. Huang, and X. Shen, “[Anxiety state and its related factors in Shanghai high school students],” Zhonghua Yu Fang Yi Xue Za Zhi, vol. 39, no. 5, pp. 348–351, Sep. 2005.
[944]	V. Starcevic, “Anxiety states: a review of conceptual and treatment issues,” Curr Opin Psychiatry, vol. 19, no. 1, pp. 79–83, Jan. 2006, doi: 10.1097/01.yco.0000194146.81024.5a.
[945]	F. Alwahhabi, “Anxiety symptoms and generalized anxiety disorder in the elderly: a review,” Harv Rev Psychiatry, vol. 11, no. 4, pp. 180–193, Aug. 2003, doi: 10.1080/10673220303944.
[946]	M. H. Schmidt and B. Blanz, “Anxiety syndromes in childhood and adolescence,” Acta Paedopsychiatr, vol. 52, no. 1, pp. 36–43, 1989.
[947]	M. Dosiak, “[Anxiety--medical aspects],” Wiad. Lek., vol. 50, no. 1–3, pp. 21–27, 1997.
[948]	G. Tomei et al., “Anxiety, musculoskeletal and visual disorders in video display terminal workers,” Minerva Med., vol. 97, no. 6, pp. 459–466, Dec. 2006.
[949]	R. Robert, P. Blakeney, C. Villarreal, and W. J. Meyer, “Anxiety: current practices in assessment and treatment of anxiety of burn patients,” Burns, vol. 26, no. 6, pp. 549–552, Sep. 2000, doi: 10.1016/s0305-4179(00)00016-4.
[950]	R. Davies, “Anxiety: the importunate companion. Psychoanalytic theory of castration and separation anxieties and implications for clinical technique,” Int J Psychoanal, vol. 93, no. 5, pp. 1101–1114, Oct. 2012, doi: 10.1111/j.1745-8315.2012.00595.x.
[951]	H. Floyd, M. Sanoufa, and J. S. Robinson, “Anxiety’s Impact on Length of Stay Following Lumbar Spinal Surgery,” Perm J, vol. 19, no. 4, pp. 58–60, 2015, doi: 10.7812/TPP/15-022.
[952]	K. M. Walsemann and A. D. Perez, “Anxiety’s relationship to inconsistent use of oral contraceptives,” Health Educ Behav, vol. 33, no. 2, pp. 197–214, Apr. 2006, doi: 10.1177/1090198105277322.
[953]	H. M. Van Praag, “Anxiety/aggression--driven depression. A paradigm of functionalization and verticalization of psychiatric diagnosis,” Prog. Neuropsychopharmacol. Biol. Psychiatry, vol. 25, no. 4, pp. 893–924, May 2001, doi: 10.1016/s0278-5846(01)00151-8.
[954]	G. Telegdy and A. Adamik, “Anxiolytic action of neuromedin-U and neurotransmitters involved in mice,” Regul. Pept., vol. 186, pp. 137–140, Sep. 2013, doi: 10.1016/j.regpep.2013.07.008.
[955]	M. Balasubramanian et al., “Aortic aneurysm/dissection and osteogenesis imperfecta: Four new families and review of the literature,” Bone, vol. 121, pp. 191–195, 2019, doi: 10.1016/j.bone.2019.01.022.
[956]	M. Kratzke, E. Candiello, B. Schmidt, O. Jahn, and P. Schu, “AP-1/σ1B-Dependent SV Protein Recycling Is Regulated in Early Endosomes and Is Coupled to AP-2 Endocytosis,” Mol. Neurobiol., vol. 52, no. 1, pp. 142–161, Aug. 2015, doi: 10.1007/s12035-014-8852-0.
[957]	J.-G. Seo, G.-H. Lee, and S.-P. Park, “Apathy in people with epilepsy and its clinical significance: A case-control study,” Seizure, vol. 51, pp. 80–86, Oct. 2017, doi: 10.1016/j.seizure.2017.08.003.
[958]	A. Verri et al., “Aphidicolin inhibits in vitro the activity of pseudorabies virus (PRV) DNA polymerase and in vivo the viral proliferation,” In Vivo, vol. 8, no. 6, pp. 1041–1046, Dec. 1994.
[959]	C. Aman et al., “Apical root resorption during orthodontic treatment with clear aligners: A retrospective study using cone-beam computed tomography,” Am J Orthod Dentofacial Orthop, vol. 153, no. 6, pp. 842–851, Jun. 2018, doi: 10.1016/j.ajodo.2017.10.026.
[960]	D. A. Butterfield and L. A. Johnson, “APOE in Alzheimer’s disease and neurodegeneration,” Neurobiol. Dis., vol. 139, p. 104847, 2020, doi: 10.1016/j.nbd.2020.104847.
[961]	B. S. Main et al., “Apolipoprotein E4 impairs spontaneous blood brain barrier repair following traumatic brain injury,” Mol Neurodegener, vol. 13, no. 1, p. 17, 04 2018, doi: 10.1186/s13024-018-0249-5.
[962]	R. Najm, E. A. Jones, and Y. Huang, “Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease,” Mol Neurodegener, vol. 14, no. 1, p. 24, 11 2019, doi: 10.1186/s13024-019-0324-6.
[963]	D. S. Marsman and J. C. Barrett, “Apoptosis and chemical carcinogenesis,” Risk Anal., vol. 14, no. 3, pp. 321–326, Jun. 1994, doi: 10.1111/j.1539-6924.1994.tb00247.x.
[964]	A. Bobba, A. Atlante, L. de Bari, S. Passarella, and E. Marra, “Apoptosis and cytochrome c release in cerebellar granule cells,” In Vivo, vol. 18, no. 3, pp. 335–344, Jun. 2004.
[965]	C. A. Rubio, J. Kumagai, T. Kanamori, and K. Nakamura, “Apoptosis in flat neoplasias of the colorectal mucosa,” In Vivo, vol. 9, no. 3, pp. 173–176, Jun. 1995.
[966]	H.-J. Yuan, R.-R. Xu, R.-S. Ding, S.-H. Jiang, and W. Lu, “[Apoptosis of in vitro cultured BMMNC from MDS patients induced by arsenic sulfide],” Zhongguo Shi Yan Xue Ye Xue Za Zhi, vol. 14, no. 2, pp. 276–280, Apr. 2006.
[967]	J. Ringleb et al., “Apoptotic Cancer Cells Suppress 5-Lipoxygenase in Tumor-Associated Macrophages,” J. Immunol., vol. 200, no. 2, pp. 857–868, 15 2018, doi: 10.4049/jimmunol.1700609.
[968]	A. M. Bajgiran, S. A. Mirak, K. Sung, A. E. Sisk, R. E. Reiter, and S. S. Raman, “Apparent Diffusion Coefficient (ADC) Ratio Versus Conventional ADC for Detecting Clinically Significant Prostate Cancer With 3-T MRI,” AJR Am J Roentgenol, vol. 213, no. 3, pp. W134–W142, 2019, doi: 10.2214/AJR.19.21365.
[969]	B. G. Jeon et al., “Appendectomy: Should it Be Performed So Quickly?,” Am Surg, vol. 82, no. 1, pp. 65–74, Jan. 2016.
[970]	P. Hindle, E. K. Davidson, L. C. Biant, and C. M. Court-Brown, “Appendicular joint dislocations,” Injury, vol. 44, no. 8, pp. 1022–1027, Aug. 2013, doi: 10.1016/j.injury.2013.01.043.
[971]	D. A. Bechtold, T. R. Ivanov, and S. M. Luckman, “Appetite-modifying actions of pro-neuromedin U-derived peptides,” Am. J. Physiol. Endocrinol. Metab., vol. 297, no. 2, pp. E545-551, Aug. 2009, doi: 10.1152/ajpendo.00255.2009.
[972]	S. Bhandari, R. Kumar, P. Tripathi, and E. Riley, “Apple-core lesion,” Curr Probl Cancer, vol. 43, no. 6, p. 100475, 2019, doi: 10.1016/j.currproblcancer.2019.04.001.
[973]	C. Bolm, M. Kesselgruber, N. Hermanns, J. P. Hildebrand, and G. Raabe, “Application of a Planar Chiral eta(5)-Cyclopentadienylrhenium(I)tricarbonyl Complex in Asymmetric Catalysis: Highly Enantioselective Phenyl Transfer to Aldehydes We are grateful to the Deutsche Forschungsgemeinschaft (DFG) within the Collaborative Research Center (SFB) 380 ‘Asymmetric Synthesis by Chemical and Biological Methods’ and the Fonds der Chemischen Industrie for financial support and to Dr. C. W. Lehmann, MPI für Kohlenforschung, Mülheim, for collecting the X-ray diffraction data. M.K. acknowledges the DFG for a predoctoral fellowship (Graduiertenkolleg). We thank Degussa and Witco for donations of chemicals and Professor Dr. A. Salzer as well as Dipl.-Ing. M. Treu for inspiring discussions. We also appreciate the stimulus of Dr. K. Muñiz for the investigation of the influence of the metal-pi-fragment on catalyses of this type.,” Angew. Chem. Int. Ed. Engl., vol. 40, no. 8, pp. 1488–1490, Apr. 2001.
[974]	P. Tian, D. Yang, L. Pan, and R. Mandrell, “Application of a receptor-binding capture quantitative reverse transcription-PCR assay to concentrate human norovirus from sewage and to study the distribution and stability of the virus,” Appl. Environ. Microbiol., vol. 78, no. 2, pp. 429–436, Jan. 2012, doi: 10.1128/AEM.06875-11.
[975]	P. Browne, P. D. Noyes, W. M. Casey, and D. J. Dix, “Application of Adverse Outcome Pathways to U.S. EPA’s Endocrine Disruptor Screening Program,” Environ. Health Perspect., vol. 125, no. 9, p. 096001, 01 2017, doi: 10.1289/EHP1304.
[976]	Z. Shi and H. Li, “Application of artificial neural network approach and remotely sensed imagery for regional eco-environmental quality evaluation,” Environ Monit Assess, vol. 128, no. 1–3, pp. 217–229, May 2007, doi: 10.1007/s10661-006-9307-5.
[977]	Y. Fei, J. Li, and W. Tian, “[Application of biological mesh for reconstruction of pelvic floor in patients with perineal hernia],” Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, vol. 28, no. 10, pp. 1270–1272, Oct. 2014.
[978]	B. Korin and A. Rolls, “Application of Chemogenetics and Optogenetics to Dissect Brain-Immune Interactions,” Methods Mol. Biol., vol. 1781, pp. 195–208, 2018, doi: 10.1007/978-1-4939-7828-1_11.
[979]	J. W. Xin, X. L. Xiao, X. C. Chen, and X. D. Pan, “[Application of Chinese version of ACE-Ⅲ in type 2 diabetes mellitus patients with mild cognitive impairment],” Zhonghua Yi Xue Za Zhi, vol. 97, no. 44, pp. 3455–3459, Nov. 2017, doi: 10.3760/cma.j.issn.0376-2491.2017.44.004.
[980]	R. W. L. So et al., “Application of CRISPR genetic screens to investigate neurological diseases,” Mol Neurodegener, vol. 14, no. 1, p. 41, 14 2019, doi: 10.1186/s13024-019-0343-3.
[981]	N. van Linden, H. Spanjers, and J. B. van Lier, “Application of dynamic current density for increased concentration factors and reduced energy consumption for concentrating ammonium by electrodialysis,” Water Res., vol. 163, p. 114856, Oct. 2019, doi: 10.1016/j.watres.2019.114856.
[982]	X. G. Fan, W. B. Mi, and J. W. Hou, “[Application of extended exergy method in driving mechanism and efficiency of regional eco-economy],” Ying Yong Sheng Tai Xue Bao, vol. 28, no. 1, pp. 273–280, Jan. 2017, doi: 10.13287/j.1001-9332.201701.008.
[983]	H. Yang, B. Wang, L. Huang, J. Li, and W. Wang, “[Application of ipsilateral digital proper artery dorsal branch flap to repair mid-phalanx degloving injury with distal segment finger defect],” Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, vol. 32, no. 11, pp. 1446–1449, 15 2018, doi: 10.7507/1002-1892.201804055.
[984]	M. Ni et al., “Application of next‑generation sequencing for molecular diagnosis in a large family with osteogenesis imperfecta type I,” Mol Med Rep, vol. 16, no. 5, pp. 6846–6849, Nov. 2017, doi: 10.3892/mmr.2017.7435.
[985]	M. Eandi, G. P. Zara, and C. Della Pepa, “Application of pharmacoeconomics to the use of antibiotics,” Clin. Microbiol. Infect., vol. 6 Suppl 3, pp. 90–92, 2000, doi: 10.1111/j.1469-0691.2000.tb02055.x.
[986]	D. Simkovic and L. Hnilica, “Application of placental extracts in cultivation in vitro III. Influence of the dialysable fraction of placental extract on the growth of chick embryo fibroblasts in tissue culture,” Neoplasma, vol. 4, no. 4, pp. 334–339, 1957.
[987]	L. Hnilica, V. Holoubek, and D. Simkovic, “Application of placental extracts in cultivation in vitro.  II.  Some properties of the non-dialysable fraction of placental extract,” Cesk Onkol, vol. 3, no. 4, pp. 292–297, 1956.
[988]	H. Ellinger-Ziegelbauer, J. Aubrecht, J. C. Kleinjans, and H.-J. Ahr, “Application of toxicogenomics to study mechanisms of genotoxicity and carcinogenicity,” Toxicol. Lett., vol. 186, no. 1, pp. 36–44, Apr. 2009, doi: 10.1016/j.toxlet.2008.08.017.
[989]	Y. Wang, J. Jiang, L. Zhao, R. Zhou, W. Yu, and T. Zhao, “Application of Whole Genome Resequencing in Mapping of a Tomato Yellow Leaf Curl Virus Resistance Gene,” Sci Rep, vol. 8, no. 1, p. 9592, 25 2018, doi: 10.1038/s41598-018-27925-w.
[990]	S. Montalvo, C. Huiliñir, R. Borja, E. Sánchez, and C. Herrmann, “Application of zeolites for biological treatment processes of solid wastes and wastewaters - A review,” Bioresour. Technol., vol. 301, p. 122808, Apr. 2020, doi: 10.1016/j.biortech.2020.122808.
[991]	I. Lanzl, R.-L. Merté, and P. Roggenkämper, “[Applications of botulinum toxin in ophthalmology],” Klin Monbl Augenheilkd, vol. 226, no. 1, pp. R1-8; quiz R9-12, Jan. 2009, doi: 10.1055/s-2008-1039275.
[992]	F. J. Thomas and G. Wood, “Applications of diagnostic radiology to radiation oncology,” In Vivo, vol. 8, no. 5, pp. 707–711, Dec. 1994.
[993]	M. M. Zhao et al., “[Applications of eco-environmental big data: Progress and prospect],” Ying Yong Sheng Tai Xue Bao, vol. 28, no. 5, pp. 1727–1734, May 2017, doi: 10.13287/j.1001-9332.201705.001.
[994]	K. Ozulken, F. Cabot, and S. H. Yoo, “Applications of femtosecond lasers in ophthalmic surgery,” Expert Rev Med Devices, vol. 10, no. 1, pp. 115–124, Jan. 2013, doi: 10.1586/erd.12.59.
[995]	S.-H. Tsai, Y.-R. Chen, Y.-L. Tsou, T.-L. Chang, H.-Z. Lai, and C.-Y. Lee, “Applications of Long-Length Carbon Nano-Tube (L-CNT) as Conductive Materials in High Energy Density Pouch Type Lithium Ion Batteries,” Polymers (Basel), vol. 12, no. 7, Jun. 2020, doi: 10.3390/polym12071471.
[996]	Y. Ju, “Applications of Matrix-Assisted Laser Desorption Ionization In-Source Decay Mass Spectrometry,” Adv. Exp. Med. Biol., vol. 1140, pp. 45–54, 2019, doi: 10.1007/978-3-030-15950-4_3.
[997]	J. W. Wallace, K. P. Decosimo, and M. C. Simon, “Applying Data Analytics to Address Social Determinants of Health in Practice,” N C Med J, vol. 80, no. 4, pp. 244–248, Aug. 2019, doi: 10.18043/ncm.80.4.244.
[998]	A. Ahmad and V. Sundelin-Wahlsten, “Applying EMDR on children with PTSD,” Eur Child Adolesc Psychiatry, vol. 17, no. 3, pp. 127–132, Apr. 2008, doi: 10.1007/s00787-007-0646-8.
[999]	M. Rerolle, “[Apposition of skin fragments in vitro: behavior of the epidermis],” Arch Anat Microsc Morphol Exp, vol. 48, pp. 325–343, Dec. 1959.
[1000]	M. E. Raichle and D. A. Gusnard, “Appraising the brain’s energy budget,” Proc. Natl. Acad. Sci. U.S.A., vol. 99, no. 16, pp. 10237–10239, Aug. 2002, doi: 10.1073/pnas.172399499.
[1001]	C. A. Ryan, B. C. Hulette, and G. F. Gerberick, “Approaches for the development of cell-based in vitro methods for contact sensitization,” Toxicol In Vitro, vol. 15, no. 1, pp. 43–55, Feb. 2001, doi: 10.1016/s0887-2333(00)00059-x.
[1002]	A. Mehlhorn, P. Rahimi, and Y. Joseph, “Aptamer-Based Biosensors for Antibiotic Detection: A Review,” Biosensors (Basel), vol. 8, no. 2, Jun. 2018, doi: 10.3390/bios8020054.
[1003]	J. E. Kim, Y. J. Lee, M. H. Kwak, J. Ko, J. T. Hong, and D. Y. Hwang, “Aqueous extracts of Liriope platyphylla induced significant laxative effects on loperamide-induced constipation of SD rats,” BMC Complement Altern Med, vol. 13, p. 333, Nov. 2013, doi: 10.1186/1472-6882-13-333.
[1004]	A. Kukay, R. Sahore, A. Parejiya, W. Blake Hawley, J. Li, and D. L. Wood, “Aqueous Ni-rich-cathode dispersions processed with phosphoric acid for lithium-ion batteries with ultra-thick electrodes,” J Colloid Interface Sci, vol. 581, no. Pt B, pp. 635–643, Aug. 2020, doi: 10.1016/j.jcis.2020.07.144.
[1005]	“AR’s 96 guide to image management & teleradiology companies,” Adm Radiol J, vol. 15, no. 4, pp. 29–36, Apr. 1996.
[1006]	D. Batulevicius, N. Pauziene, and D. H. Pauza, “Architecture and age-related analysis of the neuronal number of the guinea pig intrinsic cardiac nerve plexus,” Ann. Anat., vol. 187, no. 3, pp. 225–243, Jul. 2005, doi: 10.1016/j.aanat.2005.01.004.
[1007]	G. J. G. Asmundson, J. A. Stapleton, and S. Taylor, “Are avoidance and numbing distinct PTSD symptom clusters?,” J Trauma Stress, vol. 17, no. 6, pp. 467–475, Dec. 2004, doi: 10.1007/s10960-004-5795-7.
[1008]	R. S. Mirza and D. P. Chivers, “Are chemical alarm cues conserved within salmonid fishes?,” J. Chem. Ecol., vol. 27, no. 8, pp. 1641–1655, Aug. 2001, doi: 10.1023/a:1010414426082.
[1009]	D. Stewart, E. Lang, D. Wang, and G. Innes, “Are emergency medical services offload delay patients at increased risk of adverse outcomes?,” CJEM, vol. 21, no. 4, pp. 505–512, 2019, doi: 10.1017/cem.2018.478.
[1010]	S. A. Haist, J. F. Wilson, S. E. Fosson, and N. L. Brigham, “Are fourth-year medical students effective teachers of the physical examination to first-year medical students?,” J Gen Intern Med, vol. 12, no. 3, pp. 177–181, Mar. 1997, doi: 10.1007/s11606-006-5026-4.
[1011]	E. Buitrago et al., “Are Human Tyrosinase and Related Proteins Suitable Targets for Melanoma Therapy?,” Curr Top Med Chem, vol. 16, no. 27, pp. 3033–3047, 2016, doi: 10.2174/1568026616666160216160112.
[1012]	H. G. Welch, L. M. Schwartz, and S. Woloshin, “Are increasing 5-year survival rates evidence of success against cancer?,” JAMA, vol. 283, no. 22, pp. 2975–2978, Jun. 2000, doi: 10.1001/jama.283.22.2975.
[1013]	F. Berthold, C. Bartenhagen, and L. Krempel, “Are network growth and the contributions to congresses associated with publication success? A pediatric oncology model,” PLoS ONE, vol. 14, no. 1, p. e0210994, 2019, doi: 10.1371/journal.pone.0210994.
[1014]	R. M. Stone, “Are new agents really making a difference in MDS?,” Best Pract Res Clin Haematol, vol. 21, no. 4, pp. 639–646, Dec. 2008, doi: 10.1016/j.beha.2008.06.004.
[1015]	T. Hatta and A. Kawakami, “Are nonproper chopstick holders clumsier than proper chopstick holders in their manual movements?,” Percept Mot Skills, vol. 88, no. 3 Pt 1, pp. 809–818, Jun. 1999, doi: 10.2466/pms.1999.88.3.809.
[1016]	R. Power et al., “Are patients ready for integrated person-centered care? A qualitative study of people with epilepsy in Ireland,” Epilepsy Behav, vol. 102, p. 106668, 2020, doi: 10.1016/j.yebeh.2019.106668.
[1017]	L. A. M. Leenen, B. F. M. Wijnen, R. J. A. de Kinderen, C. M. van Heugten, S. M. A. A. Evers, and M. H. J. M. Majoie, “Are people with epilepsy using eHealth-tools?,” Epilepsy Behav, vol. 64, no. Pt A, pp. 268–272, 2016, doi: 10.1016/j.yebeh.2016.08.007.
[1018]	A. Bowen, R. Bowen, L. Balbuena, and N. Muhajarine, “Are pregnant and postpartum women moodier? Understanding perinatal mood instability,” J Obstet Gynaecol Can, vol. 34, no. 11, pp. 1038–1042, Nov. 2012, doi: 10.1016/S1701-2163(16)35433-0.
[1019]	J. C. Argüelles and R. Argüelles-Prieto, “Are the Editors Responsible for Our Obsession with the Impact Factor?,” mBio, vol. 8, no. 6, 19 2017, doi: 10.1128/mBio.02019-17.
[1020]	N. S. Consedine, “Are we worrying about the right men and are the right men feeling worried? Conscious but not unconscious prostate anxiety predicts screening among men from three ethnic groups,” Am J Mens Health, vol. 6, no. 1, pp. 37–50, Jan. 2012, doi: 10.1177/1557988311415513.
[1021]	A. Papa, “Are you a good witch or a bad witch?,” J Emerg Nurs, vol. 37, no. 3, pp. 215–216, May 2011, doi: 10.1016/j.jen.2011.03.014.
[1022]	K. Curry, “Are you publicizing your publication?,” J Am Assoc Nurse Pract, vol. 31, no. 1, pp. 1–2, Jan. 2019, doi: 10.1097/JXX.0000000000000181.
[1023]	P. Striano and F. Zara, “ARHGEF9 mutations cause a specific recognizable X-linked intellectual disability syndrome,” Neurol Genet, vol. 3, no. 3, p. e159, Jun. 2017, doi: 10.1212/NXG.0000000000000159.
[1024]	“Armenia, Maldives, Sri Lanka and Kyrgyzstan certified malaria-free,” Wkly. Epidemiol. Rec., vol. 92, no. 39, pp. 573–577, 29 2017.
[1025]	S. Zanella et al., “Arnica compositum, Hekla lava and Acidum Nitricum Together are Superior to Arnica compositum Alone in the Local Treatment of Symptomatic Calcific Periarthritis of the Shoulder: A Pilot Study,” Rev Recent Clin Trials, vol. 13, no. 2, pp. 150–155, 2018, doi: 10.2174/1574887113666180319165700.
[1026]	R. S. Herz, “Aromatherapy facts and fictions: a scientific analysis of olfactory effects on mood, physiology and behavior,” Int. J. Neurosci., vol. 119, no. 2, pp. 263–290, 2009, doi: 10.1080/00207450802333953.
[1027]	L. B. Liem, A. DiBiase, and J. S. Schroeder, “Arrhythmias and clinical electrophysiology of the transplanted human heart,” Semin. Thorac. Cardiovasc. Surg., vol. 2, no. 3, pp. 271–278, Jul. 1990.
[1028]	M. A. Hall, “Arrow on trust,” J Health Polit Policy Law, vol. 26, no. 5, pp. 1131–1144, Oct. 2001, doi: 10.1215/03616878-26-5-1131.
[1029]	J.-C. Fu, “Artemisinin and Chinese Medicine as Tu Science,” Endeavour, vol. 41, no. 3, pp. 127–135, Sep. 2017, doi: 10.1016/j.endeavour.2017.06.005.
[1030]	Y. Tu, “Artemisinin-A Gift from Traditional Chinese Medicine to the World (Nobel Lecture),” Angew. Chem. Int. Ed. Engl., vol. 55, no. 35, pp. 10210–10226, 22 2016, doi: 10.1002/anie.201601967.
[1031]	L. H. Miller and X. Su, “Artemisinin: discovery from the Chinese herbal garden,” Cell, vol. 146, no. 6, pp. 855–858, Sep. 2011, doi: 10.1016/j.cell.2011.08.024.
[1032]	X. Li, P. Lyu, Y. Ren, J. An, and Y. Dong, “Arterial stiffness and cognitive impairment,” J. Neurol. Sci., vol. 380, pp. 1–10, Sep. 2017, doi: 10.1016/j.jns.2017.06.018.
[1033]	R. Thal, W. B. Jennings, and W. L. Heusch, “Arthroscopic rotator cuff repair using the suture loop shuttle technique,” Arthroscopy, vol. 23, no. 5, p. 561.e1–4, May 2007, doi: 10.1016/j.arthro.2006.08.009.
[1034]	R. R, M. Jaseel, C. Murugan, and C. M. Kumaran, “Arthroscopic tibial spine fracture fixation: Novel techniques,” J Orthop, vol. 15, no. 2, pp. 372–374, Jun. 2018, doi: 10.1016/j.jor.2018.01.056.
[1035]	B. Metz, “[Arthrosis of the iliosacral joint and indication for its arthrodesis (proper surgical method)],” Z Orthop Ihre Grenzgeb, vol. 107, no. 2, pp. 315–334, Jan. 1970.
[1036]	P. R. Lawson, “Artifacts in PAPA camera images,” Appl Opt, vol. 33, no. 7, pp. 1146–1153, Mar. 1994, doi: 10.1364/AO.33.001146.
[1037]	J. Allen, “Artificial biospheres as a model for global ecology on planet Earth,” Life Support Biosph Sci, vol. 7, no. 3, pp. 273–282, 2000.
[1038]	V. Leso, L. Fontana, R. Romano, P. Gervetti, and I. Iavicoli, “Artificial Stone Associated Silicosis: A Systematic Review,” Int J Environ Res Public Health, vol. 16, no. 4, 16 2019, doi: 10.3390/ijerph16040568.
[1039]	S. M. Bello et al., “Artists on the edge of the world: An integrated approach to the study of Magdalenian engraved stone plaquettes from Jersey (Channel Islands),” PLoS ONE, vol. 15, no. 8, p. e0236875, Aug. 2020, doi: 10.1371/journal.pone.0236875.
[1040]	J. K. Hoober, “ASGR1 and Its Enigmatic Relative, CLEC10A,” Int J Mol Sci, vol. 21, no. 14, Jul. 2020, doi: 10.3390/ijms21144818.
[1041]	J. Delgado-Jarana, A. M. Rincón, and T. A. Benı Tez, “Aspartyl protease from Trichoderma harzianum CECT 2413: cloning and characterization,” Microbiology (Reading), vol. 148, no. Pt 5, pp. 1305–1315, May 2002, doi: 10.1099/00221287-148-5-1305.
[1042]	“Aspects of anxiety,” Br Med J, vol. 4, no. 5579, pp. 614–615, Dec. 1967.
[1043]	R. Kataoka et al., “Aspergillus luchuensis fatty acid oxygenase ppoC is necessary for 1-octen-3-ol biosynthesis in rice koji,” J. Biosci. Bioeng., vol. 129, no. 2, pp. 192–198, Feb. 2020, doi: 10.1016/j.jbiosc.2019.08.010.
[1044]	C. Dominas, S. Gadkaree, A. Z. Maxfield, S. T. Gray, and R. W. Bergmark, “Aspirin-exacerbated respiratory disease: A review,” Laryngoscope Investig Otolaryngol, vol. 5, no. 3, pp. 360–367, Jun. 2020, doi: 10.1002/lio2.387.
[1045]	Á. Savernini, N. Savernini, F. A. de Amaral, T. R. L. Romero, I. D. G. Duarte, and M. S. A. de Castro, “Assay of therapeutic ultrasound induced-antinociception in experimental trigeminal neuropathic pain,” J. Neurosci. Res., vol. 90, no. 8, pp. 1639–1645, Aug. 2012, doi: 10.1002/jnr.23056.
[1046]	K. L. Grady, J. W. Sorensen, N. Stopnisek, J. Guittar, and A. Shade, “Assembly and seasonality of core phyllosphere microbiota on perennial biofuel crops,” Nat Commun, vol. 10, no. 1, p. 4135, 12 2019, doi: 10.1038/s41467-019-11974-4.
[1047]	Q. Wang and B. C. Kelly, “Assessing bioaccumulation behaviour of hydrophobic organic contaminants in a tropical urban catchment,” J. Hazard. Mater., vol. 358, pp. 366–375, 15 2018, doi: 10.1016/j.jhazmat.2018.06.070.
[1048]	S. Jamal-Omidi et al., “Assessing depression severity with a self-rated vs. rater-administered instrument in patients with epilepsy,” Epilepsy Behav, vol. 85, pp. 52–57, 2018, doi: 10.1016/j.yebeh.2018.05.018.
[1049]	Á. Godoy-Durán, E. Galdeano-Gómez, J. C. Pérez-Mesa, and L. Piedra-Muñoz, “Assessing eco-efficiency and the determinants of horticultural family-farming in southeast Spain,” J. Environ. Manage., vol. 204, no. Pt 1, pp. 594–604, Dec. 2017, doi: 10.1016/j.jenvman.2017.09.037.
[1050]	A. J. Picazo-Tadeo, J. A. Gómez-Limón, and E. Reig-Martínez, “Assessing farming eco-efficiency: a Data Envelopment Analysis approach,” J. Environ. Manage., vol. 92, no. 4, pp. 1154–1164, Apr. 2011, doi: 10.1016/j.jenvman.2010.11.025.
[1051]	R. Khan, E. Krupinski, J. A. Graham, L. Benodin, and P. Lewis, “Assessing first year radiology resident competence pre-call: development and implementation of a computer-based exam before and after the 12 month training requirement,” Acad Radiol, vol. 19, no. 6, pp. 752–758, Jun. 2012, doi: 10.1016/j.acra.2011.12.019.
[1052]	S. Simon, N. M. Cain, L. Wallner Samstag, K. B. Meehan, and J. C. Muran, “Assessing Interpersonal Subtypes in Depression,” J Pers Assess, vol. 97, no. 4, pp. 364–373, 2015, doi: 10.1080/00223891.2015.1011330.
[1053]	L. B. Cottler, C. W. Striley, and S. O. Lasopa, “Assessing prescription stimulant use, misuse, and diversion among youth 10-18 years of age,” Curr Opin Psychiatry, vol. 26, no. 5, pp. 511–519, Sep. 2013, doi: 10.1097/YCO.0b013e3283642cb6.
[1054]	D. A. Schoenfeld and D. M. Finkelstein, “Assessing survival benefit when treatment delays disease progression,” Clin Trials, vol. 13, no. 3, pp. 352–357, 2016, doi: 10.1177/1740774515625990.
[1055]	A. Alumran, X.-Y. Hou, J. Sun, A. A. Yousef, and C. Hurst, “Assessing the construct validity and reliability of the Parental Perception on Antibiotics (PAPA) scales,” BMC Public Health, vol. 14, p. 73, Jan. 2014, doi: 10.1186/1471-2458-14-73.
[1056]	M. Caro et al., “Assessing the genetic variation of Ty-1 and Ty-3 alleles conferring resistance to tomato yellow leaf curl virus in a broad tomato germplasm,” Mol. Breed., vol. 35, no. 6, p. 132, 2015, doi: 10.1007/s11032-015-0329-y.
[1057]	R. Thomas, S. Kuruvilla, R. Hinton, S. L. B. Jensen, V. Magar, and F. Bustreo, “Assessing the Impact of a Human Rights-Based Approach across a Spectrum of Change for Women’s, Children’s, and Adolescents’ Health,” Health Hum Rights, vol. 17, no. 2, pp. 11–20, Dec. 2015.
[1058]	S. Tong, P. Mather, G. Fitzgerald, D. McRae, K. Verrall, and D. Walker, “Assessing the vulnerability of eco-environmental health to climate change,” Int J Environ Res Public Health, vol. 7, no. 2, pp. 546–564, 2010, doi: 10.3390/ijerph7020546.
[1059]	K. Lam, W. S. Y. Chan, J. K. H. Luk, and A. Y. M. Leung, “Assessment and diagnosis of dementia: a review for primary healthcare professionals,” Hong Kong Med J, vol. 25, no. 6, pp. 473–482, 2019, doi: 10.12809/hkmj198073.
[1060]	N. Sahr, “Assessment and diagnosis of elderly depression,” Clin Excell Nurse Pract, vol. 3, no. 3, pp. 158–164, May 1999.
[1061]	M. T. Caldwell, N. T. Jiam, and C. J. Limb, “Assessment and improvement of sound quality in cochlear implant users,” Laryngoscope Investig Otolaryngol, vol. 2, no. 3, pp. 119–124, 2017, doi: 10.1002/lio2.71.
[1062]	J. Ellis and A. Zaretsky, “Assessment and Management of Posttraumatic Stress Disorder,” Continuum (Minneap Minn), vol. 24, no. 3, BEHAVIORAL NEUROLOGY AND PSYCHIATRY, pp. 873–892, 2018, doi: 10.1212/CON.0000000000000610.
[1063]	R. A. Vasa et al., “Assessment and Treatment of Anxiety in Youth With Autism Spectrum Disorders,” Pediatrics, vol. 137 Suppl 2, pp. S115-123, Feb. 2016, doi: 10.1542/peds.2015-2851J.
[1064]	M. Eskelinen and P. Ollonen, “Assessment of ‘cancer-prone personality’ characteristics in healthy study subjects and in patients with breast disease and breast cancer using the commitment questionnaire: a prospective case-control study in Finland,” Anticancer Res., vol. 31, no. 11, pp. 4013–4017, Nov. 2011.
[1065]	A. Furutani, S. Sekiguchi, M. Sueyoshi, and Y. Sasaki, “Assessment of abortion risk of sows on Japanese commercial farms infected with porcine epidemic diarrhea virus,” Anim. Sci. J., vol. 91, no. 1, p. e13377, Dec. 2020, doi: 10.1111/asj.13377.
[1066]	M. Balsamo, F. Cataldi, L. Carlucci, and B. Fairfield, “Assessment of anxiety in older adults: a review of self-report measures,” Clin Interv Aging, vol. 13, pp. 573–593, 2018, doi: 10.2147/CIA.S114100.
[1067]	S. Marui, A. Misawa, Y. Tanaka, and K. Nagashima, “Assessment of axillary temperature for the evaluation of normal body temperature of healthy young adults at rest in a thermoneutral environment,” J Physiol Anthropol, vol. 36, no. 1, p. 18, Feb. 2017, doi: 10.1186/s40101-017-0133-y.
[1068]	X. Zhang, T. N. Brown, F. Wania, E. S. Heimstad, and K.-U. Goss, “Assessment of chemical screening outcomes based on different partitioning property estimation methods,” Environ Int, vol. 36, no. 6, pp. 514–520, Aug. 2010, doi: 10.1016/j.envint.2010.03.010.
[1069]	S. Pichini et al., “Assessment of chronic exposure to MDMA in a group of consumers by segmental hair analysis,” Ther Drug Monit, vol. 28, no. 1, pp. 106–109, Feb. 2006, doi: 10.1097/01.ftd.0000189900.01060.92.
[1070]	R. Margossian et al., “Assessment of Diastolic Function in Single-Ventricle Patients After the Fontan Procedure,” J Am Soc Echocardiogr, vol. 29, no. 11, pp. 1066–1073, 2016, doi: 10.1016/j.echo.2016.07.016.
[1071]	H. Ma and L. Shi, “Assessment of eco-environmental quality of Western Taiwan Straits Economic Zone,” Environ Monit Assess, vol. 188, no. 5, p. 311, May 2016, doi: 10.1007/s10661-016-5312-5.
[1072]	S. Krishnamoorthy, S. H. Lim, and G. Y. H. Lip, “Assessment of endothelial (dys)function in atrial fibrillation,” Ann. Med., vol. 41, no. 8, pp. 576–590, 2009, doi: 10.1080/07853890903160726.
[1073]	J. Roche et al., “Assessment of everyday executive functioning using the BRIEF in children and adolescents treated for brain tumor,” Brain Inj, vol. 34, no. 4, pp. 583–590, Mar. 2020, doi: 10.1080/02699052.2020.1725982.
[1074]	A. Fetveit, “Assessment of febrile seizures in children,” Eur. J. Pediatr., vol. 167, no. 1, pp. 17–27, Jan. 2008, doi: 10.1007/s00431-007-0577-x.
[1075]	H. A. Hasan, A. M. Almomany, S. Hasan, and A. M. Al-Abdallat, “Assessment of Genetic Diversity among Pleurotus spp. Isolates from Jordan,” J Fungi (Basel), vol. 4, no. 2, Apr. 2018, doi: 10.3390/jof4020052.
[1076]	H.-J. Kang et al., “Assessment of Malignant Potential in Intraductal Papillary Mucinous Neoplasms of the Pancreas: Comparison between Multidetector CT and MR Imaging with MR Cholangiopancreatography,” Radiology, vol. 279, no. 1, pp. 128–139, Apr. 2016, doi: 10.1148/radiol.2015150217.
[1077]	Y. Lu, Q. Xia, and J. Yang, “Assessment of Medical Laboratory Undergraduates Training in Different School Year Systems,” Lab Med, Aug. 2020, doi: 10.1093/labmed/lmaa033.
[1078]	Z. M. Şenol, Ü. D. Gül, and S. Şimşek, “Assessment of Pb2+ removal capacity of lichen (Evernia prunastri): application of adsorption kinetic, isotherm models, and thermodynamics,” Environ Sci Pollut Res Int, vol. 26, no. 26, pp. 27002–27013, Sep. 2019, doi: 10.1007/s11356-019-05848-x.
[1079]	S. C. Sarangi, N. Kaur, and M. Tripathi, “Assessment of psychiatric and behavioral adverse effects of antiepileptic drugs monotherapy: Could they have a neuroendocrine correlation in persons with epilepsy?,” Epilepsy Behav, vol. 100, no. Pt A, p. 106439, 2019, doi: 10.1016/j.yebeh.2019.07.040.
[1080]	A. Szczepaniak-Kubat, O. Kurnatowska, E. Jakubowska-Pietkiewicz, and D. Chlebna-Sokół, “Assessment of quality of life of parents of children with osteogenesis imperfecta,” Adv Clin Exp Med, vol. 21, no. 1, pp. 99–104, Feb. 2012.
[1081]	F. L. Rice and L. T. Stayner, “Assessment of silicosis risk for occupational exposure to crystalline silica,” Scand J Work Environ Health, vol. 21 Suppl 2, pp. 87–90, 1995.
[1082]	M. K. Kheir and M. Sheikhi, “Assessment of the anterior loop of mental nerve in an Iranian population using cone beam computed tomography scan,” Dent Res J (Isfahan), vol. 14, no. 6, pp. 418–422, Dec. 2017, doi: 10.4103/1735-3327.218566.
[1083]	Y.-L. Ho et al., “Assessment of the cost-effectiveness and clinical outcomes of a fourth-generation synchronous telehealth program for the management of chronic cardiovascular disease,” J. Med. Internet Res., vol. 16, no. 6, p. e145, Jun. 2014, doi: 10.2196/jmir.3346.
[1084]	P. Liu, C. Y. Ren, Z. M. Wang, B. Zhang, and L. Chen, “Assessment of the eco-environmental quality in the Nanweng River Nature Reserve, Northeast China by remote sensing,” Ying Yong Sheng Tai Xue Bao, vol. 29, no. 10, pp. 3347–3356, Oct. 2018, doi: 10.13287/j.1001-9332.201810.014.
[1085]	S. Zahran et al., “Assessment of the Legionnaires’ disease outbreak in Flint, Michigan,” Proc. Natl. Acad. Sci. U.S.A., vol. 115, no. 8, pp. E1730–E1739, 20 2018, doi: 10.1073/pnas.1718679115.
[1086]	A. Inotai, G. Merész, and Z. Kaló, “[Assessment of the pharmaceutical expenditure in Hungary],” Acta Pharm Hung, vol. 80, no. 4, pp. 162–172, 2010.
[1087]	X. Xie and L. Pu, “Assessment of Urban Ecosystem Health Based on Matter Element Analysis: A Case Study of 13 Cities in Jiangsu Province, China,” Int J Environ Res Public Health, vol. 14, no. 8, 21 2017, doi: 10.3390/ijerph14080940.
[1088]	S. Ray, C. Miglio, T. Eden, and D. Del Rio, “Assessment of vascular and endothelial dysfunction in nutritional studies,” Nutr Metab Cardiovasc Dis, vol. 24, no. 9, pp. 940–946, Sep. 2014, doi: 10.1016/j.numecd.2014.03.011.
[1089]	H. Kim, S. Lee, B. D. Ku, S. G. Ham, and W.-S. Park, “Associated factors for cognitive impairment in the rural highly elderly,” Brain Behav, vol. 9, no. 5, p. e01203, 2019, doi: 10.1002/brb3.1203.
[1090]	P. K. Eide and W. Sorteberg, “Association among intracranial compliance, intracranial pulse pressure amplitude and intracranial pressure in patients with intracranial bleeds,” Neurol. Res., vol. 29, no. 8, pp. 798–802, Dec. 2007, doi: 10.1179/016164107X224132.
[1091]	C.-Y. Bai et al., “Association between 5-lipoxygenase expression, and malignant behaviors and poor prognosis in esophageal squamous cell carcinoma,” Oncol Lett, vol. 15, no. 6, pp. 9353–9360, Jun. 2018, doi: 10.3892/ol.2018.8527.
[1092]	F. He, X. Wang, H. Ren, M. Yuan, and L. Sun, “Association between ACE gene polymorphism and carotid stenosisand and construction of related gene regulatory networks,” Saudi J Biol Sci, vol. 26, no. 8, pp. 2000–2005, Dec. 2019, doi: 10.1016/j.sjbs.2019.08.018.
[1093]	R. A. Bertrand and Z. Huang, “Association between audiometric patterns and probabilities of cardiovascular diseases,” Laryngoscope Investig Otolaryngol, vol. 3, no. 6, pp. 478–485, Dec. 2018, doi: 10.1002/lio2.206.
[1094]	A. A. Pereira et al., “Association between exhaled carbon monoxide and asthma outcomes in Peruvian children,” Respir Med, vol. 145, pp. 212–216, 2018, doi: 10.1016/j.rmed.2018.11.005.
[1095]	G. Mu et al., “Association between genetic polymorphisms and angiotensin-converting enzyme inhibitor-induced cough: a systematic review and meta-analysis,” Pharmacogenomics, vol. 20, no. 3, pp. 189–212, 2019, doi: 10.2217/pgs-2018-0157.
[1096]	J. K. Hohls et al., “Association between heart-focused anxiety, depressive symptoms, health behaviors and healthcare utilization in patients with coronary heart disease,” J Psychosom Res, vol. 131, p. 109958, Feb. 2020, doi: 10.1016/j.jpsychores.2020.109958.
[1097]	R. Wang, L.-L. Chen, D.-Z. Wang, and B.-X. Chen, “Association Between Helicobacter Pylori Infection and Long-term Outcome in Patients with Drug-eluting Stent Implantation,” Sci Rep, vol. 7, p. 44954, 13 2017, doi: 10.1038/srep44954.
[1098]	Q. Chen, M. Li, X. Zhang, X. Zhang, R. Zhong, and W. Lin, “Association between interleukin-6 gene polymorphisms and febrile seizure risk: A meta-analysis,” Medicine (Baltimore), vol. 98, no. 39, p. e17167, Sep. 2019, doi: 10.1097/MD.0000000000017167.
[1099]	I. Hainerová et al., “Association between neuromedin U gene variants and overweight and obesity,” J. Clin. Endocrinol. Metab., vol. 91, no. 12, pp. 5057–5063, Dec. 2006, doi: 10.1210/jc.2006-1442.
[1100]	R. Yeager et al., “Association between residential greenness and exposure to volatile organic compounds,” Sci. Total Environ., vol. 707, p. 135435, Mar. 2020, doi: 10.1016/j.scitotenv.2019.135435.
[1101]	C. Grippi et al., “Association between variants of neuromedin U gene and taste thresholds and food preferences in European children: Results from the IDEFICS study,” Appetite, vol. 142, p. 104376, 01 2019, doi: 10.1016/j.appet.2019.104376.
[1102]	K. M. Eny et al., “Association of accelerated body mass index gain with repeated measures of blood pressure in early childhood,” Int J Obes (Lond), vol. 43, no. 7, pp. 1354–1362, 2019, doi: 10.1038/s41366-019-0345-9.
[1103]	M. Saeed, S. Siddiqui, A. Khan, Z. A. Butt, S. H. Parvez, and P. M. Frossard, “Association of ACE polymorphisms with left ventricular hypertrophy,” Neuro Endocrinol. Lett., vol. 26, no. 4, pp. 393–396, Aug. 2005.
[1104]	K. Hur, J. S. Choi, M. Zheng, J. Shen, and B. Wrobel, “Association of alterations in smell and taste with depression in older adults,” Laryngoscope Investig Otolaryngol, vol. 3, no. 2, pp. 94–99, Apr. 2018, doi: 10.1002/lio2.142.
[1105]	L. Rashed, R. Abdel Hay, R. Mahmoud, N. Hasan, A. Zahra, and S. Fayez, “Association of Angiotensin-Converting Enzyme (ACE) Gene Polymorphism with Inflammation and Cellular Cytotoxicity in Vitiligo Patients,” PLoS ONE, vol. 10, no. 7, p. e0132915, 2015, doi: 10.1371/journal.pone.0132915.
[1106]	D. I. Badran, H. Nada, and R. Hassan, “Association of Angiotensin-Converting Enzyme ACE Gene Polymorphism with ACE Activity and Susceptibility to Vitiligo in Egyptian Population,” Genet Test Mol Biomarkers, vol. 19, no. 5, pp. 258–263, May 2015, doi: 10.1089/gtmb.2014.0326.
[1107]	R. Garg, S. Aggarwal, R. Kumar, and G. Sharma, “Association of atherosclerosis with dyslipidemia and co-morbid conditions: A descriptive study,” J Nat Sci Biol Med, vol. 6, no. 1, pp. 163–168, Jun. 2015, doi: 10.4103/0976-9668.149117.
[1108]	R. R. Moholisa et al., “Association of B2 receptor polymorphisms and ACE activity with ACE inhibitor-induced angioedema in black and mixed-race South Africans,” J Clin Hypertens (Greenwich), vol. 15, no. 6, pp. 413–419, Jun. 2013, doi: 10.1111/jch.12104.
[1109]	R. Speeckaert et al., “Association of haptoglobin phenotypes with the development of Kaposi’s sarcoma in HIV patients,” Arch. Dermatol. Res., vol. 303, no. 10, pp. 763–769, Dec. 2011, doi: 10.1007/s00403-011-1161-9.
[1110]	K. Abbass, W. Gul, G. Beck, R. Markert, and S. Akram, “Association of Helicobacter pylori infection with the development of colorectal polyps and colorectal carcinoma,” South. Med. J., vol. 104, no. 7, pp. 473–476, Jul. 2011, doi: 10.1097/SMJ.0b013e31821e9009.
[1111]	Y. Rahmani, S. Mohammadi, M. Babanejad, A. Rai, B. Zalei, and A. Shahmohammadi, “Association of Helicobacter Pylori with Presence of Myocardial Infarction in Iran: A Systematic Review and Meta-Analysis,” Ethiop J Health Sci, vol. 27, no. 4, pp. 433–440, Jul. 2017, doi: 10.4314/ejhs.v27i4.15.
[1112]	S. Tian et al., “Association of Increased Serum ACE Activity with Logical Memory Ability in Type 2 Diabetic Patients with Mild Cognitive Impairment,” Front Behav Neurosci, vol. 10, p. 239, 2016, doi: 10.3389/fnbeh.2016.00239.
[1113]	N. Schneider and E. Wolff, “[Association of mouse tumor with embryonic chick organs in culture in vitro],” C. R. Seances Soc. Biol. Fil., vol. 150, no. 5, pp. 845–846, Sep. 1956.
[1114]	L. A. Lanterna, S. Galliani, C. Brembilla, L. Longhi, P. Gritti, and C. Bernucci, “Association of moyamoya disease with thyroid autoantibodies and thyroid function,” Eur. J. Neurol., vol. 24, no. 2, p. e9, 2017, doi: 10.1111/ene.13209.
[1115]	J. M. E. Jende et al., “Association of Serum Cholesterol Levels With Peripheral Nerve Damage in Patients With Type 2 Diabetes,” JAMA Netw Open, vol. 2, no. 5, p. e194798, 03 2019, doi: 10.1001/jamanetworkopen.2019.4798.
[1116]	V. Vatsalya et al., “Association of serum zinc with markers of liver injury in very heavy drinking alcohol-dependent patients,” J. Nutr. Biochem., vol. 59, pp. 49–55, 2018, doi: 10.1016/j.jnutbio.2018.05.003.
[1117]	L. Tondo, G. H. Vázquez, G. Sani, M. Pinna, and R. J. Baldessarini, “Association of suicidal risk with ratings of affective temperaments,” J Affect Disord, vol. 229, pp. 322–327, 15 2018, doi: 10.1016/j.jad.2017.12.061.
[1118]	M. Saeed Mahmood, K. Saboohi, S. Osman Ali, A. M. Bokhari, and P. M. Frossard, “Association of the angiotensin-converting enzyme (ACE) gene G2350A dimorphism with essential hypertension,” J Hum Hypertens, vol. 17, no. 10, pp. 719–723, Oct. 2003, doi: 10.1038/sj.jhh.1001600.
[1119]	A. V. Sosa, “Association of the Type of Toy Used During Play With the Quantity and Quality of Parent-Infant Communication,” JAMA Pediatr, vol. 170, no. 2, pp. 132–137, Feb. 2016, doi: 10.1001/jamapediatrics.2015.3753.
[1120]	M. P. Iqbal et al., “Association study of the angiotensin-converting enzyme (ACE) gene G2350A dimorphism with myocardial infarction,” Exp. Mol. Med., vol. 36, no. 2, pp. 110–115, Apr. 2004, doi: 10.1038/emm.2004.16.
[1121]	F. O’ Donovan et al., “Associations and effects of omega-3 polyunsaturated fatty acids on cognitive function and mood in healthy adults: a protocol for a systematic review of observational and interventional studies,” BMJ Open, vol. 9, no. 6, p. e027167, 22 2019, doi: 10.1136/bmjopen-2018-027167.
[1122]	H. Wang et al., “Associations Between Gastric Cancer Risk and Virus Infection Other Than Epstein-Barr Virus: A Systematic Review and Meta-analysis Based on Epidemiological Studies,” Clin Transl Gastroenterol, vol. 11, no. 7, p. e00201, Jul. 2020, doi: 10.14309/ctg.0000000000000201.
[1123]	J. de Nijs et al., “Associations between olfactory identification and (social) cognitive functioning: A cross-sectional study in schizophrenia patients and healthy controls,” Psychiatry Res, vol. 266, pp. 147–151, 2018, doi: 10.1016/j.psychres.2018.05.009.
[1124]	Q. He et al., “Associations of ACE gene insertion/deletion polymorphism, ACE activity, and ACE mRNA expression with hypertension in a Chinese population,” PLoS ONE, vol. 8, no. 10, p. e75870, 2013, doi: 10.1371/journal.pone.0075870.
[1125]	K. Whitfield and C. Reid, “Assumptions, ambiguities, and possibilities in interdisciplinary population health research,” Can J Public Health, vol. 95, no. 6, pp. 434–436, Dec. 2004.
[1126]	S. A. Moonie, D. A. Sterling, L. Figgs, and M. Castro, “Asthma status and severity affects missed school days,” J Sch Health, vol. 76, no. 1, pp. 18–24, Jan. 2006, doi: 10.1111/j.1746-1561.2006.00062.x.
[1127]	A. P. Hatzes, “Astronomy: Earth-like planet around Sun’s neighbour,” Nature, vol. 536, no. 7617, pp. 408–409, 25 2016, doi: 10.1038/536408a.
[1128]	A. L. Melott and B. C. Thomas, “Astrophysical ionizing radiation and Earth: a brief review and census of intermittent intense sources,” Astrobiology, vol. 11, no. 4, pp. 343–361, May 2011, doi: 10.1089/ast.2010.0603.
[1129]	A. Bollenbach, E. Hanff, G. Brunner, and D. Tsikas, “Asymmetric dimethylation and citrullination of proteinic arginine and homoarginine synthesis in human Helicobacter pylori infection,” Amino Acids, vol. 51, no. 6, pp. 961–971, Jun. 2019, doi: 10.1007/s00726-019-02737-y.
[1130]	H. Asghar and J. G. McInerney, “Asymmetric dual-loop feedback to suppress spurious tones and reduce timing jitter in self-mode-locked quantum-dash lasers emitting at 1.55  μm,” Opt Lett, vol. 42, no. 18, pp. 3714–3717, Sep. 2017, doi: 10.1364/OL.42.003714.
[1131]	C. Morishige and K. McElwee, “At-sea detection of derelict fishing gear in the North Pacific: an overview,” Mar. Pollut. Bull., vol. 65, no. 1–3, pp. 1–6, 2012, doi: 10.1016/j.marpolbul.2011.05.017.
[1132]	B. Edvardsson, “Atenolol in the prophylaxis of chronic migraine: a 3-month open-label study,” Springerplus, vol. 2, p. 479, 2013, doi: 10.1186/2193-1801-2-479.
[1133]	W. L. Jaeger, L. P. Keszthelyi, A. S. McEwen, C. M. Dundas, and P. S. Russell, “Athabasca Valles, Mars: a lava-draped channel system,” Science, vol. 317, no. 5845, pp. 1709–1711, Sep. 2007, doi: 10.1126/science.1143315.
[1134]	R. G. Gibilisco, M. B. Blanco, I. Bejan, I. Barnes, P. Wiesen, and M. A. Teruel, “Atmospheric Sink of (E)-3-Hexen-1-ol, (Z)-3-Hepten-1-ol, and (Z)-3-Octen-1-ol: Rate Coefficients and Mechanisms of the OH-Radical Initiated Degradation,” Environ. Sci. Technol., vol. 49, no. 13, pp. 7717–7725, Jul. 2015, doi: 10.1021/es506125c.
[1135]	A. Wollenberg, E. Renner, and B. Hagl, “[Atopic eczema in childhood or primary immunodeficiency - what needs to be considered?],” MMW Fortschr Med, vol. 159, no. 20, pp. 59–63, Nov. 2017, doi: 10.1007/s15006-017-0330-y.
[1136]	K. S. Channer and J. V. Jones, “Atrial systole: its role in normal and diseased hearts,” Clin. Sci., vol. 75, no. 1, pp. 1–4, Jul. 1988, doi: 10.1042/cs0750001.
[1137]	C. Brechenmacher, “Atrio-His bundle tracts,” Br Heart J, vol. 37, no. 8, pp. 853–855, Aug. 1975, doi: 10.1136/hrt.37.8.853.
[1138]	M. Valderrábano, F. Chen, A. S. Dave, S. T. Lamp, T. S. Klitzner, and J. N. Weiss, “Atrioventricular ring reentry in embryonic mouse hearts,” Circulation, vol. 114, no. 6, pp. 543–549, Aug. 2006, doi: 10.1161/CIRCULATIONAHA.106.633727.
[1139]	M. Taylor-Seehafer, R. Johnson, L. Rew, R. T. Fouladi, L. Land, and E. Abel, “Attachment and sexual health behaviors in homeless youth,” J Spec Pediatr Nurs, vol. 12, no. 1, pp. 37–48, Jan. 2007, doi: 10.1111/j.1744-6155.2007.00087.x.
[1140]	E. Wolff, “[Attempted culture of a rat tumor in chick embryo organs cultured in vitro],” C. R. Hebd. Seances Acad. Sci., vol. 242, no. 11, pp. 1537–1538, Mar. 1956.
[1141]	N. Ashjazadeh, A. Sahraeian, I. Sabzgolin, and A. A. Asadi-Pooya, “Attention-deficit hyperactivity disorder in adults with epilepsy,” Epilepsy Behav, vol. 101, no. Pt A, p. 106543, 2019, doi: 10.1016/j.yebeh.2019.106543.
[1142]	Y. Iijima, K. Takano, and Y. Tanno, “Attentional bias and its association with anxious mood dynamics,” Emotion, vol. 18, no. 5, pp. 725–735, 2018, doi: 10.1037/emo0000338.
[1143]	P. C. Clasen, T. T. Wells, A. J. Ellis, and C. G. Beevers, “Attentional biases and the persistence of sad mood in major depressive disorder,” J Abnorm Psychol, vol. 122, no. 1, pp. 74–85, Feb. 2013, doi: 10.1037/a0029211.
[1144]	J. E. J. Buckman, R. Saunders, P. Fearon, J. Leibowitz, and S. Pilling, “Attentional Control as a Predictor of Response to Psychological Treatment for Depression and Relapse up to 1 year After Treatment: A Pilot Cohort Study,” Behav Cogn Psychother, vol. 47, no. 3, pp. 318–331, May 2019, doi: 10.1017/S1352465818000590.
[1145]	C. Ballesté-Delpierre, A. Fàbrega, M. Ferrer-Navarro, R. Mathur, S. Ghosh, and J. Vila, “Attenuation of in vitro host-pathogen interactions in quinolone-resistant Salmonella Typhi mutants,” J. Antimicrob. Chemother., vol. 71, no. 1, pp. 111–122, Jan. 2016, doi: 10.1093/jac/dkv299.
[1146]	R. B. Dewey and M. Agostini, “Attitudes and performance of third- vs fourth-year neurology clerkship students,” Arch. Neurol., vol. 67, no. 5, pp. 548–551, May 2010, doi: 10.1001/archneurol.2010.64.
[1147]	K. Diamond, W. Le Furgy, and S. Blass, “Attitudes of preschool children toward their peers with disabilities: a year-long investigation in integrated classrooms,” J Genet Psychol, vol. 154, no. 2, pp. 215–221, Jun. 1993, doi: 10.1080/00221325.1993.9914735.
[1148]	J. Harvey, N. Thorpe, and R. Fairchild, “Attitudes towards and perceptions of eco-driving and the role of feedback systems,” Ergonomics, vol. 56, no. 3, pp. 507–521, 2013, doi: 10.1080/00140139.2012.751460.
[1149]	A. Guekht, A. Gersamiya, I. Kaimovskiy, M. Mizinova, A. Yakovlev, and A. Shpak, “Attitudes towards people with epilepsy in Moscow,” Epilepsy Behav, vol. 70, no. Pt A, pp. 182–186, 2017, doi: 10.1016/j.yebeh.2017.03.020.
[1150]	L. Lindh-Astrand, J. Brynhildsen, M. Hoffmann, S. Liffner, and M. Hammar, “Attitudes towards the menopause and hormone therapy over the turn of the century,” Maturitas, vol. 56, no. 1, pp. 12–20, Jan. 2007, doi: 10.1016/j.maturitas.2006.05.002.
[1151]	L. A. Cope, “Atypical Chordae Tendineae of the Canine (Canis familiaris) Right Atrioventricular Valve,” Anat Histol Embryol, vol. 45, no. 6, pp. 485–489, Dec. 2016, doi: 10.1111/ahe.12231.
[1152]	S. Zollner and M. W. Ulbig, “[Atypical wet AMD],” Ophthalmologe, vol. 114, no. 3, pp. 266–268, 2017, doi: 10.1007/s00347-016-0339-0.
[1153]	J. P. Pillion and J. Shapiro, “Audiological findings in osteogenesis imperfecta,” J Am Acad Audiol, vol. 19, no. 8, pp. 595–601, Sep. 2008, doi: 10.3766/jaaa.19.8.3.
[1154]	J. F. Thong, J. K. K. Sung, T. K. C. Wong, and M. C. F. Tong, “Auditory Brainstem Implantation in Chinese Patients With Neurofibromatosis Type II: The Hong Kong Experience,” Otol. Neurotol., vol. 37, no. 7, pp. 956–962, 2016, doi: 10.1097/MAO.0000000000001101.
[1155]	Y. Sugano, M. Keetels, and J. Vroomen, “Auditory dominance in motor-sensory temporal recalibration,” Exp Brain Res, vol. 234, no. 5, pp. 1249–1262, May 2016, doi: 10.1007/s00221-015-4497-0.
[1156]	C. Morrison, S. Rabipour, F. Knoefel, C. Sheppard, and V. Taler, “Auditory Event-related Potentials in Mild Cognitive Impairment and Alzheimer’s Disease,” Curr Alzheimer Res, vol. 15, no. 8, pp. 702–715, 2018, doi: 10.2174/1567205015666180123123209.
[1157]	P. V. Vlastarakos, T. P. Nikolopoulos, E. Tavoulari, G. Papacharalambous, and S. Korres, “Auditory neuropathy: endocochlear lesion or temporal processing impairment? Implications for diagnosis and management,” Int. J. Pediatr. Otorhinolaryngol., vol. 72, no. 8, pp. 1135–1150, Aug. 2008, doi: 10.1016/j.ijporl.2008.04.004.
[1158]	G. Rance, “Auditory neuropathy/dys-synchrony and its perceptual consequences,” Trends Amplif, vol. 9, no. 1, pp. 1–43, 2005, doi: 10.1177/108471380500900102.
[1159]	L. J. Hood, “Auditory Neuropathy/Dys-Synchrony Disorder: Diagnosis and Management,” Otolaryngol. Clin. North Am., vol. 48, no. 6, pp. 1027–1040, Dec. 2015, doi: 10.1016/j.otc.2015.06.006.
[1160]	K. V. Nourski, “Auditory processing in the human cortex: An intracranial electrophysiology perspective,” Laryngoscope Investig Otolaryngol, vol. 2, no. 4, pp. 147–156, 2017, doi: 10.1002/lio2.73.
[1161]	S. E. Miller, K. Wathen, E. Cash, T. Pitts, and L. Cornell, “Auditory sensory gating predicts acceptable noise level,” Hear. Res., vol. 359, pp. 76–84, 2018, doi: 10.1016/j.heares.2017.12.020.
[1162]	A. E. Shearer and M. R. Hansen, “Auditory synaptopathy, auditory neuropathy, and cochlear implantation,” Laryngoscope Investig Otolaryngol, vol. 4, no. 4, pp. 429–440, Aug. 2019, doi: 10.1002/lio2.288.
[1163]	L. L. Matta, S. Karuppuswami, P. Chahal, and E. C. Alocilja, “AuNP-RF sensor: An innovative application of RF technology for sensing pathogens electrically in liquids (SPEL) within the food supply chain,” Biosens Bioelectron, vol. 111, pp. 152–158, Jul. 2018, doi: 10.1016/j.bios.2018.04.010.
[1164]	J. M. Marchington and G. P. Burd, “Author attitudes to professional medical writing support,” Curr Med Res Opin, vol. 30, no. 10, pp. 2103–2108, Oct. 2014, doi: 10.1185/03007995.2014.939618.
[1165]	S. Zundler et al., “Author Correction: Hobit- and Blimp-1-driven CD4+ tissue-resident memory T cells control chronic intestinal inflammation,” Nat. Immunol., vol. 20, no. 4, p. 514, Apr. 2019, doi: 10.1038/s41590-019-0360-y.
[1166]	O. Q. M. Goh, G. Lai, T. M. Tu, and K. E. Lee, “Author response,” Neurology, vol. 83, no. 22, p. 2099, Nov. 2014.
[1167]	J. J. Pandit and P. M. Odor, “Author’s reply: the 5th National Audit Project Handbook and the realities of the dynamic phases of (dys)anaesthesia and EEG limitations,” Anaesthesia, vol. 74, no. 10, pp. 1333–1334, 2019, doi: 10.1111/anae.14801.
[1168]	A. R. Alqaydi, G. Kanavakis, S. Naser-Ud-Din, and A. E. Athanasiou, “Authorship characteristics of orthodontic randomized controlled trials, systematic reviews, and meta-analyses in non-orthodontic journals with impact factor,” Eur J Orthod, vol. 40, no. 5, pp. 480–487, 28 2018, doi: 10.1093/ejo/cjx079.
[1169]	G. Zaghi et al., “Autoantibodies in silicosis patients and in silica-exposed individuals,” Rheumatol. Int., vol. 30, no. 8, pp. 1071–1075, Jun. 2010, doi: 10.1007/s00296-009-1116-z.
[1170]	V. B. Patel and N. H. Giles, “Autogenous regulation of the positive regulatory qa-1F gene in Neurospora crassa,” Mol. Cell. Biol., vol. 5, no. 12, pp. 3593–3599, Dec. 1985, doi: 10.1128/mcb.5.12.3593.
[1171]	P. L. Meroni and N. Del Papa, “Autoimmune vasculitis: a good clinical and basic exercise,” Clin Rev Allergy Immunol, vol. 15, no. 1, pp. 1–3, 1997, doi: 10.1007/BF02828273.
[1172]	O. Wolach and R. Stone, “Autoimmunity and Inflammation in Myelodysplastic Syndromes,” Acta Haematol., vol. 136, no. 2, pp. 108–117, 2016, doi: 10.1159/000446062.
[1173]	P. E. Bigazzi, “Autoimmunity induced by chemicals,” J. Toxicol. Clin. Toxicol., vol. 26, no. 3–4, pp. 125–156, 1988, doi: 10.3109/15563658809000343.
[1174]	W. M. Talaat, M. M. Ghoneim, O. Salah, and O. A. Adly, “Autologous Bone Marrow Concentrates and Concentrated Growth Factors Accelerate Bone Regeneration After Enucleation of Mandibular Pathologic Lesions,” J Craniofac Surg, vol. 29, no. 4, pp. 992–997, Jun. 2018, doi: 10.1097/SCS.0000000000004371.
[1175]	D. M. Low, K. H. Bentley, and S. S. Ghosh, “Automated assessment of psychiatric disorders using speech: A systematic review,” Laryngoscope Investig Otolaryngol, vol. 5, no. 1, pp. 96–116, Feb. 2020, doi: 10.1002/lio2.354.
[1176]	A. Klein, S. K. Vasa, and R. Linser, “Automated projection spectroscopy in solid-state NMR,” J. Biomol. NMR, vol. 72, no. 3–4, pp. 163–170, Dec. 2018, doi: 10.1007/s10858-018-0215-0.
[1177]	X. Chen, A. Smelter, and H. N. B. Moseley, “Automatic 13C chemical shift reference correction for unassigned protein NMR spectra,” J. Biomol. NMR, vol. 72, no. 1–2, pp. 11–28, Oct. 2018, doi: 10.1007/s10858-018-0202-5.
[1178]	J. P. Papa, M. E. M. Gutierrez, R. Y. M. Nakamura, L. P. Papa, I. B. F. Vicentini, and C. A. Vicentini, “Automatic classification of fish germ cells through optimum-path forest,” Conf Proc IEEE Eng Med Biol Soc, vol. 2011, pp. 5084–5087, 2011, doi: 10.1109/IEMBS.2011.6091259.
[1179]	E. M. Bucci, “Automatic detection of image manipulations in the biomedical literature,” Cell Death Dis, vol. 9, no. 3, p. 400, 14 2018, doi: 10.1038/s41419-018-0430-3.
[1180]	S. W. Tu et al., “Automating Performance Measures and Clinical Practice Guidelines: Differences and Complementarities,” AMIA Annu Symp Proc, vol. 2016, pp. 1199–1208, 2016.
[1181]	B. I. Reiner, “Automating quality assurance for digital radiography,” J Am Coll Radiol, vol. 6, no. 7, pp. 486–490, Jul. 2009, doi: 10.1016/j.jacr.2008.12.008.
[1182]	Z. Yin, C. Pascual, and D. J. Klionsky, “Autophagy: machinery and regulation,” Microb Cell, vol. 3, no. 12, pp. 588–596, Dec. 2016, doi: 10.15698/mic2016.12.546.
[1183]	A. Zimmermann, K. Kainz, A. Andryushkova, S. Hofer, F. Madeo, and D. Carmona-Gutierrez, “Autophagy: one more Nobel Prize for yeast,” Microb Cell, vol. 3, no. 12, pp. 579–581, Dec. 2016, doi: 10.15698/mic2016.12.544.
[1184]	W. H. Wolberg and R. R. Brown, “Autoradiographic studies of in vitro incorporation of uridine and thymidine by human tumor tissue,” Cancer Res., vol. 22, pp. 1113–1119, Oct. 1962.
[1185]	P. Striano and F. Zara, “Autosomal dominant cortical tremor, myoclonus and epilepsy,” Epileptic Disord, vol. 18, no. S2, pp. 139–144, Sep. 2016, doi: 10.1684/epd.2016.0860.
[1186]	P. E. Runge, N. L. Hawes, J. R. Heckenlively, S. H. Langley, and T. H. Roderick, “Autosomal dominant mouse cataract (Lop-10). Consistent differences of expression in heterozygotes,” Invest. Ophthalmol. Vis. Sci., vol. 33, no. 11, pp. 3202–3208, Oct. 1992.
[1187]	F. Zara and F. A. De Falco, “Autosomal recessive benign myoclonic epilepsy of infancy,” Adv Neurol, vol. 95, pp. 139–145, 2005.
[1188]	P. Striano, F. Zara, S. Striano, and C. Minetti, “Autosomal recessive epilepsy associated with contactin 2 mutation is different from familial cortical tremor, myoclonus and epilepsy,” Brain, vol. 136, no. Pt 10, p. e253, Oct. 2013, doi: 10.1093/brain/awt140.
[1189]	B. Baykan et al., “Autosomal recessive idiopathic epilepsy in an inbred family from Turkey: identification of a putative locus on chromosome 9q32-33,” Epilepsia, vol. 45, no. 5, pp. 479–487, May 2004, doi: 10.1111/j.0013-9580.2004.30903.x.
[1190]	E. Ferlazzo et al., “Autosomal recessive progressive myoclonus epilepsy due to impaired ceramide synthesis,” Epileptic Disord, vol. 18, no. S2, pp. 120–127, Sep. 2016, doi: 10.1684/epd.2016.0857.
[1191]	S. Nakajima, M. Takai, C. Hayashi, T. Tsuno, and Y. Endo, “Autoxidation of Fish Oil Blended with Rice Bran Oil,” J Oleo Sci, vol. 66, no. 6, pp. 573–577, Jun. 2017, doi: 10.5650/jos.ess17030.
[1192]	S. C. J. Jorgensen et al., “Averting the post-antibiotic era: successful use of meropenem/vaborbactam for carbapenem-resistant Serratia marcescens and Enterobacter aerogenes bacteraemia in a haemodialysis patient,” J. Antimicrob. Chemother., vol. 73, no. 12, pp. 3529–3531, 01 2018, doi: 10.1093/jac/dky346.
[1193]	R. Kataoka, T. Watanabe, R. Hayashi, A. Isogai, O. Yamada, and J. Ogihara, “Awamori fermentation test and 1-octen-3-ol productivity analysis using fatty acid oxygenase disruptants of Aspergillus luchuensis,” J. Biosci. Bioeng., Aug. 2020, doi: 10.1016/j.jbiosc.2020.06.006.
[1194]	M. A. Al-Qarni, N. V. Shakeela, M. A. Alamri, and Y. A. Alshaikh, “Awareness of Eco-Friendly Dentistry among Dental Faculty and Students of King Khalid University, Saudi Arabia,” J Clin Diagn Res, vol. 10, no. 10, pp. ZC75–ZC78, Oct. 2016, doi: 10.7860/JCDR/2016/21560.8663.
[1195]	A. Webber and Y. Raz, “Axon guidance cues in auditory development,” Anat Rec A Discov Mol Cell Evol Biol, vol. 288, no. 4, pp. 390–396, Apr. 2006, doi: 10.1002/ar.a.20299.
[1196]	A. Belmer, K. Beecher, A. Jacques, O. L. Patkar, F. Sicherre, and S. E. Bartlett, “Axonal Non-segregation of the Vesicular Glutamate Transporter VGLUT3 Within Serotonergic Projections in the Mouse Forebrain,” Front Cell Neurosci, vol. 13, p. 193, 2019, doi: 10.3389/fncel.2019.00193.
[1197]	Y. Tong et al., “Azaindole-Based Inhibitors of Cdc7 Kinase: Impact of the Pre-DFG Residue, Val 195,” ACS Med Chem Lett, vol. 4, no. 2, pp. 211–215, Feb. 2013, doi: 10.1021/ml300348c.
[1198]	N. Eckert, K. Werth, S. Willenzon, L. Tan, and R. Förster, “B cell hyperactivation in an Ackr4-deficient mouse strain is not caused by lack of ACKR4 expression,” J. Leukoc. Biol., vol. 107, no. 6, pp. 1155–1166, Jun. 2020, doi: 10.1002/JLB.2MA1119-300R.
[1199]	C. H. Kim, “B cell-helping functions of gut microbial metabolites,” Microb Cell, vol. 3, no. 10, pp. 529–531, Sep. 2016, doi: 10.15698/mic2016.10.536.
[1200]	J. Gleiss et al., “B-scan ultrasonographic monitoring of orthotopic xenografted plexiform neurofibroma in mice,” In Vivo, vol. 27, no. 6, pp. 723–727, Dec. 2013.
[1201]	K. Mrasek et al., “BAC-probes applied for characterization of fragile sites (FS),” Methods Mol. Biol., vol. 1227, pp. 289–298, 2015, doi: 10.1007/978-1-4939-1652-8_15.
[1202]	K.-W. Jeong et al., “Backbone dynamics of an atypical orphan response regulator protein, Helicobacter pylori 1043,” Mol. Cells, vol. 35, no. 2, pp. 158–165, Feb. 2013, doi: 10.1007/s10059-013-2303-z.
[1203]	J. Moll et al., “Bacteria inhabiting deadwood of 13 tree species are heterogeneously distributed between sapwood and heartwood,” Environ. Microbiol., vol. 20, no. 10, pp. 3744–3756, 2018, doi: 10.1111/1462-2920.14376.
[1204]	F. Fancello et al., “Bacterial Biodiversity of Extra Virgin Olive Oils and Their Potential Biotechnological Exploitation,” Microorganisms, vol. 8, no. 1, Jan. 2020, doi: 10.3390/microorganisms8010097.
[1205]	H. F. Gomez, D. A. Borgialli, M. Sharman, A. J. Scolpino, J. M. Oleske, and J. D. Bogden, “Bacterial colonization in point-of-use filters and deaths in Flint, Michigan,” Int. J. Infect. Dis., vol. 91, p. 267, 2020, doi: 10.1016/j.ijid.2019.11.031.
[1206]	S. G. Shanmugam et al., “Bacterial Diversity Patterns Differ in Soils Developing in Sub-tropical and Cool-Temperate Ecosystems,” Microb. Ecol., vol. 73, no. 3, pp. 556–569, 2017, doi: 10.1007/s00248-016-0884-8.
[1207]	M. M. Salek, F. Carrara, V. Fernandez, and R. Stocker, “Bacterial maze runners reveal hidden diversity in chemotactic performance,” Microb Cell, vol. 6, no. 8, pp. 370–372, Jul. 2019, doi: 10.15698/mic2019.08.688.
[1208]	S. Roier, F. G. Zingl, F. Cakar, and S. Schild, “Bacterial outer membrane vesicle biogenesis: a new mechanism and its implications,” Microb Cell, vol. 3, no. 6, pp. 257–259, May 2016, doi: 10.15698/mic2016.06.508.
[1209]	F. Viela, P. Speziale, G. Pietrocola, and Y. F. Dufrêne, “Bacterial pathogens under high-tension: Staphylococcus aureus adhesion to von Willebrand factor is activated by force,” Microb Cell, vol. 6, no. 7, pp. 321–323, Jun. 2019, doi: 10.15698/mic2019.07.684.
[1210]	A. D. Rowan, D. J. Cabral, and P. Belenky, “Bactericidal antibiotics induce programmed metabolic toxicity,” Microb Cell, vol. 3, no. 4, pp. 178–180, Mar. 2016, doi: 10.15698/mic2016.04.493.
[1211]	N. T. Porter, A. S. Luis, and E. C. Martens, “Bacteroides thetaiotaomicron,” Trends Microbiol., vol. 26, no. 11, pp. 966–967, 2018, doi: 10.1016/j.tim.2018.08.005.
[1212]	M. Y. Osoba, A. K. Rao, S. K. Agrawal, and A. K. Lalwani, “Balance and gait in the elderly: A contemporary review,” Laryngoscope Investig Otolaryngol, vol. 4, no. 1, pp. 143–153, Feb. 2019, doi: 10.1002/lio2.252.
[1213]	D. Carbone, L. Zuccarello, A. Messina, S. Scollo, and H. Rymer, “Balancing bulk gas accumulation and gas output before and during lava fountaining episodes at Mt. Etna,” Sci Rep, vol. 5, p. 18049, Dec. 2015, doi: 10.1038/srep18049.
[1214]	L. Harrington, “Balancing quality and costs during economic downturns,” Nurs Manage, vol. 42, no. 5, pp. 46–48, May 2011, doi: 10.1097/01.NUMA.0000396495.83517.cd.
[1215]	T. N. Nguyen et al., “Balloon guide catheter improves revascularization and clinical outcomes with the Solitaire device: analysis of the North American Solitaire Acute Stroke Registry,” Stroke, vol. 45, no. 1, pp. 141–145, Jan. 2014, doi: 10.1161/STROKEAHA.113.002407.
[1216]	A. Ilczyszyn, W. Lynn, S. Rasheed, J. Davids, R. Aguilo, and S. Agrawal, “Bariatric fellowship positively influences early outcomes for laparoscopic Roux-en-Y gastric bypass surgery over seven years of independent practice,” Ann R Coll Surg Engl, pp. 1–5, Aug. 2018, doi: 10.1308/rcsann.2018.0132.
[1217]	M. Houde, N. Khodaei, N. Benkerroum, and S. Karboune, “Barley protein concentrates: Extraction, structural and functional properties,” Food Chem, vol. 254, pp. 367–376, Jul. 2018, doi: 10.1016/j.foodchem.2018.01.156.
[1218]	N. R. Saunders, M. D. Habgood, and K. M. Dziegielewska, “Barrier mechanisms in the brain, I. Adult brain,” Clin. Exp. Pharmacol. Physiol., vol. 26, no. 1, pp. 11–19, Jan. 1999, doi: 10.1046/j.1440-1681.1999.02986.x.
[1219]	A. A. Sayampanathan, A. N. Cuttilan, and C. J. Pearce, “Barriers and enablers to proper diabetic foot care amongst community dwellers in an Asian population: a qualitative study,” Ann Transl Med, vol. 5, no. 12, p. 254, Jun. 2017, doi: 10.21037/atm.2017.04.31.
[1220]	N. R. Saunders, C. J. Ek, M. D. Habgood, and K. M. Dziegielewska, “Barriers in the brain: a renaissance?,” Trends Neurosci., vol. 31, no. 6, pp. 279–286, Jun. 2008, doi: 10.1016/j.tins.2008.03.003.
[1221]	D. Gardner, “Barriers to the implementation of management systems: lessons from the past,” Qual Assur, vol. 8, no. 1, pp. 3–10, Mar. 2000, doi: 10.1080/105294100753209147.
[1222]	M. K. Sanghera, R. G. Grossman, C. G. Kalhorn, W. J. Hamilton, W. G. Ondo, and J. Jankovic, “Basal ganglia neuronal discharge in primary and secondary dystonia in patients undergoing pallidotomy,” Neurosurgery, vol. 52, no. 6, pp. 1358–1370; discussion 1370-1373, Jun. 2003, doi: 10.1227/01.neu.0000064805.91249.f5.
[1223]	 null Gilbert-Dreyfus, M. Zara, and J. L. Frank, “[Basedow’s exophtholmos],” Sem Hop, vol. 29, no. 26, pp. 1287–1292, Apr. 1953.
[1224]	A. Mann, “Bashing holes in the tale of Earth’s troubled youth,” Nature, vol. 553, no. 7689, pp. 393–395, 25 2018, doi: 10.1038/d41586-018-01074-6.
[1225]	U. Schlötzer-Schrehardt and C. Cursiefen, “[Basic research in ophthalmology in Germany and its international context],” Ophthalmologe, vol. 114, no. 9, pp. 804–811, Sep. 2017, doi: 10.1007/s00347-017-0541-8.
[1226]	M. Yazawa, H. Ogata, T. Nakajima, T. Mori, N. Watanabe, and M. Handa, “Basic studies on the clinical applications of platelet-rich plasma,” Cell Transplant, vol. 12, no. 5, pp. 509–518, 2003, doi: 10.3727/000000003108747073.
[1227]	L. V. Allen, “Basics of compounding sterile preparations: nomenclature and considerations,” Int J Pharm Compd, vol. 18, no. 4, pp. 313–317, Aug. 2014.
[1228]	B. Gyüre and I. M. Jánosi, “Basics of lava-lamp convection,” Phys Rev E Stat Nonlin Soft Matter Phys, vol. 80, no. 4 Pt 2, p. 046307, Oct. 2009, doi: 10.1103/PhysRevE.80.046307.
[1229]	P. E. Pellett, S. Mitra, and T. C. Holland, “Basics of virology,” Handb Clin Neurol, vol. 123, pp. 45–66, 2014, doi: 10.1016/B978-0-444-53488-0.00002-X.
[1230]	R. A. Holland, J. L. Kirschvink, T. G. Doak, and M. Wikelski, “Bats use magnetite to detect the earth’s magnetic field,” PLoS ONE, vol. 3, no. 2, p. e1676, Feb. 2008, doi: 10.1371/journal.pone.0001676.
[1231]	D. Garenne, T. T. Renault, and S. Manon, “Bax mitochondrial relocation is linked to its phosphorylation and its interaction with Bcl-xL,” Microb Cell, vol. 3, no. 12, pp. 597–605, Dec. 2016, doi: 10.15698/mic2016.12.547.
[1232]	M. W. Wheeler, “Bayesian additive adaptive basis tensor product models for modeling high dimensional surfaces: an application to high-throughput toxicity testing,” Biometrics, vol. 75, no. 1, pp. 193–201, 2019, doi: 10.1111/biom.12942.
[1233]	D. S. Spiegel and E. L. Turner, “Bayesian analysis of the astrobiological implications of life’s early emergence on Earth,” Proc. Natl. Acad. Sci. U.S.A., vol. 109, no. 2, pp. 395–400, Jan. 2012, doi: 10.1073/pnas.1111694108.
[1234]	“BCG vaccines: WHO position paper – February 2018,” Wkly. Epidemiol. Rec., vol. 93, no. 8, pp. 73–96, Feb. 2018.
[1235]	Y. Yin, X. Su, L. Pan, and C. Li, “BDNF Val66Met polymorphism and cognitive impairment in Parkinson’s disease-a meta-analysis,” Neurol. Sci., vol. 40, no. 9, pp. 1901–1907, Sep. 2019, doi: 10.1007/s10072-019-03907-2.
[1236]	K. S. Adjoh et al., “[Becoming new pulmonary tuberculosis patients with sputum smear-positive at the end of second month of anti tubercular treatment in Lome],” Mali Med, vol. 28, no. 4, pp. 32–36, 2013.
[1237]	G. A. Shah, G. M. Shah, M. I. Rashid, J. C. J. Groot, B. Traore, and E. A. Lantinga, “Bedding additives reduce ammonia emission and improve crop N uptake after soil application of solid cattle manure,” J. Environ. Manage., vol. 209, pp. 195–204, Mar. 2018, doi: 10.1016/j.jenvman.2017.12.035.
[1238]	C. S. Chaboo, M. Biesele, R. K. Hitchcock, and A. Weeks, “Beetle and plant arrow poisons of the Ju|’hoan and Hai||om San peoples of Namibia (Insecta, Coleoptera, Chrysomelidae; Plantae, Anacardiaceae, Apocynaceae, Burseraceae),” Zookeys, no. 558, pp. 9–54, 2016, doi: 10.3897/zookeys.558.5957.
[1239]	E. Nieto Fernández and J. Barraca Mairal, “Behavioral activation versus cognitive restructuring to reduce automatic negative thoughts in anxiety generating situations,” Psicothema, vol. 29, no. 2, pp. 172–177, May 2017, doi: 10.7334/psicothema2016.325.
[1240]	K. Takagaki et al., “Behavioral characteristics of subthreshold depression,” J Affect Disord, vol. 168, pp. 472–475, Oct. 2014, doi: 10.1016/j.jad.2014.07.018.
[1241]	T. Byrne and A. Poling, “Behavioral effects of delayed timeouts from reinforcement,” J Exp Anal Behav, vol. 107, no. 2, pp. 208–217, 2017, doi: 10.1002/jeab.246.
[1242]	V. de C. Gomes, W. Hassan, S. Maisonnette, L. R. Johnson, A. Ramos, and J. Landeira-Fernandez, “Behavioral evaluation of eight rat lines selected for high and low anxiety-related responses,” Behav. Brain Res., vol. 257, pp. 39–48, Nov. 2013, doi: 10.1016/j.bbr.2013.09.028.
[1243]	A. M. Montgomery, P. J. Fletcher, and M. J. Burton, “Behavioural and pharmacological investigations of 5-HT hypophagia and hyperdipsia,” Pharmacol. Biochem. Behav., vol. 25, no. 1, pp. 23–28, Jul. 1986, doi: 10.1016/0091-3057(86)90224-8.
[1244]	F. O. Christiansen, M. Bakken, and B. O. Braastad, “Behavioural changes and aversive conditioning in hunting dogs by the second-year confrontation with domestic sheep,” Appl. Anim. Behav. Sci., vol. 72, no. 2, pp. 131–143, Apr. 2001, doi: 10.1016/s0168-1591(00)00203-3.
[1245]	M. Papa, “Being a (clinical) team player,” Biomed Instrum Technol, vol. 45, no. 5, p. 416, Oct. 2011, doi: 10.2345/0899-8205-45.5.416.
[1246]	J. M. Meyer, A. Kirk, J. J. Arch, P. J. Kelly, and B. J. Deacon, “Beliefs about safety behaviours in the prediction of safety behaviour use,” Behav Cogn Psychother, vol. 47, no. 6, pp. 631–644, Nov. 2019, doi: 10.1017/S1352465819000298.
[1247]	Y. Shi, J. Yao, G. Xu, and L. A. Taber, “Bending of the looping heart: differential growth revisited,” J Biomech Eng, vol. 136, no. 8, Aug. 2014, doi: 10.1115/1.4026645.
[1248]	G. Sardella et al., “Beneficial impact of prolonged dual antiplatelet therapy after drug-eluting stent implantation,” J Interv Cardiol, vol. 25, no. 6, pp. 596–603, Dec. 2012, doi: 10.1111/j.1540-8183.2011.00713.x.
[1249]	S. Kumari, N. Sharma, S. Thakur, P. R. Mondal, and K. N. Saraswathy, “Beneficial role of D allele in controlling ACE levels: a study among Brahmins of north India,” J. Genet., vol. 95, no. 2, pp. 291–295, Jun. 2016, doi: 10.1007/s12041-016-0649-7.
[1250]	S. N. Johnson, J. M. W. Ryalls, A. N. Gherlenda, A. Frew, and S. E. Hartley, “Benefits from Below: Silicon Supplementation Maintains Legume Productivity under Predicted Climate Change Scenarios,” Front Plant Sci, vol. 9, p. 202, 2018, doi: 10.3389/fpls.2018.00202.
[1251]	F. Madia et al., “Benign adult familial myoclonic epilepsy (BAFME): evidence of an extended founder haplotype on chromosome 2p11.1-q12.2 in five Italian families,” Neurogenetics, vol. 9, no. 2, pp. 139–142, May 2008, doi: 10.1007/s10048-008-0118-4.
[1252]	F. A. de Falco et al., “Benign adult familial myoclonic epilepsy: genetic heterogeneity and allelism with ADCME,” Neurology, vol. 60, no. 8, pp. 1381–1385, Apr. 2003, doi: 10.1212/01.wnl.0000055874.24000.4a.
[1253]	M. Malacarne et al., “Benign familial infantile convulsions: mapping of a novel locus on chromosome 2q24 and evidence for genetic heterogeneity,” Am. J. Hum. Genet., vol. 68, no. 6, pp. 1521–1526, Jun. 2001, doi: 10.1086/320596.
[1254]	P. You, R. Instrum, and L. Parnes, “Benign paroxysmal positional vertigo,” Laryngoscope Investig Otolaryngol, vol. 4, no. 1, pp. 116–123, Feb. 2019, doi: 10.1002/lio2.230.
[1255]	S. Kerge et al., “Benign proliferative epithelial lesions of oral mucosa are infrequently associated with α-, β-, or γ human papillomaviruses,” Laryngoscope Investig Otolaryngol, vol. 4, no. 1, pp. 43–48, Feb. 2019, doi: 10.1002/lio2.222.
[1256]	F. L. Kuang et al., “Benralizumab for PDGFRA-Negative Hypereosinophilic Syndrome,” N. Engl. J. Med., vol. 380, no. 14, pp. 1336–1346, 04 2019, doi: 10.1056/NEJMoa1812185.
[1257]	E. A. Natelson, “Benzene exposure and refractory sideroblastic erythropoiesis: is there an association?,” Am. J. Med. Sci., vol. 334, no. 5, pp. 356–360, Nov. 2007, doi: 10.1097/MAJ.0b013e3180cab70a.
[1258]	W. Li and A. R. Schnatter, “Benzene risk assessment: does new evidence on myelodysplastic syndrome justify a new approach?,” Crit. Rev. Toxicol., vol. 48, no. 6, pp. 417–432, 2018, doi: 10.1080/10408444.2018.1437389.
[1259]	H. V. Curran, “Benzodiazepines, memory and mood: a review,” Psychopharmacology (Berl.), vol. 105, no. 1, pp. 1–8, 1991, doi: 10.1007/BF02316856.
[1260]	F.-S. Yu et al., “Berberine inhibits WEHI-3 leukemia cells in vivo,” In Vivo, vol. 21, no. 2, pp. 407–412, Apr. 2007.
[1261]	E. Smith and Z. Master, “Best Practice to Order Authors in Multi/Interdisciplinary Health Sciences Research Publications,” Account Res, vol. 24, no. 4, pp. 243–267, 2017, doi: 10.1080/08989621.2017.1287567.
[1262]	E. K. DeVore, A. Redmann, R. Howell, and S. Khosla, “Best practices for emergency surgical airway: A systematic review,” Laryngoscope Investig Otolaryngol, vol. 4, no. 6, pp. 602–608, Dec. 2019, doi: 10.1002/lio2.314.
[1263]	M. Tonelli et al., “Best threshold for diagnosis of stenosis or thrombosis within six months of access flow measurement in arteriovenous fistulae,” J. Am. Soc. Nephrol., vol. 14, no. 12, pp. 3264–3269, Dec. 2003, doi: 10.1097/01.asn.0000099381.98940.2e.
[1264]	L. D. Ried, B. H. McFarland, R. E. Johnson, and K. K. Brody, “Beta-blockers and depression: the more the murkier?,” Ann Pharmacother, vol. 32, no. 6, pp. 699–708, Jun. 1998, doi: 10.1345/aph.17185.
[1265]	W. L. Close, A. N. Anderson, and P. E. Pellett, “Betaherpesvirus Virion Assembly and Egress,” Adv. Exp. Med. Biol., vol. 1045, pp. 167–207, 2018, doi: 10.1007/978-981-10-7230-7_9.
[1266]	R. Lane, “Betty Kirkwood: trailblazer in global health epidemiology,” Lancet, vol. 390, no. 10101, p. 1482, Sep. 2017, doi: 10.1016/S0140-6736(17)32361-9.
[1267]	G. J. Manayath, V. Narendran, N. Al-Kharousi, and U. K. Wali, “Bevacizumab therapy for macular edema in central retinal vein occlusion: Long-term results,” Oman J Ophthalmol, vol. 2, no. 2, pp. 73–78, May 2009, doi: 10.4103/0974-620X.53036.
[1268]	P. Fossion, C. Leys, C. Kempenaers, S. Braun, P. Verbanck, and P. Linkowski, “Beware of multiple traumas in PTSD assessment: the role of reactivation mechanism in intrusive and hyper-arousal symptoms,” Aging Ment Health, vol. 19, no. 3, pp. 258–263, 2015, doi: 10.1080/13607863.2014.924901.
[1269]	M. A. Bowman, J. W. Saultz, and W. R. Phillips, “Beware of Predatory Journals: A Caution from Editors of Three Family Medicine Journals,” J Am Board Fam Med, vol. 31, no. 5, pp. 671–676, Oct. 2018, doi: 10.3122/jabfm.2018.05.180197.
[1270]	R. García-López, V. Pérez-Brocal, and A. Moya, “Beyond cells - The virome in the human holobiont,” Microb Cell, vol. 6, no. 9, pp. 373–396, Jul. 2019, doi: 10.15698/mic2019.09.689.
[1271]	M. A. Pierle, “Beyond compliance,” Qual Assur, vol. 3, no. 1, pp. 9–12, Mar. 1994.
[1272]	T. W. Lombardo and M. J. Gray, “Beyond exposure for posttraumatic stress disorder (PTSD) symptoms: broad-spectrum PTSD treatment strategies,” Behav Modif, vol. 29, no. 1, pp. 3–9, Jan. 2005, doi: 10.1177/0145445504270853.
[1273]	B. Lo, “Beyond Legalization - Dilemmas Physicians Confront Regarding Aid in Dying,” N. Engl. J. Med., vol. 378, no. 22, pp. 2060–2062, May 2018, doi: 10.1056/NEJMp1802218.
[1274]	G. Cirillo and M. Papa, “Beyond peripheral nerve injury: spinal gliopathy and maladaptive synaptic plasticity,” Neural Regen Res, vol. 11, no. 9, pp. 1422–1423, Sep. 2016, doi: 10.4103/1673-5374.191214.
[1275]	D. Joel and A. Fausto-Sterling, “Beyond sex differences: new approaches for thinking about variation in brain structure and function,” Philos. Trans. R. Soc. Lond., B, Biol. Sci., vol. 371, no. 1688, p. 20150451, Feb. 2016, doi: 10.1098/rstb.2015.0451.
[1276]	C. Cavalin et al., “Beyond silicosis, is the world failing on silica hazards?,” Lancet Respir Med, vol. 7, no. 8, pp. 649–650, 2019, doi: 10.1016/S2213-2600(19)30174-2.
[1277]	C. A. Struble, J. D. Ellis, and L. H. Lundahl, “Beyond the Bud: Emerging Methods of Cannabis Consumption for Youth,” Pediatr. Clin. North Am., vol. 66, no. 6, pp. 1087–1097, 2019, doi: 10.1016/j.pcl.2019.08.012.
[1278]	N. J. Kopell, H. J. Gritton, M. A. Whittington, and M. A. Kramer, “Beyond the connectome: the dynome,” Neuron, vol. 83, no. 6, pp. 1319–1328, Sep. 2014, doi: 10.1016/j.neuron.2014.08.016.
[1279]	M. Vrabel, “Beyond the Impact Factor,” Oncol Nurs Forum, vol. 46, no. 2, pp. 143–145, 01 2019, doi: 10.1188/19.ONF.143-145.
[1280]	J.-D. Guo, S. E. Hammack, R. Hazra, L. Levita, and D. G. Rainnie, “Bi-directional modulation of bed nucleus of stria terminalis neurons by 5-HT: molecular expression and functional properties of excitatory 5-HT receptor subtypes,” Neuroscience, vol. 164, no. 4, pp. 1776–1793, Dec. 2009, doi: 10.1016/j.neuroscience.2009.09.028.
[1281]	D. Alvarez-Fischer and A. Westenberger, “Biallelic MYORG mutations: Primary familial brain calcification goes recessive,” Mov. Disord., vol. 34, no. 3, p. 322, 2019, doi: 10.1002/mds.27629.
[1282]	E. Emery, “[Bibliometric analysis of neurosurgery publications in France],” Neurochirurgie, vol. 65, no. 1, pp. 7–13, Feb. 2019, doi: 10.1016/j.neuchi.2018.08.006.
[1283]	F. Romaní and C. Cabezas, “[Bibliometric analysis of papers published in revista peruana de medicina experimental y salud pública, 2010-2017],” Rev Peru Med Exp Salud Publica, vol. 35, no. 4, pp. 620–629, Dec. 2018, doi: 10.17843/rpmesp.2018.354.3817.
[1284]	P. Kokol, J. Završnik, B. Žlahtič, and H. Blažun Vošner, “Bibliometric characteristics of predatory journals in pediatrics,” Pediatr. Res., vol. 83, no. 6, pp. 1093–1094, 2018, doi: 10.1038/pr.2018.54.
[1285]	T. Similowski and J. P. Derenne, “[Bibliometry of biomedical periodicals],” Rev Mal Respir, vol. 12, no. 6, pp. 543–550, 1995.
[1286]	C. A. Danilo et al., “Bifidobacterium animalis subsp. lactis 420 mitigates the pathological impact of myocardial infarction in the mouse,” Benef Microbes, vol. 8, no. 2, pp. 257–269, Apr. 2017, doi: 10.3920/BM2016.0119.
[1287]	M. Kantner and S. Yanchuk, “Bifurcation analysis of delay-induced patterns in a ring of Hodgkin-Huxley neurons,” Philos Trans A Math Phys Eng Sci, vol. 371, no. 1999, p. 20120470, Sep. 2013, doi: 10.1098/rsta.2012.0470.
[1288]	S. An, B. Kim, S. Kwon, G. Moon, M. Lee, and W. Jhe, “Bifurcation-enhanced ultrahigh sensitivity of a buckled cantilever,” Proc. Natl. Acad. Sci. U.S.A., vol. 115, no. 12, pp. 2884–2889, 20 2018, doi: 10.1073/pnas.1716067115.
[1289]	R. Raiker et al., “Biliary tract large cell neuroendocrine carcinoma: current evidence,” Orphanet J Rare Dis, vol. 14, no. 1, p. 266, 21 2019, doi: 10.1186/s13023-019-1230-2.
[1290]	Y. Kang et al., “Binder-Free Electrode based on Electrospun-Fiber for Li Ion Batteries via a Simple Rolling Formation,” Nanoscale Res Lett, vol. 15, no. 1, p. 147, Jul. 2020, doi: 10.1186/s11671-020-03369-y.
[1291]	Y. Kang et al., “Binder-Free Electrodes and Their Application for Li-Ion Batteries,” Nanoscale Res Lett, vol. 15, no. 1, p. 112, May 2020, doi: 10.1186/s11671-020-03325-w.
[1292]	J. G. Lee, L. L. Larive, K. T. Valsaraj, and B. Bharti, “Binding of Lignin Nanoparticles at Oil-Water Interfaces: An Ecofriendly Alternative to Oil Spill Recovery,” ACS Appl Mater Interfaces, vol. 10, no. 49, pp. 43282–43289, Dec. 2018, doi: 10.1021/acsami.8b17748.
[1293]	M. Seel and T. C. Werner, “Binding properties of 2-acetylnaphthalene with hydroxypropyl cyclodextrins from fluorescence quenching experiments,” Appl Spectrosc, vol. 59, no. 5, pp. 691–695, May 2005, doi: 10.1366/0003702053946119.
[1294]	P. Mengal et al., “Bio-based Industries Joint Undertaking: The catalyst for sustainable bio-based economic growth in Europe,” N Biotechnol, vol. 40, no. Pt A, pp. 31–39, Jan. 2018, doi: 10.1016/j.nbt.2017.06.002.
[1295]	E. Rodney et al., “Bioaccumulation and Tissue Distribution of Arsenic, Cadmium, Copper and Zinc in Crassostrea virginica Grown at Two Different Depths in Jamaica Bay, New York,” In Vivo (Brooklyn), vol. 29, no. 1, pp. 16–27, 2007.
[1296]	A. Kara, S. Tamburaci, F. Tihminlioglu, and H. Havitcioglu, “Bioactive fish scale incorporated chitosan biocomposite scaffolds for bone tissue engineering,” Int. J. Biol. Macromol., vol. 130, pp. 266–279, Jun. 2019, doi: 10.1016/j.ijbiomac.2019.02.067.
[1297]	R. Pelton, “Bioactive paper provides a low-cost platform for diagnostics,” Trends Analyt Chem, vol. 28, no. 8, pp. 925–942, Sep. 2009, doi: 10.1016/j.trac.2009.05.005.
[1298]	A. Katayama et al., “Bioavailability of xenobiotics in the soil environment,” Rev Environ Contam Toxicol, vol. 203, pp. 1–86, 2010, doi: 10.1007/978-1-4419-1352-4_1.
[1299]	T. Yamaguchi, K. Aihara, S. Yamada, S. Narita, and K. Kogi, “Biochemical and pharmacological properties of a newly synthesized proton pump (H+/K(+)-ATPase) inhibitor, TY-11345 in experimental animals,” Jpn. J. Pharmacol., vol. 62, no. 4, pp. 363–371, Aug. 1993, doi: 10.1254/jjp.62.363.
[1300]	S. M. Widacki, L. Flaherty, and R. G. Cook, “Biochemical characterization of the molecules reactive with Qa-6 antiserum and the monoclonal antibody 20-8-4: evidence for structural similarity with the Qa-2 molecule,” J. Immunol., vol. 135, no. 5, pp. 3333–3339, Nov. 1985.
[1301]	G. Liakakis, “Biochemical diagnosis of vascular cognitive impairment associated with subcortical small vessels disease,” Hell J Nucl Med, vol. 22 Suppl, pp. 187–193, Apr. 2019.
[1302]	S. M. Widacki, V. Mehta, L. Flaherty, and R. G. Cook, “Biochemical differences in Qa-2 antigens expressed by Qa-2+,6+ and Qa-2+,6- strains. Evidence for differential expression of the Q7 and Q9 genes,” Mol. Immunol., vol. 27, no. 6, pp. 559–570, Jun. 1990, doi: 10.1016/0161-5890(90)90075-b.
[1303]	S. Papa and V. Bocchini, “Biochemistry in Italy,” Trends Biochem. Sci., vol. 14, no. 6, pp. 209–212, Jun. 1989, doi: 10.1016/0968-0004(89)90025-x.
[1304]	C.-Y. Ke et al., “Biodegradation of crude oil by Chelatococcus daeguensis HB-4 and its potential for microbial enhanced oil recovery (MEOR) in heavy oil reservoirs,” Bioresour. Technol., vol. 287, p. 121442, Sep. 2019, doi: 10.1016/j.biortech.2019.121442.
[1305]	B. Liu et al., “[Biodiversity and functional enzymes of cultured halophilic archaeon in Lop Nur region],” Wei Sheng Wu Xue Bao, vol. 51, no. 9, pp. 1222–1231, Sep. 2011.
[1306]	A. Ferramosca and V. Zara, “Bioenergetics of mammalian sperm capacitation,” Biomed Res Int, vol. 2014, p. 902953, 2014, doi: 10.1155/2014/902953.
[1307]	A. Lee and H.-L. Wang, “Biofilm related to dental implants,” Implant Dent, vol. 19, no. 5, pp. 387–393, Oct. 2010, doi: 10.1097/ID.0b013e3181effa53.
[1308]	N. Akdeniz, K. A. Janni, and I. A. Salnikov, “Biofilter performance of pine nuggets and lava rock as media,” Bioresour. Technol., vol. 102, no. 8, pp. 4974–4980, Apr. 2011, doi: 10.1016/j.biortech.2011.01.058.
[1309]	H. La, J. P. A. Hettiaratchi, G. Achari, T. J. Verbeke, and P. F. Dunfield, “Biofiltration of methane using hybrid mixtures of biochar, lava rock and compost,” Environ. Pollut., vol. 241, pp. 45–54, Oct. 2018, doi: 10.1016/j.envpol.2018.05.039.
[1310]	V. Zara et al., “Biogenesis of eel liver citrate carrier (CIC): negative charges can substitute for positive charges in the presequence,” J. Mol. Biol., vol. 365, no. 4, pp. 958–967, Jan. 2007, doi: 10.1016/j.jmb.2006.10.077.
[1311]	A. Ferramosca and V. Zara, “Biogenesis of mitochondrial carrier proteins: molecular mechanisms of import into mitochondria,” Biochim. Biophys. Acta, vol. 1833, no. 3, pp. 494–502, Mar. 2013, doi: 10.1016/j.bbamcr.2012.11.014.
[1312]	V. Zara, A. Ferramosca, I. Palmisano, F. Palmieri, and J. Rassow, “Biogenesis of rat mitochondrial citrate carrier (CIC): the N-terminal presequence facilitates the solubility of the preprotein but does not act as a targeting signal,” J. Mol. Biol., vol. 325, no. 2, pp. 399–408, Jan. 2003, doi: 10.1016/s0022-2836(02)01236-6.
[1313]	V. Zara, I. Palmisano, J. Rassow, and F. Palmieri, “Biogenesis of the dicarboxylate carrier (DIC): translocation across the mitochondrial outer membrane and subsequent release from the TOM channel are membrane potential-independent,” J. Mol. Biol., vol. 310, no. 5, pp. 965–971, Jul. 2001, doi: 10.1006/jmbi.2001.4833.
[1314]	V. Zara et al., “Biogenesis of the mitochondrial phosphate carrier,” Eur. J. Biochem., vol. 198, no. 2, pp. 405–410, Jun. 1991, doi: 10.1111/j.1432-1033.1991.tb16029.x.
[1315]	V. Zara, L. Conte, and B. L. Trumpower, “Biogenesis of the yeast cytochrome bc1 complex,” Biochim. Biophys. Acta, vol. 1793, no. 1, pp. 89–96, Jan. 2009, doi: 10.1016/j.bbamcr.2008.04.011.
[1316]	V. Zara et al., “Biogenesis of yeast dicarboxylate carrier: the carrier signature facilitates translocation across the mitochondrial outer membrane,” J. Cell. Sci., vol. 120, no. Pt 23, pp. 4099–4106, Dec. 2007, doi: 10.1242/jcs.018929.
[1317]	H. Li, D. R. Lueking, J. R. Mihelcic, and K. Peterson, “Biogeochemical analysis of hydrogen sulfide removal by a lava-rock packed biofilter,” Water Environ. Res., vol. 77, no. 2, pp. 179–186, Apr. 2005, doi: 10.2175/106143005x41744.
[1318]	B. K. Taylor, “Bioinspired magnetic reception and multimodal sensing,” Biol Cybern, vol. 111, no. 3–4, pp. 287–308, 2017, doi: 10.1007/s00422-017-0720-3.
[1319]	B. Bhushan, “Bioinspired oil-water separation approaches for oil spill clean-up and water purification,” Philos Trans A Math Phys Eng Sci, vol. 377, no. 2150, p. 20190120, Jul. 2019, doi: 10.1098/rsta.2019.0120.
[1320]	N. Zhu et al., “Bioleaching of metal concentrates of waste printed circuit boards by mixed culture of acidophilic bacteria,” J. Hazard. Mater., vol. 192, no. 2, pp. 614–619, Aug. 2011, doi: 10.1016/j.jhazmat.2011.05.062.
[1321]	S. Anvari, S. Najar Peerayeh, M. Behmanesh, and M. Boustanshenas, “Biological activity of recombinant accessory cholerae enterotoxin (ace) on rabbit ileal loops and antibacterial assay,” Cell J, vol. 14, no. 3, pp. 209–214, 2012.
[1322]	H. Konno, Y. Yoshida, K. Nagano, J. Takebe, and Y. Hasegawa, “Biological and Biochemical Roles of Two Distinct Cyclic Dimeric Adenosine 3’,5’-Monophosphate- Associated Phosphodiesterases in Streptococcus mutans,” Front Microbiol, vol. 9, p. 2347, 2018, doi: 10.3389/fmicb.2018.02347.
[1323]	Y. Clement and G. Chapouthier, “Biological bases of anxiety,” Neurosci Biobehav Rev, vol. 22, no. 5, pp. 623–633, Sep. 1998, doi: 10.1016/s0149-7634(97)00058-4.
[1324]	C. Perrone-Capano, F. Volpicelli, and U. di Porzio, “Biological bases of human musicality,” Rev Neurosci, vol. 28, no. 3, pp. 235–245, 01 2017, doi: 10.1515/revneuro-2016-0046.
[1325]	Y. D. Nir and R. Goldwasser, “Biological characteristics of some of the arbor viruses in vivo and in vitro. I. Thermal inactivation in cell-culture medium,” Am J Hyg, vol. 73, pp. 294–296, May 1961, doi: 10.1093/oxfordjournals.aje.a120188.
[1326]	V. Moiseenko, V. Lapointe, K. James, L. Yin, M. Liu, and T. Pawlicki, “Biological consequences of MLC calibration errors in IMRT delivery and QA,” Med Phys, vol. 39, no. 4, pp. 1917–1924, Apr. 2012, doi: 10.1118/1.3692177.
[1327]	K. S. Cho, H. W. Ryu, and N. Y. Lee, “Biological deodorization of hydrogen sulfide using porous lava as a carrier of Thiobacillus thiooxidans,” J. Biosci. Bioeng., vol. 90, no. 1, pp. 25–31, 2000.
[1328]	J. M. Machado Rocha and B. A. G. Jorge Pereira, “Biological principles and clinical application of positron emission tomography-tracers in prostate cancer: a review,” Prostate Int, vol. 7, no. 2, pp. 41–46, Jun. 2019, doi: 10.1016/j.prnil.2018.12.003.
[1329]	D.-Z. Guo and J. Chen, “[Biological safety of the molluscicidal ingredient from Aspergillus fumigatus SL-30 isolated from rhizosphere of Phytolacca acinosa],” Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, vol. 30, no. 6, pp. 460–463, Dec. 2012.
[1330]	K. M. Estrellas et al., “Biological scaffold-mediated delivery of myostatin inhibitor promotes a regenerative immune response in an animal model of Duchenne muscular dystrophy,” J. Biol. Chem., vol. 293, no. 40, pp. 15594–15605, 05 2018, doi: 10.1074/jbc.RA118.004417.
[1331]	H. E. Kaiser, “Biological viewpoints of neoplastic regression,” In Vivo, vol. 8, no. 1, pp. 155–165, Feb. 1994.
[1332]	M. Zarà et al., “Biology and Role of Extracellular Vesicles (EVs) in the Pathogenesis of Thrombosis,” Int J Mol Sci, vol. 20, no. 11, Jun. 2019, doi: 10.3390/ijms20112840.
[1333]	M. Baldini and C. Sacchetti, “[Biology of hemopoietic cell cultured in vitro in amino acids deficiency],” Haematologica, vol. 37, no. 2, pp. 121–127, 1953.
[1334]	G. Hart, “Biomagnetometry: imaging the heart’s magnetic field,” Br Heart J, vol. 65, no. 2, pp. 61–62, Feb. 1991, doi: 10.1136/hrt.65.2.61.
[1335]	H. Larson, E. Chan, S. Sudarsanam, and D. E. Johnson, “Biomarkers,” Methods Mol. Biol., vol. 930, pp. 253–273, 2013, doi: 10.1007/978-1-62703-059-5_11.
[1336]	M. Delgado-Alvarado, B. Gago, I. Navalpotro-Gomez, H. Jiménez-Urbieta, and M. C. Rodriguez-Oroz, “Biomarkers for dementia and mild cognitive impairment in Parkinson’s disease,” Mov. Disord., vol. 31, no. 6, pp. 861–881, 2016, doi: 10.1002/mds.26662.
[1337]	M. A. Kipp and E. E. Stüeken, “Biomass recycling and Earth’s early phosphorus cycle,” Sci Adv, vol. 3, no. 11, p. eaao4795, 2017, doi: 10.1126/sciadv.aao4795.
[1338]	C. C. Lin, N. A. Patel, Y. Itami, M. H. McGarry, S. S. Shin, and T. Q. Lee, “Biomechanical Analysis of Thumb Ulnar Collateral Ligament Tear Kinematics,” Hand (N Y), p. 1558944719868518, Aug. 2019, doi: 10.1177/1558944719868518.
[1339]	Y. Chen and L. A. Ju, “Biomechanical thrombosis: the dark side of force and dawn of mechano-medicine,” Stroke Vasc Neurol, vol. 5, no. 2, pp. 185–197, Jun. 2020, doi: 10.1136/svn-2019-000302.
[1340]	R. Krasny, H. Kammermeier, and J. Köhler, “Biomechanics of valvular plane displacement of the heart,” Basic Res. Cardiol., vol. 86, no. 6, pp. 572–581, Dec. 1991, doi: 10.1007/BF02190708.
[1341]	J. González de Dios, A. P. Sempere, and R. Aleixandre-Benavent, “[Biomedical publications in Spain on debate (I): state of neurological journals],” Rev Neurol, vol. 44, no. 1, pp. 32–42, Jan. 2007.
[1342]	S. J. Athenikos and H. Han, “Biomedical question answering: a survey,” Comput Methods Programs Biomed, vol. 99, no. 1, pp. 1–24, Jul. 2010, doi: 10.1016/j.cmpb.2009.10.003.
[1343]	Q. P. Su and L. A. Ju, “Biophysical nanotools for single-molecule dynamics,” Biophys Rev, vol. 10, no. 5, pp. 1349–1357, Oct. 2018, doi: 10.1007/s12551-018-0447-y.
[1344]	A. C. de Vries et al., “Biopsy strategies for endoscopic surveillance of pre-malignant gastric lesions,” Helicobacter, vol. 15, no. 4, pp. 259–264, Aug. 2010, doi: 10.1111/j.1523-5378.2010.00760.x.
[1345]	B. T. Mossman and R. E. Glenn, “Bioreactivity of the crystalline silica polymorphs, quartz and cristobalite, and implications for occupational exposure limits (OELs),” Crit. Rev. Toxicol., vol. 43, no. 8, pp. 632–660, Sep. 2013, doi: 10.3109/10408444.2013.818617.
[1346]	V. de Lorenzo, P. Marlière, and R. Solé, “Bioremediation at a global scale: from the test tube to planet Earth,” Microb Biotechnol, vol. 9, no. 5, pp. 618–625, 2016, doi: 10.1111/1751-7915.12399.
[1347]	C. B. Pilcher, “Biosignatures of early earths,” Astrobiology, vol. 3, no. 3, pp. 471–486, 2003, doi: 10.1089/153110703322610582.
[1348]	P. Singh, Y. Patil, and V. Rale, “Biosurfactant production: emerging trends and promising strategies,” J. Appl. Microbiol., vol. 126, no. 1, pp. 2–13, Jan. 2019, doi: 10.1111/jam.14057.
[1349]	G. Płaza and V. Achal, “Biosurfactants: Eco-Friendly and Innovative Biocides against Biocorrosion,” Int J Mol Sci, vol. 21, no. 6, Mar. 2020, doi: 10.3390/ijms21062152.
[1350]	J. H. Erasmus and S. C. Weaver, “Biotechnological Applications of an Insect-Specific Alphavirus,” DNA Cell Biol., vol. 36, no. 12, pp. 1045–1049, Dec. 2017, doi: 10.1089/dna.2017.4019.
[1351]	A. T. Tu, “Biotoxicology of sea snake venoms,” Ann Emerg Med, vol. 16, no. 9, pp. 1023–1028, Sep. 1987, doi: 10.1016/s0196-0644(87)80752-7.
[1352]	R. M. Angell et al., “Biphenyl amide p38 kinase inhibitors 4: DFG-in and DFG-out binding modes,” Bioorg. Med. Chem. Lett., vol. 18, no. 15, pp. 4433–4437, Aug. 2008, doi: 10.1016/j.bmcl.2008.06.028.
[1353]	S. Arjmand, M. Behzadi, K. A. Kohlmeier, S. Mazhari, A. Sabahi, and M. Shabani, “Bipolar disorder and the endocannabinoid system,” Acta Neuropsychiatr, vol. 31, no. 4, pp. 193–201, Aug. 2019, doi: 10.1017/neu.2019.21.
[1354]	S. Wiggins and R. Kreikemeier, “Bisphosphonate therapy and osteogenesis imperfecta: The lived experience of children and their mothers,” J Spec Pediatr Nurs, vol. 22, no. 4, 2017, doi: 10.1111/jspn.12192.
[1355]	A. Zorzi, F. D’Ascenzi, and D. Corrado, “Black athletes’ hearts,” Eur. Heart J., vol. 40, no. 1, pp. 59–61, 01 2019, doi: 10.1093/eurheartj/ehy698.
[1356]	A. B. Borges, C. R. G. Torres, P. A. B. de Souza, T. M. F. Caneppele, L. F. T. F. Santos, and A. C. Magalhães, “Bleaching gels containing calcium and fluoride: effect on enamel erosion susceptibility,” Int J Dent, vol. 2012, p. 347848, 2012, doi: 10.1155/2012/347848.
[1357]	K. Gooijer, J. M. M. Rondeel, F. S. van Dijk, A. G. J. Harsevoort, G. J. M. Janus, and A. A. M. Franken, “Bleeding and bruising in Osteogenesis Imperfecta: International Society on Thrombosis and Haemostasis bleeding assessment tool and haemostasis laboratory assessment in 22 individuals,” Br. J. Haematol., vol. 187, no. 4, pp. 509–517, 2019, doi: 10.1111/bjh.16097.
[1358]	R. D. Valle, R. Zinicola, and M. Iaria, “Blind loop perforation after side-to-side ileocolonic anastomosis,” World J Gastrointest Surg, vol. 6, no. 8, pp. 156–159, Aug. 2014, doi: 10.4240/wjgs.v6.i8.156.
[1359]	A. I. Rogers and S. L. Rothman, “Blind loop syndrome,” Postgrad Med, vol. 55, no. 4, pp. 99–105, Apr. 1974, doi: 10.1080/00325481.1974.11713734.
[1360]	P. E. Isaacs and Y. S. Kim, “Blind loop syndrome and small bowel bacterial contamination,” Clin Gastroenterol, vol. 12, no. 2, pp. 395–414, May 1983.
[1361]	A. Cosenzi, A. M. Piemontesi, G. Pellis, and A. Spivach, “[Blind loop syndrome],” G Clin Med, vol. 68, no. 3, pp. 179–183, Mar. 1987.
[1362]	C. L. M. C. van Campen, P. C. Rowe, and F. C. Visser, “Blood Volume Status in ME/CFS Correlates With the Presence or Absence of Orthostatic Symptoms: Preliminary Results,” Front Pediatr, vol. 6, p. 352, 2018, doi: 10.3389/fped.2018.00352.
[1363]	B. D. McLean, K. White, C. J. Gore, and J. Kemp, “Blood Volumes Following Preseason Heat Versus Altitude: A Case Study of Australian Footballers,” Int J Sports Physiol Perform, pp. 1–5, Oct. 2019, doi: 10.1123/ijspp.2019-0350.
[1364]	B. Gevaert et al., “Blood-brain barrier transport kinetics of the neuromedin peptides NMU, NMN, NMB and NT,” Neuropharmacology, vol. 107, pp. 460–470, 2016, doi: 10.1016/j.neuropharm.2016.03.051.
[1365]	Q. Ma et al., “Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanism,” Mol Neurodegener, vol. 13, no. 1, p. 57, 19 2018, doi: 10.1186/s13024-018-0286-0.
[1366]	Y. Nagakawa et al., “Blumgart method using LAPRA-TY clips facilitates pancreaticojejunostomy in laparoscopic pancreaticoduodenectomy,” Medicine (Baltimore), vol. 99, no. 10, p. e19474, Mar. 2020, doi: 10.1097/MD.0000000000019474.
[1367]	K. S. Chinn and T. H. Allen, “Body fat in men from two skinfolds, weight, height, and age,” Tech Rep Brookhaven Natl Lab, vol. 248, pp. 1–23, Jul. 1960.
[1368]	L. M. Schiffer, D. C. Price, S. H. Cohn, and E. P. Cronkite, “Body retention of hydroxocobalamin and cyanocobalamin. BNL 6942,” Tech Rep Brookhaven Natl Lab, pp. 1–10, 1965.
[1369]	M. Peumans, E. B. Valjakova, J. De Munck, C. B. Mishevska, and B. Van Meerbeek, “Bonding Effectiveness of Luting Composites to Different CAD/CAM Materials,” J Adhes Dent, vol. 18, no. 4, pp. 289–302, 2016, doi: 10.3290/j.jad.a36155.
[1370]	L. R. Lee et al., “Bone Marrow Transplantation for Treatment of the Col1a2+/G610C Osteogenesis Imperfecta Mouse Model,” Calcif. Tissue Int., vol. 104, no. 4, pp. 426–436, 2019, doi: 10.1007/s00223-018-0504-3.
[1371]	R. Kocijan et al., “Bone structure assessed by HR-pQCT, TBS and DXL in adult patients with different types of osteogenesis imperfecta,” Osteoporos Int, vol. 26, no. 10, pp. 2431–2440, Oct. 2015, doi: 10.1007/s00198-015-3156-4.
[1372]	E. E. Wroblewski et al., “Bonobos Maintain Immune System Diversity with Three Functional Types of MHC-B,” J. Immunol., vol. 198, no. 9, pp. 3480–3493, May 2017, doi: 10.4049/jimmunol.1601955.
[1373]	S. N. Brixey, T. E. Corden, C. E. Guse, and P. M. Layde, “Booster seat legislation: does it work for all children?,” Inj. Prev., vol. 17, no. 4, pp. 233–237, Aug. 2011, doi: 10.1136/ip.2010.029835.
[1374]	S. G. Silverman et al., “Bosniak Classification of Cystic Renal Masses, Version 2019: An Update Proposal and Needs Assessment,” Radiology, vol. 292, no. 2, pp. 475–488, 2019, doi: 10.1148/radiol.2019182646.
[1375]	A. Hamilton, S. Pei, and L. Yang, “Botanical aspects of eco-civilisation construction,” Plant Divers, vol. 39, no. 2, pp. 65–72, Apr. 2017, doi: 10.1016/j.pld.2016.12.003.
[1376]	N. Tanaka et al., “Both 5-hydroxytryptamine 5-HT2A and 5-HT1B receptors are involved in the vasoconstrictor response to 5-HT in the human isolated internal thoracic artery,” Clin. Exp. Pharmacol. Physiol., vol. 35, no. 7, pp. 836–840, Jul. 2008, doi: 10.1111/j.1440-1681.2008.04933.x.
[1377]	R. M. Gwynne, A. J. Clarke, J. B. Furness, and J. C. Bornstein, “Both exogenous 5-HT and endogenous 5-HT, released by fluoxetine, enhance distension evoked propulsion in guinea-pig ileum in vitro,” Front Neurosci, vol. 8, p. 301, 2014, doi: 10.3389/fnins.2014.00301.
[1378]	R. de Jongh, I. Bolt, M. Schermer, and B. Olivier, “Botox for the brain: enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories,” Neurosci Biobehav Rev, vol. 32, no. 4, pp. 760–776, 2008, doi: 10.1016/j.neubiorev.2007.12.001.
[1379]	M. Gillham, A. Rich, M. Finkelman, and C. Y. Loo, “Bottle-Weaning Recommendations Among Pediatricians and Pediatric Dentists,” Pediatr Dent, vol. 41, no. 4, pp. 271–280, Jul. 2019.
[1380]	D. H. Ffytche and S. Zeki, “Brain activity related to the perception of illusory contours,” Neuroimage, vol. 3, no. 2, pp. 104–108, Apr. 1996, doi: 10.1006/nimg.1996.0012.
[1381]	P. E. Roland and K. Zilles, “Brain atlases--a new research tool,” Trends Neurosci., vol. 17, no. 11, pp. 458–467, Nov. 1994, doi: 10.1016/0166-2236(94)90131-7.
[1382]	K. Tsuruya and H. Yoshida, “Brain Atrophy and Cognitive Impairment in Chronic Kidney Disease,” Contrib Nephrol, vol. 196, pp. 27–36, 2018, doi: 10.1159/000485694.
[1383]	R. Hari and M. V. Kujala, “Brain basis of human social interaction: from concepts to brain imaging,” Physiol. Rev., vol. 89, no. 2, pp. 453–479, Apr. 2009, doi: 10.1152/physrev.00041.2007.
[1384]	N. Ishige, F. Laschi, and L. Pogliani, “Brain death in moderately injured rat brains by in vivo P-31 NMR spectroscopy,” In Vivo, vol. 3, no. 4, pp. 263–266, Aug. 1989.
[1385]	A. H. Meyer, C. Untucht, and G. C. Terstappen, “Brain delivery research in public-private partnerships: The IMI-JU COMPACT consortium as an example,” Neuropharmacology, vol. 120, pp. 8–10, Jul. 2017, doi: 10.1016/j.neuropharm.2016.06.012.
[1386]	J. Stiles, “Brain development and the nature versus nurture debate,” Prog. Brain Res., vol. 189, pp. 3–22, 2011, doi: 10.1016/B978-0-444-53884-0.00015-4.
[1387]	M. V. Maffini and T. G. Neltner, “Brain drain: the cost of neglected responsibilities in evaluating cumulative effects of environmental chemicals,” J Epidemiol Community Health, vol. 69, no. 5, pp. 496–499, May 2015, doi: 10.1136/jech-2014-203980.
[1388]	N. Ron-Harel, M. Cardon, and M. Schwartz, “Brain homeostasis is maintained by ‘danger’ signals stimulating a supportive immune response within the brain’s borders,” Brain Behav. Immun., vol. 25, no. 5, pp. 1036–1043, Jul. 2011, doi: 10.1016/j.bbi.2010.12.011.
[1389]	O. Groeneveld et al., “Brain imaging correlates of mild cognitive impairment and early dementia in patients with type 2 diabetes mellitus,” Nutr Metab Cardiovasc Dis, vol. 28, no. 12, pp. 1253–1260, 2018, doi: 10.1016/j.numecd.2018.07.008.
[1390]	Z. Fehervari, “Brain lymphatic (dys)function,” Nat. Immunol., vol. 19, no. 9, p. 901, Sep. 2018, doi: 10.1038/s41590-018-0194-z.
[1391]	N. P. Jones, H. W. Chase, and J. C. Fournier, “Brain mechanisms of anxiety’s effects on cognitive control in major depressive disorder,” Psychol Med, vol. 46, no. 11, pp. 2397–2409, 2016, doi: 10.1017/S0033291716001185.
[1392]	B. Kolb and I. Q. Whishaw, “Brain plasticity and behavior,” Annu Rev Psychol, vol. 49, pp. 43–64, 1998, doi: 10.1146/annurev.psych.49.1.43.
[1393]	D. Vallöf, A. L. Kalafateli, and E. Jerlhag, “Brain region-specific neuromedin U signalling regulates alcohol-related behaviours and food intake in rodents,” Addict Biol, vol. 25, no. 3, p. e12764, 2020, doi: 10.1111/adb.12764.
[1394]	“Brain Research Young Investigator Awards,” Brain Research, vol. 994, no. 1, p. ix, Dec. 2003, doi: 10.1016/S0006-8993(03)03899-X.
[1395]	“Brain Research Young Investigator Awards,” Brain Research, vol. 1026, no. 1, p. x, Nov. 2004, doi: 10.1016/S0006-8993(04)01516-1.
[1396]	“Brain Research Young Investigator Awards,” Brain Research, vol. 1026, no. 2, p. viii, Nov. 2004, doi: 10.1016/S0006-8993(04)01555-0.
[1397]	C. M. Matias, L. A. Frizon, F. Asfahan, J. D. Uribe, and A. G. Machado, “Brain Shift and Pneumocephalus Assessment During Frame-Based Deep Brain Stimulation Implantation With Intraoperative Magnetic Resonance Imaging,” Oper Neurosurg (Hagerstown), vol. 14, no. 6, pp. 668–674, 01 2018, doi: 10.1093/ons/opx170.
[1398]	S. T. Sakai, B. M. Arsznov, B. L. Lundrigan, and K. E. Holekamp, “Brain size and social complexity: a computed tomography study in Hyaenidae,” Brain Behav. Evol., vol. 77, no. 2, pp. 91–104, 2011, doi: 10.1159/000323849.
[1399]	V. Weisbecker and A. Goswami, “Brain size, life history, and metabolism at the marsupial/placental dichotomy,” Proc. Natl. Acad. Sci. U.S.A., vol. 107, no. 37, pp. 16216–16221, Sep. 2010, doi: 10.1073/pnas.0906486107.
[1400]	J. Weickenmeier, R. de Rooij, S. Budday, P. Steinmann, T. C. Ovaert, and E. Kuhl, “Brain stiffness increases with myelin content,” Acta Biomater, vol. 42, pp. 265–272, 15 2016, doi: 10.1016/j.actbio.2016.07.040.
[1401]	C. Solé-Padullés et al., “Brain structure and function related to cognitive reserve variables in normal aging, mild cognitive impairment and Alzheimer’s disease,” Neurobiol. Aging, vol. 30, no. 7, pp. 1114–1124, Jul. 2009, doi: 10.1016/j.neurobiolaging.2007.10.008.
[1402]	M. E. Raichle and M. A. Mintun, “Brain work and brain imaging,” Annu. Rev. Neurosci., vol. 29, pp. 449–476, 2006, doi: 10.1146/annurev.neuro.29.051605.112819.
[1403]	M. A. Lebedev and M. A. L. Nicolelis, “Brain-Machine Interfaces: From Basic Science to Neuroprostheses and Neurorehabilitation,” Physiol. Rev., vol. 97, no. 2, pp. 767–837, 2017, doi: 10.1152/physrev.00027.2016.
[1404]	E. Başar, C. Başar-Eroğlu, B. Güntekin, and G. G. Yener, “Brain’s alpha, beta, gamma, delta, and theta oscillations in neuropsychiatric diseases: proposal for biomarker strategies,” Suppl Clin Neurophysiol, vol. 62, pp. 19–54, 2013, doi: 10.1016/b978-0-7020-5307-8.00002-8.
[1405]	S. Reardon, “Brain’s stem cells slow ageing in mice,” Nature, vol. 547, no. 7664, p. 389, 26 2017, doi: 10.1038/547389a.
[1406]	C. B. Swanik, “Brains and Sprains: The Brain’s Role in Noncontact Anterior Cruciate Ligament Injuries,” J Athl Train, vol. 50, no. 10, pp. 1100–1102, Oct. 2015, doi: 10.4085/1062-6050-50.10.08.
[1407]	S. Uchiyama et al., “Branch atheromatous disease diagnosed as embolic stroke of undetermined source: A sub-analysis of NAVIGATE ESUS,” Int J Stroke, vol. 14, no. 9, pp. 915–922, 2019, doi: 10.1177/1747493019852177.
[1408]	R. K. Celeste and C. M. Warmling, “[Brazilian bibliographical output on public oral health in public health and dentistry journals],” Cien Saude Colet, vol. 19, no. 6, pp. 1921–1932, Jun. 2014, doi: 10.1590/1413-81232014196.04932013.
[1409]	E. C. de Moura, A. M. P. Lima, and M. Urdaneta, “[Brazilian men’s integral health attention: using indicators for monitoring health’s promotion and attention],” Cien Saude Colet, vol. 17, no. 10, pp. 2597–2606, Oct. 2012, doi: 10.1590/s1413-81232012001000009.
[1410]	M. J. Avena and D. A. Barbosa, “Brazilian nursing journals: strengths, weaknesses and challenges,” Rev Bras Enferm, vol. 71, no. 5, pp. 2489–2495, Oct. 2018, doi: 10.1590/0034-7167-2017-0828.
[1411]	F. L. Mayer and J. W. Kronstad, “Breaking the bad: Bacillus blocks fungal virulence factors,” Microb Cell, vol. 4, no. 11, pp. 384–386, Oct. 2017, doi: 10.15698/mic2017.11.599.
[1412]	K. E. Bonnington and M. J. Kuehn, “Breaking the bilayer: OMV formation during environmental transitions,” Microb Cell, vol. 4, no. 2, pp. 64–66, Feb. 2017, doi: 10.15698/mic2017.02.558.
[1413]	K. H. Benam, M. Königshoff, and O. Eickelberg, “Breaking the In Vitro Barrier in Respiratory Medicine. Engineered Microphysiological Systems for Chronic Obstructive Pulmonary Disease and Beyond,” Am. J. Respir. Crit. Care Med., vol. 197, no. 7, pp. 869–875, 01 2018, doi: 10.1164/rccm.201709-1795PP.
[1414]	P. Gritti, O. Akeju, F. L. Lorini, A. Lanterna, C. Brembilla, and F. Bilotta, “Breaking the rules: is it the neurointensivists’ turn?,” Crit Care, vol. 22, no. 1, p. 21, 29 2018, doi: 10.1186/s13054-017-1919-3.
[1415]	M. J. Mugavero, “Breaking the silence: the insidious effects of trauma and PTSD,” Posit Aware, vol. 24, no. 4, pp. 15–17, 2012.
[1416]	K. J. Ruddy et al., “Breast cancer presentation and diagnostic delays in young women,” Cancer, vol. 120, no. 1, pp. 20–25, Jan. 2014, doi: 10.1002/cncr.28287.
[1417]	M. Z. Papa, S. Ayalon, I. Mintz, and G. Ben-Ari, “[Breast cancer prevention in high risk individuals: the surgical aspects],” Harefuah, vol. 136, no. 6, pp. 474–476, Mar. 1999.
[1418]	D. A. Rew and Z. Rayter, “Breast Screening in India: A UK Perspective on the Practicalities,” Indian J Surg Oncol, vol. 3, no. 1, pp. 17–19, Mar. 2012, doi: 10.1007/s13193-012-0136-4.
[1419]	F. Xiao, A. Lan, and W. Mo, “Breastfeeding from mothers carrying HBV would not increase the risk of HBV infection in infants after proper immunoprophylaxis,” Minerva Pediatr., vol. 72, no. 2, pp. 109–115, Apr. 2020, doi: 10.23736/S0026-4946.17.04798-3.
[1420]	N. Drew, “Bridging the distance between the objectivism of research and the subjectivity of the researcher,” ANS Adv Nurs Sci, vol. 29, no. 2, pp. 181–191, Jun. 2006, doi: 10.1097/00012272-200604000-00011.
[1421]	R. Shankar, S. Ashby, B. McLean, and C. Newman, “Bridging the gap of risk communication and management using the SUDEP and Seizure Safety Checklist,” Epilepsy Behav, vol. 103, no. Pt B, p. 106419, 2020, doi: 10.1016/j.yebeh.2019.07.020.
[1422]	D. A. Kellman, K. V. Iserson, R. D. Levy, B. McIntosh, and Y. Maxwell, “Brief Education Improves Proper Metered-Dose Inhaler Use,” J Emerg Med, vol. 58, no. 4, pp. 667–672, Apr. 2020, doi: 10.1016/j.jemermed.2020.02.011.
[1423]	Y. Lin, M. Dai, and J. Peng, “[Brief research on the life of LUO Zhao-ju, a modern acupuncturist, and his works],” Zhongguo Zhen Jiu, vol. 30, no. 3, pp. 245–248, Mar. 2010.
[1424]	M. Zhang, A. Buekens, and X. Li, “Brominated flame retardants and the formation of dioxins and furans in fires and combustion,” J. Hazard. Mater., vol. 304, pp. 26–39, Mar. 2016, doi: 10.1016/j.jhazmat.2015.10.014.
[1425]	“Brookhaven National Laboratory. Publications, July 1, 1966-June 30, 1967. BNL 50057 (AS-21),” Tech Rep Brookhaven Natl Lab, pp. 175–218, Jul. 1967.
[1426]	“Brookhaven National Laboratory. Publications, July 1, 1968-June 30, 1969. BNL 50169 (AS-23),” Tech Rep Brookhaven Natl Lab, pp. 189–234, Jul. 1967.
[1427]	N. Y. Karimbux, “Buckets,” J Dent Educ, vol. 82, no. 8, pp. 807–808, Aug. 2018, doi: 10.21815/JDE.018.074.
[1428]	S. An, B. Kim, S. Kwon, G. Moon, M. Lee, and W. Jhe, “Buckling-Based Non-Linear Mechanical Sensor,” Sensors (Basel), vol. 18, no. 8, Aug. 2018, doi: 10.3390/s18082637.
[1429]	R. Adar and M. Z. Papa, “Buerger’s disease,” Eur J Vasc Endovasc Surg, vol. 14, no. 4, p. 322, Oct. 1997, doi: 10.1016/s1078-5884(97)80252-3.
[1430]	S. M. Chambers, J. Tchieu, and L. Studer, “Build-a-brain,” Cell Stem Cell, vol. 13, no. 4, pp. 377–378, Oct. 2013, doi: 10.1016/j.stem.2013.09.010.
[1431]	W. Fingrut, L. A. Beck, and D. Lo, “Building an oncology community of practice to improve cancer care,” Curr Oncol, vol. 25, no. 6, pp. 371–377, 2018, doi: 10.3747/co.25.4087.
[1432]	N. M. Kuiper, H. L. Cash, M. T. Welton, and C. Chung, “Building Capacity for Logic Models and Evaluation Planning Using Canoe-building Concepts,” Hawaii J Health Soc Welf, vol. 79, no. 6 Suppl 2, pp. 108–112, Jun. 2020.
[1433]	E. L. Baker, J. S. Blumenstock, J. Jensen, R. D. Morris, and A. D. Moulton, “Building the legal foundation for an effective public health system,” J Law Med Ethics, vol. 30, no. 3 Suppl, pp. 48–51, 2002.
[1434]	M. E. Dahlin and B. Runeson, “Burnout and psychiatric morbidity among medical students entering clinical training: a three year prospective questionnaire and interview-based study,” BMC Med Educ, vol. 7, p. 6, Apr. 2007, doi: 10.1186/1472-6920-7-6.
[1435]	C. M. Mack, B. J. Lin, J. D. Turner, A. F. M. Johnstone, L. D. Burgoon, and T. J. Shafer, “Burst and principal components analyses of MEA data for 16 chemicals describe at least three effects classes,” Neurotoxicology, vol. 40, pp. 75–85, Jan. 2014, doi: 10.1016/j.neuro.2013.11.008.
[1436]	C. Yelland et al., “Bushfire impact on youth,” J Trauma Stress, vol. 23, no. 2, pp. 274–277, Apr. 2010, doi: 10.1002/jts.20521.
[1437]	A. F. Harlow, S. K. Willis, M. L. Smith, and E. F. Rothman, “Bystander Prevention for Sexual Violence: #HowIWillChange and Gaps in Twitter Discourse,” J Interpers Violence, p. 886260518808854, Oct. 2018, doi: 10.1177/0886260518808854.
[1438]	H. L. Witherell et al., “C-reactive protein, Helicobacter pylori, Chlamydia pneumoniae, cytomegalovirus and risk for myocardial infarction,” Ann Epidemiol, vol. 13, no. 3, pp. 170–177, Mar. 2003, doi: 10.1016/s1047-2797(02)00276-4.
[1439]	M. Perza, S. Koczirka, and J. T. Nomura, “C1 Esterase Inhibitor for Ace-Inhibitor Angioedema: A Case Series and Literature Review,” J Emerg Med, vol. 58, no. 3, pp. e121–e127, Mar. 2020, doi: 10.1016/j.jemermed.2019.10.031.
[1440]	P. Dou et al., “C1orf109L binding DHX9 promotes DNA damage depended on the R-loop accumulation and enhances camptothecin chemosensitivity,” Cell Prolif., p. e12875, Aug. 2020, doi: 10.1111/cpr.12875.
[1441]	D. Herrmann and R. Parlato, “C9orf72-associated neurodegeneration in ALS-FTD: breaking new ground in ribosomal RNA and nucleolar dysfunction,” Cell Tissue Res., vol. 373, no. 2, pp. 351–360, 2018, doi: 10.1007/s00441-018-2806-1.
[1442]	N. Colantonio and Y. Kim, “Cadmium (II) removal mechanisms in microbial electrolysis cells,” J. Hazard. Mater., vol. 311, pp. 134–141, Jul. 2016, doi: 10.1016/j.jhazmat.2016.02.062.
[1443]	L. M. Sherief et al., “Cadmium status among pediatric cancer patients in Egypt,” Medicine (Baltimore), vol. 94, no. 20, p. e740, May 2015, doi: 10.1097/MD.0000000000000740.
[1444]	P. J. Rogers, N. J. Richardson, and C. Dernoncourt, “Caffeine use: is there a net benefit for mood and psychomotor performance?,” Neuropsychobiology, vol. 31, no. 4, pp. 195–199, 1995, doi: 10.1159/000119192.
[1445]	A. L. Ash, C. J. Saldanha, and D. J. Bailey, “Calbindin-D28K expression increases in the dorsolateral hippocampus following corticosterone treatment in female zebra finches (Taeniopygia guttata),” Hippocampus, vol. 22, no. 3, pp. 510–515, Mar. 2012, doi: 10.1002/hipo.20917.
[1446]	M. Tombini et al., “Calcium metabolism serum markers in adult patients with epilepsy and the effect of vitamin D supplementation on seizure control,” Seizure, vol. 58, pp. 75–81, May 2018, doi: 10.1016/j.seizure.2018.04.008.
[1447]	I. D. Nissanka and P. D. Yapa, “Calculation of oil droplet size distribution in ocean oil spills: A review,” Mar. Pollut. Bull., vol. 135, pp. 723–734, Oct. 2018, doi: 10.1016/j.marpolbul.2018.07.048.
[1448]	B. Saif et al., “Calibration of spatially phase-shifted DSPI for measurement of large structures,” Appl Opt, vol. 46, no. 23, pp. 5622–5630, Aug. 2007, doi: 10.1364/ao.46.005622.
[1449]	R. W. Hart et al., “Caloric restriction and chemical toxicity/carcinogenesis,” Qual Assur, vol. 1, no. 2, pp. 120–131, Feb. 1992.
[1450]	N. Preuss, G. Hasler, and F. W. Mast, “Caloric vestibular stimulation modulates affective control and mood,” Brain Stimul, vol. 7, no. 1, pp. 133–140, Feb. 2014, doi: 10.1016/j.brs.2013.09.003.
[1451]	E. Vélez et al., “Calorimetric and computational study of 3-buten-1-ol and 3-butyn-1-ol. Estimation of the enthalpies of formation of 1-alkenols and 1-alkynols,” J Phys Chem A, vol. 109, no. 34, pp. 7832–7838, Sep. 2005, doi: 10.1021/jp051161y.
[1452]	A. G. W. Gong, R. Duan, H. Y. Wang, T. T. X. Dong, and K. W. K. Tsim, “Calycosin Orchestrates Osteogenesis of Danggui Buxue Tang in Cultured Osteoblasts: Evaluating the Mechanism of Action by Omics and Chemical Knock-out Methodologies,” Front Pharmacol, vol. 9, p. 36, 2018, doi: 10.3389/fphar.2018.00036.
[1453]	B. Schöne-Seifert, D. R. Friedrich, and J.-O. Reichardt, “[CAM products as therapeutic placebos: theoretical and bioethical reflections],” Z Evid Fortbild Qual Gesundhwes, vol. 109, no. 3, pp. 245–254, 2015, doi: 10.1016/j.zefq.2014.12.001.
[1454]	D. Miura, Y. Kida, and H. Nojima, “Camellia oil and its distillate fractions effectively inhibit the spontaneous metastasis of mouse melanoma BL6 cells,” FEBS Lett., vol. 581, no. 13, pp. 2541–2548, May 2007, doi: 10.1016/j.febslet.2007.04.080.
[1455]	A. Singh, D. J. Geveke, D. R. Jones, and E. D. Tilman, “Can acceptable quality angel food cakes be made using pasteurized shell eggs? The effects of mixing factors on functional properties of angel food cakes,” Food Sci Nutr, vol. 7, no. 3, pp. 987–996, Mar. 2019, doi: 10.1002/fsn3.911.
[1456]	C. J. Borgert, T. F. Quill, L. S. McCarty, and A. M. Mason, “Can mode of action predict mixture toxicity for risk assessment?,” Toxicol. Appl. Pharmacol., vol. 201, no. 2, pp. 85–96, Dec. 2004, doi: 10.1016/j.taap.2004.05.005.
[1457]	N. J. Dent, W. J. Sweatman, and Audit Working Party of the European Forum for Good Clinical Practice, “Can non-regulators audit Independent Ethic Committees (IEC), and if so, how?,” Qual Assur, vol. 9, no. 1, pp. 43–54, Mar. 2001, doi: 10.1080/713843984.
[1458]	J. Collin, S. E. Hill, M. Kandlik Eltanani, E. Plotnikova, R. Ralston, and K. E. Smith, “Can public health reconcile profits and pandemics? An analysis of attitudes to commercial sector engagement in health policy and research,” PLoS ONE, vol. 12, no. 9, p. e0182612, 2017, doi: 10.1371/journal.pone.0182612.
[1459]	U. Müller and R. Stieglitz, “Can the earth’s magnetic field be simulated in the laboratory?,” Naturwissenschaften, vol. 87, no. 9, pp. 381–390, Sep. 2000, doi: 10.1007/s001140050746.
[1460]	K. FitzGibbon and N. R. Ju, “Can the Probiotic Lactobacillus reuteri Be Used to Treat Infant Colic?,” Ann Emerg Med, vol. 73, no. 3, pp. 272–273, 2019, doi: 10.1016/j.annemergmed.2018.09.016.
[1461]	 null The Right Honourable Justin Trudeau, “Canada’s vision for global health and gender equality,” Lancet, vol. 391, no. 10131, pp. 1651–1653, 28 2018, doi: 10.1016/S0140-6736(18)30180-6.
[1462]	J. K. Rustad, D. David, and M. B. Currier, “Cancer and post-traumatic stress disorder: diagnosis, pathogenesis and treatment considerations,” Palliat Support Care, vol. 10, no. 3, pp. 213–223, Sep. 2012, doi: 10.1017/S1478951511000897.
[1463]	R. K. Oldham, W. M. Lewko, R. W. Good, and E. Sharp, “Cancer biotherapy with interferon, interleukin-2 and tumor-derived activated cells (TDAC),” In Vivo, vol. 8, no. 5, pp. 653–663, Dec. 1994.
[1464]	C. Buzzoni, E. Crocetti, S. Guzzinati, L. Dal Maso, S. Francisci, and AIRTUM Working Group, “Cancer incidence and mortality trends from 2003 to 2014 in Italy,” Tumori, vol. 105, no. 2, pp. 121–137, Apr. 2019, doi: 10.1177/0300891619839844.
[1465]	P. Gustavsson, T. Andersson, A. Gustavsson, and C. Reuterwall, “Cancer incidence in female laboratory employees: extended follow-up of a Swedish cohort study,” Occup Environ Med, vol. 74, no. 11, pp. 823–826, 2017, doi: 10.1136/oemed-2016-104184.
[1466]	D. A. Rew, “Cancer--a degenerative disorder?,” Eur J Surg Oncol, vol. 24, no. 5, pp. 362–366, Oct. 1998, doi: 10.1016/s0748-7983(98)91907-2.
[1467]	J. L. Vardy, V. J. Bray, and H. M. Dhillon, “Cancer-induced cognitive impairment: practical solutions to reduce and manage the challenge,” Future Oncol, vol. 13, no. 9, pp. 767–771, 2017, doi: 10.2217/fon-2017-0027.
[1468]	A. D. Hutchinson, S. M. Pfeiffer, and C. Wilson, “Cancer-related cognitive impairment in children,” Curr Opin Support Palliat Care, vol. 11, no. 1, pp. 70–75, 2017, doi: 10.1097/SPC.0000000000000258.
[1469]	A. Edelstein, D. Pergolizzi, and Y. Alici, “Cancer-related cognitive impairment in older adults,” Curr Opin Support Palliat Care, vol. 11, no. 1, pp. 60–69, 2017, doi: 10.1097/SPC.0000000000000254.
[1470]	N. C. Lovejoy, D. Tabor, M. Matteis, and P. Lillis, “Cancer-related depression: Part I--Neurologic alterations and cognitive-behavioral therapy,” Oncol Nurs Forum, vol. 27, no. 4, pp. 667–678; quiz 679–680, May 2000.
[1471]	M. H. Meier, M. Docherty, S. J. Leischow, K. J. Grimm, and D. Pardini, “Cannabis Concentrate Use in Adolescents,” Pediatrics, vol. 144, no. 3, 2019, doi: 10.1542/peds.2019-0338.
[1472]	L. García Álvarez, J. J. Gomar, M. P. García-Portilla, and J. Bobes, “Cannabis use and cognitive impairment in schizophrenia and first-episode psychosis,” Adicciones, vol. 31, no. 2, pp. 89–94, Apr. 2019, doi: 10.20882/adicciones.1328.
[1473]	D.-S. Myung et al., “Cap-assisted ERCP in patients with difficult cannulation due to periampullary diverticulum,” Endoscopy, vol. 46, no. 4, pp. 352–355, Apr. 2014, doi: 10.1055/s-0034-1365060.
[1474]	H. S. Richardson, “Capabilities and the Definition of Health: Comments on Venkatapuram,” Bioethics, vol. 30, no. 1, pp. 1–7, Jan. 2016, doi: 10.1111/bioe.12219.
[1475]	A. Villalobos et al., “CAPS on the move: Crafting an approach to recruitment for a randomized controlled trial of community gardening,” Contemp Clin Trials Commun, vol. 16, p. 100482, Dec. 2019, doi: 10.1016/j.conctc.2019.100482.
[1476]	M. R. Trimble, “Carbamazepine and mood: evidence from patients with seizure disorders,” J Clin Psychiatry, vol. 49 Suppl, pp. 7–12, Apr. 1988.
[1477]	D. S. Faith, M. L. Kirby, and D. W. Sickles, “Carbohydrate, lipid and oxidative metabolism in the sympathetically aneural chick heart,” J. Mol. Cell. Cardiol., vol. 19, no. 4, pp. 349–355, Apr. 1987, doi: 10.1016/s0022-2828(87)80580-1.
[1478]	J. Guo et al., “Carbon/Polymer Bilayer-Coated Si-SiO                                              x                                       Electrodes with Enhanced Electrical Conductivity and Structural Stability,” ACS Appl Mater Interfaces, vol. 12, no. 16, pp. 19023–19032, Apr. 2020, doi: 10.1021/acsami.0c02445.
[1479]	B. Wang et al., “Carbonized cotton fiber supported flexible organic lithium ion battery cathodes,” J Colloid Interface Sci, vol. 572, pp. 1–8, Jul. 2020, doi: 10.1016/j.jcis.2020.03.047.
[1480]	M. C, K. B R, S. G, M. K. N, and S. M, “Carboxymethylation of pectin: Optimization, characterization and in-vitro drug release studies,” Carbohydr Polym, vol. 194, pp. 311–318, Aug. 2018, doi: 10.1016/j.carbpol.2018.04.042.
[1481]	I. Ember, T. Raposa, C. Varga, L. Herceg, and I. Kiss, “Carcinogenic effects of cytostatic protocols in CBA/Ca mice,” In Vivo, vol. 9, no. 1, pp. 65–69, Feb. 1995.
[1482]	B. Toth, “Carcinogenic fungal hydrazines,” In Vivo, vol. 5, no. 2, pp. 95–100, Apr. 1991.
[1483]	C. F. Kuper, R. A. Woutersen, P. J. Slootweg, and V. J. Feron, “Carcinogenic response of the nasal cavity to inhaled chemical mixtures,” Mutat. Res., vol. 380, no. 1–2, pp. 19–26, Oct. 1997, doi: 10.1016/s0027-5107(97)00123-1.
[1484]	W. Habermann, A. Berghold, T. T. DeVaney, and G. Friedrich, “Carcinoma of the larynx: predictors of diagnostic delay,” Laryngoscope, vol. 111, no. 4 Pt 1, pp. 653–656, Apr. 2001, doi: 10.1097/00005537-200104000-00018.
[1485]	A. Ashraf and A. Nygren, “Cardiac action potential wavefront tracking using optical mapping,” Conf Proc IEEE Eng Med Biol Soc, vol. 2009, pp. 1766–1769, 2009, doi: 10.1109/IEMBS.2009.5333404.
[1486]	K.-I. Sasaki et al., “Cardiac cycle-synchronized electrical muscle stimulator for lower limb training with the potential to reduce the heart’s pumping workload,” PLoS ONE, vol. 12, no. 11, p. e0187395, 2017, doi: 10.1371/journal.pone.0187395.
[1487]	M. C. Cerra et al., “Cardiac morphodynamic remodelling in the growing eel (Anguilla anguilla L.),” J. Exp. Biol., vol. 207, no. Pt 16, pp. 2867–2875, Jul. 2004, doi: 10.1242/jeb.01119.
[1488]	M. Sivaguru et al., “Cardiac muscle organization revealed in 3-D by imaging whole-mount mouse hearts using two-photon fluorescence and confocal microscopy,” BioTechniques, vol. 59, no. 5, pp. 295–308, Nov. 2015, doi: 10.2144/000114356.
[1489]	G. Fawaz and J. Simaan, “Cardiac noradrenaline stores,” Br J Pharmacol Chemother, vol. 20, pp. 569–578, Jun. 1963, doi: 10.1111/j.1476-5381.1963.tb01494.x.
[1490]	J. A. Kirk et al., “Cardiac resynchronization sensitizes the sarcomere to calcium by reactivating GSK-3β,” J. Clin. Invest., vol. 124, no. 1, pp. 129–138, Jan. 2014, doi: 10.1172/JCI69253.
[1491]	R. K. Li et al., “Cardiomyocyte transplantation improves heart function,” Ann. Thorac. Surg., vol. 62, no. 3, pp. 654–660; discussion 660-661, Sep. 1996, doi: 10.1016/s0003-4975(96)00389-x.
[1492]	J. S. Juggi, E. Koenig-Berard, and W. H. Van Gilst, “Cardioprotection by angiotensin-converting enzyme (ACE) inhibitors,” Can J Cardiol, vol. 9, no. 4, pp. 336–352, May 1993.
[1493]	K. Aihara et al., “Cardioprotective effect of TY-12533, a novel Na(+)/H(+) exchange inhibitor, on ischemia/reperfusion injury,” Eur. J. Pharmacol., vol. 404, no. 1–2, pp. 221–229, Sep. 2000, doi: 10.1016/s0014-2999(00)00613-0.
[1494]	H. Ohmura, K. Mukai, T. Takahashi, H. Aida, and J. H. Jones, “Cardiorespiratory function in Thoroughbreds during locomotion on a treadmill at an incline or decline,” Am. J. Vet. Res., vol. 78, no. 3, pp. 340–349, Mar. 2017, doi: 10.2460/ajvr.78.3.340.
[1495]	Z. Radunovic, L. L. Wekre, L. M. Diep, and K. Steine, “Cardiovascular abnormalities in adults with osteogenesis imperfecta,” Am. Heart J., vol. 161, no. 3, pp. 523–529, Mar. 2011, doi: 10.1016/j.ahj.2010.11.006.
[1496]	J. K. Han, E. M. Yano, K. E. Watson, and R. Ebrahimi, “Cardiovascular Care in Women Veterans,” Circulation, vol. 139, no. 8, pp. 1102–1109, 19 2019, doi: 10.1161/CIRCULATIONAHA.118.037748.
[1497]	N. Rae, S. Finch, and J. D. Chalmers, “Cardiovascular disease as a complication of community-acquired pneumonia,” Curr Opin Pulm Med, vol. 22, no. 3, pp. 212–218, May 2016, doi: 10.1097/MCP.0000000000000261.
[1498]	K. T. Rew, “Care of Patients With HIV Infection: Foreword,” FP Essent, vol. 443, p. 2, Apr. 2016.
[1499]	J. Gudkina and A. Brinkmane, “Caries experience in relation to oral hygiene, salivary cariogenic microflora, buffer capacity and secretion rate in 6-year olds and 12 year olds in Riga,” Stomatologija, vol. 10, no. 2, pp. 76–80, 2008.
[1500]	M. Rew, “Caring for catheterized patients: urinary catheter maintenance,” Br J Nurs, vol. 14, no. 2, pp. 87–92, Feb. 2005, doi: 10.12968/bjon.2005.14.2.17436.
[1501]	F. Lippert and K. K. Gill, “Carious lesion remineralizing potential of fluoride- and calcium-containing toothpastes: A laboratory study,” J Am Dent Assoc, vol. 150, no. 5, pp. 345–351, 2019, doi: 10.1016/j.adaj.2018.11.022.
[1502]	U. Meyer, H.-P. Wiesmann, J. Libera, R. Depprich, C. Naujoks, and J. Handschel, “Cartilage defect regeneration by ex vivo engineered autologous microtissue--preliminary results,” In Vivo, vol. 26, no. 2, pp. 251–257, Apr. 2012.
[1503]	F. Seilern-Aspang, E. Honus, and K. Kratochwil, “[Cartilage induction in a fowl sarcoma in vitro by the addition of chorda from chick embryos],” Acta Biol. Med. Ger., vol. 10, pp. 447–452, 1963.
[1504]	G. Cho, J. Kim, C. G. Park, C. Nislow, D. M. Weller, and Y.-S. Kwak, “Caryolan-1-ol, an antifungal volatile produced by Streptomyces spp., inhibits the endomembrane system of fungi,” Open Biol, vol. 7, no. 7, 2017, doi: 10.1098/rsob.170075.
[1505]	P. Liu et al., “Cascaded difference frequency generation in organic crystal 4’-dimethylamino-N-methyl-4-stilbazolium tosylate,” Opt Lett, vol. 44, no. 20, pp. 4965–4968, Oct. 2019, doi: 10.1364/OL.44.004965.
[1506]	T. G. Neilan, M. C. Price, D. Y. Sanborn, J. F. Gainor, and A. Chen, “Case 33-2018: A 57-Year-Old Man with Confusion, Fever, Malaise, and Weight Loss,” N. Engl. J. Med., vol. 379, no. 17, pp. 1658–1669, Oct. 2018, doi: 10.1056/NEJMcpc1802830.
[1507]	A. T. Fathi, T. A. Graubert, N. M. Kulkarni, F. C. Kuo, and R. P. Hasserjian, “Case 37-2016. An 86-Year-Old Woman with Leukocytosis and Splenomegaly,” N. Engl. J. Med., vol. 375, no. 23, pp. 2273–2282, 08 2016, doi: 10.1056/NEJMcpc1509539.
[1508]	G. Zara, F. Grassivaro, F. Brocadello, R. Manara, and F. F. Pesenti, “Case of sensory ataxic ganglionopathy-myelopathy in copper deficiency,” J. Neurol. Sci., vol. 277, no. 1–2, pp. 184–186, Feb. 2009, doi: 10.1016/j.jns.2008.10.017.
[1509]	A. C. Firat, C. Araz, and Z. Kayhan, “Case reports: Should we do away with them?,” J Clin Anesth, vol. 37, pp. 74–76, Feb. 2017, doi: 10.1016/j.jclinane.2016.10.006.
[1510]	C. Kaiser, S. D. S. Pion, and M. Boussinesq, “Case-control studies on the relationship between onchocerciasis and epilepsy: systematic review and meta-analysis,” PLoS Negl Trop Dis, vol. 7, no. 3, p. e2147, 2013, doi: 10.1371/journal.pntd.0002147.
[1511]	D. S. Ogunniyi, “Castor oil: a vital industrial raw material,” Bioresour. Technol., vol. 97, no. 9, pp. 1086–1091, Jun. 2006, doi: 10.1016/j.biortech.2005.03.028.
[1512]	O. M. Olivo, M. A. Gliozzi, and P. R. Carraro, “[Catabolites and mitosis in fibroblasts cultivated in vitro],” Boll. Soc. Ital. Biol. Sper., vol. 36, pp. 737–739, Aug. 1960.
[1513]	N. E. B. Zellner, “Cataclysm No More: New Views on the Timing and Delivery of Lunar Impactors,” Orig Life Evol Biosph, vol. 47, no. 3, pp. 261–280, Sep. 2017, doi: 10.1007/s11084-017-9536-3.
[1514]	S. Xu, J. Breslin, and W. Ju, “Catalyzing Future Drug, Device, and Information Technology Breakthroughs in Dermatology: Announcing Advancing Innovation in Dermatology’s Accelerator Fund,” JAMA Dermatol, vol. 154, no. 5, pp. 517–518, 01 2018, doi: 10.1001/jamadermatol.2018.0590.
[1515]	S. Huang et al., “Cathepsin g Degrades Both Glycosylated and Unglycosylated Regions of Lubricin, a Synovial Mucin,” Sci Rep, vol. 10, no. 1, p. 4215, 06 2020, doi: 10.1038/s41598-020-61161-5.
[1516]	S. Yamada, “Cation-π Interactions in Organic Synthesis,” Chem. Rev., vol. 118, no. 23, pp. 11353–11432, 12 2018, doi: 10.1021/acs.chemrev.8b00377.
[1517]	C. J. Charvet and G. F. Striedter, “Causes and consequences of expanded subventricular zones,” Eur. J. Neurosci., vol. 34, no. 6, pp. 988–993, Sep. 2011, doi: 10.1111/j.1460-9568.2011.07818.x.
[1518]	 null Elsa Rodríguez-Angulo,  null Marco Palma-Solís, and  null Rita Zapata-Vázquez, “[Causes of delays in obstetric complications care. What is necessary to address? ],” Ginecol Obstet Mex, vol. 82, no. 10, pp. 647–658, Oct. 2014.
[1519]	J. Poupin, N. Crestey, and J.-P. le Guelte, “Cave-dwelling crabs of the genus Karstarma from lava tubes of the volcano ‘Piton de la Fournaise’, in Réunion Island, with description of a new species and redescription of Karstarma jacksoni (Balss, 1934) from Christmas Island (Decapoda, Brachyura, Sesarmidae),” Zootaxa, vol. 4497, no. 3, pp. 381–397, Oct. 2018, doi: 10.11646/zootaxa.4497.3.3.
[1520]	J. A. Flores-Toro et al., “CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas,” Proc. Natl. Acad. Sci. U.S.A., vol. 117, no. 2, pp. 1129–1138, 14 2020, doi: 10.1073/pnas.1910856117.
[1521]	X. Tu, T. LaVallee, and R. Lechleider, “CD22 as a target for cancer therapy,” J. Exp. Ther. Oncol., vol. 9, no. 3, pp. 241–248, 2011.
[1522]	M. Delforge, V. Raets, V. Van Duppen, P. Vandenberghe, and M. Boogaerts, “CD34+ marrow progenitors from MDS patients with high levels of intramedullary apoptosis have reduced expression of alpha4beta1 and alpha5beta1 integrins,” Leukemia, vol. 19, no. 1, pp. 57–63, Jan. 2005, doi: 10.1038/sj.leu.2403551.
[1523]	Y. Nevo-Caspi and M. Kupiec, “cDNA-mediated Ty recombination can take place in the absence of plus-strand cDNA synthesis, but not in the absence of the integrase protein,” Curr. Genet., vol. 32, no. 1, pp. 32–40, Jul. 1997, doi: 10.1007/s002940050245.
[1524]	E. Papa, A. Sangion, and N. Chirico, “Celebrating 40 Years of Career,” Mol Inform, vol. 38, no. 8–9, p. e1980831, 2019, doi: 10.1002/minf.201980831.
[1525]	M. H. Karol, O. T. Macina, and A. Cunningham, “Cell and molecular biology of chemical allergy,” Ann. Allergy Asthma Immunol., vol. 87, no. 6 Suppl 3, pp. 28–32, Dec. 2001, doi: 10.1016/s1081-1206(10)62337-x.
[1526]	D. A. Rew, “Cell and molecular mechanisms of pathogenesis and treatment of cancer,” Postgrad Med J, vol. 74, no. 868, pp. 77–88, Feb. 1998, doi: 10.1136/pgmj.74.868.77.
[1527]	A. M. Mills et al., “Cell cycle regulatory markers in uterine atypical leiomyoma and leiomyosarcoma: immunohistochemical study of 68 cases with clinical follow-up,” Am. J. Surg. Pathol., vol. 37, no. 5, pp. 634–642, May 2013, doi: 10.1097/PAS.0b013e318287779c.
[1528]	C. P. Adler and U. Costabel, “Cell number in human heart in atrophy, hypertrophy, and under the influence of cytostatics,” Recent Adv Stud Cardiac Struct Metab, vol. 6, pp. 343–355, 1975.
[1529]	D. A. Rew and G. D. Wilson, “Cell production rates in human tissues and tumours and their significance. Part 1: an introduction to the techniques of measurement and their limitations,” Eur J Surg Oncol, vol. 26, no. 3, pp. 227–238, Apr. 2000, doi: 10.1053/ejso.1999.0781.
[1530]	D. A. Rew and G. D. Wilson, “Cell production rates in human tissues and tumours and their significance. Part II: clinical data,” Eur J Surg Oncol, vol. 26, no. 4, pp. 405–417, Jun. 2000, doi: 10.1053/ejso.1999.0907.
[1531]	M. Fossel, “Cell senescence in human aging: a review of the theory,” In Vivo, vol. 14, no. 1, pp. 29–34, Feb. 2000.
[1532]	S. Kozuka and M. Hoshino, “Cell size with special reference to multiplication of HeLa strain in vitro. II. Measurement of mitotic and intermitotic duration with special reference to size of nucleus,” Nagoya J Med Sci, vol. 24, pp. 190–196, Jan. 1962.
[1533]	S. Kozuka, “Cell size with special reference to multiplication on HeLa strain in vitro. I. Study on the relationship between cell size and nutritional environment,” Nagoya J Med Sci, vol. 24, pp. 183–189, Jan. 1962.
[1534]	E. J. Sutton, T. D. Henning, B. J. Pichler, C. Bremer, and H. E. Daldrup-Link, “Cell tracking with optical imaging,” Eur Radiol, vol. 18, no. 10, pp. 2021–2032, Oct. 2008, doi: 10.1007/s00330-008-0984-z.
[1535]	A. Arlia-Ciommo, A. Leonov, A. Piano, V. Svistkova, and V. I. Titorenko, “Cell-autonomous mechanisms of chronological aging in the yeast Saccharomyces cerevisiae,” Microb Cell, vol. 1, no. 6, pp. 163–178, May 2014, doi: 10.15698/mic2014.06.152.
[1536]	L. Siminovitch and A. A. Axelrad, “CELL-CELL INTERACTIONS IN VITRO: THEIR RELATION TO DIFFERENTIATION AND CARCINOGENESIS,” Proc Can Cancer Conf, vol. 5, pp. 149–165, 1963.
[1537]	A. Necco, “[Cells with pedunculated spherical pseudopods in tissue culture in vitro],” Tumori, vol. 37, no. 5, pp. 419–422, Oct. 1951.
[1538]	A. S. Deshpande and S. L. Goudy, “Cellular and molecular mechanisms of cleft palate development,” Laryngoscope Investig Otolaryngol, vol. 4, no. 1, pp. 160–164, Feb. 2019, doi: 10.1002/lio2.214.
[1539]	M. J. McGinn and J. T. Povlishock, “Cellular and molecular mechanisms of injury and spontaneous recovery,” Handb Clin Neurol, vol. 127, pp. 67–87, 2015, doi: 10.1016/B978-0-444-52892-6.00005-2.
[1540]	R. Kuner and T. Kuner, “Cellular circuits in the brain and their modulation in acute and chronic pain,” Physiol. Rev., Jun. 2020, doi: 10.1152/physrev.00040.2019.
[1541]	T. K. Dickinson and J. R. Connor, “Cellular distribution of iron, transferrin, and ferritin in the hypotransferrinemic (Hp) mouse brain,” J. Comp. Neurol., vol. 355, no. 1, pp. 67–80, Apr. 1995, doi: 10.1002/cne.903550109.
[1542]	D. P. Huston, R. N. Jenkins, S. E. Gresens, R. Smith, and R. R. Rich, “Cellular requirements for the generation of primary cell-mediated lympholysis responses to Qa-1 antigens,” J. Immunol., vol. 134, no. 4, pp. 2198–2204, Apr. 1985.
[1543]	L. Á. Maciel-Barón et al., “Cellular Senescence, Neurological Function, and Redox State,” Antioxid. Redox Signal., vol. 28, no. 18, pp. 1704–1723, 20 2018, doi: 10.1089/ars.2017.7112.
[1544]	J. Verne, “Cellular sensitivity to drug action in short-term tissue cultures: in vitro correlations with sensitivity in vivo,” Ann. N. Y. Acad. Sci., vol. 58, no. 7, pp. 1195–1201, Nov. 1954, doi: 10.1111/j.1749-6632.1954.tb45902.x.
[1545]	G. P. Robertson et al., “Cellulosic biofuel contributions to a sustainable energy future: Choices and outcomes,” Science, vol. 356, no. 6345, 30 2017, doi: 10.1126/science.aal2324.
[1546]	D. Apicella, M. Veltri, N. Chieffi, P. Balleri, and M. Ferrari, “Cement thickness at implant-supported single-tooth Lava assemblies: a scanning electron microscopic investigation,” Clin Oral Implants Res, vol. 21, no. 7, pp. 747–750, Jul. 2010, doi: 10.1111/j.1600-0501.2009.01882.x.
[1547]	T. Sharp and N. M. Barnes, “Central 5-HT receptors and their function; present and future,” Neuropharmacology, vol. 177, p. 108155, Jun. 2020, doi: 10.1016/j.neuropharm.2020.108155.
[1548]	T. Hanada et al., “Central actions of neuromedin U via corticotropin-releasing hormone,” Biochem. Biophys. Res. Commun., vol. 311, no. 4, pp. 954–958, Nov. 2003, doi: 10.1016/j.bbrc.2003.10.098.
[1549]	M. Niimi, K. Murao, and T. Taminato, “Central administration of neuromedin U activates neurons in ventrobasal hypothalamus and brainstem,” Endocrine, vol. 16, no. 3, pp. 201–206, Dec. 2001, doi: 10.1385/ENDO:16:3:201.
[1550]	T. K. F. Borba et al., “Central administration of REV-ERBα agonist promotes opposite responses on energy balance in fasted and fed states,” J. Neuroendocrinol., vol. 32, no. 2, p. e12833, 2020, doi: 10.1111/jne.12833.
[1551]	D. Vallöf, L. Ulenius, E. Egecioglu, J. A. Engel, and E. Jerlhag, “Central administration of the anorexigenic peptide neuromedin U decreases alcohol intake and attenuates alcohol-induced reward in rodents,” Addict Biol, vol. 22, no. 3, pp. 640–651, May 2017, doi: 10.1111/adb.12355.
[1552]	S. Sato et al., “Central control of bone remodeling by neuromedin U,” Nat. Med., vol. 13, no. 10, pp. 1234–1240, Oct. 2007, doi: 10.1038/nm1640.
[1553]	M. van Offen, P. C. van Rijen, and F. S. Leijten, “Central lobe epilepsy surgery - (functional) results and how to evaluate them,” Epilepsy Res., vol. 130, pp. 37–46, 2017, doi: 10.1016/j.eplepsyres.2017.01.006.
[1554]	E. Egecioglu et al., “Central NMU signaling in body weight and energy balance regulation: evidence from NMUR2 deletion and chronic central NMU treatment in mice,” Am. J. Physiol. Endocrinol. Metab., vol. 297, no. 3, pp. E708-716, Sep. 2009, doi: 10.1152/ajpendo.91022.2008.
[1555]	V. Petruzzella et al., “Cerebellar ataxia as atypical manifestation of the 3243A>G MELAS mutation,” Clin. Genet., vol. 65, no. 1, pp. 64–65, Jan. 2004, doi: 10.1111/j..2004.00185.x.
[1556]	L. Beishon, V. J. Haunton, R. B. Panerai, and T. G. Robinson, “Cerebral Hemodynamics in Mild Cognitive Impairment: A Systematic Review,” J. Alzheimers Dis., vol. 59, no. 1, pp. 369–385, 2017, doi: 10.3233/JAD-170181.
[1557]	K. J. Shin et al., “Cerebral hemodynamics in orthostatic intolerance with normal head-up tilt test,” Acta Neurol. Scand., vol. 134, no. 2, pp. 108–115, Aug. 2016, doi: 10.1111/ane.12516.
[1558]	C. Ohnesorge and D. Van Lancker, “Cerebral laterality for famous proper nouns: visual recognition by normal subjects,” Brain Lang, vol. 77, no. 2, pp. 135–165, May 2001, doi: 10.1006/brln.2000.2365.
[1559]	S.-Y. Yang and D. Van Lancker Sidtis, “Cerebral processing of proper and common nouns: Perception and production following left hemisphere damage,” Clin Linguist Phon, vol. 29, no. 4, pp. 319–332, Apr. 2015, doi: 10.3109/02699206.2014.991450.
[1560]	K. Wahlbeck, A. Ahokas, H. Nikkilä, K. Miettinen, and R. Rimón, “Cerebrospinal fluid angiotensin-converting enzyme (ACE) correlates with length of illness in schizophrenia,” Schizophr. Res., vol. 41, no. 2, pp. 335–340, Jan. 2000, doi: 10.1016/s0920-9964(99)00059-6.
[1561]	J. Ikeda, Y. Shimojima, Y. Usami, K.-I. Ueno, D. Kishida, and Y. Sekijima, “Cerebrospinal fluid biomarkers implicated in the pathogenesis of anti-neutrophil cytoplasmic antibody-related hypertrophic pachymeningitis,” Clin. Rheumatol., vol. 39, no. 6, pp. 1803–1811, Jun. 2020, doi: 10.1007/s10067-020-04971-2.
[1562]	Y. Alshatti et al., “Cervical bone pain revealing a bone metastatic colon cancer: A case report,” Mol Clin Oncol, vol. 13, no. 3, p. 2, Sep. 2020, doi: 10.3892/mco.2020.2072.
[1563]	A. Tadjalli and G. S. Mitchell, “Cervical spinal 5-HT2A and 5-HT2B receptors are both necessary for moderate acute intermittent hypoxia-induced phrenic long-term facilitation,” J. Appl. Physiol., vol. 127, no. 2, pp. 432–443, 01 2019, doi: 10.1152/japplphysiol.01113.2018.
[1564]	S. I. Angeli and S. Goncalves, “Cervical VEMP tuning changes by Meniere’s disease stages,” Laryngoscope Investig Otolaryngol, vol. 4, no. 5, pp. 543–549, Oct. 2019, doi: 10.1002/lio2.309.
[1565]	J. G. Janes et al., “Cervical Vertebral Lesions in Equine Stenotic Myelopathy,” Vet. Pathol., vol. 52, no. 5, pp. 919–927, Sep. 2015, doi: 10.1177/0300985815593127.
[1566]	“Cessation of use of trivalent oral polio vaccine and introduction of inactivated poliovirus vaccine worldwide, 2016,” Wkly. Epidemiol. Rec., vol. 91, no. 36–37, pp. 421–427, Sep. 2016.
[1567]	“Chagas disease in Latin  America: an epidemiological  update based on 2010 estimates,” Wkly. Epidemiol. Rec., vol. 90, no. 6, pp. 33–43, Feb. 2015.
[1568]	R. Belli et al., “Chairside CAD/CAM materials. Part 1: Measurement of elastic constants and microstructural characterization,” Dent Mater, vol. 33, no. 1, pp. 84–98, 2017, doi: 10.1016/j.dental.2016.10.009.
[1569]	N. Peiffer-Smadja et al., “Challenges and issues about organizing a hospital to respond to the COVID-19 outbreak: experience from a French reference centre,” Clin. Microbiol. Infect., vol. 26, no. 6, pp. 669–672, Jun. 2020, doi: 10.1016/j.cmi.2020.04.002.
[1570]	M. L. Wainberg et al., “Challenges and Opportunities in Global Mental Health: a Research-to-Practice Perspective,” Curr Psychiatry Rep, vol. 19, no. 5, p. 28, May 2017, doi: 10.1007/s11920-017-0780-z.
[1571]	O. Henning, C. J. Landmark, D. Henning, K. O. Nakken, and M. I. Lossius, “Challenges in epilepsy-The perspective of Norwegian epilepsy patients,” Acta Neurol. Scand., vol. 140, no. 1, pp. 40–47, Jul. 2019, doi: 10.1111/ane.13098.
[1572]	R. Clark, C. P. Burren, and R. John, “Challenges of delivery of dental care and dental pathologies in children and young people with osteogenesis imperfecta,” Eur Arch Paediatr Dent, vol. 20, no. 5, pp. 473–480, Oct. 2019, doi: 10.1007/s40368-019-00424-w.
[1573]	Y. Jiang, C.-X. Zhang, R. Chen, and S. Y. He, “Challenging battles of plants with phloem-feeding insects and prokaryotic pathogens,” Proc. Natl. Acad. Sci. U.S.A., vol. 116, no. 47, pp. 23390–23397, 19 2019, doi: 10.1073/pnas.1915396116.
[1574]	K. M. DeVeau et al., “Challenging cardiac function post-spinal cord injury with dobutamine,” Auton Neurosci, vol. 209, pp. 19–24, 2018, doi: 10.1016/j.autneu.2016.12.005.
[1575]	G. Macnaughton and D. Frey, “Challenging Neoliberalism: ILO, Human Rights, and Public Health Frameworks on Decent Work,” Health Hum Rights, vol. 20, no. 2, pp. 43–55, Dec. 2018.
[1576]	R. M. Hazen, “Chance, necessity and the origins of life: a physical sciences perspective,” Philos Trans A Math Phys Eng Sci, vol. 375, no. 2109, Dec. 2017, doi: 10.1098/rsta.2016.0353.
[1577]	S. M. Finn, A. Douglas-Hall, and R. K. Jones, “Change and stability in contraceptive use patterns among US women over a 12-month period: analysis using the 2013-2015 National Survey of Family Growth life history calendar,” Contracept X, vol. 2, p. 100028, 2020, doi: 10.1016/j.conx.2020.100028.
[1578]	T. R. Butler, E. M. O’Mara, and J. F. Wilson, “Change in drawing placement: A measure of change in mood state reflective of hemispheric lateralization of emotion,” Brain Cogn, vol. 124, pp. 14–19, 2018, doi: 10.1016/j.bandc.2018.04.004.
[1579]	E. Spada, D. Proverbio, L. Baggiani, G. Bagnagatti De Giorgi, E. Ferro, and R. Perego, “Change in haematological and selected biochemical parameters measured in feline blood donors and feline whole blood donated units,” J. Feline Med. Surg., vol. 19, no. 4, pp. 375–381, Apr. 2017, doi: 10.1177/1098612X16628919.
[1580]	B. Rosenberg, C. Levenstein, and E. Spangler, “Change in the world of occupational health: silica control, then and now,” J Public Health Policy, vol. 26, no. 2, pp. 192–202; discussion 203-205, Jul. 2005, doi: 10.1057/palgrave.jphp.3200019.
[1581]	A. François, B. Ksas, P. Gourmelon, and N. M. Griffiths, “Changes in 5-HT-mediated pathways in radiation-induced attenuation and recovery of ion transport in rat colon,” Am. J. Physiol. Gastrointest. Liver Physiol., vol. 278, no. 1, pp. G75-82, Jan. 2000, doi: 10.1152/ajpgi.2000.278.1.G75.
[1582]	T. P. Williams and R. P. Lillis, “Changes in alcohol consumption by 18-year-olds following an increase in New York State’s purchase age to 19,” J. Stud. Alcohol, vol. 47, no. 4, pp. 290–296, Jul. 1986, doi: 10.15288/jsa.1986.47.290.
[1583]	I. Mishra, N. Agarwal, A. Prabhat, T. Batra, S. K. Bhardwaj, and V. Kumar, “Changes in brain peptides associated with reproduction and energy homeostasis: Putative roles of gonadotrophin-releasing hormone-II and tyrosine hydroxylase in determining reproductive performance in response to daily food availability times in diurnal zebra finches,” J. Neuroendocrinol., vol. 32, no. 2, p. e12825, 2020, doi: 10.1111/jne.12825.
[1584]	P. Olson and H. Amit, “Changes in earth’s dipole,” Naturwissenschaften, vol. 93, no. 11, pp. 519–542, Nov. 2006, doi: 10.1007/s00114-006-0138-6.
[1585]	L. Rew, K. L. Arheart, K. Johnson, and M. Spoden, “Changes in ethnic identity and competence in middle adolescents,” J Transcult Nurs, vol. 26, no. 3, pp. 227–233, May 2015, doi: 10.1177/1043659614524250.
[1586]	C. Stenfors and S. B. Ross, “Changes in extracellular 5-HIAA concentrations as measured by in vivo microdialysis technique in relation to changes in 5-HT release,” Psychopharmacology (Berl.), vol. 172, no. 2, pp. 119–128, Mar. 2004, doi: 10.1007/s00213-003-1736-z.
[1587]	A. Hancu and G. Radulian, “Changes in Fasting Plasma Glucose, HbA1c and Triglycerides Are Related to Changes in Body Composition in Patients with Type 2 Diabetes,” Maedica (Buchar), vol. 11, no. 1, pp. 32–37, Mar. 2016.
[1588]	D. Davidson, E. Pertens, and S. W. Armstrong, “Changes in frequencies of variegated leaves in NMU treated tobacco : Evidence for a differential response to NMU,” Theor. Appl. Genet., vol. 73, no. 6, pp. 915–919, Apr. 1987, doi: 10.1007/BF00289398.
[1589]	C. Ahlstrom and K. Kircher, “Changes in glance behaviour when using a visual eco-driving system - A field study,” Appl Ergon, vol. 58, pp. 414–423, Jan. 2017, doi: 10.1016/j.apergo.2016.08.001.
[1590]	N. Miyamoto, “Changes in Legal Aspects of Public Education about Drugs and Their Importance,” Yakugaku Zasshi, vol. 136, no. 7, pp. 1001–1015, 2016, doi: 10.1248/yakushi.16-00003.
[1591]	L. J. Wainwright, P. G. Middleton, and J. L. Rees, “Changes in mean telomere length in basal cell carcinomas of the skin,” Genes Chromosomes Cancer, vol. 12, no. 1, pp. 45–49, Jan. 1995, doi: 10.1002/gcc.2870120108.
[1592]	J. J. Hsu et al., “Changes in microarchitecture of atherosclerotic calcification assessed by 18F-NaF PET and CT after a progressive exercise regimen in hyperlipidemic mice,” J Nucl Cardiol, Jan. 2020, doi: 10.1007/s12350-019-02004-3.
[1593]	M. Yamada and T. Ono, “Changes in physiological activities of the HeLa strain cells growing in vitro,” Jpn. J. Med. Sci. Biol., vol. 11, no. 1–2, pp. 73–82, Apr. 1958, doi: 10.7883/yoken1952.11.73.
[1594]	G. O. Gey and H. N. Kent, “Changes in serum proteins during growth of malignant cells in vitro,” Proc. Soc. Exp. Biol. Med., vol. 94, no. 1, pp. 205–208, Jan. 1957, doi: 10.3181/00379727-94-22901.
[1595]	L. Rew, C. Principe, and D. Hannah, “Changes in stress and coping during late childhood and preadolescence,” J Child Adolesc Psychiatr Nurs, vol. 25, no. 3, pp. 130–140, Aug. 2012, doi: 10.1111/j.1744-6171.2012.00336.x.
[1596]	H. E. Kaiser, “Changes in the course of cancer,” In Vivo, vol. 6, no. 4, pp. 467–475, Aug. 1992.
[1597]	N. I. Grigorjew, “[Changes in the gall bladder epithelium of various vertebrates & of man in vitro],” Z Mikrosk Anat Forsch, vol. 65, no. 1, pp. 113–132, 1959.
[1598]	B. E. González-Pacheco, L. Delaye, D. Ochoa, R. Rojas, and L. Silva-Rosales, “Changes in the GN/GCof the M segment show positive selection and recombination of one aggressive isolate and two mild isolates of tomato spotted wilt virus,” Virus Genes, vol. 56, no. 2, pp. 217–227, Apr. 2020, doi: 10.1007/s11262-019-01723-6.
[1599]	S. N. Tomov, R. S. Stoyanova, P. K. Atanasova, and I. Y. Dechev, “Changes in the Level of DNA Fragmentation in Sperm Cells detected by Acridine Orange Test in Men with Sub/infertility Treated with Nutritional Supplement PAPA,” Folia Med (Plovdiv), vol. 62, no. 1, pp. 112–116, 31 2020, doi: 10.3897/folmed.62.e48001.
[1600]	T. Vanishree, G. S. Panchmal, R. Shenoy, P. Jodalli, L. Sonde, and N. Kundapur, “Changes in the Oral Environment after Placement of Fixed Orthodontic Appliance for the Treatment of Malocclusion - a Descriptive Longitudinal Study,” Oral Health Prev Dent, vol. 15, no. 5, pp. 453–459, 2017, doi: 10.3290/j.ohpd.a38776.
[1601]	C. Martínez-González, “Changes in the Profile of Diseases Caused by the Inhalation of Silica,” Arch. Bronconeumol., vol. 54, no. 1, pp. 5–6, 2018, doi: 10.1016/j.arbres.2017.06.024.
[1602]	W. M. De Bruyn, “[CHANGES IN TRANSPLANTED CELLS AND IN CELLS CULTURED FOR SOME TIME IN VITRO],” Ned Tijdschr Geneeskd, vol. 107, pp. 1614–1620, Sep. 1963.
[1603]	A. Bortkiewicz, E. Gadzicka, W. Szymczak, and M. Zmyślony, “Changes in tympanic temperature during the exposure to electromagnetic fields emitted by mobile phone,” Int J Occup Med Environ Health, vol. 25, no. 2, pp. 145–150, Jun. 2012, doi: 10.2478/S13382-012-0013-y.
[1604]	X.-Y. Liu, S.-X. Wu, Y.-Y. Wang, W. Wang, L. Zhou, and Y.-Q. Li, “Changes of 5-HT receptor subtype mRNAs in rat dorsal root ganglion by bee venom-induced inflammatory pain,” Neurosci. Lett., vol. 375, no. 1, pp. 42–46, Feb. 2005, doi: 10.1016/j.neulet.2004.10.064.
[1605]	S. Liu et al., “[Changes of ocular aberration after wavefront-guided aspherical LASIK for myopia],” Zhonghua Yan Ke Za Zhi, vol. 50, no. 1, pp. 27–31, Jan. 2014.
[1606]	S. Wu, M. Zhu, W. Wang, Y. Wang, Y. Li, and D. T. Yew, “Changes of the expression of 5-HT receptor subtype mRNAs in rat dorsal root ganglion by complete Freund’s adjuvant-induced inflammation,” Neurosci. Lett., vol. 307, no. 3, pp. 183–186, Jul. 2001, doi: 10.1016/s0304-3940(01)01946-2.
[1607]	M. Akkas et al., “Changing Attitudes of Medical Students Regarding Organ Donation from a University Medical School in Turkey,” Med. Sci. Monit., vol. 24, pp. 6918–6924, Sep. 2018, doi: 10.12659/MSM.912251.
[1608]	R. A. Brand, J. D. Heckman, and J. Scott, “Changing ethical standards in scientific publication,” Clin. Orthop. Relat. Res., no. 426, pp. 1–2, Sep. 2004, doi: 10.1097/01.blo.0000141657.18423.0c.
[1609]	M. R. Crusoe and C. T. Brown, “Channeling Community Contributions to Scientific Software: A Sprint Experience,” J Open Res Softw, vol. 4, no. 1, 2016, doi: 10.5334/jors.96.
[1610]	M. J. Martin, O. D’Huys, L. Lauerbach, E. Korutcheva, and W. Kinzel, “Chaos synchronization by resonance of multiple delay times,” Phys Rev E, vol. 93, no. 2, p. 022206, Feb. 2016, doi: 10.1103/PhysRevE.93.022206.
[1611]	M. R. Gasco, L. Priano, and G. P. Zara, “Chapter 10 - Solid lipid nanoparticles and microemulsions for drug delivery The CNS,” Prog. Brain Res., vol. 180, pp. 181–192, 2009, doi: 10.1016/S0079-6123(08)80010-6.
[1612]	A. Elmougy, A. M. Schiemann, D. Wood, S. Pollington, and N. Martin, “Characterisation of machinable structural polymers in restorative dentistry,” Dent Mater, vol. 34, no. 10, pp. 1509–1517, 2018, doi: 10.1016/j.dental.2018.06.007.
[1613]	L. Rew, “Characteristics and health care needs of homeless adolescents,” Nurs. Clin. North Am., vol. 37, no. 3, pp. 423–431, Sep. 2002, doi: 10.1016/s0029-6465(02)00009-9.
[1614]	Y. Kawamura et al., “Characteristics and Predictive Factor of Helicobacter pylori-Associated Functional Dyspepsia in Japanese Patients,” Digestion, vol. 100, no. 4, pp. 277–285, 2019, doi: 10.1159/000496101.
[1615]	I. Martínez-Baz, I. Delfrade, and J. Etxeberria, “[Characteristics and statistical methods used in original articles published in Public Health journals in Spain],” An Sist Sanit Navar, vol. 41, no. 3, pp. 347–354, 26 2018, doi: 10.23938/ASSN.0382.
[1616]	P. B. Kaplowitz, D. I. Shulman, J. W. Frane, J. Jacobs, and B. Lippe, “Characteristics of children with the best and poorest first- and second-year growth during rhGH therapy: data from 25 years of the Genentech national cooperative growth study (NCGS),” Int J Pediatr Endocrinol, vol. 2013, no. 1, p. 9, May 2013, doi: 10.1186/1687-9856-2013-9.
[1617]	S. M. Wallerstedt, K. Törnebrandt, and M. Bodelsson, “Characteristics of contractile 5-HT receptors in isolated human omental arteries: presence of 5-HT1 and 5-HT2 receptors,” Pharmacol. Toxicol., vol. 78, no. 1, pp. 50–54, Jan. 1996, doi: 10.1111/j.1600-0773.1996.tb00179.x.
[1618]	X. Gonda, E. Molnár, P. Torzsa, and Z. Rihmer, “[Characteristics of depression in the elderly],” Psychiatr Hung, vol. 24, no. 3, pp. 166–174, 2009.
[1619]	A. Mariani, A. Deli, A. Ambresin, and I. Mantel, “Characteristics of eyes with secondary loss of visual acuity receiving variable dosing ranibizumab for neovascular age-related macular degeneration,” Graefes Arch. Clin. Exp. Ophthalmol., vol. 249, no. 11, pp. 1635–1642, Nov. 2011, doi: 10.1007/s00417-011-1734-5.
[1620]	C. W. Castor, R. K. Prince, and E. L. Dorstewitz, “Characteristics of human ‘fibroblasts’ cultivated in vitro from different anatomical sites,” Lab. Invest., vol. 11, pp. 703–713, Sep. 1962.
[1621]	H. A. Choi, M. J. Lee, and C.-S. Chung, “Characteristics of hypertrophic pachymeningitis in patients with granulomatosis with polyangiitis,” J. Neurol., vol. 264, no. 4, pp. 724–732, Apr. 2017, doi: 10.1007/s00415-017-8416-0.
[1622]	F. Nolte, C. Schumann, S. Klein, M. Reinwald, and W.-K. Hofmann, “Characteristics of MDS patients seen at private practices differ significantly from those treated at university hospitals in Germany,” J. Cancer Res. Clin. Oncol., vol. 138, no. 6, pp. 953–957, Jun. 2012, doi: 10.1007/s00432-012-1168-4.
[1623]	Z. Vuk-Pavlović, T. J. Kreofsky, and M. S. Rohrbach, “Characteristics of monocyte angiotensin-converting enzyme (ACE) induction by dexamethasone,” J. Leukoc. Biol., vol. 45, no. 6, pp. 503–509, Jun. 1989, doi: 10.1002/jlb.45.6.503.
[1624]	T. Shiotsuki, B. C. Bonning, M. Hirai, K. Kikuchi, and B. D. Hammock, “Characterization and affinity purification of juvenile hormone esterase from Bombyx mori,” Biosci. Biotechnol. Biochem., vol. 64, no. 8, pp. 1681–1687, Aug. 2000, doi: 10.1271/bbb.64.1681.
[1625]	T. Tsubota, T. Nakakura, T. Shinoda, and T. Shiotsuki, “Characterization and analysis of novel carboxyl/cholinesterase genes possessing the Thr-316 motif in the silkworm, Bombyx mori,” Biosci. Biotechnol. Biochem., vol. 74, no. 11, pp. 2259–2266, 2010, doi: 10.1271/bbb.100480.
[1626]	A.-K. Ball et al., “Characterization and cellular localization of human 5-lipoxygenase and its protein isoforms 5-LOΔ13, 5-LOΔ4 and 5-LOp12,” Biochim Biophys Acta Mol Cell Biol Lipids, vol. 1862, no. 5, pp. 561–571, May 2017, doi: 10.1016/j.bbalip.2017.02.015.
[1627]	H. Duan, J. Li, Y. Liu, N. Yamazaki, and W. Jiang, “Characterization and inventory of PCDD/Fs and PBDD/Fs emissions from the incineration of waste printed circuit board,” Environ. Sci. Technol., vol. 45, no. 15, pp. 6322–6328, Aug. 2011, doi: 10.1021/es2007403.
[1628]	C. C. Huang, P. M. Hoefs-Van De Putte, J. G. Haanstra-Van Der Meer, F. Meijer-Dekens, and P. Lindhout, “Characterization and mapping of resistance to Oidium lycopersicum in two Lycopersicon hirsutum accessions: evidence for close linkage of two Ol-genes on chromosome 6 of tomato,” Heredity (Edinb), vol. 85, no. Pt 6, pp. 511–520, Dec. 2000, doi: 10.1046/j.1365-2540.2000.00770.x.
[1629]	Z. C. Lu et al., “Characterization data of reference cement CEM I 42.5 R used for priority program DFG SPP 2005 ‘Opus Fluidum Futurum - Rheology of reactive, multiscale, multiphase construction materials,’” Data Brief, vol. 27, p. 104699, Dec. 2019, doi: 10.1016/j.dib.2019.104699.
[1630]	Z. C. Lu et al., “Characterization data of reference cement CEM III/A 42.5N used for priority program DFG SPP 2005 ‘Opus Fluidum Futurum - Rheology of reactive, multiscale, multiphase construction materials,’” Data Brief, vol. 30, p. 105524, Jun. 2020, doi: 10.1016/j.dib.2020.105524.
[1631]	M. P. Rogines-Velo et al., “Characterization of 5-HT receptor subtypes mediating contraction in human umbilical vein. 1. Evidence of involvement of 5-HT2A receptors using functional and radioligand binding assays,” Naunyn Schmiedebergs Arch. Pharmacol., vol. 366, no. 6, pp. 587–595, Dec. 2002, doi: 10.1007/s00210-002-0636-9.
[1632]	P. M. Larkman and J. S. Kelly, “Characterization of 5-HT-sensitive potassium conductances in neonatal rat facial motoneurones in vitro,” J. Physiol. (Lond.), vol. 508 ( Pt 1), pp. 67–81, Apr. 1998, doi: 10.1111/j.1469-7793.1998.067br.x.
[1633]	T. Puppe, A. Sell, R. Kliese, N. Hoghooghi, A. Zach, and W. Kaenders, “Characterization of a DFG comb showing quadratic scaling of the phase noise with frequency,” Opt Lett, vol. 41, no. 8, pp. 1877–1880, Apr. 2016, doi: 10.1364/OL.41.001877.
[1634]	T. K. Lee, I. Han, M. S. Kim, H. J. Seong, J.-S. Kim, and W. J. Sul, “Characterization of a nifH-Harboring Bacterial Community in the Soil-Limited Gotjawal Forest,” Front Microbiol, vol. 10, p. 1858, 2019, doi: 10.3389/fmicb.2019.01858.
[1635]	H. Wang, X.-Y. Zhi, J. Qiu, L. Shi, and Z. Lu, “Characterization of a Novel Nicotine Degradation Gene Cluster ndp in Sphingomonas melonis TY and Its Evolutionary Analysis,” Front Microbiol, vol. 8, p. 337, 2017, doi: 10.3389/fmicb.2017.00337.
[1636]	C. Nakano, S. Horinouchi, and Y. Ohnishi, “Characterization of a novel sesquiterpene cyclase involved in (+)-caryolan-1-ol biosynthesis in Streptomyces griseus,” J. Biol. Chem., vol. 286, no. 32, pp. 27980–27987, Aug. 2011, doi: 10.1074/jbc.M111.265652.
[1637]	B. F. McCutchen, A. Szekacs, T. L. Huang, T. Shiotsuki, and B. D. Hammock, “Characterization of a spectrophotometric assay for juvenile hormone esterase,” Insect Biochem. Mol. Biol., vol. 25, no. 1, pp. 119–126, Jan. 1995, doi: 10.1016/0965-1748(94)00036-h.
[1638]	G. J. Kullman, W. G. Jones, R. J. Cornwell, and J. E. Parker, “Characterization of air contaminants formed by the interaction of lava and sea water,” Environ. Health Perspect., vol. 102, no. 5, pp. 478–482, May 1994, doi: 10.1289/ehp.94102478.
[1639]	B. Jackson, R. B. Cubela, K. Sakaguchi, and C. I. Johnston, “Characterization of angiotensin converting enzyme (ACE) in the testis and assessment of the in vivo effects of the ACE inhibitor perindopril,” Endocrinology, vol. 123, no. 1, pp. 50–55, Jul. 1988, doi: 10.1210/endo-123-1-50.
[1640]	T. Bae, B. K. Kozlowicz, and G. M. Dunny, “Characterization of cis-acting prgQ mutants: evidence for two distinct repression mechanisms by Qa RNA and PrgX protein in pheromone-inducible enterococcal plasmid pCF10,” Mol. Microbiol., vol. 51, no. 1, pp. 271–281, Jan. 2004, doi: 10.1046/j.1365-2958.2003.03832.x.
[1641]	R. N. Jenkins and R. R. Rich, “Characterization of determinants encoded by four Qa-1 genotypes and their recognition by cloned cytotoxic T lymphocytes,” J. Immunol., vol. 131, no. 5, pp. 2147–2153, Nov. 1983.
[1642]	C. Gao, M. Grøtli, and L. A. Eriksson, “Characterization of interactions and pharmacophore development for DFG-out inhibitors to RET tyrosine kinase,” J Mol Model, vol. 21, no. 7, p. 167, Jul. 2015, doi: 10.1007/s00894-015-2708-z.
[1643]	Y. Wan et al., “Characterization of neuromedin U (NMU), neuromedin S (NMS) and their receptors (NMUR1, NMUR2) in chickens,” Peptides, vol. 101, pp. 69–81, 2018, doi: 10.1016/j.peptides.2017.12.022.
[1644]	T. D. Westfall et al., “Characterization of neuromedin U effects in canine smooth muscle,” J. Pharmacol. Exp. Ther., vol. 301, no. 3, pp. 987–992, Jun. 2002, doi: 10.1124/jpet.301.3.987.
[1645]	T. Fukuda et al., “Characterization of newly established adriamycin resistant human leukemic cell lines (KY-ADR1 and KY-ADR2),” Leuk. Res., vol. 18, no. 9, pp. 709–715, Sep. 1994, doi: 10.1016/0145-2126(94)90071-x.
[1646]	X. Yang et al., “Characterization of QTL for oil content in maize kernel,” Theor. Appl. Genet., vol. 125, no. 6, pp. 1169–1179, Oct. 2012, doi: 10.1007/s00122-012-1903-x.
[1647]	K. Yu et al., “Characterization of splenic MRC1hiMHCIIlo and MRC1loMHCIIhi cells from the monocyte/macrophage lineage of White Leghorn chickens,” Vet. Res., vol. 51, no. 1, p. 73, May 2020, doi: 10.1186/s13567-020-00795-9.
[1648]	B. Byloos, P. Monsieurs, M. Mysara, N. Leys, N. Boon, and R. Van Houdt, “Characterization of the bacterial communities on recent Icelandic volcanic deposits of different ages,” BMC Microbiol., vol. 18, no. 1, p. 122, 24 2018, doi: 10.1186/s12866-018-1262-0.
[1649]	N. H. Prins, M. R. Briejer, and J. A. Schuurkes, “Characterization of the contraction to 5-HT in the canine colon longitudinal muscle,” Br. J. Pharmacol., vol. 120, no. 4, pp. 714–720, Feb. 1997, doi: 10.1038/sj.bjp.0700954.
[1650]	M. Ciriacy, K. Freidel, and C. Löhning, “Characterization of trans-acting mutations affecting Ty and Ty-mediated transcription in Saccharomyces cerevisiae,” Curr. Genet., vol. 20, no. 6, pp. 441–448, Dec. 1991, doi: 10.1007/BF00334769.
[1651]	S. Furihata et al., “Characterization of Venom and Oviduct Components of Parasitoid Wasp Asobara japonica,” PLoS ONE, vol. 11, no. 7, p. e0160210, 2016, doi: 10.1371/journal.pone.0160210.
[1652]	T. T. Pham, Y. B. Chen, W. Adams, B. Wolff, M. Shannon, and E. R. Mueller, “Characterizing anxiety at the first encounter in women presenting to the clinic: the CAFÉ study,” Am. J. Obstet. Gynecol., vol. 221, no. 5, p. 509.e1-509.e7, 2019, doi: 10.1016/j.ajog.2019.06.001.
[1653]	A. Boussac, F. Rappaport, K. Brettel, and M. Sugiura, “Charge recombination in S(n)Tyr(Z)(•)Q(A)(-•) radical pairs in D1 protein variants of Photosystem II: long range electron transfer in the Marcus inverted region,” J Phys Chem B, vol. 117, no. 12, pp. 3308–3314, Mar. 2013, doi: 10.1021/jp400337j.
[1654]	A. Grey, M. J. Bolland, A. Avenell, A. A. Klein, and C. K. Gunsalus, “Check for publication integrity before misconduct,” Nature, vol. 577, no. 7789, pp. 167–169, 2020, doi: 10.1038/d41586-019-03959-6.
[1655]	N. R. Miller, “Checking for plagiarism, duplicate publication, and text recycling,” Lancet, vol. 377, no. 9775, p. 1403, Apr. 2011, doi: 10.1016/S0140-6736(11)60565-5.
[1656]	N. A. Carreau et al., “Checkpoint blockade treatment sensitises relapsed/refractory non-Hodgkin lymphoma to subsequent therapy,” Br. J. Haematol., May 2020, doi: 10.1111/bjh.16756.
[1657]	K. R. Barrett and M. A. McBrien, “Chemical and biological assessment of an urban, estuarine marsh in northeastern New Jersey USA,” Environ Monit Assess, vol. 124, no. 1–3, pp. 63–88, Jan. 2007, doi: 10.1007/s10661-006-9209-6.
[1658]	P. J. Van den Brink and B. J. Kater, “Chemical and biological evaluation of sediments from the Wadden Sea, The Netherlands,” Ecotoxicology, vol. 15, no. 5, pp. 451–460, Jul. 2006, doi: 10.1007/s10646-006-0080-6.
[1659]	W. J. Rogan and N. B. Ragan, “Chemical contaminants, pharmacokinetics, and the lactating mother,” Environ. Health Perspect., vol. 102 Suppl 11, pp. 89–95, Dec. 1994, doi: 10.1289/ehp.94102s1189.
[1660]	S. S. Wong and L. J. Wong, “Chemical crosslinking and the stabilization of proteins and enzymes,” Enzyme Microb. Technol., vol. 14, no. 11, pp. 866–874, Nov. 1992, doi: 10.1016/0141-0229(92)90049-t.
[1661]	W. C. Hamilton, “Chemical crystallography. BNL 930 (T-384),” Tech Rep Brookhaven Natl Lab, pp. 1–13, 1965.
[1662]	O. Sagsoz and N. Polat Sagsoz, “Chemical degradation of dental CAD/CAM materials,” Biomed Mater Eng, vol. 30, no. 4, pp. 419–426, 2019, doi: 10.3233/BME-191063.
[1663]	D. M. Frost, “Chemical dependency and the heart,” S D J Med, vol. 44, no. 6, pp. 149–153, Jun. 1991.
[1664]	M. J. Seed, S. J. Enoch, and R. M. Agius, “Chemical determinants of occupational hypersensitivity pneumonitis,” Occup Med (Lond), vol. 65, no. 8, pp. 673–681, Nov. 2015, doi: 10.1093/occmed/kqv143.
[1665]	B. Fegley, R. G. Prinn, H. Hartman, and G. H. Watkins, “Chemical effects of large impacts on the Earth’s primitive atmosphere,” Nature, vol. 319, pp. 305–308, Jan. 1986, doi: 10.1038/319305a0.
[1666]	K. Vähäkangas, “Chemical exposure as etiology in developmental origin of adult onset human cancer,” Front Pharmacol, vol. 2, p. 62, 2011, doi: 10.3389/fphar.2011.00062.
[1667]	R. Y. Khamitova, “[CHEMICAL FACTOR IN THE DEVELOPMENT OF ENDOCRINE DISEASES],” Gig Sanit, vol. 94, no. 8, pp. 12–16, 2015.
[1668]	C. K. Kaufman, R. M. White, and L. Zon, “Chemical genetic screening in the zebrafish embryo,” Nat Protoc, vol. 4, no. 10, pp. 1422–1432, 2009, doi: 10.1038/nprot.2009.144.
[1669]	R. Xu, L. Zhang, and J. Liu, “Chemical inhibition of Chlorella sp. by rotifers,” J. Phycol., May 2020, doi: 10.1111/jpy.13029.
[1670]	C. Ohl and F. Moser, “Chemical leasing business models: a contribution to the effective risk management of chemical substances,” Risk Anal., vol. 27, no. 4, pp. 999–1007, Aug. 2007, doi: 10.1111/j.1539-6924.2007.00938.x.
[1671]	E. M. Kollitz, C. D. Kassotis, K. Hoffman, P. L. Ferguson, J. A. Sosa, and H. M. Stapleton, “Chemical Mixtures Isolated from House Dust Disrupt Thyroid Receptor β Signaling,” Environ. Sci. Technol., vol. 52, no. 20, pp. 11857–11864, 16 2018, doi: 10.1021/acs.est.8b03283.
[1672]	I. Kimber and R. J. Dearman, “Chemical respiratory allergy: role of IgE antibody and relevance of route of exposure,” Toxicology, vol. 181–182, pp. 311–315, Dec. 2002, doi: 10.1016/s0300-483x(02)00299-8.
[1673]	C. M. Asensio, V. Nepote, and N. R. Grosso, “Chemical stability of extra-virgin olive oil added with oregano essential oil,” J. Food Sci., vol. 76, no. 7, pp. S445-450, Sep. 2011, doi: 10.1111/j.1750-3841.2011.02332.x.
[1674]	D. A. Jett, “Chemical toxins that cause seizures,” Neurotoxicology, vol. 33, no. 6, pp. 1473–1475, Dec. 2012, doi: 10.1016/j.neuro.2012.10.005.
[1675]	S. Freed, “CHEMICAL-BIOCHEMICAL SIGNAL AND NOISE. RESOLUTION AT LOW TEMPERATURES.BNL-893 (T-363),” Tech Rep Brookhaven Natl Lab, vol. 59, pp. 1–13, Sep. 1964.
[1676]	M. E. Kammüller, N. Bloksma, and W. Seinen, “Chemical-induced autoimmune reactions and Spanish toxic oil syndrome. Focus on hydantoins and related compounds,” J. Toxicol. Clin. Toxicol., vol. 26, no. 3–4, pp. 157–174, 1988, doi: 10.3109/15563658809000344.
[1677]	T. Yoshida, T. Ashino, and Y. Kobayashi, “Chemical-induced coordinated and reciprocal changes in heme metabolism, cytochrome P450 synthesis and others in the liver of humans and rodents,” J Toxicol Sci, vol. 41, no. Special, pp. SP89–SP103, 2016, doi: 10.2131/jts.41.SP89.
[1678]	V. Kukongviriyapan and N. H. Stacey, “Chemical-induced interference with hepatocellular transport. Role in cholestasis,” Chem. Biol. Interact., vol. 77, no. 3, pp. 245–261, 1991, doi: 10.1016/0009-2797(91)90035-6.
[1679]	J. E. Harris, “Chemical-Induced Vitiligo,” Dermatol Clin, vol. 35, no. 2, pp. 151–161, Apr. 2017, doi: 10.1016/j.det.2016.11.006.
[1680]	R. Pieters, J. Ezendam, and S. Nierkens, “Chemical-specific properties co-determine the type of adverse immune response,” Autoimmun Rev, vol. 2, no. 1, pp. 25–29, Jan. 2003, doi: 10.1016/s1568-9972(02)00099-x.
[1681]	Y. Shen, J. Qian, H. Yang, F. Zhong, and X. Ai, “Chemically Prelithiated Hard-Carbon Anode for High Power and High Capacity Li-Ion Batteries,” Small, vol. 16, no. 7, p. e1907602, Feb. 2020, doi: 10.1002/smll.201907602.
[1682]	V. Eckardt et al., “Chemokines and galectins form heterodimers to modulate inflammation,” EMBO Rep., vol. 21, no. 4, p. e47852, Apr. 2020, doi: 10.15252/embr.201947852.
[1683]	A. Ismail et al., “Chemometric techniques in oil classification from oil spill fingerprinting,” Mar. Pollut. Bull., vol. 111, no. 1–2, pp. 339–346, Oct. 2016, doi: 10.1016/j.marpolbul.2016.06.089.
[1684]	X. Qiu, J. Ma, K. Wang, and H. Zhang, “Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis,” Oncotarget, vol. 8, no. 1, pp. 1031–1045, Jan. 2017, doi: 10.18632/oncotarget.13715.
[1685]	M. Cascella, R. Di Napoli, D. Carbone, G. F. Cuomo, S. Bimonte, and M. R. Muzio, “Chemotherapy-related cognitive impairment: mechanisms, clinical features and research perspectives,” Recenti Prog Med, vol. 109, no. 11, pp. 523–530, Nov. 2018, doi: 10.1701/3031.30289.
[1686]	D. M. Burke, J. K. Locantore, A. A. Austin, and B. Chae, “Cherry pit primes Brad Pitt: Homophone priming effects on young and older adults’ production of proper names,” Psychol Sci, vol. 15, no. 3, pp. 164–170, Mar. 2004, doi: 10.1111/j.0956-7976.2004.01503004.x.
[1687]	S. Hamoud et al., “Chest pain unit in an internal medicine department: comparison of a year with the facility to a year without,” Isr. Med. Assoc. J., vol. 15, no. 2, pp. 79–84, Feb. 2013.
[1688]	A. P. Allen and A. P. Smith, “Chewing gum: cognitive performance, mood, well-being, and associated physiology,” Biomed Res Int, vol. 2015, p. 654806, 2015, doi: 10.1155/2015/654806.
[1689]	N. F. Nyquist, R. Rødbotten, M. Thomassen, and A. Haug, “Chicken meat nutritional value when feeding red palm oil, palm oil or rendered animal fat in combinations with linseed oil, rapeseed oil and two levels of selenium,” Lipids Health Dis, vol. 12, p. 69, May 2013, doi: 10.1186/1476-511X-12-69.
[1690]	“Chikungunya disease: gaps and opportunities in public health and research in the Americas,” Wkly. Epidemiol. Rec., vol. 90, no. 42, pp. 571–576, Oct. 2015.
[1691]	“Chikungunya: case definitions for acute, atypical and chronic cases. Conclusions of an expert consultation, Managua, Nicaragua, 20-21 May 2015,” Wkly. Epidemiol. Rec., vol. 90, no. 33, pp. 410–414, Aug. 2015.
[1692]	J. Sibeoni and M.-R. Moro, “[Childhood and adolescent depression],” Rev Prat, vol. 64, no. 4, pp. 487–490, Apr. 2014.
[1693]	G. Zara and D. P. Farrington, “Childhood and adolescent predictors of late onset criminal careers,” J Youth Adolesc, vol. 38, no. 3, pp. 287–300, Mar. 2009, doi: 10.1007/s10964-008-9350-3.
[1694]	B. L. Green et al., “Children and disaster: Age, gender, and parental effects on PTSD symptoms,” Journal of the American Academy of Child & Adolescent Psychiatry, vol. 30, no. 6, pp. 945–951, 1991.
[1695]	“Children: reducing mortality,” Wkly. Epidemiol. Rec., vol. 89, no. 38, pp. 418–420, Sep. 2014.
[1696]	D. C. Bellinger, “Children’s cognitive health: the influence of environmental chemical exposures,” Altern Ther Health Med, vol. 13, no. 2, pp. S140-144, Apr. 2007.
[1697]	A. Lang and T. Betsch, “Children’s Neglect of Probabilities in Decision Making with and without Feedback,” Front Psychol, vol. 9, p. 191, 2018, doi: 10.3389/fpsyg.2018.00191.
[1698]	J. Lodge, D. K. Harte, and G. Tripp, “Children’s self-talk under conditions of mild anxiety,” J Anxiety Disord, vol. 12, no. 2, pp. 153–176, Apr. 1998, doi: 10.1016/s0887-6185(98)00006-1.
[1699]	K. S. Dawson and R. A. Bryant, “Children’s Vantage Point of Recalling Traumatic Events,” PLoS ONE, vol. 11, no. 9, p. e0162030, 2016, doi: 10.1371/journal.pone.0162030.
[1700]	H. A. Valand, F. Huda, and R. K. Tu, “Chimeric Antigen Receptor T-Cell Therapy: What the Neuroradiologist Needs to Know,” AJNR Am J Neuroradiol, vol. 40, no. 5, pp. 766–768, 2019, doi: 10.3174/ajnr.A6042.
[1701]	J. Eckert, H. Rakoczy, J. Call, E. Herrmann, and D. Hanus, “Chimpanzees Consider Humans’ Psychological States when Drawing Statistical Inferences,” Curr. Biol., vol. 28, no. 12, pp. 1959-1963.e3, 18 2018, doi: 10.1016/j.cub.2018.04.077.
[1702]	G. L. Skinazi, S. J. Lindauer, and R. J. Isaacson, “Chin, nose, and lips. Normal ratios in young men and women,” Am J Orthod Dentofacial Orthop, vol. 106, no. 5, pp. 518–523, Nov. 1994, doi: 10.1016/S0889-5406(94)70075-3.
[1703]	B. Ataie-Ashtiani, “Chinese and Iranian Scientific Publications: Fast Growth and Poor Ethics,” Sci Eng Ethics, vol. 23, no. 1, pp. 317–319, 2017, doi: 10.1007/s11948-016-9766-1.
[1704]	D. Zeng et al., “[Chinese brain template built on 3D high resolution MR imaging at 3.0T],” Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, vol. 27, no. 3, pp. 561–564, Jun. 2010.
[1705]	S. R. Chowdhury and T. Rudel, “Chlamydia and mitochondria - an unfragmented relationship,” Microb Cell, vol. 4, no. 7, pp. 233–235, Jun. 2017, doi: 10.15698/mic2017.07.582.
[1706]	C. M. O’Connell and M. E. Ferone, “Chlamydia trachomatis Genital Infections,” Microb Cell, vol. 3, no. 9, pp. 390–403, Sep. 2016, doi: 10.15698/mic2016.09.525.
[1707]	B. S. Sixt, R. H. Valdivia, and G. Kroemer, “Chlamydia trachomatis’ struggle to keep its host alive,” Microb Cell, vol. 4, no. 3, pp. 101–104, Mar. 2017, doi: 10.15698/mic2017.03.564.
[1708]	A. Stirbet and  null Govindjee, “Chlorophyll a fluorescence induction: a personal perspective of the thermal phase, the J-I-P rise,” Photosyn. Res., vol. 113, no. 1–3, pp. 15–61, Sep. 2012, doi: 10.1007/s11120-012-9754-5.
[1709]	N. Ohnishi, Y. Kashino, K. Satoh, S.-I. Ozawa, and Y. Takahashi, “Chloroplast-encoded polypeptide PsbT is involved in the repair of primary electron acceptor QA of photosystem II during photoinhibition in Chlamydomonas reinhardtii,” J. Biol. Chem., vol. 282, no. 10, pp. 7107–7115, Mar. 2007, doi: 10.1074/jbc.M606763200.
[1710]	M. Furlanut, P. Benetello, M. Baraldo, G. Zara, G. Montanari, and F. Donzelli, “Chlorpromazine disposition in relation to age in children,” Clin Pharmacokinet, vol. 18, no. 4, pp. 329–331, Apr. 1990, doi: 10.2165/00003088-199018040-00005.
[1711]	E. Valdivielso Cortázar, J. Redondo Martínez, G. Romay Cousido, and P. Alonso-Aguirre, “Cholangitis secondary to afferent loop syndrome from a gastric stump adenocarcinoma,” Rev Esp Enferm Dig, vol. 110, no. 4, p. 253, Apr. 2018, doi: 10.17235/reed.2018.5394/2017.
[1712]	“Cholera in Bangladesh,” Wkly. Epidemiol. Rec., vol. 90, no. 40, pp. 539–542, Oct. 2015.
[1713]	“Cholera in Haiti: successes and challenges in a low income country,” Wkly. Epidemiol. Rec., vol. 90, no. 40, pp. 542–544, Oct. 2015.
[1714]	“Cholera surveillance, rapid diagnostics and laboratory networks,” Wkly. Epidemiol. Rec., vol. 90, no. 40, pp. 537–539, Oct. 2015.
[1715]	“Cholera vaccines:  WHO position paper –  August 2017,” Wkly. Epidemiol. Rec., vol. 92, no. 34, pp. 477–498, 25 2017.
[1716]	“Cholera, 2012,” Wkly. Epidemiol. Rec., vol. 88, no. 31, pp. 321–334, Aug. 2013.
[1717]	“Cholera, 2013,” Wkly. Epidemiol. Rec., vol. 89, no. 31, pp. 345–355, Aug. 2014.
[1718]	“Cholera, 2014,” Wkly. Epidemiol. Rec., vol. 90, no. 40, pp. 517–528, Oct. 2015.
[1719]	“Cholera, 2015,” Wkly. Epidemiol. Rec., vol. 91, no. 38, pp. 433–440, Sep. 2016.
[1720]	“Cholera, 2016,” Wkly. Epidemiol. Rec., vol. 92, no. 36, pp. 521–530, 08 2017.
[1721]	E. De Fabiani, D. Caruso, M. Cavaleri, M. Galli Kienle, and G. Galli, “Cholesta-5,7,9(11)-trien-3 beta-ol found in plasma of patients with Smith-Lemli-Opitz syndrome indicates formation of sterol hydroperoxide,” J. Lipid Res., vol. 37, no. 11, pp. 2280–2287, Nov. 1996.
[1722]	Y. Konno, A. Yoshimura, N. Naito, and K. Aramaki, “Cholesterol-Induced Formation of Liquid Ordered Phase-Like Structures in Non-Phospholipid Systems,” J Oleo Sci, vol. 67, no. 4, pp. 419–426, 2018, doi: 10.5650/jos.ess17069.
[1723]	S. C. Dulawa and D. S. Janowsky, “Cholinergic regulation of mood: from basic and clinical studies to emerging therapeutics,” Mol. Psychiatry, vol. 24, no. 5, pp. 694–709, 2019, doi: 10.1038/s41380-018-0219-x.
[1724]	D. Ozonoff, “Choosing health,” J Public Health Policy, vol. 35, no. 3, pp. 407–410, Aug. 2014, doi: 10.1057/jphp.2014.24.
[1725]	S. Sirobhushanam, N. Parsa, T. J. Reed, and J. M. Kahlenberg, “ChromagarTM requires secondary confirmation strategies to minimize false positive/negative results for detection of Staphylococcus aureus,” J. Microbiol. Methods, vol. 161, pp. 71–73, 2019, doi: 10.1016/j.mimet.2019.04.013.
[1726]	R. Narayanan et al., “Chromatin Remodeling BAF155 Subunit Regulates the Genesis of Basal Progenitors in Developing Cortex,” iScience, vol. 4, pp. 109–126, Jun. 2018, doi: 10.1016/j.isci.2018.05.014.
[1727]	M. G. Verlaan et al., “Chromosomal rearrangements between tomato and Solanum chilense hamper mapping and breeding of the TYLCV resistance gene Ty-1,” Plant J., vol. 68, no. 6, pp. 1093–1103, Dec. 2011, doi: 10.1111/j.1365-313X.2011.04762.x.
[1728]	J. Tanzer, M. Thomas, Y. Stoitchkov, M. Boiron, and J. Bernard, “[CHROMOSOME CHANGES OBSERVED IN MONKEY KIDNEY CELLS INFECTED IN VITRO BY THE HERPES VIRUS],” Ann Inst Pasteur (Paris), vol. 107, pp. 366–373, Sep. 1964.
[1729]	T. Praznovszky, “Chromosome engineering with lambda-integrase mediated recombination system: the ACE system,” Methods Mol. Biol., vol. 738, pp. 141–149, 2011, doi: 10.1007/978-1-61779-099-7_10.
[1730]	E. Saksela, E. Saxen, and K. Penttinen, “Chromosome heterogeneity of cell lines in vitro. 1. Differences in the effect of individual human sera on the chromosome number of HeLa cells,” Acta Pathol Microbiol Scand, vol. 51, pp. 127–131, 1961.
[1731]	E. L. Thompson et al., “Chronic administration of NMU into the paraventricular nucleus stimulates the HPA axis but does not influence food intake or body weight,” Biochem. Biophys. Res. Commun., vol. 323, no. 1, pp. 65–71, Oct. 2004, doi: 10.1016/j.bbrc.2004.08.058.
[1732]	D. Lacroix et al., “Chronic amiodarone effects on epicardial conduction and repolarization in the isolated porcine heart,” Pacing Clin Electrophysiol, vol. 23, no. 7, pp. 1133–1143, Jul. 2000, doi: 10.1111/j.1540-8159.2000.tb00914.x.
[1733]	H. Alhaddad et al., “Chronic Ethanol Consumption Alters Glucocorticoid Receptor Isoform Expression in Stress Neurocircuits and Mesocorticolimbic Brain Regions of Alcohol-Preferring Rats,” Neuroscience, vol. 437, pp. 107–116, Jun. 2020, doi: 10.1016/j.neuroscience.2020.04.033.
[1734]	D. Baptista-de-Souza et al., “Chronic Fluoxetine Impairs the Effects of 5-HT1A and 5-HT2C Receptors Activation in the PAG and Amygdala on Antinociception Induced by Aversive Situation in Mice,” Front Pharmacol, vol. 11, p. 260, 2020, doi: 10.3389/fphar.2020.00260.
[1735]	E. Levy, Y. Hasin, G. Navon, and M. Horowitz, “Chronic heat improves mechanical and metabolic response of trained rat heart on ischemia and reperfusion,” Am. J. Physiol., vol. 272, no. 5 Pt 2, pp. H2085-2094, May 1997, doi: 10.1152/ajpheart.1997.272.5.H2085.
[1736]	L. Rushton, “Chronic obstructive pulmonary disease and occupational exposure to silica,” Rev Environ Health, vol. 22, no. 4, pp. 255–272, Dec. 2007, doi: 10.1515/reveh.2007.22.4.255.
[1737]	T. J. Sharp and A. G. Harvey, “Chronic pain and posttraumatic stress disorder: mutual maintenance?,” Clin Psychol Rev, vol. 21, no. 6, pp. 857–877, Aug. 2001, doi: 10.1016/s0272-7358(00)00071-4.
[1738]	C. Eccleston, P. N. Malleson, J. Clinch, H. Connell, and C. Sourbut, “Chronic pain in adolescents: evaluation of a programme of interdisciplinary cognitive behaviour therapy,” Arch. Dis. Child., vol. 88, no. 10, pp. 881–885, Oct. 2003, doi: 10.1136/adc.88.10.881.
[1739]	O. W. Hakenberg and M. P. Wirth, “Chronic pelvic pain in men,” Urol. Int., vol. 68, no. 3, pp. 138–143, 2002, doi: 10.1159/000048438.
[1740]	I. M. Lahart and G. S. Metsios, “Chronic Physiological Effects of Swim Training Interventions in Non-Elite Swimmers: A Systematic Review and Meta-Analysis,” Sports Med, vol. 48, no. 2, pp. 337–359, Feb. 2018, doi: 10.1007/s40279-017-0805-0.
[1741]	A. R. Sedaghat, L. P. Hoehle, and S. T. Gray, “Chronic rhinosinusitis control from the patient and physician perspectives,” Laryngoscope Investig Otolaryngol, vol. 3, no. 6, pp. 419–433, Dec. 2018, doi: 10.1002/lio2.208.
[1742]	M. G. Soni, H. Kimura, and G. A. Burdock, “Chronic study of diacylglycerol oil in rats,” Food Chem. Toxicol., vol. 39, no. 4, pp. 317–329, Apr. 2001, doi: 10.1016/s0278-6915(00)00140-x.
[1743]	Y. Imai et al., “Chymase inhibition attenuates lipopolysaccharide/ d-galactosamine-induced acute liver failure in hamsters,” Pharmacology, vol. 93, no. 1–2, pp. 47–56, 2014, doi: 10.1159/000357684.
[1744]	S. Masubuchi et al., “Chymase inhibition attenuates monocrotaline-induced sinusoidal obstruction syndrome in hamsters,” Curr. Med. Chem., vol. 20, no. 21, pp. 2723–2729, 2013, doi: 10.2174/0929867311320210008.
[1745]	K. Komeda et al., “Chymase inhibition attenuates tetrachloride-induced liver fibrosis in hamsters,” Hepatol. Res., vol. 40, no. 8, pp. 832–840, Aug. 2010, doi: 10.1111/j.1872-034X.2010.00672.x.
[1746]	S. Takai et al., “Chymase inhibition improves vascular dysfunction and survival in stroke-prone spontaneously hypertensive rats,” J. Hypertens., vol. 32, no. 8, pp. 1637–1648; discussion 1649, Aug. 2014, doi: 10.1097/HJH.0000000000000231.
[1747]	Y. Miyaoka et al., “Chymase inhibitor prevents the development and progression of non-alcoholic steatohepatitis in rats fed a high-fat and high-cholesterol diet,” J. Pharmacol. Sci., vol. 134, no. 3, pp. 139–146, Jul. 2017, doi: 10.1016/j.jphs.2017.04.005.
[1748]	F. Rebischung, L. Chabot, H. Biaudet, and P. Pandard, “Cigarette butts: A small but hazardous waste, according to European regulation,” Waste Manag, vol. 82, pp. 9–14, Dec. 2018, doi: 10.1016/j.wasman.2018.09.038.
[1749]	Y. Fu et al., “Ciliostasis of airway epithelial cells facilitates influenza A virus infection,” Vet. Res., vol. 49, no. 1, p. 65, 18 2018, doi: 10.1186/s13567-018-0568-0.
[1750]	A. A. Alharthi, N. M. Kamal, M. W. Abukhatwah, and L. M. Sherief, “Cinacalcet in pediatric and adolescent chronic kidney disease: a single-center experience,” Medicine (Baltimore), vol. 94, no. 2, p. e401, Jan. 2015, doi: 10.1097/MD.0000000000000401.
[1751]	C. Pergola et al., “Cinnamyl-3,4-dihydroxy-α-cyanocinnamate is a potent inhibitor of 5-lipoxygenase,” J. Pharmacol. Exp. Ther., vol. 338, no. 1, pp. 205–213, Jul. 2011, doi: 10.1124/jpet.111.180794.
[1752]	U. Albrecht, “Circadian clocks in mood-related behaviors,” Ann. Med., vol. 42, no. 4, pp. 241–251, May 2010, doi: 10.3109/07853891003677432.
[1753]	C. A. McClung, “Circadian rhythms and mood regulation: insights from pre-clinical models,” Eur Neuropsychopharmacol, vol. 21 Suppl 4, pp. S683-693, Sep. 2011, doi: 10.1016/j.euroneuro.2011.07.008.
[1754]	J. Z. Li, “Circadian rhythms and mood: opportunities for multi-level analyses in genomics and neuroscience: circadian rhythm dysregulation in mood disorders provides clues to the brain’s organizing principles, and a touchstone for genomics and neuroscience,” Bioessays, vol. 36, no. 3, pp. 305–315, Mar. 2014, doi: 10.1002/bies.201300141.
[1755]	P. Monteleone, V. Martiadis, and M. Maj, “Circadian rhythms and treatment implications in depression,” Prog. Neuropsychopharmacol. Biol. Psychiatry, vol. 35, no. 7, pp. 1569–1574, Aug. 2011, doi: 10.1016/j.pnpbp.2010.07.028.
[1756]	L. Tonetti, M. Fabbri, M. Martoni, and V. Natale, “Circadian type and mood seasonality in adolescents,” Psychiatry Clin. Neurosci., vol. 66, no. 2, pp. 157–159, Mar. 2012, doi: 10.1111/j.1440-1819.2011.02303.x.
[1757]	N. Kondo, T. Sekijima, J. Kondo, N. Takamatsu, K. Tohya, and T. Ohtsu, “Circannual control of hibernation by HP complex in the brain,” Cell, vol. 125, no. 1, pp. 161–172, Apr. 2006, doi: 10.1016/j.cell.2006.03.017.
[1758]	E. Vermetten and J. D. Bremner, “Circuits and systems in stress. II. Applications to neurobiology and treatment in posttraumatic stress disorder,” Depress Anxiety, vol. 16, no. 1, pp. 14–38, 2002, doi: 10.1002/da.10017.
[1759]	J. B. Moore, M. L. Merchant, and S. Uchida, “Circular RNAs as diagnostic tool for renal transplant patients with acute rejection,” Ann Transl Med, vol. 7, no. Suppl 8, p. S302, Dec. 2019, doi: 10.21037/atm.2019.11.08.
[1760]	M. Han et al., “Circulating neuromedin U levels are similar in subjects with NGT and newly diagnosed T2DM and do not correlate with insulin secretion,” Diabetes Res. Clin. Pract., vol. 151, pp. 163–168, May 2019, doi: 10.1016/j.diabres.2019.04.020.
[1761]	“Circulating vaccine-derived poliovirus outbreaks in 5 countries, 2014-2015,” Wkly. Epidemiol. Rec., vol. 91, no. 6, pp. 71–72, Feb. 2016.
[1762]	B. M. Tyler, R. F. Geever, M. E. Case, and N. H. Giles, “Cis-acting and trans-acting regulatory mutations define two types of promoters controlled by the qa-1F gene of Neurospora,” Cell, vol. 36, no. 2, pp. 493–502, Feb. 1984, doi: 10.1016/0092-8674(84)90242-3.
[1763]	M. Keller and S. Prusiner, “Citations must default to the online publication date,” Nature, vol. 558, no. 7711, p. 519, 2018, doi: 10.1038/d41586-018-05387-4.
[1764]	M. H. Oermann et al., “Citations of articles in predatory nursing journals,” Nurs Outlook, vol. 67, no. 6, pp. 664–670, Dec. 2019, doi: 10.1016/j.outlook.2019.05.001.
[1765]	M. T. Anderson, L. A. Mitchell, L. Zhao, and H. L. T. Mobley, “Citrobacter freundii fitness during bloodstream infection,” Sci Rep, vol. 8, no. 1, p. 11792, 07 2018, doi: 10.1038/s41598-018-30196-0.
[1766]	A. Elbery and H. Rakha, “City-Wide Eco-Routing Navigation Considering Vehicular Communication Impacts,” Sensors (Basel), vol. 19, no. 2, Jan. 2019, doi: 10.3390/s19020290.
[1767]	J. Henschel, C. Peschel, S. Klein, F. Horsthemke, M. Winter, and S. Nowak, “Clarification of Decomposition Pathways in a State-of-the-Art Lithium Ion Battery Electrolyte through 13 C-Labeling of Electrolyte Components,” Angew. Chem. Int. Ed. Engl., vol. 59, no. 15, pp. 6128–6137, Apr. 2020, doi: 10.1002/anie.202000727.
[1768]	R. Roberts and D. S. Knopman, “Classification and epidemiology of MCI,” Clin. Geriatr. Med., vol. 29, no. 4, pp. 753–772, Nov. 2013, doi: 10.1016/j.cger.2013.07.003.
[1769]	Q. Li, Y. Gu, and J. Jia, “Classification of Multiple Chinese Liquors by Means of a QCM-based E-Nose and MDS-SVM Classifier,” Sensors (Basel), vol. 17, no. 2, Jan. 2017, doi: 10.3390/s17020272.
[1770]	D. Boglaienko and B. Tansel, “Classification of oil-particle interactions in aqueous environments: Aggregate types depending on state of oil and particle characteristics,” Mar. Pollut. Bull., vol. 133, pp. 693–700, Aug. 2018, doi: 10.1016/j.marpolbul.2018.06.037.
[1771]	F. S. Van Dijk, G. Pals, R. R. Van Rijn, P. G. J. Nikkels, and J. M. Cobben, “Classification of Osteogenesis Imperfecta revisited,” Eur J Med Genet, vol. 53, no. 1, pp. 1–5, Feb. 2010, doi: 10.1016/j.ejmg.2009.10.007.
[1772]	E. Gebhart, “Clastogenic action of chemotherapy in humans (review),” In Vivo, vol. 1, no. 1, pp. 15–21, Feb. 1987.
[1773]	F. L. Wood, J. B. Houston, and D. Hallifax, “Clearance Prediction Methodology Needs Fundamental Improvement: Trends Common to Rat and Human Hepatocytes/Microsomes and Implications for Experimental Methodology,” Drug Metab. Dispos., vol. 45, no. 11, pp. 1178–1188, 2017, doi: 10.1124/dmd.117.077040.
[1774]	J. Sueur, B. Krause, and A. Farina, “Climate Change Is Breaking Earth’s Beat,” Trends Ecol. Evol. (Amst.), vol. 34, no. 11, pp. 971–973, 2019, doi: 10.1016/j.tree.2019.07.014.
[1775]	D. Nogués-Bravo, J. Rodríguez, J. Hortal, P. Batra, and M. B. Araújo, “Climate change, humans, and the extinction of the woolly mammoth,” PLoS Biol., vol. 6, no. 4, p. e79, Apr. 2008, doi: 10.1371/journal.pbio.0060079.
[1776]	M. Dumba et al., “Clinical 18F-FDG and amyloid brain positron emission tomography/CT in the investigation of cognitive impairment: where are we now?,” Br J Radiol, vol. 92, no. 1101, p. 20181027, Sep. 2019, doi: 10.1259/bjr.20181027.
[1777]	C. Quast, S. Zimmer, M. Adam, S. Baldus, G. Nickenig, and M. Kelm, “[Clinical Advances in Aortic Diseases: from Aortic Valve to Bifurcation],” Dtsch. Med. Wochenschr., vol. 144, no. 11, pp. 734–738, 2019, doi: 10.1055/a-0663-6474.
[1778]	H. Y. Huang et al., “[Clinical analysis of thalidomide in 36 untreated patients with T-cell lymphoma],” Zhonghua Xue Ye Xue Za Zhi, vol. 37, no. 6, pp. 529–531, Jun. 2016, doi: 10.3760/cma.j.issn.0253-2727.2016.06.019.
[1779]	W. G. Yarbrough, A. Panaccione, M. T. Chang, and S. V. Ivanov, “Clinical and molecular insights into adenoid cystic carcinoma: Neural crest-like stemness as a target,” Laryngoscope Investig Otolaryngol, vol. 1, no. 4, pp. 60–77, 2016, doi: 10.1002/lio2.22.
[1780]	J. He, R. K. White, C. A. White, J. L. Schweitzer, and K. F. Woodmansey, “Clinical and Patient-centered Outcomes of Nonsurgical Root Canal Retreatment in First Molars Using Contemporary Techniques,” J Endod, vol. 43, no. 2, pp. 231–237, Feb. 2017, doi: 10.1016/j.joen.2016.10.029.
[1781]	N.-H. Choi, B.-S. Yang, and B. N. Victoroff, “Clinical and Radiological Outcomes After Hamstring Anterior Cruciate Ligament Reconstructions: Comparison Between Fixed-Loop and Adjustable-Loop Cortical Suspension Devices,” Am J Sports Med, vol. 45, no. 4, pp. 826–831, Mar. 2017, doi: 10.1177/0363546516674183.
[1782]	H. Ito, “[Clinical Application of Immunosuppressive Factors in Cancer Diagnosis and Therapy],” Rinsho Byori, vol. 64, no. 12, pp. 1360–1366, Dec. 2016.
[1783]	R. Padia, K. Zenner, R. Bly, J. Bennett, C. Bull, and J. Perkins, “Clinical application of molecular genetics in lymphatic malformations,” Laryngoscope Investig Otolaryngol, vol. 4, no. 1, pp. 170–173, Feb. 2019, doi: 10.1002/lio2.241.
[1784]	S. Ozawa and T. Nelson, “Clinical Application of Prothrombin Complex Concentrate in Blood Management in Patients,” Crit Care Nurse, vol. 37, no. 2, pp. 49–56, Apr. 2017, doi: 10.4037/ccn2017333.
[1785]	S. H. Kennedy and B. S. Eisfeld, “Clinical aspects of depression,” Clin Cornerstone, vol. 1, no. 4, pp. 1–16, 1999, doi: 10.1016/s1098-3597(99)90021-2.
[1786]	N. N. Ivanets, O. V. Lavrinenko, and T. N. Maximova, “[Clinical characteristics of depression in patients with episodic consumption of and dependence on alcohol],” Zh Nevrol Psikhiatr Im S S Korsakova, vol. 117, no. 3, pp. 11–15, 2017, doi: 10.17116/jnevro20171173111-15.
[1787]	R. Colebunders et al., “Clinical characteristics of onchocerciasis-associated epilepsy in villages in Maridi County, Republic of South Sudan,” Seizure, vol. 62, pp. 108–115, Nov. 2018, doi: 10.1016/j.seizure.2018.10.004.
[1788]	L. Vicent et al., “Clinical characteristics of patients with sustained ventricular arrhythmias after sacubitril/valsartan initiation,” Heart Vessels, vol. 35, no. 1, pp. 136–142, Jan. 2020, doi: 10.1007/s00380-019-01454-6.
[1789]	F. W. Virgin, “Clinical chronic rhinosinusitis outcomes in pediatric patients with cystic fibrosis,” Laryngoscope Investig Otolaryngol, vol. 2, no. 5, pp. 276–280, 2017, doi: 10.1002/lio2.78.
[1790]	J. M. Eisenberg, “Clinical economics. A guide to the economic analysis of clinical practices,” JAMA, vol. 262, no. 20, pp. 2879–2886, Nov. 1989, doi: 10.1001/jama.262.20.2879.
[1791]	A. Mårtensson et al., “Clinical efficacy of a topical lactic acid bacterial microbiome in chronic rhinosinusitis: A randomized controlled trial,” Laryngoscope Investig Otolaryngol, vol. 2, no. 6, pp. 410–416, 2017, doi: 10.1002/lio2.93.
[1792]	T. Fukuhara et al., “Clinical efficacy of novel elastography using acoustic radiation force impulse (ARFI) for diagnosis of malignant thyroid nodules,” Laryngoscope Investig Otolaryngol, vol. 3, no. 4, pp. 319–325, Aug. 2018, doi: 10.1002/lio2.165.
[1793]	D. J. Fasbinder, G. F. Neiva, D. Heys, and R. Heys, “Clinical evaluation of chairside Computer Assisted Design/Computer Assisted Machining nano-ceramic restorations: Five-year status,” J Esthet Restor Dent, vol. 32, no. 2, pp. 193–203, Mar. 2020, doi: 10.1111/jerd.12516.
[1794]	S. Kurtulmus-Yilmaz, H. G. Yilmaz, H. Tumer, and K. Sadettinoglu, “Clinical evaluation of the Er,Cr:YSGG Laser therapy in the treatment of denture-related traumatic ulcerations: a randomized controlled clinical study,” Photomed Laser Surg, vol. 33, no. 4, pp. 224–229, Apr. 2015, doi: 10.1089/pho.2014.3846.
[1795]	J. Sun, C.-Y. Li, and X.-N. Meng, “[Clinical experience of professor WANG Ju-yi in channel palpation treatment for polymyalgia rheumatica],” Zhongguo Zhen Jiu, vol. 39, no. 4, pp. 419–422, Apr. 2019, doi: 10.13703/j.0255-2930.2019.04.019.
[1796]	A. Kahn et al., “Clinical features and long-term outcomes of lower esophageal sphincter-dependent and lower esophageal sphincter-independent jackhammer esophagus,” Neurogastroenterol. Motil., vol. 31, no. 2, p. e13507, 2019, doi: 10.1111/nmo.13507.
[1797]	M. A. El-Fattah, “Clinical Features and Outcomes of 666 Cases with Therapy-Related Myelodysplastic Syndrome (t-MDS),” Indian J Hematol Blood Transfus, vol. 34, no. 1, pp. 83–90, Jan. 2018, doi: 10.1007/s12288-017-0813-0.
[1798]	K. Ogata and Y. Yoshida, “Clinical implications of blast immunophenotypes in myelodysplastic syndromes,” Leuk. Lymphoma, vol. 46, no. 9, pp. 1269–1274, Sep. 2005, doi: 10.1080/10428190500142155.
[1799]	K. Gulleroglu, B. Yazar, H. Sakalli, H. Ozdemir, and E. Baskin, “Clinical importance of mean platelet volume in children with nephrotic syndrome,” Ren Fail, vol. 36, no. 5, pp. 663–665, Jun. 2014, doi: 10.3109/0886022X.2014.883931.
[1800]	A. J. Hudson et al., “Clinical Interpretation of Peripheral Pulse Oximeters Labeled ‘Not for Medical Use,’” Ann Fam Med, vol. 16, no. 6, pp. 552–554, 2018, doi: 10.1370/afm.2317.
[1801]	A. P. Turner et al., “Clinical management of multiple sclerosis through home telehealth monitoring: results of a pilot project,” Int J MS Care, vol. 15, no. 1, pp. 8–14, 2013, doi: 10.7224/1537-2073.2012-012.
[1802]	P. Shahabi, G. Siest, B. Herbeth, N. C. Ndiaye, and S. Visvikis-Siest, “Clinical necessity of partitioning of human plasma haptoglobin reference intervals by recently-discovered rs2000999,” Clin. Chim. Acta, vol. 413, no. 19–20, pp. 1618–1624, Oct. 2012, doi: 10.1016/j.cca.2012.04.033.
[1803]	W. B. Ai and Q. C. Jing, “[Clinical observation of LOP chemotherapy combined with radiotherapy in the treatment of early nasal NK/T cell lymphoma],” Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, vol. 33, no. 10, pp. 990–992, Oct. 2019, doi: 10.13201/j.issn.1001-1781.2019.10.022.
[1804]	Y. F. Hu et al., “[Clinical observation on LOP regimen combined with IMRT treatment for early nasal NK/T cell lymphoma],” Zhonghua Yi Xue Za Zhi, vol. 97, no. 6, pp. 447–450, Feb. 2017, doi: 10.3760/cma.j.issn.0376-2491.2017.06.010.
[1805]	A. Munck et al., “Clinical outcome of cystic fibrosis presenting with or without meconium ileus: a matched cohort study,” J. Pediatr. Surg., vol. 41, no. 9, pp. 1556–1560, Sep. 2006, doi: 10.1016/j.jpedsurg.2006.05.014.
[1806]	E. A. Chybowski, G. N. Glickman, Y. Patel, A. Fleury, E. Solomon, and J. He, “Clinical Outcome of Non-Surgical Root Canal Treatment Using a Single-cone Technique with Endosequence Bioceramic Sealer: A Retrospective Analysis,” J Endod, vol. 44, no. 6, pp. 941–945, Jun. 2018, doi: 10.1016/j.joen.2018.02.019.
[1807]	F. Baidoun et al., “Clinical outcome of patients diagnosed with myelodysplastic syndrome-unclassifiable (MDS-U): single center experience,” Leuk. Lymphoma, vol. 60, no. 10, pp. 2483–2487, 2019, doi: 10.1080/10428194.2019.1581930.
[1808]	J. E. Yun et al., “Clinical outcomes and costs of robotic surgery in prostate cancer: a multiinstitutional study in Korea,” Prostate Int, vol. 7, no. 1, pp. 19–24, Mar. 2019, doi: 10.1016/j.prnil.2018.04.004.
[1809]	F. Fyhrquist, “Clinical pharmacology of the ACE inhibitors,” Drugs, vol. 32 Suppl 5, pp. 33–39, 1986, doi: 10.2165/00003495-198600325-00005.
[1810]	H. Gunawan, M. Sasmojo, H. E. Putri, E. Avriyanti, R. Hindritiani, and O. Suwarsa, “Clinical pilot study: Clarithromycin efficacy in multibacillary leprosy therapy,” Int J Mycobacteriol, vol. 7, no. 2, pp. 152–155, Jun. 2018, doi: 10.4103/ijmy.ijmy_58_18.
[1811]	H. Kudler, “Clinical practice guidelines for posttraumatic stress disorder: Are they still clinical?,” Psychotherapy (Chic), vol. 56, no. 3, pp. 383–390, 2019, doi: 10.1037/pst0000236.
[1812]	D. P. S. Sohal et al., “Clinical Predictors of Early Mortality in Colorectal Cancer Patients Undergoing Chemotherapy: Results From a Global Prospective Cohort Study,” JNCI Cancer Spectr, vol. 1, no. 1, p. pkx009, Sep. 2017, doi: 10.1093/jncics/pkx009.
[1813]	D. Bhwana et al., “Clinical presentation of epilepsy in six villages in an onchocerciasis endemic area in Mahenge, Tanzania,” Epileptic Disord, vol. 21, no. 5, pp. 425–435, Oct. 2019, doi: 10.1684/epd.2019.1093.
[1814]	J. F. N. Siewe et al., “Clinical presentations of onchocerciasis-associated epilepsy (OAE) in Cameroon,” Epilepsy Behav, vol. 90, pp. 70–78, 2019, doi: 10.1016/j.yebeh.2018.11.008.
[1815]	N. S. Shalaka et al., “Clinical profile and factors associated with mortality in hospitalized patients with HIV/AIDS: a retrospective analysis from Tripoli Medical Centre, Libya, 2013,” East. Mediterr. Health J., vol. 21, no. 9, pp. 635–646, Oct. 2015, doi: 10.26719/2015.21.9.635.
[1816]	R. Yehuda, “Clinical relevance of biologic findings in PTSD,” Psychiatr Q, vol. 73, no. 2, pp. 123–133, 2002, doi: 10.1023/a:1015055711424.
[1817]	J.-M. Lee et al., “Clinical Risk Factors for Upper Gastrointestinal Bleeding after Percutaneous Coronary Intervention: A Single-Center Study,” Gut Liver, vol. 10, no. 1, pp. 58–62, Jan. 2016, doi: 10.5009/gnl14127.
[1818]	S.-S. Guo, P.-P. Gao, Q.-T. Mu, and G.-F. Ouyang, “[Clinical Significance of Monosomal Karyotype in MDS],” Zhongguo Shi Yan Xue Ye Xue Za Zhi, vol. 27, no. 3, pp. 860–866, Jun. 2019, doi: 10.19746/j.cnki.issn.1009-2137.2019.03.036.
[1819]	E.-L. Dong et al., “Clinical spectrum and genetic landscape for hereditary spastic paraplegias in China,” Mol Neurodegener, vol. 13, no. 1, p. 36, 06 2018, doi: 10.1186/s13024-018-0269-1.
[1820]	B. H. Chung, S. Horie, and E. Chiong, “Clinical studies investigating the use of leuprorelin for prostate cancer in Asia,” Prostate Int, vol. 8, no. 1, pp. 1–9, Mar. 2020, doi: 10.1016/j.prnil.2019.06.001.
[1821]	F. Ye, D.-S. Ma, J. Wang, and Z.-H. Qiao, “[Clinical Study of Patients with Myelodysplastic Syndrome Transformed into Acute Myeloid Leukemia],” Zhongguo Shi Yan Xue Ye Xue Za Zhi, vol. 26, no. 1, pp. 202–207, Feb. 2018, doi: 10.7534/j.issn.1009-2137.2018.01.035.
[1822]	J. S. Rew, “[Clinical use of proton pump inhibitors in gastrointestinal diseases],” Korean J Gastroenterol, vol. 47, no. 3, pp. 181–190, Mar. 2006.
[1823]	W. O. Tatum et al., “Clinical utility of EEG in diagnosing and monitoring epilepsy in adults,” Clin Neurophysiol, vol. 129, no. 5, pp. 1056–1082, 2018, doi: 10.1016/j.clinph.2018.01.019.
[1824]	A. Abou Zahr, E. Saad Aldin, R. S. Komrokji, and A. M. Zeidan, “Clinical utility of lenalidomide in the treatment of myelodysplastic syndromes,” J Blood Med, vol. 6, pp. 1–16, 2015, doi: 10.2147/JBM.S50482.
[1825]	M. Roselli et al., “Clinical value of radiolabeled monoclonal antibodies in the management of carcinoma patients,” In Vivo, vol. 7, no. 6B, pp. 615–621, Dec. 1993.
[1826]	E. J. Smith et al., “Clinical, Molecular, and Genetic Characteristics of PAPA Syndrome: A Review,” Curr. Genomics, vol. 11, no. 7, pp. 519–527, Nov. 2010, doi: 10.2174/138920210793175921.
[1827]	J. Balmer et al., “Clinically applicable model-based method, for physiologically accurate flow waveform and stroke volume estimation,” Comput Methods Programs Biomed, vol. 185, p. 105125, Mar. 2020, doi: 10.1016/j.cmpb.2019.105125.
[1828]	F. Duncan et al., “Clinically significant fatigue after stroke: a longitudinal cohort study,” J Psychosom Res, vol. 77, no. 5, pp. 368–373, Nov. 2014, doi: 10.1016/j.jpsychores.2014.06.013.
[1829]	D. Zhu, L. Sha, X. Shen, J. Huan, and H. Wang, “[Clinicopathological significance of gastric mucosal infection with coccoid Helicobacter pylori],” Zhonghua Bing Li Xue Za Zhi, vol. 43, no. 5, pp. 326–329, May 2014.
[1830]	R. V. Tiu, F. Traina, and M. A. Sekeres, “Clofarabine for myelodysplastic syndromes,” Expert Opin Investig Drugs, vol. 20, no. 7, pp. 1005–1014, Jul. 2011, doi: 10.1517/13543784.2011.585967.
[1831]	C. J. Aldrich, R. N. Jenkins, and R. R. Rich, “Clonal analysis of the anti-Qa-1 cytotoxic T lymphocyte repertoire: definition of the Qa-1d and Qa-1c alloantigens and cross-reactivity with H-2,” J. Immunol., vol. 136, no. 2, pp. 383–388, Jan. 1986.
[1832]	Y.-Q. Li and X. Du, “[Clonal expanded T-cell repertoire in MDS],” Zhongguo Shi Yan Xue Ye Xue Za Zhi, vol. 18, no. 3, pp. 793–797, Jun. 2010.
[1833]	A. F. Elias et al., “Clonal polymorphism of Borrelia burgdorferi strain B31 MI: implications for mutagenesis in an infectious strain background,” Infect. Immun., vol. 70, no. 4, pp. 2139–2150, Apr. 2002, doi: 10.1128/iai.70.4.2139-2150.2002.
[1834]	S. Funes et al., “Cloning and characterization of murine neuromedin U receptors,” Peptides, vol. 23, no. 9, pp. 1607–1615, Sep. 2002, doi: 10.1016/s0196-9781(02)00097-9.
[1835]	C. Austin, G. Lo, K. A. Nandha, L. Meleagros, and S. R. Bloom, “Cloning and characterization of the cDNA encoding the human neuromedin U (NmU) precursor: NmU expression in the human gastrointestinal tract,” J. Mol. Endocrinol., vol. 14, no. 2, pp. 157–169, Apr. 1995, doi: 10.1677/jme.0.0140157.
[1836]	J. D. Vargas, E. Culetto, C. P. Ponting, I. Miguel-Aliaga, K. E. Davies, and D. B. Sattelle, “Cloning and developmental expression analysis of ltd-1, the Caenorhabditis elegans homologue of the mouse kyphoscoliosis (ky) gene,” Mech. Dev., vol. 117, no. 1–2, pp. 289–292, Sep. 2002, doi: 10.1016/s0925-4773(02)00182-x.
[1837]	X. Li et al., “Cloning and expression patterns of neuromedin U and its receptors in pigs,” Neuropeptides, vol. 64, pp. 47–60, Aug. 2017, doi: 10.1016/j.npep.2017.04.003.
[1838]	Q. Wu, J. Zhang, C. Zhao, and J. Zhu, “[Cloning and sequencing of the papA gene from uropathogenic Escherichia coli 4030 strain],” Wei Sheng Yan Jiu, vol. 37, no. 5, pp. 574–577, Sep. 2008.
[1839]	W. Min, “CLONING OF HUMAN CELLS IN VITRO AND THEIR CYTOGENETIC CHARACTERS,” Acta Unio Int Contra Cancrum, vol. 20, pp. 1303–1306, 1964.
[1840]	Y. Shi, S. Ding, T. Zhang, F. Lu, J. Zhang, and Y. Wang, “[Cloning of the Helicobacter pylori thioredoxin-1 gene and characterization],” Beijing Da Xue Xue Bao, vol. 46, no. 2, pp. 190–194, Apr. 2014.
[1841]	L. G. Harshman et al., “Cloning, characterization, and genetics of the juvenile hormone esterase gene from Heliothis virescens,” Insect Biochem. Mol. Biol., vol. 24, no. 7, pp. 671–676, Jul. 1994, doi: 10.1016/0965-1748(94)90054-x.
[1842]	K. Ekino, S. Yonei, H. Oyama, T. Oka, Y. Nomura, and T. Shin, “Cloning, Purification, and Characterization of Tripeptidyl Peptidase from Streptomyces herbaricolor TY-21,” Appl. Biochem. Biotechnol., vol. 184, no. 1, pp. 239–252, Jan. 2018, doi: 10.1007/s12010-017-2547-8.
[1843]	R. Kosif and N. Konuk, “Clonninger’s temperament and character inventory profiles of anatomists: is there a relation with specialty choice?,” Bratisl Lek Listy, vol. 117, no. 2, pp. 112–118, 2016, doi: 10.4149/bll_2016_022.
[1844]	L. Guillemot et al., “Close look on cubic Tm:KY3F10 crystal for highly efficient lasing on the 3H4 → 3H5 transition,” Opt Express, vol. 28, no. 3, pp. 3451–3463, Feb. 2020, doi: 10.1364/OE.382650.
[1845]	F. Barbiera, R. Ciraulo, S. Cusmà, S. Pardo, and A. Lo Casto, “[Closed loop intestinal obstruction: role of computerized tomography],” Radiol Med, vol. 97, no. 1–2, pp. 54–59, Feb. 1999.
[1846]	T. Schenk, E. U. Walther, and N. Mai, “Closed- and open-loop handwriting performance in patients with multiple sclerosis,” Eur. J. Neurol., vol. 7, no. 3, pp. 269–279, May 2000, doi: 10.1046/j.1468-1331.2000.00068.x.
[1847]	Y. Liu et al., “Closed-loop control better than open-loop control of profofol TCI guided by BIS: a randomized, controlled, multicenter clinical trial to evaluate the CONCERT-CL closed-loop system,” PLoS ONE, vol. 10, no. 4, p. e0123862, 2015, doi: 10.1371/journal.pone.0123862.
[1848]	C. Kemlin et al., “Closed-Loop Control of the Centre of Pressure in Post-Stroke Patients With Balance Impairments,” IEEE Trans Neural Syst Rehabil Eng, vol. 27, no. 2, pp. 265–274, 2019, doi: 10.1109/TNSRE.2019.2892177.
[1849]	C. Zrenner, P. Belardinelli, F. Müller-Dahlhaus, and U. Ziemann, “Closed-Loop Neuroscience and Non-Invasive Brain Stimulation: A Tale of Two Loops,” Front Cell Neurosci, vol. 10, p. 92, 2016, doi: 10.3389/fncel.2016.00092.
[1850]	Z. Jin, X. Yu, and H. Ma, “Closed-loop resonant fiber optic gyro with an improved digital serrodyne modulation,” Opt Express, vol. 21, no. 22, pp. 26578–26588, Nov. 2013, doi: 10.1364/OE.21.026578.
[1851]	A. Kamiya, T. Kawada, S. Shimizu, and M. Sugimachi, “Closed-loop spontaneous baroreflex transfer function is inappropriate for system identification of neural arc but partly accurate for peripheral arc: predictability analysis,” J. Physiol. (Lond.), vol. 589, no. Pt 7, pp. 1769–1790, Apr. 2011, doi: 10.1113/jphysiol.2011.203455.
[1852]	D. M. Aronoff, “Clostridium novyi, sordellii, and tetani: mechanisms of disease,” Anaerobe, vol. 24, pp. 98–101, Dec. 2013, doi: 10.1016/j.anaerobe.2013.08.009.
[1853]	D. P. Edwards, E. M. Chisholm, and D. R. Donaldson, “Closure of transverse loop colostomy and loop ileostomy,” Ann R Coll Surg Engl, vol. 80, no. 1, pp. 33–35, Jan. 1998.
[1854]	M. Checcucci and E. Brunner, “[CME: Depression in Primary Care],” Praxis (Bern 1994), vol. 108, no. 2, pp. 145–151, Jan. 2019, doi: 10.1024/1661-8157/a003168.
[1855]	X. Wang et al., “Co-expression of COX-2 and 5-LO in primary glioblastoma is associated with poor prognosis,” J. Neurooncol., vol. 125, no. 2, pp. 277–285, Nov. 2015, doi: 10.1007/s11060-015-1919-6.
[1856]	M. Egeland, J. Warner-Schmidt, P. Greengard, and P. Svenningsson, “Co-expression of serotonin 5-HT(1B) and 5-HT(4) receptors in p11 containing cells in cerebral cortex, hippocampus, caudate-putamen and cerebellum,” Neuropharmacology, vol. 61, no. 3, pp. 442–450, Sep. 2011, doi: 10.1016/j.neuropharm.2011.01.046.
[1857]	M. Okhovat et al., “Co-option of the lineage-specific LAVA retrotransposon in the gibbon genome,” Proc. Natl. Acad. Sci. U.S.A., vol. 117, no. 32, pp. 19328–19338, Aug. 2020, doi: 10.1073/pnas.2006038117.
[1858]	S. Uçar and S. Karagöz, “Co-processing of olive bagasse with crude rapeseed oil via pyrolysis,” Waste Manag Res, vol. 35, no. 5, pp. 480–490, May 2017, doi: 10.1177/0734242X16680729.
[1859]	X. Zhang, J. Zhou, Y. Zheng, and D. Chen, “Co0.85Se Nanoparticles Encapsulated by Nitrogen-Enriched Hierarchically Porous Carbon for High-Performance Lithium-Ion Batteries,” ACS Appl Mater Interfaces, vol. 12, no. 8, pp. 9236–9247, Feb. 2020, doi: 10.1021/acsami.9b20866.
[1860]	J. Esser et al., “Coactosin-like protein functions as a stabilizing chaperone for 5-lipoxygenase: role of tryptophan 102,” Biochem. J., vol. 425, no. 1, pp. 265–274, Dec. 2009, doi: 10.1042/BJ20090856.
[1861]	K. Maduwage, K. Kularatne, A. Wazil, and I. Gawarammana, “Coagulopthy, acute kidney injury and death following Hypnale zara envenoming: the first case report from Sri Lanka,” Toxicon, vol. 58, no. 8, pp. 641–643, Dec. 2011, doi: 10.1016/j.toxicon.2011.09.014.
[1862]	J. M. Kasper, A. E. Smith, and J. D. Hommel, “Cocaine-Evoked Locomotor Activity Negatively Correlates With the Expression of Neuromedin U Receptor 2 in the Nucleus Accumbens,” Front Behav Neurosci, vol. 12, p. 271, 2018, doi: 10.3389/fnbeh.2018.00271.
[1863]	E. M. R. De Leenheer, I. J. M. Dhooge, E. Veuillet, G. Lina-Granade, and E. Truy, “Cochlear implantation in 3 adults with auditory neuropathy/auditory dys-synchrony,” B-ENT, vol. 4, no. 3, pp. 183–191, 2008.
[1864]	X. Wang, B. S. Hawkins, and K. Dickersin, “Cochrane systematic reviews and co-publication: dissemination of evidence on interventions for ophthalmic conditions,” Syst Rev, vol. 4, p. 118, Sep. 2015, doi: 10.1186/s13643-015-0104-5.
[1865]	R. Kinsella, T. Maher, and M. E. Clegg, “Coconut oil has less satiating properties than medium chain triglyceride oil,” Physiol. Behav., vol. 179, pp. 422–426, Oct. 2017, doi: 10.1016/j.physbeh.2017.07.007.
[1866]	J. Kreuger, A. Stengl, D. Skalitzky, and P. Wehmeyer, “Code of Federal Regulations (CFRs): where it all begins,” Qual Assur, vol. 3, no. 1, pp. 82–87, Mar. 1994.
[1867]	K. N. Megha, S. Adithya, K. P. Keerthana, and S. Konadath, “Coexistence of tinnitus and hyperacusis in individuals with auditory dys-synchrony: A single case study,” Intractable Rare Dis Res, vol. 5, no. 1, pp. 50–55, Feb. 2016, doi: 10.5582/irdr.2015.01044.
[1868]	H. L. Combs et al., “Cognition and Depression Following Deep Brain Stimulation of the Subthalamic Nucleus and Globus Pallidus Pars Internus in Parkinson’s Disease: A Meta-Analysis,” Neuropsychol Rev, vol. 25, no. 4, pp. 439–454, Dec. 2015, doi: 10.1007/s11065-015-9302-0.
[1869]	S. D. Denburg, R. M. Carbotte, and J. A. Denburg, “Cognition and mood in systemic lupus erythematosus. Evaluation and pathogenesis,” Ann. N. Y. Acad. Sci., vol. 823, pp. 44–59, Aug. 1997, doi: 10.1111/j.1749-6632.1997.tb48378.x.
[1870]	P. N. Mwangala et al., “Cognition, mood and quality-of-life outcomes among low literacy adults living with epilepsy in rural Kenya: A preliminary study,” Epilepsy Behav, vol. 85, pp. 45–51, 2018, doi: 10.1016/j.yebeh.2018.05.032.
[1871]	G. Gava, I. Orsili, S. Alvisi, I. Mancini, R. Seracchioli, and M. C. Meriggiola, “Cognition, Mood and Sleep in Menopausal Transition: The Role of Menopause Hormone Therapy,” Medicina (Kaunas), vol. 55, no. 10, Oct. 2019, doi: 10.3390/medicina55100668.
[1872]	A. Abbott, “Cognition: The brain’s decline,” Nature, vol. 492, no. 7427, pp. S4-5, Dec. 2012, doi: 10.1038/492S4a.
[1873]	G. Tedrus and R. de Lima Silva, “Cognitive and clinical variables associated with interictal dysphoric disorder in patients with epilepsy,” Epilepsy Behav, vol. 82, pp. 175–178, 2018, doi: 10.1016/j.yebeh.2018.01.008.
[1874]	S. Penna, “Cognitive and emotional dysfunction in mild cognitive impairment,” Clin. Geriatr. Med., vol. 29, no. 4, pp. 773–789, Nov. 2013, doi: 10.1016/j.cger.2013.07.004.
[1875]	M. Gandy, L. Sharpe, and K. N. Perry, “Cognitive behavior therapy for depression in people with epilepsy: a systematic review,” Epilepsia, vol. 54, no. 10, pp. 1725–1734, Oct. 2013, doi: 10.1111/epi.12345.
[1876]	L. Wolgensinger, “Cognitive behavioral group therapy for anxiety: recent developments,” Dialogues Clin Neurosci, vol. 17, no. 3, pp. 347–351, Sep. 2015.
[1877]	D. Vuralli, C. Ayata, and H. Bolay, “Cognitive dysfunction and migraine,” J Headache Pain, vol. 19, no. 1, p. 109, Nov. 2018, doi: 10.1186/s10194-018-0933-4.
[1878]	N. McNicholas, K. O’Connell, S. M. Yap, R. P. Killeen, M. Hutchinson, and C. McGuigan, “Cognitive dysfunction in early multiple sclerosis: a review,” QJM, vol. 111, no. 6, pp. 359–364, Jun. 2018, doi: 10.1093/qjmed/hcx070.
[1879]	G. M. MacQueen and K. A. Memedovich, “Cognitive dysfunction in major depression and bipolar disorder: Assessment and treatment options,” Psychiatry Clin. Neurosci., vol. 71, no. 1, pp. 18–27, Jan. 2017, doi: 10.1111/pcn.12463.
[1880]	H. Atique-Ur-Rehman and J. C. Neill, “Cognitive dysfunction in major depression: From assessment to novel therapies,” Pharmacol. Ther., vol. 202, pp. 53–71, 2019, doi: 10.1016/j.pharmthera.2019.05.013.
[1881]	E. Dunmore, D. M. Clark, and A. Ehlers, “Cognitive factors involved in the onset and maintenance of posttraumatic stress disorder (PTSD) after physical or sexual assault,” Behav Res Ther, vol. 37, no. 9, pp. 809–829, Sep. 1999, doi: 10.1016/s0005-7967(98)00181-8.
[1882]	B. Fougère, J. Delrieu, N. Del Campo, G. Soriano, S. Sourdet, and B. Vellas, “Cognitive Frailty: Mechanisms, Tools to Measure, Prevention and Controversy,” Clin. Geriatr. Med., vol. 33, no. 3, pp. 339–355, 2017, doi: 10.1016/j.cger.2017.03.001.
[1883]	S. Kramer, K. J. Vasil, O. F. Adunka, D. B. Pisoni, and A. C. Moberly, “Cognitive Functions in Adult Cochlear Implant Users, Cochlear Implant Candidates, and Normal-Hearing Listeners,” Laryngoscope Investig Otolaryngol, vol. 3, no. 4, pp. 304–310, Aug. 2018, doi: 10.1002/lio2.172.
[1884]	A. F. Elliott, M. D. Hell, A. Sheldrick-Michel, and B. Nielsen, “[Cognitive impairment after depression leads to disability],” Ugeskr. Laeg., vol. 178, no. 45, Nov. 2016.
[1885]	M.-L. Wang and W.-B. Li, “Cognitive impairment after traumatic brain injury: The role of MRI and possible pathological basis,” J. Neurol. Sci., vol. 370, pp. 244–250, Nov. 2016, doi: 10.1016/j.jns.2016.09.049.
[1886]	C. J. Treanor, J. Li, and M. Donnelly, “Cognitive impairment among prostate cancer patients: An overview of reviews,” Eur J Cancer Care (Engl), vol. 26, no. 6, Nov. 2017, doi: 10.1111/ecc.12642.
[1887]	J. Kewcharoen et al., “Cognitive impairment and 30-day rehospitalization rate in patients with acute heart failure: A systematic review and meta-analysis,” Indian Heart J, vol. 71, no. 1, pp. 52–59, Feb. 2019, doi: 10.1016/j.ihj.2018.12.006.
[1888]	J. A. Cannon et al., “Cognitive Impairment and Heart Failure: Systematic Review and Meta-Analysis,” J. Card. Fail., vol. 23, no. 6, pp. 464–475, Jun. 2017, doi: 10.1016/j.cardfail.2017.04.007.
[1889]	A. L. Nau et al., “Cognitive impairment and quality of life of people with epilepsy and neurocysticercosis in Zambia,” Epilepsy Behav, vol. 80, pp. 354–359, 2018, doi: 10.1016/j.yebeh.2017.10.042.
[1890]	N. Cerulla et al., “Cognitive impairment following chemotherapy for breast cancer: The impact of practice effect on results,” J Clin Exp Neuropsychol, vol. 41, no. 3, pp. 290–299, 2019, doi: 10.1080/13803395.2018.1546381.
[1891]	B. Solé et al., “Cognitive Impairment in Bipolar Disorder: Treatment and Prevention Strategies,” Int. J. Neuropsychopharmacol., vol. 20, no. 8, pp. 670–680, 01 2017, doi: 10.1093/ijnp/pyx032.
[1892]	U. G. Bronas, H. Puzantian, and M. Hannan, “Cognitive Impairment in Chronic Kidney Disease: Vascular Milieu and the Potential Therapeutic Role of Exercise,” Biomed Res Int, vol. 2017, p. 2726369, 2017, doi: 10.1155/2017/2726369.
[1893]	G. Prinzi, A. Santoro, P. Lamonaca, V. Cardaci, M. Fini, and P. Russo, “Cognitive Impairment in Chronic Obstructive Pulmonary Disease (COPD): Possible Utility of Marine Bioactive Compounds,” Mar Drugs, vol. 16, no. 9, Sep. 2018, doi: 10.3390/md16090313.
[1894]	D. A. Drew, D. E. Weiner, and M. J. Sarnak, “Cognitive Impairment in CKD: Pathophysiology, Management, and Prevention,” Am. J. Kidney Dis., vol. 74, no. 6, pp. 782–790, 2019, doi: 10.1053/j.ajkd.2019.05.017.
[1895]	S. Angermann et al., “Cognitive impairment in hemodialysis patients: Implementation of cut-off values for the Montreal Cognitive Assessment (MoCA)-test for feasible screening,” PLoS ONE, vol. 12, no. 10, p. e0184589, 2017, doi: 10.1371/journal.pone.0184589.
[1896]	V. Freitas Castro, P. Nascimento Alves, A. C. Franco, I. P. Martins, and I. Conceição, “Cognitive impairment in liver transplanted patients with transthyretin-related hereditary amyloid polyneuropathy,” Amyloid, vol. 24, no. 2, pp. 110–114, Jun. 2017, doi: 10.1080/13506129.2017.1335639.
[1897]	A. G. Trenova, G. S. Slavov, M. G. Manova, J. B. Aksentieva, L. D. Miteva, and S. A. Stanilova, “Cognitive Impairment in Multiple Sclerosis,” Folia Med (Plovdiv), vol. 58, no. 3, pp. 157–163, 01 2016, doi: 10.1515/folmed-2016-0029.
[1898]	T. Grzegorski and J. Losy, “Cognitive impairment in multiple sclerosis - a review of current knowledge and recent research,” Rev Neurosci, vol. 28, no. 8, pp. 845–860, 27 2017, doi: 10.1515/revneuro-2017-0011.
[1899]	N. Korakas and M. Tsolaki, “Cognitive Impairment in Multiple Sclerosis: A Review of Neuropsychological Assessments,” Cogn Behav Neurol, vol. 29, no. 2, pp. 55–67, Jun. 2016, doi: 10.1097/WNN.0000000000000097.
[1900]	P. Barone, D. Aarsland, D. Burn, M. Emre, J. Kulisevsky, and D. Weintraub, “Cognitive impairment in nondemented Parkinson’s disease,” Mov. Disord., vol. 26, no. 14, pp. 2483–2495, Dec. 2011, doi: 10.1002/mds.23919.
[1901]	H. Tachibana, “[Cognitive impairment in Parkinson’s disease],” Seishin Shinkeigaku Zasshi, vol. 115, no. 11, pp. 1142–1149, 2013.
[1902]	L. Culpepper, R. W. Lam, and R. S. McIntyre, “Cognitive Impairment in Patients With Depression: Awareness, Assessment, and Management,” J Clin Psychiatry, vol. 78, no. 9, pp. 1383–1394, Dec. 2017, doi: 10.4088/JCP.tk16043ah5c.
[1903]	E. Colgecen, A. Celikbilek, and D. T. Keskin, “Cognitive Impairment in Patients with Psoriasis: A Cross-Sectional Study Using the Montreal Cognitive Assessment,” Am J Clin Dermatol, vol. 17, no. 4, pp. 413–419, Aug. 2016, doi: 10.1007/s40257-016-0187-3.
[1904]	A. McCleery and K. H. Nuechterlein, “Cognitive impairment in psychotic illness: prevalence, profile of impairment, developmental course, and treatment considerations,” Dialogues Clin Neurosci, vol. 21, no. 3, pp. 239–248, 2019, doi: 10.31887/DCNS.2019.21.3/amccleery.
[1905]	T. Meade, N. Manolios, S. R. Cumming, P. G. Conaghan, and P. Katz, “Cognitive Impairment in Rheumatoid Arthritis: A Systematic Review,” Arthritis Care Res (Hoboken), vol. 70, no. 1, pp. 39–52, 2018, doi: 10.1002/acr.23243.
[1906]	P. Neu, T. Gooren, U. Niebuhr, and P. Schlattmann, “Cognitive impairment in schizophrenia and depression: A comparison of stability and course,” Appl Neuropsychol Adult, vol. 26, no. 3, pp. 215–228, Jun. 2019, doi: 10.1080/23279095.2017.1392962.
[1907]	S. Rüdiger et al., “Cognitive Impairment Is Reflected by an Increased Difference between Real and Imagined Timed Up and Go Test Performance,” Dement Geriatr Cogn Disord, vol. 44, no. 1–2, pp. 55–62, 2017, doi: 10.1159/000477760.
[1908]	P. Dalton, “Cognitive influences on health symptoms from acute chemical exposure,” Health Psychol, vol. 18, no. 6, pp. 579–590, Nov. 1999, doi: 10.1037//0278-6133.18.6.579.
[1909]	A.-W. Kruijt et al., “Cognitive reactivity, implicit associations, and the incidence of depression: a two-year prospective study,” PLoS ONE, vol. 8, no. 7, p. e70245, 2013, doi: 10.1371/journal.pone.0070245.
[1910]	X. Y. Liu et al., “Cognitive Training in Older Adults with Mild Cognitive Impairment,” Biomed. Environ. Sci., vol. 29, no. 5, pp. 356–364, May 2016, doi: 10.3967/bes2016.046.
[1911]	L. H. Jaycox, L. Zoellner, and E. B. Foa, “Cognitive-behavior therapy for PTSD in rape survivors,” J Clin Psychol, vol. 58, no. 8, pp. 891–906, Aug. 2002, doi: 10.1002/jclp.10065.
[1912]	Y. Che et al., “Cohort study to evaluate efficacy, safety and acceptability of a two-rod contraceptive implant during third, fourth and fifth year of product use in China,” Contracept X, vol. 1, p. 100008, 2019, doi: 10.1016/j.conx.2019.100008.
[1913]	Y.-C. Shen, C.-H. Liao, T.-C. Shen, and C.-Y. Tu, “Coil migration following transcatheter arterial embolization,” Intern. Med., vol. 53, no. 5, pp. 519–520, 2014, doi: 10.2169/internalmedicine.53.1784.
[1914]	K. K. Bhattarai, Q.-G. Xie, D. Pourshalimi, T. Younglove, and I. Kaloshian, “Coil-dependent signaling pathway is not required for Mi-1-mediated potato aphid resistance,” Mol. Plant Microbe Interact., vol. 20, no. 3, pp. 276–282, Mar. 2007, doi: 10.1094/MPMI-20-3-0276.
[1915]	I. Takac and B. Gorisek, “Cold knife conization and loop excision for cervical intraepithelial neoplasia,” Tumori, vol. 85, no. 4, pp. 243–246, Aug. 1999.
[1916]	J. A. Lindquist and P. R. Mertens, “Cold shock proteins: from cellular mechanisms to pathophysiology and disease,” Cell Commun. Signal, vol. 16, no. 1, p. 63, 26 2018, doi: 10.1186/s12964-018-0274-6.
[1917]	H. Takashima et al., “[Collagen diseases complicated with myelodysplastic syndrome (MDS)--report of three cases],” Ryumachi, vol. 34, no. 1, pp. 48–53, Feb. 1994.
[1918]	O. A. Magalhaes, H. C. Rohenkohl, L. T. de Souza, L. Schuler-Faccini, and T. M. Félix, “Collagen I Defect Corneal Profiles in Osteogenesis Imperfecta,” Cornea, vol. 37, no. 12, pp. 1561–1565, Dec. 2018, doi: 10.1097/ICO.0000000000001764.
[1919]	H. Ehrlich, M. Wysokowski, S. Żółtowska-Aksamitowska, I. Petrenko, and T. Jesionowski, “Collagens of Poriferan Origin,” Mar Drugs, vol. 16, no. 3, Mar. 2018, doi: 10.3390/md16030079.
[1920]	N. Robson and D. Rew, “Collective wisdom and decision making in surgical oncology,” Eur J Surg Oncol, vol. 36, no. 3, pp. 230–236, Mar. 2010, doi: 10.1016/j.ejso.2010.01.002.
[1921]	N. Kayın, D. Atalay, T. Türken Akçay, and H. S. Erge, “Color stability and change in bioactive compounds of red beet juice concentrate stored at different temperatures,” J Food Sci Technol, vol. 56, no. 11, pp. 5097–5106, Nov. 2019, doi: 10.1007/s13197-019-03982-5.
[1922]	A. Iregren, M. Andersson, and P. Nylén, “Color vision and occupational chemical exposures: I. An overview of tests and effects,” Neurotoxicology, vol. 23, no. 6, pp. 719–733, Dec. 2002, doi: 10.1016/S0161-813X(02)00088-8.
[1923]	D. H. Lee et al., “Colorectal Cancer Liver Metastases: Diagnostic Performance and Prognostic Value of PET/MR Imaging,” Radiology, vol. 280, no. 3, pp. 782–792, 2016, doi: 10.1148/radiol.2016151975.
[1924]	P. Rychahou et al., “Colorectal cancer lung metastasis treatment with polymer-drug nanoparticles,” J Control Release, vol. 275, pp. 85–91, 10 2018, doi: 10.1016/j.jconrel.2018.02.008.
[1925]	J. C. Hoffmann et al., “Combating the Health Risks of Sedentary Behavior in the Contemporary Radiology Reading Room,” AJR Am J Roentgenol, vol. 206, no. 6, pp. 1135–1140, Jun. 2016, doi: 10.2214/AJR.15.15496.
[1926]	T. Sugiura et al., “Combination chemotherapy with JTE-522, a novel selective cyclooxygenase-2 inhibitor, and cisplatin against gastric cancer cell lines in vitro and in vivo,” In Vivo, vol. 17, no. 3, pp. 229–233, Jun. 2003.
[1927]	L. P. M. Costa et al., “Combination of pelleting and monensin does not affect antioxidant properties and fatty acids in milk of grazing dairy cows supplemented with a concentrate containing soybean seeds,” Trop Anim Health Prod, vol. 52, no. 2, pp. 573–581, Mar. 2020, doi: 10.1007/s11250-019-02044-4.
[1928]	F. Horner, P. L. Lip, B. Mushtaq, R. Chavan, B. Mohammed, and A. Mitra, “Combination Therapy for Macular Oedema in Retinal Vein Occlusions: 3-Year Results from a Real-World Clinical Practice,” Clin Ophthalmol, vol. 14, pp. 955–965, 2020, doi: 10.2147/OPTH.S241044.
[1929]	P. Hellstern et al., “Combined dys-form of homozygous factor XI deficiency and heterozygous factor XII deficiency,” Haemostasis, vol. 15, no. 3, pp. 215–219, 1985, doi: 10.1159/000215147.
[1930]	C. Hou, Q. Jiang, Z. Song, G. Tan, and Z. Shi, “Combined heating and chemical treatment for oil recovery from aging crude oil,” Waste Manag Res, vol. 34, no. 7, pp. 686–690, Jul. 2016, doi: 10.1177/0734242X16649682.
[1931]	P. J. Brandvik, C. Storey, E. J. Davies, and Ø. Johansen, “Combined releases of oil and gas under pressure; the influence of live oil and natural gas on initial oil droplet formation,” Mar. Pollut. Bull., vol. 140, pp. 485–492, Mar. 2019, doi: 10.1016/j.marpolbul.2019.01.036.
[1932]	V. A. Aleksandrov and D. Schreiber, “[Combined transplacental carcinogenic action of N-nitrosomethylurea (NMU) and N-nitrosoethylurea (NEU) in rats],” Vopr Onkol, vol. 24, no. 4, pp. 38–43, 1978.
[1933]	J. H. Yoon et al., “Combined Use of MR Fat Quantification and MR Elastography in Living Liver Donors: Can It Reduce the Need for Preoperative Liver Biopsy?,” Radiology, vol. 276, no. 2, pp. 453–464, Aug. 2015, doi: 10.1148/radiol.15140908.
[1934]	M. Tazouta et al., “[Combined vitrectomy-lensectomy surgery with bag-in-the-lens or lens in the bag implantation: comparison of final visual acuity],” J Fr Ophtalmol, vol. 43, no. 4, pp. 298–304, Apr. 2020, doi: 10.1016/j.jfo.2019.08.015.
[1935]	J. K. Hammitt and Y. Zhang, “Combining experts’ judgments: comparison of algorithmic methods using synthetic data,” Risk Anal., vol. 33, no. 1, pp. 109–120, Jan. 2013, doi: 10.1111/j.1539-6924.2012.01833.x.
[1936]	T. Feng, W. Wei, L. Chen, A. Cerdà, L. Yang, and Y. Yu, “Combining land preparation and vegetation restoration for optimal soil eco-hydrological services in the Loess Plateau, China,” Sci. Total Environ., vol. 657, pp. 535–547, Mar. 2019, doi: 10.1016/j.scitotenv.2018.11.476.
[1937]	D. C. Catling, “Comment on ‘A hydrogen-rich early Earth atmosphere,’” Science, vol. 311, no. 5757, pp. 38; author reply 38, Jan. 2006, doi: 10.1126/science.1117827.
[1938]	J. Liu, B. Zhu, and W. Gao, “Comment on ‘A planet too rich in fiber,’” EMBO Rep., vol. 20, no. 3, 2019, doi: 10.15252/embr.201847514.
[1939]	R. C. DeCoster, R.-M. F. Bautista, and B. M. Evers, “Comment on ‘Training the Surgeon-Scientist in Today’s Healthcare Environment,’” Ann. Surg., vol. 270, no. 6, pp. e124–e125, 2019, doi: 10.1097/SLA.0000000000003302.
[1940]	J. V. Carter, N. J. Galbraith, W. Kim, and S. Galandiuk, “Comment on: Patient autonomy-centered self-care checklist reduces hospital readmissions after ileostomy creation,” Surgery, vol. 162, no. 3, pp. 693–694, 2017, doi: 10.1016/j.surg.2017.05.014.
[1941]	S. Striano, F. Zara, and P. Striano, “Comment to: overlap cases of eyelid myoclonia with absences and juvenile myoclonic epilepsy,” Seizure, vol. 16, no. 6, pp. 557–558, Sep. 2007, doi: 10.1016/j.seizure.2007.04.002.
[1942]	Y. Neria and A. Pickover, “Commentary on the Special Issue on Moral Injury: Advances, Gaps in Literature, and Future Directions,” J Trauma Stress, vol. 32, no. 3, pp. 459–464, 2019, doi: 10.1002/jts.22402.
[1943]	W. P. Nash, “Commentary on the Special Issue on Moral Injury: Unpacking Two Models for Understanding Moral Injury,” J Trauma Stress, vol. 32, no. 3, pp. 465–470, 2019, doi: 10.1002/jts.22409.
[1944]	A. Y. Shalev and R. H. Segman, “Commentary: biological findings in PTSD -- too much or too little?,” Prog. Brain Res., vol. 167, pp. 187–199, 2008, doi: 10.1016/S0079-6123(07)67013-7.
[1945]	M. Brown, “Commentary: the Economic Era: now to the real change,” Health Care Manage Rev, vol. 19, no. 4, pp. 73–81, 1994, doi: 10.1097/00004010-199401940-00009.
[1946]	P. Mladenka et al., “Common biomarkers of oxidative stress do not reflect cardiovascular dys/function in rats,” Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, vol. 157, no. 2, pp. 146–152, Jun. 2013, doi: 10.5507/bp.2013.033.
[1947]	S. Byford and S. Palmer, “Common errors and controversies in pharmacoeconomic analyses,” Pharmacoeconomics, vol. 13, no. 6, pp. 659–666, Jun. 1998, doi: 10.2165/00019053-199813060-00002.
[1948]	J. Wan and K. T. Rew, “Common penile problems,” Prim. Care, vol. 37, no. 3, pp. 627–642, x, Sep. 2010, doi: 10.1016/j.pop.2010.04.010.
[1949]	U. Lagerman and O. Höök, “Communication aids for patients with dys/anarthria,” Scand J Rehabil Med, vol. 14, no. 4, pp. 155–158, 1982.
[1950]	D. Brackett and C. V. Zara, “Communication outcomes related to early implantation,” Am J Otol, vol. 19, no. 4, pp. 453–460, Jul. 1998.
[1951]	J. Bergmann, “Communication: Science is not about simple stories,” Nature, vol. 503, no. 7475, p. 198, Nov. 2013, doi: 10.1038/503198f.
[1952]	C. Marston et al., “Community participation for transformative action on women’s, children’s and adolescents’ health,” Bull. World Health Organ., vol. 94, no. 5, pp. 376–382, May 2016, doi: 10.2471/BLT.15.168492.
[1953]	H. Dolo et al., “Community perceptions of epilepsy and its treatment in an onchocerciasis endemic region in Ituri, Democratic Republic of Congo,” Infect Dis Poverty, vol. 7, no. 1, p. 115, Dec. 2018, doi: 10.1186/s40249-018-0498-0.
[1954]	R. C. Sadler, C. Hippensteel, V. Nelson, E. Greene-Moton, and C. D. Furr-Holden, “Community-engaged development of a GIS-based healthfulness index to shape health equity solutions,” Soc Sci Med, vol. 227, pp. 63–75, 2019, doi: 10.1016/j.socscimed.2018.07.030.
[1955]	Á. Frías and C. Palma, “Comorbidity between post-traumatic stress disorder and borderline personality disorder: a review,” Psychopathology, vol. 48, no. 1, pp. 1–10, 2015, doi: 10.1159/000363145.
[1956]	B. Göbel, D. Langemann, K. M. Oltmanns, and M. Chung, “Compact energy metabolism model: brain controlled energy supply,” J. Theor. Biol., vol. 264, no. 4, pp. 1214–1224, Jun. 2010, doi: 10.1016/j.jtbi.2010.02.033.
[1957]	D. Tran, J. He, G. N. Glickman, and K. F. Woodmansey, “Comparative Analysis of Calcium Silicate-based Root Filling Materials Using an Open Apex Model,” J Endod, vol. 42, no. 4, pp. 654–658, Apr. 2016, doi: 10.1016/j.joen.2016.01.015.
[1958]	X.-F. Zhang, L. Ou-Yang, D.-Q. Dai, M.-Y. Wu, Y. Zhu, and H. Yan, “Comparative analysis of housekeeping and tissue-specific driver nodes in human protein interaction networks,” BMC Bioinformatics, vol. 17, no. 1, p. 358, Sep. 2016, doi: 10.1186/s12859-016-1233-0.
[1959]	Y. Yu, J. Mao, and X. Chen, “Comparative analysis of internal and external characteristics of lead-acid battery and lithium-ion battery systems based on composite flow analysis,” Sci. Total Environ., vol. 746, p. 140763, Jul. 2020, doi: 10.1016/j.scitotenv.2020.140763.
[1960]	M. Wang, I. Vogel, and H. Kalthoff, “[Comparative analysis of metastatic variants from the colorectal tumor cell line HT-29],” Zhejiang Da Xue Xue Bao Yi Xue Ban, vol. 31, no. 5, pp. 355–358, Aug. 2002.
[1961]	T. Kaizuka and T. Hayashi, “Comparative analysis of palmitoylation sites of serotonin (5-HT) receptors in vertebrates,” Neuropsychopharmacol Rep, vol. 38, no. 2, pp. 75–85, 2018, doi: 10.1002/npr2.12011.
[1962]	Y. Kato, R. Ishii, and T. Noguchi, “Comparative Analysis of the Interaction of the Primary Quinone QA in Intact and Mn-Depleted Photosystem II Membranes Using Light-Induced ATR-FTIR Spectroscopy,” Biochemistry, vol. 55, no. 46, pp. 6355–6358, Nov. 2016, doi: 10.1021/acs.biochem.6b01052.
[1963]	D. Yang, G. Wu, P. Li, H. Zhang, and X. Qi, “Comparative analysis of the oil absorption behavior and microstructural changes of fresh and pre-frozen potato strips during frying via MRl, SEM, and XRD,” Food Res. Int., vol. 122, pp. 295–302, 2019, doi: 10.1016/j.foodres.2019.04.024.
[1964]	H. Xiang, “Comparative aspects of the role of neuropeptide Y in the regulation of the vertebrate heart,” Cardioscience, vol. 5, no. 4, pp. 209–213, Dec. 1994.
[1965]	A. Chacko, T. Tikku, R. Khanna, R. P. Maurya, and K. Srivastava, “Comparative assessment of the efficacy of closed helical loop and T-loop for space closure in lingual orthodontics-a finite element study,” Prog Orthod, vol. 19, no. 1, p. 14, May 2018, doi: 10.1186/s40510-018-0210-8.
[1966]	C.-S. Wu, “Comparative assessment of the interface between poly(3-hydroxybutyrate-co-3-hydroxyvalerate) and fish scales in composites: Preparation, characterization, and applications,” Mater Sci Eng C Mater Biol Appl, vol. 104, p. 109878, Nov. 2019, doi: 10.1016/j.msec.2019.109878.
[1967]	S. Dehning, E. Girma, S. Gasperi, S. Meyer, M. Tesfaye, and M. Siebeck, “Comparative cross-sectional study of empathy among first year and final year medical students in Jimma University, Ethiopia: steady state of the heart and opening of the eyes,” BMC Med Educ, vol. 12, p. 34, May 2012, doi: 10.1186/1472-6920-12-34.
[1968]	X. F. Dong, S. Liu, and J. M. Tong, “Comparative Effect of Dietary Soybean Oil, Fish Oil, and Coconut Oil on Performance, Egg Quality and Some Blood Parameters in Laying Hens,” Poult. Sci., vol. 97, no. 7, pp. 2460–2472, Jul. 2018, doi: 10.3382/ps/pey094.
[1969]	M. A. Nystoriak et al., “Comparative effects of parent and heated cinnamaldehyde on the function of human iPSC-derived cardiac myocytes,” Toxicol In Vitro, vol. 61, p. 104648, Dec. 2019, doi: 10.1016/j.tiv.2019.104648.
[1970]	D. Babji et al., “Comparative Evaluation of Immunohistochemical Expression of p16 with p16 Microsatellite Marker by PCR in Surgical Margins of Oral Squamous Cell Carcinoma,” Indian J Otolaryngol Head Neck Surg, vol. 71, no. Suppl 1, pp. 716–723, Oct. 2019, doi: 10.1007/s12070-018-1517-y.
[1971]	A. Sengupta et al., “Comparative evaluation of MAX, MXene, NanoMAX, and NanoMAX-derived-MXene for microwave absorption and Li ion battery anode applications,” Nanoscale, vol. 12, no. 15, pp. 8466–8476, Apr. 2020, doi: 10.1039/c9nr10980c.
[1972]	R. Yin, Y.-S. Jang, M.-H. Lee, and T.-S. Bae, “Comparative Evaluation of Mechanical Properties and Wear Ability of Five CAD/CAM Dental Blocks,” Materials (Basel), vol. 12, no. 14, Jul. 2019, doi: 10.3390/ma12142252.
[1973]	R. Yin, Y.-K. Kim, Y.-S. Jang, J.-J. Lee, M.-H. Lee, and T.-S. Bae, “Comparative evaluation of the mechanical properties of CAD/CAM dental blocks,” Odontology, vol. 107, no. 3, pp. 360–367, Jul. 2019, doi: 10.1007/s10266-018-0407-9.
[1974]	T.-K. Kwon et al., “Comparative fracture strength analysis of Lava and Digident CAD/CAM zirconia ceramic crowns,” J Adv Prosthodont, vol. 5, no. 2, pp. 92–97, May 2013, doi: 10.4047/jap.2013.5.2.92.
[1975]	I. K. Jordan and J. F. McDonald, “Comparative genomics and evolutionary dynamics of Saccharomyces cerevisiae Ty elements,” Genetica, vol. 107, no. 1–3, pp. 3–13, 1999.
[1976]	O. Adeola and D. Ragland, “Comparative ileal amino acid digestibility of distillers’ grains for growing pigs,” Anim Nutr, vol. 2, no. 4, pp. 262–266, Dec. 2016, doi: 10.1016/j.aninu.2016.07.008.
[1977]	A. Silva, P. Gunawardena, D. Weilgama, K. Maduwage, and I. Gawarammana, “Comparative in-vivo toxicity of venoms from South Asian hump-nosed pit vipers (Viperidae: Crotalinae: Hypnale),” BMC Res Notes, vol. 5, p. 471, Aug. 2012, doi: 10.1186/1756-0500-5-471.
[1978]	P. Mehra, B. K. Pandey, and J. Giri, “Comparative Morphophysiological Analyses and Molecular Profiling Reveal Pi-Efficient Strategies of a Traditional Rice Genotype,” Front Plant Sci, vol. 6, p. 1184, 2015, doi: 10.3389/fpls.2015.01184.
[1979]	T. Risler, A. Schwab, B. Kramer, N. Braun, and C. Erley, “Comparative pharmacokinetics and pharmacodynamics of loop diuretics in renal failure,” Cardiology, vol. 84 Suppl 2, pp. 155–161, 1994, doi: 10.1159/000176468.
[1980]	J. K. Rilling and M. P. van den Heuvel, “Comparative Primate Connectomics,” Brain Behav. Evol., vol. 91, no. 3, pp. 170–179, 2018, doi: 10.1159/000488886.
[1981]	X.-H. Jia et al., “Comparative studies of saponins in 1-3-year-old main roots, fibrous roots, and rhizomes of Panax notoginseng, and identification of different parts and growth-year samples,” J Nat Med, vol. 67, no. 2, pp. 339–349, Apr. 2013, doi: 10.1007/s11418-012-0691-6.
[1982]	D. K. Asch, M. Orejas, R. F. Geever, and M. E. Case, “Comparative studies of the quinic acid (qa) cluster in several Neurospora species with special emphasis on the qa-x-qa-2 intergenic region,” Mol. Gen. Genet., vol. 230, no. 3, pp. 337–344, Dec. 1991, doi: 10.1007/BF00280289.
[1983]	H. E. Schaefer, “Comparative studies on the antagonism of proliferation and atrophy in atherosclerosis,” In Vivo, vol. 13, no. 1, pp. 93–97, Feb. 1999.
[1984]	I. S. Johnson, P. J. Simpson, and J. C. Cline, “Comparative studies with chemotherapeutic agents in biologically diverse in vitro cell systems,” Cancer Res., vol. 22, pp. 617–626, Jun. 1962.
[1985]	Y. Zhou, J. Shi, L. Yang, Q. Tang, Y. Cheng, and X. Zhang, “[Comparative study of different methods of blood purification treatment of paraquat intoxication],” Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, vol. 32, no. 11, pp. 862–864, Nov. 2014.
[1986]	L. Huang et al., “Comparative Study of L-Asparaginase-Based LOP Regimen Over CHOP Regimen Before Radiotherapy for Stage IIE Extranodal Nasal Type NK/T Cell Lymphoma: A Study of 2 Centers,” Clin Lymphoma Myeloma Leuk, vol. 17, no. 3, pp. 152–158, 2017, doi: 10.1016/j.clml.2016.12.003.
[1987]	X. Chen, X. Chen, K. H. Schoenbach, S. Zheng, and R. J. Swanson, “Comparative study of long- and short-pulsed electric fields for treating melanoma in an in vivo mouse model,” In Vivo, vol. 25, no. 1, pp. 23–27, Feb. 2011.
[1988]	A. M. Joubert, A. Panzer, F. Joubert, M. L. Lottering, P. C. Bianchi, and J. C. Seegers, “Comparative study of the effects of polyunsaturated fatty acids and their metabolites on cell growth and tyrosine kinase activity in oesophageal carcinoma cells,” Prostaglandins Leukot. Essent. Fatty Acids, vol. 61, no. 3, pp. 171–182, Sep. 1999, doi: 10.1054/plef.1999.0087.
[1989]	F. Du, Q. Xie, L. Fang, and H. Su, “Comparative study on nutrient removal of agricultural non-point source pollution for three filter media filling schemes in eco-soil reactors,” J Water Health, vol. 14, no. 4, pp. 600–608, Aug. 2016, doi: 10.2166/wh.2016.189.
[1990]	M. Sajjadi and Z. Bathaie, “Comparative Study on The Preventive Effect of Saffron Carotenoids, Crocin and Crocetin, in NMU-Induced Breast Cancer in Rats,” Cell J, vol. 19, no. 1, pp. 94–101, Jun. 2017, doi: 10.22074/cellj.2016.3901.
[1991]	D. Feng, J. Hao, R. Liao, X. Chen, L. Cheng, and M. Liu, “Comparative Study on the Thermal-Aging Characteristics of Cellulose Insulation Polymer Immersed in New Three-Element Mixed Oil and Mineral Oil,” Polymers (Basel), vol. 11, no. 8, Aug. 2019, doi: 10.3390/polym11081292.
[1992]	E. Lebacq, “Comparative tolerability and immunogenicity of Typherix or Typhim Vi in healthy adults: 0, 12-month and 0, 24-month administration,” BioDrugs, vol. 15 Suppl 1, pp. 5–12, 2001, doi: 10.2165/00063030-200115001-00002.
[1993]	S. Bräuning, A. Catanach, J. M. Lord, R. Bicknell, and R. C. Macknight, “Comparative transcriptome analysis of the wild-type model apomict Hieracium praealtum and its loss of parthenogenesis (lop) mutant,” BMC Plant Biol., vol. 18, no. 1, p. 206, Sep. 2018, doi: 10.1186/s12870-018-1423-1.
[1994]	M. Liu, J. Pan, Z. Dong, Y. Cheng, J. Gong, and X. Wu, “Comparative transcriptome reveals the potential modulation mechanisms of estradiol affecting ovarian development of female Portunus trituberculatus,” PLoS ONE, vol. 14, no. 12, p. e0226698, 2019, doi: 10.1371/journal.pone.0226698.
[1995]	V. B. Dwaraka, J. J. Smith, M. R. Woodcock, and S. R. Voss, “Comparative transcriptomics of limb regeneration: Identification of conserved expression changes among three species of Ambystoma,” Genomics, vol. 111, no. 6, pp. 1216–1225, 2019, doi: 10.1016/j.ygeno.2018.07.017.
[1996]	S. A. Haist, J. F. Wilson, N. L. Brigham, S. E. Fosson, and A. V. Blue, “Comparing fourth-year medical students with faculty in the teaching of physical examination skills to first-year students,” Acad Med, vol. 73, no. 2, pp. 198–200, Feb. 1998, doi: 10.1097/00001888-199802000-00020.
[1997]	T. Najafi Ghezeljeh and F. Mohaddes Ardebili, “Comparing the effect of patients preferred music and Swedish massage on anticipatory anxiety in patients with burn injury: Randomized controlled clinical trial,” Complement Ther Clin Pract, vol. 32, pp. 55–60, Aug. 2018, doi: 10.1016/j.ctcp.2018.05.002.
[1998]	H. K. Kim, Y. J. Chai, H. Y. Lee, H. Y. Kim, and G. Dionigi, “Comparing the safety of harmonic ACE and ACE+ around the recurrent laryngeal nerve in swine models,” Ann Surg Treat Res, vol. 94, no. 6, pp. 285–290, Jun. 2018, doi: 10.4174/astr.2018.94.6.285.
[1999]	J. Rhodes, D. R. Fulton, J. C. Levine, and G. R. Marx, “Comparison Between the Mean dP/dt During Isovolumetric Contraction and Other Echocardiographic Indexes of Ventricular Systolic Function,” Echocardiography, vol. 14, no. 3, pp. 215–222, May 1997, doi: 10.1111/j.1540-8175.1997.tb00713.x.
[2000]	E. Wolff, “[Comparison between the nutritive values of embryo extract and serums in the culture in vitro of the syrinx of the chick embryo],” C. R. Seances Soc. Biol. Fil., vol. 148, no. 23–24, pp. 2078–2080, Dec. 1954.
[2001]	V. Patil, A. Vijayakumar, M. B. Ajitha, and S. Kumar L, “Comparison between Tube Ileostomy and Loop Ileostomy as a Diversion Procedure,” ISRN Surg, vol. 2012, p. 547523, 2012, doi: 10.5402/2012/547523.
[2002]	L. Lu et al., “Comparison of 3.0T MRI with 3D LAVA sequence and digital subtraction angiography for the assessment of accessory hepatic veins in Budd-Chiari syndrome,” J Magn Reson Imaging, vol. 45, no. 2, pp. 401–409, 2017, doi: 10.1002/jmri.25381.
[2003]	B. Zhu et al., “Comparison of accumulation, subcellular location, and sonodynamic cytotoxicity between hematoporphyrin and protoporphyrin IX in L1210 cells,” Chemotherapy, vol. 56, no. 5, pp. 403–410, 2010, doi: 10.1159/000317743.
[2004]	S. J. Hwang, S. T. Ho, and S. M. Shieh, “[Comparison of anesthetic morbidity and mortality before and after the implementation of quality assurance in Tri-Service General Hospital],” Ma Zui Xue Za Zhi, vol. 30, no. 1, pp. 13–20, Mar. 1992.
[2005]	K. H. Lavoie, A. S. Winter, K. J. H. Read, E. M. Hughes, M. N. Spilde, and D. E. Northup, “Comparison of bacterial communities from lava cave microbial mats to overlying surface soils from Lava Beds National Monument, USA,” PLoS ONE, vol. 12, no. 2, p. e0169339, 2017, doi: 10.1371/journal.pone.0169339.
[2006]	J. J. Marshall Hathaway et al., “Comparison of Bacterial Diversity in Azorean and Hawai’ian Lava Cave Microbial Mats,” Geomicrobiol. J., vol. 31, no. 3, pp. 205–220, 2014, doi: 10.1080/01490451.2013.777491.
[2007]	K. Mashima et al., “Comparison of blast percentage calculated based on bone marrow all nucleated cells and non-erythroid cells in myelodysplastic syndromes with erythroid hyperplasia,” Ann. Hematol., vol. 98, no. 5, pp. 1127–1133, May 2019, doi: 10.1007/s00277-018-3560-x.
[2008]	J. Zhao, L. Zou, D. He, and E. Ellis, “Comparison of bone adaptation after modification in biomet standard alloplastic temporomandibular joint prostheses,” J Craniomaxillofac Surg, vol. 46, no. 10, pp. 1707–1711, Oct. 2018, doi: 10.1016/j.jcms.2018.07.024.
[2009]	A. M. Zeidan et al., “Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs de novo myelodysplastic syndromes: a report on behalf of the MDS Clinical Research Consortium,” Leukemia, vol. 31, no. 6, pp. 1391–1397, 2017, doi: 10.1038/leu.2017.33.
[2010]	W. Ahmed, V. J. Harwood, P. Gyawali, J. P. S. Sidhu, and S. Toze, “Comparison of concentration methods for quantitative detection of sewage-associated viral markers in environmental waters,” Appl. Environ. Microbiol., vol. 81, no. 6, pp. 2042–2049, Mar. 2015, doi: 10.1128/AEM.03851-14.
[2011]	J. Fang, D. Zuo, and P. H. Yu, “Comparison of cytotoxicity of a quaternary pyridinium metabolite of haloperidol (HP+) with neurotoxin N-methyl-4-phenylpyridinium (MPP+) towards cultured dopaminergic neuroblastoma cells,” Psychopharmacology (Berl.), vol. 121, no. 3, pp. 373–378, Oct. 1995, doi: 10.1007/BF02246077.
[2012]	T. Rahim and R. Rashid, “Comparison of depression symptoms between primary depression and secondary-to-schizophrenia depression,” Int J Psychiatry Clin Pract, vol. 21, no. 4, pp. 314–317, Nov. 2017, doi: 10.1080/13651501.2017.1324036.
[2013]	H. Matsuoka, I. Kuwajima, K. Shimada, H. Mitamura, and T. Saruta, “Comparison of efficacy and safety between bisoprolol transdermal patch (TY-0201) and bisoprolol fumarate oral formulation in Japanese patients with grade I or II essential hypertension: randomized, double-blind, placebo-controlled study,” J Clin Hypertens (Greenwich), vol. 15, no. 11, pp. 806–814, Nov. 2013, doi: 10.1111/jch.12208.
[2014]	A.-S. Archambault et al., “Comparison of eight 15-lipoxygenase (LO) inhibitors on the biosynthesis of 15-LO metabolites by human neutrophils and eosinophils,” PLoS ONE, vol. 13, no. 8, p. e0202424, 2018, doi: 10.1371/journal.pone.0202424.
[2015]	S. Akhter, U. Ali Warraich, N. Rizvi, N. Idrees, and F. Zaina, “Comparison of end tidal carbon monoxide (eCO) levels in shisha (water pipe) and cigarette smokers,” Tob Induc Dis, vol. 12, no. 1, p. 10, 2014, doi: 10.1186/1617-9625-12-10.
[2016]	P. Mills, L. Braun, and D. Marohl, “Comparison of EPA’s QMS to SEI’s CMMI,” Qual Assur, vol. 9, no. 3–4, pp. 165–171, Dec. 2001, doi: 10.1080/713844030.
[2017]	K. Nakahara et al., “Comparison of feeding suppression by the anorexigenic hormones neuromedin U and neuromedin S in rats,” J. Endocrinol., vol. 207, no. 2, pp. 185–193, Nov. 2010, doi: 10.1677/JOE-10-0081.
[2018]	F. Ran, Y. Shi, T. Qiao, T. Shang, Z. Liu, and C.-J. Liu, “Comparison of Foam Sclerotherapy Alone or Combined With Stripping of the Great Saphenous Vein for Treating Varicose Veins,” Dermatol Surg, vol. 43, no. 4, pp. 541–547, Apr. 2017, doi: 10.1097/DSS.0000000000001022.
[2019]	A. Cray, C. Markham, M. Ryan, A. Herschtal, S. Y. Ngan, and S. Chander, “Comparison of four 3D conformal treatment techniques to optimise radiotherapy treatment for anal cancer,” J Med Radiat Sci, vol. 61, no. 4, pp. 253–260, Dec. 2014, doi: 10.1002/jmrs.83.
[2020]	T. Ensho et al., “Comparison of glucose tolerance between wild-type mice and mice with double knockout of neuromedin U and neuromedin S,” J. Vet. Med. Sci., vol. 81, no. 9, pp. 1305–1312, Sep. 2019, doi: 10.1292/jvms.19-0320.
[2021]	T. F. Schaible and J. Scheuer, “Comparison of heart function in male and female rats,” Basic Res. Cardiol., vol. 79, no. 4, pp. 402–412, Aug. 1984, doi: 10.1007/BF01908140.
[2022]	T. Yamashita, T. Ikeda, and Y. Akita, “Comparison of heart rate reduction effect and safety between bisoprolol transdermal patch and bisoprolol fumarate oral formulation in Japanese patients with persistent/permanent atrial fibrillation (BISONO-AF study),” J Cardiol, vol. 73, no. 5, pp. 386–393, 2019, doi: 10.1016/j.jjcc.2018.11.009.
[2023]	W. L. Whittier, H. A. Mansy, D. R. Rutz, A. M. Lewis, and R. H. Sandler, “Comparison of hemodialysis access flow measurements using flow dilution and in-line dialysance,” ASAIO J., vol. 55, no. 4, pp. 369–372, Aug. 2009, doi: 10.1097/MAT.0b013e3181a90246.
[2024]	K. Samji, A. Alrashed, W. M. Shabana, M. D. McInnes, E. Bayram, and N. Schieda, “Comparison of high-resolution T1W 3D GRE (LAVA) with 2-point Dixon fat/water separation (FLEX) to T1W fast spin echo (FSE) in prostate cancer (PCa),” Clin Imaging, vol. 40, no. 3, pp. 407–413, Jun. 2016, doi: 10.1016/j.clinimag.2015.11.023.
[2025]	T. Tarin, S. Kimm, B. Chung, R. Shinghal, and J. Reese, “Comparison of holding strength of suture anchors on human renal capsule,” J. Endourol., vol. 24, no. 2, pp. 293–297, Feb. 2010, doi: 10.1089/end.2009.0211.
[2026]	T.-C. Huang et al., “Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies,” Leukemia, vol. 22, no. 3, pp. 544–550, Mar. 2008, doi: 10.1038/sj.leu.2405076.
[2027]	X. Li, F. Xu, Q. He, L. Wu, Z. Zhang, and C. Chang, “Comparison of immunological abnormalities of lymphocytes in bone marrow in myelodysplastic syndrome (MDS) and aplastic anemia (AA),” Intern. Med., vol. 49, no. 14, pp. 1349–1355, 2010, doi: 10.2169/internalmedicine.49.3477.
[2028]	S.-J. Rew et al., “Comparison of intraductal ultrasonography-directed and cholangiography-directed endoscopic retrograde biliary drainage in patients with a biliary obstruction,” Korean J. Intern. Med., vol. 31, no. 5, pp. 872–879, Sep. 2016, doi: 10.3904/kjim.2015.291.
[2029]	K. Johansson, T. Gillgren, S. Winestrand, L. Järnström, and L. J. Jönsson, “Comparison of lignin derivatives as substrates for laccase-catalyzed scavenging of oxygen in coatings and films,” J Biol Eng, vol. 8, no. 1, p. 1, Jan. 2014, doi: 10.1186/1754-1611-8-1.
[2030]	B. T. Acar, O. Muftuoglu, and S. Acar, “Comparison of macular thickness measured by optical coherence tomography after deep anterior lamellar keratoplasty and penetrating keratoplasty,” Am. J. Ophthalmol., vol. 152, no. 5, pp. 756-761.e2, Nov. 2011, doi: 10.1016/j.ajo.2011.05.001.
[2031]	L.-Y. Liu, J.-J. Guo, Y.-X. Du, Q. Wang, and L.-H. Qiu, “[Comparison of mechanical properties of three machinable resin ceramic composite materials],” Shanghai Kou Qiang Yi Xue, vol. 28, no. 1, pp. 25–29, Feb. 2019.
[2032]	A. van der Laarse et al., “Comparison of myocardial changes between pressure induced hypertrophy and normal growth in the rat heart,” Cardiovasc. Res., vol. 23, no. 4, pp. 308–314, Apr. 1989, doi: 10.1093/cvr/23.4.308.
[2033]	A. Otomo et al., “Comparison of outcome in dogs undergoing single-incision laparoscopic-assisted intestinal surgery and open laparotomy for simple small intestinal foreign body removal,” Vet Surg, vol. 48, no. S1, pp. O83–O90, Jun. 2019, doi: 10.1111/vsu.13131.
[2034]	Y.-H. Kuan, A. M. Nafchi, N. Huda, F. Ariffin, and A. A. Karim, “Comparison of physicochemical and functional properties of duck feet and bovine gelatins,” J. Sci. Food Agric., vol. 97, no. 5, pp. 1663–1671, Mar. 2017, doi: 10.1002/jsfa.7970.
[2035]	S.-Y. Kiessling, M. A. Broglie, A. Soltermann, G. F. Huber, and S. J. Stoeckli, “Comparison of PI3K Pathway in HPV-Associated Oropharyngeal Cancer With and Without Tobacco Exposure,” Laryngoscope Investig Otolaryngol, vol. 3, no. 4, pp. 283–289, Aug. 2018, doi: 10.1002/lio2.175.
[2036]	C. Shimono et al., “[Comparison of port needle with safety device between Huber Plus (HP) and Poly PERF Safe (PPS)],” Gan To Kagaku Ryoho, vol. 37, no. 5, pp. 947–951, May 2010.
[2037]	B. F. Richards, N. A. Janovick, K. M. Moyes, D. E. Beever, and J. K. Drackley, “Comparison of prepartum low-energy or high-energy diets with a 2-diet far-off and close-up strategy for multiparous and primiparous cows,” J. Dairy Sci., Aug. 2020, doi: 10.3168/jds.2020-18603.
[2038]	S. Wiboonchutikul, S. Sungkanuparph, C. Sukasem, C. Wathipthun, and W. Chantratita, “Comparison of protease inhibitor (PI) resistance-associated mutations between PI-naïve and PI-experienced HIV-1 infected patients in Thailand where subtype A/E is predominant,” Curr. HIV Res., vol. 8, no. 6, pp. 456–460, Sep. 2010, doi: 10.2174/157016210793499321.
[2039]	C. Abe et al., “Comparison of psychiatric comorbidities and impact on quality of life in patients with epilepsy or psychogenic nonepileptic spells,” Epilepsy Behav, vol. 102, p. 106649, 2020, doi: 10.1016/j.yebeh.2019.106649.
[2040]	J. G. Cha, J. S. Yi, J. K. Han, and Y. K. Lee, “Comparison of Quantitative Cartilage T2 Measurements and Qualitative MR Imaging between Professional Ballet Dancers and Healthy Volunteers,” Radiology, vol. 276, no. 1, pp. 199–206, Jul. 2015, doi: 10.1148/radiol.15142021.
[2041]	X. Sun et al., “Comparison of safety of loop ileostomy and loop transverse colostomy for low-lying rectal cancer patients undergoing anterior resection: A retrospective, single institute, propensity score-matched study,” J BUON, vol. 24, no. 1, pp. 123–129, Feb. 2019.
[2042]	X. Sun et al., “Comparison of safety of loop ileostomy and loop transverse colostomy for low-lying rectal cancer patients undergoing anterior resection: A retrospective, single institution, propensity score-matched study,” Asia Pac J Clin Oncol, Mar. 2020, doi: 10.1111/ajco.13322.
[2043]	D. F. Keren, D. Hedstrom, R. Gulbranson, C.-N. Ou, and R. Bak, “Comparison of Sebia Capillarys capillary electrophoresis with the Primus high-pressure liquid chromatography in the evaluation of hemoglobinopathies,” Am. J. Clin. Pathol., vol. 130, no. 5, pp. 824–831, Nov. 2008, doi: 10.1309/AJCPQY80HZWHHGZF.
[2044]	H. Pult and B. Riede-Pult, “Comparison of subjective grading and objective assessment in meibography,” Cont Lens Anterior Eye, vol. 36, no. 1, pp. 22–27, Feb. 2013, doi: 10.1016/j.clae.2012.10.074.
[2045]	J. D. Bundy, K. T. Mills, and J. He, “Comparison of the 2017 ACC/AHA Hypertension Guideline with Earlier Guidelines on Estimated Reductions in Cardiovascular Disease,” Curr. Hypertens. Rep., vol. 21, no. 10, p. 76, 31 2019, doi: 10.1007/s11906-019-0980-5.
[2046]	H. Okuma et al., “Comparison of the cardiothoracic ratio between postmortem and antemortem computed tomography,” Leg Med (Tokyo), vol. 24, pp. 86–91, Jan. 2017, doi: 10.1016/j.legalmed.2016.12.006.
[2047]	R. Loughlin, B. F. Gilmore, P. A. McCarron, and M. M. Tunney, “Comparison of the cidal activity of tea tree oil and terpinen-4-ol against clinical bacterial skin isolates and human fibroblast cells,” Lett. Appl. Microbiol., vol. 46, no. 4, pp. 428–433, Apr. 2008, doi: 10.1111/j.1472-765X.2008.02334.x.
[2048]	H. K. Ahn, K. C. Koo, B. H. Chung, and K. S. Lee, “Comparison of the delta neutrophil index with procalcitonin, erythrocyte sedimentation rate, and C-reactive protein as predictors of sepsis in patients with acute prostatitis,” Prostate Int, vol. 6, no. 4, pp. 157–161, Dec. 2018, doi: 10.1016/j.prnil.2018.05.001.
[2049]	S. K. Hemrick-Luecke and D. C. Evans, “Comparison of the potency of MDL 100,907 and SB 242084 in blocking the serotonin (5-HT)(2) receptor agonist-induced increases in rat serum corticosterone concentrations: evidence for 5-HT(2A) receptor mediation of the HPA axis,” Neuropharmacology, vol. 42, no. 2, pp. 162–169, Feb. 2002, doi: 10.1016/s0028-3908(01)00166-6.
[2050]	J. F. Gomes Marin, P. S. Duarte, J. Willegaignon de Amorim de Carvalho, H. N. Sado, M. T. Sapienza, and C. A. Buchpiguel, “Comparison of the Variability of SUV Normalized by Skeletal Volume with the Variability of SUV Normalized by Body Weight in 18F-Fluoride PET/CT,” J Nucl Med Technol, vol. 47, no. 1, pp. 60–63, Mar. 2019, doi: 10.2967/jnmt.118.215111.
[2051]	M. de Onis, A. Siyam, E. Borghi, A. W. Onyango, E. Piwoz, and C. Garza, “Comparison of the World Health Organization growth velocity standards with existing US reference data,” Pediatrics, vol. 128, no. 1, pp. e18-26, Jul. 2011, doi: 10.1542/peds.2010-2630.
[2052]	Z. Chen et al., “Comparison of therapy-related myelodysplastic syndrome with ring sideroblasts and de novo myelodysplastic syndrome with ring sideroblasts,” Leuk. Res., vol. 86, p. 106227, 2019, doi: 10.1016/j.leukres.2019.106227.
[2053]	M. W. Little, G. A. Arnott, M. D. Welsh, J. P. Barley, N. E. O’ Connell, and C. P. Ferris, “Comparison of total-mixed-ration and feed-to-yield strategies on blood profiles and dairy cow health,” Vet. Rec., vol. 183, no. 21, p. 655, Dec. 2018, doi: 10.1136/vr.104781.
[2054]	S. R. Marticorena Garcia et al., “Comparison of ultrasound shear wave elastography with magnetic resonance elastography and renal microvascular flow in the assessment of chronic renal allograft dysfunction,” Acta Radiol, vol. 59, no. 9, pp. 1139–1145, Sep. 2018, doi: 10.1177/0284185117748488.
[2055]	M. N. Mohankumar, P. Venkatachalam, B. K. Prabhu, and R. K. Jeevanram, “Comparison of UV-induced unscheduled DNA synthesis in lymphocytes exposed to low doses of ionising radiation in vivo and in vitro,” Mutat. Res., vol. 447, no. 2, pp. 199–207, Feb. 2000, doi: 10.1016/s0027-5107(99)00207-9.
[2056]	B. R. Scanlon, R. C. Reedy, and J.-P. Nicot, “Comparison of water use for hydraulic fracturing for unconventional oil and gas versus conventional oil,” Environ. Sci. Technol., vol. 48, no. 20, pp. 12386–12393, Oct. 2014, doi: 10.1021/es502506v.
[2057]	X. Zhang, Z. Chen, and L. Lin, “[Comparison on dissolving sputum and anti-inflammation of ‘mao ju hong’ and ‘guang ju hong’],” Zhong Yao Cai, vol. 27, no. 2, pp. 122–123, Feb. 2004.
[2058]	R. Koechlin and P. Leblanc, “[Compensation of the effects of shifts of anatomic positions of the heart on electrical tracings],” C. R. Acad. Sci. III, Sci. Vie, vol. 303, no. 18, pp. 723–728, 1986.
[2059]	C. A. Anderson, “Competition,” Minn Med, vol. 67, no. 1, pp. 35–36, Jan. 1984.
[2060]	M. V. Pauly, “Competition in medical services and the quality of care: concepts and history,” Int J Health Care Finance Econ, vol. 4, no. 2, pp. 113–130, Jun. 2004, doi: 10.1023/B:IHFE.0000032419.89581.04.
[2061]	N. Shelton, “Competitive contingencies in selective contracting for hospital services,” Med Care Rev, vol. 46, no. 3, pp. 271–293, 1989, doi: 10.1177/107755878904600304.
[2062]	C. W. Higgins, “Competitive reform and nonprice competition: implications for the hospital industry,” Health Care Manage Rev, vol. 14, no. 4, pp. 57–66, 1989.
[2063]	M. L. Hoang et al., “Competitive repair by naturally dispersed repetitive DNA during non-allelic homologous recombination,” PLoS Genet., vol. 6, no. 12, p. e1001228, Dec. 2010, doi: 10.1371/journal.pgen.1001228.
[2064]	T. E. Mollnes and M. Huber-Lang, “Complement in sepsis-when science meets clinics,” FEBS Lett., vol. 594, no. 16, pp. 2621–2632, Aug. 2020, doi: 10.1002/1873-3468.13881.
[2065]	B. L. Vieira, N. R. Lim, M. E. Lohman, and P. A. Lio, “Complementary and Alternative Medicine for Atopic Dermatitis: An Evidence-Based Review,” Am J Clin Dermatol, vol. 17, no. 6, pp. 557–581, Dec. 2016, doi: 10.1007/s40257-016-0209-1.
[2066]	A. A. Asadi-Pooya, M. Homayoun, and S. Sharifi, “Complementary and integrative medicine in epilepsy: What patients and physicians perceive,” Epilepsy Behav, vol. 101, no. Pt A, p. 106545, 2019, doi: 10.1016/j.yebeh.2019.106545.
[2067]	S. Gupta et al., “Complementary feeding at 4 versus 6 months of age for preterm infants born at less than 34 weeks of gestation: a randomised, open-label, multicentre trial,” Lancet Glob Health, vol. 5, no. 5, pp. e501–e511, 2017, doi: 10.1016/S2214-109X(17)30074-8.
[2068]	J.-S. Lee, K. C. Lee, K. K. Kim, and B. Lee, “Complete genome sequence of the Variibacter gotjawalensis GJW-30(T) from soil of lava forest, Gotjawal,” J. Biotechnol., vol. 218, pp. 64–65, Jan. 2016, doi: 10.1016/j.jbiotec.2015.11.027.
[2069]	T. Hishinuma, Y. Katayama, M. Matsuo, T. Sasaki, and K. Hiramatsu, “Complete Genome Sequence of Vancomycin-Intermediate Staphylococcus aureus Strain MI (HIP5827),” Genome Announc, vol. 4, no. 2, Mar. 2016, doi: 10.1128/genomeA.00123-16.
[2070]	D. Bian et al., “Complete mitochondrial genome of Spilosoma lubricipedum (Noctuoidea: Erebidae) and implications for phylogeny of noctuid insects,” Genomics, Aug. 2020, doi: 10.1016/j.ygeno.2020.08.001.
[2071]	C. E. Schmalbach and C. R. Bradford, “Completion lymphadenectomy for sentinel node positive cutaneous head & neck melanoma,” Laryngoscope Investig Otolaryngol, vol. 3, no. 1, pp. 43–48, 2018, doi: 10.1002/lio2.136.
[2072]	A. Y. Emelin and V. Y. Lobzin, “[Complex diagnostic of cognitive impairment],” Zh Nevrol Psikhiatr Im S S Korsakova, vol. 117, no. 6. Vyp. 2, pp. 33–40, 2017, doi: 10.17116/jnevro20171176233-40.
[2073]	K. M. Stephenson, C. M. Schroder, G. Bertschy, and P. Bourgin, “Complex interaction of circadian and non-circadian effects of light on mood: shedding new light on an old story,” Sleep Med Rev, vol. 16, no. 5, pp. 445–454, Oct. 2012, doi: 10.1016/j.smrv.2011.09.002.
[2074]	R. A. Jongedijk, I. V. Carlier, B. J. Schreuder, and B. P. Gersons, “Complex posttraumatic stress disorder: an exploratory investigation of PTSD and DES NOS among Dutch war veterans,” J Trauma Stress, vol. 9, no. 3, pp. 577–586, Jul. 1996, doi: 10.1007/BF02103666.
[2075]	N. Ide and A. Paez, “Complex PTSD: a review of current issues,” Int J Emerg Ment Health, vol. 2, no. 1, pp. 43–49, 2000.
[2076]	J. L. Herman, “Complex PTSD: A syndrome in survivors of prolonged and repeated trauma,” Journal of traumatic stress, vol. 5, no. 3, pp. 377–391, 1992.
[2077]	P. O. Pomerleau, “Compliance education through participational QA programs,” Qual Assur, vol. 2, no. 1–2, pp. 197–205, Jun. 1993.
[2078]	R. Klemetti, T. Sevón, M. Gissler, and E. Hemminki, “Complications of IVF and ovulation induction,” Hum. Reprod., vol. 20, no. 12, pp. 3293–3300, Dec. 2005, doi: 10.1093/humrep/dei253.
[2079]	R. W. Carlson and M. Boyet, “Composition of the Earth’s interior: the importance of early events,” Philos Trans A Math Phys Eng Sci, vol. 366, no. 1883, pp. 4077–4103, Nov. 2008, doi: 10.1098/rsta.2008.0166.
[2080]	M. Xu et al., “Composting increased persistence of manure-borne antibiotic resistance genes in soils with different fertilization history,” Sci. Total Environ., vol. 689, pp. 1172–1180, Nov. 2019, doi: 10.1016/j.scitotenv.2019.06.376.
[2081]	Z. Lin, J. Zeng, and X. Wang, “Compound phenotype of osteogenesis imperfecta and Ehlers-Danlos syndrome caused by combined mutations in COL1A1 and COL5A1,” Biosci. Rep., vol. 39, no. 7, 31 2019, doi: 10.1042/BSR20181409.
[2082]	A. Kasirer and N. Mashal, “Comprehension and Generation of Metaphoric Language in Children, Adolescents, and Adults with Dyslexia,” Dyslexia, vol. 23, no. 2, pp. 99–118, May 2017, doi: 10.1002/dys.1550.
[2083]	L. P. Shapiro, E. Zurif, S. Carey, and M. Grossman, “Comprehension of lexical subcategory distinctions by aphasic patients: proper/common and mass/count nouns,” J Speech Hear Res, vol. 32, no. 3, pp. 481–488, Sep. 1989, doi: 10.1044/jshr.3203.481.
[2084]	J. N. Morris et al., “Comprehensive clinical assessment in community setting: applicability of the MDS-HC,” J Am Geriatr Soc, vol. 45, no. 8, pp. 1017–1024, Aug. 1997, doi: 10.1111/j.1532-5415.1997.tb02975.x.
[2085]	Y. Meng, M. Liu, X. Guan, and W. Liu, “Comprehensive evaluation of ecological compensation effect in the Xiaohong River Basin, China,” Environ Sci Pollut Res Int, vol. 26, no. 8, pp. 7793–7803, Mar. 2019, doi: 10.1007/s11356-019-04208-z.
[2086]	J. N. Siewe Fodjo et al., “Comprehensive management of epilepsy in onchocerciasis-endemic areas: lessons learnt from community-based surveys,” Infect Dis Poverty, vol. 8, no. 1, p. 11, Feb. 2019, doi: 10.1186/s40249-019-0523-y.
[2087]	K. F. Mak et al., “Compressing μJ-level pulses from 250  fs to sub-10  fs at 38-MHz repetition rate using two gas-filled hollow-core photonic crystal fiber stages,” Opt Lett, vol. 40, no. 7, pp. 1238–1241, Apr. 2015, doi: 10.1364/OL.40.001238.
[2088]	J. Gladfelter, “Compression garments 101,” Plast Surg Nurs, vol. 27, no. 2, pp. 73–77; quiz 78–79, Jun. 2007, doi: 10.1097/01.PSN.0000278235.87964.f5.
[2089]	J. S. Robertson and G. Moeller, “Compuation of continuous decompression schedules for deep sea dives. BNL-50104,” Tech Rep Brookhaven Natl Lab, pp. 1–37, Mar. 1968.
[2090]	A. D’Amore, E. K. L. Mitchell, C. A. Robinson, and J. E. Chesters, “Compulsory medical rural placements: senior student opinions of early-year experiential learning,” Aust J Rural Health, vol. 19, no. 5, pp. 259–266, Oct. 2011, doi: 10.1111/j.1440-1584.2011.01221.x.
[2091]	V. Cherkassky, W. Hsieh, V. Krasnopolsky, D. Solomatine, and J. Valdes, “Computational intelligence in earth and environmental sciences,” Neural Netw, vol. 20, no. 4, p. 433, May 2007, doi: 10.1016/j.neunet.2007.05.001.
[2092]	R. Krishnan, A. S. Nair, and P. K. Dhar, “Computational study of ‘HUB’ microRNA in human cardiac diseases,” Bioinformation, vol. 13, no. 1, pp. 17–20, 2017, doi: 10.6026/97320630013017.
[2093]	Y. Meng, Y. Lin, and B. Roux, “Computational study of the ‘DFG-flip’ conformational transition in c-Abl and c-Src tyrosine kinases,” J Phys Chem B, vol. 119, no. 4, pp. 1443–1456, Jan. 2015, doi: 10.1021/jp511792a.
[2094]	T. Pfeifer et al., “Computed tomography in the determination of leg geometry,” In Vivo, vol. 9, no. 3, pp. 257–261, Jun. 1995.
[2095]	S. Papathanassiou et al., “Computed Tomography Versus Dacryocystography for the Evaluation of the Nasolacrimal Duct-A Study With 72 Patients,” Laryngoscope Investig Otolaryngol, vol. 4, no. 4, pp. 393–398, Aug. 2019, doi: 10.1002/lio2.293.
[2096]	C. A. Lingley-Papadopoulos, M. H. Loew, M. J. Manyak, and J. M. Zara, “Computer recognition of cancer in the urinary bladder using optical coherence tomography and texture analysis,” J Biomed Opt, vol. 13, no. 2, p. 024003, Apr. 2008, doi: 10.1117/1.2904987.
[2097]	D. L. Brodish, “Computer validation in toxicology: historical review for FDA and EPA good laboratory practice,” Qual Assur, vol. 6, no. 4, pp. 185–199, Dec. 1998, doi: 10.1080/105294199277752.
[2098]	S. Meramo-Hurtado, K. Moreno-Sader, and Á. D. González-Delgado, “Computer-aided simulation and exergy analysis of TiO2 nanoparticles production via green chemistry,” PeerJ, vol. 7, p. e8113, 2019, doi: 10.7717/peerj.8113.
[2099]	L. Rew, S. D. Horner, L. Riesch, and R. Cauvin, “Computer-assisted survey interviewing of school-age children,” ANS Adv Nurs Sci, vol. 27, no. 2, pp. 129–137, Jun. 2004, doi: 10.1097/00012272-200404000-00006.
[2100]	J. Bail and K. Meneses, “Computer-Based Cognitive Training for Chemotherapy-Related Cognitive Impairment in Breast Cancer Survivors,” Clin J Oncol Nurs, vol. 20, no. 5, pp. 504–509, Oct. 2016, doi: 10.1188/16.CJON.504-509.
[2101]	N. T. M. Hill, L. Mowszowski, S. L. Naismith, V. L. Chadwick, M. Valenzuela, and A. Lampit, “Computerized Cognitive Training in Older Adults With Mild Cognitive Impairment or Dementia: A Systematic Review and Meta-Analysis,” Am J Psychiatry, vol. 174, no. 4, pp. 329–340, Apr. 2017, doi: 10.1176/appi.ajp.2016.16030360.
[2102]	L. Raleigh and S. P. Cole, “Con: Factor Concentrate Usage in Cardiac Surgery-A Paucity of Data Limits Their Universal Adoption,” J. Cardiothorac. Vasc. Anesth., vol. 32, no. 2, pp. 1068–1071, 2018, doi: 10.1053/j.jvca.2017.05.005.
[2103]	J. P. D. Goldring, “Concentrating Proteins by Salt, Polyethylene Glycol, Solvent, SDS Precipitation, Three-Phase Partitioning, Dialysis, Centrifugation, Ultrafiltration, Lyophilization, Affinity Chromatography, Immunoprecipitation or Increased Temperature for Protein Isolation, Drug Interaction, and Proteomic and Peptidomic Evaluation,” Methods Mol. Biol., vol. 1855, pp. 41–59, 2019, doi: 10.1007/978-1-4939-8793-1_4.
[2104]	D. J. Arora, P. Tremblay, R. Bourgault, and S. Boileau, “Concentration and purification of influenza virus from allantoic fluid,” Anal. Biochem., vol. 144, no. 1, pp. 189–192, Jan. 1985, doi: 10.1016/0003-2697(85)90103-4.
[2105]	B. P. Vajda and K. J. Háber, “Concentration and purification of mycobacteriophages with polyethylene glycol 6000,” Am. Rev. Respir. Dis., vol. 114, no. 1, pp. 245–248, Jul. 1976, doi: 10.1164/arrd.1976.114.1.245.
[2106]	S. C. Afford, R. A. Stockley, J. A. Kramps, J. H. Dijkman, and D. Burnett, “Concentration of bronchoalveolar lavage fluid by ultrafiltration: evidence of differential protein loss and functional inactivation of proteinase inhibitors,” Anal. Biochem., vol. 151, no. 1, pp. 125–130, Nov. 1985, doi: 10.1016/0003-2697(85)90061-2.
[2107]	D. M. Prazeres, “Concentration of BSA using a superabsorbent polymer: process evaluation,” J. Biotechnol., vol. 39, no. 2, pp. 157–164, Apr. 1995, doi: 10.1016/0168-1656(95)00014-h.
[2108]	Y. Suzuki and T. Takida, “Concentration of Cryptosporidium oocysts from river water by coagulation and foam separation combined with acid dissolution of ferric flocs,” J Environ Sci Health A Tox Hazard Subst Environ Eng, vol. 50, no. 3, pp. 311–316, 2015, doi: 10.1080/10934529.2015.981121.
[2109]	R. F. Atmeh, “Concentration of dilute solutions of macromolecules by electrophoresis,” Anal. Biochem., vol. 182, no. 2, pp. 315–318, Nov. 1989, doi: 10.1016/0003-2697(89)90601-5.
[2110]	L. S. Tsai, K. Ijichi, and M. W. Harris, “Concentration of Egg White by Ultrafiltration 1,” J. Food Prot., vol. 40, no. 7, pp. 449–455, Jul. 1977, doi: 10.4315/0362-028X-40.7.449.
[2111]	J. L. T. Blank and B. L. van Hulst, “[Concentration of Emergency Departments: the wrong way to economize],” Ned Tijdschr Geneeskd, vol. 161, p. D1294, 2017.
[2112]	C. Hamelin and G. Lussier, “Concentration of human cytomegalovirus from large volumes of tissue culture fluids,” J. Gen. Virol., vol. 42, no. 1, pp. 193–197, Jan. 1979, doi: 10.1099/0022-1317-42-1-193.
[2113]	P. Trépanier, P. Payment, and M. Trudel, “Concentration of human respiratory syncytial virus using ammonium sulfate, polyethylene glycol or hollow fiber ultrafiltration,” J. Virol. Methods, vol. 3, no. 4, pp. 201–211, Nov. 1981, doi: 10.1016/0166-0934(81)90071-9.
[2114]	D. W. Horn and V. A. Davis, “Concentration of lysozyme/single-walled carbon nanotube dispersions,” Colloids Surf B Biointerfaces, vol. 139, pp. 237–243, Mar. 2016, doi: 10.1016/j.colsurfb.2015.11.040.
[2115]	P. Kramberger, N. Petrovic, A. Strancar, and M. Ravnikar, “Concentration of plant viruses using monolithic chromatographic supports,” J. Virol. Methods, vol. 120, no. 1, pp. 51–57, Sep. 2004, doi: 10.1016/j.jviromet.2004.03.018.
[2116]	J. Korsak, A. Rzeszotarska, W. Marczyński, I. Jabłońska, J. Białecki, and P. Walczak, “Concentration of platelet derived-growth factors in concentrates used to regenerate injured bone tissue,” Ortop Traumatol Rehabil, vol. 15, no. 5, pp. 379–388, Oct. 2013, doi: 10.5604/15093492.1084239.
[2117]	J. G. Pressman et al., “Concentration, chlorination, and chemical analysis of drinking water for disinfection byproduct mixtures health effects research: U.S. EPA’s Four Lab Study,” Environ. Sci. Technol., vol. 44, no. 19, pp. 7184–7192, Oct. 2010, doi: 10.1021/es9039314.
[2118]	S. P. Alsemgeest, H. C. Kalsbeek, T. Wensing, J. P. Koeman, A. M. van Ederen, and E. Gruys, “Concentrations of serum amyloid-A (SAA) and haptoglobin (HP) as parameters of inflammatory diseases in cattle,” Vet Q, vol. 16, no. 1, pp. 21–23, Mar. 1994, doi: 10.1080/01652176.1994.9694410.
[2119]	I. F. Størdal et al., “Concentrations of viable oil-degrading microorganisms are increased in feces from Calanus finmarchicus feeding in petroleum oil dispersions,” Mar. Pollut. Bull., vol. 98, no. 1–2, pp. 69–77, Sep. 2015, doi: 10.1016/j.marpolbul.2015.07.011.
[2120]	M. Rowson et al., “Conceptualising global health: theoretical issues and their relevance for teaching,” Global Health, vol. 8, p. 36, Nov. 2012, doi: 10.1186/1744-8603-8-36.
[2121]	A. L. Sukstanskii and J. J. H. Ackerman, “Concise derivation of oscillating-gradient-derived ADC,” J. Magn. Reson., vol. 296, pp. 165–168, 2018, doi: 10.1016/j.jmr.2018.09.010.
[2122]	L. S. Whiting and P. S. Vickers, “Conducting qualitative research with palliative care patients: applying Hammick’s research ethics wheel,” Int J Palliat Nurs, vol. 16, no. 2, pp. 58, 60–62, 64–66, 68, Feb. 2010, doi: 10.12968/ijpn.2010.16.2.46751.
[2123]	C.-W. Chang et al., “Cone beam computed tomography of plastinated hearts for instruction of radiological anatomy,” Surg Radiol Anat, vol. 38, no. 7, pp. 843–853, Sep. 2016, doi: 10.1007/s00276-016-1645-6.
[2124]	N. Raju, W. Zhang, A. Jadhav, A. Ioannou, S. Eswaran, and R. Weltman, “Cone-Beam Computed Tomography Analysis of the Prevalence, Length, and Passage of the Anterior Loop of the Mandibular Canal,” J Oral Implantol, vol. 45, no. 6, pp. 463–468, Dec. 2019, doi: 10.1563/aaid-joi-D-18-00236.
[2125]	N. Reznikov, D. Dagdeviren, F. Tamimi, F. Glorieux, F. Rauch, and J.-M. Retrouvey, “Cone-Beam Computed Tomography of Osteogenesis Imperfecta Types III and IV: Three-Dimensional Evaluation of Craniofacial Features and Upper Airways,” JBMR Plus, vol. 3, no. 6, p. e10124, Jun. 2019, doi: 10.1002/jbm4.10124.
[2126]	I. A. Singer, M. E. Smith, and E. W. Bierly, “Conference of AEC meteorological activities May 19-22, 1964. BNL 914 (C-42),” Tech Rep Brookhaven Natl Lab, pp. 1–185, May 1964.
[2127]	M. J. Fleetwood, “Conference report: 2nd Nazareth Conference on Dental Public Health,” Br Dent J, vol. 223, no. 5, p. 316, 08 2017, doi: 10.1038/sj.bdj.2017.746.
[2128]	E. M. Sternberg and L. L. Judd, “Conference summary and conclusions. A comprehensive approach to predicting and managing mood effects of glucocorticoids,” Ann. N. Y. Acad. Sci., vol. 1179, pp. 229–233, Oct. 2009, doi: 10.1111/j.1749-6632.2009.05059.x.
[2129]	S.-M. Yuan, A. Shinfeld, and E. Raanani, “Configurations and classifications of composite arterial grafts in coronary bypass surgery,” J Cardiovasc Med (Hagerstown), vol. 9, no. 1, pp. 3–14, Jan. 2008, doi: 10.2459/JCM.0b013e3280110628.
[2130]	Y. Yao et al., “Confining Ultrafine MoO2 in a Carbon Matrix Enables Hybrid Li Ion and Li Metal Storage,” ACS Appl Mater Interfaces, Aug. 2020, doi: 10.1021/acsami.0c10833.
[2131]	N. Zabbey and G. Olsson, “Conflicts - Oil Exploration and Water,” Glob Chall, vol. 1, no. 5, p. 1600015, Aug. 2017, doi: 10.1002/gch2.201600015.
[2132]	I. Amigo and A. Pascual-García, “Conflicts of interest in scientific publishing,” EMBO Rep., vol. 18, no. 12, pp. 2081–2083, 2017, doi: 10.15252/embr.201745008.
[2133]	R. S. K. Vijayan et al., “Conformational analysis of the DFG-out kinase motif and biochemical profiling of structurally validated type II inhibitors,” J. Med. Chem., vol. 58, no. 1, pp. 466–479, Jan. 2015, doi: 10.1021/jm501603h.
[2134]	M. N. Petrov et al., “Conformational changes of blood ACE in chronic uremia,” PLoS ONE, vol. 7, no. 11, p. e49290, 2012, doi: 10.1371/journal.pone.0049290.
[2135]	S. M. Danilov et al., “Conformational fingerprint of blood and tissue ACEs: Personalized approach,” PLoS ONE, vol. 13, no. 12, p. e0209861, 2018, doi: 10.1371/journal.pone.0209861.
[2136]	S. M. Danilov et al., “Conformational fingerprinting of the angiotensin I-converting enzyme (ACE). 1. Application in sarcoidosis,” J. Proteome Res., vol. 9, no. 11, pp. 5782–5793, Nov. 2010, doi: 10.1021/pr100564r.
[2137]	S. M. Danilov, “Conformational Fingerprinting Using Monoclonal Antibodies (on the Example of Angiotensin I-Converting Enzyme-ACE),” Mol. Biol. (N.Y.), vol. 51, no. 6, pp. 906–920, 2017, doi: 10.1134/S0026893317060048.
[2138]	S. M. Danilov, “[Conformational Fingerprinting Using Monoclonal Antibodies <br />(on the Example of Angiotensin I-Converting Enzyme-ACE)],” Mol. Biol. (Mosk.), vol. 51, no. 6, pp. 1046–1061, Dec. 2017, doi: 10.7868/S0026898417060155.
[2139]	Y. Li, “Conformational sampling in template-free protein loop structure modeling: an overview,” Comput Struct Biotechnol J, vol. 5, p. e201302003, 2013, doi: 10.5936/csbj.201302003.
[2140]	S. Hoelzer et al., “Confronting actual practice with practice guidelines in oncology,” Qual Assur, vol. 7, no. 3, pp. 163–171, Sep. 1999, doi: 10.1080/105294100750035143.
[2141]	E. Charmandari, P. C. Hindmarsh, A. Johnston, and C. G. Brook, “Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: alterations in cortisol pharmacokinetics at puberty,” J. Clin. Endocrinol. Metab., vol. 86, no. 6, pp. 2701–2708, Jun. 2001, doi: 10.1210/jcem.86.6.7522.
[2142]	P. Rodari et al., “Congenital Chagas disease in a non-endemic area: Results from a control programme in Bergamo province, Northern Italy,” Travel Med Infect Dis, vol. 25, pp. 31–34, Oct. 2018, doi: 10.1016/j.tmaid.2018.04.011.
[2143]	W. W. Robertson and D. Corbett, “Congenital clubfoot. Month of conception,” Clin. Orthop. Relat. Res., no. 338, pp. 14–18, May 1997, doi: 10.1097/00003086-199705000-00004.
[2144]	A. J. Maniglia and J. V. Maniglia, “Congenital lop ear deformity,” Otolaryngol. Clin. North Am., vol. 14, no. 1, pp. 83–93, Feb. 1981.
[2145]	R. Raman, L. Gella, and M. S. Kazi, “Congenital preretinal arterial loop: Is it a misnomer?,” Oman J Ophthalmol, vol. 10, no. 1, pp. 54–55, Apr. 2017, doi: 10.4103/ojo.OJO_178_2015.
[2146]	V. N. Morozov, Y. M. Shlyapnikov, J. Kidd, T. Y. Morozova, and E. A. Shlyapnikova, “Conic electrophoretic concentrator for charged macromolecules,” Anal. Chem., vol. 83, no. 14, pp. 5548–5555, Jul. 2011, doi: 10.1021/ac201146w.
[2147]	X. Z. Li, Q. S. Gao, C. G. Yan, S. H. Choi, J. S. Shin, and M. K. Song, “Conjugated fatty acids and methane production by rumen microbes when incubated with linseed oil alone or mixed with fish oil and/or malate,” Anim. Sci. J., vol. 86, no. 8, pp. 755–764, Aug. 2015, doi: 10.1111/asj.12354.
[2148]	B. A. Christensen, “Connecting experience and economy--aspects of disguised positioning,” Integr Psychol Behav Sci, vol. 47, no. 1, pp. 77–94, Mar. 2013, doi: 10.1007/s12124-012-9214-y.
[2149]	M. Frank et al., “Connexin45 provides optimal atrioventricular nodal conduction in the adult mouse heart,” Circ. Res., vol. 111, no. 12, pp. 1528–1538, Dec. 2012, doi: 10.1161/CIRCRESAHA.112.270561.
[2150]	S. Hameroff and R. Penrose, “Consciousness in the universe: a review of the ‘Orch OR’ theory,” Phys Life Rev, vol. 11, no. 1, pp. 39–78, Mar. 2014, doi: 10.1016/j.plrev.2013.08.002.
[2151]	H. Sorgatz et al., “[Consensus building on ‘Long-term opioid administration and non-tumor pain’],” Z Arztl Fortbild Qualitatssich, vol. 96, no. 5, pp. 317–323, Jun. 2002.
[2152]	J. J. Barry et al., “Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders,” Epilepsy Behav, vol. 13 Suppl 1, pp. S1-29, Jul. 2008, doi: 10.1016/j.yebeh.2008.04.005.
[2153]	S. K. Lim, “Consequences of haemolysis without haptoglobin,” Redox Rep., vol. 6, no. 6, pp. 375–378, 2001, doi: 10.1179/135100001101536571.
[2154]	M. G. Pereira, S. M. Mudge, and J. Latchford, “Consequences of linseed oil spills in salt marsh sediments,” Mar. Pollut. Bull., vol. 44, no. 6, pp. 520–533, Jun. 2002, doi: 10.1016/s0025-326x(01)00304-6.
[2155]	D. Grechishnikova and M. Poptsova, “Conserved 3’ UTR stem-loop structure in L1 and Alu transposons in human genome: possible role in retrotransposition,” BMC Genomics, vol. 17, no. 1, p. 992, 03 2016, doi: 10.1186/s12864-016-3344-4.
[2156]	R. Nussbaum, “[Consideration on the free silica and silicates of the lithosphere],” Arch Mal Prof, vol. 13, no. 1, pp. 69–75, 1952.
[2157]	J. F. Simon and L. A. Darnell, “Considerations for proper selection of dental cements,” Compend Contin Educ Dent, vol. 33, no. 1, pp. 28–30, 32, 34–35; quiz 36, 38, Jan. 2012.
[2158]	J. Klapacz and B. B. Gollapudi, “Considerations for the Use of Mutation as a Regulatory Endpoint in Risk Assessment,” Environ. Mol. Mutagen., vol. 61, no. 1, pp. 84–93, 2020, doi: 10.1002/em.22318.
[2159]	P. A. Lio, “Considerations in Weaning or Withdrawing Dupilumab Therapy-Nothing Is Forever,” JAMA Dermatol, Dec. 2019, doi: 10.1001/jamadermatol.2019.3331.
[2160]	A. Bengtsson, G. S. Donahue, S. Nemes, G. Garellick, and O. Rolfson, “Consistency in patient-reported outcomes after total hip replacement,” Acta Orthop, vol. 88, no. 5, pp. 484–489, Oct. 2017, doi: 10.1080/17453674.2017.1339541.
[2161]	M. Lin, X. Yu, H. Ouyang, D. Luo, and C. Zhou, “Consistency of T2WI-FS/ASL fusion images in delineating the volume of nasopharyngeal carcinoma,” Sci Rep, vol. 5, p. 18431, Dec. 2015, doi: 10.1038/srep18431.
[2162]	B. Sykes et al., “Consistent linkage of dominantly inherited osteogenesis imperfecta to the type I collagen loci: COL1A1 and COL1A2,” Am. J. Hum. Genet., vol. 46, no. 2, pp. 293–307, Feb. 1990.
[2163]	M. Wiesendanger, “Constantin von Monakow (1853-1930): a pioneer in interdisciplinary brain research and a humanist,” C. R. Biol., vol. 329, no. 5–6, pp. 406–418, Jun. 2006, doi: 10.1016/j.crvi.2006.03.011.
[2164]	N. Medic, M. Müssener, B. H. Lobinger, and B. W. Young, “Constituent Year Effect in Masters Sports: An Empirical View on the Historical Development in US Masters Swimming,” J Sports Sci Med, vol. 18, no. 3, pp. 505–512, 2019.
[2165]	M. S. Gill, C. M. Hall, V. Tillmann, and P. E. Clayton, “Constitutional delay in growth and puberty (CDGP) is associated with hypoleptinaemia,” Clin. Endocrinol. (Oxf), vol. 50, no. 6, pp. 721–726, Jun. 1999, doi: 10.1046/j.1365-2265.1999.00736.x.
[2166]	N. J. Spencer, “Constitutively Active 5-HT Receptors: An Explanation of How 5-HT Antagonists Inhibit Gut Motility in Species Where 5-HT is Not an Enteric Neurotransmitter?,” Front Cell Neurosci, vol. 9, p. 487, 2015, doi: 10.3389/fncel.2015.00487.
[2167]	D. Mossman and H. Peng, “Constructing ‘proper’ ROCs from ordinal response data using weighted power functions,” Med Decis Making, vol. 34, no. 4, pp. 523–535, 2014, doi: 10.1177/0272989X13503046.
[2168]	X. Lei et al., “Construction of heterostructured NiFe2O4-C nanorods by transition metal recycling from simulated electroplating sludge leaching solution for high performance lithium ion batteries,” Nanoscale, vol. 12, no. 25, pp. 13398–13406, Jul. 2020, doi: 10.1039/d0nr02290j.
[2169]	L. Marazzi, S. Loiselle, L. G. Anderson, S. Rocliffe, and D. J. Winton, “Consumer-based actions to reduce plastic pollution in rivers: A multi-criteria decision analysis approach,” PLoS ONE, vol. 15, no. 8, p. e0236410, Aug. 2020, doi: 10.1371/journal.pone.0236410.
[2170]	C. J. Britt and C. G. Gourin, “Contemporary management of advanced laryngeal cancer,” Laryngoscope Investig Otolaryngol, vol. 2, no. 5, pp. 307–309, 2017, doi: 10.1002/lio2.85.
[2171]	J. B. Nadol, “Contemporary techniques in human otopathology and promise for the future,” Laryngoscope Investig Otolaryngol, vol. 5, no. 1, pp. 145–151, Feb. 2020, doi: 10.1002/lio2.341.
[2172]	R. Ciric, J. S. Nomi, L. Q. Uddin, and A. B. Satpute, “Contextual connectivity: A framework for understanding the intrinsic dynamic architecture of large-scale functional brain networks,” Sci Rep, vol. 7, no. 1, p. 6537, 26 2017, doi: 10.1038/s41598-017-06866-w.
[2173]	M. Ghaemmaghami, G. P. Hanley, and J. Jessel, “Contingencies promote delay tolerance,” J Appl Behav Anal, vol. 49, no. 3, pp. 548–575, 2016, doi: 10.1002/jaba.333.
[2174]	A. P. S. Carneiro, S. M. Barreto, A. L. Siqueira, F. Cavariani, and F. Forastiere, “Continued exposure to silica after diagnosis of silicosis in Brazilian gold miners,” Am. J. Ind. Med., vol. 49, no. 10, pp. 811–818, Oct. 2006, doi: 10.1002/ajim.20379.
[2175]	A. Shnier and J. Lexchin, “Continuing medical education and pharmaceutical industry involvement: An evaluation of policies adopted by Canadian professional medical associations,” Int J Risk Saf Med, vol. 29, no. 1–2, pp. 1–16, 2017, doi: 10.3233/JRS-170731.
[2176]	“Continuing risk of meningitis due to Neisseria meningitidis serogroup C in Africa: revised recommendations from a WHO expert consultation,” Wkly. Epidemiol. Rec., vol. 92, no. 41, pp. 612–617, 13 2017.
[2177]	B. K. Hønsvall, D. Altin, and L. J. Robertson, “Continuous harvesting of microalgae by new microfluidic technology for particle separation,” Bioresour. Technol., vol. 200, pp. 360–365, Jan. 2016, doi: 10.1016/j.biortech.2015.10.046.
[2178]	N. Onoda et al., “Continuous intraoperative neuromonitoring for thyroid cancer surgery: A prospective study,” Laryngoscope Investig Otolaryngol, vol. 4, no. 4, pp. 455–459, Aug. 2019, doi: 10.1002/lio2.290.
[2179]	S. F. Nadler et al., “Continuous low-level heat wrap therapy provides more efficacy than Ibuprofen and acetaminophen for acute low back pain,” Spine, vol. 27, no. 10, pp. 1012–1017, May 2002, doi: 10.1097/00007632-200205150-00003.
[2180]	M.-G. Sun et al., “Continuous-wave difference-frequency generation based on BaGa4Se7 crystal,” Opt Express, vol. 27, no. 4, pp. 4014–4023, Feb. 2019, doi: 10.1364/OE.27.004014.
[2181]	R. W. Evans and D. J. Kitzmann, “Contracting for services: liver transplantation in the era of mismanaged care,” Clin Liver Dis, vol. 1, no. 2, pp. 287–303, viii, Aug. 1997, doi: 10.1016/s1089-3261(05)70272-5.
[2182]	T. Ueno, T. Kon, K. Kaneko, T. Takahashi, and M. Tomiyama, “Contrast enhancement of hypertrophic dura mater in MOG antibody-associated disease,” Neurology, vol. 93, no. 6, pp. 271–272, 06 2019, doi: 10.1212/WNL.0000000000007909.
[2183]	H.-J. Kang, J. M. Lee, J. H. Yoon, K. Lee, H. Kim, and J. K. Han, “Contrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane for the Diagnosis of Hepatocellular Carcinoma in Individuals with High Risk,” Radiology, p. 200115, Aug. 2020, doi: 10.1148/radiol.2020200115.
[2184]	S. Gatto, G. Ball, F. Onida, H. M. Kantarjian, E. H. Estey, and M. Beran, “Contribution of beta-2 microglobulin levels to the prognostic stratification of survival in patients with myelodysplastic syndrome (MDS),” Blood, vol. 102, no. 5, pp. 1622–1625, Sep. 2003, doi: 10.1182/blood-2002-10-3264.
[2185]	T. Mine et al., “Contribution of extrahepatic collaterals to liver parenchymal circulation after proper hepatic artery embolization,” J. Gastroenterol. Hepatol., vol. 29, no. 7, pp. 1515–1521, 2014, doi: 10.1111/jgh.12571.
[2186]	N. Auclair-Ouellet, P. Lieberman, and O. Monchi, “Contribution of language studies to the understanding of cognitive impairment and its progression over time in Parkinson’s disease,” Neurosci Biobehav Rev, vol. 80, pp. 657–672, Sep. 2017, doi: 10.1016/j.neubiorev.2017.07.014.
[2187]	M. L. Bution, F. H. Caetano, and F. J. Zara, “Contribution of the Malpighian tubules for the maintenance of symbiotic microorganisms in cephalotes ants,” Micron, vol. 39, no. 8, pp. 1179–1183, Dec. 2008, doi: 10.1016/j.micron.2008.05.003.
[2188]	D. Premraj, K. Suresh, T. Banerjee, and K. Thamilmaran, “Control of bifurcation-delay of slow passage effect by delayed self-feedback,” Chaos, vol. 27, no. 1, p. 013104, 2017, doi: 10.1063/1.4973237.
[2189]	A. Echt and W. K. Sieber, “Control of silica exposure from hand tools in construction: grinding concrete,” Appl Occup Environ Hyg, vol. 17, no. 7, pp. 457–461, Jul. 2002, doi: 10.1080/10473220290035543.
[2190]	A. Echt, W. Sieber, A. Jones, and E. Jones, “Control of silica exposure in construction: scabbling concrete,” Appl Occup Environ Hyg, vol. 17, no. 12, pp. 809–813, Dec. 2002, doi: 10.1080/10473220290107110.
[2191]	E. Riva and D. Leopaldi, “Control of the cardiac consequences of myocardial ischemia and reperfusion by L-propionylcarnitine: age-response and dose-response studies in the rat heart,” Pediatr. Res., vol. 34, no. 4, pp. 465–470, Oct. 1993, doi: 10.1203/00006450-199310000-00016.
[2192]	N. T. Gabriel, S. S. Kim, and J. J. Talghader, “Control of thermal deformation in dielectric mirrors using mechanical design and atomic layer deposition,” Opt Lett, vol. 34, no. 13, pp. 1958–1960, Jul. 2009, doi: 10.1364/ol.34.001958.
[2193]	“Control of visceral leishmaniasis in Somalia: achievements in a challenging scenario, 2013–2015,” Wkly. Epidemiol. Rec., vol. 92, no. 38, pp. 566–572, 22 2017.
[2194]	L. R. Coney and G. S. Roeder, “Control of yeast gene expression by transposable elements: maximum expression requires a functional Ty activator sequence and a defective Ty promoter,” Mol. Cell. Biol., vol. 8, no. 10, pp. 4009–4017, Oct. 1988, doi: 10.1128/mcb.8.10.4009.
[2195]	V. Golla and W. Heitbrink, “Control technology for crystalline silica exposures in construction: wet abrasive blasting,” J Occup Environ Hyg, vol. 1, no. 3, pp. D26-32, Mar. 2004, doi: 10.1080/15459620490279665.
[2196]	F. Li et al., “Controlled Prelithiation of SnO2/C Nanocomposite Anodes for Building Full Lithium-Ion Batteries,” ACS Appl Mater Interfaces, vol. 12, no. 17, pp. 19423–19430, Apr. 2020, doi: 10.1021/acsami.0c00729.
[2197]	T. S.-H. Lee, C.-C. Hung, C.-K. Lin, and H.-H. Chiang, “Controlled randomized trial of walking exercise with positive education on cardiovascular fitness and happiness in retired older adults,” Geriatr Gerontol Int, vol. 19, no. 9, pp. 879–884, Sep. 2019, doi: 10.1111/ggi.13733.
[2198]	Z. Tu and H. Zhang, “[Controlled Veterinary Drug Delivery Systems against Parasitic Infection],” Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, vol. 33, no. 1, pp. 58–63, Feb. 2015.
[2199]	“Controlling silica dust from foundry casting-cleaning operations. National Institute for Occupational Safety and Health,” Appl Occup Environ Hyg, vol. 14, no. 3, p. 155, Mar. 1999, doi: 10.1080/104732299303089.
[2200]	D. C. Ratchford et al., “Controlling the Infrared Dielectric Function through Atomic-Scale Heterostructures,” ACS Nano, vol. 13, no. 6, pp. 6730–6741, Jun. 2019, doi: 10.1021/acsnano.9b01275.
[2201]	F. Vinchi, S. Hell, and U. Platzbecker, “Controversies on the Consequences of Iron Overload and Chelation in MDS,” Hemasphere, vol. 4, no. 3, p. e357, Jun. 2020, doi: 10.1097/HS9.0000000000000357.
[2202]	H. A. Leitch, “Controversies surrounding iron chelation therapy for MDS,” Blood Rev., vol. 25, no. 1, pp. 17–31, Jan. 2011, doi: 10.1016/j.blre.2010.09.003.
[2203]	K. L. Keatley, “Controversy over genetically modified organisms: the governing laws and regulations,” Qual Assur, vol. 8, no. 1, pp. 33–36, Mar. 2000, doi: 10.1080/105294100753209174.
[2204]	J. M. Icardo, “Conus arteriosus of the teleost heart: dismissed, but not missed,” Anat Rec A Discov Mol Cell Evol Biol, vol. 288, no. 8, pp. 900–908, Aug. 2006, doi: 10.1002/ar.a.20361.
[2205]	Z. Lin, X. Liu, X. Xiong, S. Wei, W. Liu, and Z. Lin, “Convenient fabrication of a core-shell Sn@TiO2 anode for lithium storage from tinplate electroplating sludge,” Chem. Commun. (Camb.), Aug. 2020, doi: 10.1039/d0cc04403b.
[2206]	P. Coccetti, R. Nicastro, and F. Tripodi, “Conventional and emerging roles of the energy sensor Snf1/AMPK in Saccharomyces cerevisiae,” Microb Cell, vol. 5, no. 11, pp. 482–494, Sep. 2018, doi: 10.15698/mic2018.11.655.
[2207]	J. S. Lodmell, C. Ehresmann, B. Ehresmann, and R. Marquet, “Convergence of natural and artificial evolution on an RNA loop-loop interaction: the HIV-1 dimerization initiation site,” RNA, vol. 6, no. 9, pp. 1267–1276, Sep. 2000, doi: 10.1017/s1355838200000698.
[2208]	C.-H. Baek, S. K. Farrand, K.-E. Lee, D.-K. Park, J. K. Lee, and K.-S. Kim, “Convergent evolution of Amadori opine catabolic systems in plasmids of Agrobacterium tumefaciens,” J. Bacteriol., vol. 185, no. 2, pp. 513–524, Jan. 2003, doi: 10.1128/jb.185.2.513-524.2003.
[2209]	Z. Xing et al., “Conversational Interfaces for Health: Bibliometric Analysis of Grants, Publications, and Patents,” J. Med. Internet Res., vol. 21, no. 11, p. e14672, 18 2019, doi: 10.2196/14672.
[2210]	Y.-N. Liu et al., “Conversion of phosphatidylinositol (PI) to PI4-phosphate (PI4P) and then to PI(4,5)P2 is essential for the cytosolic Ca2+ concentration under heat stress in Ganoderma lucidum,” Environ. Microbiol., vol. 20, no. 7, pp. 2456–2468, 2018, doi: 10.1111/1462-2920.14254.
[2211]	C. Buddeberg, “[Cool, clever, established--variations on anxiety defenses in today’s society],” Praxis (Bern 1994), vol. 87, no. 21, pp. 727–730, May 1998.
[2212]	M. Murri et al., “Cooling history and emplacement of a pyroxenitic lava as proxy for understanding Martian lava flows,” Sci Rep, vol. 9, no. 1, p. 17051, Nov. 2019, doi: 10.1038/s41598-019-53142-0.
[2213]	K. C. Miller, T. A. Di Mango, and G. E. Katt, “Cooling Rates of Hyperthermic Humans Wearing American Football Uniforms When Cold-Water Immersion Is Delayed,” J Athl Train, vol. 53, no. 12, pp. 1200–1205, Dec. 2018, doi: 10.4085/1062-6050-398-17.
[2214]	A. Serra-Cardona, D. Canadell, and J. Ariño, “Coordinate responses to alkaline pH stress in budding yeast,” Microb Cell, vol. 2, no. 6, pp. 182–196, May 2015, doi: 10.15698/mic2015.06.205.
[2215]	E. E. Fitzsimmons and A. M. Bardone-Cone, “Coping and social support as potential moderators of the relation between anxiety and eating disorder symptomatology,” Eat Behav, vol. 12, no. 1, pp. 21–28, Jan. 2011, doi: 10.1016/j.eatbeh.2010.09.002.
[2216]	X. Lin et al., “Copper nanowires and copper foam multifunctional bridges in zeolitic imidazolate framework-derived anode material for superior lithium storage,” J Colloid Interface Sci, vol. 565, pp. 156–166, Apr. 2020, doi: 10.1016/j.jcis.2020.01.009.
[2217]	X. Zhou, X. Wu, F. Fu, and Y. An, “Core belief challenge and rumination as predictors of PTSD and PTG among adolescent survivors of the Wenchuan earthquake,” Psychol Trauma, vol. 7, no. 4, pp. 391–397, Jul. 2015, doi: 10.1037/tra0000031.
[2218]	S. Perkins, “Core Concept: Lava tubes may be havens for ancient alien life and future human explorers,” Proc. Natl. Acad. Sci. U.S.A., vol. 117, no. 30, pp. 17461–17464, Jul. 2020, doi: 10.1073/pnas.2012176117.
[2219]	S. Battersby, “Core Concept: Quantum sensors probe uncharted territories, from Earth’s crust to the human brain,” Proc. Natl. Acad. Sci. U.S.A., vol. 116, no. 34, pp. 16663–16665, 20 2019, doi: 10.1073/pnas.1912326116.
[2220]	S. De Cillà et al., “Corneal involvement in uneventful cataract surgery: an in vivo confocal microscopy study,” Ophthalmologica, vol. 231, no. 2, pp. 103–110, 2014, doi: 10.1159/000355490.
[2221]	G. M. FitzGibbon, A. J. Leach, W. J. Keon, J. R. Burton, and H. P. Kafka, “Coronary bypass graft fate. Angiographic study of 1,179 vein grafts early, one year, and five years after operation,” J. Thorac. Cardiovasc. Surg., vol. 91, no. 5, pp. 773–778, May 1986.
[2222]	E. Deculllier and H. Maisonneuve, “Correcting the literature: Improvement trends seen in contents of retraction notices,” BMC Res Notes, vol. 11, no. 1, p. 490, Jul. 2018, doi: 10.1186/s13104-018-3576-2.
[2223]	L. Papa and D. Germain, “Correction for Papa and Germain, ‘SirT3 Regulates a Novel Arm of the Mitochondrial Unfolded Protein Response,’” Mol. Cell. Biol., vol. 37, no. 13, 01 2017, doi: 10.1128/MCB.00191-17.
[2224]	J. C. S. Vieira et al., “Correction to: Mercury Exposure: Protein Biomarkers of Mercury Exposure in Jaraqui Fish from the Amazon Region,” Biol Trace Elem Res, vol. 183, no. 1, p. 172, 2018, doi: 10.1007/s12011-017-1195-8.
[2225]	M. W. Enns, B. J. Cox, and S. C. Borger, “Correlates of analogue and clinical depression: a further test of the phenomenological continuity hypothesis,” J Affect Disord, vol. 66, no. 2–3, pp. 175–183, Oct. 2001, doi: 10.1016/s0165-0327(00)00305-0.
[2226]	J. Keith, R. Velezmoro, and C. O’Brien, “Correlates of cognitive flexibility in veterans seeking treatment for posttraumatic stress disorder,” J. Nerv. Ment. Dis., vol. 203, no. 4, pp. 287–293, Apr. 2015, doi: 10.1097/NMD.0000000000000280.
[2227]	O. Tunalilar, P. C. Carder, and S. Dys, “Correlates of Response to Mail Questionnaires Among Assisted Living Communities in Oregon, 2014‒2016,” J Am Med Dir Assoc, vol. 19, no. 12, pp. 1141-1143.e2, 2018, doi: 10.1016/j.jamda.2018.05.024.
[2228]	G. Zara, L. Bardi, S. Belviso, G. A. Farris, S. Zara, and M. Budroni, “Correlation between cell lipid content, gene expression and fermentative behaviour of two Saccharomyces cerevisiae wine strains,” J. Appl. Microbiol., vol. 104, no. 3, pp. 906–914, Mar. 2008, doi: 10.1111/j.1365-2672.2007.03608.x.
[2229]	J. Duun-Henriksen, T. W. Kjaer, R. E. Madsen, L. S. Remvig, C. E. Thomsen, and H. B. D. Sorensen, “Correlation between intra- and extracranial background EEG,” Conf Proc IEEE Eng Med Biol Soc, vol. 2012, pp. 5198–5201, 2012, doi: 10.1109/EMBC.2012.6347165.
[2230]	N. Patel et al., “Correlation between vancomycin MIC values and those of other agents against gram-positive bacteria among patients with bloodstream infections caused by methicillin-resistant Staphylococcus aureus,” Antimicrob. Agents Chemother., vol. 53, no. 12, pp. 5141–5144, Dec. 2009, doi: 10.1128/AAC.00307-09.
[2231]	O. Adogwa, I. O. Karikari, A. A. Elsamadicy, A. R. Sergesketter, D. Galan, and K. H. Bridwell, “Correlation of 2-year SRS-22r and ODI patient-reported outcomes with 5-year patient-reported outcomes after complex spinal fusion: a 5-year single-institution study of 118 patients,” J Neurosurg Spine, vol. 29, no. 4, pp. 422–428, Oct. 2018, doi: 10.3171/2018.2.SPINE171142.
[2232]	A. Asotic, S. Taric, and J. Asotic, “Correlation of cervical smear and pathohistological findings,” Med Arch, vol. 68, no. 2, pp. 106–109, 2014, doi: 10.5455/medarh.2014.68.106-109.
[2233]	R. Ng, G. R. Pond, P. A. Tang, P. W. MacIntosh, L. L. Siu, and E. X. Chen, “Correlation of changes between 2-year disease-free survival and 5-year overall survival in adjuvant breast cancer trials from 1966 to 2006,” Ann. Oncol., vol. 19, no. 3, pp. 481–486, Mar. 2008, doi: 10.1093/annonc/mdm486.
[2234]	M. S. Leuze, “Correlation of nurses’ knowledge and valuation of the quality assurance process,” J Nurs Qual Assur, vol. 4, no. 2, pp. 37–50, Feb. 1990.
[2235]	R. N. Jenkins, C. J. Aldrich, N. F. Landolfi, and R. R. Rich, “Correlation of Qa-1 determinants defined by antisera and by cytotoxic T lymphocytes,” Immunogenetics, vol. 21, no. 3, pp. 215–225, 1985, doi: 10.1007/BF00375374.
[2236]	N. Sriram, A. G. Greenwald, and B. A. Nosek, “Correlational biases in mean response latency differences,” Stat Methodol, vol. 7, no. 3, pp. 277–291, May 2010, doi: 10.1016/j.stamet.2009.10.004.
[2237]	G. M. Tedrus, L. M. Negreiros, R. S. Ballarim, T. A. Marques, and L. C. Fonseca, “Correlations Between Cognitive Aspects and Quantitative EEG in Adults With Epilepsy,” Clin EEG Neurosci, vol. 50, no. 5, pp. 348–353, Sep. 2019, doi: 10.1177/1550059418793553.
[2238]	A. Sharma, M. M. Stei, H. Fröhlich, F. G. Holz, K. U. Loeffler, and M. C. Herwig-Carl, “Corrigendum,” Clin. Genet., vol. 94, no. 3–4, p. 398, Oct. 2018, doi: 10.1111/cge.13407.
[2239]	“Corrigendum,” Lab. Anim., vol. 49, no. 3, pp. 263–264, Jul. 2015, doi: 10.1177/0023677215592082.
[2240]	B. Wahlang, C. McClain, S. Barve, and L. Gobejishvili, “Corrigendum to ‘Role of cAMP and phosphodiesterase signaling in liver health and disease’ [Cell. Signal. 49 (2018)105-115],” Cell. Signal., vol. 53, p. 414, Jan. 2019, doi: 10.1016/j.cellsig.2018.06.014.
[2241]	S. Slavova et al., “Corrigendum to ‘Heroin and fentanyl overdoses in Kentucky: Epidemiology and surveillance’ [International Journal of Drug Policy 46 (2017) 120-129],” Int. J. Drug Policy, vol. 58, p. 92, 2018, doi: 10.1016/j.drugpo.2018.05.006.
[2242]	A. Giuliani, F. Prattichizzo, L. Micolucci, A. Ceriello, A. D. Procopio, and M. R. Rippo, “Corrigendum to ‘Mitochondrial (Dys) Function in Inflammaging: Do MitomiRs Influence the Energetic, Oxidative, and Inflammatory Status of Senescent Cells?,’” Mediators Inflamm., vol. 2019, p. 8716351, 2019, doi: 10.1155/2019/8716351.
[2243]	S. F. Emami and A. Abdoli, “Cortical Auditory Evoked Potentials in Children with Auditory Neuropathy/Dys-Synchrony,” Indian J Otolaryngol Head Neck Surg, vol. 71, no. 2, pp. 238–242, Jun. 2019, doi: 10.1007/s12070-018-1445-x.
[2244]	M. Amalric and S. Dehaene, “Cortical circuits for mathematical knowledge: evidence for a major subdivision within the brain’s semantic networks,” Philos. Trans. R. Soc. Lond., B, Biol. Sci., vol. 373, no. 1740, 19 2017, doi: 10.1098/rstb.2016.0515.
[2245]	P. R. Hof, R. Chanis, and L. Marino, “Cortical complexity in cetacean brains,” Anat Rec A Discov Mol Cell Evol Biol, vol. 287, no. 1, pp. 1142–1152, Nov. 2005, doi: 10.1002/ar.a.20258.
[2246]	P. Yuvaraj and J. Mannarukrishnaiah, “Cortical Evoked Potentials and Hearing Aids in Individuals with Auditory Dys-Synchrony,” J Int Adv Otol, vol. 11, no. 3, pp. 236–242, Dec. 2015, doi: 10.5152/iao.2015.1162.
[2247]	L. B. Bolden, J. C. Griffis, R. Nenert, J. B. Allendorfer, and J. P. Szaflarski, “Cortical excitability affects mood state in patients with idiopathic generalized epilepsies (IGEs),” Epilepsy Behav, vol. 90, pp. 84–89, 2019, doi: 10.1016/j.yebeh.2018.11.001.
[2248]	C.-P. Chu, C.-J. Xu, H. Kannan, and D.-L. Qiu, “Corticotrophin-releasing factor inhibits neuromedin U mRNA expressing neuron in the rat hypothalamic paraventricular nucleus in vitro,” Neurosci. Lett., vol. 511, no. 2, pp. 79–83, Mar. 2012, doi: 10.1016/j.neulet.2012.01.035.
[2249]	N. Casanova, A. Palmeira-DE-Oliveira, A. Pereira, L. Crisóstomo, B. Travassos, and A. M. Costa, “Cortisol, testosterone and mood state variation during an official female football competition,” J Sports Med Phys Fitness, vol. 56, no. 6, pp. 775–781, Jun. 2016.
[2250]	C. Scharf, “Cosmic (in)significance,” Sci. Am., vol. 311, no. 2, pp. 74–77, Aug. 2014, doi: 10.1038/scientificamerican0814-74.
[2251]	F. Ferrari and E. Szuszkiewicz, “Cosmic rays: a review for astrobiologists,” Astrobiology, vol. 9, no. 4, pp. 413–436, May 2009, doi: 10.1089/ast.2007.0205.
[2252]	B.-K. Yoo, S. G. Humiston, P. G. Szilagyi, S. J. Schaffer, C. Long, and M. Kolasa, “Cost effectiveness analysis of Year 2 of an elementary school-located influenza vaccination program-Results from a randomized controlled trial,” BMC Health Serv Res, vol. 15, p. 511, Nov. 2015, doi: 10.1186/s12913-015-1169-5.
[2253]	D. Pilon, M. Queener, P. Lefebvre, and L. A. Ellis, “Cost per median overall survival month associated with abiraterone acetate and enzalutamide for treatment of patients with metastatic castration-resistant prostate cancer,” J Med Econ, vol. 19, no. 8, pp. 777–784, Aug. 2016, doi: 10.3111/13696998.2016.1173042.
[2254]	R. Philips et al., “Cost savings associated with an outpatient otolaryngology telemedicine clinic,” Laryngoscope Investig Otolaryngol, vol. 4, no. 2, pp. 234–240, Apr. 2019, doi: 10.1002/lio2.244.
[2255]	J. A. Meyer and W. R. Johnson, “Cost shifting in health care: an economic analysis,” Health Aff (Millwood), vol. 2, no. 2, pp. 20–35, 1983, doi: 10.1377/hlthaff.2.2.20.
[2256]	R. Ruiz-Cordero, A. Gupta, A. Pinto, and M. Jorda, “Cost-containment protocols for prostate core needle biopsies: hypothetical scenarios to reduce procedural costs,” Prostate Int, vol. 7, no. 1, pp. 15–18, Mar. 2019, doi: 10.1016/j.prnil.2018.02.001.
[2257]	X. Qian et al., “Cost-Effective Yarn-Shaped Lithium-Ion Battery with High Wearability,” ACS Omega, vol. 5, no. 9, pp. 4697–4704, Mar. 2020, doi: 10.1021/acsomega.0c00254.
[2258]	C. C. Earle, D. Coyle, and W. K. Evans, “Cost-effectiveness analysis in oncology,” Ann. Oncol., vol. 9, no. 5, pp. 475–482, May 1998, doi: 10.1023/a:1008292128615.
[2259]	C. Senore et al., “Cost-effectiveness of colorectal cancer screening programmes using sigmoidoscopy and immunochemical faecal occult blood test,” J Med Screen, vol. 26, no. 2, pp. 76–83, 2019, doi: 10.1177/0969141318789710.
[2260]	B. Ielpo et al., “Cost-effectiveness of Randomized Study of Laparoscopic Versus Open Bilateral Inguinal Hernia Repair,” Ann. Surg., vol. 268, no. 5, pp. 725–730, 2018, doi: 10.1097/SLA.0000000000002894.
[2261]	K. Järbrink, P. McCrone, E. Fombonne, H. Zandén, and M. Knapp, “Cost-impact of young adults with high-functioning autistic spectrum disorder,” Res Dev Disabil, vol. 28, no. 1, pp. 94–104, Feb. 2007, doi: 10.1016/j.ridd.2005.11.002.
[2262]	C. Jo, “Cost-of-illness studies: concepts, scopes, and methods,” Clin Mol Hepatol, vol. 20, no. 4, pp. 327–337, Dec. 2014, doi: 10.3350/cmh.2014.20.4.327.
[2263]	D. R. Holtgrave, K. A. Wunderink, D. M. Vallone, and C. G. Healton, “Cost-utility analysis of the National truth campaign to prevent youth smoking,” Am J Prev Med, vol. 36, no. 5, pp. 385–388, May 2009, doi: 10.1016/j.amepre.2009.01.020.
[2264]	R. Robinson, “Costs and cost-minimisation analysis,” BMJ, vol. 307, no. 6906, pp. 726–728, Sep. 1993, doi: 10.1136/bmj.307.6906.726.
[2265]	M. Pedullà et al., “Could be a link between non atopic asthma and HP infection?,” J. Biol. Regul. Homeost. Agents, vol. 26, no. 1 Suppl, pp. S49-52, Mar. 2012.
[2266]	X. Gou, Y. Tang, Y. Qu, D. Xiao, J. Ying, and D. Mu, “Could the inhibitor of DNA binding 2 and 4 play a role in white matter injury?,” Rev Neurosci, vol. 30, no. 6, pp. 625–638, 26 2019, doi: 10.1515/revneuro-2018-0090.
[2267]	C. Victora et al., “Countdown to 2030 for reproductive, maternal, newborn, child, and adolescent health and nutrition,” Lancet Glob Health, vol. 4, no. 11, pp. e775–e776, 2016, doi: 10.1016/S2214-109X(16)30204-2.
[2268]	Countdown to 2030 Collaboration, “Countdown to 2030: tracking progress towards universal coverage for reproductive, maternal, newborn, and child health,” Lancet, vol. 391, no. 10129, pp. 1538–1548, 14 2018, doi: 10.1016/S0140-6736(18)30104-1.
[2269]	L. Marquez and C. Madubuike, “Country experience in organizing for quality: Ecuador,” QA Brief, vol. 8, no. 1, pp. 9–11, Jan. 1999.
[2270]	“Country Immunization Information System Assessments (IISAs), in Kenya (2015) and Ghana (2016),” Wkly. Epidemiol. Rec., vol. 92, no. 45, pp. 694–700, 10 2017.
[2271]	D. C. Atkins, S. Dimidjian, J. D. Bedics, and A. Christensen, “Couple discord and depression in couples during couple therapy and in depressed individuals during depression treatment,” J Consult Clin Psychol, vol. 77, no. 6, pp. 1089–1099, Dec. 2009, doi: 10.1037/a0017119.
[2272]	P. C. Ouimette, P. J. Brown, and L. M. Najavits, “Course and treatment of patients with both substance use and posttraumatic stress disorders,” Addict Behav, vol. 23, no. 6, pp. 785–795, Dec. 1998, doi: 10.1016/s0306-4603(98)00064-1.
[2273]	M. Niemeyer-Guimarães, M. S. Cendoroglo, and C. M. Almada-Filho, “Course of functional status in elderly patients after coronary artery bypass surgery: 6-month follow up,” Geriatr Gerontol Int, vol. 16, no. 6, pp. 737–746, Jun. 2016, doi: 10.1111/ggi.12547.
[2274]	N. Akseer, G. Kandru, E. C. Keats, and Z. A. Bhutta, “COVID-19 pandemic and mitigation strategies: implications for maternal and child health and nutrition,” Am. J. Clin. Nutr., vol. 112, no. 2, pp. 251–256, 01 2020, doi: 10.1093/ajcn/nqaa171.
[2275]	A. Asghari, S. S. Mohammadi, and F. Hosseinzadeh, “COVID-19 pandemic and physicians in training,” Laryngoscope Investig Otolaryngol, vol. 5, no. 3, pp. 590–591, Jun. 2020, doi: 10.1002/lio2.402.
[2276]	N. M. Lovatto et al., “Crambe (Crambe abyssinica) and sunflower (Helianthus annuus) protein concentrates: production methods and nutritional properties for use in fish feed,” An. Acad. Bras. Cienc., vol. 89, no. 3 Suppl, pp. 2495–2504, 2017, doi: 10.1590/0001-3765201720140630.
[2277]	D. Bulnes-Mendizábal, A. Arredondo Colindres, L. Gómez-Valencia, and A. Ruiz-Rangel, “[Craniofacial dys-synostosis. Presentation of a case],” Bol Med Hosp Infant Mex, vol. 44, no. 6, pp. 354–359, Jun. 1987.
[2278]	C. Simon, A. Calabrese, G. Canu, M. Merlo, and L. Galletti, “Crater-Like Ulceration of Aortic Arch,” Aorta (Stamford), vol. 2, no. 6, pp. 289–292, Dec. 2014, doi: 10.12945/j.aorta.2014.14-029.
[2279]	E. Wilson et al., “Creating a Canadian stroke system,” CMAJ, vol. 164, no. 13, pp. 1853–1855, Jun. 2001.
[2280]	S. M. Thompson, M. J. Nieuwenhuijze, L. Budé, R. de Vries, and L. Kane Low, “Creating an Optimality Index - Netherlands: a validation study,” BMC Pregnancy Childbirth, vol. 18, no. 1, p. 100, 16 2018, doi: 10.1186/s12884-018-1735-z.
[2281]	“Creating new solutions to tackle old problems: the first ever evidence-based guidance on emergency risk communication policy and practice,” Wkly. Epidemiol. Rec., vol. 93, no. 6, pp. 45–54, Feb. 2018.
[2282]	R. J. Daker, R. A. Cortes, I. M. Lyons, and A. E. Green, “Creativity anxiety: Evidence for anxiety that is specific to creative thinking, from STEM to the arts,” J Exp Psychol Gen, vol. 149, no. 1, pp. 42–57, Jan. 2020, doi: 10.1037/xge0000630.
[2283]	V. Egemonye, “Credit crunch UDAs,” Br Dent J, vol. 207, no. 7, pp. 304–305, Oct. 2009, doi: 10.1038/sj.bdj.2009.861.
[2284]	A. Ghaffar, S. Qazi, and I. Shah, “Credit where credit is due: Pakistan’s role in reducing the global burden of reproductive, maternal, newborn, and child health (RMNCH),” Health Res Policy Syst, vol. 13 Suppl 1, p. 48, Nov. 2015, doi: 10.1186/s12961-015-0035-6.
[2285]	R. M. Mateen and A. Tariq, “Crime scene investigation in Pakistan: A perspective,” Forensic Sci Int, vol. 1, pp. 285–287, 2019, doi: 10.1016/j.fsisyn.2019.06.046.
[2286]	L. G. Howes, “Critical assessment of ACE inhibitors. Part 2,” Aust Fam Physician, vol. 24, no. 4, pp. 639, 641–643, Apr. 1995.
[2287]	D. K. Moser et al., “Critical care nursing practice regarding patient anxiety assessment and management,” Intensive Crit Care Nurs, vol. 19, no. 5, pp. 276–288, Oct. 2003, doi: 10.1016/s0964-3397(03)00061-2.
[2288]	M. Tröndle, S. Kondrat, A. Gambassi, L. Harnau, and S. Dietrich, “Critical Casimir effect for colloids close to chemically patterned substrates,” J Chem Phys, vol. 133, no. 7, p. 074702, Aug. 2010, doi: 10.1063/1.3464770.
[2289]	C. E. Van Skike et al., “Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse,” Prog. Neuropsychopharmacol. Biol. Psychiatry, vol. 65, pp. 269–287, Feb. 2016, doi: 10.1016/j.pnpbp.2015.11.004.
[2290]	C. O’Driscoll and M. Shaikh, “Cross-Cultural Applicability of the Montreal Cognitive Assessment (MoCA): A Systematic Review,” J. Alzheimers Dis., vol. 58, no. 3, pp. 789–801, 2017, doi: 10.3233/JAD-161042.
[2291]	J. Mahlich, J. Sindern, and M. Suppliet, “Cross-national drug price comparisons with economic weights in external reference pricing in Germany,” Expert Rev Pharmacoecon Outcomes Res, vol. 19, no. 1, pp. 37–43, 2019, doi: 10.1080/14737167.2019.1527221.
[2292]	P. Gottier, M. Serricchio, R. Vitale, A. Corcelli, and P. Bütikofer, “Cross-species complementation of bacterial- and eukaryotic-type cardiolipin synthases,” Microb Cell, vol. 4, no. 11, pp. 376–383, Nov. 2017, doi: 10.15698/mic2017.11.598.
[2293]	H. Burger and H. E. Kaiser, “Crowding,” In Vivo, vol. 10, no. 2, pp. 249–253, Apr. 1996.
[2294]	M. Su et al., “Cryo-EM Analysis Reveals Structural Basis of Helicobacter pylori VacA Toxin Oligomerization,” J. Mol. Biol., vol. 431, no. 10, pp. 1956–1965, 03 2019, doi: 10.1016/j.jmb.2019.03.029.
[2295]	M. T. Kinnison, N. G. Hairston, and A. P. Hendry, “Cryptic eco-evolutionary dynamics,” Ann. N. Y. Acad. Sci., vol. 1360, pp. 120–144, Dec. 2015, doi: 10.1111/nyas.12974.
[2296]	A. R. Menze, J. P. Sinnott, and A. Y. Nazarenko, “Crystal structure of naltrexone chloride solvates with ethanol, propan-2-ol, and 2-methyl-propan-2-ol,” Acta Crystallogr E Crystallogr Commun, vol. 73, no. Pt 7, pp. 1013–1020, Jul. 2017, doi: 10.1107/S205698901700843X.
[2297]	D. Verger, E. Bullitt, S. J. Hultgren, and G. Waksman, “Crystal structure of the P pilus rod subunit PapA,” PLoS Pathog., vol. 3, no. 5, p. e73, May 2007, doi: 10.1371/journal.ppat.0030073.
[2298]	G. Gayer, D. Barsuk, M. Hertz, S. Apter, and R. Zissin, “CT diagnosis of afferent loop syndrome,” Clin Radiol, vol. 57, no. 9, pp. 835–839, Sep. 2002.
[2299]	L. Rew, H. Becker, J. Chontichachalalauk, and H. Y. Lee, “Cultural diversity among nursing students: reanalysis of the cultural awareness scale,” J Nurs Educ, vol. 53, no. 2, pp. 71–76, Feb. 2014, doi: 10.3928/01484834-20140122-01.
[2300]	A. B. I. Bernardo, S. R. Levy, and A. E. Lytle, “Culturally Relevant Meanings of the Protestant Work Ethic and Attitudes towards Poor Persons,” Span J Psychol, vol. 21, p. E40, 25 2018, doi: 10.1017/sjp.2018.48.
[2301]	M. M. Pearson, “Culture Methods for Proteus mirabilis,” Methods Mol. Biol., vol. 2021, pp. 5–13, 2019, doi: 10.1007/978-1-4939-9601-8_2.
[2302]	C. Chany and M. Thomas, “[Culture of cells in vitro at the central temperature of homeothermal animals and in hyperthermal zones],” C. R. Hebd. Seances Acad. Sci., vol. 253, pp. 579–581, Jul. 1961.
[2303]	A. S. Ali, V. Trivedi, and M. Lesch, “Culture-negative endocarditis--a historical review and 1990s update,” Prog Cardiovasc Dis, vol. 37, no. 3, pp. 149–160, Dec. 1994, doi: 10.1016/s0033-0620(05)80040-4.
[2304]	C.-C. Su et al., “Curcumin inhibits WEHI-3 leukemia cells in BALB/c mice in vivo,” In Vivo, vol. 22, no. 1, pp. 63–68, Feb. 2008.
[2305]	R. Ivancic, H. Iqbal, B. deSilva, Q. Pan, and L. Matrka, “Current and future management of recurrent respiratory papillomatosis,” Laryngoscope Investig Otolaryngol, vol. 3, no. 1, pp. 22–34, 2018, doi: 10.1002/lio2.132.
[2306]	F. Estephan and R. V. Tiu, “Current and novel therapeutic approaches in myelodysplastic syndromes,” J Community Support Oncol, vol. 12, no. 7, pp. 236–249, Jul. 2014, doi: 10.12788/jcso.0057.
[2307]	V. V. Zakharov and D. O. Gromova, “[Current approaches to management of patients with mild cognitive impairment],” Zh Nevrol Psikhiatr Im S S Korsakova, vol. 117, no. 3, pp. 107–112, 2017, doi: 10.17116/jnevro201711731107-112.
[2308]	S. Brunty and N. Santanam, “Current assessment of the (dys)function of macrophages in endometriosis and its associated pain,” Ann Transl Med, vol. 7, no. Suppl 8, p. S381, Dec. 2019, doi: 10.21037/atm.2019.12.119.
[2309]	F. B. Schoenfeld, C. R. Marmar, and T. C. Neylan, “Current concepts in pharmacotherapy for posttraumatic stress disorder,” Psychiatr Serv, vol. 55, no. 5, pp. 519–531, May 2004, doi: 10.1176/appi.ps.55.5.519.
[2310]	E. Greszta, “[Current concepts of depression during adolescence],” Med Wieku Rozwoj, vol. 8, no. 4 Pt 1, pp. 911–923, Dec. 2004.
[2311]	F. C. Visser and C. A. Visser, “Current controversies with ACE inhibitor treatment in heart failure,” Cardiology, vol. 87 Suppl 1, pp. 23–28, 1996, doi: 10.1159/000177164.
[2312]	T. Meyer, C. Tschöpe, B. Kherad, and M. Noutsias, “[Current developments in telemedicine : Expectations, disappointments and hopes],” Herz, vol. 43, no. 4, pp. 364–366, Jun. 2018, doi: 10.1007/s00059-017-4597-7.
[2313]	Y. Li et al., “Current evaluation and management of plastic bronchitis in the pediatric population,” Int. J. Pediatr. Otorhinolaryngol., vol. 130, p. 109799, Mar. 2020, doi: 10.1016/j.ijporl.2019.109799.
[2314]	A. E. Walts and A. M. Marchevsky, “Current Evidence Does Not Warrant Frozen Section Evaluation for the Presence of Tumor Spread Through Alveolar Spaces,” Arch. Pathol. Lab. Med., vol. 142, no. 1, pp. 59–63, Jan. 2018, doi: 10.5858/arpa.2016-0635-OA.
[2315]	I. L. Schwartz, “Current ideas on the endocrine regulation of cellular processes,” Tech Rep Brookhaven Natl Lab, vol. 685, p. 18, Dec. 1960.
[2316]	K. Sugai, “Current management of febrile seizures in Japan: an overview,” Brain Dev., vol. 32, no. 1, pp. 64–70, Jan. 2010, doi: 10.1016/j.braindev.2009.09.019.
[2317]	E. F. E. Wenstedt et al., “Current practice of closed-loop mechanical ventilation modes on intensive care units - a nationwide survey in the Netherlands,” Neth J Med, vol. 75, no. 4, pp. 145–150, May 2017.
[2318]	L. Wang, X. Liu, D. Yu, L. Wang, X. Zhou, and Y. Zi, “[Current situation of prevention and treatment of silicosis in Jinshan District of Shanghai, China],” Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, vol. 33, no. 6, pp. 456–458, Jun. 2015.
[2319]	P. R. Zoladz and D. M. Diamond, “Current status on behavioral and biological markers of PTSD: a search for clarity in a conflicting literature,” Neurosci Biobehav Rev, vol. 37, no. 5, pp. 860–895, Jun. 2013, doi: 10.1016/j.neubiorev.2013.03.024.
[2320]	T. E. Van Rheenen et al., “Current understandings of the trajectory and emerging correlates of cognitive impairment in bipolar disorder: An overview of evidence,” Bipolar Disord, vol. 22, no. 1, pp. 13–27, 2020, doi: 10.1111/bdi.12821.
[2321]	M. Juznic, “[CURRENT VIEWS ON THE PATHOPHYSIOLOGY OF WOUND HEALING],” Vojnosanit Pregl, vol. 20, pp. 293–300, May 1963.
[2322]	R. Pita and S. Vidal-Asensi, “[Cutaneous and systemic toxicology of vesicants used in warfare],” Actas Dermosifiliogr, vol. 101, no. 1, pp. 7–18, Feb. 2010, doi: 10.1016/j.ad.2009.07.012.
[2323]	M. Griksaitis, V. Pennock, and A. Nair, “Cutaneous lava migrans in the paediatric foot,” BMJ Case Rep, vol. 2010, Feb. 2010, doi: 10.1136/bcr.10.2010.3406.
[2324]	A. A. van de Loosdrecht and T. M. Westers, “Cutting edge: flow cytometry in myelodysplastic syndromes,” J Natl Compr Canc Netw, vol. 11, no. 7, pp. 892–902, Jul. 2013, doi: 10.6004/jnccn.2013.0106.
[2325]	A. Papa and C. Lefton, “Cutting-edge discussions of management, policy, and program issues in emergency care,” J Emerg Nurs, vol. 40, no. 4, pp. 387–389, Jul. 2014, doi: 10.1016/j.jen.2014.04.008.
[2326]	M. A. Tyler, C. C. Zhang, A. T. Saini, and W. C. Yao, “Cutting-edge endonasal surgical approaches to thyroid ophthalmopathy,” Laryngoscope Investig Otolaryngol, vol. 3, no. 2, pp. 100–104, Apr. 2018, doi: 10.1002/lio2.143.
[2327]	S. J. Gros et al., “CXCR4/SDF-1α-mediated chemotaxis in an in vivo model of metastatic esophageal carcinoma,” In Vivo, vol. 26, no. 4, pp. 711–718, Aug. 2012.
[2328]	S. Dieterich and T. Pawlicki, “Cyberknife image-guided delivery and quality assurance,” Int. J. Radiat. Oncol. Biol. Phys., vol. 71, no. 1 Suppl, pp. S126-130, 2008, doi: 10.1016/j.ijrobp.2007.08.081.
[2329]	N. Kanda and S. Watanabe, “Cyclooxygenase-2 inhibitor enhances whereas prostaglandin E2 inhibits the production of interferon-induced protein of 10 kDa in epidermoid carcinoma A431,” J. Invest. Dermatol., vol. 119, no. 5, pp. 1080–1089, Nov. 2002, doi: 10.1046/j.1523-1747.2002.19510.x.
[2330]	E. Hunter et al., “Cysticercosis and epilepsy in rural Tanzania: a community-based case-control and imaging study,” Trop. Med. Int. Health, vol. 20, no. 9, pp. 1171–1179, Sep. 2015, doi: 10.1111/tmi.12529.
[2331]	P. Bol, “[Cystitis and urethritis],” Ned Tijdschr Tandheelkd, vol. 109, no. 5, pp. 184–185, May 2002.
[2332]	H. Nagoshi, S. Horiike, J. Kuroda, and M. Taniwaki, “Cytogenetic and molecular abnormalities in myelodysplastic syndrome,” Curr. Mol. Med., vol. 11, no. 8, pp. 678–685, Nov. 2011, doi: 10.2174/156652411797536732.
[2333]	Y. Elnahass and L. Youssif, “Cytogenetic features in primary myelodysplastic syndrome Egyptian patients,” J Adv Res, vol. 10, pp. 77–83, Mar. 2018, doi: 10.1016/j.jare.2018.02.002.
[2334]	B. Misiak et al., “Cytokine alterations and cognitive impairment in major depressive disorder: From putative mechanisms to novel treatment targets,” Prog. Neuropsychopharmacol. Biol. Psychiatry, vol. 80, no. Pt C, pp. 177–188, Jan. 2018, doi: 10.1016/j.pnpbp.2017.04.021.
[2335]	A. J. Dunn, A. H. Swiergiel, and R. de Beaurepaire, “Cytokines as mediators of depression: what can we learn from animal studies?,” Neurosci Biobehav Rev, vol. 29, no. 4–5, pp. 891–909, 2005, doi: 10.1016/j.neubiorev.2005.03.023.
[2336]	L. D. Wang et al., “Cytological screening and 15 years’ follow-up (1986-2001) for early esophageal squamous cell carcinoma and precancerous lesions in a high-risk population in Anyang County, Henan Province, Northern China,” Cancer Detect. Prev., vol. 29, no. 4, pp. 317–322, 2005, doi: 10.1016/j.cdp.2005.06.004.
[2337]	H. E. Taylor and C. F. Culling, “CYTOPATHIC EFFECT IN VITRO OF SENSITIZED HOMOLOGOUS AND HETEROLOGOUS SPLEEN CELLS ON FIBROBLASTS,” Lab. Invest., vol. 12, pp. 884–894, Sep. 1963.
[2338]	M. Bucher, T. Fanutza, and M. Mikhaylova, “Cytoskeletal makeup of the synapse: Shaft versus spine,” Cytoskeleton (Hoboken), vol. 77, no. 3–4, pp. 55–64, Mar. 2020, doi: 10.1002/cm.21583.
[2339]	S. Miyata, “Cytoskeletal Signal-Regulated Oligodendrocyte Myelination and Remyelination,” Adv. Exp. Med. Biol., vol. 1190, pp. 33–42, 2019, doi: 10.1007/978-981-32-9636-7_3.
[2340]	A. Gagliardi et al., “Cytoskeleton and nuclear lamina affection in recessive osteogenesis imperfecta: A functional proteomics perspective,” J Proteomics, vol. 167, pp. 46–59, 07 2017, doi: 10.1016/j.jprot.2017.08.007.
[2341]	F. Bouet-Toussaint et al., “Cytotoxic effector cells with antitumor activity can be amplified ex vivo from biopsies or blood of patients with renal cell carcinoma for cell therapy use,” Cancer Immunol. Immunother., vol. 52, no. 11, pp. 699–707, Nov. 2003, doi: 10.1007/s00262-003-0412-9.
[2342]	S. Muraoka, “Cytotoxic T lymphocyte precursor cells specific for the major histocompatibility complex class I-like antigen, Qa-2, require CD4+ T cells to become primed in vivo and to differentiate into effector cells in vitro,” Eur. J. Immunol., vol. 21, no. 9, pp. 2095–2103, Sep. 1991, doi: 10.1002/eji.1830210918.
[2343]	M. Namiecinski, L. Pulaski, A. Kochman, J. Skolimowski, G. Bartosz, and D. Metodiewa, “Cytotoxicity, cytoprotection and neurotoxicity of novel deprenyl-related propargylamines, stable nitroxide free radicals, in vitro and in vivo,” In Vivo, vol. 18, no. 2, pp. 171–180, Apr. 2004.
[2344]	T. Hasebe et al., “Daikenchuto (TU-100) Suppresses Tumor Development in the Azoxymethane and APCmin/+ Mouse Models of Experimental Colon Cancer,” Phytother Res, vol. 31, no. 1, pp. 90–99, Jan. 2017, doi: 10.1002/ptr.5735.
[2345]	S. Ashfaq, R. Maqbool, and Y. Rashid, “Daily dataset of oil prices and stock prices for the top oil exporting and importing countries from the region of Asia,” Data Brief, vol. 28, p. 104871, Feb. 2020, doi: 10.1016/j.dib.2019.104871.
[2346]	R. D. Crosby, S. A. Wonderlich, S. G. Engel, H. Simonich, J. Smyth, and J. E. Mitchell, “Daily mood patterns and bulimic behaviors in the natural environment,” Behav Res Ther, vol. 47, no. 3, pp. 181–188, Mar. 2009, doi: 10.1016/j.brat.2008.11.006.
[2347]	S. A. Schepers, K. Russell, K. S. Berlin, H. Zhang, F. Wang, and S. Phipps, “Daily mood profiles and psychosocial adjustment in youth with newly diagnosed cancer and healthy peers,” Health Psychol, vol. 39, no. 1, pp. 1–9, Jan. 2020, doi: 10.1037/hea0000810.
[2348]	C. D. Mohr, D. Brannan, S. Wendt, L. Jacobs, R. Wright, and M. Wang, “Daily mood-drinking slopes as predictors: a new take on drinking motives and related outcomes,” Psychol Addict Behav, vol. 27, no. 4, pp. 944–955, Dec. 2013, doi: 10.1037/a0032633.
[2349]	Y. Fogel, S. Rosenblum, R. Hirsh, M. Chevignard, and N. Josman, “Daily Performance of Adolescents with Executive Function Deficits: An Empirical Study Using a Complex-Cooking Task,” Occup Ther Int, vol. 2020, p. 3051809, 2020, doi: 10.1155/2020/3051809.
[2350]	K. C. Mitchell and J. H. Withey, “Danio rerio as a Native Host Model for Understanding Pathophysiology of Vibrio cholerae,” Methods Mol. Biol., vol. 1839, pp. 97–102, 2018, doi: 10.1007/978-1-4939-8685-9_9.
[2351]	Y.-L. Chen et al., “Danthron inhibits murine WEHI-3 cells in vivo, and enhances macrophage phagocytosis and natural killer cell cytotoxic activity in leukemic mice,” In Vivo, vol. 25, no. 3, pp. 393–398, Jun. 2011.
[2352]	N. B. Allen and P. B. T. Badcock, “Darwinian models of depression: a review of evolutionary accounts of mood and mood disorders,” Prog. Neuropsychopharmacol. Biol. Psychiatry, vol. 30, no. 5, pp. 815–826, Jul. 2006, doi: 10.1016/j.pnpbp.2006.01.007.
[2353]	V. A. Pawar, “Dashavidha Parikshya Bhava (tenfold of investigation) according to Acharya Charaka - An ancient method of research,” Ayu, vol. 40, no. 1, pp. 3–7, Mar. 2019, doi: 10.4103/ayu.AYU_199_17.
[2354]	C. Bethell, “Data and information quality strategic plan,” Qual Assur, vol. 9, no. 2, pp. 63–97, Jun. 2001.
[2355]	R. Trautman, “Data editing and processing computer program for ultracentrifuge moving boundary Schlieren pattern calculations. BNL 990(T-420),” Tech Rep Brookhaven Natl Lab, pp. 1–79, Apr. 1964.
[2356]	S. Bhargava and N. V. S. Madhav, “Data on Spectroscopic, Rheological characterization of neem oil and its isolated fractions,” Data Brief, vol. 21, pp. 996–1003, Dec. 2018, doi: 10.1016/j.dib.2018.10.049.
[2357]	H. Zhang, D. Yue, C. Dou, W. Zhao, and X. Xie, “Data-Driven Distributed Optimal Consensus Control for Unknown Multiagent Systems With Input-Delay,” IEEE Trans Cybern, vol. 49, no. 6, pp. 2095–2105, Jun. 2019, doi: 10.1109/TCYB.2018.2819695.
[2358]	E. C. Rouchka et al., “Dataset for dose and time-dependent transcriptional response to ionizing radiation exposure,” Data Brief, vol. 27, p. 104624, Dec. 2019, doi: 10.1016/j.dib.2019.104624.
[2359]	E. Matsuoka, M. Saji, and K. Kanemoto, “Daytime sleepiness in epilepsy patients with special attention to traffic accidents,” Seizure, vol. 69, pp. 279–282, Jul. 2019, doi: 10.1016/j.seizure.2019.04.006.
[2360]	M. Stella Vari et al., “De novo 12q22.q23.3 duplication associated with temporal lobe epilepsy,” Seizure, vol. 57, pp. 63–65, Apr. 2018, doi: 10.1016/j.seizure.2018.02.011.
[2361]	M. S. Vari et al., “De novo 12q22.q23.3 duplication associated with temporal lobe epilepsy,” Seizure, vol. 50, pp. 80–82, Aug. 2017, doi: 10.1016/j.seizure.2017.06.011.
[2362]	L. Zhytnik et al., “De novo and inherited pathogenic variants in collagen-related osteogenesis imperfecta,” Mol Genet Genomic Med, vol. 7, no. 3, p. e559, 2019, doi: 10.1002/mgg3.559.
[2363]	Y. Gupta, A. K. Pathak, K. Singh, S. S. Mantri, S. P. Singh, and R. Tuli, “De novo assembly and characterization of transcriptomes of early-stage fruit from two genotypes of Annona squamosa L. with contrast in seed number,” BMC Genomics, vol. 16, p. 86, Feb. 2015, doi: 10.1186/s12864-015-1248-3.
[2364]	D. L. Courtney, “Dealing with mild cognitive impairment: help for patients and caregivers,” Clin. Geriatr. Med., vol. 29, no. 4, pp. 895–905, Nov. 2013, doi: 10.1016/j.cger.2013.07.010.
[2365]	J. P. Benton, A. N. Christopher, and M. I. Walter, “Death anxiety as a function of aging anxiety,” Death Stud, vol. 31, no. 4, pp. 337–350, Apr. 2007, doi: 10.1080/07481180601187100.
[2366]	N. Bacalbasa, I. Balescu, and A. Filipescu, “Debulking Surgery for High-grade Serous Endometrial Cancer with Disseminated Peritoneal Lesions,” In Vivo, vol. 31, no. 4, pp. 719–722, Aug. 2017, doi: 10.21873/invivo.11120.
[2367]	T. C. Bosch and C. N. David, “Decision making in interstitial stem cells of Hydra,” In Vivo, vol. 5, no. 5, pp. 515–520, Oct. 1991.
[2368]	S. N. Mohanty and D. Suar, “Decision making under uncertainty and information processing in positive and negative mood states,” Psychol Rep, vol. 115, no. 1, pp. 91–105, Aug. 2014, doi: 10.2466/20.04.PR0.115c16z2.
[2369]	C. N. White, E. Liebman, and P. Stone, “Decision mechanisms underlying mood-congruent emotional classification,” Cogn Emot, vol. 32, no. 2, pp. 249–258, 2018, doi: 10.1080/02699931.2017.1296820.
[2370]	C. Geoffroy-Siraudin et al., “Decline of semen quality among 10 932 males consulting for couple infertility over a 20-year period in Marseille, France,” Asian J. Androl., vol. 14, no. 4, pp. 584–590, Jul. 2012, doi: 10.1038/aja.2011.173.
[2371]	L. E. Peterson, U. Nasim, and V. Madabhushi, “Declining Endoscopic Care by Family Physicians in Both Rural and Urban Areas,” J Am Board Fam Med, vol. 32, no. 4, pp. 460–461, Aug. 2019, doi: 10.3122/jabfm.2019.04.190064.
[2372]	J. A. Crooks, M. D. Stilwell, P. M. Oliver, Z. Zhong, and D. B. Weibel, “Decoding the Chemical Language of Motile Bacteria by Using High-Throughput Microfluidic Assays,” Chembiochem, vol. 16, no. 15, pp. 2151–2155, Oct. 2015, doi: 10.1002/cbic.201500324.
[2373]	A. Buchweitz et al., “Decoupling of the Occipitotemporal Cortex and the Brain’s Default-Mode Network in Dyslexia and a Role for the Cingulate Cortex in Good Readers: A Brain Imaging Study of Brazilian Children,” Dev Neuropsychol, vol. 44, no. 1, pp. 146–157, Feb. 2019, doi: 10.1080/87565641.2017.1292516.
[2374]	J.-C. Domec et al., “Decoupling the influence of leaf and root hydraulic conductances on stomatal conductance and its sensitivity to vapour pressure deficit as soil dries in a drained loblolly pine plantation,” Plant Cell Environ., vol. 32, no. 8, pp. 980–991, Aug. 2009, doi: 10.1111/j.1365-3040.2009.01981.x.
[2375]	C. Johnson, A. J. Prokopienko, R. E. West, T. D. Nolin, and J. R. Stubbs, “Decreased Kidney Function Is Associated with Enhanced Hepatic Flavin Monooxygenase Activity and Increased Circulating Trimethylamine N-Oxide Concentrations in Mice,” Drug Metab. Dispos., vol. 46, no. 9, pp. 1304–1309, 2018, doi: 10.1124/dmd.118.081646.
[2376]	N. Kanda, C. S. Hau, Y. Tada, S. Sato, and S. Watanabe, “Decreased serum LL-37 and vitamin D3 levels in atopic dermatitis: relationship between IL-31 and oncostatin M,” Allergy, vol. 67, no. 6, pp. 804–812, Jun. 2012, doi: 10.1111/j.1398-9995.2012.02824.x.
[2377]	M. de Taffin de Tilques et al., “Decreasing cytosolic translation is beneficial to yeast and human Tafazzin-deficient cells,” Microb Cell, vol. 5, no. 5, pp. 220–232, Feb. 2018, doi: 10.15698/mic2018.05.629.
[2378]	S. K. Krishnan and Y. Chipatecua Godoy, “Deep Eutectic Solvent-Assisted Synthesis of Au Nanostars Supported on Graphene Oxide as an Efficient Substrate for SERS-Based Molecular Sensing,” ACS Omega, vol. 5, no. 3, pp. 1384–1393, Jan. 2020, doi: 10.1021/acsomega.9b02759.
[2379]	Y. Sueoka, S. Yamashita, M. Kouduka, and Y. Suzuki, “Deep Microbial Colonization in Saponite-Bearing Fractures in Aged Basaltic Crust: Implications for Subsurface Life on Mars,” Front Microbiol, vol. 10, p. 2793, 2019, doi: 10.3389/fmicb.2019.02793.
[2380]	E. C. B. Johnson et al., “Deep proteomic network analysis of Alzheimer’s disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease,” Mol Neurodegener, vol. 13, no. 1, p. 52, 04 2018, doi: 10.1186/s13024-018-0282-4.
[2381]	F. Zara et al., “Deficiency of hyccin, a newly identified membrane protein, causes hypomyelination and congenital cataract,” Nat. Genet., vol. 38, no. 10, pp. 1111–1113, Oct. 2006, doi: 10.1038/ng1870.
[2382]	H. D. Meyer, T. Beckers, G. Tripp, and S. van der Oord, “Deficits in Conditional Discrimination Learning in Children with ADHD are Independent of Delay Aversion and Working Memory,” J Clin Med, vol. 8, no. 9, Sep. 2019, doi: 10.3390/jcm8091381.
[2383]	S. Ferman, L. Kishon-Rabin, H. Ganot-Budaga, and A. Karni, “Deficits in Explicit Language Problem Solving Rather Than in Implicit Learning in Specific Language Impairment: Evidence From Learning an Artificial Morphological Rule,” J. Speech Lang. Hear. Res., vol. 62, no. 10, pp. 3790–3807, 25 2019, doi: 10.1044/2019_JSLHR-L-17-0140.
[2384]	D. Kaur, R. R. Sharma, and N. Marwaha, “Defining an appropriate leucoreduction strategy by serial assessment of cytokine levels in platelet concentrates prepared by different methods,” Asian J Transfus Sci, vol. 9, no. 1, pp. 31–35, Jun. 2015, doi: 10.4103/0973-6247.150945.
[2385]	C. L. Franklin, V. Piazza, I. Chelminski, and M. Zimmerman, “Defining Subthreshold PTSD in the DSM-IV Literature: A Look Toward DSM-5,” J. Nerv. Ment. Dis., vol. 203, no. 8, pp. 574–577, Aug. 2015, doi: 10.1097/NMD.0000000000000332.
[2386]	S. Loghavi and S. A. Wang, “Defining the Boundary Between Myelodysplastic Syndromes and Myeloproliferative Neoplasms,” Surg Pathol Clin, vol. 12, no. 3, pp. 651–669, Sep. 2019, doi: 10.1016/j.path.2019.03.010.
[2387]	S. S. Vasani, D. Youssef, C. Lin, A. Wellham, and R. Hodge, “Defining the low-risk salvage laryngectomy-A single-center retrospective analysis of pharyngocutaneous fistula,” Laryngoscope Investig Otolaryngol, vol. 3, no. 2, pp. 115–120, Apr. 2018, doi: 10.1002/lio2.144.
[2388]	A. May Khan and B. Ky, “Defining the Role of ST2: A Multimarker Approach?,” J. Card. Fail., vol. 18, no. 4, pp. 311–312, Apr. 2012, doi: 10.1016/j.cardfail.2012.02.008.
[2389]	C. L. May and B. E. Wisco, “Defining trauma: How level of exposure and proximity affect risk for posttraumatic stress disorder,” Psychol Trauma, vol. 8, no. 2, pp. 233–240, Mar. 2016, doi: 10.1037/tra0000077.
[2390]	J. Gutiérrez Rodríguez and G. Guzmán Gutiérrez, “[Definition and prevalence of mild cognitive impairment],” Rev Esp Geriatr Gerontol, vol. 52 Suppl 1, pp. 3–6, Jun. 2017, doi: 10.1016/S0211-139X(18)30072-6.
[2391]	C.-H. Cho, Y.-H. Lee, D.-H. Kim, Y.-J. Lim, C.-S. Baek, and D.-H. Kim, “Definition, Diagnosis, Treatment, and Prognosis of Frozen Shoulder: A Consensus Survey of Shoulder Specialists,” Clin Orthop Surg, vol. 12, no. 1, pp. 60–67, Mar. 2020, doi: 10.4055/cios.2020.12.1.60.
[2392]	K. Sato, S.-I. Chitose, F. Sato, and H. Umeno, “Deglutition and respiratory patterns during sleep in the aged with OSAS,” Laryngoscope Investig Otolaryngol, vol. 3, no. 6, pp. 500–506, Dec. 2018, doi: 10.1002/lio2.213.
[2393]	S. Ammar et al., “Degradation of tyrosol by a novel electro-Fenton process using pyrite as heterogeneous source of iron catalyst,” Water Res., vol. 74, pp. 77–87, May 2015, doi: 10.1016/j.watres.2015.02.006.
[2394]	C. Escudero et al., “Dehydrated egg white: an allergen source for improving efficacy and safety in the diagnosis and treatment for egg allergy,” Pediatr Allergy Immunol, vol. 24, no. 3, pp. 263–269, May 2013, doi: 10.1111/pai.12052.
[2395]	D. A. Rew, “Deinococcus radiodurans,” Eur J Surg Oncol, vol. 29, no. 6, pp. 557–558, Aug. 2003, doi: 10.1016/s0748-7983(03)00080-5.
[2396]	L. C. Drickamer, “Delay and acceleration of puberty in female mice by urinary chemosignals from other females,” Dev Psychobiol, vol. 15, no. 5, pp. 433–445, Sep. 1982, doi: 10.1002/dev.420150505.
[2397]	G. J. Madden, M. T. Francisco, A. T. Brewer, and J. S. Stein, “Delay discounting and gambling,” Behav. Processes, vol. 87, no. 1, pp. 43–49, May 2011, doi: 10.1016/j.beproc.2011.01.012.
[2398]	G. W. Mies, E. de Water, J. R. Wiersema, and A. Scheres, “Delay discounting of monetary gains and losses in adolescents with ADHD: Contribution of delay aversion to choice,” Child Neuropsychol, vol. 25, no. 4, pp. 528–547, 2019, doi: 10.1080/09297049.2018.1508563.
[2399]	N. M. Petry, “Delay discounting of money and alcohol in actively using alcoholics, currently abstinent alcoholics, and controls,” Psychopharmacology (Berl.), vol. 154, no. 3, pp. 243–250, Mar. 2001, doi: 10.1007/s002130000638.
[2400]	L. Caplan, “Delay in breast cancer: implications for stage at diagnosis and survival,” Front Public Health, vol. 2, p. 87, 2014, doi: 10.3389/fpubh.2014.00087.
[2401]	L. M. Goedhart, J. G. Gerbers, J. J. W. Ploegmakers, and P. C. Jutte, “Delay in Diagnosis and Its Effect on Clinical Outcome in High-grade Sarcoma of Bone: A Referral Oncological Centre Study,” Orthop Surg, vol. 8, no. 2, pp. 122–128, May 2016, doi: 10.1111/os.12239.
[2402]	R. Thakur and M. Murhekar, “Delay in diagnosis and treatment among TB patients registered under RNTCP Mandi, Himachal Pradesh, India, 2010,” Indian J Tuberc, vol. 60, no. 1, pp. 37–45, Jan. 2013.
[2403]	F. Getnet, M. Demissie, N. Assefa, B. Mengistie, and A. Worku, “Delay in diagnosis of pulmonary tuberculosis in low-and middle-income settings: systematic review and meta-analysis,” BMC Pulm Med, vol. 17, no. 1, p. 202, Dec. 2017, doi: 10.1186/s12890-017-0551-y.
[2404]	F. Olesen, R. P. Hansen, and P. Vedsted, “Delay in diagnosis: the experience in Denmark,” Br. J. Cancer, vol. 101 Suppl 2, pp. S5-8, Dec. 2009, doi: 10.1038/sj.bjc.6605383.
[2405]	R. R. Farag and G. M. Tinker, “Delay in discharge of patients from an acute geriatric unit,” Health Trends, vol. 17, no. 2, p. 41, May 1985.
[2406]	D. H. Dyson and S. C. Sparling, “Delay in final publication following abstract presentation: American College of Veterinary Anesthesiologists annual meeting,” J Vet Med Educ, vol. 33, no. 1, pp. 145–148, 2006, doi: 10.3138/jvme.33.1.145.
[2407]	J. Conigliaro, J. Whittle, C. B. Good, M. Skanderson, M. Kelley, and K. Goldberg, “Delay in presentation for cardiac care by race, age, and site of care,” Med Care, vol. 40, no. 1 Suppl, pp. I97-105, Jan. 2002, doi: 10.1097/00005650-200201001-00011.
[2408]	G. Gereltsetseg et al., “Delay in the onset of puberty of intrauterine growth retarded female rats cannot be rescued with hypernutrition after birth,” Endocr. J., vol. 59, no. 11, pp. 963–972, 2012, doi: 10.1507/endocrj.ej11-0392.
[2409]	B. Reynolds, H. de Wit, and J. Richards, “Delay of gratification and delay discounting in rats,” Behav. Processes, vol. 59, no. 3, p. 157, Sep. 2002, doi: 10.1016/s0376-6357(02)00088-8.
[2410]	J. R. Anderson, H. Kuroshima, and K. Fujita, “Delay of gratification in capuchin monkeys (Cebus apella) and squirrel monkeys (Saimiri sciureus),” J Comp Psychol, vol. 124, no. 2, pp. 205–210, May 2010, doi: 10.1037/a0018240.
[2411]	D. W. Johnson, U. H. Schmidt, E. A. Bittner, B. Christensen, R. Levi, and R. M. Pino, “Delay of transfer from the intensive care unit: a prospective observational study of incidence, causes, and financial impact,” Crit Care, vol. 17, no. 4, p. R128, Jul. 2013, doi: 10.1186/cc12807.
[2412]	S. Rayne, K. Schnippel, D. Kruger, C.-A. Benn, and C. Firnhaber, “Delay to diagnosis and breast cancer stage in an urban South African breast clinic,” S. Afr. Med. J., vol. 109, no. 3, pp. 159–163, Feb. 2019, doi: 10.7196/SAMJ.2019.v109i3.13283.
[2413]	P.-L. Liu, “Delay-dependent global exponential robust stability for delayed cellular neural networks with time-varying delay,” ISA Trans, vol. 52, no. 6, pp. 711–716, Nov. 2013, doi: 10.1016/j.isatra.2013.06.011.
[2414]	X. Liang, Z. Li, Y. Wang, Y. Hou, and P. Shen, “Delay-disorder fiber Bragg grating recognition and calibration method for a Fourier domain mode-locked wavelength-swept laser-based interrogation system,” Appl Opt, vol. 57, no. 28, pp. 8148–8153, Oct. 2018, doi: 10.1364/AO.57.008148.
[2415]	L. Sheng, Z. Wang, E. Tian, and F. E. Alsaadi, “Delay-distribution-dependent H∞ state estimation for delayed neural networks with (x,v)-dependent noises and fading channels,” Neural Netw, vol. 84, pp. 102–112, Dec. 2016, doi: 10.1016/j.neunet.2016.08.013.
[2416]	A. Grönlund, P. Lötstedt, and J. Elf, “Delay-induced anomalous fluctuations in intracellular regulation,” Nat Commun, vol. 2, p. 419, Aug. 2011, doi: 10.1038/ncomms1422.
[2417]	F.-X. Brajot and D. Lawrence, “Delay-induced low-frequency modulation of the voice during sustained phonation,” J. Acoust. Soc. Am., vol. 144, no. 1, p. 282, 2018, doi: 10.1121/1.5046092.
[2418]	Z. Meng, Z. Li, A. V. Vasilakos, and S. Chen, “Delay-Induced Synchronization of Identical Linear Multiagent Systems,” IEEE Trans Cybern, vol. 43, no. 2, pp. 476–489, Apr. 2013, doi: 10.1109/TSMCB.2012.2209415.
[2419]	M. H. Zaheer, M. Rehan, G. Mustafa, and M. Ashraf, “Delay-range-dependent chaos synchronization approach under varying time-lags and delayed nonlinear coupling,” ISA Trans, vol. 53, no. 6, pp. 1716–1730, Nov. 2014, doi: 10.1016/j.isatra.2014.09.007.
[2420]	G. K. P. Spurling, C. B. Del Mar, L. Dooley, and R. Foxlee, “Delayed antibiotics for respiratory infections,” Cochrane Database Syst Rev, no. 3, p. CD004417, Jul. 2007, doi: 10.1002/14651858.CD004417.pub3.
[2421]	J. D. Hart, L. Larger, T. E. Murphy, and R. Roy, “Delayed dynamical systems: networks, chimeras and reservoir computing,” Philos Trans A Math Phys Eng Sci, vol. 377, no. 2153, p. 20180123, Sep. 2019, doi: 10.1098/rsta.2018.0123.
[2422]	A. Gjurchinovski, T. Jüngling, V. Urumov, and E. Schöll, “Delayed feedback control of unstable steady states with high-frequency modulation of the delay,” Phys Rev E Stat Nonlin Soft Matter Phys, vol. 88, no. 3, p. 032912, Sep. 2013, doi: 10.1103/PhysRevE.88.032912.
[2423]	A. L. Faria-E-Silva and C. S. Pfeifer, “Delayed photo-activation and addition of thio-urethane: Impact on polymerization kinetics and stress of dual-cured resin cements,” J Dent, vol. 65, pp. 101–109, Oct. 2017, doi: 10.1016/j.jdent.2017.07.014.
[2424]	K. A. Lattal, “Delayed reinforcement of operant behavior,” J Exp Anal Behav, vol. 93, no. 1, pp. 129–139, Jan. 2010, doi: 10.1901/jeab.2010.93-129.
[2425]	B. M. Gray and K. A. Eaton, “Delayed-type hypersensitivity determination,” Methods Mol. Biol., vol. 921, pp. 117–118, 2012, doi: 10.1007/978-1-62703-005-2_16.
[2426]	S. K. Carpenter and E. Vul, “Delaying feedback by three seconds benefits retention of face-name pairs: the role of active anticipatory processing,” Mem Cognit, vol. 39, no. 7, pp. 1211–1221, Oct. 2011, doi: 10.3758/s13421-011-0092-1.
[2427]	A. García-Vela, “Delaying the Decay of a Superposition of Resonance States,” J Phys Chem A, vol. 123, no. 34, pp. 7394–7400, Aug. 2019, doi: 10.1021/acs.jpca.9b04892.
[2428]	R. Ginn et al., “Delays in Coccidioidomycosis Diagnosis and Relationship to Healthcare Utilization, Phoenix, Arizona, USA1,” Emerging Infect. Dis., vol. 25, no. 9, pp. 1742–1744, 2019, doi: 10.3201/eid2509.190019.
[2429]	K. Handayani et al., “Delays in diagnosis and treatment of childhood cancer in Indonesia,” Pediatr Blood Cancer, vol. 63, no. 12, pp. 2189–2196, 2016, doi: 10.1002/pbc.26174.
[2430]	E. Buregyeya, B. Criel, F. Nuwaha, and R. Colebunders, “Delays in diagnosis and treatment of pulmonary tuberculosis in Wakiso and Mukono districts, Uganda,” BMC Public Health, vol. 14, p. 586, Jun. 2014, doi: 10.1186/1471-2458-14-586.
[2431]	A. W. Lim, A. J. Ramirez, W. Hamilton, P. Sasieni, J. Patnick, and L. J. Forbes, “Delays in diagnosis of young females with symptomatic cervical cancer in England: an interview-based study,” Br J Gen Pract, vol. 64, no. 627, pp. e602-610, Oct. 2014, doi: 10.3399/bjgp14X681757.
[2432]	A. Mowla et al., “Delays in door-to-needle time for acute ischemic stroke in the emergency department: A comprehensive stroke center experience,” J. Neurol. Sci., vol. 376, pp. 102–105, May 2017, doi: 10.1016/j.jns.2017.03.003.
[2433]	C. G. Sutcliffe, J. H. van Dijk, M. Muleka, J. Munsanje, P. E. Thuma, and W. J. Moss, “Delays in Initiation of Antiretroviral Therapy Among HIV-infected Children in Rural Zambia,” Pediatr. Infect. Dis. J., vol. 35, no. 4, pp. e107-112, Apr. 2016, doi: 10.1097/INF.0000000000001021.
[2434]	E. Sulu, O. Tasolar, H. Berk Takir, L. Yagci Tuncer, Z. Karakurt, and A. Yilmaz, “Delays in the diagnosis and treatment  of non-small-cell lung cancer,” Tumori, vol. 97, no. 6, pp. 693–697, Dec. 2011, doi: 10.1700/1018.11083.
[2435]	N. V. Balmant, N. de Paula Silva, M. de O Santos, R. de S Reis, and B. de Camargo, “Delays in the health care system for children, adolescents, and young adults with bone tumors in Brazil,” J Pediatr (Rio J), vol. 95, no. 6, pp. 744–751, Dec. 2019, doi: 10.1016/j.jped.2018.07.003.
[2436]	H. J. Folse et al., “Delays in treatment intensification with oral antidiabetic drugs and risk of microvascular and macrovascular events in patients with poor glycaemic control: An individual patient simulation study,” Diabetes Obes Metab, vol. 19, no. 7, pp. 1006–1013, 2017, doi: 10.1111/dom.12913.
[2437]	A. Asres, D. Jerene, and W. Deressa, “Delays to anti-tuberculosis treatment intiation among cases on directly observed treatment short course in districts of southwestern Ethiopia: a cross sectional study,” BMC Infect. Dis., vol. 19, no. 1, p. 481, May 2019, doi: 10.1186/s12879-019-4089-x.
[2438]	Z. Xu et al., “Deletion of aquaporin-4 in APP/PS1 mice exacerbates brain Aβ accumulation and memory deficits,” Mol Neurodegener, vol. 10, p. 58, Nov. 2015, doi: 10.1186/s13024-015-0056-1.
[2439]	C. C. Y. Huang, K. J. Muszynski, V. Y. Bolshakov, and D. T. Balu, “Deletion of Dtnbp1 in mice impairs threat memory consolidation and is associated with enhanced inhibitory drive in the amygdala,” Transl Psychiatry, vol. 9, no. 1, p. 132, 09 2019, doi: 10.1038/s41398-019-0465-y.
[2440]	A. Goldberg, R. Confino-Cohen, and Y. A. Mekori, “Deliberate bee sting challenge of patients receiving maintenance venom immunotherapy at 3-month intervals,” J. Allergy Clin. Immunol., vol. 93, no. 6, pp. 997–1001, Jun. 1994, doi: 10.1016/s0091-6749(94)70047-8.
[2441]	M. G. Capponi, A. M. Biffi, M. S. Spada, and L. Ansaloni, “Delirium: Time to climb this babylon tower,” Eur. J. Intern. Med., vol. 38, pp. e18–e19, Mar. 2017, doi: 10.1016/j.ejim.2016.11.005.
[2442]	“Delivering at the country level: the International Coordinating Group on Vaccine Provision and its impact in 2016 and 2017,” Wkly. Epidemiol. Rec., vol. 93, no. 10, pp. 105–116, Mar. 2018.
[2443]	I. J. Dripps and E. M. Jutkiewicz, “Delta Opioid Receptors and Modulation of Mood and Emotion,” Handb Exp Pharmacol, vol. 247, pp. 179–197, 2018, doi: 10.1007/164_2017_42.
[2444]	E. H. Wong and S. G. Revankar, “Dematiaceous Molds,” Infect. Dis. Clin. North Am., vol. 30, no. 1, pp. 165–178, Mar. 2016, doi: 10.1016/j.idc.2015.10.007.
[2445]	Y. Bocanegra, N. Trujillo-Orrego, and D. Pineda, “[Dementia and mild cognitive impairment in Parkinson’s disease: a review],” Rev Neurol, vol. 59, no. 12, pp. 555–569, Dec. 2014.
[2446]	T. F. Outeiro et al., “Dementia with Lewy bodies: an update and outlook,” Mol Neurodegener, vol. 14, no. 1, p. 5, 21 2019, doi: 10.1186/s13024-019-0306-8.
[2447]	P. Leutscher et al., “Demographic and clinical characteristics in relation to patient and health system delays in a tuberculosis low-incidence country,” Scand. J. Infect. Dis., vol. 44, no. 1, pp. 29–36, Jan. 2012, doi: 10.3109/00365548.2011.608081.
[2448]	G. Kavé, S. Fridkin, and L. Ayalon, “Demographic factors and retrieval of object and proper names after age 70,” PLoS ONE, vol. 13, no. 1, p. e0191876, 2018, doi: 10.1371/journal.pone.0191876.
[2449]	N. Chetty, I. M. Coupar, R. Chess-Williams, and K. P. Kerr, “Demonstration of 5-HT(3) receptor function and expression in the mouse bladder,” Naunyn Schmiedebergs Arch. Pharmacol., vol. 375, no. 6, pp. 359–368, Aug. 2007, doi: 10.1007/s00210-007-0173-7.
[2450]	R. Castellon and H. K. Hamdi, “Demystifying the ACE polymorphism: from genetics to biology,” Curr. Pharm. Des., vol. 13, no. 12, pp. 1191–1198, 2007, doi: 10.2174/138161207780618902.
[2451]	J. Zelmer, “Demystifying the Publication Process,” Healthc Policy, vol. 12, no. 4, pp. 6–9, 2017, doi: 10.12927/hcpol.2017.25103.
[2452]	M. Mohammadzadeh, M. Shirmohammadi, M. Ghojazadeh, L. Nikniaz, M. Raeisi, and S. A. M. Aghdas, “Dendritic cells pulsed with prostate-specific membrane antigen in metastatic castration-resistant prostate cancer patients: a systematic review and meta-analysis,” Prostate Int, vol. 6, no. 4, pp. 119–125, Dec. 2018, doi: 10.1016/j.prnil.2018.04.001.
[2453]	“Dengue vaccine: WHO position paper – July 2016,” Wkly. Epidemiol. Rec., vol. 91, no. 30, pp. 349–364, Jul. 2016.
[2454]	M. Pannekens et al., “Densely Populated Water Droplets in Heavy-Oil Seeps,” Appl. Environ. Microbiol., vol. 86, no. 11, 19 2020, doi: 10.1128/AEM.00164-20.
[2455]	M. H. Alfaruqi et al., “Density Functional Theory Investigation of Mixed Transition Metals in Olivine and Tavorite Cathode Materials for Li-Ion Batteries,” ACS Appl Mater Interfaces, vol. 12, no. 14, pp. 16376–16386, Apr. 2020, doi: 10.1021/acsami.9b23367.
[2456]	W. Loesche, “Dental caries and periodontitis: contrasting two infections that have medical implications,” Infect. Dis. Clin. North Am., vol. 21, no. 2, pp. 471–502, vii, Jun. 2007, doi: 10.1016/j.idc.2007.03.006.
[2457]	D. O. Donnell, A. Sheiham, and Y. K. Wai, “Dental findings in 4-, 14-, and 25-to 35-year-old Hong Kong residents with mental and physical disabilities,” Spec Care Dentist, vol. 22, no. 6, pp. 231–234, Dec. 2002, doi: 10.1111/j.1754-4505.2002.tb00277.x.
[2458]	R. Pereira, D. Corado, J. Silveira, R. Alves, A. Mata, and D. Marques, “Dental prophylaxis influence in tooth color assessment-Clinical study,” J Esthet Restor Dent, vol. 32, no. 6, pp. 586–592, Sep. 2020, doi: 10.1111/jerd.12593.
[2459]	A. Majorana, E. Bardellini, P. C. Brunelli, M. Lacaita, A. P. Cazzolla, and G. Favia, “Dentinogenesis imperfecta in children with osteogenesis imperfecta: a clinical and ultrastructural study,” Int J Paediatr Dent, vol. 20, no. 2, pp. 112–118, Mar. 2010, doi: 10.1111/j.1365-263X.2010.01033.x.
[2460]	D. R. House, “Dentists’ incomes, fees, practice costs, and the Economic Stabilization Act: 1952 to 1976. Bureau of Economic and Behavioral Research,” J Am Dent Assoc, vol. 99, no. 5, pp. 857–861, Nov. 1979.
[2461]	J. M. Hughes, “Department of Health Research Initiative on Nutrition Phase 2: overview of findings and recommendations,” Public Health Nutr, vol. 6, no. 1, pp. 101–125, Feb. 2003, doi: 10.1079/PHN2002435.
[2462]	Z. Zhang et al., “Depletion of juvenile hormone esterase extends larval growth in Bombyx mori,” Insect Biochem. Mol. Biol., vol. 81, pp. 72–79, 2017, doi: 10.1016/j.ibmb.2017.01.001.
[2463]	T. Monteiro-Brás, J. Wesolowski, and F. Paumet, “Depletion of SNAP-23 and Syntaxin 4 alters lipid droplet homeostasis during Chlamydia infection,” Microb Cell, vol. 7, no. 2, pp. 46–58, Dec. 2019, doi: 10.15698/mic2020.02.707.
[2464]	S. L. Walsh and K. Q. X. Long, “Deploying science to change hearts and minds: Responding to the opioid crisis,” Prev Med, vol. 128, p. 105780, 2019, doi: 10.1016/j.ypmed.2019.105780.
[2465]	“Deployments from the oral cholera vaccine stockpile, 2013–2017,” Wkly. Epidemiol. Rec., vol. 92, no. 32, pp. 437–442, 11 2017.
[2466]	L. B. Dehn and T. Beblo, “[Depressed, biased, forgetful: The interaction of emotional and cognitive dysfunctions in depression],” Neuropsychiatr, vol. 33, no. 3, pp. 123–130, Sep. 2019, doi: 10.1007/s40211-019-0307-4.
[2467]	R. E. Rakel, “Depression,” Prim. Care, vol. 26, no. 2, pp. 211–224, Jun. 1999, doi: 10.1016/s0095-4543(08)70003-4.
[2468]	G. Cardó Vila, M. C. González González, and E. C. Sumalla Gómez, “[Depression 1. Clinical aspects and nurses’ evaluation],” Rev Enferm, vol. 23, no. 4, pp. 265–270, Apr. 2000.
[2469]	R. B. Birrer, “Depression and aging too often do mix,” Postgrad Med, vol. 104, no. 3, pp. 143–149, 153–154, 163–164, Sep. 1998, doi: 10.3810/pgm.1998.09.580.
[2470]	O.-Y. Kwon and S.-P. Park, “Depression and anxiety in people with epilepsy,” J Clin Neurol, vol. 10, no. 3, pp. 175–188, Jul. 2014, doi: 10.3988/jcn.2014.10.3.175.
[2471]	D. J. Stein and O. Gureje, “Depression and anxiety in the developing world: is it time to medicalise the suffering?,” Lancet, vol. 364, no. 9430, pp. 233–234, Jul. 2004, doi: 10.1016/S0140-6736(04)16693-2.
[2472]	I. Spoletini et al., “Depression and cancer: an unexplored and unresolved emergent issue in elderly patients,” Crit. Rev. Oncol. Hematol., vol. 65, no. 2, pp. 143–155, Feb. 2008, doi: 10.1016/j.critrevonc.2007.10.005.
[2473]	Y. Zhang, Y. Chen, and L. Ma, “Depression and cardiovascular disease in elderly: Current understanding,” J Clin Neurosci, vol. 47, pp. 1–5, Jan. 2018, doi: 10.1016/j.jocn.2017.09.022.
[2474]	K. Kraft, “[Depression and depressive symptoms],” MMW Fortschr Med, vol. 152, no. 8, pp. 20–21, Feb. 2010, doi: 10.1007/BF03366151.
[2475]	A. M. Kanner et al., “Depression and epilepsy, pain and psychogenic non-epileptic seizures: clinical and therapeutic perspectives,” Epilepsy Behav, vol. 24, no. 2, pp. 169–181, Jun. 2012, doi: 10.1016/j.yebeh.2012.01.008.
[2476]	R. Lopez, L. Barateau, E. Evangelista, and Y. Dauvilliers, “Depression and Hypersomnia: A Complex Association,” Sleep Med Clin, vol. 12, no. 3, pp. 395–405, Sep. 2017, doi: 10.1016/j.jsmc.2017.03.016.
[2477]	G. Andersen, A. M. Brandt-Christensen, and F. M. Nilsson, “[Depression and neurological disorders],” Ugeskr. Laeg., vol. 169, no. 16, pp. 1467–1469, Apr. 2007.
[2478]	M. J. Bair, R. L. Robinson, W. Katon, and K. Kroenke, “Depression and pain comorbidity: a literature review,” Arch. Intern. Med., vol. 163, no. 20, pp. 2433–2445, Nov. 2003, doi: 10.1001/archinte.163.20.2433.
[2479]	L. F. Rubin, D. A. F. Haaga, J. L. Pearson, and K. C. Gunthert, “Depression as a moderator of the prospective relationship between mood and smoking,” Health Psychol, vol. 39, no. 2, pp. 99–106, Feb. 2020, doi: 10.1037/hea0000816.
[2480]	N. Forthoffer, C. Kleitz, M. Bilger, and H. Brissart, “Depression could modulate neuropsychological status in epilepsy,” Rev. Neurol. (Paris), vol. 176, no. 6, pp. 456–467, Jun. 2020, doi: 10.1016/j.neurol.2020.03.015.
[2481]	M. N. Stanners, C. A. Barton, S. Shakib, and H. R. Winefield, “Depression diagnosis and treatment amongst multimorbid patients: a thematic analysis,” BMC Fam Pract, vol. 15, p. 124, Jun. 2014, doi: 10.1186/1471-2296-15-124.
[2482]	E. J. Hauenstein, “Depression in adolescence,” J Obstet Gynecol Neonatal Nurs, vol. 32, no. 2, pp. 239–248, Apr. 2003, doi: 10.1177/0884217503252133.
[2483]	P. T. Castiglia, “Depression in adolescents,” J Pediatr Health Care, vol. 14, no. 4, pp. 180–182, Aug. 2000, doi: 10.1067/mph.2000.107817.
[2484]	E. B. Weller and R. A. Weller, “Depression in adolescents growing pains or true morbidity?,” J Affect Disord, vol. 61 Suppl 1, pp. 9–13, Dec. 2000, doi: 10.1016/s0165-0327(00)00284-6.
[2485]	P. T. Castiglia, “Depression in children,” J Pediatr Health Care, vol. 14, no. 2, pp. 73–75, Apr. 2000, doi: 10.1067/mph.2000.105025.
[2486]	B. J. Tonge, “Depression in children,” Aust Fam Physician, vol. 19, no. 9, pp. 1388–1391, 1394, Sep. 1990.
[2487]	S. E. Son and J. T. Kirchner, “Depression in children and adolescents,” Am Fam Physician, vol. 62, no. 10, pp. 2297–2308, 2311–2312, Nov. 2000.
[2488]	S. Kalinowska, K. Nitsch, P. Duda, B. Trześniowska-Drukała, and J. Samochowiec, “[Depression in children and adolescents -symptoms, etiology, therapy],” Ann Acad Med Stetin, vol. 59, no. 1, pp. 32–36, 2013.
[2489]	L. B. Gray, R. A. Weller, M. Fristad, and E. B. Weller, “Depression in children and adolescents two months after the death of a parent,” J Affect Disord, vol. 135, no. 1–3, pp. 277–283, Dec. 2011, doi: 10.1016/j.jad.2011.08.009.
[2490]	I. Seiffge-Krenke, “[Depression in children and adolescents: prevalence, diagnosis, etiology, gender differences and therapeutic approaches],” Prax Kinderpsychol Kinderpsychiatr, vol. 56, no. 3, pp. 185–205, 2007, doi: 10.13109/prkk.2007.56.3.185.
[2491]	A. M. Kanner, “Depression in epilepsy: a frequently neglected multifaceted disorder,” Epilepsy Behav, vol. 4 Suppl 4, pp. 11–19, Dec. 2003, doi: 10.1016/j.yebeh.2003.10.004.
[2492]	K. M. Fiest et al., “Depression in epilepsy: a systematic review and meta-analysis,” Neurology, vol. 80, no. 6, pp. 590–599, Feb. 2013, doi: 10.1212/WNL.0b013e31827b1ae0.
[2493]	A. Abbas Asghar-Ali and U. K. Braun, “Depression in geriatric patients,” Minerva Med., vol. 100, no. 1, pp. 105–113, Feb. 2009.
[2494]	D. G. Blazer, “Depression in late life: review and commentary,” J. Gerontol. A Biol. Sci. Med. Sci., vol. 58, no. 3, pp. 249–265, Mar. 2003, doi: 10.1093/gerona/58.3.m249.
[2495]	S. Zisook, “Depression in late life. Diagnosis, course, and consequences,” Postgrad Med, vol. 100, no. 4, pp. 143–148, 150, 156, Oct. 1996, doi: 10.3810/pgm.1996.10.98.
[2496]	R. B. Birrer and S. P. Vemuri, “Depression in later life: a diagnostic and therapeutic challenge,” Am Fam Physician, vol. 69, no. 10, pp. 2375–2382, May 2004.
[2497]	A. A. M. Gadit, “Depression in males: is this matter more serious?,” J Pak Med Assoc, vol. 60, no. 6, pp. 504–505, Jun. 2010.
[2498]	S. Rackley and J. M. Bostwick, “Depression in medically ill patients,” Psychiatr. Clin. North Am., vol. 35, no. 1, pp. 231–247, Mar. 2012, doi: 10.1016/j.psc.2011.11.001.
[2499]	R. Kumar, A. F. Jorm, R. A. Parslow, and P. S. Sachdev, “Depression in mild cognitive impairment in a community sample of individuals 60-64 years old,” Int Psychogeriatr, vol. 18, no. 3, pp. 471–480, Sep. 2006, doi: 10.1017/S1041610205003005.
[2500]	H. Williams and A. Carmichael, “Depression in mothers and behaviour problems with their preschool children,” J Paediatr Child Health, vol. 27, no. 2, pp. 76–82, Apr. 1991, doi: 10.1111/j.1440-1754.1991.tb00357.x.
[2501]	J. Snowdon, “Depression in nursing homes,” Int Psychogeriatr, vol. 22, no. 7, pp. 1143–1148, Nov. 2010, doi: 10.1017/S1041610210001602.
[2502]	A. Capurso, C. Capurso, V. Solfrizzi, A. M. Colacicco, A. D’Introno, and F. Panza, “[Depression in old age: a diagnostic and therapeutic challenge],” Recenti Prog Med, vol. 98, no. 1, pp. 43–52, Jan. 2007.
[2503]	N. C. Gulmann and A. Lolk, “[Depression in old age],” Ugeskr. Laeg., vol. 169, no. 16, pp. 1462–1465, Apr. 2007.
[2504]	J. Strnad and M. Bahro, “[Depression in old age],” Schweiz Med Wochenschr, vol. 129, no. 33, pp. 1162–1170, Aug. 1999.
[2505]	D. A. Casey, “Depression in Older Adults: A Treatable Medical Condition,” Prim. Care, vol. 44, no. 3, pp. 499–510, Sep. 2017, doi: 10.1016/j.pop.2017.04.007.
[2506]	S. D. Owolabi, L. F. Owolabi, O. Udofia, and S. Sale, “Depression in patients with epilepsy in Northwestern Nigeria: Prevalence and clinical correlates,” Ann Afr Med, vol. 15, no. 4, pp. 179–184, Dec. 2016, doi: 10.4103/1596-3519.194279.
[2507]	Q. Li et al., “Depression in people with epilepsy in West China: Status, risk factors and treatment gap,” Seizure, vol. 66, pp. 86–92, Mar. 2019, doi: 10.1016/j.seizure.2019.02.014.
[2508]	A. A. Asadi-Pooya et al., “Depression in people with epilepsy: How much do Asian colleagues acknowledge it?,” Seizure, vol. 57, pp. 45–49, Apr. 2018, doi: 10.1016/j.seizure.2018.03.012.
[2509]	G. Geulayov, J. Lipsitz, R. Sabar, and R. Gross, “Depression in primary care in Israel,” Isr. Med. Assoc. J., vol. 9, no. 8, pp. 571–578, Aug. 2007.
[2510]	L. Waintraub, “[Depression in the aged: diagnosis and treatment],” Presse Med, vol. 27, no. 40, pp. 2129–2144, Dec. 1998.
[2511]	G. S. Alexopoulos, “Depression in the elderly,” Lancet, vol. 365, no. 9475, pp. 1961–1970, Jun. 2005, doi: 10.1016/S0140-6736(05)66665-2.
[2512]	M. Takeda and T. Tanaka, “Depression in the elderly,” Geriatr Gerontol Int, vol. 10, no. 4, pp. 277–279, Oct. 2010, doi: 10.1111/j.1447-0594.2010.00644.x.
[2513]	L. T. Park and C. A. Zarate, “Depression in the Primary Care Setting,” N. Engl. J. Med., vol. 380, no. 6, pp. 559–568, 07 2019, doi: 10.1056/NEJMcp1712493.
[2514]	C. Nikendei et al., “Depression profile in cancer patients and patients without a chronic somatic disease,” Psychooncology, vol. 27, no. 1, pp. 83–90, 2018, doi: 10.1002/pon.4465.
[2515]	N. Holzapfel et al., “Depression profile in patients with and without chronic heart failure,” J Affect Disord, vol. 105, no. 1–3, pp. 53–62, Jan. 2008, doi: 10.1016/j.jad.2007.04.009.
[2516]	E. I. Fried and R. M. Nesse, “Depression sum-scores don’t add up: why analyzing specific depression symptoms is essential,” BMC Med, vol. 13, p. 72, Apr. 2015, doi: 10.1186/s12916-015-0325-4.
[2517]	B. Mårtensson, G. Andersson, J. Wålinder, and H. Agren, “[Depression treatment--then, now and in the future],” Lakartidningen, vol. 110, no. 9–10, pp. 493–495, Mar. 2013.
[2518]	H. Tao et al., “Depression uncouples brain hate circuit,” Mol. Psychiatry, vol. 18, no. 1, pp. 101–111, Jan. 2013, doi: 10.1038/mp.2011.127.
[2519]	V. Henkel et al., “Depression with atypical features in a sample of primary care outpatients: prevalence, specific characteristics and consequences,” J Affect Disord, vol. 83, no. 2–3, pp. 237–242, Dec. 2004, doi: 10.1016/j.jad.2004.07.003.
[2520]	L. V. Kessing and M. Nordentoft, “[Depression--a public disease which should be treated?],” Ugeskr. Laeg., vol. 161, no. 13, pp. 1935–1936, Mar. 1999.
[2521]	L. V. Kessing and P. Videbech, “[Depression--burden of disease, diagnosis and treatment],” Ugeskr. Laeg., vol. 165, no. 12, p. 1252, Mar. 2003.
[2522]	K. Garde, “[Depression--gender differences],” Ugeskr. Laeg., vol. 169, no. 25, pp. 2422–2425, Jun. 2007.
[2523]	B. Sanne, A. A. Dahl, and G. S. Tell, “[Depression--socioeconomic perspectives],” Tidsskr. Nor. Laegeforen., vol. 121, no. 5, pp. 590–595, Feb. 2001.
[2524]	F. Rouillon, “[Depression, yesterday, today and tomorrow: historical evolution of concepts],” Therapie, vol. 60, no. 5, pp. 425–429, Oct. 2005, doi: 10.2515/therapie:2005063.
[2525]	E. Anthes, “Depression: a change of mind,” Nature, vol. 515, no. 7526, pp. 185–187, Nov. 2014, doi: 10.1038/515185a.
[2526]	G. Cardó Vila, M. C. González González, and E. C. Sumalla Gómez, “[Depression. 2. Treatment and nursing interventions],” Rev Enferm, vol. 23, no. 5, pp. 337–342, May 2000.
[2527]	P. Bol, “[Depression],” Ned Tijdschr Tandheelkd, vol. 108, no. 4, pp. 153–154, Apr. 2001.
[2528]	T. G. Bolwig, “[Depression],” Ugeskr. Laeg., vol. 159, no. 22, pp. 3369–3373, May 1997.
[2529]	K. B. Stage, P. Casier, and O. Trosko, “[Depression],” Ugeskr. Laeg., vol. 166, no. 14, pp. 1311–1313, Mar. 2004.
[2530]	N. Mukherjee and S. K. Chaturvedi, “Depressive symptoms and disorders in type 2 diabetes mellitus,” Curr Opin Psychiatry, vol. 32, no. 5, pp. 416–421, 2019, doi: 10.1097/YCO.0000000000000528.
[2531]	X. Kuang, J. Chi, and L. Wang, “Deregulated microRNA expression and its pathogenetic implications for myelodysplastic syndromes,” Hematology, vol. 21, no. 10, pp. 593–602, Dec. 2016, doi: 10.1080/10245332.2016.1193962.
[2532]	G. W. Rhyasen and D. T. Starczynowski, “Deregulation of microRNAs in myelodysplastic syndrome,” Leukemia, vol. 26, no. 1, pp. 13–22, Jan. 2012, doi: 10.1038/leu.2011.221.
[2533]	A. Sierksma et al., “Deregulation of neuronal miRNAs induced by amyloid-β or TAU pathology,” Mol Neurodegener, vol. 13, no. 1, p. 54, 12 2018, doi: 10.1186/s13024-018-0285-1.
[2534]	H. Below et al., “Dermal and pulmonary absorption of propan-1-ol and propan-2-ol from hand rubs,” Am J Infect Control, vol. 40, no. 3, pp. 250–257, Apr. 2012, doi: 10.1016/j.ajic.2011.03.009.
[2535]	K. Chooluck, R. P. Singh, K. Sathirakul, and H. Derendorf, “Dermal pharmacokinetics of Terpinen-4-ol following topical administration of Zingiber cassumunar (plai) oil,” Planta Med., vol. 78, no. 16, pp. 1761–1766, Nov. 2012, doi: 10.1055/s-0032-1315262.
[2536]	A. K. Mathur and S. K. Khanna, “Dermal toxicity due to industrial chemicals,” Skin Pharmacol. Appl. Skin Physiol., vol. 15, no. 3, pp. 147–153, Jun. 2002, doi: 10.1159/000063543.
[2537]	M. M. Nentwich, K. Schebitz-Walter, C. Hirneiss, and C. Hintschich, “Dermis fat grafts as primary and secondary orbital implants,” Orbit, vol. 33, no. 1, pp. 33–38, Feb. 2014, doi: 10.3109/01676830.2013.844172.
[2538]	V. A. Essuman, N. N. Tagoe, T. A. Ndanu, and C. T. Ntim-Amponsah, “Dermis-fat grafts and enucleation in Ghanaian children: 5 years’ experience,” Ghana Med J, vol. 48, no. 4, pp. 204–207, Dec. 2014, doi: 10.4314/gmj.v48i4.6.
[2539]	W.-Y. Kim et al., “Descending thin limb of the intermediate loop expresses both aquaporin 1 and urea transporter A2 in the mouse kidney,” Histochem. Cell Biol., vol. 146, no. 1, pp. 1–12, Jul. 2016, doi: 10.1007/s00418-016-1434-7.
[2540]	A. Perazzi et al., “Description of a double centrifugation tube method for concentrating canine platelets,” BMC Vet. Res., vol. 9, p. 146, Jul. 2013, doi: 10.1186/1746-6148-9-146.
[2541]	J. B. Godel, “Description of facilities and mechanical components. Medical Research Reactor (MRR). Brookhaven National Laboratory Report BNL 600 (T-173),” Tech Rep Brookhaven Natl Lab, pp. 1–64, Feb. 1960.
[2542]	C. Helmer, D. Montagnier, and K. Pérès, “[Descriptive epidemiology and risk factors of depression in the elderly],” Psychol Neuropsychiatr Vieil, vol. 2 Suppl 1, pp. S7-12, Sep. 2004.
[2543]	W. Shi, R. Vafaei, M. A. Guillén Torres, N. A. F. Jaeger, and L. Chrostowski, “Design and characterization of microring reflectors with a waveguide crossing,” Opt Lett, vol. 35, no. 17, pp. 2901–2903, Sep. 2010, doi: 10.1364/OL.35.002901.
[2544]	A. A. Hales, D. Cable, E. Crossley, C. Findlay, and D. A. Rew, “Design and implementation of the stacked, synchronised and iconographic timeline-structured electronic patient record in a UK NHS Global Digital Exemplar hospital,” BMJ Health Care Inform, vol. 26, no. 1, Dec. 2019, doi: 10.1136/bmjhci-2019-100025.
[2545]	W. Guo, T. Lin, X. Niu, C. Shi, and H. Zhang, “Design and Performance Evaluation of a Dual Antenna Joint Carrier Tracking Loop,” Sensors (Basel), vol. 15, no. 10, pp. 25399–25415, Oct. 2015, doi: 10.3390/s151025399.
[2546]	N. Hareesha, J. G. G. Manjunatha, C. Raril, and G. Tigari, “Design of novel Surfactant Modified Carbon Nanotube Paste Electrochemical Sensor for the Sensitive Investigation of Tyrosine as a Pharmaceutical Drug,” Adv Pharm Bull, vol. 9, no. 1, pp. 132–137, Feb. 2019, doi: 10.15171/apb.2019.016.
[2547]	T. Kesavan et al., “Design of P-Doped Mesoporous Carbon Nitrides as High-Performance Anode Materials for Li-Ion Battery,” ACS Appl Mater Interfaces, vol. 12, no. 21, pp. 24007–24018, May 2020, doi: 10.1021/acsami.0c05123.
[2548]	K. Ding et al., “Design, synthesis, and discovery of 5-((1,3-diphenyl-1H-pyrazol-4-yl)methylene)pyrimidine-2,4,6(1H,3H,5H)-triones and related derivatives as novel inhibitors of mPGES-1,” Bioorg. Med. Chem. Lett., vol. 28, no. 5, pp. 858–862, 01 2018, doi: 10.1016/j.bmcl.2018.02.011.
[2549]	C. B. M. Poulie, N. Liu, A. A. Jensen, and L. Bunch, “Design, Synthesis, and Pharmacological Characterization of Heterobivalent Ligands for the Putative 5-HT2A/mGlu2 Receptor Complex,” J. Med. Chem., Aug. 2020, doi: 10.1021/acs.jmedchem.0c01058.
[2550]	C. J. Durovich and P. W. Roberts, “Designing a Community-Based Population Health Model,” Popul Health Manag, vol. 21, no. 1, pp. 13–19, 2018, doi: 10.1089/pop.2017.0015.
[2551]	T. T. Schug et al., “Designing Endocrine Disruption Out of the Next Generation of Chemicals,” Green Chem, vol. 15, no. 1, pp. 181–198, Jan. 2013, doi: 10.1039/C2GC35055F.
[2552]	H. Ju, P. Zhan, and X. Liu, “Designing influenza polymerase acidic endonuclease inhibitors via ‘privileged scaffold’ re-evolution/refining strategy,” Future Med Chem, Feb. 2019, doi: 10.4155/fmc-2018-0489.
[2553]	M. K. Bhowmik et al., “Designing of Ground-Truth-Annotated DBT-TU-JU Breast Thermogram Database Toward Early Abnormality Prediction,” IEEE J Biomed Health Inform, vol. 22, no. 4, pp. 1238–1249, 2018, doi: 10.1109/JBHI.2017.2740500.
[2554]	B. W. Aldiss, “Desperately seeking aliens,” Nature, vol. 409, no. 6823, pp. 1080–1082, Feb. 2001, doi: 10.1038/35059207.
[2555]	M. H. Cortez, S. Patel, and S. J. Schreiber, “Destabilizing evolutionary and eco-evolutionary feedbacks drive empirical eco-evolutionary cycles,” Proc. Biol. Sci., vol. 287, no. 1919, p. 20192298, 29 2020, doi: 10.1098/rspb.2019.2298.
[2556]	R. Stephenson, L. Gonsalves, I. Askew, L. Say, and WHO Working Group for Operationalizing Sexual Health, “Detangling and detailing sexual health in the SDG era,” Lancet, vol. 390, no. 10099, pp. 1014–1015, Sep. 2017, doi: 10.1016/S0140-6736(17)32294-8.
[2557]	J. Cameron, R. Gallagher, and S. J. Pressler, “Detecting and Managing Cognitive Impairment to Improve Engagement in Heart Failure Self-Care,” Curr Heart Fail Rep, vol. 14, no. 1, pp. 13–22, 2017, doi: 10.1007/s11897-017-0317-0.
[2558]	E. Baszanowska and Z. Otremba, “Detecting the Presence of Different Types of Oil in Seawater Using a Fluorometric Index,” Sensors (Basel), vol. 19, no. 17, Aug. 2019, doi: 10.3390/s19173774.
[2559]	S. Basu, S. Majumder, S. Chatterjee, A. Ganguly, T. Efferth, and S. K. Choudhuri, “Detection and characterization of a glutathione conjugate of a novel copper complex,” In Vivo, vol. 23, no. 3, pp. 401–408, Jun. 2009.
[2560]	M. A. Oldham, W. Piddoubny, R. Peterson, and H. B. Lee, “Detection and Management of Preexisting Cognitive Impairment in the Critical Care Unit,” Crit Care Clin, vol. 33, no. 3, pp. 441–459, Jul. 2017, doi: 10.1016/j.ccc.2017.03.001.
[2561]	L. Chen, A. J. Chamberlain, C. M. Reich, H. D. Daetwyler, and B. J. Hayes, “Detection and validation of structural variations in bovine whole-genome sequence data,” Genet. Sel. Evol., vol. 49, no. 1, p. 13, 25 2017, doi: 10.1186/s12711-017-0286-5.
[2562]	A.-M. A. Wolters et al., “Detection of an inversion in the Ty-2 region between S. lycopersicum and S. habrochaites by a combination of de novo genome assembly and BAC cloning,” Theor. Appl. Genet., vol. 128, no. 10, pp. 1987–1997, Oct. 2015, doi: 10.1007/s00122-015-2561-6.
[2563]	H. Jabeur, A. Zribi, J. Makni, A. Rebai, R. Abdelhedi, and M. Bouaziz, “Detection of Chemlali extra-virgin olive oil adulteration mixed with soybean oil, corn oil, and sunflower oil by using GC and HPLC,” J. Agric. Food Chem., vol. 62, no. 21, pp. 4893–4904, May 2014, doi: 10.1021/jf500571n.
[2564]	D. M. Aziz and A. K. Ahmad, “Detection of haptoglobin in seminal plasma of Awassi rams and the relation with its level in serum and some semen parameters,” J Adv Res, vol. 4, no. 6, pp. 559–562, Nov. 2013, doi: 10.1016/j.jare.2012.09.008.
[2565]	B. F. Ozen and L. J. Mauer, “Detection of hazelnut oil adulteration using FT-IR spectroscopy,” J. Agric. Food Chem., vol. 50, no. 14, pp. 3898–3901, Jul. 2002, doi: 10.1021/jf0201834.
[2566]	Y.-C. Su, Y.-C. Chen, S.-C. Li, C.-C. Lee, and Y.-T. Tung, “Detection of Hpdel in healthy individuals and cancer patients in Taiwan,” Clin. Chem. Lab. Med., vol. 47, no. 6, pp. 745–749, 2009, doi: 10.1515/CCLM.2009.156.
[2567]	G. T. Bardi, N. Al-Rayan, J. L. Richie, K. Yaddanapudi, and J. L. Hood, “Detection of Inflammation-Related Melanoma Small Extracellular Vesicle (sEV) mRNA Content Using Primary Melanocyte sEVs as a Reference,” Int J Mol Sci, vol. 20, no. 5, Mar. 2019, doi: 10.3390/ijms20051235.
[2568]	“Detection of influenza viruses by reverse transcription polymerase chain reaction: WHO external quality assessment programme summary analysis, 2017,” Wkly. Epidemiol. Rec., vol. 93, no. 2, pp. 9–16, Jan. 2018.
[2569]	G. Barski, “Detection of latent ectromelia virus infection in mice with the aid of human cell cultures in vitro,” Virology, vol. 10, pp. 155–157, Jan. 1960, doi: 10.1016/0042-6822(60)90017-9.
[2570]	“Detection of Sabin-like type 2 poliovirus after global cessation of trivalent oral poliovirus vaccine in Hyderabad and Ahmedabad, India, August–September 2016,” Wkly. Epidemiol. Rec., vol. 92, no. 1, pp. 9–11, 06 2017.
[2571]	R. McEgan, C. a. P. Rodrigues, A. Sbodio, T. V. Suslow, L. D. Goodridge, and M. D. Danyluk, “Detection of Salmonella spp. from large volumes of water by modified Moore swabs and tangential flow filtration,” Lett. Appl. Microbiol., vol. 56, no. 2, pp. 88–94, Feb. 2013, doi: 10.1111/lam.12016.
[2572]	T. Matsui et al., “Detection of Second Primary Malignancies of the Esophagus and Hypophraynx in Oral Squamous Cell Carcinoma Patients,” Laryngoscope Investig Otolaryngol, vol. 3, no. 4, pp. 263–267, Aug. 2018, doi: 10.1002/lio2.179.
[2573]	X. Hu et al., “[Detection of trace elements in the sediment of Lop Nur samples by ICP-MS],” Guang Pu Xue Yu Guang Pu Fen Xi, vol. 32, no. 6, pp. 1674–1676, Jun. 2012.
[2574]	F. Fang et al., “Deterioration of left ventricular systolic function in extended Pacing to Avoid Cardiac Enlargement (PACE) trial: the predictive value of early systolic dyssynchrony,” Europace, vol. 17 Suppl 2, pp. ii47-53, Oct. 2015, doi: 10.1093/europace/euv130.
[2575]	I. Kossintseva and D. Zloty, “Determinants and Timeline of Perioperative Anxiety in Mohs Surgery,” Dermatol Surg, vol. 43, no. 8, pp. 1029–1035, Aug. 2017, doi: 10.1097/DSS.0000000000001152.
[2576]	A. J. C. Eijlers, K. A. Meijer, Q. van Geest, J. J. G. Geurts, and M. M. Schoonheim, “Determinants of Cognitive Impairment in Patients with Multiple Sclerosis with and without Atrophy,” Radiology, vol. 288, no. 2, pp. 544–551, 2018, doi: 10.1148/radiol.2018172808.
[2577]	N. Ndeikoundam Ngangro, P. Chauvin, and V. Halley des Fontaines, “[Determinants of tuberculosis diagnosis delay in limited resources countries],” Rev Epidemiol Sante Publique, vol. 60, no. 1, pp. 47–57, Feb. 2012, doi: 10.1016/j.respe.2011.08.064.
[2578]	L. Mercadal, A. Hamani, B. Béné, and T. Petitclerc, “Determination of access blood flow from ionic dialysance: theory and validation,” Kidney Int., vol. 56, no. 4, pp. 1560–1565, Oct. 1999, doi: 10.1046/j.1523-1755.1999.00679.x.
[2579]	E. K. Selvi, U. Şahin, and S. Şahan, “Determination of Aluminum in Dialysis Concentrates by Atomic Absorption Spectrometry after Coprecipitation with Lanthanum Phosphate,” Iran J Pharm Res, vol. 16, no. 3, pp. 1030–1036, 2017.
[2580]	D. Vasudevan, V. Selladurai, and P. Nagaraj, “Determination of closed form solution for acceptance sampling using ANN,” Qual Assur, vol. 11, no. 1, pp. 43–61, Mar. 2004, doi: 10.1080/10529410590930002.
[2581]	J. Xu, P. Hou, Y. Wang, and Z. Pan, “Determination of Component Contents of Blend Oil Based on Characteristics Peak Value Integration,” Guang Pu Xue Yu Guang Pu Fen Xi, vol. 36, no. 1, pp. 298–302, Jan. 2016.
[2582]	M. Miyazawa and R. Haigou, “Determination of cytochrome P450 enzymes involved in the metabolism of (-)-terpinen-4-ol by human liver microsomes,” Xenobiotica, vol. 41, no. 12, pp. 1056–1062, Dec. 2011, doi: 10.3109/00498254.2011.596230.
[2583]	 null Shigemori,  null Hara,  null Kawamori, and  null Akabori, “Determination of distances from tyrosine D to QA and chlorophyllZ in photosystem II studied by ‘2+1’ pulsed EPR,” Biochim. Biophys. Acta, vol. 1363, no. 3, pp. 187–198, Mar. 1998, doi: 10.1016/s0005-2728(97)00100-x.
[2584]	S. L. Bonting and M. Jones, “Determination of microgram quantities of deoxyribonucleic acid and protein in tissues grown in vitro,” Arch. Biochem. Biophys., vol. 66, no. 2, pp. 340–353, Feb. 1957, doi: 10.1016/s0003-9861(57)80009-5.
[2585]	W. Jiang, N. Zhang, F. Zhang, and Z. Yang, “[Determination of olive oil content in olive blend oil by headspace gas chromatography-mass spectrometry],” Se Pu, vol. 35, no. 7, pp. 760–765, Jul. 2017, doi: 10.3724/SP.J.1123.2017.02025.
[2586]	Y. Zhang, S. Nitter-Hauge, and E. Myhre, “Determination of the mean pressure gradient in mitral stenosis by Doppler echocardiography,” Eur. Heart J., vol. 6, no. 10, pp. 858–864, Oct. 1985, doi: 10.1093/oxfordjournals.eurheartj.a061773.
[2587]	A. Weixlbaumer, A. Werner, C. Flamm, E. Westhof, and R. Schroeder, “Determination of thermodynamic parameters for HIV DIS type loop-loop kissing complexes,” Nucleic Acids Res., vol. 32, no. 17, pp. 5126–5133, 2004, doi: 10.1093/nar/gkh841.
[2588]	N. Mamak, L. Gençer, Y. E. Ozkanlar, and S. Ozçelik, “[Determination of tick species and treatment of cows, sheep and goats in the Sivas-Zara region],” Turkiye Parazitol Derg, vol. 30, no. 3, pp. 209–212, 2006.
[2589]	A. Thompson, J. Huberty, R. Eckert, M. J. Taylor, and A. Ortiz, “Determining Physical Therapists’ Readiness for Integrating Yoga Therapeutics into Rehabilitation,” Int J Yoga Therap, Feb. 2020, doi: 10.17761/2020-D-19-00040.
[2590]	M. J. Sheriff and O. P. Love, “Determining the adaptive potential of maternal stress,” Ecol. Lett., vol. 16, no. 2, pp. 271–280, Feb. 2013, doi: 10.1111/ele.12042.
[2591]	T. Aktar and E. Adal, “Determining the Arrhenius Kinetics of Avocado Oil: Oxidative Stability under Rancimat Test Conditions,” Foods, vol. 8, no. 7, Jun. 2019, doi: 10.3390/foods8070236.
[2592]	J. R. Steele, R. J. Meskell, J. Foy, and A. E. Garner, “Determining the osmolality of over-concentrated and supplemented infant formulas,” J Hum Nutr Diet, vol. 26, no. 1, pp. 32–37, Feb. 2013, doi: 10.1111/j.1365-277X.2012.01286.x.
[2593]	N. Ji, E. Diao, X. Li, Z. Zhang, and H. Dong, “Detoxification and safety evaluation of aflatoxin B1 in peanut oil using alkali refining,” J. Sci. Food Agric., vol. 96, no. 12, pp. 4009–4014, Sep. 2016, doi: 10.1002/jsfa.7592.
[2594]	C. Grollman et al., “Developing a dataset to track aid for reproductive, maternal, newborn and child health, 2003-2013,” Sci Data, vol. 4, p. 170038, 28 2017, doi: 10.1038/sdata.2017.38.
[2595]	R. F. Lambert, A. Yu, L. Simon, J. G. Cho, J. Barrow, and B. Seymour, “Developing an Open Access, Competency-Based Global Oral Health Curriculum: A Global Health Starter Kit,” J Dent Educ, vol. 84, no. 2, pp. 176–185, Feb. 2020, doi: 10.21815/JDE.019.176.
[2596]	L. Rew, R. J. Johnson, S. K. Jenkins, and R. Torres, “Developing holistic nursing interventions to improve adolescent health,” J Holist Nurs, vol. 22, no. 4, pp. 303–319; quiz 298–302, Dec. 2004, doi: 10.1177/0898010104269263.
[2597]	F. Maestrelli, P. Mura, M. Cirri, N. Mennini, C. Ghelardini, and L. Di Cesare Mannelli, “Development and characterization of fast dissolving tablets of oxaprozin based on hybrid systems of the drug with cyclodextrins and nanoclays,” Int J Pharm, vol. 531, no. 2, pp. 640–649, Oct. 2017, doi: 10.1016/j.ijpharm.2017.05.033.
[2598]	H. S. Thatte, L. Rousou, B. E. Hussaini, X.-G. Lu, P. R. Treanor, and S. F. Khuri, “Development and evaluation of a novel solution, Somah, for the procurement and preservation of beating and nonbeating donor hearts for transplantation,” Circulation, vol. 120, no. 17, pp. 1704–1713, Oct. 2009, doi: 10.1161/CIRCULATIONAHA.108.808907.
[2599]	G. Defraene, E. Schuit, and D. De Ruysscher, “Development and internal validation of a multinomial NTCP model for the severity of acute dyspnea after radiotherapy for lung cancer,” Radiother Oncol, vol. 136, pp. 176–184, 2019, doi: 10.1016/j.radonc.2019.03.034.
[2600]	D. L. Hill et al., “Development and Pilot Testing of a Coping Kit for Parents of Hospitalized Children,” Acad Pediatr, vol. 19, no. 4, pp. 454–463, Jun. 2019, doi: 10.1016/j.acap.2018.11.001.
[2601]	A. S. Neff, K. R. Theis, and P. R. Burghardt, “Development and Preliminary Validation of a Feasible Procedure for Isolating RNA from Fiber-Adherent Bacteria in Human Stool,” Med Sci Monit Basic Res, vol. 25, pp. 238–244, Nov. 2019, doi: 10.12659/MSMBR.918316.
[2602]	H. Zhang, G. Kalkeri, N. Mani, and T. H. Grossman, “Development and validation of a multi-dose neutropenic rat thigh infection model using real-time monitoring of Staphylococcus aureus growth in vivo,” In Vivo, vol. 22, no. 6, pp. 667–672, Dec. 2008.
[2603]	Y. Liu et al., “Development and validation of a PCR-based functional marker system for identifying the low amylose content-associated gene Wx                     hp                  in rice,” Breed. Sci., vol. 69, no. 4, pp. 702–706, Dec. 2019, doi: 10.1270/jsbbs.19043.
[2604]	A. McQuade, M. Coburn, C. H. Tu, J. Hasselmann, H. Davtyan, and M. Blurton-Jones, “Development and validation of a simplified method to generate human microglia from pluripotent stem cells,” Mol Neurodegener, vol. 13, no. 1, p. 67, 22 2018, doi: 10.1186/s13024-018-0297-x.
[2605]	D. W. K. Man, J. C. C. Chung, and M. K. Y. Mak, “Development and validation of the Online Rivermead Behavioral Memory Test (OL-RBMT) for people with stroke,” NeuroRehabilitation, vol. 24, no. 3, pp. 231–236, 2009, doi: 10.3233/NRE-2009-0473.
[2606]	K. H. Bentley, M. W. Gallagher, J. R. Carl, and D. H. Barlow, “Development and validation of the Overall Depression Severity and Impairment Scale,” Psychol Assess, vol. 26, no. 3, pp. 815–830, Sep. 2014, doi: 10.1037/a0036216.
[2607]	L. Gomot and A. Guyard, “[DEVELOPMENT IN CULTURE IN VITRO OF THE HERMAPHRODITE GLAND OF YOUNG SNAILS OF THE HELIX ASPERSA MUELL. SPECIES],” C. R. Hebd. Seances Acad. Sci., vol. 258, pp. 2902–2905, Mar. 1964.
[2608]	M. S. Frasinyuk et al., “Development of 6H-Chromeno[3,4-c]pyrido[3’,2’:4,5]thieno[2,3-e]pyridazin-6-ones as Par-4 Secretagogues,” Tetrahedron Lett., vol. 56, no. 23, pp. 3382–3384, Jun. 2015, doi: 10.1016/j.tetlet.2015.01.028.
[2609]	R. S. Kahn, S. B. Iyer, and U. R. Kotagal, “Development of a Child Health Learning Network to Improve Population Health Outcomes; Presented in Honor of Dr Robert Haggerty,” Acad Pediatr, vol. 17, no. 6, pp. 607–613, 2017, doi: 10.1016/j.acap.2017.04.024.
[2610]	F. Bafort, J. P. Barthelemy, O. Parisi, J. P. Perraudin, and H. M. Jijakli, “Development of a colorimetric method for the dosage of OI- anions and I2 in aqueous media,” Commun. Agric. Appl. Biol. Sci., vol. 79, no. 1, pp. 155–160, 2014.
[2611]	B. P. Wijesirigunawardana and B. G. K Perera, “Development of a Cotton Smart Textile with Medicinal Properties Using Lime Oil Microcapsules,” Acta Chim Slov, vol. 65, no. 1, pp. 150–159, Mar. 2018.
[2612]	S. Zhou, S. Ashok, Y. Ko, D.-M. Kim, and S. Park, “Development of a deletion mutant of Pseudomonas denitrificans that does not degrade 3-hydroxypropionic acid,” Appl. Microbiol. Biotechnol., vol. 98, no. 10, pp. 4389–4398, May 2014, doi: 10.1007/s00253-014-5562-5.
[2613]	L. Rew, M. M. Hoke, S. D. Horner, and L. Walker, “Development of a dynamic model to guide health disparities research,” Nurs Outlook, vol. 57, no. 3, pp. 132–142, Jun. 2009, doi: 10.1016/j.outlook.2008.07.008.
[2614]	P. Neuner et al., “Development of a neuromedin U-human serum albumin conjugate as a long-acting candidate for the treatment of obesity and diabetes. Comparison with the PEGylated peptide,” J. Pept. Sci., vol. 20, no. 1, pp. 7–19, Jan. 2014, doi: 10.1002/psc.2582.
[2615]	S. Nandini et al., “Development of a simple bioelectrode for the electrochemical detection of hydrogen peroxide using Pichia pastoris catalase immobilized on gold nanoparticle nanotubes and polythiophene hybrid,” Analyst, vol. 139, no. 22, pp. 5800–5812, Nov. 2014, doi: 10.1039/c4an01262c.
[2616]	K. Sarlo, G. M. Adamson, V. L. Hollis, J. D. Innis, L. S. Babcock, and D. B. Kirchner, “Development of allergic antibody to an enzyme in a body lotion: results of an 18-month clinical study,” J Immunotoxicol, vol. 1, no. 2, pp. 71–77, Apr. 2004, doi: 10.1080/15476910490496249.
[2617]	N. Shijubo, Y. Itoh, T. Yamaguchi, and S. Abe, “Development of an enzyme-linked immunosorbent assay for Clara cell 10-kDa protein: in pursuit of clinical significance of sera in patients with asthma and sarcoidosis,” Ann. N. Y. Acad. Sci., vol. 923, pp. 268–279, 2000, doi: 10.1111/j.1749-6632.2000.tb05535.x.
[2618]	H. Takano-Ohmuro, Y. Nakajima, M. Saito, and Y. Yuda, “[Development of an Informative System for Consumers and Pharmacists Aimed at the Proper Use of Kampo OTCs],” Yakugaku Zasshi, vol. 136, no. 2, pp. 273–279, 2016, doi: 10.1248/yakushi.15-00268-5.
[2619]	B. Q. Duong et al., “Development of Customizable Implementation Guides to Support Clinical Adoption of Pharmacogenomics: Experiences of the Implementing GeNomics In pracTicE (IGNITE) Network,” Pharmgenomics Pers Med, vol. 13, pp. 217–226, 2020, doi: 10.2147/PGPM.S241599.
[2620]	A. Pawar, S. Singh, S. Rajalakshmi, K. Shaikh, and C. Bothiraja, “Development of fisetin-loaded folate functionalized pluronic micelles for breast cancer targeting,” Artif Cells Nanomed Biotechnol, vol. 46, no. sup1, pp. 347–361, 2018, doi: 10.1080/21691401.2018.1423991.
[2621]	C. A. Hall, H. L. Lydon, C. H. Dalton, J. K. Chipman, J. S. Graham, and R. P. Chilcott, “Development of haemostatic decontaminants for the treatment of wounds contaminated with chemical warfare agents. 1: evaluation of in vitro clotting efficacy in the presence of certain contaminants,” J Appl Toxicol, vol. 35, no. 5, pp. 536–542, May 2015, doi: 10.1002/jat.3019.
[2622]	M. Bhattacharjee, A. S. Roy, S. Ghosh, and M. Dey, “Development of karanja oil based offset printing ink in comparison with linseed oil,” J Oleo Sci, vol. 60, no. 1, pp. 19–24, 2011, doi: 10.5650/jos.60.19.
[2623]	R. Shawahna, “Development of key performance indicators to capture in measuring the impact of pharmacists in caring for patients with epilepsy in primary healthcare: A Delphi consensual study,” Epilepsy Behav, vol. 98, no. Pt A, pp. 129–138, 2019, doi: 10.1016/j.yebeh.2019.07.034.
[2624]	J. M. Ribas-Filho, O. Malafaia, N. G. Czeczko, C. A. P. M. Ribas, and P. A. N. Nassif, “DEVELOPMENT OF METRICS FOR TECHNICAL PRODUCTION: QUALIS BOOKS AND BOOK CHAPTERS,” Rev Col Bras Cir, vol. 42 Suppl 1, pp. 48–50, 2015, doi: 10.1590/0100-69912015S01017.
[2625]	A. A. Macdonald, P. Poot, B. Colenbrander, J. C. Meijer, and C. J. Wensing, “Development of nervous tissue in the heart of the fetal and neonatal pig and the effect of decapitation in utero,” Anat. Embryol., vol. 168, no. 3, pp. 405–417, 1983, doi: 10.1007/BF00304277.
[2626]	D. Das Mukherjee et al., “Development of Novel Bis(indolyl)-hydrazide-Hydrazone Derivatives as Potent Microtubule-Targeting Cytotoxic Agents against A549 Lung Cancer Cells,” Biochemistry, vol. 55, no. 21, pp. 3020–3035, 31 2016, doi: 10.1021/acs.biochem.5b01127.
[2627]	M. M. Heidari, M. Hadadzadeh, and H. Fallahzadeh, “Development of One-Step Tetra-primer ARMS-PCR for Simultaneous Detection of the Angiotensin Converting Enzyme (ACE) I/D and rs4343 Gene Polymorphisms and the Correlation with CAD Patients,” Avicenna J Med Biotechnol, vol. 11, no. 1, pp. 118–123, Mar. 2019.
[2628]	A. De Prins et al., “Development of potent and proteolytically stable human neuromedin U receptor agonists,” Eur J Med Chem, vol. 144, pp. 887–897, Jan. 2018, doi: 10.1016/j.ejmech.2017.12.035.
[2629]	M. Wei, X. Yang, P. Watson, F. Yang, and H. Liu, “Development of QSAR model for predicting the inclusion constants of organic chemicals with α-cyclodextrin,” Environ Sci Pollut Res Int, vol. 25, no. 18, pp. 17565–17574, Jun. 2018, doi: 10.1007/s11356-018-1917-2.
[2630]	B. F. McCutchen et al., “Development of surrogate substrates for juvenile hormone esterase,” Arch. Biochem. Biophys., vol. 307, no. 2, pp. 231–241, Dec. 1993, doi: 10.1006/abbi.1993.1584.
[2631]	S. Reddy et al., “Development of the AMSER standardized examinations in radiology for medical students,” Acad Radiol, vol. 22, no. 1, pp. 130–134, Jan. 2015, doi: 10.1016/j.acra.2014.07.018.
[2632]	D. Kozłowski, M. Grzybiak, A. Owerczuk, and M. Kozłowska, “Development of the atrioventricular junctional area in the human heart,” Folia Morphol. (Warsz), vol. 60, no. 1, pp. 27–31, 2001.
[2633]	F. Szalay, “Development of the equine brain motor system,” Neurobiology (Bp), vol. 9, no. 2, pp. 107–135, 2001, doi: 10.1556/neurob.9.2001.2.4.
[2634]	B. Jensen, G. van den Berg, R. van den Doel, R.-J. Oostra, T. Wang, and A. F. M. Moorman, “Development of the hearts of lizards and snakes and perspectives to cardiac evolution,” PLoS ONE, vol. 8, no. 6, p. e63651, 2013, doi: 10.1371/journal.pone.0063651.
[2635]	N. Aydemir, B. Kaya, and G. Yıldız, “Development of the perceived stigma scale and the concealment of epilepsy scale for the Turkish population,” Epilepsy Behav, vol. 80, pp. 1–4, 2018, doi: 10.1016/j.yebeh.2017.11.032.
[2636]	L. Rew, G. McDougall, L. Riesch, and C. Parker, “Development of the self-efficacy for testicular self-examination scale,” J Mens Health Gend, vol. 2, no. 1, pp. 59–63, Mar. 2005, doi: 10.1016/j.jmhg.2004.12.007.
[2637]	L. C. Pena Cortes, R. M. LeVeque, J. Funk, T. L. Marsh, and M. H. Mulks, “Development of the tonsillar microbiome in pigs from newborn through weaning,” BMC Microbiol., vol. 18, no. 1, p. 35, 16 2018, doi: 10.1186/s12866-018-1176-x.
[2638]	S. H. Austin, W. D. Robinson, T. R. Robinson, V. A. Ellis, and R. E. Ricklefs, “Development syndromes in New World temperate and tropical songbirds,” PLoS ONE, vol. 15, no. 8, p. e0233627, Aug. 2020, doi: 10.1371/journal.pone.0233627.
[2639]	J. R. Hinchliffe, “Developmental basis of limb evolution,” Int. J. Dev. Biol., vol. 46, no. 7, pp. 835–845, 2002.
[2640]	K. B. Wexler, “Developmental disfluency in 2-, 4-, and 6-year-old boys in neutral and stress situations,” J Speech Hear Res, vol. 25, no. 2, pp. 229–234, Jun. 1982, doi: 10.1044/jshr.2502.229.
[2641]	D. Labie, “[Developmental neurotoxicity of industrial chemicals],” Med Sci (Paris), vol. 23, no. 10, pp. 868–872, Oct. 2007, doi: 10.1051/medsci/20072310868.
[2642]	H.-U. Wittchen and A. T. Gloster, “Developments in the treatment and diagnosis of anxiety disorders,” Psychiatr. Clin. North Am., vol. 32, no. 3, pp. xiii–xix, Sep. 2009, doi: 10.1016/j.psc.2009.07.001.
[2643]	S. Chetcuti Zammit, D. S. Sanders, and R. Sidhu, “Device assisted enteroscopy in the elderly - A systematic review and meta-analysis,” Dig Liver Dis, vol. 51, no. 9, pp. 1249–1256, 2019, doi: 10.1016/j.dld.2019.04.001.
[2644]	S. Tokunaga, S. Yasuda, and M. Masuda, “Devised loop-in-loop technique in mitral valve repair,” Asian Cardiovasc Thorac Ann, vol. 22, no. 9, pp. 1132–1134, Nov. 2014, doi: 10.1177/0218492313499009.
[2645]	H. S. Choi, Y. J. Park, and K. M. Kim, “Devising an objective nasal vibration test for nasal resonatory disorders,” J Voice, vol. 15, no. 2, pp. 220–230, Jun. 2001, doi: 10.1016/S0892-1997(01)00022-4.
[2646]	M. Dutra Medeiros, R. Navarro, J. Garcia-Arumí, C. Mateo, and B. Corcóstegui, “Dexamethasone intravitreal implant for treatment of patients with recalcitrant macular edema resulting from Irvine-Gass syndrome,” Invest. Ophthalmol. Vis. Sci., vol. 54, no. 5, pp. 3320–3324, May 2013, doi: 10.1167/iovs.12-11463.
[2647]	T. Andersen, A. Astrup, and F. Quaade, “Dexfenfluramine as adjuvant to a low-calorie formula diet in the treatment of obesity: a randomized clinical trial,” Int. J. Obes. Relat. Metab. Disord., vol. 16, no. 1, pp. 35–40, Jan. 1992.
[2648]	A. Bonabello et al., “Dexibuprofen (S+-isomer ibuprofen) reduces gastric damage and improves analgesic and antiinflammatory effects in rodents,” Anesth. Analg., vol. 97, no. 2, pp. 402–408, table of contents, Aug. 2003, doi: 10.1213/01.ane.0000073349.04610.42.
[2649]	A. Christa, “[DFG funding opportunities for research projects in ophthalmology],” Ophthalmologe, vol. 117, no. 5, p. 484, 2020, doi: 10.1007/s00347-020-01090-w.
[2650]	M. Schröder, A. N. Bullock, O. Fedorov, F. Bracher, A. Chaikuad, and S. Knapp, “DFG-1 Residue Controls Inhibitor Binding Mode and Affinity, Providing a Basis for Rational Design of Kinase Inhibitor Selectivity,” J. Med. Chem., Aug. 2020, doi: 10.1021/acs.jmedchem.0c00898.
[2651]	A. Campayo, C. H. Gómez-Biel, and A. Lobo, “Diabetes and depression,” Curr Psychiatry Rep, vol. 13, no. 1, pp. 26–30, Feb. 2011, doi: 10.1007/s11920-010-0165-z.
[2652]	M. Xue et al., “Diabetes mellitus and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 144 prospective studies,” Ageing Res. Rev., vol. 55, p. 100944, 2019, doi: 10.1016/j.arr.2019.100944.
[2653]	J. Vafaeimanesh, M. Bagherzadeh, A. Heidari, F. Motii, and M. Parham, “Diabetic patients infected with helicobacter pylori have a higher Insulin Resistance Degree,” Caspian J Intern Med, vol. 5, no. 3, pp. 137–142, 2014.
[2654]	S. Behrman, V. Valkanova, and C. L. Allan, “Diagnosing and managing mild cognitive impairment,” Practitioner, vol. 261, no. 1804, pp. 17–20, May 2017.
[2655]	C. B. Buhmann and H. S. Andersen, “[Diagnosing and treating post-traumatic stress disorder],” Ugeskr. Laeg., vol. 179, no. 24, Jun. 2017.
[2656]	B. A. Wandell and R. K. Le, “Diagnosing the Neural Circuitry of Reading,” Neuron, vol. 96, no. 2, pp. 298–311, Oct. 2017, doi: 10.1016/j.neuron.2017.08.007.
[2657]	B. D. Grinage, “Diagnosis and management of post-traumatic stress disorder,” Am Fam Physician, vol. 68, no. 12, pp. 2401–2408, Dec. 2003.
[2658]	C. Grafton-Clarke, K. W. Chen, and J. Wilcock, “Diagnosis and referral delays in primary care for oral squamous cell cancer: a systematic review,” Br J Gen Pract, vol. 69, no. 679, pp. e112–e126, Feb. 2019, doi: 10.3399/bjgp18X700205.
[2659]	J. P. Kahn, “Diagnosis and referral of workplace depression,” J. Occup. Environ. Med., vol. 50, no. 4, pp. 396–400, Apr. 2008, doi: 10.1097/JOM.0b013e31816c0043.
[2660]	D. G. Ju, A. Yurter, Z. L. Gokaslan, and D. M. Sciubba, “Diagnosis and surgical management of breast cancer metastatic to the spine,” World J Clin Oncol, vol. 5, no. 3, pp. 263–271, Aug. 2014, doi: 10.5306/wjco.v5.i3.263.
[2661]	P. Torzsa, L. Szeifert, K. Dunai, L. Kalabay, and M. Novák, “[Diagnosis and therapy of depression in family practice],” Orv Hetil, vol. 150, no. 36, pp. 1684–1693, Sep. 2009, doi: 10.1556/OH.2009.28675.
[2662]	T. Shiraishi, H. Murakami, and Y. Iguchi, “[Diagnosis and Treatment of Cognitive Impairment in Parkinson’s Disease],” Brain Nerve, vol. 71, no. 8, pp. 869–874, Aug. 2019, doi: 10.11477/mf.1416201367.
[2663]	A. O. Meka et al., “Diagnosis delay and duration of hospitalisation of patients with Buruli ulcer in Nigeria,” Trans. R. Soc. Trop. Med. Hyg., vol. 110, no. 9, pp. 502–509, 2016, doi: 10.1093/trstmh/trw065.
[2664]	Q. Wu, W. Wang, L. Cao, L. Sun, Y. Xu, and X. Zhong, “Diagnosis of fetal osteogenesis imperfecta by multidisciplinary assessment: a retrospective study of 10 cases,” Fetal Pediatr Pathol, vol. 34, no. 1, pp. 57–64, Feb. 2015, doi: 10.3109/15513815.2014.962198.
[2665]	T. Hata, “[Diagnosis of MDS: morphology, chromosome abnormalities and genetic mutations],” Rinsho Ketsueki, vol. 56, no. 10, pp. 1978–1984, Oct. 2015, doi: 10.11406/rinketsu.56.1978.
[2666]	D.-Y. Wu et al., “[Diagnosis of Muscular Dystrophy Using Western Blot with Micro-sample of Muscle],” Zhongguo Yi Xue Ke Xue Yuan Xue Bao, vol. 37, no. 6, pp. 705–710, Dec. 2015, doi: 10.3881/j.issn.1000-503X.2015.06.011.
[2667]	C. Le Pen and G. Berdeaux, “Diagnosis related group costs in a regulated environment. A note about their economic interpretation,” Pharmacoeconomics, vol. 17, no. 2, pp. 115–120, Feb. 2000, doi: 10.2165/00019053-200017020-00001.
[2668]	N. Tessitore et al., “Diagnostic accuracy of ultrasound dilution access blood flow measurement in detecting stenosis and predicting thrombosis in native forearm arteriovenous fistulae for hemodialysis,” Am. J. Kidney Dis., vol. 42, no. 2, pp. 331–341, Aug. 2003, doi: 10.1016/s0272-6386(03)00659-0.
[2669]	A. Maercker and J. Lalor, “Diagnostic and clinical considerations in prolonged grief disorder,” Dialogues Clin Neurosci, vol. 14, no. 2, pp. 167–176, Jun. 2012.
[2670]	S. Yimer, G. Bjune, and G. Alene, “Diagnostic and treatment delay among pulmonary tuberculosis patients in Ethiopia: a cross sectional study,” BMC Infect. Dis., vol. 5, p. 112, Dec. 2005, doi: 10.1186/1471-2334-5-112.
[2671]	V. Ghai, H. Jan, F. Shakir, P. Haines, and A. Kent, “Diagnostic delay for superficial and deep endometriosis in the United Kingdom,” J Obstet Gynaecol, vol. 40, no. 1, pp. 83–89, Jan. 2020, doi: 10.1080/01443615.2019.1603217.
[2672]	L. Hafström, H. Johansson, and J. Ahlberg, “Diagnostic delay of breast cancer - an analysis of claims to Swedish Board of Malpractice (LÖF),” Breast, vol. 20, no. 6, pp. 539–542, Dec. 2011, doi: 10.1016/j.breast.2011.06.007.
[2673]	V. Shay, A. Fattal-Valevski, L. Beni-Adani, and S. Constantini, “Diagnostic delay of pediatric brain tumors in Israel: a retrospective risk factor analysis,” Childs Nerv Syst, vol. 28, no. 1, pp. 93–100, Jan. 2012, doi: 10.1007/s00381-011-1564-0.
[2674]	J. Franco, A. N. Elghouche, M. S. Harris, and M. S. Kokoska, “Diagnostic Delays and Errors in Head and Neck Cancer Patients: Opportunities for Improvement,” Am J Med Qual, vol. 32, no. 3, pp. 330–335, Jun. 2017, doi: 10.1177/1062860616638413.
[2675]	A. E. Ahmed, “Diagnostic delays in Middle East respiratory syndrome coronavirus patients and health systems,” J Infect Public Health, vol. 12, no. 6, pp. 767–771, Dec. 2019, doi: 10.1016/j.jiph.2019.04.002.
[2676]	M. R. Fairfax and H. Salimnia, “Diagnostic molecular microbiology: a 2013 snapshot,” Clin. Lab. Med., vol. 33, no. 4, pp. 787–803, Dec. 2013, doi: 10.1016/j.cll.2013.08.003.
[2677]	M. R. Fairfax, M. H. Bluth, and H. Salimnia, “Diagnostic Molecular Microbiology: A 2018 Snapshot,” Clin. Lab. Med., vol. 38, no. 2, pp. 253–276, 2018, doi: 10.1016/j.cll.2018.02.004.
[2678]	D. H. Lee, J. M. Lee, J. H. Baek, C.-I. Shin, J. K. Han, and B. I. Choi, “Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings,” Radiology, vol. 274, no. 1, pp. 149–160, Jan. 2015, doi: 10.1148/radiol.14140141.
[2679]	B. R. Kim et al., “Diagnostic Performance of Gadoxetic Acid-enhanced Liver MR Imaging versus Multidetector CT in the Detection of Dysplastic Nodules and Early Hepatocellular Carcinoma,” Radiology, vol. 285, no. 1, pp. 134–146, 2017, doi: 10.1148/radiol.2017162080.
[2680]	M. Senda et al., “Diagnostic utility of the Addenbrooke’s Cognitive Examination - III (ACE-III), Mini-ACE, Mini-Mental State Examination, Montreal Cognitive Assessment, and Hasegawa Dementia Scale-Revised for detecting mild cognitive impairment and dementia,” Psychogeriatrics, vol. 20, no. 2, pp. 156–162, Mar. 2020, doi: 10.1111/psyg.12480.
[2681]	A. Takeuchi et al., “Diagnostic Value of Flow Cytometry Standardized Using the European LeukemiaNet for Myelodysplastic Syndrome,” Acta Haematol., vol. 143, no. 2, pp. 140–145, 2020, doi: 10.1159/000501147.
[2682]	X.-Y. Shen, C.-H. Chai, W.-B. Xiao, and Q.-D. Wang, “Diagnostic value of the fluoroscopic triggering 3D LAVA technique for primary liver cancer,” HBPD INT, vol. 9, no. 2, pp. 159–163, Apr. 2010.
[2683]	B. Charlton, “Dialog on depression,” Science, vol. 288, no. 5468, p. 975, May 2000, doi: 10.1126/science.288.5468.975b.
[2684]	A. Mannelli, L. Villevielle, and A. Zara, “[Dialudid in pre-anesthesia],” G Ital Chir, vol. 10, no. 10, pp. 836–848, Oct. 1954.
[2685]	P. Trejo, F. Fassier, F. H. Glorieux, and F. Rauch, “Diaphyseal Femur Fractures in Osteogenesis Imperfecta: Characteristics and Relationship With Bisphosphonate Treatment,” J. Bone Miner. Res., vol. 32, no. 5, pp. 1034–1039, May 2017, doi: 10.1002/jbmr.3071.
[2686]	P. J. Yim et al., “Diastolic shape of the right ventricle of the heart,” Anat. Rec., vol. 250, no. 3, pp. 316–324, 1998, doi: 10.1002/(SICI)1097-0185(199803)250:3<316::AID-AR6>3.0.CO;2-Y.
[2687]	H. White, R. Jubran, A. Chroust, A. Heck, and R. S. Bhatt, “Dichotomous Perception of Animal Categories in Infancy,” Vis cogn, vol. 26, no. 10, pp. 764–779, 2018, doi: 10.1080/13506285.2018.1553811.
[2688]	J. W. Rowe, D. L. Clark, C. E. Martin, and C. Valle, “Diel and seasonal variations in the thermal biology of San Cristobal Lava Lizards (Microlophus bivittatus),” J. Therm. Biol., vol. 88, p. 102518, Feb. 2020, doi: 10.1016/j.jtherbio.2020.102518.
[2689]	S. Caivano, F. A. B. Colugnati, and S. M. Á. Domene, “Diet Quality Index associated with Digital Food Guide: update and validation,” Cad Saude Publica, vol. 35, no. 9, p. e00043419, 16 2019, doi: 10.1590/0102-311X00043419.
[2690]	L. Y. Hemeryck and L. Vanhaecke, “Diet-related DNA adduct formation in relation to carcinogenesis,” Nutr. Rev., vol. 74, no. 8, pp. 475–489, 2016, doi: 10.1093/nutrit/nuw017.
[2691]	S. S. Mirvish, K. Karlowski, D. F. Birt, and J. P. Sams, “Dietary and other factors affecting nitrosomethylurea (NMU) formation in the rat stomach,” IARC Sci. Publ., no. 31, pp. 271–279, 1980.
[2692]	A. Ferramosca, V. Savy, L. Conte, and V. Zara, “Dietary combination of conjugated linoleic acid (CLA) and pine nut oil prevents CLA-induced fatty liver in mice,” J. Agric. Food Chem., vol. 56, no. 17, pp. 8148–8158, Sep. 2008, doi: 10.1021/jf8010728.
[2693]	M. M. El-Begearmi and G. F. Combs, “Dietary effects on selenite toxicity in the chick,” Poult. Sci., vol. 61, no. 4, pp. 770–776, Apr. 1982, doi: 10.3382/ps.0610770.
[2694]	A. Ferramosca and V. Zara, “Dietary fat and hepatic lipogenesis: mitochondrial citrate carrier as a sensor of metabolic changes,” Adv Nutr, vol. 5, no. 3, pp. 217–225, May 2014, doi: 10.3945/an.113.004762.
[2695]	Z. Ronai, Y. Y. Lau, and L. A. Cohen, “Dietary N-3 fatty acids do not affect induction of Ha-ras mutations in mammary glands of NMU-treated rats,” Mol. Carcinog., vol. 4, no. 2, pp. 120–128, 1991, doi: 10.1002/mc.2940040207.
[2696]	M. L. Castejon et al., “Dietary oleuropein and its new acyl-derivate attenuate murine lupus nephritis through HO-1/Nrf2 activation and suppressing JAK/STAT, NF-κB, MAPK and NLRP3 inflammasome signaling pathways,” J. Nutr. Biochem., vol. 74, p. 108229, 2019, doi: 10.1016/j.jnutbio.2019.108229.
[2697]	X. Qi et al., “Dietary supplementation with linseed oil improves semen quality, reproductive hormone, gene and protein expression related to testosterone synthesis in aging layer breeder roosters,” Theriogenology, vol. 131, pp. 9–15, Jun. 2019, doi: 10.1016/j.theriogenology.2019.03.016.
[2698]	V. Schorr, D. A. Crabtree, D. Wagner, and P. Wetterau, “Difference in rural and urban mortality: implications for health education and promotion,” J Rural Health, vol. 5, no. 1, pp. 67–80, Jan. 1989, doi: 10.1111/j.1748-0361.1989.tb01070.x.
[2699]	A. Iacovides, K. N. Fountoulakis, P. Grammaticos, and C. Ierodiakonou, “Difference in symptom profile between generalized anxiety disorder and anxiety secondary to hyperthyroidism,” Int J Psychiatry Med, vol. 30, no. 1, pp. 71–81, 2000, doi: 10.2190/DEGG-U4VQ-WMWA-58AB.
[2700]	S. H. Jang et al., “Difference of recovery course of motor weakness according to state of corticospinal tract in putaminal hemorrhage,” Neurosci. Lett., vol. 653, pp. 163–167, Jul. 2017, doi: 10.1016/j.neulet.2017.05.052.
[2701]	B. Dong et al., “Differences in biological features of gastric dysplasia, indefinite dysplasia, reactive hyperplasia and discriminant analysis of these lesions,” World J. Gastroenterol., vol. 11, no. 23, pp. 3595–3600, Jun. 2005, doi: 10.3748/wjg.v11.i23.3595.
[2702]	R. Teipel et al., “Differences in Cellular Composition of Peripheral Blood Stem Cell Grafts from Healthy Stem Cell Donors Mobilized with Either Granulocyte Colony-Stimulating Factor (G-CSF) Alone or G-CSF and Plerixafor,” Biol. Blood Marrow Transplant., vol. 24, no. 11, pp. 2171–2177, 2018, doi: 10.1016/j.bbmt.2018.06.023.
[2703]	E. Bora, “Differences in cognitive impairment between schizophrenia and bipolar disorder: Considering the role of heterogeneity,” Psychiatry Clin. Neurosci., vol. 70, no. 10, pp. 424–433, Oct. 2016, doi: 10.1111/pcn.12410.
[2704]	H. Avsaroglu et al., “Differences in hepatic cytochrome P450 activity correlate with the strain-specific biotransformation of medetomidine in AX/JU and IIIVO/JU inbred rabbits,” J. Vet. Pharmacol. Ther., vol. 31, no. 4, pp. 368–377, Aug. 2008, doi: 10.1111/j.1365-2885.2008.00969.x.
[2705]	C. F. Sharpley and V. Bitsika, “Differences in neurobiological pathways of four ‘clinical content’ subtypes of depression,” Behav. Brain Res., vol. 256, pp. 368–376, Nov. 2013, doi: 10.1016/j.bbr.2013.08.030.
[2706]	L. Sun et al., “Differences in neurotropism and neurotoxicity among retrograde viral tracers,” Mol Neurodegener, vol. 14, no. 1, p. 8, 08 2019, doi: 10.1186/s13024-019-0308-6.
[2707]	C. Acuña-Castillo, C. Villalobos, P. R. Moya, P. Sáez, B. K. Cassels, and J. P. Huidobro-Toro, “Differences in potency and efficacy of a series of phenylisopropylamine/phenylethylamine pairs at 5-HT(2A) and 5-HT(2C) receptors,” Br. J. Pharmacol., vol. 136, no. 4, pp. 510–519, Jun. 2002, doi: 10.1038/sj.bjp.0704747.
[2708]	B. Silverstein and E. Levin, “Differences in the developmental patterns of depression with and without additional somatic symptoms,” Psychiatry Res, vol. 220, no. 1–2, pp. 254–257, Dec. 2014, doi: 10.1016/j.psychres.2014.07.054.
[2709]	J. R. Sanem, C. J. Berg, L. C. An, M. A. Kirch, and K. A. Lust, “Differences in tobacco use among two-year and four-year college students in Minnesota,” J Am Coll Health, vol. 58, no. 2, pp. 151–159, Oct. 2009, doi: 10.1080/07448480903221376.
[2710]	R. Nair and R. Yee, “Differences in willingness to pay for an extraction, a filling, and cleaning teeth at various levels of oral health-related quality of life, as measured by oral impacts on daily performance, among older adults in Singapore,” Singapore Dent J, vol. 37, pp. 2–8, Dec. 2016, doi: 10.1016/j.sdj.2016.10.003.
[2711]	Y. Ishikawa, M. Yoshimoto, N. Yamamoto, and H. Ito, “Different brain morphologies from different genotypes in a single teleost species, the medaka (Oryzias latipes),” Brain Behav. Evol., vol. 53, no. 1, pp. 2–9, 1999, doi: 10.1159/000006577.
[2712]	F. Wu, Y. Gao, Z. Zuo, J. Feng, Z. Yan, and L. Zhu, “Different decreasing rates of chemical threshold concentrations can be explained by their toxicokinetic and toxicodynamic characteristics,” Sci. Total Environ., vol. 708, p. 135234, Mar. 2020, doi: 10.1016/j.scitotenv.2019.135234.
[2713]	T. Barbui, V. De Stefano, A. Ghirardi, A. Masciulli, G. Finazzi, and A. M. Vannucchi, “Different effect of hydroxyurea and phlebotomy on prevention of arterial and venous thrombosis in Polycythemia Vera,” Blood Cancer J, vol. 8, no. 12, p. 124, 26 2018, doi: 10.1038/s41408-018-0161-9.
[2714]	T. Fukuda et al., “Different effects of various hematopoietic growth factors on myelomonocytic cell line (KY-821) and its drug-resistant sublines,” Leuk. Res., vol. 17, no. 4, pp. 325–332, Apr. 1993, doi: 10.1016/0145-2126(93)90019-h.
[2715]	T. M. Barnhardt, “Different involuntary mechanisms underlie priming and LOP effects in stem completion tests,” Memory, vol. 12, no. 5, pp. 614–636, Sep. 2004, doi: 10.1080/09658210344000143.
[2716]	M. P. Rippe, C. Monaco, L. Volpe, M. A. Bottino, R. Scotti, and L. F. Valandro, “Different Methods for Inlay Production: Effect on Internal and Marginal Adaptation, Adjustment Time, and Contact Point,” Oper Dent, vol. 42, no. 4, pp. 436–444, Aug. 2017, doi: 10.2341/16-093-L.
[2717]	A. N. Ahn, N. Konow, C. Tijs, and A. A. Biewener, “Different Segments within Vertebrate Muscles Can Operate on Different Regions of Their Force-Length Relationships,” Integr. Comp. Biol., vol. 58, no. 2, pp. 219–231, 01 2018, doi: 10.1093/icb/icy040.
[2718]	J. Kamilic et al., “Differential ACE expression among tissues in allele-specific Wistar rat lines,” Mamm. Genome, vol. 20, no. 3, pp. 170–179, Mar. 2009, doi: 10.1007/s00335-009-9173-x.
[2719]	B. M. E. Adriaanse, M. M. Bartelings, J. M. G. van Vugt, R. Chaoui, A. C. Gittenberger-de Groot, and M. C. Haak, “Differential and linear insertion of atrioventricular valves: a useful tool?,” Ultrasound Obstet Gynecol, vol. 44, no. 5, pp. 568–574, Nov. 2014, doi: 10.1002/uog.13326.
[2720]	Z. A. Hughes and L. A. Dawson, “Differential autoreceptor control of extracellular 5-HT in guinea pig and rat: species and regional differences,” Psychopharmacology (Berl.), vol. 172, no. 1, pp. 87–93, Feb. 2004, doi: 10.1007/s00213-003-1615-7.
[2721]	A. A. Rahman, I. Z. Shahid, and P. M. Pilowsky, “Differential cardiorespiratory and sympathetic reflex responses to microinjection of neuromedin U in rat rostral ventrolateral medulla,” J. Pharmacol. Exp. Ther., vol. 341, no. 1, pp. 213–224, Apr. 2012, doi: 10.1124/jpet.111.191254.
[2722]	S. N. Banerjee and S. Chakrabarti, “Differential clastogenic sensitivity of heterochromatin and euchromatin: evidence from an in vivo study made on a submammalian vertebrate,” In Vivo, vol. 3, no. 1, pp. 55–60, Feb. 1989.
[2723]	P. Planchon et al., “Differential effects of butyrate derivatives on human breast cancer cells grown as organotypic nodules in vitro and as xenografts in vivo,” In Vivo, vol. 6, no. 6, pp. 605–610, Dec. 1992.
[2724]	T. Wakabayashi et al., “Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer’s disease,” Mol Neurodegener, vol. 14, no. 1, p. 15, 12 2019, doi: 10.1186/s13024-019-0315-7.
[2725]	Y. Gao, X. Li, Q. Gao, L. Fan, H. Jin, and Y. Guo, “Differential effects of olive oil, soybean oil, corn oil and lard oil on carbon tetrachloride-induced liver fibrosis in mice,” Biosci. Rep., vol. 39, no. 10, 30 2019, doi: 10.1042/BSR20191913.
[2726]	G. Bentsen, A. Stubhaug, and P. K. Eide, “Differential effects of osmotherapy on static and pulsatile intracranial pressure,” Crit. Care Med., vol. 36, no. 8, pp. 2414–2419, Aug. 2008, doi: 10.1097/CCM.0b013e318180fe04.
[2727]	H. Nagai et al., “Differential effects of selective agonists of neuromedin U1 and U2 receptors in obese and diabetic mice,” Br. J. Pharmacol., vol. 175, no. 2, pp. 359–373, 2018, doi: 10.1111/bph.14077.
[2728]	H. Asano et al., “Differential expression of the 5-HT(3A) and 5-HT(3B) receptor in differentiated NG108-15 cells,” Neurochem. Res., vol. 37, no. 8, pp. 1738–1746, Aug. 2012, doi: 10.1007/s11064-012-0784-3.
[2729]	C. E. Velazquez, K. E. Pasch, M. N. Laska, K. Lust, M. Story, and E. P. Ehlinger, “Differential prevalence of alcohol use among 2-year and 4-year college students,” Addict Behav, vol. 36, no. 12, pp. 1353–1356, Dec. 2011, doi: 10.1016/j.addbeh.2011.07.037.
[2730]	I. Hamming et al., “Differential regulation of renal angiotensin-converting enzyme (ACE) and ACE2 during ACE inhibition and dietary sodium restriction in healthy rats,” Exp. Physiol., vol. 93, no. 5, pp. 631–638, May 2008, doi: 10.1113/expphysiol.2007.041855.
[2731]	S. Sánchez-Campos et al., “Differential Shape of Geminivirus Mutant Spectra Across Cultivated and Wild Hosts With Invariant Viral Consensus Sequences,” Front Plant Sci, vol. 9, p. 932, 2018, doi: 10.3389/fpls.2018.00932.
[2732]	B. C. Allen et al., “DIfferential Subsampling With Cartesian Ordering With Respiratory Triggering Versus Conventional Liver Acquisition With Volume Acquisition: A Multiple Reader Preference Study,” J Comput Assist Tomogr, vol. 43, no. 4, pp. 623–627, Aug. 2019, doi: 10.1097/RCT.0000000000000888.
[2733]	P. C. Shen et al., “Differential thermal sensitivity between the recipient ooplasm and the donor nucleus in Holstein and Taiwan native yellow cattle,” Theriogenology, vol. 74, no. 9, pp. 1587–1595, Dec. 2010, doi: 10.1016/j.theriogenology.2010.06.029.
[2734]	A. Gupta, C. T. Brown, Y.-H. Zheng, and C. Adami, “Differentially-Expressed Pseudogenes in HIV-1 Infection,” Viruses, vol. 7, no. 10, pp. 5191–5205, Sep. 2015, doi: 10.3390/v7102869.
[2735]	M. A. Pikovski, “Differentiated mammary gland tumor tissue grown in an alkaline medium in vitro,” Exp. Cell Res., vol. 7, no. 1, pp. 52–57, Aug. 1954, doi: 10.1016/0014-4827(54)90041-5.
[2736]	S. K. Das and S. Dubey, “Differentiating mild cognitive impairment from normal cognition and frank dementia utilizing structural changes observed on magnetic resonance imaging,” Neurol India, vol. 66, no. 2, pp. 328–329, Apr. 2018, doi: 10.4103/0028-3886.227276.
[2737]	Y. Wang, L. B. Cottler, and C. W. Striley, “Differentiating patterns of prescription stimulant medical and nonmedical use among youth 10-18 years of age,” Drug Alcohol Depend, vol. 157, pp. 83–89, Dec. 2015, doi: 10.1016/j.drugalcdep.2015.10.006.
[2738]	M. Muthuraman, R. B. Govindan, G. Deuschl, U. Heute, and J. Raethjen, “Differentiating phase shift and delay in narrow band coherent signals,” Clin Neurophysiol, vol. 119, no. 5, pp. 1062–1070, May 2008, doi: 10.1016/j.clinph.2008.01.003.
[2739]	M. Philipp et al., “Differentiation between major and minor depression,” Psychopharmacology (Berl.), vol. 106 Suppl, pp. S75-78, 1992, doi: 10.1007/BF02246241.
[2740]	J. Ono, K. Harada, T. Mano, K. Sakurai, and S. Okada, “Differentiation of dys- and demyelination using diffusional anisotropy,” Pediatr. Neurol., vol. 16, no. 1, pp. 63–66, Jan. 1997, doi: 10.1016/s0887-8994(96)00249-4.
[2741]	M. Esposito et al., “Differentiation of human umbilical cord-derived mesenchymal stem cells, WJ-MSCs, into chondrogenic cells in the presence of pulsed electromagnetic fields,” In Vivo, vol. 27, no. 4, pp. 495–500, Aug. 2013.
[2742]	O. Peleg and C. Messerschmidt-Grandi, “Differentiation of self and trait anxiety: A cross-cultural perspective,” Int J Psychol, vol. 54, no. 6, pp. 816–827, Dec. 2019, doi: 10.1002/ijop.12535.
[2743]	K. Tigen et al., “Diffuse late gadolinium enhancement by cardiovascular magnetic resonance predicts significant intraventricular systolic dyssynchrony in patients with non-ischemic dilated cardiomyopathy,” J Am Soc Echocardiogr, vol. 23, no. 4, pp. 416–422, Apr. 2010, doi: 10.1016/j.echo.2009.12.022.
[2744]	C. Mekkaoui et al., “Diffusion MRI tractography of the developing human fetal heart,” PLoS ONE, vol. 8, no. 8, p. e72795, 2013, doi: 10.1371/journal.pone.0072795.
[2745]	K. Moriya, R. Shimada, and K. Ono, “Difluoroboron Chelation to Quinacridonequinone: A Synthetic Method for Air-Sensitive 6,13-Dihydroxyquinacridone via Boron Complexes,” Chem Asian J, vol. 14, no. 9, pp. 1452–1456, May 2019, doi: 10.1002/asia.201900219.
[2746]	L. Stødkilde, V. K. Damborg, H. Jørgensen, H. N. Lærke, and S. K. Jensen, “Digestibility of fractionated green biomass as protein source for monogastric animals,” Animal, vol. 13, no. 9, pp. 1817–1825, Sep. 2019, doi: 10.1017/S1751731119000156.
[2747]	D. Carmona-Gutierrez et al., “Digesting the crisis: autophagy and coronaviruses,” Microb Cell, vol. 7, no. 5, pp. 119–128, May 2020, doi: 10.15698/mic2020.05.715.
[2748]	D. A. Rew, “Digital knowledge,” Eur J Surg Oncol, vol. 28, no. 7, pp. 687–688, Nov. 2002, doi: 10.1053/ejso.2002.1341.
[2749]	E. Hoge, D. Bickham, and J. Cantor, “Digital Media, Anxiety, and Depression in Children,” Pediatrics, vol. 140, no. Suppl 2, pp. S76–S80, Nov. 2017, doi: 10.1542/peds.2016-1758G.
[2750]	K. Jäger and C. Vögtlin, “[Digital workflow with the Lava Chairside Oral Scanner C.O.S. and Lava technique],” Schweiz Monatsschr Zahnmed, vol. 122, no. 4, pp. 307–324, 2012.
[2751]	H. L. Bradlow and M. A. Zeligs, “Diindolylmethane (DIM) spontaneously forms from indole-3-carbinol (I3C) during cell culture experiments,” In Vivo, vol. 24, no. 4, pp. 387–391, Aug. 2010.
[2752]	I. Kimber, R. J. Dearman, and D. A. Basketter, “Diisocyanates, occupational asthma and IgE antibody: implications for hazard characterization,” J Appl Toxicol, vol. 34, no. 10, pp. 1073–1077, Oct. 2014, doi: 10.1002/jat.3041.
[2753]	M. C. Peden, M. E. Hammer, and I. J. Suñer, “DILUTE POVIDONE-IODINE PROPHYLAXIS MAINTAINS SAFETY WHILE IMPROVING PATIENT COMFORT AFTER INTRAVITREAL INJECTIONS,” Retina (Philadelphia, Pa.), vol. 39, no. 11, pp. 2219–2224, Nov. 2019, doi: 10.1097/IAE.0000000000002290.
[2754]	T. L. Turnbull, C. M. LaPrade, S. D. Smith, R. F. LaPrade, and C. A. Wijdicks, “Dimensional assessment of continuous loop cortical suspension devices and clinical implications for intraoperative button flipping and intratunnel graft length,” J. Orthop. Res., vol. 33, no. 9, pp. 1327–1331, Sep. 2015, doi: 10.1002/jor.22904.
[2755]	W.-L. Yim, O. Byl, J. T. Yates, and J. K. Johnson, “Dimensional effects on the LO-TO splitting in CF4: first-principles and infrared absorption studies,” J. Am. Chem. Soc., vol. 127, no. 9, pp. 3198–3206, Mar. 2005, doi: 10.1021/ja043540v.
[2756]	S. Rowe et al., “Dimensional measures of personality as a predictor of outcome at 5-year follow-up in women with bulimia nervosa,” Psychiatry Res, vol. 185, no. 3, pp. 414–420, Feb. 2011, doi: 10.1016/j.psychres.2010.07.017.
[2757]	A. H. Schuurs, H. J. Duivenvoorden, S. K. Thoden van Velzen, F. Verhage, P. C. Makkes, and M. A. Eijman, “Dimensionality of dental anxiety measurements,” Community Dent Oral Epidemiol, vol. 13, no. 3, pp. 152–155, Jun. 1985, doi: 10.1111/j.1600-0528.1985.tb00432.x.
[2758]	A.-K. Häfner et al., “Dimerization of human 5-lipoxygenase,” Biol. Chem., vol. 392, no. 12, pp. 1097–1111, Dec. 2011, doi: 10.1515/BC.2011.200.
[2759]	S. Manjooran and A. Major, “Diode-pumped 45 fs Yb:CALGO laser oscillator with 1.7  MW of peak power,” Opt Lett, vol. 43, no. 10, pp. 2324–2327, May 2018, doi: 10.1364/OL.43.002324.
[2760]	J. Jagadeesan, N. Nandakumar, T. Rengarajan, and M. P. Balasubramanian, “Diosgenin, a steroidal saponin, exhibits anticancer activity by attenuating lipid peroxidation via enhancing antioxidant defense system during NMU-induced breast carcinoma,” J. Environ. Pathol. Toxicol. Oncol., vol. 31, no. 2, pp. 121–129, 2012, doi: 10.1615/jenvironpatholtoxicoloncol.v31.i2.40.
[2761]	M. C. Petriello, J. B. Hoffman, O. Vsevolozhskaya, A. J. Morris, and B. Hennig, “Dioxin-like PCB 126 increases intestinal inflammation and disrupts gut microbiota and metabolic homeostasis,” Environ. Pollut., vol. 242, no. Pt A, pp. 1022–1032, Nov. 2018, doi: 10.1016/j.envpol.2018.07.039.
[2762]	L. Mathieu, F. Burgher, and A. H. Hall, “Diphoterine chemical splash decontamination solution: skin sensitization study in the guinea pig,” Cutan Ocul Toxicol, vol. 26, no. 3, pp. 181–187, 2007, doi: 10.1080/15569520701422030.
[2763]	J. Nehles, A. H. Hall, J. Blomet, and L. Mathieu, “Diphoterine for emergent decontamination of skin/eye chemical splashes: 24 cases,” Cutan Ocul Toxicol, vol. 25, no. 4, pp. 249–258, 2006, doi: 10.1080/15569520601013160.
[2764]	“Diphtheria vaccine: WHO position paper – August 2017,” Wkly. Epidemiol. Rec., vol. 92, no. 31, pp. 417–435, 04 2017.
[2765]	Y. Cakir and K. A. Hahn, “Direct action by doxycycline against canine osteosarcoma cell proliferation and collagenase (MMP-1) activity in vitro,” In Vivo, vol. 13, no. 4, pp. 327–331, Aug. 1999.
[2766]	J.-K. Han et al., “Direct conversion of adult skin fibroblasts to endothelial cells by defined factors,” Circulation, vol. 130, no. 14, pp. 1168–1178, Sep. 2014, doi: 10.1161/CIRCULATIONAHA.113.007727.
[2767]	P. Ye et al., “Direct loop gain and bandwidth measurement of phase-locked loop,” Rev Sci Instrum, vol. 88, no. 8, p. 084704, Aug. 2017, doi: 10.1063/1.4999648.
[2768]	D. Hou, J. Tian, F. Sun, and X. Huang, “Direct measurement of loop gain and bandwidth of phase-locked loop for mode-locked laser,” Opt Express, vol. 24, no. 15, pp. 17242–17249, Jul. 2016, doi: 10.1364/OE.24.017242.
[2769]	M. R. Williams and S. A. Hashsham, “Direct or DNA Extraction-Free Amplification and Quantification of Foodborne Pathogens,” Methods Mol. Biol., vol. 1918, pp. 21–33, 2019, doi: 10.1007/978-1-4939-9000-9_2.
[2770]	T. A. Williams, G. D. Leslie, L. Brearley, T. Leen, and K. O’Brien, “Discharge delay, room for improvement?,” Aust Crit Care, vol. 23, no. 3, pp. 141–149, Aug. 2010, doi: 10.1016/j.aucc.2010.02.003.
[2771]	A. Papa and C. Lefton, “Discharge Texting: The Evolution of ED Callbacks,” J Emerg Nurs, vol. 41, no. 4, pp. 345–346, Jul. 2015, doi: 10.1016/j.jen.2015.04.002.
[2772]	S. Rouis, S. Melki, H. Rouis, S. Nouira, A. Ben Abdelaziz, and A. Ben Abdelaziz, “Disciplinary and thematic mapping of Maghreb publications in ‘infectiology’. Bibliometric study (Tunisia, 2010-2014),” Tunis Med, vol. 97, no. 8–9, pp. 931–944, Sep. 2019.
[2773]	D. Grady and G. F. Sawaya, “Discontinuation of postmenopausal hormone therapy,” Am. J. Med., vol. 118 Suppl 12B, pp. 163–165, Dec. 2005, doi: 10.1016/j.amjmed.2005.09.051.
[2774]	J. K. Hammitt, “Discounting health and cost-effectiveness analysis: a response to Nord,” Health Econ, vol. 21, no. 7, pp. 878–882, Jul. 2012, doi: 10.1002/hec.1782.
[2775]	P. Bech and L. R. Olsen, “[Discovering depression],” Ugeskr. Laeg., vol. 163, no. 14, pp. 1980–1982, Apr. 2001.
[2776]	J. J. Liu et al., “Discovery and pharmacological characterization of a small-molecule antagonist at neuromedin U receptor NMUR2,” J. Pharmacol. Exp. Ther., vol. 330, no. 1, pp. 268–275, Jul. 2009, doi: 10.1124/jpet.109.152967.
[2777]	Y. Rew et al., “Discovery of a Potent and Selective Steroidal Glucocorticoid Receptor Antagonist (ORIC-101),” J. Med. Chem., vol. 61, no. 17, pp. 7767–7784, 13 2018, doi: 10.1021/acs.jmedchem.8b00743.
[2778]	Y. Rew and D. Sun, “Discovery of a small molecule MDM2 inhibitor (AMG 232) for treating cancer,” J. Med. Chem., vol. 57, no. 15, pp. 6332–6341, Aug. 2014, doi: 10.1021/jm500627s.
[2779]	N. C. Goodwin et al., “Discovery of a Type III Inhibitor of LIM Kinase 2 That Binds in a DFG-Out Conformation,” ACS Med Chem Lett, vol. 6, no. 1, pp. 53–57, Jan. 2015, doi: 10.1021/ml500242y.
[2780]	J. Tu et al., “Discovery of Carboline Derivatives as Potent Antifungal Agents for the Treatment of Cryptococcal Meningitis,” J. Med. Chem., vol. 62, no. 5, pp. 2376–2389, 14 2019, doi: 10.1021/acs.jmedchem.8b01598.
[2781]	A. Huttmann, “[Discovery of the electrical activity and conduction system of the heart],” Wien. Klin. Wochenschr., vol. 104, no. 5, pp. 124–129, 1992.
[2782]	T. W. Barrowcliffe, S. Raut, and A. R. Hubbard, “Discrepancies in potency assessment of recombinant FVIII concentrates,” Haemophilia, vol. 4, no. 4, pp. 634–640, Jul. 1998, doi: 10.1046/j.1365-2516.1998.440634.x.
[2783]	C. Chomienne, A. Chedeville, N. Balitrand, P. De Cremoux, J. P. Abita, and L. Degos, “Discrepancy between in vitro and in vivo passaged U-937 human leukemic cells: tumorigenicity and sensitivity to differentiating drugs,” In Vivo, vol. 2, no. 3–4, pp. 281–288, Aug. 1988.
[2784]	Y. Yokoi, H. Takano, M. Sakata, K. Maruo, K. Nakagome, and H. Matsuda, “Discrete effect of each mild behavioural impairment category on dementia conversion or cognitive decline in patients with mild cognitive impairment,” Psychogeriatrics, vol. 19, no. 6, pp. 591–600, Nov. 2019, doi: 10.1111/psyg.12447.
[2785]	F. Herzer, J. Wendt, and A. O. Hamm, “Discriminant validity of constructs derived from the self-regulative model for evaluation anxiety for predicting clinical manifestations of test anxiety,” Behav Res Ther, vol. 73, pp. 52–57, Oct. 2015, doi: 10.1016/j.brat.2015.07.012.
[2786]	S. Zhang et al., “Discriminating Origin Tissues of Tumor Cell Lines by Methylation Signatures and Dys-Methylated Rules,” Front Bioeng Biotechnol, vol. 8, p. 507, 2020, doi: 10.3389/fbioe.2020.00507.
[2787]	A. Omenetti et al., “Disease activity accounts for long-term efficacy of IL-1 blockers in pyogenic sterile arthritis pyoderma gangrenosum and severe acne syndrome,” Rheumatology (Oxford), vol. 55, no. 7, pp. 1325–1335, 2016, doi: 10.1093/rheumatology/kew031.
[2788]	D. Zhang and M. E. Raichle, “Disease and the brain’s dark energy,” Nat Rev Neurol, vol. 6, no. 1, pp. 15–28, Jan. 2010, doi: 10.1038/nrneurol.2009.198.
[2789]	P. Bross and P. Fernandez-Guerra, “Disease-Associated Mutations in the HSPD1 Gene Encoding the Large Subunit of the Mitochondrial HSP60/HSP10 Chaperonin Complex,” Front Mol Biosci, vol. 3, p. 49, 2016, doi: 10.3389/fmolb.2016.00049.
[2790]	A. Jawaid, R. Khan, M. Polymenidou, and P. E. Schulz, “Disease-modifying effects of metabolic perturbations in ALS/FTLD,” Mol Neurodegener, vol. 13, no. 1, p. 63, 04 2018, doi: 10.1186/s13024-018-0294-0.
[2791]	A. Porta et al., “Disentangling cardiovascular control mechanisms during head-down tilt via joint transfer entropy and self-entropy decompositions,” Front Physiol, vol. 6, p. 301, 2015, doi: 10.3389/fphys.2015.00301.
[2792]	K. J. Fritschie and J. D. Olden, “Disentangling the influences of mean body size and size structure on ecosystem functioning: an example of nutrient recycling by a non-native crayfish,” Ecol Evol, vol. 6, no. 1, pp. 159–169, Jan. 2016, doi: 10.1002/ece3.1852.
[2793]	O. Bayomy, S. Zaheer, J. S. Williams, G. Curhan, and A. Vaidya, “Disentangling the Relationships Between the Renin-Angiotensin-Aldosterone System, Calcium Physiology, and Risk for Kidney Stones,” J. Clin. Endocrinol. Metab., vol. 105, no. 6, Jun. 2020, doi: 10.1210/clinem/dgaa123.
[2794]	C. Briani, G. Zara, and P. Negrin, “Disopyramide-induced neuropathy,” Neurology, vol. 58, no. 4, p. 663, Feb. 2002, doi: 10.1212/wnl.58.4.663.
[2795]	Y. Endo, “[Disorders caused by the exposure to chemical compounds],” Nippon Rinsho, vol. 72, no. 2, pp. 216–220, Feb. 2014.
[2796]	R. L. Jamison and R. E. Oliver, “Disorders of urinary concentration and dilution,” Am. J. Med., vol. 72, no. 2, pp. 308–322, Feb. 1982, doi: 10.1016/0002-9343(82)90823-3.
[2797]	S.-L. Chen, M.-H. Zheng, T. Yang, M. Song, and Y.-P. Chen, “Disparate profiles of dys-regulated miRNAs in activated hepatic stellate cells,” Hepatology, vol. 57, no. 3, pp. 1285–1286, Mar. 2013, doi: 10.1002/hep.25975.
[2798]	R. W. Bergmark and A. R. Sedaghat, “Disparities in health in the United States: An overview of the social determinants of health for otolaryngologists,” Laryngoscope Investig Otolaryngol, vol. 2, no. 4, pp. 187–193, 2017, doi: 10.1002/lio2.81.
[2799]	N. K. Lowe, “Disparities in the Health of Women and Children,” J Obstet Gynecol Neonatal Nurs, vol. 47, no. 3, pp. 273–274, 2018, doi: 10.1016/j.jogn.2018.04.001.
[2800]	M. ApSimon, “Dispelling myths about intravenous fish oil-based lipid emulsions: a clinical perspective,” Curr Opin Clin Nutr Metab Care, vol. 21, no. 2, pp. 97–103, 2018, doi: 10.1097/MCO.0000000000000445.
[2801]	T. Pi-Sunyer, C. Zara, L. Moner, and J. M. Serena, “[Disposal of clinical waste: between safety and efficiency],” Med Clin (Barc), vol. 103, no. 20, pp. 782–786, Dec. 1994.
[2802]	M. Wang, Z. Zhao, and Y. Zhang, “Disposal of Fenton sludge with anaerobic digestion and the roles of humic acids involved in Fenton sludge,” Water Res., vol. 163, p. 114900, Oct. 2019, doi: 10.1016/j.watres.2019.114900.
[2803]	B. C. Bonning, V. K. Ward, M. M. van Meer, T. F. Booth, and B. D. Hammock, “Disruption of lysosomal targeting is associated with insecticidal potency of juvenile hormone esterase,” Proc. Natl. Acad. Sci. U.S.A., vol. 94, no. 12, pp. 6007–6012, Jun. 1997, doi: 10.1073/pnas.94.12.6007.
[2804]	B. Schwartz, E. Yeung, and D. Meinke, “Disruption of morphogenesis and transformation of the suspensor in abnormal suspensor mutants of Arabidopsis,” Development, vol. 120, no. 11, pp. 3235–3245, 1994.
[2805]	A. A. Smith, R. O. Craft, A. M. Rebecca, and S. F. M. Duncan, “Dissatisfied hand surgeons: What causes them to change jobs?,” Hand (N Y), vol. 1, no. 1, pp. 14–18, Jun. 2006, doi: 10.1007/s11552-006-9000-8.
[2806]	M. Goozner, “Dissecting the president’s budget. Crucial agencies would barely keep up with inflation under Obama’s plan,” Mod Healthc, vol. 43, no. 15, p. 25, Apr. 2013.
[2807]	L. A. Cope, “Dissection of the hippocampus proper and the associated structures in preserved horse brains,” J Undergrad Neurosci Educ, vol. 9, no. 1, pp. A43-46, 2010.
[2808]	N. Abdel-Haq, W. Abuhammour, H. Al-Tatari, and B. Asmar, “Disseminated cat scratch disease with vertebral osteomyelitis and epidural abscess,” South. Med. J., vol. 98, no. 11, pp. 1142–1145, Nov. 2005, doi: 10.1097/01.SMJ.0000163305.50078.63.
[2809]	R. Jayadevappa, B. S. Bloom, D. B. Raziano, and R. Lavizzo-Mourey, “Dissemination and characteristics of acute care for elders (ACE) units in the United States,” Int J Technol Assess Health Care, vol. 19, no. 1, pp. 220–227, 2003, doi: 10.1017/s0266462303000205.
[2810]	P. W. Roelvink, M. M. van Meer, C. A. de Kort, R. D. Possee, B. D. Hammock, and J. M. Vlak, “Dissimilar expression of Autographa californica multiple nucleocapsid nuclear polyhedrosis virus polyhedrin and p10 genes,” J. Gen. Virol., vol. 73 ( Pt 6), pp. 1481–1489, Jun. 1992, doi: 10.1099/0022-1317-73-6-1481.
[2811]	D. R. Shukla, B. F. Morrey, A. R. Thoreson, K.-N. An, and S. W. O’Driscoll, “Distal biceps tendon rupture: an in vitro study,” Clin Biomech (Bristol, Avon), vol. 27, no. 3, pp. 263–267, Mar. 2012, doi: 10.1016/j.clinbiomech.2011.09.010.
[2812]	J. Miksovska, P. Maróti, J. Tandori, M. Schiffer, D. K. Hanson, and P. Sebban, “Distant electrostatic interactions modulate the free energy level of QA- in the photosynthetic reaction center,” Biochemistry, vol. 35, no. 48, pp. 15411–15417, Dec. 1996, doi: 10.1021/bi961299u.
[2813]	M. W. Hamblin, R. W. McGuffin, M. A. Metcalf, D. M. Dorsa, and K. M. Merchant, “Distinct 5-HT(1B) and 5-HT(1D) serotonin receptors in rat: Structural and pharmacological comparison of the two cloned receptors,” Mol. Cell. Neurosci., vol. 3, no. 6, pp. 578–587, Dec. 1992, doi: 10.1016/1044-7431(92)90070-i.
[2814]	S. Li et al., “Distinct functions of neuromedin u and neuromedin s in orange-spotted grouper,” J. Mol. Endocrinol., vol. 55, no. 2, pp. 95–106, Oct. 2015, doi: 10.1530/JME-15-0018.
[2815]	S.-S. Weiterer et al., “Distinct IL-1α-responsive enhancers promote acute and coordinated changes in chromatin topology in a hierarchical manner,” EMBO J., vol. 39, no. 1, p. e101533, 02 2020, doi: 10.15252/embj.2019101533.
[2816]	C.-Y. Yao et al., “Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS),” Oncotarget, vol. 7, no. 39, pp. 63177–63188, Sep. 2016, doi: 10.18632/oncotarget.11050.
[2817]	R. Jahn, “Distinguished scientists back Germany’s DFG..,” Nature, vol. 404, no. 6781, p. 922, Apr. 2000, doi: 10.1038/35010145.
[2818]	O. Taubman-Ben-Ari, M. Chasson, S. Abu Sharkia, and E. Weiss, “Distress and anxiety associated with COVID-19 among Jewish and Arab pregnant women in Israel,” J Reprod Infant Psychol, vol. 38, no. 3, pp. 340–348, Jul. 2020, doi: 10.1080/02646838.2020.1786037.
[2819]	N. Flory and E. V. Lang, “Distress in the radiology waiting room,” Radiology, vol. 260, no. 1, pp. 166–173, Jul. 2011, doi: 10.1148/radiol.11102211.
[2820]	S. Stisi, C. Venditti, and I. Sarracco, “[Distress influence in fibromyalgia],” Reumatismo, vol. 60, no. 4, pp. 274–281, Dec. 2008, doi: 10.4081/reumatismo.2008.274.
[2821]	D. Killian et al., “Distribution changes of epithelial dendritic cells in canine cornea and mucous membranes related to hematopoietic stem cell transplantation,” In Vivo, vol. 27, no. 6, pp. 761–771, Dec. 2013.
[2822]	A. M. Kinsey, A. Wainwright, R. Heavens, D. J. Sirinathsinghji, and K. R. Oliver, “Distribution of 5-ht(5A), 5-ht(5B), 5-ht(6) and 5-HT(7) receptor mRNAs in the rat brain,” Brain Res. Mol. Brain Res., vol. 88, no. 1–2, pp. 194–198, Mar. 2001, doi: 10.1016/s0169-328x(01)00034-1.
[2823]	W. L. Shelver, S. J. Lupton, N. W. Shappell, D. J. Smith, and H. Hakk, “Distribution of Chemical Residues among Fat, Skim, Curd, Whey, and Protein Fractions in Fortified, Pasteurized Milk,” ACS Omega, vol. 3, no. 8, pp. 8697–8708, Aug. 2018, doi: 10.1021/acsomega.8b00762.
[2824]	K. Sato, T. Kurita, S.-I. Chitose, K. Sato, H. Umeno, and H. Yano, “Distribution of label-retaining cells and their properties in the vocal fold mucosa,” Laryngoscope Investig Otolaryngol, vol. 4, no. 1, pp. 76–82, Feb. 2019, doi: 10.1002/lio2.219.
[2825]	W. Ju, J. Shen, M. Toro, S. Zhao, and J. Meng, “Distribution of pathogenicity islands OI-122, OI-43/48, and OI-57 and a high-pathogenicity island in Shiga toxin-producing Escherichia coli,” Appl. Environ. Microbiol., vol. 79, no. 11, pp. 3406–3412, Jun. 2013, doi: 10.1128/AEM.03661-12.
[2826]	K. Zhang, R. Chen, A. R. Alberts, G. Zhu, Y. Sun, and M. J. Roobol, “Distribution of Prostate Imaging Reporting and Data System score and diagnostic accuracy of magnetic resonance imaging-targeted biopsy: comparison of an Asian and European cohort,” Prostate Int, vol. 7, no. 3, pp. 96–101, Sep. 2019, doi: 10.1016/j.prnil.2018.10.001.
[2827]	T. N. Lan, P. H. Son, L. V. Trung, N. T. H. Tu, M. Keifer, and S. Barnhart, “Distribution of silica-exposed workers by province and industry in Vietnam,” Int J Occup Environ Health, vol. 9, no. 2, pp. 128–133, Jun. 2003, doi: 10.1179/oeh.2003.9.2.128.
[2828]	A. Ansari, S. Y. Ho, and R. H. Anderson, “Distribution of the Purkinje fibres in the sheep heart,” Anat. Rec., vol. 254, no. 1, pp. 92–97, 1999, doi: 10.1002/(SICI)1097-0185(19990101)254:1<92::AID-AR12>3.0.CO;2-3.
[2829]	V. I. Spoormaker and P. Montgomery, “Disturbed sleep in post-traumatic stress disorder: secondary symptom or core feature?,” Sleep Med Rev, vol. 12, no. 3, pp. 169–184, Jun. 2008, doi: 10.1016/j.smrv.2007.08.008.
[2830]	N. Papageorgiou et al., “Divergent anti-inflammatory effects of different oil acute consumption on healthy individuals,” Eur J Clin Nutr, vol. 65, no. 4, pp. 514–519, Apr. 2011, doi: 10.1038/ejcn.2011.8.
[2831]	K. Sadtler et al., “Divergent immune responses to synthetic and biological scaffolds,” Biomaterials, vol. 192, pp. 405–415, 2019, doi: 10.1016/j.biomaterials.2018.11.002.
[2832]	M. A. Rosero et al., “Divergent mechanisms for regulating growth and development after imaginal disc damage in the tobacco hornworm, Manduca sexta,” J. Exp. Biol., vol. 222, no. Pt 20, 15 2019, doi: 10.1242/jeb.200352.
[2833]	Y. Yu et al., “Divergent Responses of the Diazotrophic Microbiome to Elevated CO2 in Two Rice Cultivars,” Front Microbiol, vol. 9, p. 1139, 2018, doi: 10.3389/fmicb.2018.01139.
[2834]	V. I. Holden and M. A. Bachman, “Diverging roles of bacterial siderophores during infection,” Metallomics, vol. 7, no. 6, pp. 986–995, Jun. 2015, doi: 10.1039/c4mt00333k.
[2835]	J. Gulli, E. Cook, E. Kroll, A. Rosebrock, A. Caudy, and F. Rosenzweig, “Diverse conditions support near-zero growth in yeast: Implications for the study of cell lifespan,” Microb Cell, vol. 6, no. 9, pp. 397–413, Aug. 2019, doi: 10.15698/mic2019.09.690.
[2836]	M. S. Shajib, A. Baranov, and W. I. Khan, “Diverse Effects of Gut-Derived Serotonin in Intestinal Inflammation,” ACS Chem Neurosci, vol. 8, no. 5, pp. 920–931, 17 2017, doi: 10.1021/acschemneuro.6b00414.
[2837]	E. F. Boyd and D. L. Hartl, “Diversifying selection governs sequence polymorphism in the major adhesin proteins fimA, papA, and sfaA of Escherichia coli,” J. Mol. Evol., vol. 47, no. 3, pp. 258–267, Sep. 1998, doi: 10.1007/pl00006383.
[2838]	C. D. Klink et al., “Diversion stoma after colorectal surgery: loop colostomy or ileostomy?,” Int J Colorectal Dis, vol. 26, no. 4, pp. 431–436, Apr. 2011, doi: 10.1007/s00384-010-1123-2.
[2839]	J. J. M. Hathaway, R. L. Sinsabaugh, M. D. L. N. E. Dapkevicius, and D. E. Northup, “Diversity of Ammonia Oxidation (amoA) and Nitrogen Fixation (nifH) Genes in Lava Caves of Terceira, Azores, Portugal,” Geomicrobiol. J., vol. 31, no. 3, pp. 221–235, 2014, doi: 10.1080/01490451.2012.752424.
[2840]	E. O’Brien et al., “Diversity of DNA viruses in effluents of membrane bioreactors in Traverse City, MI (USA) and La Grande Motte (France),” Water Res., vol. 111, pp. 338–345, 15 2017, doi: 10.1016/j.watres.2017.01.014.
[2841]	V. A. Bradshaw and K. McEntee, “DNA damage activates transcription and transposition of yeast Ty retrotransposons,” Mol. Gen. Genet., vol. 218, no. 3, pp. 465–474, Sep. 1989, doi: 10.1007/BF00332411.
[2842]	Y.-C. Hung, D. M. Bauer, I. Ahmed, and L. Fruk, “DNA from natural sources in design of functional devices,” Methods, vol. 67, no. 2, pp. 105–115, May 2014, doi: 10.1016/j.ymeth.2014.03.003.
[2843]	H.-L. Sung and D. J. Nesbitt, “DNA Hairpin Hybridization under Extreme Pressures: A Single-Molecule FRET Study,” J Phys Chem B, vol. 124, no. 1, pp. 110–120, 09 2020, doi: 10.1021/acs.jpcb.9b10131.
[2844]	H. Mano, “DNA micro-array analysis of myelodysplastic syndrome,” Leuk. Lymphoma, vol. 47, no. 1, pp. 9–14, Jan. 2006, doi: 10.1080/10428190500264231.
[2845]	D. A. Rew, “DNA microarray technology in cancer research,” Eur J Surg Oncol, vol. 27, no. 5, pp. 504–508, Aug. 2001, doi: 10.1053/ejso.2001.1116.
[2846]	G. Bardai, P. Moffatt, F. H. Glorieux, and F. Rauch, “DNA sequence analysis in 598 individuals with a clinical diagnosis of osteogenesis imperfecta: diagnostic yield and mutation spectrum,” Osteoporos Int, vol. 27, no. 12, pp. 3607–3613, 2016, doi: 10.1007/s00198-016-3709-1.
[2847]	K. Denich et al., “DNA sequences of three papA genes from uropathogenic Escherichia coli strains: evidence of structural and serological conservation,” Infect. Immun., vol. 59, no. 11, pp. 3849–3858, Nov. 1991, doi: 10.1128/IAI.59.11.3849-3858.1991.
[2848]	M. Zuccarini, A. Guarini, S. Savini, G. Faldella, and A. Sansavini, “Do 6-Month Motor Skills Have Cascading Effects on 12-Month Motor and Cognitive Development in Extremely Preterm and Full-Term Infants?,” Front Psychol, vol. 11, p. 1297, 2020, doi: 10.3389/fpsyg.2020.01297.
[2849]	C. Bourdais, A. Danis, C. Bacle, A. Santolini, and C. Tijus, “Do 10- and 13-month-old infants provide informative gestures for their mothers in a hiding game?,” Infant Behav Dev, vol. 36, no. 1, pp. 94–101, Feb. 2013, doi: 10.1016/j.infbeh.2012.11.006.
[2850]	C. Gosse and M. Van Reybroeck, “Do children with dyslexia present a handwriting deficit? Impact of word orthographic and graphic complexity on handwriting and spelling performance,” Res Dev Disabil, vol. 97, p. 103553, Feb. 2020, doi: 10.1016/j.ridd.2019.103553.
[2851]	P. Hoet, L. Desvallées, and D. Lison, “Do current OELs for silica protect from obstructive lung impairment? A critical review of epidemiological data,” Crit. Rev. Toxicol., vol. 47, no. 8, pp. 650–677, Sep. 2017, doi: 10.1080/10408444.2017.1315363.
[2852]	J. D. Andersen, M. H. Bünger, O. Rahbek, J. D. Hald, T. Harsløf, and B. L. Langdahl, “Do femoral fractures in adult patients with osteogenesis imperfecta imitate atypical femoral fractures? A case series,” Osteoporos Int, vol. 30, no. 2, pp. 513–517, Feb. 2019, doi: 10.1007/s00198-018-4769-1.
[2853]	H. Samuelsen, B. P. Tersbøl, and S. S. Mbuyita, “Do health systems delay the treatment of poor children? A qualitative study of child deaths in rural Tanzania,” BMC Health Serv Res, vol. 13, p. 67, Feb. 2013, doi: 10.1186/1472-6963-13-67.
[2854]	S. M. Snedeker and A. G. Hay, “Do interactions between gut ecology and environmental chemicals contribute to obesity and diabetes?,” Environ. Health Perspect., vol. 120, no. 3, pp. 332–339, Mar. 2012, doi: 10.1289/ehp.1104204.
[2855]	G. Scano, G. Innocenti-Bruni, and L. Stendardi, “Do obstructive and restrictive lung diseases share common underlying mechanisms of breathlessness?,” Respir Med, vol. 104, no. 7, pp. 925–933, Jul. 2010, doi: 10.1016/j.rmed.2010.02.019.
[2856]	N. R. Ju and A. Koyfman, “Do oral antibiotics after incision and drainage of simple abscesses improve cure rates?,” Ann Emerg Med, vol. 65, no. 1, pp. 112–113, Jan. 2015, doi: 10.1016/j.annemergmed.2014.08.007.
[2857]	C. E. A. Chagas, J. P. Roque, B. Santarosa Emo Peters, M. Lazaretti-Castro, and L. A. Martini, “Do patients with osteogenesis imperfecta need individualized nutritional support?,” Nutrition, vol. 28, no. 2, pp. 138–142, Feb. 2012, doi: 10.1016/j.nut.2011.04.003.
[2858]	N. Pavenik, “Do pharmaceutical prices respond to potential patient out-of-pocket expenses?,” Rand J Econ, vol. 33, no. 3, pp. 469–487, 2002.
[2859]	A. M. Kanner, “Do psychiatric comorbidities have a negative impact on the course and treatment of seizure disorders?,” Curr. Opin. Neurol., vol. 26, no. 2, pp. 208–213, Apr. 2013, doi: 10.1097/WCO.0b013e32835ee579.
[2860]	A. Eklund, G. Bergström, L. Bodin, and I. Axén, “Do psychological and behavioral factors classified by the West Haven-Yale Multidimensional Pain Inventory (Swedish version) predict the early clinical course of low back pain in patients receiving chiropractic care?,” BMC Musculoskelet Disord, vol. 17, p. 75, Feb. 2016, doi: 10.1186/s12891-016-0933-y.
[2861]	T. Renouf, A. Leary, and T. Wiseman, “Do psychological interventions reduce preoperative anxiety?,” Br J Nurs, vol. 23, no. 22, pp. 1208–1212, Jan. 2014, doi: 10.12968/bjon.2014.23.22.1208.
[2862]	A. Falace, N. Vanni, A. Mallamaci, P. Striano, and F. Zara, “Do regulatory regions matter in FOXG1 duplications?,” Eur. J. Hum. Genet., vol. 21, no. 4, pp. 365–366, Apr. 2013, doi: 10.1038/ejhg.2012.142.
[2863]	J. T. Bram, K. Pirruccio, J. T. Aoyama, J. Ahn, T. J. Ganley, and J. M. Flynn, “Do Year-Out Programs Make Medical Students More Competitive Candidates for Orthopedic Surgery Residencies?,” J Surg Educ, Jun. 2020, doi: 10.1016/j.jsurg.2020.05.008.
[2864]	J. V. Welie, “Do you have a healthy smile?,” Med Health Care Philos, vol. 2, no. 2, pp. 169–180, 1999, doi: 10.1023/a:1009997219023.
[2865]	J. N. James, K. B. Frazier, S. W. Looney, A. Sinha, and A. B. Faigen, “Does a Difference Exists in Comprehensive Basic Science Examination Scores of 4-Year versus 6-Year Oral-Maxillofacial Surgery Residents?,” J. Oral Maxillofac. Surg., Apr. 2020, doi: 10.1016/j.joms.2020.04.007.
[2866]	J. Remue, C. Baeken, and R. De Raedt, “Does a single neurostimulation session really affect mood in healthy individuals? A systematic review,” Neuropsychologia, vol. 85, pp. 184–198, 2016, doi: 10.1016/j.neuropsychologia.2016.03.012.
[2867]	L. B. Pedersen, T. Allen, F. B. Waldorff, and M. K. K. Andersen, “Does accreditation affect the job satisfaction of general practitioners? A combined panel data survey and cluster randomised field experiment,” Health Policy, vol. 124, no. 8, pp. 849–855, Aug. 2020, doi: 10.1016/j.healthpol.2020.04.002.
[2868]	A. Abdalla, M. Adhaduk, R. A. Haddad, Y. Alnimer, C. F. Ríos-Bedoya, and G. Bachuwa, “Does acute care for the elderly (ACE) unit decrease the incidence of falls?,” Geriatr Nurs, vol. 39, no. 3, pp. 292–295, Jun. 2018, doi: 10.1016/j.gerinurse.2017.10.011.
[2869]	J. Frand, A. Borislavsky, M. Boaz, Z. Matas, and M. Shargorodsky, “Does adiponectin level explain the atherogenic properties of Hp 2-2 phenotype in type 2 diabetic patients?,” Atherosclerosis, vol. 226, no. 1, pp. 146–148, Jan. 2013, doi: 10.1016/j.atherosclerosis.2012.10.053.
[2870]	C. N. Matthews, A. F. Chen, T. Daryoush, R. H. Rothman, M. G. Maltenfort, and W. J. Hozack, “Does an Elastic Compression Bandage Provide Any Benefit After Primary TKA?,” Clin. Orthop. Relat. Res., vol. 477, no. 1, pp. 134–144, 2019, doi: 10.1097/CORR.0000000000000459.
[2871]	R. H. Rosenman, “Does anxiety or cardiovascular reactivity have a causal role in hypertension?,” Integr Physiol Behav Sci, vol. 26, no. 4, pp. 296–304, Dec. 1991, doi: 10.1007/BF02691065.
[2872]	C. Pedone et al., “Does aspirin attenuate the beneficial effect of ACE inhibitors in elderly people with heart failure?,” Drugs Aging, vol. 22, no. 7, pp. 605–614, 2005, doi: 10.2165/00002512-200522070-00006.
[2873]	S. Papa, “Does cAMP play a part in the regulation of the mitochondrial electron transport chain in mammalian cells?,” IUBMB Life, vol. 58, no. 3, pp. 173–175, Mar. 2006, doi: 10.1080/15216540500494516.
[2874]	R. L. Melnick, “Does chemically induced hepatocyte proliferation predict liver carcinogenesis?,” FASEB J., vol. 6, no. 9, pp. 2698–2706, Jun. 1992, doi: 10.1096/fasebj.6.9.1612294.
[2875]	V. M. Loaiza and V. Camos, “Does Controlling for Temporal Parameters Change the Levels-of-Processing Effect in Working Memory?,” Adv Cogn Psychol, vol. 12, no. 1, pp. 2–9, 2016, doi: 10.5709/acp-0182-3.
[2876]	L. C. Baker, M. K. Bundorf, and D. P. Kessler, “Does health plan generosity enhance hospital market power?,” J Health Econ, vol. 44, pp. 54–62, Dec. 2015, doi: 10.1016/j.jhealeco.2015.08.007.
[2877]	A. Islam et al., “Does Helicobacter pylori exist in vocal fold pathologies and in the interarytenoid region?,” Dysphagia, vol. 28, no. 3, pp. 382–387, Sep. 2013, doi: 10.1007/s00455-012-9444-7.
[2878]	E. B. Foa, L. A. Zoellner, N. C. Feeny, E. A. Hembree, and J. Alvarez-Conrad, “Does imaginal exposure exacerbate PTSD symptoms?,” J Consult Clin Psychol, vol. 70, no. 4, pp. 1022–1028, Aug. 2002, doi: 10.1037//0022-006x.70.4.1022.
[2879]	M. L. Slovak, M. O’Donnell, D. D. Smith, and K. Gaal, “Does MDS with der(1;7)(q10;p10) constitute a distinct risk group? A retrospective single institutional analysis of clinical/pathologic features compared to -7/del(7q) MDS,” Cancer Genet. Cytogenet., vol. 193, no. 2, pp. 78–85, Sep. 2009, doi: 10.1016/j.cancergencyto.2009.04.013.
[2880]	R. L. Hansen, B. L. Langdahl, P. H. Jørgensen, K. K. Petersen, K. Søballe, and M. Stilling, “Does migration of osseointegrated implants for transfemoral amputees predict later revision? A prospective 2-year radiostereometric analysis with 5-years clinical follow-up,” Orthop Traumatol Surg Res, vol. 105, no. 5, pp. 1013–1020, 2019, doi: 10.1016/j.otsr.2019.05.010.
[2881]	Y. Wang, W. Xu, C. Zhuang, and X. Liu, “Does Mind Wandering Mediate the Association Between Mindfulness and Negative Mood? A Preliminary Study,” Psychol Rep, vol. 120, no. 1, pp. 118–129, Feb. 2017, doi: 10.1177/0033294116686036.
[2882]	K. G. Raphael and M. Cloitre, “Does mood-congruence or causal search govern recall bias? A test of life event recall,” J Clin Epidemiol, vol. 47, no. 5, pp. 555–564, May 1994, doi: 10.1016/0895-4356(94)90302-6.
[2883]	J. Snaedal, “Does my older cancer patient have cognitive impairment?,” J Geriatr Oncol, vol. 9, no. 3, pp. 183–185, 2018, doi: 10.1016/j.jgo.2017.11.010.
[2884]	P. Wu and J. Xu, “Does OsPHR2, central pi-signaling regulator, regulate some unknown factors crucial for plant growth?,” Plant Signal Behav, vol. 5, no. 6, pp. 712–714, Jun. 2010, doi: 10.4161/psb.5.6.11645.
[2885]	A. M. Osmolak, C. N. Klatt-Cromwell, A. M. Price, J. A. Sanclement, and G. A. Krempl, “Does perioperative oxandrolone improve nutritional status in patients with cachexia related to head and neck carcinoma?,” Laryngoscope Investig Otolaryngol, vol. 4, no. 3, pp. 314–318, Jun. 2019, doi: 10.1002/lio2.268.
[2886]	A. Goff, E. Rose, S. Rose, and D. Purves, “Does PTSD occur in sentenced prison populations? A systematic literature review,” Crim Behav Ment Health, vol. 17, no. 3, pp. 152–162, 2007, doi: 10.1002/cbm.653.
[2887]	P. Kaczmarek et al., “Does somatostatin confer insulinostatic effects of neuromedin u in the rat pancreas?,” Pancreas, vol. 38, no. 2, pp. 208–212, Mar. 2009, doi: 10.1097/MPA.0b013e31818d9095.
[2888]	C. E. Sharoky et al., “Does Surgeon Sex Matter?: Practice Patterns and Outcomes of Female and Male Surgeons,” Ann. Surg., vol. 267, no. 6, pp. 1069–1076, 2018, doi: 10.1097/SLA.0000000000002460.
[2889]	R. Wellmon, “Does the attentional demands of walking differ for older men and women living independently in the community?,” J Geriatr Phys Ther, vol. 35, no. 2, pp. 55–61, Jun. 2012, doi: 10.1519/JPT.0b013e31822ad40b.
[2890]	B. J. Dyson, L. Forder, and J. Sundvall, “Does the Brain’s Reward Response Occur Even Without Actual Reward? A Response to Fielding et al. (2017),” J Gambl Stud, vol. 34, no. 3, pp. 853–861, Sep. 2018, doi: 10.1007/s10899-018-9746-2.
[2891]	W. A. Craig, “Does the dose matter?,” Clin. Infect. Dis., vol. 33 Suppl 3, pp. S233-237, Sep. 2001, doi: 10.1086/321854.
[2892]	K. R. Theis et al., “Does the human placenta delivered at term have a microbiota? Results of cultivation, quantitative real-time PCR, 16S rRNA gene sequencing, and metagenomics,” Am. J. Obstet. Gynecol., vol. 220, no. 3, p. 267.e1-267.e39, 2019, doi: 10.1016/j.ajog.2018.10.018.
[2893]	B. B. Kirley, A. Feller, E. Braver, and P. Langenberg, “Does the Maryland graduated driver licensing law affect both 16-year-old drivers and those who share the road with them?,” J Safety Res, vol. 39, no. 3, pp. 295–301, 2008, doi: 10.1016/j.jsr.2007.12.005.
[2894]	C. H. Lineweaver and T. M. Davis, “Does the rapid appearance of life on Earth suggest that life is common in the universe?,” Astrobiology, vol. 2, no. 3, pp. 293–304, 2002, doi: 10.1089/153110702762027871.
[2895]	G. Pantvaidya, A. Mishra, A. Deshmukh, P. S. Pai, and A. D’Cruz, “Does the recurrent laryngeal nerve recover function after initial dysfunction in patients undergoing thyroidectomy?,” Laryngoscope Investig Otolaryngol, vol. 3, no. 3, pp. 249–252, Jun. 2018, doi: 10.1002/lio2.167.
[2896]	N. M. Korteland et al., “Does the Use of a Decision Aid Improve Decision Making in Prosthetic Heart Valve Selection? A Multicenter Randomized Trial,” Circ Cardiovasc Qual Outcomes, vol. 10, no. 2, 2017, doi: 10.1161/CIRCOUTCOMES.116.003178.
[2897]	M. Howman and M. Jones, “Does undertaking an intercalated BSc influence first clinical year exam results at a London medical school?,” BMC Med Educ, vol. 11, p. 6, Feb. 2011, doi: 10.1186/1472-6920-11-6.
[2898]	B. J. Donato and T. R. Gibson, “Does your clinical investigator understand the consequences of non-compliance?,” Qual Assur, vol. 7, no. 3, pp. 135–145, Sep. 1999, doi: 10.1080/105294100750035116.
[2899]	D. R. McLeod, A. K. C. Leung, and A. Y. F. Kong, “Dominantly inherited lop ears,” Am. J. Med. Genet. A, vol. 146A, no. 10, p. 1368, May 2008, doi: 10.1002/ajmg.a.32237.
[2900]	A. G. W. Hunter, “Dominantly-inherited lop ears,” Am. J. Med. Genet. A, vol. 146A, no. 7, p. 944, Apr. 2008, doi: 10.1002/ajmg.a.32234.
[2901]	A. K. C. Leung, A. Y. F. Kong, W. L. M. Robson, and D. R. McLeod, “Dominantly-inherited lop ears,” Am. J. Med. Genet. A, vol. 143A, no. 19, pp. 2330–2333, Oct. 2007, doi: 10.1002/ajmg.a.31933.
[2902]	V. S. Lazarev and S. A. Nazarovets, “Don’t dismiss citations to journals not published in English,” Nature, vol. 556, no. 7700, p. 174, 2018, doi: 10.1038/d41586-018-04169-2.
[2903]	F. Thurm et al., “Dopamine modulation of spatial navigation memory in Parkinson’s disease,” Neurobiol. Aging, vol. 38, pp. 93–103, Feb. 2016, doi: 10.1016/j.neurobiolaging.2015.10.019.
[2904]	“Dose-effect modifying factors in radiation protection. Report of Subcommittee M-4 (Relative Biological Effectiveness) of the National Commission on Radiation Protection. BNL-50073 (T-471),” Tech Rep Brookhaven Natl Lab, pp. 1–34, May 1966.
[2905]	D. S. Miller, G. Yiu, E. T. Hellriegel, and J. Steinfeld, “Dose-ranging study of salmeterol using a novel fluticasone propionate/salmeterol multidose dry powder inhaler in patients with persistent asthma,” Allergy Asthma Proc, vol. 37, no. 4, pp. 291–301, Jul. 2016, doi: 10.2500/aap.2016.37.3963.
[2906]	J. Visser et al., “Dosimetric comparison of library of plans and online MRI-guided radiotherapy of cervical cancer in the presence of intrafraction anatomical changes,” Radiat Oncol, vol. 14, no. 1, p. 126, Jul. 2019, doi: 10.1186/s13014-019-1322-0.
[2907]	G. J. De Vries and P. A. Boyle, “Double duty for sex differences in the brain,” Behav. Brain Res., vol. 92, no. 2, pp. 205–213, May 1998, doi: 10.1016/s0166-4328(97)00192-7.
[2908]	L. Pezzani et al., “Double homozygosity in CEP57 and DYNC2H1 genes detected by WES: Composite or expanded phenotype?,” Mol Genet Genomic Med, vol. 8, no. 3, p. e1064, 2020, doi: 10.1002/mgg3.1064.
[2909]	M. Shigeno, K. Sasaki, K. Nozawa-Kumada, and Y. Kondo, “Double-Carboxylation of Two C-H Bonds in 2-Alkylheteroarenes Using LiO- t-Bu/CsF,” Org. Lett., vol. 21, no. 12, pp. 4515–4519, 21 2019, doi: 10.1021/acs.orglett.9b01386.
[2910]	E. Head, A. M. Helman, D. Powell, and F. A. Schmitt, “Down syndrome, beta-amyloid and neuroimaging,” Free Radic. Biol. Med., vol. 114, pp. 102–109, 2018, doi: 10.1016/j.freeradbiomed.2017.09.013.
[2911]	N. Seltenrich, “Down to Earth: The Emerging Field of Planetary Health,” Environ. Health Perspect., vol. 126, no. 7, p. 072001, 2018, doi: 10.1289/EHP2374.
[2912]	D. Gao, R. P. Huibers, A. E. Loonen, R. G. Visser, A.-M. A. Wolters, and Y. Bai, “Down-regulation of acetolactate synthase compromises Ol-1- mediated resistance to powdery mildew in tomato,” BMC Plant Biol., vol. 14, p. 32, Jan. 2014, doi: 10.1186/1471-2229-14-32.
[2913]	S. Zhao et al., “Downregulation of MMP1 in MDS-derived mesenchymal stromal cells reduces the capacity to restrict MDS cell proliferation,” Sci Rep, vol. 7, p. 43849, 06 2017, doi: 10.1038/srep43849.
[2914]	D. H. W. Lau et al., “Doxazosin and serotonin (5-HT) receptor (1A, 2A, and 4) antagonists inhibit 5-HT-mediated human cavernosal contraction,” J. Androl., vol. 27, no. 5, pp. 679–685, Oct. 2006, doi: 10.2164/jandrol.106.000547.
[2915]	P. E. Ganey, L. S. Carter, R. A. Mueller, and R. G. Thurman, “Doxorubicin toxicity in perfused rat heart. Decreased cell death at low oxygen tension,” Circ. Res., vol. 68, no. 6, pp. 1610–1613, Jun. 1991, doi: 10.1161/01.res.68.6.1610.
[2916]	S. Binsaleh and K. C. Lo, “Dr. Lo’s rebuttal,” Can Urol Assoc J, vol. 1, no. 3, p. 282, Sep. 2007.
[2917]	“Dracunculiasis eradication:  global surveillance summary,  2014,” Wkly. Epidemiol. Rec., vol. 90, no. 19, pp. 201–215, May 2015.
[2918]	“Dracunculiasis eradication: global surveillance summary, 2015,” Wkly. Epidemiol. Rec., vol. 91, no. 17, pp. 219–236, Apr. 2016.
[2919]	“Dracunculiasis eradication: global surveillance summary, 2016,” Wkly. Epidemiol. Rec., vol. 92, no. 20, pp. 269–286, 19 2017.
[2920]	J. L. Gonzalez-Pimentel, V. Jurado, B. Hermosin, and C. Saiz-Jimenez, “Draft Genome Sequences of Two Streptomyces Strains, MZ03-37T and MZ03-48, Isolated from Lava Tube Speleothems,” Microbiol Resour Announc, vol. 9, no. 25, Jun. 2020, doi: 10.1128/MRA.00576-20.
[2921]	P. Striano et al., “Dramatic response to levetiracetam in post-ischaemic Holmes’ tremor,” J. Neurol. Neurosurg. Psychiatry, vol. 78, no. 4, pp. 438–439, Apr. 2007, doi: 10.1136/jnnp.2006.103275.
[2922]	M. S. W. Milne et al., “Drip ’n Ship Versus Mothership for Endovascular Treatment: Modeling the Best Transportation Options for Optimal Outcomes,” Stroke, vol. 48, no. 3, pp. 791–794, 2017, doi: 10.1161/STROKEAHA.116.015321.
[2923]	J. K. Holodinsky, T. S. Williamson, N. Kamal, D. Mayank, M. D. Hill, and M. Goyal, “Drip and Ship Versus Direct to Comprehensive Stroke Center: Conditional Probability Modeling,” Stroke, vol. 48, no. 1, pp. 233–238, 2017, doi: 10.1161/STROKEAHA.116.014306.
[2924]	F. Essl et al., “Drivers of future alien species impacts: An expert-based assessment,” Glob Chang Biol, Jul. 2020, doi: 10.1111/gcb.15199.
[2925]	O. da Silva Rabêlo and A. S. S. de Azevedo Melo, “Drivers of multidimensional eco-innovation: empirical evidence from the Brazilian industry,” Environ Technol, vol. 40, no. 19, pp. 2556–2566, Aug. 2019, doi: 10.1080/09593330.2018.1447022.
[2926]	H. M. Zinzow and S. M. Jeffirs, “Driving Aggression and Anxiety: Intersections, Assessment, and Interventions,” J Clin Psychol, vol. 74, no. 1, pp. 43–82, Jan. 2018, doi: 10.1002/jclp.22494.
[2927]	J. Y. Kang and S. Mintzer, “Driving and Epilepsy: a Review of Important Issues,” Curr Neurol Neurosci Rep, vol. 16, no. 9, p. 80, 2016, doi: 10.1007/s11910-016-0677-y.
[2928]	K. Y. Kang and J. H. Ju, “Drs. Kang and Ju reply,” J. Rheumatol., vol. 43, no. 3, p. 678, Mar. 2016, doi: 10.3899/jrheum.151268.
[2929]	W. H. De Jong and P. J. A. Borm, “Drug delivery and nanoparticles:applications and hazards,” Int J Nanomedicine, vol. 3, no. 2, pp. 133–149, 2008, doi: 10.2147/ijn.s596.
[2930]	I. Takeuchi, Y. Koshi, and K. Makino, “Drug Delivery Properties of Nanocomposite Particles for Inhalation: Comparison of Drug Concentrations in Lungs and Blood,” In Vivo, vol. 34, no. 2, pp. 543–547, Apr. 2020, doi: 10.21873/invivo.11806.
[2931]	R. D. Heilman, “Drug development history, ‘overview,’ and what are GCPs?,” Qual Assur, vol. 4, no. 1, pp. 75–79, Mar. 1995.
[2932]	P. Sun and K. Liu, “Drug-drug Interactions of Angiotensin Converting Enzyme Inhibitors Mediated by Metabolizing Enzymes and Transporters,” Curr. Drug Metab., vol. 19, no. 13, pp. 1119–1129, 2018, doi: 10.2174/1389200219666180730163953.
[2933]	B. P. Binks, T. Sekine, and A. T. Tyowua, “Dry oil powders and oil foams stabilised by fluorinated clay platelet particles,” Soft Matter, vol. 10, no. 4, pp. 578–589, Jan. 2014, doi: 10.1039/c3sm52748d.
[2934]	A. Animut and Y. Negash, “Dry season occurrence of Anopheles mosquitoes and implications in Jabi Tehnan District, West Gojjam Zone, Ethiopia,” Malar. J., vol. 17, no. 1, p. 445, Nov. 2018, doi: 10.1186/s12936-018-2599-4.
[2935]	P. Ossola, C. De Panfilis, M. Tonna, D. Ardissino, and C. Marchesi, “DS14 is more likely to measure depression rather than a personality disposition in patients with acute coronary syndrome,” Scand J Psychol, vol. 56, no. 6, pp. 685–692, Dec. 2015, doi: 10.1111/sjop.12244.
[2936]	B. Huot et al., “Dual impact of elevated temperature on plant defence and bacterial virulence in Arabidopsis,” Nat Commun, vol. 8, no. 1, p. 1808, 27 2017, doi: 10.1038/s41467-017-01674-2.
[2937]	J. Zhao, J. Fan, H. Tian, and M. Hu, “Dual-mode and two-signal-wavelength femtosecond optical parametric oscillator based on LiB3O5,” Opt Lett, vol. 45, no. 14, pp. 3985–3988, Jul. 2020, doi: 10.1364/OL.397032.
[2938]	G. Cao et al., “Dually Prewetted Underwater Superoleophobic and under Oil Superhydrophobic Fabric for Successive Separation of Light Oil/Water/Heavy Oil Three-Phase Mixtures,” ACS Appl Mater Interfaces, vol. 9, no. 41, pp. 36368–36376, Oct. 2017, doi: 10.1021/acsami.7b08997.
[2939]	D. Blazer, W. Bradford, and C. Reilly, “Duke’s 3rd year: a 35-year retrospective,” Teach Learn Med, vol. 13, no. 3, pp. 192–198, 2001, doi: 10.1207/S15328015TLM1303_9.
[2940]	B. J. Hillman, “Duplicate Publication,” J Am Coll Radiol, vol. 13, no. 1, p. 4, Jan. 2016, doi: 10.1016/j.jacr.2015.10.007.
[2941]	C. Sukontapol, S. Kemsen, S. Chansirikarn, D. Nakawiro, O. Kuha, and U. Taemeeyapradit, “DUPLICATE: The effectiveness of a cognitive training program in people with mild cognitive impairment: A study in urban community,” Asian J Psychiatr, vol. 35, pp. 61–66, 2018, doi: 10.1016/j.ajp.2018.05.019.
[2942]	T. K. Patel et al., “Dural lymphatics regulate clearance of extracellular tau from the CNS,” Mol Neurodegener, vol. 14, no. 1, p. 11, 27 2019, doi: 10.1186/s13024-019-0312-x.
[2943]	S. S. Upadhyay, M. J. Saji, and A. C. Yau, “Duration of antituberculosis chemotherapy in conjunction with radical surgery in the management of spinal tuberculosis,” Spine, vol. 21, no. 16, pp. 1898–1903, Aug. 1996, doi: 10.1097/00007632-199608150-00014.
[2944]	V. G. Kulikov, S. G. Domnin, L. I. Tartakovskaia, and O. F. Roslyĭ, “[Dust as a factor in crystalline silicon production],” Med Tr Prom Ekol, no. 8, pp. 6–9, 1999.
[2945]	D. Cressey, “Dust regulations trigger backlash,” Nature, vol. 507, no. 7490, p. 18, Mar. 2014, doi: 10.1038/507018a.
[2946]	A. M. Al-Etaibi and M. A. El-Apasery, “Dyeing Performance of Disperse Dyes on Polyester Fabrics Using Eco-Friendly Carrier and Their Antioxidant and Anticancer Activities,” Int J Environ Res Public Health, vol. 16, no. 23, 20 2019, doi: 10.3390/ijerph16234603.
[2947]	V. Bercier et al., “Dynactin1 depletion leads to neuromuscular synapse instability and functional abnormalities,” Mol Neurodegener, vol. 14, no. 1, p. 27, 10 2019, doi: 10.1186/s13024-019-0327-3.
[2948]	H. Moriyama, S. Tomita, and G. Watanabe, “Dynamic evaluation of the loop technique using the U-Clip,” Asian Cardiovasc Thorac Ann, vol. 22, no. 2, pp. 160–164, Feb. 2014, doi: 10.1177/0218492313478215.
[2949]	B. C. Boettger et al., “Dynamic of High-Risk Acinetobacter baumannii Major Clones in a Brazilian Tertiary Hospital During a Short Time Period,” Microb. Drug Resist., Aug. 2020, doi: 10.1089/mdr.2020.0195.
[2950]	M. Lin, K. Tang, and X. Yao, “Dynamic sampling approach to training neural networks for multiclass imbalance classification,” IEEE Trans Neural Netw Learn Syst, vol. 24, no. 4, pp. 647–660, Apr. 2013, doi: 10.1109/TNNLS.2012.2228231.
[2951]	G. K. Paink et al., “Dynamic Self-Repairing Hybrid Liquid-in-Solid Protective Barrier for Cementitious Materials,” ACS Appl Mater Interfaces, vol. 12, no. 28, pp. 31922–31932, Jul. 2020, doi: 10.1021/acsami.0c06357.
[2952]	G. A. King, T. A. A. Oliver, and M. N. R. Ashfold, “Dynamical insights into (1)pi sigma(*) state mediated photodissociation of aniline,” J Chem Phys, vol. 132, no. 21, p. 214307, Jun. 2010, doi: 10.1063/1.3427544.
[2953]	L. P. Izakova, “[Dynamics of glycogen in cells cultured in vitro],” Tsitologiia, vol. 4, pp. 427–433, Aug. 1962.
[2954]	T. Severin, H. P. Bacosa, A. Sato, and D. L. Erdner, “Dynamics of Heterocapsa sp. and the associated attached and free-living bacteria under the influence of dispersed and undispersed crude oil,” Lett. Appl. Microbiol., vol. 63, no. 6, pp. 419–425, Dec. 2016, doi: 10.1111/lam.12661.
[2955]	D. Fischer, G. Erben, G. Dunst, and B. Glaser, “Dynamics of labile and stable carbon and priming effects during composting of sludge and lop mixtures amended with low and high amounts of biochar,” Waste Manag, vol. 78, pp. 880–893, Aug. 2018, doi: 10.1016/j.wasman.2018.06.056.
[2956]	W. G. Cooper and I. R. Konigsberg, “Dynamics of myogenesis in vitro,” Anat. Rec., vol. 140, pp. 195–205, Jul. 1961, doi: 10.1002/ar.1091400305.
[2957]	Z. Sieglová et al., “Dynamics of telomere erosion and its association with genome instability in myelodysplastic syndromes (MDS) and acute myelogenous leukemia arising from MDS: a marker of disease prognosis?,” Leuk. Res., vol. 28, no. 10, pp. 1013–1021, Oct. 2004, doi: 10.1016/j.leukres.2003.11.020.
[2958]	Q. Liu, S. Wang, B. Li, and W. Zhang, “Dynamics, differences, influencing factors of eco-efficiency in China: A spatiotemporal perspective analysis,” J. Environ. Manage., vol. 264, p. 110442, Jun. 2020, doi: 10.1016/j.jenvman.2020.110442.
[2959]	A. Betz, G. Bässler, G. Dietl, X. Steil, G. Weyermann, and W. Pflug, “DYS STR analysis with epithelial cells in a rape case,” Forensic Sci. Int., vol. 118, no. 2–3, pp. 126–130, May 2001, doi: 10.1016/s0379-0738(00)00482-5.
[2960]	H. Warnatz, “[Dys- and parapproteinoses],” Fortschr. Med., vol. 91, no. 17, pp. 735–741, Jun. 1973.
[2961]	L.-Q. Yu, G.-L. Gao, F.-J. Liu, and Q.-J. Zeng, “Dys-psychological Stress Effect on Expressions of P53 and NFκBp65 in Human Ovarian Carcinoma In Vivo,” Chin. J. Cancer Res., vol. 24, no. 3, pp. 245–248, Sep. 2012, doi: 10.1007/s11670-012-0245-1.
[2962]	O. W. Guthrie, “Dys-synchronous regulation of XPC and XPA in trigeminal ganglion neurons following cisplatin treatment cycles,” Anticancer Res., vol. 28, no. 5A, pp. 2637–2640, Oct. 2008.
[2963]	F. Papaleo et al., “Dysbindin-1 modulates prefrontal cortical activity and schizophrenia-like behaviors via dopamine/D2 pathways,” Mol. Psychiatry, vol. 17, no. 1, pp. 85–98, Jan. 2012, doi: 10.1038/mp.2010.106.
[2964]	B. M. Nathan et al., “Dysglycemia and Index60 as Prediagnostic End Points for Type 1 Diabetes Prevention Trials,” Diabetes Care, vol. 40, no. 11, pp. 1494–1499, 2017, doi: 10.2337/dc17-0916.
[2965]	Y.-J. Yang et al., “Dysgonomonas macrotermitis sp. nov., isolated from the hindgut of a fungus-growing termite,” Int. J. Syst. Evol. Microbiol., vol. 64, no. Pt 9, pp. 2956–2961, Sep. 2014, doi: 10.1099/ijs.0.061739-0.
[2966]	G. Meckenstock et al., “Dyshematopoiesis in de novo acute myeloid leukemia: cell biological features and prognostic significance,” Leuk. Lymphoma, vol. 29, no. 5–6, pp. 523–531, May 1998, doi: 10.3109/10428199809050912.
[2967]	K. M. Hellman et al., “Dysmenorrhea subtypes exhibit differential quantitative sensory assessment profiles,” Pain, vol. 161, no. 6, pp. 1227–1236, 2020, doi: 10.1097/j.pain.0000000000001826.
[2968]	D. P. Steensma, “Dysplasia has A differential diagnosis: distinguishing genuine myelodysplastic syndromes (MDS) from mimics, imitators, copycats and impostors,” Curr Hematol Malig Rep, vol. 7, no. 4, pp. 310–320, Dec. 2012, doi: 10.1007/s11899-012-0140-3.
[2969]	E. M. Buhl et al., “Dysregulated mesenchymal PDGFR-β drives kidney fibrosis,” EMBO Mol Med, vol. 12, no. 3, p. e11021, Mar. 2020, doi: 10.15252/emmm.201911021.
[2970]	P. Mistry et al., “Dysregulated neutrophil responses and neutrophil extracellular trap formation and degradation in PAPA syndrome,” Ann. Rheum. Dis., vol. 77, no. 12, pp. 1825–1833, 2018, doi: 10.1136/annrheumdis-2018-213746.
[2971]	G. R. Jeong et al., “Dysregulated phosphorylation of Rab GTPases by LRRK2 induces neurodegeneration,” Mol Neurodegener, vol. 13, no. 1, p. 8, 13 2018, doi: 10.1186/s13024-018-0240-1.
[2972]	O. Taghli-Lamallem et al., “Dystrophin deficiency in Drosophila reduces lifespan and causes a dilated cardiomyopathy phenotype,” Aging Cell, vol. 7, no. 2, pp. 237–249, Mar. 2008, doi: 10.1111/j.1474-9726.2008.00367.x.
[2973]	S. Sulpizio and R. Job, “Early and multiple-loci divergency of proper and common names: An event-related potential investigation,” Neuropsychologia, vol. 119, pp. 107–117, 2018, doi: 10.1016/j.neuropsychologia.2018.07.034.
[2974]	E. Çaglar, N. Topcuoglu, H. Ozbey, N. Sandalli, and G. Kulekci, “Early Colonization of Lactobacillus reuteri after Exposure to Probiotics,” J Clin Pediatr Dent, vol. 39, no. 4, pp. 326–330, 2015, doi: 10.17796/1053-4628-39.4.326.
[2975]	D. Wendling, P. Claudepierre, and C. Prati, “Early diagnosis and management are crucial in spondyloarthritis,” Joint Bone Spine, vol. 80, no. 6, pp. 582–585, Dec. 2013, doi: 10.1016/j.jbspin.2013.03.003.
[2976]	Y. Miura et al., “Early diagnosis of lymph node metastasis: Importance of intranodal pressures,” Cancer Sci., vol. 107, no. 3, pp. 224–232, Mar. 2016, doi: 10.1111/cas.12873.
[2977]	B. Bourdon, M. Touboul, G. Caro, and T. Kleine, “Early differentiation of the Earth and the Moon,” Philos Trans A Math Phys Eng Sci, vol. 366, no. 1883, pp. 4105–4128, Nov. 2008, doi: 10.1098/rsta.2008.0125.
[2978]	K. S. Choi, S. H. Kim, S. G. Kim, and J. K. Han, “Early Gastric Cancers: Is CT Surveillance Necessary after Curative Endoscopic Submucosal Resection for Cancers That Meet the Expanded Criteria?,” Radiology, vol. 281, no. 2, pp. 444–453, Nov. 2016, doi: 10.1148/radiol.2016152866.
[2979]	Y. Gao, X. Zhang, Y. Yang, and W. Li, “Early haemoperfusion with continuous venovenous haemofiltration improves survival of acute paraquat-poisoned patients,” J. Int. Med. Res., vol. 43, no. 1, pp. 26–32, Feb. 2015, doi: 10.1177/0300060514549782.
[2980]	M. Suárez-Calvet et al., “Early increase of CSF sTREM2 in Alzheimer’s disease is associated with tau related-neurodegeneration but not with amyloid-β pathology,” Mol Neurodegener, vol. 14, no. 1, p. 1, 10 2019, doi: 10.1186/s13024-018-0301-5.
[2981]	J. Sosna et al., “Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer’s disease,” Mol Neurodegener, vol. 13, no. 1, p. 11, 01 2018, doi: 10.1186/s13024-018-0244-x.
[2982]	F. Fang et al., “Early pacing-induced systolic dyssynchrony is a strong predictor of left ventricular adverse remodeling: analysis from the Pacing to Avoid Cardiac Enlargement (PACE) trial,” Int. J. Cardiol., vol. 168, no. 2, pp. 723–728, Sep. 2013, doi: 10.1016/j.ijcard.2012.08.005.
[2983]	A. Haehner, A. Habersack, M. Wienecke, A. Storch, H. Reichmann, and T. Hummel, “Early Parkinson’s disease patients on rasagiline present with better odor discrimination,” J Neural Transm (Vienna), vol. 122, no. 11, pp. 1541–1546, Nov. 2015, doi: 10.1007/s00702-015-1433-1.
[2984]	T. L. Carper, M. A. Mills, M. M. Steenkamp, A. Nickerson, K. Salters-Pedneault, and B. T. Litz, “Early PTSD symptom sub-clusters predicting chronic posttraumatic stress following sexual assault,” Psychol Trauma, vol. 7, no. 5, pp. 442–447, Sep. 2015, doi: 10.1037/tra0000060.
[2985]	W. D. Chey, L. S. Dove, D. A. Andrae, and P. S. Covington, “Early response predicts a sustained response to eluxadoline in patients with irritable bowel syndrome with diarrhoea in two Phase 3 studies,” Aliment. Pharmacol. Ther., vol. 45, no. 10, pp. 1319–1328, May 2017, doi: 10.1111/apt.14031.
[2986]	M. M. Schoels, U. Landesmann, F. Alasti, D. Baker, J. S. Smolen, and D. Aletaha, “Early response to therapy predicts 6-month and 1-year disease activity outcomes in psoriatic arthritis patients,” Rheumatology (Oxford), vol. 57, no. 6, pp. 969–976, 01 2018, doi: 10.1093/rheumatology/key004.
[2987]	A. Li, W. Li, F. Hao, and H. Wang, “Early Stage Blood Purification for Paraquat Poisoning: A Multicenter Retrospective Study,” Blood Purif., vol. 42, no. 2, pp. 93–99, 2016, doi: 10.1159/000445991.
[2988]	L. Oliver, R. Lepeule, A. Moussafeur, A. Fiore, P. Lim, and J. Ternacle, “Early surgery in infective endocarditis: Why should we wait?,” Arch Cardiovasc Dis, vol. 109, no. 12, pp. 651–654, Dec. 2016, doi: 10.1016/j.acvd.2016.10.002.
[2989]	S. Blinkhorn, “Early US immigrants were tested for cognitive impairment, not IQ,” Nature, vol. 574, no. 7776, p. 36, 2019, doi: 10.1038/d41586-019-02925-6.
[2990]	N. Brima et al., “Early virological response to HIV treatment: can we predict who is likely to experience subsequent treatment failure? Results from an observational cohort study, London, UK,” J Int AIDS Soc, vol. 20, no. 1, p. 21567, 30 2017, doi: 10.7448/IAS.20.21567.
[2991]	“Early warning, alert and response system in emergencies: a field experience of a novel WHO project in north-east Nigeria,” Wkly. Epidemiol. Rec., vol. 92, no. 5, pp. 45–50, 03 2017.
[2992]	A. Wójtowicz, M. Zembala-Szczerba, D. Babczyk, M. Kołodziejczyk-Pietruszka, O. Lewaczyńska, and H. Huras, “Early- and Late-Onset Preeclampsia: A Comprehensive Cohort Study of Laboratory and Clinical Findings according to the New ISHHP Criteria,” Int J Hypertens, vol. 2019, p. 4108271, 2019, doi: 10.1155/2019/4108271.
[2993]	E. Theodorakopoulou et al., “Early- and late-onset psoriasis: a cross-sectional clinical and immunocytochemical investigation,” Br. J. Dermatol., vol. 175, no. 5, pp. 1038–1044, Nov. 2016, doi: 10.1111/bjd.14886.
[2994]	P. Kirk, “Earmuff effectiveness against chainsaw noise over a 12-month period,” Appl Ergon, vol. 24, no. 4, pp. 279–283, Aug. 1993, doi: 10.1016/0003-6870(93)90463-j.
[2995]	T. D. Robinson et al., “Earth as an extrasolar planet: Earth model validation using EPOXI earth observations,” Astrobiology, vol. 11, no. 5, pp. 393–408, Jun. 2011, doi: 10.1089/ast.2011.0642.
[2996]	C. Marzban, R. Viswanathan, and U. Yurtsever, “Earth before life,” Biol. Direct, vol. 9, p. 1, Jan. 2014, doi: 10.1186/1745-6150-9-1.
[2997]	J. M. Turner and A. C. Isenberg, “Earth Day at 50,” Science, vol. 368, no. 6488, p. 215, Apr. 2020, doi: 10.1126/science.abc1967.
[2998]	I. Katz, L. Shtirberg, G. Shakour, and A. Blank, “Earth field NMR with chemical shift spectral resolution: theory and proof of concept,” J. Magn. Reson., vol. 219, pp. 13–24, Jun. 2012, doi: 10.1016/j.jmr.2012.04.011.
[2999]	L. D. Leet, “Earth motion from the atomic bomb test,” Am. Sci., vol. 34, pp. 198–211, Apr. 1946.
[3000]	J. M. D. Day, “Earth science: Extraordinary world,” Nature, vol. 537, no. 7620, pp. 310–311, 15 2016, doi: 10.1038/537310a.
[3001]	L. J. Rothschild, “Earth science: Life battered but unbowed,” Nature, vol. 459, no. 7245, pp. 335–336, May 2009, doi: 10.1038/459335a.
[3002]	J. T. Perron and J. G. Venditti, “Earth science: Megafloods downsized,” Nature, vol. 538, no. 7624, pp. 174–175, 13 2016, doi: 10.1038/538174a.
[3003]	B. Scaillet and F. Gaillard, “Earth science: Redox state of early magmas,” Nature, vol. 480, no. 7375, pp. 48–49, Nov. 2011, doi: 10.1038/480048a.
[3004]	J. Lawton, “Earth system science,” Science, vol. 292, no. 5524, p. 1965, Jun. 2001, doi: 10.1126/science.292.5524.1965.
[3005]	D. Shweiki, “Earth--moon evolution: implications for the mechanism of the biological clock?,” Med. Hypotheses, vol. 56, no. 4, pp. 547–551, Apr. 2001, doi: 10.1054/mehy.2000.1259.
[3006]	R. V. White, “Earth’s biggest ‘whodunnit’: unravelling the clues in the case of the end-Permian mass extinction,” Philos Trans A Math Phys Eng Sci, vol. 360, no. 1801, pp. 2963–2985, Dec. 2002, doi: 10.1098/rsta.2002.1097.
[3007]	“Earth’s boundaries?,” Nature, vol. 461, no. 7263, pp. 447–448, Sep. 2009, doi: 10.1038/461447b.
[3008]	F. B. Estabrook, “Earth’s crust: A toast to the deep-drilling idea,” Nature, vol. 530, no. 7588, p. 33, Feb. 2016, doi: 10.1038/530033e.
[3009]	S. McMahon, “Earth’s earliest and deepest purported fossils may be iron-mineralized chemical gardens,” Proc. Biol. Sci., vol. 286, no. 1916, p. 20192410, 04 2019, doi: 10.1098/rspb.2019.2410.
[3010]	K. Zahnle, L. Schaefer, and B. Fegley, “Earth’s earliest atmospheres,” Cold Spring Harb Perspect Biol, vol. 2, no. 10, p. a004895, Oct. 2010, doi: 10.1101/cshperspect.a004895.
[3011]	M. Brasier, O. Green, J. Lindsay, and A. Steele, “Earth’s oldest (approximately 3.5 Ga) fossils and the ‘Early Eden hypothesis’: questioning the evidence,” Orig Life Evol Biosph, vol. 34, no. 1–2, pp. 257–269, Feb. 2004, doi: 10.1023/b:orig.0000009845.62244.d3.
[3012]	C. T. Reinhard, N. J. Planavsky, S. L. Olson, T. W. Lyons, and D. H. Erwin, “Earth’s oxygen cycle and the evolution of animal life,” Proc. Natl. Acad. Sci. U.S.A., vol. 113, no. 32, pp. 8933–8938, 09 2016, doi: 10.1073/pnas.1521544113.
[3013]	C. Houser, “Earth’s rugged lower mantle,” Science, vol. 363, no. 6428, pp. 696–697, 15 2019, doi: 10.1126/science.aaw4601.
[3014]	J. C. E. Irving, “Earth’s soft heart,” Science, vol. 362, no. 6412, p. 294, 19 2018, doi: 10.1126/science.aav2296.
[3015]	N. Fierer, “Earthworms’ place on Earth,” Science, vol. 366, no. 6464, pp. 425–426, 25 2019, doi: 10.1126/science.aaz5670.
[3016]	D. T. Carrell and M. Simoni, “‘Easier ways to get a publication’: the problem of low quality scientific publications,” Andrology, vol. 6, no. 1, pp. 1–2, Jan. 2018, doi: 10.1111/andr.12460.
[3017]	S. Kim and G. Ju, “Eastern Medicine Needs Substantiation by Scientific Research,” Med Acupunct, vol. 31, no. 3, p. 141, Jun. 2019, doi: 10.1089/acu.2019.1333.
[3018]	J. T. Avila, N. H. Golden, and T. Aye, “Eating Disorder Screening in Transgender Youth,” J Adolesc Health, vol. 65, no. 6, pp. 815–817, 2019, doi: 10.1016/j.jadohealth.2019.06.011.
[3019]	C. Willem et al., “Eating in case of emotion dys-regulation, depression and anxiety: Different pathways to emotional eating in moderate and severe obesity,” Clin Obes, p. e12388, Jul. 2020, doi: 10.1111/cob.12388.
[3020]	“Ebola virus disease (EVD) in  West Africa: an extraordinary  epidemic,” Wkly. Epidemiol. Rec., vol. 90, no. 10, pp. 89–96, Mar. 2015.
[3021]	Z. Li and M. Ma, “ECG Modeling with DFG,” Conf Proc IEEE Eng Med Biol Soc, vol. 2005, pp. 2691–2694, 2005, doi: 10.1109/IEMBS.2005.1617025.
[3022]	J. Tomcsányi, Z. Nényei, A. Kelemen, and A. Kamondi, “[ECG pearl: tonic-clonic seizure detected by implantable loop recorder],” Orv Hetil, vol. 160, no. 29, pp. 1143–1145, Jul. 2019, doi: 10.1556/650.2019.31460.
[3023]	S. Tanghe, S. Millet, and S. De Smet, “Echium oil and linseed oil as alternatives for fish oil in the maternal diet: Blood fatty acid profiles and oxidative status of sows and piglets,” J. Anim. Sci., vol. 91, no. 7, pp. 3253–3264, Jul. 2013, doi: 10.2527/jas.2012-5874.
[3024]	K. S. Al-Senaidi, I. Ullah, H. Javad, M. Al-Khabori, and S. Al-Yaarubi, “Echocardiographic Evidence of Early Diastolic Dysfunction in Asymptomatic Children with Osteogenesis Imperfecta,” Sultan Qaboos Univ Med J, vol. 15, no. 4, pp. e456-462, Nov. 2015, doi: 10.18295/squmj.2015.15.04.003.
[3025]	L. Kamiński, E. Płońska, A. Szyszka, M. Peregud, and R. Olszewski, “[Echocardiographic examination of cardiac structure and function in male athletes of static and dynamic disciplines],” Pol. Merkur. Lekarski, vol. 20, no. 117, pp. 274–278, Mar. 2006.
[3026]	A. Srinivasan et al., “Echocardiographic linear fractional shortening for quantification of right ventricular systolic function-A cardiac magnetic resonance validation study,” Echocardiography, vol. 34, no. 3, pp. 348–358, Mar. 2017, doi: 10.1111/echo.13438.
[3027]	W. Braksator, W. Król, A. Mamcarz, H. Krysztofiak, K. Wrzosek, and M. Dłuzniewski, “[Echocardiographic picture of Polish Olympic Team--Athens 2004],” Prz. Lek., vol. 63, no. 2, pp. 53–57, 2006.
[3028]	G. L. Fialho, A. G. Pagani, P. Wolf, R. Walz, and K. Lin, “Echocardiographic risk markers of sudden death in patients with temporal lobe epilepsy,” Epilepsy Res., vol. 140, pp. 192–197, 2018, doi: 10.1016/j.eplepsyres.2018.01.016.
[3029]	Y. Kim, I. Lee, and S. Kang, “Eco Assist Techniques through Real-time Monitoring of BEV Energy Usage Efficiency,” Sensors (Basel), vol. 15, no. 7, pp. 14946–14959, Jun. 2015, doi: 10.3390/s150714946.
[3030]	J. M. Rosenberg and P. Greene, “Eco RI* specificity and hydrogen bonding,” DNA, vol. 1, no. 2, pp. 117–124, 1982, doi: 10.1089/dna.1.1982.1.117.
[3031]	M. Jonell, M. Phillips, P. Rönnbäck, and M. Troell, “Eco-certification of farmed seafood: will it make a difference?,” Ambio, vol. 42, no. 6, pp. 659–674, Oct. 2013, doi: 10.1007/s13280-013-0409-3.
[3032]	W. Shang, Y. Gong, Z. Wang, and M. J. Stewardson, “Eco-compensation in China: Theory, practices and suggestions for the future,” J. Environ. Manage., vol. 210, pp. 162–170, Mar. 2018, doi: 10.1016/j.jenvman.2017.12.077.
[3033]	M. Gannotti, “Eco-cultural frameworks and childhood disability: a case study from Puerto Rico,” Physiother Theory Pract, vol. 22, no. 3, pp. 137–151, Jun. 2006, doi: 10.1080/09593980600732363.
[3034]	P. Saling, “Eco-Efficiency Analysis of biotechnological processes,” Appl. Microbiol. Biotechnol., vol. 68, no. 1, pp. 1–8, Jul. 2005, doi: 10.1007/s00253-005-1951-0.
[3035]	R. D. Magarey, S. S. Klammer, T. M. Chappell, C. M. Trexler, G. R. Pallipparambil, and E. F. Hain, “Eco-efficiency as a strategy for optimizing the sustainability of pest management,” Pest Manag. Sci., vol. 75, no. 12, pp. 3129–3134, Dec. 2019, doi: 10.1002/ps.5560.
[3036]	J. Sorvari, R. Antikainen, M.-L. Kosola, P. Hokkanen, and T. Haavisto, “Eco-efficiency in contaminated land management in Finland: barriers and development needs,” J. Environ. Manage., vol. 90, no. 5, pp. 1715–1727, Apr. 2009, doi: 10.1016/j.jenvman.2008.11.002.
[3037]	O. Michelsen, A. M. Fet, and A. Dahlsrud, “Eco-efficiency in extended supply chains: a case study of furniture production,” J. Environ. Manage., vol. 79, no. 3, pp. 290–297, May 2006, doi: 10.1016/j.jenvman.2005.07.007.
[3038]	T. J. Hengen, H. L. Sieverding, N. A. Cole, J. M. Ham, and J. J. Stone, “Eco-Efficiency Model for Evaluating Feedlot Rations in the Great Plains, United States,” J. Environ. Qual., vol. 45, no. 4, pp. 1234–1242, Jul. 2016, doi: 10.2134/jeq2015.09.0464.
[3039]	J.-S. Mao, R. Zeng, Y.-C. Du, and P. Jiang, “[Eco-efficiency of industry sectors for China],” Huan Jing Ke Xue, vol. 31, no. 11, pp. 2788–2794, Nov. 2010.
[3040]	Y. Du, P. Jiang, J. Mao, and L. Xu, “[Eco-efficiency of Jiaozuo industry sectors],” Huan Jing Ke Xue, vol. 32, no. 5, pp. 1529–1536, May 2011.
[3041]	R. E. Miller, “Eco-epidemiology as anti-terrorism,” Int Q Community Health Educ, vol. 26, no. 3, pp. 307–317, 2007 2006, doi: 10.2190/IQ.26.3.g.
[3042]	L. E. Bain and P. K. Awah, “Eco-epidemiology: challenges and opportunities for tomorrow’s epidemiologists,” Pan Afr Med J, vol. 17, p. 317, 2014, doi: 10.11604/pamj.2014.17.317.4080.
[3043]	P. Bizouarn, “[Eco-epidemiology: towards epidemiology of complexity],” Med Sci (Paris), vol. 32, no. 5, pp. 500–505, May 2016, doi: 10.1051/medsci/20163205018.
[3044]	M. J. Wittmann and T. Fukami, “Eco-Evolutionary Buffering: Rapid Evolution Facilitates Regional Species Coexistence despite Local Priority Effects,” Am. Nat., vol. 191, no. 6, pp. E171–E184, 2018, doi: 10.1086/697187.
[3045]	I. Hanski, “Eco-evolutionary dynamics in a changing world,” Ann. N. Y. Acad. Sci., vol. 1249, pp. 1–17, Feb. 2012, doi: 10.1111/j.1749-6632.2011.06419.x.
[3046]	J. Frickel, M. Sieber, and L. Becks, “Eco-evolutionary dynamics in a coevolving host-virus system,” Ecol. Lett., vol. 19, no. 4, pp. 450–459, Apr. 2016, doi: 10.1111/ele.12580.
[3047]	N. Loeuille, “Eco-evolutionary dynamics in a disturbed world: implications for the maintenance of ecological networks,” F1000Res, vol. 8, 2019, doi: 10.12688/f1000research.15629.1.
[3048]	M. Alberti, “Eco-evolutionary dynamics in an urbanizing planet,” Trends Ecol. Evol. (Amst.), vol. 30, no. 2, pp. 114–126, Feb. 2015, doi: 10.1016/j.tree.2014.11.007.
[3049]	K. I. Harrington and A. Sanchez, “Eco-evolutionary dynamics of complex social strategies in microbial communities,” Commun Integr Biol, vol. 7, no. 1, p. e28230, Jan. 2014, doi: 10.4161/cib.28230.
[3050]	M. K. Burak, J. D. Monk, and O. J. Schmitz, “Eco-Evolutionary Dynamics: The Predator-Prey Adaptive Play and the Ecological Theater,” Yale J Biol Med, vol. 91, no. 4, pp. 481–489, 2018.
[3051]	S. Patel and R. Bürger, “Eco-evolutionary feedbacks between prey densities and linkage disequilibrium in the predator maintain diversity,” Evolution, vol. 73, no. 8, pp. 1533–1548, 2019, doi: 10.1111/evo.13785.
[3052]	W. W. Driscoll, J. D. Hackett, and R. Ferrière, “Eco-evolutionary feedbacks between private and public goods: evidence from toxic algal blooms,” Ecol. Lett., vol. 19, no. 1, pp. 81–97, Jan. 2016, doi: 10.1111/ele.12533.
[3053]	D. M. Post and E. P. Palkovacs, “Eco-evolutionary feedbacks in community and ecosystem ecology: interactions between the ecological theatre and the evolutionary play,” Philos. Trans. R. Soc. Lond., B, Biol. Sci., vol. 364, no. 1523, pp. 1629–1640, Jun. 2009, doi: 10.1098/rstb.2009.0012.
[3054]	I. A. Hanski, “Eco-evolutionary spatial dynamics in the Glanville fritillary butterfly,” Proc. Natl. Acad. Sci. U.S.A., vol. 108, no. 35, pp. 14397–14404, Aug. 2011, doi: 10.1073/pnas.1110020108.
[3055]	D. J. Páez, V. Dukic, J. Dushoff, A. Fleming-Davies, and G. Dwyer, “Eco-Evolutionary Theory and Insect Outbreaks,” Am. Nat., vol. 189, no. 6, pp. 616–629, Jun. 2017, doi: 10.1086/691537.
[3056]	H. Lu, F. Fu, H. Li, D. E. Campbell, and H. Ren, “Eco-exergy and emergy based self-organization of three forest plantations in lower subtropical China,” Sci Rep, vol. 5, p. 15047, Oct. 2015, doi: 10.1038/srep15047.
[3057]	L. Wang, L.-Q. Zhu, S.-W. Zhang, P.-Q. Zhang, M.-L. Xu, and X.-M. Bian, “[Eco-fitness of county-level agricultural leading industry structure: assessment and development prediction],” Ying Yong Sheng Tai Xue Bao, vol. 23, no. 11, pp. 3164–3172, Nov. 2012.
[3058]	E. S. Dunlop, M. Heino, and U. Dieckmann, “Eco-genetic modeling of contemporary life-history evolution,” Ecol Appl, vol. 19, no. 7, pp. 1815–1834, Oct. 2009, doi: 10.1890/08-1404.1.
[3059]	T. V. Ramachandra, S. Vinay, S. Bharath, and A. Shashishankar, “Eco-Hydrological Footprint of a River Basin in Western Ghats,” Yale J Biol Med, vol. 91, no. 4, pp. 431–444, 2018.
[3060]	A. Ociepa-Kubicka and P. Pachura, “Eco-innovations in the functioning of companies,” Environ. Res., vol. 156, pp. 284–290, 2017, doi: 10.1016/j.envres.2017.02.027.
[3061]	U. Klaschka, M. Liebig, and T. Knacker, “Eco-labelling of shampoos, shower gels and foam baths,” Environ Sci Pollut Res Int, vol. 14, no. 1, pp. 24–29, Jan. 2007, doi: 10.1065/espr2006.02.295.
[3062]	K. Jenson and B. M. Cornelson, “Eco-maps: a systems tool for family physicians,” Can Fam Physician, vol. 33, pp. 172–177, Jan. 1987.
[3063]	J. Moya-Salazar and V. Rojas-Zumaran, “Eco-Pap: The Ecological Modification of the Papanicolaou Stain for Sustainable Cervical Cancer Diagnosis,” Acta Cytol., vol. 63, no. 1, pp. 35–43, 2019, doi: 10.1159/000493113.
[3064]	S. H. Bai and S. Ogbourne, “Eco-toxicological effects of the avermectin family with a focus on abamectin and ivermectin,” Chemosphere, vol. 154, pp. 204–214, Jul. 2016, doi: 10.1016/j.chemosphere.2016.03.113.
[3065]	A. Avery, “Eco-wellness nursing: getting serious about innovation and change,” Nurs Inq, vol. 3, no. 2, pp. 67–73, Jun. 1996, doi: 10.1111/j.1440-1800.1996.tb00016.x.
[3066]	M. Giglio et al., “ECO, the Evidence & Conclusion Ontology: community standard for evidence information,” Nucleic Acids Res., vol. 47, no. D1, pp. D1186–D1194, 08 2019, doi: 10.1093/nar/gky1036.
[3067]	J. G. C. Smits and J. K. L. van Beek, “ECO: a generic eutrophication model including comprehensive sediment-water interaction,” PLoS ONE, vol. 8, no. 7, p. e68104, 2013, doi: 10.1371/journal.pone.0068104.
[3068]	H. Mao, X. He, J. He, D. Niu, and C. Bao, “[Ecological demonstration activity and eco-civilization construction mode: review and prospects],” Ying Yong Sheng Tai Xue Bao, vol. 24, no. 4, pp. 1177–1182, Apr. 2013.
[3069]	A. M. L. Li, “Ecological determinants of health: food and environment on human health,” Environ Sci Pollut Res Int, vol. 24, no. 10, pp. 9002–9015, Apr. 2017, doi: 10.1007/s11356-015-5707-9.
[3070]	A. Shade, M.-A. Jacques, and M. Barret, “Ecological patterns of seed microbiome diversity, transmission, and assembly,” Curr. Opin. Microbiol., vol. 37, pp. 15–22, Jun. 2017, doi: 10.1016/j.mib.2017.03.010.
[3071]	H. Xie, P. Wang, and H. Huang, “Ecological risk assessment of land use change in the Poyang Lake Eco-economic Zone, China,” Int J Environ Res Public Health, vol. 10, no. 1, pp. 328–346, Jan. 2013, doi: 10.3390/ijerph10010328.
[3072]	J. W. Sorensen, T. K. Dunivin, T. C. Tobin, and A. Shade, “Ecological selection for small microbial genomes along a temperate-to-thermal soil gradient,” Nat Microbiol, vol. 4, no. 1, pp. 55–61, 2019, doi: 10.1038/s41564-018-0276-6.
[3073]	J. P. Stahl, J. Fauconnier, and M. R. Mallaret, “[Economic aspects of surgical antibiotic prophylaxis],” Ann Fr Anesth Reanim, vol. 13, no. 5 Suppl, pp. S19-24, 1994, doi: 10.1016/s0750-7658(05)81772-1.
[3074]	D. Galligan, “Economic assessment of animal health performance,” Vet. Clin. North Am. Food Anim. Pract., vol. 22, no. 1, pp. 207–227, Mar. 2006, doi: 10.1016/j.cvfa.2005.11.007.
[3075]	J. N. Siewe Fodjo et al., “Economic Burden of Epilepsy in Rural Ituri, Democratic Republic of Congo,” EClinicalMedicine, vol. 9, pp. 60–66, Mar. 2019, doi: 10.1016/j.eclinm.2019.03.010.
[3076]	J. A. Bell et al., “Economic Burden of Patients Treated for Higher-Risk Myelodysplastic Syndromes (HR-MDS) in Routine Clinical Care in the United States,” Pharmacoecon Open, vol. 3, no. 2, pp. 237–245, Jun. 2019, doi: 10.1007/s41669-018-0100-5.
[3077]	L. L. Curtin, “Economic competition: has the ‘solution’ become the problem?,” Nurs Manage, vol. 20, no. 5, pp. 7–8, May 1989.
[3078]	G. S. Freedman, W. H. Stephens, and B. Fisher, “Economic considerations in MRI,” Appl Radiol, vol. 13, no. 3, pp. 55–64, Jun. 1984.
[3079]	F. Goldman, “Economic constraints on health care,” Ann. N. Y. Acad. Sci., vol. 368, pp. 155–166, 1981, doi: 10.1111/j.1749-6632.1981.tb15444.x.
[3080]	E. Kondilis, S. Giannakopoulos, M. Gavana, I. Ierodiakonou, H. Waitzkin, and A. Benos, “Economic crisis, restrictive policies, and the population’s health and health care: the Greek case,” Am J Public Health, vol. 103, no. 6, pp. 973–979, Jun. 2013, doi: 10.2105/AJPH.2012.301126.
[3081]	R. T. Meenan et al., “Economic Evaluation of an Intervention Promoting Adoption of Occupational Sun Protection Policies,” J. Occup. Environ. Med., vol. 61, no. 12, pp. 978–983, 2019, doi: 10.1097/JOM.0000000000001707.
[3082]	M. Johannesson, “Economic evaluation of drugs and its potential uses in policy making,” Pharmacoeconomics, vol. 8, no. 3, pp. 190–198, Sep. 1995, doi: 10.2165/00019053-199508030-00003.
[3083]	Z. Gábor, “[Economic glossary: pitfalls of interpretation],” Orv Hetil, vol. 134, no. 31, pp. 1699–1702, Aug. 1993.
[3084]	L. Johns, “Economic impact analysis: a theoretical approach,” Am J Health Plann, vol. 1, no. 3, pp. 20–26, Jan. 1977.
[3085]	M. Eandi and G. P. Zara, “Economic impact of resistance in the community,” Int J Clin Pract Suppl, vol. 95, pp. 27–38, Jun. 1998.
[3086]	D. E. Koshland, “Economic impact report,” Science, vol. 256, no. 5062, p. 1373, Jun. 1992, doi: 10.1126/science.1604307.
[3087]	J. K. Hammitt, “Economic implications of hormesis,” Hum Exp Toxicol, vol. 23, no. 6, pp. 267–278; discussion 279-280, 303–305, Jun. 2004, doi: 10.1191/0960327104ht447oa.
[3088]	B. E. Rittenhouse, “Economic incentives and disincentives for efficient prescribing,” Pharmacoeconomics, vol. 6, no. 3, pp. 222–232, Sep. 1994, doi: 10.2165/00019053-199406030-00006.
[3089]	J. Grant and M. J. Buxton, “Economic returns to medical research funding,” BMJ Open, vol. 8, no. 9, p. e022131, 10 2018, doi: 10.1136/bmjopen-2018-022131.
[3090]	T. D. Szucs and E. Sokolovic, “[Economic significance of heart failure. An overview of costs and economics of therapy],” Herz, vol. 25, no. 5, pp. 538–546, Aug. 2000, doi: 10.1007/pl00001966.
[3091]	M. Jing and R. Zhang, “[Economic studies of in vitro fertilization and embryo transfer],” Zhejiang Da Xue Xue Bao Yi Xue Ban, vol. 48, no. 5, pp. 580–585, Jul. 2019.
[3092]	K. Ortolon, “Economic survival,” Tex Med, vol. 103, no. 6, pp. 35–37, Jun. 2007.
[3093]	“Economic turmoil, new administration to affect revenue cycle in 2009,” Revenue-cycle Strateg, vol. 6, no. 1, p. 7, Jan. 2009.
[3094]	H.-J. Fugel, M. Nuijten, and M. Postma, “Economic viability of Stratified Medicine concepts: An investor perspective on drivers and conditions that favour using Stratified Medicine approaches in a cost-contained healthcare environment,” N Biotechnol, vol. 33, no. 6, pp. 860–867, Dec. 2016, doi: 10.1016/j.nbt.2016.09.003.
[3095]	J. Grund and H. Husbyn, “[Economical evaluation of drugs. A steering method for the pharmaceutical sector of the 1990’s?],” Tidsskr. Nor. Laegeforen., vol. 114, no. 8, pp. 947–950, Mar. 1994.
[3096]	M. Bachl, “[Economical thinking yes, sacrificing quality no],” Krankenpfl Soins Infirm, vol. 104, no. 2, p. 7, 2011.
[3097]	L. Trasande, “Economics of children’s environmental health,” Mt. Sinai J. Med., vol. 78, no. 1, pp. 98–106, Feb. 2011, doi: 10.1002/msj.20234.
[3098]	M. V. Pauly, “Economics of multispecialty group practice,” J Ambul Care Manage, vol. 19, no. 3, pp. 26–33, Jul. 1996, doi: 10.1097/00004479-199607000-00004.
[3099]	E. M. Melhado, “Economists, public provision, and the market: changing values in policy debate,” J Health Polit Policy Law, vol. 23, no. 2, pp. 215–263, Apr. 1998, doi: 10.1215/03616878-23-2-215.
[3100]	D. Gouveia et al., “Ecotoxico-Proteomics for Aquatic Environmental Monitoring: First in Situ Application of a New Proteomics-Based Multibiomarker Assay Using Caged Amphipods,” Environ. Sci. Technol., vol. 51, no. 22, pp. 13417–13426, Nov. 2017, doi: 10.1021/acs.est.7b03736.
[3101]	S. Helsley, T. Sheikh, K. Y. Kim, and S. K. Park, “ECT therapy in PTSD,” Am J Psychiatry, vol. 156, no. 3, pp. 494–495, Mar. 1999, doi: 10.1176/ajp.156.3.494a.
[3102]	J. Obbels, E. Verwijk, F. Bouckaert, and P. Sienaert, “ECT-Related Anxiety: A Systematic Review,” J ECT, vol. 33, no. 4, pp. 229–236, Dec. 2017, doi: 10.1097/YCT.0000000000000383.
[3103]	A. Kanda, M. Yasukohchi, K. Ohnishi, A. Kiba, T. Okuno, and Y. Hikichi, “Ectopic expression of Ralstonia solanacearum effector protein PopA early in invasion results in loss of virulence,” Mol. Plant Microbe Interact., vol. 16, no. 5, pp. 447–455, May 2003, doi: 10.1094/MPMI.2003.16.5.447.
[3104]	A. Rosa et al., “Ectopic pacing at physiological rate improves postanoxic recovery of the developing heart,” Am. J. Physiol. Heart Circ. Physiol., vol. 284, no. 6, pp. H2384-2392, Jun. 2003, doi: 10.1152/ajpheart.00758.2002.
[3105]	S. A. F. Darroch, E. F. Smith, M. Laflamme, and D. H. Erwin, “Ediacaran Extinction and Cambrian Explosion,” Trends Ecol. Evol. (Amst.), vol. 33, no. 9, pp. 653–663, 2018, doi: 10.1016/j.tree.2018.06.003.
[3106]	A. G. Palmer, “Editorial,” J. Biomol. NMR, vol. 73, no. 1–2, p. 3, Feb. 2019, doi: 10.1007/s10858-019-00232-w.
[3107]	E. A. L. Stine-Morrow, “Editorial,” Psychol Aging, vol. 34, no. 1, pp. 1–3, Feb. 2019, doi: 10.1037/pag0000327.
[3108]	D. B. Welling, “Editorial,” Laryngoscope Investig Otolaryngol, vol. 1, no. 1, p. 5, Feb. 2016, doi: 10.1002/lio2.2.
[3109]	R. P. Ribeiro and M. H. P. Marziale, “Editorial characteristics and quality of the articles published by Brazilian Nursing journals,” Rev Esc Enferm USP, vol. 52, p. e03367, 2018, doi: 10.1590/s1980-220x2017030003367.
[3110]	S. Louryan, “[Editorial from the editor-in-chief],” Rev Med Brux, vol. 36, no. 4, p. 203, Sep. 2015.
[3111]	“Editorial note: cholera a public health priority,” Wkly. Epidemiol. Rec., vol. 90, no. 40, p. 529, Oct. 2015.
[3112]	R. Cui, “Editorial: A Systematic Review of Depression,” Curr Neuropharmacol, vol. 13, no. 4, p. 480, 2015, doi: 10.2174/1570159x1304150831123535.
[3113]	D. Rew, “Editorial: the multidisciplinary team process: the next steps,” Eur J Surg Oncol, vol. 36, no. 3, pp. 221–223, Mar. 2010, doi: 10.1016/j.ejso.2009.08.008.
[3114]	“Education Silent Abstracts,” In Vitro Cell. Dev. Biol. Anim., vol. 53, no. Suppl 1, pp. 45–46, Jun. 2017, doi: 10.1007/s11626-017-0160-3.
[3115]	“Education Symposia and Workshops,” In Vitro Cell. Dev. Biol. Anim., vol. 54, no. Suppl 1, pp. 11–12, Jun. 2018, doi: 10.1007/s11626-018-0248-4.
[3116]	L. Longhi et al., “EEG reactivity predicts recovery of consciousness in patients with acute brain injury and signs of intracranial hypertension,” Clin Neurophysiol, vol. 130, no. 10, pp. 1741–1742, 2019, doi: 10.1016/j.clinph.2019.07.015.
[3117]	Y. Zheng, X. Shen, Y. Zhou, J. Ma, X. Shang, and Y. Shi, “[Effect and safety of testosterone undecanoate in the treatment of late-onset hypogonadism: a meta-analysis],” Zhonghua Nan Ke Xue, vol. 21, no. 3, pp. 263–271, Mar. 2015.
[3118]	Y.-S. Cheng, Y.-S. Liu, and M. Yang, “[Effect of 5-hydroxtryptamine on megakaryocytopoiesis--review],” Zhongguo Shi Yan Xue Ye Xue Za Zhi, vol. 14, no. 2, pp. 403–407, Apr. 2006.
[3119]	R. Solianik, A. Sujeta, A. Terentjevienė, and A. Skurvydas, “Effect of 48 h Fasting on Autonomic Function, Brain Activity, Cognition, and Mood in Amateur Weight Lifters,” Biomed Res Int, vol. 2016, p. 1503956, 2016, doi: 10.1155/2016/1503956.
[3120]	Y. Katsumi et al., “Effect of a single inhalation of laninamivir octanoate in children with influenza,” Pediatrics, vol. 129, no. 6, pp. e1431-1436, Jun. 2012, doi: 10.1542/peds.2011-2054.
[3121]	S. Ngambu, V. Muchenje, and U. Marume, “Effect of Acacia karroo Supplementation on Growth, Ultimate pH, Colour and Cooking Losses of Meat from Indigenous Xhosa Lop-eared Goats,” Asian-australas. J. Anim. Sci., vol. 26, no. 1, pp. 128–133, Jan. 2013, doi: 10.5713/ajas.2012.12046.
[3122]	C. A. Martin et al., “Effect of Activation Wavefront on Electrogram Characteristics During Ventricular Tachycardia Ablation,” Circ Arrhythm Electrophysiol, vol. 12, no. 6, p. e007293, 2019, doi: 10.1161/CIRCEP.119.007293.
[3123]	K. Akiyama and J. Suemaru, “Effect of acute and chronic administration of methamphetamine on calcium-calmodulin dependent protein kinase II activity in the rat brain,” Ann. N. Y. Acad. Sci., vol. 914, pp. 263–274, Sep. 2000, doi: 10.1111/j.1749-6632.2000.tb05201.x.
[3124]	S. E. Keating et al., “Effect of aerobic exercise training dose on liver fat and visceral adiposity,” J. Hepatol., vol. 63, no. 1, pp. 174–182, Jul. 2015, doi: 10.1016/j.jhep.2015.02.022.
[3125]	S. Singh et al., “Effect of Age of Onset of Psoriasis on Clinical Outcomes with Systemic Treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR),” Am J Clin Dermatol, vol. 19, no. 6, pp. 879–886, Dec. 2018, doi: 10.1007/s40257-018-0388-z.
[3126]	A. Spinillo, E. Capuzzo, S. Acciano, A. De Santolo, and F. Zara, “Effect of antibiotic use on the prevalence of symptomatic vulvovaginal candidiasis,” Am. J. Obstet. Gynecol., vol. 180, no. 1 Pt 1, pp. 14–17, Jan. 1999, doi: 10.1016/s0002-9378(99)70141-9.
[3127]	J. Park, “Effect of arousal and retention delay on memory: a meta-analysis,” Psychol Rep, vol. 97, no. 2, pp. 339–355, Oct. 2005, doi: 10.2466/pr0.97.2.339-355.
[3128]	R. Duque et al., “Effect of artificial cell miniaturization on urea degradation by immobilized E. coli DH5α (pKAU17),” Artif Cells Nanomed Biotechnol, vol. 46, no. sup2, pp. 766–775, 2018, doi: 10.1080/21691401.2018.1469026.
[3129]	T. Nakamura, M. Tanida, A. Niijima, and K. Nagai, “Effect of auditory stimulation on parasympathetic nerve activity in urethane-anesthetized rats,” In Vivo, vol. 23, no. 3, pp. 415–419, Jun. 2009.
[3130]	E. O. Beale et al., “Effect of bolus enteral tube feeding on body weight in ambulatory adults with obesity and type 2 diabetes: a feasibility pilot randomized trial,” Nutr Diabetes, vol. 10, no. 1, p. 22, 17 2020, doi: 10.1038/s41387-020-0125-6.
[3131]	E. M. Kondaurova, V. S. Naumenko, and N. K. Popova, “Effect of chronic activation of 5-HT3 receptors on 5-HT3, 5-HT(1A) and 5-HT(2A) receptors functional activity and expression of key genes of the brain serotonin system,” Neurosci. Lett., vol. 522, no. 1, pp. 52–56, Jul. 2012, doi: 10.1016/j.neulet.2012.06.015.
[3132]	S. M. Hrabovsky et al., “Effect of Cigarette Rod Length on Smokers Switching to SPECTRUM Cigarettes,” Am J Health Behav, vol. 43, no. 2, pp. 380–392, 01 2019, doi: 10.5993/AJHB.43.2.14.
[3133]	G. Z. Laporta and M. A. M. Sallum, “Effect of CO₂ and 1-octen-3-ol attractants for estimating species richness and the abundance of diurnal mosquitoes in the southeastern Atlantic forest, Brazil,” Mem. Inst. Oswaldo Cruz, vol. 106, no. 3, pp. 279–284, May 2011, doi: 10.1590/s0074-02762011000300005.
[3134]	F. C. Peedikayil, P. Sreenivasan, and A. Narayanan, “Effect of coconut oil in plaque related gingivitis - A preliminary report,” Niger Med J, vol. 56, no. 2, pp. 143–147, Apr. 2015, doi: 10.4103/0300-1652.153406.
[3135]	J. K. Ahola et al., “Effect of copper, zinc, and manganese supplementation and source on reproduction, mineral status, and performance in grazing beef cattle over a two-year period,” J. Anim. Sci., vol. 82, no. 8, pp. 2375–2383, Aug. 2004, doi: 10.2527/2004.8282375x.
[3136]	E. S. De Lustig and A. Parodi, “[Effect of Coxsackie virus on chick embryo muscle cultivated in vitro],” Rev Soc Argent Biol, vol. 30, no. 3–4, pp. 57–61, Jul. 1954.
[3137]	E. Sacerdote De Lustig and A. Parodi, “[Effect of Coxsackie virus on chick embryo muscle in in vitro culture],” C. R. Seances Soc. Biol. Fil., vol. 148, no. 19–20, pp. 1648–1649, Oct. 1954.
[3138]	Z. Mulissa et al., “Effect of data quality improvement intervention on health management information system data accuracy: An interrupted time series analysis,” PLoS ONE, vol. 15, no. 8, p. e0237703, Aug. 2020, doi: 10.1371/journal.pone.0237703.
[3139]	I. Kobayashi, M. Yamamoto, M. Hasegawa, Y. Sato, U. Uchino, and A. Kaneko, “[Effect of delay of blood cultures on positive detection by automated blood culture system],” Kansenshogaku Zasshi, vol. 78, no. 11, pp. 959–966, Nov. 2004, doi: 10.11150/kansenshogakuzasshi1970.78.959.
[3140]	D. L. Skaggs, S. M. Kautz, R. M. Kay, and V. T. Tolo, “Effect of delay of surgical treatment on rate of infection in open fractures in children,” J Pediatr Orthop, vol. 20, no. 1, pp. 19–22, Feb. 2000.
[3141]	K. Pakdaman, C. P. Malta, C. Grotta-Ragazzo, and J. F. Vibert, “Effect of delay on the boundary of the basin of attraction in a self-excited single graded-response neuron,” Neural Comput, vol. 9, no. 2, pp. 319–336, Feb. 1997, doi: 10.1162/neco.1997.9.2.319.
[3142]	J.-F. Vibert, O. Arino, C. P. Malta, C. Grotta-Ragazzo, and K. Pakdaman, “Effect of delay on the boundary of the basin of attraction in a system of two neurons,” Neural Netw, vol. 11, no. 3, pp. 509–519, Apr. 1998, doi: 10.1016/s0893-6080(97)00112-3.
[3143]	R. Ohnishi et al., “Effect of dietary components on renal inorganic phosphate (Pi) excretion induced by a Pi-depleted diet,” J. Med. Invest., vol. 61, no. 1–2, pp. 162–170, 2014, doi: 10.2152/jmi.61.162.
[3144]	J. P. Andrade, D. Stona, H. R. Bittencourt, G. A. Borges, L. H. Burnett, and A. M. Spohr, “Effect of Different Computer-aided Design/Computer-aided Manufacturing (CAD/CAM) Materials and Thicknesses on the Fracture Resistance of Occlusal Veneers,” Oper Dent, vol. 43, no. 5, pp. 539–548, Oct. 2018, doi: 10.2341/17-131-L.
[3145]	B. K. Semin, L. N. Davletshina, and M. D. Mamedov, “Effect of different methods of Ca2+ extraction from PSII oxygen-evolving complex on the QA- oxidation kinetics,” Photosyn. Res., vol. 136, no. 1, pp. 83–91, Apr. 2018, doi: 10.1007/s11120-017-0441-4.
[3146]	B. a. C. Loomans et al., “Effect of different surface treatment techniques on the repair strength of indirect composites,” J Dent, vol. 59, pp. 18–25, Apr. 2017, doi: 10.1016/j.jdent.2017.01.010.
[3147]	M. Sharif, M. Shoaib, M. A. U. Rahman, F. Ahmad, and S. U. Rehman, “Effect of distillery yeast sludge on growth performance, nutrient digestibility and slaughter parameters in Japanese quails,” Sci Rep, vol. 8, no. 1, p. 8418, 30 2018, doi: 10.1038/s41598-018-26741-6.
[3148]	E.-J. Yeo et al., “Effect of Duck Feet Gelatin on Physicochemical, Textural, and Sensory Properties of Low-fat Frankfurters,” Korean J Food Sci Anim Resour, vol. 34, no. 4, pp. 415–422, 2014, doi: 10.5851/kosfa.2014.34.4.415.
[3149]	D. Xu, Y. Gao, L. Guo, C. Lin, and Y. Sun, “Effect of dys-1 mutation on gene expression profile in space-flown Caenorhabditis elegans,” Muscle Nerve, Jan. 2018, doi: 10.1002/mus.26076.
[3150]	K. Nozaki et al., “Effect of early eradication on Helicobacter pylori-related gastric carcinogenesis in Mongolian gerbils,” Cancer Sci., vol. 94, no. 3, pp. 235–239, Mar. 2003, doi: 10.1111/j.1349-7006.2003.tb01426.x.
[3151]	H. Dochi, M. Nojima, M. Matsumura, I. Cammack, and Y. Furuta, “Effect of early tracheostomy in mechanically ventilated patients,” Laryngoscope Investig Otolaryngol, vol. 4, no. 3, pp. 292–299, Jun. 2019, doi: 10.1002/lio2.265.
[3152]	T. Ogawa, J. Nishio, and S. Okada, “Effect of edible sesame oil on growth of clinical isolates of Candida albicans,” Biol Res Nurs, vol. 16, no. 3, pp. 335–343, Jul. 2014, doi: 10.1177/1099800413501539.
[3153]	R.-L. Cai et al., “[Effect of Electroacupuncture at ‘Shenmen’ (HT 7)- ‘Tongli’ (HT 5) of Heart Meridian on Neuronal Activities in Paraventricular Nucleus of Hypothalamus in Myocardial Ischemia Rats],” Zhen Ci Yan Jiu, vol. 43, no. 7, pp. 406–413, Jul. 2018, doi: 10.13702/j.1000-0607.180144.
[3154]	Z. Amin, T. Canli, and C. N. Epperson, “Effect of estrogen-serotonin interactions on mood and cognition,” Behav Cogn Neurosci Rev, vol. 4, no. 1, pp. 43–58, Mar. 2005, doi: 10.1177/1534582305277152.
[3155]	Y. Hua, F. S. Mirnaghi, Z. Yang, B. P. Hollebone, and C. E. Brown, “Effect of evaporative weathering and oil-sediment interactions on the fate and behavior of diluted bitumen in marine environments. Part 1. Spill-related properties, oil buoyancy, and oil-particulate aggregates characterization,” Chemosphere, vol. 191, pp. 1038–1047, Jan. 2018, doi: 10.1016/j.chemosphere.2017.10.156.
[3156]	F. Yu, H. Li, C. Tai, T. Guo, and D. Pang, “Effect of family education program on cognitive impairment, anxiety, and depression in persons who have had a stroke: A randomized, controlled study,” Nurs Health Sci, vol. 21, no. 1, pp. 44–53, Mar. 2019, doi: 10.1111/nhs.12548.
[3157]	H. Toplak, “[Effect of fat distribution on risk],” Acta Med. Austriaca, vol. 25, no. 4–5, pp. 131–132, 1998.
[3158]	L. Saliba, R. Gervais, Y. Lebeuf, J.-C. Vuillemard, J. Fortin, and P. Y. Chouinard, “Effect of feeding linseed oil in diets differing in forage to concentrate ratio: 2. Milk lactone profile,” J. Dairy Res., vol. 81, no. 1, pp. 91–97, Feb. 2014, doi: 10.1017/S0022029913000708.
[3159]	P. H. Andersen, B. Bergelin, and K. A. Christensen, “Effect of feeding regimen on concentration of free endotoxin in ruminal fluid of cattle,” J. Anim. Sci., vol. 72, no. 2, pp. 487–491, Feb. 1994, doi: 10.2527/1994.722487x.
[3160]	B. Hildebrand, J. Boguhn, S. Dänicke, and M. Rodehutscord, “Effect of Fusarium toxin-contaminated triticale and forage-to-concentrate ratio on fermentation and microbial protein synthesis in the rumen,” J Anim Physiol Anim Nutr (Berl), vol. 96, no. 2, pp. 307–318, Apr. 2012, doi: 10.1111/j.1439-0396.2011.01143.x.
[3161]	E. J. Hopkins, A. K. Stone, J. Wang, D. R. Korber, and M. T. Nickerson, “Effect of glycerol on the physicochemical properties of films based on legume protein concentrates: A comparative study,” J Texture Stud, vol. 50, no. 6, pp. 539–546, 2019, doi: 10.1111/jtxs.12460.
[3162]	C. Dietz and M. Dekker, “Effect of Green Tea Phytochemicals on Mood and Cognition,” Curr. Pharm. Des., vol. 23, no. 19, pp. 2876–2905, 2017, doi: 10.2174/1381612823666170105151800.
[3163]	F. S. Ludovichetti, F. Z. Trindade, G. L. Adabo, L. Pezzato, and R. G. Fonseca, “Effect of grinding and polishing on the roughness and fracture resistance of cemented CAD-CAM monolithic materials submitted to mechanical aging,” J Prosthet Dent, vol. 121, no. 5, p. 866.e1-866.e8, May 2019, doi: 10.1016/j.prosdent.2019.02.012.
[3164]	T. F. Fabris et al., “Effect of heat stress during early, late, and entire dry period on dairy cattle,” J. Dairy Sci., vol. 102, no. 6, pp. 5647–5656, Jun. 2019, doi: 10.3168/jds.2018-15721.
[3165]	J. Vafaeimanesh, M. Bagherzadeh, A. Mirzaei, M. Parham, M. Norouzinia, and R. Vafaee, “Effect of Helicobacter pylori on metabolic syndrome parameters in diabetic patients,” Gastroenterol Hepatol Bed Bench, vol. 9, no. Suppl1, pp. S36–S41, Dec. 2016.
[3166]	P. Sehdev, G. Crews, and A. M. Soto, “Effect of helix stability on the formation of loop-loop complexes,” Biochemistry, vol. 51, no. 48, pp. 9612–9623, Dec. 2012, doi: 10.1021/bi300481v.
[3167]	I. S. Furlan, E. C. Bridi, F. L. B. do Amaral, F. M. G. França, C. P. Turssi, and R. T. Basting, “Effect of high- or low-concentration bleaching agents containing calcium and/or fluoride on enamel microhardness,” Gen Dent, vol. 65, no. 3, pp. 66–70, Jun. 2017.
[3168]	L. F. T. F. Santos, C. R. G. Torres, T. M. F. Caneppele, A. C. Magalhães, and A. B. Borges, “Effect of home-bleaching gels modified by calcium and/or fluoride and the application of nano-hydroxyapatite paste on in vitro enamel erosion susceptibility,” Acta Odontol. Scand., vol. 74, no. 2, pp. 121–126, 2016, doi: 10.3109/00016357.2015.1053150.
[3169]	E. Sacerdote De Lustig, “[Effect of human cerebrospinal fluid on the fibroblast in vitro],” Rev Soc Argent Biol, vol. 27, no. 3–4, pp. 114–117, Jul. 1951.
[3170]	X. Song et al., “Effect of hydrothermal pretreatment severity on the pretreatment characteristics and anaerobic digestion performance of corn stover,” Bioresour. Technol., vol. 289, p. 121646, Oct. 2019, doi: 10.1016/j.biortech.2019.121646.
[3171]	R. R. Pacheco et al., “Effect of indirect restorative material and thickness on light transmission at different wavelengths,” J Prosthodont Res, vol. 63, no. 2, pp. 232–238, Apr. 2019, doi: 10.1016/j.jpor.2018.12.004.
[3172]	R. Liu, Z. Yang, Y. Yang, Z. Liu, and W. Yue, “[Effect of Ju-Pi-Tang on Cisplatin-induced Emetic Model in Minks],” Zhong Yao Cai, vol. 38, no. 2, pp. 339–343, Feb. 2015.
[3173]	M. Umeki, K. Oue, S. Mochizuki, Y. Shirai, and K. Sakai, “Effect of Lactobacillus rhamnosus KY-3 and cellobiose as synbiotics on lipid metabolism in rats,” J. Nutr. Sci. Vitaminol., vol. 50, no. 5, pp. 330–334, Oct. 2004, doi: 10.3177/jnsv.50.330.
[3174]	Z. Mekonnen, A. Gebreselema, and Y. Abere, “Effect of Locally Manufactured Niger Seed Oil on Lipid Profile Compared to Imported Palm and Sunflower Oils on Rat Models,” J Lipids, vol. 2018, p. 7846350, 2018, doi: 10.1155/2018/7846350.
[3175]	V. Kasture, A. Kale, K. Randhir, D. Sundrani, and S. Joshi, “Effect of maternal omega-3 fatty acids and vitamin E supplementation on placental apoptotic markers in rat model of early and late onset preeclampsia,” Life Sci., vol. 239, p. 117038, Dec. 2019, doi: 10.1016/j.lfs.2019.117038.
[3176]	A. S. Rele and R. B. Mohile, “Effect of mineral oil, sunflower oil, and coconut oil on prevention of hair damage,” J Cosmet Sci, vol. 54, no. 2, pp. 175–192, Apr. 2003.
[3177]	C.-Y. Lin and W.-T. Huang, “Effect of mineral viscosity-enhancing admixtures on the solidification of evaporator concentrates,” J. Hazard. Mater., vol. 298, pp. 294–302, Nov. 2015, doi: 10.1016/j.jhazmat.2015.05.048.
[3178]	H. G. Colt, A. Powers, and T. G. Shanks, “Effect of music on state anxiety scores in patients undergoing fiberoptic bronchoscopy,” Chest, vol. 116, no. 3, pp. 819–824, Sep. 1999, doi: 10.1378/chest.116.3.819.
[3179]	X. Ren, F. Dong, Y. Zhuang, Y. Wang, and W. Ma, “Effect of neuromedin U on allergic airway inflammation in an asthma model,” Exp Ther Med, vol. 19, no. 2, pp. 809–816, Feb. 2020, doi: 10.3892/etm.2019.8283.
[3180]	A. Hirashima, E. Suetsugu, S. Hirokado, E. Kuwano, E. Taniguchi, and M. Eto, “Effect of octopamine on the activity of juvenile-hormone esterase in the silkworm Bombyx mori and the red flour beetle Tribolium freemani,” Gen. Comp. Endocrinol., vol. 116, no. 3, pp. 373–381, Dec. 1999, doi: 10.1006/gcen.1999.7378.
[3181]	K. Keis, C. L. Huemmer, and Y. K. Kamath, “Effect of oil films on moisture vapor absorption on human hair,” J Cosmet Sci, vol. 58, no. 2, pp. 135–145, Apr. 2007.
[3182]	X. Nan, Q. Wu, S. Nan, X. Zeng, Y. Dai, and L. Kang, “Effect of Oil Oxidation on Acrylamide Formation in Oil-Rich Model Systems without the Participation of Reducing Sugars,” J. Food Prot., pp. 342–349, Jan. 2020, doi: 10.4315/0362-028X.JFP-19-353.
[3183]	J. Qi, X. Wang, X. Wang, C. C. Akoh, and Q. Jin, “Effect of Oil Type and Emulsifier on Oil Absorption of Steam-and-fried Instant Noodles,” J Oleo Sci, vol. 68, no. 6, pp. 559–566, Jun. 2019, doi: 10.5650/jos.ess18217.
[3184]	K. P. Datla and G. Curzon, “Effect of p-chlorophenylalanine at moderate dosage on 5-HT and 5-HIAA concentrations in brain regions of control and p-chloroamphetamine treated rats,” Neuropharmacology, vol. 35, no. 3, pp. 315–320, Mar. 1996, doi: 10.1016/0028-3908(96)00175-x.
[3185]	S. S. Kim, W. Y. Baek, and S. B. Ju, “Effect of Particulate Matter Concentration on Changes in Physiological Fatigue Variables with Resistance Exercise,” Iran. J. Public Health, vol. 48, no. 12, pp. 2306–2307, Dec. 2019.
[3186]	A. Tanaka, J. Saeki, S.-I. Hayama, and P. H. Kass, “Effect of Pets on Human Behavior and Stress in Disaster,” Front Vet Sci, vol. 6, p. 113, 2019, doi: 10.3389/fvets.2019.00113.
[3187]	A. Lauzin, A. Bérubé, M. Britten, and Y. Pouliot, “Effect of pH adjustment on the composition and rennet-gelation properties of milk concentrates made from ultrafiltration and reverse osmosis,” J. Dairy Sci., vol. 102, no. 5, pp. 3939–3946, May 2019, doi: 10.3168/jds.2018-15902.
[3188]	W. a. J. P. Wijesinghe, S.-C. Ko, and Y.-J. Jeon, “Effect of phlorotannins isolated from Ecklonia cava on angiotensin I-converting enzyme (ACE) inhibitory activity,” Nutr Res Pract, vol. 5, no. 2, pp. 93–100, Apr. 2011, doi: 10.4162/nrp.2011.5.2.93.
[3189]	I. Shrier and S. R. Kahn, “Effect of physical activity after recent deep venous thrombosis: a cohort study,” Med Sci Sports Exerc, vol. 37, no. 4, pp. 630–634, Apr. 2005, doi: 10.1249/01.mss.0000158192.07412.89.
[3190]	I. Ostádalová, B. Ostádal, and F. Kolár, “Effect of prenatal hypoxia on contractile performance and responsiveness to Ca2+ in the isolated perinatal rat heart,” Physiol Res, vol. 44, no. 2, pp. 135–137, 1995.
[3191]	F. Caylakli, H. Yavuz, C. Yilmazer, I. Yilmaz, and L. N. Ozluoglu, “Effect of preoperative hearing level on success of stapes surgery,” Otolaryngol Head Neck Surg, vol. 141, no. 1, pp. 12–15, Jul. 2009, doi: 10.1016/j.otohns.2009.02.023.
[3192]	L. S. Rupp, M. S. Molitor, and J. A. Lucey, “Effect of processing methods and protein content of the concentrate on the properties of milk protein concentrate with 80% protein,” J. Dairy Sci., vol. 101, no. 9, pp. 7702–7713, Sep. 2018, doi: 10.3168/jds.2018-14383.
[3193]	D. M. Radhakrishnan, B. Ramanujam, P. Srivastava, D. Dash, and M. Tripathi, “Effect of providing sudden unexpected death in epilepsy (SUDEP) information to persons with epilepsy (PWE) and their caregivers-Experience from a tertiary care hospital,” Acta Neurol. Scand., vol. 138, no. 5, pp. 417–424, Nov. 2018, doi: 10.1111/ane.12994.
[3194]	Q. D. Jiang and X. P. Li, “Effect of puerarin on the expression of NMU, NPY, and POMC genes in the hypothalamus,” Genet. Mol. Res., vol. 15, no. 1, p. 15017362, Feb. 2016, doi: 10.4238/gmr.15017362.
[3195]	Z. Zhu et al., “Effect of renal function status on the prognostic value of heart rate in acute ischemic stroke patients,” Atherosclerosis, vol. 263, pp. 1–6, Aug. 2017, doi: 10.1016/j.atherosclerosis.2017.05.020.
[3196]	E. E. Babiker et al., “Effect of Rosemary Extracts on Stabilitiy of Sunflower Oil Used in Frying,” J Oleo Sci, Aug. 2020, doi: 10.5650/jos.ess20060.
[3197]	G. Sun, D. Wang, Z. Wei, W. Jin, and C. Deng, “[Effect of scrotal reconstruction with free skin graft on spermatogenesis],” Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, vol. 25, no. 11, pp. 1357–1359, Nov. 2011.
[3198]	J. Li et al., “Effect of sex on biomechanical properties of the proper hepatic artery in pigs and humans for liver xenotransplant,” Exp Clin Transplant, vol. 10, no. 4, pp. 356–362, Aug. 2012, doi: 10.6002/ect.2011.0136.
[3199]	M. T. H. Swe and P. Asavapichayont, “Effect of silicone oil on the microstructure, gelation and rheological properties of sorbitan monostearate-sesame oil oleogels,” Asian J Pharm Sci, vol. 13, no. 5, pp. 485–497, Sep. 2018, doi: 10.1016/j.ajps.2018.04.006.
[3200]	S. O. Olarewaju, E. O. Oyekunle, and A. O. Bamiro, “Effect of Sociodemographic Variables on Patient and Diagnostic Delay of Breast Cancer at the Foremost Health Care Institution in Nigeria,” J Glob Oncol, vol. 5, pp. 1–8, 2019, doi: 10.1200/JGO.19.00108.
[3201]	H. H. Vieira et al., “Effect of sodium metabisulfite gel on the bond strength of dentin of bleached teeth,” Eur J Dent, vol. 12, no. 2, pp. 163–170, Jun. 2018, doi: 10.4103/ejd.ejd_165_17.
[3202]	B. Moyo, P. J. Masika, and V. Muchenje, “Effect of supplementing crossbred Xhosa lop-eared goat castrates with Moringa oleifera leaves on growth performance, carcass and non-carcass characteristics,” Trop Anim Health Prod, vol. 44, no. 4, pp. 801–809, Apr. 2012, doi: 10.1007/s11250-011-9970-6.
[3203]	N. C. Lawson et al., “Effect of Surface Treatment and Cement on Fracture Load of Traditional Zirconia (3Y), Translucent Zirconia (5Y), and Lithium Disilicate Crowns,” J Prosthodont, vol. 28, no. 6, pp. 659–665, Jul. 2019, doi: 10.1111/jopr.13088.
[3204]	T. J. Smith, P. D. Gerard, and M. A. Drake, “Effect of temperature and concentration on benzoyl peroxide bleaching efficacy and benzoic acid levels in whey protein concentrate,” J. Dairy Sci., vol. 98, no. 11, pp. 7614–7627, Nov. 2015, doi: 10.3168/jds.2015-9890.
[3205]	M. A. Valentich, A. R. Eynard, N. N. Barotto, M. P. Díaz, and G. A. Bongiovanni, “Effect of the co-administration of phenobarbital, quercetin and mancozeb on nitrosomethylurea-induced pancreatic tumors in rats,” Food Chem. Toxicol., vol. 44, no. 12, pp. 2101–2105, Dec. 2006, doi: 10.1016/j.fct.2006.07.013.
[3206]	D. R. Perinelli, M. Cespi, F. Rendina, G. Bonacucina, and G. F. Palmieri, “Effect of the concentration process on unloaded and doxorubicin loaded liposomal dispersions,” Int J Pharm, vol. 560, pp. 385–393, Apr. 2019, doi: 10.1016/j.ijpharm.2019.02.021.
[3207]	P. G. Kranz, J. D. Wylie, J. K. Hoang, and A. S. Kosinski, “Effect of the CT table strap on radiation exposure and image quality during cervical spine CT,” AJNR Am J Neuroradiol, vol. 35, no. 10, pp. 1870–1876, Oct. 2014, doi: 10.3174/ajnr.A4074.
[3208]	C. Leopold et al., “Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries,” Bull. World Health Organ., vol. 92, no. 9, pp. 630-640D, Sep. 2014, doi: 10.2471/BLT.13.129114.
[3209]	E. Sacerdote De Lustig, “[Effect of the normal and cancerous human blood serum on cell growth in tissue cultured in vitro],” Prensa Med Argent, vol. 39, no. 15, pp. 724–732, Apr. 1952.
[3210]	P. Shekelle et al., “Effect of the supplemental use of antioxidants vitamin C, vitamin E, and coenzyme Q10 for the prevention and treatment of cancer,” Evid Rep Technol Assess (Summ), no. 75, pp. 1–3, Oct. 2003.
[3211]	B. L. Hahn and P. G. Sohnle, “Effect of thioridazine on experimental cutaneous staphylococcal infections,” In Vivo, vol. 28, no. 1, pp. 33–38, Feb. 2014.
[3212]	M. Li, B. Lu, L. Chu, L. Zhang, and L.-Y. Tao, “[Effect of tongxie yaofang on intestinal mast cells and cytokine expression of rats with visceral hypersensitivity],” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 34, no. 9, pp. 1130–1134, Sep. 2014.
[3213]	Y.-P. Dai, X.-P. Gao, J.-M. Wu, X. Li, F.-H. Huang, and W.-J. Zou, “[Effect of total saponins from Sanguisorba officinalis on megakaryocyte progenitor cells proliferation, differentiation and relative receptor expression],” Zhongguo Zhong Yao Za Zhi, vol. 39, no. 9, pp. 1685–1689, May 2014.
[3214]	A. Grensman et al., “Effect of traditional yoga, mindfulness-based cognitive therapy, and cognitive behavioral therapy, on health related quality of life: a randomized controlled trial on patients on sick leave because of burnout,” BMC Complement Altern Med, vol. 18, no. 1, p. 80, Mar. 2018, doi: 10.1186/s12906-018-2141-9.
[3215]	C. C. Egwuatu et al., “EFFECT OF TRIMETHOPRIM-SULFAMETHOXAZOLE PROPHYLAXIS ON FAECAL CARRIAGE RATES OF RESISTANT ISOLATES OF ESCHERICHIA COLI IN HIV-INFECTED ADULT PATIENTS IN LAGOS,” Afr J Infect Dis, vol. 10, no. 2, pp. 156–163, 2016, doi: 10.21010/ajid.v10i2.12.
[3216]	C. C. Egwuatu et al., “EFFECT OF TRIMETHOPRIM-SULFAMETHOXAZOLE PROPHYLAXIS ON FEACAL CARRIAGE RATES OF RESISTANT ISOLATES OF ESCHERICHIA COLI IN HIV-INFECTED ADULT PATIENTS IN LAGOS,” Afr J Infect Dis, vol. 11, no. 1, pp. 18–25, 2017, doi: 10.4314/ajid.v11i1.4536.
[3217]	A. Tofangchi, P. Han, J. Izquierdo, A. Iyengar, and K. Hsu, “Effect of Ultrasonic Vibration on Interlayer Adhesion in Fused Filament Fabrication 3D Printed ABS,” Polymers (Basel), vol. 11, no. 2, Feb. 2019, doi: 10.3390/polym11020315.
[3218]	J. Azimian, O. Assar, A. Javadi, and Z. Froughi, “Effect of Using Eye Masks and Earplugs on the Risk of Post-traumatic Stress Disorder Development in Patients Admitted to Cardiac Surgery Intensive Care Units,” Indian J Crit Care Med, vol. 23, no. 1, pp. 31–34, Jan. 2019, doi: 10.5005/jp-journals-10071-23109.
[3219]	M. R. Acharya and V. V. Mistry, “Effect of vacuum-condensed or ultrafiltered milk on pasteurized process cheese,” J. Dairy Sci., vol. 88, no. 9, pp. 3037–3043, Sep. 2005, doi: 10.3168/jds.S0022-0302(05)72984-2.
[3220]	A. Hunt, J. W. Park, and A. Handa, “Effect of various types of egg white on characteristics and gelation of fish myofibrillar proteins,” J. Food Sci., vol. 74, no. 9, pp. C683-692, Dec. 2009, doi: 10.1111/j.1750-3841.2009.01354.x.
[3221]	I. Gomes, L. P. Lopes, M. Fonseca, and J. Portugal, “Effect of Zirconia Pigmentation on Translucency,” Eur J Prosthodont Restor Dent, vol. 26, no. 3, pp. 136–142, Aug. 2018, doi: 10.1922/EJPRD_01779Gomes07.
[3222]	A. D. Marsh et al., “Effective coverage measurement in maternal, newborn, child, and adolescent health and nutrition: progress, future prospects, and implications for quality health systems,” Lancet Glob Health, vol. 8, no. 5, pp. e730–e736, 2020, doi: 10.1016/S2214-109X(20)30104-2.
[3223]	J. B. Ludlow et al., “Effective dose of dental CBCT-a meta analysis of published data and additional data for nine CBCT units,” Dentomaxillofac Radiol, vol. 44, no. 1, p. 20140197, 2015, doi: 10.1259/dmfr.20140197.
[3224]	S. Li et al., “Effective noise-suppressed and artifact-reduced reconstruction of SPECT data using a preconditioned alternating projection algorithm,” Med Phys, vol. 42, no. 8, pp. 4872–4887, Aug. 2015, doi: 10.1118/1.4926846.
[3225]	J. Zheng and H. Yu, “Effective supply of eco-product and its influence factors at provincial scale of China from the perspective of supply-side reform,” Ying Yong Sheng Tai Xue Bao, vol. 29, no. 10, pp. 3326–3336, Oct. 2018, doi: 10.13287/j.1001-9332.201810.010.
[3226]	E. Kim et al., “Effectiveness and Safety of Polydioxanone Thread-Embedding Acupuncture as an Adjunctive Therapy for Patients with Chronic Nonspecific Neck Pain: A Randomized Controlled Trial,” J Altern Complement Med, vol. 25, no. 4, pp. 417–426, Apr. 2019, doi: 10.1089/acm.2018.0228.
[3227]	J. Albers, A. Jäkel, K. Wellmann, U. von Hehn, and T. Schmidt, “Effectiveness of 2 Osteopathic Treatment Approaches on Pain, Pressure-Pain Threshold, and Disease Severity in Patients with Fibromyalgia: A Randomized Controlled Trial,” Complement Med Res, vol. 25, no. 2, pp. 122–128, 2018, doi: 10.1159/000464343.
[3228]	Y. Kang et al., “[Effectiveness of Nice knot combined with elastic intramedullary nailing fixation in treatment of Robinson type 2B midshaft clavicular fracture in adults],” Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, vol. 33, no. 11, pp. 1394–1398, Nov. 2019, doi: 10.7507/1002-1892.201901027.
[3229]	M. Soto-Beltran, L. A. Ikner, and K. R. Bright, “Effectiveness of poliovirus concentration and recovery from treated wastewater by two electropositive filter methods,” Food Environ Virol, vol. 5, no. 2, pp. 91–96, Jun. 2013, doi: 10.1007/s12560-013-9104-6.
[3230]	R. Pathak and A. Pathak, “Effectiveness of Zinc Supplementation on Lithium-Induced Alterations in Thyroid Functions,” Biol Trace Elem Res, Aug. 2020, doi: 10.1007/s12011-020-02356-9.
[3231]	Y. Sugiyama, M. Fujinoki, and H. Shibahara, “Effects of 5-hydroxytryptamine on spermatozoal hyperactivation and in vitro fertilization in mice,” J. Reprod. Dev., vol. 65, no. 6, pp. 541–550, Dec. 2019, doi: 10.1262/jrd.2019-082.
[3232]	D. Francomano, A. Ilacqua, R. Bruzziches, A. Lenzi, and A. Aversa, “Effects of 5-year treatment with testosterone undecanoate on lower urinary tract symptoms in obese men with hypogonadism and metabolic syndrome,” Urology, vol. 83, no. 1, pp. 167–173, Jan. 2014, doi: 10.1016/j.urology.2013.08.019.
[3233]	S. Permpongkosol, K. Khupulsup, S. Leelaphiwat, S. Pavavattananusorn, S. Thongpradit, and T. Petchthong, “Effects of 8-Year Treatment of Long-Acting Testosterone Undecanoate on Metabolic Parameters, Urinary Symptoms, Bone Mineral Density, and Sexual Function in Men With Late-Onset Hypogonadism,” J Sex Med, vol. 13, no. 8, pp. 1199–1211, 2016, doi: 10.1016/j.jsxm.2016.06.003.
[3234]	M. Deng et al., “Effects of 45S5 bioglass on surface properties of dental enamel subjected to 35% hydrogen peroxide,” Int J Oral Sci, vol. 5, no. 2, pp. 103–110, Jun. 2013, doi: 10.1038/ijos.2013.31.
[3235]	A. R. Dodesini et al., “Effects of a low glycemic index high in fiber diet on blood glucose in women with gestational diabetes,” J. Matern. Fetal. Neonatal. Med., pp. 1–2, Jun. 2019, doi: 10.1080/14767058.2019.1622674.
[3236]	M. Tanaka, Y. Adachi, K. Adachi, and C. Sato, “Effects of a non-face-to-face behavioral weight-control program among Japanese overweight males: a randomized controlled trial,” Int J Behav Med, vol. 17, no. 1, pp. 17–24, Mar. 2010, doi: 10.1007/s12529-009-9057-1.
[3237]	J. Fang and P. H. Yu, “Effects of a quaternary pyridinium metabolite of haloperidol (HP+) on the viability and catecholamine levels of cultured PC12 cells,” Can. J. Physiol. Pharmacol., vol. 75, no. 8, pp. 996–1000, Aug. 1997.
[3238]	C. Wang, J. Bi, and B. D. Fath, “Effects of abiotic factors on ecosystem health of Taihu Lake, China based on eco-exergy theory,” Sci Rep, vol. 7, p. 42872, 21 2017, doi: 10.1038/srep42872.
[3239]	S. Adams and E. Wijk, “Effects of Acute Alcohol Consumption on Food Intake and Pictorial Stroop Response to High-Calorie Food Cues,” Alcohol Alcohol., Jul. 2020, doi: 10.1093/alcalc/agaa063.
[3240]	A. K. Eppolito, C. P. France, and L. R. Gerak, “Effects of acute and chronic morphine on delay discounting in pigeons,” J Exp Anal Behav, vol. 99, no. 3, pp. 277–289, May 2013, doi: 10.1002/jeab.25.
[3241]	B. Shah et al., “Effects of Acute Colchicine Administration Prior to Percutaneous Coronary Intervention: COLCHICINE-PCI Randomized Trial,” Circ Cardiovasc Interv, vol. 13, no. 4, p. e008717, Apr. 2020, doi: 10.1161/CIRCINTERVENTIONS.119.008717.
[3242]	M. Sudo and S. Ando, “Effects of Acute Stretching on Cognitive Function and Mood States of Physically Inactive Young Adults,” Percept Mot Skills, vol. 127, no. 1, pp. 142–153, 2020, doi: 10.1177/0031512519888304.
[3243]	H. C. Kwak, H. C. Kim, S. J. Oh, and S. K. Kim, “Effects of age increase on hepatic expression and activity of cytochrome P450 in male C57BL/6 mice,” Arch. Pharm. Res., vol. 38, no. 5, pp. 857–864, 2015, doi: 10.1007/s12272-014-0452-z.
[3244]	J. S. Damoiseaux, “Effects of aging on functional and structural brain connectivity,” Neuroimage, vol. 160, pp. 32–40, 15 2017, doi: 10.1016/j.neuroimage.2017.01.077.
[3245]	M. S. Bahrke and B. Shukitt-Hale, “Effects of altitude on mood, behaviour and cognitive functioning. A review,” Sports Med, vol. 16, no. 2, pp. 97–125, Aug. 1993, doi: 10.2165/00007256-199316020-00003.
[3246]	G. Bakris and D. White, “Effects of an ACE inhibitor combined with a calcium channel blocker on progression of diabetic nephropathy,” J Hum Hypertens, vol. 11, no. 1, pp. 35–38, Jan. 1997, doi: 10.1038/sj.jhh.1000398.
[3247]	X. Li, A. Vaezipour, A. Rakotonirainy, and S. Demmel, “Effects of an in-vehicle eco-safe driving system on drivers’ glance behaviour,” Accid Anal Prev, vol. 122, pp. 143–152, Jan. 2019, doi: 10.1016/j.aap.2018.10.007.
[3248]	S. Zhu et al., “Effects of an intra-ventricular assist device on the stroke volume of failing ventricle: Analysis of a mock circulatory system,” Technol Health Care, vol. 26, no. S1, pp. 471–479, 2018, doi: 10.3233/THC-174752.
[3249]	J. J. Newham, A. Wittkowski, J. Hurley, J. D. Aplin, and M. Westwood, “Effects of antenatal yoga on maternal anxiety and depression: a randomized controlled trial,” Depress Anxiety, vol. 31, no. 8, pp. 631–640, Aug. 2014, doi: 10.1002/da.22268.
[3250]	R. Andraws, J. S. Berger, and D. L. Brown, “Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials,” JAMA, vol. 293, no. 21, pp. 2641–2647, Jun. 2005, doi: 10.1001/jama.293.21.2641.
[3251]	J. L. de Geus, E. Fernández, S. Kossatz, A. D. Loguercio, and A. Reis, “Effects of At-home Bleaching in Smokers: 30-month Follow-up,” Oper Dent, vol. 42, no. 6, pp. 572–580, Dec. 2017, doi: 10.2341/16-126-C.
[3252]	J. G. Ekström and C. M. Beaven, “Effects of blue light and caffeine on mood,” Psychopharmacology (Berl.), vol. 231, no. 18, pp. 3677–3683, Sep. 2014, doi: 10.1007/s00213-014-3503-8.
[3253]	S. N. Haque, S. R. Booreddy, and D. K. Welsh, “Effects of BMAL1 Manipulation on the Brain’s Master Circadian Clock and Behavior,” Yale J Biol Med, vol. 92, no. 2, pp. 251–258, 2019.
[3254]	W. R. Leonard, J. J. Snodgrass, and M. L. Robertson, “Effects of brain evolution on human nutrition and metabolism,” Annu. Rev. Nutr., vol. 27, pp. 311–327, 2007, doi: 10.1146/annurev.nutr.27.061406.093659.
[3255]	G. Astaldi, E. Strosselli, and C. Rinaldi, “Effects of cartilage and bone marrow extracts on tissue cultures in vitro,” Med Exp Int J Exp Med, vol. 2, pp. 349–359, 1960, doi: 10.1159/000134897.
[3256]	A. Scholey and L. Owen, “Effects of chocolate on cognitive function and mood: a systematic review,” Nutr. Rev., vol. 71, no. 10, pp. 665–681, Oct. 2013, doi: 10.1111/nure.12065.
[3257]	A. Katsumi et al., “Effects of cognitive remediation on cognitive and social functions in individuals with schizophrenia,” Neuropsychol Rehabil, vol. 29, no. 9, pp. 1475–1487, Oct. 2019, doi: 10.1080/09602011.2017.1409639.
[3258]	N. Shams Najafabadi, M. A. Sahari, M. Barzegar, and Z. Hamidi Esfahani, “Effects of concentration method and storage time on some bioactive compounds and color of jujube (Ziziphus jujuba var vulgaris) concentrate,” J Food Sci Technol, vol. 54, no. 9, pp. 2947–2955, Aug. 2017, doi: 10.1007/s13197-017-2733-2.
[3259]	J. N. Kim, B.-S. Kim, S.-J. Kim, and C. E. Cerniglia, “Effects of crude oil, dispersant, and oil-dispersant mixtures on human fecal microbiota in an in vitro culture system,” mBio, vol. 3, no. 5, Oct. 2012, doi: 10.1128/mBio.00376-12.
[3260]	K. Kimura, A. Ishida, A. Uemura, Y. Matsumoto, and I. Terashima, “Effects of current-year and previous-year PPFDs on shoot gross morphology and leaf properties in Fagus japonica,” Tree Physiol., vol. 18, no. 7, pp. 459–466, Jul. 1998, doi: 10.1093/treephys/18.7.459.
[3261]	P. G. Stovin and T. A. English, “Effects of cyclosporine on the transplanted human heart,” J Heart Transplant, vol. 6, no. 3, pp. 180–185, Jun. 1987.
[3262]	Q. Zhang, J. Hu, L. Wei, Y. Jia, and Y. Jin, “Effects of dance therapy on cognitive and mood symptoms in people with Parkinson’s disease: A systematic review and meta-analysis,” Complement Ther Clin Pract, vol. 36, pp. 12–17, Aug. 2019, doi: 10.1016/j.ctcp.2019.04.005.
[3263]	C.-C. Chou, H.-L. Lee, P.-C. Chang, H.-T. Wo, M.-S. Wen, and S.-J. Yeh, “Effects of dantrolene on arrhythmogenicity in isolated regional ischemia-reperfusion rabbit hearts with or without pacing-induced heart failure,” Biomed Res Int, vol. 2015, p. 532820, 2015, doi: 10.1155/2015/532820.
[3264]	J. Vessells, J. R. Sy, A. Wilson, and L. Green, “Effects of delay fading and signals on self-control choices by children,” J Appl Behav Anal, vol. 51, no. 2, pp. 374–381, 2018, doi: 10.1002/jaba.454.
[3265]	P. J. Bushnell, “Effects of delay, intertrial interval, delay behavior and trimethyltin on spatial delayed response in rats,” Neurotoxicol Teratol, vol. 10, no. 3, pp. 237–244, Jun. 1988, doi: 10.1016/0892-0362(88)90023-2.
[3266]	S. Choi, L. Hasche, and D. Nguyen, “Effects of depression on the subsequent year’s healthcare expenditures among older adults: two-year panel study,” Psychiatr Q, vol. 86, no. 2, pp. 225–241, Jun. 2015, doi: 10.1007/s11126-014-9324-4.
[3267]	Y.-C. Yeh et al., “Effects of Dexmedetomidine on Intestinal Microcirculation and Intestinal Epithelial Barrier in Endotoxemic Rats,” Anesthesiology, vol. 125, no. 2, pp. 355–367, 2016, doi: 10.1097/ALN.0000000000001135.
[3268]	K. A. Beauchemin, “Effects of dietary neutral detergent fiber concentration and alfalfa hay quality on chewing, rumen function, and milk production of dairy cows,” J. Dairy Sci., vol. 74, no. 9, pp. 3140–3151, Sep. 1991, doi: 10.3168/jds.S0022-0302(91)78499-3.
[3269]	F. I. M. Craik, E. Eftekhari, and M. A. Binns, “Effects of divided attention at encoding and retrieval: Further data,” Mem Cognit, vol. 46, no. 8, pp. 1263–1277, 2018, doi: 10.3758/s13421-018-0835-3.
[3270]	X. Bu et al., “Effects of early blood pressure reduction on cognitive function in patients with acute ischemic stroke,” Int J Stroke, vol. 11, no. 9, pp. 1009–1019, 2016, doi: 10.1177/1747493016660094.
[3271]	J. Dong, N. Gruda, S. K. Lam, X. Li, and Z. Duan, “Effects of Elevated CO2 on Nutritional Quality of Vegetables: A Review,” Front Plant Sci, vol. 9, p. 924, 2018, doi: 10.3389/fpls.2018.00924.
[3272]	U. Ortecho-Zuta et al., “Effects of Enzymatic Activation of Bleaching Gels on Hydrogen Peroxide Degradation Rates, Bleaching Effectiveness, and Cytotoxicity,” Oper Dent, vol. 44, no. 4, pp. 414–423, Aug. 2019, doi: 10.2341/17-276-L.
[3273]	G. P. Zara, H. H. Thompson, M. A. Pilot, and H. D. Ritchie, “Effects of erythromycin on gastrointestinal tract motility,” J. Antimicrob. Chemother., vol. 16 Suppl A, pp. 175–179, Jul. 1985, doi: 10.1093/jac/16.suppl_a.175.
[3274]	S. Sassa et al., “Effects of estrone with or without medroxyprogesterone acetate on the femur in aged rats,” In Vivo, vol. 10, no. 4, pp. 455–457, Aug. 1996.
[3275]	I. Ellingsen, G. Sydnes, A. Hauge, and G. Nicolaysen, “Effects of exercise and CO2 inhalation on the breathing pattern in man,” Acta Physiol. Scand., vol. 134, no. 2, pp. 161–173, Oct. 1988, doi: 10.1111/j.1748-1716.1988.tb08476.x.
[3276]	K. E. Hemmann, N. M. Koho, O. M. Vainio, and M. R. Raekallio, “Effects of feed on plasma leptin and ghrelin concentrations in crib-biting horses,” Vet. J., vol. 198, no. 1, pp. 122–126, Oct. 2013, doi: 10.1016/j.tvjl.2013.06.002.
[3277]	M.-T. Kleefisch, Q. Zebeli, E. Humer, L. Gruber, and F. Klevenhusen, “Effects of feeding high-quality hay with graded amounts of concentrate on feed intake, performance and blood metabolites of cows in early lactation,” Arch Anim Nutr, vol. 72, no. 4, pp. 290–307, Aug. 2018, doi: 10.1080/1745039X.2018.1474004.
[3278]	A. a. A. Jacobs et al., “Effects of feeding rapeseed oil, soybean oil, or linseed oil on stearoyl-CoA desaturase expression in the mammary gland of dairy cows,” J. Dairy Sci., vol. 94, no. 2, pp. 874–887, Feb. 2011, doi: 10.3168/jds.2010-3511.
[3279]	E.-J. Kim, J.-E. Oh, and Y.-S. Chang, “Effects of forest fire on the level and distribution of PCDD/Fs and PAHs in soil,” Sci. Total Environ., vol. 311, no. 1–3, pp. 177–189, Jul. 2003, doi: 10.1016/S0048-9697(03)00095-0.
[3280]	T. A. Nicholl, G. D. Lopaschuk, and J. H. McNeill, “Effects of free fatty acids and dichloroacetate on isolated working diabetic rat heart,” Am. J. Physiol., vol. 261, no. 4 Pt 2, pp. H1053-1059, Oct. 1991, doi: 10.1152/ajpheart.1991.261.4.H1053.
[3281]	S. Takci, D. Gulmez, S. Yigit, O. Dogan, K. Dik, and G. Hascelik, “Effects of freezing on the bactericidal activity of human milk,” J. Pediatr. Gastroenterol. Nutr., vol. 55, no. 2, pp. 146–149, Aug. 2012, doi: 10.1097/MPG.0b013e31824f7889.
[3282]	Y.-M. Wong and L.-F. Siow, “Effects of heat, pH, antioxidant, agitation and light on betacyanin stability using red-fleshed dragon fruit (Hylocereus polyrhizus) juice and concentrate as models,” J Food Sci Technol, vol. 52, no. 5, pp. 3086–3092, May 2015, doi: 10.1007/s13197-014-1362-2.
[3283]	G. V. Papatheodoridis, S. Sougioultzis, and A. J. Archimandritis, “Effects of Helicobacter pylori and nonsteroidal anti-inflammatory drugs on peptic ulcer disease: a systematic review,” Clin. Gastroenterol. Hepatol., vol. 4, no. 2, pp. 130–142, Feb. 2006, doi: 10.1016/j.cgh.2005.10.006.
[3284]	A. Yanaka and H. Muto, “[Effects of Helicobacter pylori(Hp) eradication on gastric mucosal pathophysiology in Hp-positive, NSAIDs-induced gastric ulcer],” Nippon Rinsho, vol. 57, no. 1, pp. 201–207, Jan. 1999.
[3285]	N. A. Masento, M. Golightly, D. T. Field, L. T. Butler, and C. M. van Reekum, “Effects of hydration status on cognitive performance and mood,” Br. J. Nutr., vol. 111, no. 10, pp. 1841–1852, May 2014, doi: 10.1017/S0007114513004455.
[3286]	J. D. Gabourel, “Effects of hydroxychloroquine on the growth of mammalian cells in vitro,” J. Pharmacol. Exp. Ther., vol. 141, pp. 122–130, Jul. 1963.
[3287]	A. V. Kuzemenskiĭ, “[Effects of intergenic interaction of the high pigmentation gene hp-2(dg) (high pigment-2 dark green) with the gene B (beta-carotene) in tomato],” Tsitol. Genet., vol. 42, no. 5, pp. 32–40, Oct. 2008.
[3288]	K. Yayou, S. Kitagawa, S. Ito, E. Kasuya, and M. Sutoh, “Effects of intracerebroventricular administration of neuromedin U or neuromedin S in steers,” Gen. Comp. Endocrinol., vol. 163, no. 3, pp. 324–328, Sep. 2009, doi: 10.1016/j.ygcen.2009.04.033.
[3289]	M. Sakanashi, K. Noguchi, T. Chibana, Y. Ojiri, and M. Shoji, “Effects of intraduodenal administration of ‘kyushin,’ a senso (toad venom)-containing drug, on systemic hemodynamics, cardiacfunction and myocardial oxygen consumption in anesthetized dogs,” Am. J. Chin. Med., vol. 21, no. 1, pp. 7–16, 1993, doi: 10.1142/S0192415X93000030.
[3290]	C. M. Bassis, J. E. Allsworth, H. N. Wahl, D. E. Sack, V. B. Young, and J. D. Bell, “Effects of intrauterine contraception on the vaginal microbiota,” Contraception, vol. 96, no. 3, pp. 189–195, Sep. 2017, doi: 10.1016/j.contraception.2017.05.017.
[3291]	T. Iwasaki, Y. Takino, and T. Suzuki, “Effects of isoproterenol on the developing heart in rats,” Jpn. Circ. J., vol. 54, no. 1, pp. 109–116, Jan. 1990, doi: 10.1253/jcj.54.109.
[3292]	E.-S. A. El-Sheikh, S. G. Kamita, and B. D. Hammock, “Effects of juvenile hormone (JH) analog insecticides on larval development and JH esterase activity in two spodopterans,” Pestic Biochem Physiol, vol. 128, pp. 30–36, Mar. 2016, doi: 10.1016/j.pestbp.2015.10.008.
[3293]	R. Gursoy, “Effects of left- or right-hand preference on the success of boxers in Turkey,” Br J Sports Med, vol. 43, no. 2, pp. 142–144, Feb. 2009, doi: 10.1136/bjsm.2007.043547.
[3294]	C.-C. Li, H.-F. Yu, C.-H. Chang, Y.-T. Liu, and H.-T. Yao, “Effects of lemongrass oil and citral on hepatic drug-metabolizing enzymes, oxidative stress, and acetaminophen toxicity in rats,” J Food Drug Anal, vol. 26, no. 1, pp. 432–438, 2018, doi: 10.1016/j.jfda.2017.01.008.
[3295]	J. He and L. A. Bazzano, “Effects of lifestyle modification on treatment and prevention of hypertension,” Curr. Opin. Nephrol. Hypertens., vol. 9, no. 3, pp. 267–271, May 2000, doi: 10.1097/00041552-200005000-00010.
[3296]	X. Zhong et al., “Effects of linseed oil and palm oil on growth performance, tibia fatty acid and biomarkers of bone metabolism in broilers,” Br. Poult. Sci., vol. 55, no. 3, pp. 335–342, 2014, doi: 10.1080/00071668.2014.891097.
[3297]	D. J. Stillwell and R. J. Tunney, “Effects of measurement methods on the relationship between smoking and delay reward discounting,” Addiction, vol. 107, no. 5, pp. 1003–1012, May 2012, doi: 10.1111/j.1360-0443.2011.03742.x.
[3298]	K. A. Korotenko, “Effects of mesoscale eddies on behavior of an oil spill resulting from an accidental deepwater blowout in the Black Sea: an assessment of the environmental impacts,” PeerJ, vol. 6, p. e5448, 2018, doi: 10.7717/peerj.5448.
[3299]	I. C. Schrieks, D. Ripken, A. Stafleu, R. F. Witkamp, and H. F. J. Hendriks, “Effects of mood inductions by meal ambiance and moderate alcohol consumption on endocannabinoids and N-acylethanolamines in humans: a randomized crossover trial,” PLoS ONE, vol. 10, no. 5, p. e0126421, 2015, doi: 10.1371/journal.pone.0126421.
[3300]	V. Dirisala, G. Karami, and M. Ziejewski, “Effects of neck damping properties on brain response underimpact loading,” Int J Numer Method Biomed Eng, vol. 28, no. 4, pp. 472–494, Apr. 2012, doi: 10.1002/cnm.1480.
[3301]	L. K. Malendowicz, G. G. Nussdorfer, A. Markowska, C. Tortorella, M. Nowak, and J. B. Warchol, “Effects of neuromedin U (NMU)-8 on the rat hypothalamo-pituitary-adrenal axis. Evidence of a direct effect of NMU-8 on the adrenal gland,” Neuropeptides, vol. 26, no. 1, pp. 47–53, Jan. 1994, doi: 10.1016/0143-4179(94)90092-2.
[3302]	A. De Prins et al., “Effects of neuromedin U-8 on stress responsiveness and hypothalamus-pituitary-adrenal axis activity in male C57BL/6J mice,” Horm Behav, vol. 121, p. 104666, May 2020, doi: 10.1016/j.yhbeh.2019.104666.
[3303]	L. K. Malendowicz et al., “Effects of neuromedin-K on the rat hypothalamo-pituitary-adrenal axis,” Neuropeptides, vol. 29, no. 6, pp. 337–341, Dec. 1995, doi: 10.1016/0143-4179(95)90005-5.
[3304]	S. J. Walsh, “Effects of non-mining occupational silica exposure on proportional mortality from silicosis and systemic sclerosis,” J. Rheumatol., vol. 26, no. 10, pp. 2179–2185, Oct. 1999.
[3305]	E. A. Wagener and W. L. Kerr, “Effects of oil content on the sensory, textural, and physical properties of pecan butter (Carya illinoinensis),” J Texture Stud, vol. 49, no. 3, pp. 286–292, 2018, doi: 10.1111/jtxs.12304.
[3306]	C. H. Maclean et al., “Effects of omega-3 fatty acids on cancer,” Evid Rep Technol Assess (Summ), no. 113, pp. 1–4, Feb. 2005.
[3307]	M. Włodarczyk-Stasiak, A. Mazurek, and J. Jamroz, “Effects of operative conditions on products obtained of starch-oil mixtures by single-screw extrusion,” Acta Sci Pol Technol Aliment, vol. 16, no. 2, pp. 191–198, Jun. 2017, doi: 10.17306/J.AFS.0457.
[3308]	C. King, M. Myrthil, M. A. Carroll, and E. J. Catapane, “Effects of p-Aminosalicylic acid on the Neurotoxicity of Manganese and Levels of Dopamine and Serotonin in the Nervous System and Innervated Organs of Crassostrea virginica,” In Vivo (Brooklyn), vol. 29, no. 3, pp. 26–34, 2008.
[3309]	X. Sun, M. Perc, and J. Kurths, “Effects of partial time delays on phase synchronization in Watts-Strogatz small-world neuronal networks,” Chaos, vol. 27, no. 5, p. 053113, May 2017, doi: 10.1063/1.4983838.
[3310]	T. Kaisho et al., “Effects of peripheral administration of a Neuromedin U receptor 2-selective agonist on food intake and body weight in obese mice,” Int J Obes (Lond), vol. 41, no. 12, pp. 1790–1797, Dec. 2017, doi: 10.1038/ijo.2017.176.
[3311]	A. M. Peier et al., “Effects of peripherally administered neuromedin U on energy and glucose homeostasis,” Endocrinology, vol. 152, no. 7, pp. 2644–2654, Jul. 2011, doi: 10.1210/en.2010-1463.
[3312]	F. Li et al., “Effects of phoxim pesticide on the immune system of silkworm midgut,” Pestic Biochem Physiol, vol. 164, pp. 58–64, Mar. 2020, doi: 10.1016/j.pestbp.2019.12.007.
[3313]	Y. Yu, Z. Qi, W. Li, S. Fu, X. Yu, and D. Xiong, “Effects of physical parameters and chemical dispersant on the formation of oil-particle aggregates (OPAs) in marine environments,” Mar. Pollut. Bull., vol. 148, pp. 66–74, Nov. 2019, doi: 10.1016/j.marpolbul.2019.07.069.
[3314]	F. M. Siri and R. M. Smith, “Effects of plasma norepinephrine elevation on the heart’s adaptation to chronic aortic constriction in rats,” Can. J. Physiol. Pharmacol., vol. 64, no. 7, pp. 934–939, Jul. 1986, doi: 10.1139/y86-161.
[3315]	C. G. Oakley and A. A. Winn, “Effects of population size and isolation on heterosis, mean fitness, and inbreeding depression in a perennial plant,” New Phytol., vol. 196, no. 1, pp. 261–270, Oct. 2012, doi: 10.1111/j.1469-8137.2012.04240.x.
[3316]	M. Grol, E. H. W. Koster, L. Bruyneel, and R. De Raedt, “Effects of positive mood on attention broadening for self-related information,” Psychol Res, vol. 78, no. 4, pp. 566–573, Jul. 2014, doi: 10.1007/s00426-013-0508-6.
[3317]	J. Bakic, M. Jepma, R. De Raedt, and G. Pourtois, “Effects of positive mood on probabilistic learning: behavioral and electrophysiological correlates,” Biol Psychol, vol. 103, pp. 223–232, Dec. 2014, doi: 10.1016/j.biopsycho.2014.09.012.
[3318]	J. D. Luxama, M. A. Carroll, and E. J. Catapane, “Effects of Potential Therapeutic Agents on Copper Accumulations in Gill of Crassostrea virginica,” In Vivo (Brooklyn), vol. 31, no. 2, pp. 34–42, 2010.
[3319]	S. Mouren, J. F. Baron, C. Albo, B. Szekely, M. Arthaud, and P. Viars, “Effects of propofol and thiopental on coronary blood flow and myocardial performance in an isolated rabbit heart,” Anesthesiology, vol. 80, no. 3, pp. 634–641, Mar. 1994, doi: 10.1097/00000542-199403000-00021.
[3320]	J. J. Sherman, “Effects of psychotherapeutic treatments for PTSD: a meta-analysis of controlled clinical trials,” J Trauma Stress, vol. 11, no. 3, pp. 413–435, Jul. 1998, doi: 10.1023/A:1024444410595.
[3321]	I. Kouwijzer, C. F. J. Nooijen, K. van Breukelen, T. W. J. Janssen, and S. de Groot, “Effects of push-off ability and handcycle type on handcycling performance in able-bodied participants,” J Rehabil Med, vol. 50, no. 6, pp. 563–568, Jun. 2018, doi: 10.2340/16501977-2343.
[3322]	J. Su and S. Cai, “Effects of Quartz Splint Woven fiber periodontal fixtures on evaluating masticatory efficiency and efficacy,” Medicine (Baltimore), vol. 97, no. 44, p. e13056, Nov. 2018, doi: 10.1097/MD.0000000000013056.
[3323]	S. Kilic et al., “Effects of radial versus femoral artery access in patients with acute myocardial infarction: A large centre prospective registry,” Neth Heart J, vol. 25, no. 1, pp. 33–39, Jan. 2017, doi: 10.1007/s12471-016-0887-6.
[3324]	Y. Takarada, H. Takazawa, Y. Sato, S. Takebayashi, Y. Tanaka, and N. Ishii, “Effects of resistance exercise combined with moderate vascular occlusion on muscular function in humans,” J. Appl. Physiol., vol. 88, no. 6, pp. 2097–2106, Jun. 2000, doi: 10.1152/jappl.2000.88.6.2097.
[3325]	J. De Vry and R. Schreiber, “Effects of selected serotonin 5-HT(1) and 5-HT(2) receptor agonists on feeding behavior: possible mechanisms of action,” Neurosci Biobehav Rev, vol. 24, no. 3, pp. 341–353, May 2000, doi: 10.1016/s0149-7634(99)00083-4.
[3326]	H. Liu et al., “Effects of separate or combined exposure of nonylphenol and octylphenol on central 5-HT system and related learning and memory in the rats,” Ecotoxicol. Environ. Saf., vol. 172, pp. 523–529, May 2019, doi: 10.1016/j.ecoenv.2019.02.007.
[3327]	M. A. McDevitt and B. A. Williams, “Effects of signaled versus unsignaled delay of reinforcement on choice,” J Exp Anal Behav, vol. 75, no. 2, pp. 165–182, Mar. 2001, doi: 10.1901/jeab.2001.75-165.
[3328]	A. D. Backer, E. A. Münchow, G. J. Eckert, A. T. Hara, J. A. Platt, and M. C. Bottino, “Effects of Simulated Gastric Juice on CAD/CAM Resin Composites-Morphological and Mechanical Evaluations,” J Prosthodont, vol. 26, no. 5, pp. 424–431, Jul. 2017, doi: 10.1111/jopr.12420.
[3329]	S. Hirooka, M. Ueno, S. Fukuda, A. Miyajima, and T. Hirota, “Effects of Simvastatin on Alveolar Regeneration and Its Relationship to Exposure in Mice with Dexamethasone-Induced Emphysema,” Biol. Pharm. Bull., vol. 40, no. 2, pp. 155–160, 2017, doi: 10.1248/bpb.b16-00637.
[3330]	P. Weis et al., “Effects of Spacers on Photoinduced Reversible Solid-to-Liquid Transitions of Azobenzene-Containing Polymers,” Chemistry, vol. 25, no. 46, pp. 10946–10953, Aug. 2019, doi: 10.1002/chem.201902273.
[3331]	Z. Gu et al., “Effects of sublethal phoxim exposure and lower food intake on nutrient metabolism in the midguts of Bombyx mori,” Pestic Biochem Physiol, vol. 167, p. 104593, Jul. 2020, doi: 10.1016/j.pestbp.2020.104593.
[3332]	L. A. Merriman, C. L. Walk, C. M. Parsons, and H. H. Stein, “Effects of tallow, choice white grease, palm oil, corn oil, or soybean oil on apparent total tract digestibility of minerals in diets fed to growing pigs,” J. Anim. Sci., vol. 94, no. 10, pp. 4231–4238, Oct. 2016, doi: 10.2527/jas.2016-0682.
[3333]	G. Pratesi and G. Savi, “Effects of tauromustine, a water-soluble nitrosourea compound on NMU-1 murine lung tumor,” Oncology, vol. 46, no. 2, pp. 132–135, 1989, doi: 10.1159/000226700.
[3334]	F. Jakob et al., “Effects of teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteo Observational Study,” Eur. J. Endocrinol., vol. 166, no. 1, pp. 87–97, Jan. 2012, doi: 10.1530/EJE-11-0740.
[3335]	M. C. Meriggiola et al., “Effects of testosterone undecanoate administered alone or in combination with letrozole or dutasteride in female to male transsexuals,” J Sex Med, vol. 5, no. 10, pp. 2442–2453, Oct. 2008, doi: 10.1111/j.1743-6109.2008.00909.x.
[3336]	A. P. Mena-Serrano et al., “Effects of the concentration and composition of in-office bleaching gels on hydrogen peroxide penetration into the pulp chamber,” Oper Dent, vol. 40, no. 2, pp. E76-82, Apr. 2015, doi: 10.2341/13-352-L.
[3337]	D. Klingenberger, “[Effects of the new German quarterly practice fee on dental treatment -- cost-benefit analysis],” Gesundheitswesen, vol. 67, no. 3, pp. 196–203, Mar. 2005, doi: 10.1055/s-2005-857957.
[3338]	Z.-T. Deng et al., “Effects of the novel vascular targeting agent MDS-11P on tumor vascularity and its antitumor activity,” Biochem. Pharmacol., vol. 82, no. 12, pp. 1832–1842, Dec. 2011, doi: 10.1016/j.bcp.2011.08.024.
[3339]	J. J. Galligan, T. Tokimasa, and R. A. North, “Effects of three mammalian tachykinins on single enteric neurons,” Neurosci. Lett., vol. 82, no. 2, pp. 167–171, Nov. 1987, doi: 10.1016/0304-3940(87)90123-6.
[3340]	A. Prabhat, T. Batra, and V. Kumar, “Effects of timed food availability on reproduction and metabolism in zebra finches: Molecular insights into homeostatic adaptation to food-restriction in diurnal vertebrates,” Horm Behav, vol. 125, p. 104820, Jul. 2020, doi: 10.1016/j.yhbeh.2020.104820.
[3341]	B. Y. Silber and J. a. J. Schmitt, “Effects of tryptophan loading on human cognition, mood, and sleep,” Neurosci Biobehav Rev, vol. 34, no. 3, pp. 387–407, Mar. 2010, doi: 10.1016/j.neubiorev.2009.08.005.
[3342]	K. Uchiyama, D. Wakatsuki, B. Kakinoki, Y. Takeuchi, T. Araki, and Y. Morinaka, “Effects of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion and gastroduodenal ulcers in rats,” Methods Find Exp Clin Pharmacol, vol. 21, no. 2, pp. 115–122, Mar. 1999, doi: 10.1358/mf.1999.21.2.529238.
[3343]	M. F. M. Costa, H. M. Davies, G. A. Anderson, and R. F. Slocombe, “Effects of two training protocols on Angiotensin I-converting enzyme (ACE) activity in horses,” Equine Vet. J., vol. 43, no. 4, pp. 466–470, Jul. 2011, doi: 10.1111/j.2042-3306.2010.00320.x.
[3344]	S. J. Silverman and G. R. Fink, “Effects of Ty insertions on HIS4 transcription in Saccharomyces cerevisiae,” Mol. Cell. Biol., vol. 4, no. 7, pp. 1246–1251, Jul. 1984, doi: 10.1128/mcb.4.7.1246.
[3345]	S. A. Gustitus, G. F. John, and T. P. Clement, “Effects of weathering on the dispersion of crude oil through oil-mineral aggregation,” Sci. Total Environ., vol. 587–588, pp. 36–46, Jun. 2017, doi: 10.1016/j.scitotenv.2017.02.044.
[3346]	S. M. Pond, “Effects on the liver of chemicals encountered in the workplace,” West. J. Med., vol. 137, no. 6, pp. 506–514, Dec. 1982.
[3347]	S.-I. Momomura et al., “Efficacy and Safety of Switching From Oral Bisoprolol to Transdermal Patch in Japanese Patients With Chronic Heart Failure,” Circ. J., vol. 82, no. 1, pp. 141–147, 25 2017, doi: 10.1253/circj.CJ-17-0532.
[3348]	S. Stefoni et al., “Efficacy and safety outcomes among de novo renal transplant recipients managed by C2 monitoring of cyclosporine a microemulsion: results of a 12-month, randomized, multicenter study,” Transplantation, vol. 79, no. 5, pp. 577–583, Mar. 2005, doi: 10.1097/01.tp.0000153158.91683.34.
[3349]	M. Jutel, M. Rudert, F. Kreimendahl, and P. Kuna, “Efficacy and tolerability of a house dust mite allergoid in allergic bronchial asthma: a randomized dose-ranging trial,” Immunotherapy, vol. 10, no. 13, pp. 1149–1161, 2018, doi: 10.2217/imt-2018-0087.
[3350]	C. E. Jäkel, K. Meschenmoser, Y. Kim, H. Weiher, and I. G. H. Schmidt-Wolf, “Efficacy of a proapoptotic peptide towards cancer cells,” In Vivo, vol. 26, no. 3, pp. 419–426, Jun. 2012.
[3351]	Q. Yang, K. Zhao, Y. Shen, Z. Shen, and J. Yu, “[Efficacy of combined modality therapy for intractable difficult-to-treat rhinosinusitis],” Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, vol. 30, no. 2, pp. 111–114, Jan. 2016.
[3352]	N. C. Orobello, C. O. Dirain, P. E. Kaufman, and P. J. Antonelli, “Efficacy of common reagents for killing ticks in the ear canal,” Laryngoscope Investig Otolaryngol, vol. 3, no. 6, pp. 492–495, Dec. 2018, doi: 10.1002/lio2.217.
[3353]	S. Suzuki, H. Togari, J. L. Potenziano, and M. D. Schreiber, “Efficacy of inhaled nitric oxide in neonates with hypoxic respiratory failure and pulmonary hypertension: the Japanese experience,” J Perinat Med, vol. 46, no. 6, pp. 657–663, Aug. 2018, doi: 10.1515/jpm-2017-0040.
[3354]	K. Özata, M. Atum, E. Çelik, E. Doğan, and G. Alagöz, “Efficacy of intravitreal dexamethasone implant in persistent diabetic macular edema after primary treatment with intravitreal ranibizumab,” J Curr Ophthalmol, vol. 31, no. 3, pp. 281–286, Sep. 2019, doi: 10.1016/j.joco.2019.03.002.
[3355]	C. Weber, V. Thai, K. Neuheuser, K. Groover, and O. Christ, “Efficacy of physical therapy for the treatment of lateral epicondylitis: a meta-analysis,” BMC Musculoskelet Disord, vol. 16, p. 223, Aug. 2015, doi: 10.1186/s12891-015-0665-4.
[3356]	S. Marcazzan, R. L. Weinstein, and M. Del Fabbro, “Efficacy of platelets in bone healing: A systematic review on animal studies,” Platelets, vol. 29, no. 4, pp. 326–337, Jun. 2018, doi: 10.1080/09537104.2017.1327652.
[3357]	H.-P. Spaans, K. H. Kho, E. Verwijk, R. M. Kok, and M. L. Stek, “Efficacy of ultrabrief pulse electroconvulsive therapy for depression: a systematic review,” J Affect Disord, vol. 150, no. 3, pp. 720–726, Sep. 2013, doi: 10.1016/j.jad.2013.05.072.
[3358]	I. S. Mukhamadeev and A. A. Oborin, “[Efficacy of using loop endarterectomy],” Angiol Sosud Khir, vol. 25, no. 1, pp. 182–188, 2019, doi: 10.33529/angio2019125.
[3359]	M. Pocard, H. Tsukui, R. J. Salmon, B. Dutrillaux, and M. F. Poupon, “Efficiency of orthotopic xenograft models for human colon cancers,” In Vivo, vol. 10, no. 5, pp. 463–469, Oct. 1996.
[3360]	B. M. Hopkinson, C. L. Dupont, A. E. Allen, and F. M. M. Morel, “Efficiency of the CO2-concentrating mechanism of diatoms,” Proc. Natl. Acad. Sci. U.S.A., vol. 108, no. 10, pp. 3830–3837, Mar. 2011, doi: 10.1073/pnas.1018062108.
[3361]	R. Visser et al., “Efficient and reliable 3D dose quality assurance for IMRT by combining independent dose calculations with measurements,” Med Phys, vol. 40, no. 2, p. 021710, Feb. 2013, doi: 10.1118/1.4774048.
[3362]	G. Sun et al., “Efficient purification and concentration of viruses from a large body of high turbidity seawater,” MethodsX, vol. 1, pp. 197–206, 2014, doi: 10.1016/j.mex.2014.09.001.
[3363]	O. P. Naraniya, M. R. Shenoy, and K. Thyagarajan, “Efficient scheme for mid-infrared generation using simultaneous optical parametric oscillators and DFG processes in a double-pass pump configuration,” Appl Opt, vol. 54, no. 24, pp. 7234–7239, Aug. 2015, doi: 10.1364/AO.54.007234.
[3364]	M. E. Case, M. Schweizer, S. R. Kushner, and N. H. Giles, “Efficient transformation of Neurospora crassa by utilizing hybrid plasmid DNA,” Proc. Natl. Acad. Sci. U.S.A., vol. 76, no. 10, pp. 5259–5263, Oct. 1979, doi: 10.1073/pnas.76.10.5259.
[3365]	A. M. El-Arabi et al., “Eighteen-Year Review of Resident Performance on the American Urological Association In-Service Examination,” Urology, vol. 137, pp. 33–37, 2020, doi: 10.1016/j.urology.2019.10.027.
[3366]	“Eighth World Melioidosis Congress, 2016: presenting an emerging infectious disease in the context of ‘One Health,’” Wkly. Epidemiol. Rec., vol. 91, no. 46, pp. 543–547, Nov. 2016.
[3367]	V. S. Kuzmin, Y. V. Egorov, and L. V. Rozenshtraukh, “[Electrhopysiological Effect of the Polyamine Spermine in Normoxic and Ischemic Ventricular Myocardium],” Kardiologiia, vol. 59, no. 3, pp. 43–51, Apr. 2019, doi: 10.18087/cardio.2019.3.10240.
[3368]	P. Rezai, S. Salam, P. R. Selvaganapathy, and B. P. Gupta, “Electrical sorting of Caenorhabditis elegans,” Lab Chip, vol. 12, no. 10, pp. 1831–1840, Apr. 2012, doi: 10.1039/c2lc20967e.
[3369]	D. J. Park, J. H. Shin, K. H. Park, and H. C. Ryu, “Electrically controllable THz asymmetric split-loop resonator with an outer square loop based on VO2,” Opt Express, vol. 26, no. 13, pp. 17397–17406, Jun. 2018, doi: 10.1364/OE.26.017397.
[3370]	R. Adorni, M. Manfredi, and A. M. Proverbio, “Electro-cortical manifestations of common vs. proper name processing during reading,” Brain Lang, vol. 135, pp. 1–8, Aug. 2014, doi: 10.1016/j.bandl.2014.05.002.
[3371]	X. Wang, B. Yang, J. Yin, W. Wei, and J. D. Z. Chen, “Electroacupuncture via chronically implanted electrodes improves gastrointestinal motility by balancing sympathovagal activities in a rat model of constipation,” Am. J. Physiol. Gastrointest. Liver Physiol., vol. 316, no. 6, pp. G797–G805, 01 2019, doi: 10.1152/ajpgi.00018.2018.
[3372]	S. Nishimura, T. Ohzono, K. Shoji, S. Yagihara, M. Hayashi, and H. Tanaka, “Electrocapillary Phenomena at Edible Oil/Saline Interfaces,” J Oleo Sci, vol. 66, no. 3, pp. 235–249, Mar. 2017, doi: 10.5650/jos.ess16182.
[3373]	Leonard H. L., Meyer M. C., and Swedo S. E., “Electrocardiographic changes during desipramine and clomipramine treatment in children and adolescents,” J Am Acad Child Adolesc Psychiatry, vol. 34, no. 11, pp. 1460–1468, 1995, doi: http://dx.doi.org/10.1097/00004583-199511000-00012.
[3374]	J. Ker and E. C. Webb, “Electrocardiographic surrogates of structural myocardial alterations in the Dorper sheep heart,” Onderstepoort J. Vet. Res., vol. 72, no. 4, pp. 273–277, Dec. 2005, doi: 10.4102/ojvr.v72i4.182.
[3375]	N. Lavanya, J. Nizeyimana Claude, and C. Sekar, “Electrochemical determination of purine and pyrimidine bases using copper doped cerium oxide nanoparticles,” J Colloid Interface Sci, vol. 530, pp. 202–211, Nov. 2018, doi: 10.1016/j.jcis.2018.06.046.
[3376]	E. Lökçü, Ç. Toparli, and M. Anik, “Electrochemical Performance of (MgCoNiZn)1-xLi                     x                 O High-Entropy Oxides in Lithium-Ion Batteries,” ACS Appl Mater Interfaces, vol. 12, no. 21, pp. 23860–23866, May 2020, doi: 10.1021/acsami.0c03562.
[3377]	P. Striano, F. Madia, C. Minetti, S. Striano, and F. Zara, “Electroclinical and genetic findings in a family with cortical tremor, myoclonus, and epilepsy,” Epilepsia, vol. 46, no. 12, pp. 1993–1995, Dec. 2005, doi: 10.1111/j.1528-1167.2005.00346.x.
[3378]	S. Deng and H. Ju, “Electrogenerated chemiluminescence of nanomaterials for bioanalysis,” Analyst, vol. 138, no. 1, pp. 43–61, Jan. 2013, doi: 10.1039/c2an36122a.
[3379]	P. W. Livermore, R. Hollerbach, and A. Jackson, “Electromagnetically driven westward drift and inner-core superrotation in Earth’s core,” Proc. Natl. Acad. Sci. U.S.A., vol. 110, no. 40, pp. 15914–15918, Oct. 2013, doi: 10.1073/pnas.1307825110.
[3380]	H. Meyer, “Electron microscope study of nerve fibres grown in vitro,” Exp. Cell Res., vol. 7, no. 1, pp. 15–22, Aug. 1954, doi: 10.1016/0014-4827(54)90037-3.
[3381]	A. Frankl, M. Mari, and F. Reggiori, “Electron microscopy for ultrastructural analysis and protein localization in Saccharomyces cerevisiae,” Microb Cell, vol. 2, no. 11, pp. 412–428, Oct. 2015, doi: 10.15698/mic2015.11.237.
[3382]	M. Flores et al., “Electron-nuclear and electron-electron double resonance spectroscopies show that the primary quinone acceptor QA in reaction centers from photosynthetic bacteria Rhodobacter sphaeroides remains in the same orientation upon light-induced reduction,” J Phys Chem B, vol. 114, no. 50, pp. 16894–16901, Dec. 2010, doi: 10.1021/jp107051r.
[3383]	J. L. Hermens, “Electrophiles and acute toxicity to fish,” Environ. Health Perspect., vol. 87, pp. 219–225, Jul. 1990, doi: 10.1289/ehp.9087219.
[3384]	K. Awwad et al., “Electrophilic fatty acid species inhibit 5-lipoxygenase and attenuate sepsis-induced pulmonary inflammation,” Antioxid. Redox Signal., vol. 20, no. 17, pp. 2667–2680, Jun. 2014, doi: 10.1089/ars.2013.5473.
[3385]	R. Benigni, M. Cotta-Ramusino, C. Andreoli, and A. Giuliani, “Electrophilicity as measured by Ke: molecular determinants, relationship with other physical-chemical and quantum mechanical parameters, and ability to predict rodent carcinogenicity,” Carcinogenesis, vol. 13, no. 4, pp. 547–553, Apr. 1992, doi: 10.1093/carcin/13.4.547.
[3386]	Y. Komatsu et al., “Electrophysiologic characterization of local abnormal ventricular activities in postinfarction ventricular tachycardia with respect to their anatomic location,” Heart Rhythm, vol. 10, no. 11, pp. 1630–1637, Nov. 2013, doi: 10.1016/j.hrthm.2013.08.031.
[3387]	P. Blier, C. de Montigny, and Y. Chaput, “Electrophysiological assessment of the effects of antidepressant treatments on the efficacy of 5-HT neurotransmission,” Clin Neuropharmacol, vol. 11 Suppl 2, pp. S1-10, 1988.
[3388]	M. Cholanian, S. J. Krajewski-Hall, R. B. Levine, N. T. McMullen, and N. E. Rance, “Electrophysiology of arcuate neurokinin B neurons in female Tac2-EGFP transgenic mice,” Endocrinology, vol. 155, no. 7, pp. 2555–2565, Jul. 2014, doi: 10.1210/en.2014-1065.
[3389]	P. Alboni, R. Pirani, N. Paparella, A. M. Tomasi, and A. Masoni, “Electrophysiology of normal anterograde atrio-ventricular conduction with and without autonomic blockade,” Eur. Heart J., vol. 6, no. 7, pp. 602–608, Jul. 1985, doi: 10.1093/oxfordjournals.eurheartj.a061908.
[3390]	A. Schönfeld, M. Constantinescu, K. Peters, and M. Frenz, “Electrospinning of highly concentrated albumin patches by using auxiliary polymers for laser-assisted vascular anastomosis,” Biomed Mater, vol. 13, no. 5, p. 055001, 29 2018, doi: 10.1088/1748-605X/aac332.
[3391]	P. Rezai, A. Siddiqui, P. R. Selvaganapathy, and B. P. Gupta, “Electrotaxis of Caenorhabditis elegans in a microfluidic environment,” Lab Chip, vol. 10, no. 2, pp. 220–226, Jan. 2010, doi: 10.1039/b917486a.
[3392]	C. N. Lo, “Electrotherapy on tattoo is to be concerned,” Hong Kong Physiother J, vol. 39, no. 2, pp. 89–90, Dec. 2019, doi: 10.1142/S1013702519200014.
[3393]	X. Zhu, P. Jiang, L. Zhang, B. Li, J. Sheng, and H. Wu, “Element Geochemistry of Lake Sediments from L07-10 in the ‘Great Ear’ Area of Lop Nur and Its Significance for Climate Variation Change with ICP-OES,” Guang Pu Xue Yu Guang Pu Fen Xi, vol. 36, no. 10, pp. 3308–3312, Oct. 2016.
[3394]	C. Huiliñir et al., “Elemental sulfur-based autotrophic denitrification in stoichiometric S0/N ratio: Calibration and validation of a kinetic model,” Bioresour. Technol., vol. 307, p. 123229, Jul. 2020, doi: 10.1016/j.biortech.2020.123229.
[3395]	J. Shoshani, W. J. Kupsky, and G. H. Marchant, “Elephant brain. Part I: gross morphology, functions, comparative anatomy, and evolution,” Brain Res. Bull., vol. 70, no. 2, pp. 124–157, Jun. 2006, doi: 10.1016/j.brainresbull.2006.03.016.
[3396]	J. Yin et al., “Elevated circulating homocysteine and high-sensitivity C-reactive protein jointly predicts post-stroke depression among Chinese patients with acute ischemic stroke,” Clin. Chim. Acta, vol. 479, pp. 132–137, Apr. 2018, doi: 10.1016/j.cca.2018.01.011.
[3397]	T. Zhang and L. Xiang, “Elevated Plasma Haptoglobin Level as a Potential Marker for Poor Prognosis in Acute Cerebral Infarction,” Eur. Neurol., vol. 79, no. 3–4, pp. 154–160, 2018, doi: 10.1159/000487648.
[3398]	P. L. Vera et al., “Elevated Urine Levels of Macrophage Migration Inhibitory Factor in Inflammatory Bladder Conditions: A Potential Biomarker for a Subgroup of Interstitial Cystitis/Bladder Pain Syndrome Patients,” Urology, vol. 116, pp. 55–62, 2018, doi: 10.1016/j.urology.2018.02.039.
[3399]	S. M. Prezioso, N. E. Brown, and J. B. Goldberg, “Elfamycins: inhibitors of elongation factor-Tu,” Mol. Microbiol., vol. 106, no. 1, pp. 22–34, Oct. 2017, doi: 10.1111/mmi.13750.
[3400]	“Eliminate Yellow fever Epidemics (EYE): a global strategy, 2017–2026,” Wkly. Epidemiol. Rec., vol. 92, no. 16, pp. 193–204, 21 2017.
[3401]	“Elimination of  onchocerciasis in the WHO  Region of the Americas:  Ecuador’s progress towards  verification of elimination,” Wkly. Epidemiol. Rec., vol. 89, no. 37, pp. 401–405, Sep. 2014.
[3402]	Y. Li et al., “Elk-1-mediated 15-lipoxygenase expression is required for hypoxia-induced pulmonary vascular adventitial fibroblast dynamics,” Acta Physiol (Oxf), vol. 218, no. 4, pp. 276–289, 2016, doi: 10.1111/apha.12711.
[3403]	M. Hosoya, S. B. Minami, C. Enomoto, T. Matsunaga, and K. Kaga, “Elongated EABR wave latencies observed in patients with auditory neuropathy caused by OTOF mutation,” Laryngoscope Investig Otolaryngol, vol. 3, no. 5, pp. 388–393, Oct. 2018, doi: 10.1002/lio2.210.
[3404]	M. Sonnewald, S. Dutkiewicz, C. Hill, and G. Forget, “Elucidating ecological complexity: Unsupervised learning determines global marine eco-provinces,” Sci Adv, vol. 6, no. 22, p. eaay4740, May 2020, doi: 10.1126/sciadv.aay4740.
[3405]	K. Sakamaki, S. Ishizaki, Y. Ohkubo, Y. Tateno, A. Nakanishi, and A. Fujita, “Elucidating the formation pathway of the off-flavor compound 6-propylbenzofuran-7-ol,” J. Agric. Food Chem., vol. 60, no. 40, pp. 9967–9973, Oct. 2012, doi: 10.1021/jf302762j.
[3406]	P. W. Wiessner, “Embers of society: Firelight talk among the Ju/’hoansi Bushmen,” Proc. Natl. Acad. Sci. U.S.A., vol. 111, no. 39, pp. 14027–14035, Sep. 2014, doi: 10.1073/pnas.1404212111.
[3407]	L. Veenstra, I. K. Schneider, and S. L. Koole, “Embodied mood regulation: the impact of body posture on mood recovery, negative thoughts, and mood-congruent recall,” Cogn Emot, vol. 31, no. 7, pp. 1361–1376, 2017, doi: 10.1080/02699931.2016.1225003.
[3408]	C. C. Assis, J. de L. Lopes, L. A. Nogueira-Martins, and A. L. B. L. de Barros, “[Embracement and anxiety symptoms in patients before cardiac surgery],” Rev Bras Enferm, vol. 67, no. 3, pp. 401–407, Jun. 2014, doi: 10.5935/0034-7167.20140053.
[3409]	S. D. Manning, “Emergence of a hypervirulent neonatal pathogen,” Lancet Infect Dis, vol. 14, no. 11, pp. 1028–1030, Nov. 2014, doi: 10.1016/S1473-3099(14)70938-7.
[3410]	“Emergence of monkeypox in West Africa and Central Africa, 1970–2017,” Wkly. Epidemiol. Rec., vol. 93, no. 11, pp. 125–132, Mar. 2018.
[3411]	W. J. Scott, N. Schrage, and C. Dohlman, “Emergency eye rinse for chemical injuries: new considerations,” JAMA Ophthalmol, vol. 133, no. 3, p. 245, Mar. 2015, doi: 10.1001/jamaophthalmol.2014.5045.
[3412]	L. Bruijstens, I. Titulaer, G. J. Scheffer, M. Steegers, and F. van den Hoogen, “Emergency front-of-neck airway by ENT surgeons and residents: A dutch national survey,” Laryngoscope Investig Otolaryngol, vol. 3, no. 5, pp. 356–363, Oct. 2018, doi: 10.1002/lio2.183.
[3413]	2011 ENA Emergency Nursing Resources Development Committee et al., “Emergency Nursing Resource: difficult intravenous access,” J Emerg Nurs, vol. 38, no. 4, pp. 335–343, Jul. 2012, doi: 10.1016/j.jen.2012.05.010.
[3414]	D. P. Sklar, C. S. Crandall, T. Zola, and R. Cunningham, “Emergency physician perceptions of patient safety risks,” Ann Emerg Med, vol. 55, no. 4, pp. 336–340, Apr. 2010, doi: 10.1016/j.annemergmed.2009.08.020.
[3415]	H. Sandvik, “Emergency primary health care consultations on Christmas Eve, New Year’s Eve and a normal Saturday,” Tidsskr. Nor. Laegeforen., vol. 139, no. 18, Dec. 2019, doi: 10.4045/tidsskr.19.0245.
[3416]	J. P. Sturmberg, “Emergent properties define the subjective nature of health and dis-ease,” J Public Health Policy, vol. 35, no. 3, pp. 414–419, Aug. 2014, doi: 10.1057/jphp.2014.20.
[3417]	M. Mathis, S. Briand, and T. Prentice, “Emerging and re-emerging infectious threats in the 21st century,” Wkly. Epidemiol. Rec., vol. 90, no. 20, pp. 238–244, May 2015.
[3418]	A. Papa, “Emerging arboviral human diseases in Southern Europe,” J. Med. Virol., vol. 89, no. 8, pp. 1315–1322, 2017, doi: 10.1002/jmv.24803.
[3419]	S. Kahl, S. Kleinsteuber, J. Nivala, M. van Afferden, and T. Reemtsma, “Emerging Biodegradation of the Previously Persistent Artificial Sweetener Acesulfame in Biological Wastewater Treatment,” Environ. Sci. Technol., vol. 52, no. 5, pp. 2717–2725, 06 2018, doi: 10.1021/acs.est.7b05619.
[3420]	A. M. Zeidan, M. Stahl, and R. Komrokji, “Emerging biological therapies for the treatment of myelodysplastic syndromes,” Expert Opin Emerg Drugs, vol. 21, no. 3, pp. 283–300, Sep. 2016, doi: 10.1080/14728214.2016.1220534.
[3421]	B. Canaud and S. K. Bowry, “Emerging clinical evidence on online hemodiafiltration: does volume of ultrafiltration matter?,” Blood Purif., vol. 35, no. 1–3, pp. 55–62, 2013, doi: 10.1159/000345175.
[3422]	M. Ihara and Y. Yamamoto, “Emerging Evidence for Pathogenesis of Sporadic Cerebral Small Vessel Disease,” Stroke, vol. 47, no. 2, pp. 554–560, Feb. 2016, doi: 10.1161/STROKEAHA.115.009627.
[3423]	F. Faraji, D. W. Eisele, and C. Fakhry, “Emerging insights into recurrent and metastatic human papillomavirus-related oropharyngeal squamous cell carcinoma,” Laryngoscope Investig Otolaryngol, vol. 2, no. 1, pp. 10–18, 2017, doi: 10.1002/lio2.37.
[3424]	H. J. Talib, “Emerging Issues in Adolescent Sexual and Reproductive Health,” Pediatr Ann, vol. 48, no. 2, pp. e56–e57, Feb. 2019, doi: 10.3928/19382359-20190116-02.
[3425]	A. Aydogdu and R. S. Swerdloff, “Emerging medication for the treatment of male hypogonadism,” Expert Opin Emerg Drugs, vol. 21, no. 3, pp. 255–266, Sep. 2016, doi: 10.1080/14728214.2016.1226799.
[3426]	H. Sakano and J. P. Harris, “Emerging options in immune-mediated hearing loss,” Laryngoscope Investig Otolaryngol, vol. 4, no. 1, pp. 102–108, Feb. 2019, doi: 10.1002/lio2.205.
[3427]	J. D. Mitchell, J. J. Maguire, and A. P. Davenport, “Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S,” Br. J. Pharmacol., vol. 158, no. 1, pp. 87–103, Sep. 2009, doi: 10.1111/j.1476-5381.2009.00252.x.
[3428]	J. Sun, X. Yuan, G. Liu, and K. Tian, “Emergy and eco-exergy evaluation of wetland restoration based on the construction of a wetland landscape in the northwest Yunnan Plateau, China,” J. Environ. Manage., vol. 252, p. 109499, Dec. 2019, doi: 10.1016/j.jenvman.2019.109499.
[3429]	S. Song et al., “Emission characteristics of polychlorinated, polybrominated and mixed polybrominated/chlorinated dibenzo-p-dioxins and dibenzofurans (PCDD/Fs, PBDD/Fs, and PBCDD/Fs) from waste incineration and metallurgical processes in China,” Ecotoxicol. Environ. Saf., vol. 184, p. 109608, Nov. 2019, doi: 10.1016/j.ecoenv.2019.109608.
[3430]	S.-J. Chen et al., “Emission factors and congener-specific characterization of PCDD/Fs, PCBs, PBDD/Fs and PBDEs from an off-road diesel engine using waste cooking oil-based biodiesel blends,” J. Hazard. Mater., vol. 339, pp. 274–280, Oct. 2017, doi: 10.1016/j.jhazmat.2017.06.045.
[3431]	N. Ortuño, S. Lundstedt, and L. Lundin, “Emissions of PBDD/Fs, PCDD/Fs and PBDEs from flame-retarded high-impact polystyrene under thermal stress,” Chemosphere, vol. 123, pp. 64–70, Mar. 2015, doi: 10.1016/j.chemosphere.2014.10.085.
[3432]	T. Huang, B. J. Engelmann, R. M. Morgan, K. J. Absher, J. M. Kolesar, and J. L. Villano, “EML4-ALK rearrangement in squamous cell carcinoma shows significant response to anti-ALK inhibitor drugs crizotinib and alectinib,” Cancer Chemother. Pharmacol., vol. 81, no. 5, pp. 965–968, 2018, doi: 10.1007/s00280-018-3571-2.
[3433]	M. Shukla, E. C. Rasmussen, and P. G. Nestor, “Emotion and decision-making: Induced mood influences IGT scores and deck selection strategies,” J Clin Exp Neuropsychol, vol. 41, no. 4, pp. 341–352, 2019, doi: 10.1080/13803395.2018.1562049.
[3434]	T. H. Kelly and M. T. Bardo, “Emotion regulation and drug abuse: Implications for prevention and treatment,” Drug Alcohol Depend, vol. 163 Suppl 1, pp. S1-2, 01 2016, doi: 10.1016/j.drugalcdep.2016.02.038.
[3435]	N. Warren, K. Walford, A. Susilo, and P. W. New, “Emotional Consequences of Delays in Spinal Rehabilitation Unit Admission or Discharge: A Qualitative Study on the Importance of Communication,” Top Spinal Cord Inj Rehabil, vol. 24, no. 1, pp. 54–62, 2018, doi: 10.1310/sci17-00026.
[3436]	H. Yiltiz and L. Chen, “Emotional cues and social anxiety resolve ambiguous perception of biological motion,” Exp Brain Res, vol. 236, no. 5, pp. 1409–1420, 2018, doi: 10.1007/s00221-018-5233-3.
[3437]	G. Egidi and H. C. Nusbaum, “Emotional language processing: how mood affects integration processes during discourse comprehension,” Brain Lang, vol. 122, no. 3, pp. 199–210, Sep. 2012, doi: 10.1016/j.bandl.2011.12.008.
[3438]	D. Li, H. Xu, M. Kang, and S. Ma, “Empathy in Chinese eight-year medical program students: differences by school year, educational stage, and future career preference,” BMC Med Educ, vol. 18, no. 1, p. 241, Oct. 2018, doi: 10.1186/s12909-018-1348-2.
[3439]	D. Zippel, R. Shapiro, O. Goitein, O. Halshtok, and M. Papa, “Emphysematous cholecystitis: don’t be lulled into complacency,” J Emerg Med, vol. 41, no. 4, pp. 400–401, Oct. 2011, doi: 10.1016/j.jemermed.2009.08.013.
[3440]	P. L. de Zwart, B. F. Jeronimus, and P. de Jonge, “Empirical evidence for definitions of episode, remission, recovery, relapse and recurrence in depression: a systematic review,” Epidemiol Psychiatr Sci, vol. 28, no. 5, pp. 544–562, Oct. 2019, doi: 10.1017/S2045796018000227.
[3441]	S. Bello et al., “Empirical evidence of delays in diagnosis and treatment of pulmonary tuberculosis: systematic review and meta-regression analysis,” BMC Public Health, vol. 19, no. 1, p. 820, Jun. 2019, doi: 10.1186/s12889-019-7026-4.
[3442]	M. C. M. Wo, K. S. Lim, W. Y. Choo, and C. T. Tan, “Employability in people with epilepsy: A systematic review,” Epilepsy Res., vol. 116, pp. 67–78, Oct. 2015, doi: 10.1016/j.eplepsyres.2015.06.016.
[3443]	F. Stinglhamber et al., “Employees’ organizational identification and affective organizational commitment: an integrative approach,” PLoS ONE, vol. 10, no. 4, p. e0123955, 2015, doi: 10.1371/journal.pone.0123955.
[3444]	A. Jacoby, J. Gorry, and G. A. Baker, “Employers’ attitudes to employment of people with epilepsy: still the same old story?,” Epilepsia, vol. 46, no. 12, pp. 1978–1987, Dec. 2005, doi: 10.1111/j.1528-1167.2005.00345.x.
[3445]	B. Majkowska-Zwolińska, J. Jędrzejczak, and K. Owczarek, “Employment in people with epilepsy from the perspectives of patients, neurologists, and the general population,” Epilepsy Behav, vol. 25, no. 4, pp. 489–494, Dec. 2012, doi: 10.1016/j.yebeh.2012.10.001.
[3446]	F. S. van Dijk et al., “EMQN best practice guidelines for the laboratory diagnosis of osteogenesis imperfecta,” Eur. J. Hum. Genet., vol. 20, no. 1, pp. 11–19, Jan. 2012, doi: 10.1038/ejhg.2011.141.
[3447]	Y. Cheng and S. Yuan, “Emulsification of Surfactant on Oil Droplets by Molecular Dynamics Simulation,” Molecules, vol. 25, no. 13, Jun. 2020, doi: 10.3390/molecules25133008.
[3448]	A. Pinto et al., “Enamel Mineral Content Changes After Bleaching With High and Low Hydrogen Peroxide Concentrations: Colorimetric Spectrophotometry and Total Reflection X-ray Fluorescence Analyses,” Oper Dent, vol. 42, no. 3, pp. 308–318, Jun. 2017, doi: 10.2341/16-032-L.
[3449]	B. Ju, S. Chen, and W. Kong, “Enantioselective palladium-catalyzed diarylation of unactivated alkenes,” Chem. Commun. (Camb.), vol. 55, no. 95, pp. 14311–14314, Nov. 2019, doi: 10.1039/c9cc07036b.
[3450]	C. Zhao et al., “Encapsulation of lycopene within oil-in-water nanoemulsions using lactoferrin: Impact of carrier oils on physicochemical stability and bioaccessibility,” Int. J. Biol. Macromol., vol. 153, pp. 912–920, Jun. 2020, doi: 10.1016/j.ijbiomac.2020.03.063.
[3451]	E. M. Gubba, C. M. Netherton, and J. Herbert, “Endangerment of the brain by glucocorticoids: experimental and clinical evidence,” J. Neurocytol., vol. 29, no. 5–6, pp. 439–449, Jun. 2000, doi: 10.1023/a:1007177610378.
[3452]	Z. P. Van Acker, M. Bretou, and W. Annaert, “Endo-lysosomal dysregulations and late-onset Alzheimer’s disease: impact of genetic risk factors,” Mol Neurodegener, vol. 14, no. 1, p. 20, 03 2019, doi: 10.1186/s13024-019-0323-7.
[3453]	Y. Komatsu et al., “Endocardial ablation to eliminate epicardial arrhythmia substrate in scar-related ventricular tachycardia,” J. Am. Coll. Cardiol., vol. 63, no. 14, pp. 1416–1426, Apr. 2014, doi: 10.1016/j.jacc.2013.10.087.
[3454]	J. M. Goldman, S. C. Laws, S. K. Balchak, R. L. Cooper, and R. J. Kavlock, “Endocrine-disrupting chemicals: prepubertal exposures and effects on sexual maturation and thyroid activity in the female rat. A focus on the EDSTAC recommendations,” Crit. Rev. Toxicol., vol. 30, no. 2, pp. 135–196, Mar. 2000, doi: 10.1080/10408440091159185.
[3455]	D. Delgermurun, S. Ito, T. Ohta, S. Yamaguchi, and K. Otsuguro, “Endogenous 5-HT outflow from chicken aorta by 5-HT uptake inhibitors and amphetamine derivatives,” J. Vet. Med. Sci., vol. 78, no. 1, pp. 71–76, Jan. 2016, doi: 10.1292/jvms.15-0146.
[3456]	S. Shousha, K. Nakahara, M. Miyazato, K. Kangawa, and N. Murakami, “Endogenous neuromedin U has anorectic effects in the Japanese quail,” Gen. Comp. Endocrinol., vol. 140, no. 3, pp. 156–163, Feb. 2005, doi: 10.1016/j.ygcen.2004.11.002.
[3457]	T. Ito et al., “Endolymphatic volume in patients with meniere’s disease and healthy controls: Three-dimensional analysis with magnetic resonance imaging,” Laryngoscope Investig Otolaryngol, vol. 4, no. 6, pp. 653–658, Dec. 2019, doi: 10.1002/lio2.313.
[3458]	C. Leibiger et al., “Endolysosomal pathway activity protects cells from neurotoxic TDP-43,” Microb Cell, vol. 5, no. 4, pp. 212–214, Mar. 2018, doi: 10.15698/mic2018.04.627.
[3459]	N. T. Sprenkle, S. G. Sims, C. L. Sánchez, and G. P. Meares, “Endoplasmic reticulum stress and inflammation in the central nervous system,” Mol Neurodegener, vol. 12, no. 1, p. 42, 25 2017, doi: 10.1186/s13024-017-0183-y.
[3460]	J. K. Kim et al., “Endoscopic management of afferent loop syndrome after a pylorus preserving pancreatoduodenecotomy presenting with obstructive jaundice and ascending cholangitis,” Clin Endosc, vol. 44, no. 1, pp. 59–64, Sep. 2011, doi: 10.5946/ce.2011.44.1.59.
[3461]	A. R. Alves, N. Almeida, M. Ferreira, and L. Tomé, “Endoscopic management of afferent loop syndrome caused by enteroliths and anastomotic stricture. A case report,” Rev Esp Enferm Dig, vol. 109, no. 6, p. 457, Jun. 2017.
[3462]	H.-R. Koh et al., “Endoscopic retrograde cholangiopancreatography in patients with previous acute coronary syndrome,” Gut Liver, vol. 8, no. 6, pp. 674–679, Nov. 2014, doi: 10.5009/gnl13301.
[3463]	C. Hill et al., “Endoscopic sleeve gastroplasty: the learning curve,” Endosc Int Open, vol. 5, no. 9, pp. E900–E904, Sep. 2017, doi: 10.1055/s-0043-115387.
[3464]	A. Nassimizadeh, S. M. Zaidi, M. Nassimizadeh, A. Kholief, and S. K. Ahmed, “Endoscopic training-is the future three-dimensional?,” Laryngoscope Investig Otolaryngol, vol. 3, no. 5, pp. 345–348, Oct. 2018, doi: 10.1002/lio2.207.
[3465]	S. H. Kim et al., “Endoscopic treatment of duodenal neuroendocrine tumors,” Clin Endosc, vol. 46, no. 6, pp. 656–661, Nov. 2013, doi: 10.5946/ce.2013.46.6.656.
[3466]	W. Y. Lee and J. S. Moon, “Endoscopic treatment of efferent loop syndrome with insertion of double pigtail stent,” World J. Gastroenterol., vol. 19, no. 41, pp. 7209–7212, Nov. 2013, doi: 10.3748/wjg.v19.i41.7209.
[3467]	P. Taunk, N. Cosgrove, D. E. Loren, T. Kowalski, and A. A. Siddiqui, “Endoscopic ultrasound-guided gastroenterostomy using a lumen-apposing self-expanding metal stent for decompression of afferent loop obstruction,” Endoscopy, vol. 47 Suppl 1 UCTN, pp. E395-396, 2015, doi: 10.1055/s-0034-1392564.
[3468]	H. Shiomi et al., “Endoscopic ultrasound-guided gastrojejunostomy using fully covered metal stent combined with large-loop double-pigtail stent for malignant afferent loop syndrome,” Endoscopy, vol. 51, no. 10, pp. E303–E304, 2019, doi: 10.1055/a-0916-8532.
[3469]	E. Cho et al., “Endoscopic variceal ligation-induced ulcer bleeding: What are the risk factors and treatment strategies?,” Medicine (Baltimore), vol. 96, no. 24, p. e7157, Jun. 2017, doi: 10.1097/MD.0000000000007157.
[3470]	G.-H. Lo, “Endoscopy Examination Time: Longer Is Really Better?,” Gastroenterology, vol. 154, no. 3, p. 765, 2018, doi: 10.1053/j.gastro.2017.09.056.
[3471]	M. F. O’Rourke, “Endothelial (DYS)Function:  Quo vadis, Cur vadis,” J. Hypertens., vol. 30, no. 7, pp. 1321–1324, Jul. 2012, doi: 10.1097/HJH.0b013e32835522e2.
[3472]	P. A. Bacon, “Endothelial cell dysfunction in systemic vasculitis: new developments and therapeutic prospects,” Curr Opin Rheumatol, vol. 17, no. 1, pp. 49–55, Jan. 2005, doi: 10.1097/01.bor.0000149084.16639.b0.
[3473]	S. S. Hasan et al., “Endothelial Notch signaling controls insulin transport in muscle,” EMBO Mol Med, vol. 12, no. 4, p. e09271, Apr. 2020, doi: 10.15252/emmm.201809271.
[3474]	R. C. Grenn et al., “Endothelial progenitor dysfunction associates with a type I interferon signature in primary antiphospholipid syndrome,” Ann. Rheum. Dis., vol. 76, no. 2, pp. 450–457, Feb. 2017, doi: 10.1136/annrheumdis-2016-209442.
[3475]	Z. Zhang, M. Ji, Y. Liao, J. Yang, and J. Gao, “Endotoxin tolerance induced by lipopolysaccharide preconditioning protects against surgery‑induced cognitive impairment in aging mice,” Mol Med Rep, vol. 17, no. 3, pp. 3845–3852, Mar. 2018, doi: 10.3892/mmr.2018.8370.
[3476]	S. C. Cunnane and M. A. Crawford, “Energetic and nutritional constraints on infant brain development: implications for brain expansion during human evolution,” J. Hum. Evol., vol. 77, pp. 88–98, Dec. 2014, doi: 10.1016/j.jhevol.2014.05.001.
[3477]	Y. Mu and X. Mu, “Energy conservation in the earth’s crust and climate change,” J Air Waste Manag Assoc, vol. 63, no. 2, pp. 150–160, Feb. 2013, doi: 10.1080/10962247.2012.739501.
[3478]	J. M. Olson, “Energy conversion in photosynthesis. BNL 50051 (T-458),” Tech Rep Brookhaven Natl Lab, pp. 1–9, May 1966.
[3479]	T. Niem, N. Youssef, and B. Wöstmann, “Energy dissipation capacities of CAD-CAM restorative materials: A comparative evaluation of resilience and toughness,” J Prosthet Dent, vol. 121, no. 1, pp. 101–109, Jan. 2019, doi: 10.1016/j.prosdent.2018.05.003.
[3480]	J. D. Meeker, M. R. Cooper, D. Lefkowitz, and P. Susi, “Engineering control technologies to reduce occupational silica exposures in masonry cutting and tuckpointing,” Public Health Rep, vol. 124 Suppl 1, pp. 101–111, Aug. 2009, doi: 10.1177/00333549091244S112.
[3481]	K. T. Hamorsky et al., “Engineering of a Lectibody Targeting High-Mannose-Type Glycans of the HIV Envelope,” Mol. Ther., vol. 27, no. 11, pp. 2038–2052, 06 2019, doi: 10.1016/j.ymthe.2019.07.021.
[3482]	F. C. Emrich et al., “Enhanced caspase activity contributes to aortic wall remodeling and early aneurysm development in a murine model of Marfan syndrome,” Arterioscler. Thromb. Vasc. Biol., vol. 35, no. 1, pp. 146–154, Jan. 2015, doi: 10.1161/ATVBAHA.114.304364.
[3483]	O. Pluchery, C. Humbert, M. Valamanesh, E. Lacaze, and B. Busson, “Enhanced detection of thiophenol adsorbed on gold nanoparticles by SFG and DFG nonlinear optical spectroscopy,” Phys Chem Chem Phys, vol. 11, no. 35, pp. 7729–7737, Sep. 2009, doi: 10.1039/b902142f.
[3484]	L. K. Kuehl, C. E. Deuter, J. Hellmann-Regen, M. Kaczmarczyk, C. Otte, and K. Wingenfeld, “Enhanced noradrenergic activity by yohimbine and differential fear conditioning in patients with major depression with and without adverse childhood experiences,” Prog. Neuropsychopharmacol. Biol. Psychiatry, vol. 96, p. 109751, 10 2020, doi: 10.1016/j.pnpbp.2019.109751.
[3485]	S. J. Harris, A. J. Gearing, G. T. Layton, S. E. Adams, and A. J. Kingsman, “Enhanced proliferative cellular responses to HIV-1 V3 peptide and gp120 following immunization with V3:Ty virus-like particles,” Immunology, vol. 77, no. 3, pp. 315–321, Nov. 1992.
[3486]	K. S. Hougaard and A. M. Hansen, “Enhancement of developmental toxicity effects of chemicals by gestational stress. A review,” Neurotoxicol Teratol, vol. 29, no. 4, pp. 425–445, Aug. 2007, doi: 10.1016/j.ntt.2007.02.003.
[3487]	N. Ghosh and U. Chattopadhyay, “Enhancement of immune response by phenothiazine administration in vivo,” In Vivo, vol. 7, no. 5, pp. 435–440, Oct. 1993.
[3488]	M. Fang, W.-R. Guo, Y. Park, H.-G. Kang, and H. Zarbl, “Enhancement of NAD+-dependent SIRT1 deacetylase activity by methylselenocysteine resets the circadian clock in carcinogen-treated mammary epithelial cells,” Oncotarget, vol. 6, no. 40, pp. 42879–42891, Dec. 2015, doi: 10.18632/oncotarget.6002.
[3489]	A. Hori, T. Morita, I. Yoshida, and M. Tsubokura, “Enhancement of PTSD treatment through social support in Idobata-Nagaya community housing after Fukushima’s triple disaster,” BMJ Case Rep, vol. 2018, Jun. 2018, doi: 10.1136/bcr-2018-224935.
[3490]	G. Ribeiro-dos-Santos, A. C. Schenberg, D. C. Gardner, and S. G. Oliver, “Enhancement of Ty transposition at the ADH4 and ADH2 loci in meiotic yeast cells,” Mol. Gen. Genet., vol. 254, no. 5, pp. 555–561, May 1997, doi: 10.1007/s004380050451.
[3491]	J. Hauber, P. Nelböck, U. Pilz, and H. Feldmann, “Enhancer-like stimulation of yeast tRNA gene expression by a defined region of the Ty element micro-injected into Xenopus oocytes,” Biol. Chem. Hoppe-Seyler, vol. 367, no. 11, pp. 1141–1146, Nov. 1986, doi: 10.1515/bchm3.1986.367.2.1141.
[3492]	S. D. Horner, A. Brown, S. A. Brown, and D. L. Rew, “Enhancing Asthma Self-Management in Rural School-Aged Children: A Randomized Controlled Trial,” J Rural Health, vol. 32, no. 3, pp. 260–268, 2016, doi: 10.1111/jrh.12150.
[3493]	S. E. Mondello, S. C. Jefferson, W. A. O’Steen, and D. R. Howland, “Enhancing Fluorogold-based neural tract tracing,” J. Neurosci. Methods, vol. 270, pp. 85–91, 01 2016, doi: 10.1016/j.jneumeth.2016.06.004.
[3494]	X.-Y. Yu et al., “Enhancing the chemical mixture methodology in emergency preparedness and consequence assessment analysis,” Toxicology, vol. 313, no. 2–3, pp. 174–184, Nov. 2013, doi: 10.1016/j.tox.2012.10.011.
[3495]	J. Ranse, A. Hutton, S. A. Turris, and A. Lund, “Enhancing the minimum data set for mass-gathering research and evaluation: an integrative literature review,” Prehosp Disaster Med, vol. 29, no. 3, pp. 280–289, Jun. 2014, doi: 10.1017/S1049023X14000429.
[3496]	J. I. Dawson et al., “Enhancing the osteogenic efficacy of human bone marrow aspirate: concentrating osteoprogenitors using wave-assisted filtration,” Cytotherapy, vol. 15, no. 2, pp. 242–252, Feb. 2013, doi: 10.1016/j.jcyt.2012.09.004.
[3497]	N. L. Sin and S. Lyubomirsky, “Enhancing well-being and alleviating depressive symptoms with positive psychology interventions: a practice-friendly meta-analysis,” J Clin Psychol, vol. 65, no. 5, pp. 467–487, May 2009, doi: 10.1002/jclp.20593.
[3498]	S. Manjula and R. Subramanian, “Enriching oryzanol in rice bran oil using membranes,” Appl. Biochem. Biotechnol., vol. 151, no. 2–3, pp. 629–637, Dec. 2008, doi: 10.1007/s12010-008-8273-5.
[3499]	“Ensuring the timely supply and management of medicines for preventive chemotherapy against neglected tropical diseases,” Wkly. Epidemiol. Rec., vol. 92, no. 13, pp. 155–164, 31 2017.
[3500]	S. Ankri, “Entamoeba histolytica - tumor necrosis factor: a fatal attraction,” Microb Cell, vol. 2, no. 7, pp. 216–218, Jul. 2015, doi: 10.15698/mic2015.07.216.
[3501]	D. Y. Yi, “Enteral Nutrition in Pediatric Patients,” Pediatr Gastroenterol Hepatol Nutr, vol. 21, no. 1, pp. 12–19, Jan. 2018, doi: 10.5223/pghn.2018.21.1.12.
[3502]	L. Gútiez et al., “Enterococcus faecalis strains from food, environmental, and clinical origin produce ACE-inhibitory peptides and other bioactive peptides during growth in bovine skim milk,” Int. J. Food Microbiol., vol. 166, no. 1, pp. 93–101, Aug. 2013, doi: 10.1016/j.ijfoodmicro.2013.06.019.
[3503]	M. C. Lee, J. T. Bui, M.-G. Knuttinen, R. C. Gaba, W. Scott Helton, and C. A. Owens, “Enterolith causing afferent loop obstruction: a case report and literature review,” Cardiovasc Intervent Radiol, vol. 32, no. 5, pp. 1091–1096, Sep. 2009, doi: 10.1007/s00270-009-9561-3.
[3504]	D. Henao, M. Navarrete, M. Valderrama, and M. Le Van Quyen, “Entrainment and synchronization of brain oscillations to auditory stimulations,” Neurosci. Res., vol. 156, pp. 271–278, Jul. 2020, doi: 10.1016/j.neures.2020.03.004.
[3505]	R. M. Cunningham, “Entrepreneurialism in medicine,” N. Engl. J. Med., vol. 309, no. 21, pp. 1313–1314, Nov. 1983, doi: 10.1056/NEJM198311243092109.
[3506]	T. R. Smith and A. Bhatnagar, “Enviromics: understanding aging,” Aging (Albany NY), vol. 11, no. 1, pp. 9–10, 14 2018, doi: 10.18632/aging.101709.
[3507]	D. deB Richter and M. L. Mobley, “Environment. Monitoring Earth’s critical zone,” Science, vol. 326, no. 5956, pp. 1067–1068, Nov. 2009, doi: 10.1126/science.1179117.
[3508]	E. Smith, “Environmental chemicals, respiratory hypersensitization and international chemical safety,” Toxicol. Lett., vol. 86, no. 2–3, pp. 61–63, Aug. 1996, doi: 10.1016/0378-4274(96)03673-9.
[3509]	R. Y. Wang and L. L. Needham, “Environmental chemicals: from the environment to food, to breast milk, to the infant,” J Toxicol Environ Health B Crit Rev, vol. 10, no. 8, pp. 597–609, Dec. 2007, doi: 10.1080/10937400701389891.
[3510]	J. V. Nabholz, “Environmental hazard and risk assessment under the United States Toxic Substances Control Act,” Sci. Total Environ., vol. 109–110, pp. 649–665, Dec. 1991, doi: 10.1016/0048-9697(91)90218-4.
[3511]	M. Neira, E. Fletcher, M. N. Brune-Drisse, M. Pfeiffer, H. Adair-Rohani, and C. Dora, “Environmental health policies for women’s, children’s and adolescents’ health,” Bull. World Health Organ., vol. 95, no. 8, pp. 604–606, Aug. 2017, doi: 10.2471/BLT.16.171736.
[3512]	“Environmental isolation of circulating vaccine-derived poliovirus after interruption of wild poliovirus transmission, Nigeria, 2016,” Wkly. Epidemiol. Rec., vol. 91, no. 31, pp. 375–379, Aug. 2016.
[3513]	S. K. Meyer et al., “Environmental Xenoestrogens Super-Activate a Variant Murine ER Beta in Cholangiocytes,” Toxicol. Sci., vol. 156, no. 1, pp. 54–71, 01 2017, doi: 10.1093/toxsci/kfw234.
[3514]	J. Jin, X. Dou, L. Meng, and H. Yu, “Environmental-friendly Eco-labeling Matters: Evidences From an ERPs Study,” Front Hum Neurosci, vol. 12, p. 417, 2018, doi: 10.3389/fnhum.2018.00417.
[3515]	M. S. Bamji, N. Chowdhury, B. A. Ramalakshmi, and C. M. Jacob, “Enzymatic evaluation of riboflavin status of infants,” Eur J Clin Nutr, vol. 45, no. 6, pp. 309–313, Jun. 1991.
[3516]	L.-A. Fraser, J. G. Burneo, and J. A. Fraser, “Enzyme-inducing antiepileptic drugs and fractures in people with epilepsy: A systematic review,” Epilepsy Res., vol. 116, pp. 59–66, Oct. 2015, doi: 10.1016/j.eplepsyres.2015.07.003.
[3517]	W. Choi et al., “Eosinophilic gastroenteritis due to rhus ingestion presenting with gastrointestinal hemorrhage,” Clin Endosc, vol. 48, no. 2, pp. 174–177, Mar. 2015, doi: 10.5946/ce.2015.48.2.174.
[3518]	“Epidemic focus,” Wkly. Epidemiol. Rec., vol. 91, no. 17, pp. 217–218, Apr. 2016.
[3519]	“Epidemic focus: Cholera,” Wkly. Epidemiol. Rec., vol. 91, no. 23, pp. 297–298, Jun. 2016.
[3520]	“Epidemic focus: Influenza,” Wkly. Epidemiol. Rec., vol. 91, no. 22, pp. 285–286, Jun. 2016.
[3521]	“Epidemic focus: Lassa Fever,” Wkly. Epidemiol. Rec., vol. 91, no. 21, pp. 265–266, May 2016.
[3522]	“Epidemic focus. Waiting in the wings: Aedes mosquitoes and flavivirus epidemics,” Wkly. Epidemiol. Rec., vol. 91, no. 19, pp. 249–250, May 2016.
[3523]	“Epidemic meningitis control in countries of the African meningitis belt, 2016,” Wkly. Epidemiol. Rec., vol. 92, no. 13, pp. 145–154, 31 2017.
[3524]	I. I. Kessler, “Epidemiological considerations in the role of dendritic/Langerhans cells in human cancer,” In Vivo, vol. 7, no. 3, pp. 305–312, Jun. 1993.
[3525]	M. A. Parker and J. C. Anthony, “Epidemiological evidence on extra-medical use of prescription pain relievers: transitions from newly incident use to dependence among 12-21 year olds in the United States using meta-analysis, 2002-13,” PeerJ, vol. 3, p. e1340, 2015, doi: 10.7717/peerj.1340.
[3526]	G. M. Gabb, P. Ryan, L. M. Wing, and K. A. Hutchinson, “Epidemiological study of angioedema and ACE inhibitors,” Aust N Z J Med, vol. 26, no. 6, pp. 777–782, Dec. 1996, doi: 10.1111/j.1445-5994.1996.tb00624.x.
[3527]	H. Hauner, “[Epidemiology and costs of diabetes mellitus in Germany],” Dtsch. Med. Wochenschr., vol. 130 Suppl 2, pp. S64-65, Jul. 2005, doi: 10.1055/s-2005-870872.
[3528]	L. P. Garcia and E. Duarte, “Epidemiology and Health Services: the trajectory of the Brazilian National Health System Journal,” Cien Saude Colet, vol. 20, no. 7, pp. 2081–2090, Jul. 2015, doi: 10.1590/1413-81232015207.06122015.
[3529]	E. McCarthy and I. Petrakis, “Epidemiology and management of alcohol dependence in individuals with post-traumatic stress disorder,” CNS Drugs, vol. 24, no. 12, pp. 997–1007, Dec. 2010, doi: 10.2165/11539710-000000000-00000.
[3530]	L. Ouellette, M. Hamati, M. Flannigan, M. Singh, C. Bush, and J. Jones, “Epidemiology of and risk factors for iliopsoas abscess in a large community-based study,” Am J Emerg Med, vol. 37, no. 1, pp. 158–159, 2019, doi: 10.1016/j.ajem.2018.05.021.
[3531]	S. Gimeno-Martos, C. Pérez-Riera, S. Guardiola-Vilarroig, and C. Cavero-Carbonell, “[Epidemiology of Imperfect Osteogenesis: a Rare Disease in the Valencia Region.],” Rev. Esp. Salud Publica, vol. 91, Nov. 2017.
[3532]	P. D. Baade, D. R. Youlden, S. M. Cramb, J. Dunn, and R. A. Gardiner, “Epidemiology of prostate cancer in the Asia-Pacific region,” Prostate Int, vol. 1, no. 2, pp. 47–58, 2013, doi: 10.12954/PI.12014.
[3533]	A. Covic et al., “Epidemiology of renal disease in Romania: a 10 year review of two regional renal biopsy databases,” Nephrol. Dial. Transplant., vol. 21, no. 2, pp. 419–424, Feb. 2006, doi: 10.1093/ndt/gfi207.
[3534]	L. V. Kessing, “Epidemiology of subtypes of depression,” Acta Psychiatr Scand Suppl, no. 433, pp. 85–89, 2007, doi: 10.1111/j.1600-0447.2007.00966.x.
[3535]	M. Alabousi et al., “Epidemiology of systematic reviews in imaging journals: evaluation of publication trends and sustainability?,” Eur Radiol, vol. 29, no. 2, pp. 517–526, Feb. 2019, doi: 10.1007/s00330-018-5567-z.
[3536]	C. I. Ioannou, J. Hafer, A. Lee, and E. Altenmüller, “Epidemiology, Treatment Efficacy, and Anxiety Aspects of Music Students Affected by Playing-Related Pain: A Retrospective Evaluation with Follow-up,” Med Probl Perform Art, vol. 33, no. 1, pp. 26–38, 2018, doi: 10.21091/mppa.2018.1006.
[3537]	M. A. Duffy, “Epidemiology. It helps to be well connected,” Science, vol. 344, no. 6189, pp. 1229–1230, Jun. 2014, doi: 10.1126/science.1255350.
[3538]	Y. Mizukawa, T. Doi, Y. Yamazaki, A. Kudo, and T. Shiohara, “Epidermal Neuromedin U Attenuates IgE-Mediated Allergic Skin Inflammation,” PLoS ONE, vol. 11, no. 7, p. e0160122, 2016, doi: 10.1371/journal.pone.0160122.
[3539]	A. Thangamuthu, I. F. Russell, and M. Purva, “Epidural failure rate using a standardised definition,” Int J Obstet Anesth, vol. 22, no. 4, pp. 310–315, Nov. 2013, doi: 10.1016/j.ijoa.2013.04.013.
[3540]	U. Schmidt, F. Holsboer, and T. Rein, “Epigenetic aspects of posttraumatic stress disorder,” Dis. Markers, vol. 30, no. 2–3, pp. 77–87, 2011, doi: 10.3233/DMA-2011-0749.
[3541]	D. Tsukamoto, M. Ito, and N. Takamatsu, “Epigenetic regulation of hibernation-associated HP-20 and HP-27 gene transcription in chipmunk liver,” Biochem. Biophys. Res. Commun., vol. 495, no. 2, pp. 1758–1765, 08 2018, doi: 10.1016/j.bbrc.2017.12.052.
[3542]	Y. Wu and B. P. Zhou, “Epigenetic regulation of LSD1 during mammary carcinogenesis,” Mol Cell Oncol, vol. 1, no. 3, p. e963426, Sep. 2014, doi: 10.4161/21624011.2014.963426.
[3543]	R. Itzykson and P. Fenaux, “Epigenetics of myelodysplastic syndromes,” Leukemia, vol. 28, no. 3, pp. 497–506, Mar. 2014, doi: 10.1038/leu.2013.343.
[3544]	J. S. Bird, E. Shah, and P. Shotbolt, “Epilepsy and concomitant obsessive-compulsive disorder,” Epilepsy Behav Case Rep, vol. 10, pp. 106–110, 2018, doi: 10.1016/j.ebcr.2018.07.001.
[3545]	M. Matsuura, “[Epilepsy and driving],” Brain Nerve, vol. 65, no. 1, pp. 67–75, Jan. 2013.
[3546]	A. Verrotti, D. Carrozzino, M. Milioni, M. Minna, and M. Fulcheri, “Epilepsy and its main psychiatric comorbidities in adults and children,” J. Neurol. Sci., vol. 343, no. 1–2, pp. 23–29, Aug. 2014, doi: 10.1016/j.jns.2014.05.043.
[3547]	M. Matsuura, “[Epilepsy and law],” Rinsho Shinkeigaku, vol. 52, no. 11, pp. 1033–1035, 2012, doi: 10.5692/clinicalneurol.52.1033.
[3548]	A. M. Kanner, “Epilepsy and mood disorders,” Epilepsia, vol. 48 Suppl 9, pp. 20–22, 2007, doi: 10.1111/j.1528-1167.2007.01395.x.
[3549]	J. Pimentel, R. Tojal, and J. Morgado, “Epilepsy and physical exercise,” Seizure, vol. 25, pp. 87–94, Feb. 2015, doi: 10.1016/j.seizure.2014.09.015.
[3550]	A. W. Selassie, D. A. Wilson, G. U. Martz, G. G. Smith, J. L. Wagner, and B. B. Wannamaker, “Epilepsy beyond seizure: a population-based study of comorbidities,” Epilepsy Res., vol. 108, no. 2, pp. 305–315, Feb. 2014, doi: 10.1016/j.eplepsyres.2013.12.002.
[3551]	S. Hwang, A. Ettinger, and E. L. So, “Epilepsy comorbidities,” Continuum (Minneap Minn), vol. 16, no. 3 Epilepsy, pp. 86–104, Jun. 2010, doi: 10.1212/01.CON.0000368233.57233.c8.
[3552]	S. Amudhan, G. Gururaj, and P. Satishchandra, “Epilepsy in India I: Epidemiology and public health,” Ann Indian Acad Neurol, vol. 18, no. 3, pp. 263–277, Sep. 2015, doi: 10.4103/0972-2327.160093.
[3553]	H. O. Tayeb, “Epilepsy stigma in Saudi Arabia: The roles of mind-body dualism, supernatural beliefs, and religiosity,” Epilepsy Behav, vol. 95, pp. 175–180, 2019, doi: 10.1016/j.yebeh.2019.04.022.
[3554]	M. Tombini et al., “Epilepsy-associated stigma from the perspective of people with epilepsy and the community in Italy,” Epilepsy Behav, vol. 98, no. Pt A, pp. 66–72, 2019, doi: 10.1016/j.yebeh.2019.06.026.
[3555]	J. Sanchez-Davies, “Epilepsy, literature and linguistics: spotlighting subjective symptoms,” Med Humanit, vol. 45, no. 4, pp. 371–380, Dec. 2019, doi: 10.1136/medhum-2018-011460.
[3556]	J. Carrizosa-Moog et al., “Epilepsy, Physical Activity and Sports: A Narrative Review,” Can J Neurol Sci, vol. 45, no. 6, pp. 624–632, 2018, doi: 10.1017/cjn.2018.340.
[3557]	J. McCagh, J. E. Fisk, and G. A. Baker, “Epilepsy, psychosocial and cognitive functioning,” Epilepsy Res., vol. 86, no. 1, pp. 1–14, Sep. 2009, doi: 10.1016/j.eplepsyres.2009.04.007.
[3558]	G. M. A. S. Tedrus, R. B. Pereira, and M. Zoppi, “Epilepsy, stigma, and family,” Epilepsy Behav, vol. 78, pp. 265–268, 2018, doi: 10.1016/j.yebeh.2017.08.007.
[3559]	P. Striano and F. Zara, “Epilepsy: Common and rare epilepsies share genetic determinants,” Nat Rev Neurol, vol. 13, no. 4, pp. 200–201, Apr. 2017, doi: 10.1038/nrneurol.2017.30.
[3560]	P. Striano and F. Zara, “Epilepsy: HLA alleles linked to carbamazepine hypersensitivity,” Nat Rev Neurol, vol. 7, no. 7, pp. 365–366, Jun. 2011, doi: 10.1038/nrneurol.2011.90.
[3561]	P. Striano, F. Zara, A. Coppola, C. Ciampa, M. Pezzella, and S. Striano, “Epileptic myoclonus as ciprofloxacin-associated adverse effect,” Mov. Disord., vol. 22, no. 11, pp. 1675–1676, Aug. 2007, doi: 10.1002/mds.21456.
[3562]	M. Reuber, “‘Epileptics’, ‘people with epilepsy’, ‘PWE’, ‘epilepsy patients’--what is the best label?,” Seizure, vol. 23, no. 5, p. 327, May 2014, doi: 10.1016/j.seizure.2014.01.014.
[3563]	I. V. Balyasnikova et al., “Epitope mapping of mAbs to denatured human testicular ACE (CD143),” Tissue Antigens, vol. 72, no. 4, pp. 354–368, Oct. 2008, doi: 10.1111/j.1399-0039.2008.01112.x.
[3564]	O. A. Kost, I. V. Balyasnikova, E. E. Chemodanova, I. I. Nikolskaya, R. F. Albrecht, and S. M. Danilov, “Epitope-dependent blocking of the angiotensin-converting enzyme dimerization by monoclonal antibodies to the N-terminal domain of ACE: possible link of ACE dimerization and shedding from the cell surface,” Biochemistry, vol. 42, no. 23, pp. 6965–6976, Jun. 2003, doi: 10.1021/bi034645y.
[3565]	K. A. Pease, “Equipment records for modular analytical systems,” Qual Assur, vol. 4, no. 4, pp. 329–331, Dec. 1995.
[3566]	L. A. Dyck, S. Snelling, V. Morrison, M. Haworth-Brockman, and D. Atkinson, “Equity reporting: a framework for putting knowledge mobilization and health equity at the core of population health status reporting,” Health Promot Chronic Dis Prev Can, vol. 38, no. 3, pp. 116–124, Mar. 2018, doi: 10.24095/hpcdp.38.3.02.
[3567]	J. R. Masuda, T. Zupancic, E. Crighton, N. Muhajarine, and E. Phipps, “Equity-focused knowledge translation: a framework for ‘reasonable action’ on health inequities,” Int J Public Health, vol. 59, no. 3, pp. 457–464, Jun. 2014, doi: 10.1007/s00038-013-0520-z.
[3568]	“Eradication of yaws in India,” Wkly. Epidemiol. Rec., vol. 90, no. 15, pp. 161–168, Apr. 2015.
[3569]	K. T. Rew and J. J. Heidelbaugh, “Erectile Dysfunction,” Am Fam Physician, vol. 94, no. 10, pp. 820–827, Nov. 2016.
[3570]	“Errata,” In Vivo, vol. 29, no. 5, p. 617, Oct. 2015.
[3571]	“Errata,” In Vivo, vol. 34, no. 3, p. 1565, Jun. 2020.
[3572]	“Erratum,” J Minim Invasive Gynecol, vol. 22, no. 6, p. 1121, Oct. 2015, doi: 10.1016/j.jmig.2015.07.012.
[3573]	“Erratum,” Laryngoscope Investig Otolaryngol, vol. 4, no. 3, p. 374, Jun. 2019, doi: 10.1002/lio2.261.
[3574]	M. S. Vari et al., “Erratum to ‘De novo 12q22.q23.3 duplication associated with temporal lobe epilepsy’ [Seizure 57 (2018) 63-65],” Seizure, vol. 57, p. R1, 2018, doi: 10.1016/j.seizure.2018.04.003.
[3575]	S. La Gioia et al., “Erythroblastaemia in natalizumab-treated patients with multiple sclerosis,” Mult Scler Relat Disord, vol. 8, pp. 141–144, Jul. 2016, doi: 10.1016/j.msard.2016.05.020.
[3576]	G. P. Zara, X. Y. Qin, M. A. Pilot, H. H. Thomson, and J. P. Maskell, “Erythromycin and gastrointestinal motility,” Lancet, vol. 2, no. 8566, p. 1036, Oct. 1987, doi: 10.1016/s0140-6736(87)92611-0.
[3577]	N. Deshet-Unger et al., “Erythropoietin administration is associated with improved T-cell properties in patients with myelodysplastic syndromes,” Leuk. Res., vol. 52, pp. 20–27, Jan. 2017, doi: 10.1016/j.leukres.2016.11.002.
[3578]	W.-D. Zhao, D.-X. Liu, and Y.-H. Chen, “Escherichia coli hijack Caspr1 receptor to invade cerebral vascular and neuronal hosts,” Microb Cell, vol. 5, no. 9, pp. 418–420, Aug. 2018, doi: 10.15698/mic2018.09.647.
[3579]	O. M. Crespin et al., “Esophageal hypermotility: cause or effect?,” Dis. Esophagus, vol. 29, no. 5, pp. 497–502, Jul. 2016, doi: 10.1111/dote.12367.
[3580]	M. M. Oliveira et al., “Essential and toxic elements in human milk concentrate with human milk lyophilizate: A preclinical study,” Environ. Res., vol. 188, p. 109733, Sep. 2020, doi: 10.1016/j.envres.2020.109733.
[3581]	A. de Groot and E. Schmidt, “Essential Oils, Part V: Peppermint Oil, Lavender Oil, and Lemongrass Oil,” Dermatitis, vol. 27, no. 6, pp. 325–332, Dec. 2016, doi: 10.1097/DER.0000000000000218.
[3582]	T. Kiyama et al., “Essential roles of mitochondrial biogenesis regulator Nrf1 in retinal development and homeostasis,” Mol Neurodegener, vol. 13, no. 1, p. 56, 17 2018, doi: 10.1186/s13024-018-0287-z.
[3583]	N. J. Dent, “Essentials of quality in ‘the gold standard veterinary clinical trial,’” Qual Assur, vol. 6, no. 3, pp. 165–172, Sep. 1998, doi: 10.1080/105294199277833.
[3584]	J.-Y. Wang, “[Essentials of the treatment based on syndrome differentiation belonging to the meridian theory by professor Wang Ju-yi],” Zhongguo Zhen Jiu, vol. 30, no. 12, pp. 1021–1024, Dec. 2010.
[3585]	K. Wolf and M. C. Quimby, “Established eurythermic line of fish cells in vitro,” Science, vol. 135, no. 3508, pp. 1065–1066, Mar. 1962, doi: 10.1126/science.135.3508.1065.
[3586]	L. Rodriguez and R. T. Magari, “Establishing tolerance levels for customer complaints,” Qual Assur, vol. 11, no. 2, pp. 63–73, Jun. 2005, doi: 10.1080/10529410500280948.
[3587]	T. Kuzume et al., “Establishment and characterization of a thymic carcinoma cell line (Ty-82) carrying t(15;19)(q15;p13) chromosome abnormality,” Int. J. Cancer, vol. 50, no. 2, pp. 259–264, Jan. 1992, doi: 10.1002/ijc.2910500216.
[3588]	K. Kawashima, “ESTABLISHMENT OF A CELL LINE IN VITRO FROM A CASE OF HUMAN LUNG CANCER,” Sci Rep Res Inst Tohoku Univ Med, vol. 11, pp. 386–400, Apr. 1964.
[3589]	M. Matsuda et al., “Establishment of a myelodysplastic syndrome (MDS)/secondary AML-derived T lymphoid cell line K2-MDS,” Leuk. Res., vol. 24, no. 2, pp. 103–108, Feb. 2000, doi: 10.1016/s0145-2126(99)00168-x.
[3590]	K. W. Fagerstedt, T. Salonen, F. Zhao, S. Kytölä, T. Böhling, and L. C. Andersson, “Establishment of a spontaneously transformed cell line (JU-PI) from a myxoinflammatory fibroblastic sarcoma,” Tumour Biol., vol. 40, no. 5, p. 1010428318777936, May 2018, doi: 10.1177/1010428318777936.
[3591]	M. Liu, L. Yang, and Q. Min, “Establishment of an eco-compensation fund based on eco-services consumption,” J. Environ. Manage., vol. 211, pp. 306–312, Apr. 2018, doi: 10.1016/j.jenvman.2018.01.037.
[3592]	C. Arai, Y. Tsuzaki, N. Arai, M. Takeuchi, M. Kurimoto, and Y. Nagano, “Establishment of an in vivo human myeloid leukemia model in the SCID mouse,” In Vivo, vol. 13, no. 1, pp. 35–40, Feb. 1999.
[3593]	R. Kariya, K. Matsuda, K. Gotoh, K. Vaeteewoottacharn, S. Hattori, and S. Okada, “Establishment of nude mice with complete loss of lymphocytes and NK cells and application for in vivo bio-imaging,” In Vivo, vol. 28, no. 5, pp. 779–784, Oct. 2014.
[3594]	D. Gyenwali, G. Khanal, R. Paudel, A. Amatya, J. Pariyar, and S. R. Onta, “Estimates of delays in diagnosis of cervical cancer in Nepal,” BMC Womens Health, vol. 14, no. 1, p. 29, Feb. 2014, doi: 10.1186/1472-6874-14-29.
[3595]	F. L. Lynch and G. N. Clarke, “Estimating the economic burden of depression in children and adolescents,” Am J Prev Med, vol. 31, no. 6 Suppl 1, pp. S143-151, Dec. 2006, doi: 10.1016/j.amepre.2006.07.001.
[3596]	J. R. Frytak, H. J. Henk, C. M. De Castro, R. Halpern, and M. Nelson, “Estimation of economic costs associated with transfusion dependence in adults with MDS,” Curr Med Res Opin, vol. 25, no. 8, pp. 1941–1951, Aug. 2009, doi: 10.1185/03007990903076699.
[3597]	R. M. Lindsay, P. G. Blake, and E. Bradfield, “Estimation of hemodialysis access blood flow rates by a urea method is a poor predictor of access outcome,” ASAIO J., vol. 44, no. 6, pp. 818–822, Dec. 1998, doi: 10.1097/00002480-199811000-00010.
[3598]	C. Lindholm, A. Pekkarinen, O. Sipilä, A.-L. Manninen, M. Lehtinen, and T. Siiskonen, “ESTIMATION OF HP(3) AMONG STAFF MEMBERS IN TWO NUCLEAR MEDICINE UNITS IN FINLAND,” Radiat Prot Dosimetry, vol. 190, no. 2, pp. 176–184, Aug. 2020, doi: 10.1093/rpd/ncaa096.
[3599]	R. L. Bailey, S. G. Pac, V. L. Fulgoni, K. C. Reidy, and P. M. Catalano, “Estimation of Total Usual Dietary Intakes of Pregnant Women in the United States,” JAMA Netw Open, vol. 2, no. 6, p. e195967, 05 2019, doi: 10.1001/jamanetworkopen.2019.5967.
[3600]	S. V. Poorna Pillutla, C. Kaur, T. S. Roy, and T. G. Jacob, “Estimation of Volume of Stria Vascularis and the Length of Its Capillaries in the Human Cochlea,” J Microsc Ultrastruct, vol. 7, no. 3, pp. 117–123, Sep. 2019, doi: 10.4103/JMAU.JMAU_12_19.
[3601]	S. J. Krajewski-Hall, E. M. Blackmore, J. R. McMinn, and N. E. Rance, “Estradiol alters body temperature regulation in the female mouse,” Temperature (Austin), vol. 5, no. 1, pp. 56–69, 2018, doi: 10.1080/23328940.2017.1384090.
[3602]	F. Shimizu et al., “Estradiol suppresses NMU mRNA expression during sexual maturation in the female rat pituitary,” Int. J. Dev. Neurosci., vol. 26, no. 3–4, pp. 381–384, Jun. 2008, doi: 10.1016/j.ijdevneu.2007.11.002.
[3603]	J. I. Raeside, H. L. Christie, R. O. Waelchli, and K. J. Betteridge, “Estrogen metabolism by the equine embryo proper during the fourth week of pregnancy,” Reproduction, vol. 138, no. 6, pp. 953–960, Dec. 2009, doi: 10.1530/REP-09-0235.
[3604]	C. H. Anderson, R. A. Hussain, M. C. Han, and C. W. Beattie, “Estrous cycle dependence of nitrosomethylurea (NMU)-induced preneoplastic lesions in rat mammary gland,” Cancer Lett., vol. 56, no. 1, pp. 77–84, Jan. 1991, doi: 10.1016/0304-3835(91)90197-p.
[3605]	S. B. Park et al., “Ethanol extracts from the branch of Taxillus yadoriki parasitic to Neolitsea sericea induces cyclin D1 proteasomal degradation through cyclin D1 nuclear export,” BMC Complement Altern Med, vol. 18, no. 1, p. 189, Jun. 2018, doi: 10.1186/s12906-018-2258-x.
[3606]	S. Zara, M. K. Gross, G. Zara, M. Budroni, and A. T. Bakalinsky, “Ethanol-independent biofilm formation by a flor wine yeast strain of Saccharomyces cerevisiae,” Appl. Environ. Microbiol., vol. 76, no. 12, pp. 4089–4091, Jun. 2010, doi: 10.1128/AEM.00111-10.
[3607]	S. Pérez-Hoyos and A. Plasència, “[Ethical considerations in the publication of manuscripts in public health journals],” Gac Sanit, vol. 17, no. 4, pp. 266–267, Aug. 2003, doi: 10.1016/s0213-9111(03)71745-2.
[3608]	C. J. Humbyrd and J. Sugarman, “Ethical Considerations Related to Impaired Driving After Orthopaedic Injuries,” J Bone Joint Surg Am, vol. 98, no. 14, p. e60, Jul. 2016, doi: 10.2106/JBJS.15.00875.
[3609]	O. Babalola, J. M. Grant-Kels, and L. C. Parish, “Ethical dilemmas in journal publication,” Clin. Dermatol., vol. 30, no. 2, pp. 231–236, Apr. 2012, doi: 10.1016/j.clindermatol.2011.06.013.
[3610]	S. von Haehling, J. E. Morley, A. J. S. Coats, and S. D. Anker, “Ethical guidelines for publishing in the journal of cachexia, sarcopenia and muscle: update 2017,” J Cachexia Sarcopenia Muscle, vol. 8, no. 6, pp. 1081–1083, Dec. 2017, doi: 10.1002/jcsm.12261.
[3611]	E. Wager and P. J. Wiffen, “Ethical issues in preparing and publishing systematic reviews,” J Evid Based Med, vol. 4, no. 2, pp. 130–134, May 2011, doi: 10.1111/j.1756-5391.2011.01122.x.
[3612]	L. E. Ferris and M. A. Winker, “Ethical issues in publishing in predatory journals,” Biochem Med (Zagreb), vol. 27, no. 2, pp. 279–284, Jun. 2017, doi: 10.11613/BM.2017.030.
[3613]	H. Reyes B, “[Ethical problems in scientific publications],” Rev Med Chil, vol. 146, no. 3, pp. 373–378, Mar. 2018, doi: 10.4067/s0034-98872018000300373.
[3614]	J. Fritsch, “[Ethics committees in security-relevant research according to the recommendations of Leopoldina and the German Research Foundation],” Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, vol. 62, no. 6, pp. 744–750, Jun. 2019, doi: 10.1007/s00103-019-02954-6.
[3615]	L. S. W. Spångberg, “Ethics in publication,” Oral Surg Oral Med Oral Pathol Oral Radiol Endod, vol. 109, no. 6, pp. 797–798, Jun. 2010, doi: 10.1016/j.tripleo.2010.03.027.
[3616]	M. B. Wallace, D. Bowman, H. Hamilton-Gibbs, and P. D. Siersema, “Ethics in publication, part 2: duplicate publishing, salami slicing, and large retrospective multicenter case series,” Gastrointest. Endosc., vol. 87, no. 5, pp. 1335–1337, May 2018, doi: 10.1016/j.gie.2018.01.002.
[3617]	A. M. Hetherington and S. Lennon, “Ethics in scientific publishing,” New Phytol., vol. 213, no. 1, pp. 5–6, 2017, doi: 10.1111/nph.14349.
[3618]	F. Enqueselassie, “Ethiopian Medical Journal: an overview assessment of the last 50 years,” Ethiop. Med. J., vol. 50 Suppl 1, pp. 1–58, Jan. 2012.
[3619]	C. M. P. O’Tuathaigh et al., “Ethologically based behavioural and neurochemical characterisation of mice with isoform-specific loss of dysbindin-1A in the context of schizophrenia,” Neurosci. Lett., vol. 736, p. 135218, Jun. 2020, doi: 10.1016/j.neulet.2020.135218.
[3620]	B. Cyrulnik, “Ethology and the biological correlates of mood,” Dialogues Clin Neurosci, vol. 7, no. 3, pp. 217–221, 2005.
[3621]	S. Zaidi et al., “Etiology, Diagnosis, and Management of Seminal Vesicle Stones,” Curr Urol, vol. 12, no. 3, pp. 113–120, May 2019, doi: 10.1159/000489429.
[3622]	Y. Auxemery, “Etiopathogenic perspectives on chronic psycho traumatic and chronic psychotic symptoms: the hypothesis of a hyperdopaminergic endophenotype of PTSD,” Med. Hypotheses, vol. 79, no. 5, pp. 667–672, Nov. 2012, doi: 10.1016/j.mehy.2012.08.005.
[3623]	P. Coumel, J. F. Leclercq, and P. Assayag, “European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias,” Am. J. Cardiol., vol. 54, no. 9, pp. 60D-66D, Nov. 1984, doi: 10.1016/s0002-9149(84)80288-x.
[3624]	N. J. Dent, “European Good Laboratory and Clinical Practices: their relevance to clinical pathology laboratories,” Qual Assur, vol. 1, no. 1, pp. 82–88, Oct. 1991.
[3625]	E.-L. Winnacker, “European science,” Science, vol. 295, no. 5554, p. 446, Jan. 2002, doi: 10.1126/science.1068921.
[3626]	S. Papa and European Working Group on Clinical Cell Analysis, “European Working Group on Clinical Cell Analysis (EWGCCA): 6 years on,” J. Biol. Regul. Homeost. Agents, vol. 16, no. 4, pp. 253–256, Dec. 2002.
[3627]	N. Shaw, D. Hitch, N. Lyons, K. Alharthi, B. Grant, and B. Laupert, “Evaluating a wayfinding video,” Clin Teach, vol. 16, no. 3, pp. 226–231, 2019, doi: 10.1111/tct.12911.
[3628]	S. M. Valente, “Evaluating and managing adult PTSD in primary care,” Nurse Pract, vol. 35, no. 11, pp. 41–47, Nov. 2010, doi: 10.1097/01.NPR.0000388940.54617.99.
[3629]	S. F. Kaszubinski, J. L. Pechal, C. J. Schmidt, H. R. Jordan, M. E. Benbow, and M. H. Meek, “Evaluating Bioinformatic Pipeline Performance for Forensic Microbiome Analysis*,†,‡,” J. Forensic Sci., vol. 65, no. 2, pp. 513–525, Mar. 2020, doi: 10.1111/1556-4029.14213.
[3630]	S. Ul Haq, I. Boz, P. Shahbaz, and Ç. Yıldırım, “Evaluating eco-efficiency and optimal levels of fertilizer use based on the social cost and social benefits in tea production,” Environ Sci Pollut Res Int, vol. 27, no. 26, pp. 33008–33019, Sep. 2020, doi: 10.1007/s11356-020-09533-2.
[3631]	B. J. Van Voorhis, “Evaluating economic studies in reproductive medicine,” Semin. Reprod. Med., vol. 21, no. 1, pp. 85–93, Feb. 2003, doi: 10.1055/s-2003-39998.
[3632]	M. Meissner, M. H. Cantell, R. Steiner, and X. Sanchez, “Evaluating Emotional Well-Being after a Short-Term Traditional Yoga Practice Approach in Yoga Practitioners with an Existing Western-Type Yoga Practice,” Evid Based Complement Alternat Med, vol. 2016, p. 7216982, 2016, doi: 10.1155/2016/7216982.
[3633]	I. Johanna et al., “Evaluating in vivo efficacy - toxicity profile of TEG001 in humanized mice xenografts against primary human AML disease and healthy hematopoietic cells,” J Immunother Cancer, vol. 7, no. 1, p. 69, 12 2019, doi: 10.1186/s40425-019-0558-4.
[3634]	G. Garcia-Manero, A. S. Yang, and M. Jagasia, “Evaluating new treatment options for MDS,” Clin Adv Hematol Oncol, vol. 5, no. 11, pp. 1–9; quiz 10–12, Nov. 2007.
[3635]	Y.-M. Tan, H. Clewell, J. Campbell, and M. Andersen, “Evaluating pharmacokinetic and pharmacodynamic interactions with computational models in supporting cumulative risk assessment,” Int J Environ Res Public Health, vol. 8, no. 5, pp. 1613–1630, 2011, doi: 10.3390/ijerph8051613.
[3636]	S. Yu, J. Liu, and L. Li, “Evaluating provincial eco-efficiency in China: an improved network data envelopment analysis model with undesirable output,” Environ Sci Pollut Res Int, vol. 27, no. 7, pp. 6886–6903, Mar. 2020, doi: 10.1007/s11356-019-06958-2.
[3637]	L. Shao, X. Yu, and C. Feng, “Evaluating the eco-efficiency of China’s industrial sectors: A two-stage network data envelopment analysis,” J. Environ. Manage., vol. 247, pp. 551–560, Oct. 2019, doi: 10.1016/j.jenvman.2019.06.099.
[3638]	R. Rathi, M. Lavania, V. Kukreti, and B. Lal, “Evaluating the potential of indigenous methanogenic consortium for enhanced oil and gas recovery from high temperature depleted oil reservoir,” J. Biotechnol., vol. 283, pp. 43–50, Oct. 2018, doi: 10.1016/j.jbiotec.2018.06.347.
[3639]	H.-S. Chen, “Evaluation and Analysis of Eco-Security in Environmentally Sensitive Areas Using an Emergy Ecological Footprint,” Int J Environ Res Public Health, vol. 14, no. 2, 30 2017, doi: 10.3390/ijerph14020136.
[3640]	W. Tu et al., “Evaluation of a free-breathing respiratory-triggered (Navigator) 3-D T1-weighted (T1W) gradient recalled echo sequence (LAVA) for detection of enhancement in cystic and solid renal masses,” Eur Radiol, vol. 29, no. 5, pp. 2507–2517, May 2019, doi: 10.1007/s00330-018-5839-7.
[3641]	M. K. Rippy, S. Baron, M. Rosenthal, and B. A. Senior, “Evaluation of absorbable PLA nasal implants in an ovine model,” Laryngoscope Investig Otolaryngol, vol. 3, no. 3, pp. 156–161, Jun. 2018, doi: 10.1002/lio2.166.
[3642]	V. Shunmugam and Y.-H. Say, “Evaluation of Association of ADRA2A rs553668 and ACE I/D Gene Polymorphisms with Obesity Traits in the Setapak Population, Malaysia,” Iran Red Crescent Med J, vol. 18, no. 2, p. e22452, Feb. 2016, doi: 10.5812/ircmj.22452.
[3643]	J. Zhao, Z. Li, M. Lyu, L. Liu, X. Piao, and D. Li, “Evaluation of available energy and total tract digestibility of acid-hydrolyzed ether extract of cottonseed oil for growing pigs by the difference and regression methods,” Asian-australas. J. Anim. Sci., vol. 30, no. 5, pp. 712–719, May 2017, doi: 10.5713/ajas.16.0546.
[3644]	T. P. M. Haris, P. G. Francis, V. A. Margaret, G. Roshan, V. Menon, and V. Jojee, “Evaluation of Biomechanical Properties of Four Loops at Different Activation: A Finite Element Method Study,” J Contemp Dent Pract, vol. 19, no. 7, pp. 778–784, Jul. 2018.
[3645]	R. M. Walsh, K. F. Woodmansey, G. N. Glickman, and J. He, “Evaluation of compressive strength of hydraulic silicate-based root-end filling materials,” J Endod, vol. 40, no. 7, pp. 969–972, Jul. 2014, doi: 10.1016/j.joen.2013.11.018.
[3646]	V. Chander, R. A. Gibbs, and F. J. Sedlazeck, “Evaluation of computational genotyping of structural variation for clinical diagnoses,” Gigascience, vol. 8, no. 9, 01 2019, doi: 10.1093/gigascience/giz110.
[3647]	R. Kohno et al., “[Evaluation of daily quality assurance for proton therapy at National Cancer Center Hospital East.],” Igaku Butsuri, vol. 26, no. 4, pp. 153–162, 2006.
[3648]	A. Cantù Rajnoldi et al., “Evaluation of dysplastic features in myelodysplastic syndromes: experience from the morphology group of the European Working Group of MDS in Childhood (EWOG-MDS),” Ann. Hematol., vol. 84, no. 7, pp. 429–433, Jul. 2005, doi: 10.1007/s00277-005-1034-4.
[3649]	L. Yang and Y. Yang, “Evaluation of eco-efficiency in China from 1978 to 2016: Based on a modified ecological footprint model,” Sci. Total Environ., vol. 662, pp. 581–590, Apr. 2019, doi: 10.1016/j.scitotenv.2019.01.225.
[3650]	S. K. Kamisetty, R. N, R. N, C. N,  null Dwaragesh, and  null Praven, “Evaluation of Effects and Effectiveness of Various α and β Angulations for Three Different Loop Made of Stainless Steel Arch Wires - A FEM Study,” J Clin Diagn Res, vol. 8, no. 7, pp. ZC33-37, Jul. 2014, doi: 10.7860/JCDR/2014/8941.4576.
[3651]	P. Ferri, S. Rovesti, L. Bonetti, S. Stifani, N. Panzera, and R. Di Lorenzo, “Evaluation of empathy among undergraduate nursing students: a three-year longitudinal study,” Acta Biomed, vol. 90, no. 11-S, pp. 98–107, 11 2019, doi: 10.23750/abm.v90i11-S.8874.
[3652]	M. Marcantonini et al., “Evaluation of equivalent dose to eye lens through dose equivalent Hp(3),” Phys Med, vol. 64, pp. 29–32, Aug. 2019, doi: 10.1016/j.ejmp.2019.04.030.
[3653]	 null SudhindraVooturi, A. N. R. Lakshmi, and S. Jayalakshmi, “Evaluation of factors influencing obesity and the effect of a 12-week home-based exercise program in people with epilepsy - Randomized control trial,” Epilepsy Behav, vol. 110, p. 107148, Sep. 2020, doi: 10.1016/j.yebeh.2020.107148.
[3654]	Z. Fu et al., “Evaluation of five diffeomorphic image registration algorithms for mouse brain magnetic resonance microscopy,” J Microsc, vol. 268, no. 2, pp. 141–154, 2017, doi: 10.1111/jmi.12594.
[3655]	B. C. Dash, B. Roy, and R. K. Das, “Evaluation of genotoxicity of clofazimine, an antileprosy drug, in mice in vivo. III. Sister chromatid exchange analysis in bone marrow cells,” In Vivo, vol. 5, no. 1, pp. 69–70, Feb. 1991.
[3656]	L. Olar et al., “Evaluation of Helicobacter pylori infection in patients with eso-gastro-duodenal pathology,” Rom J Morphol Embryol, vol. 58, no. 3, pp. 809–815, 2017.
[3657]	D. H. Lee, J. Y. Lee, K. B. Lee, and J. K. Han, “Evaluation of Hepatic Steatosis by Using Acoustic Structure Quantification US in a Rat Model: Comparison with Pathologic Examination and MR Spectroscopy,” Radiology, vol. 285, no. 2, pp. 445–453, 2017, doi: 10.1148/radiol.2017161923.
[3658]	E. Buiatti, “Evaluation of human trial design,” IARC Sci. Publ., no. 139, pp. 261–269, 1996.
[3659]	D. Trout, D. N. Weissman, D. Lewis, R. A. Brundage, A. Franzblau, and D. Remick, “Evaluation of hypersensitivity pneumonitis among workers exposed to metal removal fluids,” Appl Occup Environ Hyg, vol. 18, no. 11, pp. 953–960, Nov. 2003, doi: 10.1080/10473220390237683.
[3660]	S. Saito, K. Tanaka, H. Tarewaki, Y. Koyama, and T. Hashido, “Evaluation of Image Quality in Three-dimensional Fat-suppressed T1-weighted Images with Fast Acquisition Mode for Upper Abdomen,” Nihon Hoshasen Gijutsu Gakkai Zasshi, vol. 72, no. 11, pp. 1122–1127, 2016, doi: 10.6009/jjrt.2016_JSRT_72.11.1122.
[3661]	C. Nieh, S. Dorevitch, L. C. Liu, and R. M. Jones, “Evaluation of imputation methods for microbial surface water quality studies,” Environ Sci Process Impacts, vol. 16, no. 5, pp. 1145–1153, May 2014, doi: 10.1039/c3em00721a.
[3662]	D. Rodricks, T. Phulambrikar, S. K. Singh, and A. Gupta, “Evaluation of incidence of mental nerve loop in Central India population using cone beam computed tomography,” Indian J Dent Res, vol. 29, no. 5, pp. 627–633, Oct. 2018, doi: 10.4103/ijdr.IJDR_50_17.
[3663]	H. Kosińska, G. Rowicka, and H. Weker, “[Evaluation of infant feeding practices after implementation of recommendations for coeliac disease prophylaxis - pilot study],” Med Wieku Rozwoj, vol. 15, no. 4, pp. 493–500, Dec. 2011.
[3664]	R. R. Gammon, T. Kozel, P. Morel, and C. Kendrick, “Evaluation of Iron Stores by Zinc Protoporphyrin Analysis in Blood Donors,” Lab Med, vol. 49, no. 4, pp. 311–315, Oct. 2018, doi: 10.1093/labmed/lmy007.
[3665]	M. Cecconi et al., “Evaluation of mean right atrial pressure by two-dimensional and Doppler echocardiography in patients with cardiac disease,” G Ital Cardiol, vol. 28, no. 4, pp. 357–364, Apr. 1998.
[3666]	A. Stendardi et al., “Evaluation of mitochondrial respiratory efficiency during in vitro capacitation of human spermatozoa,” Int. J. Androl., vol. 34, no. 3, pp. 247–255, Jun. 2011, doi: 10.1111/j.1365-2605.2010.01078.x.
[3667]	E. Gündüz, G. Demirel, C. Bal, and Z. Gulbas, “Evaluation of mobilized peripheral stem cells according to CD34 and aldehyde dehydrogenase expression and effect of SSC(lo) ALDH(br) cells on hematopoietic recovery,” Cytotherapy, vol. 12, no. 8, pp. 1006–1012, Dec. 2010, doi: 10.3109/14653249.2010.509393.
[3668]	A. Marcovigi, L. Ciampalini, P. Perazzini, P. Caldora, G. Grandi, and F. Catani, “Evaluation of Native Femoral Neck Version and Final Stem Version Variability in Patients With Osteoarthritis Undergoing Robotically Implanted Total Hip Arthroplasty,” J Arthroplasty, vol. 34, no. 1, pp. 108–115, 2019, doi: 10.1016/j.arth.2018.06.027.
[3669]	T. R. Ivanov, C. B. Lawrence, P. J. Stanley, and S. M. Luckman, “Evaluation of neuromedin U actions in energy homeostasis and pituitary function,” Endocrinology, vol. 143, no. 10, pp. 3813–3821, Oct. 2002, doi: 10.1210/en.2002-220121.
[3670]	J. Whipps, M. Byra, K. G. Gerow, and E. Hill Guseman, “Evaluation of Nighttime Media Use and Sleep Patterns in First-semester College Students,” Am J Health Behav, vol. 42, no. 3, pp. 47–55, 01 2018, doi: 10.5993/AJHB.42.3.5.
[3671]	N. C. Gupta, P. Sharma, M. Rao, P. K. Rai, and A. K. Gupta, “Evaluation of non-injury inoculation technique for assessing Sclerotinia stem rot (Sclerotinia sclerotiorum) in oilseed Brassica,” J. Microbiol. Methods, vol. 175, p. 105983, Aug. 2020, doi: 10.1016/j.mimet.2020.105983.
[3672]	F.-J. Tsai et al., “Evaluation of Oral Antiretroviral Drugs in Mice With Metabolic and Neurologic Complications,” Front Pharmacol, vol. 9, p. 1004, 2018, doi: 10.3389/fphar.2018.01004.
[3673]	P. Lassalas et al., “Evaluation of Oxetan-3-ol, Thietan-3-ol, and Derivatives Thereof as Bioisosteres of the Carboxylic Acid Functional Group,” ACS Med Chem Lett, vol. 8, no. 8, pp. 864–868, Aug. 2017, doi: 10.1021/acsmedchemlett.7b00212.
[3674]	H. K. Muniraman et al., “Evaluation of Oxygen Saturation Index Compared With Oxygenation Index in Neonates With Hypoxemic Respiratory Failure,” JAMA Netw Open, vol. 2, no. 3, p. e191179, 01 2019, doi: 10.1001/jamanetworkopen.2019.1179.
[3675]	M. Lu, Y.-J. Luo, Z.-Z. Zhang, M. Xiao, and M. Zhang, “Evaluation of PCDD/Fs emissions during ceramic production: a laboratory study,” J. Hazard. Mater., vol. 229–230, pp. 36–41, Aug. 2012, doi: 10.1016/j.jhazmat.2012.05.055.
[3676]	A. Alassod, M. A. Abedalwafa, and G. Xu, “Evaluation of polypropylene melt blown nonwoven as the interceptor for oil,” Environ Technol, pp. 1–13, Jan. 2020, doi: 10.1080/09593330.2020.1714743.
[3677]	F. Celik and I. S. Edipoglu, “Evaluation of preoperative anxiety and fear of anesthesia using APAIS score,” Eur. J. Med. Res., vol. 23, no. 1, p. 41, Sep. 2018, doi: 10.1186/s40001-018-0339-4.
[3678]	H. S. Jung and H.-S. Jung, “Evaluation of proper height for squatting stool,” Ergonomics, vol. 51, no. 5, pp. 671–690, May 2008, doi: 10.1080/00140130701744506.
[3679]	E. C. Chern, D. King, R. Haugland, and S. Pfaller, “Evaluation of quantitative polymerase chain reaction assays targeting Mycobacterium avium, M. intracellulare, and M. avium subspecies paratuberculosis in drinking water biofilms,” J Water Health, vol. 13, no. 1, pp. 131–139, Mar. 2015, doi: 10.2166/wh.2014.060.
[3680]	K. V. Garland, “Evaluation of resources for an interactive infection control instructional program,” J Dent Hyg, vol. 88, no. 2, pp. 124–129, Apr. 2014.
[3681]	J. C. Falman, C. S. Fagnant-Sperati, A. L. Kossik, D. S. Boyle, and J. S. Meschke, “Evaluation of Secondary Concentration Methods for Poliovirus Detection in Wastewater,” Food Environ Virol, vol. 11, no. 1, pp. 20–31, 2019, doi: 10.1007/s12560-018-09364-y.
[3682]	S. R. Martha et al., “Evaluation of sex differences in acid/base and electrolyte concentrations in acute large vessel stroke,” Exp. Neurol., vol. 323, p. 113078, 2020, doi: 10.1016/j.expneurol.2019.113078.
[3683]	S. Li, G. Sciumbato, D. Boykin, G. Shannon, and P. Chen, “Evaluation of soybean genotypes for reaction to natural field infection by Cercospora species causing purple seed stain,” PLoS ONE, vol. 14, no. 10, p. e0222673, 2019, doi: 10.1371/journal.pone.0222673.
[3684]	Y. Wu et al., “[Evaluation of sperm mitochondrial function using Rh123/PI dual fluorescent staining],” Zhonghua Nan Ke Xue, vol. 12, no. 9, pp. 803–806, Sep. 2006.
[3685]	D. Smoląg, M. Kulesa-Mrowiecka, and J. Sułko, “Evaluation of stomatognathic problems in children with osteogenesis imperfecta (osteogenesis imperfecta - oi) - preliminary study,” Dev Period Med, vol. 21, no. 2, pp. 144–153, 2017.
[3686]	D. P. de Sousa, F. F. F. Nóbrega, L. C. S. L. de Morais, and R. N. de Almeida, “Evaluation of the anticonvulsant activity of terpinen-4-ol,” Z. Naturforsch., C, J. Biosci., vol. 64, no. 1–2, pp. 1–5, Feb. 2009, doi: 10.1515/znc-2009-1-201.
[3687]	K. Fujii, “Evaluation of the newborn mouse model for chemical tumorigenesis,” Carcinogenesis, vol. 12, no. 8, pp. 1409–1415, Aug. 1991, doi: 10.1093/carcin/12.8.1409.
[3688]	K. Mukaihara, M. Hasegawa-Moriyama, T. Iwasaki, Y. Yamasaki, and Y. Kanmura, “Evaluation of the pharyngeal airway using computational fluid dynamics in patients with acromegaly,” Laryngoscope Investig Otolaryngol, vol. 3, no. 2, pp. 133–138, Apr. 2018, doi: 10.1002/lio2.151.
[3689]	S. Reilly et al., “Evaluation of the role of miR-31-dependent reduction in dystrophin and nNOS on atrial-fibrillation-induced electrical remodelling in man,” Lancet, vol. 385 Suppl 1, p. S82, Feb. 2015, doi: 10.1016/S0140-6736(15)60397-X.
[3690]	D. Poppinga, J. Kretschmer, L. Brodbek, J. Meyners, B. Poppe, and H. K. Looe, “Evaluation of the RUBY modular QA phantom for planar and non-coplanar VMAT and stereotactic radiations,” J Appl Clin Med Phys, Aug. 2020, doi: 10.1002/acm2.13006.
[3691]	A. I. Bisi-Onyemaechi, N. A. Akani, A. N. Ikefuna, B. N. Tagbo, and J. M. Chinawa, “Evaluation of the School Environment of Public and Private Schools in Enugu to Ensure Child Health Promotion,” Niger J Clin Pract, vol. 21, no. 2, pp. 195–200, Feb. 2018, doi: 10.4103/njcp.njcp_224_17.
[3692]	S. Caivano, B. J. Ferreira, and S. M. Á. Domene, “[Evaluation of the usability of a mobile Digital Food Guide based on user perception],” Cien Saude Colet, vol. 19, no. 5, pp. 1437–1446, May 2014, doi: 10.1590/1413-81232014195.13932013.
[3693]	K. Ashing-Giwa and M. Rosales, “Evaluation of therapeutic care delay among Latina- and European-American cervical cancer survivors,” Gynecol. Oncol., vol. 128, no. 2, pp. 160–165, Feb. 2013, doi: 10.1016/j.ygyno.2012.11.015.
[3694]	E. Cui, L. Ren, and H. Sun, “Evaluation of variations and affecting factors of eco-environmental quality during urbanization,” Environ Sci Pollut Res Int, vol. 22, no. 5, pp. 3958–3968, Mar. 2015, doi: 10.1007/s11356-014-3779-6.
[3695]	F. Profeta et al., “Evaluation of veterinary autogenous vaccines safety by an MTT in-vitro cytotoxicity assay,” Vet. Ital., vol. 55, no. 4, pp. 299–305, 31 2019, doi: 10.12834/VetIt.1778.9390.2.
[3696]	C. Ruiz de Alegría-Puig et al., “Evaluation of Vitek-MSTM and Microflex LTTM commercial systems for identification of Acinetobacter calcoaceticus-baumannii complex,” Enferm. Infecc. Microbiol. Clin., Apr. 2020, doi: 10.1016/j.eimc.2020.02.028.
[3697]	J. M. Baena-Cañada et al., “Evaluation of waiting times for breast cancer diagnosis and surgical treatment,” Clin Transl Oncol, vol. 20, no. 10, pp. 1345–1352, Oct. 2018, doi: 10.1007/s12094-018-1867-7.
[3698]	S. Y. Wong, M. Cabodi, J. Rolland, and C. M. Klapperich, “Evaporative concentration on a paper-based device to concentrate analytes in a biological fluid,” Anal. Chem., vol. 86, no. 24, pp. 11981–11985, Dec. 2014, doi: 10.1021/ac503751a.
[3699]	N. Vijakkhana, T. Wilaisakditipakorn, K. Ruedeekhajorn, C. Pruksananonda, and W. Chonchaiya, “Evening media exposure reduces night-time sleep,” Acta Paediatr., vol. 104, no. 3, pp. 306–312, Mar. 2015, doi: 10.1111/apa.12904.
[3700]	J. Bartgis, A. R. Lilly, and D. G. Thomas, “Event-related potential and behavioral measures of attention in 5-, 7-, and 9-year-olds,” J Gen Psychol, vol. 130, no. 3, pp. 311–335, Jul. 2003, doi: 10.1080/00221300309601162.
[3701]	M. J. Chandler, A. C. Parks, M. Marsiske, L. J. Rotblatt, and G. E. Smith, “Everyday Impact of Cognitive Interventions in Mild Cognitive Impairment: a Systematic Review and Meta-Analysis,” Neuropsychol Rev, vol. 26, no. 3, pp. 225–251, 2016, doi: 10.1007/s11065-016-9330-4.
[3702]	D. Centurión, M. I. Ortiz, A. Sánchez-López, P. De Vries, P. R. Saxena, and C. M. Villalón, “Evidence for 5-HT(1B/1D) and 5-HT(2A) receptors mediating constriction of the canine internal carotid circulation,” Br. J. Pharmacol., vol. 132, no. 5, pp. 983–990, Mar. 2001, doi: 10.1038/sj.bjp.0703914.
[3703]	A. E. Epstein, B. I. Hirschowitz, J. K. Kirklin, K. A. Kirk, G. N. Kay, and V. J. Plumb, “Evidence for a central site of action to explain the negative chronotropic effect of atropine: studies on the human transplanted heart,” J. Am. Coll. Cardiol., vol. 15, no. 7, pp. 1610–1617, Jun. 1990, doi: 10.1016/0735-1097(90)92834-o.
[3704]	J. D. Mitchell, R. E. Kuc, J. J. Maguire, and A. P. Davenport, “Evidence for a novel vasospastic transmitter system, neuromedin U, in the equine digital circulation,” Vet. J., vol. 186, no. 1, pp. 106–109, Oct. 2010, doi: 10.1016/j.tvjl.2009.06.026.
[3705]	R. Dziak, D. Leishman, M. Radovic, B. K. Tye, and K. Yankulov, “Evidence for a role of MCM (mini-chromosome maintenance)5 in transcriptional repression of sub-telomeric and Ty-proximal genes in Saccharomyces cerevisiae,” J. Biol. Chem., vol. 278, no. 30, pp. 27372–27381, Jul. 2003, doi: 10.1074/jbc.M301110200.
[3706]	I. Masakane, K. Kikuchi, and H. Kawanishi, “Evidence for the Clinical Advantages of Predilution On-Line Hemodiafiltration,” Contrib Nephrol, vol. 189, pp. 17–23, 2017, doi: 10.1159/000450635.
[3707]	G. E. Janssens and L. M. Veenhoff, “Evidence for the hallmarks of human aging in replicatively aging yeast,” Microb Cell, vol. 3, no. 7, pp. 263–274, Jun. 2016, doi: 10.15698/mic2016.07.510.
[3708]	A. M. Vermunt, A. B. Koopmanschap, J. M. Vlak, and C. A. de Kort, “Evidence for two juvenile hormone esterase-related genes in the Colorado potato beetle,” Insect Mol. Biol., vol. 7, no. 4, pp. 327–336, Nov. 1998, doi: 10.1046/j.1365-2583.1998.740327.x.
[3709]	C. Semenza and M. Zettin, “Evidence from aphasia for the role of proper names as pure referring expressions,” Nature, vol. 342, no. 6250, pp. 678–679, Dec. 1989, doi: 10.1038/342678a0.
[3710]	G. E. Crites, M. C. McNamara, E. A. Akl, W. S. Richardson, C. A. Umscheid, and J. Nishikawa, “Evidence in the learning organization,” Health Res Policy Syst, vol. 7, p. 4, Mar. 2009, doi: 10.1186/1478-4505-7-4.
[3711]	Y. A. Lai, I. H. Lai, C. F. Tseng, J. Lee, and S. J. T. Mao, “Evidence of tandem repeat and extra thiol-groups resulted in the polymeric formation of bovine haptoglobin: a unique structure of Hp 2-2 phenotype,” J. Biochem. Mol. Biol., vol. 40, no. 6, pp. 1028–1038, Nov. 2007, doi: 10.5483/bmbrep.2007.40.6.1028.
[3712]	M. Hansen, J. Ross, and C. Armour, “Evidence of the dissociative PTSD subtype: A systematic literature review of latent class and profile analytic studies of PTSD,” J Affect Disord, vol. 213, pp. 59–69, Apr. 2017, doi: 10.1016/j.jad.2017.02.004.
[3713]	W. Gao et al., “Evidence on the emergence of the brain’s default network from 2-week-old to 2-year-old healthy pediatric subjects,” Proc. Natl. Acad. Sci. U.S.A., vol. 106, no. 16, pp. 6790–6795, Apr. 2009, doi: 10.1073/pnas.0811221106.
[3714]	R. Saitz, “Evidence-Based Medicine these 7 years: time for the editor to go on permanent sabbatical,” Evid Based Med, vol. 22, no. 3, pp. 79–80, 2017, doi: 10.1136/ebmed-2017-110705.
[3715]	T. Nall, K. Reynolds, L. Smith, and C. Steele, “Evidence-based practices to promote breastfeeding,” Ky Nurse, vol. 54, no. 2, p. 12, Jun. 2006.
[3716]	S. Classen, A. M. Crizzle, S. M. Winter, W. Silver, and S. Eisenschenk, “Evidence-based review on epilepsy and driving,” Epilepsy Behav, vol. 23, no. 2, pp. 103–112, Feb. 2012, doi: 10.1016/j.yebeh.2011.11.015.
[3717]	L. Traeger, J. A. Greer, C. Fernandez-Robles, J. S. Temel, and W. F. Pirl, “Evidence-based treatment of anxiety in patients with cancer,” J. Clin. Oncol., vol. 30, no. 11, pp. 1197–1205, Apr. 2012, doi: 10.1200/JCO.2011.39.5632.
[3718]	A. R. Burmeister and J. J. Smith, “Evolution across the Curriculum: Microbiology,” J Microbiol Biol Educ, vol. 17, no. 2, pp. 252–260, May 2016, doi: 10.1128/jmbe.v17i2.988.
[3719]	R. I. M. Dunbar and S. Shultz, “Evolution in the social brain,” Science, vol. 317, no. 5843, pp. 1344–1347, Sep. 2007, doi: 10.1126/science.1145463.
[3720]	S. M. Farris, “Evolution of brain elaboration,” Philos. Trans. R. Soc. Lond., B, Biol. Sci., vol. 370, no. 1684, Dec. 2015, doi: 10.1098/rstb.2015.0054.
[3721]	J. G. Goldman, S. K. Holden, I. Litvan, I. McKeith, G. T. Stebbins, and J.-P. Taylor, “Evolution of diagnostic criteria and assessments for Parkinson’s disease mild cognitive impairment,” Mov. Disord., vol. 33, no. 4, pp. 503–510, 2018, doi: 10.1002/mds.27323.
[3722]	T. LaBar and C. Adami, “Evolution of drift robustness in small populations,” Nat Commun, vol. 8, no. 1, p. 1012, 18 2017, doi: 10.1038/s41467-017-01003-7.
[3723]	J. L. Brune, F. Yang, D. R. Barnett, and B. H. Bowman, “Evolution of haptoglobin: comparison of complementary DNA encoding Hp alpha 1S and Hp alpha 2FS,” Nucleic Acids Res., vol. 12, no. 11, pp. 4531–4538, Jun. 1984, doi: 10.1093/nar/12.11.4531.
[3724]	M. Jaiteh, A. Taly, and J. Hénin, “Evolution of Pentameric Ligand-Gated Ion Channels: Pro-Loop Receptors,” PLoS ONE, vol. 11, no. 3, p. e0151934, 2016, doi: 10.1371/journal.pone.0151934.
[3725]	M. Beavan, A. McNeill, C. Proukakis, D. A. Hughes, A. Mehta, and A. H. V. Schapira, “Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort,” JAMA Neurol, vol. 72, no. 2, pp. 201–208, Feb. 2015, doi: 10.1001/jamaneurol.2014.2950.
[3726]	A. Kourkoulou, A. A. Pittis, and G. Diallinas, “Evolution of substrate specificity in the Nucleobase-Ascorbate Transporter (NAT) protein family,” Microb Cell, vol. 5, no. 6, pp. 280–292, Mar. 2018, doi: 10.15698/mic2018.06.636.
[3727]	R. L. Bærentsen, D. E. Brodersen, and Y. E. Zhang, “Evolution of the bacterial nucleosidase PpnN and its relation to the stringent response,” Microb Cell, vol. 6, no. 9, pp. 450–453, Jul. 2019, doi: 10.15698/mic2019.09.692.
[3728]	R. J. P. Williams and J. J. R. Fraústo Da Silva, “Evolution was chemically constrained,” J. Theor. Biol., vol. 220, no. 3, pp. 323–343, Feb. 2003, doi: 10.1006/jtbi.2003.3152.
[3729]	A. J. Zera and Y. Huang, “EVOLUTIONARY ENDOCRINOLOGY OF JUVENILE HORMONE ESTERASE: FUNCTIONAL RELATIONSHIP WITH WING POLYMORPHISM IN THE CRICKET, GRYLLUS FIRMUS,” Evolution, vol. 53, no. 3, pp. 837–847, Jun. 1999, doi: 10.1111/j.1558-5646.1999.tb05377.x.
[3730]	M. Carr, D. Bensasson, and C. M. Bergman, “Evolutionary genomics of transposable elements in Saccharomyces cerevisiae,” PLoS ONE, vol. 7, no. 11, p. e50978, 2012, doi: 10.1371/journal.pone.0050978.
[3731]	C. E. Lee et al., “Evolutionary responses to crude oil from the Deepwater Horizon oil spill by the copepod Eurytemora affinis,” Evol Appl, vol. 10, no. 8, pp. 813–828, 2017, doi: 10.1111/eva.12502.
[3732]	G. Barski, F. Cornefert, and L. J. Biedler, “[Evolutive and permanent characteristics of human and rabbit cells during their adaptation to life in vitro],” Ann Inst Pasteur (Paris), vol. 100, pp. 324–336, Mar. 1961.
[3733]	A. Aydin and J. M. Degraff, “Evoluton of polygonal fracture patterns in lava flows,” Science, vol. 239, no. 4839, pp. 471–476, Jan. 1988, doi: 10.1126/science.239.4839.471.
[3734]	Y.-Y. Lee, C.-Y. Wu, C.-H. Teng, W.-C. Hsu, K.-C. Chang, and P. Chen, “Evolving methods to combine cognitive and physical training for individuals with mild cognitive impairment: study protocol for a randomized controlled study,” Trials, vol. 17, no. 1, p. 526, 28 2016, doi: 10.1186/s13063-016-1650-4.
[3735]	J. P. Bewersdorf and A. M. Zeidan, “Evolving therapies for lower-risk myelodysplastic syndromes,” Ann. Hematol., vol. 99, no. 4, pp. 677–692, Apr. 2020, doi: 10.1007/s00277-020-03963-1.
[3736]	T. Rajakumar, A. B. Munkacsi, and S. L. Sturley, “Exacerbating and reversing lysosomal storage diseases: from yeast to humans,” Microb Cell, vol. 4, no. 9, pp. 278–293, Aug. 2017, doi: 10.15698/mic2017.09.588.
[3737]	C. S. Miller, R. B. Gammage, and J. T. Jankovic, “Exacerbation of chemical sensitivity: a case study,” Toxicol Ind Health, vol. 15, no. 3–4, pp. 398–402, Jun. 1999, doi: 10.1177/074823379901500313.
[3738]	A. Tursi and A. Papa, “Exacerbation of Crohn’s disease as paradoxical effect of infliximab,” J Crohns Colitis, vol. 6, no. 3, p. 396, Apr. 2012, doi: 10.1016/j.crohns.2012.01.001.
[3739]	B. Karthik, B. M. Kumar, and R. I. Sujith, “Exact solutions to one-dimensional acoustic fields with temperature gradient and mean flow,” J. Acoust. Soc. Am., vol. 108, no. 1, pp. 38–43, Jul. 2000, doi: 10.1121/1.429442.
[3740]	S. Fu, H. Zhuo, H. Song, J. Wang, and L. Ren, “Examination of a coupling coordination relationship between urbanization and the eco-environment: a case study in Qingdao, China,” Environ Sci Pollut Res Int, vol. 27, no. 19, pp. 23981–23993, Jul. 2020, doi: 10.1007/s11356-020-08683-7.
[3741]	P. Cho, G. B. Schneider, K. Krizan, and J. C. Keller, “Examination of the bone-implant interface in experimentally induced osteoporotic bone,” Implant Dent, vol. 13, no. 1, pp. 79–87, Mar. 2004, doi: 10.1097/01.id.0000116456.76235.bc.
[3742]	A. Blanch, A. Aluja, E. Blanco, and F. Balada, “Examining habituation of the startle reflex with the reinforcement sensitivity theory of personality,” Psychophysiology, vol. 53, no. 10, pp. 1535–1541, 2016, doi: 10.1111/psyp.12725.
[3743]	J. He, D. McGee, X. Niu, and W. Choi, “Examining the dynamic association of BMI and mortality in the Framingham Heart Study,” Int J Environ Res Public Health, vol. 6, no. 12, pp. 3115–3126, 2009, doi: 10.3390/ijerph6123115.
[3744]	H. Rouzikhah, M. King, and A. Rakotonirainy, “Examining the effects of an eco-driving message on driver distraction,” Accid Anal Prev, vol. 50, pp. 975–983, Jan. 2013, doi: 10.1016/j.aap.2012.07.024.
[3745]	D. S. Desmond et al., “Examining the physical processes of corn oil (medium crude oil surrogate) in sea ice and its resultant effect on complex permittivity and normalized radar cross-section,” Mar. Pollut. Bull., vol. 142, pp. 484–493, May 2019, doi: 10.1016/j.marpolbul.2019.03.067.
[3746]	K. S. DeMartini, B. Pittman, J. H. Krystal, S. S. O’Malley, and S. Krishnan-Sarin, “Examining the Relationship Between Self-Reported Drinking and In-Laboratory Drinking and Craving: Is There Concordance?,” Alcohol. Clin. Exp. Res., vol. 44, no. 5, pp. 1151–1157, 2020, doi: 10.1111/acer.14329.
[3747]	I. Gridchyna, M. Baumevieille, M. Aulois-Griot, and B. Bégaud, “[Exception drugs status: specific characteristics and the role in the proper use of drugs],” Rev Epidemiol Sante Publique, vol. 61, no. 5, pp. 485–492, Oct. 2013, doi: 10.1016/j.respe.2013.02.015.
[3748]	A. S. Giorelli, P. Passos, T. Carnaval, and M. da M. Gomes, “Excessive daytime sleepiness and epilepsy: a systematic review,” Epilepsy Res Treat, vol. 2013, p. 629469, 2013, doi: 10.1155/2013/629469.
[3749]	G. A. Hicks et al., “Excitation of rat colonic afferent fibres by 5-HT(3) receptors,” J. Physiol. (Lond.), vol. 544, no. 3, pp. 861–869, 01 2002, doi: 10.1113/jphysiol.2002.025452.
[3750]	T. Nakamura et al., “Excitatory and inhibitory 5-hydroxytryptamine (5-HT) receptors expressed in the isolated porcine uterine muscles,” Eur. J. Pharmacol., vol. 600, no. 1–3, pp. 123–129, Dec. 2008, doi: 10.1016/j.ejphar.2008.10.019.
[3751]	B. T. Gold, “Executive control, brain aging and bilingualism,” Cortex, vol. 73, pp. 369–370, Dec. 2015, doi: 10.1016/j.cortex.2015.06.014.
[3752]	N. Kleinhans, N. Akshoomoff, and D. C. Delis, “Executive functions in autism and Asperger’s disorder: flexibility, fluency, and inhibition,” Dev Neuropsychol, vol. 27, no. 3, pp. 379–401, 2005, doi: 10.1207/s15326942dn2703_5.
[3753]	“Executive summary of the 9th meeting of the WHO working group RT-PCR for the detection and subtyping of influenza viruses,” Wkly. Epidemiol. Rec., vol. 92, no. 41, pp. 609–610, 13 2017.
[3754]	K. Mikkelsen, L. Stojanovska, M. Polenakovic, M. Bosevski, and V. Apostolopoulos, “Exercise and mental health,” Maturitas, vol. 106, pp. 48–56, Dec. 2017, doi: 10.1016/j.maturitas.2017.09.003.
[3755]	C. Göransson, N. Vejlstrup, and J. Carlsen, “Exercise cardiovascular magnetic resonance imaging allows differentiation of low-risk pulmonary arterial hypertension,” J. Heart Lung Transplant., vol. 38, no. 6, pp. 627–635, 2019, doi: 10.1016/j.healun.2019.01.1305.
[3756]	O. J. Price, J. H. Hull, L. Ansley, M. Thomas, and C. Eyles, “Exercise-induced bronchoconstriction in athletes - A qualitative assessment of symptom perception,” Respir Med, vol. 120, pp. 36–43, 2016, doi: 10.1016/j.rmed.2016.09.017.
[3757]	J. Lederberg, “Exobiology: approaches to life beyond the earth,” Science, vol. 132, no. 3424, pp. 393–400, Aug. 1960, doi: 10.1126/science.132.3424.393.
[3758]	C. C. Beaucham, T. J. Lentz, and F. L. Rice, “Expanding control banding for workplace silica exposures throughout the Americas,” Int J Occup Environ Health, vol. 18, no. 4, pp. 344–347, Dec. 2012, doi: 10.1179/2049396712Y.0000000001.
[3759]	C.-M. Lo, “Expanding living donor liver transplantation,” Liver Transpl., vol. 22, no. S1, pp. 37–39, 2016, doi: 10.1002/lt.24618.
[3760]	P. Dimitri et al., “Expanding the Clinical Spectrum Associated With GLIS3 Mutations,” J. Clin. Endocrinol. Metab., vol. 100, no. 10, pp. E1362-1369, Oct. 2015, doi: 10.1210/jc.2015-1827.
[3761]	I. Carrió, “Expanding the scope of EJNMMI in the era of electronic publishing,” Eur. J. Nucl. Med. Mol. Imaging, vol. 37, no. 12, pp. 2229–2230, Dec. 2010, doi: 10.1007/s00259-010-1659-y.
[3762]	Z. Xing, J. Wang, and J. Zhang, “Expansion of environmental impact assessment for eco-efficiency evaluation of China’s economic sectors: An economic input-output based frontier approach,” Sci. Total Environ., vol. 635, pp. 284–293, Sep. 2018, doi: 10.1016/j.scitotenv.2018.04.076.
[3763]	J. Solheim and A. Papa, “Experience talks,” J Emerg Nurs, vol. 37, no. 5, pp. 499–502, Sep. 2011, doi: 10.1016/j.jen.2011.06.012.
[3764]	D. C. O’Brien, B. Kellermeyer, J. Chung, and M. M. Carr, “Experience with key indicator cases among otolaryngology residents,” Laryngoscope Investig Otolaryngol, vol. 4, no. 4, pp. 387–392, Aug. 2019, doi: 10.1002/lio2.274.
[3765]	M. Dako-Gyeke and M. D. Donkor, “Experiences and perspectives of stigmatization and discrimination against people with epilepsy in Accra, Ghana,” Epilepsy Behav, vol. 87, pp. 101–107, 2018, doi: 10.1016/j.yebeh.2018.07.025.
[3766]	S. Erichsen, “Experiences with the cultivation of different bovine cells and their use in the study of oestrogen metabolism in vitro,” Acta Pathol Microbiol Scand Suppl, vol. 51(Suppl 144), pp. 221–223, 1961.
[3767]	H. Hidai et al., “Experimental and theoretical study on the driving force and glass flow by laser-induced metal sphere migration in glass,” Sci Rep, vol. 6, p. 38545, 09 2016, doi: 10.1038/srep38545.
[3768]	D. J. Whittaker et al., “Experimental evidence that symbiotic bacteria produce chemical cues in a songbird,” J. Exp. Biol., vol. 222, no. Pt 20, 16 2019, doi: 10.1242/jeb.202978.
[3769]	K. Okishige and P. L. Friedman, “Experimental study of cryofreezing energy applications on the ventricular myocardium using sheep hearts,” Pacing Clin Electrophysiol, vol. 40, no. 8, pp. 932–939, Aug. 2017, doi: 10.1111/pace.13117.
[3770]	O. L. Bokeriya et al., “Experimental Study of Kinematic Activity of Left Ventricular Myocardium,” Bull. Exp. Biol. Med., vol. 159, no. 6, pp. 805–808, Oct. 2015, doi: 10.1007/s10517-015-3081-8.
[3771]	J. Cui, X. Gong, Z. Jiang, X. Yu, Y. Liu, and L. Lu, “Experimental study of the functional reserve of median nerve in rats,” Int J Clin Exp Med, vol. 8, no. 9, pp. 16015–16021, 2015.
[3772]	Y. H. Pei, Y. Z. He, X. G. Zhang, and B. S. Sun, “[Experimental study scavenging effect of paraquat by hemoperfusion],” Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, vol. 35, no. 7, pp. 523–525, Jul. 2017, doi: 10.3760/cma.j.issn.1001-9391.2017.07.013.
[3773]	O. A. Trowell, “Experiments on lymph nodes cultured in vitro,” Ann. N. Y. Acad. Sci., vol. 59, no. 5, pp. 1066–1069, Mar. 1955, doi: 10.1111/j.1749-6632.1955.tb46002.x.
[3774]	S. Kar and J. Leszczynski, “Exploration of Computational Approaches to Predict the Toxicity of Chemical Mixtures,” Toxics, vol. 7, no. 1, Mar. 2019, doi: 10.3390/toxics7010015.
[3775]	L. Gerges, D. Popiolek, and A. B. Rosenkrantz, “Explorative Investigation of Whole-Lesion Histogram MRI Metrics for Differentiating Uterine Leiomyomas and Leiomyosarcomas,” AJR Am J Roentgenol, vol. 210, no. 5, pp. 1172–1177, May 2018, doi: 10.2214/AJR.17.18605.
[3776]	X. Wan et al., “Exploratory study of oral mucosal colonization of human gastric Helicobacter pylori in mice,” Int J Clin Exp Med, vol. 7, no. 3, pp. 523–529, 2014.
[3777]	M. Desmedt et al., “Exploring and Evaluating Patient Safety Culture in a Community-Based Primary Care Setting,” J Patient Saf, Feb. 2018, doi: 10.1097/PTS.0000000000000458.
[3778]	L. Cinnamon Bidwell, S. L. YorkWilliams, R. L. Mueller, A. D. Bryan, and K. E. Hutchison, “Exploring cannabis concentrates on the legal market: User profiles, product strength, and health-related outcomes,” Addict Behav Rep, vol. 8, pp. 102–106, Dec. 2018, doi: 10.1016/j.abrep.2018.08.004.
[3779]	K. Hamel, “Exploring crystalline silica exposure,” Occup Health Saf, vol. 82, no. 11, pp. 26–27, Nov. 2013.
[3780]	E. Solomon-Moore, S. J. Sebire, C. Macdonald-Wallis, J. L. Thompson, D. A. Lawlor, and R. Jago, “Exploring parents’ screen-viewing behaviours and sedentary time in association with their attitudes toward their young child’s screen-viewing,” Prev Med Rep, vol. 7, pp. 198–205, Sep. 2017, doi: 10.1016/j.pmedr.2017.06.011.
[3781]	K. X. Hu et al., “Exploring Pharmacological Mechanisms of Xiang Ju Tablets in the Treatment of Allergic Rhinitis via a Network Pharmacology Approach,” Evid Based Complement Alternat Med, vol. 2019, p. 6272073, 2019, doi: 10.1155/2019/6272073.
[3782]	L. Gu and Z. Zhang, “Exploring Potential Electrophysiological Biomarkers in Mild Cognitive Impairment: A Systematic Review and Meta-Analysis of Event-Related Potential Studies,” J. Alzheimers Dis., vol. 58, no. 4, pp. 1283–1292, 2017, doi: 10.3233/JAD-161286.
[3783]	B. A. Seed, T. M. Lang, M. J. Caraher, and A. S. Ostry, “Exploring Public Health’s roles and limitations in advancing food security in British Columbia,” Can J Public Health, vol. 105, no. 5, pp. e324-329, Jul. 2014, doi: 10.17269/cjph.105.4414.
[3784]	S. Hamann and C. L. Harenski, “Exploring the brain’s interface between personality, mood, and emotion: theoretical comment on Canli et al. (2004),” Behav. Neurosci., vol. 118, no. 5, pp. 1134–1136, Oct. 2004, doi: 10.1037/0735-7044.118.5.1134.
[3785]	S. Neal, F. Rice, T. Ng-Knight, L. Riglin, and N. Frederickson, “Exploring the longitudinal association between interventions to support the transition to secondary school and child anxiety,” J Adolesc, vol. 50, pp. 31–43, 2016, doi: 10.1016/j.adolescence.2016.04.003.
[3786]	A. A. Gilmartin and W. A. Petri, “Exploring the mechanism of amebic trogocytosis: the role of amebic lysosomes,” Microb Cell, vol. 5, no. 1, pp. 1–3, Dec. 2017, doi: 10.15698/mic2018.01.606.
[3787]	M. L. Diamond et al., “Exploring the planetary boundary for chemical pollution,” Environ Int, vol. 78, pp. 8–15, May 2015, doi: 10.1016/j.envint.2015.02.001.
[3788]	F. W. Guirgis et al., “Exploring the Predictive Ability of Dysfunctional High-Density Lipoprotein for Adverse Outcomes in Emergency Department Patients with Sepsis: A Preliminary Investigation,” Shock, vol. 48, no. 5, pp. 539–544, 2017, doi: 10.1097/SHK.0000000000000887.
[3789]	J. Kay, J. R. Hanley, and R. Miles, “Exploring the relationship between proper name anomia and word retrieval: a single case study,” Cortex, vol. 37, no. 4, pp. 501–517, Sep. 2001, doi: 10.1016/s0010-9452(08)70590-2.
[3790]	A. R. Castro, K. Chougui, C. Bilodeau, and A. Tsimicalis, “Exploring the Views of Osteogenesis Imperfecta Caregivers on Internet-Based Technologies: Qualitative Descriptive Study,” J. Med. Internet Res., vol. 21, no. 12, p. e15924, 18 2019, doi: 10.2196/15924.
[3791]	R. Park, F. Rice, L. Stayner, R. Smith, S. Gilbert, and H. Checkoway, “Exposure to crystalline silica, silicosis, and lung disease other than cancer in diatomaceous earth industry workers: a quantitative risk assessment,” Occup Environ Med, vol. 59, no. 1, pp. 36–43, Jan. 2002, doi: 10.1136/oem.59.1.36.
[3792]	K. Steinsvåg, M. Bråtveit, and B. E. Moen, “Exposure to oil mist and oil vapour during offshore drilling in norway, 1979-2004,” Ann Occup Hyg, vol. 50, no. 2, pp. 109–122, Mar. 2006, doi: 10.1093/annhyg/mei049.
[3793]	J. Bartůnková et al., “Exposure to silica and risk of ANCA-associated vasculitis,” Am. J. Ind. Med., vol. 49, no. 7, pp. 569–576, Jul. 2006, doi: 10.1002/ajim.20327.
[3794]	R. Ghosh et al., “Exposure to Sound Vibrations Lead to Transcriptomic, Proteomic and Hormonal Changes in Arabidopsis,” Sci Rep, vol. 6, p. 33370, Sep. 2016, doi: 10.1038/srep33370.
[3795]	R. Ghosh et al., “Expression Analysis of Sound Vibration-Regulated Genes by Touch Treatment in Arabidopsis,” Front Plant Sci, vol. 8, p. 100, 2017, doi: 10.3389/fpls.2017.00100.
[3796]	J. Zhang, G. Wang, W.-W. He, M. Losh, E. Berry-Kravis, and W. E. Funk, “Expression and Characterization of Human Fragile X Mental Retardation Protein Isoforms and Interacting Proteins in Human Cells,” Proteomics Insights, vol. 10, p. 1178641818825268, 2019, doi: 10.1177/1178641818825268.
[3797]	R. Fu, M. Chen, Y. Chen, G. Mao, and S. Liu, “Expression and clinical significance of 5-HT and 5-HT3R in the intestinal mucosa of patient with diarrhea-type irritable bowel syndrome,” Exp Ther Med, vol. 17, no. 4, pp. 3077–3082, Apr. 2019, doi: 10.3892/etm.2019.7297.
[3798]	J. D. Mitchell, J. J. Maguire, R. E. Kuc, and A. P. Davenport, “Expression and vasoconstrictor function of anorexigenic peptides neuromedin U-25 and S in the human cardiovascular system,” Cardiovasc. Res., vol. 81, no. 2, pp. 353–361, Feb. 2009, doi: 10.1093/cvr/cvn302.
[3799]	K. R. Gheorghe et al., “Expression of 5-lipoxygenase and 15-lipoxygenase in rheumatoid arthritis synovium and effects of intraarticular glucocorticoids,” Arthritis Res. Ther., vol. 11, no. 3, p. R83, 2009, doi: 10.1186/ar2717.
[3800]	S. Hirano, Q. Yan, and S. T. Suzuki, “Expression of a novel protocadherin, OL-protocadherin, in a subset of functional systems of the developing mouse brain,” J. Neurosci., vol. 19, no. 3, pp. 995–1005, Feb. 1999.
[3801]	E. Spruth et al., “Expression of ACE mRNA in the human atrial myocardium is not dependent on left ventricular function, ACE inhibitor therapy, or the ACE I/D genotype,” J. Mol. Med., vol. 77, no. 11, pp. 804–810, Nov. 1999, doi: 10.1007/s001099900056.
[3802]	T. H. Wheeler-Schilling, M. Sautter, E. Guenther, and K. Kohler, “Expression of angiotensin-converting enzyme (ACE) in the developing chicken retina,” Exp. Eye Res., vol. 72, no. 2, pp. 173–182, Feb. 2001, doi: 10.1006/exer.2000.0944.
[3803]	W.-C. Ji, K.-Y. Ding, W.-B. Zhu, J. Wang, L. Zhang, and J.-S. Wu, “[Expression of c/ebpα gene in MDS and its clinical significance],” Zhongguo Shi Yan Xue Ye Xue Za Zhi, vol. 19, no. 1, pp. 90–93, Feb. 2011.
[3804]	K. Horiguchi, C. Ilmiawati, K. Fujiwara, T. Tsukada, M. Kikuchi, and T. Yashiro, “Expression of chemokine CXCL12 and its receptor CXCR4 in folliculostellate (FS) cells of the rat anterior pituitary gland: the CXCL12/CXCR4 axis induces interconnection of FS cells,” Endocrinology, vol. 153, no. 4, pp. 1717–1724, Apr. 2012, doi: 10.1210/en.2011-1937.
[3805]	T. Hirai, K. Tokumo, D. Tsuchiya, and H. Nishio, “Expression of mRNA for 5-HT2 receptors and proteins related to inactivation of 5-HT in mouse osteoblasts,” J. Pharmacol. Sci., vol. 109, no. 2, pp. 319–323, Feb. 2009, doi: 10.1254/jphs.08243sc.
[3806]	J. A. Baum, R. Geever, and N. H. Giles, “Expression of qa-1F activator protein: identification of upstream binding sites in the qa gene cluster and localization of the DNA-binding domain,” Mol. Cell. Biol., vol. 7, no. 3, pp. 1256–1266, Mar. 1987, doi: 10.1128/mcb.7.3.1256.
[3807]	T. Eberl et al., “Expression of stress proteins, adhesion molecules, and interleukin-8 in endothelial cells after preservation and reoxygenation,” Cryobiology, vol. 38, no. 2, pp. 106–118, Mar. 1999, doi: 10.1006/cryo.1999.2154.
[3808]	C. D. O’Connor and G. O. Humphreys, “Expression of the Eco RI restriction-modification system and the construction of positive-selection cloning vectors,” Gene, vol. 20, no. 2, pp. 219–229, Dec. 1982, doi: 10.1016/0378-1119(82)90041-5.
[3809]	A. M. W. Vermunt, A. B. Koopmanschap, J. M. Vlak, and C. a. D. de Kort, “Expression of the juvenile hormone esterase gene in the Colorado potato beetle, Leptinotarsa decemlineata: photoperiodic and juvenile hormone analog response,” J. Insect Physiol., vol. 45, no. 2, pp. 135–142, Feb. 1999, doi: 10.1016/s0022-1910(98)00107-3.
[3810]	K. Deschet, F. Bourrat, F. Ristoratore, D. Chourrout, and J. S. Joly, “Expression of the medaka (Oryzias latipes) Ol-Rx3 paired-like gene in two diencephalic derivatives, the eye and the hypothalamus,” Mech. Dev., vol. 83, no. 1–2, pp. 179–182, May 1999, doi: 10.1016/s0925-4773(99)00037-4.
[3811]	N. Seo et al., “Expression of the Qa-2k phenotype encoded by the Q5k gene on the surface of tumor cells derived from H-2k mice,” J. Exp. Med., vol. 175, no. 3, pp. 647–654, Mar. 1992, doi: 10.1084/jem.175.3.647.
[3812]	Y. Hua-Jun et al., “Expression pattern of enzymes related to juvenile hormone metabolism in the silkworm, Bombyx mori L,” Mol. Biol. Rep., vol. 38, no. 7, pp. 4337–4342, Oct. 2011, doi: 10.1007/s11033-010-0559-3.
[3813]	W. Wilson, M. H. Malim, J. Mellor, A. J. Kingsman, and S. M. Kingsman, “Expression strategies of the yeast retrotransposon Ty: a short sequence directs ribosomal frameshifting,” Nucleic Acids Res., vol. 14, no. 17, pp. 7001–7016, Sep. 1986, doi: 10.1093/nar/14.17.7001.
[3814]	S. E. Adams, S. Mark, H. Richardson, S. M. Kingsman, and A. J. Kingsman, “Expression Vectors for the Construction of Hybrid Ty-VLPs,” Methods Mol. Biol., vol. 8, pp. 265–276, 1992, doi: 10.1385/0-89603-191-8:265.
[3815]	M. S. Aslam, B. Zhang, Y. Zhang, and Z. Zhang, “Extended dissipative filter design for T-S fuzzy systems with multiple time delays,” ISA Trans, vol. 80, pp. 22–34, Sep. 2018, doi: 10.1016/j.isatra.2018.05.014.
[3816]	A. Gaye, “Extending the R Library PROPER to Enable Power Calculations for Isoform-Level Analysis with EBSeq,” Front Genet, vol. 7, p. 225, 2016, doi: 10.3389/fgene.2016.00225.
[3817]	M. A. Miranda-Ackerman and C. Azzaro-Pantel, “Extending the scope of eco-labelling in the food industry to drive change beyond sustainable agriculture practices,” J. Environ. Manage., vol. 204, no. Pt 3, pp. 814–824, Dec. 2017, doi: 10.1016/j.jenvman.2017.05.027.
[3818]	A. Bohadana, Y. Freier-Dror, V. Peles, P. Babai, and G. Izbicki, “Extending varenicline preloading to 6 weeks facilitates smoking cessation: A single-site, randomised controlled trial,” EClinicalMedicine, vol. 19, p. 100228, Feb. 2020, doi: 10.1016/j.eclinm.2019.11.021.
[3819]	C. B. Higgins, S. F. Vatner, D. Franklin, and E. Braunwald, “Extent of regulation of the heart’s contractile state in the conscious dog by alteration in the frequency of contraction,” J. Clin. Invest., vol. 52, no. 5, pp. 1187–1194, May 1973, doi: 10.1172/JCI107285.
[3820]	L. de Groote, B. Olivier, and H. G. M. Westenberg, “Extracellular serotonin in the prefrontal cortex is limited through terminal 5-HT(1B) autoreceptors: a microdialysis study in knockout mice,” Psychopharmacology (Berl.), vol. 162, no. 4, pp. 419–424, Aug. 2002, doi: 10.1007/s00213-002-1117-z.
[3821]	K. Yamada and T. Iwatsubo, “Extracellular α-synuclein levels are regulated by neuronal activity,” Mol Neurodegener, vol. 13, no. 1, p. 9, 22 2018, doi: 10.1186/s13024-018-0241-0.
[3822]	M. Kanoatov, L. T. Cherney, and S. N. Krylov, “Extracting kinetics from affinity capillary electrophoresis (ACE) data: a new blade for the old tool,” Anal. Chem., vol. 86, no. 2, pp. 1298–1305, Jan. 2014, doi: 10.1021/ac4038976.
[3823]	A. Abedinia, F. Ariffin, N. Huda, and A. M. Nafchi, “Extraction and characterization of gelatin from the feet of Pekin duck (Anas platyrhynchos domestica) as affected by acid, alkaline, and enzyme pretreatment,” Int. J. Biol. Macromol., vol. 98, pp. 586–594, May 2017, doi: 10.1016/j.ijbiomac.2017.01.139.
[3824]	N. V. Tonello, F. D’Eramo, J. M. Marioli, A. G. Crevillen, and A. Escarpa, “Extraction-free colorimetric determination of thymol and carvacrol isomers in essential oils by pH-dependent formation of gold nanoparticles,” Mikrochim Acta, vol. 185, no. 7, p. 352, 02 2018, doi: 10.1007/s00604-018-2893-4.
[3825]	F. Soikkeli, M. Hashim, M. Ouwens, M. Postma, and B. Heeg, “Extrapolating Survival Data Using Historical Trial-Based a Priori Distributions,” Value Health, vol. 22, no. 9, pp. 1012–1017, 2019, doi: 10.1016/j.jval.2019.03.017.
[3826]	J. Bean, “Extrasolar planets: Homing in on another Earth,” Nature, vol. 478, no. 7367, pp. 41–42, Sep. 2011, doi: 10.1038/nature10578.
[3827]	K. Stouten et al., “Extreme elevation of serum angiotensin-converting enzyme (ACE) activity: always consider familial ACE hyperactivity,” Ann. Clin. Biochem., vol. 51, no. Pt 2, pp. 289–293, Mar. 2014, doi: 10.1177/0004563213489812.
[3828]	E. J. Javaux, “Extreme life on Earth--past, present and possibly beyond,” Res. Microbiol., vol. 157, no. 1, pp. 37–48, Feb. 2006, doi: 10.1016/j.resmic.2005.07.008.
[3829]	J.-Y. Wang et al., “Extremely low level of serum pigment epithelium-derived factor is a special biomarker of Chinese osteogenesis imperfecta patients with SERPINF1 mutations,” Clin. Chim. Acta, vol. 478, pp. 216–221, Mar. 2018, doi: 10.1016/j.cca.2017.10.032.
[3830]	K. T. Rew, “Eye Conditions in Older Adults: Foreword,” FP Essent, vol. 445, p. 2; quiz 7, Jun. 2016.
[3831]	C. Cámara, C. de la Malla, J. López-Moliner, and E. Brenner, “Eye movements in interception with delayed visual feedback,” Exp Brain Res, vol. 236, no. 7, pp. 1837–1847, Jul. 2018, doi: 10.1007/s00221-018-5257-8.
[3832]	K. Hwang and S. K. Yoo, “Eyebrow Shapes of Chinese Empresses of the Ming and Qing Dynasties,” J Craniofac Surg, vol. 29, no. 5, pp. 1370–1375, Jul. 2018, doi: 10.1097/SCS.0000000000004498.
[3833]	K. Hwang and S. K. Yoo, “Eyebrow Shapes Over the Last Century,” J Craniofac Surg, vol. 27, no. 8, pp. 2181–2184, Nov. 2016, doi: 10.1097/SCS.0000000000003194.
[3834]	W. B. Ventres and M. P. Fort, “Eyes wide open: an essay on developing an engaged awareness in global medicine and public health,” BMC Int Health Hum Rights, vol. 14, p. 29, Oct. 2014, doi: 10.1186/s12914-014-0029-4.
[3835]	C. Thorley, S. A. Dewhurst, J. W. Abel, and L. M. Knott, “Eyewitness memory: The impact of a negative mood during encoding and/or retrieval upon recall of a non-emotive event,” Memory, vol. 24, no. 6, pp. 838–852, 2016, doi: 10.1080/09658211.2015.1058955.
[3836]	C. Lai et al., “Fabrication and Emission Performance of Nanostructured Re-W Matrix Impregnated Cathodes,” J Nanosci Nanotechnol, vol. 18, no. 6, pp. 4236–4242, Jun. 2018, doi: 10.1166/jnn.2018.15186.
[3837]	M.-J. Kim et al., “Facile fabrication of solution-processed solid-electrolytes for high-energy-density all-solid-state-batteries by enhanced interfacial contact,” Sci Rep, vol. 10, no. 1, p. 11923, Jul. 2020, doi: 10.1038/s41598-020-68885-4.
[3838]	Y. Shichiri, T. Kanno, T. Oida, and H. Kanamaru, “Facilitating the technique of laparoscopic running urethrovesical anastomosis using Lapra-ty absorbable suture clips,” Int. J. Urol., vol. 13, no. 2, pp. 192–194, Feb. 2006, doi: 10.1111/j.1442-2042.2006.01260.x.
[3839]	“Fact sheet on Ebola virus disease (updated May 2017),” Wkly. Epidemiol. Rec., vol. 92, no. 20, pp. 286–292, 19 2017.
[3840]	“Fact sheet on Guillain-Barré syndrome (updated October 2016,” Wkly. Epidemiol. Rec., vol. 92, no. 5, pp. 50–52, 03 2017.
[3841]	“Fact sheet on Middle East respiratory syndrome coronavirus (June 2015),” Wkly. Epidemiol. Rec., vol. 90, no. 24, pp. 305–308, Jun. 2015.
[3842]	“Fact sheet on pneumonia,” Wkly. Epidemiol. Rec., vol. 88, no. 11, pp. 126–127, Mar. 2013.
[3843]	“Fact sheet on tuberculosis (updated January 2018),” Wkly. Epidemiol. Rec., vol. 93, no. 4–5, pp. 39–43, Jan. 2018.
[3844]	G. Romano and M. Molinos-Senante, “Factors affecting eco-efficiency of municipal waste services in Tuscan municipalities: An empirical investigation of different management models,” Waste Manag, vol. 105, pp. 384–394, Mar. 2020, doi: 10.1016/j.wasman.2020.02.028.
[3845]	S. J. Bhosai, T. Sinthusake, S. Miwa, and E. Bradley, “Factors affecting patient access in Thailand: understanding delay in care seeking for patients with cancer,” Glob Public Health, vol. 6, no. 4, pp. 385–397, 2011, doi: 10.1080/17441692.2010.508750.
[3846]	F. Kawano, Y. Ishizaki, J. Yoshimoto, N. Fujiwara, and S. Kawasaki, “Factors Affecting Persistent Splenomegaly After Adult-to-Adult Living Donor Liver Transplantation Using a Left Lobe,” Transplant. Proc., vol. 51, no. 6, pp. 1946–1949, Aug. 2019, doi: 10.1016/j.transproceed.2019.02.033.
[3847]	S. N. Young, W. R. Vanwye, M. A. Schafer, T. A. Robertson, and A. V. Poore, “Factors Affecting PhD Student Success,” Int J Exerc Sci, vol. 12, no. 1, pp. 34–45, 2019.
[3848]	A. Koskinen et al., “Factors affecting revision rate of chronic rhinosinusitis,” Laryngoscope Investig Otolaryngol, vol. 1, no. 4, pp. 96–105, 2016, doi: 10.1002/lio2.27.
[3849]	O. J. Ginther and S. V. Dangudubiyyam, “Factors affecting side of ovulation in heifers and mares-A comparative study,” Anim. Reprod. Sci., vol. 199, pp. 72–78, Dec. 2018, doi: 10.1016/j.anireprosci.2018.10.008.
[3850]	M. C. M. Wo, K. S. Lim, W. Y. Choo, and C. T. Tan, “Factors affecting the employability in people with epilepsy,” Epilepsy Res., vol. 128, pp. 6–11, 2016, doi: 10.1016/j.eplepsyres.2016.10.003.
[3851]	M. Tonelli et al., “Factors associated with access blood flow in native vessel arteriovenous fistulae,” Nephrol. Dial. Transplant., vol. 19, no. 10, pp. 2559–2563, Oct. 2004, doi: 10.1093/ndt/gfh406.
[3852]	E. Osei, P. Akweongo, and F. Binka, “Factors associated with DELAY in diagnosis among tuberculosis patients in Hohoe Municipality, Ghana,” BMC Public Health, vol. 15, p. 721, Jul. 2015, doi: 10.1186/s12889-015-1922-z.
[3853]	Y. Yang, W. Xiong, S. Wang, J. Xu, M. A. McNutt, and L. Zhang, “Factors Associated With Detection of Helicobacter pylori in Gastric Biopsies: A Case-Control Study of 396 Biopsies,” Appl. Immunohistochem. Mol. Morphol., vol. 26, no. 5, pp. 345–350, Jun. 2018, doi: 10.1097/PAI.0000000000000421.
[3854]	L. Rew, S. D. Horner, and R. T. Fouladi, “Factors associated with health behaviors in middle childhood,” J Pediatr Nurs, vol. 25, no. 3, pp. 157–166, Jun. 2010, doi: 10.1016/j.pedn.2008.10.006.
[3855]	O. Bojovic et al., “Factors associated with patient and health system delays in diagnosis and treatment of tuberculosis in Montenegro, 2015-2016,” PLoS ONE, vol. 13, no. 3, p. e0193997, 2018, doi: 10.1371/journal.pone.0193997.
[3856]	J. Cai, X. Wang, A. Ma, Q. Wang, X. Han, and Y. Li, “Factors associated with patient and provider delays for tuberculosis diagnosis and treatment in Asia: a systematic review and meta-analysis,” PLoS ONE, vol. 10, no. 3, p. e0120088, 2015, doi: 10.1371/journal.pone.0120088.
[3857]	M. Tovar, J. L. Walker, and L. Rew, “Factors Associated With Physical Activity in Latina Women: A Systematic Review,” West J Nurs Res, vol. 40, no. 2, pp. 270–297, 2018, doi: 10.1177/0193945916681004.
[3858]	A. D. Banks and K. Dracup, “Factors associated with prolonged prehospital delay of African Americans with acute myocardial infarction,” Am. J. Crit. Care, vol. 15, no. 2, pp. 149–157, Mar. 2006.
[3859]	L. Rodriguez, S. Nurko, and A. Flores, “Factors associated with successful decrease and discontinuation of antegrade continence enemas (ACE) in children with defecation disorders: a study evaluating the effect of ACE on colon motility,” Neurogastroenterol. Motil., vol. 25, no. 2, pp. 140-e81, Feb. 2013, doi: 10.1111/nmo.12018.
[3860]	F. L. Tianyi, V. N. Agbor, A. K. Njamnshi, and J. Atashili, “Factors Associated with the Prevalence of Cognitive Impairment in a Rural Elderly Cameroonian Population: A Community-Based Study in Sub-Saharan Africa,” Dement Geriatr Cogn Disord, vol. 47, no. 1–2, pp. 104–113, 2019, doi: 10.1159/000496825.
[3861]	M. Delva, N. Lytvynenko, and I. Delva, “FACTORS ASSOCIATED WITH THE TIME-BASED PHENOMENOLOGY OF POST-STROKE FATIGUE OVER THE FIRST YEAR AFTER STROKE OCCURRENCE,” Georgian Med News, no. 279, pp. 92–97, Jun. 2018.
[3862]	S. V. Abraham, S. V. Krishnan, F. Thaha, J. M. Balakrishnan, T. Thomas, and B. U. Palatty, “Factors delaying management of acute stroke: An Indian scenario,” Int J Crit Illn Inj Sci, vol. 7, no. 4, pp. 224–230, Dec. 2017, doi: 10.4103/IJCIIS.IJCIIS_20_17.
[3863]	D. Toroser et al., “Factors impacting time to acceptance and publication for peer-reviewed publications,” Curr Med Res Opin, vol. 33, no. 7, pp. 1183–1189, 2017, doi: 10.1080/03007995.2016.1271778.
[3864]	T. Fujiwara, T. Oguni, G. Unishi, T. Tanabe, K. Ohbayashi, and K. Kaneko, “Factors related to patterns of body mass index in early infancy: 18 month longitudinal study,” Pediatr Int, vol. 56, no. 3, pp. 406–410, Jun. 2014, doi: 10.1111/ped.12272.
[3865]	K. B. Nooner, L. O. Linares, J. Batinjane, R. A. Kramer, R. Silva, and M. Cloitre, “Factors related to posttraumatic stress disorder in adolescence,” Trauma Violence Abuse, vol. 13, no. 3, pp. 153–166, Jul. 2012, doi: 10.1177/1524838012447698.
[3866]	T. Dierssen-Sotos, M. de la Cal-López, M. Navarro-Córdoba, H. Rebollo-Rodrigo, F. M. Antolín-Juarez, and J. Llorca, “[Factors related with the performance of a proper hand hygiene],” Med Clin (Barc), vol. 135, no. 13, pp. 592–595, Nov. 2010, doi: 10.1016/j.medcli.2010.02.040.
[3867]	R. E. McCoy, N. A. Costa, and A. E. Morris, “Factors that determine stability of highly concentrated chemically defined production media,” Biotechnol. Prog., vol. 31, no. 2, pp. 493–502, Apr. 2015, doi: 10.1002/btpr.2047.
[3868]	F.-A. Dohm, F. M. Cachelin, and R. H. Striegel-Moore, “Factors that influence food amount ratings by white, Hispanic, and Asian samples,” Obes. Res., vol. 13, no. 6, pp. 1061–1069, Jun. 2005, doi: 10.1038/oby.2005.124.
[3869]	E. M. Johnson and M. E. Coles, “Failure and delay in treatment-seeking across anxiety disorders,” Community Ment Health J, vol. 49, no. 6, pp. 668–674, Dec. 2013, doi: 10.1007/s10597-012-9543-9.
[3870]	B. Stimmel, D. Korts, G. Jackson, and H. S. Gilbert, “Failure of mean red cell volume to serve as a biologic marker for alcoholism in narcotic dependence. A randomized control trial,” Am. J. Med., vol. 74, no. 3, pp. 369–374, Mar. 1983, doi: 10.1016/0002-9343(83)90953-1.
[3871]	Z. Li et al., “Failure of rapamycin in the treatment of multiple haemangiomas associated with Maffucci syndrome,” Clin. Exp. Dermatol., vol. 40, no. 8, pp. 951–954, Dec. 2015, doi: 10.1111/ced.12545.
[3872]	G. S. Malhi and E. Bell, “Fake views: Irritable mood or moody irritability or simply being irritable and moody?,” Aust N Z J Psychiatry, vol. 53, no. 11, pp. 1126–1129, 2019, doi: 10.1177/0004867419885017.
[3873]	L. M. Wagner, V. L. Phillips, A. E. Hunsaker, and P. G. Forducey, “Falls among community-residing stroke survivors following inpatient rehabilitation: a descriptive analysis of longitudinal data,” BMC Geriatr, vol. 9, p. 46, Oct. 2009, doi: 10.1186/1471-2318-9-46.
[3874]	P. Striano, F. A. de Falco, C. Minetti, and F. Zara, “Familial benign nonprogressive myoclonic epilepsies,” Epilepsia, vol. 50 Suppl 5, pp. 37–40, May 2009, doi: 10.1111/j.1528-1167.2009.02118.x.
[3875]	P. Striano, A. Robbiano, F. Zara, and S. Striano, “Familial cortical tremor and epilepsy: a well-defined syndrome with genetic heterogeneity waiting for nosological placement in the ILAE classification,” Epilepsy Behav, vol. 19, no. 4, p. 669, Dec. 2010, doi: 10.1016/j.yebeh.2010.09.032.
[3876]	C. Kramers, G. J. Adema, M. Korte, and J. Deinum, “[Familial hyperactivity of angiotensin-converting enzyme (ACE)],” Ned Tijdschr Geneeskd, vol. 147, no. 11, pp. 507–510, Mar. 2003.
[3877]	F. A. de Falco, L. Majello, R. Santangelo, M. Stabile, F. D. Bricarelli, and F. Zara, “Familial infantile myoclonic epilepsy: clinical features in a large kindred with autosomal recessive inheritance,” Epilepsia, vol. 42, no. 12, pp. 1541–1548, Dec. 2001, doi: 10.1046/j.1528-1157.2001.26701.x.
[3878]	N. S. Yeghiazaryan et al., “Familial nonkinesigenic paroxysmal dyskinesia and intracranial calcifications: a new syndrome?,” Mov. Disord., vol. 25, no. 14, pp. 2468–2470, Oct. 2010, doi: 10.1002/mds.23267.
[3879]	Y. Wang, M. Haslam, M. Yu, J. Ding, Q. Lu, and F. Pan, “Family functioning, marital quality and social support in Chinese patients with epilepsy,” Health Qual Life Outcomes, vol. 13, p. 10, Jan. 2015, doi: 10.1186/s12955-015-0208-6.
[3880]	L. J. Dietz, “Family-Based Interpersonal Psychotherapy: An Intervention for Preadolescent Depression,” Am J Psychother, vol. 73, no. 1, pp. 22–28, Mar. 2020, doi: 10.1176/appi.psychotherapy.20190028.
[3881]	L. Hinton, A. F. Sciolla, J. Unützer, E. Elizarraras, R. L. Kravitz, and E. C. Apesoa-Varano, “Family-centered depression treatment for older men in primary care: a qualitative study of stakeholder perspectives,” BMC Fam Pract, vol. 18, no. 1, p. 88, Sep. 2017, doi: 10.1186/s12875-017-0659-4.
[3882]	C.-C. Lin, C.-F. Chang, M.-Y. Lai, T.-W. Chen, P.-C. Lee, and W.-C. Yang, “Far-infrared therapy: a novel treatment to improve access blood flow and unassisted patency of arteriovenous fistula in hemodialysis patients,” J. Am. Soc. Nephrol., vol. 18, no. 3, pp. 985–992, Mar. 2007, doi: 10.1681/ASN.2006050534.
[3883]	M. H. Stoler, “Farewell,” Int. J. Gynecol. Pathol., vol. 34, no. 1, pp. 1–2, Jan. 2015, doi: 10.1097/PGP.0000000000000191.
[3884]	G. Yu and S. B. Jacobsen, “Fast accretion of the earth with a late moon-forming giant impact,” Proc. Natl. Acad. Sci. U.S.A., vol. 108, no. 43, pp. 17604–17609, Oct. 2011, doi: 10.1073/pnas.1108544108.
[3885]	Y. Yan et al., “Fast and Stable Batteries with High Capacity Enabled by Germanium-Phosphorus Binary Nanoparticles Embedded in a Porous Carbon Matrix via Metallothermic Reduction,” ACS Appl Mater Interfaces, vol. 12, no. 19, pp. 21579–21585, May 2020, doi: 10.1021/acsami.0c01978.
[3886]	A. Shajii, D. Yorukoglu, Y. William Yu, and B. Berger, “Fast genotyping of known SNPs through approximate k-mer matching,” Bioinformatics, vol. 32, no. 17, pp. i538–i544, 01 2016, doi: 10.1093/bioinformatics/btw460.
[3887]	S. M. Smith, “Fast robust automated brain extraction,” Hum Brain Mapp, vol. 17, no. 3, pp. 143–155, Nov. 2002, doi: 10.1002/hbm.10062.
[3888]	Y.-H. Yoo et al., “Fast Track to Discover Novel Promoters in Rice,” Plants (Basel), vol. 9, no. 1, Jan. 2020, doi: 10.3390/plants9010125.
[3889]	C. M. Wendl et al., “Fat suppression in magnetic resonance imaging of the head and neck region: is the two-point DIXON technique superior to spectral fat suppression?,” Br J Radiol, vol. 91, no. 1085, p. 20170078, May 2018, doi: 10.1259/bjr.20170078.
[3890]	J. M. Oteiza, S. Soto, V. O. Alvarenga, A. S. Sant’Ana, and L. Gianuzzi, “Fate of Alicyclobacillus spp. in enrichment broth and in juice concentrates,” Int. J. Food Microbiol., vol. 210, pp. 73–78, Oct. 2015, doi: 10.1016/j.ijfoodmicro.2015.05.021.
[3891]	A. G. J. Harsevoort et al., “Fatigue in adults with Osteogenesis Imperfecta,” BMC Musculoskelet Disord, vol. 21, no. 1, p. 6, Jan. 2020, doi: 10.1186/s12891-019-3000-7.
[3892]	A. Badaoui, S. A. Kassm, and W. Naja, “Fear and Anxiety Disorders Related to Childbirth: Epidemiological and Therapeutic Issues,” Curr Psychiatry Rep, vol. 21, no. 4, p. 27, 12 2019, doi: 10.1007/s11920-019-1010-7.
[3893]	J. E. Dunsmoor and R. Paz, “Fear Generalization and Anxiety: Behavioral and Neural Mechanisms,” Biol. Psychiatry, vol. 78, no. 5, pp. 336–343, Sep. 2015, doi: 10.1016/j.biopsych.2015.04.010.
[3894]	E. P. Ahearn, T. Juergens, T. Smith, D. Krahn, and N. Kalin, “Fear, anxiety, and the neuroimaging of PTSD,” Psychopharmacol Bull, vol. 40, no. 3, pp. 88–103, 2007.
[3895]	D. H. Barlow, B. F. Chorpita, and J. Turovsky, “Fear, panic, anxiety, and disorders of emotion,” Nebr Symp Motiv, vol. 43, pp. 251–328, 1996.
[3896]	P. Gilbert, K. McEwan, F. Catarino, R. Baião, and L. Palmeira, “Fears of happiness and compassion in relationship with depression, alexithymia, and attachment security in a depressed sample,” Br J Clin Psychol, vol. 53, no. 2, pp. 228–244, Jun. 2014, doi: 10.1111/bjc.12037.
[3897]	H. S. Ki et al., “Feasibility of cap-assisted endoscopic retrograde cholangiopancreatography in patients with altered gastrointestinal anatomy,” Gut Liver, vol. 9, no. 1, pp. 109–112, Jan. 2015, doi: 10.5009/gnl13447.
[3898]	H. Kim et al., “Feasibility of chemically modified cellulose nanofiber membrane as lithium ion battery separators,” ACS Appl Mater Interfaces, Aug. 2020, doi: 10.1021/acsami.0c08820.
[3899]	H. Lei, S. Montessuit, S. Herzig, and J.-C. Martinou, “Feasibility of neurochemically profiling mouse embryonic brain and its development in utero using 1 H MRS at 14.1 T,” NMR Biomed, vol. 32, no. 11, p. e4163, 2019, doi: 10.1002/nbm.4163.
[3900]	C.-H. Jun et al., “Feasibility of self-expandable metal stents for preservation of sphincter of Oddi function in patients with common bile duct stones: a pilot study,” Gastrointest. Endosc., vol. 82, no. 4, pp. 719–723, Oct. 2015, doi: 10.1016/j.gie.2015.01.034.
[3901]	M. J. van Amerongen and F. B. Engel, “Features of cardiomyocyte proliferation and its potential for cardiac regeneration,” J. Cell. Mol. Med., vol. 12, no. 6A, pp. 2233–2244, Dec. 2008, doi: 10.1111/j.1582-4934.2008.00439.x.
[3902]	A. E. Richard, I. E. Scheffer, and S. J. Wilson, “Features of the broader autism phenotype in people with epilepsy support shared mechanisms between epilepsy and autism spectrum disorder,” Neurosci Biobehav Rev, vol. 75, pp. 203–233, Apr. 2017, doi: 10.1016/j.neubiorev.2016.12.036.
[3903]	S. Chung, “Febrile seizures,” Korean J Pediatr, vol. 57, no. 9, pp. 384–395, Sep. 2014, doi: 10.3345/kjp.2014.57.9.384.
[3904]	M. H. Scantlebury and J. G. Heida, “Febrile seizures and temporal lobe epileptogenesis,” Epilepsy Res., vol. 89, no. 1, pp. 27–33, Mar. 2010, doi: 10.1016/j.eplepsyres.2009.11.002.
[3905]	S. Papa, G. Gilardi, and W. Just, “FEBS Letters. Turin special issue: Biochemistry for tomorrow’s medicine,” FEBS Lett., vol. 585, no. 11, p. 1503, Jun. 2011, doi: 10.1016/j.febslet.2011.05.009.
[3906]	K. Rao and V. B. Young, “Fecal microbiota transplantation for the management of Clostridium difficile infection,” Infect. Dis. Clin. North Am., vol. 29, no. 1, pp. 109–122, Mar. 2015, doi: 10.1016/j.idc.2014.11.009.
[3907]	A. Das et al., “Feed consumption, diet digestibility and mineral utilization in captive blackbuck (Antelope cervicapra) fed different levels of concentrates,” J Anim Physiol Anim Nutr (Berl), vol. 97, no. 1, pp. 80–90, Feb. 2013, doi: 10.1111/j.1439-0396.2011.01245.x.
[3908]	L. Botzer and A. Karniel, “Feedback and feedforward adaptation to visuomotor delay during reaching and slicing movements,” Eur. J. Neurosci., vol. 38, no. 1, pp. 2108–2123, Jul. 2013, doi: 10.1111/ejn.12211.
[3909]	R. Schween and M. Hegele, “Feedback delay attenuates implicit but facilitates explicit adjustments to a visuomotor rotation,” Neurobiol Learn Mem, vol. 140, pp. 124–133, Apr. 2017, doi: 10.1016/j.nlm.2017.02.015.
[3910]	N. Oeri, D. Buttelmann, A. E. Voelke, and C. M. Roebers, “Feedback Enhances Preschoolers’ Performance in an Inhibitory Control Task,” Front Psychol, vol. 10, p. 977, 2019, doi: 10.3389/fpsyg.2019.00977.
[3911]	W. Wiseman et al., “Feeding blueberry diets inhibits angiotensin II-converting enzyme (ACE) activity in spontaneously hypertensive stroke-prone rats,” Can. J. Physiol. Pharmacol., vol. 89, no. 1, pp. 67–71, Jan. 2011, doi: 10.1139/y10-101.
[3912]	J. D. Sutton, I. C. Hart, S. V. Morant, E. Schuller, and A. D. Simmonds, “Feeding frequency for lactating cows: diurnal patterns of hormones and metabolites in peripheral blood in relation to milk-fat concentration,” Br. J. Nutr., vol. 60, no. 2, pp. 265–274, Sep. 1988, doi: 10.1079/bjn19880098.
[3913]	J. D. Sutton, I. C. Hart, W. H. Broster, R. J. Elliott, and E. Schuller, “Feeding frequency for lactating cows: effects on rumen fermentation and blood metabolites and hormones,” Br. J. Nutr., vol. 56, no. 1, pp. 181–192, Jul. 1986, doi: 10.1079/bjn19860098.
[3914]	J. K. Suagee-Bedore, D. R. Linden, K. Bennett-Wimbush, and R. K. Splan, “Feeding Grass Hay Before Concentrate Mitigates the Effect of Grain-Based Concentrates on Postprandial Plasma Interleukin-1β,” J. Equine Vet. Sci., vol. 86, p. 102899, Mar. 2020, doi: 10.1016/j.jevs.2019.102899.
[3915]	S. Papa and C. Bubici, “Feeding the Hedgehog: A new meaning for JNK signalling in liver regeneration,” J. Hepatol., vol. 69, no. 3, pp. 572–574, 2018, doi: 10.1016/j.jhep.2018.05.026.
[3916]	M. Izaute, P. Chambres, and S. Larochelle, “Feeling-of-knowing for proper names,” Can J Exp Psychol, vol. 56, no. 4, pp. 263–272, Dec. 2002, doi: 10.1037/h0087402.
[3917]	E. D. Levine, “Feline fear and anxiety,” Vet. Clin. North Am. Small Anim. Pract., vol. 38, no. 5, pp. 1065–1079, vii, Sep. 2008, doi: 10.1016/j.cvsm.2008.04.010.
[3918]	J. P. Sumpter, “Feminized responses in fish to environmental estrogens,” Toxicol. Lett., vol. 82–83, pp. 737–742, Dec. 1995, doi: 10.1016/0378-4274(95)03517-6.
[3919]	R. Kocijan et al., “Femoral geometric parameters and BMD measurements by DXA in adult patients with different types of osteogenesis imperfecta,” Skeletal Radiol., vol. 42, no. 2, pp. 187–194, Feb. 2013, doi: 10.1007/s00256-012-1512-4.
[3920]	A. Vestergaard, A. Ivarsen, S. Asp, and J. Ø. Hjortdal, “Femtosecond (FS) laser vision correction procedure for moderate to high myopia: a prospective study of ReLEx(®) flex and comparison with a retrospective study of FS-laser in situ keratomileusis,” Acta Ophthalmol, vol. 91, no. 4, pp. 355–362, Jun. 2013, doi: 10.1111/j.1755-3768.2012.02406.x.
[3921]	O. Novák, P. R. Krogen, T. Kroh, T. Mocek, F. X. Kärtner, and K.-H. Hong, “Femtosecond 8.5  μm source based on intrapulse difference-frequency generation of 2.1  μm pulses,” Opt Lett, vol. 43, no. 6, pp. 1335–1338, Mar. 2018, doi: 10.1364/OL.43.001335.
[3922]	W. Li et al., “FeOF/TiO2 Hetero-Nanostructures for High-Areal-Capacity Fluoride Cathodes,” ACS Appl Mater Interfaces, vol. 12, no. 30, pp. 33803–33809, Jul. 2020, doi: 10.1021/acsami.0c09185.
[3923]	R. Ahmed, I. Segal, and H. Hassan, “Fermentation of dietary starch in humans,” Am. J. Gastroenterol., vol. 95, no. 4, pp. 1017–1020, Apr. 2000, doi: 10.1111/j.1572-0241.2000.01848.x.
[3924]	E. S. Partlow, N. R. Campbell, S. C. Chan, K. M. Pap, K. Granberg, and B. B. Hasinoff, “Ferrous sulfate does not reduce serum levels of famotidine or cimetidine after concurrent ingestion,” Clin. Pharmacol. Ther., vol. 59, no. 4, pp. 389–393, Apr. 1996, doi: 10.1016/S0009-9236(96)90106-X.
[3925]	M. Naito, R. Suzuki, H. Abe, J. F. Rodriguez-Vazquez, G. Murakami, and S. Aizawa, “Fetal Development of the Human Obturator Internus Muscle With Special Reference to the Tendon and Pulley,” Anat Rec (Hoboken), vol. 298, no. 7, pp. 1282–1293, Jul. 2015, doi: 10.1002/ar.23121.
[3926]	S. Baulac et al., “Fever, genes, and epilepsy,” Lancet Neurol, vol. 3, no. 7, pp. 421–430, Jul. 2004, doi: 10.1016/S1474-4422(04)00808-7.
[3927]	S. Gupta, T. Mizunami, T. Yamao, and T. Shimomura, “Fiber Bragg grating cryogenic temperature sensors,” Appl Opt, vol. 35, no. 25, pp. 5202–5205, Sep. 1996, doi: 10.1364/AO.35.005202.
[3928]	R. Yeluri and A. K. Munshi, “Fiber reinforced composite loop space maintainer: An alternative to the conventional band and loop,” Contemp Clin Dent, vol. 3, no. Suppl 1, pp. S26-28, Apr. 2012, doi: 10.4103/0976-237X.95099.
[3929]	Y. Liu, P. Krogen, K.-H. Hong, Q. Cao, P. Keathley, and F. X. Kärtner, “Fiber-amplifier-pumped, 1-MHz, 1-µJ, 2.1-µm, femtosecond OPA with chirped-pulse DFG front-end,” Opt Express, vol. 27, no. 6, pp. 9144–9154, Mar. 2019, doi: 10.1364/OE.27.009144.
[3930]	J. Hanna, D. Winstedt, and U. Schött, “Fibrinogen and FXIII dose response effects on albumin-induced coagulopathy,” Scand. J. Clin. Lab. Invest., vol. 73, no. 7, pp. 553–562, Oct. 2013, doi: 10.3109/00365513.2013.821710.
[3931]	M. a. S. Meyer, S. R. Ostrowski, N. A. Windeløv, and P. I. Johansson, “Fibrinogen concentrates for bleeding trauma patients: what is the evidence?,” Vox Sang., vol. 101, no. 3, pp. 185–190, Oct. 2011, doi: 10.1111/j.1423-0410.2011.01478.x.
[3932]	Z. Ke, X. Hao, W. Ning, M. Zu, and Y. Fun, “Fibrinolysis status in the Budd-Chiari syndrome in China,” Blood Coagul. Fibrinolysis, vol. 26, no. 7, pp. 721–726, Oct. 2015, doi: 10.1097/MBC.0000000000000143.
[3933]	C. Zhao et al., “Fibroblast growth factor 21 is required for the therapeutic effects of Lactobacillus rhamnosus GG against fructose-induced fatty liver in mice,” Mol Metab, vol. 29, pp. 145–157, 2019, doi: 10.1016/j.molmet.2019.08.020.
[3934]	X. Lu, L. Duan, J. Zhang, Z. Zeng, and R. Kuang, “Fibroblasts from pBOO promote tumorigenesis by secreting TGFbeta1 to induce EMT in bladder urothelial carcinoma cells,” Biosci. Rep., Jun. 2018, doi: 10.1042/BSR20170944.
[3935]	D. G. Ju, E. M. Debbi, A. Z. Neustein, and C. N. Moon, “Fibular Lengthening Osteotomy With Revision Syndesmotic Repair for Ankle Fracture Malunion,” J Orthop Trauma, vol. 33 Suppl 1, pp. S38–S39, Aug. 2019, doi: 10.1097/BOT.0000000000001534.
[3936]	M. Qualls, “Field phase,” Qual Assur, vol. 3, no. 3, p. 267, Sep. 1994.
[3937]	D. Hexsel, M. Soirefmann, M. D. Porto, C. Siega, J. Schilling-Souza, and T. C. Rodrigues, “Fields of muscular and anhidrotic effects of 2 botulinum toxin-A commercial preparations: a prospective, double-blind, randomized, multicenter study,” Dermatol Surg, vol. 41 Suppl 1, pp. S110-118, Jan. 2015, doi: 10.1097/01.DSS.0000452645.76270.88.
[3938]	R. T. Sterner and K. A. Fagerstone, “FIFRA-88, GLP, and QA: pesticide registration,” Qual Assur, vol. 5, no. 3, pp. 171–182, Sep. 1997.
[3939]	U. Alexy, W. Sichert-Hellert, and M. Kersting, “Fifteen-year time trends in energy and macronutrient intake in German children and adolescents: results of the DONALD study,” Br. J. Nutr., vol. 87, no. 6, pp. 595–604, Jun. 2002, doi: 10.1079/BJNBJN/2002572.
[3940]	M. P. Martín, P. P. Daniëls, D. Erickson, and J. L. Spouge, “Figures of merit and statistics for detecting faulty species identification with DNA barcodes: A case study in Ramaria and related fungal genera,” PLoS ONE, vol. 15, no. 8, p. e0237507, Aug. 2020, doi: 10.1371/journal.pone.0237507.
[3941]	J. Beatham, R. Romero, S. K. M. Townsend, T. Hacker, P. F. M. van der Ven, and G. Blanco, “Filamin C interacts with the muscular dystrophy KY protein and is abnormally distributed in mouse KY deficient muscle fibres,” Hum. Mol. Genet., vol. 13, no. 22, pp. 2863–2874, Nov. 2004, doi: 10.1093/hmg/ddh308.
[3942]	E. Thauer et al., “Filled Carbon Nanotubes as Anode Materials for Lithium-Ion Batteries,” Molecules, vol. 25, no. 5, Feb. 2020, doi: 10.3390/molecules25051064.
[3943]	“Final report on the safety assessment of Peanut (Arachis hypogaea) Oil, Hydrogenated Peanut Oil, Peanut Acid, Peanut Glycerides, and Peanut (Arachis hypogaea) Flour,” Int. J. Toxicol., vol. 20 Suppl 2, pp. 65–77, 2001, doi: 10.1080/10915810160233776.
[3944]	“Final report on the safety assessment of Ricinus Communis (Castor) Seed Oil, Hydrogenated Castor Oil, Glyceryl Ricinoleate, Glyceryl Ricinoleate SE, Ricinoleic Acid, Potassium Ricinoleate, Sodium Ricinoleate, Zinc Ricinoleate, Cetyl Ricinoleate, Ethyl Ricinoleate, Glycol Ricinoleate, Isopropyl Ricinoleate, Methyl Ricinoleate, and Octyldodecyl Ricinoleate,” Int. J. Toxicol., vol. 26 Suppl 3, pp. 31–77, 2007, doi: 10.1080/10915810701663150.
[3945]	M. J. Friedman, “Finalizing PTSD in DSM-5: getting here from there and where to go next,” J Trauma Stress, vol. 26, no. 5, pp. 548–556, Oct. 2013, doi: 10.1002/jts.21840.
[3946]	S. Galea, M. Tracy, F. Norris, and S. F. Coffey, “Financial and social circumstances and the incidence and course of PTSD in Mississippi during the first two years after Hurricane Katrina,” J Trauma Stress, vol. 21, no. 4, pp. 357–368, Aug. 2008, doi: 10.1002/jts.20355.
[3947]	M. Heberer and F. Harder, “[Financial planning for surgical research. Project portfolio as an instrument for research planning],” Chirurg, vol. 61, no. 4, pp. 251–258, Apr. 1990.
[3948]	E. L. May, “Financial planning in a value-based world,” Healthc Exec, vol. 29, no. 3, pp. 10–12, 14, 16–18, Jun. 2014.
[3949]	P. C. W. Davies and C. H. Lineweaver, “Finding a second sample of life on earth,” Astrobiology, vol. 5, no. 2, pp. 154–163, Apr. 2005, doi: 10.1089/ast.2005.5.154.
[3950]	S. Yao and H. N. B. Moseley, “Finding High-Quality Metal Ion-Centric Regions Across the Worldwide Protein Data Bank,” Molecules, vol. 24, no. 17, Sep. 2019, doi: 10.3390/molecules24173179.
[3951]	J. P. Klein et al., “[Finding the needles in the haystack: quality criteria for the use of internet-based self-management interventions in the prevention and treatment of mental disorders],” Fortschr Neurol Psychiatr, vol. 87, no. 3, pp. 187–191, Mar. 2019, doi: 10.1055/a-0849-9902.
[3952]	X. Yang et al., “Fine mapping of the tomato yellow leaf curl virus resistance gene Ty-2 on chromosome 11 of tomato,” Mol. Breed., vol. 34, pp. 749–760, 2014, doi: 10.1007/s11032-014-0072-9.
[3953]	C.-M. Chung et al., “Fine-mapping angiotensin-converting enzyme gene: separate QTLs identified for hypertension and for ACE activity,” PLoS ONE, vol. 8, no. 3, p. e56119, 2013, doi: 10.1371/journal.pone.0056119.
[3954]	B. G. Richmond et al., “Finite element analysis in functional morphology,” Anat Rec A Discov Mol Cell Evol Biol, vol. 283, no. 2, pp. 259–274, Apr. 2005, doi: 10.1002/ar.a.20169.
[3955]	T. Yamashita, K. Tose, and Y. Shichida, “First cytoplasmic loop of glucagon-like peptide-1 receptor can function at the third cytoplasmic loop position of rhodopsin,” Photochem. Photobiol., vol. 84, no. 4, pp. 931–936, Aug. 2008, doi: 10.1111/j.1751-1097.2008.00327.x.
[3956]	M. D. Gemmellaro, C. Bucolo, E. Musumeci, G. C. Hamilton, and L. M. Weidner, “First Observations of Initial Blow Fly (Diptera: Calliphoridae) Activity on Lava Fields and in Subterranean Environments in Sicily in Cool Temperatures,” J. Med. Entomol., vol. 55, no. 6, pp. 1622–1626, 25 2018, doi: 10.1093/jme/tjy099.
[3957]	O. O. Zaidat et al., “First Pass Effect: A New Measure for Stroke Thrombectomy Devices,” Stroke, vol. 49, no. 3, pp. 660–666, 2018, doi: 10.1161/STROKEAHA.117.020315.
[3958]	S. S. T. Hua, D. E. Parfitt, S. B. L. Sarreal, B. G. Lee, and D. F. Wood, “First report of an atypical new Aspergillus parasiticus isolates with nucleotide insertion in aflR gene resembling to A. sojae,” Mycotoxin Res, vol. 34, no. 2, pp. 151–157, May 2018, doi: 10.1007/s12550-018-0309-2.
[3959]	B. P. Cheng, Y. H. Huang, X. B. Song, A. T. Peng, J. F. Ling, and X. Chen, “First Report of Colletotrichum siamense Causing Leaf Drop and Fruit Spot of Citrus reticulata Blanco cv. Shiyue Ju in China,” Plant Dis., vol. 97, no. 11, p. 1508, Nov. 2013, doi: 10.1094/PDIS-04-13-0352-PDN.
[3960]	F. H. Caetano, M. L. Bution, and F. J. Zara, “First report of endocytobionts in the digestive tract of ponerine ants,” Micron, vol. 40, no. 2, pp. 194–197, Feb. 2009, doi: 10.1016/j.micron.2008.09.004.
[3961]	B. P. Cheng, L. M. Lu, A. T. Peng, X. B. Song, J. F. Ling, and X. Chen, “First Report of Foliar Blight Caused by Phytophthora capsici on Citrus reticulata Blanco cv. Nian Ju in Guangdong, China,” Plant Dis., vol. 98, no. 6, p. 845, Jun. 2014, doi: 10.1094/PDIS-09-13-0951-PDN.
[3962]	B. P. Cheng, Y. H. Huang, A. T. Peng, J. F. Ling, X. B. Song, and X. Chen, “First Report of Leaf and Fruit Spot of Citrus reticulata Blanco cv. Nian Ju Caused by Colletotrichum truncatum in China,” Plant Dis., vol. 98, no. 3, p. 422, Mar. 2014, doi: 10.1094/PDIS-07-13-0712-PDN.
[3963]	H. D. Lopez-Nicora, T. Mekete, N. J. Taylor, and T. L. Niblack, “First Report of Lesion Nematode (Pratylenchus vulnus) on Boxwood in Ohio,” Plant Dis., vol. 96, no. 9, p. 1385, Sep. 2012, doi: 10.1094/PDIS-03-12-0272-PDN.
[3964]	M. V. Marin and N. A. Peres, “First Report of Sclerotinia sclerotiorum Causing Strawberry Fruit Rot in Florida,” Plant Dis., Aug. 2020, doi: 10.1094/PDIS-04-20-0879-PDN.
[3965]	A. M. Bassols et al., “First- and last-year medical students: is there a difference in the prevalence and intensity of anxiety and depressive symptoms?,” Braz J Psychiatry, vol. 36, no. 3, pp. 233–240, Sep. 2014, doi: 10.1590/1516-4446-2013-1183.
[3966]	S. Mlinar, “First- and third-year student nurses’ perceptions of caring behaviours,” Nurs Ethics, vol. 17, no. 4, pp. 491–500, Jul. 2010, doi: 10.1177/0969733010364903.
[3967]	J. Lüder and S. Manzhos, “First-Principle Insights Into Molecular Design for High-Voltage Organic Electrode Materials for Mg Based Batteries,” Front Chem, vol. 8, p. 83, 2020, doi: 10.3389/fchem.2020.00083.
[3968]	S. Nyamdelger, T. Ochirkhuyag, D. Sangaa, and D. Odkhuu, “First-principles prediction of a two-dimensional vanadium carbide (MXene) as the anode for lithium ion batteries,” Phys Chem Chem Phys, vol. 22, no. 10, pp. 5807–5818, Mar. 2020, doi: 10.1039/c9cp06472a.
[3969]	F. Meheus and D. McIntyre, “Fiscal space for domestic funding of health and other social services,” Health Econ Policy Law, vol. 12, no. 2, pp. 159–177, Apr. 2017, doi: 10.1017/S1744133116000438.
[3970]	S. Y. Al-Okbi, S. E. Mohammed, E. S. K. Al-Siedy, and N. A. Ali, “Fish Oil and Primrose Oil Suppress the Progression of Alzheimer’s Like Disease Induced by Aluminum in Rats,” J Oleo Sci, vol. 69, no. 7, pp. 771–782, Jul. 2020, doi: 10.5650/jos.ess20015.
[3971]	M. Mori, S. Kuwabara, and N. Yuki, “Fisher syndrome: clinical features, immunopathogenesis and management,” Expert Rev Neurother, vol. 12, no. 1, pp. 39–51, Jan. 2012, doi: 10.1586/ern.11.182.
[3972]	U. B. Dogan, Y. Gumurdulu, M. S. Akin, and S. Yalaki, “Five percent weight lost in the first month of intragastric balloon treatment may be a predictor for long-term weight maintenance,” Obes Surg, vol. 23, no. 7, pp. 892–896, Jul. 2013, doi: 10.1007/s11695-013-0876-4.
[3973]	R. P. Ellis, “Five questions for health economists,” Int J Health Care Finance Econ, vol. 12, no. 3, pp. 217–233, Sep. 2012, doi: 10.1007/s10754-012-9112-3.
[3974]	I. K. Crombie and N. Cramer, “Five-year age-specific incidence rates. I. Their nature and limitations,” J Epidemiol Community Health, vol. 34, no. 3, pp. 223–228, Sep. 1980, doi: 10.1136/jech.34.3.223.
[3975]	M. Salah, A. G. Ahmed, M. Abo-Eloyoun, and M. M. Shaaban, “Five-year experience with Norplant implants in Assiut, Egypt,” Contraception, vol. 35, no. 6, pp. 543–550, Jun. 1987, doi: 10.1016/s0010-7824(87)80015-x.
[3976]	D. R. Taylor et al., “Five-year institutional bibliometric profiles for 103 US neurosurgical residency programs,” J. Neurosurg., vol. 123, no. 3, pp. 547–560, Sep. 2015, doi: 10.3171/2014.10.JNS141025.
[3977]	I. Rustenbeck, “[Fixed drug combinations--the pros and the cons],” Med Monatsschr Pharm, vol. 32, no. 4, pp. 141–146, Apr. 2009.
[3978]	M. D. Kendig and M. J. Morris, “Fizzing out: No effect of acute carbohydrate consumption on mood,” Neurosci Biobehav Rev, vol. 104, pp. 56–57, 2019, doi: 10.1016/j.neubiorev.2019.06.028.
[3979]	D. Suzuki, J. H. Kim, S. Shibata, H. Abe, G. Murakami, and J. F. Rodríguez-Vázquez, “Flap valve of the heart foramen ovale revisited: macroscopic and histologic observations of human near-term fetuses,” Ann. Anat., vol. 224, pp. 8–16, Jul. 2019, doi: 10.1016/j.aanat.2019.03.006.
[3980]	S. Masumoto, S. Aoki, T. Miura, and T. Shoji, “Flavan-3-ol/Procyanidin Metabolomics in Rat Urine Using HPLC-Quadrupole TOF/MS,” Mol Nutr Food Res, vol. 62, no. 19, p. e1700867, 2018, doi: 10.1002/mnfr.201700867.
[3981]	V. Enea and I. Dafinoiu, “Flexibility in processing visual information: effects of mood and hypnosis,” Int J Clin Exp Hypn, vol. 61, no. 1, pp. 55–70, 2013, doi: 10.1080/00207144.2013.729435.
[3982]	L. Brückner, N. Müller, and M. Motzkus, “Flexible and broadly tunable infrared light source based on shaped sub-10-fs pulses for a multimodal microscopy setup,” Opt Lett, vol. 43, no. 9, pp. 2054–2057, May 2018, doi: 10.1364/OL.43.002054.
[3983]	G. Zara, P. Goffrini, T. Lodi, S. Zara, I. Mannazzu, and M. Budroni, “FLO11 expression and lipid biosynthesis are required for air-liquid biofilm formation in a Saccharomyces cerevisiae flor strain,” FEMS Yeast Res., vol. 12, no. 7, pp. 864–866, Nov. 2012, doi: 10.1111/j.1567-1364.2012.00831.x.
[3984]	G. Zara, S. Zara, C. Pinna, S. Marceddu, and M. Budroni, “FLO11 gene length and transcriptional level affect biofilm-forming ability of wild flor strains of Saccharomyces cerevisiae,” Microbiology (Reading), vol. 155, no. Pt 12, pp. 3838–3846, Dec. 2009, doi: 10.1099/mic.0.028738-0.
[3985]	S. Zara, A. T. Bakalinsky, G. Zara, G. Pirino, M. A. Demontis, and M. Budroni, “FLO11-based model for air-liquid interfacial biofilm formation by Saccharomyces cerevisiae,” Appl. Environ. Microbiol., vol. 71, no. 6, pp. 2934–2939, Jun. 2005, doi: 10.1128/AEM.71.6.2934-2939.2005.
[3986]	A. Ratriyanto and S. Prastowo, “Floor space and betaine supplementation alter the nutrient digestibility and performance of Japanese quail in a tropical environment,” J. Therm. Biol., vol. 83, pp. 80–86, Jul. 2019, doi: 10.1016/j.jtherbio.2019.05.008.
[3987]	O. R. Diermann and M. Holthaus, “Floquet-state cooling,” Sci Rep, vol. 9, no. 1, p. 17614, Nov. 2019, doi: 10.1038/s41598-019-53877-w.
[3988]	J.-L. Legras et al., “Flor Yeast: New Perspectives Beyond Wine Aging,” Front Microbiol, vol. 7, p. 503, 2016, doi: 10.3389/fmicb.2016.00503.
[3989]	F. Bellos and W. Kern, “Flow cytometry in the diagnosis of myelodysplastic syndromes (MDS) and the value of myeloid nuclear differentiation antigen (MNDA),” Cytometry B Clin Cytom, Sep. 2014, doi: 10.1002/cytob.21190.
[3990]	C. J. Clancy, V. L. Yu, A. J. Morris, D. R. Snydman, and M. H. Nguyen, “Fluconazole MIC and the fluconazole dose/MIC ratio correlate with therapeutic response among patients with candidemia,” Antimicrob. Agents Chemother., vol. 49, no. 8, pp. 3171–3177, Aug. 2005, doi: 10.1128/AAC.49.8.3171-3177.2005.
[3991]	A. Kroemeke, Z. Kwissa-Gajewska, and M. Sobczyk-Kruszelnicka, “Fluctuation in physical symptoms, coping, and mood in patients following hematopoietic stem cell transplantation: assessing mediation effects using a daily diary approach,” J Behav Med, vol. 42, no. 2, pp. 224–233, 2019, doi: 10.1007/s10865-018-9968-x.
[3992]	A. Santhanakrishnan and L. A. Miller, “Fluid dynamics of heart development,” Cell Biochem. Biophys., vol. 61, no. 1, pp. 1–22, Sep. 2011, doi: 10.1007/s12013-011-9158-8.
[3993]	J. J. Walton, T. Hiasa, H. Kumita, K. Takeshi, and G. Sandford, “Fluorocyanoesters as Additives for Lithium-Ion Battery Electrolytes,” ACS Appl Mater Interfaces, vol. 12, no. 13, pp. 15893–15902, Apr. 2020, doi: 10.1021/acsami.9b23028.
[3994]	R. Farajzadeh, A. Andrianov, R. Krastev, G. J. Hirasaki, and W. R. Rossen, “Foam-oil interaction in porous media: implications for foam assisted enhanced oil recovery,” Adv Colloid Interface Sci, vol. 183–184, pp. 1–13, Nov. 2012, doi: 10.1016/j.cis.2012.07.002.
[3995]	P. Salvador, E. Saguer, D. Parés, C. Carretero, and M. Toldrà, “Foaming and emulsifying properties of porcine red cell protein concentrate,” Food Sci Technol Int, vol. 16, no. 4, pp. 289–296, Aug. 2010, doi: 10.1177/1082013209353223.
[3996]	S. Marshall and S. Taneja, “Focal therapy for prostate cancer: The current status,” Prostate Int, vol. 3, no. 2, pp. 35–41, Jun. 2015, doi: 10.1016/j.prnil.2015.03.007.
[3997]	C. F. Otieno, P. M. Nyamu, and G. Atieno-Jalango, “Focus on delay as a strategy for care designs and evaluation of diabetic foot ulcers in developing countries: a review,” East Afr Med J, vol. 82, no. 12 Suppl, pp. S204-208, Dec. 2005, doi: 10.4314/eamj.v82i12.9383.
[3998]	F. de V. Papa, “[Focused cardiac ultrasound: is there room for intraoperative use?],” Rev Bras Anestesiol, vol. 68, no. 5, pp. 539–540, Oct. 2018, doi: 10.1016/j.bjan.2018.02.003.
[3999]	M. H. El-Shabrawi et al., “Folic Acid Intake and Neural Tube Defects: Two Egyptian Centers Experience,” Medicine (Baltimore), vol. 94, no. 37, p. e1395, Sep. 2015, doi: 10.1097/MD.0000000000001395.
[4000]	T. Tsukada et al., “Folliculostellate cells are required for laminin release from gonadotrophs in rat anterior pituitary,” Acta Histochem Cytochem, vol. 47, no. 5, pp. 239–245, 2014, doi: 10.1267/ahc.14036.
[4001]	U. Michel et al., “Follistatin (FS) in human cerebrospinal fluid and regulation of FS expression in a mouse model of meningitis,” Eur. J. Endocrinol., vol. 143, no. 6, pp. 809–816, Dec. 2000, doi: 10.1530/eje.0.1430809.
[4002]	H. Sugino, K. Sugino, O. Hashimoto, H. Shoji, and T. Nakamura, “Follistatin and its role as an activin-binding protein,” J. Med. Invest., vol. 44, no. 1–2, pp. 1–14, Aug. 1997.
[4003]	P. Spirhanzlova, M. Leemans, B. A. Demeneix, and J.-B. Fini, “Following Endocrine-Disrupting Effects on Gene Expression in Xenopus laevis,” Cold Spring Harb Protoc, vol. 2019, no. 7, 01 2019, doi: 10.1101/pdb.prot098301.
[4004]	J. S. Mills, J. Polivy, and A. Iqbal, “Food-based social comparisons influence liking and consumption,” Appetite, vol. 151, p. 104720, 01 2020, doi: 10.1016/j.appet.2020.104720.
[4005]	J. Wallace, H. White, S. Augsburger, R. Shapiro, and J. Walker, “Foot pressure analysis using the emed® in typically developing children and adolescents: A summary of current techniques and typically developing cohort data for comparison with pathology,” Foot (Edinb), vol. 37, pp. 28–37, Dec. 2018, doi: 10.1016/j.foot.2018.04.007.
[4006]	A. S. Baldridge, M. D. Huffman, G. S. Bloomfield, and D. Prabhakaran, “Footprint and imprint: an ecologic time-trend analysis of cardiovascular publications in general and specialty journals,” Glob Heart, vol. 9, no. 2, pp. 263-269.e2, Jun. 2014, doi: 10.1016/j.gheart.2013.12.006.
[4007]	Z. Bodie, R. S. Kaplan, and R. C. Merton, “For the last time: stock options are an expense,” Harv Bus Rev, vol. 81, no. 3, pp. 62–71, 140, Mar. 2003.
[4008]	M. Price, “For these intrepid crickets, lava is home sweet home,” Science, vol. 363, no. 6433, p. 1262, 22 2019, doi: 10.1126/science.363.6433.1262.
[4009]	N. E. Wilson, “For-profit status and industry evolution in health care markets: evidence from the dialysis industry,” Int J Health Econ Manag, vol. 16, no. 4, pp. 297–319, Dec. 2016, doi: 10.1007/s10754-016-9192-6.
[4010]	M. Bianchi, C. Moser, C. Lazzarini, E. Vecchiato, and F. Crespi, “Forced swimming test and fluoxetine treatment: in vivo evidence that peripheral 5-HT in rat platelet-rich plasma mirrors cerebral extracellular 5-HT levels, whilst 5-HT in isolated platelets mirrors neuronal 5-HT changes,” Exp Brain Res, vol. 143, no. 2, pp. 191–197, Mar. 2002, doi: 10.1007/s00221-001-0979-3.
[4011]	J. Wesseler, R. D. Smart, J. Thomson, and D. Zilberman, “Foregone benefits of important food crop improvements in Sub-Saharan Africa,” PLoS ONE, vol. 12, no. 7, p. e0181353, 2017, doi: 10.1371/journal.pone.0181353.
[4012]	H. Deng, P. Zheng, T. Liu, and X. Liu, “Forest ecosystem services and eco-compensation mechanisms in China,” Environ Manage, vol. 48, no. 6, pp. 1079–1085, Dec. 2011, doi: 10.1007/s00267-011-9742-0.
[4013]	N. Báez-Vallejo et al., “Forest tree associated bacteria for potential biological control of Fusarium solani and of Fusarium kuroshium, causal agent of Fusarium dieback,” Microbiol. Res., vol. 235, p. 126440, May 2020, doi: 10.1016/j.micres.2020.126440.
[4014]	V. Cheynier, H. Halbwirth, K. Stich, and S. Martens, “Foreword focus on polyphenols,” Planta, vol. 246, no. 2, p. 183, 2017, doi: 10.1007/s00425-017-2745-1.
[4015]	H. Colonius and A. Diederich, “Formal models and quantitative measures of multisensory integration: a selective overview,” Eur. J. Neurosci., vol. 51, no. 5, pp. 1161–1178, Mar. 2020, doi: 10.1111/ejn.13813.
[4016]	K. Miyamoto, T. Murakami, P. Kakumyan, N. P. Keller, and K. Matsui, “Formation of 1-octen-3-ol from Aspergillus flavus conidia is accelerated after disruption of cells independently of Ppo oxygenases, and is not a main cause of inhibition of germination,” PeerJ, vol. 2, p. e395, 2014, doi: 10.7717/peerj.395.
[4017]	H. D. Møller, C. E. Larsen, L. Parsons, A. J. Hansen, B. Regenberg, and T. Mourier, “Formation of Extrachromosomal Circular DNA from Long Terminal Repeats of Retrotransposons in Saccharomyces cerevisiae,” G3 (Bethesda), vol. 6, no. 2, pp. 453–462, Dec. 2015, doi: 10.1534/g3.115.025858.
[4018]	L. Hunt et al., “Formation of the Stomatal Outer Cuticular Ledge Requires a Guard Cell Wall Proline-Rich Protein,” Plant Physiol., vol. 174, no. 2, pp. 689–699, Jun. 2017, doi: 10.1104/pp.16.01715.
[4019]	T. Lenzy, “Former director of RCN Wales Liz Hewett began at Ty Maeth in 1998,” Nurs Stand, vol. 30, no. 40, p. 33, Jun. 2016, doi: 10.7748/ns.30.40.33.s41.
[4020]	N. K. Alruwaili et al., “Formulation of amorphous ternary solid dispersions of dapagliflozin using PEG 6000 and Poloxamer 188: solid-state characterization, ex vivo study, and molecular simulation assessment,” Drug Dev Ind Pharm, pp. 1–10, Aug. 2020, doi: 10.1080/03639045.2020.1802482.
[4021]	S. O. Ochanda et al., “Fortification of alcoholic beverages (12% v/v) with tea (Camellia sinensis) reduces harmful effects of alcohol ingestion and metabolism in mouse model,” BMJ Open Gastroenterol, vol. 3, no. 1, p. e000058, 2016, doi: 10.1136/bmjgast-2015-000058.
[4022]	S. Puebla-Barragan and G. Reid, “Forty-five-year evolution of probiotic therapy,” Microb Cell, vol. 6, no. 4, pp. 184–196, Apr. 2019, doi: 10.15698/mic2019.04.673.
[4023]	B. Rood, C. Zhang, E. Inniss, and Z. Hu, “Forward osmosis with an algal draw solution to concentrate municipal wastewater and recover resources,” Water Environ. Res., vol. 92, no. 5, pp. 689–697, May 2020, doi: 10.1002/wer.1262.
[4024]	J. Couzin, “Foundations. Economic woes threaten to deflate plans for 2009,” Science, vol. 322, no. 5903, p. 841, Nov. 2008, doi: 10.1126/science.322.5903.841.
[4025]	A. Wagstaff and A. J. Culyer, “Four decades of health economics through a bibliometric lens,” J Health Econ, vol. 31, no. 2, pp. 406–439, Mar. 2012, doi: 10.1016/j.jhealeco.2012.03.002.
[4026]	R. Hienerwadel, A. Boussac, J. Breton, and C. Berthomieu, “Fourier transform infrared difference study of tyrosineD oxidation and plastoquinone QA reduction in photosystem II,” Biochemistry, vol. 35, no. 48, pp. 15447–15460, Dec. 1996, doi: 10.1021/bi961952d.
[4027]	M. Rosentritt, S. Krifka, T. Strasser, and V. Preis, “Fracture force of CAD/CAM resin composite crowns after in vitro aging,” Clin Oral Investig, vol. 24, no. 7, pp. 2395–2401, Jul. 2020, doi: 10.1007/s00784-019-03099-1.
[4028]	J. Zieba et al., “Fracture Healing in Collagen-Related Preclinical Models of Osteogenesis Imperfecta,” J. Bone Miner. Res., vol. 35, no. 6, pp. 1132–1148, Jun. 2020, doi: 10.1002/jbmr.3979.
[4029]	K. V. Peddada, B. T. Sullivan, A. Margalit, and P. D. Sponseller, “Fracture Patterns Differ Between Osteogenesis Imperfecta and Routine Pediatric Fractures,” J Pediatr Orthop, vol. 38, no. 4, pp. e207–e212, Apr. 2018, doi: 10.1097/BPO.0000000000001137.
[4030]	A. Mete, Y. Yilmaz, and S. S. Derelioglu, “Fracture resistance force of primary molar crowns milled from polymeric computer-aided design/computer-assisted manufactured resin blocks,” Niger J Clin Pract, vol. 21, no. 4, pp. 525–530, Apr. 2018, doi: 10.4103/njcp.njcp_169_17.
[4031]	C. S. Greeley, M. Donaruma-Kwoh, M. Vettimattam, C. Lobo, C. Williard, and L. Mazur, “Fractures at diagnosis in infants and children with osteogenesis imperfecta,” J Pediatr Orthop, vol. 33, no. 1, pp. 32–36, Jan. 2013, doi: 10.1097/BPO.0b013e318279c55d.
[4032]	A. A. Saleem and S. N. Siddiqui, “Fraser Syndrome,” J Coll Physicians Surg Pak, vol. 25 Suppl 2, pp. S124-126, Oct. 2015, doi: 10.2015/JCPSP.S124S126.
[4033]	S. Chiang et al., “Frataxin and the molecular mechanism of mitochondrial iron-loading in Friedreich’s ataxia,” Clin. Sci., vol. 130, no. 11, pp. 853–870, 01 2016, doi: 10.1042/CS20160072.
[4034]	J. Hanson, “Fraud or confusion?,” RDH, vol. 19, no. 4, pp. 40–42, 44, Apr. 1999.
[4035]	G. A. Sunde et al., “Freeze dried plasma and fresh red blood cells for civilian prehospital hemorrhagic shock resuscitation,” J Trauma Acute Care Surg, vol. 78, no. 6 Suppl 1, pp. S26-30, Jun. 2015, doi: 10.1097/TA.0000000000000633.
[4036]	E. W. Lindsey, “Frequency and Intensity of Emotional Expressiveness and Preschool Children’s Peer Competence,” J Genet Psychol, vol. 180, no. 1, pp. 45–61, Feb. 2019, doi: 10.1080/00221325.2019.1579168.
[4037]	K. Denich, A. Craiu, H. Rugo, G. Muralidhar, and P. O’Hanley, “Frequency and organization of papA homologous DNA sequences among uropathogenic digalactoside-binding Escherichia coli strains,” Infect. Immun., vol. 59, no. 6, pp. 2089–2096, Jun. 1991, doi: 10.1128/IAI.59.6.2089-2096.1991.
[4038]	N. Saeed, J. Zafar, and A. Atta, “Frequency of patients with diabetes taking proper foot care according to international guidelines and its impact on their foot health,” J Pak Med Assoc, vol. 60, no. 9, pp. 732–735, Sep. 2010.
[4039]	D. von Lewinski et al., “Frequency-dependence of the slow force response,” Front. Biosci., vol. 13, pp. 7202–7209, May 2008, doi: 10.2741/3222.
[4040]	J. Skelhorn and C. Rowe, “Frequency-dependent taste-rejection by avian predation may select for defence chemical polymorphisms in aposematic prey,” Biol. Lett., vol. 1, no. 4, pp. 500–503, Dec. 2005, doi: 10.1098/rsbl.2005.0359.
[4041]	C. Capelli et al., “Frequent occurrence of non-malignant genetic alterations in clinical grade mesenchymal stromal cells expanded for cell therapy protocols,” Haematologica, vol. 99, no. 6, pp. e94-97, Jun. 2014, doi: 10.3324/haematol.2014.104711.
[4042]	K. Knop and D. Hefner, “[Friend or Foe in the Pocket? - The Role of the Individual, Peergroup and Parents for (dys)functional Mobile Phone Use],” Prax Kinderpsychol Kinderpsychiatr, vol. 67, no. 2, pp. 204–216, Feb. 2018, doi: 10.13109/prkk.2018.67.2.204.
[4043]	T. J. Liu et al., “From (pi,0) magnetic order to superconductivity with (pi,pi) magnetic resonance in Fe(1.02)Te(1-x)Se(x),” Nat Mater, vol. 9, no. 9, pp. 716–720, Sep. 2010, doi: 10.1038/nmat2800.
[4044]	G. C. Patton, S. M. Sawyer, D. A. Ross, R. M. Viner, and J. S. Santelli, “From Advocacy to Action in Global Adolescent Health,” J Adolesc Health, vol. 59, no. 4, pp. 375–377, 2016, doi: 10.1016/j.jadohealth.2016.08.002.
[4045]	T. Malti and S. P. Dys, “From being nice to being kind: development of prosocial behaviors,” Curr Opin Psychol, vol. 20, pp. 45–49, 2018, doi: 10.1016/j.copsyc.2017.07.036.
[4046]	U. S. Neill, “From branch to bedside: Youyou Tu is awarded  the 2011 Lasker~DeBakey Clinical Medical  Research Award for discovering artemisinin  as a treatment for malaria,” J. Clin. Invest., vol. 121, no. 10, pp. 3768–3773, Oct. 2011, doi: 10.1172/jci60887.
[4047]	L. Rew, “From course assignment paper to publishable manuscript,” J Holist Nurs, vol. 30, no. 4, pp. 270–276, Dec. 2012, doi: 10.1177/0898010112453328.
[4048]	R. Cutzu et al., “From crude glycerol to carotenoids by using a Rhodotorula glutinis mutant,” World J. Microbiol. Biotechnol., vol. 29, no. 6, pp. 1009–1017, Jun. 2013, doi: 10.1007/s11274-013-1264-x.
[4049]	K. Porter and B. Day, “From filaments to function: The role of the plant actin cytoskeleton in pathogen perception, signaling and immunity,” J Integr Plant Biol, vol. 58, no. 4, pp. 299–311, Apr. 2016, doi: 10.1111/jipb.12445.
[4050]	B. François, M. Armand, D. Marie-José, and G. Thouand, “From laboratory to environmental conditions: a new approach for chemical’s biodegradability assessment,” Environ Sci Pollut Res Int, vol. 23, no. 18, pp. 18684–18693, Sep. 2016, doi: 10.1007/s11356-016-7062-x.
[4051]	J. M. Jackson Filho, E. Algranti, C. A. Saito, and E. G. Garcia, “From occupational safety and health to Workers’ Health: history and challenges to the Brazilian Journal of Occupational Health,” Cien Saude Colet, vol. 20, no. 7, pp. 2041–2051, Jul. 2015, doi: 10.1590/1413-81232015207.05812015.
[4052]	Z. I. Cabantchik and H. Drakesmith, “From one Nobel Prize (P. Ehrlich) to another (Tu Youyou): 100 years of chemotherapy of infectious diseases,” Clin. Microbiol. Infect., vol. 22, no. 3, pp. 213–214, Mar. 2016, doi: 10.1016/j.cmi.2015.11.011.
[4053]	H. Gibbons, R. Schnuerch, and J. Stahl, “From Positivity to Negativity Bias: Ambiguity Affects the Neurophysiological Signatures of Feedback Processing,” J Cogn Neurosci, vol. 28, no. 4, pp. 542–557, Apr. 2016, doi: 10.1162/jocn_a_00921.
[4054]	E. Brähler, “[From reviewer to collegiate--the reform of the DFG-review system],” Psychother Psychosom Med Psychol, vol. 53, no. 5, pp. 211–212, May 2003, doi: 10.1055/s-2003-38868.
[4055]	A. S. Reddy, D. Vijay, G. M. Sastry, and G. N. Sastry, “From subtle to substantial: role of metal ions on pi-pi interactions,” J Phys Chem B, vol. 110, no. 6, pp. 2479–2481, Feb. 2006, doi: 10.1021/jp060018h.
[4056]	R. Menezes, S. Tenreiro, D. Macedo, C. N. Santos, and T. F. Outeiro, “From the baker to the bedside: yeast models of Parkinson’s disease,” Microb Cell, vol. 2, no. 8, pp. 262–279, Jul. 2015, doi: 10.15698/mic2015.08.219.
[4057]	J. Dagenais et al., “Frozen Sections for Margins During Partial Nephrectomy Do Not Influence Recurrence Rates,” J. Endourol., vol. 32, no. 8, pp. 759–764, 2018, doi: 10.1089/end.2018.0314.
[4058]	J. D. Zuckerman and A. Rokito, “Frozen shoulder: a consensus definition,” J Shoulder Elbow Surg, vol. 20, no. 2, pp. 322–325, Mar. 2011, doi: 10.1016/j.jse.2010.07.008.
[4059]	J.-K. Ma, H. Zhang, T. Tsuchiya, Y. Akiyama, and J.-Y. Chen, “Frying stability of rapeseed Kizakinonatane (Brassica napus) oil in comparison with canola oil,” Food Sci Technol Int, vol. 21, no. 3, pp. 163–174, Apr. 2015, doi: 10.1177/1082013213520173.
[4060]	E. Johnson, S. Wayne, and R. Nagoshi, “fs (1) Yb is required for ovary follicle cell differentiation in Drosophila melanogaster and has genetic interactions with the Notch group of neurogenic genes,” Genetics, vol. 140, no. 1, pp. 207–217, May 1995.
[4061]	K. Krzempek, G. Sobon, J. Sotor, and K. M. Abramski, “Fully-integrated dual-wavelength all-fiber source for mode-locked square-shaped mid-IR pulse generation via DFG in PPLN,” Opt Express, vol. 23, no. 25, pp. 32080–32086, Dec. 2015, doi: 10.1364/OE.23.032080.
[4062]	D. Sedmera, “Function and form in the developing cardiovascular system,” Cardiovasc. Res., vol. 91, no. 2, pp. 252–259, Jul. 2011, doi: 10.1093/cvr/cvr062.
[4063]	R. Verheggen et al., “Functional 5-HT receptors in human occipital artery,” Naunyn Schmiedebergs Arch. Pharmacol., vol. 369, no. 4, pp. 391–401, Apr. 2004, doi: 10.1007/s00210-004-0878-9.
[4064]	A. D. Thome et al., “Functional alterations of myeloid cells during the course of Alzheimer’s disease,” Mol Neurodegener, vol. 13, no. 1, p. 61, 13 2018, doi: 10.1186/s13024-018-0293-1.
[4065]	R. Sahyouni, D. T. Chang, O. Moshtaghi, A. Mahmoodi, H. R. Djalilian, and H. W. Lin, “Functional and Histological Effects of Chronic Neural Electrode Implantation,” Laryngoscope Investig Otolaryngol, vol. 2, no. 2, pp. 80–93, 2017, doi: 10.1002/lio2.66.
[4066]	S. H. Stewart, R. O. Pihl, P. J. Conrod, and M. Dongier, “Functional associations among trauma, PTSD, and substance-related disorders,” Addict Behav, vol. 23, no. 6, pp. 797–812, Dec. 1998, doi: 10.1016/s0306-4603(98)00070-7.
[4067]	C. Gadgaard and A. A. Jensen, “Functional characterization of 5-HT1A and 5-HT1B serotonin receptor signaling through G-protein-activated inwardly rectifying K+ channels in a fluorescence-based membrane potential assay,” Biochem. Pharmacol., vol. 175, p. 113870, May 2020, doi: 10.1016/j.bcp.2020.113870.
[4068]	C. A. Lindbergh, R. K. Dishman, and L. S. Miller, “Functional Disability in Mild Cognitive Impairment: A Systematic Review and Meta-Analysis,” Neuropsychol Rev, vol. 26, no. 2, pp. 129–159, 2016, doi: 10.1007/s11065-016-9321-5.
[4069]	C. Biswas et al., “Functional disruption of yeast metacaspase, Mca1, leads to miltefosine resistance and inability to mediate miltefosine-induced apoptotic effects,” Fungal Genet. Biol., vol. 67, pp. 71–81, Jun. 2014, doi: 10.1016/j.fgb.2014.04.003.
[4070]	C. E. Nerantzis, J. C. Papachristos, J. E. Gribizi, V. A. Voudris, G. P. Infantis, and G. T. Koroxenidis, “Functional dominance of the right coronary artery: incidence in the human heart,” Clin Anat, vol. 9, no. 1, pp. 10–13, 1996, doi: 10.1002/(SICI)1098-2353(1996)9:1<10::AID-CA2>3.0.CO;2-3.
[4071]	R. Gupta et al., “Functional Duration of Closure Systems Used in Partial Nephrectomy,” J. Urol., vol. 196, no. 5, pp. 1560–1565, 2016, doi: 10.1016/j.juro.2016.06.093.
[4072]	L. Hecker, L. Khait, S. K. Sessions, and R. K. Birla, “Functional evaluation of isolated zebrafish hearts,” Zebrafish, vol. 5, no. 4, pp. 319–322, Dec. 2008, doi: 10.1089/zeb.2008.0550.
[4073]	A. Hüttmann, S. L. Liu, A. W. Boyd, and C. L. Li, “Functional heterogeneity within rhodamine123(lo) Hoechst33342(lo/sp) primitive hemopoietic stem cells revealed by pyronin Y,” Exp. Hematol., vol. 29, no. 9, pp. 1109–1116, Sep. 2001, doi: 10.1016/s0301-472x(01)00684-1.
[4074]	I. Corcoles-Saez, J.-L. Ferat, M. Costanzo, C. M. Boone, and R. S. Cha, “Functional link between mitochondria and Rnr3, the minor catalytic subunit of yeast ribonucleotide reductase,” Microb Cell, vol. 6, no. 6, pp. 286–294, May 2019, doi: 10.15698/mic2019.06.680.
[4075]	L. Lu and W. Chen, “Functional maturation of mouse CD4+CD8- thymocytes induced by medullary-type thymus epithelial cells,” Sci. China, C, Life Sci., vol. 39, no. 4, pp. 427–439, Aug. 1996.
[4076]	P. Hosseini, Y. Tadavarthi, B. Martin-Harris, and W. G. Pearson, “Functional Modules of Pharyngeal Swallowing Mechanics,” Laryngoscope Investig Otolaryngol, vol. 4, no. 3, pp. 341–346, Jun. 2019, doi: 10.1002/lio2.273.
[4077]	M. A. Rocca, E. De Meo, and M. Filippi, “Functional MRI in investigating cognitive impairment in multiple sclerosis,” Acta Neurol. Scand., vol. 134 Suppl 200, pp. 39–46, Sep. 2016, doi: 10.1111/ane.12654.
[4078]	H. C. Baggio and C. Junqué, “Functional MRI in Parkinson’s Disease Cognitive Impairment,” Int. Rev. Neurobiol., vol. 144, pp. 29–58, 2019, doi: 10.1016/bs.irn.2018.09.010.
[4079]	S. D. Youngren, J. D. Boeke, N. J. Sanders, and D. J. Garfinkel, “Functional organization of the retrotransposon Ty from Saccharomyces cerevisiae: Ty protease is required for transposition,” Mol. Cell. Biol., vol. 8, no. 4, pp. 1421–1431, Apr. 1988, doi: 10.1128/mcb.8.4.1421.
[4080]	E. Ashby, K. Montpetit, R. C. Hamdy, and F. Fassier, “Functional Outcome of Forearm Rodding in Children With Osteogenesis Imperfecta,” J Pediatr Orthop, vol. 38, no. 1, pp. 54–59, Jan. 2018, doi: 10.1097/BPO.0000000000000724.
[4081]	H. G. Trier, “[Functional properties of diagnostic ultrasound instruments. A concept of trial building blocks for implementing quality assurance],” Ultraschall Med, vol. 15, no. 5, pp. 223–232, Oct. 1994, doi: 10.1055/s-2007-1004017.
[4082]	K. Nakajima and S. Kohsaka, “Functional roles of microglia in the brain,” Neurosci. Res., vol. 17, no. 3, pp. 187–203, Aug. 1993, doi: 10.1016/0168-0102(93)90047-t.
[4083]	C. Porcaro, C. Cottone, A. Cancelli, C. Salustri, and F. Tecchio, “Functional Semi-Blind Source Separation Identifies Primary Motor Area Without Active Motor Execution,” Int J Neural Syst, vol. 28, no. 3, p. 1750047, Apr. 2018, doi: 10.1142/S0129065717500472.
[4084]	M. Takumida and M. Anniko, “Functional significance of nitric oxide in the inner ear,” In Vivo, vol. 18, no. 3, pp. 345–350, Jun. 2004.
[4085]	R. Roca-Tey, R. Samon, O. Ibrik, R. Martínes-Cercós, and J. Viladoms, “Functional vascular access evaluation after elective intervention for stenosis,” J Vasc Access, vol. 7, no. 1, pp. 29–34, Mar. 2006, doi: 10.1177/112972980600700106.
[4086]	H. Bartsch, M. Baca, U. Fernekorn, J. Müller, A. Schober, and H. Witte, “Functionalized Thick Film Impedance Sensors for Use in In Vitro Cell Culture,” Biosensors (Basel), vol. 8, no. 2, Apr. 2018, doi: 10.3390/bios8020037.
[4087]	E. Gobbini, C. Cassani, M. Villa, D. Bonetti, and M. P. Longhese, “Functions and regulation of the MRX complex at DNA double-strand breaks,” Microb Cell, vol. 3, no. 8, pp. 329–337, Jul. 2016, doi: 10.15698/mic2016.08.517.
[4088]	L. Keene, P. Bagshaw, M. G. Nicholls, B. Rosenberg, C. M. Frampton, and I. Powell, “Funding New Zealand’s public healthcare system: time for an honest appraisal and public debate,” N. Z. Med. J., vol. 129, no. 1435, pp. 10–20, May 2016.
[4089]	L. Ostrosky-Zeichner and J. D. Sobel, “Fungal Infections,” Infect. Dis. Clin. North Am., vol. 30, no. 1, pp. xiii–xiv, Mar. 2016, doi: 10.1016/j.idc.2015.12.001.
[4090]	K. Kainz, M. A. Bauer, F. Madeo, and D. Carmona-Gutierrez, “Fungal infections in humans: the silent crisis,” Microb Cell, vol. 7, no. 6, pp. 143–145, Jun. 2020, doi: 10.15698/mic2020.06.718.
[4091]	H.-Y. Sohn, C.-S. Kwon, and K.-H. Son, “Fungicidal effect of prenylated flavonol, papyriflavonol A, isolated from Broussonetia papyrifera (L.) vent. against Candida albicans,” J. Microbiol. Biotechnol., vol. 20, no. 10, pp. 1397–1402, Oct. 2010, doi: 10.4014/jmb.1007.07026.
[4092]	F. Miranda, E. Hong, H. Sánchez, and D. N. Velázquez-Martínez, “Further evidence that the discriminative stimulus properties of indorenate are mediated by 5-HT 1A/1B/2C receptors,” Pharmacol. Biochem. Behav., vol. 74, no. 2, pp. 371–380, Jan. 2003, doi: 10.1016/s0091-3057(02)01010-9.
[4093]	M. Pedersen and A. Omidvarnia, “Further Insight into the Brain’s Rich-Club Architecture,” J. Neurosci., vol. 36, no. 21, pp. 5675–5676, 25 2016, doi: 10.1523/JNEUROSCI.0754-16.2016.
[4094]	P. Quérée, S. Peters, and T. Sharp, “Further pharmacological characterization of 5-HT(2C) receptor agonist-induced inhibition of 5-HT neuronal activity in the dorsal raphe nucleus in vivo,” Br. J. Pharmacol., vol. 158, no. 6, pp. 1477–1485, Nov. 2009, doi: 10.1111/j.1476-5381.2009.00406.x.
[4095]	M. Gomirato Sandrucci, N. Nigro, L. Benso, C. Bonenti, and G. Papa, “Further research about the haemagglutination of serum-fractions from leukaemic subjects,” Panminerva Med, vol. 9, no. 7, pp. 269–272, Aug. 1967.
[4096]	E. Oliva, G. Bargiggia, G. Quinzan, P. Lanza, and C. Farina, “Furuncular myiasis in Italian traveler returning from Kenya,” J Infect Dev Ctries, vol. 14, no. 1, pp. 114–116, 31 2020, doi: 10.3855/jidc.11560.
[4097]	M. Kurd, S. Cohick, A. Park, K. Ahmadinia, J. Lee, and H. An, “Fusion in degenerative spondylolisthesis: comparison of osteoconductive and osteoinductive bone graft substitutes,” Eur Spine J, vol. 24, no. 5, pp. 1066–1073, May 2015, doi: 10.1007/s00586-014-3635-x.
[4098]	B. L. Hankin, “Future directions in vulnerability to depression among youth: integrating risk factors and processes across multiple levels of analysis,” J Clin Child Adolesc Psychol, vol. 41, no. 5, pp. 695–718, 2012, doi: 10.1080/15374416.2012.711708.
[4099]	B. Provenzano-Castro, S. Oizerovich, and B. Stray-Pedersen, “Future healthcare professionals’ knowledge about the Argentinean abortion law,” Int J Med Educ, vol. 7, pp. 95–101, Mar. 2016, doi: 10.5116/ijme.56e0.74be.
[4100]	M. J. Besso et al., “FXYD5/Dysadherin, a Biomarker of Endometrial Cancer Myometrial Invasion and Aggressiveness: Its Relationship With TGF-β1 and NF-κB Pathways,” Front Oncol, vol. 9, p. 1306, 2019, doi: 10.3389/fonc.2019.01306.
[4101]	M. Grönkvist, B. Levin, and O. Eiken, “G Tolerance During Open- vs. Closed-Loop G-Time Control,” Aerosp Med Hum Perform, vol. 89, no. 9, pp. 798–804, Sep. 2018, doi: 10.3357/AMHP.5096.2018.
[4102]	R. Heit, J. B. Rattner, G. K. T. Chan, and M. J. Hendzel, “G2 histone methylation is required for the proper segregation of chromosomes,” J. Cell. Sci., vol. 122, no. Pt 16, pp. 2957–2968, Aug. 2009, doi: 10.1242/jcs.045351.
[4103]	C. Roberts, D. R. Thomas, S. T. Bate, and J. N. C. Kew, “GABAergic modulation of 5-HT7 receptor-mediated effects on 5-HT efflux in the guinea-pig dorsal raphe nucleus,” Neuropharmacology, vol. 46, no. 7, pp. 935–941, Jun. 2004, doi: 10.1016/j.neuropharm.2004.01.010.
[4104]	R. Vickers-Smith, J. Sun, R. J. Charnigo, M. R. Lofwall, S. L. Walsh, and J. R. Havens, “Gabapentin drug misuse signals: A pharmacovigilance assessment using the FDA adverse event reporting system,” Drug Alcohol Depend, vol. 206, p. 107709, 01 2020, doi: 10.1016/j.drugalcdep.2019.107709.
[4105]	R. J. McDonald et al., “Gadolinium Retention: A Research Roadmap from the 2018 NIH/ACR/RSNA Workshop on Gadolinium Chelates,” Radiology, vol. 289, no. 2, pp. 517–534, 2018, doi: 10.1148/radiol.2018181151.
[4106]	J. F. Stolz, “Gaia and her microbiome,” FEMS Microbiol. Ecol., vol. 93, no. 2, 2017, doi: 10.1093/femsec/fiw247.
[4107]	C. R. Garman, A. Graf, J. Krzak, A. Caudill, P. Smith, and G. Harris, “Gait Deviations in Children With Osteogenesis Imperfecta Type I,” J Pediatr Orthop, vol. 39, no. 8, pp. e641–e646, Sep. 2019, doi: 10.1097/BPO.0000000000001062.
[4108]	M. Karamanou, C. Stefanadis, G. Tsoucalas, K. Laios, and G. Androutsos, “Galen’s (130-201 AD) Conceptions of the Heart,” Hellenic J Cardiol, vol. 56, no. 3, pp. 197–200, Jun. 2015.
[4109]	C.-C. Ho et al., “Gallic acid inhibits murine leukemia WEHI-3 cells in vivo and promotes macrophage phagocytosis,” In Vivo, vol. 23, no. 3, pp. 409–413, Jun. 2009.
[4110]	K. S. Fjællingsdal and C. A. Klöckner, “Gaming Green: The Educational Potential of Eco - A Digital Simulated Ecosystem,” Front Psychol, vol. 10, p. 2846, 2019, doi: 10.3389/fpsyg.2019.02846.
[4111]	J. M. Kasper et al., “Gamma-Aminobutyric Acidergic Projections From the Dorsal Raphe to the Nucleus Accumbens Are Regulated by Neuromedin U,” Biol. Psychiatry, vol. 80, no. 11, pp. 878–887, 01 2016, doi: 10.1016/j.biopsych.2016.02.031.
[4112]	M. Wanaguru and K. N. Bishop, “Gammaretroviruses tether to mitotic chromatin by directly binding nucleosomal histone proteins,” Microb Cell, vol. 5, no. 8, pp. 385–388, Jul. 2018, doi: 10.15698/mic2018.08.643.
[4113]	N. Kanda and S. Watanabe, “Ganglioside GD1a enhances immunoglobulin production by human peripheral blood mononuclear cells,” Exp. Hematol., vol. 28, no. 6, pp. 672–679, Jun. 2000, doi: 10.1016/s0301-472x(00)00167-3.
[4114]	N. Kanda and S. Watanabe, “Gangliosides GD1b, GT1b, and GQ1b enhance IL-2 and IFN-gamma production and suppress IL-4 and IL-5 production in phytohemagglutinin-stimulated human T cells,” J. Immunol., vol. 166, no. 1, pp. 72–80, Jan. 2001, doi: 10.4049/jimmunol.166.1.72.
[4115]	N. Kanda, K. Nakai, and S. Watanabe, “Gangliosides GD1b, GT1b, and GQ1b suppress the growth of human melanoma by inhibiting interleukin-8 production: the inhibition of adenylate cyclase,” J. Invest. Dermatol., vol. 117, no. 2, pp. 284–293, Aug. 2001, doi: 10.1046/j.0022-202x.2001.01423.x.
[4116]	C. Pfrang, R. S. Martin, C. E. Canosa-Mas, and R. P. Wayne, “Gas-phase reactions of NO3 and N2O5 with (Z)-hex-4-en-1-ol, (Z)-hex-3-en-1-ol ('leaf alcohol’), (E)-hex-3-en-1-ol, (Z)-hex-2-en-1-ol and (E)-hex-2-en-1-ol,” Phys Chem Chem Phys, vol. 8, no. 3, pp. 354–363, Jan. 2006, doi: 10.1039/b510835g.
[4117]	C. H. Pan, C. H. Lin, T. Y. Chang, T. C. Lu, and C. P. Lee, “GaSb-based mid infrared photonic crystal surface emitting lasers,” Opt Express, vol. 23, no. 9, pp. 11741–11747, May 2015, doi: 10.1364/OE.23.011741.
[4118]	V. I. Onopriev and I. B. Uvarov, “[Gastrectomy with end-loop jejunogastroplasty in stomach cancer],” Khirurgiia (Mosk), no. 9, pp. 32–36, 2004.
[4119]	M. Scatizzi et al., “Gastric duplication cyst in an adult: case report,” In Vivo, vol. 19, no. 6, pp. 975–978, Dec. 2005.
[4120]	R. Gerig, B. Ernst, B. Wilms, M. Thurnheer, and B. Schultes, “Gastric Helicobacter pylori infection is associated with adverse metabolic traits in severely obese subjects,” Obesity (Silver Spring), vol. 21, no. 3, pp. 535–537, Mar. 2013, doi: 10.1002/oby.20098.
[4121]	E. A. Kotteas et al., “Gastrointestinal bleeding as initial presentation of melanoma of unknown primary origin: report of a case and review of the literature,” In Vivo, vol. 23, no. 3, pp. 487–489, Jun. 2009.
[4122]	Y. S. Park and K.-W. Sung, “Gastroprokinetic agent, mosapride inhibits 5-HT3 receptor currents in NCB-20 cells,” Korean J. Physiol. Pharmacol., vol. 23, no. 5, pp. 419–426, Sep. 2019, doi: 10.4196/kjpp.2019.23.5.419.
[4123]	R. Yu and W. Dang, “Gearing up for survival - HSP-containing granules accumulate in quiescent cells and promote survival,” Microb Cell, vol. 3, no. 3, pp. 95–96, Mar. 2016, doi: 10.15698/mic2016.03.481.
[4124]	W. M. Munir, M. K. El Mallah, W. M. Janda, and E. Y. Tu, “Gemella haemolysans infectious crystalline keratopathy,” Cornea, vol. 27, no. 2, pp. 258; author reply 258, Feb. 2008, doi: 10.1097/ICO.0b013e31815b8535.
[4125]	L. Rew, K. L. Arheart, S. D. Horner, S. Thompson, and K. E. Johnson, “Gender and ethnic differences in health-promoting behaviors of rural adolescents,” J Sch Nurs, vol. 31, no. 3, pp. 219–232, Jun. 2015, doi: 10.1177/1059840514541855.
[4126]	J. C. Leonard and K. E. Ellsbury, “Gender and interest in academic careers among first- and third-year residents,” Acad Med, vol. 71, no. 5, pp. 502–504, May 1996, doi: 10.1097/00001888-199605000-00023.
[4127]	Y.-F. Zhang et al., “Gender difference of serum angiotensin-converting enzyme (ACE) activity in DD genotype of ACE insertion/deletion polymorphism in elderly Chinese,” J Renin Angiotensin Aldosterone Syst, vol. 15, no. 4, pp. 547–552, Dec. 2014, doi: 10.1177/1470320313475906.
[4128]	C. E. Miyawaki and M. Liu, “Gender differences in cognitive impairment among the old and the oldest-old in China,” Geriatr Gerontol Int, vol. 19, no. 7, pp. 586–592, Jul. 2019, doi: 10.1111/ggi.13666.
[4129]	R. L. Gobin et al., “Gender Differences in Response to Acceptance and Commitment Therapy Among Operation Enduring Freedom/Operation Iraqi Freedom/Operation New Dawn Veterans,” Womens Health Issues, May 2019, doi: 10.1016/j.whi.2019.03.003.
[4130]	Y.-S. Tyan, J.-R. Liao, C.-Y. Shen, Y.-C. Lin, and J.-C. Weng, “Gender differences in the structural connectome of the teenage brain revealed by generalized q-sampling MRI,” Neuroimage Clin, vol. 15, pp. 376–382, 2017, doi: 10.1016/j.nicl.2017.05.014.
[4131]	F. Wang, J. Ni, L. Wu, Y. Wang, B. He, and D. Yu, “Gender disparity in the survival of patients with primary myelodysplastic syndrome,” J Cancer, vol. 10, no. 5, pp. 1325–1332, 2019, doi: 10.7150/jca.28220.
[4132]	A. G. Palapattu, J. N. Kingery, and G. S. Ginsburg, “Gender role orientation and anxiety symptoms among African american adolescents,” J Abnorm Child Psychol, vol. 34, no. 3, pp. 441–449, Jun. 2006, doi: 10.1007/s10802-006-9023-1.
[4133]	D. M. Christiansen and E. T. Berke, “Gender- and Sex-Based Contributors to Sex Differences in PTSD,” Curr Psychiatry Rep, vol. 22, no. 4, p. 19, 03 2020, doi: 10.1007/s11920-020-1140-y.
[4134]	D. Mehta and E. B. Binder, “Gene × environment vulnerability factors for PTSD: the HPA-axis,” Neuropharmacology, vol. 62, no. 2, pp. 654–662, Feb. 2012, doi: 10.1016/j.neuropharm.2011.03.009.
[4135]	D. Breilmann, J. Gafner, and M. Ciriacy, “Gene conversion and reciprocal exchange in a Ty-mediated translocation in yeast,” Curr. Genet., vol. 9, no. 7, pp. 553–560, 1985, doi: 10.1007/BF00381167.
[4136]	P. Mauriège et al., “Gene expression of different adipose tissues of severely obese women with or without a dysmetabolic profile,” J. Physiol. Biochem., vol. 71, no. 4, pp. 719–732, Dec. 2015, doi: 10.1007/s13105-015-0436-6.
[4137]	P. R. Towers et al., “Gene expression profiling studies on Caenorhabditis elegans dystrophin mutants dys-1(cx-35) and dys-1(cx18),” Genomics, vol. 88, no. 5, pp. 642–649, Nov. 2006, doi: 10.1016/j.ygeno.2006.07.014.
[4138]	M. E. Case and N. H. Giles, “Gene order in the qa gene cluster of Neurospora crassa,” Mol. Gen. Genet., vol. 147, no. 1, pp. 83–89, Aug. 1976, doi: 10.1007/BF00337940.
[4139]	A. Kumar, S. K. Jindal, M. S. Dhaliwal, A. Sharma, S. Kaur, and S. Jain, “Gene pyramiding for elite tomato genotypes against ToLCV (Begomovirus spp.), late blight (Phytophthora infestans) and RKN (Meloidogyne spp.) for northern India farmers,” Physiol Mol Biol Plants, vol. 25, no. 5, pp. 1197–1209, Sep. 2019, doi: 10.1007/s12298-019-00700-5.
[4140]	T. Kotani, Y. Kawashima, H. Yurimoto, N. Kato, and Y. Sakai, “Gene structure and regulation of alkane monooxygenases in propane-utilizing Mycobacterium sp. TY-6 and Pseudonocardia sp. TY-7,” J. Biosci. Bioeng., vol. 102, no. 3, pp. 184–192, Sep. 2006, doi: 10.1263/jbb.102.184.
[4141]	C. Niyibizi, S. Wang, Z. Mi, and P. D. Robbins, “Gene therapy approaches for osteogenesis imperfecta,” Gene Ther., vol. 11, no. 4, pp. 408–416, Feb. 2004, doi: 10.1038/sj.gt.3302199.
[4142]	A. H. Nilsen, A.-S. Helvik, W. M. Thorstensen, Ø. Salvesen, and V. Bugten, “General health, vitality, and social function after sinus surgery in chronic rhinosinusitis,” Laryngoscope Investig Otolaryngol, vol. 4, no. 5, pp. 476–483, Oct. 2019, doi: 10.1002/lio2.299.
[4143]	E. Wolff, “[General properties of embryonic organs in culture in vitro],” Acta Anat (Basel), vol. 30, no. 1–4, pp. 952–969, 1957.
[4144]	R. J. Sargisson and K. G. White, “Generalization of delayed matching to sample following training at different delays,” J Exp Anal Behav, vol. 75, no. 1, pp. 1–14, Jan. 2001, doi: 10.1901/jeab.2001.75-1.
[4145]	M. Kanayama, K. Nakao, S. Horie, and A. Aiba, “Generation of transgenic mouse line with prostate-specific expression of codon-improved Cre recombinase,” Prostate Int, vol. 6, no. 3, pp. 99–103, Sep. 2018, doi: 10.1016/j.prnil.2018.04.003.
[4146]	C.-H. Baek, S. K. Farrand, D.-K. Park, K.-E. Lee, W. Hwang, and K.-S. Kim, “Genes for utilization of deoxyfructosyl glutamine (DFG), an amadori compound, are widely dispersed in the family Rhizobiaceae,” FEMS Microbiol. Ecol., vol. 53, no. 2, pp. 221–233, Jul. 2005, doi: 10.1016/j.femsec.2004.12.008.
[4147]	N. Hosono, “Genetic abnormalities and pathophysiology of MDS,” Int. J. Clin. Oncol., vol. 24, no. 8, pp. 885–892, Aug. 2019, doi: 10.1007/s10147-019-01462-6.
[4148]	L. Ueberham et al., “Genetic ACE I/D polymorphism and recurrence of atrial fibrillation after catheter ablation,” Circ Arrhythm Electrophysiol, vol. 6, no. 4, pp. 732–737, Aug. 2013, doi: 10.1161/CIRCEP.113.000253.
[4149]	O. Essawi et al., “Genetic analysis of osteogenesis imperfecta in the Palestinian population: molecular screening of 49 affected families,” Mol Genet Genomic Med, vol. 6, no. 1, pp. 15–26, 2018, doi: 10.1002/mgg3.331.
[4150]	L. Ries-Levavi et al., “Genetic and biochemical analyses of Israeli osteogenesis imperfecta patients,” Hum. Mutat., vol. 23, no. 4, pp. 399–400, Apr. 2004, doi: 10.1002/humu.9230.
[4151]	S. C. Jhanwar, “Genetic and epigenetic pathways in myelodysplastic syndromes: A brief overview,” Adv Biol Regul, vol. 58, pp. 28–37, May 2015, doi: 10.1016/j.jbior.2014.11.002.
[4152]	A. Papa, S. Danese, G. Gasbarrini, and A. Gasbarrini, “Genetic and nutritional predictors of hyperhomocysteinemia in inflammatory bowel disease,” Am. J. Gastroenterol., vol. 97, no. 2, pp. 490–491, Feb. 2002, doi: 10.1111/j.1572-0241.2002.05506.x.
[4153]	H. Tanaka, “[Genetic basis for skeletal disease. Osteogenesis imperfecta],” Clin Calcium, vol. 20, no. 8, pp. 1245–1252, Aug. 2010, doi: CliCa100812451252.
[4154]	J. T. McCrone and A. S. Lauring, “Genetic bottlenecks in intraspecies virus transmission,” Curr Opin Virol, vol. 28, pp. 20–25, 2018, doi: 10.1016/j.coviro.2017.10.008.
[4155]	J. A. Baum and N. H. Giles, “Genetic control of chromatin structure 5’ to the qa-x and qa-2 genes of Neurospora,” J. Mol. Biol., vol. 182, no. 1, pp. 79–89, Mar. 1985, doi: 10.1016/0022-2836(85)90029-4.
[4156]	M. Medici, W. E. Visser, T. J. Visser, and R. P. Peeters, “Genetic determination of the hypothalamic-pituitary-thyroid axis: where do we stand?,” Endocr. Rev., vol. 36, no. 2, pp. 214–244, Apr. 2015, doi: 10.1210/er.2014-1081.
[4157]	Y. Zhang et al., “Genetic diversity of Y-chromosome microsatellites in the Fujian Han and the Sichuan Han populations of China,” Anthropol Anz, vol. 65, no. 1, pp. 1–14, Mar. 2007.
[4158]	P. Striano and F. Zara, “Genetic epilepsies,” Eur. J. Paediatr. Neurol., vol. 15, no. 1, pp. 88–89, Jan. 2011, doi: 10.1016/j.ejpn.2010.05.004.
[4159]	P. Striano, P. de Jonghe, and F. Zara, “Genetic epileptic encephalopathies: is all written into the DNA?,” Epilepsia, vol. 54 Suppl 8, pp. 22–26, Nov. 2013, doi: 10.1111/epi.12419.
[4160]	P. H. Byers, D. Krakow, M. E. Nunes, M. Pepin, and American college of medical genetics, “Genetic evaluation of suspected osteogenesis imperfecta (OI),” Genet. Med., vol. 8, no. 6, pp. 383–388, Jun. 2006, doi: 10.1097/01.gim.0000223557.54670.aa.
[4161]	C. Simon, J. Tang, S. Dalwadi, G. Staley, J. Deniega, and T. R. Unnasch, “Genetic evidence for assortative mating between 13-year cicadas and sympatric ‘17-year cicadas with 13-year life cycles’ provides support for allochronic speciation,” Evolution, vol. 54, no. 4, pp. 1326–1336, Aug. 2000, doi: 10.1111/j.0014-3820.2000.tb00565.x.
[4162]	M. Soejima et al., “Genetic factors associated with serum haptoglobin level in a Japanese population,” Clin. Chim. Acta, vol. 433, pp. 54–57, Jun. 2014, doi: 10.1016/j.cca.2014.02.029.
[4163]	P. Striano, G. Coppola, F. Zara, and R. Nabbout, “Genetic heterogeneity in malignant migrating partial seizures of infancy,” Ann. Neurol., vol. 75, no. 2, pp. 324–326, Feb. 2014, doi: 10.1002/ana.24061.
[4164]	M. P. Matsuoka, A. J. Gharrett, R. L. Wilmot, and W. W. Smoker, “Genetic linkage mapping of allozyme loci in even- and odd-year pink salmon (Oncorhynchus gorbuscha),” J. Hered., vol. 95, no. 5, pp. 421–429, Oct. 2004, doi: 10.1093/jhered/esh069.
[4165]	H. L. Klein and T. D. Petes, “Genetic mapping of Ty elements in Saccharomyces cerevisiae,” Mol. Cell. Biol., vol. 4, no. 2, pp. 329–339, Feb. 1984, doi: 10.1128/mcb.4.2.329.
[4166]	S. Trowbridge, N. Narboux-Nême, and P. Gaspar, “Genetic models of serotonin (5-HT) depletion: what do they tell us about the developmental role of 5-HT?,” Anat Rec (Hoboken), vol. 294, no. 10, pp. 1615–1623, Oct. 2011, doi: 10.1002/ar.21248.
[4167]	M. G. Anderson et al., “Genetic modification of glaucoma associated phenotypes between AKXD-28/Ty and DBA/2J mice,” BMC Genet., vol. 2, p. 1, 2001, doi: 10.1186/1471-2156-2-1.
[4168]	M. M. Kucherenko et al., “Genetic modifier screens reveal new components that interact with the Drosophila dystroglycan-dystrophin complex,” PLoS ONE, vol. 3, no. 6, p. e2418, Jun. 2008, doi: 10.1371/journal.pone.0002418.
[4169]	V. B. Patel, M. Schweizer, C. C. Dykstra, S. R. Kushner, and N. H. Giles, “Genetic organization and transcriptional regulation in the qa gene cluster of Neurospora crassa,” Proc. Natl. Acad. Sci. U.S.A., vol. 78, no. 9, pp. 5783–5787, Sep. 1981, doi: 10.1073/pnas.78.9.5783.
[4170]	M. Okhovat et al., “Genetic variation in the developmental regulation of cortical avpr1a among prairie voles,” Genes Brain Behav., vol. 17, no. 1, pp. 36–48, 2018, doi: 10.1111/gbb.12396.
[4171]	M. E. Case, C. Pueyo, J. L. Barea, and N. H. Giles, “Genetical and biochemical characterization of QA-3 mutants and revertants in the QA gene cluster of Neurospora crassa,” Genetics, vol. 90, no. 1, pp. 69–84, Sep. 1978.
[4172]	M. E. Case, “Genetical and molecular analyses of qa-2 transformants in Neurospora crassa,” Genetics, vol. 113, no. 3, pp. 569–587, Jul. 1986.
[4173]	R. Asleh et al., “Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease,” Circ. Res., vol. 92, no. 11, pp. 1193–1200, Jun. 2003, doi: 10.1161/01.RES.0000076889.23082.F1.
[4174]	L. Montanelli and M. Tonacchera, “Genetics and phenomics of hypothyroidism and thyroid dys- and agenesis due to PAX8 and TTF1 mutations,” Mol. Cell. Endocrinol., vol. 322, no. 1–2, pp. 64–71, Jun. 2010, doi: 10.1016/j.mce.2010.03.009.
[4175]	S. Ogawa, “Genetics of MDS,” Blood, vol. 133, no. 10, pp. 1049–1059, 07 2019, doi: 10.1182/blood-2018-10-844621.
[4176]	A. J. Menssen and M. J. Walter, “Genetics of progression from MDS to secondary leukemia,” Blood, vol. 136, no. 1, pp. 50–60, Jul. 2020, doi: 10.1182/blood.2019000942.
[4177]	J. Pedersen-Bjergaard, M. K. Andersen, M. T. Andersen, and D. H. Christiansen, “Genetics of therapy-related myelodysplasia and acute myeloid leukemia,” Leukemia, vol. 22, no. 2, pp. 240–248, Feb. 2008, doi: 10.1038/sj.leu.2405078.
[4178]	P. Striano and F. Zara, “Genetics: mutations in mTOR pathway linked to megalencephaly syndromes,” Nat Rev Neurol, vol. 8, no. 10, pp. 542–544, Oct. 2012, doi: 10.1038/nrneurol.2012.178.
[4179]	D. Jaishankar and D. Shukla, “Genital Herpes: Insights into Sexually Transmitted Infectious Disease,” Microb Cell, vol. 3, no. 9, pp. 438–450, Jun. 2016, doi: 10.15698/mic2016.09.528.
[4180]	M. L. Lalumière, A. Fairweather, G. T. Harris, K. D. Suschinsky, and M. C. Seto, “Genital Responses to Rape Vignettes Among Young Men: The Influence of Mood and Directed Attention,” Arch Sex Behav, vol. 46, no. 3, pp. 685–695, Apr. 2017, doi: 10.1007/s10508-016-0809-0.
[4181]	K. Shankar, C. M. Capitini, and K. Saha, “Genome engineering of induced pluripotent stem cells to manufacture natural killer cell therapies,” Stem Cell Res Ther, vol. 11, no. 1, p. 234, Jun. 2020, doi: 10.1186/s13287-020-01741-4.
[4182]	D. J. Garfinkel, “Genome evolution mediated by Ty elements in Saccharomyces,” Cytogenet. Genome Res., vol. 110, no. 1–4, pp. 63–69, 2005, doi: 10.1159/000084939.
[4183]	Y. Fujii et al., “Genome Sequences of Rotavirus A Strains Ty-1 and Ty-3, Isolated from Turkeys in Ireland in 1979,” Genome Announc, vol. 4, no. 1, Jan. 2016, doi: 10.1128/genomeA.01565-15.
[4184]	Y. Cheng, X. Song, Y. Qin, and Y. Qu, “Genome shuffling improves production of cellulase by Penicillium decumbens JU-A10,” J. Appl. Microbiol., vol. 107, no. 6, pp. 1837–1846, Dec. 2009, doi: 10.1111/j.1365-2672.2009.04362.x.
[4185]	C. Bleykasten-Grosshans, A. Friedrich, and J. Schacherer, “Genome-wide analysis of intraspecific transposon diversity in yeast,” BMC Genomics, vol. 14, p. 399, Jun. 2013, doi: 10.1186/1471-2164-14-399.
[4186]	M. Sanada and S. Ogawa, “Genome-wide analysis of myelodysplastic syndromes,” Curr. Pharm. Des., vol. 18, no. 22, pp. 3163–3169, 2012, doi: 10.2174/1381612811209023163.
[4187]	S. Sima, L. Schmauder, and K. Richter, “Genome-wide analysis of yeast expression data based on a priori generated co-regulation cliques,” Microb Cell, vol. 6, no. 3, pp. 160–176, Jan. 2019, doi: 10.15698/mic2019.03.671.
[4188]	C. Boudhrioua, M. Bastien, D. Torkamaneh, and F. Belzile, “Genome-wide association mapping of Sclerotinia sclerotiorum resistance in soybean using whole-genome resequencing data,” BMC Plant Biol., vol. 20, no. 1, p. 195, May 2020, doi: 10.1186/s12870-020-02401-8.
[4189]	M. H. de Moraes et al., “Genome-Wide Comparative Functional Analyses Reveal Adaptations of Salmonella sv. Newport to a Plant Colonization Lifestyle,” Front Microbiol, vol. 9, p. 877, 2018, doi: 10.3389/fmicb.2018.00877.
[4190]	H. Wang et al., “Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal model,” Mol Neurodegener, vol. 13, no. 1, p. 65, 17 2018, doi: 10.1186/s13024-018-0296-y.
[4191]	Y. Harari and M. Kupiec, “Genome-wide studies of telomere biology in budding yeast,” Microb Cell, vol. 1, no. 3, pp. 70–80, Mar. 2014, doi: 10.15698/mic2014.01.132.
[4192]	H. Makishima, “[Genomic aberrations in myelodysplastic syndromes and related disorders],” Rinsho Ketsueki, vol. 60, no. 6, pp. 600–609, 2019, doi: 10.11406/rinketsu.60.600.
[4193]	Q. Wu, J. Zhang, J. Chen, M. Zheng, F. You, and Y. Jiang, “[Genomic analysis of an unknown pap genotype from uropathogenic Escherichia coli 4030 strain],” Zhonghua Liu Xing Bing Xue Za Zhi, vol. 29, no. 11, pp. 1123–1127, Nov. 2008.
[4194]	D. Gusenleitner, S. S. Auerbach, T. Melia, H. F. Gómez, D. H. Sherr, and S. Monti, “Genomic models of short-term exposure accurately predict long-term chemical carcinogenicity and identify putative mechanisms of action,” PLoS ONE, vol. 9, no. 7, p. e102579, 2014, doi: 10.1371/journal.pone.0102579.
[4195]	L. Dong, S. Xiao, J. Chen, L. Wan, and Z. Wang, “Genomic Selection Using Extreme Phenotypes and Pre-Selection of SNPs in Large Yellow Croaker (Larimichthys crocea),” Mar. Biotechnol., vol. 18, no. 5, pp. 575–583, Oct. 2016, doi: 10.1007/s10126-016-9718-4.
[4196]	C. Van Waes and O. Musbahi, “Genomics and advances towards precision medicine for head and neck squamous cell carcinoma,” Laryngoscope Investig Otolaryngol, vol. 2, no. 5, pp. 310–319, 2017, doi: 10.1002/lio2.86.
[4197]	N. Lawlor, S. Khetan, D. Ucar, and M. L. Stitzel, “Genomics of Islet (Dys)function and Type 2 Diabetes,” Trends Genet., vol. 33, no. 4, pp. 244–255, 2017, doi: 10.1016/j.tig.2017.01.010.
[4198]	K. Yan, J. Yesensky, R. Hasina, and N. Agrawal, “Genomics of mucoepidermoid and adenoid cystic carcinomas,” Laryngoscope Investig Otolaryngol, vol. 3, no. 1, pp. 56–61, 2018, doi: 10.1002/lio2.139.
[4199]	P. K. Khan, K. Amod, M. Haque, and A. Nath, “Genotoxicity of nimesulide in murine bone marrow cells,” In Vivo, vol. 17, no. 5, pp. 439–440, Oct. 2003.
[4200]	T. Shibamoto, “Genotoxicity testing of Maillard reaction products,” Prog. Clin. Biol. Res., vol. 304, pp. 359–376, 1989.
[4201]	Z. Jabbour et al., “Genotype and malocclusion in patients with osteogenesis imperfecta,” Orthod Craniofac Res, vol. 21, no. 2, pp. 71–77, May 2018, doi: 10.1111/ocr.12218.
[4202]	Y. Liu et al., “Genotype-phenotype analysis of a rare type of osteogenesis imperfecta in four Chinese families with WNT1 mutations,” Clin. Chim. Acta, vol. 461, pp. 172–180, Oct. 2016, doi: 10.1016/j.cca.2016.07.012.
[4203]	N. Mohd Nawawi et al., “Genotype-phenotype correlation among Malaysian patients with osteogenesis imperfecta,” Clin. Chim. Acta, vol. 484, pp. 141–147, Sep. 2018, doi: 10.1016/j.cca.2018.05.048.
[4204]	W. Koch et al., “Genotyping of the common haptoglobin Hp 1/2 polymorphism based on PCR,” Clin. Chem., vol. 48, no. 9, pp. 1377–1382, Sep. 2002.
[4205]	M. Tabares, H. Dulay, and G. Reguera, “Geobacter sulfurreducens,” Trends Microbiol., vol. 28, no. 4, pp. 327–328, Apr. 2020, doi: 10.1016/j.tim.2019.11.004.
[4206]	D. Dolejš, “Geochemistry: Ions surprise in Earth’s deep fluids,” Nature, vol. 539, no. 7629, pp. 362–364, 17 2016, doi: 10.1038/539362a.
[4207]	B. Marty, “Geochemistry: on the Moon as it was on Earth,” Nature, vol. 436, no. 7051, pp. 631–632, Aug. 2005, doi: 10.1038/436631a.
[4208]	J. M. Hayes, “Geochemistry. Earth’s redox history,” Science, vol. 334, no. 6063, pp. 1654–1655, Dec. 2011, doi: 10.1126/science.1216481.
[4209]	W. Maziak, “Geography of biomedical publications,” Lancet, vol. 363, no. 9407, p. 490, Feb. 2004, doi: 10.1016/S0140-6736(04)15500-1.
[4210]	A. C. Allwood, “Geology: Evidence of life in Earth’s oldest rocks,” Nature, vol. 537, no. 7621, pp. 500–501, 22 2016, doi: 10.1038/nature19429.
[4211]	H. Ryu and S. A. Campbell, “Geometric analysis of synchronization in neuronal networks with global inhibition and coupling delays,” Philos Trans A Math Phys Eng Sci, vol. 377, no. 2153, p. 20180129, Sep. 2019, doi: 10.1098/rsta.2018.0129.
[4212]	B. Romanowicz, “Geophysics: The buoyancy of Earth’s deep mantle,” Nature, vol. 551, no. 7680, pp. 308–309, 15 2017, doi: 10.1038/551308a.
[4213]	J. Hu, C. Ouyang, S. A. Yang, and H. Y. Yang, “Germagraphene as a promising anode material for lithium-ion batteries predicted from first-principles calculations,” Nanoscale Horiz, vol. 4, no. 2, pp. 457–463, Mar. 2019, doi: 10.1039/c8nh00333e.
[4214]	M. Scherer, D. Lühmann, and H. Raspe, “[German Research Foundation (DFG) Early Career Investigators Workshop in Health Services Research: concept - progress - feedback],” Z Evid Fortbild Qual Gesundhwes, vol. 106, no. 1, pp. 46–53, 2012, doi: 10.1016/j.zefq.2011.04.001.
[4215]	A. J. Scott, M. C. Tokaz, M. F. Jacobs, A. M. Chinnaiyan, T. J. Phillips, and R. A. Wilcox, “Germline variants discovered in lymphoma patients undergoing tumor profiling: a case series,” Fam. Cancer, Jun. 2020, doi: 10.1007/s10689-020-00192-3.
[4216]	J. H. Yoon, S.-Y. Park, and J. K. Ju, “Giant Colonic Cavernous Hemangioma Causing Hematochezia in a 14-Year-Old Boy,” Clin. Gastroenterol. Hepatol., vol. 16, no. 8, pp. A35–A36, 2018, doi: 10.1016/j.cgh.2017.10.010.
[4217]	A. L. Roupie et al., “Giant-cell arteritis associated with myelodysplastic syndrome: French multicenter case control study and literature review,” Autoimmun Rev, vol. 19, no. 2, p. 102446, Feb. 2020, doi: 10.1016/j.autrev.2019.102446.
[4218]	J. P. DeLong and J. P. Gibert, “Gillespie eco-evolutionary models (GEMs) reveal the role of heritable trait variation in eco-evolutionary dynamics,” Ecol Evol, vol. 6, no. 4, pp. 935–945, Feb. 2016, doi: 10.1002/ece3.1959.
[4219]	D. O. Kennedy and A. B. Scholey, “Ginseng: potential for the enhancement of cognitive performance and mood,” Pharmacol. Biochem. Behav., vol. 75, no. 3, pp. 687–700, Jun. 2003, doi: 10.1016/s0091-3057(03)00126-6.
[4220]	G. Sagoe et al., “GIS-aided optimisation of faecal sludge management in developing countries: the case of the Greater Accra Metropolitan Area, Ghana,” Heliyon, vol. 5, no. 9, p. e02505, Sep. 2019, doi: 10.1016/j.heliyon.2019.e02505.
[4221]	C. E. G. Leyns and D. M. Holtzman, “Glial contributions to neurodegeneration in tauopathies,” Mol Neurodegener, vol. 12, no. 1, p. 50, 29 2017, doi: 10.1186/s13024-017-0192-x.
[4222]	G. Moonen, G. Franck, and E. Schoffeniels, “Glial control of neuronal excitability in mammals : I. Electrophysiological and isotopic evidence in culture,” Neurochem. Int., vol. 2C, pp. 299–310, 1980, doi: 10.1016/0197-0186(80)90037-6.
[4223]	M.-E. Tremblay, M. R. Cookson, and L. Civiero, “Glial phagocytic clearance in Parkinson’s disease,” Mol Neurodegener, vol. 14, no. 1, p. 16, 05 2019, doi: 10.1186/s13024-019-0314-8.
[4224]	E. Barrascout and M. Lamuraglia, “Glioblastoma and bevacizumab in elderly patients: Monocentric study,” J Oncol Pharm Pract, p. 1078155220940396, Jul. 2020, doi: 10.1177/1078155220940396.
[4225]	“Global Advisory Committee on Vaccine Safety, 2-3 December 2015,” Wkly. Epidemiol. Rec., vol. 91, no. 3, pp. 21–31, Jan. 2016.
[4226]	“Global Advisory Committee on Vaccine Safety, 6–7 December 2017,” Wkly. Epidemiol. Rec., vol. 93, no. 2, pp. 17–30, Jan. 2018.
[4227]	“Global Advisory Committee on Vaccine Safety, 10-11 June 2015,” Wkly. Epidemiol. Rec., vol. 90, no. 29, pp. 365–372, Jul. 2015.
[4228]	“Global Advisory Committee on Vaccine Safety, 30 November – 1 December 2016,” Wkly. Epidemiol. Rec., vol. 92, no. 2, pp. 13–20, 13 2017.
[4229]	L. M. Cullins and A. I. Mian, “Global Child and Adolescent Mental Health: A Culturally Informed Focus,” Child Adolesc Psychiatr Clin N Am, vol. 24, no. 4, pp. 823–830, Oct. 2015, doi: 10.1016/j.chc.2015.06.010.
[4230]	A. Rajtar-Zembaty, J. Rajtar-Zembaty, A. Sałkowski, A. Starowicz-Filip, and A. Skalska, “Global cognitive functioning and physical mobility in older adults with and without mild cognitive impairment: evidence and implications,” Folia Med Cracov, vol. 59, no. 1, pp. 75–88, 2019.
[4231]	K. T. Mills et al., “Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries,” Circulation, vol. 134, no. 6, pp. 441–450, Aug. 2016, doi: 10.1161/CIRCULATIONAHA.115.018912.
[4232]	B. S. Schwartz, C. Parker, T. A. Glass, and H. Hu, “Global environmental change: what can health care providers and the environmental health community do about it now?,” Environ. Health Perspect., vol. 114, no. 12, pp. 1807–1812, Dec. 2006, doi: 10.1289/ehp.9313.
[4233]	K. Martin and P. J. Landrigan, “Global Health’s Grand Challenge: A Healthy Planet and Healthy People,” Ann Glob Health, vol. 82, no. 3, pp. 317–318, Jun. 2016, doi: 10.1016/j.aogh.2016.05.003.
[4234]	“Global leishmaniasis update, 2006–2015: a turning point in leishmaniasis surveillance,” Wkly. Epidemiol. Rec., vol. 92, no. 38, pp. 557–565, 22 2017.
[4235]	“Global leprosy situation, 2012,” Wkly. Epidemiol. Rec., vol. 87, no. 34, pp. 317–328, Aug. 2012.
[4236]	“Global leprosy update, 2013;  reducing disease burden,” Wkly. Epidemiol. Rec., vol. 89, no. 36, pp. 389–400, Sep. 2014.
[4237]	“Global leprosy update, 2014: need for early case detection,” Wkly. Epidemiol. Rec., vol. 90, no. 36, pp. 461–474, Sep. 2015.
[4238]	“Global leprosy update, 2015: time for action, accountability and inclusion,” Wkly. Epidemiol. Rec., vol. 91, no. 35, pp. 405–420, Sep. 2015.
[4239]	“Global leprosy update, 2016: accelerating reduction of disease burden,” Wkly. Epidemiol. Rec., vol. 92, no. 35, pp. 501–519, 01 2017.
[4240]	“Global measles and rubella laboratory network support for elimination goals, 2010–2015,” Wkly. Epidemiol. Rec., vol. 91, no. 18, pp. 240–246, May 2016.
[4241]	D. Bemme and N. A. D’souza, “Global mental health and its discontents: an inquiry into the making of global and local scale,” Transcult Psychiatry, vol. 51, no. 6, pp. 850–874, Dec. 2014, doi: 10.1177/1363461514539830.
[4242]	V. Patel, “Global mental health: from science to action,” Harv Rev Psychiatry, vol. 20, no. 1, pp. 6–12, Feb. 2012, doi: 10.3109/10673229.2012.649108.
[4243]	H. Lee, M. Lomazzi, A. Lee, and R. Bedi, “Global oral health in the framework of the Global Charter for the Public’s Health,” J Public Health Policy, vol. 39, no. 2, pp. 245–253, May 2018, doi: 10.1057/s41271-018-0121-4.
[4244]	G. K. Seeberger, “Global oral health: A proposal for a change of picture,” Indian J Dent Res, vol. 30, no. 4, pp. 483–485, Aug. 2019, doi: 10.4103/ijdr.IJDR_674_19.
[4245]	“Global polio eradication: progress towards containment of poliovirus type 2, worldwide 2017,” Wkly. Epidemiol. Rec., vol. 92, no. 25, pp. 350–356, 23 2017.
[4246]	“Global programme to eliminate lymphatic filariasis: progress report, 2015,” Wkly. Epidemiol. Rec., vol. 91, no. 39, pp. 441–455, Sep. 2016.
[4247]	“Global programme to eliminate lymphatic filariasis: progress report, 2016,” Wkly. Epidemiol. Rec., vol. 92, no. 40, pp. 594–607, 06 2017.
[4248]	T. Oni et al., “Global public health starts at home: upstream approaches to global health training,” Lancet Glob Health, vol. 7, no. 3, pp. e301–e302, 2019, doi: 10.1016/S2214-109X(18)30558-8.
[4249]	“Global routine vaccination coverage, 2013,” Wkly. Epidemiol. Rec., vol. 89, no. 47, pp. 517–522, Nov. 2014.
[4250]	“Global routine vaccination coverage, 2014,” Wkly. Epidemiol. Rec., vol. 90, no. 46, pp. 617–623, Nov. 2015.
[4251]	“Global routine vaccination coverage, 2015,” Wkly. Epidemiol. Rec., vol. 91, no. 46, pp. 537–543, Nov. 2016.
[4252]	“Global routine vaccination coverage, 2016,” Wkly. Epidemiol. Rec., vol. 92, no. 46, pp. 701–707, 17 2017.
[4253]	“Global routine vaccination coverage,2011,” Wkly. Epidemiol. Rec., vol. 87, no. 44, pp. 432–435, Nov. 2012.
[4254]	“Global RSV surveillance,” Wkly. Epidemiol. Rec., vol. 91, no. 44, pp. 523–524, Nov. 2016.
[4255]	C. E. Pulker, G. S. A. Trapp, J. A. Scott, and C. M. Pollard, “Global supermarkets’ corporate social responsibility commitments to public health: a content analysis,” Global Health, vol. 14, no. 1, p. 121, 29 2018, doi: 10.1186/s12992-018-0440-z.
[4256]	V. Rowthorn, L. A. Edwards, J. Lipscomb, and J. Olsen, “Global to Local: Methods and Models,” Ann Glob Health, vol. 82, no. 6, pp. 951–954, Dec. 2016, doi: 10.1016/j.aogh.2016.11.009.
[4257]	E. West, S. Mutasa, Z. Zhu, and R. Ha, “Global Trend in Artificial Intelligence-Based Publications in Radiology From 2000 to 2018,” AJR Am J Roentgenol, vol. 213, no. 6, pp. 1204–1206, 2019, doi: 10.2214/AJR.19.21346.
[4258]	J. Mani et al., “Globalization in Urology: A Bibliographical Analysis of Cross-Continent Publication between 2002 and 2012,” Urol. Int., vol. 95, no. 3, pp. 281–287, 2015, doi: 10.1159/000438830.
[4259]	D. D. Belke, T. S. Larsen, G. D. Lopaschuk, and D. L. Severson, “Glucose and fatty acid metabolism in the isolated working mouse heart,” Am. J. Physiol., vol. 277, no. 4, pp. R1210-1217, 1999, doi: 10.1152/ajpregu.1999.277.4.R1210.
[4260]	N. Kalariti and M. Koutsilieris, “Glutamatergic system in bone physiology,” In Vivo, vol. 18, no. 5, pp. 621–628, Oct. 2004.
[4261]	G. W. Yelland, “Gluten-induced cognitive impairment (‘brain fog’) in coeliac disease,” J. Gastroenterol. Hepatol., vol. 32 Suppl 1, pp. 90–93, Mar. 2017, doi: 10.1111/jgh.13706.
[4262]	K. Barton, L. Donovan, I. Giroux, D. Miller, M. Mottola, and R. McManus, “Glycated hemoglobin measurements at three, 12 and 24 months postpartum after gestational diabetes,” Clin Invest Med, vol. 42, no. 4, pp. E37–E41, 29 2019, doi: 10.25011/cim.v42i4.33343.
[4263]	J. K. Hwang et al., “Glycemic Control Status After Percutaneous Coronary Intervention and Long-Term Clinical Outcomes in Patients With Type 2 Diabetes Mellitus,” Circ Cardiovasc Interv, vol. 10, no. 4, Apr. 2017, doi: 10.1161/CIRCINTERVENTIONS.116.004157.
[4264]	B. M. van den Berg, M. Nieuwdorp, E. S. G. Stroes, and H. Vink, “Glycocalyx and endothelial (dys) function: from mice to men,” Pharmacol Rep, vol. 58 Suppl, pp. 75–80, 2006.
[4265]	L. P. Izakova, “GLYCOGEN DYNAMICS IN CELLS CULTIVATED IN VITRO,” Fed Proc Transl Suppl, vol. 22, pp. 1053–1057, Dec. 1963.
[4266]	T. M. Achariyar et al., “Glymphatic distribution of CSF-derived apoE into brain is isoform specific and suppressed during sleep deprivation,” Mol Neurodegener, vol. 11, no. 1, p. 74, 08 2016, doi: 10.1186/s13024-016-0138-8.
[4267]	H. Benveniste, P. M. Heerdt, M. Fontes, D. L. Rothman, and N. D. Volkow, “Glymphatic System Function in Relation to Anesthesia and Sleep States,” Anesth. Analg., vol. 128, no. 4, pp. 747–758, 2019, doi: 10.1213/ANE.0000000000004069.
[4268]	Y. K. Lim, L. Retnam, B. Bhagavath, S. K. Sethi, A. bin Ali, and S. K. Lim, “Gonadal effects on plasma ACE activity in mice,” Atherosclerosis, vol. 160, no. 2, pp. 311–316, Feb. 2002, doi: 10.1016/s0021-9150(01)00576-7.
[4269]	D. R. Rubinow and P. J. Schmidt, “Gonadal steroid regulation of mood: the lessons of premenstrual syndrome,” Front Neuroendocrinol, vol. 27, no. 2, pp. 210–216, Jul. 2006, doi: 10.1016/j.yfrne.2006.02.003.
[4270]	S. A. Hill, T. L. Masters, and J. Wachter, “Gonorrhea - an evolving disease of the new millennium,” Microb Cell, vol. 3, no. 9, pp. 371–389, Sep. 2016, doi: 10.15698/mic2016.09.524.
[4271]	P. K. Kohl, Y. Tu, M. Kratofiel, and D. Petzoldt, “Gonorrhoea: single-dose oral treatment,” Curr. Probl. Dermatol., vol. 24, pp. 82–89, 1996, doi: 10.1159/000424887.
[4272]	L. Frederick and D. Chemburkar, “Good Laboratory Practice feud: training that is entertaining,” Qual Assur, vol. 4, no. 4, pp. 271–273, Dec. 1995.
[4273]	A. Heinonen, P. Kannus, H. Sievänen, M. Pasanen, P. Oja, and I. Vuori, “Good maintenance of high-impact activity-induced bone gain by voluntary, unsupervised exercises: An 8-month follow-up of a randomized controlled trial,” J. Bone Miner. Res., vol. 14, no. 1, pp. 125–128, Jan. 1999, doi: 10.1359/jbmr.1999.14.1.125.
[4274]	P. B. Persson, “Good publication practice in physiology 2017: Current Revisions of the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals,” Acta Physiol (Oxf), vol. 221, no. 4, pp. 283–284, 2017, doi: 10.1111/apha.12984.
[4275]	D. R. Herman and R. W. Usher, “Good research practices: a commonsense approach to ensuring quality in research facilities,” Qual Assur, vol. 3, no. 4, pp. 355–359, Dec. 1994.
[4276]	S. R. Stetina and J. E. Erpelding, “Gossypium arboreum Accessions Resistant to Rotylenchulus reniformis,” J. Nematol., vol. 48, no. 4, pp. 223–230, Dec. 2016, doi: 10.21307/jofnem-2017-030.
[4277]	P. J. Gaillard, “[Grafts in man with tissues cultured in vitro],” Rev Med Liege, vol. 9, no. 9, pp. 271–276, May 1954.
[4278]	X. Zhan, B. Stamova, L.-W. Jin, C. DeCarli, B. Phinney, and F. R. Sharp, “Gram-negative bacterial molecules associate with Alzheimer disease pathology,” Neurology, vol. 87, no. 22, pp. 2324–2332, Nov. 2016, doi: 10.1212/WNL.0000000000003391.
[4279]	E.-Y. K. Choi and L. W. Lamps, “Granulomas in the Liver, with a Focus on Infectious Causes,” Surg Pathol Clin, vol. 11, no. 2, pp. 231–250, Jun. 2018, doi: 10.1016/j.path.2018.02.008.
[4280]	M. J. Adams, “Graph decompositions for demographic loop analysis,” J Math Biol, vol. 57, no. 2, pp. 209–221, Aug. 2008, doi: 10.1007/s00285-007-0152-0.
[4281]	Z. Wei, S. Alcauter, K. Jin, Z.-W. Peng, and W. Gao, “Graph theoretical analysis of sedation’s effect on whole brain functional system in school-aged children,” Brain Connect, vol. 3, no. 2, pp. 177–189, 2013, doi: 10.1089/brain.2012.0125.
[4282]	M. Radunovic et al., “Graphene oxide enrichment of collagen membranes improves DPSCs differentiation and controls inflammation occurrence,” J Biomed Mater Res A, vol. 105, no. 8, pp. 2312–2320, Aug. 2017, doi: 10.1002/jbm.a.36085.
[4283]	F. Göhringer, M. Löhr-Limpens, C. Hesse, and T. Schenk, “Grasping Discriminates between Object Sizes Less Not More Accurately than the Perceptual System,” Vision (Basel), vol. 3, no. 3, Jul. 2019, doi: 10.3390/vision3030036.
[4284]	R. López et al., “Green and simple extraction of free seleno-amino acids from powdered and lyophilized milk samples with natural deep eutectic solvents,” Food Chem, vol. 326, p. 126965, Oct. 2020, doi: 10.1016/j.foodchem.2020.126965.
[4285]	R. A. Yeager, T. R. Smith, and A. Bhatnagar, “Green environments and cardiovascular health,” Trends Cardiovasc. Med., vol. 30, no. 4, pp. 241–246, May 2020, doi: 10.1016/j.tcm.2019.06.005.
[4286]	A. Maertens, N. Anastas, P. J. Spencer, M. Stephens, A. Goldberg, and T. Hartung, “Green toxicology,” ALTEX, vol. 31, no. 3, pp. 243–249, 2014, doi: 10.14573/altex.1406181.
[4287]	F. J. Pérez-Barbería and I. J. Gordon, “Gregariousness increases brain size in ungulates,” Oecologia, vol. 145, no. 1, pp. 41–52, Aug. 2005, doi: 10.1007/s00442-005-0067-7.
[4288]	L.-L. Chen, T. Huang, K.-J. Chen, S.-J. Song, H. Gao, and J.-M. Ma, “[Gridded Atmospheric Emission Inventory of PCDD/Fs in China],” Huan Jing Ke Xue, vol. 41, no. 2, pp. 510–519, Feb. 2020, doi: 10.13227/j.hjkx.201908056.
[4289]	A. Zara, “Grief intensity, coping and psychological health among family members and friends following a terrorist attack,” Death Stud, vol. 44, no. 6, pp. 366–374, 2020, doi: 10.1080/07481187.2019.1578302.
[4290]	A. J. K. Chua, B. W. S. Tan, T. Y. Tan, and H. H. W. Heah, “Grisel’s Syndrome in an Adult After Endoscopic Nasopharyngectomy,” Laryngoscope Investig Otolaryngol, vol. 4, no. 5, pp. 504–507, Oct. 2019, doi: 10.1002/lio2.298.
[4291]	A. Lundberg, “Gross and fine motor performance in healthy Swedish children aged fifteen and eighteen months,” Neuropadiatrie, vol. 10, no. 1, pp. 35–50, Feb. 1979, doi: 10.1055/s-0028-1085312.
[4292]	W. Pérez, H. Katz, and M. Lima, “Gross heart anatomy of Arctocephalus australis (Zimmerman, 1783),” Anat Sci Int, vol. 83, no. 1, pp. 6–10, Mar. 2008, doi: 10.1111/j.1447-073X.2007.00189.x.
[4293]	K. A. Morano, “Groupthink: chromosomal clustering during transcriptional memory,” Microb Cell, vol. 2, no. 12, pp. 454–457, Nov. 2015, doi: 10.15698/mic2015.12.244.
[4294]	L. Bergmann, “Growth and division of single cells of higher plants in vitro,” J. Gen. Physiol., vol. 43, pp. 841–851, Mar. 1960, doi: 10.1085/jgp.43.4.841.
[4295]	T. T. Puck, “Growth and genetics in somatic mammalian cells in vitro,” J Cell Physiol Suppl, vol. 52, no. Supp 1, pp. 287–302; discussion 302-311, Dec. 1958.
[4296]	G. Sarinsky, M. A. Carroll, E. Nduka, and E. J. Catapane, “Growth and Survival of the American Oyster Crassostrea virginica in Jamaica Bay, New York,” In Vivo (Brooklyn), vol. 27, no. 1, pp. 15–26, 2005.
[4297]	K. Dahal and G. C. Vanlerberghe, “Growth at Elevated CO2 Requires Acclimation of the Respiratory Chain to Support Photosynthesis,” Plant Physiol., vol. 178, no. 1, pp. 82–100, 2018, doi: 10.1104/pp.18.00712.
[4298]	M. A. Gliozzi, “[Growth in culture in vitro in hanging drop alternatively transplanted & renourished],” Boll. Soc. Ital. Biol. Sper., vol. 35, no. 7, pp. 377–379, Apr. 1959.
[4299]	V. J. Evans, H. A. Kerr, W. T. McQUILKIN, W. R. Earle, and R. N. Hull, “Growth in vitro of a long-term strain of monkey-kidney cells in medium NCTC 109 free of any added protein,” Am J Hyg, vol. 70, pp. 297–302, Nov. 1959, doi: 10.1093/oxfordjournals.aje.a120078.
[4300]	A. D. Flanagan and J. Colter, “Growth of Mengo encephalitis virus in Ehrlich ascites cells in vitro,” Cancer Res., vol. 15, no. 10, pp. 657–662, Nov. 1955.
[4301]	H. Eideh, B. Jonsson, and Z. Hochberg, “Growth of the Kalahari Desert’s bushman--the Ju/’hoansi San,” Acta Paediatr., vol. 101, no. 5, pp. 528–532, May 2012, doi: 10.1111/j.1651-2227.2011.02573.x.
[4302]	N. Siddiqi, M. John C, M. Norrish, and T. Heming, “Growth Retardation Of Chick Embryo Exposed To A Low Dose Of Electromagnetic Waves,” J Ayub Med Coll Abbottabad, vol. 28, no. 2, pp. 224–228, Jun. 2016.
[4303]	H. Zhu et al., “GSK3β-mediated tau hyperphosphorylation triggers diabetic retinal neurodegeneration by disrupting synaptic and mitochondrial functions,” Mol Neurodegener, vol. 13, no. 1, p. 62, 22 2018, doi: 10.1186/s13024-018-0295-z.
[4304]	A. Pisoni, M. Vernice, L. Iasevoli, Z. Cattaneo, and C. Papagno, “Guess who? Investigating the proper name processing network by means of tDCS,” Neuropsychologia, vol. 66, pp. 267–278, Jan. 2015, doi: 10.1016/j.neuropsychologia.2014.11.025.
[4305]	C. McGrath, H. P. Lawrence, and A. Blinkhorn, “Guest editorial on the Festschrift ‘Challenges in population oral health for the 21st century,’” Community Dent Oral Epidemiol, vol. 40 Suppl 2, pp. 1–4, Oct. 2012, doi: 10.1111/j.1600-0528.2012.00736.x.
[4306]	D. R. Lakkireddy et al., “Guidance for Cardiac Electrophysiology During the COVID-19 Pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association,” Circulation, vol. 141, no. 21, pp. e823–e831, 26 2020, doi: 10.1161/CIRCULATIONAHA.120.047063.
[4307]	J. I. Kass, E. Prisman, and B. A. Miles, “Guide design in virtual planning for scapular tip free flap reconstruction,” Laryngoscope Investig Otolaryngol, vol. 3, no. 3, pp. 162–168, Jun. 2018, doi: 10.1002/lio2.162.
[4308]	J. Gail Neely, R. J. Smith, E. M. Graboyes, R. C. Paniello, and S. Paul Gubbels, “Guide to Academic Research Career Development,” Laryngoscope Investig Otolaryngol, vol. 1, no. 1, pp. 19–24, 2016, doi: 10.1002/lio2.5.
[4309]	D. Carmona-Gutierrez et al., “Guidelines and recommendations on yeast cell death nomenclature,” Microb Cell, vol. 5, no. 1, pp. 4–31, Jan. 2018, doi: 10.15698/mic2018.01.607.
[4310]	H. L. Klein et al., “Guidelines for DNA recombination and repair studies: Cellular assays of DNA repair pathways,” Microb Cell, vol. 6, no. 1, pp. 1–64, Jan. 2019, doi: 10.15698/mic2019.01.664.
[4311]	H. L. Klein et al., “Guidelines for DNA recombination and repair studies: Mechanistic assays of DNA repair processes,” Microb Cell, vol. 6, no. 1, pp. 65–101, Jan. 2019, doi: 10.15698/mic2019.01.665.
[4312]	D. Straton, “Guilt and PTSD,” Aust N Z J Psychiatry, vol. 38, no. 4, pp. 269–270, Apr. 2004, doi: 10.1080/j.1440-1614.2004.01350.x.
[4313]	L. Li et al., “Gut microbes in correlation with mood: case study in a closed experimental human life support system,” Neurogastroenterol. Motil., vol. 28, no. 8, pp. 1233–1240, 2016, doi: 10.1111/nmo.12822.
[4314]	G. Caspani, S. Kennedy, J. A. Foster, and J. Swann, “Gut microbial metabolites in depression: understanding the biochemical mechanisms,” Microb Cell, vol. 6, no. 10, pp. 454–481, Sep. 2019, doi: 10.15698/mic2019.10.693.
[4315]	H.-X. Wang and Y.-P. Wang, “Gut Microbiota-brain Axis,” Chin. Med. J., vol. 129, no. 19, pp. 2373–2380, 05 2016, doi: 10.4103/0366-6999.190667.
[4316]	E. Jerlhag, “Gut-brain axis and addictive disorders: A review with focus on alcohol and drugs of abuse,” Pharmacol. Ther., vol. 196, pp. 1–14, 2019, doi: 10.1016/j.pharmthera.2018.11.005.
[4317]	F. F. Tu, K. M. Hellman, and M. M. Backonja, “Gynecologic management of neuropathic pain,” Am. J. Obstet. Gynecol., vol. 205, no. 5, pp. 435–443, Nov. 2011, doi: 10.1016/j.ajog.2011.05.011.
[4318]	J. Forman, “H-2 unrestricted cytotoxic T cell activity against antigens controlled by genes in the QA/TLA region,” J. Immunol., vol. 123, no. 6, pp. 2451–2455, Dec. 1979.
[4319]	D. Angerhausen et al., “HABEBEE: habitability of eyeball-exo-Earths,” Astrobiology, vol. 13, no. 3, pp. 309–314, Mar. 2013, doi: 10.1089/ast.2012.0846.
[4320]	B. Hermann et al., “Habituation of auditory startle reflex is a new sign of minimally conscious state,” Brain, vol. 143, no. 7, pp. 2154–2172, Jul. 2020, doi: 10.1093/brain/awaa159.
[4321]	T. Honda, M. Hirashima, and D. Nozaki, “Habituation to feedback delay restores degraded visuomotor adaptation by altering both sensory prediction error and the sensitivity of adaptation to the error,” Front Psychol, vol. 3, p. 540, 2012, doi: 10.3389/fpsyg.2012.00540.
[4322]	R. Arguedas et al., “Haematology and biochemistry of the San Cristóbal Lava Lizard (Microlophus bivittatus),” Conserv Physiol, vol. 6, no. 1, p. coy046, 2018, doi: 10.1093/conphys/coy046.
[4323]	T. Hanke, E. I. Charitos, H. Paarmann, U. Stierle, and H.-H. Sievers, “Haemodynamic performance of a new pericardial aortic bioprosthesis during exercise and recovery: comparison with pulmonary autograft, stentless aortic bioprosthesis and healthy control groups,” Eur J Cardiothorac Surg, vol. 44, no. 4, pp. e295-301, Oct. 2013, doi: 10.1093/ejcts/ezt367.
[4324]	C. M. Papa, “Hair,” in Clinical Methods: The History, Physical, and Laboratory Examinations, 3rd ed., H. K. Walker, W. D. Hall, and J. W. Hurst, Eds. Boston: Butterworths, 1990.
[4325]	A. Slominski, G. Goodman-Snitkoff, M. Maurer, and R. Paus, “Hair cycle-associated changes in splenocyte proliferation,” In Vivo, vol. 11, no. 1, pp. 101–102, Feb. 1997.
[4326]	B. H. Lee, J. S. Lee, and Y. C. Kim, “Hair Growth-Promoting Effects of Lavender Oil in C57BL/6 Mice,” Toxicol Res, vol. 32, no. 2, pp. 103–108, Apr. 2016, doi: 10.5487/TR.2016.32.2.103.
[4327]	J. A. Lee, D. A. Levy, K. G. Patel, E. Brennan, and S. L. Oyer, “Hair transplantation in frontal fibrosing alopecia and lichen planopilaris: A systematic review,” Laryngoscope, Feb. 2020, doi: 10.1002/lary.28551.
[4328]	B.-B. Liu et al., “Halalkalicoccus paucihalophilus sp. nov., a halophilic archaeon from Lop Nur region in Xinjiang, northwest of China,” Antonie Van Leeuwenhoek, vol. 103, no. 5, pp. 1007–1014, May 2013, doi: 10.1007/s10482-013-9880-x.
[4329]	S. Iyer et al., “Halo Gravity Traction Can Mitigate Preoperative Risk Factors and Early Surgical Complications in Complex Spine Deformity,” Spine, vol. 44, no. 9, pp. 629–636, May 2019, doi: 10.1097/BRS.0000000000002906.
[4330]	J. Schwabedissen et al., “Halogen Bonds of Halotetrafluoropyridines in Crystals and Co-crystals with Benzene and Pyridine,” Chemistry, vol. 25, no. 30, pp. 7339–7350, May 2019, doi: 10.1002/chem.201900334.
[4331]	J. Schomaker, M. Rangel-Gomez, and M. Meeter, “Happier, faster: Developmental changes in the effects of mood and novelty on responses,” Q J Exp Psychol (Hove), vol. 69, no. 1, pp. 37–47, 2016, doi: 10.1080/17470218.2015.1019520.
[4332]	C. Houston, “Happy Doctor’s Day,” J Ky Med Assoc, vol. 106, no. 3, pp. 127–128, Mar. 2008.
[4333]	P. Lesage and A. L. Todeschini, “Happy together: the life and times of Ty retrotransposons and their hosts,” Cytogenet. Genome Res., vol. 110, no. 1–4, pp. 70–90, 2005, doi: 10.1159/000084940.
[4334]	C. B. F. Andersen et al., “Haptoglobin,” Antioxid. Redox Signal., vol. 26, no. 14, pp. 814–831, 10 2017, doi: 10.1089/ars.2016.6793.
[4335]	V. Napolioni, P. Giannì, F. M. Carpi, F. Concetti, and N. Lucarini, “Haptoglobin (HP) polymorphisms and human longevity: a cross-sectional association study in a Central Italy population,” Clin. Chim. Acta, vol. 412, no. 7–8, pp. 574–577, Mar. 2011, doi: 10.1016/j.cca.2010.12.006.
[4336]	U. S. Alwis, S. Roggeman, T. F. Monaghan, M.-A. Denys, K. Everaert, and J. Delanghe, “Haptoglobin 1-1 phenotype: A risk factor for 24-hours polyuria,” Int. J. Clin. Pract., p. e13419, Sep. 2019, doi: 10.1111/ijcp.13419.
[4337]	B. Lazalde, H. M. Huerta-Guerrero, L. E. Simental-Mendía, M. Rodríguez-Morán, and F. Guerrero-Romero, “Haptoglobin 2-2 genotype is associated with TNF- α and IL-6 levels in subjects with obesity,” Dis. Markers, vol. 2014, p. 912756, 2014, doi: 10.1155/2014/912756.
[4338]	N. H. Hunt, C. Driussi, and L. Sai-Kiang, “Haptoglobin and malaria,” Redox Rep., vol. 6, no. 6, pp. 389–392, 2001, doi: 10.1179/135100001101536508.
[4339]	Y. L. McGrotty, A. Arteaga, C. M. Knottenbelt, I. K. Ramsey, and P. D. Eckersall, “Haptoglobin concentrations in dogs undergoing trilostane treatment for hyperadrenocorticism,” Vet Clin Pathol, vol. 34, no. 3, pp. 255–258, Sep. 2005, doi: 10.1111/j.1939-165x.2005.tb00050.x.
[4340]	O. Gamucci et al., “Haptoglobin deficiency determines changes in adipocyte size and adipogenesis,” Adipocyte, vol. 1, no. 3, pp. 142–183, Jul. 2012, doi: 10.4161/adip.20041.
[4341]	A. L. Miranda-Vilela et al., “Haptoglobin gene subtypes in three Brazilian population groups of different ethnicities,” Genet. Mol. Biol., vol. 32, no. 3, pp. 456–461, Jul. 2009, doi: 10.1590/S1415-47572009005000051.
[4342]	H. Goldenstein, N. S. Levy, J. Ward, T. Costacou, and A. P. Levy, “Haptoglobin Genotype Is a Determinant of Hemoglobin Adducts and Vitamin E Content in HDL,” J Diabetes Res, vol. 2018, p. 6125420, 2018, doi: 10.1155/2018/6125420.
[4343]	R. Asaf et al., “Haptoglobin genotype is a determinant of survival and cardiac remodeling after myocardial infarction in diabetic mice,” Cardiovasc Diabetol, vol. 8, p. 29, Jun. 2009, doi: 10.1186/1475-2840-8-29.
[4344]	K. U. Park, J. Song, and J. Q. Kim, “Haptoglobin genotypic distribution (including Hp0 allele) and associated serum haptoglobin concentrations in Koreans,” J. Clin. Pathol., vol. 57, no. 10, pp. 1094–1095, Oct. 2004, doi: 10.1136/jcp.2004.017582.
[4345]	Z. Armaly, K. Farhat, S. Kinaneh, and J. Farah, “Haptoglobin Phenotype Among Arab Patients With Mental Disorders,” J Clin Med Res, vol. 10, no. 3, pp. 196–201, Mar. 2018, doi: 10.14740/jocmr3279w.
[4346]	J. Constans, M. Viau, C. Gouaillard, and A. Clerc, “Haptoglobin polymorphism among Saharian and West African groups. Haptoglobin phenotype determination by radioimmunoelectrophoresis on Hp O samples,” Am. J. Hum. Genet., vol. 33, no. 4, pp. 606–616, Jul. 1981.
[4347]	M. B. Adinortey et al., “Haptoglobin polymorphism and association with complications in ghanaian type 2 diabetic patients,” Indian J Clin Biochem, vol. 26, no. 4, pp. 366–372, Oct. 2011, doi: 10.1007/s12291-011-0141-3.
[4348]	M. Maes et al., “Haptoglobin polymorphism and schizophrenia: genetic variation on chromosome 16,” Psychiatry Res, vol. 104, no. 1, pp. 1–9, Oct. 2001, doi: 10.1016/s0165-1781(01)00298-0.
[4349]	B. Teige, B. Olaisen, and P. Teisberg, “Haptoglobin subtypes in Norway and a review of HP subtypes in various populations,” Hum. Hered., vol. 42, no. 2, pp. 93–106, 1992, doi: 10.1159/000154048.
[4350]	K. Carter and M. Worwood, “Haptoglobin: a review of the major allele frequencies worldwide and their association with diseases,” Int J Lab Hematol, vol. 29, no. 2, pp. 92–110, Apr. 2007, doi: 10.1111/j.1751-553X.2007.00898.x.
[4351]	K. V. Nair, B. V. Holla, and S. N. Yoganarasimhan, “Haritaki - its proper way of using as per brihatrayee,” Anc Sci Life, vol. 7, no. 3–4, pp. 180–182, Jan. 1988.
[4352]	L. P. Samuel, “Harmonization of microbiology processes and standards: work in progress,” Clin. Chem. Lab. Med., vol. 56, no. 10, pp. 1624–1628, 25 2018, doi: 10.1515/cclm-2017-1074.
[4353]	S. J. Byrnes, R. Blanchard, and F. Capasso, “Harvesting renewable energy from Earth’s mid-infrared emissions,” Proc. Natl. Acad. Sci. U.S.A., vol. 111, no. 11, pp. 3927–3932, Mar. 2014, doi: 10.1073/pnas.1402036111.
[4354]	G. M. Rosen, “Has DSM-5 saved PTSD from itself?,” Br J Psychiatry, vol. 209, no. 4, pp. 275–276, 2016, doi: 10.1192/bjp.bp.116.183731.
[4355]	F. Caponio, G. Squeo, G. Difonzo, A. Pasqualone, C. Summo, and V. M. Paradiso, “Has the use of talc an effect on yield and extra virgin olive oil quality?,” J. Sci. Food Agric., vol. 96, no. 10, pp. 3292–3299, Aug. 2016, doi: 10.1002/jsfa.7658.
[4356]	R. Lorini, R. Gastaldi, C. Traggiai, and P. P. Perucchin, “Hashimoto’s Thyroiditis,” Pediatr Endocrinol Rev, vol. 1 Suppl 2, pp. 205–211; discussion 211, Dec. 2003.
[4357]	Y. Yu et al., “Hashimoto’s thyroiditis with elevated serum IgG4 concentrations is not equivalent to IgG4 Hashimoto’s thyroiditis,” Clin. Endocrinol. (Oxf), vol. 88, no. 6, pp. 943–949, 2018, doi: 10.1111/cen.13596.
[4358]	P. Hennebert, H. A. van der Sloot, F. Rebischung, R. Weltens, L. Geerts, and O. Hjelmar, “Hazard property classification of waste according to the recent propositions of the EC using different methods,” Waste Manag, vol. 34, no. 10, pp. 1739–1751, Oct. 2014, doi: 10.1016/j.wasman.2014.05.021.
[4359]	J. P. Harris, “Hazards of predatory publication,” ANZ J Surg, vol. 88, no. 1–2, p. 9, 2018, doi: 10.1111/ans.14255.
[4360]	P. Bottermann, “[HbA1c 8.5% in elderly people with diabetes: is it good enough?],” MMW Fortschr Med, vol. 151, no. 26–29, pp. 38–39, Jun. 2009.
[4361]	K. Le Prigent, D. Lagadic-Gossmann, E. Mongodin, and D. Feuvray, “HCO3(-)-dependent alkalinizing transporter in adult rat ventricular myocytes: characterization and modulation,” Am. J. Physiol., vol. 273, no. 6, pp. H2596-2603, 1997, doi: 10.1152/ajpheart.1997.273.6.H2596.
[4362]	A. von Eckardstein and L. Rohrer, “HDLs in crises,” Curr. Opin. Lipidol., vol. 27, no. 3, pp. 264–273, 2016, doi: 10.1097/MOL.0000000000000294.
[4363]	J. D. Smith et al., “Head and neck paragangliomas: A two-decade institutional experience and algorithm for management,” Laryngoscope Investig Otolaryngol, vol. 2, no. 6, pp. 380–389, 2017, doi: 10.1002/lio2.122.
[4364]	H. Lee et al., “Head formation requires Dishevelled degradation that is mediated by March2 in concert with Dapper1,” Development, vol. 145, no. 7, 10 2018, doi: 10.1242/dev.143107.
[4365]	T. Holsinger et al., “Head injury in early adulthood and the lifetime risk of depression,” Arch. Gen. Psychiatry, vol. 59, no. 1, pp. 17–22, Jan. 2002, doi: 10.1001/archpsyc.59.1.17.
[4366]	T. Loetscher, U. Schwarz, M. Schubiger, and P. Brugger, “Head turns bias the brain’s internal random generator,” Curr. Biol., vol. 18, no. 2, pp. R60-62, Jan. 2008, doi: 10.1016/j.cub.2007.11.015.
[4367]	A. Horinaka et al., “Head-Up Sleep May Cure Patients With Intractable Benign Paroxysmal Positional Vertigo: A six-Month Randomized Trial,” Laryngoscope Investig Otolaryngol, vol. 4, no. 3, pp. 353–358, Jun. 2019, doi: 10.1002/lio2.270.
[4368]	E. Şenel, “Health and Ancient Beliefs: A Scientometric Analysis of Health Literature Related to Shamanism, Paganism and Spirituality,” J Relig Health, vol. 58, no. 6, pp. 2019–2035, Dec. 2019, doi: 10.1007/s10943-019-00823-9.
[4369]	E. J. Yerxa, “Health and the human spirit for occupation,” Am J Occup Ther, vol. 52, no. 6, pp. 412–418, Jun. 1998, doi: 10.5014/ajot.52.6.412.
[4370]	B. Simons-Morton, “Health behavior in ecological context,” Health Educ Behav, vol. 40, no. 1, pp. 6–10, Feb. 2013, doi: 10.1177/1090198112464494.
[4371]	M. S. Watts, “Health care and not enough dollars,” West. J. Med., vol. 140, no. 2, pp. 274–275, Feb. 1984.
[4372]	C. C. Havighurst, “Health care as a (big) business: the antitrust response,” J Health Polit Policy Law, vol. 26, no. 5, pp. 939–955, Oct. 2001, doi: 10.1215/03616878-26-5-939.
[4373]	J. Litmathe, “[Health care economic guidance in Germany from the example Morbi-RSA],” Wien Med Wochenschr, vol. 166, no. 5–6, pp. 182–187, Apr. 2016, doi: 10.1007/s10354-015-0422-1.
[4374]	G. J. Bazzoli, “Health care for the indigent: overview of critical issues,” Health Serv Res, vol. 21, no. 3, pp. 353–393, Aug. 1986.
[4375]	B. Abel-Smith, “Health care in a cold economic climate,” Lancet, vol. 1, no. 8216, pp. 373–376, Feb. 1981, doi: 10.1016/s0140-6736(81)91684-6.
[4376]	“Health conditions for travellers to Saudi Arabia for the pilgrimage to Mecca (Hajj), 2016,” Wkly. Epidemiol. Rec., vol. 91, no. 26–27, pp. 331–335, Jul. 2016.
[4377]	S. Simoens, “Health economic assessment: a methodological primer,” Int J Environ Res Public Health, vol. 6, no. 12, pp. 2950–2966, 2009, doi: 10.3390/ijerph6122950.
[4378]	M. Wildner, “Health economic issues of screening programmes,” Eur. J. Pediatr., vol. 162 Suppl 1, pp. S5-7, Dec. 2003, doi: 10.1007/s00431-003-1341-5.
[4379]	R. Busse, “[Health economics. Objectives, methodology, relevance],” Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, vol. 49, no. 1, pp. 3–10, Jan. 2006, doi: 10.1007/s00103-005-1196-1.
[4380]	J. Steensberg, “Health effects of chemical products,” Ecol Dis, vol. 1, no. 4, pp. 201–212, 1982.
[4381]	A. Ananta, R. Toersilaningsih, and D. Handayani, “Health financing during an economic crisis: Indonesian experiences (July 1997-July 1998),” Cah Sociol Demogr Med, vol. 40, no. 1, pp. 47–71, Mar. 2000.
[4382]	S. A. Glied, “Health insurance and market failure since Arrow,” J Health Polit Policy Law, vol. 26, no. 5, pp. 957–965, Oct. 2001, doi: 10.1215/03616878-26-5-957.
[4383]	N. L. Dowshen, J. Christensen, and S. M. Gruschow, “Health Insurance Coverage of Recommended Gender-Affirming Health Care Services for Transgender Youth: Shopping Online for Coverage Information,” Transgend Health, vol. 4, no. 1, pp. 131–135, 2019, doi: 10.1089/trgh.2018.0055.
[4384]	M. E. Duffy, “Health insurance for type 1 diabetes mellitus: US competition and French coverage,” Nurs Outlook, vol. 53, no. 1, pp. 26–32, Feb. 2005, doi: 10.1016/j.outlook.2004.09.004.
[4385]	R. Klemetti, T. Sevón, M. Gissler, and E. Hemminki, “Health of children born after ovulation induction,” Fertil. Steril., vol. 93, no. 4, pp. 1157–1168, Mar. 2010, doi: 10.1016/j.fertnstert.2008.12.025.
[4386]	F. P. Cowan, “Health physics problems of high energy accelerators. BNL 50005 (T-429),” Tech Rep Brookhaven Natl Lab, pp. 1–14, May 1966.
[4387]	J. Ndjepel, P. Ngangue, and E. Vii Mballa Elanga, “[Health promotion in Cameroon: current situation and prospects],” Sante Publique, vol. 26, no. 1 Suppl, pp. S35-38, 2014.
[4388]	J. DeJong et al., “Health research in a turbulent region: the Reproductive Health Working Group,” Reprod Health Matters, vol. 25, no. sup1, pp. 4–15, Oct. 2017, doi: 10.1080/09688080.2017.1379864.
[4389]	B. Laursen and K. Helweg-Larsen, “Health service use in adults 20-64 years with traumatic brain injury, spinal cord injury or pelvic fracture. A cohort study with 9-year follow-up,” BMJ Open, vol. 2, no. 5, 2012, doi: 10.1136/bmjopen-2012-001521.
[4390]	A. Di Giorgio et al., “Health status of patients with autoimmune liver disease during SARS-CoV-2 outbreak in northern Italy,” J. Hepatol., vol. 73, no. 3, pp. 702–705, 2020, doi: 10.1016/j.jhep.2020.05.008.
[4391]	J. I. Roberts, S. B. Patten, S. Wiebe, B. R. Hemmelgarn, T. Pringsheim, and N. Jetté, “Health-related behaviors and comorbidities in people with epilepsy: Changes in the past decade,” Epilepsia, vol. 56, no. 12, pp. 1973–1981, Dec. 2015, doi: 10.1111/epi.13207.
[4392]	G. Márquez-Montero, C. Loret de Mola, A. Bernabé-Ortiz, L. Smeeth, R. H. Gilman, and J. J. Miranda, “[Health-related quality of life among urban and rural to urban migrant populations in Lima, Peru],” Rev Peru Med Exp Salud Publica, vol. 28, no. 1, pp. 35–41, Mar. 2011, doi: 10.1590/s1726-46342011000100006.
[4393]	N. Grytten et al., “Health-related quality of life and disease-modifying treatment behaviour in relapsing-remitting multiple sclerosis--a multicentre cohort study,” Acta Neurol. Scand., Suppl., no. 195, pp. 51–57, 2012, doi: 10.1111/ane.12033.
[4394]	B. Blissmer, D. Riebe, G. Dye, L. Ruggiero, G. Greene, and M. Caldwell, “Health-related quality of life following a clinical weight loss intervention among overweight and obese adults: intervention and 24 month follow-up effects,” Health Qual Life Outcomes, vol. 4, p. 43, Jul. 2006, doi: 10.1186/1477-7525-4-43.
[4395]	J. D. Hald, L. Folkestad, T. Harsløf, K. Brixen, and B. Langdahl, “Health-Related Quality of Life in Adults with Osteogenesis Imperfecta,” Calcif. Tissue Int., vol. 101, no. 5, pp. 473–478, 2017, doi: 10.1007/s00223-017-0301-4.
[4396]	Y. Song et al., “Health-related quality of life in children with osteogenesis imperfecta: a large-sample study,” Osteoporos Int, vol. 30, no. 2, pp. 461–468, Feb. 2019, doi: 10.1007/s00198-018-4801-5.
[4397]	L. Rew, S. D. Horner, and A. Brown, “Health-risk behaviors in early adolescence,” Issues Compr Pediatr Nurs, vol. 34, no. 2, pp. 79–96, 2011, doi: 10.3109/01460862.2011.574452.
[4398]	A. Guerrini, “Health, national character and the English diet in 1700,” Stud Hist Philos Biol Biomed Sci, vol. 43, no. 2, pp. 349–356, Jun. 2012, doi: 10.1016/j.shpsc.2011.10.027.
[4399]	C. A. Galemore, “Health’s multiple dimensions,” NASN Sch Nurse, vol. 26, no. 2, p. 68, Mar. 2011, doi: 10.1177/1942602X11398950.
[4400]	K. Noyes, E. A. Singer, and E. M. Messing, “Healthcare economics of bladder cancer: cost-enhancing and cost-reducing factors,” Curr Opin Urol, vol. 18, no. 5, pp. 533–539, Sep. 2008, doi: 10.1097/MOU.0b013e32830b8910.
[4401]	I. Towers, A. Spencer, and J. Brazier, “Healthy year equivalents versus quality-adjusted life years: the debate continues,” Expert Rev Pharmacoecon Outcomes Res, vol. 5, no. 3, pp. 245–254, Jun. 2005, doi: 10.1586/14737167.5.3.245.
[4402]	R. S. Thomson, P. Auduong, A. T. Miller, and R. K. Gurgel, “Hearing loss as a risk factor for dementia: A systematic review,” Laryngoscope Investig Otolaryngol, vol. 2, no. 2, pp. 69–79, 2017, doi: 10.1002/lio2.65.
[4403]	V. Fischer et al., “Heart adrenoceptor gene expression and binding sites in the human failing heart,” Ann. N. Y. Acad. Sci., vol. 1148, pp. 400–408, Dec. 2008, doi: 10.1196/annals.1410.013.
[4404]	F. L. Meijler and T. D. Meijler, “[Heart and evolution--form and function of all mammalian hearts are identical],” Ned Tijdschr Geneeskd, vol. 153, p. A1056, 2009.
[4405]	“Heart failure prevention essentials: take these steps. Exercise, healthy eating, and appropriate treatment will protect the heart’s pumping power,” Harv Mens Health Watch, vol. 18, no. 4, p. 3, Nov. 2013.
[4406]	S. Pieperhoff et al., “Heart on a plate: histological and functional assessment of isolated adult zebrafish hearts maintained in culture,” PLoS ONE, vol. 9, no. 5, p. e96771, 2014, doi: 10.1371/journal.pone.0096771.
[4407]	B. Frey, G. Heger, C. Mayer, B. Kiegler, H. Stöhr, and G. Steurer, “Heart rate variability in isolated rabbit hearts,” Pacing Clin Electrophysiol, vol. 19, no. 11 Pt 2, pp. 1882–1885, Nov. 1996, doi: 10.1111/j.1540-8159.1996.tb03245.x.
[4408]	C.-L. Lien, M. R. Harrison, T.-L. Tuan, and V. A. Starnes, “Heart repair and regeneration: recent insights from zebrafish studies,” Wound Repair Regen, vol. 20, no. 5, pp. 638–646, Oct. 2012, doi: 10.1111/j.1524-475X.2012.00814.x.
[4409]	J. Lian and D. Müssig, “Heart rhythm and cardiac pacing: an integrated dual-chamber heart and pacer model,” Ann Biomed Eng, vol. 37, no. 1, pp. 64–81, Jan. 2009, doi: 10.1007/s10439-008-9585-x.
[4410]	B. Muschalla, J. Glatz, and M. Linden, “Heart-related anxieties in relation to general anxiety and severity of illness in cardiology patients,” Psychol Health Med, vol. 19, no. 1, pp. 83–92, 2014, doi: 10.1080/13548506.2013.774428.
[4411]	M. Horowitz, Y. Shimoni, S. Parnes, M. S. Gotsman, and Y. Hasin, “Heat acclimation: cardiac performance of isolated rat heart,” J. Appl. Physiol., vol. 60, no. 1, pp. 9–13, Jan. 1986, doi: 10.1152/jappl.1986.60.1.9.
[4412]	S. A. M. Loos and S. H. L. Klapp, “Heat flow due to time-delayed feedback,” Sci Rep, vol. 9, no. 1, p. 2491, Feb. 2019, doi: 10.1038/s41598-019-39320-0.
[4413]	A. Pacak et al., “Heat Stress Affects Pi-related Genes Expression and Inorganic Phosphate Deposition/Accumulation in Barley,” Front Plant Sci, vol. 7, p. 926, 2016, doi: 10.3389/fpls.2016.00926.
[4414]	L. Zeitlin, F. Rauch, H. Plotkin, and F. H. Glorieux, “Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV,” Pediatrics, vol. 111, no. 5 Pt 1, pp. 1030–1036, May 2003, doi: 10.1542/peds.111.5.1030.
[4415]	C. Danne and F. Powrie, “Helicobacter hepaticus polysaccharide induces an anti-inflammatory response in intestinal macrophages,” Microb Cell, vol. 5, no. 4, pp. 208–211, Mar. 2018, doi: 10.15698/mic2018.04.626.
[4416]	D. Trajkov, K. Stardelova, M. Dimitrova, J. Mishevski, and V. Serafimoski, “Helicobacter pylori and gastric carcinoma,” Prilozi, vol. 28, no. 2, pp. 39–46, Dec. 2007.
[4417]	B. Deng, Y. Li, Y. Zhang, L. Bai, and P. Yang, “Helicobacter pylori infection and lung cancer: a review of an emerging hypothesis,” Carcinogenesis, vol. 34, no. 6, pp. 1189–1195, Jun. 2013, doi: 10.1093/carcin/bgt114.
[4418]	W. Y. Lee, W. T. Yoon, H. Y. Shin, S. H. Jeon, and P.-L. Rhee, “Helicobacter pylori infection and motor fluctuations in patients with Parkinson’s disease,” Mov. Disord., vol. 23, no. 12, pp. 1696–1700, Sep. 2008, doi: 10.1002/mds.22190.
[4419]	K.-C. Yee, “[Helicobacter pylori infection in children: a new focus],” Zhongguo Dang Dai Er Ke Za Zhi, vol. 16, no. 3, pp. 248–254, Mar. 2014.
[4420]	F. Gottrand and D. Turck, “[Helicobacter pylori infection in children],” Arch Pediatr, vol. 2, no. 6, pp. 573–579, Jun. 1995, doi: 10.1016/0929-693x(96)81204-8.
[4421]	J. Vafaeimanesh, M. Parham, and M. Bagherzadeh, “Helicobacter pylori infection prevalence: Is it different in diabetics and nondiabetics?,” Indian J Endocrinol Metab, vol. 19, no. 3, pp. 364–368, Jun. 2015, doi: 10.4103/2230-8210.152773.
[4422]	K. Rudnicka et al., “Helicobacter pylori-driven modulation of NK cell expansion, intracellular cytokine expression and cytotoxic activity,” Innate Immun, vol. 21, no. 2, pp. 127–139, Feb. 2015, doi: 10.1177/1753425913518225.
[4423]	C. Slinger, R. Slinger, A. Vyas, J. Haines, and S. J. Fowler, “Heliox for inducible laryngeal obstruction (vocal cord dysfunction): A systematic literature review,” Laryngoscope Investig Otolaryngol, vol. 4, no. 2, pp. 255–258, Apr. 2019, doi: 10.1002/lio2.229.
[4424]	K. O’Donnell, “Help for Heroes: PTSD, Warrior Recovery, and the Liturgy,” J Relig Health, vol. 54, no. 6, pp. 2389–2397, Dec. 2015, doi: 10.1007/s10943-015-0034-5.
[4425]	K. T. Rew, “Hematologic Conditions: Foreword,” FP Essent, vol. 485, p. 2, Oct. 2019.
[4426]	D. Okamura et al., “Hematologic improvements in a myelodysplastic syndromes with myelofibrosis (MDS-F) patient treated with azacitidine,” Leuk Res Rep, vol. 3, no. 1, pp. 24–27, 2014, doi: 10.1016/j.lrr.2014.03.002.
[4427]	R. P. Costa et al., “Hematologic toxicity of radium-223 in elderly patients with metastatic Castration Resistant Prostate Cancer: a real-life experience,” Prostate Int, vol. 7, no. 1, pp. 25–29, Mar. 2019, doi: 10.1016/j.prnil.2018.08.001.
[4428]	J. W. Vardiman, “Hematopathological concepts and controversies in the diagnosis and classification of myelodysplastic syndromes,” Hematology Am Soc Hematol Educ Program, pp. 199–204, 2006, doi: 10.1182/asheducation-2006.1.199.
[4429]	T. D. Zaikos et al., “Hematopoietic Stem and Progenitor Cells Are a Distinct HIV Reservoir that Contributes to Persistent Viremia in Suppressed Patients,” Cell Rep, vol. 25, no. 13, pp. 3759-3773.e9, 26 2018, doi: 10.1016/j.celrep.2018.11.104.
[4430]	A. Bazarbachi et al., “Hematopoietic stem cell transplantation in Lebanon: first comprehensive report,” Bone Marrow Transplant., vol. 42 Suppl 1, pp. S96–S102, Aug. 2008, doi: 10.1038/bmt.2008.128.
[4431]	M. Ty, “Hematuria,” Can Fam Physician, vol. 21, no. 12, pp. 44–46, Dec. 1975.
[4432]	B. Maeder, M. Hanauer, P. Poglia, F. Chevalley, and E. Thein, “Hemiarthroplasty of the Hip in a 52-Year-old Patient with Osteogenesis Imperfecta-Related Femoral Neck Fracture: A Case Report,” J Orthop Case Rep, vol. 8, no. 5, pp. 86–88, Oct. 2018, doi: 10.13107/jocr.2250-0685.1226.
[4433]	P. Striano, F. Caranci, S. Pappatà, F. Zara, and S. Striano, “Hemidystonia in uncontrolled type 2 diabetes mellitus,” Arch. Neurol., vol. 68, no. 5, p. 674, May 2011, doi: 10.1001/archneurol.2011.92.
[4434]	M. Dinomais et al., “Hemispheric Asymmetry of Supplementary Motor Area Proper: A Functional Connectivity Study of the Motor Network,” Motor Control, vol. 20, no. 1, pp. 33–49, Jan. 2016, doi: 10.1123/mc.2014-0076.
[4435]	K. Amano, T. Sakamoto, and T. Sugimoto, “[Hemodynamic state at rest and during maximal bicycle exercise in university students with small cardiac silhouettes on chest radiography],” J Cardiol, vol. 19, no. 1, pp. 219–230, Mar. 1989.
[4436]	A. Wenning and E. P. Meyer, “Hemodynamics in the leech: blood flow in two hearts switching between two constriction patterns,” J. Exp. Biol., vol. 210, no. Pt 15, pp. 2627–2636, Aug. 2007, doi: 10.1242/jeb.001644.
[4437]	S. Kallakuri, E. Ascher, A. Hingorani, T. Jacob, and S. Salles-Cunha, “Hemodynamics of infrapopliteal PTFE bypasses and adjunctive arteriovenous fistulas,” Cardiovasc Surg, vol. 11, no. 2, pp. 125–129, Apr. 2003, doi: 10.1016/s0967-2109(03)00008-5.
[4438]	C. Zara and P. F. Bolis, “[Hemolytic anemia due to autoantibodies during pregnancy (description of 2 cases)],” Ann Ostet Ginecol Med Perinat, vol. 93, no. 7, pp. 468–472, Jul. 1972.
[4439]	P. V. Bystrom, R. J. Beck, and J. A. Prahlow, “Hemolytic uremic syndrome caused by E. coli O157 infection,” Forensic Sci Med Pathol, vol. 13, no. 2, pp. 240–244, Jun. 2017, doi: 10.1007/s12024-017-9852-y.
[4440]	H. Kuwabara, K. Yamamoto, T. Terada, R. Kawata, T. Nagao, and Y. Hirose, “Hemorrhage of MRI and Immunohistochemical Panels Distinguish Secretory Carcinoma From Acinic Cell Carcinoma,” Laryngoscope Investig Otolaryngol, vol. 3, no. 4, pp. 268–274, Aug. 2018, doi: 10.1002/lio2.169.
[4441]	P. Yu and J. Gong, “Hemosuccus pancreaticus: A mini-review,” Ann Med Surg (Lond), vol. 28, pp. 45–48, Apr. 2018, doi: 10.1016/j.amsu.2018.03.002.
[4442]	C. Schluttenhofer and L. Yuan, “Hemp hemp hooray for cannabis research,” Science, vol. 363, no. 6428, pp. 701–702, Feb. 2019, doi: 10.1126/science.aaw3537.
[4443]	M. M. Kemp and R. J. Linhardt, “Heparin-based nanoparticles,” Wiley Interdiscip Rev Nanomed Nanobiotechnol, vol. 2, no. 1, pp. 77–87, Feb. 2010, doi: 10.1002/wnan.68.
[4444]	C. Lian et al., “Heparin-Binding Epidermal Growth Factor-Like Growth Factor as a Potent Target for Breast Cancer Therapy,” Cancer Biother. Radiopharm., vol. 31, no. 3, pp. 85–90, Apr. 2016, doi: 10.1089/cbr.2015.1956.
[4445]	J. H. Yoon et al., “Hepatic fibrosis: prospective comparison of MR elastography and US shear-wave elastography for evaluation,” Radiology, vol. 273, no. 3, pp. 772–782, Dec. 2014, doi: 10.1148/radiol.14132000.
[4446]	P. Deng, J. Barney, M. C. Petriello, A. J. Morris, B. Wahlang, and B. Hennig, “Hepatic metabolomics reveals that liver injury increases PCB 126-induced oxidative stress and metabolic dysfunction,” Chemosphere, vol. 217, pp. 140–149, Feb. 2019, doi: 10.1016/j.chemosphere.2018.10.196.
[4447]	H. C. Park et al., “[Hepatic portal venous gas associated with acute pancreatitis: reports of two cases and review of literature],” Korean J Gastroenterol, vol. 50, no. 2, pp. 131–135, Aug. 2007.
[4448]	J. E. Hardesty et al., “Hepatic signalling disruption by pollutant Polychlorinated biphenyls in steatohepatitis,” Cell. Signal., vol. 53, pp. 132–139, 2019, doi: 10.1016/j.cellsig.2018.10.004.
[4449]	I. Hwang et al., “Hepatic steatosis in living liver donor candidates: preoperative assessment by using breath-hold triple-echo MR imaging and 1H MR spectroscopy,” Radiology, vol. 271, no. 3, pp. 730–738, Jun. 2014, doi: 10.1148/radiol.14130863.
[4450]	J.-Y. Son et al., “Hepatic Steatosis: Assessment with Acoustic Structure Quantification of US Imaging,” Radiology, vol. 278, no. 1, pp. 257–264, Jan. 2016, doi: 10.1148/radiol.2015141779.
[4451]	“Hepatitis B vaccines: WHO position paper – July 2017,” Wkly. Epidemiol. Rec., vol. 92, no. 27, pp. 369–392, 07 2017.
[4452]	T. Inoue and Y. Tanaka, “Hepatitis B virus and its sexually transmitted infection - an update,” Microb Cell, vol. 3, no. 9, pp. 420–437, Sep. 2016, doi: 10.15698/mic2016.09.527.
[4453]	“Hepatitis E vaccine:  WHO position paper, May 2015,” Wkly. Epidemiol. Rec., vol. 90, no. 18, pp. 185–200, May 2015.
[4454]	Y. J. Lee et al., “Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging-a systematic review and meta-analysis,” Radiology, vol. 275, no. 1, pp. 97–109, Apr. 2015, doi: 10.1148/radiol.14140690.
[4455]	A. Takano, R. Takahashi, H. Suzuki, and T. Noguchi, “Herbicide effect on the hydrogen-bonding interaction of the primary quinone electron acceptor QA in photosystem II as studied by Fourier transform infrared spectroscopy,” Photosyn. Res., vol. 98, no. 1–3, pp. 159–167, Dec. 2008, doi: 10.1007/s11120-008-9302-5.
[4456]	M. C. Voelkle, N. C. Ebner, U. Lindenberger, and M. Riediger, “Here we go again: anticipatory and reactive mood responses to recurring unpleasant situations throughout adulthood,” Emotion, vol. 13, no. 3, pp. 424–433, Jun. 2013, doi: 10.1037/a0031351.
[4457]	M. P. Cuajungco et al., “Hereditary dysautonomias: current knowledge and collaborations for the future,” Clin. Auton. Res., vol. 13, no. 3, pp. 180–195, Jun. 2003, doi: 10.1007/s10286-003-0098-2.
[4458]	A. Semmler, R. W. Stein, L. Caplan, S. M. Danilov, T. Klockgether, and M. Linnebank, “Hereditary hyper-ACE-emia due to the Pro1199Leu mutation of somatic ACE as a potential pitfall in diagnosis: a first family outside Europe,” Clin. Chem. Lab. Med., vol. 44, no. 9, pp. 1088–1089, 2006, doi: 10.1515/CCLM.2006.200.
[4459]	I. Moutkine, E. Quentin, B. P. Guiard, L. Maroteaux, and S. Doly, “Heterodimers of serotonin receptor subtypes 2 are driven by 5-HT2C protomers,” J. Biol. Chem., vol. 292, no. 15, pp. 6352–6368, 14 2017, doi: 10.1074/jbc.M117.779041.
[4460]	G. R. Pape, M. Troye, and P. Perlmann, “Heterogeneity and mechanism of action of human natural killer lymphocytes: differential distribution of receptors for Helix pomatia haemagglutinin (HP receptors),” Scand. J. Immunol., vol. 10, no. 2, pp. 109–118, 1979, doi: 10.1111/j.1365-3083.1979.tb03265.x.
[4461]	C. A. Colton, “Heterogeneity of microglial activation in the innate immune response in the brain,” J Neuroimmune Pharmacol, vol. 4, no. 4, pp. 399–418, Dec. 2009, doi: 10.1007/s11481-009-9164-4.
[4462]	K. N. Devlin and T. Giovannetti, “Heterogeneity of Neuropsychological Impairment in HIV Infection: Contributions from Mild Cognitive Impairment,” Neuropsychol Rev, vol. 27, no. 2, pp. 101–123, Jun. 2017, doi: 10.1007/s11065-017-9348-2.
[4463]	L. C. Kolb, “Heterogeneity of PTSD,” Am J Psychiatry, vol. 146, no. 6, pp. 811–812, Jun. 1989, doi: 10.1176/ajp.146.6.aj1466811.
[4464]	H. P. Too, J. L. Cordova, and J. E. Maggio, “Heterogeneity of tachykinin-like immunoreactive peptides in rat spinal cord and dorsal root ganglia,” Peptides, vol. 10, no. 1, pp. 25–30, Feb. 1989, doi: 10.1016/0196-9781(89)90070-3.
[4465]	M. Imai and K. Yoshitomi, “Heterogeneity of the descending thin limb of Henle’s loop,” Kidney Int., vol. 38, no. 4, pp. 687–694, Oct. 1990, doi: 10.1038/ki.1990.260.
[4466]	K. S. Bücher, P. B. Konietzny, N. L. Snyder, and L. Hartmann, “Heteromultivalent Glycooligomers as Mimetics of Blood Group Antigens,” Chemistry, vol. 25, no. 13, pp. 3301–3309, Mar. 2019, doi: 10.1002/chem.201804505.
[4467]	H. Ogata, T. Oshio, H. Ishibashi, S. Takano, and M. Yagi, “Heterotopic pancreas in children: review of the literature and report of 12 cases,” Pediatr. Surg. Int., vol. 24, no. 3, pp. 271–275, Mar. 2008, doi: 10.1007/s00383-007-2098-0.
[4468]	A. S. Randi et al., “Hexachlorobenzene is a tumor co-carcinogen and induces alterations in insulin-growth factors signaling pathway in the rat mammary gland,” Toxicol. Sci., vol. 89, no. 1, pp. 83–92, Jan. 2006, doi: 10.1093/toxsci/kfj023.
[4469]	D. N. Hauser et al., “Hexokinases link DJ-1 to the PINK1/parkin pathway,” Mol Neurodegener, vol. 12, no. 1, p. 70, 29 2017, doi: 10.1186/s13024-017-0212-x.
[4470]	J. K. Han, Z. Feliciano, and M. Bersohn, “Hidden in plain sight,” Am. J. Med., vol. 121, no. 2, pp. 117–118, Feb. 2008, doi: 10.1016/j.amjmed.2007.08.030.
[4471]	G. Papantonopoulos, C. Delatola, K. Takahashi, M. L. Laine, and B. G. Loos, “Hidden noise in immunologic parameters might explain rapid progression in early-onset periodontitis,” PLoS ONE, vol. 14, no. 11, p. e0224615, 2019, doi: 10.1371/journal.pone.0224615.
[4472]	O. Muzik and V. A. Diwadkar, “Hierarchical control systems for the regulation of physiological homeostasis and affect: Can their interactions modulate mood and anhedonia?,” Neurosci Biobehav Rev, vol. 105, pp. 251–261, 2019, doi: 10.1016/j.neubiorev.2019.08.015.
[4473]	R. Kozma and M. Puljic, “Hierarchical random cellular neural networks for system-level brain-like signal processing,” Neural Netw, vol. 45, pp. 101–110, Sep. 2013, doi: 10.1016/j.neunet.2013.02.010.
[4474]	L. Li et al., “Hierarchical Ti3C2@TiO2 MXene hybrids with tunable interlayer distance for highly durable lithium-ion batteries,” Nanoscale, vol. 12, no. 18, pp. 10369–10379, May 2020, doi: 10.1039/d0nr01222j.
[4475]	W. Zhao, J. Wen, Y. Zhao, Z. Wang, Y. Shi, and Y. Zhao, “Hierarchically Porous Carbon Derived from Biomass Reed Flowers as Highly Stable Li-Ion Battery Anode,” Nanomaterials (Basel), vol. 10, no. 2, Feb. 2020, doi: 10.3390/nano10020346.
[4476]	A. W. Deal, O. Seshie, A. Lenzo, N. Cooper, N. Ozimek, and L. C. Solberg Woods, “High fat diet negatively impacts both metabolic and behavioral health in an outbred rat model,” Physiol. Genomics, Jul. 2020, doi: 10.1152/physiolgenomics.00018.2020.
[4477]	Y.-C. Chang, J.-D. Hsu, W.-L. Lin, Y.-J. Lee, and C.-J. Wang, “High incidence of acute promyelocytic leukemia specifically induced by N-nitroso-N-methylurea (NMU) in Sprague-Dawley rats,” Arch. Toxicol., vol. 86, no. 2, pp. 315–327, Feb. 2012, doi: 10.1007/s00204-011-0753-7.
[4478]	D. Dreyfuss, P. Soler, G. Basset, and G. Saumon, “High inflation pressure pulmonary edema. Respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure,” Am. Rev. Respir. Dis., vol. 137, no. 5, pp. 1159–1164, May 1988, doi: 10.1164/ajrccm/137.5.1159.
[4479]	M. R. Panda et al., “High Performance Lithium-Ion Batteries Using Layered 2H-MoTe2 as Anode,” Small, p. e2002669, Aug. 2020, doi: 10.1002/smll.202002669.
[4480]	X.-R. Zhu et al., “High risk of anxiety and depression in caregivers of adult patients with epilepsy and its negative impact on patients’ quality of life,” Epilepsy Behav, vol. 90, pp. 132–136, 2019, doi: 10.1016/j.yebeh.2018.11.015.
[4481]	Y. Guo, A. G. Barnett, and S. Tong, “High temperatures-related elderly mortality varied greatly from year to year: important information for heat-warning systems,” Sci Rep, vol. 2, p. 830, 2012, doi: 10.1038/srep00830.
[4482]	T. J. Martin, A. K. Goodhead, K. Acharya, I. M. Head, J. R. Snape, and R. J. Davenport, “High Throughput Biodegradation-Screening Test To Prioritize and Evaluate Chemical Biodegradability,” Environ. Sci. Technol., vol. 51, no. 12, pp. 7236–7244, Jun. 2017, doi: 10.1021/acs.est.7b00806.
[4483]	J. K. Hoang, A. Riofrio, M. R. Bashir, P. G. Kranz, and J. D. Eastwood, “High variability in radiologists’ reporting practices for incidental thyroid nodules detected on CT and MRI,” AJNR Am J Neuroradiol, vol. 35, no. 6, pp. 1190–1194, Jun. 2014, doi: 10.3174/ajnr.A3834.
[4484]	O. Chan et al., “High volume image guided injections in chronic Achilles tendinopathy,” Disabil Rehabil, vol. 30, no. 20–22, pp. 1697–1708, 2008, doi: 10.1080/09638280701788225.
[4485]	A. Takeiri et al., “High-content imaging analyses of γH2AX-foci and micronuclei in TK6 cells elucidated genotoxicity of chemicals and their clastogenic/aneugenic mode of action,” Genes Environ, vol. 41, p. 4, 2019, doi: 10.1186/s41021-019-0117-8.
[4486]	N. B. Swarnalatha, N. Roy, M. M. Gouda, R. Moger, and A. Abraham, “High-fat, simple-carbohydrate diet intake induces hypothalamic-pituitary-thyroid axis dysregulation in C57BL/6J male mice,” Appl Physiol Nutr Metab, vol. 43, no. 4, pp. 371–380, Apr. 2018, doi: 10.1139/apnm-2017-0410.
[4487]	H. Xu and J. D. Boeke, “High-frequency deletion between homologous sequences during retrotransposition of Ty elements in Saccharomyces cerevisiae,” Proc. Natl. Acad. Sci. U.S.A., vol. 84, no. 23, pp. 8553–8557, Dec. 1987, doi: 10.1073/pnas.84.23.8553.
[4488]	C. Alvarez, R. Ramirez-Campillo, C. Martinez-Salazar, A. Castillo, F. Gallardo, and E. G. Ciolac, “High-Intensity Interval Training as a Tool for Counteracting Dyslipidemia in Women,” Int J Sports Med, vol. 39, no. 5, pp. 397–406, May 2018, doi: 10.1055/s-0044-100387.
[4489]	C. Gmachl et al., “High-power, continuous-wave, current-tunable, single-mode quantum-cascade distributed-feedback lasers at lambda - 5.2 and lambda - 7.95 mum,” Opt Lett, vol. 25, no. 4, pp. 230–232, Feb. 2000, doi: 10.1364/ol.25.000230.
[4490]	J. Buchen, “High-pressure experiments cast light on deep-Earth mineralogy,” Nature, vol. 565, no. 7738, pp. 168–170, 2019, doi: 10.1038/d41586-018-07864-2.
[4491]	G. Shen and H. K. Mao, “High-pressure studies with x-rays using diamond anvil cells,” Rep Prog Phys, vol. 80, no. 1, p. 016101, 2017, doi: 10.1088/1361-6633/80/1/016101.
[4492]	L. Xu et al., “High-Q silk fibroin whispering gallery microresonator,” Opt Express, vol. 24, no. 18, pp. 20825–20830, Sep. 2016, doi: 10.1364/OE.24.020825.
[4493]	J. Männer, L. Thrane, K. Norozi, and T. M. Yelbuz, “High-resolution in vivo imaging of the cross-sectional deformations of contracting embryonic heart loops using optical coherence tomography,” Dev. Dyn., vol. 237, no. 4, pp. 953–961, Apr. 2008, doi: 10.1002/dvdy.21483.
[4494]	M. Orita et al., “High-resolution NMR study of a GdAGA tetranucleotide loop that is an improved substrate for ricin, a cytotoxic plant protein,” Nucleic Acids Res., vol. 24, no. 4, pp. 611–618, Feb. 1996, doi: 10.1093/nar/24.4.611.
[4495]	M. M. Lewis et al., “Higher iron in the red nucleus marks Parkinson’s dyskinesia,” Neurobiol. Aging, vol. 34, no. 5, pp. 1497–1503, May 2013, doi: 10.1016/j.neurobiolaging.2012.10.025.
[4496]	T. Sawas et al., “Higher Rate of Barrett’s Detection in the First Year After Successful Endoscopic Therapy: Meta-analysis,” Am. J. Gastroenterol., vol. 113, no. 7, pp. 959–971, 2018, doi: 10.1038/s41395-018-0090-z.
[4497]	A. Grzeszczuk and J. Stańczak, “Highly variable year-to-year prevalence of Anaplasma phagocytophilum in Ixodes ricinus ticks in northeastern Poland: a 4-year follow-up,” Ann. N. Y. Acad. Sci., vol. 1078, pp. 309–311, Oct. 2006, doi: 10.1196/annals.1374.057.
[4498]	W. Kishta, F. H. Abduljabbar, M. Gdalevitch, F. Rauch, R. Hamdy, and F. Fassier, “Hip Dysplasia in Children With Osteogenesis Imperfecta: Association With Collagen Type I C-Propeptide Mutations,” J Pediatr Orthop, vol. 37, no. 7, pp. 479–483, Nov. 2017, doi: 10.1097/BPO.0000000000000644.
[4499]	M. Ceresoli, F. Coccolini, and L. Ansaloni, “HIPEC and nephrotoxicity: A cisplatin induced effect?,” Eur J Surg Oncol, vol. 42, no. 6, pp. 909–910, Jun. 2016, doi: 10.1016/j.ejso.2015.08.174.
[4500]	J. J. Bruintjes, R. H. Henning, W. Douwenga, and E. A. van der Zee, “Hippocampal cystathionine beta synthase in young and aged mice,” Neurosci. Lett., vol. 563, pp. 135–139, Mar. 2014, doi: 10.1016/j.neulet.2014.01.049.
[4501]	M.-A. Micci et al., “Hippocampal stem cells promotes synaptic resistance to the dysfunctional impact of amyloid beta oligomers via secreted exosomes,” Mol Neurodegener, vol. 14, no. 1, p. 25, 14 2019, doi: 10.1186/s13024-019-0322-8.
[4502]	F. Lihoreau, J.-R. Boisserie, F. K. Manthi, and S. Ducrocq, “Hippos stem from the longest sequence of terrestrial cetartiodactyl evolution in Africa,” Nat Commun, vol. 6, p. 6264, Feb. 2015, doi: 10.1038/ncomms7264.
[4503]	S. Wu, X. Sun, Y. Yu, and Y. Shen, “Hirschsprung’s Disease-Related Giant Sigmoid Volvulus Complicated by Refractory Hypertension in an Elderly Man,” Am J Case Rep, vol. 19, pp. 467–471, Apr. 2018, doi: 10.12659/ajcr.908389.
[4504]	N. Kanda and S. Watanabe, “Histamine enhances the production of granulocyte-macrophage colony-stimulating factor via protein kinase Calpha and extracellular signal-regulated kinase in human keratinocytes,” J. Invest. Dermatol., vol. 122, no. 4, pp. 863–872, Apr. 2004, doi: 10.1111/j.0022-202X.2004.22432.x.
[4505]	N. Kanda and S. Watanabe, “Histamine enhances the production of nerve growth factor in human keratinocytes,” J. Invest. Dermatol., vol. 121, no. 3, pp. 570–577, Sep. 2003, doi: 10.1046/j.1523-1747.2003.12428.x.
[4506]	N. Kanda and S. Watanabe, “Histamine inhibits the production of interferon-induced protein of 10 kDa in human squamous cell carcinoma and melanoma,” J. Invest. Dermatol., vol. 119, no. 6, pp. 1411–1419, Dec. 2002, doi: 10.1046/j.1523-1747.2002.19627.x.
[4507]	M. U. Rahman, Q. Ma, B. Ahmad, M. Hanif, and Y. Zhang, “Histochemical and Microscopic Studies Predict that Grapevine Genotype ‘Ju mei gui’ is Highly Resistant against Botrytis cinerea,” Pathogens, vol. 9, no. 4, Mar. 2020, doi: 10.3390/pathogens9040253.
[4508]	S. Messer, E. Moseley, M. Marinescu, C. Freeman, M. Goddard, and S. Nair, “Histologic analysis of the right atrioventricular junction in the adult human heart,” J. Heart Valve Dis., vol. 21, no. 3, pp. 368–373, May 2012.
[4509]	R. L. Eigsti, S. L. Bayan, R. A. Robinson, and H. T. Hoffman, “Histologic effect of the potassium-titanyl phosphorous laser on laryngeal papilloma,” Laryngoscope Investig Otolaryngol, vol. 4, no. 3, pp. 323–327, Jun. 2019, doi: 10.1002/lio2.250.
[4510]	G. Karpathiou et al., “Histologic findings in hysterectomies after endometrial ablation,” Pathol. Res. Pract., vol. 216, no. 8, p. 152992, Aug. 2020, doi: 10.1016/j.prp.2020.152992.
[4511]	T. J. Murray, A. A. Ucci, M. V. Maffini, C. Sonnenschein, and A. M. Soto, “Histological analysis of low dose NMU effects in the rat mammary gland,” BMC Cancer, vol. 9, p. 267, Aug. 2009, doi: 10.1186/1471-2407-9-267.
[4512]	S. R. R. Nascimento, C. R. Ruiz, and S. U. de Oliva, “Histological and anatomical variations of septomarginal trabecula in bovine hearts,” Anat Histol Embryol, vol. 48, no. 3, pp. 228–233, May 2019, doi: 10.1111/ahe.12427.
[4513]	E. de Alava et al., “Histological outcome of chronic hepatitis C treated with a 12-month course of lymphoblastoid alfa interferon,” Liver, vol. 13, no. 2, pp. 73–79, Apr. 1993, doi: 10.1111/j.1600-0676.1993.tb00610.x.
[4514]	S. Qiu, D. P. Fyhrie, S. Palnitkar, and D. S. Rao, “Histomorphometric assessment of Haversian canal and osteocyte lacunae in different-sized osteons in human rib,” Anat Rec A Discov Mol Cell Evol Biol, vol. 272, no. 2, pp. 520–525, Jun. 2003, doi: 10.1002/ar.a.10058.
[4515]	B. Fahrenkrog, “Histone modifications as regulators of life and death in Saccharomyces cerevisiae,” Microb Cell, vol. 3, no. 1, pp. 1–13, Dec. 2015, doi: 10.15698/mic2016.01.472.
[4516]	V. Kasirajan, S. Sayeed, E. Filler, A. Knarik, J. N. Koneru, and K. A. Ellenbogen, “Histopathology of Bipolar Radiofrequency Ablation in the Human Atrium,” Ann. Thorac. Surg., vol. 101, no. 2, pp. 638–643, Feb. 2016, doi: 10.1016/j.athoracsur.2015.07.027.
[4517]	J.-F. Sauvé, “Historical and emerging workplaces affected by silica exposure since the 1930 Johannesburg conference on Silicosis, with special reference to construction,” Am. J. Ind. Med., vol. 58 Suppl 1, pp. S67-71, Nov. 2015, doi: 10.1002/ajim.22507.
[4518]	N. Fernandez et al., “Historical bibliometric analysis of the top cited articles on vesicoureteral reflux 1950-2016, and incorporation of a novel impact index,” J Pediatr Urol, vol. 14, no. 5, p. 446.e1-446.e9, 2018, doi: 10.1016/j.jpurol.2018.04.004.
[4519]	M. Hadi, “Historical development of the global political agenda around sexual and reproductive health and rights: A literature review,” Sex Reprod Healthc, vol. 12, pp. 64–69, Jun. 2017, doi: 10.1016/j.srhc.2017.03.005.
[4520]	P.-Y. Robillard, G. Dekker, G. Chaouat, M. Scioscia, S. Iacobelli, and T. C. Hulsey, “Historical evolution of ideas on eclampsia/preeclampsia: A proposed optimistic view of preeclampsia,” J. Reprod. Immunol., vol. 123, pp. 72–77, 2017, doi: 10.1016/j.jri.2017.09.006.
[4521]	M. A. Jordan and H. L. Snell, “Historical fragmentation of islands and genetic drift in populations of Galápagos lava lizards (Microlophus albemarlensis complex),” Mol. Ecol., vol. 17, no. 5, pp. 1224–1237, Mar. 2008, doi: 10.1111/j.1365-294X.2007.03658.x.
[4522]	Y. Kim, “[Historical perspective of PTSD and future revision in DSM-5],” Seishin Shinkeigaku Zasshi, vol. 114, no. 9, pp. 1031–1036, 2012.
[4523]	W. Allaerts and H. Vankelecom, “History and perspectives of pituitary folliculo-stellate cell research,” Eur. J. Endocrinol., vol. 153, no. 1, pp. 1–12, Jul. 2005, doi: 10.1530/eje.1.01949.
[4524]	L. J. Rew et al., “Hitching a ride: Seed accrual rates on different types of vehicles,” J. Environ. Manage., vol. 206, pp. 547–555, Jan. 2018, doi: 10.1016/j.jenvman.2017.10.060.
[4525]	J. G. Rabkin, “HIV and depression: 2008 review and update,” Curr HIV/AIDS Rep, vol. 5, no. 4, pp. 163–171, Nov. 2008, doi: 10.1007/s11904-008-0025-1.
[4526]	J. D. Kaner et al., “HIV portends a poor prognosis in myelodysplastic syndromes,” Leuk. Lymphoma, vol. 60, no. 14, pp. 3529–3535, 2019, doi: 10.1080/10428194.2019.1633631.
[4527]	L. Registre et al., “HIV-1 Coreceptor Usage and Variable Loop Contact Impact V3 Loop Broadly Neutralizing Antibody Susceptibility,” J. Virol., vol. 94, no. 2, 06 2020, doi: 10.1128/JVI.01604-19.
[4528]	L. M. Sherief et al., “Hodgkin lymphoma in childhood: clinicopathological features and therapy outcome at 2 centers from a developing country,” Medicine (Baltimore), vol. 94, no. 15, p. e670, Apr. 2015, doi: 10.1097/MD.0000000000000670.
[4529]	B. Paka, R. Bossemeyer, M. Tourojman, R. Gupta, and B. R. Lane, “Holding Strength of a Hem-o-lok/Lapra-Ty Clip Combination on Sutures Used During Partial Nephrectomy,” Urology, vol. 107, pp. 138–143, Sep. 2017, doi: 10.1016/j.urology.2017.06.024.
[4530]	H. Liu, Y. Chen, B. Jiang, Y. Zhao, X. Guo, and T. Ma, “Hollow-structure engineering of a silicon-carbon anode for ultra-stable lithium-ion batteries,” Dalton Trans, vol. 49, no. 17, pp. 5669–5676, May 2020, doi: 10.1039/d0dt00566e.
[4531]	X. Mateos et al., “Holmium thin-disk laser based on Ho:KY(WO4)2/KY(WO4)2 epitaxy with 60% slope efficiency and simplified pump geometry,” Opt Lett, vol. 42, no. 17, pp. 3490–3493, Sep. 2017, doi: 10.1364/OL.42.003490.
[4532]	K. Iwai et al., “Home blood pressure is associated with cognitive impairment among elderly patients with type 2 diabetes: KAMOGAWA-HBP study,” Diab Vasc Dis Res, vol. 16, no. 6, pp. 506–512, 2019, doi: 10.1177/1479164119847479.
[4533]	V. F.-S. Shih et al., “Homeostatic IL-23 receptor signaling limits Th17 response through IL-22-mediated containment of commensal microbiota,” Proc. Natl. Acad. Sci. U.S.A., vol. 111, no. 38, pp. 13942–13947, Sep. 2014, doi: 10.1073/pnas.1323852111.
[4534]	C. Chany and M. Thomas, “Homeothermic cell culture in vitro,” Am. J. Dis. Child., vol. 103, pp. 319–324, Mar. 1962, doi: 10.1001/archpedi.1962.02080020331027.
[4535]	L. J. McHenry and I. de la Torre, “Hominin raw material procurement in the Oldowan-Acheulean transition at Olduvai Gorge,” J. Hum. Evol., vol. 120, pp. 378–401, 2018, doi: 10.1016/j.jhevol.2017.11.010.
[4536]	E. J. Feldman, K. P. Seiter, T. Ahmed, P. Baskind, and Z. A. Arlin, “Homoharringtonine in patients with myelodysplastic syndrome (MDS) and MDS evolving to acute myeloid leukemia,” Leukemia, vol. 10, no. 1, pp. 40–42, Jan. 1996.
[4537]	B. A. Thomas, W. B. Church, T. R. Lane, and B. D. Hammock, “Homology model of juvenile hormone esterase from the crop pest, Heliothis virescens,” Proteins, vol. 34, no. 2, pp. 184–196, Feb. 1999.
[4538]	M. S. Kennedy, J. Barnsteiner, and J. Daly, “Honorary and ghost authorship in nursing publications,” J Nurs Scholarsh, vol. 46, no. 6, pp. 416–422, Nov. 2014, doi: 10.1111/jnu.12093.
[4539]	A. Papa, “Hope for the future,” J Emerg Nurs, vol. 37, no. 6, p. 523, Nov. 2011, doi: 10.1016/j.jen.2011.09.019.
[4540]	S. Y. Li, “Hopf bifurcation, stability switches and chaos in a prey-predator system with three stage structure and two time delays,” Math Biosci Eng, vol. 16, no. 6, pp. 6934–6961, 30 2019, doi: 10.3934/mbe.2019348.
[4541]	E. J. Calabrese, “Hormesis: a fundamental concept in biology,” Microb Cell, vol. 1, no. 5, pp. 145–149, Apr. 2014, doi: 10.15698/mic2014.05.145.
[4542]	J. Dotlic et al., “Hormonal therapy in menopausal transition: implications for improvement of health-related quality of life,” Gynecol. Endocrinol., vol. 36, no. 4, pp. 327–332, Apr. 2020, doi: 10.1080/09513590.2019.1676409.
[4543]	C. Tennant and P. A. Roberts, “Hoshin Kanri: a technique for strategic quality management,” Qual Assur, vol. 8, no. 2, pp. 77–90, Jun. 2000, doi: 10.1080/105294100317173862.
[4544]	“Hospital consolidation: investigating causes and consequences,” Find Brief, vol. 9, no. 2, pp. 1–4, May 2006.
[4545]	S. R. Eastaugh, “Hospital diversification,” J Health Care Finance, vol. 31, no. 4, pp. 1–13, 2005.
[4546]	C. Neely, “Hospital economic forecast,” Hospitals, vol. 58, no. 7, pp. 83–84, 87, 89, Apr. 1984.
[4547]	D. H. Talbot, “Hospitals,” Bull N Y Acad Med, vol. 61, no. 1, pp. 23–30, Feb. 1985.
[4548]	P. C. Olden and K. E. Hoffman, “Hospitals’ health promotion services in their communities: findings from a literature review,” Health Care Manage Rev, vol. 36, no. 2, pp. 104–113, Jun. 2011, doi: 10.1097/HMR.0b013e3181fb0f2b.
[4549]	D. Channon, E. Channon, T. Roberts, and R. Haines, “Hotspots: are some areas of sewer network prone to re-infestation by rats ( Rattus norvegicus ) year after year?,” Epidemiol. Infect., vol. 134, no. 1, pp. 41–48, Feb. 2006, doi: 10.1017/S0950268805004607.
[4550]	A. M. Proverbio, S. Mariani, A. Zani, and R. Adorni, “How are ‘Barack Obama’ and ‘President Elect’ differentially stored in the brain? An ERP investigation on the processing of proper and common noun pairs,” PLoS ONE, vol. 4, no. 9, p. e7126, Sep. 2009, doi: 10.1371/journal.pone.0007126.
[4551]	L. Tappy and D. D’Alessio, “How are we going to understand (dys)regulation of glucose metabolism?,” Curr Opin Clin Nutr Metab Care, vol. 7, no. 4, pp. 467–469, Jul. 2004, doi: 10.1097/01.mco.0000134367.84276.c2.
[4552]	R. Overberg, W. Otten, A. de Man, P. Toussaint, J. Westenbrink, and B. Zwetsloot-Schonk, “How breast cancer patients want to search for and retrieve information from stories of other patients on the internet: an online randomized controlled experiment,” J. Med. Internet Res., vol. 12, no. 1, p. e7, Mar. 2010, doi: 10.2196/jmir.1215.
[4553]	J. Zara, “How can states provide affordable pharmaceuticals to the underserved?,” J Health Care Poor Underserved, vol. 17, no. 4, pp. 808–820, Nov. 2006, doi: 10.1353/hpu.2006.0138.
[4554]	D. P. Sklar, “How Can We Create a More Family-Friendly, Healthful Environment for Our Future Health Professionals?,” Acad Med, vol. 93, no. 11, pp. 1595–1598, 2018, doi: 10.1097/ACM.0000000000002397.
[4555]	S. Y. Ho and R. H. Anderson, “How constant anatomically is the tendon of Todaro as a marker for the triangle of Koch?,” J. Cardiovasc. Electrophysiol., vol. 11, no. 1, pp. 83–89, Jan. 2000, doi: 10.1111/j.1540-8167.2000.tb00741.x.
[4556]	L. Schmidt, V. Skvortsova, C. Kullen, B. Weber, and H. Plassmann, “How context alters value: The brain’s valuation and affective regulation system link price cues to experienced taste pleasantness,” Sci Rep, vol. 7, no. 1, p. 8098, 14 2017, doi: 10.1038/s41598-017-08080-0.
[4557]	J. I. Arrarás and E. Manrique, “[How depression and its treatment are perceived],” An Sist Sanit Navar, vol. 42, no. 1, pp. 5–8, 25 2019, doi: 10.23938/ASSN.0591.
[4558]	C. Yu, J. Park, and Y. S. Hwang, “How Do Anticipated and Self Regulations and Information Sourcing Openness Drive Firms to Implement Eco-Innovation? Evidence from Korean Manufacturing Firms,” Int J Environ Res Public Health, vol. 16, no. 15, 26 2019, doi: 10.3390/ijerph16152678.
[4559]	Y. Sakurai, “How do cell assemblies encode information in the brain?,” Neurosci Biobehav Rev, vol. 23, no. 6, pp. 785–796, 1999, doi: 10.1016/s0149-7634(99)00017-2.
[4560]	M. Wittner, A. Di Stefano, P. Wangemann, and R. Greger, “How do loop diuretics act?,” Drugs, vol. 41 Suppl 3, pp. 1–13, 1991, doi: 10.2165/00003495-199100413-00003.
[4561]	B. Etingen et al., “How Do Patients with Mental Health Diagnoses Use Online Patient Portals? An Observational Analysis from the Veterans Health Administration,” Adm Policy Ment Health, May 2019, doi: 10.1007/s10488-019-00938-x.
[4562]	J. I. Glendinning, “How do predators cope with chemically defended foods?,” Biol. Bull., vol. 213, no. 3, pp. 252–266, Dec. 2007, doi: 10.2307/25066643.
[4563]	D. A. Knorre, S. S. Sokolov, A. N. Zyrina, and F. F. Severin, “How do yeast sense mitochondrial dysfunction?,” Microb Cell, vol. 3, no. 11, pp. 532–539, Sep. 2016, doi: 10.15698/mic2016.11.537.
[4564]	L. Wyder, C. Fawcett, U. Hepp, M. Grosse Holtforth, and N. Stulz, “[How does Home Treatment Work out in Practice? A Qualitative Study Among Patients, Relatives, and Staff],” Psychiatr Prax, vol. 45, no. 8, pp. 405–411, 2018, doi: 10.1055/a-0665-6094.
[4565]	H.-P. Sun, W.-F. Sun, Y. Geng, X. Yang, and B. K. Edziah, “How does natural resource dependence affect public education spending?,” Environ Sci Pollut Res Int, vol. 26, no. 4, pp. 3666–3674, Feb. 2019, doi: 10.1007/s11356-018-3853-6.
[4566]	A. Kleidon, “How does the Earth system generate and maintain thermodynamic disequilibrium and what does it imply for the future of the planet?,” Philos Trans A Math Phys Eng Sci, vol. 370, no. 1962, pp. 1012–1040, Mar. 2012, doi: 10.1098/rsta.2011.0316.
[4567]	H. Ishikita, K. Hasegawa, and T. Noguchi, “How does the QB site influence propagate to the QA site in photosystem II?,” Biochemistry, vol. 50, no. 24, pp. 5436–5442, Jun. 2011, doi: 10.1021/bi102023x.
[4568]	C.-C. Tsai, Z. Yue, and J. Shen, “How Electrostatic Coupling Enables Conformational Plasticity in a Tyrosine Kinase,” J. Am. Chem. Soc., vol. 141, no. 38, pp. 15092–15101, 25 2019, doi: 10.1021/jacs.9b06064.
[4569]	I. K. Hariharan, “How growth abnormalities delay ‘puberty’ in Drosophila,” Sci Signal, vol. 5, no. 229, p. pe27, Jun. 2012, doi: 10.1126/scisignal.2003238.
[4570]	N. Roberts, “How humans changed the face of Earth,” Science, vol. 365, no. 6456, pp. 865–866, 30 2019, doi: 10.1126/science.aay4627.
[4571]	“How Liberia reached zero cases of Ebola virus disease,” Wkly. Epidemiol. Rec., vol. 90, no. 21, pp. 259–260, May 2015.
[4572]	M. Gross, “How life shaped Earth,” Curr. Biol., vol. 25, no. 19, pp. R847-850, Oct. 2015, doi: 10.1016/j.cub.2015.09.011.
[4573]	C. J. Brown, E. A. Fulton, H. P. Possingham, and A. J. Richardson, “How long can fisheries management delay action in response to ecosystem and climate change?,” Ecol Appl, vol. 22, no. 1, pp. 298–310, Jan. 2012, doi: 10.1890/11-0419.1.
[4574]	Y. Choi, S. Agarwal, and C. M. Deane, “How long is a piece of loop?,” PeerJ, vol. 1, p. e1, 2013, doi: 10.7717/peerj.1.
[4575]	A. K. Khoo, E. Askouni, S. Basson, J. Ng, and S. Cleeve, “How long will I have my ACE? The natural history of the antegrade continence enema stoma in idiopathic constipation,” Pediatr. Surg. Int., vol. 33, no. 11, pp. 1159–1166, Nov. 2017, doi: 10.1007/s00383-017-4128-x.
[4576]	W. Caan and M. Cole, “How much doctoral research on clinical topics is published?,” Evid Based Med, vol. 17, no. 3, pp. 71–74, Jun. 2012, doi: 10.1136/ebmed-2011-100227.
[4577]	A. Gupta, L. G. Smithers, A. Braunack-Mayer, and J. Harford, “How much free sugar do Australians consume? Findings from a national survey,” Aust N Z J Public Health, vol. 42, no. 6, pp. 533–540, Dec. 2018, doi: 10.1111/1753-6405.12836.
[4578]	H. Xiang, Y. H. Wang, Q. Q. Huang, and Q. Y. Yang, “How Much Is the Eco-Efficiency of Agricultural Production in West China? Evidence from the Village Level Data,” Int J Environ Res Public Health, vol. 17, no. 11, 05 2020, doi: 10.3390/ijerph17114049.
[4579]	P. Hodiamont, “How normal are anxiety and fear?,” Int J Soc Psychiatry, vol. 37, no. 1, pp. 43–50, 1991, doi: 10.1177/002076409103700106.
[4580]	E. Calkoen et al., “How Normal is a ‘Normal’ Heart in Fetuses and Infants with Down Syndrome?,” Fetal. Diagn. Ther., vol. 39, no. 1, pp. 13–20, 2016, doi: 10.1159/000381710.
[4581]	Y. Sekiguchi et al., “How often and when Fisher syndrome is overlapped by Guillain-Barré syndrome or Bickerstaff brainstem encephalitis?,” Eur. J. Neurol., vol. 23, no. 6, pp. 1058–1063, 2016, doi: 10.1111/ene.12983.
[4582]	J. L. Thompson et al., “How parents perceive screen viewing in their 5-6 year old child within the context of their own screen viewing time: a mixed-methods study,” BMC Public Health, vol. 17, no. 1, p. 471, 01 2017, doi: 10.1186/s12889-017-4394-5.
[4583]	F. J. M. Ruby, J. Smallwood, H. Engen, and T. Singer, “How self-generated thought shapes mood--the relation between mind-wandering and mood depends on the socio-temporal content of thoughts,” PLoS ONE, vol. 8, no. 10, p. e77554, 2013, doi: 10.1371/journal.pone.0077554.
[4584]	M. S. Bauer, “How solid is the evidence for the efficacy of mood stabilizers in bipolar disorder?,” Essent Psychopharmacol, vol. 6, no. 6, pp. 301–318, 2005.
[4585]	R. G. Bettinardi et al., “How structure sculpts function: Unveiling the contribution of anatomical connectivity to the brain’s spontaneous correlation structure,” Chaos, vol. 27, no. 4, p. 047409, Apr. 2017, doi: 10.1063/1.4980099.
[4586]	A. Abbott, “How the brain’s face code might unlock the mysteries of perception,” Nature, vol. 564, no. 7735, pp. 176–179, 2018, doi: 10.1038/d41586-018-07668-4.
[4587]	U. Passow, J. Sweet, and A. Quigg, “How the dispersant Corexit impacts the formation of sinking marine oil snow,” Mar. Pollut. Bull., vol. 125, no. 1–2, pp. 139–145, Dec. 2017, doi: 10.1016/j.marpolbul.2017.08.015.
[4588]	D. Nagorsen and F. M. Marincola, “How to analyze ex vivo T-cell responses in cancer patients,” In Vivo, vol. 16, no. 6, pp. 519–525, Dec. 2002.
[4589]	M. Lange et al., “How to assess and manage cognitive impairment induced by treatments of non-central nervous system cancer,” Neurosci Biobehav Rev, vol. 107, pp. 602–614, 2019, doi: 10.1016/j.neubiorev.2019.09.028.
[4590]	S. Schütt, B. Gräbner, H. Saathoff, J. Martin, and D. A. Vagts, “[How to calculate the budget of an anaesthetic or intensive care department from revenues of g-DRGs],” Anasthesiol Intensivmed Notfallmed Schmerzther, vol. 42, no. 11, pp. 834–839, Nov. 2007, doi: 10.1055/s-2007-1003597.
[4591]	J. Ater, “How to ease a patient’s anxiety,” Nursing, vol. 33, no. 6, p. 86, Jun. 2003, doi: 10.1097/00152193-200306000-00066.
[4592]	L. Hernandez-Ronquillo, F. Moien-Afshari, K. Knox, J. Britz, and J. F. Tellez-Zenteno, “How to measure fatigue in epilepsy? The validation of three scales for clinical use,” Epilepsy Res., vol. 95, no. 1–2, pp. 119–129, Jun. 2011, doi: 10.1016/j.eplepsyres.2011.03.010.
[4593]	R. Hammersley, M. Reid, and S. L. Atkin, “How to measure mood in nutrition research,” Nutr Res Rev, vol. 27, no. 2, pp. 284–294, Dec. 2014, doi: 10.1017/S0954422414000201.
[4594]	J. K. Hoang, W. Sung, M. Bahl, and C. D. Phillips, “How to perform parathyroid 4D CT: tips and traps for technique and interpretation,” Radiology, vol. 270, no. 1, pp. 15–24, Jan. 2014, doi: 10.1148/radiol.13122661.
[4595]	R. Wang, Y. Jiang, E. Michael, and G. Zhao, “How to select a proper early warning threshold to detect infectious disease outbreaks based on the China infectious disease automated alert and response system (CIDARS),” BMC Public Health, vol. 17, no. 1, p. 570, 12 2017, doi: 10.1186/s12889-017-4488-0.
[4596]	R. Cofiño, S. Lopez-Villar, and O. Suárez, “How to work with local communities to improve population health: big data and small data,” J Epidemiol Community Health, vol. 71, no. 7, pp. 657–659, 2017, doi: 10.1136/jech-2016-207449.
[4597]	P. Fenaux, U. Platzbecker, and L. Ades, “How we manage adults with myelodysplastic syndrome,” Br. J. Haematol., vol. 189, no. 6, pp. 1016–1027, Jun. 2020, doi: 10.1111/bjh.16206.
[4598]	T. T. Lineweaver and J. W. Brolsma, “How you ask matters: an experimental investigation of the influence of mood on memory self-perceptions and their relationship with objective memory,” Memory, vol. 22, no. 8, pp. 1103–1115, 2014, doi: 10.1080/09658211.2013.870209.
[4599]	V. Gurganious, “How your medical practice can weather an economic recession,” Tenn Med, vol. 102, no. 1, p. 35, Jan. 2009.
[4600]	A. Nabulsi, K. Christiansen, E. Zervakis, and A. Rodewald, “HP and GC subtype distribution in the !Kung San and Kavango in Namibia,” Anthropol Anz, vol. 53, no. 2, pp. 133–135, Jun. 1995.
[4601]	R. I. Boysen and M. T. Hearn, “HPLC of peptides and proteins: preparation and system set-up,” Curr Protoc Mol Biol, vol. Chapter 10, p. Unit 10.12, May 2001, doi: 10.1002/0471142727.mb1012s54.
[4602]	R. I. Boysen and M. T. Hearn, “HPLC of peptides and proteins: standard operating conditions,” Curr Protoc Mol Biol, vol. Chapter 10, p. Unit 10.13, May 2001, doi: 10.1002/0471142727.mb1013s54.
[4603]	N. D. Christensen, “HPV disease transmission protection and control,” Microb Cell, vol. 3, no. 9, pp. 476–490, Sep. 2016, doi: 10.15698/mic2016.09.530.
[4604]	N. Varma et al., “HRS/EHRA/APHRS/LAHRS/ACC/AHA Worldwide Practice Update for Telehealth and Arrhythmia Monitoring During and After a Pandemic,” Circ Arrhythm Electrophysiol, vol. 13, no. 7, p. e009007, 2020, doi: 10.1161/CIRCEP.120.009007.
[4605]	S. Zara, G. Antonio Farris, M. Budroni, and A. T. Bakalinsky, “HSP12 is essential for biofilm formation by a Sardinian wine strain of S. cerevisiae,” Yeast, vol. 19, no. 3, pp. 269–276, Feb. 2002, doi: 10.1002/yea.831.
[4606]	M. Morino et al., “HSP47 as a possible marker for malignancy of tumors in vivo,” In Vivo, vol. 8, no. 3, pp. 285–288, Jun. 1994.
[4607]	M. Tuppurainen, “HT and SERMs in the long-term management of osteoporosis,” Minerva Ginecol, vol. 64, no. 3, pp. 195–205, Jun. 2012.
[4608]	C. G. Haj et al., “HU-444, a Novel, Potent Anti-Inflammatory, Nonpsychotropic Cannabinoid,” J. Pharmacol. Exp. Ther., vol. 355, no. 1, pp. 66–75, Oct. 2015, doi: 10.1124/jpet.115.226100.
[4609]	“Huangxian Ju,” Angew. Chem. Int. Ed. Engl., Mar. 2020, doi: 10.1002/anie.202002723.
[4610]	Z. Chen, P. A. Deddish, R. D. Minshall, R. P. Becker, E. G. Erdös, and F. Tan, “Human ACE and bradykinin B2 receptors form a complex at the plasma membrane,” FASEB J., vol. 20, no. 13, pp. 2261–2270, Nov. 2006, doi: 10.1096/fj.06-6113com.
[4611]	T. H. Allen, H. J. Krzywicki, W. S. Worth, and R. M. Nims, “Human body volumeter based on water displacement,” Tech Rep Brookhaven Natl Lab, vol. 250, pp. 1–31, Sep. 1960.
[4612]	U. Hasson and R. Malach, “Human brain activation during viewing of dynamic natural scenes,” Novartis Found. Symp., vol. 270, pp. 203–212; discussion 212-216, 232–237, 2006.
[4613]	“Human cases of influenza at the human-animal interface, January 2015–April 2017,” Wkly. Epidemiol. Rec., vol. 92, no. 33, pp. 460–475, 18 2017.
[4614]	“Human cases of influenza at the human–animal  interface, 2013,” Wkly. Epidemiol. Rec., vol. 89, no. 28, pp. 309–320, Jul. 2014.
[4615]	K. S. M. Yong et al., “Human CD34(lo)CD133(lo) fetal liver cells support the expansion of human CD34(hi)CD133(hi) hematopoietic stem cells,” Cell. Mol. Immunol., vol. 13, no. 5, pp. 605–614, 2016, doi: 10.1038/cmi.2015.40.
[4616]	G. J. Basura, X.-S. Hu, J. S. Juan, A.-M. Tessier, and I. Kovelman, “Human central auditory plasticity: A review of functional near-infrared spectroscopy (fNIRS) to measure cochlear implant performance and tinnitus perception,” Laryngoscope Investig Otolaryngol, vol. 3, no. 6, pp. 463–472, Dec. 2018, doi: 10.1002/lio2.185.
[4617]	J. R. Schramski, D. K. Gattie, and J. H. Brown, “Human domination of the biosphere: Rapid discharge of the earth-space battery foretells the future of humankind,” Proc. Natl. Acad. Sci. U.S.A., vol. 112, no. 31, pp. 9511–9517, Aug. 2015, doi: 10.1073/pnas.1508353112.
[4618]	O. Taboureau and K. Audouze, “Human Environmental Disease Network: A computational model to assess toxicology of contaminants,” ALTEX, vol. 34, no. 2, pp. 289–300, 2017, doi: 10.14573/altex.1607201.
[4619]	R. Eichner, P. Rew, A. Engel, and U. Aebi, “Human epidermal keratin filaments: studies on their structure and assembly,” Ann. N. Y. Acad. Sci., vol. 455, pp. 381–402, 1985, doi: 10.1111/j.1749-6632.1985.tb50424.x.
[4620]	S. Mathews et al., “Human Interleukin-34 facilitates microglia-like cell differentiation and persistent HIV-1 infection in humanized mice,” Mol Neurodegener, vol. 14, no. 1, p. 12, 05 2019, doi: 10.1186/s13024-019-0311-y.
[4621]	A. Sorokowska et al., “Human Leukocyte Antigen similarity decreases partners’ and strangers’ body odor attractiveness for women not using hormonal contraception,” Horm Behav, vol. 106, pp. 144–149, 2018, doi: 10.1016/j.yhbeh.2018.10.007.
[4622]	K. A. Dugi, H. L. Dichek, G. D. Talley, H. B. Brewer, and S. Santamarina-Fojo, “Human lipoprotein lipase: the loop covering the catalytic site is essential for interaction with lipid substrates,” J. Biol. Chem., vol. 267, no. 35, pp. 25086–25091, Dec. 1992.
[4623]	D. Suplatov, K. Kopylov, Y. Sharapova, and V. Švedas, “Human p38α mitogen-activated protein kinase in the Asp168-Phe169-Gly170-in (DFG-in) state can bind allosteric inhibitor Doramapimod,” J. Biomol. Struct. Dyn., vol. 37, no. 8, pp. 2049–2060, May 2019, doi: 10.1080/07391102.2018.1475260.
[4624]	“Human papillomavirus  vaccines: WHO position  paper, October 2014,” Wkly. Epidemiol. Rec., vol. 89, no. 43, pp. 465–491, Oct. 2014.
[4625]	J. L. Jacobs-Wingo, C. C. Jim, and A. V. Groom, “Human Papillomavirus Vaccine Uptake: Increase for American Indian Adolescents, 2013-2015,” Am J Prev Med, vol. 53, no. 2, pp. 162–168, Aug. 2017, doi: 10.1016/j.amepre.2017.01.024.
[4626]	“Human papillomavirus vaccines: WHO position paper, May 2017,” Wkly. Epidemiol. Rec., vol. 92, no. 19, pp. 241–268, 12 2017.
[4627]	M. Tallavaara, M. Luoto, N. Korhonen, H. Järvinen, and H. Seppä, “Human population dynamics in Europe over the Last Glacial Maximum,” Proc. Natl. Acad. Sci. U.S.A., vol. 112, no. 27, pp. 8232–8237, Jul. 2015, doi: 10.1073/pnas.1503784112.
[4628]	“Human rabies transmitted by dogs: current status of global data, 2015,” Wkly. Epidemiol. Rec., vol. 91, no. 2, pp. 13–20, Jan. 2016.
[4629]	“Human rabies: 2016 updates and call for data,” Wkly. Epidemiol. Rec., vol. 92, no. 7, pp. 77–86, 17 2017.
[4630]	R. Basson, “Human sexual response,” Handb Clin Neurol, vol. 130, pp. 11–18, 2015, doi: 10.1016/B978-0-444-63247-0.00002-X.
[4631]	N. Kanda, M. Kamata, Y. Tada, T. Ishikawa, S. Sato, and S. Watanabe, “Human β-defensin-2 enhances IFN-γ and IL-10 production and suppresses IL-17 production in T cells,” J. Leukoc. Biol., vol. 89, no. 6, pp. 935–944, Jun. 2011, doi: 10.1189/jlb.0111004.
[4632]	C. J. Borgert, J. C. Matthews, and S. P. Baker, “Human-relevant potency threshold (HRPT) for ERα agonism,” Arch. Toxicol., vol. 92, no. 5, pp. 1685–1702, 2018, doi: 10.1007/s00204-018-2186-z.
[4633]	K. Servick, “Humans may sense Earth’s magnetic field,” Science, vol. 363, no. 6433, pp. 1257–1258, 22 2019, doi: 10.1126/science.363.6433.1257.
[4634]	T. Hanstein, O. Kumpe, W. Mittelmeier, and R. Skripitz, “[Hybrid and uncemented hip arthroplasty: Contribution margin in the German lump sum reimbursement system],” Orthopade, vol. 44, no. 8, pp. 617–622, Aug. 2015, doi: 10.1007/s00132-015-3139-3.
[4635]	S. E. Adams, N. R. Burns, G. T. Layton, and A. J. Kingsman, “Hybrid Ty virus-like particles,” Int. Rev. Immunol., vol. 11, no. 2, pp. 133–141, 1994, doi: 10.3109/08830189409061721.
[4636]	T. Noguchi, Y. Inoue, and X. S. Tang, “Hydrogen bonding interaction between the primary quinone acceptor QA and a histidine side chain in photosystem II as revealed by Fourier transform infrared spectroscopy,” Biochemistry, vol. 38, no. 1, pp. 399–403, Jan. 1999, doi: 10.1021/bi982294v.
[4637]	S. B. Berger, C. P. M. Tabchoury, G. M. B. Ambrosano, and M. Giannini, “Hydrogen peroxide penetration into the pulp chamber and dental permeability after bleaching,” Gen Dent, vol. 61, no. 3, pp. e21-25, Jun. 2013.
[4638]	R. Wordsworth and R. Pierrehumbert, “Hydrogen-nitrogen greenhouse warming in Earth’s early atmosphere,” Science, vol. 339, no. 6115, pp. 64–67, Jan. 2013, doi: 10.1126/science.1225759.
[4639]	D. Yamazaki and M. A. Trigg, “Hydrology: The dynamics of Earth’s surface water,” Nature, vol. 540, no. 7633, pp. 348–349, 15 2016, doi: 10.1038/nature21100.
[4640]	F. Reisen, S. M. Aschmann, R. Atkinson, and J. Arey, “Hydroxyaldehyde products from hydroxyl radical reactions of Z-3-hexen-1-ol and 2-methyl-3-buten-2-ol quantified by SPME and API-MS,” Environ. Sci. Technol., vol. 37, no. 20, pp. 4664–4671, Oct. 2003, doi: 10.1021/es034142f.
[4641]	A. Kaneko, E. Marukawa, and H. Harada, “Hydroxyapatite Nanoparticles as Injectable Bone Substitute Material in a Vertical Bone Augmentation Model,” In Vivo, vol. 34, no. 3, pp. 1053–1061, Jun. 2020, doi: 10.21873/invivo.11875.
[4642]	K. F. Garrity, K. M. Rabe, and D. Vanderbilt, “Hyperferroelectrics: proper ferroelectrics with persistent polarization,” Phys. Rev. Lett., vol. 112, no. 12, p. 127601, Mar. 2014, doi: 10.1103/PhysRevLett.112.127601.
[4643]	J. Waltimo, “Hyperfibers and vesicles in dentin matrix in dentinogenesis imperfecta (DI) associated with osteogenesis imperfecta (OI),” J. Oral Pathol. Med., vol. 23, no. 9, pp. 389–393, Oct. 1994, doi: 10.1111/j.1600-0714.1994.tb00082.x.
[4644]	M. Saltiel, “Hyperinflation-Introduction,” J Pharm Pract, vol. 31, no. 4, p. 369, Aug. 2018, doi: 10.1177/0897190018776391.
[4645]	D. Ofluoglu, O. H. Gunduz, E. Kul-Panza, and Z. Guven, “Hypermobility in women with fibromyalgia syndrome,” Clin. Rheumatol., vol. 25, no. 3, pp. 291–293, May 2006, doi: 10.1007/s10067-005-0040-1.
[4646]	C. A. Rubio and G. Hubbard, “Hyperplastic foveolar gastropathy and hyperplastic foveolar gastritis in baboons,” In Vivo, vol. 10, no. 5, pp. 507–510, Oct. 1996.
[4647]	L. C. Mohr, “Hypersensitivity pneumonitis,” Curr Opin Pulm Med, vol. 10, no. 5, pp. 401–411, Sep. 2004, doi: 10.1097/01.mcp.0000135675.95674.29.
[4648]	J. D. Bundy and J. He, “Hypertension and Related Cardiovascular Disease Burden in China,” Ann Glob Health, vol. 82, no. 2, pp. 227–233, Apr. 2016, doi: 10.1016/j.aogh.2016.02.002.
[4649]	K. T. Rew, “Hypertension Update: Foreword,” FP Essent, vol. 469, p. 2, Jun. 2018.
[4650]	H. J. Won and K. R. Sung, “Hypertensive Phase Following Silicone Plate Ahmed Glaucoma Valve Implantation,” J. Glaucoma, vol. 25, no. 4, pp. e313-317, Apr. 2016, doi: 10.1097/IJG.0000000000000249.
[4651]	G. Baronzio, A. Gramaglia, and G. Fiorentini, “Hyperthermia and immunity. A brief overview,” In Vivo, vol. 20, no. 6A, pp. 689–695, Dec. 2006.
[4652]	A. K. Marrone, M. M. Kucherenko, R. Wiek, M. C. Göpfert, and H. R. Shcherbata, “Hyperthermic seizures and aberrant cellular homeostasis in Drosophila dystrophic muscles,” Sci Rep, vol. 1, p. 47, 2011, doi: 10.1038/srep00047.
[4653]	P. Bol, “[Hyperthyroidism],” Ned Tijdschr Tandheelkd, vol. 110, no. 1, pp. 55–56, Jan. 2003.
[4654]	M. Ragaller and D. M. Albrecht, “[Hypertonic solutions: volume steal?],” Anasthesiol Intensivmed Notfallmed Schmerzther, vol. 36 Suppl 2, pp. S155-158, Nov. 2001, doi: 10.1055/s-2001-18194.
[4655]	Y. Shimojima, D. Kishida, A. Hineno, M. Yazaki, Y. Sekijima, and S.-I. Ikeda, “Hypertrophic pachymeningitis is a characteristic manifestation of granulomatosis with polyangiitis: A retrospective study of anti-neutrophil cytoplasmic antibody-associated vasculitis,” Int J Rheum Dis, vol. 20, no. 4, pp. 489–496, Apr. 2017, doi: 10.1111/1756-185X.13046.
[4656]	N. Tuzuner, C. Cox, J. M. Rowe, D. Watrous, and J. M. Bennett, “Hypocellular myelodysplastic syndromes (MDS): new proposals,” Br. J. Haematol., vol. 91, no. 3, pp. 612–617, Nov. 1995, doi: 10.1111/j.1365-2141.1995.tb05356.x.
[4657]	L. A. Lanterna, C. Brembilla, and P. Gritti, “Hypocortisolism: an underestimated complication of subarachnoid hemorrhage,” World Neurosurg, vol. 82, no. 5, p. e665, Nov. 2014, doi: 10.1016/j.wneu.2014.05.013.
[4658]	B. Weeks, G. Bao, T. M. Gilbert, and L. Emdur, “Hypoglossal Nerve Stimulator Implantation in a Non-Academic Setting: Two-Year Result,” Laryngoscope Investig Otolaryngol, vol. 3, no. 4, pp. 315–318, Aug. 2018, doi: 10.1002/lio2.176.
[4659]	J. Johannesen et al., “Hypoglycemia, S-ACE and ACE genotypes in a Danish nationwide population of children and adolescents with type 1 diabetes,” Pediatr Diabetes, vol. 12, no. 2, pp. 100–106, Mar. 2011, doi: 10.1111/j.1399-5448.2010.00660.x.
[4660]	S. Nakamura et al., “Hypolipidemic and antioxidant activity of the novel acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor KY-455 in rabbits and hamsters,” Arzneimittelforschung, vol. 54, no. 2, pp. 102–108, 2004, doi: 10.1055/s-0031-1296943.
[4661]	S. Janett, M. G. Bianchetti, G. P. Milani, and S. A. G. Lava, “Hypomagnesemia Following Prolonged Use of Proton-pump Inhibitors,” J. Pediatr. Gastroenterol. Nutr., vol. 62, no. 4, p. e39, Apr. 2016, doi: 10.1097/MPG.0000000000001087.
[4662]	N. Kagansky, S. Levy, N. Koren-Morag, D. Berger, and H. Knobler, “Hypophosphataemia in old patients is associated with the refeeding syndrome and reduced survival,” J. Intern. Med., vol. 257, no. 5, pp. 461–468, May 2005, doi: 10.1111/j.1365-2796.2005.01457.x.
[4663]	J. Hallet et al., “Hypophosphatemia and recovery of post-hepatectomy liver insufficiency,” Hepatobiliary Surg Nutr, vol. 5, no. 3, pp. 217–224, Jun. 2016, doi: 10.21037/hbsn.2015.12.13.
[4664]	Y. Koh et al., “Hypoplastic myelodysplastic syndrome (h-MDS) is a distinctive clinical entity with poorer prognosis and frequent karyotypic and FISH abnormalities compared to aplastic anemia (AA),” Leuk. Res., vol. 34, no. 10, pp. 1344–1350, Oct. 2010, doi: 10.1016/j.leukres.2010.03.001.
[4665]	P. Ghazi, B. S. Moffett, and A. G. Cabrera, “Hypotension as the etiology for angiotensin-converting enzyme (ACE) inhibitor-associated acute kidney injury in pediatric patients,” Pediatr Cardiol, vol. 35, no. 5, pp. 767–770, Jun. 2014, doi: 10.1007/s00246-013-0850-x.
[4666]	A. M. Wren et al., “Hypothalamic actions of neuromedin U,” Endocrinology, vol. 143, no. 11, pp. 4227–4234, Nov. 2002, doi: 10.1210/en.2002-220308.
[4667]	F. M. Nakhoul, R. Miller-Lotan, H. Awaad, R. Asleh, and A. P. Levy, “Hypothesis--haptoglobin genotype and diabetic nephropathy,” Nat Clin Pract Nephrol, vol. 3, no. 6, pp. 339–344, Jun. 2007, doi: 10.1038/ncpneph0467.
[4668]	J. Vandermeer and I. Perfecto, “Hysteresis and critical transitions in a coffee agroecosystem,” Proc. Natl. Acad. Sci. U.S.A., vol. 116, no. 30, pp. 15074–15079, 23 2019, doi: 10.1073/pnas.1902773116.
[4669]	M. N. van Ĳsselmuiden et al., “Hysteropexy in the treatment of uterine prolapse stage 2 or higher: a multicenter randomized controlled non-inferiority trial comparing laparoscopic sacrohysteropexy with vaginal sacrospinous hysteropexy (LAVA-trial, study protocol),” BMC Womens Health, vol. 14, p. 112, Sep. 2014, doi: 10.1186/1472-6874-14-112.
[4670]	H. M. Utidjian, “I. Recommendations for a crystalline silica standard,” J Occup Med, vol. 17, no. 12, pp. 775–781, Dec. 1975.
[4671]	R. R. Kaliev, A. B. Budaĭchiev, A. A. Aldashev, and M. M. Mirrakhimov, “[I/D relationship between polymorphism of ACE gene and progression of chronic glomerulonephritis],” Ter. Arkh., vol. 77, no. 6, pp. 12–15, 2005.
[4672]	A. Kaser and B. Pasaniuc, “IBD genetics: focus on (dys) regulation in immune cells and the epithelium,” Gastroenterology, vol. 146, no. 4, pp. 896–899, Apr. 2014, doi: 10.1053/j.gastro.2014.02.023.
[4673]	A. Maercker, T. Hecker, M. Augsburger, and S. Kliem, “ICD-11 Prevalence Rates of Posttraumatic Stress Disorder and Complex Posttraumatic Stress Disorder in a German Nationwide Sample,” J. Nerv. Ment. Dis., vol. 206, no. 4, pp. 270–276, 2018, doi: 10.1097/NMD.0000000000000790.
[4674]	E. McElroy et al., “ICD-11 PTSD and complex PTSD: structural validation using network analysis,” World Psychiatry, vol. 18, no. 2, pp. 236–237, Jun. 2019, doi: 10.1002/wps.20638.
[4675]	D. Shin, J. Hwang, and W. Jhe, “Ice-VII-like molecular structure of ambient water nanomeniscus,” Nat Commun, vol. 10, no. 1, p. 286, 17 2019, doi: 10.1038/s41467-019-08292-0.
[4676]	P. Valent, “ICUS, IDUS, CHIP and CCUS: Diagnostic Criteria, Separation from MDS and Clinical Implications,” Pathobiology, vol. 86, no. 1, pp. 30–38, 2019, doi: 10.1159/000489042.
[4677]	D. A. Rew, “IDEALFirst: electronic pre-publication for the EJSO,” Eur J Surg Oncol, vol. 27, no. 2, p. 123, Mar. 2001, doi: 10.1053/ejso.2001.1071.
[4678]	P. Muangphrom, H. Seki, S. Matsumoto, M. Nishiwaki, E. O. Fukushima, and T. Muranaka, “Identification and characterization of a novel sesquiterpene synthase, 4-amorphen-11-ol synthase, from Artemisia maritima,” Plant Biotechnol (Tokyo), vol. 35, no. 2, pp. 113–121, Jun. 2018, doi: 10.5511/plantbiotechnology.18.0324a.
[4679]	H. Bai, P. Ramaseshadri, and S. R. Palli, “Identification and characterization of juvenile hormone esterase gene from the yellow fever mosquito, Aedes aegypti,” Insect Biochem. Mol. Biol., vol. 37, no. 8, pp. 829–837, Aug. 2007, doi: 10.1016/j.ibmb.2007.05.010.
[4680]	H. Yao, Q. Sun, and J. Zhu, “Identification and Characterization of Small-Molecule Inhibitors to Selectively Target the DFG-in over the DFG-out Conformation of the B-Raf Kinase V600E Mutant in Colorectal Cancer,” Arch. Pharm. (Weinheim), vol. 349, no. 10, pp. 808–815, Oct. 2016, doi: 10.1002/ardp.201600184.
[4681]	R.-H. Qi et al., “Identification and characterization of two novel cathelicidins from the frog Odorrana livida,” Zool Res, vol. 40, no. 2, pp. 94–101, Mar. 2019, doi: 10.24272/j.issn.2095-8137.2018.062.
[4682]	M. I. Natukunda et al., “Identification and Genetic Characterization of Soybean Accessions Exhibiting Antibiosis and Antixenosis Resistance to Aphis glycines (Hemiptera: Aphididae),” J. Econ. Entomol., vol. 112, no. 3, pp. 1428–1438, 22 2019, doi: 10.1093/jee/toz017.
[4683]	T. Kono et al., “Identification and immunoregulatory function of neuromedin U (Nmu) in the Japanese pufferfish Takifugu rubripes,” Dev. Comp. Immunol., vol. 73, pp. 246–256, 2017, doi: 10.1016/j.dci.2017.03.007.
[4684]	Y. Wang et al., “Identification and Inhibitory Mechanism of Angiotensin I-Converting Enzyme Inhibitory Peptides Derived from Bovine Hemoglobin,” Protein J., vol. 36, no. 3, pp. 166–173, 2017, doi: 10.1007/s10930-017-9708-z.
[4685]	U. G. Elayidam and D. Muraleedharen, “Identification and partial characterization of juvenile hormone esterase from cotton pest Dysdercus cingulatus,” Indian J. Biochem. Biophys., vol. 45, no. 2, pp. 121–125, Apr. 2008.
[4686]	S. Rangaraju et al., “Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease,” Mol Neurodegener, vol. 13, no. 1, p. 24, 21 2018, doi: 10.1186/s13024-018-0254-8.
[4687]	D.-J. Xie et al., “Identification of 5-HT receptor subtypes enhancing inhibitory transmission in the rat spinal dorsal horn in vitro,” Mol Pain, vol. 8, p. 58, Aug. 2012, doi: 10.1186/1744-8069-8-58.
[4688]	P. Linciano et al., “Identification of a 2,4-diaminopyrimidine scaffold targeting Trypanosoma brucei pteridine reductase 1 from the LIBRA compound library screening campaign,” Eur J Med Chem, vol. 189, p. 112047, Mar. 2020, doi: 10.1016/j.ejmech.2020.112047.
[4689]	I. Timofejeva et al., “Identification of a Group’s Physiological Synchronization with Earth’s Magnetic Field,” Int J Environ Res Public Health, vol. 14, no. 9, 01 2017, doi: 10.3390/ijerph14090998.
[4690]	A. Geusau et al., “Identification of a homozygous PSTPIP1 mutation in a patient with a PAPA-like syndrome responding to canakinumab treatment,” JAMA Dermatol, vol. 149, no. 2, pp. 209–215, Feb. 2013, doi: 10.1001/2013.jamadermatol.717.
[4691]	W. Hao, Y. Zhang, and Y. Xu, “Identification of a juvenile hormone esterase binding protein gene and its developmental and hormone regulation in the silkworm, Bombyx mori,” J. Insect Physiol., vol. 59, no. 9, pp. 906–912, Sep. 2013, doi: 10.1016/j.jinsphys.2013.06.009.
[4692]	A. M. Ray et al., “Identification of a novel 5-HT(4) receptor splice variant (r5-HT(4c1)) and preliminary characterisation of specific 5-HT(4a) and 5-HT(4b) receptor antibodies,” Eur. J. Pharmacol., vol. 604, no. 1–3, pp. 1–11, Feb. 2009, doi: 10.1016/j.ejphar.2008.11.056.
[4693]	M. Rose and F. Winston, “Identification of a Ty insertion within the coding sequence of the S. cerevisiae URA3 gene,” Mol. Gen. Genet., vol. 193, no. 3, pp. 557–560, 1984, doi: 10.1007/BF00382100.
[4694]	W. He and T. Lei, “Identification of camellia oil using FT-IR spectroscopy and chemometrics based on both isolated unsaponifiables and vegetable oils,” Spectrochim Acta A Mol Biomol Spectrosc, vol. 228, p. 117839, Mar. 2020, doi: 10.1016/j.saa.2019.117839.
[4695]	S. Anador et al., “Identification of dopamine D2 receptors in gill of Crassostrea virginica,” In Vivo (Brooklyn), vol. 32, no. 3, pp. 74–79, 2011.
[4696]	X. Xiao and B. X. Li, “Identification of lamins as the molecular targets of LBL1 using a clickable photoaffinity probe,” Meth. Enzymol., vol. 633, pp. 185–201, 2020, doi: 10.1016/bs.mie.2019.02.038.
[4697]	S. X. Chen, J. N. Du, L. N. Hao, C. Y. Wang, Q. Chen, and Y. X. Chang, “Identification of markers tightly linked to tomato  yellow leaf curl disease and root-knot nematode resistance by multiplex PCR,” Genet. Mol. Res., vol. 11, no. 3, pp. 2917–2928, Aug. 2012, doi: 10.4238/2012.July.10.4.
[4698]	E. Villard, L. Tiret, S. Visvikis, R. Rakotovao, F. Cambien, and F. Soubrier, “Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis,” Am. J. Hum. Genet., vol. 58, no. 6, pp. 1268–1278, Jun. 1996.
[4699]	S. You and L. Gao, “Identification of NMU as a potential gene conferring alectinib resistance in non-small cell lung cancer based on bioinformatics analyses,” Gene, vol. 678, pp. 137–142, Dec. 2018, doi: 10.1016/j.gene.2018.08.032.
[4700]	G. Abella et al., “Identification of resilient sows in Porcine Reproductive and Respiratory Syndrome virus infected farms,” J. Anim. Sci., Jun. 2019, doi: 10.1093/jas/skz192.
[4701]	L. W. Han, X. Fu, Y. Yan, C. X. Wang, and G. Wu, “[Identification of the cumulative eco-environment effect of coal-electricity integration based on interpretative structural model],” Ying Yong Sheng Tai Xue Bao, vol. 28, no. 5, pp. 1653–1660, May 2017, doi: 10.13287/j.1001-9332.201705.008.
[4702]	J. F. Havens, O. G. Gudiño, E. A. Biggs, U. N. Diamond, J. R. Weis, and M. Cloitre, “Identification of trauma exposure and PTSD in adolescent psychiatric inpatients: an exploratory study,” J Trauma Stress, vol. 25, no. 2, pp. 171–178, Apr. 2012, doi: 10.1002/jts.21683.
[4703]	H. Gourdeau et al., “Identification, characterization and potent antitumor activity of ECO-4601, a novel peripheral benzodiazepine receptor ligand,” Cancer Chemother. Pharmacol., vol. 61, no. 6, pp. 911–921, May 2008, doi: 10.1007/s00280-007-0544-2.
[4704]	T.-Y. Lin, W.-L. Huang, W.-Y. Lee, and C.-W. Luo, “Identifying a Neuromedin U Receptor 2 Splice Variant and Determining Its Roles in the Regulation of Signaling and Tumorigenesis In Vitro,” PLoS ONE, vol. 10, no. 8, p. e0136836, 2015, doi: 10.1371/journal.pone.0136836.
[4705]	B. G. Hammond, P. Garcia-Filion, P. Kang, M. Y. Rao, B. C. Willis, and H. J. Dalton, “Identifying an Oxygenation Index Threshold for Increased Mortality in Acute Respiratory Failure,” Respir Care, vol. 62, no. 10, pp. 1249–1254, Oct. 2017, doi: 10.4187/respcare.05092.
[4706]	M. Corbett, P. O’Connor, D. Byrne, M. Thornton, and I. Keogh, “Identifying and reducing risks in functional endoscopic sinus surgery through a hierarchical task analysis,” Laryngoscope Investig Otolaryngol, vol. 4, no. 1, pp. 5–12, Feb. 2019, doi: 10.1002/lio2.220.
[4707]	J. Blechert, M. Lajtman, T. Michael, J. Margraf, and F. H. Wilhelm, “Identifying anxiety states using broad sampling and advanced processing of peripheral physiological information,” Biomed Sci Instrum, vol. 42, pp. 136–141, 2006.
[4708]	A. Miorelli and L. Seré, “[Identifying anxiety symptoms in psychosis: the challenge is on],” Vertex, vol. 21, no. 93, pp. 359–364, Oct. 2010.
[4709]	F. Lima et al., “Identifying cognitive subgroups in bipolar disorder: A cluster analysis,” J Affect Disord, vol. 246, pp. 252–261, 01 2019, doi: 10.1016/j.jad.2018.12.044.
[4710]	L. Tian, D. Zou, H. Yuan, L. Wang, X. Zhang, and X. Li, “Identifying proper agitation interval to prevent floating layers formation of corn stover and improve biogas production in anaerobic digestion,” Bioresour. Technol., vol. 186, pp. 1–7, Jun. 2015, doi: 10.1016/j.biortech.2015.03.018.
[4711]	V. C. Cahen et al., “Identifying relapses and stem cell transplants in pediatric acute lymphoblastic leukemia using administrative data: Capturing national outcomes irrespective of trial enrollment,” Pediatr Blood Cancer, p. e28315, May 2020, doi: 10.1002/pbc.28315.
[4712]	K. D. Rode et al., “Identifying reliable indicators of fitness in polar bears,” PLoS ONE, vol. 15, no. 8, p. e0237444, Aug. 2020, doi: 10.1371/journal.pone.0237444.
[4713]	B. Wahlang et al., “Identifying sex differences arising from polychlorinated biphenyl exposures in toxicant-associated liver disease,” Food Chem. Toxicol., vol. 129, pp. 64–76, Jul. 2019, doi: 10.1016/j.fct.2019.04.007.
[4714]	J. F. Heitner et al., “Identifying the Infarct-Related Artery in Patients With Non-ST-Segment-Elevation Myocardial Infarction,” Circ Cardiovasc Interv, vol. 12, no. 5, p. e007305, 2019, doi: 10.1161/CIRCINTERVENTIONS.118.007305.
[4715]	J. Durrani and J. P. Maciejewski, “Idiopathic aplastic anemia vs hypocellular myelodysplastic syndrome,” Hematology Am Soc Hematol Educ Program, vol. 2019, no. 1, pp. 97–104, 06 2019, doi: 10.1182/hematology.2019000019.
[4716]	L. Zhytnik et al., “IFITM5 pathogenic variant causes osteogenesis imperfecta V with various phenotype severity in Ukrainian and Vietnamese patients,” Hum. Genomics, vol. 13, no. 1, p. 25, 03 2019, doi: 10.1186/s40246-019-0209-3.
[4717]	E. V. Efimova et al., “IG20, in contrast to DENN-SV, (MADD splice variants) suppresses tumor cell survival, and enhances their susceptibility to apoptosis and cancer drugs,” Oncogene, vol. 23, no. 5, pp. 1076–1087, Feb. 2004, doi: 10.1038/sj.onc.1207210.
[4718]	A. Tagliabue et al., “IgA-driven T cell-mediated anti-bacterial immunity in man after live oral Ty 21a vaccine,” J. Immunol., vol. 137, no. 5, pp. 1504–1510, Sep. 1986.
[4719]	“IIF-Cover,” Laryngoscope Investig Otolaryngol, vol. 1, no. 1, p. I, Feb. 2016, doi: 10.1002/lio2.6.
[4720]	X. Xiong, L. Xu, L. Wei, R. E. White, Y.-B. Ouyang, and R. G. Giffard, “IL-4 Is Required for Sex Differences in Vulnerability to Focal Ischemia in Mice,” Stroke, vol. 46, no. 8, pp. 2271–2276, Aug. 2015, doi: 10.1161/STROKEAHA.115.008897.
[4721]	N. Kanda and S. Watanabe, “IL-12, IL-23, and IL-27 enhance human beta-defensin-2 production in human keratinocytes,” Eur. J. Immunol., vol. 38, no. 5, pp. 1287–1296, May 2008, doi: 10.1002/eji.200738051.
[4722]	N. Kanda, S. Koike, and S. Watanabe, “IL-17 suppresses TNF-alpha-induced CCL27 production through induction of COX-2 in human keratinocytes,” J. Allergy Clin. Immunol., vol. 116, no. 5, pp. 1144–1150, Nov. 2005, doi: 10.1016/j.jaci.2005.08.014.
[4723]	N. Kanda, T. Shimizu, Y. Tada, and S. Watanabe, “IL-18 enhances IFN-gamma-induced production of CXCL9, CXCL10, and CXCL11 in human keratinocytes,” Eur. J. Immunol., vol. 37, no. 2, pp. 338–350, Feb. 2007, doi: 10.1002/eji.200636420.
[4724]	L. Tu, C. Phan, M. Humbert, and C. Guignabert, “[IL6R is the key therapeutical target in pulmonary arterial hypertension],” Med Sci (Paris), vol. 34, no. 10, pp. 765–768, Oct. 2018, doi: 10.1051/medsci/2018201.
[4725]	P. Jousset, “Illuminating Earth’s faults,” Science, vol. 366, no. 6469, pp. 1076–1077, 29 2019, doi: 10.1126/science.aaz7750.
[4726]	S. H. Kim, “Image quality and artifacts in automated breast ultrasonography,” Ultrasonography, vol. 38, no. 1, pp. 83–91, Jan. 2019, doi: 10.14366/usg.18016.
[4727]	C. L. M. Lam, J. Yiend, and T. M. C. Lee, “Imaging and neuropsychological correlates of white matter lesions in different subtypes of Mild Cognitive Impairment: A systematic review,” NeuroRehabilitation, vol. 41, no. 1, pp. 189–204, 2017, doi: 10.3233/NRE-171471.
[4728]	A. Miglani, D. Lal, S. M. Weindling, C. P. Wood, and J. M. Hoxworth, “Imaging characteristics and clinical outcomes of biphenotypic sinonasal sarcoma,” Laryngoscope Investig Otolaryngol, vol. 4, no. 5, pp. 484–488, Oct. 2019, doi: 10.1002/lio2.305.
[4729]	L. M. Leijser, A. Siddiqi, and S. P. Miller, “Imaging Evidence of the Effect of Socio-Economic Status on Brain Structure and Development,” Semin Pediatr Neurol, vol. 27, pp. 26–34, 2018, doi: 10.1016/j.spen.2018.03.004.
[4730]	A. Barletta, M. Pace, L. D’Antiga, M. Cheli, G. Mangili, and S. Sironi, “Imaging of liver fusion and vascular intra-hepatic shunts in omphalopagus conjoined twins: The role of a double CT study,” Clin Imaging, vol. 54, pp. 25–30, Apr. 2019, doi: 10.1016/j.clinimag.2018.11.009.
[4731]	U. Anwer and C. M. Yablon, “Imaging of Osteomyelitis of the Extremities,” Semin Roentgenol, vol. 52, no. 1, pp. 49–54, Jan. 2017, doi: 10.1053/j.ro.2016.05.011.
[4732]	B. Kim, A. Kawashima, J.-A. Ryu, N. Takahashi, R. P. Hartman, and B. F. King, “Imaging of the seminal vesicle and vas deferens,” Radiographics, vol. 29, no. 4, pp. 1105–1121, Aug. 2009, doi: 10.1148/rg.294085235.
[4733]	R. L. Winslow et al., “Imaging-based integrative models of the heart: closing the loop between experiment and simulation,” Novartis Found. Symp., vol. 247, pp. 129–141; discussion 141-143, 144–150, 244–252, 2002.
[4734]	M. Bahl, J. A. Sosa, R. C. Nelson, and J. K. Hoang, “Imaging-detected incidental thyroid nodules that undergo surgery: a single-center experience over 1 year,” AJNR Am J Neuroradiol, vol. 35, no. 11, pp. 2176–2180, Dec. 2014, doi: 10.3174/ajnr.A4004.
[4735]	C. Marazia and H. Fangerau, “Imagining the brain as a book: Oskar and Cécile Vogt’s ‘library of brains,’” Prog. Brain Res., vol. 243, pp. 181–203, 2018, doi: 10.1016/bs.pbr.2018.10.012.
[4736]	T. K. Soderborg and J. E. Friedman, “Imbalance in gut microbes from babies born to obese mothers increases gut permeability and myeloid cell adaptations that provoke obesity and NAFLD,” Microb Cell, vol. 6, no. 1, pp. 102–104, Dec. 2018, doi: 10.15698/mic2019.01.666.
[4737]	G. Northoff, “Immanuel Kant’s mind and the brain’s resting state,” Trends Cogn. Sci. (Regul. Ed.), vol. 16, no. 7, pp. 356–359, Jul. 2012, doi: 10.1016/j.tics.2012.06.001.
[4738]	M. Macht and J. Mueller, “Immediate effects of chocolate on experimentally induced mood states,” Appetite, vol. 49, no. 3, pp. 667–674, Nov. 2007, doi: 10.1016/j.appet.2007.05.004.
[4739]	K. T. Rew, S. L. Clarke, W. Gossa, and D. Savin, “Immigrant and refugee health: common infectious diseases,” FP Essent, vol. 423, pp. 24–29, Aug. 2014.
[4740]	K. T. Rew, S. L. Clarke, W. Gossa, and D. Savin, “Immigrant and refugee health: cross-cultural communication,” FP Essent, vol. 423, pp. 30–39, Aug. 2014.
[4741]	K. T. Rew, S. L. Clarke, W. Gossa, and D. Savin, “Immigrant and refugee health: medical evaluation,” FP Essent, vol. 423, pp. 11–18, Aug. 2014.
[4742]	P. Mewawalla and C. A. Dasanu, “Immune alterations in untreated and treated myelodysplastic syndrome,” Expert Opin Drug Saf, vol. 10, no. 3, pp. 351–361, May 2011, doi: 10.1517/14740338.2011.534456.
[4743]	C. Woolsey et al., “Immune correlates of postexposure vaccine protection against Marburg virus,” Sci Rep, vol. 10, no. 1, p. 3071, 20 2020, doi: 10.1038/s41598-020-59976-3.
[4744]	S. L. Patterson, “Immune dysregulation and cognitive vulnerability in the aging brain: Interactions of microglia, IL-1β, BDNF and synaptic plasticity,” Neuropharmacology, vol. 96, no. Pt A, pp. 11–18, Sep. 2015, doi: 10.1016/j.neuropharm.2014.12.020.
[4745]	C. Wang et al., “Immune dysregulation in myelodysplastic syndrome: Clinical features, pathogenesis and therapeutic strategies,” Crit. Rev. Oncol. Hematol., vol. 122, pp. 123–132, Feb. 2018, doi: 10.1016/j.critrevonc.2017.12.013.
[4746]	M. S. Kalliny and M. I. Bassyouni, “Immune response due to silica exposure in Egyptian phosphate mines,” J Health Care Poor Underserved, vol. 22, no. 4 Suppl, pp. 91–109, 2011, doi: 10.1353/hpu.2011.0156.
[4747]	“Immunization and Vaccine-related Implementation Research Advisory Committee (IVIR-AC): summary of conclusions and recommendations, 1–2 February 2017 meeting,” Wkly. Epidemiol. Rec., vol. 92, no. 15, pp. 181–188, 14 2017.
[4748]	“Immunization and Vaccine-related Implementation Research Advisory Committee (IVIR-AC): summary of conclusions and recommendations, 20–22 September 2017,” Wkly. Epidemiol. Rec., vol. 93, no. 1, pp. 1–7, Jan. 2018.
[4749]	C. L. Kaufman et al., “Immunobiology in VCA,” Transpl. Int., vol. 29, no. 6, pp. 644–654, Jun. 2016, doi: 10.1111/tri.12764.
[4750]	J.-H. Tao-Cheng, “Immunogold labeling of synaptic vesicle proteins in developing hippocampal neurons,” Mol Brain, vol. 13, no. 1, p. 9, 20 2020, doi: 10.1186/s13041-020-0549-x.
[4751]	Y. Guo et al., “Immunological changes of T helper cells in flow cytometer-sorted CD4+ T cells from patients with Hashimoto’s thyroiditis,” Exp Ther Med, vol. 15, no. 4, pp. 3596–3602, Apr. 2018, doi: 10.3892/etm.2018.5825.
[4752]	C. G. Ioannides, C. D. Platsoucas, and R. S. Freedman, “Immunological effects of tumor vaccines: II. T cell responses directed against cellular antigens in the viral oncolysates,” In Vivo, vol. 4, no. 1, pp. 17–24, Feb. 1990.
[4753]	T. Berger, “Immunological processes related to cognitive impairment in MS,” Acta Neurol. Scand., vol. 134 Suppl 200, pp. 34–38, Sep. 2016, doi: 10.1111/ane.12647.
[4754]	D. Halperin, C. Reuben, G. Rashid, S. Ben-Efraim, and D. W. Weiss, “Immunological reactivity to a mycobacterial fraction is associated with nonspecific suppression of immunological responsiveness in vivo,” In Vivo, vol. 4, no. 4, pp. 263–268, Aug. 1990.
[4755]	L. Adès and P. Fenaux, “Immunomodulating drugs in myelodysplastic syndromes,” Hematology Am Soc Hematol Educ Program, vol. 2011, pp. 556–560, 2011, doi: 10.1182/asheducation-2011.1.556.
[4756]	A. R. Parikh, M. J. Olnes, and A. J. Barrett, “Immunomodulatory treatment of myelodysplastic syndromes: antithymocyte globulin, cyclosporine, and alemtuzumab,” Semin. Hematol., vol. 49, no. 4, pp. 304–311, Oct. 2012, doi: 10.1053/j.seminhematol.2012.07.004.
[4757]	A. P. Lourenço et al., “Immunosenescence in honey bees (Apis mellifera L.) is caused by intrinsic senescence and behavioral physiology,” Exp. Gerontol., vol. 119, pp. 174–183, 2019, doi: 10.1016/j.exger.2019.02.005.
[4758]	R. M. Shallis, N. Chokr, M. Stahl, A. B. Pine, and A. M. Zeidan, “Immunosuppressive therapy in myelodysplastic syndromes: a borrowed therapy in search of the right place,” Expert Rev Hematol, vol. 11, no. 9, pp. 715–726, 2018, doi: 10.1080/17474086.2018.1503049.
[4759]	T. Shimamoto and K. Ohyashiki, “Immunosuppressive treatments for myelodysplastic syndromes,” Leuk. Lymphoma, vol. 44, no. 4, pp. 593–604, Apr. 2003, doi: 10.1080/1042819021000055345.
[4760]	S. Ravulapati, C. Leung, N. Poddar, and Y. Tu, “Immunotherapy in Squamous Cell Skin Carcinoma: A Game Changer?,” Am. J. Med., vol. 130, no. 5, pp. e207–e208, May 2017, doi: 10.1016/j.amjmed.2016.12.020.
[4761]	M. Fiala, L. Restrepo, and M. Pellegrini, “Immunotherapy of Mild Cognitive Impairment by ω-3 Supplementation: Why Are Amyloid-β Antibodies and ω-3 Not Working in Clinical Trials?,” J. Alzheimers Dis., vol. 62, no. 3, pp. 1013–1022, 2018, doi: 10.3233/JAD-170579.
[4762]	C. Kim et al., “Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation,” Mol Neurodegener, vol. 13, no. 1, p. 43, 09 2018, doi: 10.1186/s13024-018-0276-2.
[4763]	K. M. Summers, K. E. Martin, and K. Watson, “Impact and clinical management of depression in patients with coronary artery disease,” Pharmacotherapy, vol. 30, no. 3, pp. 304–322, Mar. 2010, doi: 10.1592/phco.30.3.304.
[4764]	B. S. Nagoba and N. M. Suryawanshi, “Impact factor: An important parameter to decide the quality of publication,” Indian J Med Microbiol, vol. 35, no. 2, p. 314, Jun. 2017, doi: 10.4103/0255-0857.209587.
[4765]	E. Eriksson, “Impact factors and publication times,” Knee Surg Sports Traumatol Arthrosc, vol. 12, no. 4, p. 261, Jul. 2004, doi: 10.1007/s00167-004-0542-4.
[4766]	M. G. Gasparri, W. B. Tisol, and S. Masroor, “Impact of a six-year integrated thoracic surgery training program at the Medical College of Wisconsin,” Ann. Thorac. Surg., vol. 93, no. 2, pp. 592–595; discussion 596-597, Feb. 2012, doi: 10.1016/j.athoracsur.2011.11.005.
[4767]	C. Bourgier et al., “Impact of adjuvant hormonotherapy on radiation-induced breast fibrosis according to the individual radiosensitivity: results of a multicenter prospective French trial,” Oncotarget, vol. 9, no. 21, pp. 15757–15765, Mar. 2018, doi: 10.18632/oncotarget.24606.
[4768]	A. Tursi and A. Papa, “Impact of anti-tnfα antibodies on the risk of Covid-19 and its severity in patients with inflammatory Bowel Diseases,” J Crohns Colitis, Apr. 2020, doi: 10.1093/ecco-jcc/jjaa076.
[4769]	J. Hjelmesæth et al., “Impact of body weight, low energy diet and gastric bypass on drug bioavailability, cardiovascular risk factors and metabolic biomarkers: protocol for an open, non-randomised, three-armed single centre study (COCKTAIL),” BMJ Open, vol. 8, no. 5, p. e021878, 29 2018, doi: 10.1136/bmjopen-2018-021878.
[4770]	J. Völker, G. E. Plum, V. Gindikin, H. H. Klump, and K. J. Breslauer, “Impact of bulge loop size on DNA triplet repeat domains: Implications for DNA repair and expansion,” Biopolymers, vol. 101, no. 1, pp. 1–12, Jan. 2014, doi: 10.1002/bip.22236.
[4771]	C. Lin, A. K. Thung, K. R. Jatana, J. N. Cooper, L. C. Barron, and C. A. Elmaraghy, “Impact of coblation versus electrocautery on acute post-operative outcomes in pediatric tonsillectomy,” Laryngoscope Investig Otolaryngol, vol. 4, no. 1, pp. 154–159, Feb. 2019, doi: 10.1002/lio2.212.
[4772]	D. H. Allen and A. R. Loughan, “Impact of Cognitive Impairment in Patients with Gliomas,” Semin Oncol Nurs, vol. 34, no. 5, pp. 528–546, 2018, doi: 10.1016/j.soncn.2018.10.010.
[4773]	S. G. Yoo, K. D. Han, K. H. Lee, Y. La, D. E. Kwon, and S. H. Han, “Impact of Cytomegalovirus Disease on New-Onset Type 2 Diabetes Mellitus: Population-Based Matched Case-Control Cohort Study,” Diabetes Metab J, vol. 43, no. 6, pp. 815–829, 2019, doi: 10.4093/dmj.2018.0167.
[4774]	D. Kim, B.-O. Kwon, and K. Choi, “Impact of derelict fishing gear on the seafloor integrity and benthic communities in the macrotidal flats from northern Gyeonggi Bay, west coast of Korea,” Sci. Total Environ., vol. 745, p. 141168, Jul. 2020, doi: 10.1016/j.scitotenv.2020.141168.
[4775]	D. Noh, G. Ryu, J. Lee, and M. Sagong, “Impact of Early Anatomical and Functional Responses to Bevacizumab in Macular Edema Secondary to Branch Retinal Vein Occlusion,” Ophthalmologica, vol. 239, no. 4, pp. 194–204, 2018, doi: 10.1159/000486248.
[4776]	B. Berte et al., “Impact of Electrode Type on Mapping of Scar-Related VT,” J. Cardiovasc. Electrophysiol., vol. 26, no. 11, pp. 1213–1223, Nov. 2015, doi: 10.1111/jce.12761.
[4777]	Y. Li et al., “Impact of Elevated CO2 on Seed Quality of Soybean at the Fresh Edible and Mature Stages,” Front Plant Sci, vol. 9, p. 1413, 2018, doi: 10.3389/fpls.2018.01413.
[4778]	K. Sackmann, T. Reemtsma, M. Rahmberg, and D. Bunke, “Impact of European chemicals regulation on the industrial use of plasticizers and patterns of substitution in Scandinavia,” Environ Int, vol. 119, pp. 346–352, 2018, doi: 10.1016/j.envint.2018.06.037.
[4779]	N. G. Rampello, M. Stenger, B. Westermann, and H. D. Osiewacz, “Impact of F1Fo-ATP-synthase dimer assembly factors on mitochondrial function and organismic aging,” Microb Cell, vol. 5, no. 4, pp. 198–207, Jan. 2018, doi: 10.15698/mic2018.04.625.
[4780]	G. Pasquier et al., “Impact of foliar symptoms of ‘Esca proper’ on proteins related to defense and oxidative stress of grape skins during ripening,” Proteomics, vol. 13, no. 1, pp. 108–118, Jan. 2013, doi: 10.1002/pmic.201200194.
[4781]	O. E. Osadchii, “Impact of hypokalemia on electromechanical window, excitation wavelength and repolarization gradients in guinea-pig and rabbit hearts,” PLoS ONE, vol. 9, no. 8, p. e105599, 2014, doi: 10.1371/journal.pone.0105599.
[4782]	S. Deguchi, N. Komasawa, H. Kido, T. Ueno, and T. Minami, “Impact of pillow height on double-lumen endotracheal tube intubation with McGRATH MAC: a prospective randomized clinical trial,” J Clin Anesth, vol. 34, pp. 339–343, Nov. 2016, doi: 10.1016/j.jclinane.2016.05.024.
[4783]	M. Jang et al., “Impact of poorly controlled epilepsy in the Republic of Guinea,” Seizure, vol. 61, pp. 71–77, Oct. 2018, doi: 10.1016/j.seizure.2018.07.018.
[4784]	A. Wesol and S. Woolley, “Impact of power morcellator removal on hysterectomy practice patterns,” Eur. J. Obstet. Gynecol. Reprod. Biol., vol. 215, pp. 41–44, Aug. 2017, doi: 10.1016/j.ejogrb.2017.05.015.
[4785]	S. Wiesemann et al., “Impact of sequence type and field strength (1.5, 3, and 7T) on 4D flow MRI hemodynamic aortic parameters in healthy volunteers,” Magn Reson Med, Aug. 2020, doi: 10.1002/mrm.28450.
[4786]	K. Takeishi et al., “Impact of Splenic Volume and Splenectomy on Prognosis of Hepatocellular Carcinoma Within Milan Criteria After Curative Hepatectomy,” World J Surg, vol. 42, no. 4, pp. 1120–1128, 2018, doi: 10.1007/s00268-017-4232-z.
[4787]	A. Liebermann, D. Vehling, M. Eichberger, and B. Stawarczyk, “Impact of storage media and temperature on color stability of tooth-colored CAD/CAM materials for final restorations,” J Appl Biomater Funct Mater, vol. 17, no. 4, p. 2280800019836832, Dec. 2019, doi: 10.1177/2280800019836832.
[4788]	P. Gottschalk, B. Brodesser, D. Poncelet, H. Jaeger, H. Rennhofer, and S. Cole, “Impact of storage on the physico-chemical properties of microparticles comprising a hydrogenated vegetable oil matrix and different essential oil concentrations,” J Microencapsul, vol. 36, no. 1, pp. 72–82, Jan. 2019, doi: 10.1080/02652048.2019.1599456.
[4789]	A. Nijamudheen, D. Sarbapalli, J. Hui, J. Rodríguez-López, and J. L. Mendoza-Cortes, “Impact of Surface Modification on the Lithium, Sodium, and Potassium Intercalation Efficiency and Capacity of Few-Layer Graphene Electrodes,” ACS Appl Mater Interfaces, vol. 12, no. 17, pp. 19393–19401, Apr. 2020, doi: 10.1021/acsami.9b23105.
[4790]	T. Karaahmet et al., “Impact of systemic sclerosis on electromechanical characteristics of the heart,” Heart Vessels, vol. 25, no. 3, pp. 223–228, May 2010, doi: 10.1007/s00380-009-1197-3.
[4791]	L. Benjamin, V. Buthion, G. Vidal-Trécan, and P. Briot, “Impact of the healthcare payment system on patient access to oral anticancer drugs: an illustration from the French and United States contexts,” BMC Health Serv Res, vol. 14, p. 274, Jun. 2014, doi: 10.1186/1472-6963-14-274.
[4792]	C. G. K. Lüder and T. Rahman, “Impact of the host on Toxoplasma stage differentiation,” Microb Cell, vol. 4, no. 7, pp. 203–211, Jun. 2017, doi: 10.15698/mic2017.07.579.
[4793]	C. Gomes et al., “Impact of the timing of capsule endoscopy in overt obscure gastrointestinal bleeding on yield and rebleeding rate - is sooner than 14 d advisable?,” World J Gastrointest Endosc, vol. 10, no. 4, pp. 74–82, Apr. 2018, doi: 10.4253/wjge.v10.i4.74.
[4794]	Y. Yu, Y. Zhang, and X. Miao, “Impacts of Dynamic Agglomeration Externalities on Eco-Efficiency: Empirical Evidence from China,” Int J Environ Res Public Health, vol. 15, no. 10, 19 2018, doi: 10.3390/ijerph15102304.
[4795]	G. Brunetti et al., “Impaired bone remodeling in children with osteogenesis imperfecta treated and untreated with bisphosphonates: the role of DKK1, RANKL, and TNF-α,” Osteoporos Int, vol. 27, no. 7, pp. 2355–2365, 2016, doi: 10.1007/s00198-016-3501-2.
[4796]	A. Masato, N. Plotegher, D. Boassa, and L. Bubacco, “Impaired dopamine metabolism in Parkinson’s disease pathogenesis,” Mol Neurodegener, vol. 14, no. 1, p. 35, 20 2019, doi: 10.1186/s13024-019-0332-6.
[4797]	S. J. H. van Rooij and T. Jovanovic, “Impaired inhibition as an intermediate phenotype for PTSD risk and treatment response,” Prog. Neuropsychopharmacol. Biol. Psychiatry, vol. 89, pp. 435–445, 08 2019, doi: 10.1016/j.pnpbp.2018.10.014.
[4798]	K. Hasegawa, K. Kataoka, M. Inoue, Y. Seino, T. Morishima, and H. Tanaka, “Impaired pyridinoline cross-link formation in patients with osteogenesis imperfecta,” J. Bone Miner. Metab., vol. 26, no. 4, pp. 394–399, 2008, doi: 10.1007/s00774-007-0827-z.
[4799]	X. Luo, Y. Shui, F. Wang, R. Yamamoto, and N. Kato, “Impaired retention of depression-like behavior in a mouse model of Alzheimer’s disease,” IBRO Rep, vol. 2, pp. 81–86, Jun. 2017, doi: 10.1016/j.ibror.2017.05.001.
[4800]	N. Vanni et al., “Impairment of ceramide synthesis causes a novel progressive myoclonus epilepsy,” Ann. Neurol., vol. 76, no. 2, pp. 206–212, Aug. 2014, doi: 10.1002/ana.24170.
[4801]	C. Miguelez, A. Benazzouz, L. Ugedo, and P. De Deurwaerdère, “Impairment of Serotonergic Transmission by the Antiparkinsonian Drug L-DOPA: Mechanisms and Clinical Implications,” Front Cell Neurosci, vol. 11, p. 274, 2017, doi: 10.3389/fncel.2017.00274.
[4802]	Q. Zhou et al., “Imparting Boron Nanosheets with Ambient Stability through Methyl Group Functionalization for Mechanistic Investigation of Their Lithiation Process,” ACS Appl Mater Interfaces, vol. 12, no. 20, pp. 23370–23377, May 2020, doi: 10.1021/acsami.0c05236.
[4803]	M. M. Bait-Suwailam, I. I Labiano, and A. Alomainy, “Impedance Enhancement of Textile Grounded Loop Antenna Using High-Impedance Surface (HIS) for Healthcare Applications,” Sensors (Basel), vol. 20, no. 14, Jul. 2020, doi: 10.3390/s20143809.
[4804]	R. Lewis et al., “Implantation of the nyxoah bilateral hypoglossal nerve stimulator for obstructive sleep apnea,” Laryngoscope Investig Otolaryngol, vol. 4, no. 6, pp. 703–707, Dec. 2019, doi: 10.1002/lio2.312.
[4805]	“Implementation of hepatitis B birth dose vaccination – worldwide, 2016,” Wkly. Epidemiol. Rec., vol. 93, no. 7, pp. 61–72, Feb. 2018.
[4806]	A. Portela, S. A. Qazi, and N. Tran, “Implementation research for maternal, newborn and child health,” Acta Paediatr., vol. 107 Suppl 471, pp. 3–6, 2018, doi: 10.1111/apa.14641.
[4807]	Z. Samad et al., “Implementing a Continuous Quality Improvement Program in a High-Volume Clinical Echocardiography Laboratory: Improving Care for Patients With Aortic Stenosis,” Circ Cardiovasc Imaging, vol. 9, no. 3, Mar. 2016, doi: 10.1161/CIRCIMAGING.115.003708.
[4808]	C. D. Furman et al., “Implementing Chief Resident Immersion Training (CRIT) in the Care of Older Adults: Overcoming Barriers and Promoting Facilitators,” Geriatrics (Basel), vol. 3, no. 4, Sep. 2018, doi: 10.3390/geriatrics3040062.
[4809]	C. Clavier, “Implementing Health in All Policies - Time and Ideas Matter Too! Comment on ‘Understanding the Role of Public Administration in Implementing Action on the Social Determinants of Health and Health Inequities,’” Int J Health Policy Manag, vol. 5, no. 10, pp. 609–610, 01 2016, doi: 10.15171/ijhpm.2016.81.
[4810]	H. B. Peterson, J. Haidar, D. Fixsen, R. Ramaswamy, B. J. Weiner, and S. Leatherman, “Implementing Innovations in Global Women’s, Children’s, and Adolescents’ Health: Realizing the Potential for Implementation Science,” Obstet Gynecol, vol. 131, no. 3, pp. 423–430, 2018, doi: 10.1097/AOG.0000000000002494.
[4811]	S. L. Diaz and L. Maroteaux, “Implication of 5-HT(2B) receptors in the serotonin syndrome,” Neuropharmacology, vol. 61, no. 3, pp. 495–502, Sep. 2011, doi: 10.1016/j.neuropharm.2011.01.025.
[4812]	P. Elek, E. Takács, G. Merész, and Z. Kaló, “Implication of external price referencing and parallel trade on pharmaceutical expenditure: indirect evidence from lower-income European countries,” Health Policy Plan, vol. 32, no. 3, pp. 349–358, Apr. 2017, doi: 10.1093/heapol/czw133.
[4813]	Y. Xu et al., “Implications of mutational spectrum in myelodysplastic syndromes based on targeted next-generation sequencing,” Oncotarget, vol. 8, no. 47, pp. 82475–82490, Oct. 2017, doi: 10.18632/oncotarget.19628.
[4814]	O. Gershon, N. E. Ezenwa, and R. Osabohien, “Implications of oil price shocks on net oil-importing African countries,” Heliyon, vol. 5, no. 8, p. e02208, Aug. 2019, doi: 10.1016/j.heliyon.2019.e02208.
[4815]	H. Harada, Y. Harada, and A. Kimura, “Implications of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome (MDS): future molecular therapeutic directions for MDS,” Curr Cancer Drug Targets, vol. 6, no. 6, pp. 553–565, Sep. 2006, doi: 10.2174/156800906778194595.
[4816]	T. M. Keane, J. A. Fairbank, J. M. Caddell, and R. T. Zimering, “Implosive (flooding) therapy reduces symptoms of PTSD in Vietnam combat veterans,” Behavior Therapy, vol. 20, no. 2, pp. 245–260, 1989.
[4817]	V. Zara, A. Ferramosca, P. Papatheodorou, F. Palmieri, and J. Rassow, “Import of rat mitochondrial citrate carrier (CIC) at increasing salt concentrations promotes presequence binding to import receptor Tom20 and inhibits membrane translocation,” J. Cell. Sci., vol. 118, no. Pt 17, pp. 3985–3995, Sep. 2005, doi: 10.1242/jcs.02526.
[4818]	A. L. Bricker and J. G. Belasco, “Importance of a 5’ stem-loop for longevity of papA mRNA in Escherichia coli,” J. Bacteriol., vol. 181, no. 11, pp. 3587–3590, Jun. 1999, doi: 10.1128/JB.181.11.3587-3590.1999.
[4819]	J. R. Sinclair, “Importance of a One Health approach in advancing global health security and the Sustainable Development Goals,” Rev. - Off. Int. Epizoot., vol. 38, no. 1, pp. 145–154, May 2019, doi: 10.20506/rst.38.1.2949.
[4820]	F. O. Tzul and B. E. Bowler, “Importance of contact persistence in denatured state loop formation: kinetic insights into sequence effects on nucleation early in folding,” J. Mol. Biol., vol. 390, no. 1, pp. 124–134, Jul. 2009, doi: 10.1016/j.jmb.2009.04.075.
[4821]	M. Modi, R. Nilkanthe, P. Trivedi, A. Shah, J. Shah, and J. Chaudhari, “Importance of intraoperative consultation for the diagnosis of central nervous system lesions and evaluation of its diagnostic accuracy,” J Cancer Res Ther, vol. 14, no. 6, pp. 1176–1179, Dec. 2018, doi: 10.4103/0973-1482.191034.
[4822]	E. Svansdottir, S. A. Arngrimsson, T. Sveinsson, and E. Johannsson, “Importance of physical health and health-behaviors in adolescence for risk of dropout from secondary education in young adulthood: an 8-year prospective study,” Int J Equity Health, vol. 14, p. 140, Nov. 2015, doi: 10.1186/s12939-015-0272-x.
[4823]	K. Kohl et al., “Importance of polyphosphate in the Leishmania life cycle,” Microb Cell, vol. 5, no. 8, pp. 371–384, Jun. 2018, doi: 10.15698/mic2018.08.642.
[4824]	C. Leithead et al., “Importance of postprocedural Wound, Ischemia, and foot Infection (WIfI) restaging in predicting limb salvage,” J. Vasc. Surg., vol. 67, no. 2, pp. 498–505, 2018, doi: 10.1016/j.jvs.2017.07.109.
[4825]	P. Bottermann, “[Important aspects in social and working life in persons with diabetes mellitus],” MMW Fortschr Med, vol. 150, no. 5, pp. 42–44, Jan. 2008, doi: 10.1007/BF03365319.
[4826]	J. Marotti, J. Broeckmann, F. Chuembou Pekam, L. Praça, K. Radermacher, and S. Wolfart, “Impression of Subgingival Dental Preparation Can Be Taken with Ultrasound,” Ultrasound Med Biol, vol. 45, no. 2, pp. 558–567, 2019, doi: 10.1016/j.ultrasmedbio.2018.09.027.
[4827]	W. Zhu, X. Jin, J. Ni, B. Wei, and Z. Lu, “Improve word embedding using both writing and pronunciation,” PLoS ONE, vol. 13, no. 12, p. e0208785, 2018, doi: 10.1371/journal.pone.0208785.
[4828]	H. Ip, S. M. Z. Hyder, F. Haseen, M. Rahman, and S. H. Zlotkin, “Improved adherence and anaemia cure rates with flexible administration of micronutrient Sprinkles: a new public health approach to anaemia control,” Eur J Clin Nutr, vol. 63, no. 2, pp. 165–172, Feb. 2009, doi: 10.1038/sj.ejcn.1602917.
[4829]	M. S. Lin and T. Head-Gordon, “Improved Energy Selection of Nativelike Protein Loops from Loop Decoys,” J Chem Theory Comput, vol. 4, no. 3, pp. 515–521, Mar. 2008, doi: 10.1021/ct700292u.
[4830]	S. L. Flesher and R. S. Domanico, “Improved growth and development in premature infants managed with nasal continuous positive airway pressure,” W V Med J, vol. 110, no. 2, pp. 14, 16–18, Apr. 2014.
[4831]	M. D. Agrawal et al., “Improved hepatic arterial phase MRI with 3-second temporal resolution,” J Magn Reson Imaging, vol. 37, no. 5, pp. 1129–1136, May 2013, doi: 10.1002/jmri.23920.
[4832]	P. G. Jakeman, T. E. Hills, A. B. Tedcastle, Y. Di, K. D. Fisher, and L. W. Seymour, “Improved in vitro human tumor models for cancer gene therapy,” Hum. Gene Ther., vol. 26, no. 5, pp. 249–256, May 2015, doi: 10.1089/hum.2015.028.
[4833]	J. M. de Almeida and C. R. Miranda, “Improved oil recovery in nanopores: NanoIOR,” Sci Rep, vol. 6, p. 28128, 20 2016, doi: 10.1038/srep28128.
[4834]	T. Tsai, Y.-T. Yang, T.-H. Wang, H.-F. Chien, and C.-T. Chen, “Improved photodynamic inactivation of gram-positive bacteria using hematoporphyrin encapsulated in liposomes and micelles,” Lasers Surg Med, vol. 41, no. 4, pp. 316–322, Apr. 2009, doi: 10.1002/lsm.20754.
[4835]	L. A. Ross, D. McCoy, H. B. Coslett, I. R. Olson, and D. A. Wolk, “Improved proper name recall in aging after electrical stimulation of the anterior temporal lobes,” Front Aging Neurosci, vol. 3, p. 16, 2011, doi: 10.3389/fnagi.2011.00016.
[4836]	P. Maier, D. Böhringer, F. Birnbaum, and T. Reinhard, “Improved wound stability of top-hat profiled femtosecond laser-assisted penetrating keratoplasty in vitro,” Cornea, vol. 31, no. 8, pp. 963–966, Aug. 2012, doi: 10.1097/ICO.0b013e3182400048.
[4837]	T. L. Neoh, T. Tanimoto, S. Ikefuji, H. Yoshii, and T. Furuta, “Improvement of antifungal activity of 10-undecyn-1-ol by inclusion complexation with cyclodextrin derivatives,” J. Agric. Food Chem., vol. 56, no. 10, pp. 3699–3705, May 2008, doi: 10.1021/jf0731898.
[4838]	S. Bru, J. Jiménez, D. Canadell, J. Ariño, and J. Clotet, “Improvement of biochemical methods of polyP quantification,” Microb Cell, vol. 4, no. 1, pp. 6–15, Dec. 2016, doi: 10.15698/mic2017.01.551.
[4839]	A. Matsuda et al., “Improvement of criteria for refractory cytopenia with multilineage dysplasia according to the WHO classification based on prognostic significance of morphological features in patients with refractory anemia according to the FAB classification,” Leukemia, vol. 21, no. 4, pp. 678–686, Apr. 2007, doi: 10.1038/sj.leu.2404571.
[4840]	Z. Liang, M. Zhang, Q. Mao, B. Yu, and B. Ma, “Improvement of Eco-Efficiency in China: A Comparison of Mandatory and Hybrid Environmental Policy Instruments,” Int J Environ Res Public Health, vol. 15, no. 7, 12 2018, doi: 10.3390/ijerph15071473.
[4841]	M. Aufderheide, W.-D. Heller, O. Krischenowski, N. Möhle, and D. Hochrainer, “Improvement of the CULTEX® exposure technology by radial distribution of the test aerosol,” Exp. Toxicol. Pathol., vol. 69, no. 6, pp. 359–365, Jul. 2017, doi: 10.1016/j.etp.2017.02.004.
[4842]	C. E. Irwin, “Improving Adolescent Sexual and Reproductive Health and Rights: Reflections on the Past 25 Years,” J Adolesc Health, vol. 65, no. 6, pp. 713–714, 2019, doi: 10.1016/j.jadohealth.2019.09.012.
[4843]	J. M. Onoye et al., “Improving assessment of race, ethnicity, and culture to further veteran PTSD research,” Psychol Trauma, vol. 9, no. 2, pp. 222–229, 2017, doi: 10.1037/tra0000181.
[4844]	N. Haenn, B. Schmook, Y. Reyes, and S. Calmé, “Improving conservation outcomes with insights from local experts and bureaucracies,” Conserv. Biol., vol. 28, no. 4, pp. 951–958, Aug. 2014, doi: 10.1111/cobi.12265.
[4845]	N. Kamal et al., “Improving Door-to-Needle Times for Acute Ischemic Stroke: Effect of Rapid Patient Registration, Moving Directly to Computed Tomography, and Giving Alteplase at the Computed Tomography Scanner,” Circ Cardiovasc Qual Outcomes, vol. 10, no. 1, 2017, doi: 10.1161/CIRCOUTCOMES.116.003242.
[4846]	M. Boele van Hensbroek and M. van Furth, “Improving Global Child Health in the Light of the (Old) Millennium Development Goals and the (New) Sustainable Development Goals,” Pediatr. Infect. Dis. J., vol. 35, no. 8, pp. 918–919, 2016, doi: 10.1097/INF.0000000000001219.
[4847]	T. Nordam, C. J. Beegle-Krause, J. Skancke, R. Nepstad, and M. Reed, “Improving oil spill trajectory modelling in the Arctic,” Mar. Pollut. Bull., vol. 140, pp. 65–74, Mar. 2019, doi: 10.1016/j.marpolbul.2019.01.019.
[4848]	K. Piper, J. Morphet, and J. Bonnamy, “Improving student-centered feedback through self-assessment,” Nurse Educ Today, vol. 83, p. 104193, Dec. 2019, doi: 10.1016/j.nedt.2019.08.011.
[4849]	E. Saouter et al., “Improving substance information in USEtox® , part 1: Discussion on data and approaches for estimating freshwater ecotoxicity effect factors,” Environ. Toxicol. Chem., vol. 36, no. 12, pp. 3450–3462, 2017, doi: 10.1002/etc.3889.
[4850]	C. Ogg, “Improving the quality of data used in environmental economics research,” Qual Assur, vol. 8, no. 3–4, pp. 169–179, Dec. 2000, doi: 10.1080/10529410052852321.
[4851]	G. Yamey, M. Schäferhoff, and K. Kennedy, “Improving tracking of aid for women’s, children’s, and adolescents’ health,” Lancet Glob Health, vol. 6, no. 8, pp. e814–e815, 2018, doi: 10.1016/S2214-109X(18)30320-6.
[4852]	S. Arulkumaran and T. Johnson, “Improving women’s health,” Int J Gynaecol Obstet, vol. 119 Suppl 1, pp. S1-2, Oct. 2012, doi: 10.1016/j.ijgo.2012.05.013.
[4853]	X. Li, J. Cao, and D. W. C. Ho, “Impulsive Control of Nonlinear Systems With Time-Varying Delay and Applications,” IEEE Trans Cybern, vol. 50, no. 6, pp. 2661–2673, Jun. 2020, doi: 10.1109/TCYB.2019.2896340.
[4854]	S. Fovargue and M. Neal, “‘In good conscience’: conscience-based exemptions and proper medical treatment,” Med Law Rev, vol. 23, no. 2, pp. 221–241, 2015, doi: 10.1093/medlaw/fwv007.
[4855]	N. C. Doherty et al., “In Helicobacter pylori, LuxS is a key enzyme in cysteine provision through a reverse transsulfuration pathway,” J. Bacteriol., vol. 192, no. 5, pp. 1184–1192, Mar. 2010, doi: 10.1128/JB.01372-09.
[4856]	R. K. Hopper et al., “In Pulmonary Arterial Hypertension, Reduced BMPR2 Promotes Endothelial-to-Mesenchymal Transition via HMGA1 and Its Target Slug,” Circulation, vol. 133, no. 18, pp. 1783–1794, May 2016, doi: 10.1161/CIRCULATIONAHA.115.020617.
[4857]	E. Haagensen and N. C. Lind, “IN REPLY,” Isis, vol. 107, no. 1, pp. 132–133, Mar. 2016, doi: 10.1086/686179.
[4858]	Q. Xu, M. Kong, and J. Huang, “In Response to ‘Regional Cerebral Oxygen Saturation and Mortality in Patients with Left Ventricular Assist Device,’” J. Cardiothorac. Vasc. Anesth., vol. 33, no. 7, pp. 2107–2108, 2019, doi: 10.1053/j.jvca.2019.02.024.
[4859]	J. Langerman, S. G. Doukas, H. Hasegawa, J. Goodrich, M. Lerner, and C. Sasaki, “In search of a longitudinal animal model of evoked swallow function,” Laryngoscope Investig Otolaryngol, vol. 3, no. 3, pp. 191–197, Jun. 2018, doi: 10.1002/lio2.161.
[4860]	J. T. O’Malley-James, J. S. Greaves, J. A. Raven, and C. S. Cockell, “In search of future earths: assessing the possibility of finding Earth analogues in the later stages of their habitable lifetimes,” Astrobiology, vol. 15, no. 5, pp. 400–411, May 2015, doi: 10.1089/ast.2014.1229.
[4861]	J. Lee et al., “In Situ Deprotection of Polymeric Binders for Solution-Processible Sulfide-Based All-Solid-State Batteries,” Adv. Mater. Weinheim, p. e2001702, Aug. 2020, doi: 10.1002/adma.202001702.
[4862]	M. Yamashita, M. Matsuda, and T. Mori, “In situ detection of prolactin receptor mRNA and apoptotic cell death in mouse uterine tissues with adenomyosis,” In Vivo, vol. 13, no. 1, pp. 57–60, Feb. 1999.
[4863]	M. Oborník, “In the beginning was the word: How terminology drives our understanding of endosymbiotic organelles,” Microb Cell, vol. 6, no. 2, pp. 134–141, Jan. 2019, doi: 10.15698/mic2019.02.669.
[4864]	Y. Su, R. R. Eason, Y. Geng, S. R. Till, T. M. Badger, and R. C. M. Simmen, “In utero exposure to maternal diets containing soy protein isolate, but not genistein alone, protects young adult rat offspring from NMU-induced mammary tumorigenesis,” Carcinogenesis, vol. 28, no. 5, pp. 1046–1051, May 2007, doi: 10.1093/carcin/bgl240.
[4865]	M. Z. Scelza, I. P. Caldas, J. M. de Mattos, F. Oliveira, W. Carvalho, and G. G. Alves, “In Vitro Analysis of the Cytotoxicity of Indirect Restorative Materials,” Braz Dent J, vol. 29, no. 5, pp. 507–512, Oct. 2018, doi: 10.1590/0103-6440201801919.
[4866]	Y. Obana, H. Hashizume, A. Yoshimi, and T. Nishino, “In vitro and in vivo antibacterial activity of KY-109, a new orally active cephalosporin,” J. Antibiot., vol. 41, no. 7, pp. 949–958, Jul. 1988, doi: 10.7164/antibiotics.41.949.
[4867]	N. K. Dutta, K. Mazumdar, S. G. Dastidar, A. N. Chakrabarty, Y. Shirataki, and N. Motohashi, “In vitro and in vivo antimycobacterial activity of an antihypertensive agent methyl-L-DOPA,” In Vivo, vol. 19, no. 3, pp. 539–545, Jun. 2005.
[4868]	S. Geboers, J. Stappaerts, J. Tack, P. Annaert, and P. Augustijns, “In vitro and in vivo investigation of the gastrointestinal behavior of simvastatin,” Int J Pharm, vol. 510, no. 1, pp. 296–303, Aug. 2016, doi: 10.1016/j.ijpharm.2016.06.048.
[4869]	W. D. Segura et al., “In vitro and in vivo persistence of IncN plasmids carrying qnr genes in uropathogenic Escherichia coli isolates,” J Glob Antimicrob Resist, vol. 22, pp. 806–810, Jul. 2020, doi: 10.1016/j.jgar.2020.07.006.
[4870]	L. L. Coriell, R. M. McALLISTER, A. Greene, W. Flagg, M. Tall, and B. Wagner, “In vitro and in vivo studies on a tissue culture cell line derived from normal monkey heart,” J. Immunol., vol. 80, no. 2, pp. 142–148, Feb. 1958.
[4871]	H. Takahashi et al., “In vitro and in vivo transfer of bcl-2 gene into keratinocytes suppresses UVB-induced apoptosis,” Photochem. Photobiol., vol. 74, no. 4, pp. 579–586, Oct. 2001, doi: 10.1562/0031-8655(2001)074<0579:ivaivt>2.0.co;2.
[4872]	C. Xiong, Q. Li, S. Li, C. Chen, Z. Chen, and W. Huang, “In vitro Antimicrobial Activities and Mechanism of 1-Octen-3-ol against Food-related Bacteria and Pathogenic Fungi,” J Oleo Sci, vol. 66, no. 9, pp. 1041–1049, Sep. 2017, doi: 10.5650/jos.ess16196.
[4873]	M. Gielen et al., “In vitro antiproliferative effects, toxicity profiles in vivo in mice and antitumour activity in tumour-bearing mice of five organotin compounds,” In Vivo, vol. 9, no. 1, pp. 59–63, Feb. 1995.
[4874]	M. Dusinska et al., “In Vitro Approaches for Assessing the Genotoxicity of Nanomaterials,” Methods Mol. Biol., vol. 1894, pp. 83–122, 2019, doi: 10.1007/978-1-4939-8916-4_6.
[4875]	H. F. S. do Nascimento et al., “In vitro assessment of anticytotoxic and antigenotoxic effects of CANOVA(®),” Homeopathy, vol. 105, no. 3, pp. 265–269, Aug. 2016, doi: 10.1016/j.homp.2016.04.003.
[4876]	B. Sulaiman Ghandourah et al., “In Vitro Caries Models for the Assessment of Novel Restorative Materials,” Methods Mol. Biol., vol. 1922, pp. 369–377, 2019, doi: 10.1007/978-1-4939-9012-2_33.
[4877]	R. K. Sajja, P. Cudic, and L. Cucullo, “In vitro characterization of odorranalectin for peptide-based drug delivery across the blood-brain barrier,” BMC Neurosci, vol. 20, no. 1, p. 22, 08 2019, doi: 10.1186/s12868-019-0504-x.
[4878]	M. De Colli et al., “In vitro comparison of new bisphosphonic acids and zoledronate effects on human gingival fibroblasts viability, inflammation and matrix turnover,” Clin Oral Investig, vol. 20, no. 8, pp. 2013–2021, Nov. 2016, doi: 10.1007/s00784-015-1690-2.
[4879]	M. E. McCLAIN, S. H. Madin, and P. C. Andriese, “In vitro cultivation and cytopathogenicity of vesicular exanthema virus,” Proc. Soc. Exp. Biol. Med., vol. 86, no. 4, pp. 771–774, Sep. 1954, doi: 10.3181/00379727-86-21229.
[4880]	C. L. Foote and F. M. Foote, “In vitro cultivation of gonads of larval anurans,” Anat. Rec., vol. 130, no. 3, pp. 553–565, Mar. 1958, doi: 10.1002/ar.1091300307.
[4881]	N. Purshottam and G. Pincus, “In vitro cultivation of mammalian eggs,” Anat. Rec., vol. 140, pp. 51–55, May 1961, doi: 10.1002/ar.1091400108.
[4882]	W. Lefkowitz and P. Swayne, “In vitro cultivation of rat molar tooth germs.  II,” J. Dent. Res., vol. 35, no. 4, pp. 523–532, Aug. 1956, doi: 10.1177/00220345560350040501.
[4883]	V. Pipitone, G. Destasio, and R. Russo, “[IN VITRO CULTURE OF LYMPHOCYTES IN THE STUDY OF CELLULAR IMMUNITY],” Folia Allergol (Roma), vol. 12, pp. 137–141, Apr. 1965.
[4884]	G. Attardi and F. Moro, “[In vitro culture of malignant melanoma of the choroid],” Arch De Vecchi Anat Patol, vol. 20, no. 1, pp. 125–180, Nov. 1953.
[4885]	R. Sparrow, “In vitro eugenics,” J Med Ethics, vol. 40, no. 11, pp. 725–731, Nov. 2014, doi: 10.1136/medethics-2012-101200.
[4886]	B. Heiser, E. B. Okrasinski, R. Murray, and K. McCord, “In Vitro Evaluation of Evacuated Blood Collection Tubes as a Closed-Suction Surgical Drain Reservoir,” J Am Anim Hosp Assoc, vol. 54, no. 1, pp. 30–35, Feb. 2018, doi: 10.5326/JAAHA-MS-6519.
[4887]	E. Williams and W. Linert, “In vitro evidence supporting the therapeutic role of nicotine against neurodegeneration,” In Vivo, vol. 18, no. 3, pp. 391–399, Jun. 2004.
[4888]	A. C. Hinton and B. D. Hammock, “In vitro expression and biochemical characterization of juvenile hormone esterase from Manduca sexta,” Insect Biochem. Mol. Biol., vol. 33, no. 3, pp. 317–329, Mar. 2003, doi: 10.1016/s0965-1748(02)00246-1.
[4889]	H. M. Martin and B. O. Vidler, “In vitro growth of tick tissues (Rhipicephalus appendiculatus Neumann, 1901),” Exp. Parasitol., vol. 12, pp. 192–203, Jun. 1962, doi: 10.1016/0014-4894(62)90057-7.
[4890]	J.-E. Shin, J.-M. Kim, E.-A. Bae, Y.-J. Hyun, and D.-H. Kim, “In vitro inhibitory effect of flavonoids on growth, infection and vacuolation of Helicobacter pylori,” Planta Med., vol. 71, no. 3, pp. 197–201, Mar. 2005, doi: 10.1055/s-2005-837816.
[4891]	P. Ebbesen, F. D. Toth, J. A. Villadsen, and N. Nørskov-Lauritsen, “In vitro interferon and virus production at in vivo physiologic oxygen tensions,” In Vivo, vol. 5, no. 4, pp. 355–358, Aug. 1991.
[4892]	A. J. Miller and J. R. Spence, “In Vitro Models to Study Human Lung Development, Disease and Homeostasis,” Physiology (Bethesda), vol. 32, no. 3, pp. 246–260, 2017, doi: 10.1152/physiol.00041.2016.
[4893]	A. J. Hill et al., “In vitro studies of human hearts,” Ann. Thorac. Surg., vol. 79, no. 1, pp. 168–177, Jan. 2005, doi: 10.1016/j.athoracsur.2004.06.080.
[4894]	M. Rottke, D. J. Lunter, and R. Daniels, “In vitro studies on release and skin permeation of nonivamide from novel oil-in-oil-emulsions,” Eur J Pharm Biopharm, vol. 86, no. 2, pp. 260–266, Feb. 2014, doi: 10.1016/j.ejpb.2013.09.018.
[4895]	O. C. Croxatto, A. Lanari, and M. Molins, “[In vitro survival of bronchial cells in contact with autologous and homologous sera],” Medicina (B Aires), vol. 15, no. 2, pp. 90–93, Apr. 1955.
[4896]	G. T. Cuba et al., “In vitro synergy of ceftolozane/tazobactam in combination with fosfomycin or aztreonam against MDR Pseudomonas aeruginosa,” J. Antimicrob. Chemother., vol. 75, no. 7, pp. 1874–1878, Jul. 2020, doi: 10.1093/jac/dkaa095.
[4897]	A. Ghallab and H. M. Bolt, “In vitro systems: current limitations and future perspectives,” Arch. Toxicol., vol. 88, no. 12, pp. 2085–2087, Dec. 2014, doi: 10.1007/s00204-014-1404-6.
[4898]	A. A. Elzagallaai and M. J. Rieder, “In vitro testing for diagnosis of idiosyncratic adverse drug reactions: Implications for pathophysiology,” Br J Clin Pharmacol, vol. 80, no. 4, pp. 889–900, Oct. 2015, doi: 10.1111/bcp.12505.
[4899]	B. J. Blaauboer, “In vitro, ex vivo, in vivo toxicology, the terminology issue,” Toxicol In Vitro, vol. 45, no. Pt 1, pp. iii–iv, 2017, doi: 10.1016/j.tiv.2017.09.028.
[4900]	Z. Ćetković, S. Cvijić, and D. Vasiljević, “In vitro/in silico approach in the development of simvastatin-loaded self-microemulsifying drug delivery systems,” Drug Dev Ind Pharm, vol. 44, no. 5, pp. 849–860, May 2018, doi: 10.1080/03639045.2017.1414835.
[4901]	G. S. Caglar, M. Hammadeh, B. Asimakopoulos, N. Nikolettos, K. Diedrich, and S. Al-Hassani, “In vivo and in vitro decondensation of human sperm and assisted reproduction technologies,” In Vivo, vol. 19, no. 3, pp. 623–630, Jun. 2005.
[4902]	C. S. Tsao, W. B. Dunham, and P. Y. Leung, “In vivo antineoplastic activity of ascorbic acid for human mammary tumor,” In Vivo, vol. 2, no. 2, pp. 147–150, Apr. 1988.
[4903]	V. Quemener et al., “In vivo antitumor activity of 4-amino 4-methyl 2-pentyne 1-al, an inhibitor of aldehyde dehydrogenase,” In Vivo, vol. 3, no. 5, pp. 325–330, Oct. 1989.
[4904]	F. A. Harms and E. G. Mik, “In vivo assessment of mitochondrial oxygen consumption,” Methods Mol. Biol., vol. 1264, pp. 219–229, 2015, doi: 10.1007/978-1-4939-2257-4_20.
[4905]	W. C. Rose, J. B. Huftalen, W. T. Bradner, and J. E. Schurig, “In vivo characterization of P388 leukemia resistant to mitomycin C,” In Vivo, vol. 1, no. 1, pp. 47–52, Feb. 1987.
[4906]	P. Lemieux, M. Pagé, and C. Noël, “In vivo cytotoxicity and antineoplastic activity of a transferrin-daunorubicin conjugate,” In Vivo, vol. 6, no. 6, pp. 621–627, Dec. 1992.
[4907]	Z. Steplewski, C. Rosales, K. A. Jeglum, and J. McDonald-Smith, “In vivo destruction of canine lymphoma mediated by murine monoclonal antibodies,” In Vivo, vol. 4, no. 4, pp. 231–234, Aug. 1990.
[4908]	Y. Chin, J. Janssens, J. Bleus, J. Zhang, and J. Raus, “In vivo distribution of radio-labeled tumor infiltrating lymphocytes in cancer patients,” In Vivo, vol. 7, no. 1, pp. 27–30, Feb. 1993.
[4909]	V. S. Aboobaker, A. D. Balgi, and R. K. Bhattacharya, “In vivo effect of dietary factors on the molecular action of aflatoxin B1: role of non-nutrient phenolic compounds on the catalytic activity of liver fractions,” In Vivo, vol. 8, no. 6, pp. 1095–1098, Dec. 1994.
[4910]	I. Szanyi et al., “In vivo effects of afobazole (2-mercaptobenzimidazole derivative) on the 7,12-dimethylbenz [alpha]anthracene-induced oncogene and suppressor gene expression,” In Vivo, vol. 21, no. 6, pp. 1059–1063, Dec. 2007.
[4911]	I. Ember, I. Kiss, and T. Raposa, “In vivo effects of COPP protocol on onco- and suppressor gene expression in a ‘follow up study,’” In Vivo, vol. 11, no. 5, pp. 399–402, Oct. 1997.
[4912]	C. S. Johnson, P. G. Braunschweiger, and P. Furmanski, “In vivo effects of recombinant human and murine interleukin-1 alpha (IL-1 alpha) on murine hematopoiesis,” In Vivo, vol. 4, no. 2, pp. 93–96, Apr. 1990.
[4913]	E. Kamimura, S. Tanaka, M. Takaba, K. Tachi, and K. Baba, “In vivo evaluation of inter-operator reproducibility of digital dental and conventional impression techniques,” PLoS ONE, vol. 12, no. 6, p. e0179188, 2017, doi: 10.1371/journal.pone.0179188.
[4914]	L. K. Jensen et al., “In Vivo Gentamicin Susceptibility Test for Prevention of Bacterial Biofilms in Bone Tissue and on Implants,” Antimicrob. Agents Chemother., vol. 63, no. 2, 2019, doi: 10.1128/AAC.01889-18.
[4915]	L. Somerville, A. H. Cory, and J. G. Cory, “In vivo growth of mouse leukemia L1210 cells with metabolic alterations in the subunits of ribonucleotide reductase,” In Vivo, vol. 16, no. 3, pp. 175–177, Jun. 2002.
[4916]	A. Halapas et al., “In vivo models for heart failure research,” In Vivo, vol. 22, no. 6, pp. 767–780, Dec. 2008.
[4917]	N. Mucci et al., “In vivo modulation of ETS genes induced by electromagnetic fields,” In Vivo, vol. 15, no. 6, pp. 489–494, Dec. 2001.
[4918]	G. C. Langhout et al., “In vivo nerve identification in head and neck surgery using diffuse reflectance spectroscopy,” Laryngoscope Investig Otolaryngol, vol. 3, no. 5, pp. 349–355, Oct. 2018, doi: 10.1002/lio2.174.
[4919]	A. Ender, M. Zimmermann, T. Attin, and A. Mehl, “In vivo precision of conventional and digital methods for obtaining quadrant dental impressions,” Clin Oral Investig, vol. 20, no. 7, pp. 1495–1504, Sep. 2016, doi: 10.1007/s00784-015-1641-y.
[4920]	J. P. Ternaux, A. Boireau, S. Bourgoin, M. Hamon, F. Hery, and J. Glowinski, “In vivo release of 5-HT in the lateral ventricle of the rat: effects of 5-hydroxytryptophan and tryptophan,” Brain Res., vol. 101, no. 3, pp. 533–548, Jan. 1976, doi: 10.1016/0006-8993(76)90476-5.
[4921]	R. Seabra and N. Bhogal, “In vivo research using early life stage models,” In Vivo, vol. 24, no. 4, pp. 457–462, Aug. 2010.
[4922]	J. Hsiao et al., “In Vivo Rodent Models for Studying Dental Caries and Pulp Disease,” Methods Mol. Biol., vol. 1922, pp. 393–403, 2019, doi: 10.1007/978-1-4939-9012-2_35.
[4923]	S. R. Grobler, A. Majeed, M. H. Moola, R. J. Rossouw, and T. van Wyk Kotze, “In vivo Spectrophotometric Assessment of the Tooth Whitening Effectiveness of Nite White 10% with Amorphous Calcium Phosphate, Potassium Nitrate and Fluoride, Over a 6-month Period,” Open Dent J, vol. 5, pp. 18–23, Mar. 2011, doi: 10.2174/1874210601105010018.
[4924]	S. J. Teipel et al., “In vivo staging of regional amyloid deposition predicts functional conversion in the preclinical and prodromal phases of Alzheimer’s disease,” Neurobiol. Aging, vol. 93, pp. 98–108, Sep. 2020, doi: 10.1016/j.neurobiolaging.2020.03.011.
[4925]	J. K. Holodinsky et al., “In What Scenarios Does a Mobile Stroke Unit Predict Better Patient Outcomes?: A Modeling Study,” Stroke, vol. 51, no. 6, pp. 1805–1812, Jun. 2020, doi: 10.1161/STROKEAHA.119.028474.
[4926]	J. S. Marschall et al., “In-House Digital Workflow for the Management of Acute Mandible Fractures,” J. Oral Maxillofac. Surg., vol. 77, no. 10, p. 2084.e1-2084.e9, Oct. 2019, doi: 10.1016/j.joms.2019.05.027.
[4927]	P.-Y. Lin, Y.-W. Cheng, C.-Y. Chu, K.-L. Chien, C.-P. Lin, and Y.-K. Tu, “In-office treatment for dentin hypersensitivity: a systematic review and network meta-analysis,” J. Clin. Periodontol., vol. 40, no. 1, pp. 53–64, Jan. 2013, doi: 10.1111/jcpe.12011.
[4928]	J. I. Urgel et al., “In-Situ Growth of Gadolinium Phthalocyaninato Sandwich Complexes on the Ag(111) Surface,” Chemphyschem, vol. 20, no. 18, pp. 2301–2304, 17 2019, doi: 10.1002/cphc.201900253.
[4929]	F. Sivandzade and L. Cucullo, “In-vitro blood-brain barrier modeling: A review of modern and fast-advancing technologies,” J. Cereb. Blood Flow Metab., vol. 38, no. 10, pp. 1667–1681, 2018, doi: 10.1177/0271678X18788769.
[4930]	C. A. Shea, R. E. Ward, S. A. Welch, D. K. Kiely, R. Goldstein, and J. F. Bean, “Inability to Perform the Repeated Chair Stand Task Predicts Fall-Related Injury in Older Primary Care Patients,” Am J Phys Med Rehabil, vol. 97, no. 6, pp. 426–432, 2018, doi: 10.1097/PHM.0000000000000889.
[4931]	I. Hide and S. Yamawaki, “Inactivation of presynaptic 5-HT autoreceptors by lithium in rat hippocampus,” Neurosci. Lett., vol. 107, no. 1–3, pp. 323–326, Dec. 1989, doi: 10.1016/0304-3940(89)90839-2.
[4932]	A. L. Asher et al., “Inadequacy of 3-month Oswestry Disability Index outcome for assessing individual longer-term patient experience after lumbar spine surgery,” J Neurosurg Spine, vol. 25, no. 2, pp. 170–180, Aug. 2016, doi: 10.3171/2015.11.SPINE15872.
[4933]	J. D. Rummel and C. A. Conley, “Inadvertently Finding Earth Contamination on Mars Should Not Be a Priority for Anyone,” Astrobiology, vol. 18, no. 2, pp. 108–115, 2018, doi: 10.1089/ast.2017.1785.
[4934]	Q.-Z. Li et al., “InAs/GaAs Quantum Dot Dual-Mode Distributed Feedback Laser Towards Large Tuning Range Continuous-Wave Terahertz Application,” Nanoscale Res Lett, vol. 13, no. 1, p. 267, Sep. 2018, doi: 10.1186/s11671-018-2674-3.
[4935]	S. L. Goldberg et al., “Incidence and clinical complications of myelodysplastic syndromes among United States Medicare beneficiaries,” J. Clin. Oncol., vol. 28, no. 17, pp. 2847–2852, Jun. 2010, doi: 10.1200/JCO.2009.25.2395.
[4936]	V. Ortiz-Soriano et al., “Incidence and Cost of Acute Kidney Injury in Hospitalized Patients with Infective Endocarditis,” J Clin Med, vol. 8, no. 7, Jun. 2019, doi: 10.3390/jcm8070927.
[4937]	W. A. Goudriaan, G. J. Harsevoort, M. van Leeuwen, A. A. Franken, and G. J. M. Janus, “Incidence and treatment of femur fractures in adults with osteogenesis imperfecta: an analysis of an expert clinic of 216 patients,” Eur J Trauma Emerg Surg, vol. 46, no. 1, pp. 165–171, Feb. 2020, doi: 10.1007/s00068-018-1005-9.
[4938]	M. Karvonen, M. Viik-Kajander, E. Moltchanova, I. Libman, R. LaPorte, and J. Tuomilehto, “Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group,” Diabetes Care, vol. 23, no. 10, pp. 1516–1526, Oct. 2000, doi: 10.2337/diacare.23.10.1516.
[4939]	M. P. Oksvold, “Incidence of Data Duplications in a Randomly Selected Pool of Life Science Publications,” Sci Eng Ethics, vol. 22, no. 2, pp. 487–496, Apr. 2016, doi: 10.1007/s11948-015-9668-7.
[4940]	J. J. I. Van den Heurck, K. B. M. Boven, J. Van Looveren, D. G. P. Mathysen, I. Chiairi, and M.-J. Tassignon, “Incidence of rhegmatogenous retinal detachment after bag-in-the-lens IOL implantation: extended follow-up in a larger cohort of patients,” J Cataract Refract Surg, vol. 46, no. 6, pp. 820–826, Jun. 2020, doi: 10.1097/j.jcrs.0000000000000164.
[4941]	S. Torres, L. B. Perdiz, and E. A. Medeiros, “Incidence of surgical site infection after craniotomy: comparison between three months and twelve months of epidemiological surveillance,” Braz J Infect Dis, vol. 22, no. 5, pp. 433–437, Oct. 2018, doi: 10.1016/j.bjid.2018.08.001.
[4942]	M. W. Sherwood et al., “Incidence, Temporal Trends, and Associated Outcomes of Vascular and Bleeding Complications in Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapies Registry,” Circ Cardiovasc Interv, vol. 13, no. 1, p. e008227, 2020, doi: 10.1161/CIRCINTERVENTIONS.119.008227.
[4943]	M.-A. Martinie, Y. Almecija, C. Ros, and S. Gil, “Incidental mood state before dissonance induction affects attitude change,” PLoS ONE, vol. 12, no. 7, p. e0180531, 2017, doi: 10.1371/journal.pone.0180531.
[4944]	M. H. Fritsch, “Incisionless otoplasty,” Facial Plast Surg, vol. 20, no. 4, pp. 267–270, Nov. 2004, doi: 10.1055/s-2005-865384.
[4945]	M. H. Fritsch, “Incisionless otoplasty,” Otolaryngol. Clin. North Am., vol. 42, no. 6, pp. 1199–1208, Table of Contents, Dec. 2009, doi: 10.1016/j.otc.2009.09.003.
[4946]	G. L. Christeson, K. D. McIntosh, and J. A. Karson, “Inconsistent correlation of seismic layer 2a and lava layer thickness in oceanic crust,” Nature, vol. 445, no. 7126, pp. 418–421, Jan. 2007, doi: 10.1038/nature05517.
[4947]	J. Sorz, B. Wallner, H. Seidler, and M. Fieder, “Inconsistent year-to-year fluctuations limit the conclusiveness of global higher education rankings for university management,” PeerJ, vol. 3, p. e1217, 2015, doi: 10.7717/peerj.1217.
[4948]	K. Anargyrou, T. P. Vassilakopoulos, M. K. Angelopoulou, and E. Terpos, “Incorporating novel agents in the treatment of myelodysplastic syndromes,” Leuk. Res., vol. 34, no. 1, pp. 6–17, Jan. 2010, doi: 10.1016/j.leukres.2009.07.021.
[4949]	K. Handmaker, “Incorporating social determinants into population health management,” Healthc Financ Manage, vol. 71, no. 3, pp. 60–64, Mar. 2017.
[4950]	T. Swezey et al., “Incorporating the patient perspective in the study of rare bone disease: insights from the osteogenesis imperfecta community,” Osteoporos Int, vol. 30, no. 2, pp. 507–511, Feb. 2019, doi: 10.1007/s00198-018-4690-7.
[4951]	E. K. Bekedam, H. A. Schols, M. A. J. S. Van Boekel, and G. Smit, “Incorporation of chlorogenic acids in coffee brew melanoidins,” J. Agric. Food Chem., vol. 56, no. 6, pp. 2055–2063, Mar. 2008, doi: 10.1021/jf073157k.
[4952]	H. Wrba, R. Kageyama,  null Rabesh, and A. Geipel, “[Incorporation of labelled substance by cells in vitro as a measure of the suitability of the culture medium],” Z Zellforsch Mikrosk Anat, vol. 57, pp. 371–375, 1962.
[4953]	Y. Takei et al., “Increase in circulating ACE-positive endothelial microparticles during acute lung injury,” Eur. Respir. J., vol. 54, no. 4, 2019, doi: 10.1183/13993003.01188-2018.
[4954]	K. Chen et al., “Increased 15-lipoxygenase-1 expression in chondrocytes contributes to the pathogenesis of osteoarthritis,” Cell Death Dis, vol. 8, no. 10, p. e3109, 12 2017, doi: 10.1038/cddis.2017.511.
[4955]	J. Schmitt et al., “Increased attention-deficit/hyperactivity symptoms in atopic dermatitis are associated with history of antihistamine use,” Allergy, vol. 73, no. 3, pp. 615–626, 2018, doi: 10.1111/all.13326.
[4956]	W. S. Helton and M. Maginnity, “Increased attentiveness is associated with hemispheric asymmetry measured with lateral tympanic membrane temperature in humans and dogs,” Exp Brain Res, vol. 219, no. 3, pp. 321–326, Jun. 2012, doi: 10.1007/s00221-012-3093-9.
[4957]	S. Park, J. A. Harrold, P. S. Widdowson, and G. Williams, “Increased binding at 5-HT(1A), 5-HT(1B), and 5-HT(2A) receptors and 5-HT transporters in diet-induced obese rats,” Brain Res., vol. 847, no. 1, pp. 90–97, Nov. 1999, doi: 10.1016/s0006-8993(99)02055-7.
[4958]	P.-Y. Robillard et al., “Increased BMI has a linear association with late-onset preeclampsia: A population-based study,” PLoS ONE, vol. 14, no. 10, p. e0223888, 2019, doi: 10.1371/journal.pone.0223888.
[4959]	S. Shah et al., “Increased burden of disease and role of health economics: Asia-pacific region,” Expert Rev Pharmacoecon Outcomes Res, vol. 19, no. 5, pp. 517–528, Oct. 2019, doi: 10.1080/14737167.2019.1650643.
[4960]	C. M. Baldwin and I. R. Bell, “Increased cardiopulmonary disease risk in a community-based sample with chemical odor intolerance: implications for women’s health and health-care utilization,” Arch. Environ. Health, vol. 53, no. 5, pp. 347–353, Oct. 1998, doi: 10.1080/00039899809605720.
[4961]	M. L. Conte, S. L. Maat, and M. B. Omary, “Increased co-first authorships in biomedical and clinical publications: a call for recognition,” FASEB J., vol. 27, no. 10, pp. 3902–3904, Oct. 2013, doi: 10.1096/fj.13-235630.
[4962]	N. Nathoo et al., “Increased expression of 5-lipoxygenase in high-grade astrocytomas,” Neurosurgery, vol. 58, no. 2, pp. 347–354; discussion 347-354, Feb. 2006, doi: 10.1227/01.NEU.0000195096.43258.94.
[4963]	B.-K. Kim, H.-Y. Lee, I. Kim, K. Choi, J. Park, and S. K. Yoon, “Increased expression of Dkk1 by HR is associated with alteration of hair cycle in hairpoor mice,” J. Dermatol. Sci., vol. 74, no. 1, pp. 81–87, Apr. 2014, doi: 10.1016/j.jdermsci.2013.12.007.
[4964]	J. Buriticá and E. Alcalá, “Increased generalization in a peak procedure after delayed reinforcement,” Behav. Processes, vol. 169, p. 103978, Dec. 2019, doi: 10.1016/j.beproc.2019.103978.
[4965]	M. Schmidt et al., “Increased in vivo efficacy of lenalidomide and thalidomide by addition of ethacrynic acid,” In Vivo, vol. 25, no. 3, pp. 325–333, Jun. 2011.
[4966]	Y. Kim et al., “Increased in vivo efficacy of lenalidomide by addition of piroctone olamine,” In Vivo, vol. 25, no. 1, pp. 99–103, Feb. 2011.
[4967]	M. I. Huang, M. A. O’Riordan, E. Fitzenrider, L. McDavid, A. R. Cohen, and S. Robinson, “Increased incidence of nonaccidental head trauma in infants associated with the economic recession,” J Neurosurg Pediatr, vol. 8, no. 2, pp. 171–176, Aug. 2011, doi: 10.3171/2011.5.PEDS1139.
[4968]	V. Vardakastani, D. Saletti, W. Skalli, P. Marry, J. M. Allain, and C. Adam, “Increased intra-cortical porosity reduces bone stiffness and strength in pediatric patients with osteogenesis imperfecta,” Bone, vol. 69, pp. 61–67, Dec. 2014, doi: 10.1016/j.bone.2014.09.003.
[4969]	K. Kominato et al., “Increased levels of circulating adrenomedullin following treatment with TU‑100 in patients with Crohn’s disease,” Mol Med Rep, vol. 14, no. 3, pp. 2264–2268, Sep. 2016, doi: 10.3892/mmr.2016.5488.
[4970]	K. A. Kirchner, “Increased loop chloride uptake precedes hypertension in Dahl salt-sensitive rats,” Am. J. Physiol., vol. 262, no. 2 Pt 2, pp. R263-268, Feb. 1992, doi: 10.1152/ajpregu.1992.262.2.R263.
[4971]	T. Ivert, M. Dalén, C. Ander, R. Stålesen, M. Lordkipanidzé, and P. Hjemdahl, “Increased platelet reactivity and platelet-leukocyte aggregation after elective coronary bypass surgery,” Platelets, vol. 30, no. 8, pp. 975–981, 2019, doi: 10.1080/09537104.2018.1542122.
[4972]	R. Saban-Bezalel, N. Coral, and N. Mashal, “Increased reliance on a right hemispheric mechanism during idiom processing in adults with dyslexia,” Laterality, vol. 24, no. 4, pp. 417–431, Jul. 2019, doi: 10.1080/1357650X.2018.1533023.
[4973]	S. Yusuf et al., “Increased sensitivity of the denervated transplanted human heart to isoprenaline both before and after beta-adrenergic blockade,” Circulation, vol. 75, no. 4, pp. 696–704, Apr. 1987, doi: 10.1161/01.cir.75.4.696.
[4974]	N. Kanda and S. Watanabe, “Increased serum human β-defensin-2 levels in atopic dermatitis: relationship to IL-22 and oncostatin M,” Immunobiology, vol. 217, no. 4, pp. 436–445, Apr. 2012, doi: 10.1016/j.imbio.2011.10.010.
[4975]	N. Kanda, T. Ishikawa, M. Kamata, Y. Tada, and S. Watanabe, “Increased serum leucine, leucine-37 levels in psoriasis: positive and negative feedback loops of leucine, leucine-37 and pro- or anti-inflammatory cytokines,” Hum. Immunol., vol. 71, no. 12, pp. 1161–1171, Dec. 2010, doi: 10.1016/j.humimm.2010.09.005.
[4976]	J. Graessler et al., “Increasing plasma lysophosphatidylcholine levels in patients with regular dextran sulfate lipoprotein apheresis,” Atheroscler Suppl, vol. 18, pp. 170–175, May 2015, doi: 10.1016/j.atherosclerosissup.2015.02.026.
[4977]	E. M. Klemperer, J. R. Hughes, and P. W. Callas, “Increasing Quit Attempts by Transitioning to Very Low Nicotine Content Cigarettes Versus Reducing Number of Cigarettes Per Day: A Secondary Analysis of an Exploratory Randomized Trial,” Nicotine Tob. Res., vol. 21, no. Suppl 1, pp. S81–S87, 23 2019, doi: 10.1093/ntr/ntz145.
[4978]	J. Tu, A. McLean-Tooke, and R. Junckerstorff, “Increasing recognition of dermatomyositis with subcutaneous edema - is this a poorer prognostic marker?,” Dermatol. Online J., vol. 20, no. 1, p. 21244, Jan. 2014.
[4979]	P. Gómora-Arrati, O. González-Flores, J. C. Morales-Medina, and B. Komisaruk, “Increasing the antinociceptive effect of ingested glycinamide in female rats by increasing its palatability,” Neurosci. Lett., p. 135314, Aug. 2020, doi: 10.1016/j.neulet.2020.135314.
[4980]	S. Halligan et al., “Incremental benefit of computer-aided detection when used as a second and concurrent reader of CT colonographic data: multiobserver study,” Radiology, vol. 258, no. 2, pp. 469–476, Feb. 2011, doi: 10.1148/radiol.10100354.
[4981]	N. McCormick, C. A. Marra, M. Sadatsafavi, and J. A. Aviña-Zubieta, “Incremental direct medical costs of systemic lupus erythematosus patients in the years preceding diagnosis: A general population-based study,” Lupus, vol. 27, no. 8, pp. 1247–1258, Jul. 2018, doi: 10.1177/0961203318768882.
[4982]	Y. G. Dai, L. E. Miller, R. K. Ramsey, D. L. Robins, D. A. Fein, and T. Dumont-Mathieu, “Incremental Utility of 24-Month Autism Spectrum Disorder Screening After Negative 18-Month Screening,” J Autism Dev Disord, vol. 50, no. 6, pp. 2030–2040, Jun. 2020, doi: 10.1007/s10803-019-03959-5.
[4983]	S. N. Smith, “Independent Transurethral Urinary Tract Inoculation in a Murine Model of Ascending Infection with Proteus mirabilis,” Methods Mol. Biol., vol. 2021, pp. 159–172, 2019, doi: 10.1007/978-1-4939-9601-8_15.
[4984]	“Index, Volume 92, 2017, Nos. 1–52,” Wkly. Epidemiol. Rec., vol. 92, no. 51–52, pp. 784–787, Dec. 2017.
[4985]	V. R. N and S. B. Patil, “Indian Publications on SARS-CoV-2: A bibliometric study of WHO COVID-19 database,” Diabetes Metab Syndr, vol. 14, no. 5, pp. 1171–1178, Jul. 2020, doi: 10.1016/j.dsx.2020.07.007.
[4986]	B. Kjellman, “[Indications that physical activity has a therapeutic effect in depression. Exercise a valuable complement to current antidepressive therapy],” Lakartidningen, vol. 102, no. 5, pp. 312–314, Feb. 2005.
[4987]	A. L. Packer, “Indicators of national focus of the research published by Public Health journals edited in Brazil,” Cien Saude Colet, vol. 20, no. 7, pp. 1983–1995, Jul. 2015, doi: 10.1590/1413-81232015207.07122015.
[4988]	M. Dosemeci et al., “Indirect validation of a retrospective method of exposure assessment used in a nested case-control study of lung cancer and silica exposure,” Occup Environ Med, vol. 51, no. 2, pp. 136–138, Feb. 1994, doi: 10.1136/oem.51.2.136.
[4989]	M. A. Sutherland, H. C. Fantasia, M. K. Hutchinson, and J. Katz, “Individual and Institutional Predictors of IPV/SV Screening in College Health Centers,” J Interpers Violence, p. 886260517741211, Nov. 2017, doi: 10.1177/0886260517741211.
[4990]	A. J. Fuligni, S. Bai, J. L. Krull, and N. A. Gonzales, “Individual Differences in Optimum Sleep for Daily Mood During Adolescence,” J Clin Child Adolesc Psychol, vol. 48, no. 3, pp. 469–479, Jun. 2019, doi: 10.1080/15374416.2017.1357126.
[4991]	M. Larsen et al., “Individualized Ranibizumab Regimen Driven by Stabilization Criteria for Central Retinal Vein Occlusion: Twelve-Month Results of the CRYSTAL Study,” Ophthalmology, vol. 123, no. 5, pp. 1101–1111, May 2016, doi: 10.1016/j.ophtha.2016.01.011.
[4992]	D. R. Johnson and S. D. Gronlund, “Individuals lower in working memory capacity are particularly vulnerable to anxiety’s disruptive effect on performance,” Anxiety Stress Coping, vol. 22, no. 2, pp. 201–213, Mar. 2009, doi: 10.1080/10615800802291277.
[4993]	D. Afriyanti, C. Kroeze, and A. Saad, “Indonesia palm oil production without deforestation and peat conversion by 2050,” Sci. Total Environ., vol. 557–558, pp. 562–570, 01 2016, doi: 10.1016/j.scitotenv.2016.03.032.
[4994]	B. T. Howard and P. A. Iaizzo, “Induced functional modulations of isolated large mammalian hearts,” Pflugers Arch., vol. 471, no. 8, pp. 1095–1101, 2019, doi: 10.1007/s00424-019-02277-0.
[4995]	J. M. Haynes et al., “Induced Pluripotent Stem Cell-Derived Podocyte-Like Cells as Models for Assessing Mechanisms Underlying Heritable Disease Phenotype: Initial Studies Using Two Alport Syndrome Patient Lines Indicate Impaired Potassium Channel Activity,” J. Pharmacol. Exp. Ther., vol. 367, no. 2, pp. 335–347, 2018, doi: 10.1124/jpet.118.250142.
[4996]	G. T. Layton et al., “Induction of HIV-specific cytotoxic T lymphocytes in vivo with hybrid HIV-1 V3:Ty-virus-like particles,” J. Immunol., vol. 151, no. 2, pp. 1097–1107, Jul. 1993.
[4997]	A. S. Rabson and R. L. Kirschstein, “Induction of malignancy in vitro in newborn hamster kidney tissue infected with simian vacuolating virus (SV40),” Proc. Soc. Exp. Biol. Med., vol. 111, pp. 323–328, Nov. 1962, doi: 10.3181/00379727-111-27780.
[4998]	S. J. Greay et al., “Induction of necrosis and cell cycle arrest in murine cancer cell lines by Melaleuca alternifolia (tea tree) oil and terpinen-4-ol,” Cancer Chemother. Pharmacol., vol. 65, no. 5, pp. 877–888, Apr. 2010, doi: 10.1007/s00280-009-1093-7.
[4999]	G. T. Layton et al., “Induction of single and dual cytotoxic T-lymphocyte responses to viral proteins in mice using recombinant hybrid Ty-virus-like particles,” Immunology, vol. 87, no. 2, pp. 171–178, Feb. 1996, doi: 10.1046/j.1365-2567.1996.464539.x.
[5000]	Y. Nevo-Caspi and M. Kupiec, “Induction of Ty recombination in yeast by cDNA and transcription: role of the RAD1 and RAD52 genes,” Genetics, vol. 144, no. 3, pp. 947–955, Nov. 1996.
[5001]	J. A. Benoit, “[INDUCTIVE ACTION OF VARIABLE DURATION ON THE OTIC MESENCHYMA OF THE CHICK EMBRYO IN CULTURE IN VITRO],” C. R. Hebd. Seances Acad. Sci., vol. 258, pp. 334–336, Jan. 1964.
[5002]	R. Van Berkel, T. Fujita, S. Hashimoto, and Y. Geng, “Industrial and urban symbiosis in Japan: analysis of the Eco-Town Program 1997-2006,” J. Environ. Manage., vol. 90, no. 3, pp. 1544–1556, Mar. 2009, doi: 10.1016/j.jenvman.2008.11.010.
[5003]	D. R. Shonnard, A. Kicherer, and P. Saling, “Industrial applications using BASF eco-efficiency analysis: perspectives on green engineering principles,” Environ. Sci. Technol., vol. 37, no. 23, pp. 5340–5348, Dec. 2003, doi: 10.1021/es034462z.
[5004]	F. J. Hearl, “Industrial hygiene sampling and applications to ambient silica monitoring,” J Expo Anal Environ Epidemiol, vol. 7, no. 3, pp. 279–289, Sep. 1997.
[5005]	Y. Fang, R. P. Côté, and R. Qin, “Industrial sustainability in China: practice and prospects for eco-industrial development,” J. Environ. Manage., vol. 83, no. 3, pp. 315–328, May 2007, doi: 10.1016/j.jenvman.2006.03.007.
[5006]	L. Wanhong, L. Fang, W. Fan, D. Maiqi, and L. Tiansen, “Industrial water pollution and transboundary eco-compensation: analyzing the case of Songhua River Basin, China,” Environ Sci Pollut Res Int, vol. 27, no. 28, pp. 34746–34759, Oct. 2020, doi: 10.1007/s11356-019-07254-9.
[5007]	C. T. Ellis and N. B. Turk-Browne, “Infant fMRI: A Model System for Cognitive Neuroscience,” Trends Cogn. Sci. (Regul. Ed.), vol. 22, no. 5, pp. 375–387, 2018, doi: 10.1016/j.tics.2018.01.005.
[5008]	I. Softić, N. Atić, and H. Tahirović, “[Infants feeding practice in first six month in Tuzla canton],” Med Arh, vol. 60, no. 1, pp. 38–40, 2006.
[5009]	A. P. B. Vieira, R. P. Carvalho, A. M. F. Barela, and J. A. Barela, “Infants’ Age and Walking Experience Shapes Perception-Action Coupling When Crossing Obstacles,” Percept Mot Skills, vol. 126, no. 2, pp. 185–201, Apr. 2019, doi: 10.1177/0031512518820791.
[5010]	S. A. Khan and J. R. Wingard, “Infection and mucosal injury in cancer treatment,” J. Natl. Cancer Inst. Monographs, no. 29, pp. 31–36, 2001, doi: 10.1093/oxfordjournals.jncimonographs.a003437.
[5011]	V. Kak, “Infections in confined spaces: cruise ships, military barracks, and college dormitories,” Infect. Dis. Clin. North Am., vol. 21, no. 3, pp. 773–784, ix–x, Sep. 2007, doi: 10.1016/j.idc.2007.06.004.
[5012]	N. R. Ju and L. W. Conlon, “Inferior Vena Cava Filter Migration,” J Emerg Med, vol. 50, no. 3, pp. e151-153, Mar. 2016, doi: 10.1016/j.jemermed.2015.07.028.
[5013]	E. M. Jenoh et al., “Infestation mechanisms of two woodborer species in the mangrove Sonneratia alba J. Smith in Kenya and co-occurring endophytic fungi,” PLoS ONE, vol. 14, no. 10, p. e0221285, 2019, doi: 10.1371/journal.pone.0221285.
[5014]	S. Hanafy, M. Tavasoli, and F. Jamali, “Inflammation alters angiotensin converting enzymes (ACE and ACE-2) balance in rat heart,” Inflammation, vol. 34, no. 6, pp. 609–613, Dec. 2011, doi: 10.1007/s10753-010-9269-1.
[5015]	H. Hori and Y. Kim, “Inflammation and post-traumatic stress disorder,” Psychiatry Clin. Neurosci., vol. 73, no. 4, pp. 143–153, Apr. 2019, doi: 10.1111/pcn.12820.
[5016]	D. Wang et al., “Inflammation in mice ectopically expressing human Pyogenic Arthritis, Pyoderma Gangrenosum, and Acne (PAPA) Syndrome-associated PSTPIP1 A230T mutant proteins,” J. Biol. Chem., vol. 288, no. 7, pp. 4594–4601, Feb. 2013, doi: 10.1074/jbc.M112.443077.
[5017]	M. J. Marino, J. O. Garcia, M. A. Zarka, and D. Lal, “Inflammatory cell predominance and patterns in chronic rhinosinusitis with and without nasal polyposis patients,” Laryngoscope Investig Otolaryngol, vol. 4, no. 6, pp. 573–577, Dec. 2019, doi: 10.1002/lio2.328.
[5018]	H. J. Bachofer and C. F. Cohen, “Inflation continues to hammer hospitals,” Hospitals, vol. 53, no. 21, pp. 63–66, Nov. 1979.
[5019]	P. Sasanakul, R. S. Ampornaramveth, and P. Chivatxaranukul, “Influence of Adjuncts to Irrigation in the Disinfection of Large Root Canals,” J Endod, vol. 45, no. 3, pp. 332–337, Mar. 2019, doi: 10.1016/j.joen.2018.11.015.
[5020]	A. C. Castonguay et al., “Influence of age on clinical and revascularization outcomes in the North American Solitaire Stent-Retriever Acute Stroke Registry,” Stroke, vol. 45, no. 12, pp. 3631–3636, Dec. 2014, doi: 10.1161/STROKEAHA.114.006487.
[5021]	L. Rodríguez-Lago, A. Molina-Leyva, M. Pereiro-Ferreirós, and I. García-Doval, “Influence of Article Type on the Impact Factor of Dermatology Journals,” Actas Dermosifiliogr, vol. 109, no. 5, pp. 432–438, Jun. 2018, doi: 10.1016/j.ad.2018.01.003.
[5022]	H. Sievert et al., “Influence of carvedilol and propranolol on coronary blood flow,” Eur. J. Clin. Pharmacol., vol. 38 Suppl 2, pp. S122-124, 1990, doi: 10.1007/BF01409480.
[5023]	M. Seijo-Martinez, J. M. Cancela, C. Ayán, S. Varela, and H. Vila, “Influence of cognitive impairment on fall risk among elderly nursing home residents,” Int Psychogeriatr, vol. 28, no. 12, pp. 1975–1987, 2016, doi: 10.1017/S1041610216001113.
[5024]	C. R. G. Torres, C. S. Souza, A. B. Borges, M. F. R. L. Huhtala, and T. M. F. Caneppele, “Influence of concentration and activation on hydrogen peroxide diffusion through dental tissues in vitro,” ScientificWorldJournal, vol. 2013, p. 193241, 2013, doi: 10.1155/2013/193241.
[5025]	M. J. Azevedo, M. de L. Pereira, R. Araujo, C. Ramalho, E. Zaura, and B. Sampaio-Maia, “Influence of delivery and feeding mode in oral fungi colonization - a systematic review,” Microb Cell, vol. 7, no. 2, pp. 36–45, Jan. 2020, doi: 10.15698/mic2020.02.706.
[5026]	A. Beck et al., “Influence of diclofenac (group of nonsteroidal anti-inflammatory drugs) on fracture healing,” Arch Orthop Trauma Surg, vol. 123, no. 7, pp. 327–332, Sep. 2003, doi: 10.1007/s00402-003-0537-5.
[5027]	M. A. Schlenz, M. Skroch, A. Schmidt, P. Rehmann, and B. Wöstmann, “Influence of Different Luting Systems on Microleakage of CAD/CAM Composite Crowns: A Pilot Study,” Int J Prosthodont, vol. 32, no. 6, pp. 530–532, Dec. 2019, doi: 10.11607/ijp.6210.
[5028]	J. D. Meyer, K. F. Koltyn, A. J. Stegner, J.-S. Kim, and D. B. Cook, “Influence of Exercise Intensity for Improving Depressed Mood in Depression: A Dose-Response Study,” Behav Ther, vol. 47, no. 4, pp. 527–537, 2016, doi: 10.1016/j.beth.2016.04.003.
[5029]	V. Monesi, “[Influence of glucagon on growth of fibroblasts of chick embryo heart in vitro],” Tumori, vol. 42, no. 3, pp. 460–468, Jun. 1956.
[5030]	N. Cui, H. Luo, H. Xia, W. Chen, and G. Yu, “Influence of Helicobacter pylori Infection on Gastrointestinal Hormone and Colon Motility of Rats,” Am. J. Med. Sci., vol. 351, no. 5, pp. 520–524, 2016, doi: 10.1016/j.amjms.2016.02.031.
[5031]	A. Krieger-Liszkay and A. W. Rutherford, “Influence of herbicide binding on the redox potential of the quinone acceptor in photosystem II: relevance to photodamage and phytotoxicity,” Biochemistry, vol. 37, no. 50, pp. 17339–17344, Dec. 1998, doi: 10.1021/bi9822628.
[5032]	D. J. Casa et al., “Influence of hydration on physiological function and performance during trail running in the heat,” J Athl Train, vol. 45, no. 2, pp. 147–156, Apr. 2010, doi: 10.4085/1062-6050-45.2.147.
[5033]	M. N. Mohankumar, S. F. Paul, P. Venkatachalam, and R. K. Jeevanram, “Influence of in vitro low-level gamma-radiation on the UV-induced DNA repair capacity of human lymphocytes--analysed by unscheduled DNA synthesis (UDS) and comet assay,” Radiat Environ Biophys, vol. 37, no. 4, pp. 267–275, Dec. 1998, doi: 10.1007/s004110050128.
[5034]	M. M. Senior, R. A. Jones, and K. J. Breslauer, “Influence of loop residues on the relative stabilities of DNA hairpin structures,” Proc. Natl. Acad. Sci. U.S.A., vol. 85, no. 17, pp. 6242–6246, Sep. 1988, doi: 10.1073/pnas.85.17.6242.
[5035]	R. A. Ibáñez et al., “Influence of milk pH on the chemical, physical and sensory properties of a milk-based alcoholic beverage,” J. Dairy Res., vol. 86, no. 2, pp. 248–251, May 2019, doi: 10.1017/S0022029919000360.
[5036]	M. Allgower, C. M. Pomerat, and T. G. Blocker, “Influence of normal serum, its derivatives, and of ‘wound healing agents’ on human epidermis in vitro,” Ann. Surg., vol. 135, no. 6, pp. 923–937, Jun. 1952, doi: 10.1097/00000658-195206000-00018.
[5037]	H. Kubinski, G. Koch, and B. Hieronymi, “Influence of nutritional conditions on the cellular RNA metabolism in vivo and in vitro,” Experientia, vol. 19, pp. 311–312, Jun. 1963, doi: 10.1007/BF02150426.
[5038]	J. Wan, S. Zhong, P. Schwarz, B. Chen, and J. Rao, “Influence of oil phase composition on the antifungal and mycotoxin inhibitory activity of clove oil nanoemulsions,” Food Funct, vol. 9, no. 5, pp. 2872–2882, May 2018, doi: 10.1039/c7fo02073b.
[5039]	K.-L. Lin, D. F. Lin, and H. L. Luo, “Influence of phosphate of the waste sludge on the hydration characteristics of eco-cement,” J. Hazard. Mater., vol. 168, no. 2–3, pp. 1105–1110, Sep. 2009, doi: 10.1016/j.jhazmat.2009.02.149.
[5040]	H.-S. Pak, J.-S. Han, J.-B. Lee, S.-H. Kim, and J.-H. Yang, “Influence of porcelain veneering on the marginal fit of Digident and Lava CAD/CAM zirconia ceramic crowns,” J Adv Prosthodont, vol. 2, no. 2, pp. 33–38, Jun. 2010, doi: 10.4047/jap.2010.2.2.33.
[5041]	I. Emsermann, F. Eggmann, G. Krastl, R. Weiger, and J. Amato, “Influence of Pretreatment Methods on the Adhesion of Composite and Polymer Infiltrated Ceramic CAD-CAM Blocks,” J Adhes Dent, vol. 21, no. 5, pp. 433–443, 2019, doi: 10.3290/j.jad.a43179.
[5042]	L. A. van Tuijl, J. R. L. Verwoerd, and P. J. de Jong, “Influence of sad mood induction on implicit self-esteem and its relationship with symptoms of depression and anxiety,” J Behav Ther Exp Psychiatry, vol. 60, pp. 104–110, 2018, doi: 10.1016/j.jbtep.2018.02.003.
[5043]	M. E. M. Cruz, R. Simões, S. B. Martins, F. Z. Trindade, L. N. Dovigo, and R. G. Fonseca, “Influence of simulated gastric juice on surface characteristics of CAD-CAM monolithic materials,” J Prosthet Dent, vol. 123, no. 3, pp. 483–490, Mar. 2020, doi: 10.1016/j.prosdent.2019.04.018.
[5044]	E. Sentex, C. Héliès-Toussaint, D. Rousseau, A. Lucien, E. Ferrary, and A. Grynberg, “Influence of trimetazidine on the synthesis of complex lipids in the heart and other target organs,” Fundam Clin Pharmacol, vol. 15, no. 4, pp. 255–264, Aug. 2001, doi: 10.1046/j.1472-8206.2001.00031.x.
[5045]	R. F. Rickard and D. A. Hudson, “Influence of vascular delay on abdominal wall complications in unipedicled TRAM flap breast reconstruction,” Ann Plast Surg, vol. 50, no. 2, pp. 138–142, Feb. 2003, doi: 10.1097/01.SAP.0000037342.23064.C4.
[5046]	P. Dewhurst, J. Rix, and D. Newell, “Influence of year-on-year performance on final degree classification in a chiropractic master’s degree program,” J Chiropr Educ, vol. 30, no. 1, pp. 14–19, Mar. 2016, doi: 10.7899/JCE-14-26.
[5047]	S. M. Weinstein and R. J. Mermelstein, “Influences of mood variability, negative moods, and depression on adolescent cigarette smoking,” Psychol Addict Behav, vol. 27, no. 4, pp. 1068–1078, Dec. 2013, doi: 10.1037/a0031488.
[5048]	G. J. Martínez-Colón et al., “Influenza-induced immune suppression to methicillin-resistant Staphylococcus aureus is mediated by TLR9,” PLoS Pathog., vol. 15, no. 1, p. e1007560, 2019, doi: 10.1371/journal.ppat.1007560.
[5049]	A. Porta et al., “Information domain analysis of the spontaneous baroreflex during pharmacological challenges,” Auton Neurosci, vol. 178, no. 1–2, pp. 67–75, Nov. 2013, doi: 10.1016/j.autneu.2013.03.003.
[5050]	A. H. Salibian, J. K. Harness, and D. S. Mowlds, “Inframammary approach to nipple-areola-sparing mastectomy,” Plast. Reconstr. Surg., vol. 132, no. 5, pp. 700e–708e, Nov. 2013, doi: 10.1097/PRS.0b013e3182a4d64f.
[5051]	H. Vainio, “Inhalation anesthetics, anticancer drugs and sterilants as chemical hazards in hospitals,” Scand J Work Environ Health, vol. 8, no. 2, pp. 94–107, Jun. 1982, doi: 10.5271/sjweh.2483.
[5052]	W. Xing, Q. Zhao, K. G. Scheckel, L. Zheng, and L. Li, “Inhalation bioaccessibility of Cd, Cu, Pb and Zn and speciation of Pb in particulate matter fractions from areas with different pollution characteristics in Henan Province, China,” Ecotoxicol. Environ. Saf., vol. 175, pp. 192–200, Jul. 2019, doi: 10.1016/j.ecoenv.2019.03.062.
[5053]	W. M. Mars, P. Patmasiriwat, T. Maity, V. Huff, M. M. Weil, and G. F. Saunders, “Inheritance of unequal numbers of the genes encoding the human neutrophil defensins HP-1 and HP-3,” J. Biol. Chem., vol. 270, no. 51, pp. 30371–30376, Dec. 1995, doi: 10.1074/jbc.270.51.30371.
[5054]	A. Falace et al., “Inherited neuromyotonia: a clinical and genetic study of a family,” Neuromuscul. Disord., vol. 17, no. 1, pp. 23–27, Jan. 2007, doi: 10.1016/j.nmd.2006.09.014.
[5055]	L. Kofler, M. Prattes, and H. Bergler, “Inhibiting eukaryotic ribosome biogenesis: Mining new tools for basic research and medical applications,” Microb Cell, vol. 6, no. 10, pp. 491–493, Aug. 2019, doi: 10.15698/mic2019.10.695.
[5056]	J. A. Troca-Marín and E. Geijo-Barrientos, “Inhibition by 5-HT of the synaptic responses evoked by callosal fibers on cortical neurons in the mouse,” Pflugers Arch., vol. 460, no. 6, pp. 1073–1085, Nov. 2010, doi: 10.1007/s00424-010-0875-4.
[5057]	H. Ni, L. Li, G. Liu, and S.-Q. Hu, “Inhibition mechanism and model of an angiotensin I-converting enzyme (ACE)-inhibitory hexapeptide from yeast (Saccharomyces cerevisiae),” PLoS ONE, vol. 7, no. 5, p. e37077, 2012, doi: 10.1371/journal.pone.0037077.
[5058]	M. Hörnig et al., “Inhibition of 5-lipoxygenase by U73122 is due to covalent binding to cysteine 416,” Biochim. Biophys. Acta, vol. 1821, no. 2, pp. 279–286, Feb. 2012, doi: 10.1016/j.bbalip.2011.11.001.
[5059]	J. Faulkner, C. Pye, M. Al-Shabrawey, and A. A. Elmarakby, “Inhibition of 12/15-Lipoxygenase Reduces Renal Inflammation and Injury in Streptozotocin-Induced Diabetic Mice,” J Diabetes Metab, vol. 6, no. 6, Jun. 2015, doi: 10.4172/2155-6156.1000555.
[5060]	W. Wang, W. Xiao, L. Sun, C. Zhang, G. Chen, and H. Yang, “Inhibition of ACE activity contributes to the intestinal structural compensation in a massive intestinal resection rat model,” Pediatr. Surg. Int., vol. 28, no. 5, pp. 533–541, May 2012, doi: 10.1007/s00383-012-3075-9.
[5061]	B. Fabris, B. Z. Chen, V. Pupic, R. Perich, and C. I. Johnston, “Inhibition of angiotensin-converting enzyme (ACE) in plasma and tissue,” J. Cardiovasc. Pharmacol., vol. 15 Suppl 2, pp. S6-13, 1990, doi: 10.1097/00005344-199000152-00003.
[5062]	S. Jain, D. Keys, T. Nydam, R. J. Plenter, C. L. Edelstein, and A. Jani, “Inhibition of autophagy increases apoptosis during re-warming after cold storage in renal tubular epithelial cells,” Transpl. Int., vol. 28, no. 2, pp. 214–223, Feb. 2015, doi: 10.1111/tri.12465.
[5063]	J.-J. Song, I. Noh, and S.-W. Chae, “Inhibition of biofilm formation on ventilation tubes by surface modification,” In Vivo, vol. 26, no. 6, pp. 907–911, Dec. 2012.
[5064]	J. Chen and U. Steidl, “Inhibition of HIF1α Signaling: A Grand Slam for MDS Therapy?,” Cancer Discov, vol. 8, no. 11, pp. 1355–1357, 2018, doi: 10.1158/2159-8290.CD-18-1061.
[5065]	I. A. Butovich and S. M. Lukyanova, “Inhibition of lipoxygenases and cyclooxygenases by linoleyl hydroxamic acid: comparative in vitro studies,” J. Lipid Res., vol. 49, no. 6, pp. 1284–1294, Jun. 2008, doi: 10.1194/jlr.M700602-JLR200.
[5066]	J. Chen, X. Xu, and M. Fan, “Inhibition of mitochondrial translation selectively targets osteosarcoma,” Biochem. Biophys. Res. Commun., vol. 515, no. 1, pp. 9–15, 12 2019, doi: 10.1016/j.bbrc.2019.05.070.
[5067]	F. Uslusoy, M. Nazıroğlu, and B. Çiğ, “Inhibition of the TRPM2 and TRPV1 Channels through Hypericum perforatum in Sciatic Nerve Injury-induced Rats Demonstrates their Key Role in Apoptosis and Mitochondrial Oxidative Stress of Sciatic Nerve and Dorsal Root Ganglion,” Front Physiol, vol. 8, p. 335, 2017, doi: 10.3389/fphys.2017.00335.
[5068]	M. Kolp, D. W. Fulbright, and A. M. Jarosz, “Inhibition of virulent and hypovirulent Cryphonectria parasitica growth in dual culture by fungi commonly isolated from chestnut blight cankers,” Fungal Biol, vol. 122, no. 10, pp. 935–942, 2018, doi: 10.1016/j.funbio.2018.05.007.
[5069]	J. Shen, R. Li, and G. Li, “Inhibitory effects of decoy-ODN targeting activated STAT3 on human glioma growth in vivo,” In Vivo, vol. 23, no. 2, pp. 237–243, Apr. 2009.
[5070]	N. M. Kenner, J. A. Mumford, R. E. Hommer, M. Skup, E. Leibenluft, and R. A. Poldrack, “Inhibitory motor control in response stopping and response switching,” J. Neurosci., vol. 30, no. 25, pp. 8512–8518, Jun. 2010, doi: 10.1523/JNEUROSCI.1096-10.2010.
[5071]	Y. Krakowsky, W. Conners, E. Davidson, A. Rawji, and A. Morgentaler, “Initial Clinical Experience With Testosterone Undecanoate Therapy (AVEED) in Men With Testosterone Deficiency in the United States,” Urology, vol. 109, pp. 27–31, Nov. 2017, doi: 10.1016/j.urology.2017.07.007.
[5072]	D. Weintraub, A. I. Tröster, C. Marras, and G. Stebbins, “Initial cognitive changes in Parkinson’s disease,” Mov. Disord., vol. 33, no. 4, pp. 511–519, 2018, doi: 10.1002/mds.27330.
[5073]	M. Lewis, J. L. Ireland, J. Abbott, and C. A. Ireland, “Initial development of the Psychopathic Processing and Personality Assessment (PAPA) across populations,” Int J Law Psychiatry, vol. 54, pp. 118–132, Oct. 2017, doi: 10.1016/j.ijlp.2017.06.006.
[5074]	C. R. Garcia, S. A. Slone, M. Chau, J. H. Neltner, T. Pittman, and J. L. Villano, “Initial management of meningiomas: Analysis of the National Cancer Database,” Cancer Epidemiol, vol. 60, pp. 16–22, 2019, doi: 10.1016/j.canep.2019.02.018.
[5075]	B. A. Hijaz and L. A. Volpicelli-Daley, “Initiation and propagation of α-synuclein aggregation in the nervous system,” Mol Neurodegener, vol. 15, no. 1, p. 19, 06 2020, doi: 10.1186/s13024-020-00368-6.
[5076]	N. H. Sleep, K. Zahnle, and P. S. Neuhoff, “Initiation of clement surface conditions on the earliest Earth,” Proc. Natl. Acad. Sci. U.S.A., vol. 98, no. 7, pp. 3666–3672, Mar. 2001, doi: 10.1073/pnas.071045698.
[5077]	G. Corona, E. Maseroli, and M. Maggi, “Injectable testosterone undecanoate for the treatment of hypogonadism,” Expert Opin Pharmacother, vol. 15, no. 13, pp. 1903–1926, Sep. 2014, doi: 10.1517/14656566.2014.944896.
[5078]	J. F. Téllez-Zenteno, G. Hunter, and S. Wiebe, “Injuries in people with self-reported epilepsy: a population-based study,” Epilepsia, vol. 49, no. 6, pp. 954–961, Jun. 2008, doi: 10.1111/j.1528-1167.2007.01499.x.
[5079]	B. Szeto, H. Chiang, C. Valentini, M. Yu, J. W. Kysar, and A. K. Lalwani, “Inner ear delivery: Challenges and opportunities,” Laryngoscope Investig Otolaryngol, vol. 5, no. 1, pp. 122–131, Feb. 2020, doi: 10.1002/lio2.336.
[5080]	S. Ravindran, “Inner Workings: Bacteria work together to survive Earth’s depths,” Proc. Natl. Acad. Sci. U.S.A., vol. 114, no. 5, pp. 788–790, 31 2017, doi: 10.1073/pnas.1621079114.
[5081]	T. Yamazaki, Y. Yamazaki, H. Mizutani, and M. Sano, “Innovation: design and working mechanism of a newly developed toothbrush with irrigation and suctioning capabilities (TY e-Brush),” Spec Care Dentist, vol. 26, no. 4, pp. 135–136, Aug. 2006, doi: 10.1111/j.1754-4505.2006.tb01713.x.
[5082]	L. Serpe, R. Canaparo, F. Foglietta, and G. P. Zara, “Innovative formulations for the controlled and site-specific delivery of antiinflammatory drugs,” Curr. Pharm. Des., vol. 19, no. 41, pp. 7219–7236, 2013, doi: 10.2174/138161281941131219124517.
[5083]	K. Ho, C. Boorer, U. Khan, A. Deva, and L. Chang, “Innovative technique for correction of the congenital lop ear,” J Plast Reconstr Aesthet Surg, vol. 59, no. 5, pp. 494–498, 2006, doi: 10.1016/j.bjps.2005.09.029.
[5084]	“Innovative WASH interventions to prevent cholera,” Wkly. Epidemiol. Rec., vol. 90, no. 40, pp. 534–537, Oct. 2015.
[5085]	N. Uemura, H. Yagi, M. T. Uemura, Y. Hatanaka, H. Yamakado, and R. Takahashi, “Inoculation of α-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve,” Mol Neurodegener, vol. 13, no. 1, p. 21, 11 2018, doi: 10.1186/s13024-018-0257-5.
[5086]	T. Wang et al., “Inosine is an alternative carbon source for CD8+-T-cell function under glucose restriction,” Nat Metab, vol. 2, no. 7, pp. 635–647, Jul. 2020, doi: 10.1038/s42255-020-0219-4.
[5087]	P. H. Munley, D. S. Bains, J. Frazee, and L. T. Schwartz, “Inpatient PTSD treatment: a study of pretreatment measures, treatment dropout, and therapist ratings of response to treatment,” J Trauma Stress, vol. 7, no. 2, pp. 319–325, Apr. 1994, doi: 10.1007/BF02102952.
[5088]	T. Schuldt, A. Ovari, E. Guder, and B. Olzowy, “[Inpatient vs. outpatient costs analysis of septumplasty in Germany],” Laryngorhinootologie, vol. 94, no. 1, pp. 18–24, Jan. 2015, doi: 10.1055/s-0034-1377006.
[5089]	T. Schuldt, “[Inpatient vs. outpatient costs analysis of the tonsillectomy],” Laryngorhinootologie, vol. 93, no. 2, pp. 107–114, Feb. 2014, doi: 10.1055/s-0033-1345167.
[5090]	B. C. Bonning, R. D. Possee, and B. D. Hammock, “Insecticidal efficacy of a recombinant baculovirus expressing JHE-KK, a modified juvenile hormone esterase,” J. Invertebr. Pathol., vol. 73, no. 2, pp. 234–236, Mar. 1999, doi: 10.1006/jipa.1998.4839.
[5091]	R. Eldridge, D. R. O’Reilly, B. D. Hammock, and L. K. Miller, “Insecticidal properties of genetically engineered baculoviruses expressing an insect juvenile hormone esterase gene,” Appl. Environ. Microbiol., vol. 58, no. 5, pp. 1583–1591, May 1992, doi: 10.1128/AEM.58.5.1583-1591.1992.
[5092]	M. R. Greenberg, “Insidious trends and social/environmental justice: public health’s challenge for responding to hazard events,” Am J Public Health, vol. 104, no. 10, pp. 1802–1804, Oct. 2014, doi: 10.2105/AJPH.2014.302162.
[5093]	N. K. Verma and B. Singh, “Insight from the structural molecular model of cytidylate kinase from Mycobacterium tuberculosis,” Bioinformation, vol. 9, no. 13, pp. 680–684, 2013, doi: 10.6026/97320630009680.
[5094]	R. Garnier and A. L. Graham, “Insights from parasite-specific serological tools in eco-immunology,” Integr. Comp. Biol., vol. 54, no. 3, pp. 363–376, Sep. 2014, doi: 10.1093/icb/icu022.
[5095]	F. Filomia, F. De Rienzo, and M. C. Menziani, “Insights into MAPK p38alpha DFG flip mechanism by accelerated molecular dynamics,” Bioorg. Med. Chem., vol. 18, no. 18, pp. 6805–6812, Sep. 2010, doi: 10.1016/j.bmc.2010.07.047.
[5096]	T. R. O’Meara and L. E. Cowen, “Insights into the host-pathogen interaction: C. albicans manipulation of macrophage pyroptosis,” Microb Cell, vol. 5, no. 12, pp. 566–568, Nov. 2018, doi: 10.15698/mic2018.12.662.
[5097]	P. J. O. M. Macêdo, P. S. de Oliveira, N. Foldvary-Schaefer, and M. da M. Gomes, “Insomnia in people with epilepsy: A review of insomnia prevalence, risk factors and associations with epilepsy-related factors,” Epilepsy Res., vol. 135, pp. 158–167, 2017, doi: 10.1016/j.eplepsyres.2017.05.014.
[5098]	S.-A. Lee, H. J. Kim, H.-W. Kim, and Y. S. Koo, “Insomnia symptoms and obesity are associated with aggression independent of depression in patients with epilepsy,” Seizure, vol. 74, pp. 65–70, Jan. 2020, doi: 10.1016/j.seizure.2019.12.003.
[5099]	T. Mori, “Instability of the mean-field states and generalization of phase separation in long-range interacting systems,” Phys Rev E Stat Nonlin Soft Matter Phys, vol. 84, no. 3 Pt 1, p. 031128, Sep. 2011, doi: 10.1103/PhysRevE.84.031128.
[5100]	H. K. M. Tanaka, “Instant snapshot of the internal structure of Unzen lava dome, Japan with airborne muography,” Sci Rep, vol. 6, p. 39741, 23 2016, doi: 10.1038/srep39741.
[5101]	R. D. Holmes, “Insufficient evidence for the role of school dental screening in improving oral health,” Evid Based Dent, vol. 19, no. 1, pp. 3–4, 23 2018, doi: 10.1038/sj.ebd.6401281.
[5102]	S. Geyh et al., “Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells,” Leukemia, vol. 27, no. 9, pp. 1841–1851, Sep. 2013, doi: 10.1038/leu.2013.193.
[5103]	D. M. Cutler, “Insurers Again at Odds With Hospitals and Physicians,” JAMA, vol. 314, no. 13, pp. 1329–1330, Oct. 2015, doi: 10.1001/jama.2015.11886.
[5104]	S. Varghese, P. Blixt, D. Darby, and S. Nair, “Integrated C-band erbium-doped fiber amplifier and dispersion compensation module with negligible pump power penalty,” Appl Opt, vol. 48, no. 31, pp. G73-76, Nov. 2009, doi: 10.1364/AO.48.000G73.
[5105]	S. Astnell, U. von Thiele Schwarz, H. Hasson, H. Augustsson, and T. Stenfors-Hayes, “Integrating health promotion with quality improvement in a Swedish hospital,” Health Promot Int, vol. 31, no. 3, pp. 495–504, Sep. 2016, doi: 10.1093/heapro/dav027.
[5106]	J. Huang et al., “Integrating hierarchical bioavailability and population distribution into potential eco-risk assessment of heavy metals in road dust: A case study in Xiandao District, Changsha city, China,” Sci. Total Environ., vol. 541, pp. 969–976, Jan. 2016, doi: 10.1016/j.scitotenv.2015.09.139.
[5107]	A. Gravvanis, G. Petrocheilou, D. Tsoutsos, I. Delikonstantinou, and D. Karakitsos, “Integrating imaging techniques in lower limb microsurgical reconstruction: focusing on ultrasonography versus computed tomography angiography,” In Vivo, vol. 27, no. 3, pp. 371–375, Jun. 2013.
[5108]	J. I. Ramírez García, “Integrating Latina/o ethnic determinants of health in research to promote population health and reduce health disparities,” Cultur Divers Ethnic Minor Psychol, vol. 25, no. 1, pp. 21–31, Jan. 2019, doi: 10.1037/cdp0000265.
[5109]	T. Del Rio, J. C. J. Groot, F. DeClerck, and N. Estrada-Carmona, “Integrating local knowledge and remote sensing for eco-type classification map in the Barotse Floodplain, Zambia,” Data Brief, vol. 19, pp. 2297–2304, Aug. 2018, doi: 10.1016/j.dib.2018.07.009.
[5110]	C. Winder, “Integrating OHS, environmental, and quality management standards,” Qual Assur, vol. 8, no. 2, pp. 105–135, Jun. 2000, doi: 10.1080/105294100317173880.
[5111]	A. Lee, M. Lomazzi, H. Lee, and R. Bedi, “Integrating oral health with public health systems under the framework of the Global Charter for the Public’s Health,” Int Dent J, vol. 69, no. 3, pp. 167–170, 2019, doi: 10.1111/idj.12448.
[5112]	M. Z. Lilly, K. W. Gold, and R. R. Rogers, “Integrating QA principles with basic elements of a research program promotes quality science in a non-GLP research laboratory,” Qual Assur, vol. 3, no. 3, pp. 304–311, Sep. 1994.
[5113]	C. Winder, “Integrating quality, safety, and environment management systems,” Qual Assur, vol. 5, no. 1, pp. 27–48, Mar. 1997.
[5114]	“Integrating reproductive health services into family planning programs,” Popul Briefs, vol. 1, no. 2, p. 7, Jun. 1995.
[5115]	R. D. Irons et al., “Integrating WHO 2001-2008 criteria for the diagnosis of Myelodysplastic Syndrome (MDS): a case-case analysis of benzene exposure,” Chem. Biol. Interact., vol. 184, no. 1–2, pp. 30–38, Mar. 2010, doi: 10.1016/j.cbi.2009.11.016.
[5116]	J. M. McCleery and A. G. Harvey, “Integration of psychological and biological approaches to trauma memory: implications for pharmacological prevention of PTSD,” J Trauma Stress, vol. 17, no. 6, pp. 485–496, Dec. 2004, doi: 10.1007/s10960-004-5797-5.
[5117]	C. T. Nguyen, M. B. Taw, and M. B. Wang, “Integrative care of the patient with head and neck cancer,” Laryngoscope Investig Otolaryngol, vol. 3, no. 5, pp. 364–371, Oct. 2018, doi: 10.1002/lio2.184.
[5118]	S. Stryeck, R. Birner-Gruenberger, and T. Madl, “Integrative metabolomics as emerging tool to study autophagy regulation,” Microb Cell, vol. 4, no. 8, pp. 240–258, Jul. 2017, doi: 10.15698/mic2017.08.584.
[5119]	T. Amen and D. Kaganovich, “Integrative modules for efficient genome engineering in yeast,” Microb Cell, vol. 4, no. 6, pp. 182–190, Jun. 2017, doi: 10.15698/mic2017.06.576.
[5120]	T. Elhasi and A. Blomberg, “Integrins in disguise - mechanosensors in Saccharomyces cerevisiae as functional integrin analogues,” Microb Cell, vol. 6, no. 8, pp. 335–355, Jul. 2019, doi: 10.15698/mic2019.08.686.
[5121]	G. Letkovsky, “[Inter-dependence of growth and function of the myoblasts in vitro],” Bratisl Lek Listy, vol. 34, no. 12, pp. 1377–1381, Dec. 1954.
[5122]	R. J. Dearman, D. A. Basketter, and I. Kimber, “Inter-relationships between different classes of chemical allergens,” J Appl Toxicol, vol. 33, no. 7, pp. 558–565, Jul. 2013, doi: 10.1002/jat.1758.
[5123]	Z. Barskii, “[INTERACTION AND TRANSFORMATION OF CELLS IN MIXED CULTURES  IN VITRO],” Vopr Onkol, vol. 9, pp. 42–50, 1963.
[5124]	A. Spinillo, E. Capuzzo, S. Nicola, L. Colonna, A. Iasci, and C. Zara, “Interaction between fetal gender and risk factors for fetal growth retardation,” Am. J. Obstet. Gynecol., vol. 171, no. 5, pp. 1273–1277, Nov. 1994, doi: 10.1016/0002-9378(94)90146-5.
[5125]	A. W. J. W. Tepper, L. Bubacco, and G. W. Canters, “Interaction between the type-3 copper protein tyrosinase and the substrate analogue p-nitrophenol studied by NMR,” J. Am. Chem. Soc., vol. 127, no. 2, pp. 567–575, Jan. 2005, doi: 10.1021/ja0454687.
[5126]	P. C. Konturek, S. J. Konturek, M. Cześnikiewicz, M. Płonka, and W. Bielański, “Interaction of Helicobacter pylori (Hp) and nonsteroidal anti-inflammatory drugs (NSAID) on gastric mucosa and risk of ulcerations,” Med. Sci. Monit., vol. 8, no. 9, pp. RA197-209, Sep. 2002.
[5127]	S. Danilov et al., “Interaction of mAb to angiotensin-converting enzyme (ACE) with antigen in vitro and in vivo: antibody targeting to the lung induces ACE antigenic modulation,” Int. Immunol., vol. 6, no. 8, pp. 1153–1160, Aug. 1994, doi: 10.1093/intimm/6.8.1153.
[5128]	J. L. Nyland, K. M. Ybarra, K. L. Sammut, E. M. Rienecker, and D. M. Kameda, “Interaction of psychological type and anxiety sensitivity on academic achievement,” Percept Mot Skills, vol. 90, no. 3 Pt 1, pp. 731–739, Jun. 2000, doi: 10.2466/pms.2000.90.3.731.
[5129]	G. Mukwaya et al., “Interaction of ritonavir-boosted tipranavir with loperamide does not result in loperamide-associated neurologic side effects in healthy volunteers,” Antimicrob. Agents Chemother., vol. 49, no. 12, pp. 4903–4910, Dec. 2005, doi: 10.1128/AAC.49.12.4903-4910.2005.
[5130]	M. R. Perfit et al., “Interaction of sea water and lava during submarine eruptions at mid-ocean ridges,” Nature, vol. 426, no. 6962, pp. 62–65, Nov. 2003, doi: 10.1038/nature02032.
[5131]	V. Nilsson, D. Bernin, D. Brandell, K. Edström, and P. Johansson, “Interactions and Transport in Highly Concentrated LiTFSI-based Electrolytes,” Chemphyschem, vol. 21, no. 11, pp. 1166–1176, Jun. 2020, doi: 10.1002/cphc.202000153.
[5132]	L. A. Cohen, M. Epstein, V. Saa-Pabon, C. Meschter, and E. Zang, “Interactions between 4-HPR and diet in NMU-induced mammary tumorigenesis,” Nutr Cancer, vol. 21, no. 3, pp. 271–283, 1994, doi: 10.1080/01635589409514325.
[5133]	C. Xiao et al., “Interactions between depolymerized fucosylated glycosaminoglycan and coagulation proteases or inhibitors,” Thromb. Res., vol. 146, pp. 59–68, Oct. 2016, doi: 10.1016/j.thromres.2016.08.027.
[5134]	O. Yucel, “Interactions between Helicobacter pylori and gastroesophageal reflux disease,” Esophagus, vol. 16, no. 1, pp. 52–62, 2019, doi: 10.1007/s10388-018-0637-5.
[5135]	A. Singh, L. Sethaphong, and Y. G. Yingling, “Interactions of cations with RNA loop-loop complexes,” Biophys. J., vol. 101, no. 3, pp. 727–735, Aug. 2011, doi: 10.1016/j.bpj.2011.06.033.
[5136]	N. Berggren, H. M. Curtis, and N. Derakshan, “Interactions of emotion and anxiety on visual working memory performance,” Psychon Bull Rev, vol. 24, no. 4, pp. 1274–1281, 2017, doi: 10.3758/s13423-016-1213-4.
[5137]	O. Fatunmbi, R. R. Abzalimov, S. N. Savinov, A. Gershenson, and I. A. Kaltashov, “Interactions of Haptoglobin with Monomeric Globin Species: Insights from Molecular Modeling and Native Electrospray Ionization Mass Spectrometry,” Biochemistry, vol. 55, no. 12, pp. 1918–1928, Mar. 2016, doi: 10.1021/acs.biochem.5b00807.
[5138]	B. Chen et al., “Interactive Effect of Depression and Cognitive Impairment on Olfactory Identification in Elderly People,” J. Alzheimers Dis., vol. 66, no. 4, pp. 1645–1655, 2018, doi: 10.3233/JAD-180760.
[5139]	G. Barski and J. Belehradek, “[Intercellular nuclear transfer in mixed cultures in vitro],” Exp. Cell Res., vol. 29, pp. 102–111, Jan. 1963, doi: 10.1016/0014-4827(63)90363-x.
[5140]	L. Tong et al., “Interface Engineering of Silicon/Carbon Thin-Film Anodes for High-Rate Lithium-Ion Batteries,” ACS Appl Mater Interfaces, vol. 12, no. 26, pp. 29242–29252, Jul. 2020, doi: 10.1021/acsami.0c05140.
[5141]	D.-Y. Shin and H.-J. Ahn, “Interfacial Engineering of a Heteroatom-Doped Graphene Layer on Patterned Aluminum Foil for Ultrafast Lithium Storage Kinetics,” ACS Appl Mater Interfaces, vol. 12, no. 16, pp. 19210–19217, Apr. 2020, doi: 10.1021/acsami.0c01774.
[5142]	D. Kardamakis, “Interferons in the treatment of malignancies,” In Vivo, vol. 5, no. 6, pp. 589–597, Dec. 1991.
[5143]	S. D. Sommerfeld et al., “Interleukin-36γ-producing macrophages drive IL-17-mediated fibrosis,” Sci Immunol, vol. 4, no. 40, 11 2019, doi: 10.1126/sciimmunol.aax4783.
[5144]	M. R. Zahner and E. Beaumont, “Intermittent Fasting After Spinal Cord Injury Does Not Improve the Recovery of Baroreflex Regulation in the Rat,” Front Physiol, vol. 11, p. 865, 2020, doi: 10.3389/fphys.2020.00865.
[5145]	D. Ebrahimi-Fakhari, M. Agrawal, and L. Wahlster, “International electives in the final year of German medical school education--a student’s perspective,” GMS Z Med Ausbild, vol. 31, no. 3, p. Doc26, 2014, doi: 10.3205/zma000918.
[5146]	J. Ausserer et al., “International publication trends originating from anaesthetic departments from 2001 to 2015,” Anaesthesia, vol. 72, no. 10, pp. 1243–1250, Oct. 2017, doi: 10.1111/anae.14016.
[5147]	S. Grandel, “International research supported by the German Research Foundation (DFG)--examples of activities in the field of chemistry,” Angew. Chem. Int. Ed. Engl., vol. 50, no. 37, pp. A6-10, Sep. 2011.
[5148]	Handbook of Non Drug Intervention (HANDI) Project Team, “Internet-based cognitive behaviour therapy for depression and anxiety,” Aust Fam Physician, vol. 42, no. 11, pp. 803–804, Nov. 2013.
[5149]	L. Kris Kostanski, R. Huang, C. D. M. Filipe, and R. Ghosh, “Interpenetrating polymer networks as a route to tunable multi-responsive biomaterials: development of novel concepts,” J Biomater Sci Polym Ed, vol. 20, no. 3, pp. 271–297, 2009, doi: 10.1163/156856208X3999107.
[5150]	J. C. Markowitz, B. Milrod, K. Bleiberg, and R. D. Marshall, “Interpersonal factors in understanding and treating posttraumatic stress disorder,” J Psychiatr Pract, vol. 15, no. 2, pp. 133–140, Mar. 2009, doi: 10.1097/01.pra.0000348366.34419.28.
[5151]	H. Jin, V. P. Keeling, D. A. Johnson, and S. Ahmad, “Interplay effect of angular dependence and calibration field size of MapCHECK 2 on RapidArc quality assurance,” J Appl Clin Med Phys, vol. 15, no. 3, p. 4638, May 2014, doi: 10.1120/jacmp.v15i3.4638.
[5152]	J. Howells, S. Sangari, J. M. Matamala, M. C. Kiernan, V. Marchand-Pauvert, and D. Burke, “Interrogating interneurone function using threshold tracking of the H reflex in healthy subjects and patients with motor neurone disease,” Clin Neurophysiol, vol. 131, no. 8, pp. 1986–1996, Aug. 2020, doi: 10.1016/j.clinph.2020.03.028.
[5153]	S. Guaschino, P. Pesando, and C. Zara, “[Intersexual states],” Ann Ostet Ginecol Med Perinat, vol. 96, no. 5, pp. 334–344, Oct. 1975.
[5154]	A. N. Iwaniuk, K. M. Dean, and J. E. Nelson, “Interspecific allometry of the brain and brain regions in parrots (psittaciformes): comparisons with other birds and primates,” Brain Behav. Evol., vol. 65, no. 1, pp. 40–59, 2005, doi: 10.1159/000081110.
[5155]	W. Gao et al., “Intersubject variability of and genetic effects on the brain’s functional connectivity during infancy,” J. Neurosci., vol. 34, no. 34, pp. 11288–11296, Aug. 2014, doi: 10.1523/JNEUROSCI.5072-13.2014.
[5156]	L. Rew, M. Banner, K. Johnson, and N. Slesnick, “Intervention Fidelity and Facilitator Training,” West J Nurs Res, vol. 40, no. 12, pp. 1843–1860, 2018, doi: 10.1177/0193945917752092.
[5157]	B. van der Kolk, “Interview: what is PTSD really? Surprises, twists of history, and the politics of diagnosis and treatment. Interview by Lisa M Najavits,” J Clin Psychol, vol. 69, no. 5, pp. 516–522, May 2013, doi: 10.1002/jclp.21992.
[5158]	E. Norin, “Intestinal cholesterol conversion in adults and elderly from four different European countries,” Ann. Nutr. Metab., vol. 52 Suppl 1, pp. 12–14, 2008, doi: 10.1159/000115341.
[5159]	T. Shao et al., “Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction,” J. Hepatol., vol. 69, no. 4, pp. 886–895, Oct. 2018, doi: 10.1016/j.jhep.2018.05.021.
[5160]	L. Norsa, C. Valle, D. Morotti, P. A. Bonaffini, A. Indriolo, and A. Sonzogni, “Intestinal ischemia in the COVID-19 era,” Dig Liver Dis, Jun. 2020, doi: 10.1016/j.dld.2020.05.030.
[5161]	T. Incharoen, K. Yamauchi, and N. Thongwittaya, “Intestinal villus histological alterations in broilers fed dietary dried fermented ginger,” J Anim Physiol Anim Nutr (Berl), vol. 94, no. 5, pp. e130-137, Oct. 2010, doi: 10.1111/j.1439-0396.2010.00994.x.
[5162]	A. Papa, M. Bonizzi, G. Andrisani, C. Felice, G. Mocci, and A. Gasbarrini, “Intima-media thickness in inflammatory bowel disease patients: a still open question,” Am. J. Gastroenterol., vol. 103, no. 2, pp. 490; author reply 490-491, Feb. 2008, doi: 10.1111/j.1572-0241.2007.01646_9.x.
[5163]	G. Zara and S. Gino, “Intimate Partner Violence and its Escalation Into Femicide. Frailty thy Name Is ‘Violence Against Women,’” Front Psychol, vol. 9, p. 1777, 2018, doi: 10.3389/fpsyg.2018.01777.
[5164]	M. Olff and S. Wall, “Intimate partner violence and mental health--remarks from two Chief Editors on a joint publishing venture,” Glob Health Action, vol. 7, p. 25711, 2014, doi: 10.3402/gha.v7.25711.
[5165]	“Into the future: are we ready to face modern outbreaks?,” Wkly. Epidemiol. Rec., vol. 91, no. 13, pp. 178–180, Apr. 2016.
[5166]	S. Zhang, L. Baams, D. van de Bongardt, and J. S. Dubas, “Intra- and Inter-Individual Differences in Adolescent Depressive Mood: the Role of Relationships with Parents and Friends,” J Abnorm Child Psychol, vol. 46, no. 4, pp. 811–824, 2018, doi: 10.1007/s10802-017-0321-6.
[5167]	H. N. Jacobs, S. Rathod, M. T. Wolf, and J. H. Elisseeff, “Intra-articular Injection of Urinary Bladder Matrix Reduces Osteoarthritis Development,” AAPS J, vol. 19, no. 1, pp. 141–149, 2017, doi: 10.1208/s12248-016-9999-6.
[5168]	S. F. Zaidi et al., “Intraarterial Thrombolysis as Rescue Therapy for Large Vessel Occlusions,” Stroke, vol. 50, no. 4, pp. 1003–1006, 2019, doi: 10.1161/STROKEAHA.118.024442.
[5169]	H. J. Warraich, J. A. Rymer, J. N. Schroder, H. W. Kim, M. E. Leithe, and J. K. Harrison, “Intracardiac Echinococcal Cyst Causing Biventricular Cavity Obliteration,” Circ Heart Fail, vol. 11, no. 2, p. e004830, 2018, doi: 10.1161/CIRCHEARTFAILURE.117.004830.
[5170]	N. Kanda and S. Watanabe, “Intracellular 3’,5’-adenosine cyclic monophosphate level regulates house dust mite-induced interleukin-13 production by T cells from mite-sensitive patients with atopic dermatitis,” J. Invest. Dermatol., vol. 116, no. 1, pp. 3–11, Jan. 2001, doi: 10.1046/j.1523-1747.2001.01196.x.
[5171]	M. J. Foggia, R. V. Quevedo, and M. R. Hansen, “Intracochlear fibrosis and the foreign body response to cochlear implant biomaterials,” Laryngoscope Investig Otolaryngol, vol. 4, no. 6, pp. 678–683, Dec. 2019, doi: 10.1002/lio2.329.
[5172]	I. Krause et al., “Intradialytic parenteral nutrition in malnourished children treated with hemodialysis,” J Ren Nutr, vol. 12, no. 1, pp. 55–59, Jan. 2002, doi: 10.1053/jren.2002.29601.
[5173]	S. H. Kim et al., “Intraductal papillary mucinous neoplasms of the pancreas: evaluation of malignant potential and surgical resectability by using MR imaging with MR cholangiography,” Radiology, vol. 274, no. 3, pp. 723–733, Mar. 2015, doi: 10.1148/radiol.14132960.
[5174]	A. T. Schwalje and H. T. Hoffman, “Intraductal Salivary Gland Infusion With Botulinum Toxin,” Laryngoscope Investig Otolaryngol, vol. 4, no. 5, pp. 520–525, Oct. 2019, doi: 10.1002/lio2.306.
[5175]	S.-U. Lim et al., “Intraductal Ultrasonography without Radiocontrast Cholangiogramin Patients with Extrahepatic Biliary Disease,” Gut Liver, vol. 9, no. 4, pp. 540–546, Jul. 2015, doi: 10.5009/gnl14200.
[5176]	J.-M. Lee et al., “Intraductal ultrasonography-directed endoscopic retrograde biliary drainage without fluoroscopy,” Endoscopy, vol. 46 Suppl 1 UCTN, p. E495, 2014, doi: 10.1055/s-0034-1377587.
[5177]	S.-Y. Park et al., “Intraductal US-directed management of bile duct stones without radiocontrast cholangiography,” Gastrointest. Endosc., vol. 82, no. 5, pp. 939–943, Nov. 2015, doi: 10.1016/j.gie.2015.06.015.
[5178]	C. A. Rubio, Y. Kato, and T. Hirota, “Intraepithelial lymphocytes in flat colorectal adenomas,” In Vivo, vol. 11, no. 5, pp. 393–394, Oct. 1997.
[5179]	K. Nair et al., “Intramural activation during early human ventricular fibrillation,” Circ Arrhythm Electrophysiol, vol. 4, no. 5, pp. 692–703, Oct. 2011, doi: 10.1161/CIRCEP.110.961037.
[5180]	S. Sasaki-Hamada et al., “Intranasal administration of neuromedin U derivatives containing cell-penetrating peptides and a penetration-accelerating sequence induced memory improvements in mice,” Peptides, vol. 99, pp. 241–246, 2018, doi: 10.1016/j.peptides.2017.10.010.
[5181]	M. Amoroso, E. Kempter, T. Eleslambouly, C. A. Lowry, D. Langgartner, and S. O. Reber, “Intranasal Mycobacterium vaccae administration prevents stress-induced aggravation of dextran sulfate sodium (DSS) colitis,” Brain Behav. Immun., May 2019, doi: 10.1016/j.bbi.2019.05.005.
[5182]	A. Sanyal, J. Lenoir, C. O’Neill, F. Dubois, and G. Decocq, “Intraspecific and interspecific adaptive latitudinal cline in Brassicaceae seed oil traits,” Am. J. Bot., vol. 105, no. 1, pp. 85–94, 2018, doi: 10.1002/ajb2.1014.
[5183]	A. A. Rahman, I. Z. Shahid, and P. M. Pilowsky, “Intrathecal neuromedin U induces biphasic effects on sympathetic vasomotor tone, increases respiratory drive and attenuates sympathetic reflexes in rat,” Br. J. Pharmacol., vol. 164, no. 2b, pp. 617–631, Sep. 2011, doi: 10.1111/j.1476-5381.2011.01436.x.
[5184]	I. Armandari, A. R. Hamid, G. Verhaegh, and J. Schalken, “Intratumoral steroidogenesis in castration-resistant prostate cancer: a target for therapy,” Prostate Int, vol. 2, no. 3, pp. 105–113, Sep. 2014, doi: 10.12954/PI.14063.
[5185]	G. P. Zara, R. Cavalli, A. Bargoni, A. Fundarò, D. Vighetto, and M. R. Gasco, “Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: pharmacokinetics and distribution of doxorubicin in brain and other tissues,” J Drug Target, vol. 10, no. 4, pp. 327–335, Jun. 2002, doi: 10.1080/10611860290031868.
[5186]	B. M. Mervak, R. H. Cohan, J. H. Ellis, S. Khalatbari, and M. S. Davenport, “Intravenous Corticosteroid Premedication Administered 5 Hours before CT Compared with a Traditional 13-Hour Oral Regimen,” Radiology, vol. 285, no. 2, pp. 425–433, 2017, doi: 10.1148/radiol.2017170107.
[5187]	J. M. Léger, B. Chassande, L. Musset, V. Meininger, P. Bouche, and N. Baumann, “Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study,” Brain, vol. 124, no. Pt 1, pp. 145–153, Jan. 2001, doi: 10.1093/brain/124.1.145.
[5188]	C. R. Garcia, M. F. Villamar, and J. L. Villano, “Intraventricular Glioblastoma,” Neurohospitalist, vol. 9, no. 4, pp. 239–240, Oct. 2019, doi: 10.1177/1941874418817950.
[5189]	K. M. Kang, J. M. Lee, J. H. Yoon, B. Kiefer, J. K. Han, and B. I. Choi, “Intravoxel incoherent motion diffusion-weighted MR imaging for characterization of focal pancreatic lesions,” Radiology, vol. 270, no. 2, pp. 444–453, Feb. 2014, doi: 10.1148/radiol.13122712.
[5190]	I. Joo, J. M. Lee, J. K. Han, and B. I. Choi, “Intravoxel incoherent motion diffusion-weighted MR imaging for monitoring the therapeutic efficacy of the vascular disrupting agent CKD-516 in rabbit VX2 liver tumors,” Radiology, vol. 272, no. 2, pp. 417–426, Aug. 2014, doi: 10.1148/radiol.14131165.
[5191]	S. Woo, J. M. Lee, J. H. Yoon, I. Joo, J. K. Han, and B. I. Choi, “Intravoxel incoherent motion diffusion-weighted MR imaging of hepatocellular carcinoma: correlation with enhancement degree and histologic grade,” Radiology, vol. 270, no. 3, pp. 758–767, Mar. 2014, doi: 10.1148/radiol.13130444.
[5192]	A. Das et al., “Intriguing pi(+)-pi Interaction in crystal packing,” J Phys Chem B, vol. 114, no. 12, pp. 4166–4170, Apr. 2010, doi: 10.1021/jp910129u.
[5193]	A. Campbell, “Introducing a buddying scheme for first year pre-registration students,” Br J Nurs, vol. 24, no. 20, pp. 992–996, Nov. 2015, doi: 10.12968/bjon.2015.24.20.992.
[5194]	S. Prinsen, S. Dohle, C. Evers, D. T. D. de Ridder, and W. Hofmann, “Introducing functional and dysfunctional self-licensing: Associations with indices of (un)successful dietary regulation,” J Pers, vol. 87, no. 5, pp. 934–947, 2019, doi: 10.1111/jopy.12445.
[5195]	S. Sreedharan and S. Nanni, “Introducing One Health to medical and veterinary students,” Lancet Planet Health, vol. 3, no. 5, p. e210, 2019, doi: 10.1016/S2542-5196(19)30069-5.
[5196]	F. Y. Shah, “Introduction to ‘tension loop internal fixation’ of simple fractures and ‘Faisal’s double noose loops,’” J Clin Orthop Trauma, vol. 8, no. 4, pp. 348–352, Dec. 2017, doi: 10.1016/j.jcot.2016.12.011.
[5197]	J. M. Anderies, H. G. Kaper, E. F. Shuckburgh, and A. Zagaris, “Introduction to focus issue: Nonlinear dynamics for planet Earth,” Chaos, vol. 25, no. 3, p. 036201, Mar. 2015, doi: 10.1063/1.4915260.
[5198]	D. S. Weiss, “Introduction to the special feature on complex PTSD,” J Trauma Stress, vol. 25, no. 3, pp. 239–240, Jun. 2012, doi: 10.1002/jts.21711.
[5199]	D. M. Aronoff, J. M. Marrazzo, and C. L. Sears, “Introduction to the special issue highlighting Anaerobe 2012,” Anaerobe, vol. 24, pp. 85–86, Dec. 2013, doi: 10.1016/j.anaerobe.2013.08.008.
[5200]	Y. P. Wu, L. J. Herbert, L. R. Walker-Harding, and K. P. Tercyak, “Introduction to the special issue on child and family health: the role of behavioral medicine in understanding and optimizing child health,” Transl Behav Med, vol. 9, no. 3, pp. 399–403, 16 2019, doi: 10.1093/tbm/ibz056.
[5201]	J. M. T. Thompson, “Introduction. Progress in Earth science and climate studies,” Philos Trans A Math Phys Eng Sci, vol. 366, no. 1885, pp. 4503–4508, Dec. 2008, doi: 10.1098/rsta.2008.0215.
[5202]	C. S. Cockell, S. L. Cady, and N. McLoughlin, “Introduction. Volcanism and astrobiology: life on earth and beyond,” Astrobiology, vol. 11, no. 7, pp. 583–584, Sep. 2011, doi: 10.1089/ast.2011.8080.
[5203]	L. Rew, W. Agor, M. R. Emery, and S. C. Harper, “Intuitive skills in crisis management,” Nursingconnections, vol. 13, no. 3, pp. 45–54, 2000.
[5204]	N. Neil, T. Malmfors, and P. Slovic, “Intuitive toxicology: expert and lay judgments of chemical risks,” Toxicol Pathol, vol. 22, no. 2, pp. 198–201, Apr. 1994, doi: 10.1177/019262339402200214.
[5205]	S. Schwettmann, J. B. Tenenbaum, and N. Kanwisher, “Invariant representations of mass in the human brain,” Elife, vol. 8, 17 2019, doi: 10.7554/eLife.46619.
[5206]	M. O. Popova et al., “[Invasive mycoses during hematopoietic stem cell transplantation],” Ter. Arkh., vol. 84, no. 7, pp. 50–57, 2012.
[5207]	V. Audinot, A. Newman-Tancredi, D. Cussac, and M. J. Millan, “Inverse agonist properties of antipsychotic agents at cloned, human (h) serotonin (5-HT)(1B) and h5-HT(1D) receptors,” Neuropsychopharmacology, vol. 25, no. 3, pp. 410–422, Sep. 2001, doi: 10.1016/S0893-133X(01)00237-8.
[5208]	K. Matsuda, T. Yokoyama, M. Fukui, T. Morita, and M. Kozaki, “Inverse Analysis of the Relationship between Ocular Refraction and Birth Month Using Matrix Equations,” Nippon Ganka Gakkai Zasshi, vol. 120, no. 8, pp. 533–539, Aug. 2016.
[5209]	V. De Luca, M. D. Orfei, S. Gaudenzi, C. Caltagirone, and G. Spalletta, “Inverse effect of the APOE epsilon4 allele in late- and early-onset Alzheimer’s disease,” Eur Arch Psychiatry Clin Neurosci, vol. 266, no. 7, pp. 599–606, Oct. 2016, doi: 10.1007/s00406-015-0663-4.
[5210]	P.-F. Lee et al., “Inverted orientation improves decellularization of whole porcine hearts,” Acta Biomater, vol. 49, pp. 181–191, 2017, doi: 10.1016/j.actbio.2016.11.047.
[5211]	E. M. Maroudas, A. R. Ayoob, and D. J. DiSantis, “Inverted V sign,” Abdom Radiol (NY), vol. 41, no. 5, p. 1004, 2016, doi: 10.1007/s00261-016-0643-9.
[5212]	J. J. Lee, C. Dhepnorrarat, J. Nyhof-Young, and I. Witterick, “Investigating Patient and Physician Delays in the Diagnosis of Head and Neck Cancers: a Canadian Perspective,” J Cancer Educ, vol. 31, no. 1, pp. 8–14, Mar. 2016, doi: 10.1007/s13187-014-0777-9.
[5213]	M. H. Alhagamhmad and N. M. Shembesh, “Investigating the awareness, behavior, and attitude toward epilepsy among university students in Benghazi, Libya,” Epilepsy Behav, vol. 83, pp. 22–27, 2018, doi: 10.1016/j.yebeh.2018.03.021.
[5214]	F. Kurth, P. M. Thompson, and E. Luders, “Investigating the differential contributions of sex and brain size to gray matter asymmetry,” Cortex, vol. 99, pp. 235–242, 2018, doi: 10.1016/j.cortex.2017.11.017.
[5215]	C. Byrne, R. Coetzer, and K. Addy, “Investigating the discrepancy between subjective and objective cognitive impairment following acquired brain injury: The role of psychological affect,” NeuroRehabilitation, vol. 41, no. 2, pp. 501–512, 2017, doi: 10.3233/NRE-162015.
[5216]	L. Hanf, M. Diehl, L.-S. Kemper, M. Winter, and S. Nowak, “Investigating the oxidation state of Fe from LiFePO4 -based lithium ion battery cathodes via capillary electrophoresis,” Electrophoresis, Jun. 2020, doi: 10.1002/elps.202000097.
[5217]	T. Ohnishi et al., “Investigation of betaine as a novel psychotherapeutic for schizophrenia,” EBioMedicine, vol. 45, pp. 432–446, Jul. 2019, doi: 10.1016/j.ebiom.2019.05.062.
[5218]	S. Ostovar Pour, S. M. Fowler, D. L. Hopkins, P. J. Torley, H. Gill, and E. W. Blanch, “Investigation of chemical composition of meat using spatially off-set Raman spectroscopy,” Analyst, vol. 144, no. 8, pp. 2618–2627, Apr. 2019, doi: 10.1039/c8an01958d.
[5219]	F. A. Redeker, M. A. Ellwanger, H. Beckers, and S. Riedel, “Investigation of Molecular Alkali Tetrafluorido Aurates by Matrix-Isolation Spectroscopy,” Chemistry, vol. 25, no. 66, pp. 15059–15061, Nov. 2019, doi: 10.1002/chem.201904335.
[5220]	S. M. Marino et al., “Investigation of Streptomyces antibioticus tyrosinase reactivity toward chlorophenols,” Arch. Biochem. Biophys., vol. 505, no. 1, pp. 67–74, Jan. 2011, doi: 10.1016/j.abb.2010.09.019.
[5221]	Y. J. Cao, R. Xu, X. Y. Tao, J. B. Shi, and F. H. Chen, “[Investigation of temporal and spatial characteristics of allergic rhinitis epidemics by Baidu Index in China],” Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, vol. 54, no. 12, pp. 888–893, Dec. 2019, doi: 10.3760/cma.j.issn.1673-0860.2019.12.002.
[5222]	L. J. Boothman, S. N. Mitchell, and T. Sharp, “Investigation of the SSRI augmentation properties of 5-HT(2) receptor antagonists using in vivo microdialysis,” Neuropharmacology, vol. 50, no. 6, pp. 726–732, May 2006, doi: 10.1016/j.neuropharm.2005.11.020.
[5223]	M. Wufuer, M. Nijiati, A. Simayi, W. Han, and F. Li, “[Investigation on physiological characteristics in ‘offspring of Lop Nor people’],” Beijing Da Xue Xue Bao, vol. 43, no. 4, pp. 591–595, Aug. 2011.
[5224]	Q. Dou and J. Cai, “Investigation on Polylactide (PLA)/Poly(butylene adipate-co-terephthalate) (PBAT)/Bark Flour of Plane Tree (PF) Eco-Composites,” Materials (Basel), vol. 9, no. 5, May 2016, doi: 10.3390/ma9050393.
[5225]	J. Min et al., “Investigation on the Gradient Nanomechanical Behavior of Dental Fluorosis Enamel,” Nanoscale Res Lett, vol. 13, no. 1, p. 347, Oct. 2018, doi: 10.1186/s11671-018-2768-y.
[5226]	S. Mehra, S. Daral, and S. Sharma, “Investing in our Adolescents: Assertions of the 11th World Congress on Adolescent Health,” J Adolesc Health, vol. 63, no. 1, pp. 9–11, 2018, doi: 10.1016/j.jadohealth.2018.05.005.
[5227]	M. S. R. Macêdo, S. C. L. Chaves, and A. L. de C. Fernandes, “Investments and costs of oral health care for Family Health Care,” Rev Saude Publica, vol. 50, Jul. 2016, doi: 10.1590/S1518-8787.2016050005771.
[5228]	K. Nakahara et al., “Involvement of endogenous neuromedin U and neuromedin S in thermoregulation,” Biochem. Biophys. Res. Commun., vol. 470, no. 4, pp. 930–935, Feb. 2016, doi: 10.1016/j.bbrc.2016.01.155.
[5229]	D. Ibi, A. Tsuchihashi, T. Nomura, and M. Hiramatsu, “Involvement of GAT2/BGT-1 in the preventive effects of betaine on cognitive impairment and brain oxidative stress in amyloid β peptide-injected mice,” Eur. J. Pharmacol., vol. 842, pp. 57–63, Jan. 2019, doi: 10.1016/j.ejphar.2018.10.037.
[5230]	A. A. Desta, U. Kulkarni, K. Abraha, S. Worku, and B. W. Sahle, “Iodine level concentration, coverage of adequately iodized salt consumption and factors affecting proper iodized salt utilization among households in North Ethiopia: a community based cross sectional study,” BMC Nutr, vol. 5, p. 28, 2019, doi: 10.1186/s40795-019-0291-x.
[5231]	A. Rjasanow, M. G. Leitner, V. Thallmair, C. R. Halaszovich, and D. Oliver, “Ion channel regulation by phosphoinositides analyzed with VSPs-PI(4,5)P2 affinity, phosphoinositide selectivity, and PI(4,5)P2 pool accessibility,” Front Pharmacol, vol. 6, p. 127, 2015, doi: 10.3389/fphar.2015.00127.
[5232]	R. Greger, “Ion transport mechanisms in thick ascending limb of Henle’s loop of mammalian nephron,” Physiol. Rev., vol. 65, no. 3, pp. 760–797, Jul. 1985, doi: 10.1152/physrev.1985.65.3.760.
[5233]	R. Tao et al., “Ionic Liquid-Directed Nanoporous TiNb2 O7 Anodes with Superior Performance for Fast-Rechargeable Lithium-Ion Batteries,” Small, vol. 16, no. 29, p. e2001884, Jul. 2020, doi: 10.1002/smll.202001884.
[5234]	M. Zitzmann, A. Mattern, J. Hanisch, L. Gooren, H. Jones, and M. Maggi, “IPASS: a study on the tolerability and effectiveness of injectable testosterone undecanoate for the treatment of male hypogonadism in a worldwide sample of 1,438 men,” J Sex Med, vol. 10, no. 2, pp. 579–588, Feb. 2013, doi: 10.1111/j.1743-6109.2012.02853.x.
[5235]	F.-Z. Teng, N. Dauphas, and R. T. Helz, “Iron isotope fractionation during magmatic differentiation in Kilauea Iki lava lake,” Science, vol. 320, no. 5883, pp. 1620–1622, Jun. 2008, doi: 10.1126/science.1157166.
[5236]	L. Lyle and A. Hirose, “Iron Overload in Myelodysplastic Syndromes: Pathophysiology, Consequences, Diagnosis, and Treatment,” J Adv Pract Oncol, vol. 9, no. 4, pp. 392–405, Jun. 2018.
[5237]	Z. D. Zhou and E.-K. Tan, “Iron regulatory protein (IRP)-iron responsive element (IRE) signaling pathway in human neurodegenerative diseases,” Mol Neurodegener, vol. 12, no. 1, p. 75, 23 2017, doi: 10.1186/s13024-017-0218-4.
[5238]	R. W. Smith, R. D. Moccia, C. E. Mothersill, and C. B. Seymour, “Irradiation of rainbow trout at early life stages results in a proteomic legacy in adult gills. Part B; the effect of a second radiation dose, after one year, on the proteomic responses in the irradiated and non-irradiated bystander fish,” Environ. Res., vol. 163, pp. 307–313, 2018, doi: 10.1016/j.envres.2018.01.020.
[5239]	G. W. Paltridge, “Irreversible thermodynamics and the structure of life and the planet: comment on ‘Life, hierarchy, and the thermodynamic machinery of planet Earth’ by A. Kleidon,” Phys Life Rev, vol. 7, no. 4, pp. 465–466; discussion 473-476, Dec. 2010, doi: 10.1016/j.plrev.2010.10.005.
[5240]	E. Di Maria and R. Tenconi, “Is a proper name the proper name? A survey on attitude of clinical geneticists towards eponyms in Italy,” Am. J. Med. Genet. A, vol. 152A, no. 3, pp. 795–796, Mar. 2010, doi: 10.1002/ajmg.a.33275.
[5241]	M. Kanazawa, Y. Nakashima, S. Hamai, M. Hirata, and Y. Iwamoto, “Is a Stem Version on the Crosstable Lateral Radiograph Accurate in Total Hip Arthroplasty?,” J Arthroplasty, vol. 31, no. 6, pp. 1356–1360, 2016, doi: 10.1016/j.arth.2015.12.022.
[5242]	S. P. Dunn, W. Weintraub, C. D. Vinocur, D. F. Billmire, and K. Falkenstein, “Is age less than 1 year a high-risk category for orthotopic liver transplantation?,” J. Pediatr. Surg., vol. 28, no. 8, pp. 1048–1050, Aug. 1993, doi: 10.1016/0022-3468(93)90516-n.
[5243]	E. P. Gomez-Sanchez, N. Ahmad, D. G. Romero, and C. E. Gomez-Sanchez, “Is aldosterone synthesized within the rat brain?,” Am. J. Physiol. Endocrinol. Metab., vol. 288, no. 2, pp. E342-346, Feb. 2005, doi: 10.1152/ajpendo.00355.2004.
[5244]	C. R. Kovach, J. L. Ellis, and R. F. Schiffman, “Is Assisted Self-Management a Viable Concept for Individuals With Cognitive Impairment?,” Res Gerontol Nurs, vol. 11, no. 3, pp. 115–117, 01 2018, doi: 10.3928/19404921-20180413-01.
[5245]	S. Zisook and K. S. Kendler, “Is bereavement-related depression different than non-bereavement-related depression?,” Psychol Med, vol. 37, no. 6, pp. 779–794, Jun. 2007, doi: 10.1017/S0033291707009865.
[5246]	H. S. Oster et al., “Is bone marrow examination always necessary to establish the diagnosis of myelodysplastic syndromes? A proposed non-invasive diagnostic model,” Leuk. Lymphoma, vol. 59, no. 9, pp. 2227–2232, 2018, doi: 10.1080/10428194.2017.1416363.
[5247]	S. Maestroni, M. Imazio, A. Valenti, A. Assolari, and A. Brucato, “Is colchicine really harmful in viral myocarditis?,” Int. J. Cardiol., vol. 229, p. 42, Feb. 2017, doi: 10.1016/j.ijcard.2016.10.031.
[5248]	J. P. Newhouse, “Is competition the answer?,” J Health Econ, vol. 1, no. 1, pp. 110–116, May 1982, doi: 10.1016/0167-6296(82)90023-6.
[5249]	U. Yucetas et al., “Is cystoscopy follow-up protocol safe for low-risk bladder cancer without muscle invasion?,” Urol Ann, vol. 12, no. 1, pp. 25–30, Mar. 2020, doi: 10.4103/UA.UA_143_18.
[5250]	A. Thomas, “Is depression really different in older people?,” Int Psychogeriatr, vol. 25, no. 11, pp. 1739–1742, Nov. 2013, doi: 10.1017/S1041610213001038.
[5251]	B. Ramanujam, B. K. Bajaj, K. Kaur, K. S. Anand, and G. Buxi, “Is Depression Related to Low Folate Levels in People with Epilepsy? An Observational Study and Meta-analysis,” J Neurosci Rural Pract, vol. 8, no. 3, pp. 381–388, Sep. 2017, doi: 10.4103/jnrp.jnrp_468_16.
[5252]	T. C. Erren, C. B. Glende, P. Morfeld, and C. Piekarski, “Is exposure to silica associated with lung cancer in the absence of silicosis? A meta-analytical approach to an important public health question,” Int Arch Occup Environ Health, vol. 82, no. 8, pp. 997–1004, Aug. 2009, doi: 10.1007/s00420-008-0387-0.
[5253]	D. C. Whittet, “Is extraterrestrial organic matter relevant to the origin of life on Earth?,” Orig Life Evol Biosph, vol. 27, no. 1–3, pp. 249–262, Jun. 1997.
[5254]	N. C. Nath, “Is health a commodity?,” J Indian Med Assoc, vol. 109, no. 12, pp. 868–869, Dec. 2011.
[5255]	J. D. Thompson, P. M. Harari, and G. K. Hartig, “Is HPV-Associated Oropharyngeal Cancer Becoming More Common in Older Patients?,” Laryngoscope Investig Otolaryngol, vol. 3, no. 6, pp. 446–449, Dec. 2018, doi: 10.1002/lio2.181.
[5256]	N. S. Halıcı-Tülüce, İ. Doğan, and C. Dumrul, “Is income relevant for health expenditure and economic growth nexus?,” Int J Health Econ Manag, vol. 16, no. 1, pp. 23–49, Mar. 2016, doi: 10.1007/s10754-015-9179-8.
[5257]	M. H. M. Hatz, K. Schremser, and W. H. Rogowski, “Is individualized medicine more cost-effective? A systematic review,” Pharmacoeconomics, vol. 32, no. 5, pp. 443–455, May 2014, doi: 10.1007/s40273-014-0143-0.
[5258]	K. Tanabe et al., “Is it safe to continue antithrombotic agents before prostate biopsy?,” Prostate Int, vol. 7, no. 2, pp. 78–81, Jun. 2019, doi: 10.1016/j.prnil.2018.06.004.
[5259]	A. Bulbena et al., “Is joint hypermobility related to anxiety in a nonclinical population also?,” Psychosomatics, vol. 45, no. 5, pp. 432–437, Oct. 2004, doi: 10.1176/appi.psy.45.5.432.
[5260]	S.-Y. Park and J.-S. Rew, “Is Lipase Supplementation before a High Fat Meal Helpful to Patients with Functional Dyspepsia?,” Gut Liver, vol. 9, no. 4, pp. 433–434, Jul. 2015, doi: 10.5009/gnl15206.
[5261]	T. M. Vo, P. Perry, M. Ellerby, and K. Bohnert, “Is lithium a neuroprotective agent?,” Ann Clin Psychiatry, vol. 27, no. 1, pp. 49–54, Feb. 2015.
[5262]	E. Castrén, “Is mood chemistry?,” Nat. Rev. Neurosci., vol. 6, no. 3, pp. 241–246, Mar. 2005, doi: 10.1038/nrn1629.
[5263]	D. C. Breh and G. H. Seidler, “Is peritraumatic dissociation a risk factor for PTSD?,” J Trauma Dissociation, vol. 8, no. 1, pp. 53–69, 2007, doi: 10.1300/J229v08n01_04.
[5264]	J. Cullberg, “[Is psychotherapy in depression efficient? Physician-patient relations are significant for therapeutic results],” Lakartidningen, vol. 93, no. 48, pp. 4405–4406, Nov. 1996.
[5265]	H. Checkoway and A. Franzblau, “Is silicosis required for silica-associated lung cancer?,” Am. J. Ind. Med., vol. 37, no. 3, pp. 252–259, Mar. 2000, doi: 10.1002/(sici)1097-0274(200003)37:3<252::aid-ajim2>3.0.co;2-#.
[5266]	S. Arver et al., “Is testosterone replacement therapy in males with hypogonadism cost-effective? An analysis in Sweden,” J Sex Med, vol. 11, no. 1, pp. 262–272, Jan. 2014, doi: 10.1111/jsm.12277.
[5267]	B. M. Adhikari, K. M. Quinn, and M. Dhamala, “Is the brain’s inertia for motor movements different for acceleration and deceleration?,” PLoS ONE, vol. 8, no. 10, p. e78055, 2013, doi: 10.1371/journal.pone.0078055.
[5268]	B. Terluin and M. J. T. Oud, “[Is the diagnosis ‘depression’ still useful?],” Ned Tijdschr Geneeskd, vol. 156, no. 51, p. A5684, 2012.
[5269]	R. Bondí, “IS THE EARTH SICK?,” Arch Int Hist Sci (Paris), vol. 64, no. 172–173, pp. 231–244, Dec. 2014, doi: 10.1484/j.arihs.5.110286.
[5270]	I. Sombié et al., “[Is the fight against maternal mortality in Burkina Faso adapted to reduce the three delays?],” Sante Publique, vol. 30, no. 2, pp. 273–282, Apr. 2018, doi: 10.3917/spub.182.0273.
[5271]	K. Glynn, R. Coen, and B. A. Lawlor, “Is the Quick Mild Cognitive Impairment Screen (QMCI) more accurate at detecting mild cognitive impairment than existing short cognitive screening tests? A systematic review of the current literature,” Int J Geriatr Psychiatry, vol. 34, no. 12, pp. 1739–1746, 2019, doi: 10.1002/gps.5201.
[5272]	G. Northoff, “Is the self a higher-order or fundamental function of the brain? The ‘basis model of self-specificity’ and its encoding by the brain’s spontaneous activity,” Cogn Neurosci, vol. 7, no. 1–4, pp. 203–222, Oct. 2016, doi: 10.1080/17588928.2015.1111868.
[5273]	N. Plurphanswat and B. Rodu, “Is the smoking population in the United States really softening?,” Addiction, vol. 111, no. 7, pp. 1299–1303, 2016, doi: 10.1111/add.13340.
[5274]	S.-H. S. Huang, P. A. Heidenheim, K. Gallo, S. Jayakumar, and R. M. Lindsay, “Is there a necessity for individual blood water corrections when conductivity-based access blood flow measurements are made?,” Blood Purif., vol. 32, no. 3, pp. 174–180, 2011, doi: 10.1159/000328336.
[5275]	J. Wang and P. Shapira, “Is there a relationship between research sponsorship and publication impact? An analysis of funding acknowledgments in nanotechnology papers,” PLoS ONE, vol. 10, no. 2, p. e0117727, 2015, doi: 10.1371/journal.pone.0117727.
[5276]	J. R. Harper, “Is there a role for pharmacoeconomics in developing countries?,” Pharmacoeconomics, vol. 29, no. 5, pp. 435–436; author reply 436-437, May 2011, doi: 10.2165/11585770-000000000-00000.
[5277]	J. Togno and S. Eaton, “Is there a role for prazosin in the treatment of post-traumatic stress disorder?,” Aust Fam Physician, vol. 44, no. 9, pp. 647–649, Sep. 2015.
[5278]	D. R. Rubinow and P. J. Schmidt, “Is there a role for reproductive steroids in the etiology and treatment of affective disorders?,” Dialogues Clin Neurosci, vol. 20, no. 3, pp. 187–196, 2018.
[5279]	T. J. Galama, P. Hullegie, E. Meijer, and S. Outcault, “Is there empirical evidence for decreasing returns to scale in a health capital model?,” Health Econ, vol. 21, no. 9, pp. 1080–1100, Sep. 2012, doi: 10.1002/hec.2843.
[5280]	L. Friedman, “Is there life after enactment? The idea of a patient’s proper work,” J Am Psychoanal Assoc, vol. 56, no. 2, pp. 431–453, Jun. 2008, doi: 10.1177/0003065108319860.
[5281]	A. A. Asadi-Pooya and J. H. Cross, “Is wearing a face mask safe for people with epilepsy?,” Acta Neurol. Scand., Jul. 2020, doi: 10.1111/ane.13316.
[5282]	A. G. Ordemann, A. J. Hartzog, S. R. Seals, C. Spankovich, and S. P. Stringer, “Is weight a predictive risk factor of postoperative tonsillectomy bleed?,” Laryngoscope Investig Otolaryngol, vol. 3, no. 3, pp. 238–243, Jun. 2018, doi: 10.1002/lio2.155.
[5283]	H. Otani, “Ischemic preconditioning: from molecular mechanisms to therapeutic opportunities,” Antioxid. Redox Signal., vol. 10, no. 2, pp. 207–247, Feb. 2008, doi: 10.1089/ars.2007.1679.
[5284]	G. Eisenbrand and Senate Commission on Food Safety (SKLM) of the German Research Foundation (DFG), “Isoflavones as phytoestrogens in food supplements and dietary foods for special medical purposes. Opinion of the Senate Commission on Food Safety (SKLM) of the German Research Foundation (DFG)-(shortened version),” Mol Nutr Food Res, vol. 51, no. 10, pp. 1305–1312, Oct. 2007, doi: 10.1002/mnfr.200700217.
[5285]	G. Maréchal, G. Beckers-Bleukx, A. Berquin, and G. Coulton, “Isoforms of myosin in growing muscles of ky (kyphoscoliotic) mice,” Eur. J. Biochem., vol. 241, no. 3, pp. 916–922, Nov. 1996, doi: 10.1111/j.1432-1033.1996.00916.x.
[5286]	T. L. Demmy, G. J. Magovern, and R. L. Kao, “Isolated biventricular working rat heart preparation,” Ann. Thorac. Surg., vol. 54, no. 5, pp. 915–920, Nov. 1992, doi: 10.1016/0003-4975(92)90649-o.
[5287]	D. U. Kim, S. W. Kim, and C. I. Ju, “Isolated coccygeal tuberculosis,” J Korean Neurosurg Soc, vol. 52, no. 5, pp. 495–497, Nov. 2012, doi: 10.3340/jkns.2012.52.5.495.
[5288]	E. Chinchoy et al., “Isolated four-chamber working swine heart model,” Ann. Thorac. Surg., vol. 70, no. 5, pp. 1607–1614, Nov. 2000, doi: 10.1016/s0003-4975(00)01977-9.
[5289]	C. D. Damme, J. Luo, and K. L. Buesing, “Isolated prehospital hypotension correlates with injury severity and outcomes in patients with trauma,” Trauma Surg Acute Care Open, vol. 1, no. 1, p. e000013, 2016, doi: 10.1136/tsaco-2016-000013.
[5290]	L. D. Segel and S. V. Rendig, “Isolated working rat heart perfusion with perfluorochemical emulsion Fluosol-43,” Am. J. Physiol., vol. 242, no. 4, pp. H485-489, Apr. 1982, doi: 10.1152/ajpheart.1982.242.4.H485.
[5291]	J. S. Fassler and F. Winston, “Isolation and analysis of a novel class of suppressor of Ty insertion mutations in Saccharomyces cerevisiae,” Genetics, vol. 118, no. 2, pp. 203–212, Feb. 1988.
[5292]	K. Maruyama et al., “Isolation and characterisation of four cDNAs encoding neuromedin U (NMU) from the brain and gut of goldfish, and the inhibitory effect of a deduced NMU on food intake and locomotor activity,” J. Neuroendocrinol., vol. 20, no. 1, pp. 71–78, Jan. 2008, doi: 10.1111/j.1365-2826.2007.01615.x.
[5293]	K. Maruyama et al., “Isolation and characterisation of two cDNAs encoding the neuromedin U receptor from goldfish brain,” J. Neuroendocrinol., vol. 23, no. 3, pp. 282–291, Mar. 2011, doi: 10.1111/j.1365-2826.2010.02106.x.
[5294]	M. Laget, M. De Meo, G. Balansard, A. Babadjamian, and G. Dumenil, “Isolation and characterization of a novel methylhopanoid from a facultative methylotrophic Corynebacterium sp,” Folia Microbiol. (Praha), vol. 32, no. 2, pp. 116–123, 1987, doi: 10.1007/BF02883238.
[5295]	D. A. Kool, S. M. Matsui, H. B. Greenberg, and I. H. Holmes, “Isolation and characterization of a novel reassortant between avian Ty-1 and simian RRV rotaviruses,” J. Virol., vol. 66, no. 11, pp. 6836–6839, Nov. 1992, doi: 10.1128/JVI.66.11.6836-6839.1992.
[5296]	A. Vincent and T. D. Petes, “Isolation and characterization of a Ty element inserted into the ribosomal DNA of the yeast Saccharomyces cerevisiae,” Nucleic Acids Res., vol. 14, no. 7, pp. 2939–2949, Apr. 1986, doi: 10.1093/nar/14.7.2939.
[5297]	V. Sumi, S. D. Singh, K. Dhama, V. Gowthaman, R. Barathidasan, and K. Sukumar, “Isolation and molecular characterization of infectious bronchitis virus from recent outbreaks in broiler flocks reveals emergence of novel strain in India,” Trop Anim Health Prod, vol. 44, no. 7, pp. 1791–1795, Oct. 2012, doi: 10.1007/s11250-012-0140-2.
[5298]	H. Li et al., “Isotope and Hydrogen-Bond Effects on the Self-Assembly of Macroions in Dilute Solution,” Chemistry, vol. 25, no. 71, pp. 16288–16293, Dec. 2019, doi: 10.1002/chem.201902444.
[5299]	S. B. Jacobsen, M. C. Ranen, M. I. Petaev, J. L. Remo, R. J. O’Connell, and D. D. Sasselov, “Isotopes as clues to the origin and earliest differentiation history of the Earth,” Philos Trans A Math Phys Eng Sci, vol. 366, no. 1883, pp. 4129–4162, Nov. 2008, doi: 10.1098/rsta.2008.0174.
[5300]	M. T. McCulloch, “Isotopic constraints on the age and early differentiation of the Earth,” J R Soc West Aust, vol. 79 Pt 1, pp. 131–139, Mar. 1996.
[5301]	J. G. Baggs, “Issues and rules for authors concerning authorship versus acknowledgements, dual publication, self plagiarism, and salami publishing,” Res Nurs Health, vol. 31, no. 4, pp. 295–297, Aug. 2008, doi: 10.1002/nur.20280.
[5302]	K. T. Rew, “Issues in Nutrition: Foreword,” FP Essent, vol. 452, p. 2, Jan. 2017.
[5303]	M. F. Drummond, “Issues in the conduct of economic evaluations of pharmaceutical products,” Pharmacoeconomics, vol. 6, no. 5, pp. 405–411, Nov. 1994, doi: 10.2165/00019053-199406050-00001.
[5304]	Y. Huang, M. Liao, Q. Yang, J. Xiao, Z. Hu, and H. Cao, “iTRAQ-based quantitative proteome revealed metabolic changes of Sitophilus zeamais in response to terpinen-4-ol fumigation,” Pest Manag. Sci., vol. 75, no. 2, pp. 444–451, Feb. 2019, doi: 10.1002/ps.5135.
[5305]	M. A. Carroll, D. Skeete, and E. J. Catapane, “Its Time to Step into Science at Medgar Evers College,” In Vivo (Brooklyn), vol. 30, no. 1, pp. 22–28, 2008.
[5306]	D. M. L. de Andrade, L. L. Borges, I. M. S. Torres, E. C. da Conceição, and M. L. Rocha, “Jabuticaba-Induced Endothelium-Independent Vasodilating Effect on Isolated Arteries,” Arq. Bras. Cardiol., vol. 107, no. 3, pp. 223–229, Sep. 2016, doi: 10.5935/abc.20160118.
[5307]	M. Spoont, “JAMA PATIENT PAGE. Posttraumatic Stress Disorder (PTSD),” JAMA, vol. 314, no. 5, p. 532, Aug. 2015, doi: 10.1001/jama.2015.8109.
[5308]	M. McCrae, “James Hutton’s Theory of the Earth..., 1785,” J R Coll Physicians Edinb, vol. 42, no. 1, pp. 87–89, Mar. 2012, doi: 10.4997/JRCPE.2012.120.
[5309]	“Japanese Encephalitis  Vaccines: WHO position paper  – February 2015,” Wkly. Epidemiol. Rec., vol. 90, no. 9, pp. 69–87, Feb. 2015.
[5310]	“Japanese encephalitis: surveillance and immunization in Asia and the Western Pacific, 2016,” Wkly. Epidemiol. Rec., vol. 92, no. 23, pp. 323–331, 09 2017.
[5311]	L. Zhang, F. Zhang, M. Melotto, J. Yao, and S. Y. He, “Jasmonate signaling and manipulation by pathogens and insects,” J. Exp. Bot., vol. 68, no. 6, pp. 1371–1385, 01 2017, doi: 10.1093/jxb/erw478.
[5312]	E. J. Crone et al., “Jhe in Gryllus assimilis: cloning, sequence-activity associations and phylogeny,” Insect Biochem. Mol. Biol., vol. 37, no. 12, pp. 1359–1365, Dec. 2007, doi: 10.1016/j.ibmb.2007.08.005.
[5313]	J. Rosta, M. Nylenna, and O. G. Aasland, “Job satisfaction among hospital doctors in Norway and Germany. A comparative study on national samples,” Scand J Public Health, vol. 37, no. 5, pp. 503–508, Jul. 2009, doi: 10.1177/1403494809106504.
[5314]	 null The Lancet, “Join the Lancet 2020 Campaign on child and adolescent health,” Lancet, vol. 395, no. 10218, p. 89, 11 2020, doi: 10.1016/S0140-6736(20)30002-7.
[5315]	C. F. Sharpley and V. Bitsika, “Joining the dots: neurobiological links in a functional analysis of depression,” Behav Brain Funct, vol. 6, p. 73, Dec. 2010, doi: 10.1186/1744-9081-6-73.
[5316]	B. Wang et al., “Joint use of the radiomics method and frozen sections should be considered in the prediction of the final classification of peripheral lung adenocarcinoma manifesting as ground-glass nodules,” Lung Cancer, vol. 139, pp. 103–110, 2020, doi: 10.1016/j.lungcan.2019.10.031.
[5317]	S. M. Al Shatrat, D. Shuman, M. L. Darby, and H. A. Jeng, “Jordanian dentists’ knowledge and implementation of eco-friendly dental office strategies,” Int Dent J, vol. 63, no. 3, pp. 161–168, Jun. 2013, doi: 10.1111/idj.12031.
[5318]	M. Roca-Cusachs, J. Kim, R. GarcÍa-Becerra, and S. Jung, “Journey to the Center of the Earth: Description of a new troglomorphic litter-bug species inhabiting lava tubes in the Canary Islands (Heteroptera: Dipsocoromorpha: Ceratocombidae),” Zootaxa, vol. 4550, no. 4, pp. 557–564, Jan. 2019, doi: 10.11646/zootaxa.4550.4.5.
[5319]	I. Datta, M. Banerjee, S. K. Mukherjee, and S. K. Majumdar, “JU-2, a novel phosphorous-containing antifungal antibiotic from Streptomyces kanamyceticus M8,” Indian J. Exp. Biol., vol. 39, no. 6, pp. 604–606, Jun. 2001.
[5320]	A. Bucher and A. Voss, “Judging the mood of the crowd: Attention is focused on happy faces,” Emotion, vol. 19, no. 6, pp. 1044–1059, Sep. 2019, doi: 10.1037/emo0000507.
[5321]	K. Lirdprapamongkol et al., “Juice of eclipta prostrata inhibits cell migration in vitro and exhibits anti-angiogenic activity in vivo,” In Vivo, vol. 22, no. 3, pp. 363–368, Jun. 2008.
[5322]	Y. Saito, S. G. Kamita, B. D. Hammock, Y. Kunimi, M. N. Inoue, and M. Nakai, “Juvenile hormone (JH) esterase activity but not JH epoxide hydrolase activity is downregulated in larval Adoxophyes honmai following nucleopolyhedroviruses infection,” J. Insect Physiol., vol. 80, pp. 71–80, Sep. 2015, doi: 10.1016/j.jinsphys.2015.02.005.
[5323]	S. G. Kamita et al., “Juvenile hormone (JH) esterase: why are you so JH specific?,” Insect Biochem. Mol. Biol., vol. 33, no. 12, pp. 1261–1273, Dec. 2003, doi: 10.1016/j.ibmb.2003.08.004.
[5324]	U. G. Elayidam and D. Muraleedharan, “Juvenile hormone activity in Dysdercus cingulatus Fabr by juvenile hormone esterase inhibitor, OTFP,” Indian J. Exp. Biol., vol. 45, no. 10, pp. 901–906, Oct. 2007.
[5325]	A. Niewiadomska-Cimicka, M. Schmidt, A. Ożyhar, D. Jones, G. Jones, and M. Kochman, “Juvenile hormone binding protein core promoter is TATA-driven with a suppressory element,” Biochim. Biophys. Acta, vol. 1809, no. 4–6, pp. 226–235, Jun. 2011, doi: 10.1016/j.bbagrm.2011.02.001.
[5326]	A. D. Bomtorin et al., “Juvenile hormone biosynthesis gene expression in the corpora allata of honey bee (Apis mellifera L.) female castes,” PLoS ONE, vol. 9, no. 1, p. e86923, 2014, doi: 10.1371/journal.pone.0086923.
[5327]	A. C. Hinton and B. D. Hammock, “Juvenile hormone esterase (JHE) from Tenebrio molitor: full-length cDNA sequence, in vitro expression, and characterization of the recombinant protein,” Insect Biochem. Mol. Biol., vol. 33, no. 5, pp. 477–487, May 2003, doi: 10.1016/s0965-1748(03)00010-9.
[5328]	C. Schafellner, M. Eizaguirre, C. López, and F. Sehnal, “Juvenile hormone esterase activity in the pupating and diapausing larvae of Sesamia nonagrioides,” J. Insect Physiol., vol. 54, no. 6, pp. 916–921, Jun. 2008, doi: 10.1016/j.jinsphys.2008.04.015.
[5329]	S. G. Kamita and B. D. Hammock, “Juvenile hormone esterase: biochemistry and structure,” J Pestic Sci, vol. 35, no. 3, pp. 265–274, Aug. 2010, doi: 10.1584/jpestics.R10-09.
[5330]	J. Larriva-Sahd, “Juxtacapsular nucleus of the stria terminalis of the adult rat: extrinsic inputs, cell types, and neuronal modules: a combined Golgi and electron microscopic study,” J. Comp. Neurol., vol. 475, no. 2, pp. 220–237, Jul. 2004, doi: 10.1002/cne.20185.
[5331]	G. B. Dalrymple and W. K. Hamblin, “K-Ar ages of Pleistocene lava dams in the Grand Canyon in Arizona,” Proc. Natl. Acad. Sci. U.S.A., vol. 95, no. 17, pp. 9744–9749, Aug. 1998, doi: 10.1073/pnas.95.17.9744.
[5332]	Y. Koyama et al., “K-YTM jelly inhibits increase in endotracheal tube cuff pressure during nitrous oxide exposure in vitro,” BMC Anesthesiol, vol. 18, no. 1, p. 99, 28 2018, doi: 10.1186/s12871-018-0566-9.
[5333]	N. Ivashikina and R. Hedrich, “K+ currents through SV-type vacuolar channels are sensitive to elevated luminal sodium levels,” Plant J., vol. 41, no. 4, pp. 606–614, Feb. 2005, doi: 10.1111/j.1365-313X.2004.02324.x.
[5334]	I. Mounsey, K. A. Brady, J. Carroll, R. Fisher, and D. N. Middlemiss, “K+-evoked [3H]-5-HT release from rat frontal cortex slices: the effect of 5-HT agonists and antagonists,” Biochem. Pharmacol., vol. 31, no. 1, pp. 49–53, Jan. 1982, doi: 10.1016/0006-2952(82)90234-9.
[5335]	H. Liu et al., “Kaempferol Modulates Autophagy and Alleviates Silica-Induced Pulmonary Fibrosis,” DNA Cell Biol., vol. 38, no. 12, pp. 1418–1426, Dec. 2019, doi: 10.1089/dna.2019.4941.
[5336]	P. Sarkar, P. K. Basu, and I. Miller, “Karyologic studies on cells from rabbit cornea and other tissues grown in vitro,” Invest Ophthalmol, vol. 1, pp. 33–40, Feb. 1962.
[5337]	O. Bucher, “[Karyometric studies on tissue culture in vitro.  XVII.  Nuclei and nucleoli size in various fast growing connective tissue cultures],” Z Anat Entwicklungsgesch, vol. 118, no. 6, pp. 531–542, 1955.
[5338]	P. Wang, M. N. Fedoruk, and J. L. Rupert, “Keeping pace with ACE: are ACE inhibitors and angiotensin II type 1 receptor antagonists potential doping agents?,” Sports Med, vol. 38, no. 12, pp. 1065–1079, 2008, doi: 10.2165/00007256-200838120-00008.
[5339]	A. Chattopadhyay, O. Arevalo, and J. C. Cecil, “Kentucky’s oral health indicators and progress towards Healthy People 2010 objectives,” J Ky Med Assoc, vol. 106, no. 4, pp. 165–174, Apr. 2008.
[5340]	J. Hennen and B. Blömeke, “Keratinocytes improve prediction of sensitization potential and potency of chemicals with THP-1 cells,” ALTEX, vol. 34, no. 2, pp. 279–288, 2017, doi: 10.14573/altex.1606171.
[5341]	N. Kanda and S. Watanabe, “Ketoconazole suppresses interleukin-4 plus anti-CD40-induced IgE class switching in surface IgE negative B cells from patients with atopic dermatitis,” J. Invest. Dermatol., vol. 119, no. 3, pp. 590–599, Sep. 2002, doi: 10.1046/j.1523-1747.2002.01864.x.
[5342]	N. Kanda and S. Watanabe, “Ketoconazole suppresses prostaglandin E(2)-induced cyclooxygenase-2 expression in human epidermoid carcinoma A-431 cells,” J. Invest. Dermatol., vol. 119, no. 1, pp. 174–181, Jul. 2002, doi: 10.1046/j.1523-1747.2002.01804.x.
[5343]	X. Cheng, Z. Li, X.-T. Wu, M. Hong, M.-H. Whangbo, and S. Deng, “Key Factors Controlling the Large Second Harmonic Generation in Nonlinear Optical Materials,” ACS Appl Mater Interfaces, vol. 12, no. 8, pp. 9434–9439, Feb. 2020, doi: 10.1021/acsami.9b20023.
[5344]	M. B. Ospina, K. Bond, M. Schull, G. Innes, S. Blitz, and B. H. Rowe, “Key indicators of overcrowding in Canadian emergency departments: a Delphi study,” CJEM, vol. 9, no. 5, pp. 339–346, Sep. 2007, doi: 10.1017/s1481803500015281.
[5345]	S.-M. Lee et al., “Key lime (Citrus aurantifolia) inhibits the growth of triple drug resistant Helicobacter pylori,” Gut Pathog, vol. 10, p. 16, 2018, doi: 10.1186/s13099-018-0244-y.
[5346]	L. Chung, D. R. Maestas, F. Housseau, and J. H. Elisseeff, “Key players in the immune response to biomaterial scaffolds for regenerative medicine,” Adv. Drug Deliv. Rev., vol. 114, pp. 184–192, 15 2017, doi: 10.1016/j.addr.2017.07.006.
[5347]	J. H. Watson, “Keynote address,” J Am Coll Health Assoc, vol. 28, no. 1, pp. 11–14, Aug. 1979, doi: 10.1080/01644300.1979.10392889.
[5348]	P. F. Pearce, R. W. Hicks, and C. A. Pierson, “Keywords matter: A critical factor in getting published work discovered,” J Am Assoc Nurse Pract, vol. 30, no. 4, pp. 179–181, Apr. 2018, doi: 10.1097/JXX.0000000000000048.
[5349]	J. Woodhead et al., “Kimberlites reveal 2.5-billion-year evolution of a deep, isolated mantle reservoir,” Nature, vol. 573, no. 7775, pp. 578–581, 2019, doi: 10.1038/s41586-019-1574-8.
[5350]	A. V. LeFever and R. L. Truitt, “Kinetic analysis of Qa-1-specific cloned cytotoxic T lymphocytes: lytic parameters and evaluation of cellular inhibition,” Scand. J. Immunol., vol. 25, no. 6, pp. 541–553, Jun. 1987, doi: 10.1111/j.1365-3083.1987.tb01080.x.
[5351]	S. Badhyal et al., “Kinetic and Kinematic Analysis of Gait in Type IV Osteogenesis Imperfecta Patients: A Comparative Study,” Indian J Orthop, vol. 53, no. 4, pp. 560–566, Aug. 2019, doi: 10.4103/ortho.IJOrtho_291_18.
[5352]	A. Rodríguez, D. Rodríguez, A. Garzón, A. Soto, A. Aranda, and A. Notario, “Kinetics and mechanism of the atmospheric reactions of atomic chlorine with 1-penten-3-ol and (Z)-2-penten-1-ol: an experimental and theoretical study,” Phys Chem Chem Phys, vol. 12, no. 38, pp. 12245–12258, Oct. 2010, doi: 10.1039/c0cp00625d.
[5353]	E. O. Omeje, G. B. Okide, C. O. Esimone, and U. Ajali, “Kinetics of Autoxidation of an Oil Extract from Terminalia catappa,” Indian J Pharm Sci, vol. 70, no. 2, pp. 260–262, Apr. 2008, doi: 10.4103/0250-474X.41472.
[5354]	F. Di Palma, S. Bottaro, and G. Bussi, “Kissing loop interaction in adenine riboswitch: insights from umbrella sampling simulations,” BMC Bioinformatics, vol. 16 Suppl 9, p. S6, 2015, doi: 10.1186/1471-2105-16-S9-S6.
[5355]	M. Zara and A. Cohen, “[Klinefelter syndrome],” Fr Med, vol. 20, no. 5, pp. 17–18; passim, 1957.
[5356]	Y. Huang, M. Liao, Q. Yang, S. Shi, J. Xiao, and H. Cao, “Knockdown of NADPH-cytochrome P450 reductase and CYP6MS1 increases the susceptibility of Sitophilus zeamais to terpinen-4-ol,” Pestic Biochem Physiol, vol. 162, pp. 15–22, Jan. 2020, doi: 10.1016/j.pestbp.2019.07.008.
[5357]	M. G. Arend, T. Franke, and N. A. Stanton, “Know-how or know-why? The role of hybrid electric vehicle drivers’ acquisition of eco-driving knowledge for eco-driving success,” Appl Ergon, vol. 75, pp. 221–229, Feb. 2019, doi: 10.1016/j.apergo.2018.10.009.
[5358]	Y. Bahou, L. Alzghoul, E. M. Alajloni, M. A. Albliwi, N. O. Alsabatin, and Y. K. Toubah, “Knowledge and awareness among patients with epilepsy observed at Jordan University Hospital,” Epilepsy Behav, vol. 102, p. 106697, 2020, doi: 10.1016/j.yebeh.2019.106697.
[5359]	W. M. Otte et al., “Knowledge and beliefs about epilepsy among people with and without epilepsy in urban Suriname,” Epilepsy Behav, vol. 29, no. 1, pp. 128–132, Oct. 2013, doi: 10.1016/j.yebeh.2013.07.001.
[5360]	E. Ramos-Silva, M. G. Nava-Galán, and D. San-Juan, “[Knowledge and perceptions of the proper completion of nursing records in a tertiary hospital],” Enferm Clin, vol. 21, no. 3, pp. 151–158, Jun. 2011, doi: 10.1016/j.enfcli.2011.01.008.
[5361]	F. Bustreo, R. Gorna, and D. Nabarro, “Knowledge for effective action to improve the health of women, children and adolescents in the sustainable development era,” Bull. World Health Organ., vol. 94, no. 5, pp. 310-310A, May 2016, doi: 10.2471/BLT.16.174243.
[5362]	D. Atakli, P. Dogan Ak, B. T. Guveli, and B. Yuksel, “Knowledge of epilepsy among persons with epilepsy in Turkey,” Epilepsy Behav, vol. 57, no. Pt A, pp. 41–45, Apr. 2016, doi: 10.1016/j.yebeh.2016.01.030.
[5363]	E. Smith, S. Haustein, P. Mongeon, F. Shu, V. Ridde, and V. Larivière, “Knowledge sharing in global health research - the impact, uptake and cost of open access to scholarly literature,” Health Res Policy Syst, vol. 15, no. 1, p. 73, Aug. 2017, doi: 10.1186/s12961-017-0235-3.
[5364]	N. Kissani, M. Moro, and S. Arib, “Knowledge, attitude and traditional practices towards epilepsy among relatives of PWE (patients with epilepsy) in Marrakesh, Morocco,” Epilepsy Behav, vol. 111, p. 107257, Jul. 2020, doi: 10.1016/j.yebeh.2020.107257.
[5365]	M. Lujo, M. Meštrović, A. Ivanišević Malčić, Z. Karlović, J. Matijević, and S. Jukić, “Knowledge, Attitudes and Habits Regarding Oral Health in First- and Final-Year Dental Students,” Acta Clin Croat, vol. 55, no. 4, pp. 636–643, 2016, doi: 10.20471/acc.2016.55.04.15.
[5366]	C. H. Hounsossou et al., “Knowledge, attitudes, and behavior among key people involved in the employment of people with epilepsy in southern Benin,” Epilepsy Behav, vol. 42, pp. 153–158, Jan. 2015, doi: 10.1016/j.yebeh.2014.10.022.
[5367]	C. E. Nerantzis, S. K. Marianou, S. N. Koulouris, E. B. Agapitos, J. A. Papaioannou, and L. J. Vlahos, “Kugel’s artery: an anatomical and angiographic study using a new technique,” Tex Heart Inst J, vol. 31, no. 3, pp. 267–270, 2004.
[5368]	D. Shannahoff-Khalsa et al., “Kundalini Yoga Meditation Versus the Relaxation Response Meditation for Treating Adults With Obsessive-Compulsive Disorder: A Randomized Clinical Trial,” Front Psychiatry, vol. 10, p. 793, 2019, doi: 10.3389/fpsyt.2019.00793.
[5369]	J. R. Graybill et al., “KY-62, a polyene analog of amphotericin B, for treatment of murine candidiasis,” Antimicrob. Agents Chemother., vol. 42, no. 1, pp. 147–150, Jan. 1998, doi: 10.1128/AAC.42.1.147.
[5370]	M. Sun, Y. Shinoda, and K. Fukunaga, “KY-226 Protects Blood-brain Barrier Function Through the Akt/FoxO1 Signaling Pathway in Brain Ischemia,” Neuroscience, vol. 399, pp. 89–102, 10 2019, doi: 10.1016/j.neuroscience.2018.12.024.
[5371]	Y. Wei, C. Su, H. Zhang, and Z. Fu, “KY(MoO4)2:Eu3+ Phosphor: Template-Free Hydrothermal Synthesis and Luminescent Properties,” J Nanosci Nanotechnol, vol. 16, no. 3, pp. 3150–3156, Mar. 2016, doi: 10.1166/jnn.2016.11797.
[5372]	M. Bou Zeidan et al., “L-histidine inhibits biofilm formation and FLO11-associated phenotypes in Saccharomyces cerevisiae flor yeasts,” PLoS ONE, vol. 9, no. 11, p. e112141, 2014, doi: 10.1371/journal.pone.0112141.
[5373]	B. Sharma, S. Singh, and S. S. Kanwar, “L-methionase: a therapeutic enzyme to treat malignancies,” Biomed Res Int, vol. 2014, p. 506287, 2014, doi: 10.1155/2014/506287.
[5374]	R. Lukács, M. Guillong, A. K. Schmitt, K. Molnár, O. Bachmann, and S. Harangi, “LA-ICP-MS and SIMS U-Pb and U-Th zircon geochronological data of Late Pleistocene lava domes of the Ciomadul Volcanic Dome Complex (Eastern Carpathians),” Data Brief, vol. 18, pp. 808–813, Jun. 2018, doi: 10.1016/j.dib.2018.03.100.
[5375]	M. W. Greene, L. G. Stang, and M. Hillman, “LABELING OF HUMAN GAMMA GLOBULIN WITH I-124. BNL 777 (T-293),” Tech Rep Brookhaven Natl Lab, vol. 86, pp. 1–4, Feb. 1963.
[5376]	D. E. Bradway and F. L. Siegelman, “Laboratory accreditation,” Qual Assur, vol. 3, no. 3, pp. 242–247, Sep. 1994.
[5377]	J. Sun, A. Khelifa, C. Zhao, D. Zhao, and Z. Wang, “Laboratory investigation of oil-suspended particulate matter aggregation under different mixing conditions,” Sci. Total Environ., vol. 473–474, pp. 742–749, Mar. 2014, doi: 10.1016/j.scitotenv.2013.12.078.
[5378]	“Laboratory response to the West African Ebola outbreak 2014-2015,” Wkly. Epidemiol. Rec., vol. 90, no. 32, pp. 393–399, Aug. 2015.
[5379]	T. A. Ferguson, K. S. Jones, C. R. Freeman, and J. W. T. Byrd, “Labral Ossification and Sacroiliac Joint Disease: Could There Be a Link to an Autoimmune Etiology?,” Arthroscopy, vol. 35, no. 8, pp. 2333–2337, 2019, doi: 10.1016/j.arthro.2019.03.049.
[5380]	G. Diatkine, “Lacan,” Int J Psychoanal, vol. 88, no. Pt 3, pp. 643–660, Jun. 2007, doi: 10.1516/f2r2-2204-1427-3j23.
[5381]	S. W. Woo, S. Bang, M. W. Chung, S. K. Jin, Y. S. Kim, and S. H. Lee, “Lack of association between ACE and bradykinin B2 receptor gene polymorphisms and ACE inhibitor-induced coughing in hypertensive Koreans,” J Clin Pharm Ther, vol. 34, no. 5, pp. 561–567, Oct. 2009, doi: 10.1111/j.1365-2710.2009.01028.x.
[5382]	Y.-W. Lee et al., “Lack of association between oxidized LDL-cholesterol concentrations and haptoglobin phenotypes in healthy subjects,” Ann. Clin. Biochem., vol. 41, no. Pt 6, pp. 485–487, Nov. 2004, doi: 10.1258/0004563042466703.
[5383]	K. Kanemoto, Y. Tadokoro, A. J. Sheldrick, and T. Oshima, “Lack of data on depression-like states and antidepressant pharmacotherapy in patients with epilepsy: randomised controlled trials are badly needed,” Curr. Pharm. Des., vol. 18, no. 36, pp. 5828–5836, 2012, doi: 10.2174/138161212803523563.
[5384]	L. D. Saravolatz, V. Labalo, J. Fishbain, S. Szpunar, and L. B. Johnson, “Lack of effect of antibiotics on biopsy culture results in vertebral osteomyelitis,” Diagn. Microbiol. Infect. Dis., vol. 91, no. 3, pp. 273–274, Jul. 2018, doi: 10.1016/j.diagmicrobio.2018.02.017.
[5385]	M. Malacarne et al., “Lack of SCN1A mutations in familial febrile seizures,” Epilepsia, vol. 43, no. 5, pp. 559–562, May 2002, doi: 10.1046/j.1528-1157.2002.29301.x.
[5386]	E. De Grandis et al., “Lack of SLC2A1 (glucose transporter 1) mutations in 30 Italian patients with alternating hemiplegia of childhood,” J. Child Neurol., vol. 28, no. 7, pp. 863–866, Jul. 2013, doi: 10.1177/0883073812452789.
[5387]	J. P. Codde, J. A. Vines, P. H. van der Meide, M. A. Burton, and B. N. Gray, “Lack of synergy between 5-fluorouracil and interferon-gamma in the treatment of malignancy in the rat,” In Vivo, vol. 5, no. 4, pp. 413–417, Aug. 1991.
[5388]	L. H. Bergersen, “[Lactate in the brain--without turning sour],” Tidsskr. Nor. Laegeforen., vol. 126, no. 16, pp. 2094–2097, Aug. 2006.
[5389]	M. Passera et al., “Lactobacillus casei subsp. rhamnosus septicaemia in three patients of the paediatric intensive care unit,” J. Hosp. Infect., Oct. 2016, doi: 10.1016/j.jhin.2016.09.018.
[5390]	C. S. Sripada, D. Kessler, and M. Angstadt, “Lag in maturation of the brain’s intrinsic functional architecture in attention-deficit/hyperactivity disorder,” Proc. Natl. Acad. Sci. U.S.A., vol. 111, no. 39, pp. 14259–14264, Sep. 2014, doi: 10.1073/pnas.1407787111.
[5391]	T. Jüngling, T. Stemler, and M. Small, “Laminar chaos in nonlinear electronic circuits with delay clock modulation,” Phys Rev E, vol. 101, no. 1–1, p. 012215, Jan. 2020, doi: 10.1103/PhysRevE.101.012215.
[5392]	K. J. Kim, S. H. Jeun, and K.-W. Sung, “Lamotrigine, an antiepileptic drug, inhibits 5-HT3 receptor currents in NCB-20 neuroblastoma cells,” Korean J. Physiol. Pharmacol., vol. 21, no. 2, pp. 169–177, Mar. 2017, doi: 10.4196/kjpp.2017.21.2.169.
[5393]	H. Yang and Q. Wu, “Land Use Eco-Efficiency and Its Convergence Characteristics Under the Constraint of Carbon Emissions in China,” Int J Environ Res Public Health, vol. 16, no. 17, 30 2019, doi: 10.3390/ijerph16173172.
[5394]	E. J. van Rensburg, W. F. van Heerden, and E. J. Raubenheimer, “Langerhans cells and human papillomaviruses in oesophageal and laryngeal carcinomas,” In Vivo, vol. 7, no. 3, pp. 229–232, Jun. 1993.
[5395]	R. J. Ruben, “Language development in the pediatric cochlear implant patient,” Laryngoscope Investig Otolaryngol, vol. 3, no. 3, pp. 209–213, Jun. 2018, doi: 10.1002/lio2.156.
[5396]	J. Praveena, H. Prakash, and T. M. Rukmangathan, “Language Outcomes Using Hearing Aids in Children with Auditory Dys-Synchrony,” Audiol Res, vol. 4, no. 1, p. 80, Mar. 2014, doi: 10.4081/audiores.2014.80.
[5397]	W. F. Swanson, “Laparoscopic oviductal embryo transfer and artificial insemination in felids--challenges, strategies and successes,” Reprod. Domest. Anim., vol. 47 Suppl 6, pp. 136–140, Dec. 2012, doi: 10.1111/rda.12069.
[5398]	R. Kassir, P. Blanc, P. Lointier, C. Breton, T. Debs, and O. Tiffet, “Laparoscopic Revision of an Omega Loop Gastric Bypass to Treat Afferent Loop Syndrome,” Obes Surg, vol. 25, no. 10, pp. 1976–1978, Oct. 2015, doi: 10.1007/s11695-015-1805-5.
[5399]	J. Guo et al., “Laparoscopic versus open orchiopexy for non-palpable undescended testes in children: a systemic review and meta-analysis,” Pediatr. Surg. Int., vol. 27, no. 9, pp. 943–952, Sep. 2011, doi: 10.1007/s00383-011-2889-1.
[5400]	C. I. van Emmerik, R. Kooijman, M. Dijkstra, and S. M. Garcia-Blanco, “Lapping and Polishing of Crystalline KY(WO4)2: Toward High Refractive Index Contrast Slab Waveguides,” Micromachines (Basel), vol. 10, no. 10, Oct. 2019, doi: 10.3390/mi10100674.
[5401]	K. J. Weld, J. Arzola, C. Montiglio, A. C. Bush, and R. D. Cespedes, “Lapra-Ty holding strength and slippage with various suture types and sizes,” Urology, vol. 71, no. 1, pp. 32–35, Jan. 2008, doi: 10.1016/j.urology.2007.08.061.
[5402]	 null Raines et al., “Large Proper-Motion Infrared,” Astrophys. J., vol. 528, no. 2, pp. L115–L118, Jan. 2000, doi: 10.1086/312427.
[5403]	B. H. Kim, S. H. Lee, A. Lin, C.-L. Lee, J. Lee, and W.-T. Han, “Large temperature sensitivity of Sagnac loop interferometer based on the birefringent holey fiber filled with metal indium,” Opt Express, vol. 17, no. 3, pp. 1789–1794, Feb. 2009, doi: 10.1364/oe.17.001789.
[5404]	T. Meng et al., “Large-Scale Electric-Field Confined Silicon with Optimized Charge-Transfer Kinetics and Structural Stability for High-Rate Lithium-Ion Batteries,” ACS Nano, vol. 14, no. 6, pp. 7066–7076, Jun. 2020, doi: 10.1021/acsnano.0c01796.
[5405]	A. Hildenbrand, F. O. Marques, and J. Catalão, “Large-scale mass wasting on small volcanic islands revealed by the study of Flores Island (Azores),” Sci Rep, vol. 8, no. 1, p. 13898, 17 2018, doi: 10.1038/s41598-018-32253-0.
[5406]	J. Kuipers, R. D. Kalicharan, A. H. G. Wolters, T. J. van Ham, and B. N. G. Giepmans, “Large-scale Scanning Transmission Electron Microscopy (Nanotomy) of Healthy and Injured Zebrafish Brain,” J Vis Exp, no. 111, 25 2016, doi: 10.3791/53635.
[5407]	R. F. Johnson and A. Isaiah, “Laryngeal stenosis among hospitalized children: Results from a nationwide cross-sectional survey,” Laryngoscope Investig Otolaryngol, vol. 3, no. 3, pp. 244–248, Jun. 2018, doi: 10.1002/lio2.153.
[5408]	L. A. Orloff, A. P. Mann, J. F. Damrose, and S. N. Goldman, “Laser-assisted voice adjustment (LAVA) in transsexuals,” Laryngoscope, vol. 116, no. 4, pp. 655–660, Apr. 2006, doi: 10.1097/01.mlg.0000205198.65797.59.
[5409]	D. A. Rew, G. Woltmann, and A. J. Wardlaw, “Laser-scanning cytometry,” Lancet, vol. 353, no. 9149, pp. 255–256, Jan. 1999, doi: 10.1016/S0140-6736(05)74940-0.
[5410]	T. M. Schmid, D. K. Bonen, L. Luchene, and T. F. Linsenmayer, “Late events in chondrocyte differentiation: hypertrophy, type X collagen synthesis and matrix calcification,” In Vivo, vol. 5, no. 5, pp. 533–540, Oct. 1991.
[5411]	A. G. Efthymiou and A. M. Goate, “Late onset Alzheimer’s disease genetics implicates microglial pathways in disease risk,” Mol Neurodegener, vol. 12, no. 1, p. 43, 26 2017, doi: 10.1186/s13024-017-0184-x.
[5412]	G. Grisaru-Soen, T. Friedman, S. Dollberg, H. Mishali, and Y. Carmeli, “Late-onset bloodstream infections in preterm infants: a 2-year survey,” Pediatr Int, vol. 54, no. 6, pp. 748–753, Dec. 2012, doi: 10.1111/j.1442-200X.2012.03679.x.
[5413]	Y. N. Suen et al., “Late-onset psychosis and very-late-onset-schizophrenia-like-psychosis: an updated systematic review,” Int Rev Psychiatry, vol. 31, no. 5–6, pp. 523–542, Sep. 2019, doi: 10.1080/09540261.2019.1670624.
[5414]	R. E. Friedrich, H. A. Scheuer, and J. Zustin, “Lateral periodontal cyst,” In Vivo, vol. 28, no. 4, pp. 595–598, Aug. 2014.
[5415]	M. Frewein, B. Kollmitzer, P. Heftberger, and G. Pabst, “Lateral pressure-mediated protein partitioning into liquid-ordered/liquid-disordered domains,” Soft Matter, vol. 12, no. 13, pp. 3189–3195, Apr. 2016, doi: 10.1039/c6sm00042h.
[5416]	N. Greenberg, S. Brooks, and R. Dunn, “Latest developments in post-traumatic stress disorder: diagnosis and treatment,” Br. Med. Bull., vol. 114, no. 1, pp. 147–155, Jun. 2015, doi: 10.1093/bmb/ldv014.
[5417]	C. Garcia, L. Zhang, K. Holt, R. Hardeman, and B. Peterson, “Latina adolescent sleep and mood: an ecological momentary assessment pilot study,” J Child Adolesc Psychiatr Nurs, vol. 27, no. 3, pp. 132–141, Aug. 2014, doi: 10.1111/jcap.12082.
[5418]	D. P. Bockmühl, J. Schages, and L. Rehberg, “Laundry and textile hygiene in healthcare and beyond,” Microb Cell, vol. 6, no. 7, pp. 299–306, Jul. 2019, doi: 10.15698/mic2019.07.682.
[5419]	W. Nikel, “Lava cake for the Apocalypse,” Nature, vol. 555, no. 7694, p. 134, Mar. 2018, doi: 10.1038/d41586-018-02408-0.
[5420]	D. E. Northup et al., “Lava cave microbial communities within mats and secondary mineral deposits: implications for life detection on other planets,” Astrobiology, vol. 11, no. 7, pp. 601–618, Sep. 2011, doi: 10.1089/ast.2010.0562.
[5421]	C. Del Negro, A. Cappello, M. Neri, G. Bilotta, A. Hérault, and G. Ganci, “Lava flow hazards at Mount Etna: constraints imposed by eruptive history and numerical simulations,” Sci Rep, vol. 3, p. 3493, Dec. 2013, doi: 10.1038/srep03493.
[5422]	“Lava flows, stem-cell crackdown and Ebola returns,” Nature, vol. 557, no. 7705, pp. 284–285, 2018, doi: 10.1038/d41586-018-05141-w.
[5423]	T. A. Clark, “Lava lamp optics,” Appl Opt, vol. 50, no. 28, pp. F16-20, Oct. 2011, doi: 10.1364/AO.50.000F16.
[5424]	M. Koller, G. V. Arnetzl, L. Holly, and G. Arnetzl, “Lava ultimate resin nano ceramic for CAD/ CAM: customization case study,” Int J Comput Dent, vol. 15, no. 2, pp. 159–164, 2012.
[5425]	D. Suttor, K. Bunke, S. Hoescheler, H. Hauptmann, and G. Hertlein, “LAVA--the system for all-ceramic ZrO2 crown and bridge frameworks,” Int J Comput Dent, vol. 4, no. 3, pp. 195–206, Jul. 2001.
[5426]	C. Torres, E. A. Vitalis, B. R. Baker, S. N. Gardner, M. W. Torres, and J. M. Dzenitis, “LAVA: an open-source approach to designing LAMP (loop-mediated isothermal amplification) DNA signatures,” BMC Bioinformatics, vol. 12, p. 240, Jun. 2011, doi: 10.1186/1471-2105-12-240.
[5427]	C. Kallweit, D. Pförringer, P. Biberthaler, and K.-G. Kanz, “[Lawn mower injury in children - a lesson for life],” MMW Fortschr Med, vol. 159, no. 12, pp. 41–42, Jun. 2017, doi: 10.1007/s15006-017-9845-5.
[5428]	J. E. Kim et al., “Laxative Effect of Spicatoside A by Cholinergic Regulation of Enteric Nerve in Loperamide-Induced Constipation: ICR Mice Model,” Molecules, vol. 24, no. 5, Mar. 2019, doi: 10.3390/molecules24050896.
[5429]	Q. Zhang, X. Zhang, and Q. You, “Lead Discovery of Type II BRAF V600E Inhibitors Targeting the Structurally Validated DFG-Out Conformation Based upon Selected Fragments,” Molecules, vol. 21, no. 7, Jul. 2016, doi: 10.3390/molecules21070879.
[5430]	R. Garestier, D. Pasty, and M. H. Louvet, “[Leaf extracts of Ruta graveolens L., factors in the in vitro growth of fragments of Helanthus tuberosus L. tubercles],” C. R. Seances Soc. Biol. Fil., vol. 156, pp. 1148–1153, 1962.
[5431]	N. Dhami, D. T. Tissue, and C. I. Cazzonelli, “Leaf-age dependent response of carotenoid accumulation to elevated CO2 in Arabidopsis,” Arch. Biochem. Biophys., vol. 647, pp. 67–75, 01 2018, doi: 10.1016/j.abb.2018.03.034.
[5432]	A. D. Treister, C. Kraff-Cooper, and P. A. Lio, “Learning About Dupilumab-Associated Conjunctivitis-Reply,” JAMA Dermatol, vol. 155, no. 6, pp. 754–755, 01 2019, doi: 10.1001/jamadermatol.2019.0209.
[5433]	S. Khosla, G. Sharma, and I. Yaseen, “Learning epigenetic regulation from mycobacteria,” Microb Cell, vol. 3, no. 2, pp. 92–94, Jan. 2016, doi: 10.15698/mic2016.02.480.
[5434]	J. E. George, P. J. Larmer, and N. Kayes, “Learning from those who have gone before: strengthening the rural allied health workforce in Aotearoa New Zealand,” Rural Remote Health, vol. 19, no. 3, p. 4878, 2019, doi: 10.22605/RRH4878.
[5435]	N. M. Saha, S. N. Del Tufo, and L. E. Cutting, “Learning Lexical Information Depends Upon Task, Learning Approach, and Reader Subtype,” J Learn Disabil, vol. 52, no. 6, pp. 442–455, Dec. 2019, doi: 10.1177/0022219419862266.
[5436]	V. K. Jaswal and E. M. Markman, “Learning proper and common names in inferential versus ostensive contexts,” Child Dev, vol. 72, no. 3, pp. 768–786, Jun. 2001, doi: 10.1111/1467-8624.00314.
[5437]	M. Imai and E. Haryu, “Learning proper nouns and common nouns without clues from syntax,” Child Dev, vol. 72, no. 3, pp. 787–802, Jun. 2001, doi: 10.1111/1467-8624.00315.
[5438]	R. A. McTaggart et al., “Leaving No Large Vessel Occlusion Stroke Behind: Reorganizing Stroke Systems of Care to Improve Timely Access to Endovascular Therapy,” Stroke, vol. 51, no. 7, pp. 1951–1960, Jul. 2020, doi: 10.1161/STROKEAHA.119.026735.
[5439]	D. V. Shumakov, V. V. Dontsov, and D. I. Zybin, “[Left ventricle myocardium hypertrophy of donor heart: the results and outlook],” Kardiologiia, vol. 59, no. 9S, pp. 16–24, Sep. 2019, doi: 10.18087/cardio.n460.
[5440]	L. van Garsse et al., “Left ventricular dyssynchrony is associated with recurrence of ischemic mitral regurgitation after restrictive annuloplasty,” Int. J. Cardiol., vol. 168, no. 1, pp. 176–184, Sep. 2013, doi: 10.1016/j.ijcard.2012.09.098.
[5441]	J. L. Palladino, R. L. Zukus, A. Marchidan, and A. Noordergraaf, “Left ventricular model parameters and cardiac rate variability,” Conf Proc IEEE Eng Med Biol Soc, vol. 2011, pp. 6817–6820, 2011, doi: 10.1109/IEMBS.2011.6091681.
[5442]	G. Barletta, F. Venditti, P. Stefano, R. Del Bene, and C. Di Mario, “Left ventricular outflow tract shape after aortic valve replacement with St. Jude Trifecta prosthesis,” Echocardiography, vol. 35, no. 3, pp. 329–336, 2018, doi: 10.1111/echo.13778.
[5443]	M.-A. Hartley et al., “Leishmania guyanensis parasites block the activation of the inflammasome by inhibiting maturation of IL-1β,” Microb Cell, vol. 5, no. 3, pp. 137–149, Jan. 2018, doi: 10.15698/mic2018.03.619.
[5444]	“Leishmaniasis in high-burden countries: an epidemiological  update based on data reported in 2014,” Wkly. Epidemiol. Rec., vol. 91, no. 22, pp. 287–296, Jun. 2016.
[5445]	K. Han, S. Choi-Kwon, and S.-K. Lee, “Leisure time physical activity in patients with epilepsy in Seoul, South Korea,” Epilepsy Behav, vol. 20, no. 2, pp. 321–325, Feb. 2011, doi: 10.1016/j.yebeh.2010.11.018.
[5446]	L. Ouellette, M. Barnes, M. Flannigan, E. Tavares, D. Whalen, and J. Jones, “Lemierre’s syndrome: A forgotten complication of acute pharyngitis,” Am J Emerg Med, vol. 37, no. 5, pp. 992–993, 2019, doi: 10.1016/j.ajem.2018.09.049.
[5447]	S. Tejpal, A. M. Wemyss, C. C. Bastie, and J. Klein-Seetharaman, “Lemon Extract Reduces Angiotensin Converting Enzyme (ACE) Expression and Activity and Increases Insulin Sensitivity and Lipolysis in Mouse Adipocytes,” Nutrients, vol. 12, no. 8, Aug. 2020, doi: 10.3390/nu12082348.
[5448]	M. Stahl and A. M. Zeidan, “Lenalidomide use in myelodysplastic syndromes: Insights into the biologic mechanisms and clinical applications,” Cancer, vol. 123, no. 10, pp. 1703–1713, 15 2017, doi: 10.1002/cncr.30585.
[5449]	G. Langlhofer, D. Janzen, H. Meiselbach, and C. Villmann, “Length of the TM3-4 loop of the glycine receptor modulates receptor desensitization,” Neurosci. Lett., vol. 600, pp. 176–181, Jul. 2015, doi: 10.1016/j.neulet.2015.06.017.
[5450]	Y. Zhou, T. M. Bennett, and A. Shiels, “Lens ER-stress response during cataract development in Mip-mutant mice,” Biochim. Biophys. Acta, vol. 1862, no. 8, pp. 1433–1442, 2016, doi: 10.1016/j.bbadis.2016.05.003.
[5451]	“Leprosy update, 2011,” Wkly. Epidemiol. Rec., vol. 86, no. 36, pp. 389–399, Sep. 2011.
[5452]	N. Kanda and S. Watanabe, “Leptin enhances human beta-defensin-2 production in human keratinocytes,” Endocrinology, vol. 149, no. 10, pp. 5189–5198, Oct. 2008, doi: 10.1210/en.2008-0343.
[5453]	K.-W. Yoon et al., “Leptin-induced adhesion and invasion in colorectal cancer cell lines,” Oncol. Rep., vol. 31, no. 6, pp. 2493–2498, Jun. 2014, doi: 10.3892/or.2014.3128.
[5454]	P. Striano et al., “Lesional reflex epilepsy associated with the thought of food,” Neurology, vol. 75, no. 3, pp. 288–289; author reply 289, Jul. 2010, doi: 10.1212/WNL.0b013e3181e7924b.
[5455]	A. J. Masot, A. Gázquez, S. Regodón, A. Franco, and E. Redondo, “Lesions in lambs experimentally infected with bovine respiratory syncytial virus,” Histol. Histopathol., vol. 10, no. 1, pp. 71–77, Jan. 1995.
[5456]	L. Arogundade et al., “Lessons from a training needs assessment to strengthen the capacity of routine immunization service providers in Nigeria,” BMC Health Serv Res, vol. 19, no. 1, p. 664, Sep. 2019, doi: 10.1186/s12913-019-4514-2.
[5457]	M. D. Agee and Z. Gates, “Lessons from game theory about healthcare system price inflation: evidence from a community-level case study,” Appl Health Econ Health Policy, vol. 11, no. 1, pp. 45–51, Feb. 2013, doi: 10.1007/s40258-012-0003-z.
[5458]	T. Hata, D. Imanishi, and Y. Miyazaki, “Lessons from the atomic bomb about secondary MDS,” Curr Hematol Malig Rep, vol. 9, no. 4, pp. 407–411, Dec. 2014, doi: 10.1007/s11899-014-0235-0.
[5459]	T. W. Schultz and M. T. D. Cronin, “Lessons learned from read-across case studies for repeated-dose toxicity,” Regul. Toxicol. Pharmacol., vol. 88, pp. 185–191, Aug. 2017, doi: 10.1016/j.yrtph.2017.06.011.
[5460]	H. M. Elsangedy et al., “Let the Pleasure Guide Your Resistance Training Intensity,” Med Sci Sports Exerc, vol. 50, no. 7, pp. 1472–1479, 2018, doi: 10.1249/MSS.0000000000001573.
[5461]	D. Silver, “Lethal injection, autonomy and the proper ends of medicine,” Bioethics, vol. 17, no. 2, pp. 205–211, Apr. 2003, doi: 10.1111/1467-8519.00333.
[5462]	J. Plewko et al., “Letter and Speech Sound Association in Emerging Readers With Familial Risk of Dyslexia,” Front Hum Neurosci, vol. 12, p. 393, 2018, doi: 10.3389/fnhum.2018.00393.
[5463]	S. Rammelt, “Letter from the editor: improving biomaterials through matrix engineering,” Biomatter, vol. 2, no. 3, p. 114, Sep. 2012, doi: 10.4161/biom.22011.
[5464]	H. S. Lo, “Letter From the Guest Editor,” Semin. Ultrasound CT MR, vol. 39, no. 4, p. 323, 2018, doi: 10.1053/j.sult.2018.04.004.
[5465]	L. Wall, “Letter to the Editor,” Occup Med (Lond), vol. 69, no. 5, p. 380, 22 2019, doi: 10.1093/occmed/kqz086.
[5466]	A. R. Memon, “LETTER TO THE EDITOR: Dealing with predatory publishing is a shared responsibility: the role of Latin American journals,” An. Acad. Bras. Cienc., vol. 91, no. 4, p. e20180631, 11 2019, doi: 10.1590/0001-3765201920180631.
[5467]	Q. Wang and Y. Ju, “Letter to the Editor. Can the ETVSS adequately predict success of repeat ETV?,” J Neurosurg Pediatr, vol. 21, no. 6, pp. 666–668, 2018, doi: 10.3171/2017.10.PEDS17594.
[5468]	Q. Wang, X. Hui, Q. Li, and Y. Ju, “Letter to the Editor. Preoperative third ventricle shape and ETV,” J Neurosurg Pediatr, vol. 21, no. 5, pp. 542–543, 2018, doi: 10.3171/2017.10.PEDS17534.
[5469]	C. M. Papa, “Letter: Acne and hidden iodides,” Arch Dermatol, vol. 112, no. 4, pp. 555–556, Apr. 1976, doi: 10.1001/archderm.1976.01630280073026.
[5470]	C. N. Lo, “Letters,” Spine, vol. 44, no. 24, p. E1470, 15 2019, doi: 10.1097/BRS.0000000000003266.
[5471]	J. J. Montenegro-Idrogo, J. W. Mejía-Dolores, and J. L. Chalco-Huamán, “[Letters to the editor published in Peruvian biomedical journals indexed in SciELO-Peru 2006-2013],” Rev Peru Med Exp Salud Publica, vol. 32, no. 1, pp. 104–109, Mar. 2015.
[5472]	A. P. Polednak and C. Phillips, “Leukemia as a cause of death among patients with myelodysplastic syndromes (MDS) in a population- based cancer registry: improving estimates of MDS-related mortality in the population,” J Registry Manag, vol. 39, no. 3, pp. 115–120, 2012.
[5473]	J. M. Bennett, “Leukemia Research welcomes a new co-editor-in-chief: Eric J. Feldman, M.D,” Leuk. Res., vol. 36, no. 6, p. 663, Jun. 2012, doi: 10.1016/j.leukres.2012.03.021.
[5474]	A. Podgorska, D. B. Hier, A. Pytlewski, and A. Czlonkowska, “Leukoaraiosis and stroke outcome,” J Stroke Cerebrovasc Dis, vol. 11, no. 6, pp. 336–340, Dec. 2002, doi: 10.1053/jscd.2002.130123.
[5475]	T. Nishimaki-Mogami, “[Leukoderma caused by chemicals: mechanisms underlying 4-alkyl/aryl-substituted phenols- and rhododendrol-induced melanocyte loss],” Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku, no. 133, pp. 13–20, 2015.
[5476]	N. Kanda and S. Watanabe, “Leukotriene B(4) enhances tumour necrosis factor-alpha-induced CCL27 production in human keratinocytes,” Clin. Exp. Allergy, vol. 37, no. 7, pp. 1074–1082, Jul. 2007, doi: 10.1111/j.1365-2222.2007.02743.x.
[5477]	N. Volpato, J. Kobashigawa, C. L. Yasuda, S. T. Kishimoto, P. T. Fernandes, and F. Cendes, “Level of physical activity and aerobic capacity associate with quality of life in patients with temporal lobe epilepsy,” PLoS ONE, vol. 12, no. 7, p. e0181505, 2017, doi: 10.1371/journal.pone.0181505.
[5478]	F. I. M. Craik, “Levels of processing: past, present. and future?,” Memory, vol. 10, no. 5–6, pp. 305–318, Nov. 2002, doi: 10.1080/09658210244000135.
[5479]	B. M. Appelhans et al., “Leveraging delay discounting for health: Can time delays influence food choice?,” Appetite, vol. 126, pp. 16–25, 01 2018, doi: 10.1016/j.appet.2018.03.010.
[5480]	E. J. Tomayko, B. Godlewski, S. Bowman, R. A. Settersten, R. B. Weber, and G. Krahn, “Leveraging Public Health Research to Inform State Legislative Policy that Promotes Health for Children and Families,” Matern Child Health J, vol. 23, no. 6, pp. 733–738, Jun. 2019, doi: 10.1007/s10995-018-02708-x.
[5481]	J. Rudolph et al., “Leveraging the Pre-DFG Residue Thr-406 To Obtain High Kinase Selectivity in an Aminopyrazole-Type PAK1 Inhibitor Series,” ACS Med Chem Lett, vol. 6, no. 6, pp. 711–715, Jun. 2015, doi: 10.1021/acsmedchemlett.5b00151.
[5482]	F. Brighina, A. Palermo, A. Aloisio, M. Francolini, G. Giglia, and B. Fierro, “Levetiracetam in the prophylaxis of migraine with aura: a 6-month open-label study,” Clin Neuropharmacol, vol. 29, no. 6, pp. 338–342, Dec. 2006, doi: 10.1097/01.WNF.0000236766.08409.03.
[5483]	N. Amato et al., “Levodopa-induced dyskinesia in Parkinson disease: Sleep matters,” Ann. Neurol., vol. 84, no. 6, pp. 905–917, 2018, doi: 10.1002/ana.25360.
[5484]	H. Shi, X. Kuang, and C. Lu, “LiB13: A New Member of Tetrahedral-Typed B13 Ligand Half-Surround Cluster,” Sci Rep, vol. 10, no. 1, p. 1642, Feb. 2020, doi: 10.1038/s41598-020-57769-2.
[5485]	J. Gollihue et al., “Liberation of recalcitrant cell wall sugars from oak barrels into bourbon whiskey during aging,” Sci Rep, vol. 8, no. 1, p. 15899, 26 2018, doi: 10.1038/s41598-018-34204-1.
[5486]	M. Fan et al., “Libertellenone M, a diterpene derived from an endophytic fungus Phomopsis sp. S12, protects against DSS-induced colitis via inhibiting both nuclear translocation of NF-κB and NLRP3 inflammasome activation,” Int. Immunopharmacol., vol. 80, p. 106144, Mar. 2020, doi: 10.1016/j.intimp.2019.106144.
[5487]	V. Sironval et al., “LiCoO2 particles used in Li-ion batteries induce primary mutagenicity in lung cells via their capacity to generate hydroxyl radicals,” Part Fibre Toxicol, vol. 17, no. 1, p. 6, 29 2020, doi: 10.1186/s12989-020-0338-9.
[5488]	A. Gallego-Schmid, H. K. Jeswani, J. M. F. Mendoza, and A. Azapagic, “Life cycle environmental evaluation of kettles: Recommendations for the development of eco-design regulations in the European Union,” Sci. Total Environ., vol. 625, pp. 135–146, Jun. 2018, doi: 10.1016/j.scitotenv.2017.12.262.
[5489]	A. R. Gerken and J. F. Campbell, “Life history changes in Trogoderma variabile and T. inclusum due to mating delay with implications for mating disruption as a management tactic,” Ecol Evol, vol. 8, no. 5, pp. 2428–2439, 2018, doi: 10.1002/ece3.3865.
[5490]	S. Kounaves, “Life on Mars may be hidden like Earth’s extremophiles,” Nature, vol. 449, no. 7160, p. 281, Sep. 2007, doi: 10.1038/449281c.
[5491]	A. Brack, “Life on Mars: a clue to life on Earth?,” Chem. Biol., vol. 4, no. 1, pp. 9–12, Jan. 1997, doi: 10.1016/s1074-5521(97)90231-3.
[5492]	A. Kleidon, “Life, hierarchy, and the thermodynamic machinery of planet Earth,” Phys Life Rev, vol. 7, no. 4, pp. 424–460, Dec. 2010, doi: 10.1016/j.plrev.2010.10.002.
[5493]	E. Miqueleiz et al., “[Lifestyles and Styles of Parental Care Related to Childhood Obesity: compare Spain with Northern European Countries: ENERGY-Project],” Rev. Esp. Salud Publica, vol. 89, no. 5, pp. 523–531, Oct. 2015, doi: 10.4321/S1135-57272015000500009.
[5494]	A. R. King and T. D. Russell, “Lifetime Acts of Violence Assessment (LAVA) predictors of laboratory aggression,” Aggress Behav, vol. 45, no. 5, pp. 477–488, 2019, doi: 10.1002/ab.21835.
[5495]	M. Shanmugavelu, L. Porubleva, P. Chitnis, and B. C. Bonning, “Ligand blot analysis of juvenile hormone esterase binding proteins in Manduca sexta L,” Insect Biochem. Mol. Biol., vol. 31, no. 1, pp. 51–56, Jan. 2001, doi: 10.1016/s0965-1748(00)00104-1.
[5496]	K. Alhosaini, O. Bahattab, H. Qassam, R. A. J. Challiss, and G. B. Willars, “Ligand-Specific Signaling Profiles and Resensitization Mechanisms of the Neuromedin U2 Receptor,” Mol. Pharmacol., vol. 94, no. 1, pp. 674–688, 2018, doi: 10.1124/mol.117.111070.
[5497]	C. Roberts, G. W. Price, and D. N. Middlemiss, “Ligands for the investigation of 5-HT autoreceptor function,” Brain Res. Bull., vol. 56, no. 5, pp. 463–469, Nov. 2001, doi: 10.1016/s0361-9230(01)00628-1.
[5498]	A. Kuijsters, J. Redi, B. de Ruyter, and I. Heynderickx, “Lighting to Make You Feel Better: Improving the Mood of Elderly People with Affective Ambiences,” PLoS ONE, vol. 10, no. 7, p. e0132732, 2015, doi: 10.1371/journal.pone.0132732.
[5499]	S. Beisl, A. Friedl, and A. Miltner, “Lignin from Micro- to Nanosize: Applications,” Int J Mol Sci, vol. 18, no. 11, Nov. 2017, doi: 10.3390/ijms18112367.
[5500]	M. A. Kilgas, J. McDaniel, J. Stavres, B. S. Pollock, T. J. Singer, and S. J. Elmer, “Limb blood flow and tissue perfusion during exercise with blood flow restriction,” Eur. J. Appl. Physiol., vol. 119, no. 2, pp. 377–387, Feb. 2019, doi: 10.1007/s00421-018-4029-2.
[5501]	S. Estebe, C. Montenat, A. Tremoureux, C. Rousseau, F. Bouilloud, and F. Jegoux, “Limitation of intraoperative frozen section during thyroid surgery,” Eur Arch Otorhinolaryngol, vol. 274, no. 3, pp. 1671–1676, Mar. 2017, doi: 10.1007/s00405-016-4398-2.
[5502]	V. Cataldo, D. A. Williams, C. M. Dundas, and L. P. Keszthelyi, “Limited role for thermal erosion by turbulent lava in proximal Athabasca Valles, Mars,” J Geophys Res Planets, vol. 120, no. 11, pp. 1800–1819, Nov. 2015, doi: 10.1002/2014JE004761.
[5503]	C. S. Klein, “LIMS user acceptance testing,” Qual Assur, vol. 10, no. 2, pp. 91–106, Jun. 2003, doi: 10.1080/10529410390262736.
[5504]	A. Damert, “LINE-1 ORF1p does not determine substrate preference for human/orangutan SVA and gibbon LAVA,” Mob DNA, vol. 11, p. 27, 2020, doi: 10.1186/s13100-020-00222-y.
[5505]	I. Lupan, P. Bulzu, O. Popescu, and A. Damert, “Lineage specific evolution of the VNTR composite retrotransposon central domain and its role in retrotransposition of gibbon LAVA elements,” BMC Genomics, vol. 16, p. 389, May 2015, doi: 10.1186/s12864-015-1543-z.
[5506]	E. Montanya, V. Nacher, M. Biarnés, and J. Soler, “Linear correlation between beta-cell mass and body weight throughout the lifespan in Lewis rats: role of beta-cell hyperplasia and hypertrophy,” Diabetes, vol. 49, no. 8, pp. 1341–1346, Aug. 2000, doi: 10.2337/diabetes.49.8.1341.
[5507]	S. Zaghi et al., “Lingual frenuloplasty with myofunctional therapy: Exploring safety and efficacy in 348 cases,” Laryngoscope Investig Otolaryngol, vol. 4, no. 5, pp. 489–496, Oct. 2019, doi: 10.1002/lio2.297.
[5508]	M. M. Nargesi et al., “Linkage between prostate cancer occurrence and Y-chromosomal DYS loci in Malaysian subjects,” Asian Pac. J. Cancer Prev., vol. 12, no. 5, pp. 1265–1268, 2011.
[5509]	A. Seifi et al., “Linked, if not the same, Mi-1 homologues confer resistance to tomato powdery mildew and root-knot nematodes,” Mol. Plant Microbe Interact., vol. 24, no. 4, pp. 441–450, Apr. 2011, doi: 10.1094/MPMI-06-10-0145.
[5510]	X. Zhang et al., “LiO2: Cryosynthesis and Chemical/Electrochemical Reactivities,” J Phys Chem Lett, vol. 8, no. 10, pp. 2334–2338, 18 2017, doi: 10.1021/acs.jpclett.7b00680.
[5511]	M. D. Grounds et al., “Lipid accumulation in dysferlin-deficient muscles,” Am. J. Pathol., vol. 184, no. 6, pp. 1668–1676, Jun. 2014, doi: 10.1016/j.ajpath.2014.02.005.
[5512]	M. G. Kim, I. Yang, H. S. Lee, J.-Y. Lee, and K. Kim, “Lipid-modifying effects of krill oil vs fish oil: a network meta-analysis,” Nutr. Rev., vol. 78, no. 9, pp. 699–708, Sep. 2020, doi: 10.1093/nutrit/nuz102.
[5513]	I. Ošťádalová, Z. Charvátová, and J. Wilhelm, “Lipofuscin-like pigments in the rat heart during early postnatal development: effect of selenium supplementation,” Physiol Res, vol. 59, no. 6, pp. 881–886, 2010.
[5514]	M. Mahboubi-Rabbani and A. Zarghi, “Lipoxygenase inhibitors as cancer chemopreventives: discovery, recent developments, and future perspectives,” Curr. Med. Chem., Dec. 2019, doi: 10.2174/0929867326666191210104820.
[5515]	V. E. Steele et al., “Lipoxygenase inhibitors as potential cancer chemopreventives,” Cancer Epidemiol. Biomarkers Prev., vol. 8, no. 5, pp. 467–483, May 1999.
[5516]	S. Yoo, S. Han, Y. S. Park, J.-H. Lee, U. Oh, and S. W. Hwang, “Lipoxygenase inhibitors suppressed carrageenan-induced Fos-expression and inflammatory pain responses in the rat,” Mol. Cells, vol. 27, no. 4, pp. 417–422, Apr. 2009, doi: 10.1007/s10059-009-0059-2.
[5517]	L. Zhao and C. D. Funk, “Lipoxygenase pathways in atherogenesis,” Trends Cardiovasc. Med., vol. 14, no. 5, pp. 191–195, Jul. 2004, doi: 10.1016/j.tcm.2004.04.003.
[5518]	C. L. Nykiforuk, “Liquid-Liquid Phase Separation of Oil Bodies from Seeds,” Methods Mol. Biol., vol. 1385, pp. 173–188, 2016, doi: 10.1007/978-1-4939-3289-4_13.
[5519]	K. Riwotzki, H. Meyssamy, H. Schnablegger, A. Kornowski, and M. Haase, “Liquid-Phase Synthesis of Colloids and Redispersible Powders of Strongly Luminescing LaPO(4):Ce,Tb Nanocrystals This work was supported by the Deutsche Forschungsgemeinschaft (DFG). We thank S. Bartholdi-Nawrath for help with the electron micrographs and J. Kolny for measuring the powder X-ray diffraction data.,” Angew. Chem. Int. Ed. Engl., vol. 40, no. 3, pp. 573–576, Feb. 2001.
[5520]	M. Clark and D. Adams, “Listening to parents to understand their priorities for autism research,” PLoS ONE, vol. 15, no. 8, p. e0237376, Aug. 2020, doi: 10.1371/journal.pone.0237376.
[5521]	H. Ogawa and H. Mori, “Lithium salt/amide-based deep eutectic electrolytes for lithium-ion batteries: electrochemical, thermal and computational study,” Phys Chem Chem Phys, vol. 22, no. 16, pp. 8853–8863, Apr. 2020, doi: 10.1039/d0cp01255f.
[5522]	H. K. Manji and R. H. Lenox, “Lithium: a molecular transducer of mood-stabilization in the treatment of bipolar disorder,” Neuropsychopharmacology, vol. 19, no. 3, pp. 161–166, Sep. 1998, doi: 10.1016/S0893-133X(98)00021-9.
[5523]	D. Severs, “Lithium: balancing mood, water, and renal function decline,” Neth J Med, vol. 77, no. 4, pp. 129–130, 2019.
[5524]	S. Ozkavukcu, C. Celik-Ozenci, E. Konuk, and C. Atabekoglu, “Live birth after Laser Assisted Viability Assessment (LAVA) to detect pentoxifylline resistant ejaculated immotile spermatozoa during ICSI in a couple with male Kartagener’s syndrome,” Reprod. Biol. Endocrinol., vol. 16, no. 1, p. 10, Feb. 2018, doi: 10.1186/s12958-018-0321-6.
[5525]	J. Jiménez, S. Bru, M. Ribeiro, and J. Clotet, “Live fast, die soon: cell cycle progression and lifespan in yeast cells,” Microb Cell, vol. 2, no. 3, pp. 62–67, Mar. 2015, doi: 10.15698/mic2015.03.191.
[5526]	G. S. Shadel, “Live longer on MARS: a yeast paradigm of mitochondrial adaptive ROS signaling in aging,” Microb Cell, vol. 1, no. 5, pp. 140–144, Apr. 2014, doi: 10.15698/mic2014.05.143.
[5527]	E. F. Iannetti, A. Prigione, J. A. M. Smeitink, W. J. H. Koopman, J. Beyrath, and H. Renkema, “Live-Imaging Readouts and Cell Models for Phenotypic Profiling of Mitochondrial Function,” Front Genet, vol. 10, p. 131, 2019, doi: 10.3389/fgene.2019.00131.
[5528]	W. Cao et al., “Liver acquisition with acceleration volume acquisition gadolinium-enhanced magnetic resonance combined with T2 sequences in the diagnosis of local recurrence of rectal cancer,” J Xray Sci Technol, vol. 24, no. 6, pp. 855–863, 22 2016, doi: 10.3233/XST-160594.
[5529]	S. Saito, K. Tanaka, and T. Hashido, “Liver acquisition with volume acceleration flex on 70-cm wide-bore and 60-cm conventional-bore 3.0-T MRI,” Radiol Phys Technol, vol. 9, no. 2, pp. 154–160, Jul. 2016, doi: 10.1007/s12194-015-0344-z.
[5530]	W. Chang et al., “Liver Fibrosis Staging with MR Elastography: Comparison of Diagnostic Performance between Patients with Chronic Hepatitis B and Those with Other Etiologic Causes,” Radiology, vol. 280, no. 1, pp. 88–97, 2016, doi: 10.1148/radiol.2016150397.
[5531]	J. H. Elliott et al., “Living systematic reviews: an emerging opportunity to narrow the evidence-practice gap,” PLoS Med., vol. 11, no. 2, p. e1001603, Feb. 2014, doi: 10.1371/journal.pmed.1001603.
[5532]	R.-M. Wang and G.-D. Chen, “[LO phonon-plasmon coupled mode in hexagonal IngaN alloy],” Guang Pu Xue Yu Guang Pu Fen Xi, vol. 29, no. 1, pp. 138–141, Jan. 2009.
[5533]	N. Puff, C. Watanabe, M. Seigneuret, M. I. Angelova, and G. Staneva, “Lo/Ld phase coexistence modulation induced by GM1,” Biochim. Biophys. Acta, vol. 1838, no. 8, pp. 2105–2114, Aug. 2014, doi: 10.1016/j.bbamem.2014.05.002.
[5534]	A. R. Krohn, E. T. Diepeveen, K. Bi, and E. B. Rosenblum, “Local adaptation does not lead to genome-wide differentiation in lava flow lizards,” Ecol Evol, vol. 9, no. 12, pp. 6810–6820, Jun. 2019, doi: 10.1002/ece3.5231.
[5535]	C.-H. Hung, C.-C. Chiu, C.-C. Liu, and Y.-W. Chen, “Local Application of Ultrasound Attenuates Neuropathic Allodynia and Proinflammatory Cytokines in Rats After Thoracotomy,” Reg Anesth Pain Med, vol. 43, no. 2, pp. 193–199, Feb. 2018, doi: 10.1097/AAP.0000000000000717.
[5536]	O. H. Jeon et al., “Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment,” Nat. Med., vol. 23, no. 6, pp. 775–781, Jun. 2017, doi: 10.1038/nm.4324.
[5537]	K. Finzel, “Local conditions for the Pauli potential in order to yield self-consistent electron densities exhibiting proper atomic shell structure,” J Chem Phys, vol. 144, no. 3, p. 034108, Jan. 2016, doi: 10.1063/1.4940035.
[5538]	C. Kim et al., “Local delivery of a carbohydrate analog for reducing arthritic inflammation and rebuilding cartilage,” Biomaterials, vol. 83, pp. 93–101, 2016, doi: 10.1016/j.biomaterials.2015.12.029.
[5539]	F. Gólcher Valverde, A. López Gómez, R. Ballestero Harley, and M. León Barth, “[Local health systems, strategy for the consolidation of the national health system in Costa Rica],” Bol Oficina Sanit Panam, vol. 109, no. 5–6, pp. 541–546, Dec. 1990.
[5540]	F. Vollrath, P. Barth, A. Basedow, W. Engström, and H. List, “Local tolerance to spider silks and protein polymers in vivo,” In Vivo, vol. 16, no. 4, pp. 229–234, Aug. 2002.
[5541]	J. Gartlon et al., “Localisation of NMU1R and NMU2R in human and rat central nervous system and effects of neuromedin-U following central administration in rats,” Psychopharmacology (Berl.), vol. 177, no. 1–2, pp. 1–14, Dec. 2004, doi: 10.1007/s00213-004-1918-3.
[5542]	T. F. Booth, B. C. Bonning, and B. D. Hammock, “Localization of juvenile hormone esterase during development in normal and in recombinant baculovirus-infected larvae of the moth Trichoplusia ni,” Tissue Cell, vol. 24, no. 2, pp. 267–282, 1992, doi: 10.1016/0040-8166(92)90100-l.
[5543]	F. Lindberg, B. Lund, L. Johansson, and S. Normark, “Localization of the receptor-binding protein adhesin at the tip of the bacterial pilus,” Nature, vol. 328, no. 6125, pp. 84–87, Jul. 1987, doi: 10.1038/328084a0.
[5544]	E. Jerby and Y. Shoshani, “Localized microwave-heating (LMH) of basalt - Lava, dusty-plasma, and ball-lightning ejection by a ‘miniature volcano,’” Sci Rep, vol. 9, no. 1, p. 12954, Sep. 2019, doi: 10.1038/s41598-019-49049-5.
[5545]	G. M. Landau, U. Vishkin, and R. Nussinov, “Locating alignments with k differences for nucleotide and amino acid sequences,” Comput. Appl. Biosci., vol. 4, no. 1, pp. 19–24, Mar. 1988, doi: 10.1093/bioinformatics/4.1.19.
[5546]	S. M. Holmes, J. A. Greene, and S. D. Stonington, “Locating global health in social medicine,” Glob Public Health, vol. 9, no. 5, pp. 475–480, 2014, doi: 10.1080/17441692.2014.897361.
[5547]	A. J. Masot, C. Gómez-Tejedor, I. Tovar, A. Gázquez, and E. Redondo, “Location of bovine respiratory syncytial virus antigens in the lung of experimentally-infected lambs: comparative study using indirect fluorescent antibody test, avidin-biotin-peroxidase complex and transmission electron microscopy,” Eur J Histochem, vol. 37, no. 1, pp. 75–82, 1993.
[5548]	A. Dettlaff-Kakol and R. Pawłowski, “[Locus DYS 439--polymorphism in Polish population],” Arch Med Sadowej Kryminol, vol. 53, no. 3, pp. 203–207, Sep. 2003.
[5549]	T. Akimoto, H. Suzuki, K. Nakama, and K. Suzuki, “Locus of dominant hairless gene (Ht) causing abnormal hair and keratinization maps to rat chromosome 10,” Exp. Anim., vol. 49, no. 2, pp. 137–140, Apr. 2000, doi: 10.1538/expanim.49.137.
[5550]	R. Chen, X. Piao, M. Xiao, F. Wang, and L. Liu, “Long noncoding RNAs interact with mRNAs: A new perspective on the mechanism of premature brain injury,” Neurosci. Lett., vol. 707, p. 134274, 10 2019, doi: 10.1016/j.neulet.2019.05.028.
[5551]	T. D. Zaikos and K. L. Collins, “Long-lived reservoirs of HIV-1,” Trends Microbiol., vol. 22, no. 4, pp. 173–175, Apr. 2014, doi: 10.1016/j.tim.2014.02.015.
[5552]	M. T. W. Ebbert et al., “Long-read sequencing across the C9orf72 ‘GGGGCC’ repeat expansion: implications for clinical use and genetic discovery efforts in human disease,” Mol Neurodegener, vol. 13, no. 1, p. 46, 21 2018, doi: 10.1186/s13024-018-0274-4.
[5553]	K. Kaito et al., “Long-term administration of G-CSF for aplastic anaemia is closely related to the early evolution of monosomy 7 MDS in adults,” Br. J. Haematol., vol. 103, no. 2, pp. 297–303, Nov. 1998, doi: 10.1046/j.1365-2141.1998.01014.x.
[5554]	P. Gupta, S. C. LeRoy, S. D. Luikart, A. Bateman, and V. A. Morrison, “Long-term blood product transfusion support for patients with myelodysplastic syndromes (MDS): cost analysis and complications,” Leuk. Res., vol. 23, no. 10, pp. 953–959, Oct. 1999, doi: 10.1016/s0145-2126(99)00113-7.
[5555]	B. J. Barborka, K. F. Woodmansey, G. N. Glickman, E. Schneiderman, and J. He, “Long-term Clinical Outcome of Teeth Obturated with Resilon,” J Endod, vol. 43, no. 4, pp. 556–560, Apr. 2017, doi: 10.1016/j.joen.2016.12.005.
[5556]	J. S. Liu and S. Rao, “Long-term drug costs per life-month gained associated with first-line treatments for unresectable or metastatic melanoma,” Exp Hematol Oncol, vol. 5, p. 9, 2015, doi: 10.1186/s40164-016-0039-0.
[5557]	L. Benedetti et al., “Long-term effect of rituximab in anti-mag polyneuropathy,” Neurology, vol. 71, no. 21, pp. 1742–1744, Nov. 2008, doi: 10.1212/01.wnl.0000335268.70325.33.
[5558]	N. Akdogan, S. Dogan, and N. Atakan, “Long-term effects of biologic therapies on peripheral blood eosinophils in patients with psoriasis: a 3-year single-center study,” J Dermatolog Treat, pp. 1–5, Apr. 2019, doi: 10.1080/09546634.2019.1605139.
[5559]	L. Rew, “Long-term effects of childhood sexual exploitation,” Issues Ment Health Nurs, vol. 10, no. 3–4, pp. 229–244, 1989, doi: 10.3109/01612848909140847.
[5560]	N. Akdogan, N. Demirel Ogut, S. Dogan, and N. Atakan, “Long-term effects of omalizumab on peripheral blood cells and C-reactive protein levels in patients with chronic spontaneous urticaria,” Dermatol Ther, vol. 32, no. 4, p. e12966, 2019, doi: 10.1111/dth.12966.
[5561]	R. Schlösser et al., “Long-term effects of the substituted benzamide derivative amisulpride on baseline and stimulated prolactin levels,” Neuropsychobiology, vol. 46, no. 1, pp. 33–40, 2002, doi: 10.1159/000063574.
[5562]	“Long-term follow-up of a clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council,” Am. Rev. Respir. Dis., vol. 133, no. 5, pp. 779–783, May 1986.
[5563]	G. Mertens, A. K. Punte, E. Cochet, M. De Bodt, and P. Van de Heyning, “Long-term follow-up of hearing preservation in electric-acoustic stimulation patients,” Otol. Neurotol., vol. 35, no. 10, pp. 1765–1772, Dec. 2014, doi: 10.1097/MAO.0000000000000538.
[5564]	J. H. Tu, E. Tafoya, M. Jeng, and J. M. Teng, “Long-Term Follow-Up of Lymphatic Malformations in Children Treated with Sildenafil,” Pediatr Dermatol, vol. 34, no. 5, pp. 559–565, Sep. 2017, doi: 10.1111/pde.13237.
[5565]	J. W. Lambshead et al., “Long-Term Maintenance of Human Pluripotent Stem Cells on cRGDfK-Presenting Synthetic Surfaces,” Sci Rep, vol. 8, no. 1, p. 701, 15 2018, doi: 10.1038/s41598-018-19209-0.
[5566]	Y.-C. Chang, C.-C. Huang, and S.-C. Huang, “Long-term neuroplasticity effects of febrile seizures in the developing brain,” Chang Gung Med J, vol. 31, no. 2, pp. 125–135, Apr. 2008.
[5567]	W. L. Lee, “Long-term outcome of children with febrile seizures,” Ann Acad Med Singap, vol. 18, no. 1, pp. 32–34, Jan. 1989.
[5568]	M. Wolf et al., “Long-Term Outcome of Substrate Modification in Ablation of Post-Myocardial Infarction Ventricular Tachycardia,” Circ Arrhythm Electrophysiol, vol. 11, no. 2, p. e005635, 2018, doi: 10.1161/CIRCEP.117.005635.
[5569]	A. C. Modugno et al., “Long-term outcomes after cosmetic customized prostheses and dermis fat graft in congenital anophthalmia: a retrospective multicentre study,” Eye (Lond), vol. 32, no. 12, pp. 1803–1810, 2018, doi: 10.1038/s41433-018-0179-z.
[5570]	A. Uzun et al., “Long-term patency of autogenous saphenous veins vs. PTFE interposition graft for prosthetic hemodialysis access,” Anadolu Kardiyol Derg, vol. 14, no. 6, pp. 542–546, Sep. 2014, doi: 10.5152/akd.2014.4910.
[5571]	M. Lindemann, F. M. Heinemann, P. A. Horn, and O. Witzke, “Long-term response to vaccination against pneumococcal antigens in kidney transplant recipients,” Transplantation, vol. 94, no. 1, pp. 50–56, Jul. 2012, doi: 10.1097/TP.0b013e318250fc8c.
[5572]	L. Y. Kosowicz, C. A. Pfeiffer, and M. Vargas, “Long-term retention of smoking cessation counseling skills learned in the first year of medical school,” J Gen Intern Med, vol. 22, no. 8, pp. 1161–1165, Aug. 2007, doi: 10.1007/s11606-007-0255-8.
[5573]	A. Chawla, A. Barua, and N. Patton, “LONG-TERM STRUCTURAL AND FUNCTIONAL OUTCOMES AFTER MACULAR HOLE SURGERY,” Retina (Philadelphia, Pa.), vol. 36, no. 2, pp. 321–324, Feb. 2016, doi: 10.1097/IAE.0000000000000730.
[5574]	X.-Z. Chen et al., “Long-term survival outcomes of laparoscopic versus open gastrectomy for gastric cancer: a systematic review and meta-analysis,” Medicine (Baltimore), vol. 94, no. 4, p. e454, Jan. 2015, doi: 10.1097/MD.0000000000000454.
[5575]	D.-J. Yassin, G. Doros, P. G. Hammerer, and A. A. Yassin, “Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life,” J Sex Med, vol. 11, no. 6, pp. 1567–1576, Jun. 2014, doi: 10.1111/jsm.12523.
[5576]	J. R. T. Davidson, “Long-term treatment and prevention of posttraumatic stress disorder,” J Clin Psychiatry, vol. 65 Suppl 1, pp. 44–48, 2004.
[5577]	B. Sampaio-Marques, W. C. Burhans, and P. Ludovico, “Longevity pathways and maintenance of the proteome: the role of autophagy and mitophagy during yeast ageing,” Microb Cell, vol. 1, no. 4, pp. 118–127, Apr. 2014, doi: 10.15698/mic2014.04.136.
[5578]	J. N. García-Sesnich, M. G. Flores, M. H. Ríos, and J. G. Aravena, “Longitudinal and Immediate Effect of Kundalini Yoga on Salivary Levels of Cortisol and Activity of Alpha-Amylase and Its Effect on Perceived Stress,” Int J Yoga, vol. 10, no. 2, pp. 73–80, Aug. 2017, doi: 10.4103/ijoy.IJOY_45_16.
[5579]	S. A. Cooley et al., “Longitudinal Change in Performance on the Montreal Cognitive Assessment in Older Adults,” Clin Neuropsychol, vol. 29, no. 6, pp. 824–835, 2015, doi: 10.1080/13854046.2015.1087596.
[5580]	L. A. Barber, C. Abbott, V. Nakhate, A. N. D. Do, A. R. Blissett, and J. C. Marini, “Longitudinal growth curves for children with classical osteogenesis imperfecta (types III and IV) caused by structural pathogenic variants in type I collagen,” Genet. Med., vol. 21, no. 5, pp. 1233–1239, 2019, doi: 10.1038/s41436-018-0307-y.
[5581]	M. Nagai et al., “Longitudinal Optical Phonons Modified by Organic Molecular Cation Motions in Organic-Inorganic Hybrid Perovskites,” Phys. Rev. Lett., vol. 121, no. 14, p. 145506, Oct. 2018, doi: 10.1103/PhysRevLett.121.145506.
[5582]	T. Peleg and A. Y. Shalev, “Longitudinal studies of PTSD: overview of findings and methods,” CNS Spectr, vol. 11, no. 8, pp. 589–602, Aug. 2006, doi: 10.1017/s109285290001364x.
[5583]	D. W. Davis et al., “Longitudinal Trends in the Diagnosis of Attention-Deficit/Hyperactivity Disorder and Stimulant Use in Preschool Children on Medicaid,” J. Pediatr., vol. 207, pp. 185-191.e1, 2019, doi: 10.1016/j.jpeds.2018.10.062.
[5584]	H. Mosbah et al., “Looking at New Unexpected Disease Targets in LMNA-Linked Lipodystrophies in the Light of Complex Cardiovascular Phenotypes: Implications for Clinical Practice,” Cells, vol. 9, no. 3, Mar. 2020, doi: 10.3390/cells9030765.
[5585]	C. A. Ford, “Looking Forward: Amplifying the Journal of Adolescent Health’s Impact on Adolescent and Young Adult Health,” J Adolesc Health, vol. 65, no. 1, pp. 1–2, 2019, doi: 10.1016/j.jadohealth.2019.04.007.
[5586]	W.-J. Kim and J. Kim, “Looking to the metabolic landscapes for prostate health monitoring,” Prostate Int, vol. 5, no. 3, pp. 85–88, Sep. 2017, doi: 10.1016/j.prnil.2017.03.004.
[5587]	D. M. Morris and D. Rayburn, “Loop colostomies are totally diverting in adults,” Am. J. Surg., vol. 161, no. 6, pp. 668–671, Jun. 1991, doi: 10.1016/0002-9610(91)91252-e.
[5588]	L. O. Vejerslev et al., “Loop diathermy or laser excisional conization for cervical intraepithelial neoplasia,” Acta Obstet Gynecol Scand, vol. 78, no. 10, pp. 900–905, Nov. 1999.
[5589]	I. Nakano et al., “Loop diuretic use is associated with skeletal muscle wasting in patients with heart failure,” J Cardiol, vol. 76, no. 1, pp. 109–114, Jul. 2020, doi: 10.1016/j.jjcc.2020.01.003.
[5590]	B. S. Apgar, T. C. Wright, and J. L. Pfenninger, “Loop electrosurgical excision procedure for CIN,” Am Fam Physician, vol. 46, no. 2, pp. 505–520, Aug. 1992.
[5591]	A. Ferenczy, D. Choukroun, and J. Arseneau, “Loop electrosurgical excision procedure for squamous intraepithelial lesions of the cervix: advantages and potential pitfalls,” Obstet Gynecol, vol. 87, no. 3, pp. 332–337, Mar. 1996, doi: 10.1016/0029-7844(95)00453-x.
[5592]	L. Wang, E. V. Rivera, M. G. Benavides-Garcia, and B. T. Nall, “Loop entropy and cytochrome c stability,” J. Mol. Biol., vol. 353, no. 3, pp. 719–729, Oct. 2005, doi: 10.1016/j.jmb.2005.08.038.
[5593]	Y. Zheng, C. Zhang, L. Li, L. Song, and W. Chen, “Loop gain stabilizing with an all-digital automatic-gain-control method for high-precision fiber-optic gyroscope,” Appl Opt, vol. 55, no. 17, pp. 4589–4595, Jun. 2016, doi: 10.1364/AO.55.004589.
[5594]	E. Rullier, N. Le Toux, C. Laurent, J. L. Garrelon, M. Parneix, and J. Saric, “Loop ileostomy versus loop colostomy for defunctioning low anastomoses during rectal cancer surgery,” World J Surg, vol. 25, no. 3, pp. 274–277; discussion 277-278, Mar. 2001, doi: 10.1007/s002680020091.
[5595]	S. H. Kim et al., “Loop securities of arthroscopic sliding-knot techniques when the suture loop is not evenly tensioned,” Arthroscopy, vol. 29, no. 8, pp. 1380–1386, Aug. 2013, doi: 10.1016/j.arthro.2013.05.013.
[5596]	M. Totrov, “Loop simulations,” Methods Mol. Biol., vol. 857, pp. 207–229, 2012, doi: 10.1007/978-1-61779-588-6_9.
[5597]	S. Yanagisawa and C. Dennison, “Loop-contraction mutagenesis of type 1 copper sites,” J. Am. Chem. Soc., vol. 126, no. 48, pp. 15711–15719, Dec. 2004, doi: 10.1021/ja047295r.
[5598]	K. J. Berg, “[Loop-diuretics anno 1992. Mechanisms of effect and current therapeutic principles],” Tidsskr. Nor. Laegeforen., vol. 112, no. 5, pp. 656–658, Feb. 1992.
[5599]	K. Okamoto, R. Yozu, and M. Kudo, “Loop-in-loop technique in mitral valve repair via minithoracotomy,” Ann. Thorac. Surg., vol. 93, no. 4, pp. 1329–1330, Apr. 2012, doi: 10.1016/j.athoracsur.2011.11.066.
[5600]	T. Klockars, “[Lop ear - knife, tape, or nothing at all?],” Duodecim, vol. 129, no. 4, pp. 359–363, 2013.
[5601]	J. Kruk, “[Lop ears],” Otolaryngol Pol, vol. 39, no. 2, pp. 140–145, 1985.
[5602]	J. C. Johnson and C. C. Burn, “Lop-eared rabbits have more aural and dental problems than erect-eared rabbits: a rescue population study,” Vet. Rec., vol. 185, no. 24, p. 758, 21 2019, doi: 10.1136/vr.105163.
[5603]	T. Shui, W.-X. Yang, L. Li, and X. Wang, “Lop-sided Raman-Nath diffraction in PT-antisymmetric atomic lattices,” Opt Lett, vol. 44, no. 8, pp. 2089–2092, Apr. 2019, doi: 10.1364/OL.44.002089.
[5604]	I. Y. Kim et al., “Loperamide overcomes the resistance of colon cancer cells to bortezomib by inducing CHOP-mediated paraptosis-like cell death,” Biochem. Pharmacol., vol. 162, pp. 41–54, 2019, doi: 10.1016/j.bcp.2018.12.006.
[5605]	G. V. Carr, K. A. Jenkins, D. R. Weinberger, and F. Papaleo, “Loss of dysbindin-1 in mice impairs reward-based operant learning by increasing impulsive and compulsive behavior,” Behav. Brain Res., vol. 241, pp. 173–184, Mar. 2013, doi: 10.1016/j.bbr.2012.12.021.
[5606]	J. W. Gillespie, A. Nasir, and H. E. Kaiser, “Loss of heterozygosity in papillary and follicular thyroid carcinoma: a mini review,” In Vivo, vol. 14, no. 1, pp. 139–140, Feb. 2000.
[5607]	T. McLaughlin et al., “Loss of XBP1 accelerates age-related decline in retinal function and neurodegeneration,” Mol Neurodegener, vol. 13, no. 1, p. 16, 04 2018, doi: 10.1186/s13024-018-0250-z.
[5608]	T. Wirth et al., “Loss-of-Function Mutations in NR4A2 Cause Dopa-Responsive Dystonia Parkinsonism,” Mov. Disord., vol. 35, no. 5, pp. 880–885, 2020, doi: 10.1002/mds.27982.
[5609]	D. Müller, “Lost tectonic history recovered from Earth’s deep mantle,” Nature, vol. 565, no. 7740, pp. 432–433, 2019, doi: 10.1038/d41586-019-00160-7.
[5610]	N. T. Porter and E. C. Martens, “Love Thy Neighbor: Sharing and Cooperativity in the Gut Microbiota,” Cell Host Microbe, vol. 19, no. 6, pp. 745–746, Jun. 2016, doi: 10.1016/j.chom.2016.05.019.
[5611]	M. Salvadori et al., “Low 1-year cyclosporine microemulsion doses are associated with better 5-year renal graft function: an insight from MOST, a multinational observational study,” Transplant. Proc., vol. 38, no. 4, pp. 1010–1013, May 2006, doi: 10.1016/j.transproceed.2006.03.060.
[5612]	A. von Schwerin, “Low dose intoxication and a crisis of regulatory models. Chemical mutagens in the Deutsche Forschungsgemeinschaft (DFG), 1963-1973,” Ber Wiss, vol. 33, no. 4, pp. 401–418, Dec. 2010, doi: 10.1002/bewi.201001489.
[5613]	S. Y. Park et al., “Low pepsinogen I level predicts multiple gastric epithelial neoplasias for endoscopic resection,” Gut Liver, vol. 8, no. 3, pp. 277–281, May 2014, doi: 10.5009/gnl.2014.8.3.277.
[5614]	G.-Q. Huang et al., “Low triiodothyronine syndrome is associated with hemorrhagic transformation in patients with acute ischaemic stroke,” Aging (Albany NY), vol. 11, no. 16, pp. 6385–6397, 27 2019, doi: 10.18632/aging.102195.
[5615]	E. M. Draper et al., “Low Vision Rehabilitation for Adult African Americans in Two Settings,” Optom Vis Sci, vol. 93, no. 7, pp. 673–682, 2016, doi: 10.1097/OPX.0000000000000870.
[5616]	H. Y. Saleem, Y. AlJamal, N. Prabhakar, M. Baloul, P. Balachandran, and D. Farley, “Low-cost materials yield high resolution assessment of anatomic knowledge in surgical residents,” Surgery, vol. 165, no. 6, pp. 1088–1092, 2019, doi: 10.1016/j.surg.2019.01.017.
[5617]	C.-L. Hsieh, C.-H. Peng, C.-C. Chyau, Y.-C. Lin, H.-E. Wang, and R. Y. Peng, “Low-density lipoprotein, collagen, and thrombin models reveal that Rosemarinus officinalis L. exhibits potent antiglycative effects,” J. Agric. Food Chem., vol. 55, no. 8, pp. 2884–2891, Apr. 2007, doi: 10.1021/jf0631833.
[5618]	C. T. Antachopoulos et al., “Low-dose heparin treatment does not inhibit SW480 human colon cancer growth and metastasis in vivo,” In Vivo, vol. 10, no. 5, pp. 527–531, Oct. 1996.
[5619]	F. Varghese, J. U. Neuber, F. Xie, J. M. Philpott, A. G. Pakhomov, and C. W. Zemlin, “Low-energy defibrillation with nanosecond electric shocks,” Cardiovasc. Res., vol. 113, no. 14, pp. 1789–1797, Dec. 2017, doi: 10.1093/cvr/cvx172.
[5620]	Z. Chen et al., “Low-Grade Myelodysplastic Syndromes with Preserved CD34+ B-Cell Precursors (CD34+ Hematogones),” Cytometry B Clin Cytom, vol. 98, no. 1, pp. 36–42, 2020, doi: 10.1002/cyto.b.21830.
[5621]	J. K. Luttrull, “LOW-INTENSITY/HIGH-DENSITY SUBTHRESHOLD DIODE MICROPULSE LASER FOR CENTRAL SEROUS CHORIORETINOPATHY,” Retina (Philadelphia, Pa.), vol. 36, no. 9, pp. 1658–1663, Sep. 2016, doi: 10.1097/IAE.0000000000001005.
[5622]	D. M. Williams, J. F. Kasting, and L. A. Frakes, “Low-latitude glaciation and rapid changes in the Earth’s obliquity explained by obliquity-oblateness feedback,” Nature, vol. 396, no. 6710, pp. 453–455, Dec. 1998, doi: 10.1038/24845.
[5623]	N. A. Ashford, “Low-level chemical sensitivity: implications for research and social policy,” Toxicol Ind Health, vol. 15, no. 3–4, pp. 421–427, Jun. 1999, doi: 10.1177/074823379901500317.
[5624]	S. J. Lee, K. W. Seo, and C. D. Kim, “LPS Increases 5-LO Expression on Monocytes via an Activation of Akt-Sp1/NF-κB Pathways,” Korean J. Physiol. Pharmacol., vol. 19, no. 3, pp. 263–268, May 2015, doi: 10.4196/kjpp.2015.19.3.263.
[5625]	F. Gardillou, Y. E. Romanyuk, C. N. Borca, R.-P. Salathé, and M. Pollnau, “Lu, Gd codoped KY(WO(4))(2):Yb epitaxial layers: towards integrated optics based on KY(WO(4))(2),” Opt Lett, vol. 32, no. 5, pp. 488–490, Mar. 2007, doi: 10.1364/ol.32.000488.
[5626]	S. A. Tuncel, E. Yılmaz, B. Çağlı, A. Tekataş, Y. Çelik, and M. E. Ünlü, “Lumbar Opening Pressure and Radiologic Scoring in Idiopathic Intracranial Hypertension: Is There Any Correlation?,” Pol J Radiol, vol. 82, pp. 701–705, 2017, doi: 10.12659/PJR.903662.
[5627]	A. N. Herrity, C. S. Williams, C. A. Angeli, S. J. Harkema, and C. H. Hubscher, “Lumbosacral spinal cord epidural stimulation improves voiding function after human spinal cord injury,” Sci Rep, vol. 8, no. 1, p. 8688, 06 2018, doi: 10.1038/s41598-018-26602-2.
[5628]	G. De Angelis, J. W. Wilson, M. S. Clowdsley, J. E. Nealy, D. H. Humes, and J. M. Clem, “Lunar lava tube radiation safety analysis,” J. Radiat. Res., vol. 43 Suppl, pp. S41-45, Dec. 2002, doi: 10.1269/jrr.43.s41.
[5629]	U. Oleander, “Lunar mineral extraction to correct for potential loss of Earth mass caused by fossil fuel consumption,” Sci. Total Environ., vol. 557–558, p. 911, 01 2016, doi: 10.1016/j.scitotenv.2016.03.020.
[5630]	C. Zeng et al., “Lung Atelectasis Promotes Immune and Barrier Dysfunction as Revealed by Transcriptome Sequencing in Female Sheep,” Anesthesiology, Aug. 2020, doi: 10.1097/ALN.0000000000003491.
[5631]	P. Cocco, C. H. Rice, J. Q. Chen, M. A. McCawley, J. K. McLaughlin, and M. Dosemeci, “Lung cancer risk, silica exposure, and silicosis in Chinese mines and pottery factories: the modifying role of other workplace lung carcinogens,” Am. J. Ind. Med., vol. 40, no. 6, pp. 674–682, Dec. 2001, doi: 10.1002/ajim.10022.
[5632]	K. T. Rew, “Lung Cancer: Foreword,” FP Essent, vol. 464, p. 2, Jan. 2018.
[5633]	M. Polatli, H. T. Tuna, C. Yenisey, M. Serter, and O. Cildag, “Lung function and IFN-gamma levels in the sera of silica-exposed workers,” J. Interferon Cytokine Res., vol. 28, no. 5, pp. 311–316, May 2008, doi: 10.1089/jir.2007.0093.
[5634]	T. P. Ng and S. L. Chan, “Lung function in relation to silicosis and silica exposure in granite workers,” Eur. Respir. J., vol. 5, no. 8, pp. 986–991, Sep. 1992.
[5635]	W. Xie et al., “Lymphoblastic leukemia following myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms,” Leuk. Lymphoma, vol. 60, no. 12, pp. 2993–3001, 2019, doi: 10.1080/10428194.2019.1605509.
[5636]	D. Bonacina, S. Buoro, A. P. Callegaro, and M. Nacoti, “Lymphocyte morphology supports early diagnosis of Bordetella pertussis infection in neonates,” Intensive Care Med, vol. 45, no. 6, pp. 894–895, 2019, doi: 10.1007/s00134-018-5385-4.
[5637]	M. T. van Leeuwen et al., “Lymphoid neoplasm incidence by WHO subtype in Australia 1982-2006,” Int. J. Cancer, vol. 135, no. 9, pp. 2146–2156, Nov. 2014, doi: 10.1002/ijc.28849.
[5638]	S. T. Abedon, “Lysis from without,” Bacteriophage, vol. 1, no. 1, pp. 46–49, Jan. 2011, doi: 10.4161/bact.1.1.13980.
[5639]	S. M. Danilov et al., “Lysozyme and bilirubin bind to ACE and regulate its conformation and shedding,” Sci Rep, vol. 6, p. 34913, 13 2016, doi: 10.1038/srep34913.
[5640]	J. J. Bertone, K. S. Paull, W. E. Wingfield, and J. A. Boon, “M-mode echocardiographs of endurance horses in the recovery phase of long-distance competition,” Am. J. Vet. Res., vol. 48, no. 12, pp. 1708–1712, Dec. 1987.
[5641]	A. Papa, E. Papadimitriou, A. Papoutsi, and A. Antoniadis, “M36I, protease gene, HIV-1: resistant mutation or genetic polymorphism?,” AIDS, vol. 17, no. 12, pp. 1858–1859, Aug. 2003, doi: 10.1097/01.aids.0000076331.42412.01.
[5642]	R. Chavali, A. H. Nejat, and N. C. Lawson, “Machinability of CAD-CAM materials,” J Prosthet Dent, vol. 118, no. 2, pp. 194–199, Aug. 2017, doi: 10.1016/j.prosdent.2016.09.022.
[5643]	S. Nitta et al., “Machine learning methods can more efficiently predict prostate cancer compared with prostate-specific antigen density and prostate-specific antigen velocity,” Prostate Int, vol. 7, no. 3, pp. 114–118, Sep. 2019, doi: 10.1016/j.prnil.2019.01.001.
[5644]	A. C. Vergunst et al., “Macrophages as drivers of an opportunistic infection,” Microb Cell, vol. 4, no. 10, pp. 362–364, Sep. 2017, doi: 10.15698/mic2017.10.595.
[5645]	K. Righter, “Magma Ocean Depth and Oxygen Fugacity in the Early Earth--Implications for Biochemistry,” Orig Life Evol Biosph, vol. 45, no. 3, pp. 361–366, Sep. 2015, doi: 10.1007/s11084-015-9445-2.
[5646]	Y. Moussallam et al., “Magmatic gas percolation through the old lava dome of El Misti volcano,” Bull Volcanol, vol. 79, no. 6, p. 46, 2017, doi: 10.1007/s00445-017-1129-5.
[5647]	W. Vierling, D.-H. Liebscher, O. Micke, B. von Ehrlich, and K. Kisters, “[Magnesium deficiency and therapy in cardiac arrhythmias: recommendations of the German Society for Magnesium Research],” Dtsch. Med. Wochenschr., vol. 138, no. 22, pp. 1165–1171, May 2013, doi: 10.1055/s-0033-1343206.
[5648]	D. Ganguly, A. P. V S, A. Ghosh, and S. Ramaprabhu, “Magnetic field assisted high capacity durable Li-ion battery using magnetic α-Fe2O3 nanoparticles decorated expired drug derived N-doped carbon anode,” Sci Rep, vol. 10, no. 1, p. 9945, Jun. 2020, doi: 10.1038/s41598-020-67042-1.
[5649]	Z. Ozmen, F. Aktas, N. Uluocak, E. Albayrak, A. Altunkaş, and F. Çelikyay, “Magnetic resonance imaging and clinical findings in seminal vesicle pathologies,” Int Braz J Urol, vol. 44, no. 1, pp. 86–94, Feb. 2018, doi: 10.1590/S1677-5538.IBJU.2017.0153.
[5650]	C. B. Higgins, M. Saeed, M. Wendland, and W. M. Chew, “Magnetic resonance spectroscopy of the heart. Overview of studies in animals and man,” Invest Radiol, vol. 24, no. 12, pp. 962–968, Dec. 1989, doi: 10.1097/00004424-198912000-00008.
[5651]	A. May and C. Gaser, “Magnetic resonance-based morphometry: a window into structural plasticity of the brain,” Curr. Opin. Neurol., vol. 19, no. 4, pp. 407–411, Aug. 2006, doi: 10.1097/01.wco.0000236622.91495.21.
[5652]	M. S. Hämäläinen, “Magnetoencephalography: a tool for functional brain imaging,” Brain Topogr, vol. 5, no. 2, pp. 95–102, 1992, doi: 10.1007/BF01129036.
[5653]	M. Winklhofer, “Magnetoreception: A Dynamo in the Inner Ear of Pigeons,” Curr. Biol., vol. 29, no. 23, pp. R1224–R1226, 02 2019, doi: 10.1016/j.cub.2019.10.022.
[5654]	M. B. Stein, M. E. Tancer, C. S. Gelernter, B. J. Vittone, and T. W. Uhde, “Major depression in patients with social phobia,” Am J Psychiatry, vol. 147, no. 5, pp. 637–639, May 1990, doi: 10.1176/ajp.147.5.637.
[5655]	G. Parker and H. Brotchie, “[Major depression invites major concerns],” Braz J Psychiatry, vol. 31 Suppl 1, pp. S3-6, May 2009, doi: 10.1590/s1516-44462009000500002.
[5656]	R. M. Hirschfeld, “Major depression, dysthymia and depressive personality disorder,” Br J Psychiatry Suppl, no. 26, pp. 23–30, Dec. 1994.
[5657]	R. A. Remick, A. D. Sadovnick, R. W. Lam, A. P. Zis, and I. M. Yee, “Major depression, minor depression, and double depression: are they distinct clinical entities?,” Am. J. Med. Genet., vol. 67, no. 4, pp. 347–353, Jul. 1996, doi: 10.1002/(SICI)1096-8628(19960726)67:4<347::AID-AJMG6>3.0.CO;2-J.
[5658]	M. Kim, Y.-S. Kim, D.-H. Kim, T.-W. Yang, and O.-Y. Kwon, “Major depressive disorder in epilepsy clinics: A meta-analysis,” Epilepsy Behav, vol. 84, pp. 56–69, 2018, doi: 10.1016/j.yebeh.2018.04.015.
[5659]	G. M. A. S. Tedrus, L. C. Fonseca, M. N. Augusto, and F. S. Trindade, “Major depressive episode, cognition, and epilepsy,” Epilepsy Behav, vol. 64, no. Pt A, pp. 219–223, 2016, doi: 10.1016/j.yebeh.2016.09.035.
[5660]	D. B. Moore, “Make them laugh. Therapeutic humor for patients with grief-related stress or anxiety,” Adv Nurse Pract, vol. 8, no. 8, pp. 34–37, Aug. 2000.
[5661]	D. Kendrick et al., “Making a successful return to work: the UK burden of injury multicentre longitudinal study,” Br J Gen Pract, vol. 62, no. 595, pp. e82-90, Feb. 2012, doi: 10.3399/bjgp12X625139.
[5662]	G. Staneva, M. Seigneuret, H. Conjeaud, N. Puff, and M. I. Angelova, “Making a tool of an artifact: the application of photoinduced Lo domains in giant unilamellar vesicles to the study of Lo/Ld phase spinodal decomposition and its modulation by the ganglioside GM1,” Langmuir, vol. 27, no. 24, pp. 15074–15082, Dec. 2011, doi: 10.1021/la203101y.
[5663]	D. Saliba and J. Buchanan, “Making the investment count: revision of the Minimum Data Set for nursing homes, MDS 3.0,” J Am Med Dir Assoc, vol. 13, no. 7, pp. 602–610, Sep. 2012, doi: 10.1016/j.jamda.2012.06.002.
[5664]	“Malaria control improves for vulnerable in Africa, but global progress off-track,” Wkly. Epidemiol. Rec., vol. 91, no. 51–52, pp. 622–624, 16 2016.
[5665]	“Malaria elimination: report from the inaugural global forum of countries with potential to eliminate malaria by 2020,” Wkly. Epidemiol. Rec., vol. 92, no. 39, pp. 578–586, 29 2017.
[5666]	E. A. Mueller and G. Neumann, “[Malaria prevention in travellers to malaria-endemic regions],” Dtsch. Med. Wochenschr., vol. 136, no. 14, pp. 725–730, Apr. 2011, doi: 10.1055/s-0031-1275801.
[5667]	“Malaria situation, 2015,” Wkly. Epidemiol. Rec., vol. 90, no. 45, pp. 610–616, Nov. 2015.
[5668]	“Malaria vaccine: WHO position paper-January 2016,” Wkly. Epidemiol. Rec., vol. 91, no. 4, pp. 33–51, Jan. 2016.
[5669]	T. J. Haley, “Maleic hydrazide: should the Delaney amendment apply to its use?,” J Toxicol Environ Health, vol. 2, no. 5, pp. 1085–1094, May 1977, doi: 10.1080/15287397709529506.
[5670]	Y. Kuwashima et al., “Malignant squamous cell elements in the ovarian cancer: report of 5 cases and review of the literature,” In Vivo, vol. 8, no. 6, pp. 1063–1066, Dec. 1994.
[5671]	T.-Y. Wang et al., “Malignant transformation of Taiwanese patients with oral leukoplakia: A nationwide population-based retrospective cohort study,” J. Formos. Med. Assoc., vol. 117, no. 5, pp. 374–380, May 2018, doi: 10.1016/j.jfma.2018.01.017.
[5672]	G. Sundborn, “Malohani, bula vinaka, fakalofa lahi atu, kia orana, talofa lava, malo e lelei, greetings,” Pac Health Dialog, vol. 20, no. 1, pp. 5–6, Mar. 2014.
[5673]	N. Kannikeswaran and D. Kamat, “Mammalian bites,” Clin Pediatr (Phila), vol. 48, no. 2, pp. 145–148, Mar. 2009, doi: 10.1177/0009922808324494.
[5674]	T. C. Hsu and O. Klatt, “Mammalian chromosomes in vitro. IX. On genetic polymorphism in cell populations,” J. Natl. Cancer Inst., vol. 21, no. 3, pp. 437–473, Sep. 1958.
[5675]	T. C. Hsu and D. J. Merchant, “Mammalian chromosomes in vitro. XIV. Genotypic replacement in cell populations,” J. Natl. Cancer Inst., vol. 26, pp. 1075–1083, May 1961.
[5676]	“Managed care executives see utility in economic modeling for specialty injectables,” Manag Care Interface, vol. Suppl, pp. 12–13, 2005.
[5677]	A. Sharobeam, A. Mamun, A. Kwok, M. Zandiehvakili, and R. G. Beran, “Management and attitudes toward patients with epilepsy in general practice: How far have we come in three decades?,” Epilepsy Behav, vol. 97, pp. 92–95, 2019, doi: 10.1016/j.yebeh.2019.05.020.
[5678]	E. E. Sullivan, Z. Ibrahim, A. L. Ellner, and L. J. Giesen, “Management Lessons for High-Functioning Primary Care Teams,” J Healthc Manag, vol. 61, no. 6, pp. 449–465, Dec. 2016.
[5679]	K. Blouhos, K. A. Boulas, K. Tsalis, and A. Hatzigeorgiadis, “Management of afferent loop obstruction: Reoperation or endoscopic and percutaneous interventions?,” World J Gastrointest Surg, vol. 7, no. 9, pp. 190–195, Sep. 2015, doi: 10.4240/wjgs.v7.i9.190.
[5680]	R. N. White, “Management of calcium ureterolithiasis in a French lop rabbit,” J Small Anim Pract, vol. 42, no. 12, pp. 595–598, Dec. 2001, doi: 10.1111/j.1748-5827.2001.tb06035.x.
[5681]	W. R. Robinson, S. Webb, J. Tirpack, S. Degefu, and A. G. O’Quinn, “Management of cervical intraepithelial neoplasia during pregnancy with LOOP excision,” Gynecol. Oncol., vol. 64, no. 1, pp. 153–155, Jan. 1997, doi: 10.1006/gyno.1996.4546.
[5682]	H. van Marwijk, G. H. de Bock, J. M. de Jong, A. A. Kaptein, and J. D. Mulder, “Management of depression in elderly general practice patients,” Scand J Prim Health Care, vol. 12, no. 3, pp. 162–168, Sep. 1994, doi: 10.3109/02813439409003693.
[5683]	P. Striano, M. S. Vari, C. Mazzocchetti, A. Verrotti, and F. Zara, “Management of genetic epilepsies: From empirical treatment to precision medicine,” Pharmacol. Res., vol. 107, pp. 426–429, 2016, doi: 10.1016/j.phrs.2016.04.006.
[5684]	K. S. Bingham, A. J. Flint, and B. H. Mulsant, “Management of Late-Life Depression in the Context of Cognitive Impairment: a Review of the Recent Literature,” Curr Psychiatry Rep, vol. 21, no. 8, p. 74, 05 2019, doi: 10.1007/s11920-019-1047-7.
[5685]	K. Asare, “Management of loop diuretic resistance in the intensive care unit,” Am J Health Syst Pharm, vol. 66, no. 18, pp. 1635–1640, Sep. 2009, doi: 10.2146/ajhp090068.
[5686]	M. Stahl and A. M. Zeidan, “Management of lower-risk myelodysplastic syndromes without del5q: current approach and future trends,” Expert Rev Hematol, vol. 10, no. 4, pp. 345–364, Apr. 2017, doi: 10.1080/17474086.2017.1297704.
[5687]	B. Lojanapiwat et al., “Management of metastatic castration-resistant prostate cancer: Insights from urology experts in Thailand,” Prostate Int, vol. 5, no. 1, pp. 1–7, Mar. 2017, doi: 10.1016/j.prnil.2017.01.002.
[5688]	M. R. Luskin and G. A. Abel, “Management of older adults with myelodysplastic syndromes (MDS),” J Geriatr Oncol, vol. 9, no. 4, pp. 302–307, 2018, doi: 10.1016/j.jgo.2017.12.002.
[5689]	S. H. Ralston and M. S. Gaston, “Management of Osteogenesis Imperfecta,” Front Endocrinol (Lausanne), vol. 10, p. 924, 2019, doi: 10.3389/fendo.2019.00924.
[5690]	N. E. Crittenden and C. McClain, “Management of patients with moderate alcoholic liver disease,” Clin Liver Dis (Hoboken), vol. 2, no. 2, pp. 76–79, Apr. 2013, doi: 10.1002/cld.190.
[5691]	B. C. Baumann et al., “Management of primary skin cancer during a pandemic: Multidisciplinary recommendations,” Cancer, vol. 126, no. 17, pp. 3900–3906, 01 2020, doi: 10.1002/cncr.32969.
[5692]	A. M. Kanner, “Management of psychiatric and neurological comorbidities in epilepsy,” Nat Rev Neurol, vol. 12, no. 2, pp. 106–116, Feb. 2016, doi: 10.1038/nrneurol.2015.243.
[5693]	K. H. Butler and B. Clyne, “Management of the difficult airway: alternative airway techniques and adjuncts,” Emerg. Med. Clin. North Am., vol. 21, no. 2, pp. 259–289, May 2003, doi: 10.1016/s0733-8627(03)00007-5.
[5694]	M. Buda et al., “Management of Thyroid Nodules Seen on US Images: Deep Learning May Match Performance of Radiologists,” Radiology, vol. 292, no. 3, pp. 695–701, 2019, doi: 10.1148/radiol.2019181343.
[5695]	J. Lin and A. Kacker, “Management strategies for recurrent acute rhinosinusitis,” Laryngoscope Investig Otolaryngol, vol. 4, no. 4, pp. 379–382, Aug. 2019, doi: 10.1002/lio2.294.
[5696]	P. Brizendine, “Managing cholesterol,” Ky Nurse, vol. 56, no. 2, p. 10, Jun. 2008.
[5697]	T. Singh and R. K. Goel, “Managing epilepsy-associated depression: Serotonin enhancers or serotonin producers?,” Epilepsy Behav, vol. 66, pp. 93–99, 2017, doi: 10.1016/j.yebeh.2016.10.007.
[5698]	H. Y. Mak, “Managing imperfect competition by pay for performance and reference pricing,” J Health Econ, vol. 57, pp. 131–146, 2018, doi: 10.1016/j.jhealeco.2017.11.002.
[5699]	C. Marr, A. Seasman, and N. Bishop, “Managing the patient with osteogenesis imperfecta: a multidisciplinary approach,” J Multidiscip Healthc, vol. 10, pp. 145–155, 2017, doi: 10.2147/JMDH.S113483.
[5700]	L. Casalino, “Managing uncertainty: intermediate organizations as triple agents,” J Health Polit Policy Law, vol. 26, no. 5, pp. 1055–1068, Oct. 2001, doi: 10.1215/03616878-26-5-1055.
[5701]	H. G. Drexler, W. G. Dirks, and R. A. F. Macleod, “Many are called MDS cell lines: one is chosen,” Leuk. Res., vol. 33, no. 8, pp. 1011–1016, Aug. 2009, doi: 10.1016/j.leukres.2009.03.005.
[5702]	D. Zamir et al., “Mapping and introgression of a tomato yellow leaf curl virus tolerance gene, TY-1,” Theor. Appl. Genet., vol. 88, no. 2, pp. 141–146, May 1994, doi: 10.1007/BF00225889.
[5703]	I. Teh et al., “Mapping cardiac microstructure of rabbit heart in different mechanical states by high resolution diffusion tensor imaging: A proof-of-principle study,” Prog. Biophys. Mol. Biol., vol. 121, no. 2, pp. 85–96, 2016, doi: 10.1016/j.pbiomolbio.2016.06.001.
[5704]	K.-A. Nguyen and Y.-A. Liou, “Mapping global eco-environment vulnerability due to human and nature disturbances,” MethodsX, vol. 6, pp. 862–875, 2019, doi: 10.1016/j.mex.2019.03.023.
[5705]	F. Zara et al., “Mapping of a locus for a familial autosomal recessive idiopathic myoclonic epilepsy of infancy to chromosome 16p13,” Am. J. Hum. Genet., vol. 66, no. 5, pp. 1552–1557, May 2000, doi: 10.1086/302876.
[5706]	W. A. Van Haeringen et al., “Mapping of a QTL for serum HDL cholesterol in the rabbit using AFLP technology,” J. Hered., vol. 92, no. 4, pp. 322–326, Aug. 2001, doi: 10.1093/jhered/92.4.322.
[5707]	F. Zara et al., “Mapping of genes predisposing to idiopathic generalized epilepsy,” Hum. Mol. Genet., vol. 4, no. 7, pp. 1201–1207, Jul. 1995, doi: 10.1093/hmg/4.7.1201.
[5708]	C. G. Davey, J. Pujol, and B. J. Harrison, “Mapping the self in the brain’s default mode network,” Neuroimage, vol. 132, pp. 390–397, 15 2016, doi: 10.1016/j.neuroimage.2016.02.022.
[5709]	R. Euán, O. Figueras-Álvarez, J. Cabratosa-Termes, and R. Oliver-Parra, “Marginal adaptation of zirconium dioxide copings: influence of the CAD/CAM system and the finish line design,” J Prosthet Dent, vol. 112, no. 2, pp. 155–162, Aug. 2014, doi: 10.1016/j.prosdent.2013.10.012.
[5710]	S. E. Halıcı, C. Hekimoğlu, and O. Ersoy, “Marginal Fit of All-Ceramic Crowns Before and After Cementation: An In Vitro Study,” Int J Periodontics Restorative Dent, vol. 38, no. 3, pp. e41–e48, Jun. 2018, doi: 10.11607/prd.3169.
[5711]	B. D. Hegarty and G. B. Parker, “Marine omega-3 fatty acids and mood disorders--linking the sea and the soul. ‘Food for Thought’ I,” Acta Psychiatr Scand, vol. 124, no. 1, pp. 42–51, Jul. 2011, doi: 10.1111/j.1600-0447.2011.01703.x.
[5712]	Y. Funaki et al., “Markedly Effective Steroid Treatment of Three Patients with Allergy-related Jackhammer Esophagus,” Intern. Med., vol. 59, no. 5, pp. 633–639, Mar. 2020, doi: 10.2169/internalmedicine.3865-19.
[5713]	X.-W. Chen, S.-G. Li, Y.-Q. Ma, H.-Y. Li, K.-D. Zhou, and L.-H. Zhu, “[Marker-assisted selection and pyramiding for three blast resistance genes, Pi-d(t)1, Pi-b, Pi-ta2, in rice],” Sheng Wu Gong Cheng Xue Bao, vol. 20, no. 5, pp. 708–714, Sep. 2004.
[5714]	M. Le-Carlson, S. Seki, D. Abarbanel, A. Quiros, K. Cox, and K. C. Nadeau, “Markers of antigen presentation and activation on eosinophils and T cells in the esophageal tissue of patients with eosinophilic esophagitis,” J. Pediatr. Gastroenterol. Nutr., vol. 56, no. 3, pp. 257–262, Mar. 2013, doi: 10.1097/MPG.0b013e3182758d49.
[5715]	R. S. Halbersma, M. C. Mikkers, E. Motchenkova, and I. Seinen, “Market structure and hospital-insurer bargaining in the Netherlands,” Eur J Health Econ, vol. 12, no. 6, pp. 589–603, Dec. 2011, doi: 10.1007/s10198-010-0273-z.
[5716]	S. Heshmat, “Market-based hospital pricing decisions,” Hosp Top, vol. 67, no. 6, pp. 25–27, Dec. 1989, doi: 10.1080/00185868.1989.10544753.
[5717]	A. R. Fakhreldin, “Maternal and Infantile Adiponectin as Marker for Anthropometric Parameters of Lactating Mothers and their Breast-Fed Infants,” Indian J Endocrinol Metab, vol. 22, no. 1, pp. 16–22, Feb. 2018, doi: 10.4103/ijem.IJEM_249_17.
[5718]	S. H. Vermund, R. Garg, Y.-R. Lo, E. K. Sheldon, and K. Mwinga, “Maternal and Neonatal and Child Health Priorities in Africa and Asia,” Biomed Res Int, vol. 2016, p. 9107970, 2016, doi: 10.1155/2016/9107970.
[5719]	“Maternal and neonatal tetanus elimination: validation in Punjab Province, Pakistan, November 2016,” Wkly. Epidemiol. Rec., vol. 92, no. 3, pp. 21–34, 20 2017.
[5720]	“Maternal and neonatal tetanus validation assessment in Region 4, Indonesia, May 2016,” Wkly. Epidemiol. Rec., vol. 91, no. 25, pp. 317–328, Jun. 2016.
[5721]	A. M. St John, K. Kao, J. Liederman, P. G. Grieve, and A. R. Tarullo, “Maternal cortisol slope at 6 months predicts infant cortisol slope and EEG power at 12 months,” Dev Psychobiol, vol. 59, no. 6, pp. 787–801, 2017, doi: 10.1002/dev.21540.
[5722]	L. Z. Garamszegi, C. Biard, M. Eens, A. P. Møller, N. Saino, and P. Surai, “Maternal effects and the evolution of brain size in birds: overlooked developmental constraints,” Neurosci Biobehav Rev, vol. 31, no. 4, pp. 498–515, 2007, doi: 10.1016/j.neubiorev.2006.11.008.
[5723]	K. O. Duffany, K. H. McVeigh, T. S. Kershaw, H. S. Lipkind, and J. R. Ickovics, “Maternal Obesity: Risks for Developmental Delays in Early Childhood,” Matern Child Health J, vol. 20, no. 2, pp. 219–230, Feb. 2016, doi: 10.1007/s10995-015-1821-z.
[5724]	V. Kasture, D. Sundrani, S. Dalvi, M. Swamy, A. Kale, and S. Joshi, “Maternal omega-3 fatty acids and vitamin E improve placental angiogenesis in late-onset but not early-onset preeclampsia,” Mol. Cell. Biochem., vol. 461, no. 1–2, pp. 159–170, Nov. 2019, doi: 10.1007/s11010-019-03599-4.
[5725]	M. Yaari et al., “Maternal resolution of preterm birth from 1 to 18 months,” Attach Hum Dev, vol. 19, no. 5, pp. 487–503, Oct. 2017, doi: 10.1080/14616734.2017.1324499.
[5726]	G. Ndeezi, “Maternal, adolescent and child health issues in low and middle income countries: towards achieving the sustainable development goals,” Afr Health Sci, vol. 19, no. 2, p. I–III, Jun. 2019, doi: 10.4314/ahs.v19i2.1.
[5727]	A. Costello and Z. Naimy, “Maternal, newborn, child and adolescent health: challenges for the next decade,” Int Health, vol. 11, no. 5, pp. 349–352, 02 2019, doi: 10.1093/inthealth/ihz051.
[5728]	E. A. Maloney and S. L. Beilock, “Math anxiety: who has it, why it develops, and how to guard against it,” Trends Cogn. Sci. (Regul. Ed.), vol. 16, no. 8, pp. 404–406, Aug. 2012, doi: 10.1016/j.tics.2012.06.008.
[5729]	J. K. Holodinsky, M. A. Almekhlafi, M. Goyal, and N. Kamal, “Mathematical Modeling for Decision-Making in the Field for Acute Stroke Patients With Suspected Large Vessel Occlusion,” Stroke, p. STROKEAHA118021381, Oct. 2018, doi: 10.1161/STROKEAHA.118.021381.
[5730]	E. Hayden, S. Chen, A. Chumley, Q. Zhong, and S. Ju, “Mating-based Overexpression Library Screening in Yeast,” J Vis Exp, no. 137, 06 2018, doi: 10.3791/57978.
[5731]	R. Kunkel, E. Kim, F. B. Tuncer, F. Siddiqi, and B. Gociman, “Maxillary Distraction Osteogenesis in a Patient With Osteogenesis Imperfecta,” J Craniofac Surg, vol. 30, no. 8, pp. 2530–2532, Dec. 2019, doi: 10.1097/SCS.0000000000006001.
[5732]	B. Song et al., “Maximal flexibility in dynamic functional connectivity with critical dynamics revealed by fMRI data analysis and brain network modelling,” J Neural Eng, vol. 16, no. 5, p. 056002, 23 2019, doi: 10.1088/1741-2552/ab20bc.
[5733]	G. L. Fialho, A. G. Pagani, R. Walz, P. Wolf, and K. Lin, “Maximal/exhaustive treadmill test features in patients with temporal lobe epilepsy: Search for sudden unexpected death biomarkers,” Epilepsy Res., vol. 133, pp. 83–88, 2017, doi: 10.1016/j.eplepsyres.2017.04.014.
[5734]	U. P. Jorde et al., “Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure,” Circulation, vol. 101, no. 8, pp. 844–846, Feb. 2000, doi: 10.1161/01.cir.101.8.844.
[5735]	D. Ramirez and C. D. Collins, “Maximisation of oil recovery from an oil-water separator sludge: Influence of type, concentration, and application ratio of surfactants,” Waste Manag, vol. 82, pp. 100–110, Dec. 2018, doi: 10.1016/j.wasman.2018.10.016.
[5736]	B. Sessa, “MDMA and PTSD treatment: ‘PTSD: From novel pathophysiology to innovative therapeutics,’” Neurosci. Lett., vol. 649, pp. 176–180, 10 2017, doi: 10.1016/j.neulet.2016.07.004.
[5737]	M. C. Mithoefer et al., “MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials,” Psychopharmacology (Berl.), May 2019, doi: 10.1007/s00213-019-05249-5.
[5738]	T. N. Tanaka and R. Bejar, “MDS overlap disorders and diagnostic boundaries,” Blood, vol. 133, no. 10, pp. 1086–1095, 07 2019, doi: 10.1182/blood-2018-10-844670.
[5739]	I. Litvan et al., “MDS Task Force on mild cognitive impairment in Parkinson’s disease: critical review of PD-MCI,” Mov. Disord., vol. 26, no. 10, pp. 1814–1824, Aug. 2011, doi: 10.1002/mds.23823.
[5740]	S. Ohmori, M. Ohmori, M. Yamagishi, and M. Okuma, “MDS-macrophage derived inhibitory activity on myelopoiesis of MDS abnormal clones,” Br. J. Haematol., vol. 83, no. 3, pp. 388–391, Mar. 1993, doi: 10.1111/j.1365-2141.1993.tb04661.x.
[5741]	H. Harada, “MDS: Recent progress in molecular pathogenesis and clinical aspects,” Rinsho Ketsueki, vol. 58, no. 10, pp. 1941–1950, 2017, doi: 10.11406/rinketsu.58.1941.
[5742]	J. J. Pérez Fontán, G. P. Heldt, and G. A. Gregory, “Mean airway pressure and mean alveolar pressure during high-frequency jet ventilation in rabbits,” J. Appl. Physiol., vol. 61, no. 2, pp. 456–463, Aug. 1986, doi: 10.1152/jappl.1986.61.2.456.
[5743]	J. J. Marini and S. A. Ravenscraft, “Mean airway pressure: physiologic determinants and clinical importance--Part 1: Physiologic determinants and measurements,” Crit. Care Med., vol. 20, no. 10, pp. 1461–1472, Oct. 1992.
[5744]	J. J. Marini and S. A. Ravenscraft, “Mean airway pressure: physiologic determinants and clinical importance--Part 2: Clinical implications,” Crit. Care Med., vol. 20, no. 11, pp. 1604–1616, Nov. 1992.
[5745]	R. Masutani et al., “Mean platelet component and mean platelet volume as useful screening markers for myelodysplastic syndrome,” Health Sci Rep, vol. 1, no. 5, p. e50, May 2018, doi: 10.1002/hsr2.50.
[5746]	S. Y. Cho, H. J. Lee, J. W. Kim, and T. S. Park, “Mean platelet volume and mean platelet volume/platelet count ratio in patients with chronic alcohol consumption,” Platelets, vol. 26, no. 4, pp. 371–372, 2015, doi: 10.3109/09537104.2014.887200.
[5747]	E. Kucuk and I. Kucuk, “Mean Platelet Volume is Reduced in Acute Appendicitis,” Turk J Emerg Med, vol. 15, no. 1, pp. 23–27, Mar. 2015, doi: 10.5505/1304.7361.2015.32657.
[5748]	P. Veng-Pedersen, “Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part I),” Clin Pharmacokinet, vol. 17, no. 5, pp. 345–366, Nov. 1989, doi: 10.2165/00003088-198917050-00004.
[5749]	C. E. Johnson et al., “Measles vaccine immunogenicity and antibody persistence in 12 vs 15-month old infants,” Vaccine, vol. 18, no. 22, pp. 2411–2415, May 2000, doi: 10.1016/s0264-410x(99)00574-5.
[5750]	C. E. Johnson, D. R. Nalin, L. W. Chui, J. Whitwell, R. G. Marusyk, and M. L. Kumar, “Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era,” Pediatrics, vol. 93, no. 6 Pt 1, pp. 939–944, Jun. 1994.
[5751]	“Measles vaccines: WHO position paper – April 2017,” Wkly. Epidemiol. Rec., vol. 92, no. 17, pp. 205–227, 28 2017.
[5752]	“Measles virus nomenclature update: 2012,” Wkly. Epidemiol. Rec., vol. 87, no. 9, pp. 73–81, Mar. 2012.
[5753]	L. S. Elwood, K. Wolitzky-Taylor, and B. O. Olatunji, “Measurement of anxious traits: a contemporary review and synthesis,” Anxiety Stress Coping, vol. 25, no. 6, pp. 647–666, Nov. 2012, doi: 10.1080/10615806.2011.582949.
[5754]	J. S. Helm, M. Nishioka, J. G. Brody, R. A. Rudel, and R. E. Dodson, “Measurement of endocrine disrupting and asthma-associated chemicals in hair products used by Black women,” Environ. Res., vol. 165, pp. 448–458, 2018, doi: 10.1016/j.envres.2018.03.030.
[5755]	Q. Pei, T. Zetterström, and M. Fillenz, “Measurement of extracellular 5-HT and 5-HIAA in hippocampus of freely moving rats using microdialysis: long-term applications,” Neurochem. Int., vol. 15, no. 4, pp. 503–509, 1989, doi: 10.1016/0197-0186(89)90170-8.
[5756]	A. Starostin et al., “Measurement of pi(0)pi(0) production in the nuclear medium by pi(-) interactions at 0.408 GeV/c,” Phys. Rev. Lett., vol. 85, no. 26 Pt 1, pp. 5539–5542, Dec. 2000, doi: 10.1103/PhysRevLett.85.5539.
[5757]	G. P. Milani, M. G. Bianchetti, and S. A. Lava, “Measurement of sodium in heart failure,” Heart, vol. 104, no. 20, p. 1724, 2018, doi: 10.1136/heartjnl-2017-312799.
[5758]	X. C. Tian et al., “Measurement of the wrong-sign decays D0 --> K+ pi- pi0 and D0 --> K+ pi- pi+ pi-, and search for CP violation,” Phys. Rev. Lett., vol. 95, no. 23, p. 231801, Dec. 2005, doi: 10.1103/PhysRevLett.95.231801.
[5759]	P. Stacey, “Measurements of silica in air: Reliability at new and proposed occupational exposure limits,” J Occup Environ Hyg, vol. 4, no. 1, pp. D1-4, Jan. 2007, doi: 10.1080/15459620601027997.
[5760]	S. Golbabaei, A. Dadashi, and H. Soltanian-Zadeh, “Measures of the brain functional network that correlate with Alzheimer’s neuropsychological test scores: An fMRI and graph analysis study,” Conf Proc IEEE Eng Med Biol Soc, vol. 2016, pp. 5554–5557, 2016, doi: 10.1109/EMBC.2016.7591985.
[5761]	X. Dong, X. Zhang, and S. Zeng, “Measuring and explaining eco-efficiencies of wastewater treatment plants in China: An uncertainty analysis perspective,” Water Res., vol. 112, pp. 195–207, 01 2017, doi: 10.1016/j.watres.2017.01.026.
[5762]	R. Wang, J. Zhu, S. Rastan, and F. Haghighat, “Measuring chemical emissions from wet products--development of a new measurement technique,” J. Hazard. Mater., vol. 192, no. 3, pp. 1026–1032, Sep. 2011, doi: 10.1016/j.jhazmat.2011.06.004.
[5763]	R. J. Kelly-Campbell and K. Wendel, “Measuring cognitive anxiety through the consultation process for hearing aids: Older adults and their significant others,” J Commun Disord, vol. 56, pp. 29–39, Aug. 2015, doi: 10.1016/j.jcomdis.2015.06.006.
[5764]	L. Rew, H. Becker, J. Cookston, S. Khosropour, and S. Martinez, “Measuring cultural awareness in nursing students,” J Nurs Educ, vol. 42, no. 6, pp. 249–257, Jun. 2003.
[5765]	B. Krainovich-Miller et al., “Measuring cultural awareness of nursing students: a first step toward cultural competency,” J Transcult Nurs, vol. 19, no. 3, pp. 250–258, Jul. 2008, doi: 10.1177/1043659608317451.
[5766]	M. Palmer and A. Ruhi, “Measuring Earth’s rivers,” Science, vol. 361, no. 6402, pp. 546–547, 10 2018, doi: 10.1126/science.aau3842.
[5767]	D. Whalley and S. P. McKenna, “Measuring quality of life in patients with depression or anxiety,” Pharmacoeconomics, vol. 8, no. 4, pp. 305–315, Oct. 1995, doi: 10.2165/00019053-199508040-00005.
[5768]	D. Nogueira, E. Reis, P. Ferreira, and A. Schindler, “Measuring Quality of Life in the Speaker with Dysarthria: Reliability and Validity of the European Portuguese Version of the QoL-DyS,” Folia Phoniatr Logop, vol. 71, no. 4, pp. 176–190, 2019, doi: 10.1159/000495564.
[5769]	W. Ren, Z. Zhang, Y. Wang, B. Xue, and X. Chen, “Measuring Regional Eco-Efficiency in China (2003-2016): A ‘Full World’ Perspective and Network Data Envelopment Analysis,” Int J Environ Res Public Health, vol. 17, no. 10, 15 2020, doi: 10.3390/ijerph17103456.
[5770]	K. Schüttpelz-Brauns, E. Narciß, M. Giesler, and U. Obertacke, “[Measuring Satisfaction with Deployment in the Final Year of Undergraduate Medical Study (Ma-FEZ-PJ) to Ensure the Quality of Training in the Final Year - Psychometrics of a Self-Evaluation Questionnaire],” Zentralbl Chir, vol. 144, no. 6, pp. 580–586, Dec. 2019, doi: 10.1055/a-0774-8123.
[5771]	C. Wu, P. Dagg, and C. Molgat, “Measuring stability of cognitive impairment in inpatients with schizophrenia with alternate forms of the Montreal Cognitive Assessment during acute hospitalization,” Psychiatry Res, vol. 258, pp. 299–304, 2017, doi: 10.1016/j.psychres.2017.08.065.
[5772]	M. Carandini, “Measuring the brain’s assumptions,” Nat. Neurosci., vol. 9, no. 4, pp. 468–470, Apr. 2006, doi: 10.1038/nn0406-468.
[5773]	R. E. Blanco, C. Göbel, and R. Méndez-Galain, “Measuring the CP violating phase gamma using B+/- --> pi(+/-)pi(+)pi(-) and B+/- --> K+/-pi(+)pi(-) decays,” Phys. Rev. Lett., vol. 86, no. 13, pp. 2720–2723, Mar. 2001, doi: 10.1103/PhysRevLett.86.2720.
[5774]	T. Gómez, G. Gémar, M. Molinos-Senante, R. Sala-Garrido, and R. Caballero, “Measuring the eco-efficiency of wastewater treatment plants under data uncertainty,” J. Environ. Manage., vol. 226, pp. 484–492, Nov. 2018, doi: 10.1016/j.jenvman.2018.08.067.
[5775]	U. Tomažin, N. Batorek-Lukač, M. Škrlep, M. Prevolnik-Povše, and M. Čandek-Potokar, “Meat and fat quality of Krškopolje pigs reared in conventional and organic production systems,” Animal, vol. 13, no. 5, pp. 1103–1110, May 2019, doi: 10.1017/S1751731118002409.
[5776]	E. A. Zamir, V. Srinivasan, R. Perucchio, and L. A. Taber, “Mechanical asymmetry in the embryonic chick heart during looping,” Ann Biomed Eng, vol. 31, no. 11, pp. 1327–1336, Dec. 2003, doi: 10.1114/1.1623487.
[5777]	S. C. Roe, “Mechanical characteristics and comparisons of cerclage wires: introduction of the double-wrap and loop/twist tying methods,” Vet Surg, vol. 26, no. 4, pp. 310–316, Aug. 1997, doi: 10.1111/j.1532-950x.1997.tb01503.x.
[5778]	G. Maréchal, G. R. Coulton, and G. Beckers-Bleukx, “Mechanical power and myosin composition of soleus and extensor digitorum longus muscles of ky mice,” Am. J. Physiol., vol. 268, no. 2 Pt 1, pp. C513-519, Feb. 1995, doi: 10.1152/ajpcell.1995.268.2.C513.
[5779]	J. Kjelstrup-Hansen, O. Hansen, H.-G. Rubahn, and P. Bøggild, “Mechanical properties of organic nanofibers,” Small, vol. 2, no. 5, pp. 660–666, May 2006, doi: 10.1002/smll.200500457.
[5780]	K. J. MacArthur et al., “Mechanical versus biological heart valves: a ten-year comparison in a single centre,” Eur J Cardiothorac Surg, vol. 2, no. 3, pp. 143–150, 1988, doi: 10.1016/1010-7940(88)90062-0.
[5781]	V. J. Dzau, “Mechanism of action of angiotensin-converting enzyme (ACE) inhibitors in hypertension and heart failure. Role of plasma versus tissue ACE,” Drugs, vol. 39 Suppl 2, pp. 11–16, 1990, doi: 10.2165/00003495-199000392-00004.
[5782]	L. Skibsbye and U. Ravens, “Mechanism of Proarrhythmic Effects of Potassium Channel Blockers,” Card Electrophysiol Clin, vol. 8, no. 2, pp. 395–410, 2016, doi: 10.1016/j.ccep.2016.02.004.
[5783]	O. Scholz, M. Kintrup, M. Reich, and W. Hillen, “Mechanism of Tet repressor induction by tetracyclines: length compensates for sequence in the alpha8-alpha9 loop,” J. Mol. Biol., vol. 310, no. 5, pp. 979–986, Jul. 2001, doi: 10.1006/jmbi.2001.4820.
[5784]	Y. Okamoto, N. Shirao, K. Ueda, M. Sekida, H. Yamashita, and S. Yamawaki, “[Mechanism of the brain’s adaptation to stress],” Seishin Shinkeigaku Zasshi, vol. 106, no. 3, pp. 365–371, 2004.
[5785]	M. E. Koshland, “Mechanism of the immune response. BNL 912 (T-374),” Tech Rep Brookhaven Natl Lab, pp. 1–15, 1965.
[5786]	P.-H. Chang, W.-T. Jiang, and Z. Li, “Mechanism of tyramine adsorption on Ca-montmorillonite,” Sci. Total Environ., vol. 642, pp. 198–207, Nov. 2018, doi: 10.1016/j.scitotenv.2018.05.190.
[5787]	N.-C. Chung, A. K. Walker, H. M. Dhillon, and J. L. Vardy, “Mechanisms and Treatment for Cancer- and Chemotherapy-Related Cognitive Impairment in Survivors of Non-CNS Malignancies,” Oncology (Williston Park, N.Y.), vol. 32, no. 12, pp. 591–598, 17 2018.
[5788]	B. T. Mossman and A. Churg, “Mechanisms in the pathogenesis of asbestosis and silicosis,” Am. J. Respir. Crit. Care Med., vol. 157, no. 5 Pt 1, pp. 1666–1680, May 1998, doi: 10.1164/ajrccm.157.5.9707141.
[5789]	H. Wang and A. W. Tai, “Mechanisms of Cellular Membrane Reorganization to Support Hepatitis C Virus Replication,” Viruses, vol. 8, no. 5, 20 2016, doi: 10.3390/v8050142.
[5790]	E. C. Miller and J. A. Miller, “Mechanisms of chemical carcinogenesis,” Cancer, vol. 47, no. 5 Suppl, pp. 1055–1064, Mar. 1981, doi: 10.1002/1097-0142(19810301)47:5+<1055::aid-cncr2820471302>3.0.co;2-3.
[5791]	Y. Tan, Z. Zhang, C. Zheng, K. A. Wintergerst, B. B. Keller, and L. Cai, “Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence,” Nat Rev Cardiol, vol. 17, no. 9, pp. 585–607, Sep. 2020, doi: 10.1038/s41569-020-0339-2.
[5792]	B. Wahlang et al., “Mechanisms of Environmental Contributions to Fatty Liver Disease,” Curr Environ Health Rep, vol. 6, no. 3, pp. 80–94, 2019, doi: 10.1007/s40572-019-00232-w.
[5793]	Y. Zhang, X. Li, and K. Mi, “Mechanisms of fluoroquinolone resistance in Mycobacterium tuberculosis,” Yi Chuan, vol. 38, no. 10, pp. 918–927, 20 2016, doi: 10.16288/j.yczz.16-136.
[5794]	S. Fujii et al., “Mechanisms of G1 cell cycle arrest and apoptosis in myeloma cells induced by hybrid-compound histone deacetylase inhibitor,” Biochem. Biophys. Res. Commun., vol. 434, no. 3, pp. 413–420, May 2013, doi: 10.1016/j.bbrc.2013.03.043.
[5795]	C. J. Beinlich, C. J. Rissinger, and H. E. Morgan, “Mechanisms of rapid growth in the neonatal pig heart,” J. Mol. Cell. Cardiol., vol. 27, no. 1, pp. 273–281, Jan. 1995, doi: 10.1016/s0022-2828(08)80026-0.
[5796]	A. Arlia-Ciommo et al., “Mechanisms through which lithocholic acid delays yeast chronological aging under caloric restriction conditions,” Oncotarget, vol. 9, no. 79, pp. 34945–34971, Oct. 2018, doi: 10.18632/oncotarget.26188.
[5797]	L. Rivard and P. Khairy, “Mechanisms, Clinical Significance, and Prevention of Cognitive Impairment in Patients With Atrial Fibrillation,” Can J Cardiol, vol. 33, no. 12, pp. 1556–1564, 2017, doi: 10.1016/j.cjca.2017.09.024.
[5798]	K. Laksari, M. Kurt, H. Babaee, S. Kleiven, and D. Camarillo, “Mechanistic Insights into Human Brain Impact Dynamics through Modal Analysis,” Phys. Rev. Lett., vol. 120, no. 13, p. 138101, Mar. 2018, doi: 10.1103/PhysRevLett.120.138101.
[5799]	B. C. Bonning, T. F. Booth, and B. D. Hammock, “Mechanistic studies of the degradation of juvenile hormone esterase in Manduca sexta,” Arch. Insect Biochem. Physiol., vol. 34, no. 3, pp. 275–286, 1997, doi: 10.1002/(SICI)1520-6327(1997)34:3<275::AID-ARCH3>3.0.CO;2-U.
[5800]	O. Friedrich, S. Wagner, A. R. Battle, S. Schürmann, and B. Martinac, “Mechano-regulation of the beating heart at the cellular level--mechanosensitive channels in normal and diseased heart,” Prog. Biophys. Mol. Biol., vol. 110, no. 2–3, pp. 226–238, Nov. 2012, doi: 10.1016/j.pbiomolbio.2012.08.009.
[5801]	J.-L. Teillaud, “[médecine/sciences 2017: the French touch of the advances in biomedical kowledge in… French],” Med Sci (Paris), vol. 33, no. 1, pp. 7–8, Jan. 2017, doi: 10.1051/medsci/20173301001.
[5802]	S. B. Park, H.-J. Yang, and S. H. Lee, “Medial loop of v2 segment of vertebral artery causing compression of proximal cervical root,” J Korean Neurosurg Soc, vol. 52, no. 6, pp. 513–516, Dec. 2012, doi: 10.3340/jkns.2012.52.6.513.
[5803]	G. Telegdy and A. Adamik, “Mediators involved in the hyperthermic action of neuromedin U in rats,” Regul. Pept., vol. 192–193, pp. 24–29, Aug. 2014, doi: 10.1016/j.regpep.2014.07.004.
[5804]	H. S. Luft, “Medical care in a changing economic environment,” Pharos Alpha Omega Alpha Honor Med Soc, vol. 48, no. 1, pp. 2–5, 1985.
[5805]	G. Bin Nun and A. Afek, “[Medical ethics and economics in the era of insufficient resources],” Harefuah, vol. 148, no. 3, pp. 144–148, 212, Mar. 2009.
[5806]	M. Grivaux, “[Medical journals publication: Let’s change],” Rev Pneumol Clin, vol. 74, no. 6, pp. 365–366, 2018, doi: 10.1016/j.pneumo.2018.11.002.
[5807]	G. Lorin de la Grandmaison, “[Medical publications: The multiple flaws of the system],” Presse Med, vol. 48, no. 3 Pt 1, pp. 223–226, Mar. 2019, doi: 10.1016/j.lpm.2019.01.005.
[5808]	H. Ledford, “Medical research: if depression were cancer,” Nature, vol. 515, no. 7526, pp. 182–184, Nov. 2014, doi: 10.1038/515182a.
[5809]	M. F. Ugarte-Gil and G. S. Alarcón, “Medical Scientific Publications From Latin America: A Commentary,” J Clin Rheumatol, vol. 25, no. 4, pp. 157–158, 2019, doi: 10.1097/RHU.0000000000000907.
[5810]	G. J. Bazzoli, “Medical service risk and the evolution of provider compensation arrangements,” J Health Polit Policy Law, vol. 26, no. 5, pp. 1003–1018, Oct. 2001, doi: 10.1215/03616878-26-5-1003.
[5811]	C. I. Ping Tsao, D. Simpson, and R. Treat, “Medical student communication skills and specialty choice,” Acad Psychiatry, vol. 39, no. 3, pp. 275–279, Jun. 2015, doi: 10.1007/s40596-014-0165-0.
[5812]	R. A. Prayson, S. B. Bierer, and E. F. Dannefer, “Medical student resilience strategies: A content analysis of medical students’ portfolios,” Perspect Med Educ, vol. 6, no. 1, pp. 29–35, Feb. 2017, doi: 10.1007/s40037-016-0313-1.
[5813]	R. A. Conard et al., “Medical survey of Rongelap people eight years after exposure to fallout,” Tech Rep Brookhaven Natl Lab, pp. 1–74, Jan. 1963.
[5814]	R. A. Conard et al., “Medical survey of Rongelap people five and six years after exposure to fallout (with an addendum on vegetation),” Tech Rep Brookhaven Natl Lab, vol. T-179, pp. 1–86, Sep. 1960.
[5815]	R. A. Conard et al., “Medical survey of the people of Rongelap and Utirik Islands eleven and twelve years after exposure to fallout radiation (March 1965 and March 1966),” Tech Rep Brookhaven Natl Lab, pp. 1–163, Apr. 1964.
[5816]	J. O. Fadare, T. A. Sunmonu, I. A. Bankole, K. A. Adekeye, and S. A. Abubakar, “Medication adherence and adverse effect profile of antiepileptic drugs in Nigerian patients with epilepsy,” Neurodegener Dis Manag, vol. 8, no. 1, pp. 25–36, 2018, doi: 10.2217/nmt-2017-0044.
[5817]	P. Strålin and J. Hetta, “Medication, hospitalizations and mortality in 5 years after first-episode psychosis in a Swedish nation-wide cohort,” Early Interv Psychiatry, vol. 13, no. 4, pp. 902–907, 2019, doi: 10.1111/eip.12697.
[5818]	D. N. Taylor, D. H. Hamer, and D. R. Shlim, “Medications for the prevention and treatment of travellers’ diarrhea,” J Travel Med, vol. 24, no. suppl_1, pp. S17–S22, Apr. 2017, doi: 10.1093/jtm/taw097.
[5819]	K. Takayama, “[Medicinal Chemistry Focused on Mid-sized Peptides Derived from Biomolecules],” Yakugaku Zasshi, vol. 139, no. 11, pp. 1377–1384, 2019, doi: 10.1248/yakushi.19-00149.
[5820]	S. Gorbea-Portal and M. L. Atrián-Salazar, “Medición de la obsolescencia de la información en revistas de salud pública de México,” Gac Med Mex, vol. 154, no. 3, pp. 335–341, 2018, doi: 10.24875/GMM.18003293.
[5821]	E. Haagensen and N. C. Lind, “Medieval Round Churches and the Shape of the Earth,” Isis, vol. 106, no. 4, pp. 825–834, Dec. 2015, doi: 10.1086/684766.
[5822]	V. C. Bachelet, “Medwaves editorial history, policies and guidelines: 4. Author instructions and journal guidelines,” Medwave, vol. 17, no. 3, p. e6911, Apr. 2017, doi: 10.5867/medwave.2017.03.6911.
[5823]	“Meeting of the Global Advisory Committee on Vaccine Safety, 7–8 June 2017,” Wkly. Epidemiol. Rec., vol. 92, no. 28, pp. 393–402, 14 2017.
[5824]	“Meeting of the International Task Force for Disease Eradication, June 2017,” Wkly. Epidemiol. Rec., vol. 92, no. 37, pp. 537–556, 15 2017.
[5825]	“Meeting of the International Task Force for Disease Eradication, November 2015,” Wkly. Epidemiol. Rec., vol. 91, no. 6, pp. 61–71, Feb. 2016.
[5826]	“Meeting of the International Task Force for Disease Eradication, October 2017,” Wkly. Epidemiol. Rec., vol. 93, no. 4–5, pp. 33–38, Jan. 2018.
[5827]	“Meeting of the Strategic Advisory Group of Experts on immunization, April 2017 – conclusions and recommendations,” Wkly. Epidemiol. Rec., vol. 92, no. 22, pp. 301–320, 02 2017.
[5828]	“Meeting of the Strategic Advisory Group of Experts on immunization, October 2017 – conclusions and recommendations,” Wkly. Epidemiol. Rec., vol. 92, no. 48, pp. 729–747, 01 2017.
[5829]	R. Awad, J. Oropeza, and K. M. Uhler, “Meeting the Joint Committee on Infant Hearing Standards in a Large Metropolitan Children’s Hospital: Barriers and Next Steps,” Am J Audiol, vol. 28, no. 2, pp. 251–259, Jun. 2019, doi: 10.1044/2019_AJA-18-0001.
[5830]	J. Martinez-Frias and A. D. Huertas, “Megacryometeors: distribution on Earth and current research,” Ambio, vol. 35, no. 6, pp. 314–316, Sep. 2006, doi: 10.1579/06-s-187.1.
[5831]	S. Buoro, M. Seghezzi, G. Borleri, and B. Manenti, “Megakaryoblasts in a newborn with Down syndrome,” Blood Res, vol. 53, no. 2, p. 102, Jun. 2018, doi: 10.5045/br.2018.53.2.102.
[5832]	M. Sasaki, S. E. Tischfield, M. van Overbeek, and S. Keeney, “Meiotic recombination initiation in and around retrotransposable elements in Saccharomyces cerevisiae,” PLoS Genet., vol. 9, no. 8, p. e1003732, Aug. 2013, doi: 10.1371/journal.pgen.1003732.
[5833]	M. Mirhoseini, G. Saki, M. Hemadi, A. Khodadadi, and J. Mohammadi Asl, “Melatonin and testicular damage in busulfan treated mice,” Iran Red Crescent Med J, vol. 16, no. 2, p. e14463, Feb. 2014, doi: 10.5812/ircmj.14463.
[5834]	S. König et al., “Melleolides from Honey Mushroom Inhibit 5-Lipoxygenase via Cys159,” Cell Chem Biol, vol. 26, no. 1, pp. 60-70.e4, 17 2019, doi: 10.1016/j.chembiol.2018.10.010.
[5835]	M. A. Livshits, D. N. Kaluzhny, and E. E. Minyat, “Melting of model HIV-1 stem-loop 1 RNA dimers monitored by 2-aminopurine fluorescence,” J. Biomol. Struct. Dyn., vol. 28, no. 6, pp. 939–947, Jun. 2011, doi: 10.1080/07391102.2011.10508620.
[5836]	A. H. Pande, S. Qin, and S. A. Tatulian, “Membrane fluidity is a key modulator of membrane binding, insertion, and activity of 5-lipoxygenase,” Biophys. J., vol. 88, no. 6, pp. 4084–4094, Jun. 2005, doi: 10.1529/biophysj.104.056788.
[5837]	E. M. Krämer, A. Schardt, and K. A. Nave, “Membrane traffic in myelinating oligodendrocytes,” Microsc. Res. Tech., vol. 52, no. 6, pp. 656–671, Mar. 2001, doi: 10.1002/jemt.1050.
[5838]	A. Papa, “Memories and the human spirit,” J Emerg Nurs, vol. 37, no. 5, p. 429, Sep. 2011, doi: 10.1016/j.jen.2011.07.013.
[5839]	H. O. Kim and S. J. Yoo, “Memoryless disturbance-observer-based adaptive tracking of uncertain pure-feedback nonlinear time-delay systems with unmatched disturbances,” ISA Trans, vol. 70, pp. 419–431, Sep. 2017, doi: 10.1016/j.isatra.2017.07.017.
[5840]	P. T. Malone and C. G. Johnson, “Men and depression,” J Med Assoc Ga, vol. 87, no. 1, pp. 27–29, Jan. 1998.
[5841]	M.-E. Robinson and F. Rauch, “Mendelian bone fragility disorders,” Bone, vol. 126, pp. 11–17, 2019, doi: 10.1016/j.bone.2019.04.021.
[5842]	P. Kothiyal, W. S. W. Wong, D. L. Bodian, and J. E. Niederhuber, “Mendelian Inconsistent Signatures from 1314 Ancestrally Diverse Family Trios Distinguish Biological Variation from Sequencing Error,” J. Comput. Biol., vol. 26, no. 5, pp. 405–419, 2019, doi: 10.1089/cmb.2018.0253.
[5843]	“Meningitis control in countries of the African meningitis belt, 2015,” Wkly. Epidemiol. Rec., vol. 91, no. 16, pp. 209–216, Apr. 2016.
[5844]	“Meningococcal A conjugate  vaccine: updated guidance,  February 2015,” Wkly. Epidemiol. Rec., vol. 90, no. 8, pp. 57–62, Feb. 2015.
[5845]	P. Coker-Bolt et al., “Menstrual Education and Personal Hygiene Supplies to Empower Young Women in Haiti,” OTJR (Thorofare N J), vol. 37, no. 4, pp. 210–217, 2017, doi: 10.1177/1539449217719866.
[5846]	J. Shigemura, T. Tanigawa, Y. Kobayashi, M. Kurosawa, A. Noda, and A. Yoshino, “[Mental and Organic Features of Posttraumatic Stress Disorder],” Brain Nerve, vol. 70, no. 11, pp. 1247–1254, Nov. 2018, doi: 10.11477/mf.1416201170.
[5847]	K. T. Rew, “Mental Disorders and Learning Disabilities in Children and Adolescents: Foreword,” FP Essent, vol. 475, p. 2, Dec. 2018.
[5848]	P. J. O’Connor, “Mental energy: Assessing the mood dimension,” Nutr. Rev., vol. 64, no. 7 Pt 2, pp. S7-9, Jul. 2006, doi: 10.1111/j.1753-4887.2006.tb00256.x.
[5849]	A. Schaefer, H. Matthess, G. Pfitzer, and K. Köhle, “[Mental health and performance of medical students with high and low test anxiety],” Psychother Psychosom Med Psychol, vol. 57, no. 7, pp. 289–297, Jul. 2007, doi: 10.1055/s-2006-951974.
[5850]	K. Smith, “Mental health: a world of depression,” Nature, vol. 515, no. 7526, p. 181, Nov. 2014, doi: 10.1038/515180a.
[5851]	H. Siemens, “Mental hygiene in a health unit,” Can Med Assoc J, vol. 68, no. 3, pp. 205–209, Mar. 1953.
[5852]	M. Fischer-Kern and A. Tmej, “Mentalization and Depression: Theoretical Concepts, Treatment Approaches and Empirical Studies - an Overview,” Z Psychosom Med Psychother, vol. 65, no. 2, pp. 162–177, Jun. 2019, doi: 10.13109/zptm.2019.65.2.162.
[5853]	D. K. Berner et al., “Meprin β cleaves TREM2 and controls its phagocytic activity on macrophages,” FASEB J., vol. 34, no. 5, pp. 6675–6687, May 2020, doi: 10.1096/fj.201902183R.
[5854]	D. Sarhan et al., “Mesenchymal stromal cells shape the MDS microenvironment by inducing suppressive monocytes that dampen NK cell function,” JCI Insight, vol. 5, no. 5, Mar. 2020, doi: 10.1172/jci.insight.130155.
[5855]	E. B. Koo, T. D. Petersen, and A. B. Kimball, “Meta-analysis comparing efficacy of antibiotics versus oral contraceptives in acne vulgaris,” J. Am. Acad. Dermatol., vol. 71, no. 3, pp. 450–459, Sep. 2014, doi: 10.1016/j.jaad.2014.03.051.
[5856]	W. Wang et al., “Metabolic Deregulation of the Blood-Outer Retinal Barrier in Retinitis Pigmentosa,” Cell Rep, vol. 28, no. 5, pp. 1323-1334.e4, 30 2019, doi: 10.1016/j.celrep.2019.06.093.
[5857]	V. Troselj and D. Wall, “Metabolic disharmony and sibling conflict mediated by T6SS,” Microb Cell, vol. 5, no. 5, pp. 256–258, Apr. 2018, doi: 10.15698/mic2018.05.632.
[5858]	I. Boraschi-Diaz et al., “Metabolic phenotype in the mouse model of osteogenesis imperfecta,” J. Endocrinol., vol. 234, no. 3, pp. 279–289, Sep. 2017, doi: 10.1530/JOE-17-0335.
[5859]	G. K. Dimitriadis et al., “Metabolic phenotype of male obesity-related secondary hypogonadism pre-replacement and post-replacement therapy with intra-muscular testosterone undecanoate therapy,” Endocrine, vol. 60, no. 1, pp. 175–184, 2018, doi: 10.1007/s12020-017-1516-x.
[5860]	J. Telser et al., “Metabolic reprogramming of Salmonella infected macrophages and its modulation by iron availability and the mTOR pathway,” Microb Cell, vol. 6, no. 12, pp. 531–543, Nov. 2019, doi: 10.15698/mic2019.12.700.
[5861]	R. Haigou and M. Miyazawa, “Metabolism of (+)-terpinen-4-ol by cytochrome P450 enzymes in human liver microsomes,” J Oleo Sci, vol. 61, no. 1, pp. 35–43, 2012, doi: 10.5650/jos.61.35.
[5862]	J. Michl, “Metabolism of cells in tissue culture in vitro. II. Long-term cultivation of cell strains and cells isolated directly from animals in a stationary culture,” Exp. Cell Res., vol. 26, pp. 129–135, Feb. 1962, doi: 10.1016/0014-4827(62)90208-2.
[5863]	J. Paul and E. S. Pearson, “Metabolism of chick embryonic heart explants during transition from in vivo to in vitro conditions,” Exp. Cell Res., vol. 12, no. 2, pp. 212–222, Apr. 1957, doi: 10.1016/0014-4827(57)90135-0.
[5864]	J. Paul and E. S. Pearson, “Metabolism of chick embryonic liver explants during transition from in vivo to in vitro conditions,” Exp. Cell Res., vol. 12, no. 2, pp. 223–230, Apr. 1957, doi: 10.1016/0014-4827(57)90136-2.
[5865]	S. Schroeder et al., “Metabolites in aging and autophagy,” Microb Cell, vol. 1, no. 4, pp. 110–114, Apr. 2014, doi: 10.15698/mic2014.04.142.
[5866]	J. E. Kim et al., “Metabolomics approach to serum biomarker for laxative effects of red Liriope platyphylla in loperamide-induced constipation of SD rats,” Lab Anim Res, vol. 35, p. 9, 2019, doi: 10.1186/s42826-019-0009-x.
[5867]	N. S. Taylor, A. Gavin, and M. R. Viant, “Metabolomics Discovers Early-Response Metabolic Biomarkers that Can Predict Chronic Reproductive Fitness in Individual Daphnia magna,” Metabolites, vol. 8, no. 3, Jul. 2018, doi: 10.3390/metabo8030042.
[5868]	P. L. Fisher, J. Reilly, and A. Noble, “Metacognitive beliefs and illness perceptions are associated with emotional distress in people with epilepsy,” Epilepsy Behav, vol. 86, pp. 9–14, 2018, doi: 10.1016/j.yebeh.2018.07.008.
[5869]	S. K. Tauber and M. G. Rhodes, “Metacognitive errors contribute to the difficulty in remembering proper names,” Memory, vol. 18, no. 5, pp. 522–532, Jul. 2010, doi: 10.1080/09658211.2010.481818.
[5870]	J. P. Dekker, “Metagenomics for Clinical Infectious Disease Diagnostics Steps Closer to Reality,” J. Clin. Microbiol., vol. 56, no. 9, 2018, doi: 10.1128/JCM.00850-18.
[5871]	L. de Nazaré Almeida Dos Reis, M. E. de N. Fonseca, S. G. Ribeiro, F. Y. B. Naito, L. S. Boiteux, and R. de C. Pereira-Carvalho, “Metagenomics of Neotropical Single-Stranded DNA Viruses in Tomato Cultivars with and without the Ty-1 Gene,” Viruses, vol. 12, no. 8, Jul. 2020, doi: 10.3390/v12080819.
[5872]	J.-H. Huang et al., “Metal biogeochemistry in constructed wetlands based on fluviatile sand and zeolite- and clinopyroxene-dominated lava sand,” Sci Rep, vol. 7, no. 1, p. 2981, 07 2017, doi: 10.1038/s41598-017-03055-7.
[5873]	C. Brembilla et al., “Metal release from spinal arthrodesis: implant failure and local metal release but only slightly elevated serum levels,” J Neurosurg Sci, vol. 63, no. 4, pp. 481–484, Aug. 2019, doi: 10.23736/S0390-5616.17.04252-7.
[5874]	F. Mori, C. Della Rocca, and D. Lazzaro, “Metallothionein colon crypt immuno-positivity as a rapid in vivo essay for drug efficacy studies,” In Vivo, vol. 26, no. 4, pp. 693–702, Aug. 2012.
[5875]	B. Desoize, “Metals and metal compounds in carcinogenesis,” In Vivo, vol. 17, no. 6, pp. 529–539, Dec. 2003.
[5876]	B. Bojková, K. Kajo, P. Kubatka, P. Solár, M. Péč, and M. Adamkov, “Metformin and melatonin improve histopathological outcome of NMU-induced mammary tumors in rats,” Pathol. Res. Pract., vol. 215, no. 4, pp. 722–729, Apr. 2019, doi: 10.1016/j.prp.2019.01.007.
[5877]	S.-Y. Wang et al., “Metformin and the incidence of cancer in patients with diabetes: a nested case-control study,” Diabetes Care, vol. 36, no. 9, pp. e155-156, Sep. 2013, doi: 10.2337/dc13-0708.
[5878]	L. P. Bharath et al., “Metformin Enhances Autophagy and Normalizes Mitochondrial Function to Alleviate Aging-Associated Inflammation,” Cell Metab., vol. 32, no. 1, pp. 44-55.e6, Jul. 2020, doi: 10.1016/j.cmet.2020.04.015.
[5879]	R. Raiker, W. C. Lippert, and R. Chadha, “Methemoglobinemia in an HIV patient,” Cleve Clin J Med, vol. 85, no. 3, pp. 186–187, Mar. 2018, doi: 10.3949/ccjm.85a.17004.
[5880]	M. E. Funke, C. E. Fischetti, A. M. Rodino, and S. P. Shaheen, “Methemoglobinemia Induced By Ingesting Lava Lamp Contents,” Clin Pract Cases Emerg Med, vol. 2, no. 3, pp. 207–210, Aug. 2018, doi: 10.5811/cpcem.2018.5.38261.
[5881]	T. Hoomans, J. L. Severens, N. van der Roer, and G. O. Delwel, “Methodological quality of economic evaluations of new pharmaceuticals in The Netherlands,” Pharmacoeconomics, vol. 30, no. 3, pp. 219–227, Mar. 2012, doi: 10.2165/11539850-000000000-00000.
[5882]	J. V. Raimondo et al., “Methodological standards for in vitro models of epilepsy and epileptic seizures. A TASK1-WG4 report of the AES/ILAE Translational Task Force of the ILAE,” Epilepsia, vol. 58 Suppl 4, pp. 40–52, 2017, doi: 10.1111/epi.13901.
[5883]	P. Van Dijck et al., “Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms,” Microb Cell, vol. 5, no. 7, pp. 300–326, 14 2018, doi: 10.15698/mic2018.07.638.
[5884]	“Methodology puts science behind capping chiropractic care,” Capitation Manag Rep, vol. 5, no. 10, pp. 154–158, Oct. 1998.
[5885]	R. A. Canales, A. M. Wilson, J. I. Pearce-Walker, M. P. Verhougstraete, and K. A. Reynolds, “Methods for Handling Left-Censored Data in Quantitative Microbial Risk Assessment,” Appl. Environ. Microbiol., vol. 84, no. 20, 15 2018, doi: 10.1128/AEM.01203-18.
[5886]	K. E. Johnson, M. Goyal, A. J. Simonton, R. Richardson, M. Morris, and L. Rew, “Methods Matter: Tracking Health Disparities in Alternative High Schools,” Public Health Nurs, vol. 34, no. 3, pp. 303–311, 2017, doi: 10.1111/phn.12314.
[5887]	B. Kumar, S. Dhar, S. Handa, and I. Kaur, “Methotrexate in childhood psoriasis,” Pediatr Dermatol, vol. 11, no. 3, pp. 271–273, Sep. 1994, doi: 10.1111/j.1525-1470.1994.tb00602.x.
[5888]	A. M. Cummings, “Methoxychlor as a model for environmental estrogens,” Crit. Rev. Toxicol., vol. 27, no. 4, pp. 367–379, Jul. 1997, doi: 10.3109/10408449709089899.
[5889]	J. Bełdowski, M. Miotk, and J. Pempkowiak, “Methylation index as means of quantification of the compliance of sedimentary mercury to be methylated,” Environ Monit Assess, vol. 187, no. 8, p. 498, Aug. 2015, doi: 10.1007/s10661-015-4716-y.
[5890]	W.-J. Ding et al., “Methylation level of Rap1GAP and the clinical significance in MDS,” Oncol Lett, vol. 16, no. 6, pp. 7287–7294, Dec. 2018, doi: 10.3892/ol.2018.9503.
[5891]	T. Matsubara et al., “Methylene blue in place of acridine orange as a photosensitizer in photodynamic therapy of osteosarcoma,” In Vivo, vol. 22, no. 3, pp. 297–303, Jun. 2008.
[5892]	W.-J. Tu, “Methylmalonic acidemia in mainland China,” Ann. Nutr. Metab., vol. 58, no. 4, p. 281, Oct. 2011, doi: 10.1159/000331469.
[5893]	K. M. May and L. Rew, “Mexican American youths’ and mothers’ explanatory models of diabetes prevention,” J Spec Pediatr Nurs, vol. 15, no. 1, pp. 6–15, Jan. 2010, doi: 10.1111/j.1744-6155.2009.00207.x.
[5894]	C. Wu et al., “Mg Doped Li-LiB Alloy with In Situ Formed Lithiophilic LiB Skeleton for Lithium Metal Batteries,” Adv Sci (Weinh), vol. 7, no. 6, p. 1902643, Mar. 2020, doi: 10.1002/advs.201902643.
[5895]	M. Komatsu-Wakui et al., “MIC-A polymorphism in Japanese and a MIC-A-MIC-B null haplotype,” Immunogenetics, vol. 49, no. 7–8, pp. 620–628, Jul. 1999, doi: 10.1007/s002510050658.
[5896]	R. Luo et al., “MICA: A fast short-read aligner that takes full advantage of Many Integrated Core Architecture (MIC),” BMC Bioinformatics, vol. 16 Suppl 7, p. S10, 2015, doi: 10.1186/1471-2105-16-S7-S10.
[5897]	M. A. Kanzler, A. M. Van Dyke, Y. He, J. A. Hewett, and S. J. Hewett, “Mice lacking L-12/15-lipoxygenase show increased mortality during kindling despite demonstrating resistance to epileptogenesis,” Epilepsia Open, vol. 3, no. 2, pp. 255–263, Jun. 2018, doi: 10.1002/epi4.12221.
[5898]	Y. Shimizu, J. Hosomichi, S. Nakamura, and T. Ono, “Micro-computed tomography analysis of changes in the periodontal ligament and alveolar bone proper induced by occlusal hypofunction of rat molars,” Korean J Orthod, vol. 44, no. 5, pp. 263–267, Sep. 2014, doi: 10.4041/kjod.2014.44.5.263.
[5899]	J. Rajesh Banu,  null Preethi, S. Kavitha, M. Gunasekaran, and G. Kumar, “Microalgae based biorefinery promoting circular bioeconomy-techno economic and life-cycle analysis,” Bioresour. Technol., vol. 302, p. 122822, Apr. 2020, doi: 10.1016/j.biortech.2020.122822.
[5900]	R. M. M. K. Namal Rathnayaka, A. N. Ranathunga, S. A. M. Kularatne, J. Rajapakse, S. Ranasinghe, and R. Jayathunga, “Microangiopathic Hemolytic Anemia Following Three Different Species of Hump-Nosed Pit Viper (Genus: Hypnale) Envenoming in Sri Lanka,” Wilderness Environ Med, vol. 29, no. 1, pp. 94–101, 2018, doi: 10.1016/j.wem.2017.11.003.
[5901]	G. A. Kowalchuk, S. E. Jones, and L. L. Blackall, “Microbes orchestrate life on Earth,” ISME J, vol. 2, no. 8, pp. 795–796, Aug. 2008, doi: 10.1038/ismej.2008.61.
[5902]	S. M. Gao, Y. J. Wen, W. Q. Zhang, D. Z. Zhang, and Y. S. Yang, “[Microbial characteristics and eco-health implication of mineral spring water in Wudalianchi, Northeast China],” Ying Yong Sheng Tai Xue Bao, vol. 30, no. 8, pp. 2865–2874, Aug. 2019, doi: 10.13287/j.1001-9332.201908.036.
[5903]	D. J. Cabral, S. Penumutchu, C. Norris, J. R. Morones-Ramirez, and P. Belenky, “Microbial competition between Escherichia coli and Candida albicans reveals a soluble fungicidal factor,” Microb Cell, vol. 5, no. 5, pp. 249–255, Mar. 2018, doi: 10.15698/mic2018.05.631.
[5904]	L. Nevermann, H. E. Kaiser, and W. E. Xylander, “Microbial induced hemocytic immune reactions in chilopods,” In Vivo, vol. 10, no. 2, pp. 161–167, Apr. 1996.
[5905]	A. Faulkner and J. M. Turner, “Microbial metabolism of amino alcohols. Aminoacetone metabolism via 1-aminopropan-2-ol in Pseudomonas sp. N.C.I.B. 8858,” Biochem. J., vol. 138, no. 2, pp. 263–276, Feb. 1974, doi: 10.1042/bj1380263.
[5906]	G. Reguera, “Microbial nanowires and electroactive biofilms,” FEMS Microbiol. Ecol., vol. 94, no. 7, 01 2018, doi: 10.1093/femsec/fiy086.
[5907]	V. B. Carruthers, P. A. Cotter, and C. A. Kumamoto, “Microbial pathogenesis: mechanisms of infectious disease,” Cell Host Microbe, vol. 2, no. 4, pp. 214–219, Oct. 2007, doi: 10.1016/j.chom.2007.09.007.
[5908]	S. Magrisso, Y. Erel, and S. Belkin, “Microbial reporters of metal bioavailability,” Microb Biotechnol, vol. 1, no. 4, pp. 320–330, Jul. 2008, doi: 10.1111/j.1751-7915.2008.00022.x.
[5909]	S. J. Finley, J. L. Pechal, M. E. Benbow, B. K. Robertson, and G. T. Javan, “Microbial Signatures of Cadaver Gravesoil During Decomposition,” Microb. Ecol., vol. 71, no. 3, pp. 524–529, Apr. 2016, doi: 10.1007/s00248-015-0725-1.
[5910]	M. A. Bauer, K. Kainz, D. Carmona-Gutierrez, and F. Madeo, “Microbial wars: Competition in ecological niches and within the microbiome,” Microb Cell, vol. 5, no. 5, pp. 215–219, May 2018, doi: 10.15698/mic2018.05.628.
[5911]	X. Zhao, R. Egli, S. A. Gilder, and S. Müller, “Microbially assisted recording of the Earth’s magnetic field in sediment,” Nat Commun, vol. 7, p. 10673, Feb. 2016, doi: 10.1038/ncomms10673.
[5912]	J. R. Ebright, “Microbiology of chronic leg and pressure ulcers: clinical significance and implications for treatment,” Nurs. Clin. North Am., vol. 40, no. 2, pp. 207–216, Jun. 2005, doi: 10.1016/j.cnur.2004.09.003.
[5913]	I. A. Kirpich, D. Parajuli, and C. J. McClain, “Microbiome in NAFLD and ALD,” Clin Liver Dis (Hoboken), vol. 6, no. 3, pp. 55–58, Sep. 2015, doi: 10.1002/cld.494.
[5914]	F. Kalafut and M. Kosa, “[Microcinematographic apparatus for recording the activity of live cells cultivated in vitro],” Biologia, vol. 17, pp. 685–690, 1962.
[5915]	M. Prunieras and Y. Chardonnet, “[Microcinematographic study in interferential contrast of epidermic cells cultivated ‘in vitro’],” Pathol Biol, vol. 8, pp. 687–696, Apr. 1960.
[5916]	G. Dix, “Microeconomic forecasting: Constructing commensurable futures of educational reforms,” Soc Stud Sci, vol. 49, no. 2, pp. 180–207, 2019, doi: 10.1177/0306312719837364.
[5917]	P. Pais, M. Galocha, R. Viana, M. Cavalheiro, D. Pereira, and M. C. Teixeira, “Microevolution of the pathogenic yeasts Candida albicans and Candida glabrata during antifungal therapy and host infection,” Microb Cell, vol. 6, no. 3, pp. 142–159, Feb. 2019, doi: 10.15698/mic2019.03.670.
[5918]	M. Andoh, Y. Ikegaya, and R. Koyama, “Microglia as possible therapeutic targets for autism spectrum disorders,” Prog Mol Biol Transl Sci, vol. 167, pp. 223–245, 2019, doi: 10.1016/bs.pmbts.2019.06.012.
[5919]	R. Zhao, W. Hu, J. Tsai, W. Li, and W.-B. Gan, “Microglia limit the expansion of β-amyloid plaques in a mouse model of Alzheimer’s disease,” Mol Neurodegener, vol. 12, no. 1, p. 47, 12 2017, doi: 10.1186/s13024-017-0188-6.
[5920]	W. J. Streit, “Microglial senescence: does the brain’s immune system have an expiration date?,” Trends Neurosci., vol. 29, no. 9, pp. 506–510, Sep. 2006, doi: 10.1016/j.tins.2006.07.001.
[5921]	S. M. Imani et al., “Micropatterned biofunctional lubricant-infused surfaces promote selective localized cell adhesion and patterning,” Lab Chip, vol. 19, no. 19, pp. 3228–3237, 07 2019, doi: 10.1039/c9lc00608g.
[5922]	Y. Zhou et al., “MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson’s disease,” Mol Neurodegener, vol. 11, p. 28, Apr. 2016, doi: 10.1186/s13024-016-0094-3.
[5923]	H. Fan et al., “MicroRNA-34a mediates ethanol-induced impairment of neural differentiation of neural crest cells by targeting autophagy-related gene 9a,” Exp. Neurol., vol. 320, p. 112981, 2019, doi: 10.1016/j.expneurol.2019.112981.
[5924]	W. T. Kim and W.-J. Kim, “MicroRNAs in prostate cancer,” Prostate Int, vol. 1, no. 1, pp. 3–9, 2013, doi: 10.12954/PI.12011.
[5925]	A. Su, H. Chen, C. He, M. Lei, C. Lei, and P. Wang, “Microscopic Fluorescence Spectral Characteristics of Mixing Ratio of Crude Oil Experiment,” Guang Pu Xue Yu Guang Pu Fen Xi, vol. 36, no. 9, pp. 3039–3046, Sep. 2016.
[5926]	R. B. Moss, H. B. Moss, and R. Peterson, “Microstress, mood, and natural killer-cell activity,” Psychosomatics, vol. 30, no. 3, pp. 279–283, 1989, doi: 10.1016/S0033-3182(89)72272-6.
[5927]	D. Geskus, S. Aravazhi, C. Grivas, K. Wörhoff, and M. Pollnau, “Microstructured KY(WO(4))(2):Gd(3+), Lu(3+), Yb(3+) channel waveguide laser,” Opt Express, vol. 18, no. 9, pp. 8853–8858, Apr. 2010, doi: 10.1364/OE.18.008853.
[5928]	C. Zeiger, I. C. Rodrigues da Silva, M. Mail, M. N. Kavalenka, W. Barthlott, and H. Hölscher, “Microstructures of superhydrophobic plant leaves - inspiration for efficient oil spill cleanup materials,” Bioinspir Biomim, vol. 11, no. 5, p. 056003, 16 2016, doi: 10.1088/1748-3190/11/5/056003.
[5929]	C. S. Simmons, B. C. Petzold, and B. L. Pruitt, “Microsystems for biomimetic stimulation of cardiac cells,” Lab Chip, vol. 12, no. 18, pp. 3235–3248, Sep. 2012, doi: 10.1039/c2lc40308k.
[5930]	N. Tekçe, S. Tuncer, M. Demirci, D. Kara, and C. Baydemir, “Microtensile Bond Strength of CAD/CAM Resin Blocks to Dual-Cure Adhesive Cement: The Effect of Different Sandblasting Procedures,” J Prosthodont, vol. 28, no. 2, pp. e485–e490, Feb. 2019, doi: 10.1111/jopr.12737.
[5931]	R. Abi Hachem, S. Goncalves, T. Walker, and S. Angeli, “Middle ear irrigation using a hydrodebrider decreases biofilm surface area in an animal model of otitis media,” Laryngoscope Investig Otolaryngol, vol. 3, no. 3, pp. 231–237, Jun. 2018, doi: 10.1002/lio2.164.
[5932]	F. Kuzu et al., “Midkine: A Novel Biomarker to Predict Malignancy in Patients with Nodular Thyroid Disease,” Int J Endocrinol, vol. 2016, p. 6035024, 2016, doi: 10.1155/2016/6035024.
[5933]	F. Fasslrinner et al., “Midostaurin abrogates CD33-directed UniCAR and CD33-CD3 bispecific antibody therapy in acute myeloid leukaemia,” Br. J. Haematol., vol. 186, no. 5, pp. 735–740, 2019, doi: 10.1111/bjh.15975.
[5934]	C. Gordon and D. J. Martin, “Mild cognitive impairment,” Expert Rev Neurother, vol. 13, no. 11, pp. 1247–1261, Nov. 2013, doi: 10.1586/14737175.2013.856265.
[5935]	O. L. Lopez, “Mild cognitive impairment,” Continuum (Minneap Minn), vol. 19, no. 2 Dementia, pp. 411–424, Apr. 2013, doi: 10.1212/01.CON.0000429175.29601.97.
[5936]	A. M. Sanford, “Mild Cognitive Impairment,” Clin. Geriatr. Med., vol. 33, no. 3, pp. 325–337, 2017, doi: 10.1016/j.cger.2017.02.005.
[5937]	Q. Wu, J. S. Y. Chan, and J. H. Yan, “Mild cognitive impairment affects motor control and skill learning,” Rev Neurosci, vol. 27, no. 2, pp. 197–217, Feb. 2016, doi: 10.1515/revneuro-2015-0020.
[5938]	M. Poletti, M. Emre, and U. Bonuccelli, “Mild cognitive impairment and cognitive reserve in Parkinson’s disease,” Parkinsonism Relat. Disord., vol. 17, no. 8, pp. 579–586, Sep. 2011, doi: 10.1016/j.parkreldis.2011.03.013.
[5939]	M. H. Connors, D. Ames, M. Woodward, and H. Brodaty, “Mild Cognitive Impairment and Driving Cessation: A 3-Year Longitudinal Study,” Dement Geriatr Cogn Disord, vol. 44, no. 1–2, pp. 63–70, 2017, doi: 10.1159/000478740.
[5940]	D. S. Knopman and R. C. Petersen, “Mild cognitive impairment and mild dementia: a clinical perspective,” Mayo Clin. Proc., vol. 89, no. 10, pp. 1452–1459, Oct. 2014, doi: 10.1016/j.mayocp.2014.06.019.
[5941]	R. A. Barker and C. H. Williams-Gray, “Mild cognitive impairment and Parkinson’s disease--something to remember,” J Parkinsons Dis, vol. 4, no. 4, pp. 651–656, 2014, doi: 10.3233/JPD-140427.
[5942]	S. Jongsiriyanyong and P. Limpawattana, “Mild Cognitive Impairment in Clinical Practice: A Review Article,” Am J Alzheimers Dis Other Demen, vol. 33, no. 8, pp. 500–507, 2018, doi: 10.1177/1533317518791401.
[5943]	E. G. Tangalos and R. C. Petersen, “Mild Cognitive Impairment in Geriatrics,” Clin. Geriatr. Med., vol. 34, no. 4, pp. 563–589, 2018, doi: 10.1016/j.cger.2018.06.005.
[5944]	K. A. Jellinger, “Mild cognitive impairment in Parkinson disease: heterogenous mechanisms,” J Neural Transm (Vienna), vol. 120, no. 1, pp. 157–167, Jan. 2013, doi: 10.1007/s00702-012-0771-5.
[5945]	J. G. Goldman and I. Litvan, “Mild cognitive impairment in Parkinson’s disease,” Minerva Med., vol. 102, no. 6, pp. 441–459, Dec. 2011.
[5946]	A. J. Yarnall, L. Rochester, and D. J. Burn, “Mild cognitive impairment in Parkinson’s disease,” Age Ageing, vol. 42, no. 5, pp. 567–576, Sep. 2013, doi: 10.1093/ageing/aft085.
[5947]	K. Wada and K. Nakashima, “[Mild cognitive impairment in Parkinson’s disease],” Brain Nerve, vol. 64, no. 12, pp. 1365–1375, Dec. 2012.
[5948]	G. Assaf and M. Tanielian, “Mild cognitive impairment in primary care: a clinical review,” Postgrad Med J, vol. 94, no. 1117, pp. 647–652, Nov. 2018, doi: 10.1136/postgradmedj-2018-136035.
[5949]	M. Gallucci et al., “Mild cognitive impairment, from theory to practical intervention: ‘Camminando e leggendo… ricordo’ (Walking and reading… I remember), an action plan. The Treviso Dementia (TREDEM) Registry,” Ann. Ist. Super. Sanita, vol. 52, no. 2, pp. 240–248, Jun. 2016, doi: 10.4415/ANN_16_02_16.
[5950]	S. Ghosh, D. Libon, and C. Lippa, “Mild Cognitive Impairment: A Brief Review and Suggested Clinical Algorithm,” Am J Alzheimers Dis Other Demen, vol. 29, no. 4, pp. 293–302, Jun. 2014, doi: 10.1177/1533317513517040.
[5951]	R. C. Petersen, B. Caracciolo, C. Brayne, S. Gauthier, V. Jelic, and L. Fratiglioni, “Mild cognitive impairment: a concept in evolution,” J. Intern. Med., vol. 275, no. 3, pp. 214–228, Mar. 2014, doi: 10.1111/joim.12190.
[5952]	J. N. Vega and P. A. Newhouse, “Mild cognitive impairment: diagnosis, longitudinal course, and emerging treatments,” Curr Psychiatry Rep, vol. 16, no. 10, p. 490, Oct. 2014, doi: 10.1007/s11920-014-0490-8.
[5953]	A. Ward, H. M. Arrighi, S. Michels, and J. M. Cedarbaum, “Mild cognitive impairment: disparity of incidence and prevalence estimates,” Alzheimers Dement, vol. 8, no. 1, pp. 14–21, Jan. 2012, doi: 10.1016/j.jalz.2011.01.002.
[5954]	G. R. Tabeeva, “[Mild cognitive impairment: what’s next?],” Zh Nevrol Psikhiatr Im S S Korsakova, vol. 119, no. 10, pp. 103–110, 2019, doi: 10.17116/jnevro2019119101103.
[5955]	S. Shimizu and H. Hanyu, “[Mild cognitive impairment],” Nippon Rinsho, vol. 74, no. 3, pp. 455–458, Mar. 2016.
[5956]	A. D. Thames, S. E. Panos, A. Arentoft, D. A. Byrd, C. H. Hinkin, and N. Arbid, “Mild test anxiety influences neurocognitive performance among African Americans and European Americans: identifying interfering and facilitating sources,” Cultur Divers Ethnic Minor Psychol, vol. 21, no. 1, pp. 105–113, Jan. 2015, doi: 10.1037/a0037530.
[5957]	A. Papa, J. Solheim, and C. Lefton, “Military experience talks,” J Emerg Nurs, vol. 39, no. 6, pp. 637–639, Nov. 2013, doi: 10.1016/j.jen.2013.07.011.
[5958]	A. K. Agrawal et al., “Milk-derived exosomes for oral delivery of paclitaxel,” Nanomedicine, vol. 13, no. 5, pp. 1627–1636, 2017, doi: 10.1016/j.nano.2017.03.001.
[5959]	J. Schröders, S. Wall, H. Kusnanto, and N. Ng, “Millennium development goal four and child health inequities in indonesia: a systematic review of the literature,” PLoS ONE, vol. 10, no. 5, p. e0123629, 2015, doi: 10.1371/journal.pone.0123629.
[5960]	S. Piluso et al., “Mimicking the Articular Joint with In Vitro Models,” Trends Biotechnol., vol. 37, no. 10, pp. 1063–1077, 2019, doi: 10.1016/j.tibtech.2019.03.003.
[5961]	V. Zara et al., “Mimivirus-Encoded Nucleotide Translocator VMC1 Targets the Mitochondrial Inner Membrane,” J. Mol. Biol., vol. 430, no. 24, pp. 5233–5245, 07 2018, doi: 10.1016/j.jmb.2018.09.012.
[5962]	E. D. Louis, J. L. Joyce, and S. Cosentino, “Mind the gaps: What we don’t know about cognitive impairment in essential tremor,” Parkinsonism Relat. Disord., vol. 63, pp. 10–19, 2019, doi: 10.1016/j.parkreldis.2019.02.038.
[5963]	G. L. Poerio, P. Totterdell, and E. Miles, “Mind-wandering and negative mood: does one thing really lead to another?,” Conscious Cogn, vol. 22, no. 4, pp. 1412–1421, Dec. 2013, doi: 10.1016/j.concog.2013.09.012.
[5964]	J. E. Boyd, R. A. Lanius, and M. C. McKinnon, “Mindfulness-based treatments for posttraumatic stress disorder: a review of the treatment literature and neurobiological evidence,” J Psychiatry Neurosci, vol. 42, no. 6, p. 170021, Nov. 2017, doi: 10.1503/jpn.170021.
[5965]	Z. Zhu, M. Kimura, and Y. Itokawa, “Mineral status in selenium-deficient rats compared to selenium-sufficient rats fed vitamin-free casein-based or torula yeast-based diet,” Biol Trace Elem Res, vol. 37, no. 2–3, pp. 219–231, Jun. 1993, doi: 10.1007/BF02783797.
[5966]	D. Varon et al., “Minimal atrophy of the entorhinal cortex and hippocampus: progression of cognitive impairment,” Dement Geriatr Cogn Disord, vol. 31, no. 4, pp. 276–283, 2011, doi: 10.1159/000324711.
[5967]	F. Schakowski et al., “Minimal size MIDGE vectors improve transgene expression in vivo,” In Vivo, vol. 21, no. 1, pp. 17–23, Feb. 2007.
[5968]	J. O. Russell, S. I. Noureldine, M. G. Al Khadem, and R. P. Tufano, “Minimally invasive and remote-access thyroid surgery in the era of the 2015 American Thyroid Association guidelines,” Laryngoscope Investig Otolaryngol, vol. 1, no. 6, pp. 175–179, 2016, doi: 10.1002/lio2.36.
[5969]	H. V. Salfity et al., “Minimally Invasive Incision and Drainage Technique in the Treatment of Simple Subcutaneous Abscess in Adults,” Am Surg, vol. 83, no. 7, pp. 699–703, Jul. 2017.
[5970]	L. P. Guiot, R. P. Guillou, and L. M. Déjardin, “Minimally invasive percutaneous medial plate rod osteosynthesis for treatment of bicondylar humeral fractures in dogs: Surgical technique and case report,” Vet Surg, vol. 48, no. S1, pp. O34–O40, Jun. 2019, doi: 10.1111/vsu.13196.
[5971]	J. P. Ritz, M. Stufler, and H. J. Buhr, “[Minimally invasive surgery and the economics of it. Can minimally invasive surgery be cost efficient from a business point of view?],” Chirurg, vol. 78, no. 6, pp. 501–504, 506–510, Jun. 2007, doi: 10.1007/s00104-007-1345-1.
[5972]	D. Christidis, S. McGrath, M. Perera, T. Manning, D. Bolton, and N. Lawrentschuk, “Minimally invasive surgical therapies for benign prostatic hypertrophy: The rise in minimally invasive surgical therapies,” Prostate Int, vol. 5, no. 2, pp. 41–46, Jun. 2017, doi: 10.1016/j.prnil.2017.01.007.
[5973]	B. Guha, A. Gondarenko, and M. Lipson, “Minimizing temperature sensitivity of silicon Mach-Zehnder interferometers,” Opt Express, vol. 18, no. 3, pp. 1879–1887, Feb. 2010, doi: 10.1364/OE.18.001879.
[5974]	K. Frederiksen, P. Tariot, and E. De Jonghe, “Minimum Data Set Plus (MDS+) scores compared with scores from five rating scales,” J Am Geriatr Soc, vol. 44, no. 3, pp. 305–309, Mar. 1996, doi: 10.1111/j.1532-5415.1996.tb00920.x.
[5975]	C. H. Emmerich and C. M. Harris, “Minimum Information and Quality Standards for Conducting, Reporting, and Organizing In Vitro Research,” Handb Exp Pharmacol, vol. 257, pp. 177–196, 2020, doi: 10.1007/164_2019_284.
[5976]	K. Kroenke, “Minor depression: midway between major depression and euthymia,” Ann. Intern. Med., vol. 144, no. 7, pp. 528–530, Apr. 2006, doi: 10.7326/0003-4819-144-7-200604040-00013.
[5977]	J. Ju, J. Jiang, and A. Fesler, “miRNA: the new frontier in cancer medicine,” Future Med Chem, vol. 5, no. 9, pp. 983–985, Jun. 2013, doi: 10.4155/fmc.13.74.
[5978]	M. Erfanian, C. Kartsonaki, and A. Keshavarz, “Misophonia and comorbid psychiatric symptoms: a preliminary study of clinical findings,” Nord J Psychiatry, pp. 1–10, May 2019, doi: 10.1080/08039488.2019.1609086.
[5979]	A. B. Finaret and M. Hutchinson, “Missingness of Height Data from the Demographic and Health Surveys in Africa between 1991 and 2016 Was Not Random but Is Unlikely to Have Major Implications for Biases in Estimating Stunting Prevalence or the Determinants of Child Height,” J. Nutr., vol. 148, no. 5, pp. 781–789, 01 2018, doi: 10.1093/jn/nxy037.
[5980]	K. L. Fulghum et al., “Mitochondria-associated lactate dehydrogenase is not a biologically significant contributor to bioenergetic function in murine striated muscle,” Redox Biol, vol. 24, p. 101177, 2019, doi: 10.1016/j.redox.2019.101177.
[5981]	A. Légiot, C. Céré, T. Dupoiron, M. Kaabouni, N. Camougrand, and S. Manon, “Mitochondria-Associated Membranes (MAMs) are involved in Bax mitochondrial localization and cytochrome c release,” Microb Cell, vol. 6, no. 5, pp. 257–266, Mar. 2019, doi: 10.15698/mic2019.05.678.
[5982]	W.-X. Wang, N. P. Visavadiya, J. D. Pandya, P. T. Nelson, P. G. Sullivan, and J. E. Springer, “Mitochondria-associated microRNAs in rat hippocampus following traumatic brain injury,” Exp. Neurol., vol. 265, pp. 84–93, Mar. 2015, doi: 10.1016/j.expneurol.2014.12.018.
[5983]	A. Saada, “Mitochondria: mitochondrial OXPHOS (dys) function ex vivo--the use of primary fibroblasts,” Int. J. Biochem. Cell Biol., vol. 48, pp. 60–65, Mar. 2014, doi: 10.1016/j.biocel.2013.12.010.
[5984]	V. Zara, A. Ferramosca, P. Robitaille-Foucher, F. Palmieri, and J. C. Young, “Mitochondrial carrier protein biogenesis: role of the chaperones Hsc70 and Hsp90,” Biochem. J., vol. 419, no. 2, pp. 369–375, Apr. 2009, doi: 10.1042/BJ20082270.
[5985]	J. Finsterer and U. Ahting, “Mitochondrial depletion syndromes in children and adults,” Can J Neurol Sci, vol. 40, no. 5, pp. 635–644, Sep. 2013, doi: 10.1017/s0317167100014852.
[5986]	S. Papa, S. Scacco, M. Schliebs, J. Trappe, and P. Seibel, “Mitochondrial diseases and aging,” Mol. Aspects Med., vol. 17, no. 6, pp. 513–563, Dec. 1996, doi: 10.1016/s0098-2997(96)00013-1.
[5987]	S. Papa, “Mitochondrial oxidative phosphorylation changes in the life span. Molecular aspects and physiopathological implications,” Biochim. Biophys. Acta, vol. 1276, no. 2, pp. 87–105, Sep. 1996, doi: 10.1016/0005-2728(96)00077-1.
[5988]	M. Opalińska and C. Meisinger, “Mitochondrial protein import under kinase surveillance,” Microb Cell, vol. 1, no. 2, pp. 51–57, Jan. 2014, doi: 10.15698/mic2014.01.127.
[5989]	L. Galluzzi, O. Kepp, and G. Kroemer, “Mitochondrial regulation of cell death: a phylogenetically conserved control,” Microb Cell, vol. 3, no. 3, pp. 101–108, 23 2016, doi: 10.15698/mic2016.03.483.
[5990]	A. Ferramosca, S. P. Provenzano, L. Coppola, and V. Zara, “Mitochondrial respiratory efficiency is positively correlated with human sperm motility,” Urology, vol. 79, no. 4, pp. 809–814, Apr. 2012, doi: 10.1016/j.urology.2011.12.042.
[5991]	F. Palmieri, F. Bisaccia, V. Iacobazzi, C. Indiveri, and V. Zara, “Mitochondrial substrate carriers,” Biochim. Biophys. Acta, vol. 1101, no. 2, pp. 223–227, Jul. 1992.
[5992]	A. P. Gonçalves and A. Videira, “Mitochondrial type II NAD(P)H dehydrogenases in fungal cell death,” Microb Cell, vol. 2, no. 3, pp. 68–73, Mar. 2015, doi: 10.15698/mic2015.03.192.
[5993]	A. Glucksmann, “MITOSIS AND DEGENERATION IN THE MORPHOGENESIS OF THE HUMAN FOETAL LUNG IN VITRO,” Z Zellforsch Mikrosk Anat, vol. 64, pp. 101–110, Sep. 1964, doi: 10.1007/BF00339189.
[5994]	O. M. Olivo and S. Tagliavini, “[Mitotic activity of fibroblasts cultured in vitro in the hanging drop],” Boll. Soc. Ital. Biol. Sper., vol. 38, pp. 75–78, Jan. 1962.
[5995]	H. Jilaihawi et al., “Mitral annular reduction with subablative therapeutic ultrasound: pre-clinical evaluation of the ReCor device,” EuroIntervention, vol. 6, no. 1, pp. 54–62, May 2010, doi: 10.4244/.
[5996]	A. C. Gittenberger-de Groot and A. C. Wenink, “Mitral atresia. Morphological details,” Br Heart J, vol. 51, no. 3, pp. 252–258, Mar. 1984, doi: 10.1136/hrt.51.3.252.
[5997]	J. L. Quill, A. J. Hill, T. G. Laske, O. Alfieri, and P. A. Iaizzo, “Mitral leaflet anatomy revisited,” J. Thorac. Cardiovasc. Surg., vol. 137, no. 5, pp. 1077–1081, May 2009, doi: 10.1016/j.jtcvs.2008.10.008.
[5998]	J. Roostaei, Y. Zhang, K. Gopalakrishnan, and A. J. Ochocki, “Mixotrophic Microalgae Biofilm: A Novel Algae Cultivation Strategy for Improved Productivity and Cost-efficiency of Biofuel Feedstock Production,” Sci Rep, vol. 8, no. 1, p. 12528, 21 2018, doi: 10.1038/s41598-018-31016-1.
[5999]	J. Y. Lim et al., “MK886-induced apoptosis depends on the 5-LO expression level in human malignant glioma cells,” J. Neurooncol., vol. 97, no. 3, pp. 339–346, May 2010, doi: 10.1007/s11060-009-0036-9.
[6000]	G. Kim, D. Cao, and T. Pawlicki, “MO-B-211-01: Linac-Based IMRT/VMAT Commissioning and QA Program Development,” Med Phys, vol. 39, no. 6Part21, p. 3863, Jun. 2012, doi: 10.1118/1.4735773.
[6001]	M. Casale et al., “Mobile applications in otolaryngology for patients: An update,” Laryngoscope Investig Otolaryngol, vol. 3, no. 6, pp. 434–438, Dec. 2018, doi: 10.1002/lio2.201.
[6002]	D. Schwarz, B. Merget, C. Deane, and S. Fulle, “Modeling conformational flexibility of kinases in inactive states,” Proteins, vol. 87, no. 11, pp. 943–951, 2019, doi: 10.1002/prot.25756.
[6003]	F. S. Boretti, J. H. Baek, A. F. Palmer, D. J. Schaer, and P. W. Buehler, “Modeling hemoglobin and hemoglobin:haptoglobin complex clearance in a non-rodent species-pharmacokinetic and therapeutic implications,” Front Physiol, vol. 5, p. 385, 2014, doi: 10.3389/fphys.2014.00385.
[6004]	J. Koenig, S. J. Theobald, and R. Stripecke, “Modeling Human Cytomegalovirus in Humanized Mice for Vaccine Testing,” Vaccines (Basel), vol. 8, no. 1, Feb. 2020, doi: 10.3390/vaccines8010089.
[6005]	P. M. Holloway and F. N. E. Gavins, “Modeling Ischemic Stroke In Vitro: Status Quo and Future Perspectives,” Stroke, vol. 47, no. 2, pp. 561–569, Feb. 2016, doi: 10.1161/STROKEAHA.115.011932.
[6006]	G. Koch, W. Krzyzanski, J. J. Pérez-Ruixo, and J. Schropp, “Modeling of delays in PKPD: classical approaches and a tutorial for delay differential equations,” J Pharmacokinet Pharmacodyn, vol. 41, no. 4, pp. 291–318, Aug. 2014, doi: 10.1007/s10928-014-9368-y.
[6007]	H. Li, L. Sun, S. Luo, X. Xia, and Q. Lyu, “Modeling Protein Loop Structure by Cyclic Coordinate Descent-based Approach,” J. Comput. Biol., vol. 23, no. 2, pp. 123–136, Feb. 2016, doi: 10.1089/cmb.2015.0145.
[6008]	M. Ernst et al., “Modeling the Optimal Transportation for Acute Stroke Treatment: The Impact of the Drip-and-Drive Paradigm,” Stroke, vol. 51, no. 1, pp. 275–281, 2020, doi: 10.1161/STROKEAHA.119.027493.
[6009]	O. Z. Maniya et al., “Modeling the Potential Economic Impact of the Medicare Comprehensive Care for Joint Replacement Episode-Based Payment Model,” J Arthroplasty, vol. 32, no. 11, pp. 3268-3273.e4, 2017, doi: 10.1016/j.arth.2017.05.054.
[6010]	R. He et al., “Modeling the QSAR of ACE-Inhibitory Peptides with ANN and Its Applied Illustration,” Int J Pept, vol. 2012, p. 620609, 2012, doi: 10.1155/2012/620609.
[6011]	X. Li, G. Chen, and H. Zhu, “Modelling and assessment of accidental oil release from damaged subsea pipelines,” Mar. Pollut. Bull., vol. 123, no. 1–2, pp. 133–141, Oct. 2017, doi: 10.1016/j.marpolbul.2017.09.004.
[6012]	T. Nordam, E. Litzler, J. Skancke, I. Singsaas, F. Leirvik, and Ø. Johansen, “Modelling of oil thickness in the presence of an ice edge,” Mar. Pollut. Bull., vol. 156, p. 111229, Jul. 2020, doi: 10.1016/j.marpolbul.2020.111229.
[6013]	R. Lardner and G. Zodiatis, “Modelling oil plumes from subsurface spills,” Mar. Pollut. Bull., vol. 124, no. 1, pp. 94–101, Nov. 2017, doi: 10.1016/j.marpolbul.2017.07.018.
[6014]	H. W. Berhe, O. D. Makinde, and D. M. Theuri, “Modelling the dynamics of direct and pathogens-induced dysentery diarrhoea epidemic with controls,” J Biol Dyn, vol. 13, no. 1, pp. 192–217, 2019, doi: 10.1080/17513758.2019.1588400.
[6015]	F. Gabsi and T. G. Preuss, “Modelling the impact of the environmental scenario on population recovery from chemical stress exposure: a case study using Daphnia magna,” Aquat. Toxicol., vol. 156, pp. 221–229, Nov. 2014, doi: 10.1016/j.aquatox.2014.09.002.
[6016]	S. P. Coburn and D. W. Townsend, “Modelling vitamin B6 metabolism in rodents (review),” In Vivo, vol. 3, no. 3, pp. 215–223, Jun. 1989.
[6017]	A. A. Al-Sayed, R. U. Agu, and E. Massoud, “Models for the study of nasal and sinus physiology in health and disease: A review of the literature,” Laryngoscope Investig Otolaryngol, vol. 2, no. 6, pp. 398–409, 2017, doi: 10.1002/lio2.117.
[6018]	M. Gujski, J. Pinkas, M. Witczak, A. Owoc, and I. Bojar, “Models of cognitive functions with respect to selected parameters of functional state of the thyroid gland in post-menopausal women,” Endokrynol Pol, vol. 68, no. 3, pp. 290–298, 2017, doi: 10.5603/EP.2017.0022.
[6019]	J. G. Kunkel, “Models of pattern formation in insect oocytes,” In Vivo, vol. 5, no. 5, pp. 443–456, Oct. 1991.
[6020]	F. J. J. Kloostra, R. Arnold, R. Hofman, J. G. M. Burgerhof, and P. van Dijk, “Models to predict positive and negative effects of cochlear implantation on tinnitus,” Laryngoscope Investig Otolaryngol, vol. 4, no. 1, pp. 138–142, Feb. 2019, doi: 10.1002/lio2.224.
[6021]	R. F. Edlich et al., “Modern concepts of treatment and prevention of chemical injuries,” J Long Term Eff Med Implants, vol. 15, no. 3, pp. 303–318, 2005, doi: 10.1615/jlongtermeffmedimplants.v15.i3.70.
[6022]	Y. Sahle, H. Reyes-Centeno, and C. Bentz, “Modern human origins and dispersal: current state of knowledge and future directions,” Evol. Anthropol., vol. 27, no. 2, pp. 64–67, Mar. 2018, doi: 10.1002/evan.21573.
[6023]	J. Hillyer et al., “Modification of Osseointegrated Device Parameters to Improve Speech in Noise and Localization Ability: Clinical Recommendations,” Otol. Neurotol., vol. 37, no. 8, pp. 1084–1091, 2016, doi: 10.1097/MAO.0000000000001127.
[6024]	H. Wang, X. Yang, C. Chen, Y. Huo, B. Wang, and W. Wang, “Modified Heterodigital Neurovascular Island Flap for Sensory Reconstruction of Pulp or Volar Soft Tissue Defect of Digits,” J Hand Surg Am, vol. 45, no. 1, p. 67.e1-67.e8, Jan. 2020, doi: 10.1016/j.jhsa.2019.04.014.
[6025]	H. Wang, X. Yang, C. Chen, B. Wang, W. Wang, and S. Jia, “Modified Littler flap for sensory reconstruction of large thumb pulp defects,” J Hand Surg Eur Vol, vol. 43, no. 5, pp. 546–553, Jun. 2018, doi: 10.1177/1753193417754191.
[6026]	Z. Miao et al., “Modified Posterior Scleral Reinforcement as a Treatment for High Myopia in Children and Its Therapeutic Effect,” Biomed Res Int, vol. 2019, p. 5185780, 2019, doi: 10.1155/2019/5185780.
[6027]	K. Gunasekaran and R. Nussinov, “Modulating functional loop movements: the role of highly conserved residues in the correlated loop motions,” Chembiochem, vol. 5, no. 2, pp. 224–230, Feb. 2004, doi: 10.1002/cbic.200300732.
[6028]	M. Abenoza, J. Raso, R. Oria, and A. C. Sánchez-Gimeno, “Modulating the bitterness of Empeltre olive oil by partitioning polyphenols between oil and water phases: Effect on quality and shelf life,” Food Sci Technol Int, vol. 25, no. 1, pp. 47–55, Jan. 2019, doi: 10.1177/1082013218795803.
[6029]	M. Stojak, P. Kaczara, R. Motterlini, and S. Chlopicki, “Modulation of cellular bioenergetics by CO-releasing molecules and NO-donors inhibits the interaction of cancer cells with human lung microvascular endothelial cells,” Pharmacol. Res., vol. 136, pp. 160–171, 2018, doi: 10.1016/j.phrs.2018.09.005.
[6030]	C. R. Butler et al., “Modulation of epileptogenesis: A paradigm for the integration of enzyme-based microelectrode arrays and optogenetics,” Epilepsy Res., vol. 159, p. 106244, 2020, doi: 10.1016/j.eplepsyres.2019.106244.
[6031]	J.-H. Seo, Y. Tsutsumi, A. Kobari, M. Shimojo, T. Hanawa, and N. Yui, “Modulation of friction dynamics in water by changing the combination of the loop- and graft-type poly(ethylene glycol) surfaces,” Soft Matter, vol. 11, no. 5, pp. 936–942, Feb. 2015, doi: 10.1039/c4sm02082k.
[6032]	A. Sánchez-Cruz et al., “Modulation of GSK-3 provides cellular and functional neuroprotection in the rd10 mouse model of retinitis pigmentosa,” Mol Neurodegener, vol. 13, no. 1, p. 19, 16 2018, doi: 10.1186/s13024-018-0251-y.
[6033]	A. Ferramosca and V. Zara, “Modulation of hepatic steatosis by dietary fatty acids,” World J. Gastroenterol., vol. 20, no. 7, pp. 1746–1755, Feb. 2014, doi: 10.3748/wjg.v20.i7.1746.
[6034]	A. H. Pande, D. Moe, K. N. Nemec, S. Qin, S. Tan, and S. A. Tatulian, “Modulation of human 5-lipoxygenase activity by membrane lipids,” Biochemistry, vol. 43, no. 46, pp. 14653–14666, Nov. 2004, doi: 10.1021/bi048775y.
[6035]	D. Duan et al., “Modulation of Juvenile Hormone Esterase Gene Expression Against Development of Plutella xylostella (Lepidoptera: Plutellidae),” J. Econ. Entomol., vol. 109, no. 2, pp. 865–872, Apr. 2016, doi: 10.1093/jee/tow003.
[6036]	M. C. Petriello, B. J. Newsome, T. D. Dziubla, J. Z. Hilt, D. Bhattacharyya, and B. Hennig, “Modulation of persistent organic pollutant toxicity through nutritional intervention: emerging opportunities in biomedicine and environmental remediation,” Sci. Total Environ., vol. 491–492, pp. 11–16, Sep. 2014, doi: 10.1016/j.scitotenv.2014.01.109.
[6037]	L. Rinyu, E. W. Martin, E. Takahashi, P. Maróti, and C. A. Wraight, “Modulation of the free energy of the primary quinone acceptor (QA) in reaction centers from Rhodobacter sphaeroides: contributions from the protein and protein-lipid(cardiolipin) interactions,” Biochim. Biophys. Acta, vol. 1655, no. 1–3, pp. 93–101, Apr. 2004, doi: 10.1016/j.bbabio.2003.07.012.
[6038]	O. Edling, G. Bao, M. Feelisch, T. Unger, and P. Gohlke, “Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril,” J. Pharmacol. Exp. Ther., vol. 275, no. 2, pp. 854–863, Nov. 1995.
[6039]	J. M. Zdziarski, N. A. Sarich, K. E. Witecki, and J. A. Lednicky, “Molecular analysis of SV-40-CAL, a new slow growing SV-40 strain from the kidney of a caged New World monkey with fatal renal disease,” Virus Genes, vol. 29, no. 2, pp. 183–190, Oct. 2004, doi: 10.1023/B:VIRU.0000036378.42136.7c.
[6040]	L. Huiet, “Molecular analysis of the Neurospora qa-1 regulatory region indicates that two interacting genes control qa gene expression,” Proc. Natl. Acad. Sci. U.S.A., vol. 81, no. 4, pp. 1174–1178, Feb. 1984, doi: 10.1073/pnas.81.4.1174.
[6041]	E. Nürenberg-Goloub et al., “Molecular analysis of the ribosome recycling factor ABCE1 bound to the 30S post-splitting complex,” EMBO J., vol. 39, no. 9, p. e103788, May 2020, doi: 10.15252/embj.2019103788.
[6042]	Y. Mishima, “Molecular and biological control of melanogenesis through tyrosinase genes and intrinsic and extrinsic regulatory factors,” Pigment Cell Res., vol. 7, no. 6, pp. 376–387, Dec. 1994, doi: 10.1111/j.1600-0749.1994.tb00065.x.
[6043]	H. K. Manji and C. A. Zarate, “Molecular and cellular mechanisms underlying mood stabilization in bipolar disorder: implications for the development of improved therapeutics,” Mol. Psychiatry, vol. 7 Suppl 1, pp. S1-7, 2002, doi: 10.1038/sj.mp.4001068.
[6044]	K. Ikeda, T. Oshima, H. Hidaka, and T. Takasaka, “Molecular and clinical implications of loop diuretic ototoxicity,” Hear. Res., vol. 107, no. 1–2, pp. 1–8, May 1997, doi: 10.1016/s0378-5955(97)00009-9.
[6045]	D. K. Kim et al., “Molecular and functional signatures in a novel Alzheimer’s disease mouse model assessed by quantitative proteomics,” Mol Neurodegener, vol. 13, no. 1, p. 2, 16 2018, doi: 10.1186/s13024-017-0234-4.
[6046]	M. J. Soloski, M. Oudshoorn-Snoek, G. Einhorn, and P. Demant, “Molecular basis of Qa-11 antigen and paradoxical Qa-gene expression in an H-2 recombinant,” J. Immunol., vol. 143, no. 9, pp. 3074–3080, Nov. 1989.
[6047]	P. R. Hartig, “Molecular biology of 5-HT receptors,” Trends Pharmacol. Sci., vol. 10, no. 2, pp. 64–69, Feb. 1989, doi: 10.1016/0165-6147(89)90080-1.
[6048]	T. Segawa et al., “Molecular characterization and validation of commercially available methods for haptoglobin measurement in bottlenose dolphin,” Results Immunol, vol. 3, pp. 57–63, 2013, doi: 10.1016/j.rinim.2013.05.003.
[6049]	R. Asselta, M. Robusto, M. Platé, C. Santoro, F. Peyvandi, and S. Duga, “Molecular characterization of 7 patients affected by dys- or hypo-dysfibrinogenemia: Identification of a novel mutation in the fibrinogen Bbeta chain causing a gain of glycosylation,” Thromb. Res., vol. 136, no. 1, pp. 168–174, Jul. 2015, doi: 10.1016/j.thromres.2015.05.007.
[6050]	C. A. Snidal et al., “Molecular Characterization of an SV Capture Site in the Mid-Region of the Presynaptic CaV2.1 Calcium Channel C-Terminal,” Front Cell Neurosci, vol. 12, p. 127, 2018, doi: 10.3389/fncel.2018.00127.
[6051]	I. Kubokawa et al., “Molecular characterization of the 5’-UTR of retinal dystrophin reveals a cryptic intron that regulates translational activity,” Mol. Vis., vol. 16, pp. 2590–2597, Dec. 2010.
[6052]	B. J. Rutledge, “Molecular characterization of the qa-4 gene of Neurospora crassa,” Gene, vol. 32, no. 3, pp. 275–287, Dec. 1984, doi: 10.1016/0378-1119(84)90003-9.
[6053]	S. Liu et al., “Molecular cloning and characterization of a juvenile hormone esterase gene from brown planthopper, Nilaparvata lugens,” J. Insect Physiol., vol. 54, no. 12, pp. 1495–1502, Dec. 2008, doi: 10.1016/j.jinsphys.2008.08.010.
[6054]	F. N. Munyiri and Y. Ishikawa, “Molecular cloning and developmental expression of the gene encoding juvenile hormone esterase in the yellow-spotted longicorn beetle, Psacothea hilaris,” Insect Biochem. Mol. Biol., vol. 37, no. 5, pp. 497–505, May 2007, doi: 10.1016/j.ibmb.2007.02.006.
[6055]	Y. Xu et al., “Molecular cloning, characterization and expression analysis of two juvenile hormone esterase-like carboxylesterase cDNAs in Chinese mitten crab, Eriocheir sinensis,” Comp. Biochem. Physiol. B, Biochem. Mol. Biol., vol. 205, pp. 46–53, Mar. 2017, doi: 10.1016/j.cbpb.2017.01.002.
[6056]	F. Lussana et al., “Molecular Detection of Minimal Residual Disease before Allogeneic Stem Cell Transplantation Predicts a High Incidence of Early Relapse in Adult Patients with NPM1 Positive Acute Myeloid Leukemia,” Cancers (Basel), vol. 11, no. 10, Sep. 2019, doi: 10.3390/cancers11101455.
[6057]	A. Aleksandrov and T. Simonson, “Molecular dynamics simulations show that conformational selection governs the binding preferences of imatinib for several tyrosine kinases,” J. Biol. Chem., vol. 285, no. 18, pp. 13807–13815, Apr. 2010, doi: 10.1074/jbc.M110.109660.
[6058]	L. Vitagliano, A. Ruggiero, C. Pedone, and R. Berisio, “Molecular dynamics studies of the P pilus rod subunit PapA,” J. Pept. Sci., vol. 15, no. 3, pp. 192–199, Mar. 2009, doi: 10.1002/psc.1084.
[6059]	A. C. LeBoeuf et al., “Molecular evolution of juvenile hormone esterase-like proteins in a socially exchanged fluid,” Sci Rep, vol. 8, no. 1, p. 17830, 13 2018, doi: 10.1038/s41598-018-36048-1.
[6060]	C. Mecucci, “Molecular features of primary MDS with cytogenetic changes,” Leuk. Res., vol. 22, no. 4, pp. 293–302, Apr. 1998, doi: 10.1016/s0145-2126(97)00193-8.
[6061]	T. Haferlach, “Molecular genetics in myelodysplastic syndromes,” Leuk. Res., vol. 36, no. 12, pp. 1459–1462, Dec. 2012, doi: 10.1016/j.leukres.2012.08.009.
[6062]	K. Zhao, X. Zhou, and M. Ding, “Molecular insight into mutation-induced conformational change in metastasic bowel cancer BRAF kinase domain and its implications for selective inhibitor design,” J. Mol. Graph. Model., vol. 79, pp. 59–64, 2018, doi: 10.1016/j.jmgm.2017.11.005.
[6063]	R. Suzuki, Y. Inoue, S. Limmatvapirat, I. Murata, and I. Kanamoto, “Molecular interactions of the inclusion complexes of hinokitiol and various cyclodextrins,” AAPS PharmSciTech, vol. 18, no. 7, pp. 2717–2726, Oct. 2017, doi: 10.1208/s12249-017-0748-7.
[6064]	H. Kawasaki, “Molecular investigations of the brain of higher mammals using gyrencephalic carnivore ferrets,” Neurosci. Res., vol. 86, pp. 59–65, Sep. 2014, doi: 10.1016/j.neures.2014.06.006.
[6065]	L. Palomo et al., “Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms,” Blood, Jun. 2020, doi: 10.1182/blood.2019004229.
[6066]	H. Jiang, W. Shao, Y. Wang, R. Xu, L. Zhou, and X. Mu, “Molecular mechanism of D816X mutation-induced c-Kit activation and -mediated inhibitor resistance in gastrointestinal stromal tumor,” J. Mol. Graph. Model., vol. 84, pp. 189–196, 2018, doi: 10.1016/j.jmgm.2018.07.003.
[6067]	F. Wang, M. Deng, J. Xu, X. Zhu, and C. Mao, “Molecular mechanisms of phosphate transport and signaling in higher plants,” Semin. Cell Dev. Biol., vol. 74, pp. 114–122, 2018, doi: 10.1016/j.semcdb.2017.06.013.
[6068]	J. E. Karp, “Molecular pathogenesis and targets for therapy in myelodysplastic syndrome (MDS) and MDS-related leukemias,” Curr Opin Oncol, vol. 10, no. 1, pp. 3–9, Jan. 1998, doi: 10.1097/00001622-199801000-00002.
[6069]	H. Nakajima, “Molecular Pathogenesis and Treatment of Myelodysplastic Syndromes,” Intern. Med., Feb. 2020, doi: 10.2169/internalmedicine.4214-19.
[6070]	X. Zhang, J. E. Lancet, and L. Zhang, “Molecular pathology of myelodysplastic syndromes: new developments and implications for diagnosis and treatment,” Leuk. Lymphoma, vol. 56, no. 11, pp. 3022–3030, 2015, doi: 10.3109/10428194.2015.1037756.
[6071]	L. M. Holdt, A. Kohlmaier, and D. Teupser, “Molecular roles and function of circular RNAs in eukaryotic cells,” Cell. Mol. Life Sci., vol. 75, no. 6, pp. 1071–1098, 2018, doi: 10.1007/s00018-017-2688-5.
[6072]	C. Raimondi, B. Jagla, C. Proux, H. Waxin, S. Gangloff, and B. Arcangioli, “Molecular signature of the imprintosome complex at the mating-type locus in fission yeast,” Microb Cell, vol. 5, no. 4, pp. 169–183, Jan. 2018, doi: 10.15698/mic2018.04.623.
[6073]	Y. Mori and S. Takamori, “Molecular Signatures Underlying Synaptic Vesicle Cargo Retrieval,” Front Cell Neurosci, vol. 11, p. 422, 2017, doi: 10.3389/fncel.2017.00422.
[6074]	M. Brommels, “Money consuming monuments or efficient echelons?--Assessing the economic role of hospitals in national health care systems,” Scand J Soc Med Suppl, vol. 46, pp. 125–132, 1991.
[6075]	H. Zhu, J.-L. Wang, F. Cheng, H. Deng, E.-W. Zhang, and Y.-X. Li, “[Monitoring and evaluation of eco-environmental quality of lake basin regions in Central Yunnan Province, China],” Ying Yong Sheng Tai Xue Bao, vol. 31, no. 4, pp. 1289–1297, Apr. 2020, doi: 10.13287/j.1001-9332.202004.011.
[6076]	“Monitoring and evaluation of preventive chemotherapy,” Wkly. Epidemiol. Rec., vol. 88, no. 2, pp. 17–24, Jan. 2013.
[6077]	M. Lamuraglia et al., “Monitoring Dual VEGF Inhibition in Human Pancreatic Tumor Xenografts With Dynamic Contrast-Enhanced Ultrasound,” Technol. Cancer Res. Treat., vol. 19, p. 1533033819886896, Dec. 2020, doi: 10.1177/1533033819886896.
[6078]	S. Kesen, “Monitoring Fatty Acid and Sterol Profile of Nizip Yaglik Olive Oil Adulterated by Cotton and Sunflower Oil,” J Oleo Sci, vol. 68, no. 9, pp. 817–826, Sep. 2019, doi: 10.5650/jos.ess19130.
[6079]	I. Joo, J. M. Lee, R. Grimm, J. K. Han, and B. I. Choi, “Monitoring Vascular Disrupting Therapy in a Rabbit Liver Tumor Model: Relationship between Tumor Perfusion Parameters at IVIM Diffusion-weighted MR Imaging and Those at Dynamic Contrast-enhanced MR Imaging,” Radiology, vol. 278, no. 1, pp. 104–113, Jan. 2016, doi: 10.1148/radiol.2015141974.
[6080]	N. Akhras and R. A. Blackwood, “Monkey bites: case report and literature review,” Clin Pediatr (Phila), vol. 52, no. 6, pp. 574–576, Jun. 2013, doi: 10.1177/0009922812437033.
[6081]	D. Svob Strac, N. Pivac, I. J. Smolders, W. A. Fogel, P. De Deurwaerdere, and G. Di Giovanni, “Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target Drugs,” Front Neurosci, vol. 10, p. 492, 2016, doi: 10.3389/fnins.2016.00492.
[6082]	I. V. Balyasnikova et al., “Monoclonal Antibodies 1G12 and 6A12 to the N-domain of human angiotensin-converting enzyme: fine epitope mapping and antibody-based detection of ACE inhibitors in human blood,” J. Proteome Res., vol. 6, no. 4, pp. 1580–1594, Apr. 2007, doi: 10.1021/pr060658x.
[6083]	I. V. Balyasnikova et al., “Monoclonal antibodies to native mouse angiotensin-converting enzyme (CD143): ACE expression quantification, lung endothelial cell targeting and gene delivery,” Tissue Antigens, vol. 67, no. 1, pp. 10–29, Jan. 2006, doi: 10.1111/j.1399-0039.2005.00516.x.
[6084]	V. Lummaa and M. Tremblay, “Month of birth predicted reproductive success and fitness in pre-modern Canadian women,” Proc. Biol. Sci., vol. 270, no. 1531, pp. 2355–2361, Nov. 2003, doi: 10.1098/rspb.2003.2507.
[6085]	P. H. Jongbloet, H. M. M. Groenewoud, S. Huber, M. Fieder, and N. Roeleveld, “Month of birth related to fecundity and childlessness among contemporary women,” Hum. Biol., vol. 79, no. 5, pp. 479–490, Oct. 2007, doi: 10.1353/hub.2008.0006.
[6086]	F. Cosci, G. A. Fava, and N. Sonino, “Mood and anxiety disorders as early manifestations of medical illness: a systematic review,” Psychother Psychosom, vol. 84, no. 1, pp. 22–29, 2015, doi: 10.1159/000367913.
[6087]	R. L. Rodríguez et al., “Mood and cognitive changes with deep brain stimulation. What we know and where we should go,” Minerva Med., vol. 96, no. 3, pp. 125–144, Jun. 2005.
[6088]	A. Steptoe and J. Wardle, “Mood and drinking: a naturalistic diary study of alcohol, coffee and tea,” Psychopharmacology (Berl.), vol. 141, no. 3, pp. 315–321, Jan. 1999, doi: 10.1007/s002130050839.
[6089]	J. D. Wardell, J. P. Read, J. J. Curtin, and J. E. Merrill, “Mood and implicit alcohol expectancy processes: predicting alcohol consumption in the laboratory,” Alcohol. Clin. Exp. Res., vol. 36, no. 1, pp. 119–129, Jan. 2012, doi: 10.1111/j.1530-0277.2011.01589.x.
[6090]	E. Laan, W. Everaerd, R. van Berlo, and L. Rijs, “Mood and sexual arousal in women,” Behav Res Ther, vol. 33, no. 4, pp. 441–443, May 1995, doi: 10.1016/0005-7967(94)00059-s.
[6091]	K. Schmeck et al., “Mood changes following acute tryptophan depletion in healthy adults,” Psychopathology, vol. 35, no. 4, pp. 234–240, Aug. 2002, doi: 10.1159/000063827.
[6092]	J. Provenzano, P. Verduyn, N. Daniels, P. Fossati, and P. Kuppens, “Mood congruency effects are mediated by shifts in salience and central executive network efficiency,” Soc Cogn Affect Neurosci, vol. 14, no. 9, pp. 987–995, 30 2019, doi: 10.1093/scan/nsz065.
[6093]	J. Christodoulou and D. M. Burke, “Mood congruity and episodic memory in young children,” J Exp Child Psychol, vol. 142, pp. 221–229, Feb. 2016, doi: 10.1016/j.jecp.2015.09.019.
[6094]	L. Szeifert, S. Hamvas, G. Adorjáni, and M. Novák, “[Mood disorders in patients with chronic kidney disease. Diagnosis, screening and treatment of depression],” Orv Hetil, vol. 150, no. 37, pp. 1723–1730, Sep. 2009, doi: 10.1556/OH.2009.28698.
[6095]	N. Mikita and A. Stringaris, “Mood dysregulation,” Eur Child Adolesc Psychiatry, vol. 22 Suppl 1, pp. S11-16, Feb. 2013, doi: 10.1007/s00787-012-0355-9.
[6096]	S. Yamawaki, G. Okada, Y. Okamoto, and I. Liberzon, “Mood dysregulation and stabilization: perspectives from emotional cognitive neuroscience,” Int. J. Neuropsychopharmacol., vol. 15, no. 5, pp. 681–694, Jun. 2012, doi: 10.1017/S1461145711000757.
[6097]	I. Falkenberg, N. Kohn, R. Schoepker, and U. Habel, “Mood induction in depressive patients: a comparative multidimensional approach,” PLoS ONE, vol. 7, no. 1, p. e30016, 2012, doi: 10.1371/journal.pone.0030016.
[6098]	A. Awad and A. Cipriani, “Mood instability and regulatory oversight: Checkpoints on the pursuit of ‘true’ mood stabilisers,” Aust N Z J Psychiatry, vol. 52, no. 1, pp. 87–88, 2018, doi: 10.1177/0004867417717800.
[6099]	M. A. Basińska, M. Merc, and O. Juraniec, “[Mood of individuals with Graves-Basedow’s disease and Hashimoto’s disease],” Endokrynol Pol, vol. 60, no. 6, pp. 461–468, Dec. 2009.
[6100]	F. Lamers et al., “Mood reactivity and affective dynamics in mood and anxiety disorders,” J Abnorm Psychol, vol. 127, no. 7, pp. 659–669, Oct. 2018, doi: 10.1037/abn0000378.
[6101]	R. Havermans, N. A. Nicolson, J. Berkhof, and M. W. deVries, “Mood reactivity to daily events in patients with remitted bipolar disorder,” Psychiatry Res, vol. 179, no. 1, pp. 47–52, Aug. 2010, doi: 10.1016/j.psychres.2009.10.020.
[6102]	I. Landa, T. J. Bono, and T. English, “Mood regulation and relationship quality predict change in homesickness during college,” Br J Psychol, vol. 111, no. 1, pp. 55–69, Feb. 2020, doi: 10.1111/bjop.12386.
[6103]	A. J. Pereira-Morales, L. P. Casiraghi, A. Adan, and A. Camargo, “Mood rhythmicity is associated with depressive symptoms and caffeinated drinks consumption in South American young adults,” Chronobiol. Int., vol. 36, no. 2, pp. 225–236, 2019, doi: 10.1080/07420528.2018.1530257.
[6104]	J. R. Calabrese et al., “Mood state at study entry as predictor of the polarity of relapse in bipolar disorder,” Biol. Psychiatry, vol. 56, no. 12, pp. 957–963, Dec. 2004, doi: 10.1016/j.biopsych.2004.09.022.
[6105]	Y. Tran, E. Blumgart, and A. Craig, “Mood state sub-types in adults who stutter: A prospective study,” J Fluency Disord, vol. 56, pp. 100–111, 2018, doi: 10.1016/j.jfludis.2017.10.001.
[6106]	Y. Kajita, K. Yoshida, T. Nagai, and T. Wakabayashi, “[Mood States in outpatients with lesional epilepsy at the neurosurgical clinic and improvement in mood States after lamotrigine addiction],” No Shinkei Geka, vol. 41, no. 3, pp. 209–218, Mar. 2013.
[6107]	S. Schuch and I. Koch, “Mood states influence cognitive control: the case of conflict adaptation,” Psychol Res, vol. 79, no. 5, pp. 759–772, Sep. 2015, doi: 10.1007/s00426-014-0602-4.
[6108]	D. J. Safer, “Mood swing and mood stabilizer: how specific are these terms?,” Bipolar Disord, vol. 12, no. 7, pp. 685–690, Nov. 2010, doi: 10.1111/j.1399-5618.2010.00870.x.
[6109]	E. Isometsä, “Mood Zoom could be a promising tool for daily mood variability monitoring, potentially differentiating bipolar from borderline patients,” Evid Based Ment Health, vol. 20, no. 2, p. e9, 2017, doi: 10.1136/eb-2017-102629.
[6110]	L. M. Knott and C. Thorley, “Mood-congruent false memories persist over time,” Cogn Emot, vol. 28, no. 5, pp. 903–912, 2014, doi: 10.1080/02699931.2013.860016.
[6111]	G. Egidi and A. Caramazza, “Mood-dependent integration in discourse comprehension: happy and sad moods affect consistency processing via different brain networks,” Neuroimage, vol. 103, pp. 20–32, Dec. 2014, doi: 10.1016/j.neuroimage.2014.09.008.
[6112]	P. D. Rokke and C. M. Lystad, “Mood-specific effects in the allocation of attention across time,” Cogn Emot, vol. 29, no. 1, pp. 27–50, 2015, doi: 10.1080/02699931.2014.893865.
[6113]	P. Willner, M. Field, K. Pitts, and G. Reeve, “Mood, cue and gender influences on motivation, craving and liking for alcohol in recreational drinkers,” Behav Pharmacol, vol. 9, no. 7, pp. 631–642, Nov. 1998, doi: 10.1097/00008877-199811000-00018.
[6114]	A. L. Goldstein, S. H. Stewart, P. N. S. Hoaken, and G. L. Flett, “Mood, motives, and gambling in young adults: an examination of within- and between-person variations using experience sampling,” Psychol Addict Behav, vol. 28, no. 1, pp. 217–228, Mar. 2014, doi: 10.1037/a0033001.
[6115]	J. B. McClure et al., “Mood, side-effects and smoking outcomes among persons with and without probable lifetime depression taking varenicline,” J Gen Intern Med, vol. 24, no. 5, pp. 563–569, May 2009, doi: 10.1007/s11606-009-0926-8.
[6116]	J. A. Doll et al., “Morbidity and Mortality Conference for Percutaneous Coronary Intervention,” Circ Cardiovasc Qual Outcomes, vol. 10, no. 8, Aug. 2017, doi: 10.1161/CIRCOUTCOMES.116.003538.
[6117]	F. Saad et al., “More than eight years’ hands-on experience with the novel long-acting parenteral testosterone undecanoate,” Asian J. Androl., vol. 9, no. 3, pp. 291–297, May 2007, doi: 10.1111/j.1745-7262.2007.00275.x.
[6118]	P. J. Kilner, G.-Z. Yang, and D. N. Firmin, “Morphodynamics of flow through sinuous curvatures of the heart,” Biorheology, vol. 39, no. 3–4, pp. 409–417, 2002.
[6119]	R. Bartl, B. Frisch, and R. Baumgart, “Morphologic classification of the myelodysplastic syndromes (MDS): combined utilization of bone marrow aspirates and trephine biopsies,” Leuk. Res., vol. 16, no. 1, pp. 15–33, 1992, doi: 10.1016/0145-2126(92)90096-p.
[6120]	M. Deniz, M. Kilinç, and E. S. Hatipoglu, “Morphologic study of left ventricular bands,” Surg Radiol Anat, vol. 26, no. 3, pp. 230–234, Jun. 2004, doi: 10.1007/s00276-003-0212-0.
[6121]	L. Fadei and I. Pop, “MORPHOLOGICAL ALTERATIONS INDUCED IN THE I.O.B. H10 TUMOUR BY ALTERNATIVE IN VIVO AND IN VITRO CULTIVATION,” Rum Med Rev, vol. 7, pp. 65–70, Sep. 1963.
[6122]	A. Pica, S. Scacco, F. Papa, E. De Nitto, and S. Papa, “Morphological and biochemical characterization of mitochondria in Torpedo red blood cells,” Comp. Biochem. Physiol. B, Biochem. Mol. Biol., vol. 128, no. 2, pp. 213–219, Feb. 2001, doi: 10.1016/s1096-4959(00)00312-2.
[6123]	T. Kitamura, H. Suzuki, H. Yokota, E. Watanabe, and J. Yamada, “Morphological changes indicative of brain hemisphere development and handedness in fixed brains and on CT/MRI images,” Okajimas Folia Anat Jpn, vol. 94, no. 1, pp. 7–15, 2017, doi: 10.2535/ofaj.94.7.
[6124]	T. Göpel and C. S. Wirkner, “Morphological description, character conceptualization and the reconstruction of ancestral states exemplified by the evolution of arthropod hearts,” PLoS ONE, vol. 13, no. 9, p. e0201702, 2018, doi: 10.1371/journal.pone.0201702.
[6125]	S. F. Vershinina and A. B. Markochev, “Morphological studies of the metastatic process after LIO-1 tumor transplantation by different methods,” Bull. Exp. Biol. Med., vol. 151, no. 5, pp. 625–626, Sep. 2011, doi: 10.1007/s10517-011-1399-4.
[6126]	J. He and H. E. P. Bazan, “Morphology and neurochemistry of rabbit iris innervation,” Exp. Eye Res., vol. 135, pp. 182–191, Jun. 2015, doi: 10.1016/j.exer.2015.03.005.
[6127]	M. B. Khamar, S. R. Soni, S. V. Mehta, S. Srivastava, and V. A. Vasavada, “Morphology of functioning trabeculectomy blebs using anterior segment optical coherence tomography,” Indian J Ophthalmol, vol. 62, no. 6, pp. 711–714, Jun. 2014, doi: 10.4103/0301-4738.136227.
[6128]	D. Kozłowski, M. Grzybiak, E. Koźluk, and A. Owerczuk, “Morphology of the tendon of Todaro within the human heart in ontogenesis,” Folia Morphol. (Warsz), vol. 59, no. 3, pp. 201–206, 2000.
[6129]	N. Kong, H. Yuan, F. Miao, L. Xie, L. Zhu, and N. Chen, “[Morphology study of mandibular incisive canal in adults based on cone-beam computed tomography],” Zhonghua Kou Qiang Yi Xue Za Zhi, vol. 50, no. 2, pp. 69–73, Feb. 2015.
[6130]	T. L. Thomas, “Mortality among flavour and fragrance chemical plant workers in the United States,” Br J Ind Med, vol. 44, no. 11, pp. 733–737, Nov. 1987, doi: 10.1136/oem.44.11.733.
[6131]	E. Ok et al., “Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study,” Nephrol. Dial. Transplant., vol. 28, no. 1, pp. 192–202, Jan. 2013, doi: 10.1093/ndt/gfs407.
[6132]	L. Folkestad et al., “Mortality and Causes of Death in Patients With Osteogenesis Imperfecta: A Register-Based Nationwide Cohort Study,” J. Bone Miner. Res., vol. 31, no. 12, pp. 2159–2166, 2016, doi: 10.1002/jbmr.2895.
[6133]	L. Folkestad, “Mortality and morbidity in patients with osteogenesis imperfecta in Denmark,” Dan Med J, vol. 65, no. 4, Apr. 2018.
[6134]	C. Goonasekera et al., “Mortality following congenital diaphragmatic hernia repair: the role of anesthesia,” Paediatr Anaesth, vol. 26, no. 12, pp. 1197–1201, Dec. 2016, doi: 10.1111/pan.13008.
[6135]	D. A. Wilson, A. M. Malek, J. L. Wagner, B. B. Wannamaker, and A. W. Selassie, “Mortality in people with epilepsy: A statewide retrospective cohort study,” Epilepsy Res., vol. 122, pp. 7–14, May 2016, doi: 10.1016/j.eplepsyres.2016.01.008.
[6136]	Y. Si, X. Xiao, and H. Sun, “Mortality-specific comorbidity among inpatients with epilepsy: A preliminary cross-sectional study in West China,” Epilepsy Behav, vol. 84, pp. 70–73, 2018, doi: 10.1016/j.yebeh.2018.01.035.
[6137]	F. H. Top, “Mortality, fatality, and morbidity (proper use of terms),” Pediatrics, vol. 50, no. 6, p. 976, Dec. 1972.
[6138]	Z. Pavlík et al., “Mortars with Crushed Lava Granulate for Repair of Damp Historical Buildings,” Materials (Basel), vol. 12, no. 21, Oct. 2019, doi: 10.3390/ma12213557.
[6139]	A. M. Kanner, “Most antidepressant drugs are safe for patients with epilepsy at therapeutic doses: A review of the evidence,” Epilepsy Behav, vol. 61, pp. 282–286, 2016, doi: 10.1016/j.yebeh.2016.03.022.
[6140]	L. E. Brumariu and K. A. Kerns, “Mother-child attachment patterns and different types of anxiety symptoms: is there specificity of relations?,” Child Psychiatry Hum Dev, vol. 41, no. 6, pp. 663–674, Dec. 2010, doi: 10.1007/s10578-010-0195-0.
[6141]	D. Hirjak, K. M. Kubera, F. Sambataro, and R. C. Wolf, “Motor domain in psychotic disorders: the rebirth of a concept,” Eur Arch Psychiatry Clin Neurosci, vol. 270, no. 3, pp. 399–400, Apr. 2020, doi: 10.1007/s00406-019-01036-7.
[6142]	E. Gajewska, E. Barańska, M. Sobieska, and J. Moczko, “Motor performance in the third, not the second month, predicts further motor development,” J Mot Behav, vol. 47, no. 3, pp. 246–255, 2015, doi: 10.1080/00222895.2014.974495.
[6143]	H. Werner, M. Jung, M. Klugmann, M. Sereda, I. R. Griffiths, and K. A. Nave, “Mouse models of myelin diseases,” Brain Pathol., vol. 8, no. 4, pp. 771–793, Oct. 1998, doi: 10.1111/j.1750-3639.1998.tb00200.x.
[6144]	G. S. Roeder and G. R. Fink, “Movement of yeast transposable elements by gene conversion,” Proc. Natl. Acad. Sci. U.S.A., vol. 79, no. 18, pp. 5621–5625, Sep. 1982, doi: 10.1073/pnas.79.18.5621.
[6145]	S. Ohara et al., “Movement-related change of electrocorticographic activity in human supplementary motor area proper,” Brain, vol. 123 ( Pt 6), pp. 1203–1215, Jun. 2000, doi: 10.1093/brain/123.6.1203.
[6146]	T. Pawlicki et al., “Moving from IMRT QA measurements toward independent computer calculations using control charts,” Radiother Oncol, vol. 89, no. 3, pp. 330–337, Dec. 2008, doi: 10.1016/j.radonc.2008.07.002.
[6147]	“Moving Words, Moving Meanings: The Discourse of Population Health,” J Prof Nurs, vol. 35, no. 2, pp. 71–73, Apr. 2019, doi: 10.1016/j.profnurs.2019.02.007.
[6148]	V. Moioli et al., “Mozhaisk haemoglobin variant effects on leukocyte differential channel using the Sysmex XN series,” Clin. Chem. Lab. Med., vol. 57, no. 12, pp. e324–e327, Nov. 2019, doi: 10.1515/cclm-2019-0373.
[6149]	G. Zara, R. Gasparotti, and R. Manara, “MR imaging of peripheral nervous system involvement: Parsonage-Turner syndrome,” J. Neurol. Sci., vol. 315, no. 1–2, pp. 170–171, Apr. 2012, doi: 10.1016/j.jns.2011.11.020.
[6150]	N. Li, C. Liu, W. Bi, X. Lin, H. Jiao, and P. Zhao, “MRCP and 3D LAVA imaging of extrahepatic cholangiocarcinoma at 3 T MRI,” Clin Radiol, vol. 67, no. 6, pp. 579–586, Jun. 2012, doi: 10.1016/j.crad.2011.10.016.
[6151]	M. Artzi, O. Aizenstein, R. Abramovitch, and D. B. Bashat, “MRI multiparametric hemodynamic characterization of the normal brain,” Neuroscience, vol. 240, pp. 269–276, Jun. 2013, doi: 10.1016/j.neuroscience.2013.03.004.
[6152]	H. O. Duarte, D. Freitas, C. Gomes, J. Gomes, A. Magalhães, and C. A. Reis, “Mucin-Type O-Glycosylation in Gastric Carcinogenesis,” Biomolecules, vol. 6, no. 3, 11 2016, doi: 10.3390/biom6030033.
[6153]	J. Kelpin, M. Fahrenkopf, J. Kelley, M. Eichhorn, and M. Martin, “Mucormycosis Osteomyelitis of the Hand,” J Hand Surg Am, vol. 44, no. 5, p. 424.e1-424.e4, May 2019, doi: 10.1016/j.jhsa.2018.04.034.
[6154]	G. Andrisani, A. Papa, L. Guidi, and A. Armuzzi, “Mucosal healing in ulcerative colitis: surveillance or colectomy?,” Ann Gastroenterol, vol. 26, no. 4, p. 355, 2013.
[6155]	R. Sinha et al., “Mucosal injury following short-term tracheal intubation: A novel animal model and composite tracheal injury score,” Laryngoscope Investig Otolaryngol, vol. 3, no. 4, pp. 257–262, Aug. 2018, doi: 10.1002/lio2.168.
[6156]	A. Najafi, K. Koulia, P. Aubert, and C. A. Binkert, “Multi loop snare technique for difficult inferior vena cava filter retrievals,” CVIR Endovasc, vol. 1, no. 1, p. 33, 2018, doi: 10.1186/s42155-018-0042-0.
[6157]	B. Lang, M. S. Kindy, F. A. Kozel, S. K. Schultz, and S. Taheri, “Multi-Parametric Classification of Vascular Cognitive Impairment and Dementia: The Impact of Diverse Cerebrovascular Injury Biomarkers,” J. Alzheimers Dis., vol. 62, no. 1, pp. 39–60, 2018, doi: 10.3233/JAD-170733.
[6158]	K. de Kleer et al., “Multi-phase volcanic resurfacing at Loki Patera on Io,” Nature, vol. 545, no. 7653, pp. 199–202, 10 2017, doi: 10.1038/nature22339.
[6159]	M. Wleklik et al., “Multidimensional Approach to Frailty,” Front Psychol, vol. 11, p. 564, 2020, doi: 10.3389/fpsyg.2020.00564.
[6160]	E. M. García-Granero, L. Piedra-Muñoz, and E. Galdeano-Gómez, “Multidimensional Assessment of Eco-Innovation Implementation: Evidence from Spanish Agri-Food Sector,” Int J Environ Res Public Health, vol. 17, no. 4, 23 2020, doi: 10.3390/ijerph17041432.
[6161]	T. Gagné, J. Lapalme, and D. V. McQueen, “Multidisciplinarity in health promotion: a bibliometric analysis of current research,” Health Promot Int, vol. 33, no. 4, pp. 610–621, Aug. 2018, doi: 10.1093/heapro/dax002.
[6162]	K. Montpetit, T. Palomo, F. H. Glorieux, F. Fassier, and F. Rauch, “Multidisciplinary Treatment of Severe Osteogenesis Imperfecta: Functional Outcomes at Skeletal Maturity,” Arch Phys Med Rehabil, vol. 96, no. 10, pp. 1834–1839, Oct. 2015, doi: 10.1016/j.apmr.2015.06.006.
[6163]	M. Miesner et al., “Multilineage dysplasia (MLD) in acute myeloid leukemia (AML) correlates with MDS-related cytogenetic abnormalities and a prior history of MDS or MDS/MPN but has no independent prognostic relevance: a comparison of 408 cases classified as ‘AML not otherwise specified’ (AML-NOS) or ‘AML with myelodysplasia-related changes’ (AML-MRC),” Blood, vol. 116, no. 15, pp. 2742–2751, Oct. 2010, doi: 10.1182/blood-2010-04-279794.
[6164]	K. G. Weinstock, M. F. Mastrangelo, T. J. Burkett, D. J. Garfinkel, and J. N. Strathern, “Multimeric arrays of the yeast retrotransposon Ty,” Mol. Cell. Biol., vol. 10, no. 6, pp. 2882–2892, Jun. 1990, doi: 10.1128/mcb.10.6.2882.
[6165]	C. Delorme et al., “Multimodal neurometabolic investigation of the effects of Zolpidem on leukoencephalopathy-related apathy,” Eur. J. Neurol., Aug. 2020, doi: 10.1111/ene.14465.
[6166]	X. Yuan and T. Braun, “Multimodal Regulation of Cardiac Myocyte Proliferation,” Circ. Res., vol. 121, no. 3, pp. 293–309, Jul. 2017, doi: 10.1161/CIRCRESAHA.117.308428.
[6167]	A. Y. X. Yu et al., “Multiphase CT angiography increases detection of anterior circulation intracranial occlusion,” Neurology, vol. 87, no. 6, pp. 609–616, Aug. 2016, doi: 10.1212/WNL.0000000000002951.
[6168]	D. Combes, Y. Fedon, J.-P. Toutant, and M. Arpagaus, “Multiple ace genes encoding acetylcholinesterases of Caenorhabditis elegans have distinct tissue expression,” Eur. J. Neurosci., vol. 18, no. 3, pp. 497–512, Aug. 2003, doi: 10.1046/j.1460-9568.2003.02749.x.
[6169]	K. Fujii and M. Fukumoto, “Multiple acrosomal vesicles and their differentiation during spermiogenesis in Ascidia zara and Ascidia gemmata (Ascidiacea, tunicata),” J. Morphol., vol. 242, no. 2, pp. 101–106, Nov. 1999, doi: 10.1002/(SICI)1097-4687(199911)242:2<101::AID-JMOR3>3.0.CO;2-3.
[6170]	C. Zhong et al., “Multiple biomarkers covering distinct pathways for predicting outcomes after ischemic stroke,” Neurology, vol. 92, no. 4, pp. e295–e304, 22 2019, doi: 10.1212/WNL.0000000000006717.
[6171]	Z. Zhu et al., “Multiple biomarkers covering several pathways improve predictive ability for cognitive impairment among ischemic stroke patients with elevated blood pressure,” Atherosclerosis, vol. 287, pp. 30–37, 2019, doi: 10.1016/j.atherosclerosis.2019.05.028.
[6172]	J. Das-Munshi, G. J. Rubin, and S. Wessely, “Multiple chemical sensitivities: A systematic review of provocation studies,” J. Allergy Clin. Immunol., vol. 118, no. 6, pp. 1257–1264, Dec. 2006, doi: 10.1016/j.jaci.2006.07.046.
[6173]	S. Araki, T. Sakai, H. Sato, T. Kaneko, R. Sakai, and K. Yokoyama, “[Multiple chemical sensitivities: case definition, etiology and relations to allergy, poisoning, psychogenic illness etc],” Nihon Koshu Eisei Zasshi, vol. 46, no. 9, pp. 769–778, Sep. 1999.
[6174]	D. I. Bernstein, “Multiple chemical sensitivity: state of the art symposium. The role of chemical allergens,” Regul. Toxicol. Pharmacol., vol. 24, no. 1 Pt 2, pp. S28-31, Aug. 1996, doi: 10.1006/rtph.1996.0073.
[6175]	G. E. Ziem, “Multiple chemical sensitivity: treatment and followup with avoidance and control of chemical exposures,” Toxicol Ind Health, vol. 8, no. 4, pp. 73–86, Aug. 1992.
[6176]	J. F. Cavanagh, A. W. Bismark, M. J. Frank, and J. J. B. Allen, “Multiple Dissociations Between Comorbid Depression and Anxiety on Reward and Punishment Processing: Evidence From Computationally Informed EEG,” Comput Psychiatr, vol. 3, pp. 1–17, Jan. 2019, doi: 10.1162/cpsy_a_00024.
[6177]	M. Battauz, “Multiple Equating of Separate IRT Calibrations,” Psychometrika, Oct. 2016, doi: 10.1007/s11336-016-9517-x.
[6178]	D. Jones, G. Jones, A. Click, M. Rudnicka, and S. Sreekrishna, “Multiple forms of juvenile hormone esterase active sites in the hemolymph of larvae of Trichoplusia ni,” Comp. Biochem. Physiol., B, vol. 85, no. 4, pp. 773–781, 1986, doi: 10.1016/0305-0491(86)90175-6.
[6179]	B. J. Goldstein, R. Choi, and G. M. Goss, “Multiple polycomb epigenetic regulatory proteins are active in normal and regenerating adult olfactory epithelium,” Laryngoscope Investig Otolaryngol, vol. 3, no. 5, pp. 337–344, Oct. 2018, doi: 10.1002/lio2.180.
[6180]	K. Buckenmaier et al., “Multiple Quantum Coherences Hyperpolarized at Ultra-Low Fields,” Chemphyschem, vol. 20, no. 21, pp. 2823–2829, 05 2019, doi: 10.1002/cphc.201900757.
[6181]	G. Cornélissen et al., “Multiple resonances among time structures, chronomes, around and in US. Is an about 1.3-year periodicity in solar wind built into the human cardiovascular chronome?,” Fiziol Cheloveka, vol. 30, no. 2, pp. 86–92, Apr. 2004.
[6182]	N. Rachidi, P. Barre, and B. Blondin, “Multiple Ty-mediated chromosomal translocations lead to karyotype changes in a wine strain of Saccharomyces cerevisiae,” Mol. Gen. Genet., vol. 261, no. 4–5, pp. 841–850, Jun. 1999, doi: 10.1007/s004380050028.
[6183]	L. A. Cope, “Multiple ventricular bands and the associated trabecula septomarginalis dextra in the right ventricle of the domestic dog (Canis familiaris),” Anat Histol Embryol, vol. 48, no. 5, pp. 397–403, Sep. 2019, doi: 10.1111/ahe.12451.
[6184]	M. Traverso et al., “Multiplex real-time PCR for detection of deletions and duplications in dystrophin gene,” Biochem. Biophys. Res. Commun., vol. 339, no. 1, pp. 145–150, Jan. 2006, doi: 10.1016/j.bbrc.2005.11.006.
[6185]	R. Depoux, “[MULTIPLICATION OF RABIES VIRUS FIXED IN DOG SALIVARY GLAND CELLS  CULTIVATED IN VITRO],” C. R. Hebd. Seances Acad. Sci., vol. 257, pp. 2757–2759, Oct. 1963.
[6186]	M. Saleem and L. A. Moe, “Multitrophic microbial interactions for eco- and agro-biotechnological processes: theory and practice,” Trends Biotechnol., vol. 32, no. 10, pp. 529–537, Oct. 2014, doi: 10.1016/j.tibtech.2014.08.002.
[6187]	R. J. W. Vernon, A. D. Gouws, S. J. D. Lawrence, A. R. Wade, and A. B. Morland, “Multivariate Patterns in the Human Object-Processing Pathway Reveal a Shift from Retinotopic to Shape Curvature Representations in Lateral Occipital Areas, LO-1 and LO-2,” J. Neurosci., vol. 36, no. 21, pp. 5763–5774, 25 2016, doi: 10.1523/JNEUROSCI.3603-15.2016.
[6188]	H. K M Tanaka and I. Yokoyama, “Muon radiography and deformation analysis of the lava dome formed by the 1944 eruption of Usu, Hokkaido--contact between high-energy physics and volcano physics--,” Proc. Jpn. Acad., Ser. B, Phys. Biol. Sci., vol. 84, no. 4, pp. 107–116, 2008, doi: 10.2183/pjab.84.107.
[6189]	N. A. Wilski, C. Del Casale, T. J. Purwin, A. E. Aplin, and C. M. Snyder, “Murine Cytomegalovirus Infection of Melanoma Lesions Delays Tumor Growth by Recruiting and Repolarizing Monocytic Phagocytes in the Tumor,” J. Virol., vol. 93, no. 20, 15 2019, doi: 10.1128/JVI.00533-19.
[6190]	L. N. Veilleux, P. Trejo, and F. Rauch, “Muscle abnormalities in osteogenesis imperfecta,” J Musculoskelet Neuronal Interact, vol. 17, no. 2, pp. 1–7, 01 2017.
[6191]	D. D. Streeter and C. Ramon, “Muscle pathway geometry in the heart wall,” J Biomech Eng, vol. 105, no. 4, pp. 367–373, Nov. 1983, doi: 10.1115/1.3138434.
[6192]	T. Sousa, V. Bompadre, and K. K. White, “Musculoskeletal functional outcomes in children with osteogenesis imperfecta: associations with disease severity and pamidronate therapy,” J Pediatr Orthop, vol. 34, no. 1, pp. 118–122, Jan. 2014, doi: 10.1097/BPO.0b013e3182a006a0.
[6193]	F. H. Rauscher, G. L. Shaw, and K. N. Ky, “Music and spatial task performance,” Nature, vol. 365, no. 6447, p. 611, Oct. 1993, doi: 10.1038/365611a0.
[6194]	S. Pittman and S. Kridli, “Music intervention and preoperative anxiety: an integrative review,” Int Nurs Rev, vol. 58, no. 2, pp. 157–163, Jun. 2011, doi: 10.1111/j.1466-7657.2011.00888.x.
[6195]	I. Peyre et al., “Music Restores Propriospinal Excitation During Stroke Locomotion,” Front Syst Neurosci, vol. 14, p. 17, 2020, doi: 10.3389/fnsys.2020.00017.
[6196]	V. Putkinen, T. Makkonen, and T. Eerola, “Music-induced positive mood broadens the scope of auditory attention,” Soc Cogn Affect Neurosci, vol. 12, no. 7, pp. 1159–1168, 01 2017, doi: 10.1093/scan/nsx038.
[6197]	M. Bukhtiyarova, M. Karpusas, K. Northrop, H. V. M. Namboodiri, and E. B. Springman, “Mutagenesis of p38alpha MAP kinase establishes key roles of Phe169 in function and structural dynamics and reveals a novel DFG-OUT state,” Biochemistry, vol. 46, no. 19, pp. 5687–5696, May 2007, doi: 10.1021/bi0622221.
[6198]	M. Franssen and J. Moutschen, “Mutagenicity of N-methylnitrosourea (NMU) and N-ethyl nitrosourea (NEU) in the moss Pogonatum aloides (Hedw.) P. Beauv,” Mutat. Res., vol. 16, no. 2, pp. 141–150, Oct. 1972, doi: 10.1016/0027-5107(72)90174-1.
[6199]	B. B. Pal and S. P. Bhunya, “Mutagenicity testing of a rodenticide, zinctox (zinc phosphide) in a mouse in vivo system,” In Vivo, vol. 9, no. 1, pp. 81–83, Feb. 1995.
[6200]	L. Zhytnik, K. Maasalu, E. Reimann, E. Prans, S. Kõks, and A. Märtson, “Mutational analysis of COL1A1 and COL1A2 genes among Estonian osteogenesis imperfecta patients,” Hum. Genomics, vol. 11, no. 1, p. 19, 15 2017, doi: 10.1186/s40246-017-0115-5.
[6201]	P. Nilsson, S. Naureckiene, and B. E. Uhlin, “Mutations affecting mRNA processing and fimbrial biogenesis in the Escherichia coli pap operon,” J. Bacteriol., vol. 178, no. 3, pp. 683–690, Feb. 1996, doi: 10.1128/jb.178.3.683-690.1996.
[6202]	F. Winston, D. T. Chaleff, B. Valent, and G. R. Fink, “Mutations affecting Ty-mediated expression of the HIS4 gene of Saccharomyces cerevisiae,” Genetics, vol. 107, no. 2, pp. 179–197, Jun. 1984.
[6203]	C. Bessou, J. B. Giugia, C. J. Franks, L. Holden-Dye, and L. Ségalat, “Mutations in the Caenorhabditis elegans dystrophin-like gene dys-1 lead to hyperactivity and suggest a link with cholinergic transmission,” Neurogenetics, vol. 2, no. 1, pp. 61–72, Dec. 1998, doi: 10.1007/s100480050053.
[6204]	J. Giugia, K. Gieseler, M. Arpagaus, and L. Ségalat, “Mutations in the dystrophin-like dys-1 gene of Caenorhabditis elegans result in reduced acetylcholinesterase activity,” FEBS Lett., vol. 463, no. 3, pp. 270–272, Dec. 1999, doi: 10.1016/s0014-5793(99)01651-8.
[6205]	K. Sugimoto et al., “Mutations of the p53 gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia,” Blood, vol. 81, no. 11, pp. 3022–3026, Jun. 1993.
[6206]	K. T. Rew, “Myalgias and Myopathies: Foreword,” FP Essent, vol. 440, p. 2, Jan. 2016.
[6207]	L. C. Werneck, F. M. Cunha, and R. H. Scola, “Myasthenia gravis: a retrospective study comparing thymectomy to conservative treatment,” Acta Neurol. Scand., vol. 101, no. 1, pp. 41–46, Jan. 2000.
[6208]	E. Jacobs, “Mycoplasma pneumoniae: now in the focus of clinicians and epidemiologists,” Euro Surveill., vol. 17, no. 6, Feb. 2012.
[6209]	L. Stipkovits and I. Kempf, “Mycoplasmoses in poultry,” Rev. - Off. Int. Epizoot., vol. 15, no. 4, pp. 1495–1525, Dec. 1996, doi: 10.20506/rst.15.4.986.
[6210]	S. Camagni et al., “Mycotic aneurysm of the hepatic artery in pediatric liver transplantation: A case series and literature review,” Transpl Infect Dis, vol. 20, no. 3, p. e12861, Jun. 2018, doi: 10.1111/tid.12861.
[6211]	S. Giannouli, T. Kanellopoulou, and M. Voulgarelis, “Myelodysplasia and autoimmunity,” Curr Opin Rheumatol, vol. 24, no. 1, pp. 97–102, Jan. 2012, doi: 10.1097/BOR.0b013e32834db4ee.
[6212]	S. Thota and A. T. Gerds, “Myelodysplastic and myeloproliferative neoplasms: updates on the overlap syndromes,” Leuk. Lymphoma, vol. 59, no. 4, pp. 803–812, 2018, doi: 10.1080/10428194.2017.1357179.
[6213]	H. H. Niller, “Myelodysplastic syndrome (MDS) as a late stage of subclinical hemophagocytic lymphohistiocytosis (HLH): a putative role for Leptospira infection. A hypothesis,” Acta Microbiol Immunol Hung, vol. 57, no. 3, pp. 181–189, Sep. 2010, doi: 10.1556/AMicr.57.2010.3.3.
[6214]	J. Li, “Myelodysplastic syndrome hematopoietic stem cell,” Int. J. Cancer, vol. 133, no. 3, pp. 525–533, Aug. 2013, doi: 10.1002/ijc.27896.
[6215]	E. Margolskee et al., “Myelodysplastic Syndrome, Unclassifiable (MDS-U) With 1% Blasts Is a Distinct Subgroup of MDS-U With a Poor Prognosis,” Am. J. Clin. Pathol., vol. 148, no. 1, pp. 49–57, Jul. 2017, doi: 10.1093/ajcp/aqx043.
[6216]	P. L. Greenberg, N. S. Young, and N. Gattermann, “Myelodysplastic syndromes,” Hematology Am Soc Hematol Educ Program, pp. 136–161, 2002, doi: 10.1182/asheducation-2002.1.136.
[6217]	C. Sultan, M. Imbert, H. Jouault, and J. Y. Scoazec, “Myelodysplastic syndromes,” Acta Haematol., vol. 78 Suppl 1, pp. 91–93, 1987, doi: 10.1159/000205910.
[6218]	T. Braun and P. Fenaux, “Myelodysplastic Syndromes (MDS) and autoimmune disorders (AD): cause or consequence?,” Best Pract Res Clin Haematol, vol. 26, no. 4, pp. 327–336, Dec. 2013, doi: 10.1016/j.beha.2013.09.003.
[6219]	A. Schmitt-Graeff, D. Mattern, H. Köhler, J. Hezel, and M. Lübbert, “[Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis],” Pathologe, vol. 21, no. 1, pp. 1–15, Jan. 2000, doi: 10.1007/s002920050001.
[6220]	M. Kizaki, “[Myelodysplastic syndromes (MDS)],” Nippon Rinsho, vol. 72, no. 6, pp. 1079–1086, Jun. 2014.
[6221]	R. Bejar, “Myelodysplastic Syndromes Diagnosis: What Is the Role of Molecular Testing?,” Curr Hematol Malig Rep, vol. 10, no. 3, pp. 282–291, Sep. 2015, doi: 10.1007/s11899-015-0270-5.
[6222]	J. D. Troy, E. Atallah, J. T. Geyer, and W. Saber, “Myelodysplastic syndromes in the United States: an update for clinicians,” Ann. Med., vol. 46, no. 5, pp. 283–289, Aug. 2014, doi: 10.3109/07853890.2014.898863.
[6223]	D. P. Steensma, “Myelodysplastic Syndromes: Diagnosis and Treatment,” Mayo Clin. Proc., vol. 90, no. 7, pp. 969–983, Jul. 2015, doi: 10.1016/j.mayocp.2015.04.001.
[6224]	M. Becha and N. Braham Jmili, “[Myelodysplastic syndromes: pathophysiology, clinical and biological features],” Ann. Biol. Clin. (Paris), vol. 73, no. 6, pp. 643–656, Dec. 2015, doi: 10.1684/abc.2015.1104.
[6225]	A. M. Zeidan, B. Faltas, B. Douglas Smith, and S. Gore, “Myelodysplastic syndromes: what do hospitalists need to know?,” J Hosp Med, vol. 8, no. 6, pp. 351–357, Jun. 2013, doi: 10.1002/jhm.2049.
[6226]	R. M. Shallis and A. M. Zeidan, “Myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U): More than just a ‘catch-all’ term?,” Best Pract Res Clin Haematol, vol. 33, no. 2, p. 101132, 2020, doi: 10.1016/j.beha.2019.101132.
[6227]	E. Hyjek and J. W. Vardiman, “Myelodysplastic/myeloproliferative neoplasms,” Semin Diagn Pathol, vol. 28, no. 4, pp. 283–297, Nov. 2011, doi: 10.1053/j.semdp.2011.07.002.
[6228]	S. Chaouch and G. Noctor, “Myo-inositol abolishes salicylic acid-dependent cell death and pathogen defence responses triggered by peroxisomal hydrogen peroxide,” New Phytol., vol. 188, no. 3, pp. 711–718, Nov. 2010, doi: 10.1111/j.1469-8137.2010.03453.x.
[6229]	C. Kröger, J. Stolz, and T. M. Fuchs, “myo-Inositol transport by Salmonella enterica serovar Typhimurium,” Microbiology (Reading), vol. 156, no. Pt 1, pp. 128–138, Jan. 2010, doi: 10.1099/mic.0.032250-0.
[6230]	J. Narula and H. W. Strauss, “Myo-Myo: Yes, papa. Eating sugar? No, papa! Modulating the myocardial menu for imaging coronary inflammation..,” Eur. J. Nucl. Med. Mol. Imaging, vol. 38, no. 11, pp. 2014–2017, Nov. 2011, doi: 10.1007/s00259-011-1896-8.
[6231]	J. D. Sink, R. C. Hill, D. E. Attarian, and A. S. Wechsler, “Myocardial blood flow and oxygen consumption in the empty-beating, fibrillating, and potassium-arrested hypertrophied canine heart,” Ann. Thorac. Surg., vol. 35, no. 4, pp. 372–379, Apr. 1983, doi: 10.1016/s0003-4975(10)61587-1.
[6232]	C. P. Adler and H. Friedburg, “Myocardial DNA content, ploidy level and cell number in geriatric hearts: post-mortem examinations of human myocardium in old age,” J. Mol. Cell. Cardiol., vol. 18, no. 1, pp. 39–53, Jan. 1986, doi: 10.1016/s0022-2828(86)80981-6.
[6233]	D. A. Wilson, B. B. Wannamaker, A. M. Malek, and A. W. Selassie, “Myocardial infarction after epilepsy onset: A population-based retrospective cohort study,” Epilepsy Behav, vol. 88, pp. 181–188, 2018, doi: 10.1016/j.yebeh.2018.09.009.
[6234]	A. A. Demin and V. P. Drobysheva, “[Myocardial infarction in patients with infectious endocarditis],” Kardiologiia, vol. 44, no. 1, pp. 4–9, 2004.
[6235]	C. L. Wainwright, “Myocardial preconditioning as the heart’s self-protecting response against the consequences of ischaemia,” Trends Pharmacol. Sci., vol. 13, no. 3, pp. 90–93, Mar. 1992, doi: 10.1016/0165-6147(92)90033-3.
[6236]	S. Yamashita et al., “Myocardial wall thinning predicts transmural substrate in patients with scar-related ventricular tachycardia,” Heart Rhythm, vol. 14, no. 2, pp. 155–163, 2017, doi: 10.1016/j.hrthm.2016.11.012.
[6237]	F. Schrub, F. Schnell, E. Donal, and E. Galli, “Myocardial work is a predictor of exercise tolerance in patients with dilated cardiomyopathy and left ventricular dyssynchrony,” Int J Cardiovasc Imaging, vol. 36, no. 1, pp. 45–53, Jan. 2020, doi: 10.1007/s10554-019-01689-4.
[6238]	M. Balter, “Mysteries of the brain. Why are our brains so big?,” Science, vol. 338, no. 6103, pp. 33–34, Oct. 2012, doi: 10.1126/science.338.6103.33.
[6239]	F. J. Zara, A. L. Diogo Reigada, L. F. Domingues Passero, and M. H. Toyama, “Myzobdella platensis (Hirundinida: Piscicolidae) is true parasite of blue crabs (Crustacea: Portunidae),” J. Parasitol., vol. 95, no. 1, pp. 124–128, Feb. 2009, doi: 10.1645/GE-1616.1.
[6240]	P. A. Deddish, B. Marcic, H. L. Jackman, H. Z. Wang, R. A. Skidgel, and E. G. Erdös, “N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE,” Hypertension, vol. 31, no. 4, pp. 912–917, Apr. 1998, doi: 10.1161/01.hyp.31.4.912.
[6241]	X. Ju, Y. Qiao, Z. Gao, and L. Kong, “N’-Cyclo-hexyl-idenebenzohydrazide,” Acta Crystallogr Sect E Struct Rep Online, vol. 66, no. Pt 1, p. o94, Dec. 2009, doi: 10.1107/S1600536809052143.
[6242]	A. Bertini et al., “Na(+), K(+), Cl(-), acid-base or H2O homeostasis in children with urinary tract infections: a narrative review,” Pediatr. Nephrol., vol. 31, no. 9, pp. 1403–1409, 2016, doi: 10.1007/s00467-015-3273-5.
[6243]	M. W. Ma et al., “NADPH oxidase in brain injury and neurodegenerative disorders,” Mol Neurodegener, vol. 12, no. 1, p. 7, 17 2017, doi: 10.1186/s13024-017-0150-7.
[6244]	K. Belarbi, E. Cuvelier, A. Destée, B. Gressier, and M.-C. Chartier-Harlin, “NADPH oxidases in Parkinson’s disease: a systematic review,” Mol Neurodegener, vol. 12, no. 1, p. 84, Nov. 2017, doi: 10.1186/s13024-017-0225-5.
[6245]	T. O’Rourke and R. de Diego Balaguer, “Names and their meanings: A dual-process account of proper-name encoding and retrieval,” Neurosci Biobehav Rev, vol. 108, pp. 308–321, 2020, doi: 10.1016/j.neubiorev.2019.11.005.
[6246]	C. Semenza, “Naming with proper names: the left temporal pole theory,” Behav Neurol, vol. 24, no. 4, pp. 277–284, 2011, doi: 10.3233/BEN-2011-0338.
[6247]	F. Nasser, J. Constantinou, and I. Lynch, “Nanomaterials in the Environment Acquire an ‘Eco-Corona’ Impacting their Toxicity to Daphnia Magna-a Call for Updating Toxicity Testing Policies,” Proteomics, vol. 20, no. 9, p. e1800412, 2020, doi: 10.1002/pmic.201800412.
[6248]	M. Paranjpe and C. C. Müller-Goymann, “Nanoparticle-mediated pulmonary drug delivery: a review,” Int J Mol Sci, vol. 15, no. 4, pp. 5852–5873, Apr. 2014, doi: 10.3390/ijms15045852.
[6249]	S. An and W. Jhe, “Nanopipette/Nanorod-Combined Quartz Tuning Fork−Atomic Force Microscope,” Sensors (Basel), vol. 19, no. 8, Apr. 2019, doi: 10.3390/s19081794.
[6250]	M. Shiota, T. Kamigaki, R. Wakui, Y. Ito, Y. Nishino, and A. Miyazawa, “Nanostructured Fat Crystal and Solid Fat Content Effects on the Physical Properties of Water-in-Oil Semisolid Fat Blends,” J Oleo Sci, vol. 67, no. 7, pp. 829–837, 2018, doi: 10.5650/jos.ess17205.
[6251]	J. Yin et al., “Naringenin induces laxative effects by upregulating the expression levels of c-Kit and SCF, as well as those of aquaporin 3 in mice with loperamide-induced constipation,” Int. J. Mol. Med., vol. 41, no. 2, pp. 649–658, Feb. 2018, doi: 10.3892/ijmm.2017.3301.
[6252]	J. E. Holt and G. R. Holt, “Nasolacrimal evaluation and surgery,” Otolaryngol. Clin. North Am., vol. 21, no. 1, pp. 119–134, Feb. 1988.
[6253]	S. Tabtabai, D. DeFaria Yeh, A. Stefanescu, K. Kennedy, R. W. Yeh, and A. B. Bhatt, “National Trends in Hospitalizations for Patients With Single-Ventricle Anatomy,” Am. J. Cardiol., vol. 116, no. 5, pp. 773–778, Sep. 2015, doi: 10.1016/j.amjcard.2015.05.053.
[6254]	“Nationwide rubella epidemic in Japan, 2013,” Wkly. Epidemiol. Rec., vol. 88, no. 24, pp. 251–256, Jun. 2013.
[6255]	M. Monroy-Cuadros, A. Salazar, S. Yilmaz, and K. McLaughlin, “Native arteriovenous fistulas: correlation of intra-access blood flow with characteristics of stenoses found during diagnostic angiography,” Semin Dial, vol. 21, no. 1, pp. 89–92, Feb. 2008, doi: 10.1111/j.1525-139X.2007.00386.x.
[6256]	D. Ekstein and S. C. Schachter, “Natural Products in Epilepsy-the Present Situation and Perspectives for the Future,” Pharmaceuticals (Basel), vol. 3, no. 5, pp. 1426–1445, May 2010, doi: 10.3390/ph3051426.
[6257]	L. Marino and P. R. Hof, “Nature’s experiments in brain diversity,” Anat Rec A Discov Mol Cell Evol Biol, vol. 287, no. 1, pp. 997–1000, Nov. 2005, doi: 10.1002/ar.a.20261.
[6258]	J. H. Yoon et al., “Navigated three-dimensional T1-weighted gradient-echo sequence for gadoxetic acid liver magnetic resonance imaging in patients with limited breath-holding capacity,” Abdom Imaging, vol. 40, no. 2, pp. 278–288, Feb. 2015, doi: 10.1007/s00261-014-0214-x.
[6259]	M. T. Craig and C. J. McBain, “Navigating the circuitry of the brain’s GPS system: Future challenges for neurophysiologists,” Hippocampus, vol. 25, no. 6, pp. 736–743, Jun. 2015, doi: 10.1002/hipo.22456.
[6260]	R. A. Holland, K. Thorup, M. J. Vonhof, W. W. Cochran, and M. Wikelski, “Navigation: bat orientation using Earth’s magnetic field,” Nature, vol. 444, no. 7120, p. 702, Dec. 2006, doi: 10.1038/444702a.
[6261]	S. Hong, J. Lee, and S. Lim, “Navigational threats by derelict fishing gear to navy ships in the Korean seas,” Mar. Pollut. Bull., vol. 119, no. 2, pp. 100–105, Jun. 2017, doi: 10.1016/j.marpolbul.2017.04.006.
[6262]	H. Wang, P. Zhu, Y. Zhang, K. Sun, and Z. Lu, “ndpT encodes a new protein involved in nicotine catabolism by Sphingomonas melonis TY,” Appl. Microbiol. Biotechnol., vol. 102, no. 23, pp. 10171–10181, Dec. 2018, doi: 10.1007/s00253-018-9371-0.
[6263]	K. Kakumoto, K. Harada, Y. Sankoda, S. Taniguchi, and K. Fukuyama, “Near-infrared spectroscopy cerebral oximetry as a predictor of neurological intolerance during carotid artery stenting with proximal protection,” J Clin Neurosci, vol. 58, pp. 89–93, Dec. 2018, doi: 10.1016/j.jocn.2018.09.034.
[6264]	M. Heib, S. Rose-John, and D. Adam, “Necroptosis, ADAM proteases and intestinal (dys)function,” Int Rev Cell Mol Biol, vol. 353, pp. 83–152, 2020, doi: 10.1016/bs.ircmb.2020.02.001.
[6265]	E. J. Kim, S. Chotai, K. R. Archer, M. Bydon, A. L. Asher, and C. J. Devin, “Need for Two-Year Patient-Reported Outcomes Score for Lumbar Spine Surgery Is Procedure-Specific: Analysis From a Prospective Longitudinal Spine Registry,” Spine, vol. 42, no. 17, pp. 1331–1338, Sep. 2017, doi: 10.1097/BRS.0000000000002087.
[6266]	E. M. Scheiderer, T. Wang, R. L. Tomko, P. K. Wood, and T. J. Trull, “Negative Affect Instability among Individuals with Comorbid Borderline Personality Disorder and Posttraumatic Stress Disorder,” Clin Psychol Sci, vol. 4, no. 1, pp. 67–81, Jan. 2016, doi: 10.1177/2167702615573214.
[6267]	R. Nogueiras et al., “Negative energy balance and leptin regulate neuromedin-U expression in the rat pars tuberalis,” J. Endocrinol., vol. 190, no. 2, pp. 545–553, Aug. 2006, doi: 10.1677/joe.1.06577.
[6268]	M. Irrmischer, C. N. van der Wal, H. D. Mansvelder, and K. Linkenkaer-Hansen, “Negative mood and mind wandering increase long-range temporal correlations in attention fluctuations,” PLoS ONE, vol. 13, no. 5, p. e0196907, 2018, doi: 10.1371/journal.pone.0196907.
[6269]	K. A. Perkins, J. L. Karelitz, G. E. Giedgowd, and C. A. Conklin, “Negative mood effects on craving to smoke in women versus men,” Addict Behav, vol. 38, no. 2, pp. 1527–1531, Feb. 2013, doi: 10.1016/j.addbeh.2012.06.002.
[6270]	A. Guhn, B. Steinacher, A. Merkl, P. Sterzer, and S. Köhler, “Negative mood induction: Affective reactivity in recurrent, but not persistent depression,” PLoS ONE, vol. 14, no. 1, p. e0208616, 2019, doi: 10.1371/journal.pone.0208616.
[6271]	J. Yuan, J. Chen, J. Yang, E. Ju, G. J. Norman, and N. Ding, “Negative mood state enhances the susceptibility to unpleasant events: neural correlates from a music-primed emotion classification task,” PLoS ONE, vol. 9, no. 2, p. e89844, 2014, doi: 10.1371/journal.pone.0089844.
[6272]	S. Aizawa, I. Sakata, M. Nagasaka, Y. Higaki, and T. Sakai, “Negative regulation of neuromedin U mRNA expression in the rat pars tuberalis by melatonin,” PLoS ONE, vol. 8, no. 7, p. e67118, 2013, doi: 10.1371/journal.pone.0067118.
[6273]	B. Muschalla, “Negative work perception not changed in a short work-anxiety-coping group therapy intervention,” Int J Occup Environ Health, vol. 22, no. 4, pp. 321–324, 2016, doi: 10.1080/10773525.2016.1238663.
[6274]	S. Kılınç, C. Campbell, A. Guy, and A. van Wersch, “Negotiating the boundaries of the medical model: Experiences of people with epilepsy,” Epilepsy Behav, vol. 102, p. 106674, 2020, doi: 10.1016/j.yebeh.2019.106674.
[6275]	C.-D. Zhang, Y.-J. Zeng, H.-W. Li, Z.-M. Zhao, J.-K. Zhang, and D.-Q. Dai, “Neoadjuvant chemotherapy for nonmetastatic esophago-gastric adenocarcinomas: a systematic review and meta-analysis,” Cancer Invest., vol. 31, no. 6, pp. 421–431, Jul. 2013, doi: 10.3109/07357907.2013.802801.
[6276]	F. Leal et al., “Neoadjuvant endocrine therapy for resectable breast cancer: A systematic review and meta-analysis,” Breast, vol. 24, no. 4, pp. 406–412, Aug. 2015, doi: 10.1016/j.breast.2015.03.004.
[6277]	A. Vassileva, D. van Blooijs, F. Leijten, and G. Huiskamp, “Neocortical electrical stimulation for epilepsy: Closed-loop versus open-loop,” Epilepsy Res., vol. 141, pp. 95–101, 2018, doi: 10.1016/j.eplepsyres.2018.02.010.
[6278]	K. Yazawa, “Neonatal encephalopathy and cerebral palsy,” J Nippon Med Sch, vol. 72, no. 2, pp. 85–88, Apr. 2005, doi: 10.1272/jnms.72.85.
[6279]	D. Federici, S. Marcora, R. Trezzi, and L. Galletti, “Neonatal intrapericardial teratoma,” J Card Surg, vol. 33, no. 5, pp. 296–297, May 2018, doi: 10.1111/jocs.13571.
[6280]	K. Iwayama and M. Eishima, “Neonatal sucking behaviour and its development until 14 months,” Early Hum. Dev., vol. 47, no. 1, pp. 1–9, Jan. 1997, doi: 10.1016/s0378-3782(96)01750-1.
[6281]	M. Arslan et al., “Nerve root to lumbar disc relationships at the intervertebral foramen from a surgical viewpoint: An anatomical study,” Clin Anat, vol. 25, no. 2, pp. 218–223, Mar. 2012, doi: 10.1002/ca.21213.
[6282]	S. Beltran et al., “Network approach identifies Pacer as an autophagy protein involved in ALS pathogenesis,” Mol Neurodegener, vol. 14, no. 1, p. 14, 27 2019, doi: 10.1186/s13024-019-0313-9.
[6283]	D. S. Modha and R. Singh, “Network architecture of the long-distance pathways in the macaque brain,” Proc. Natl. Acad. Sci. U.S.A., vol. 107, no. 30, pp. 13485–13490, Jul. 2010, doi: 10.1073/pnas.1008054107.
[6284]	G. Giaever, E. Lissina, and C. Nislow, “Network dynamics of the yeast methyltransferome,” Microb Cell, vol. 6, no. 8, pp. 356–369, Jul. 2019, doi: 10.15698/mic2019.08.687.
[6285]	N. Benfer et al., “Network models of posttraumatic stress symptoms across trauma types,” J Anxiety Disord, vol. 58, pp. 70–77, 2018, doi: 10.1016/j.janxdis.2018.07.004.
[6286]	J. M. Hall and S. J. G. Lewis, “Neural Correlates of Cognitive Impairment in Parkinson’s Disease: A Review of Structural MRI Findings,” Int. Rev. Neurobiol., vol. 144, pp. 1–28, 2019, doi: 10.1016/bs.irn.2018.09.009.
[6287]	S. Stickel et al., “Neural correlates of depression in women across the reproductive lifespan - An fMRI review,” J Affect Disord, vol. 246, pp. 556–570, 01 2019, doi: 10.1016/j.jad.2018.12.133.
[6288]	H. Hulshoff Pol and E. Bullmore, “Neural networks in psychiatry,” Eur Neuropsychopharmacol, vol. 23, no. 1, pp. 1–6, Jan. 2013, doi: 10.1016/j.euroneuro.2012.12.004.
[6289]	O. Isacson and T. Deacon, “Neural transplantation studies reveal the brain’s capacity for continuous reconstruction,” Trends Neurosci., vol. 20, no. 10, pp. 477–482, Oct. 1997, doi: 10.1016/s0166-2236(97)01081-3.
[6290]	P. Vuust, L. K. Gebauer, and M. A. G. Witek, “Neural underpinnings of music: the polyrhythmic brain,” Adv. Exp. Med. Biol., vol. 829, pp. 339–356, 2014, doi: 10.1007/978-1-4939-1782-2_18.
[6291]	O. Maleci and G. Pessina, “[Neurinoma culture in vitro],” G Psichiatr Neuropatol, vol. 82, no. 2, pp. 529–534, 1954.
[6292]	M. W. Ruff, J. H. Uhm, and E. E. Benarroch, “Neuro-oncology: Implications of the molecular era,” Neurology, vol. 92, no. 12, pp. 568–574, 19 2019, doi: 10.1212/WNL.0000000000007126.
[6293]	J. Machon et al., “Neuroanatomy of a hydrothermal vent shrimp provides insights into the evolution of crustacean integrative brain centers,” Elife, vol. 8, 06 2019, doi: 10.7554/eLife.47550.
[6294]	J. L. Alexander et al., “Neurobehavioral impact of menopause on mood,” Expert Rev Neurother, vol. 7, no. 11 Suppl, pp. S81-91, Nov. 2007, doi: 10.1586/14737175.7.11s.S81.
[6295]	R. Ribot and A. M. Kanner, “Neurobiologic properties of mood disorders may have an impact on epilepsy: Should this motivate neurologists to screen for this psychiatric comorbidity in these patients?,” Epilepsy Behav, vol. 98, no. Pt B, pp. 298–301, 2019, doi: 10.1016/j.yebeh.2019.01.026.
[6296]	E. Covey, “Neurobiological specializations in echolocating bats,” Anat Rec A Discov Mol Cell Evol Biol, vol. 287, no. 1, pp. 1103–1116, Nov. 2005, doi: 10.1002/ar.a.20254.
[6297]	C. Heim and C. B. Nemeroff, “Neurobiology of posttraumatic stress disorder,” CNS Spectr, vol. 14, no. 1 Suppl 1, pp. 13–24, Jan. 2009.
[6298]	C. G. Abdallah, S. M. Southwick, and J. H. Krystal, “Neurobiology of posttraumatic stress disorder (PTSD): A path from novel pathophysiology to innovative therapeutics,” Neurosci. Lett., vol. 649, pp. 130–132, 10 2017, doi: 10.1016/j.neulet.2017.04.046.
[6299]	M. D. Horner and M. B. Hamner, “Neurocognitive functioning in posttraumatic stress disorder,” Neuropsychol Rev, vol. 12, no. 1, pp. 15–30, Mar. 2002, doi: 10.1023/a:1015439106231.
[6300]	J. Munson, S. Faja, A. Meltzoff, R. Abbott, and G. Dawson, “Neurocognitive predictors of social and communicative developmental trajectories in preschoolers with autism spectrum disorders,” J Int Neuropsychol Soc, vol. 14, no. 6, pp. 956–966, Nov. 2008, doi: 10.1017/S1355617708081393.
[6301]	M. Weiergräber, D. Ehninger, and K. Broich, “Neuroenhancement and mood enhancement – Physiological and pharmacodynamical background,” Med Monatsschr Pharm, vol. 40, no. 4, pp. 154–164, Apr. 2017.
[6302]	Q.-F. Li et al., “Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3,” Mol Neurodegener, vol. 14, no. 1, p. 39, 04 2019, doi: 10.1186/s13024-019-0338-0.
[6303]	F. Spaans, “Neurographic assessment of lesions of single proper digital nerves,” Clin Neurophysiol, vol. 112, no. 11, pp. 2113–2117, Nov. 2001, doi: 10.1016/s1388-2457(01)00655-1.
[6304]	F. Márquez and M. A. Yassa, “Neuroimaging Biomarkers for Alzheimer’s Disease,” Mol Neurodegener, vol. 14, no. 1, p. 21, 07 2019, doi: 10.1186/s13024-019-0325-5.
[6305]	D. W. Orme-Johnson, R. H. Schneider, Y. D. Son, S. Nidich, and Z.-H. Cho, “Neuroimaging of meditation’s effect on brain reactivity to pain,” Neuroreport, vol. 17, no. 12, pp. 1359–1363, Aug. 2006, doi: 10.1097/01.wnr.0000233094.67289.a8.
[6306]	M. A. Mittelman-Smith, S. J. Krajewski-Hall, N. T. McMullen, and N. E. Rance, “Neurokinin 3 Receptor-Expressing Neurons in the Median Preoptic Nucleus Modulate Heat-Dissipation Effectors in the Female Rat,” Endocrinology, vol. 156, no. 7, pp. 2552–2562, Jul. 2015, doi: 10.1210/en.2014-1974.
[6307]	G. Zara et al., “Neurological complications in hyperemesis gravidarum,” Neurol. Sci., vol. 33, no. 1, pp. 133–135, Feb. 2012, doi: 10.1007/s10072-011-0660-y.
[6308]	M. Török, “Neurological infections: clinical advances and emerging threats,” Lancet Neurol, vol. 6, no. 1, pp. 16–18, Jan. 2007, doi: 10.1016/S1474-4422(06)70666-4.
[6309]	N. Pandita et al., “Neurological Recovery Pattern in Cervical Spondylotic Myelopathy after Anterior Surgery: A Prospective Study with Literature Review,” Asian Spine J, vol. 13, no. 3, pp. 423–431, Jun. 2019, doi: 10.31616/asj.2018.0139.
[6310]	J. Fang et al., “Neurologists’ attitudes toward driving among persons with epilepsy in China: A pilot electronic survey,” Epilepsy Behav, vol. 94, pp. 47–51, 2019, doi: 10.1016/j.yebeh.2019.02.023.
[6311]	A. Chrapusta, J. D. Kropotov, and M. Pąchalska, “Neuromarkers of Post-Traumatic Stress Disorder (PTSD) in a patient after bilateral hand amputation - ERP case study,” Ann Agric Environ Med, vol. 24, no. 2, pp. 265–270, Jun. 2017, doi: 10.26444/aaem/74597.
[6312]	G. Orzan, I. A. Zara, and V. L. Purcarea, “Neuromarketing techniques in pharmaceutical drugs advertising. A discussion and agenda for future research,” J Med Life, vol. 5, no. 4, pp. 428–432, Dec. 2012.
[6313]	K. Mori, M. Miyazato, and K. Kangawa, “Neuromedin S: discovery and functions,” Results Probl Cell Differ, vol. 46, pp. 201–212, 2008, doi: 10.1007/400_2007_054.
[6314]	Y.-T. Hsiao et al., “Neuromedin U (NMU) regulates osteoblast differentiation and activity,” Biochem. Biophys. Res. Commun., vol. 524, no. 4, pp. 890–894, Apr. 2020, doi: 10.1016/j.bbrc.2020.02.003.
[6315]	M. S. Mondal et al., “Neuromedin U acts in the central nervous system to inhibit gastric acid secretion via CRH system,” Am. J. Physiol. Gastrointest. Liver Physiol., vol. 284, no. 6, pp. G963-969, Jun. 2003, doi: 10.1152/ajpgi.00218.2002.
[6316]	V. G. Martinez, J. Crown, R. K. Porter, and L. O’Driscoll, “Neuromedin U alters bioenergetics and expands the cancer stem cell phenotype in HER2-positive breast cancer,” Int. J. Cancer, vol. 140, no. 12, pp. 2771–2784, 15 2017, doi: 10.1002/ijc.30705.
[6317]	P. J. Brighton, P. G. Szekeres, and G. B. Willars, “Neuromedin U and its receptors: structure, function, and physiological roles,” Pharmacol. Rev., vol. 56, no. 2, pp. 231–248, Jun. 2004, doi: 10.1124/pr.56.2.3.
[6318]	E. S. Graham et al., “Neuromedin U and Neuromedin U receptor-2 expression in the mouse and rat hypothalamus: effects of nutritional status,” J. Neurochem., vol. 87, no. 5, pp. 1165–1173, Dec. 2003, doi: 10.1046/j.1471-4159.2003.02079.x.
[6319]	A. A. Rahman, I. Z. Shahid, and P. M. Pilowsky, “Neuromedin U causes biphasic cardiovascular effects and impairs baroreflex function in rostral ventrolateral medulla of spontaneously hypertensive rat,” Peptides, vol. 44, pp. 15–24, Jun. 2013, doi: 10.1016/j.peptides.2013.03.017.
[6320]	D.-L. Qiu et al., “Neuromedin U depolarizes rat hypothalamic paraventricular nucleus neurons in vitro by enhancing IH channel activity,” J. Neurophysiol., vol. 90, no. 2, pp. 843–850, Aug. 2003, doi: 10.1152/jn.00225.2003.
[6321]	M. Rucinski, A. Ziolkowska, M. Tyczewska, M. Szyszka, and L. K. Malendowicz, “Neuromedin U directly stimulates growth of cultured rat calvarial osteoblast-like cells acting via the NMU receptor 2 isoform,” Int. J. Mol. Med., vol. 22, no. 3, pp. 363–368, Sep. 2008.
[6322]	R. E. Kuhre et al., “Neuromedin U Does Not Act as a Decretin in Rats,” Cell Metab., vol. 29, no. 3, pp. 719-726.e5, 05 2019, doi: 10.1016/j.cmet.2018.10.008.
[6323]	E. N. Johnson et al., “Neuromedin U elicits cytokine release in murine Th2-type T cell clone D10.G4.1,” J. Immunol., vol. 173, no. 12, pp. 7230–7238, Dec. 2004, doi: 10.4049/jimmunol.173.12.7230.
[6324]	Y. P. Wang, C. Chen, L. X. Li, X. B. Cui, and M. Y. Xu, “[Neuromedin U expression related to the occurrence of laryngeal carcinoma and the regional lymph node metastasis],” Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, vol. 30, no. 10, pp. 811–814, May 2016, doi: 10.13201/j.issn.1001-1781.2016.10.013.
[6325]	R. Hanada et al., “Neuromedin U has a novel anorexigenic effect independent of the leptin signaling pathway,” Nat. Med., vol. 10, no. 10, pp. 1067–1073, Oct. 2004, doi: 10.1038/nm1106.
[6326]	P. H. Jethwa et al., “Neuromedin U has a physiological role in the regulation of food intake and partially mediates the effects of leptin,” Am. J. Physiol. Endocrinol. Metab., vol. 289, no. 2, pp. E301-305, Aug. 2005, doi: 10.1152/ajpendo.00404.2004.
[6327]	C. M. Novak, M. Zhang, and J. A. Levine, “Neuromedin U in the paraventricular and arcuate hypothalamic nuclei increases non-exercise activity thermogenesis,” J. Neuroendocrinol., vol. 18, no. 8, pp. 594–601, Aug. 2006, doi: 10.1111/j.1365-2826.2006.01454.x.
[6328]	J. Vestlund, A. L. Kalafateli, E. Studer, L. Westberg, and E. Jerlhag, “Neuromedin U induces self-grooming in socially-stimulated mice,” Neuropharmacology, vol. 162, p. 107818, 01 2020, doi: 10.1016/j.neuropharm.2019.107818.
[6329]	L. S. Dalbøge, S. L. Pedersen, T. Secher, B. Holst, N. Vrang, and J. Jelsing, “Neuromedin U inhibits food intake partly by inhibiting gastric emptying,” Peptides, vol. 69, pp. 56–65, Jul. 2015, doi: 10.1016/j.peptides.2015.04.010.
[6330]	T. Iwai, Y. Iinuma, R. Kodani, and J.-I. Oka, “Neuromedin U inhibits inflammation-mediated memory impairment and neuronal cell-death in rodents,” Neurosci. Res., vol. 61, no. 1, pp. 113–119, May 2008, doi: 10.1016/j.neures.2008.01.018.
[6331]	F. Wang et al., “Neuromedin U inhibits T-type Ca2+ channel currents and decreases membrane excitability in small dorsal root ganglia neurons in mice,” Cell Calcium, vol. 49, no. 1, pp. 12–22, Jan. 2011, doi: 10.1016/j.ceca.2010.11.002.
[6332]	A.-C. Jarry et al., “Neuromedin U is a gut peptide that alters oral glucose tolerance by delaying gastric emptying via direct contraction of the pylorus and vagal-dependent mechanisms,” FASEB J., vol. 33, no. 4, pp. 5377–5388, 2019, doi: 10.1096/fj.201801718R.
[6333]	K. Nakahara et al., “Neuromedin U is involved in nociceptive reflexes and adaptation to environmental stimuli in mice,” Biochem. Biophys. Res. Commun., vol. 323, no. 2, pp. 615–620, Oct. 2004, doi: 10.1016/j.bbrc.2004.08.136.
[6334]	Y. Nakashima et al., “Neuromedin U is necessary for normal gastrointestinal motility and is regulated by serotonin,” Ann. N. Y. Acad. Sci., vol. 1200, pp. 104–111, Jul. 2010, doi: 10.1111/j.1749-6632.2010.05504.x.
[6335]	K. Ketterer et al., “Neuromedin U is overexpressed in pancreatic cancer and increases invasiveness via the hepatocyte growth factor c-Met pathway,” Cancer Lett., vol. 277, no. 1, pp. 72–81, May 2009, doi: 10.1016/j.canlet.2008.11.028.
[6336]	Y. Wu, K. McRoberts, S. S. Berr, H. F. Frierson, M. Conaway, and D. Theodorescu, “Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia,” Oncogene, vol. 26, no. 5, pp. 765–773, Feb. 2007, doi: 10.1038/sj.onc.1209835.
[6337]	P. H. Jethwa et al., “Neuromedin U partially mediates leptin-induced hypothalamo-pituitary adrenal (HPA) stimulation and has a physiological role in the regulation of the HPA axis in the rat,” Endocrinology, vol. 147, no. 6, pp. 2886–2892, Jun. 2006, doi: 10.1210/en.2005-0983.
[6338]	G. Helfer, A. W. Ross, and P. J. Morgan, “Neuromedin U partly mimics thyroid-stimulating hormone and triggers Wnt/β-catenin signalling in the photoperiodic response of F344 rats,” J. Neuroendocrinol., vol. 25, no. 12, pp. 1264–1272, Dec. 2013, doi: 10.1111/jne.12116.
[6339]	C. Grippi et al., “Neuromedin U potentiates ADP- and epinephrine-induced human platelet activation,” Thromb. Res., vol. 159, pp. 100–108, Nov. 2017, doi: 10.1016/j.thromres.2017.09.027.
[6340]	T. Ensho et al., “Neuromedin U precursor-related peptide (NURP) exerts neuromedin U-like sympathetic nerve action in the rat,” Biochem. Biophys. Res. Commun., vol. 492, no. 3, pp. 412–418, 21 2017, doi: 10.1016/j.bbrc.2017.08.084.
[6341]	D.-L. Qiu et al., “Neuromedin U receptor-2 mRNA and HCN channels mRNA expression in NMU-sensitive neurons in rat hypothalamic paraventricular nucleus,” Neurosci. Lett., vol. 374, no. 1, pp. 69–72, Feb. 2005, doi: 10.1016/j.neulet.2004.10.033.
[6342]	W. Zhang et al., “Neuromedin U suppresses glucose-stimulated insulin secretion in pancreatic β cells,” Biochem. Biophys. Res. Commun., vol. 493, no. 1, pp. 677–683, 04 2017, doi: 10.1016/j.bbrc.2017.08.132.
[6343]	W. Zhang, H. Sakoda, and M. Nakazato, “Neuromedin U suppresses insulin secretion by triggering mitochondrial dysfunction and endoplasmic reticulum stress in pancreatic β-cells,” FASEB J., vol. 34, no. 1, pp. 133–147, 2020, doi: 10.1096/fj.201901743R.
[6344]	K. Nakahara et al., “Neuromedin U suppresses prolactin secretion via dopamine neurons of the arcuate nucleus,” Biochem. Biophys. Res. Commun., vol. 521, no. 2, pp. 521–526, 08 2020, doi: 10.1016/j.bbrc.2019.10.156.
[6345]	K. Maruyama et al., “Neuromedin U-induced anorexigenic action is mediated by the corticotropin-releasing hormone receptor-signaling pathway in goldfish,” Peptides, vol. 30, no. 12, pp. 2483–2486, Dec. 2009, doi: 10.1016/j.peptides.2009.08.013.
[6346]	S. Rani et al., “Neuromedin U: a candidate biomarker and therapeutic target to predict and overcome resistance to HER-tyrosine kinase inhibitors,” Cancer Res., vol. 74, no. 14, pp. 3821–3833, Jul. 2014, doi: 10.1158/0008-5472.CAN-13-2053.
[6347]	V. G. Martinez and L. O’Driscoll, “Neuromedin U: a multifunctional neuropeptide with pleiotropic roles,” Clin. Chem., vol. 61, no. 3, pp. 471–482, Mar. 2015, doi: 10.1373/clinchem.2014.231753.
[6348]	S. E. Shetzline et al., “Neuromedin U: a Myb-regulated autocrine growth factor for human myeloid leukemias,” Blood, vol. 104, no. 6, pp. 1833–1840, Sep. 2004, doi: 10.1182/blood-2003-10-3577.
[6349]	P. Przygodzka, K. Soboska, E. Sochacka, and J. Boncela, “Neuromedin U: A Small Peptide in the Big World of Cancer,” Cancers (Basel), vol. 11, no. 9, Sep. 2019, doi: 10.3390/cancers11091312.
[6350]	S. Budhiraja and A. Chugh, “Neuromedin U: physiology, pharmacology and therapeutic potential,” Fundam Clin Pharmacol, vol. 23, no. 2, pp. 149–157, Apr. 2009, doi: 10.1111/j.1472-8206.2009.00667.x.
[6351]	E. S. Graham, P. Littlewood, Y. Turnbull, J. G. Mercer, P. J. Morgan, and P. Barrett, “Neuromedin-U is regulated by the circadian clock in the SCN of the mouse,” Eur. J. Neurosci., vol. 21, no. 3, pp. 814–819, Feb. 2005, doi: 10.1111/j.1460-9568.2005.03923.x.
[6352]	L. K. Malendowicz and A. Markowska, “Neuromedins and their involvement in the regulation of growth, structure and function of the adrenal cortex,” Histol. Histopathol., vol. 9, no. 3, pp. 591–601, Jul. 1994.
[6353]	S.-C. Li, “Neuromodulation and developmental contextual influences on neural and cognitive plasticity across the lifespan,” Neurosci Biobehav Rev, vol. 37, no. 9 Pt B, pp. 2201–2208, Nov. 2013, doi: 10.1016/j.neubiorev.2013.07.019.
[6354]	T. Hines, “Neuromythology of Einstein’s brain,” Brain Cogn, vol. 88, pp. 21–25, Jul. 2014, doi: 10.1016/j.bandc.2014.04.004.
[6355]	N. K. Popova and V. S. Naumenko, “Neuronal and behavioral plasticity: the role of serotonin and BDNF systems tandem,” Expert Opin. Ther. Targets, vol. 23, no. 3, pp. 227–239, 2019, doi: 10.1080/14728222.2019.1572747.
[6356]	F. Bartels, T. Strönisch, K. Farmer, K. Rentzsch, F. Kiecker, and C. Finke, “Neuronal autoantibodies associated with cognitive impairment in melanoma patients,” Ann. Oncol., vol. 30, no. 5, pp. 823–829, 01 2019, doi: 10.1093/annonc/mdz083.
[6357]	M. Andrés and M. C. Göpfert, “Neuronal osmotransduction: push-activating TRPV1 with microtubules,” Dev. Cell, vol. 30, no. 4, pp. 363–364, Aug. 2014, doi: 10.1016/j.devcel.2014.08.012.
[6358]	L. S. Watson, E. D. Hamlett, T. D. Stone, and C. Sims-Robinson, “Neuronally derived extracellular vesicles: an emerging tool for understanding Alzheimer’s disease,” Mol Neurodegener, vol. 14, no. 1, p. 22, 10 2019, doi: 10.1186/s13024-019-0317-5.
[6359]	N. B. Finnerup, R. Kuner, and T. S. Jensen, “Neuropathic pain: From mechanisms to treatment,” Physiol. Rev., Jun. 2020, doi: 10.1152/physrev.00045.2019.
[6360]	W. Li, H.-I. Tong, S. Gorantla, L. Y. Poluektova, H. E. Gendelman, and Y. Lu, “Neuropharmacologic Approaches to Restore the Brain’s Microenvironment,” J Neuroimmune Pharmacol, vol. 11, no. 3, pp. 484–494, 2016, doi: 10.1007/s11481-016-9686-5.
[6361]	V. B. Risbrough and M. B. Stein, “Neuropharmacology special issue on posttraumatic stress disorder (PTSD): current state of the art in clinical and preclinical PTSD research,” Neuropharmacology, vol. 62, no. 2, pp. 539–541, Feb. 2012, doi: 10.1016/j.neuropharm.2011.08.021.
[6362]	G. Zara, R. Zambello, and M. Ermani, “Neurophysiological and clinical responses to rituximab in patients with anti-MAG polyneuropathy,” Clin Neurophysiol, vol. 122, no. 12, pp. 2518–2522, Dec. 2011, doi: 10.1016/j.clinph.2011.05.015.
[6363]	M. R. Schaeffer et al., “Neurophysiological mechanisms of exertional dyspnoea in fibrotic interstitial lung disease,” Eur. Respir. J., vol. 51, no. 1, 2018, doi: 10.1183/13993003.01726-2017.
[6364]	O. A. Shavlovskaya, “[Neuroprotectors in the correction of cognitive impairment],” Zh Nevrol Psikhiatr Im S S Korsakova, vol. 118, no. 9, pp. 130–132, 2018, doi: 10.17116/jnevro2018118091130.
[6365]	I. R. Bell, C. S. Miller, G. E. Schwartz, J. M. Peterson, and D. Amend, “Neuropsychiatric and somatic characteristics of young adults with and without self-reported chemical odor intolerance and chemical sensitivity,” Arch. Environ. Health, vol. 51, no. 1, pp. 9–21, Feb. 1996, doi: 10.1080/00039896.1996.9935987.
[6366]	Y. Zhao and H. Li, “Neuropsychological intervention of minimal cognitive impairment including language deficits,” Eur Rev Med Pharmacol Sci, vol. 21, no. 4 Suppl, pp. 58–64, Oct. 2017.
[6367]	J. Golier and R. Yehuda, “Neuropsychological processes in post-traumatic stress disorder,” Psychiatr. Clin. North Am., vol. 25, no. 2, pp. 295–315, vi, Jun. 2002, doi: 10.1016/s0193-953x(01)00004-1.
[6368]	R. D. Fields, “Neuroscience: Map the other brain,” Nature, vol. 501, no. 7465, pp. 25–27, Sep. 2013, doi: 10.1038/501025a.
[6369]	E. Underwood, “Neuroscience. Sleep: the brain’s housekeeper?,” Science, vol. 342, no. 6156, p. 301, Oct. 2013, doi: 10.1126/science.342.6156.301.
[6370]	M. E. Raichle, “Neuroscience. The brain’s dark energy,” Science, vol. 314, no. 5803, pp. 1249–1250, Nov. 2006, doi: 10.1126/science. 1134405.
[6371]	G. Miller, “Neuroscience. The brain’s social network,” Science, vol. 334, no. 6056, pp. 578–579, Nov. 2011, doi: 10.1126/science.334.6056.578.
[6372]	M. Tanaka and G. Telegdy, “Neurotransmissions of antidepressant-like effects of neuromedin U-23 in mice,” Behav. Brain Res., vol. 259, pp. 196–199, Feb. 2014, doi: 10.1016/j.bbr.2013.11.005.
[6373]	M. Lader, “Neurotransmitters and anxiety: overview,” Psychopathology, vol. 17 Suppl 3, pp. 3–7, 1984, doi: 10.1159/000284126.
[6374]	F. Shah et al., “Neurotrophic factor BDNF is upregulated in soft palate muscles of snorers and sleep apnea patients,” Laryngoscope Investig Otolaryngol, vol. 4, no. 1, pp. 174–180, Feb. 2019, doi: 10.1002/lio2.225.
[6375]	P. J. W. Naudé et al., “Neutrophil gelatinase-associated lipocalin: a novel inflammatory marker associated with late-life depression,” J Psychosom Res, vol. 75, no. 5, pp. 444–450, Nov. 2013, doi: 10.1016/j.jpsychores.2013.08.023.
[6376]	N. H. Adams, “Never audit alone--the case for audit teams,” Qual Assur, vol. 7, no. 4, pp. 195–200, Dec. 1999, doi: 10.1080/105294199750061308.
[6377]	D. Zips, H. D. Thames, and M. Baumann, “New anticancer agents: in vitro and in vivo evaluation,” In Vivo, vol. 19, no. 1, pp. 1–7, Feb. 2005.
[6378]	M. G. Kiuchi et al., “New Approaches in the Management of Sudden Cardiac Death in Patients with Heart Failure-Targeting the Sympathetic Nervous System,” Int J Mol Sci, vol. 20, no. 10, May 2019, doi: 10.3390/ijms20102430.
[6379]	L. C. Pratchett, K. Daly, L. M. Bierer, and R. Yehuda, “New approaches to combining pharmacotherapy and psychotherapy for posttraumatic stress disorder,” Expert Opin Pharmacother, vol. 12, no. 15, pp. 2339–2354, Oct. 2011, doi: 10.1517/14656566.2011.604030.
[6380]	W. L. Chiou, “New calculation method of mean total body clearance of drugs and its application to dosage regimens,” J Pharm Sci, vol. 69, no. 1, pp. 90–91, Jan. 1980, doi: 10.1002/jps.2600690125.
[6381]	M. L. Danielson and M. A. Lill, “New computational method for prediction of interacting protein loop regions,” Proteins, vol. 78, no. 7, pp. 1748–1759, May 2010, doi: 10.1002/prot.22690.
[6382]	M. Li, C. Wang, Z. Chen, K. Xu, and J. Lu, “New Concepts in Electrolytes,” Chem. Rev., vol. 120, no. 14, pp. 6783–6819, Jul. 2020, doi: 10.1021/acs.chemrev.9b00531.
[6383]	C. L. Bowden, “New concepts in mood stabilization: evidence for the effectiveness of valproate and lamotrigine,” Neuropsychopharmacology, vol. 19, no. 3, pp. 194–199, Sep. 1998, doi: 10.1016/S0893-133X(98)00025-6.
[6384]	J. Abbasi, “New Deep Brain Stimulation Target for Mood Disorders,” JAMA, vol. 321, no. 6, p. 537, Feb. 2019, doi: 10.1001/jama.2019.0295.
[6385]	H. R. Karimi and H. Gao, “New delay-dependent exponential H(infinity) synchronization for uncertain neural networks with mixed time delays,” IEEE Trans Syst Man Cybern B Cybern, vol. 40, no. 1, pp. 173–185, Feb. 2010, doi: 10.1109/TSMCB.2009.2024408.
[6386]	D. Donev, “New developments in publishing related to authorship,” Pril (Makedon Akad Nauk Umet Odd Med Nauki), vol. 35, no. 3, pp. 57–66, 2014, doi: 10.1515/prilozi-2015-0009.
[6387]	F. Huaux, “New developments in the understanding of immunology in silicosis,” Curr Opin Allergy Clin Immunol, vol. 7, no. 2, pp. 168–173, Apr. 2007, doi: 10.1097/ACI.0b013e32802bf8a5.
[6388]	R. M. Post, T. A. Ketter, P. J. Pazzaglia, M. S. George, L. Marangell, and K. Denicoff, “New developments in the use of anticonvulsants as mood stabilizers,” Neuropsychobiology, vol. 27, no. 3, pp. 132–137, 1993, doi: 10.1159/000118968.
[6389]	S. A. Beaudreau and N. A. Pachana, “New Directions in Alleviating Anxiety in Older Adults: Applications, Modifications, and Innovations,” Clin Gerontol, vol. 40, no. 3, pp. 139–140, Jun. 2017, doi: 10.1080/07317115.2017.1299466.
[6390]	S. Yoo, S. Y. Choi, D. You, and C.-S. Kim, “New drugs in prostate cancer,” Prostate Int, vol. 4, no. 2, pp. 37–42, Jun. 2016, doi: 10.1016/j.prnil.2016.05.001.
[6391]	M. Allaire, C. Goumard, C. Lim, A. Le Cleach, M. Wagner, and O. Scatton, “New frontiers in liver resection for hepatocellular carcinoma,” JHEP Rep, vol. 2, no. 4, p. 100134, Aug. 2020, doi: 10.1016/j.jhepr.2020.100134.
[6392]	J. C. Marini and A. R. Blissett, “New genes in bone development: what’s new in osteogenesis imperfecta,” J. Clin. Endocrinol. Metab., vol. 98, no. 8, pp. 3095–3103, Aug. 2013, doi: 10.1210/jc.2013-1505.
[6393]	C. Barroso and Independent Accountability Panel, “New hopes for accountability for women, children, and adolescent health,” Lancet, vol. 388, no. 10052, pp. 1360–1361, Oct. 2016, doi: 10.1016/S0140-6736(16)31772-X.
[6394]	P. Chakraborty, “New insight into the biology of R-loops,” Mutat. Res., vol. 821, p. 111711, May 2020, doi: 10.1016/j.mrfmmm.2020.111711.
[6395]	H. Shaaban, “New insights into liquid chromatography for more eco-friendly analysis of pharmaceuticals,” Anal Bioanal Chem, vol. 408, no. 25, pp. 6929–6944, Oct. 2016, doi: 10.1007/s00216-016-9726-2.
[6396]	S. Foster and M. Mohler-Kuo, “New insights into the correlation structure of DSM-IV depression symptoms in the general population v. subsamples of depressed individuals,” Epidemiol Psychiatr Sci, vol. 27, no. 3, pp. 288–300, 2018, doi: 10.1017/S2045796016001086.
[6397]	M. Gratuze, C. E. G. Leyns, and D. M. Holtzman, “New insights into the role of TREM2 in Alzheimer’s disease,” Mol Neurodegener, vol. 13, no. 1, p. 66, 20 2018, doi: 10.1186/s13024-018-0298-9.
[6398]	K. Kondo and B. McClure, “New microsome-associated HT-family proteins from Nicotiana respond to pollination and define an HT/NOD-24 protein family,” Mol Plant, vol. 1, no. 4, pp. 634–644, Jul. 2008, doi: 10.1093/mp/ssn018.
[6399]	“New momentum in prevention, control and elimination of cholera in Africa: priority actions identified by affected countries,” Wkly. Epidemiol. Rec., vol. 91, no. 24, pp. 305–314, Jun. 2016.
[6400]	C.-X. Li and L.-R. Shen, “New observations on the effect of camellia oil on fatty liver disease in rats,” J Zhejiang Univ Sci B, vol. 21, no. 8, pp. 657–667, Aug. 2020, doi: 10.1631/jzus.B2000101.
[6401]	S. Pannach and J. Beyer-Westendorf, “[New oral anticoagulants and endoscopy--what do you have to consider?],” Dtsch. Med. Wochenschr., vol. 140, no. 16, pp. 1227–1230, Aug. 2015, doi: 10.1055/s-0041-102666.
[6402]	N. Guaragnella et al., “New perspectives from South-Y-East, not all about death. A report of the 12th lnternational Meeting on Yeast Apoptosis in Bari, Italy, May 14th-18th, 2017,” Microb Cell, vol. 5, no. 2, pp. 112–115, Jan. 2018, doi: 10.15698/mic2018.02.616.
[6403]	M. Fagyas et al., “New perspectives in the renin-angiotensin-aldosterone system (RAAS) I: endogenous angiotensin converting enzyme (ACE) inhibition,” PLoS ONE, vol. 9, no. 4, p. e87843, 2014, doi: 10.1371/journal.pone.0087843.
[6404]	M. Fagyas et al., “New perspectives in the renin-angiotensin-aldosterone system (RAAS) II: albumin suppresses angiotensin converting enzyme (ACE) activity in human,” PLoS ONE, vol. 9, no. 4, p. e87844, 2014, doi: 10.1371/journal.pone.0087844.
[6405]	R. Borde, M. Zara, and B. Kirkiacharian, “[NEW PERSPECTIVES OPENED BY THE USE OF SYNTHETIC PROGESTATIVE AGENTS],” Rev Fr Endocrinol Clin, vol. 4, pp. 511–523, Dec. 1963.
[6406]	C. Strupp et al., “New proposals of the WHO working group (2016) for the diagnosis of myelodysplastic syndromes (MDS): Characteristics of refined MDS types,” Leuk. Res., vol. 57, pp. 78–84, 2017, doi: 10.1016/j.leukres.2017.02.008.
[6407]	M. Goodman, C. Zapf, and Y. Rew, “New reagents, reactions, and peptidomimetics for drug design,” Biopolymers, vol. 60, no. 3, pp. 229–245, 2001, doi: 10.1002/1097-0282(2001)60:3<229::AID-BIP10034>3.0.CO;2-P.
[6408]	R. Boateng and A. K. Allen, “New Role for an Old Protein: An Educational Primer for Use with ‘The Identification of a Novel Mutant Allele of topoisomerase II in Caenorhabditis elegans Reveals a Unique Role in Chromosome Segregation During Spermatogenesis,’” Genetics, vol. 208, no. 1, pp. 79–88, Jan. 2018, doi: 10.1534/genetics.117.300482.
[6409]	J. Brea et al., “New serotonin 5-HT(2A), 5-HT(2B), and 5-HT(2C) receptor antagonists: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo and heterocycloalkanones,” J. Med. Chem., vol. 45, no. 1, pp. 54–71, Jan. 2002, doi: 10.1021/jm011014y.
[6410]	“New shroud design controls silica dust from surface mine and construction blast hole drills,” Appl Occup Environ Hyg, vol. 17, no. 1, pp. 8–9, Jan. 2002, doi: 10.1080/104732202753306069.
[6411]	A. Pastel, R. Taub, and A. Zara, “[New therapeutic approach to cutaneo-mucous mycoses],” Sem Hop Ther, vol. 52, no. 10, pp. 549–552, Dec. 1976.
[6412]	C. Cursiefen et al., “[New Therapeutic Approaches in Inflammatory Diseases of the Eye - Targeting Lymphangiogenesis and Cellular Immunity: Research Unit FOR 2240 Presents Itself],” Klin Monbl Augenheilkd, vol. 234, no. 5, pp. 679–685, May 2017, doi: 10.1055/s-0043-108247.
[6413]	K. N. Diakopoulos and H. Algül, “New wine into old wineskins: PGC-1α and NF-κB in obesity and acute pancreatitis,” J. Pathol., vol. 248, no. 1, pp. 6–8, May 2019, doi: 10.1002/path.5220.
[6414]	H. B. Waldman and S. P. Perlman, “New York State Dental Establishments and Dentists: 2007-2012. Economic Survey,” N Y State Dent J, vol. 82, no. 1, pp. 17–20, Jan. 2016.
[6415]	J. Sahu, P. P. Nair, V. Wadwekar, and R. Aghoram, “New-onset interictal headache in Persons with epilepsy (PWE): A case-control study,” Epilepsy Behav, vol. 88, pp. 172–175, 2018, doi: 10.1016/j.yebeh.2018.08.035.
[6416]	D. Cadman, A. Gafni, and J. McNamee, “Newborn circumcision: an economic perspective,” Can Med Assoc J, vol. 131, no. 11, pp. 1353–1355, Dec. 1984.
[6417]	A. Salvetti, “Newer ACE inhibitors. A look at the future,” Drugs, vol. 40, no. 6, pp. 800–828, Dec. 1990, doi: 10.2165/00003495-199040060-00004.
[6418]	N. S. Khoo, E. B. Tham, and P. F. Kantor, “Newer imaging modalities in the assessment of heart function in single ventricle hearts,” Can J Cardiol, vol. 29, no. 7, pp. 886–889, Jul. 2013, doi: 10.1016/j.cjca.2013.03.025.
[6419]	J. Caspermeyer, “Next Generation TimeTree: An Expanded History of Life on Earth at Your Fingertips,” Mol. Biol. Evol., vol. 34, no. 7, pp. 1822–1823, 01 2017, doi: 10.1093/molbev/msx133.
[6420]	S. Zara et al., “NF-κB involvement in hyperoxia-induced myocardial damage in newborn rat hearts,” Histochem. Cell Biol., vol. 140, no. 5, pp. 575–583, Nov. 2013, doi: 10.1007/s00418-013-1092-y.
[6421]	C. M. Papa, “Niacinamide and acanthosis nigricans,” Arch Dermatol, vol. 120, no. 10, p. 1281, Oct. 1984.
[6422]	T. Tanaka, T. Nishioka, and J. Oda, “Nicked multifunctional loop of glutathione synthetase still protects the catalytic intermediate,” Arch. Biochem. Biophys., vol. 339, no. 1, pp. 151–156, Mar. 1997, doi: 10.1006/abbi.1996.9821.
[6423]	M. Yuan, S. J. Cross, S. E. Loughlin, and F. M. Leslie, “Nicotine and the adolescent brain,” J. Physiol. (Lond.), vol. 593, no. 16, pp. 3397–3412, Aug. 2015, doi: 10.1113/JP270492.
[6424]	R. Malenka, “NIH workshop report: taming the brain’s complexity,” Neuron, vol. 36, no. 1, pp. 29–30, Sep. 2002, doi: 10.1016/s0896-6273(02)00938-8.
[6425]	S. Cho, J. Kim, S. Kim, and S.-S. Lee, “Nitrogen and phosphorus treatment of marine wastewater by a laboratory-scale sequencing batch reactor with eco-friendly marine high-efficiency sediment,” Environ Technol, vol. 39, no. 13, pp. 1721–1732, Jul. 2018, doi: 10.1080/09593330.2017.1337234.
[6426]	J. F. Allen, B. Thake, and W. F. Martin, “Nitrogenase Inhibition Limited Oxygenation of Earth’s Proterozoic Atmosphere,” Trends Plant Sci., vol. 24, no. 11, pp. 1022–1031, 2019, doi: 10.1016/j.tplants.2019.07.007.
[6427]	L. Y. Yang et al., “[NIX-mediated mitochondrial autophagy in pathogenesis of myelodysplastic syndrome anemia],” Zhonghua Yi Xue Za Zhi, vol. 97, no. 14, pp. 1071–1075, Apr. 2017, doi: 10.3760/cma.j.issn.0376-2491.2017.14.009.
[6428]	V. Martini, P. Schiavone, R. Bonacina, U. Mariani, and A. Rambaldi, “NK leukemia: a rare case of oral manifestations representing the initial sign,” Ann Stomatol (Roma), vol. 4, no. Suppl 2, p. 28, 2013.
[6429]	M. L. Pall, “NMDA sensitization and stimulation by peroxynitrite, nitric oxide, and organic solvents as the mechanism of chemical sensitivity in multiple chemical sensitivity,” FASEB J., vol. 16, no. 11, pp. 1407–1417, Sep. 2002, doi: 10.1096/fj.01-0861hyp.
[6430]	D. Das Mukherjee et al., “NMK-BH2, a novel microtubule-depolymerising bis (indolyl)-hydrazide-hydrazone, induces apoptotic and autophagic cell death in cervical cancer cells by binding to tubulin at colchicine - site,” Biochim Biophys Acta Mol Cell Res, vol. 1867, no. 10, p. 118762, Oct. 2020, doi: 10.1016/j.bbamcr.2020.118762.
[6431]	S. Bhattacharya, N. M. Kumar, A. Ganguli, M. P. Tantak, D. Kumar, and G. Chakrabarti, “NMK-TD-100, a novel microtubule modulating agent, blocks mitosis and induces apoptosis in HeLa cells by binding to tubulin,” PLoS ONE, vol. 8, no. 10, p. e76286, 2013, doi: 10.1371/journal.pone.0076286.
[6432]	B. C. Hamans, A. Andreychenko, A. Heerschap, S. S. Wijmenga, and M. Tessari, “NMR at earth’s magnetic field using para-hydrogen induced polarization,” J. Magn. Reson., vol. 212, no. 1, pp. 224–228, Sep. 2011, doi: 10.1016/j.jmr.2011.06.011.
[6433]	W. R. P. Scott, S.-B. Baek, D. Jung, R. E. W. Hancock, and S. K. Straus, “NMR structural studies of the antibiotic lipopeptide daptomycin in DHPC micelles,” Biochim. Biophys. Acta, vol. 1768, no. 12, pp. 3116–3126, Dec. 2007, doi: 10.1016/j.bbamem.2007.08.034.
[6434]	J. Wang, T. M. Henkin, and E. P. Nikonowicz, “NMR structure and dynamics of the Specifier Loop domain from the Bacillus subtilis tyrS T box leader RNA,” Nucleic Acids Res., vol. 38, no. 10, pp. 3388–3398, Jun. 2010, doi: 10.1093/nar/gkq020.
[6435]	T.-Y. Lin, F.-J. Wu, C.-L. Chang, Z. Li, and C.-W. Luo, “NMU signaling promotes endometrial cancer cell progression by modulating adhesion signaling,” Oncotarget, vol. 7, no. 9, pp. 10228–10242, Mar. 2016, doi: 10.18632/oncotarget.7169.
[6436]	G. Pratesi, G. Pezzoni, and G. Parmiani, “NMU-1, a new transplantable mouse lung tumor: biological and chemosensitivity properties in vivo,” Cancer Treat Rep, vol. 69, no. 2, pp. 219–221, Feb. 1985.
[6437]	E. Adámeková, M. Marková, P. Kubatka, B. Bojková, I. Ahlers, and E. Ahlersová, “NMU-induced mammary carcinogenesis in female rats is influenced by repeated psychoemotional stress,” Neoplasma, vol. 50, no. 6, pp. 428–432, 2003.
[6438]	Z.-H. Li, X.-M. Pan, B.-W. Han, H. Han, Z. Zhang, and L.-B. Gao, “No association between ACE polymorphism and risk of nasopharyngeal carcinoma,” J Renin Angiotensin Aldosterone Syst, vol. 13, no. 1, pp. 210–215, Mar. 2012, doi: 10.1177/1470320311426168.
[6439]	M. S. Koehle, P. Wang, J. A. Guenette, and J. L. Rupert, “No association between variants in the ACE and angiotensin II receptor 1 genes and acute mountain sickness in Nepalese pilgrims to the Janai Purnima Festival at 4380 m,” High Alt. Med. Biol., vol. 7, no. 4, pp. 281–289, 2006, doi: 10.1089/ham.2006.7.281.
[6440]	S. H. Day, P. Gohlke, S. S. Dhamrait, and A. G. Williams, “No correlation between circulating ACE activity and VO2max or mechanical efficiency in women,” Eur. J. Appl. Physiol., vol. 99, no. 1, pp. 11–18, Jan. 2007, doi: 10.1007/s00421-006-0309-3.
[6441]	T. Barbui, A. Carobbio, A. Ghirardi, A. Masciulli, A. Rambaldi, and A. M. Vannucchi, “No correlation of intensity of phlebotomy regimen with risk of thrombosis in polycythemia vera: evidence from European Collaboration on Low-Dose Aspirin in Polycythemia Vera and Cytoreductive Therapy in Polycythemia Vera clinical trials,” Haematologica, vol. 102, no. 6, pp. e219–e221, 2017, doi: 10.3324/haematol.2017.165126.
[6442]	H. Schulz et al., “No evidence for a BRD2 promoter hypermethylation in blood leukocytes of Europeans with juvenile myoclonic epilepsy,” Epilepsia, vol. 60, no. 5, pp. e31–e36, 2019, doi: 10.1111/epi.14657.
[6443]	F. Madia et al., “No evidence of GABRG2 mutations in severe myoclonic epilepsy of infancy,” Epilepsy Res., vol. 53, no. 3, pp. 196–200, Mar. 2003, doi: 10.1016/s0920-1211(03)00022-6.
[6444]	H. Okumura et al., “[No relation between angiotensin-converting enzyme (ACE) inhibitor-induced cough and ACE gene polymorphism, plasma bradykinin, substance P and ACE inhibitor concentration in Japanese patients],” Yakugaku Zasshi, vol. 121, no. 3, pp. 253–257, Mar. 2001, doi: 10.1248/yakushi.121.253.
[6445]	J. Lamont et al., “No. 279-Female Sexual Health Consensus Clinical Guidelines,” J Obstet Gynaecol Can, vol. 39, no. 12, pp. e535–e541, Dec. 2017, doi: 10.1016/j.jogc.2017.10.015.
[6446]	S. Al-Hayder, M. Warnecke, and J. Hesselfeldt-Nielsen, “Nodular fasciitis of the face: A case report,” Int J Surg Case Rep, vol. 61, pp. 207–209, 2019, doi: 10.1016/j.ijscr.2019.07.003.
[6447]	P. D’Odorico, F. Laio, and L. Ridolfi, “Noise-sustained fluctuations in stochastic dynamics with a delay,” Phys Rev E Stat Nonlin Soft Matter Phys, vol. 85, no. 4 Pt 1, p. 041106, Apr. 2012, doi: 10.1103/PhysRevE.85.041106.
[6448]	Å. B. Tornberg and K. Lauruschkus, “Non-ambulatory children with cerebral palsy: effects of four months of static and dynamic standing exercise on passive range of motion and spasticity in the hip,” PeerJ, vol. 8, p. e8561, 2020, doi: 10.7717/peerj.8561.
[6449]	E. Gamero-Sandemetrio, L. Payá-Tormo, R. Gómez-Pastor, A. Aranda, and E. Matallana, “Non-canonical regulation of glutathione and trehalose biosynthesis characterizes non-Saccharomyces wine yeasts with poor performance in active dry yeast production,” Microb Cell, vol. 5, no. 4, pp. 184–197, Jan. 2018, doi: 10.15698/mic2018.04.624.
[6450]	A. Kleidon, “Non-equilibrium thermodynamics, maximum entropy production and Earth-system evolution,” Philos Trans A Math Phys Eng Sci, vol. 368, no. 1910, pp. 181–196, Jan. 2010, doi: 10.1098/rsta.2009.0188.
[6451]	N. F. Johnson et al., “Non-fasting High-Density Lipoprotein Is Associated With White Matter Microstructure in Healthy Older Adults,” Front Aging Neurosci, vol. 11, p. 100, 2019, doi: 10.3389/fnagi.2019.00100.
[6452]	K. H. Sitoci-Ficici et al., “Non-functionalized soft alginate hydrogel promotes locomotor recovery after spinal cord injury in a rat hemimyelonectomy model,” Acta Neurochir (Wien), vol. 160, no. 3, pp. 449–457, 2018, doi: 10.1007/s00701-017-3389-4.
[6453]	S. Simoens, C. Meuleman, and T. D’Hooghe, “Non-health-care costs associated with endometriosis,” Hum. Reprod., vol. 26, no. 9, pp. 2363–2367, Sep. 2011, doi: 10.1093/humrep/der215.
[6454]	E. M. Thompson, “Non-invasive prenatal diagnosis of osteogenesis imperfecta,” Am. J. Med. Genet., vol. 45, no. 2, pp. 201–206, Jan. 1993, doi: 10.1002/ajmg.1320450210.
[6455]	V. Osborne, M. Serdarevic, H. Crooke, C. Striley, and L. B. Cottler, “Non-medical opioid use in youth: Gender differences in risk factors and prevalence,” Addict Behav, vol. 72, pp. 114–119, 2017, doi: 10.1016/j.addbeh.2017.03.024.
[6456]	N. E. Webb, D. M. Wood, J. C. Black, E. Amioka, R. C. Dart, and P. I. Dargan, “Non-medical use of loperamide in the UK and the USA,” QJM, vol. 113, no. 1, pp. 25–30, Jan. 2020, doi: 10.1093/qjmed/hcz215.
[6457]	P. D. James, A. S. Fida, P. Konovalov, and B. P. Smyth, “Non-medical use of olanzapine by people on methadone treatment,” BJPsych Bull, vol. 40, no. 6, pp. 314–317, Dec. 2016, doi: 10.1192/pb.bp.115.052886.
[6458]	D. Zweers, E. de Graaf, and S. C. C. M. Teunissen, “Non-pharmacological nurse-led interventions to manage anxiety in patients with advanced cancer: A systematic literature review,” Int J Nurs Stud, vol. 56, pp. 102–113, Apr. 2016, doi: 10.1016/j.ijnurstu.2015.10.022.
[6459]	N. da C. Ferreira, E. da S. Ramalho, and J. de L. Lopes, “Non-pharmacological strategies to decrease anxiety in cardiac catheterization: integrative review,” Rev Bras Enferm, vol. 68, no. 6, pp. 1093–1102, Dec. 2015, doi: 10.1590/0034-7167.2015680614i.
[6460]	E. Engl, R. Jolivet, C. N. Hall, and D. Attwell, “Non-signalling energy use in the developing rat brain,” J. Cereb. Blood Flow Metab., vol. 37, no. 3, pp. 951–966, Mar. 2017, doi: 10.1177/0271678X16648710.
[6461]	D. Sun et al., “Non-viral Gene Therapy for Stargardt Disease with ECO/pRHO-ABCA4 Self-Assembled Nanoparticles,” Mol. Ther., vol. 28, no. 1, pp. 293–303, 08 2020, doi: 10.1016/j.ymthe.2019.09.010.
[6462]	A. D. Struthers, G. Anderson, R. J. MacFadyen, C. Fraser, and T. M. MacDonald, “Nonadherence with ACE inhibitors is common and can be detected in clinical practice by routine serum ACE activity,” Congest Heart Fail, vol. 7, no. 1, pp. 43–46, Feb. 2001, doi: 10.1111/j.1527-5299.2001.990867.x.
[6463]	I. Joo, J. M. Lee, J. H. Yoon, J. J. Jang, J. K. Han, and B. I. Choi, “Nonalcoholic Fatty Liver Disease: Intravoxel Incoherent Motion Diffusion-weighted MR Imaging-An Experimental Study in a Rabbit Model,” Radiology, p. 122506, Oct. 2013, doi: 10.1148/radiology.13122506.
[6464]	I. Joo, J. M. Lee, J. H. Yoon, J. J. Jang, J. K. Han, and B. I. Choi, “Nonalcoholic fatty liver disease: intravoxel incoherent motion diffusion-weighted MR imaging-an experimental study in a rabbit model,” Radiology, vol. 270, no. 1, pp. 131–140, Jan. 2014, doi: 10.1148/radiol.13122506.
[6465]	N. P. Daskalakis, A. C. Provost, R. G. Hunter, and G. Guffanti, “Noncoding RNAs: Stress, Glucocorticoids, and Posttraumatic Stress Disorder,” Biol. Psychiatry, vol. 83, no. 10, pp. 849–865, 15 2018, doi: 10.1016/j.biopsych.2018.01.009.
[6466]	J. L. Fernández-Torre, M. Rebollo, A. Gutiérrez, F. López-Espadas, and M. A. Hernández-Hernández, “Nonconvulsive status epilepticus in adults: electroclinical differences between proper and comatose forms,” Clin Neurophysiol, vol. 123, no. 2, pp. 244–251, Feb. 2012, doi: 10.1016/j.clinph.2011.06.020.
[6467]	W. G. Danton, J. Altrocchi, D. Antonuccio, and R. Basta, “Nondrug treatment of anxiety,” Am Fam Physician, vol. 49, no. 1, pp. 161–166, Jan. 1994.
[6468]	S. K. Jeon et al., “Nonhypervascular Pancreatic Neuroendocrine Tumors: Differential Diagnosis from Pancreatic Ductal Adenocarcinomas at MR Imaging-Retrospective Cross-sectional Study,” Radiology, vol. 284, no. 1, pp. 77–87, 2017, doi: 10.1148/radiol.2016160586.
[6469]	C. Ramanathan, R. N. Ghanem, P. Jia, K. Ryu, and Y. Rudy, “Noninvasive electrocardiographic imaging for cardiac electrophysiology and arrhythmia,” Nat. Med., vol. 10, no. 4, pp. 422–428, Apr. 2004, doi: 10.1038/nm1011.
[6470]	H. Yang, H. Zheng, H. Liu, and Q. Wu, “NonLinear Effects of Environmental Regulation on Eco-Efficiency under the Constraint of Land Use Carbon Emissions: Evidence Based on a Bootstrapping Approach and Panel Threshold Model,” Int J Environ Res Public Health, vol. 16, no. 10, 14 2019, doi: 10.3390/ijerph16101679.
[6471]	D. R. Rigney and A. L. Goldberger, “Nonlinear mechanics of the heart’s swinging during pericardial effusion,” Am. J. Physiol., vol. 257, no. 4 Pt 2, pp. H1292-1305, Oct. 1989, doi: 10.1152/ajpheart.1989.257.4.H1292.
[6472]	L.-Y. Chen et al., “Nonmedical prescription drug use of analgesics and sedatives/hypnotics in Taiwan: Results from the 2014 National Survey of Substance Use,” Prev Med Rep, vol. 15, p. 100900, Sep. 2019, doi: 10.1016/j.pmedr.2019.100900.
[6473]	C. W. Striley, N. E. Kelso-Chichetto, and L. B. Cottler, “Nonmedical Prescription Stimulant Use Among Girls 10-18 Years of Age: Associations With Other Risky Behavior,” J Adolesc Health, vol. 60, no. 3, pp. 328–332, Mar. 2017, doi: 10.1016/j.jadohealth.2016.10.013.
[6474]	T. A. Cassidy, S. Varughese, L. Russo, S. H. Budman, T. A. Eaton, and S. F. Butler, “Nonmedical Use and Diversion of ADHD Stimulants Among U.S. Adults Ages 18-49: A National Internet Survey,” J Atten Disord, vol. 19, no. 7, pp. 630–640, Jul. 2015, doi: 10.1177/1087054712468486.
[6475]	J. Hockenhull et al., “Nonmedical use of alprazolam in the UK: Results from a nationally representative survey,” Br J Clin Pharmacol, vol. 85, no. 8, pp. 1841–1845, 2019, doi: 10.1111/bcp.13959.
[6476]	J. Hockenhull et al., “Nonmedical use of benzodiazepines and Z-drugs in the UK,” Br J Clin Pharmacol, May 2020, doi: 10.1111/bcp.14397.
[6477]	J. Kryger, “Nonsurgical management of the neurogenic bladder in children,” ScientificWorldJournal, vol. 8, pp. 1177–1183, Nov. 2008, doi: 10.1100/tsw.2008.146.
[6478]	R. Bureau, “Nontest Methods to Predict Acute Toxicity: State of the Art for Applications of In Silico Methods,” Methods Mol. Biol., vol. 1800, pp. 519–534, 2018, doi: 10.1007/978-1-4939-7899-1_24.
[6479]	K. Dowdell, S.-J. Haig, L. J. Caverly, Y. Shen, J. J. LiPuma, and L. Raskin, “Nontuberculous mycobacteria in drinking water systems - the challenges of characterization and risk mitigation,” Curr. Opin. Biotechnol., vol. 57, pp. 127–136, 2019, doi: 10.1016/j.copbio.2019.03.010.
[6480]	P. Wiessner, “Norm enforcement among the Ju/’hoansi Bushmen : A case of strong reciprocity?,” Hum Nat, vol. 16, no. 2, pp. 115–145, Jun. 2005, doi: 10.1007/s12110-005-1000-9.
[6481]	A. Schnitzler and J. Gross, “Normal and pathological oscillatory communication in the brain,” Nat. Rev. Neurosci., vol. 6, no. 4, pp. 285–296, Apr. 2005, doi: 10.1038/nrn1650.
[6482]	A. Bogte, A. J. Bredenoord, J. Oors, P. D. Siersema, and A. J. P. M. Smout, “Normal values for esophageal high-resolution manometry,” Neurogastroenterol. Motil., vol. 25, no. 9, pp. 762-e579, Sep. 2013, doi: 10.1111/nmo.12167.
[6483]	C. Kiese-Himmel and T. Risse, “[Norms for the Mottier-Test from 4- to 6-year old children],” HNO, vol. 57, no. 9, pp. 943–948, Sep. 2009, doi: 10.1007/s00106-009-1958-4.
[6484]	A. Abou-Chebl et al., “North American SOLITAIRE Stent-Retriever Acute Stroke Registry: choice of anesthesia and outcomes,” Stroke, vol. 45, no. 5, pp. 1396–1401, May 2014, doi: 10.1161/STROKEAHA.113.003698.
[6485]	M. Clark et al., “Nosebleeds in hereditary hemorrhagic telangiectasia: Development of a patient-completed daily eDiary,” Laryngoscope Investig Otolaryngol, vol. 3, no. 6, pp. 439–445, Dec. 2018, doi: 10.1002/lio2.211.
[6486]	L. Yu-Hsien, C. Te-Li, C. Chien-Pei, and T. Chen-Chi, “Nosocomial acinetobacter genomic species 13 TU endocarditis following an endoscopic procedure,” Intern. Med., vol. 47, no. 8, pp. 799–802, 2008, doi: 10.2169/internalmedicine.47.0826.
[6487]	S. Herculano-Houzel, “Not all brains are made the same: new views on brain scaling in evolution,” Brain Behav. Evol., vol. 78, no. 1, pp. 22–36, 2011, doi: 10.1159/000327318.
[6488]	O. Cortés Rico et al., “[Not Available],” Aten Primaria, vol. 48 Suppl 1, pp. 127–147, Jun. 2016, doi: 10.1016/S0212-6567(16)30192-5.
[6489]	 null Gilbert-Dreyfus, F. Siguier, M. Zara, and G. Lagrue, “[Not Available],” Sem Hop, vol. 30, no. 63, pp. 3543–3545, Oct. 1954.
[6490]	P. Nieminen, “[Not Available],” Duodecim, vol. 123, no. 5, pp. 533–536, 2007.
[6491]	C. Papa, “[Not Available],” Stor Med Pop, vol. 8, no. 2–3, pp. 121–139, 1990.
[6492]	U. Papa, “[Not Available],” Policlinico Prat, vol. 55, no. No 34, p. 1036, Aug. 1948.
[6493]	B. Zango, B. Kirakoya, F. Kabor, C. Yameogo, and B. Ky, “[Not Available],” Prog. Urol., vol. 25, no. 13, p. 815, Nov. 2015, doi: 10.1016/j.purol.2015.08.199.
[6494]	“[Not Available],” Nurs Manag (Harrow), vol. 11, no. 9, p. 5, Feb. 2005, doi: 10.7748/nm.11.9.5.s5.
[6495]	L. Zhao et al., “Notch signaling regulates cardiomyocyte proliferation during zebrafish heart regeneration,” Proc. Natl. Acad. Sci. U.S.A., vol. 111, no. 4, pp. 1403–1408, Jan. 2014, doi: 10.1073/pnas.1311705111.
[6496]	J. M. Mazurek, P. L. Schleiff, J. M. Wood, S. A. Hendricks, A. Weston, and Centers for Disease Control and Prevention (CDC), “Notes from the Field: Update: Silicosis Mortality - United States, 1999-2013,” MMWR Morb. Mortal. Wkly. Rep., vol. 64, no. 23, pp. 653–654, Jun. 2015.
[6497]	J. A. Teixeira da Silva and J. Dobránszki, “Notices and Policies for Retractions, Expressions of Concern, Errata and Corrigenda: Their Importance, Content, and Context,” Sci Eng Ethics, vol. 23, no. 2, pp. 521–554, 2017, doi: 10.1007/s11948-016-9769-y.
[6498]	W. Zhao, S. Xue, Z. Yu, L. Ding, J. Li, and J. Liu, “Novel ACE inhibitors derived from soybean proteins using in silico and in vitro studies,” J. Food Biochem., vol. 43, no. 9, p. e12975, 2019, doi: 10.1111/jfbc.12975.
[6499]	S. M. Danilov et al., “Novel ACE mutations mimicking sarcoidosis by increasing blood ACE levels,” Transl Res, Jul. 2020, doi: 10.1016/j.trsl.2020.07.010.
[6500]	A. Accogli et al., “Novel AMPD2 mutation in pontocerebellar hypoplasia, dysmorphisms, and teeth abnormalities,” Neurol Genet, vol. 3, no. 5, p. e179, Oct. 2017, doi: 10.1212/NXG.0000000000000179.
[6501]	E. Huri, “Novel anatomical identification of nerve-sparing radical prostatectomy: fascial-sparing radical prostatectomy,” Prostate Int, vol. 2, no. 1, pp. 1–7, Mar. 2014, doi: 10.12954/PI.13038.
[6502]	Y. Kryachko, “Novel approaches to microbial enhancement of oil recovery,” J. Biotechnol., vol. 266, pp. 118–123, Jan. 2018, doi: 10.1016/j.jbiotec.2017.12.019.
[6503]	K. Syed, S. Naguib, Z.-J. Liu, L. Cimmino, and F.-C. Yang, “Novel combinations to improve hematopoiesis in myelodysplastic syndrome,” Stem Cell Res Ther, vol. 11, no. 1, p. 132, Mar. 2020, doi: 10.1186/s13287-020-01647-1.
[6504]	R. Koyama and N. Matsuki, “Novel etiological and therapeutic strategies for neurodiseases: mechanisms and consequences of febrile seizures: lessons from animal models,” J. Pharmacol. Sci., vol. 113, no. 1, pp. 14–22, 2010, doi: 10.1254/jphs.09r19fm.
[6505]	X. Chen et al., “Novel GLI3 Mutations in Chinese Patients with Non-syndromic Post-axial Polydactyly,” Curr. Mol. Med., vol. 19, no. 3, pp. 228–235, 2019, doi: 10.2174/1566524019666190308110122.
[6506]	N. H. Kalin, “Novel Insights Into Pathological Anxiety and Anxiety-Related Disorders,” Am J Psychiatry, vol. 177, no. 3, pp. 187–189, 01 2020, doi: 10.1176/appi.ajp.2020.20010057.
[6507]	V. Anagnostou, G. Pardalos, M. Athanasiou-Metaxa, and A. Papa, “Novel phlebovirus in febrile child, Greece,” Emerging Infect. Dis., vol. 17, no. 5, pp. 940–941, May 2011, doi: 10.3201/eid1705.101958.
[6508]	E. Lindwall, S. Singla, W. E. Davis, and R. J. Quinet, “Novel PSTPIP1 gene mutation in a patient with pyogenic arthritis, pyoderma gangrenosum and acne (PAPA) syndrome,” Semin. Arthritis Rheum., vol. 45, no. 1, pp. 91–93, Aug. 2015, doi: 10.1016/j.semarthrit.2015.02.012.
[6509]	L. Tian et al., “Novel reusable porous polyimide fibers for hot-oil adsorption,” J. Hazard. Mater., vol. 340, pp. 67–76, Oct. 2017, doi: 10.1016/j.jhazmat.2017.06.063.
[6510]	E. Vigo et al., “Novel role of the anorexigenic peptide neuromedin U in the control of LH secretion and its regulation by gonadal hormones and photoperiod,” Am. J. Physiol. Endocrinol. Metab., vol. 293, no. 5, pp. E1265-1273, Nov. 2007, doi: 10.1152/ajpendo.00425.2007.
[6511]	S. Frosch et al., “Novel single-loop and double-loop knot stitch in comparison with the modified Mason-Allen stitch for rotator cuff repair,” Knee Surg Sports Traumatol Arthrosc, vol. 23, no. 5, pp. 1552–1558, May 2015, doi: 10.1007/s00167-014-2976-7.
[6512]	J. H. Tu, S. L. Sheu, and J. M. Teng, “Novel Treatment Using Cimetidine for Erythropoietic Protoporphyria in Children,” JAMA Dermatol, vol. 152, no. 11, pp. 1258–1261, 01 2016, doi: 10.1001/jamadermatol.2016.2303.
[6513]	J.-H. Han et al., “Noxa mitochondrial targeting domain induces necrosis via VDAC2 and mitochondrial catastrophe,” Cell Death Dis, vol. 10, no. 7, p. 519, 08 2019, doi: 10.1038/s41419-019-1753-4.
[6514]	X. Dai, X. Yan, K. A. Wintergerst, L. Cai, B. B. Keller, and Y. Tan, “Nrf2: Redox and Metabolic Regulator of Stem Cell State and Function,” Trends Mol Med, vol. 26, no. 2, pp. 185–200, Feb. 2020, doi: 10.1016/j.molmed.2019.09.007.
[6515]	E. E. McConnell, “NTP carcinogens--interpretational problems,” Mutat. Res., vol. 248, no. 2, pp. 233–237, Jun. 1991, doi: 10.1016/0027-5107(91)90059-w.
[6516]	J.-L. Kruger, N. Patzke, K. Fuxe, N. C. Bennett, and P. R. Manger, “Nuclear organization of cholinergic, putative catecholaminergic, serotonergic and orexinergic systems in the brain of the African pygmy mouse (Mus minutoides): organizational complexity is preserved in small brains,” J. Chem. Neuroanat., vol. 44, no. 1, pp. 45–56, May 2012, doi: 10.1016/j.jchemneu.2012.04.002.
[6517]	P. J. Hensley and N. Kyprianou, “Nuclear spindles pave the way to metastasis,” Oncotarget, vol. 9, no. 16, pp. 12544–12545, Feb. 2018, doi: 10.18632/oncotarget.23728.
[6518]	P. S. Patole and H.-J. Anders, “Nucleic acids modulate autoimmunity through nucleic-acid-specific toll-like receptors,” Curr. Med. Chem., vol. 13, no. 25, pp. 3061–3067, 2006, doi: 10.2174/092986706778521832.
[6519]	J. Hauber, P. Nelböck-Hochstetter, and H. Feldmann, “Nucleotide sequence and characteristics of a Ty element from yeast,” Nucleic Acids Res., vol. 13, no. 8, pp. 2745–2758, Apr. 1985, doi: 10.1093/nar/13.8.2745.
[6520]	A. Mampel, M. I. Echeverría, A. L. Vargas, and M. Roque, “[Numeric alterations in the dys gene and their association with clinical features],” Medicina (B Aires), vol. 71, no. 2, pp. 151–157, 2011.
[6521]	W. Wriggers and J. He, “Numerical geometry of map and model assessment,” J. Struct. Biol., vol. 192, no. 2, pp. 255–261, Nov. 2015, doi: 10.1016/j.jsb.2015.09.011.
[6522]	S. T. Prepeliţă, J. G. Bolaños, V. Pulkki, L. Savioja, and R. Mehra, “Numerical simulations of near-field head-related transfer functions: Magnitude verification and validation with laser spark sources,” J. Acoust. Soc. Am., vol. 148, no. 1, p. 153, Jul. 2020, doi: 10.1121/10.0001409.
[6523]	T. Huschto, G. Feichtinger, R. F. Hartl, P. M. Kort, S. Sager, and A. Seidl, “Numerical solution of a conspicuous consumption model with constant control delay,” Automatica (Oxf), vol. 47, no. 9, pp. 1868–1877, Sep. 2011, doi: 10.1016/j.automatica.2011.06.004.
[6524]	L. Rew, “Nurses’ intuition,” Appl Nurs Res, vol. 1, no. 1, pp. 27–31, May 1988, doi: 10.1016/s0897-1897(88)80042-9.
[6525]	L. Rew and E. M. Barrow, “Nurses’ intuition. Can it coexist with the nursing process?,” AORN J, vol. 50, no. 2, pp. 353–354, 356, 358, Aug. 1989, doi: 10.1016/s0001-2092(07)65985-7.
[6526]	J. de L. Lopes, D. A. Barbosa, L. A. Nogueira-Martins, and A. L. B. L. de Barros, “Nursing guidance on bed baths to reduce anxiety,” Rev Bras Enferm, vol. 68, no. 3, pp. 437–443, 497–503, Jun. 2015, doi: 10.1590/0034-7167.2015680317i.
[6527]	P. Katriina, V. Sari, R. Anja, S. Christina, A. Paula, and S. Tarja, “Nursing power as viewed by nursing professionals,” Scand J Caring Sci, vol. 27, no. 3, pp. 580–588, Sep. 2013, doi: 10.1111/j.1471-6712.2012.01069.x.
[6528]	R. de Carvalho, O. G. D. Farah, and L. E. Galdeano, “[Nursing undergraduates’ anxiety about the first surgical instrumentation],” Rev Lat Am Enfermagem, vol. 12, no. 6, pp. 918–923, Dec. 2004, doi: 10.1590/s0104-11692004000600011.
[6529]	P. Schloss, “Nurturing the microbiome field,” Science, vol. 350, no. 6264, p. 1044, Nov. 2015, doi: 10.1126/science.350.6264.1044.
[6530]	M. V. Fonseca and M. S. Swanson, “Nutrient salvaging and metabolism by the intracellular pathogen Legionella pneumophila,” Front Cell Infect Microbiol, vol. 4, p. 12, 2014, doi: 10.3389/fcimb.2014.00012.
[6531]	A. B. Thomson, K. Doring, M. Keelan, and G. Armstrong, “Nutrient uptake into undifferentiated and differentiated HT-29 cells in culture,” Can. J. Physiol. Pharmacol., vol. 75, no. 5, pp. 351–356, May 1997, doi: 10.1139/cjpp-75-5-351.
[6532]	V. Hernando-Requejo, “Nutrition and cognitive impairment,” Nutr Hosp, vol. 33, no. Suppl 4, p. 346, 12 2016, doi: 10.20960/nh.346.
[6533]	G. A. Scardina and P. Messina, “[Nutrition and oral health],” Recenti Prog Med, vol. 99, no. 2, pp. 106–111, Feb. 2008.
[6534]	S. Felesky-Hunt, “Nutrition for runners,” Clin Podiatr Med Surg, vol. 18, no. 2, pp. 337–350, vii, Apr. 2001.
[6535]	H. Gutierrez, B. Taghizada, and M. D. Meneghini, “Nutritional and meiotic induction of transiently heritable stress resistant states in budding yeast,” Microb Cell, vol. 5, no. 11, pp. 511–521, Oct. 2018, doi: 10.15698/mic2018.11.657.
[6536]	J. S. da Silva et al., “Nutritive value and fermentation quality of palisadegrass and stylo mixed silages,” Anim. Sci. J., vol. 89, no. 1, pp. 72–78, Jan. 2018, doi: 10.1111/asj.12854.
[6537]	M. S. Ellulu, “Obesity, Hypertension, and Type-2 Diabetes Mellitus: The Interrelationships and the Determinants among Adults in Gaza City, Palestine,” Osong Public Health Res Perspect, vol. 9, no. 6, pp. 289–298, Dec. 2018, doi: 10.24171/j.phrp.2018.9.6.02.
[6538]	B. Shakiba and S. Irani, “Objective method for author determination (OMAD),” J Eval Clin Pract, vol. 25, no. 5, pp. 903–905, Oct. 2019, doi: 10.1111/jep.13130.
[6539]	M. Brichacek, B. Sultan, K. D. Boahene, L. Ishii, and P. J. Byrne, “Objective Outcomes of Minimally Invasive Temporalis Tendon Transfer for Prolonged Complete Facial Paralysis,” Plast Surg (Oakv), vol. 25, no. 3, pp. 200–210, Aug. 2017, doi: 10.1177/2292550317728033.
[6540]	E. Poy, “Objectives of QC systems and QA function in clinical research,” Qual Assur, vol. 2, no. 4, pp. 326–331, Dec. 1993.
[6541]	F. A. Sawair, Y. Hassoneh, A. O. Jamleh, and M. Al-Rabab’ah, “Observance of proper mercury hygiene practices by Jordanian general dental practitioners,” Int J Occup Med Environ Health, vol. 23, no. 1, pp. 47–54, 2010, doi: 10.2478/v10001-010-0012-9.
[6542]	P. Naik et al., “Observation of eta’ decays to pi+pi-pi0 and pi+pi-e+e-,” Phys. Rev. Lett., vol. 102, no. 6, p. 061801, Feb. 2009, doi: 10.1103/PhysRevLett.102.061801.
[6543]	Y. Liu, L. Li, G. Xu, and W. Wang, “[Observation on long-term efficacy of half-dose photodynamic therapy with chronic central serous chorioretinopathy using optical coherence tomography],” Zhonghua Yan Ke Za Zhi, vol. 52, no. 5, pp. 328–334, May 2016, doi: 10.3760/cma.j.issn.0412-4081.2016.05.004.
[6544]	H. Manell, “[OBSERVATIONS ON THE IN VITRO CULTURE OF THE HEMATIC BLASTEMA OF THE CHICK EMBRYO],” Ric Sci 2 Ser Pt 2 Rend B, vol. 3, pp. 493–498, Dec. 1963.
[6545]	J.-H. Seo, W.-K. Lee, and S.-P. Park, “Obsessive-compulsive symptoms and their impacts on psychosocial functioning in people with epilepsy,” J Clin Neurol, vol. 10, no. 2, pp. 125–132, Apr. 2014, doi: 10.3988/jcn.2014.10.2.125.
[6546]	A. M. Kanner, “Obstacles in the treatment of common psychiatric comorbidities in patients with epilepsy: What is wrong with this picture?,” Epilepsy Behav, vol. 98, no. Pt B, pp. 291–292, 2019, doi: 10.1016/j.yebeh.2019.03.013.
[6547]	C. J. Greenlee, M. A. Scholes, D. Gao, and N. R. Friedman, “Obstructive Sleep Apnea and Sleep Position: Does It Matter for Infants With a Cleft Palate?,” Cleft Palate Craniofac. J., vol. 56, no. 7, pp. 890–895, 2019, doi: 10.1177/1055665618817664.
[6548]	V. V. Kemstach, L. S. Korostovtseva, M. S. Golovkova-Kucheriavaia, M. V. Bochkarev, Y. V. Sviryaev, and A. N. Alekhin, “[Obstructive sleep apnea syndrome and cognitive impairment],” Zh Nevrol Psikhiatr Im S S Korsakova, vol. 120, no. 1, pp. 90–95, 2020, doi: 10.17116/jnevro202012001190.
[6549]	Z. Lin, Q. Si, and Z. Xiaoyi, “Obstructive sleep apnoea in patients with epilepsy: a meta-analysis,” Sleep Breath, vol. 21, no. 2, pp. 263–270, May 2017, doi: 10.1007/s11325-016-1391-3.
[6550]	J. Mulnard, “[OBTAINING IN VITRO OF THE CONTINUOUS DEVELOPMENT OF THE MOUSE OVUM FROM  STAGE II TO THE BLASTOCYST STAGE],” C. R. Hebd. Seances Acad. Sci., vol. 258, pp. 6228–6229, Jun. 1964.
[6551]	M. S. Nguyen et al., “Occlusal features and need for orthodontic treatment in persons with osteogenesis imperfecta,” Clin Exp Dent Res, vol. 3, no. 1, pp. 19–24, Feb. 2017, doi: 10.1002/cre2.53.
[6552]	E. R. Plunkett and B. J. Dewitt, “Occupational exposure to Hi-Sil and Silene. Report of an 18-year study,” Arch. Environ. Health, vol. 5, pp. 469–472, Nov. 1962, doi: 10.1080/00039896.1962.10663313.
[6553]	Occupational Safety and Health Administration (OSHA), Department of Labor, “Occupational Exposure to Respirable Crystalline Silica. Final rule,” Fed Regist, vol. 81, no. 58, pp. 16285–16890, Mar. 2016.
[6554]	N. Wang et al., “Occupational functional plasticity revealed by brain entropy: A resting-state fMRI study of seafarers,” Hum Brain Mapp, vol. 39, no. 7, pp. 2997–3004, 2018, doi: 10.1002/hbm.24055.
[6555]	D. Gardner and C. Winder, “Occupational health and safety management systems,” Qual Assur, vol. 5, no. 3, pp. 183–196, Sep. 1997.
[6556]	C. S. Colgan, “Occupational medicine. Economics,” Occup Med, vol. 4, no. 1, pp. 11–38, Mar. 1989.
[6557]	J. Howard and F. Hearl, “Occupational safety and health in the USA: now and the future,” Ind Health, vol. 50, no. 2, pp. 80–83, 2012, doi: 10.2486/indhealth.ms1356.
[6558]	S. Iavicoli, B. M. Rondinone, and F. Boccuni, “Occupational safety and health’s role in sustainable, responsible nanotechnology: gaps and needs,” Hum Exp Toxicol, vol. 28, no. 6–7, pp. 433–443, Jun. 2009, doi: 10.1177/0960327109105162.
[6559]	C. Pelucchi, E. Pira, G. Piolatto, M. Coggiola, P. Carta, and C. La Vecchia, “Occupational silica exposure and lung cancer risk: a review of epidemiological studies 1996-2005,” Ann. Oncol., vol. 17, no. 7, pp. 1039–1050, Jul. 2006, doi: 10.1093/annonc/mdj125.
[6560]	G. M. Calvert, F. L. Rice, J. M. Boiano, J. W. Sheehy, and W. T. Sanderson, “Occupational silica exposure and risk of various diseases: an analysis using death certificates from 27 states of the United States,” Occup Environ Med, vol. 60, no. 2, pp. 122–129, Feb. 2003, doi: 10.1136/oem.60.2.122.
[6561]	S. Chalupka, “Occupational silica exposure in hydraulic fracturing,” Workplace Health Saf, vol. 60, no. 10, p. 460, Oct. 2012, doi: 10.1177/216507991206001009.
[6562]	J. L. Wenzel et al., “Occupational traumatic injuries rarely affect genitourinary organs: a retrospective, comparative study,” World J Urol, vol. 38, no. 2, pp. 505–510, Feb. 2020, doi: 10.1007/s00345-019-02796-6.
[6563]	C. Muraleedharan, D. Talreja, M. Kanwar, A. Kumar, and S. K. Walia, “Occurrence of extended-spectrum β-lactamase-producing bacteria in urban Clinton River habitat,” J Glob Antimicrob Resist, vol. 16, pp. 225–235, 2019, doi: 10.1016/j.jgar.2018.10.007.
[6564]	F. Bjurlid, M. Dam, K. Hoydal, and J. Hagberg, “Occurrence of polybrominated dibenzo-p-dioxins, dibenzofurans (PBDD/Fs) and polybrominated diphenyl ethers (PBDEs) in pilot whales (Globicephala melas) caught around the Faroe Islands,” Chemosphere, vol. 195, pp. 11–20, Mar. 2018, doi: 10.1016/j.chemosphere.2017.12.044.
[6565]	R. Meissner, “Ocean governance for human health and the role of the social sciences,” Lancet Planet Health, vol. 2, no. 7, pp. e275–e276, 2018, doi: 10.1016/S2542-5196(18)30139-6.
[6566]	M. McNutt, “Oceans and Earth’s habitability,” Science, vol. 348, no. 6237, p. 841, May 2015, doi: 10.1126/science.aac5755.
[6567]	S. K. Bhattacharya, G. G. Hom, C. Fernandez, and L. G. Hom, “Ocular effects of exposure to industrial chemicals: clinical management and proteomic approaches to damage assessment,” Cutan Ocul Toxicol, vol. 26, no. 3, pp. 203–225, 2007, doi: 10.1080/15569520701402594.
[6568]	V. Papa, A. R. Blanco, and M. Santocono, “Ocular flora and their antibiotic susceptibility in patients having cataract surgery in Italy,” J Cataract Refract Surg, vol. 42, no. 9, pp. 1312–1317, 2016, doi: 10.1016/j.jcrs.2016.07.022.
[6569]	A. Bulbulia, R. Shaik, N. Khan, S. Vayej, B. Kistnasamy, and T. Page, “Ocular health status of chemical industrial workers,” Optom Vis Sci, vol. 72, no. 4, pp. 233–240, Apr. 1995, doi: 10.1097/00006324-199504000-00003.
[6570]	R. E. Little, C. M. Long, T. A. Loehrl, and D. M. Poetker, “Odontogenic sinusitis: A review of the current literature,” Laryngoscope Investig Otolaryngol, vol. 3, no. 2, pp. 110–114, Apr. 2018, doi: 10.1002/lio2.147.
[6571]	D. A. Rew, “Of digital mice and men,” Eur J Surg Oncol, vol. 29, no. 7, pp. 624–627, Sep. 2003, doi: 10.1016/s0748-7983(03)00081-7.
[6572]	J. F. DeLucca, D. Amin, J. M. Peloquin, E. J. Vresilovic, J. J. Costi, and D. M. Elliott, “Off-axis response due to mechanical coupling across all six degrees of freedom in the human disc,” JOR Spine, vol. 2, no. 1, p. e1047, Mar. 2019, doi: 10.1002/jsp2.1047.
[6573]	F. Moulis, G. Durrieu, and M. Lapeyre-Mestre, “Off-label and unlicensed drug use in children population,” Therapie, vol. 73, no. 2, pp. 135–149, Apr. 2018, doi: 10.1016/j.therap.2018.02.002.
[6574]	D. R. Pan and D. E. Rosow, “Office-based corticosteroid injections as adjuvant therapy for subglottic stenosis,” Laryngoscope Investig Otolaryngol, vol. 4, no. 4, pp. 414–419, Aug. 2019, doi: 10.1002/lio2.284.
[6575]	N. van den Broek, “Official Development Assistance for reproductive health has increased but may not be going to those who need it the most,” BJOG, vol. 123, no. 10, p. 1705, 2016, doi: 10.1111/1471-0528.13908.
[6576]	S. W. Watts, “Oh, the places you’ll go! My many colored serotonin (apologies to Dr. Seuss),” Am. J. Physiol. Heart Circ. Physiol., vol. 311, no. 5, pp. H1225–H1233, 01 2016, doi: 10.1152/ajpheart.00538.2016.
[6577]	M. El Riachy, A. Hamade, R. Ayoub, F. Dandachi, and L. Chalak, “Oil Content, Fatty Acid and Phenolic Profiles of Some Olive Varieties Growing in Lebanon,” Front Nutr, vol. 6, p. 94, 2019, doi: 10.3389/fnut.2019.00094.
[6578]	B. Matthäus and M. Musazcan Özcan, “Oil Content, Fatty Acid Composition and Distributions of Vitamin-E-Active Compounds of Some Fruit Seed Oils,” Antioxidants (Basel), vol. 4, no. 1, pp. 124–133, Jan. 2015, doi: 10.3390/antiox4010124.
[6579]	H. Adelmann, B. P. Binks, and R. Mezzenga, “Oil powders and gels from particle-stabilized emulsions,” Langmuir, vol. 28, no. 3, pp. 1694–1697, Jan. 2012, doi: 10.1021/la204811c.
[6580]	M. Pannekens, L. Kroll, H. Müller, F. T. Mbow, and R. U. Meckenstock, “Oil reservoirs, an exceptional habitat for microorganisms,” N Biotechnol, vol. 49, pp. 1–9, Mar. 2019, doi: 10.1016/j.nbt.2018.11.006.
[6581]	I. D. Nissanka and P. D. Yapa, “Oil slicks on water surface: Breakup, coalescence, and droplet formation under breaking waves,” Mar. Pollut. Bull., vol. 114, no. 1, pp. 480–493, Jan. 2017, doi: 10.1016/j.marpolbul.2016.10.006.
[6582]	G. Thilagavathi, C. Praba Karan, and D. Das, “Oil sorption and retention capacities of thermally-bonded hybrid nonwovens prepared from cotton, kapok, milkweed and polypropylene fibers,” J. Environ. Manage., vol. 219, pp. 340–349, Aug. 2018, doi: 10.1016/j.jenvman.2018.04.107.
[6583]	F. J. Hidalgo, G. Gómez, J. L. Navarro, and R. Zamora, “Oil stability prediction by high-resolution (13)C nuclear magnetic resonance spectroscopy,” J. Agric. Food Chem., vol. 50, no. 21, pp. 5825–5831, Oct. 2002, doi: 10.1021/jf0256539.
[6584]	K. Müller, S. Hirano, L. Puelles, and C. Redies, “OL-protocadherin expression in the visual system of the chicken embryo,” J. Comp. Neurol., vol. 470, no. 3, pp. 240–255, Mar. 2004, doi: 10.1002/cne.11044.
[6585]	S. Tayne and P. A. Smith, “Olecranon Fractures in Pediatric Patients With Osteogenesis Imperfecta,” J Pediatr Orthop, vol. 39, no. 7, pp. e558–e562, Aug. 2019, doi: 10.1097/BPO.0000000000001333.
[6586]	S. Landolfo, G. Zara, S. Zara, M. Budroni, M. Ciani, and I. Mannazzu, “Oleic acid and ergosterol supplementation mitigates oxidative stress in wine strains of Saccharomyces cerevisiae,” Int. J. Food Microbiol., vol. 141, no. 3, pp. 229–235, Jul. 2010, doi: 10.1016/j.ijfoodmicro.2010.05.020.
[6587]	G. Tezcan et al., “Oleuropein modulates glioblastoma miRNA pattern different from Olea europaea leaf extract,” Hum Exp Toxicol, vol. 38, no. 9, pp. 1102–1110, Sep. 2019, doi: 10.1177/0960327119855123.
[6588]	M. Kühn, N. Abolmaali, M. Smitka, D. Podlesek, and T. Hummel, “[Olfactory dysfunction : Update on diagnosis and treatment],” HNO, vol. 64, no. 7, pp. 517–529, Jul. 2016, doi: 10.1007/s00106-016-0175-1.
[6589]	R. Choi and B. J. Goldstein, “Olfactory epithelium: Cells, clinical disorders, and insights from an adult stem cell niche,” Laryngoscope Investig Otolaryngol, vol. 3, no. 1, pp. 35–42, 2018, doi: 10.1002/lio2.135.
[6590]	G. Besser, D. T. Liu, B. Renner, T. Hummel, and C. A. Mueller, “Olfactory implant: Demand for a future treatment option in patients with olfactory dysfunction,” Laryngoscope, vol. 129, no. 2, pp. 312–316, 2019, doi: 10.1002/lary.27476.
[6591]	A. Almad, F. R. Sahinkaya, and D. M. McTigue, “Oligodendrocyte fate after spinal cord injury,” Neurotherapeutics, vol. 8, no. 2, pp. 262–273, Apr. 2011, doi: 10.1007/s13311-011-0033-5.
[6592]	S. Tu, S. Okamoto, S. A. Lipton, and H. Xu, “Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease,” Mol Neurodegener, vol. 9, p. 48, Nov. 2014, doi: 10.1186/1750-1326-9-48.
[6593]	R. N. Jenkins, C. J. Aldrich, L. A. Lopez, and R. R. Rich, “Oligosaccharide-dependent and independent Qa-1 determinants,” J. Immunol., vol. 134, no. 5, pp. 3218–3225, May 1985.
[6594]	I. Kalaiselvan, M. Samuthirapandi, A. Govindaraju, D. Sheeja Malar, and P. D. Kasi, “Olive oil and its phenolic compounds (hydroxytyrosol and tyrosol) ameliorated TCDD-induced heptotoxicity in rats via inhibition of oxidative stress and apoptosis,” Pharm Biol, vol. 54, no. 2, pp. 338–346, 2016, doi: 10.3109/13880209.2015.1042980.
[6595]	A. Ferramosca, V. Savy, and V. Zara, “Olive oil increases the hepatic triacylglycerol content in mice by a distinct influence on the synthesis and oxidation of fatty acids,” Biosci. Biotechnol. Biochem., vol. 72, no. 1, pp. 62–69, Jan. 2008, doi: 10.1271/bbb.70369.
[6596]	V. Kasture, S. Dalvi, M. Swamy, A. Kale, and S. Joshi, “Omega-3 fatty acids differentially influences embryotoxicity in subtypes of preeclampsia,” Clin. Exp. Hypertens., vol. 42, no. 3, pp. 205–212, 2020, doi: 10.1080/10641963.2019.1601208.
[6597]	D. L. Hart and M. W. Werneke, “On ‘motor control exercise for chronic low back pain...’ Costa LOP, Maher CG, Latimer J, et al. Phys Ther. 2009;89:1275-1286,” Phys Ther, vol. 90, no. 2, pp. 308–310; author reply 310-311, Feb. 2010, doi: 10.2522/ptj.2010.90.2.308.
[6598]	K. Karzel, “[ON A PERMANENT STRAIN OF EHRLICH-ASCITES TUMOR CELLS GROWING IN SUSPENSION IN VITRO],” Med Pharmacol Exp Int J Exp Med, vol. 12, pp. 137–144, 1965.
[6599]	N. M. Katz, “On a question of Rudnick: do we have square root cancellation for error terms in moment calculations?,” Philos Trans A Math Phys Eng Sci, vol. 239, no. 2040, Apr. 2015, doi: 10.1098/rsta.2014.0312.
[6600]	 null Wang and  null Schwarz, “On Closed-Shell Interactions, Polar Covalences, d Shell Holes, and Direct Images of Orbitals: The Case of Cuprite Discussions with Professors and Doctors G. von Bünau, B. Engelen, H. D. Lutz, J. Niu-Schwarz, and A. Pfitzner (Siegen, Germany), R. Hoffmann (Ithaka, NY, USA), C. J. Humphreys (Cambridge, UK), A. Kirfel (Bonn, Germany), T. Lippman and J. Schneider (Hamburg, Germany), K. Schwarz (Vienna, Austria), M. Spackman (Armidale, Australia), J. C. H. Spence, M. O’Keefe and J. M. Zuo (Tempe AZ, USA), and financial support by Deutsche Forschungsgemeinschaft (DFG) and by Fonds der Chemischen Industrie (FCI) are all gratefully acknowledged,” Angew. Chem. Int. Ed. Engl., vol. 39, no. 10, pp. 1757–1761, May 2000, doi: 10.1002/(sici)1521-3773(20000515)39:10<1757::aid-anie1757>3.0.co;2-i.
[6601]	A. F. Zakharov, E. P. Ugriumov, and I. I. Podoplelov, “[On conditions for obtaining growth of cells cultured in vitro in the form of isolated colonies],” Biull Eksp Biol Med, vol. 55(3), pp. 91–96, 1963.
[6602]	T. O. Tobore, “On Energy Efficiency and the Brain’s Resistance to Change: The Neurological Evolution of Dogmatism and Close-Mindedness,” Psychol Rep, vol. 122, no. 6, pp. 2406–2416, Dec. 2019, doi: 10.1177/0033294118792670.
[6603]	R. E. Rudd, O. R. Groene, and M. D. Navarro-Rubio, “On health literacy and health outcomes: background, impact, and future directions,” Rev Calid Asist, vol. 28, no. 3, pp. 188–192, Jun. 2013, doi: 10.1016/j.cali.2013.03.003.
[6604]	P. P. Barros and X. Martinez-Giralt, “On international cost-sharing of pharmaceutical R&D,” Int J Health Care Finance Econ, vol. 8, no. 4, pp. 301–312, Dec. 2008, doi: 10.1007/s10754-008-9042-2.
[6605]	Z. Páles and P. Pasteczka, “On Kedlaya-type inequalities for weighted means,” J Inequal Appl, vol. 2018, no. 1, p. 99, 2018, doi: 10.1186/s13660-018-1685-z.
[6606]	R. R. Yager, “On mean type aggregation,” IEEE Trans Syst Man Cybern B Cybern, vol. 26, no. 2, pp. 209–221, 1996, doi: 10.1109/3477.485833.
[6607]	H. P. Zhang, “[On medical and religious significance of burial Ephedra in Lop Nur region],” Zhonghua Yi Shi Za Zhi, vol. 50, no. 3, pp. 131–137, May 2020, doi: 10.3760/cma.j.cn112155-20200415-00044.
[6608]	P. Liu and W. Tang, “[On planning methods of sustainable eco-environmental management in mining areas],” Ying Yong Sheng Tai Xue Bao, vol. 14, no. 2, pp. 301–304, Feb. 2003.
[6609]	I. I. Katkov, “On proper linearization, construction and analysis of the Boyle-van’t Hoff plots and correct calculation of the osmotically inactive volume,” Cryobiology, vol. 62, no. 3, pp. 232–241, Jun. 2011, doi: 10.1016/j.cryobiol.2011.02.006.
[6610]	F. Peressotti, R. Cubelli, and R. Job, “On recognizing proper names: the orthographic cue hypothesis,” Cogn Psychol, vol. 47, no. 1, pp. 87–116, Aug. 2003, doi: 10.1016/s0010-0285(03)00004-5.
[6611]	C. Marrone and L. Galletti, “On rough road of hypoplastic left heart syndrome after Norwood procedure,” J Thorac Dis, vol. 11, no. Suppl 3, pp. S465–S467, Mar. 2019, doi: 10.21037/jtd.2018.11.27.
[6612]	L. Sprenger-Charolles, P. Colé, P. Lacert, and W. Serniclaes, “On subtypes of developmental dyslexia: evidence from processing time and accuracy scores,” Can J Exp Psychol, vol. 54, no. 2, pp. 87–104, Jun. 2000, doi: 10.1037/h0087332.
[6613]	K. S. Crump, “On summarizing group exposures in risk assessment: is an arithmetic mean or a geometric mean more appropriate?,” Risk Anal., vol. 18, no. 3, pp. 293–297, Jun. 1998, doi: 10.1111/j.1539-6924.1998.tb01296.x.
[6614]	E. Wolff, “[On the behavior of human cancer strains in association with chick embryo organs cultured in vitro],” C. R. Seances Soc. Biol. Fil., vol. 153, pp. 1898–1900, 1959.
[6615]	R. Majumdar and S. Majumdar, “On the conditional distribution of a multivariate Normal given a transformation - the linear case,” Heliyon, vol. 5, no. 2, p. e01136, Feb. 2019, doi: 10.1016/j.heliyon.2019.e01136.
[6616]	W. Halle, “[On the cultivation and behavior of spontaneously pulsating heart ventricles in semisynthetic culture media in in vitro conditions],” Acta Biol. Med. Ger., vol. 10, pp. 387–413, 1963.
[6617]	B. L. Liu, L. H. Yang, and A. J. Hoff, “On the depletion and reconstitution of both QA and metal in reaction centers of the photosynthetic bacterium Rb. sphaeroides R-26,” Photosyn. Res., vol. 28, no. 2, pp. 51–58, May 1991, doi: 10.1007/BF00033714.
[6618]	E. Braunwald, “On the difference between the heart’s output and its contractile state,” Circulation, vol. 43, no. 2, pp. 171–174, Feb. 1971, doi: 10.1161/01.cir.43.2.171.
[6619]	E. Bannert et al., “On the distribution and metabolism of Fusarium-toxins along the gastrointestinal tract of endotoxaemic pigs,” Arch Anim Nutr, vol. 72, no. 3, pp. 163–177, Jun. 2018, doi: 10.1080/1745039X.2018.1465261.
[6620]	G. Folkers, “[On the Economization of Medicine],” Praxis (Bern 1994), vol. 109, no. 3, pp. 181–182, 2020, doi: 10.1024/1661-8157/a003405.
[6621]	J. Männer, “On the form problem of embryonic heart loops, its geometrical solutions, and a new biophysical concept of cardiac looping,” Ann. Anat., vol. 195, no. 4, pp. 312–323, Jul. 2013, doi: 10.1016/j.aanat.2013.02.008.
[6622]	P. H. Roberts and E. M. King, “On the genesis of the Earth’s magnetism,” Rep Prog Phys, vol. 76, no. 9, p. 096801, Sep. 2013, doi: 10.1088/0034-4885/76/9/096801.
[6623]	U. Siemoneit et al., “On the interference of boswellic acids with 5-lipoxygenase: mechanistic studies in vitro and pharmacological relevance,” Eur. J. Pharmacol., vol. 606, no. 1–3, pp. 246–254, Mar. 2009, doi: 10.1016/j.ejphar.2009.01.044.
[6624]	W. Liao, P. Long, Z. Ren, and J. Wu, “On the Lawson-Lim means and Karcher mean for positive invertible operators,” J Inequal Appl, vol. 2018, no. 1, p. 229, 2018, doi: 10.1186/s13660-018-1817-5.
[6625]	G. Izzo, F. Guerrieri, and S. Papa, “On the mechanism of inhibition of the respiratory chain by 2-heptyl-4-hydroxyquinoline-N-oxide,” FEBS Lett., vol. 93, no. 2, pp. 320–322, Sep. 1978, doi: 10.1016/0014-5793(78)81130-2.
[6626]	T. Tsukada and T. Tango, “On the methods calculating mean survival time in 51Cr-platelet survival study,” Am. J. Hematol., vol. 8, no. 3, pp. 281–290, 1980, doi: 10.1002/ajh.2830080306.
[6627]	M. Johansson and T. Köster, “On the move through time - a historical review of plant clock research,” Plant Biol (Stuttg), vol. 21 Suppl 1, pp. 13–20, Jan. 2019, doi: 10.1111/plb.12729.
[6628]	R. E. Spitzer and A. E. Stitzel, “On the origin and control of C3NeF,” In Vivo, vol. 2, no. 1, pp. 79–81, Feb. 1988.
[6629]	A. B. Roginsky, M. B. Ujiki, X.-Z. Ding, and T. E. Adrian, “On the potential use of flavonoids in the treatment and prevention of pancreatic cancer,” In Vivo, vol. 19, no. 1, pp. 61–67, Feb. 2005.
[6630]	A. T. Kravchenko, N. A. Kolesnikova, and G. T. Patrikeev, “[On the presence of species-specific and organ-specific antigens in cells cultured in vitro for a long period],” Biull Eksp Biol Med, vol. 54, pp. 74–78, Sep. 1962.
[6631]	A. Stigebrandt, “On the response of the Baltic proper to changes of the total phosphorus supply,” Ambio, vol. 47, no. 1, pp. 31–44, Feb. 2018, doi: 10.1007/s13280-017-0933-7.
[6632]	G. Oberg and A. Leopold, “On the role of review papers in the face of escalating publication rates - a case study of research on contaminants of emerging concern (CECs),” Environ Int, vol. 131, p. 104960, 2019, doi: 10.1016/j.envint.2019.104960.
[6633]	S. Pan and K. Duraisamy, “On the structure of time-delay embedding in linear models of non-linear dynamical systems,” Chaos, vol. 30, no. 7, p. 073135, Jul. 2020, doi: 10.1063/5.0010886.
[6634]	T. Gustafson and E. Klein, “On the substrate induced enzyme formation in animal cells cultured in vitro,” Pathol Biol, vol. 9, pp. 914–916, Apr. 1961.
[6635]	J. Kanter, M. C. Puerta, R. P. García, J. M. L. Gómez, R. Jofré, and P. B. Rodríguez, “[On-line sequential hemodiafiltration (HDF-OL-S): a new therapeutic option],” Nefrologia, vol. 28, no. 4, pp. 433–438, 2008.
[6636]	J. N. Siewe Fodjo et al., “Onchocerciasis-associated epilepsy in the Democratic Republic of Congo: Clinical description and relationship with microfilarial density,” PLoS Negl Trop Dis, vol. 13, no. 7, p. e0007300, 2019, doi: 10.1371/journal.pntd.0007300.
[6637]	S. Garczyk et al., “Oncogenic features of neuromedin U in breast cancer are associated with NMUR2 expression involving crosstalk with members of the WNT signaling pathway,” Oncotarget, vol. 8, no. 22, pp. 36246–36265, May 2017, doi: 10.18632/oncotarget.16121.
[6638]	K. Steenland, “One agent, many diseases: exposure-response data and comparative risks of different outcomes following silica exposure,” Am. J. Ind. Med., vol. 48, no. 1, pp. 16–23, Jul. 2005, doi: 10.1002/ajim.20181.
[6639]	D. Carmona-Gutierrez, G. Kroemer, and F. Madeo, “One cell, one love: a journal for microbial research,” Microb Cell, vol. 1, no. 1, pp. 1–5, Jan. 2014, doi: 10.15698/mic2014.01.118.
[6640]	K. Hueffer, M. Ehrlander, K. Etz, and A. Reynolds, “One health in the circumpolar North,” Int J Circumpolar Health, vol. 78, no. 1, p. 1607502, 2019, doi: 10.1080/22423982.2019.1607502.
[6641]	P. Kingsley and E. M. Taylor, “One Health: competing perspectives in an emerging field,” Parasitology, vol. 144, no. 1, pp. 7–14, 2017, doi: 10.1017/S0031182015001845.
[6642]	E. A. C. Burger, H. Meshkini, and J. A. H. Lindeboom, “One versus two titanium screw fixation of autologous onlay bone grafts in the anterior maxilla: a randomised histological pilot study,” Eur J Oral Implantol, vol. 4, no. 3, pp. 219–225, 2011.
[6643]	A. J. L. Harris and J. S. Allen, “One-, two- and three-phase viscosity treatments for basaltic lava flows,” J. Geophys. Res., vol. 113, Jan. 2008, doi: 10.1029/2007JB005035.
[6644]	A. Abbasnezhad, H. Asgharzadeh, A. Ansari Hamedani, and S. Hayat Soytas, “One-pot synthesis of tin chalcogenide-reduced graphene oxide-carbon nanotube nanocomposite as anode material for lithium-ion batteries,” Dalton Trans, vol. 49, no. 18, pp. 5890–5897, May 2020, doi: 10.1039/d0dt00857e.
[6645]	R. Nandra, N. Hwang, G. S. Matharu, K. Reddy, and R. Grimer, “One-year mortality in patients with bone and soft tissue sarcomas as an indicator of delay in presentation,” Ann R Coll Surg Engl, vol. 97, no. 6, pp. 425–433, Sep. 2015, doi: 10.1308/003588415X14181254790284.
[6646]	J. M. Lyness, B. P. Chapman, J. McGriff, R. Drayer, and P. R. Duberstein, “One-year outcomes of minor and subsyndromal depression in older primary care patients,” Int Psychogeriatr, vol. 21, no. 1, pp. 60–68, Feb. 2009, doi: 10.1017/S1041610208007746.
[6647]	M. Salvadori et al., “One-year posttransplant renal function is a strong predictor of long-term kidney function: results from the Neoral-MOST Observational Study,” Transplant. Proc., vol. 35, no. 8, pp. 2863–2867, Dec. 2003, doi: 10.1016/j.transproceed.2003.10.070.
[6648]	A. T. Bjerkreim, H. Naess, A. N. Khanevski, L. Thomassen, U. Waje-Andreassen, and N. Logallo, “One-year versus five-year hospital readmission after ischemic stroke and TIA,” BMC Neurol, vol. 19, no. 1, p. 15, Jan. 2019, doi: 10.1186/s12883-019-1242-5.
[6649]	J. R. Linzey et al., “Online Impact and Presence of a Specialized Social Media Team for the Journal of Neurosurgery: Descriptive Analysis,” J. Med. Internet Res., vol. 22, no. 5, p. e17741, May 2020, doi: 10.2196/17741.
[6650]	D. Marcusson-Clavertz, O. N. E. Kjell, S. D. Persson, and E. Cardeña, “Online validation of combined mood induction procedures,” PLoS ONE, vol. 14, no. 6, p. e0217848, 2019, doi: 10.1371/journal.pone.0217848.
[6651]	R. Lill, “Only functional localization is faithful localization,” Microb Cell, vol. 1, no. 4, pp. 115–117, Apr. 2014, doi: 10.15698/mic2014.04.141.
[6652]	E. J. Crone, T. D. Sutherland, P. M. Campbell, C. W. Coppin, R. J. Russell, and J. G. Oakeshott, “Only one esterase of Drosophila melanogaster is likely to degrade juvenile hormone in vivo,” Insect Biochem. Mol. Biol., vol. 37, no. 6, pp. 540–549, Jun. 2007, doi: 10.1016/j.ibmb.2007.02.010.
[6653]	M. E. Guitart, M. Vence, J. Correale, J. M. Pasquini, and M. V. Rosato-Siri, “Ontogenetic oligodendrocyte maturation through gestational iron deprivation: The road not taken,” Glia, vol. 67, no. 9, pp. 1760–1774, 2019, doi: 10.1002/glia.23647.
[6654]	H. B. Lillywhite and S. M. Lillywhite, “Ontogenetic shifts of heart position in snakes,” J. Morphol., vol. 278, no. 8, pp. 1105–1113, 2017, doi: 10.1002/jmor.20697.
[6655]	G. P. Matherne, J. P. Headrick, and R. M. Berne, “Ontogeny of adenosine response in guinea pig heart and aorta,” Am. J. Physiol., vol. 259, no. 6 Pt 2, pp. H1637-1642, Dec. 1990, doi: 10.1152/ajpheart.1990.259.6.H1637.
[6656]	A. K. Gupta and L. Q. Tu, “Onychomycosis therapies: strategies to improve efficacy,” Dermatol Clin, vol. 24, no. 3, pp. 381–386, Jul. 2006, doi: 10.1016/j.det.2006.03.009.
[6657]	C. J. MacCallum and H. Parthasarathy, “Open access increases citation rate,” PLoS Biol., vol. 4, no. 5, p. e176, May 2006, doi: 10.1371/journal.pbio.0040176.
[6658]	S. Sabharwal, N. Patel, and K. Johal, “Open access publishing: a study of current practices in orthopaedic research,” Int Orthop, vol. 38, no. 6, pp. 1297–1302, Jun. 2014, doi: 10.1007/s00264-013-2250-5.
[6659]	R. Chandra et al., “Open access: Is there a predator at the door?,” Laryngoscope Investig Otolaryngol, vol. 3, no. 1, pp. 6–7, Feb. 2018, doi: 10.1002/lio2.141.
[6660]	N. Shea and V. Prasad, “Open issues with open access publication,” Am. J. Med., vol. 126, no. 7, pp. 563–564, Jul. 2013, doi: 10.1016/j.amjmed.2012.11.027.
[6661]	F. Oesch, “Open letter to the German Research Foundation (DFG, Deutsche Forschungsgemeinschaft). Some comments on the recent exclusion of a renowned scientist from a toxicological commission,” Toxicol. Lett., vol. 306, pp. 11–12, 15 2019, doi: 10.1016/j.toxlet.2019.02.004.
[6662]	C. Kendall et al., “Open Medicine at five years,” Open Med, vol. 6, no. 2, pp. e59-61, 2012.
[6663]	M.-S. Kim et al., “Operando Identification of the Chemical and Structural Origin of Li-Ion Battery Aging at Near-Ambient Temperature,” J. Am. Chem. Soc., vol. 142, no. 31, pp. 13406–13414, Aug. 2020, doi: 10.1021/jacs.0c02203.
[6664]	R. Burkes, G. Pfister, B. Guinn, and R. Cavallazzi, “Opioid overdose leading to intensive care unit admission: Epidemiology and outcomes,” J Crit Care, vol. 37, p. 261, 2017, doi: 10.1016/j.jcrc.2016.10.024.
[6665]	D. J. Greenblatt and J. S. Bertino, “Opportunistic Journals in the Clinical Pharmacology Space: A Policy Statement From the Publications and Public Policy Committees of the American College of Clinical Pharmacology,” Clin Pharmacol Drug Dev, vol. 7, no. 4, pp. 353–357, 2018, doi: 10.1002/cpdd.466.
[6666]	P. D. Ganzer and G. Sharma, “Opportunities and challenges for developing closed-loop bioelectronic medicines,” Neural Regen Res, vol. 14, no. 1, pp. 46–50, Jan. 2019, doi: 10.4103/1673-5374.243697.
[6667]	H. Kilinc and S. Turgut, “Optical behaviors of esthetic CAD-CAM restorations after different surface finishing and polishing procedures and UV aging: An in vitro study,” J Prosthet Dent, vol. 120, no. 1, pp. 107–113, Jul. 2018, doi: 10.1016/j.prosdent.2017.09.019.
[6668]	F. DI Staso, M. Ciancaglini, S. Abdolrahimzadeh, F. D’Apolito, and G. Scuderi, “Optical Coherence Tomography of Choroid in Common Neurological Diseases,” In Vivo, vol. 33, no. 5, pp. 1403–1409, Oct. 2019, doi: 10.21873/invivo.11617.
[6669]	K. J. Major, M. K. Poutous, K. J. Ewing, K. F. Dunnill, J. S. Sanghera, and I. D. Aggarwal, “Optical filter selection for high confidence discrimination of strongly overlapping infrared chemical spectra,” Anal. Chem., vol. 87, no. 17, pp. 8798–8808, Sep. 2015, doi: 10.1021/acs.analchem.5b01723.
[6670]	S. Fujii, A. Hirota, and K. Kamino, “Optical indications of pace-maker potential and rhythm generation in early embryonic chick heart,” J. Physiol. (Lond.), vol. 312, pp. 253–263, Mar. 1981, doi: 10.1113/jphysiol.1981.sp013627.
[6671]	J.-F. Güth and P. Magne, “Optical integration of CAD/CAM materials,” Int J Esthet Dent, vol. 11, no. 3, pp. 394–409, Autumn 2016.
[6672]	B. H. Kim, S. H. Lee, D. H. Son, T.-J. Ahn, S. E. Kim, and W.-T. Han, “Optical properties of the fiber-optic temperature sensor based on the side-hole fiber filled with indium,” Appl Opt, vol. 52, no. 4, pp. 666–673, Feb. 2013, doi: 10.1364/AO.52.000666.
[6673]	Y. Deng et al., “Optical second harmonic generation in LiB3O5 modulated by intense femtosecond X-ray pulses,” Opt Express, vol. 28, no. 8, pp. 11117–11127, Apr. 2020, doi: 10.1364/OE.388911.
[6674]	M. Eisenblätter, C. Höltke, T. Persigehl, and C. Bremer, “Optical techniques for the molecular imaging of angiogenesis,” Eur. J. Nucl. Med. Mol. Imaging, vol. 37 Suppl 1, pp. S127-137, Aug. 2010, doi: 10.1007/s00259-010-1514-1.
[6675]	L. Göllmann and H. Maurer, “Optimal control problems with time delays: Two case studies in biomedicine,” Math Biosci Eng, vol. 15, no. 5, pp. 1137–1154, 01 2018, doi: 10.3934/mbe.2018051.
[6676]	D.-H. Kim, Y.-S. Kim, T.-W. Yang, and O.-Y. Kwon, “Optimal cutoff score of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E) for detecting major depressive disorder: A meta-analysis,” Epilepsy Behav, vol. 92, pp. 61–70, 2019, doi: 10.1016/j.yebeh.2018.12.006.
[6677]	Y. Nakamura et al., “Optimal duration of macrolide treatment for chronic sinusitis after endoscopic sinus surgery,” Auris Nasus Larynx, vol. 40, no. 4, pp. 366–372, Aug. 2013, doi: 10.1016/j.anl.2012.09.009.
[6678]	M. K. Anser, Q. Abbas, I. S. Chaudhry, and A. Khan, “Optimal oil stockpiling, peak oil, and general equilibrium: case study of South Asia (oil importers) and Middle East (oil supplier),” Environ Sci Pollut Res Int, vol. 27, no. 16, pp. 19304–19313, Jun. 2020, doi: 10.1007/s11356-020-08419-7.
[6679]	J.-P. Sánchez and C. R. McInnes, “Optimal Sunshade Configurations for Space-Based Geoengineering near the Sun-Earth L1 Point,” PLoS ONE, vol. 10, no. 8, p. e0136648, 2015, doi: 10.1371/journal.pone.0136648.
[6680]	A. M. Burhan, S. M. Abdel-Hamid, M. E. Soliman, and O. A. Sammour, “Optimisation of the microencapsulation of lavender oil by spray drying,” J Microencapsul, vol. 36, no. 3, pp. 250–266, May 2019, doi: 10.1080/02652048.2019.1620355.
[6681]	S. H. Yoon, “Optimization of the refining process and oxidative stability of chufa (Cyperus esculentus L.) oil for edible purposes,” Food Sci. Biotechnol., vol. 25, no. 1, pp. 85–90, 2016, doi: 10.1007/s10068-016-0012-z.
[6682]	K. Miyamoto, S. Ohno, M. Fujiwara, H. Minamide, H. Hashimoto, and H. Ito, “Optimized terahertz-wave generation using BNA-DFG,” Opt Express, vol. 17, no. 17, pp. 14832–14838, Aug. 2009, doi: 10.1364/oe.17.014832.
[6683]	B. Hartman and S. F. S. Miguel, “Optimizing client and student learning from the brain’s perspective,” J. Am. Vet. Med. Assoc., vol. 251, no. 1, pp. 33–35, 01 2017, doi: 10.2460/javma.251.1.33.
[6684]	T. Belding, “Optimizing Pyxis to Reduce the Cost of Hyperinflation Medications,” J Pharm Pract, vol. 31, no. 4, pp. 411–412, Aug. 2018, doi: 10.1177/0897190018776404.
[6685]	R. P. Martins, P. H. Buschang, L. P. Martins, and L. G. Gandini, “Optimizing the design of preactivated titanium T-loop springs with Loop software,” Am J Orthod Dentofacial Orthop, vol. 134, no. 1, pp. 161–166, Jul. 2008, doi: 10.1016/j.ajodo.2007.04.034.
[6686]	C. Cameron, J. Habert, L. Anand, and M. Furtado, “Optimizing the management of depression: primary care experience,” Psychiatry Res, vol. 220 Suppl 1, pp. S45-57, Dec. 2014, doi: 10.1016/S0165-1781(14)70005-8.
[6687]	R. Brahmbhatt and E. B. Tapper, “Optimizing the Outcomes Associated With Spontaneous Bacterial Peritonitis,” J. Clin. Gastroenterol., vol. 51, no. 3, pp. 191–194, 2017, doi: 10.1097/MCG.0000000000000749.
[6688]	A. T. Issa Roach, G. Chaitanya, K. O. Riley, W. Muhlhofer, and S. Pati, “Optimizing therapies for neurobehavioral comorbidities of epilepsy using chronic ambulatory electrocorticography,” Epilepsy Behav, vol. 102, p. 106814, 2020, doi: 10.1016/j.yebeh.2019.106814.
[6689]	T. Watanabe et al., “Optimum culture conditions for production of exfoliative toxin by Staphylococcus hyicus,” Microbiol. Immunol., vol. 39, no. 6, pp. 369–377, 1995, doi: 10.1111/j.1348-0421.1995.tb02215.x.
[6690]	A. Murray, T. M. Nguyen, C. E. Parker, B. G. Feagan, and J. K. MacDonald, “Oral 5‐aminosalicylic acid for maintenance of remission in ulcerative colitis,” Cochrane Database of Systematic Reviews, no. 8, 2020, doi: 10.1002/14651858.CD000544.pub5.
[6691]	W.-Y. Ni et al., “Oral administration of benzyl-isothiocyanate inhibits in vivo growth of subcutaneous xenograft tumors of human malignant melanoma A375.S2 cells,” In Vivo, vol. 27, no. 5, pp. 623–626, Oct. 2013.
[6692]	J. H. Hara et al., “Oral and intratympanic steroid therapy for idiopathic sudden sensorineural hearing loss,” Laryngoscope Investig Otolaryngol, vol. 3, no. 2, pp. 73–77, Apr. 2018, doi: 10.1002/lio2.148.
[6693]	T. Yasui, W. Shioyama, M. Oboshi, T. Oka, and M. Fujita, “Oral Anticoagulants in Japanese Patients with Atrial Fibrillation and Active Cancer,” Intern. Med., vol. 58, no. 13, pp. 1845–1849, Jul. 2019, doi: 10.2169/internalmedicine.2415-18.
[6694]	L. S. Kahn and U. Halbreich, “Oral contraceptives and mood,” Expert Opin Pharmacother, vol. 2, no. 9, pp. 1367–1382, Sep. 2001, doi: 10.1517/14656566.2.9.1367.
[6695]	M. A. Peres, B. Daly, C. C. Guarnizo-Herreño, H. Benzian, and R. G. Watt, “Oral diseases: a global public health challenge - Authors’ reply,” Lancet, vol. 395, no. 10219, pp. 186–187, 18 2020, doi: 10.1016/S0140-6736(19)32997-6.
[6696]	D. Croser, “Oral health waits another seven UN years,” Br Dent J, vol. 225, no. 10, pp. 927–929, 23 2018, doi: 10.1038/sj.bdj.2018.1021.
[6697]	K. T. Rew, “Oral health: foreword,” FP Essent, vol. 428, p. 2, Jan. 2015.
[6698]	M. Benaroia and E. A. Iliescu, “Oral intake during hemodialysis: is there an association with intradialytic hypotension?,” Hemodial Int, vol. 12, no. 1, pp. 62–65, Jan. 2008, doi: 10.1111/j.1542-4758.2008.00242.x.
[6699]	C. Briceno and R. S. Douglas, “Orbital and periorbital infections,” Arch. Ophthalmol., vol. 130, no. 2, pp. 233–234, Feb. 2012, doi: 10.1001/archopthalmol.2011.1741.
[6700]	M. Wang and C. Ju, “Orchestrating liver repair: A newly discovered function of hepatic iNKT cells,” Hepatology, vol. 68, no. 2, pp. 773–775, 2018, doi: 10.1002/hep.29828.
[6701]	S. A. Amiel, “Organ fuel selection: brain,” Proc Nutr Soc, vol. 54, no. 1, pp. 151–155, Mar. 1995, doi: 10.1079/pns19950044.
[6702]	S. L. Miller and H. C. Urey, “Organic compound synthesis on the primitive earth,” Science, vol. 130, no. 3370, pp. 245–251, Jul. 1959, doi: 10.1126/science.130.3370.245.
[6703]	P. Wolkoff, C. K. Wilkins, P. A. Clausen, and G. D. Nielsen, “Organic compounds in office environments - sensory irritation, odor, measurements and the role of reactive chemistry,” Indoor Air, vol. 16, no. 1, pp. 7–19, Feb. 2006, doi: 10.1111/j.1600-0668.2005.00393.x.
[6704]	M. J. Dahm, A. V. Samonte, and A. R. Shows, “Organic foods: do eco-friendly attitudes predict eco-friendly behaviors?,” J Am Coll Health, vol. 58, no. 3, pp. 195–202, Dec. 2009, doi: 10.1080/07448480903295292.
[6705]	Y. Lee and T.-W. Lee, “Organic Synapses for Neuromorphic Electronics: From Brain-Inspired Computing to Sensorimotor Nervetronics,” Acc. Chem. Res., vol. 52, no. 4, pp. 964–974, 16 2019, doi: 10.1021/acs.accounts.8b00553.
[6706]	S. Barbut and A. Marangoni, “Organogels use in meat processing - Effects of fat/oil type and heating rate,” Meat Sci., vol. 149, pp. 9–13, Mar. 2019, doi: 10.1016/j.meatsci.2018.11.003.
[6707]	C. L. Croft, H. S. Futch, B. D. Moore, and T. E. Golde, “Organotypic brain slice cultures to model neurodegenerative proteinopathies,” Mol Neurodegener, vol. 14, no. 1, p. 45, 02 2019, doi: 10.1186/s13024-019-0346-0.
[6708]	E. Gottwald and S. Giselbrecht, “Organotypic tissue models in MRI method development,” Z Med Phys, vol. 24, no. 2, pp. 89–90, May 2014, doi: 10.1016/j.zemedi.2014.02.006.
[6709]	J. Zhang, “Orientisargidae fam. n., a new Jurassic family of Archisargoidea (Diptera, Brachycera), with review of Archisargidae from China,” Zookeys, no. 238, pp. 57–76, 2012, doi: 10.3897/zookeys.238.3624.
[6710]	A. P. Jephcoat and A. N. Halliday, “Origin and differentiation of the Earth: past to present. Preface,” Philos Trans A Math Phys Eng Sci, vol. 366, no. 1883, pp. 4059–4060, Nov. 2008, doi: 10.1098/rsta.2008.0221.
[6711]	J. Liu, A. Morel, T. Wannier, and E. M. Rouiller, “Origins of callosal projections to the supplementary motor area (SMA): a direct comparison between pre-SMA and SMA-proper in macaque monkeys,” J. Comp. Neurol., vol. 443, no. 1, pp. 71–85, Jan. 2002, doi: 10.1002/cne.10087.
[6712]	K. Bjerklin, R. Lindsten, J. S. Tunge, and C. Sjövall, “Orthodontic treatment need, outcome and residual treatment need in 15- and 20-year-olds,” Swed Dent J, vol. 36, no. 3, pp. 157–165, 2012.
[6713]	K. Okike and K. J. Bozic, “Orthopaedic healthcare worldwide: the transparent pricing revolution in healthcare,” Clin. Orthop. Relat. Res., vol. 472, no. 8, pp. 2325–2328, Aug. 2014, doi: 10.1007/s11999-014-3701-z.
[6714]	E. Hohmann, V. Glatt, and K. Tetsworth, “Orthopaedic research in Australia: a bibliographic analysis of the publication rates in the top 15 journals,” ANZ J Surg, vol. 87, no. 9, pp. 709–713, Sep. 2017, doi: 10.1111/ans.13932.
[6715]	W. G. Cole, “Orthopaedic treatment of osteogenesis imperfecta,” Ann. N. Y. Acad. Sci., vol. 543, pp. 157–166, 1988, doi: 10.1111/j.1749-6632.1988.tb55328.x.
[6716]	O. H. Jeon and J. Elisseeff, “Orthopedic tissue regeneration: cells, scaffolds, and small molecules,” Drug Deliv Transl Res, vol. 6, no. 2, pp. 105–120, Apr. 2016, doi: 10.1007/s13346-015-0266-7.
[6717]	T. Mizota, Y. Iwata, H. Daijo, T. Koyama, T. Tanaka, and K. Fukuda, “Orthostatic intolerance during early mobilization following video-assisted thoracic surgery,” J Anesth, vol. 27, no. 6, pp. 895–900, Dec. 2013, doi: 10.1007/s00540-013-1634-4.
[6718]	J. R. Eriksen, P. Munk-Madsen, H. Kehlet, and I. Gögenur, “Orthostatic intolerance in enhanced recovery laparoscopic colorectal resection,” Acta Anaesthesiol Scand, vol. 63, no. 2, pp. 171–177, 2019, doi: 10.1111/aas.13238.
[6719]	I. Marijanović, M. Radnić, I. Matić, and I. Erceg-Ivkosić, “[Osteogenesis imperfecta and achievements in cell and gene therapy],” Acta Med Croatica, vol. 64, no. 3, pp. 191–200, Jul. 2010.
[6720]	J. D. Hald et al., “Osteogenesis imperfecta and the teeth, eyes, and ears-a study of non-skeletal phenotypes in adults,” Osteoporos Int, vol. 29, no. 12, pp. 2781–2789, Dec. 2018, doi: 10.1007/s00198-018-4663-x.
[6721]	D. Primorac et al., “Osteogenesis imperfecta at the beginning of bone and joint decade,” Croat. Med. J., vol. 42, no. 4, pp. 393–415, Aug. 2001.
[6722]	M. Singh Kocher and L. Dichtel, “Osteogenesis imperfecta misdiagnosed as child abuse,” J Pediatr Orthop B, vol. 20, no. 6, pp. 440–443, Nov. 2011, doi: 10.1097/BPB.0b013e328347a2e1.
[6723]	D. S. Ablin, “Osteogenesis imperfecta: a review,” Can Assoc Radiol J, vol. 49, no. 2, pp. 110–123, Apr. 1998.
[6724]	F. S. van Dijk et al., “Osteogenesis Imperfecta: A Review with Clinical Examples,” Mol Syndromol, vol. 2, no. 1, pp. 1–20, Dec. 2011, doi: 10.1159/000332228.
[6725]	F. S. Van Dijk and D. O. Sillence, “Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment,” Am. J. Med. Genet. A, vol. 164A, no. 6, pp. 1470–1481, Jun. 2014, doi: 10.1002/ajmg.a.36545.
[6726]	B. L. Jensen and A. M. Lund, “Osteogenesis imperfecta: clinical, cephalometric, and biochemical investigations of OI types I, III, and IV,” J. Craniofac. Genet. Dev. Biol., vol. 17, no. 3, pp. 121–132, Sep. 1997.
[6727]	A. Biggin and C. F. Munns, “Osteogenesis imperfecta: diagnosis and treatment,” Curr Osteoporos Rep, vol. 12, no. 3, pp. 279–288, Sep. 2014, doi: 10.1007/s11914-014-0225-0.
[6728]	C. L. Phillips and Y. Jeong, “Osteogenesis Imperfecta: Muscle-Bone Interactions when Bi-directionally Compromised,” Curr Osteoporos Rep, vol. 16, no. 4, pp. 478–489, 2018, doi: 10.1007/s11914-018-0456-6.
[6729]	H. Kang, S. Aryal A C, and J. C. Marini, “Osteogenesis imperfecta: new genes reveal novel mechanisms in bone dysplasia,” Transl Res, vol. 181, pp. 27–48, 2017, doi: 10.1016/j.trsl.2016.11.005.
[6730]	H. Skarzynski, K. Osinska, and P. H. Skarzynski, “Osteogenesis Imperfecta: Phenotypic and Intraoperative Findings Observed in Patients Treated Surgically at the World Hearing Centre,” J Int Adv Otol, vol. 14, no. 3, pp. 478–483, Dec. 2018, doi: 10.5152/iao.2018.5643.
[6731]	A. Forlino and J. C. Marini, “Osteogenesis imperfecta: prospects for molecular therapeutics,” Mol. Genet. Metab., vol. 71, no. 1–2, pp. 225–232, Oct. 2000, doi: 10.1006/mgme.2000.3039.
[6732]	M. S. Cheung and F. H. Glorieux, “Osteogenesis Imperfecta: update on presentation and management,” Rev Endocr Metab Disord, vol. 9, no. 2, pp. 153–160, Jun. 2008, doi: 10.1007/s11154-008-9074-4.
[6733]	E. Martin and J. R. Shapiro, “Osteogenesis imperfecta:epidemiology and pathophysiology,” Curr Osteoporos Rep, vol. 5, no. 3, pp. 91–97, Sep. 2007, doi: 10.1007/s11914-007-0023-z.
[6734]	A. Modi, J. Tang, S. Sen, and A. Díez-Pérez, “Osteoporotic fracture rate among women with at least 1 year of adherence to osteoporosis treatment,” Curr Med Res Opin, vol. 31, no. 4, pp. 767–777, Apr. 2015, doi: 10.1185/03007995.2015.1016606.
[6735]	M. J. Duarte et al., “Otogenic brain abscesses: A systematic review,” Laryngoscope Investig Otolaryngol, vol. 3, no. 3, pp. 198–208, Jun. 2018, doi: 10.1002/lio2.150.
[6736]	N. D. Cass, T. S. Okland, K. Rodriguez, and S. E. Mann, “Otolaryngology Education: Recent Trends in Publication,” Otolaryngol Head Neck Surg, vol. 156, no. 6, pp. 1124–1129, 2017, doi: 10.1177/0194599816684098.
[6737]	J. G. Naples, M. Canfarotta, R. Tabtabai, D. Sparks, K. Parham, and T. Falcone, “Otolaryngology interest groups: A potential solution to the residency match crisis,” Laryngoscope Investig Otolaryngol, vol. 4, no. 1, pp. 24–29, Feb. 2019, doi: 10.1002/lio2.234.
[6738]	N. A. Dewyer, J. J. Rosowski, J. B. Nadol, and A. M. Quesnel, “Otopathology Findings in Otosclerosis With Lateral Semicircular Canal Fenestration,” Laryngoscope Investig Otolaryngol, vol. 4, no. 4, pp. 425–428, Aug. 2019, doi: 10.1002/lio2.286.
[6739]	J. X. Chen, A. Nourmahnad, J. O’Malley, K. Reinshagen, J. B. Nadol, and A. M. Quesnel, “Otopathology in CHARGE syndrome,” Laryngoscope Investig Otolaryngol, vol. 5, no. 1, pp. 157–162, Feb. 2020, doi: 10.1002/lio2.347.
[6740]	J. Lin and A. P. Sclafani, “Otoplasty for Congenital Auricular Malformations,” Facial Plast Surg Clin North Am, vol. 26, no. 1, pp. 31–40, Feb. 2018, doi: 10.1016/j.fsc.2017.09.003.
[6741]	U. T. Hinderer, J. L. del Rio, and F. J. Fregenal, “Otoplasty for lop ears,” Aesthetic Plast Surg, vol. 11, no. 2, pp. 75–80, 1987, doi: 10.1007/BF01575490.
[6742]	A. Papa and C. Lefton, “Our backyards,” J Emerg Nurs, vol. 41, no. 2, pp. 146–147, Mar. 2015, doi: 10.1016/j.jen.2014.12.010.
[6743]	Y. Kamide, “Our life is protected by the Earth’s atmosphere and magnetic field: what aurora research tells us,” Biomed. Pharmacother., vol. 55 Suppl 1, pp. 21s–24s, 2001, doi: 10.1016/s0753-3322(01)90002-2.
[6744]	J. L. Oschman, “Our place in nature: reconnecting with the Earth,” J Altern Complement Med, vol. 16, no. 3, pp. 225–226, Mar. 2010, doi: 10.1089/acm.2009.0656.
[6745]	“Outbreak news. Chikungunya, Spain,” Wkly. Epidemiol. Rec., vol. 90, no. 33, p. 409, Aug. 2015.
[6746]	“Outbreak news. Cholera, Sierra Leone,” Wkly. Epidemiol. Rec., vol. 87, no. 36, pp. 337–338, Sep. 2012.
[6747]	“Outbreak news. Dengue fever in Madeira,Portugal,” Wkly. Epidemiol. Rec., vol. 87, no. 43, p. 413, Oct. 2012.
[6748]	“Outbreak news. Ebola virus disease, West Africa,” Wkly. Epidemiol. Rec., vol. 89, no. 20, pp. 205–206, May 2014.
[6749]	“Outbreak news. Rift Valley fever, Mauritania,” Wkly. Epidemiol. Rec., vol. 87, no. 45, p. 438, Nov. 2012.
[6750]	A. S. Parikh et al., “Outcomes and prognostic factors in parotid gland malignancies: A 10-year single center experience,” Laryngoscope Investig Otolaryngol, vol. 4, no. 6, pp. 632–639, Dec. 2019, doi: 10.1002/lio2.326.
[6751]	M. H. Ibrahim et al., “Outcomes of Early Ligation of Patent Ductus Arteriosus in Preterms, Multicenter Experience,” Medicine (Baltimore), vol. 94, no. 25, p. e915, Jun. 2015, doi: 10.1097/MD.0000000000000915.
[6752]	S. A. Halim et al., “Outcomes of Transcatheter Aortic Valve Replacement in Patients With Bicuspid Aortic Valve Disease: A Report From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry,” Circulation, vol. 141, no. 13, pp. 1071–1079, Mar. 2020, doi: 10.1161/CIRCULATIONAHA.119.040333.
[6753]	Y. Xie, N. A. Orabi, T. A. Zwolan, and G. J. Basura, “Outcomes of unilateral idiopathic sudden sensorineural hearing loss: Two decades of experience,” Laryngoscope Investig Otolaryngol, vol. 4, no. 6, pp. 693–702, Dec. 2019, doi: 10.1002/lio2.331.
[6754]	K. Pretorius and L. Rew, “Outpatient- or community-based interventions to prevent SIDS and sleep-related deaths,” J Spec Pediatr Nurs, vol. 25, no. 2, p. e12279, 2020, doi: 10.1111/jspn.12279.
[6755]	D. Bresters et al., “Ovarian insufficiency and pubertal development after hematopoietic stem cell transplantation in childhood,” Pediatr Blood Cancer, vol. 61, no. 11, pp. 2048–2053, Nov. 2014, doi: 10.1002/pbc.25162.
[6756]	T.-Y. Lin, F.-J. Wu, W.-Y. Lee, C.-L. Hsiao, and C.-W. Luo, “Ovarian regulation of neuromedin U and its local actions in the ovary, mediated through neuromedin U receptor 2,” Am. J. Physiol. Endocrinol. Metab., vol. 304, no. 8, pp. E800-809, Apr. 2013, doi: 10.1152/ajpendo.00548.2012.
[6757]	B. Kocher and E. J. Emanuel, “Overcoming the pricing power of hospitals,” JAMA, vol. 308, no. 12, pp. 1213–1214, Sep. 2012, doi: 10.1001/2012.jama.11910.
[6758]	Z. Liu, X. Li, J. R. Prasifka, R. Jurenka, and B. C. Bonning, “Overexpression of Drosophila juvenile hormone esterase binding protein results in anti-JH effects and reduced pheromone abundance,” Gen. Comp. Endocrinol., vol. 156, no. 1, pp. 164–172, Mar. 2008, doi: 10.1016/j.ygcen.2008.01.006.
[6759]	L. Wang et al., “Overexpression of neuromedin U is correlated with regional metastasis of head and neck squamous cell carcinoma,” Mol Med Rep, vol. 14, no. 2, pp. 1075–1082, Aug. 2016, doi: 10.3892/mmr.2016.5347.
[6760]	D. Choi et al., “Overlapping ablation using a coaxial radiofrequency electrode and multiple cannulae system: experimental study in ex-vivo bovine liver,” Korean J Radiol, vol. 4, no. 2, pp. 117–123, Jun. 2003, doi: 10.3348/kjr.2003.4.2.117.
[6761]	J. J. Rahona, S. Ruiz Fernández, B. Rolke, C. Vázquez, and G. Hervás, “Overt head movements moderate the effect of depressive symptoms on mood regulation,” Cogn Emot, vol. 28, no. 7, pp. 1328–1337, 2014, doi: 10.1080/02699931.2014.881323.
[6762]	R. A. Ettlin et al., “Overview of quantitative methods in toxicologic pathology,” In Vivo, vol. 7, no. 4, pp. 315–324, Aug. 1993.
[6763]	M. T. Quail, “Overview of Silica-Related Clusters in the United States: Will Fracking Operations Become the Next Cluster?,” J Environ Health, vol. 79, no. 6, pp. 20–27, Feb. 2017.
[6764]	M. Vallejo, M. Fresnedo San Román, I. Ortiz, and A. Irabien, “Overview of the PCDD/Fs degradation potential and formation risk in the application of advanced oxidation processes (AOPs) to wastewater treatment,” Chemosphere, vol. 118, pp. 44–56, Jan. 2015, doi: 10.1016/j.chemosphere.2014.05.077.
[6765]	A. Linke, J. Weiss, and R. Kohlus, “Oxidation rate of the non-encapsulated- and encapsulated oil and their contribution to the overall oxidation of microencapsulated fish oil particles,” Food Res. Int., vol. 127, p. 108705, 2020, doi: 10.1016/j.foodres.2019.108705.
[6766]	M. Jalali, M. J. Zare Sakhvidi, A. Bahrami, N. Berijani, and H. Mahjub, “Oxidative Stress Biomarkers in Exhaled Breath of Workers Exposed to Crystalline Silica Dust by SPME-GC-MS,” J Res Health Sci, vol. 16, no. 3, pp. 153–161, 2016.
[6767]	B. Oh et al., “Oxidative stress in prostate cancer patients: A systematic review of case control studies,” Prostate Int, vol. 4, no. 3, pp. 71–87, Sep. 2016, doi: 10.1016/j.prnil.2016.05.002.
[6768]	A. Ferramosca, S. Pinto Provenzano, D. D. Montagna, L. Coppola, and V. Zara, “Oxidative stress negatively affects human sperm mitochondrial respiration,” Urology, vol. 82, no. 1, pp. 78–83, Jul. 2013, doi: 10.1016/j.urology.2013.03.058.
[6769]	M. Ahotupa, “Oxidized lipoprotein lipids and atherosclerosis,” Free Radic. Res., vol. 51, no. 4, pp. 439–447, Apr. 2017, doi: 10.1080/10715762.2017.1319944.
[6770]	X.-L. Yao, Z.-H. Yao, L. Li, L. Nie, and S.-F. Zhang, “Oxiracetam can improve cognitive impairment after chronic cerebral hypoperfusion in rats,” Psychiatry Res, vol. 246, pp. 284–292, Dec. 2016, doi: 10.1016/j.psychres.2016.10.006.
[6771]	J. Lee, N. Ohba, and R. Asahi, “Oxygen conduction mechanism in Ca3Fe2Ge3O12 garnet-type oxide,” Sci Rep, vol. 9, no. 1, p. 2593, Feb. 2019, doi: 10.1038/s41598-019-39288-x.
[6772]	N. Totani, M. Yawata, T. Mori, and E. G. Hammond, “Oxygen content and oxidation in frying oil,” J Oleo Sci, vol. 62, no. 12, pp. 989–995, 2013, doi: 10.5650/jos.62.989.
[6773]	G. Zara et al., “Oxygen is required to restore flor strain viability and lipid biosynthesis under fermentative conditions,” FEMS Yeast Res., vol. 9, no. 2, pp. 217–225, Mar. 2009, doi: 10.1111/j.1567-1364.2008.00472.x.
[6774]	M. Rawat et al., “Oxygen saturation index and severity of hypoxic respiratory failure,” Neonatology, vol. 107, no. 3, pp. 161–166, 2015, doi: 10.1159/000369774.
[6775]	A. Ferramosca, R. Focarelli, P. Piomboni, L. Coppola, and V. Zara, “Oxygen uptake by mitochondria in demembranated human spermatozoa: a reliable tool for the evaluation of sperm respiratory efficiency,” Int. J. Androl., vol. 31, no. 3, pp. 337–345, Jun. 2008, doi: 10.1111/j.1365-2605.2007.00775.x.
[6776]	M. Li, X. Bi, K. Amine, and J. Lu, “Oxygen-Based Anion Redox for Lithium Batteries,” Acc. Chem. Res., vol. 53, no. 8, pp. 1436–1444, Aug. 2020, doi: 10.1021/acs.accounts.0c00104.
[6777]	A. Petrovic and A. Heusner, “[Oxygenation of an organ fragment in vitro: principle of organotypic culture in suspension in the liquid phase],” C. R. Hebd. Seances Acad. Sci., vol. 253, pp. 3066–3067, Dec. 1961.
[6778]	J. H. Broadbear, D. Kabel, L. Tracy, and P. Mak, “Oxytocinergic regulation of endogenous as well as drug-induced mood,” Pharmacol. Biochem. Behav., vol. 119, pp. 61–71, Apr. 2014, doi: 10.1016/j.pbb.2013.07.002.
[6779]	K. Hori, “[P wave (loop) and Ta wave (loop)],” Saishin Igaku, vol. 25, no. 4, pp. 827–837, Apr. 1970.
[6780]	T. Brockamp et al., “[P.A.R.T.Y. An initiative for more risk awareness among young road users],” Unfallchirurg, vol. 119, no. 5, pp. 428–432, May 2016, doi: 10.1007/s00113-015-0031-x.
[6781]	L. Baciou, E. Rivas, and P. Sebban, “P+QA- and P+QB- charge recombinations in Rhodopseudomonas viridis chromatophores and in reaction centers reconstituted in phosphatidylcholine liposomes. Existence of two conformational states of the reaction centers and effects of pH and o-phenanthroline,” Biochemistry, vol. 29, no. 12, pp. 2966–2976, Mar. 1990, doi: 10.1021/bi00464a012.
[6782]	X. Lyon, L. Kappenberger, D. Sedmera, A. C. Rochat, P. Kucera, and E. Raddatz, “Pacing redistributes glycogen within the developing myocardium,” J. Mol. Cell. Cardiol., vol. 33, no. 3, pp. 513–520, Mar. 2001, doi: 10.1006/jmcc.2000.1325.
[6783]	W. Y. Vanagt et al., “Pacing-induced dys-synchrony preconditions rabbit myocardium against ischemia/reperfusion injury,” Circulation, vol. 114, no. 1 Suppl, pp. I264-269, Jul. 2006, doi: 10.1161/CIRCULATIONAHA.105.000893.
[6784]	M. J. Terry, S. M. Moeschler, B. C. Hoelzer, and W. M. Hooten, “Pain Catastrophizing and Anxiety are Associated With Heat Pain Perception in a Community Sample of Adults With Chronic Pain,” Clin J Pain, vol. 32, no. 10, pp. 875–881, 2016, doi: 10.1097/AJP.0000000000000333.
[6785]	B. Kaneshiro, D. A. Grimes, and L. M. Lopez, “Pain management for tubal sterilization by hysteroscopy,” Cochrane Database Syst Rev, no. 8, p. CD009251, Aug. 2012, doi: 10.1002/14651858.CD009251.pub2.
[6786]	E. Olszewska and B. T. Woodson, “Palatal anatomy for sleep apnea surgery,” Laryngoscope Investig Otolaryngol, vol. 4, no. 1, pp. 181–187, Feb. 2019, doi: 10.1002/lio2.238.
[6787]	X.-H. Sun, Y.-J. Zhao, C.-L. Liu, P.-C. Jiao, H. Zhang, and C.-H. Wu, “Paleoclimatic information recorded in fluid inclusions in halites from Lop Nur, Western China,” Sci Rep, vol. 7, no. 1, p. 16411, 27 2017, doi: 10.1038/s41598-017-16619-4.
[6788]	J. Ricci, J. Carlut, and J.-P. Valet, “Paleosecular variation recorded by Quaternary lava flows from Guadeloupe Island,” Sci Rep, vol. 8, no. 1, p. 10147, 05 2018, doi: 10.1038/s41598-018-28384-z.
[6789]	E. Gesteiro, J. Galera-Gordo, and M. González-Gross, “[Palm oil and cardiovascular health: considerations to evaluate the literature critically],” Nutr Hosp, vol. 35, no. 5, pp. 1229–1242, Oct. 2018, doi: 10.20960/nh.1970.
[6790]	O. J. Odia, S. Ofori, and O. Maduka, “Palm oil and the heart: A review,” World J Cardiol, vol. 7, no. 3, pp. 144–149, Mar. 2015, doi: 10.4330/wjc.v7.i3.144.
[6791]	A. S. H. Ong and S. H. Goh, “Palm oil: a healthful and cost-effective dietary component,” Food Nutr Bull, vol. 23, no. 1, pp. 11–22, Mar. 2002, doi: 10.1177/156482650202300102.
[6792]	D. O. Edem, “Palm oil: biochemical, physiological, nutritional, hematological, and toxicological aspects: a review,” Plant Foods Hum Nutr, vol. 57, no. 3–4, pp. 319–341, 2002, doi: 10.1023/a:1021828132707.
[6793]	J. H. Yoon et al., “Pancreatic Steatosis and Fibrosis: Quantitative Assessment with Preoperative Multiparametric MR Imaging,” Radiology, vol. 279, no. 1, pp. 140–150, Apr. 2016, doi: 10.1148/radiol.2015142254.
[6794]	K. Blouhos, K. A. Boulas, E. Tsiomita, I. Papageorgiou, K. Ioannidis, and A. Hatzigeorgiadis, “Pancreaticojejuno-jejunostomy during reconstruction of the afferent loop in surgery of radiation-induced afferent loop obstruction following pancreaticoduodenectomy with Roux-en-Y reconstruction,” Updates Surg, vol. 66, no. 1, pp. 51–57, Mar. 2014, doi: 10.1007/s13304-013-0238-8.
[6795]	K. Tsuji, K. Takemura, N. Inaki, and H. Doyama, “Pancreatitis due to afferent loop obstruction,” Intern. Med., vol. 52, no. 22, p. 2589, 2013, doi: 10.2169/internalmedicine.52.1237.
[6796]	A. Burstein, “Panic disorder and PTSD,” J Clin Psychiatry, vol. 46, no. 10, p. 454, Oct. 1985.
[6797]	C. Muhtz, K. Wiedemann, and M. Kellner, “Panicogens in patients with Post-Traumatic Stress Disorder (PTSD),” Curr. Pharm. Des., vol. 18, no. 35, pp. 5608–5618, 2012, doi: 10.2174/138161212803530817.
[6798]	S. Kariyawasam and L. K. Nolan, “papA gene of avian pathogenic Escherichia coli,” Avian Dis., vol. 55, no. 4, pp. 532–538, Dec. 2011, doi: 10.1637/9663-011911-Reg.1.
[6799]	S. Buoro et al., “Papa Giovanni XXIII Bergamo Hospital at the time of the COVID-19 outbreak: Letter from the warfront…,” Int J Lab Hematol, vol. 42 Suppl 1, pp. 8–10, 2020, doi: 10.1111/ijlh.13207.
[6800]	G. Genovese, C. Moltrasio, S. Garcovich, and A. V. Marzano, “PAPA spectrum disorders,” G Ital Dermatol Venereol, Jul. 2020, doi: 10.23736/S0392-0488.20.06629-8.
[6801]	H. Schäffler et al., “[PAPA syndrome with Crohn’s disease and primary sclerosing cholangitis/autoimmune hepatitis overlap syndrome],” Hautarzt, vol. 70, no. 2, pp. 116–122, Feb. 2019, doi: 10.1007/s00105-018-4312-5.
[6802]	Y.-H. Wang et al., “PapA, a peptidoglycan-associated protein, interacts with OmpC and maintains cell envelope integrity,” Environ. Microbiol., Apr. 2020, doi: 10.1111/1462-2920.15038.
[6803]	Y. Wen, W. Wang, X. Guo, and F. Zhang, “PAPA: a flexible tool for identifying pleiotropic pathways using genome-wide association study summaries,” Bioinformatics, vol. 32, no. 6, pp. 946–948, 15 2016, doi: 10.1093/bioinformatics/btv668.
[6804]	P. Weinzaepfflen, “[Papa’s electric train],” Cah Odontostomatol Touraine, vol. 7, no. 2, pp. 65–69, Jun. 1975.
[6805]	J. Luo, S. Yau, S. White, and L. Wilfert, “Paperless medical physics QA in radiation therapy,” Australas Phys Eng Sci Med, vol. 35, no. 2, pp. 237–243, Jun. 2012, doi: 10.1007/s13246-012-0137-1.
[6806]	K. Tigen et al., “Papillary muscle dyssynchrony as a cause of functional mitral regurgitation in non-ischemic dilated cardiomyopathy patients with narrow QRS complexes,” Anadolu Kardiyol Derg, vol. 9, no. 3, pp. 196–203, Jun. 2009.
[6807]	T. Knöpfel, N. Himmerkus, D. Günzel, M. Bleich, N. Hernando, and C. A. Wagner, “Paracellular transport of phosphate along the intestine,” Am. J. Physiol. Gastrointest. Liver Physiol., vol. 317, no. 2, pp. G233–G241, 01 2019, doi: 10.1152/ajpgi.00032.2019.
[6808]	P. J. Brighton, A. Wise, N. B. Dass, and G. B. Willars, “Paradoxical behavior of neuromedin U in isolated smooth muscle cells and intact tissue,” J. Pharmacol. Exp. Ther., vol. 325, no. 1, pp. 154–164, Apr. 2008, doi: 10.1124/jpet.107.132803.
[6809]	J. W. Denham et al., “Paradoxical metastatic progression following 3 months of neo-adjuvant androgen suppression in the TROG 96.01 trial for men with locally advanced prostate cancer,” Radiother Oncol, vol. 107, no. 2, pp. 123–128, May 2013, doi: 10.1016/j.radonc.2013.03.025.
[6810]	J. Xavier-Neto et al., “Parallel avenues in the evolution of hearts and pumping organs,” Cell. Mol. Life Sci., vol. 64, no. 6, pp. 719–734, Mar. 2007, doi: 10.1007/s00018-007-6524-1.
[6811]	J. Tung, J. Rudolph, J. Altmann, and S. C. Alberts, “Parallel effects of genetic variation in ACE activity in baboons and humans,” Am. J. Phys. Anthropol., vol. 134, no. 1, pp. 1–8, Sep. 2007, doi: 10.1002/ajpa.20614.
[6812]	M. Palkowski and W. Bielecki, “Parallel tiled Nussinov RNA folding loop nest generated using both dependence graph transitive closure and loop skewing,” BMC Bioinformatics, vol. 18, no. 1, p. 290, Jun. 2017, doi: 10.1186/s12859-017-1707-8.
[6813]	T. N. Bart, “Parallel trade of pharmaceuticals: a review of legal, economic, and political aspects,” Value Health, vol. 11, no. 5, pp. 996–1005, Oct. 2008, doi: 10.1111/j.1524-4733.2008.00339.x.
[6814]	J. Madero-Pérez et al., “Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation,” Mol Neurodegener, vol. 13, no. 1, p. 3, 23 2018, doi: 10.1186/s13024-018-0235-y.
[6815]	S. A. Wong, B. I. Dalal, and H. A. Leitch, “Paroxysmal nocturnal hemoglobinuria testing in patients with myelodysplastic syndrome in clinical practice-frequency and indications,” Curr Oncol, vol. 25, no. 5, pp. e391–e397, 2018, doi: 10.3747/co.25.4018.
[6816]	M. A. Cornejo et al., “Partial Body Mass Recovery After Caloric Restriction Abolishes Improved Glucose Tolerance in Obese, Insulin Resistant Rats,” Front Endocrinol (Lausanne), vol. 11, p. 363, 2020, doi: 10.3389/fendo.2020.00363.
[6817]	J. Ju, P. Zhang, and B. Jiang, “Partial Oral Therapy for Osteomyelitis and Endocarditis,” N. Engl. J. Med., vol. 381, no. 12, p. 1183, 19 2019, doi: 10.1056/NEJMc1904725.
[6818]	N. Breslau, V. C. Lucia, and G. C. Davis, “Partial PTSD versus full PTSD: an empirical examination of associated impairment,” Psychol Med, vol. 34, no. 7, pp. 1205–1214, Oct. 2004, doi: 10.1017/s0033291704002594.
[6819]	A. E. Arrant, A. M. Nicholson, X. Zhou, R. Rademakers, and E. D. Roberson, “Partial Tmem106b reduction does not correct abnormalities due to progranulin haploinsufficiency,” Mol Neurodegener, vol. 13, no. 1, p. 32, 22 2018, doi: 10.1186/s13024-018-0264-6.
[6820]	L. C. R. Silva, T. R. L. Romero, L. S. Guzzo, and I. D. G. Duarte, “Participation of cannabinoid receptors in peripheral nociception induced by some NSAIDs,” Braz. J. Med. Biol. Res., vol. 45, no. 12, pp. 1240–1243, Dec. 2012, doi: 10.1590/s0100-879x2012007500153.
[6821]	S. Tsuji, “[Participation of People with Epilepsy in Sports],” Brain Nerve, vol. 69, no. 2, pp. 151–158, Feb. 2017, doi: 10.11477/mf.1416200655.
[6822]	N. Mukai, Y. Abe, Y. Chang, K. Niki, and S. Takanashi, “Particle Based Simulation of the Aortic Valve by Considering Heart’s Pulsation,” Stud Health Technol Inform, vol. 196, pp. 285–289, 2014.
[6823]	S. I. Cheon, L. Batista Capaverde Silva, R. Ditzler, and L. D. Zarzar, “Particle Stabilization of Oil-Fluorocarbon Interfaces and Effects on Multiphase Oil-in-Water Complex Emulsion Morphology and Reconfigurability,” Langmuir, vol. 36, no. 25, pp. 7083–7090, Jun. 2020, doi: 10.1021/acs.langmuir.9b03830.
[6824]	B. P. Binks, S. K. Johnston, T. Sekine, and A. T. Tyowua, “Particles at Oil-Air Surfaces: Powdered Oil, Liquid Oil Marbles, and Oil Foam,” ACS Appl Mater Interfaces, vol. 7, no. 26, pp. 14328–14337, Jul. 2015, doi: 10.1021/acsami.5b02890.
[6825]	D. Boglaienko and B. Tansel, “Partitioning of fresh crude oil between floating, dispersed and sediment phases: Effect of exposure order to dispersant and granular materials,” J. Environ. Manage., vol. 175, pp. 40–45, Jun. 2016, doi: 10.1016/j.jenvman.2016.03.017.
[6826]	P. T. Joshi and L. M. Cullins, “Partnering for Our World’s Children,” Child Adolesc Psychiatr Clin N Am, vol. 24, no. 4, pp. xi–xii, Oct. 2015, doi: 10.1016/j.chc.2015.06.012.
[6827]	A. Papa, “Passing the Experience Talks Baton,” J Emerg Nurs, vol. 42, no. 4, p. 357, Jul. 2016, doi: 10.1016/j.jen.2016.05.004.
[6828]	Z. T. Shasha, Y. Geng, H.-P. Sun, W. Musakwa, and L. Sun, “Past, current, and future perspectives on eco-tourism: a bibliometric review between 2001 and 2018,” Environ Sci Pollut Res Int, vol. 27, no. 19, pp. 23514–23528, Jul. 2020, doi: 10.1007/s11356-020-08584-9.
[6829]	B. Palmieri, J. P. Tremblay, and L. Daniele, “Past, present and future of myoblast transplantation in the treatment of Duchenne muscular dystrophy,” Pediatr Transplant, vol. 14, no. 7, pp. 813–819, Nov. 2010, doi: 10.1111/j.1399-3046.2010.01377.x.
[6830]	J. M. Keller and M. Frega, “Past, Present, and Future of Neuronal Models In Vitro,” Adv Neurobiol, vol. 22, pp. 3–17, 2019, doi: 10.1007/978-3-030-11135-9_1.
[6831]	L. J. Caverly, Y. J. Huang, and M. A. Sze, “Past, Present, and Future Research on the Lung Microbiome in Inflammatory Airway Disease,” Chest, vol. 156, no. 2, pp. 376–382, 2019, doi: 10.1016/j.chest.2019.05.011.
[6832]	M. A. Kelly, “Patellofemoral complications following total knee arthroplasty,” Instr Course Lect, vol. 50, pp. 403–407, 2001.
[6833]	T. M. Pinto, C. Samorinha, I. Tendais, R. Nunes-Costa, and B. Figueiredo, “Paternal Adjustment and Paternal Attitudes Questionnaire: Antenatal and Postnatal Portuguese Versions,” Assessment, vol. 24, no. 6, pp. 820–830, Sep. 2017, doi: 10.1177/1073191115621794.
[6834]	W. Białaszek and P. Marcowski, “Path Dependency in the Discounting of Delayed and Probabilistic Gains and Losses,” Sci Rep, vol. 9, no. 1, p. 8738, 19 2019, doi: 10.1038/s41598-019-45376-9.
[6835]	K. Stalder, “[Pathogenesis and industrial hygiene of silicosis],” Klin. Wochenschr., vol. 46, no. 9, pp. 457–464, May 1968, doi: 10.1007/BF01810785.
[6836]	V. Visconte, R. V. Tiu, and H. J. Rogers, “Pathogenesis of myelodysplastic syndromes: an overview of molecular and non-molecular aspects of the disease,” Blood Res, vol. 49, no. 4, pp. 216–227, Dec. 2014, doi: 10.5045/br.2014.49.4.216.
[6837]	T. Kurita et al., “Pathological mechanisms of laryngeal papillomatosis based on laryngeal epithelial characteristics,” Laryngoscope Investig Otolaryngol, vol. 4, no. 1, pp. 89–94, Feb. 2019, doi: 10.1002/lio2.242.
[6838]	L. M. Taylor et al., “Pathological phosphorylation of tau and TDP-43 by TTBK1 and TTBK2 drives neurodegeneration,” Mol Neurodegener, vol. 13, no. 1, p. 7, 06 2018, doi: 10.1186/s13024-018-0237-9.
[6839]	A. J. Masot, C. Gomez-Tejedor, L. Gomez, A. Gazquez, and E. Redondo, “Pathological study of experimentally induced bovine respiratory syncytial viral infection in lambs,” Zentralblatt Veterinarmedizin Reihe B, vol. 43, no. 4, pp. 233–243, Jun. 1996, doi: 10.1111/j.1439-0450.1996.tb00310.x.
[6840]	F. Paul, “Pathology and MRI: exploring cognitive impairment in MS,” Acta Neurol. Scand., vol. 134 Suppl 200, pp. 24–33, Sep. 2016, doi: 10.1111/ane.12649.
[6841]	K. Miyakawa, C. L. Swenson, L. Mendoza, M. H. Boyle, and B. A. Steficek, “Pathology in practice. Penicilliosis,” J. Am. Vet. Med. Assoc., vol. 238, no. 1, pp. 51–53, Jan. 2011, doi: 10.2460/javma.238.1.51.
[6842]	C. Villanueva and J. Argente, “Pathology or normal variant: what constitutes a delay in puberty?,” Horm Res Paediatr, vol. 82, no. 4, pp. 213–221, 2014, doi: 10.1159/000362600.
[6843]	A. Roquilly et al., “Pathophysiological role of respiratory dysbiosis in hospital-acquired pneumonia,” Lancet Respir Med, vol. 7, no. 8, pp. 710–720, 2019, doi: 10.1016/S2213-2600(19)30140-7.
[6844]	M. Ichikawa, “Pathophysiology of MDS: genomic aberrations,” Rinsho Ketsueki, vol. 57, no. 10, pp. 1972–1979, 2016, doi: 10.11406/rinketsu.57.1972.
[6845]	A. Flieger, F. Frischknecht, G. Häcker, M. W. Hornef, and G. Pradel, “Pathways of host cell exit by intracellular pathogens,” Microb Cell, vol. 5, no. 12, pp. 525–544, Oct. 2018, doi: 10.15698/mic2018.12.659.
[6846]	D. Gilbert, “Patient Commentary: Online screening for depression-old (paternalistic) wine in new (digital) bottles,” BMJ, vol. 358, p. j4207, 13 2017, doi: 10.1136/bmj.j4207.
[6847]	M. Fischer, “Patient experience. Changing the NHS from the inside out,” Health Serv J, vol. 123, no. 6337, pp. 27–29, Jan. 2013.
[6848]	B. Potenzi and A. K. H. Lim, “Patient factors affecting the proper completion of a Goals-Of-Care form in a general medicine hospital admission,” Intern Med J, Nov. 2019, doi: 10.1111/imj.14703.
[6849]	D. S. Shannahoff-Khalsa, “Patient perspectives: Kundalini yoga meditation techniques for psycho-oncology and as potential therapies for cancer,” Integr Cancer Ther, vol. 4, no. 1, pp. 87–100, Mar. 2005, doi: 10.1177/1534735404273841.
[6850]	J. Barr, S. McKinley, E. O’Brien, and G. Herkes, “Patient recognition of and response to symptoms of TIA or stroke,” Neuroepidemiology, vol. 26, no. 3, pp. 168–175, 2006, doi: 10.1159/000091659.
[6851]	L. Eichhorn et al., “[Patient Satisfaction as a Measure of Quality of Patient Care - Comparison between a University Hospital and a General Hospital],” Gesundheitswesen, vol. 79, no. 8–09, pp. 627–632, Aug. 2017, doi: 10.1055/s-0041-110528.
[6852]	L. A. Stutts et al., “Patient-centered outcome criteria for successful treatment of facial pain and fibromyalgia,” J Orofac Pain, vol. 23, no. 1, pp. 47–53, 2009.
[6853]	T. H. Tran, G. M. Ruiz-Palacios, F. G. Hayden, and J. Farrar, “Patient-oriented pandemic influenza research,” Lancet, vol. 373, no. 9681, pp. 2085–2086, Jun. 2009, doi: 10.1016/S0140-6736(09)61131-4.
[6854]	S. L. Parker, A. L. Asher, S. S. Godil, C. J. Devin, and M. J. McGirt, “Patient-reported outcomes 3 months after spine surgery: is it an accurate predictor of 12-month outcome in real-world registry platforms?,” Neurosurg Focus, vol. 39, no. 6, p. E17, Dec. 2015, doi: 10.3171/2015.9.FOCUS15356.
[6855]	D. Gilstrap and J. Davies, “Patient-Ventilator Interactions,” Clin. Chest Med., vol. 37, no. 4, pp. 669–681, Dec. 2016, doi: 10.1016/j.ccm.2016.07.007.
[6856]	N. MacIntyre, “Patient-ventilator trigger dys-synchrony: a common phenomenon with important implications,” Crit Care, vol. 17, no. 3, p. 157, Jun. 2013, doi: 10.1186/cc12729.
[6857]	K. J. de Burlet, B. Desmond, S. J. Harper, P. D. Larsen, and E. R. Dennett, “Patients requiring an acute operation: where are the delays in the process?,” ANZ J Surg, vol. 88, no. 9, pp. 865–869, 2018, doi: 10.1111/ans.14718.
[6858]	L. J. Hood, C. I. Berlin, J. Bordelon, and K. Rose, “Patients with auditory neuropathy/dys-synchrony lack efferent suppression of transient evoked otoacoustic emissions,” J Am Acad Audiol, vol. 14, no. 6, pp. 302–313, Aug. 2003.
[6859]	S. Woodward and M. Rew, “Patients’ quality of life and clean intermittent self-catheterization,” Br J Nurs, vol. 12, no. 18, pp. 1066–1074, Oct. 2003, doi: 10.12968/bjon.2003.12.18.11782.
[6860]	P. R. Aldinger et al., “Pattern of periprosthetic bone remodeling around stable uncemented tapered hip stems: a prospective 84-month follow-up study and a median 156-month cross-sectional study with DXA,” Calcif. Tissue Int., vol. 73, no. 2, pp. 115–121, Aug. 2003, doi: 10.1007/s00223-002-2036-z.
[6861]	F. Lübkemann et al., “Patterning of Nanoparticle-Based Aerogels and Xerogels by Inkjet Printing,” Small, vol. 15, no. 39, p. e1902186, Sep. 2019, doi: 10.1002/smll.201902186.
[6862]	N. Asdaghi et al., “Patterns and Outcomes of Endovascular Therapy in Mild Stroke,” Stroke, vol. 50, no. 8, pp. 2101–2107, 2019, doi: 10.1161/STROKEAHA.118.023893.
[6863]	P. E. Neill, N. Rozbaczylo, C. Villaseñor-Parada, G. Guzmán-Rendón, S. Sampértegui, and C. E. Hernández, “Patterns of association of native and exotic boring polychaetes on the southeastern Pacific coast of Chile: the combined importance of negative, positive and random interactions,” PeerJ, vol. 8, p. e8560, 2020, doi: 10.7717/peerj.8560.
[6864]	D. Pelech, “Paying more for less? Insurer competition and health plan generosity in the Medicare Advantage program,” J Health Econ, vol. 61, pp. 77–92, 2018, doi: 10.1016/j.jhealeco.2018.07.002.
[6865]	Y.-G. Du, H.-J. Zhang, J.-P. Chen, Y. Fan, and Y.-W. Ni, “[PCDD/Fs formation from pentachlorobenzene under the catalysis of CuO],” Huan Jing Ke Xue, vol. 31, no. 11, pp. 2774–2779, Nov. 2010.
[6866]	E. Guerriero, A. Guarnieri, S. Mosca, G. Rossetti, and M. Rotatori, “PCDD/Fs removal efficiency by electrostatic precipitator and wetfine scrubber in an iron ore sintering plant,” J. Hazard. Mater., vol. 172, no. 2–3, pp. 1498–1504, Dec. 2009, doi: 10.1016/j.jhazmat.2009.08.019.
[6867]	B. Ju, S. Chen, and W. Kong, “Pd-Catalyzed Enantioselective Double Heck Reaction,” Org. Lett., vol. 21, no. 23, pp. 9343–9347, 06 2019, doi: 10.1021/acs.orglett.9b03517.
[6868]	I. Triantafyllidis, A. Ciobanu, O. Stanca, C. Draghici, S. Angelescu, and E. Tapelea, “Peculiarities in the Diagnosis Approach of MDS /MPN-U Patients,” Maedica (Buchar), vol. 7, no. 2, pp. 173–176, Jun. 2012.
[6869]	M. Budroni, S. Zara, G. Zara, G. Pirino, and I. Mannazzu, “Peculiarities of flor strains adapted to Sardinian sherry-like wine ageing conditions,” FEMS Yeast Res., vol. 5, no. 10, pp. 951–958, Jul. 2005, doi: 10.1016/j.femsyr.2005.04.002.
[6870]	B. Tallon and M. Corkill, “Peculiarities of PAPA syndrome,” Rheumatology (Oxford), vol. 45, no. 9, pp. 1140–1143, Sep. 2006, doi: 10.1093/rheumatology/kei178.
[6871]	D. T. McDowell, E. J. Hyland, J. G. Harvey, and A. J. A. Holland, “Pediatric burns research: A history or an evolution?,” Burns, vol. 41, no. 7, pp. 1556–1561, Nov. 2015, doi: 10.1016/j.burns.2015.04.014.
[6872]	T. D. Sanger et al., “Pediatric Deep Brain Stimulation Using Awake Recording and Stimulation for Target Selection in an Inpatient Neuromodulation Monitoring Unit,” Brain Sci, vol. 8, no. 7, Jul. 2018, doi: 10.3390/brainsci8070135.
[6873]	K. R. Billings et al., “Pediatric emergency department visits for uncontrolled pain in postoperative adenotonsillectomy patients,” Laryngoscope Investig Otolaryngol, vol. 4, no. 1, pp. 165–169, Feb. 2019, doi: 10.1002/lio2.237.
[6874]	E. Stieglitz and M. L. Loh, “Pediatric MDS: GATA screen the germline,” Blood, vol. 127, no. 11, pp. 1377–1378, Mar. 2016, doi: 10.1182/blood-2016-01-690016.
[6875]	R. Kao, V. J. Campiti, C. C. Rabbani, J. Y. Ting, M. W. Sim, and T. Z. Shipchandler, “Pediatric Midface Fractures: Outcomes and Complications of 218 Patients,” Laryngoscope Investig Otolaryngol, vol. 4, no. 6, pp. 597–601, Dec. 2019, doi: 10.1002/lio2.315.
[6876]	G. M. Brilis and J. G. Lyon, “Peer Review as a QA Tool in Environmental Applications,” Qual Assur, vol. 11, no. 2, pp. 111–129, Jun. 2005, doi: 10.1080/10529410500481991.
[6877]	S.-C. Lai and R. Devenish, “Peering into the ‘black box’ of pathogen recognition by cellular autophagy systems,” Microb Cell, vol. 2, no. 9, pp. 322–328, Aug. 2015, doi: 10.15698/mic2015.09.225.
[6878]	Y. Masuda, S. Kumano, J. Noguchi, K. Sakamoto, H. Inooka, and T. Ohtaki, “PEGylated neuromedin U-8 shows long-lasting anorectic activity and anti-obesity effect in mice by peripheral administration,” Peptides, vol. 94, pp. 99–105, Aug. 2017, doi: 10.1016/j.peptides.2017.04.001.
[6879]	P. Ingallinella et al., “PEGylation of Neuromedin U yields a promising candidate for the treatment of obesity and diabetes,” Bioorg. Med. Chem., vol. 20, no. 15, pp. 4751–4759, Aug. 2012, doi: 10.1016/j.bmc.2012.06.003.
[6880]	D. Djuric, “Penetrating the omerta of predatory publishing: the romanian connection,” Sci Eng Ethics, vol. 21, no. 1, pp. 183–202, Feb. 2015, doi: 10.1007/s11948-014-9521-4.
[6881]	V. Papa, “Penetration of topical chloramphenicol into the anterior chamber,” Clin. Experiment. Ophthalmol., vol. 43, no. 5, pp. 493–494, Jul. 2015, doi: 10.1111/ceo.12468.
[6882]	M. De Bernardo, M. Borrelli, M. Mariniello, M. Lanza, and N. Rosa, “Pentacam vs SP3000P specular microscopy in measuring corneal thickness,” Cont Lens Anterior Eye, vol. 38, no. 1, pp. 21–27, Feb. 2015, doi: 10.1016/j.clae.2014.08.006.
[6883]	O. Henning, K. O. Nakken, and M. I. Lossius, “People with epilepsy and their relatives want more information about risks of injuries and premature death,” Epilepsy Behav, vol. 82, pp. 6–10, 2018, doi: 10.1016/j.yebeh.2018.02.023.
[6884]	R. Tu, H. M. Grover, and L. P. Kotra, “Peptidyl Arginine Deiminases and Neurodegenerative Diseases,” Curr. Med. Chem., vol. 23, no. 2, pp. 104–114, 2016, doi: 10.2174/0929867323666151118120710.
[6885]	V. Tosato and C. V. Bruschi, “Per aspera ad astra: When harmful chromosomal translocations become a plus value in genetic evolution. Lessons from Saccharomyces cerevisiae,” Microb Cell, vol. 2, no. 10, pp. 363–375, Aug. 2015, doi: 10.15698/mic2015.10.230.
[6886]	R. Shankar et al., “Perampanel in the general population and in people with intellectual disability: Differing responses,” Seizure, vol. 49, pp. 30–35, Jul. 2017, doi: 10.1016/j.seizure.2017.05.012.
[6887]	C. H. Van Houtven et al., “Perceived discrimination and reported delay of pharmacy prescriptions and medical tests,” J Gen Intern Med, vol. 20, no. 7, pp. 578–583, Jul. 2005, doi: 10.1111/j.1525-1497.2005.0123.x.
[6888]	S. Abdollahpour, S. A. Mousavi, H. Esmaily, and A. Khosrav, “Perceived Psychological Traumatic Childbirth in Iranian Mothers: Diagnostic Value of Coping Strategies,” Osong Public Health Res Perspect, vol. 10, no. 2, pp. 72–77, Apr. 2019, doi: 10.24171/j.phrp.2019.10.2.05.
[6889]	E. Nurjannah, N. Nurdin,  null Andriani, and K. Kadar, “Perception and psychosocial burden of people with epilepsy (PWE): Experience from Indonesia,” Enferm Clin, vol. 30 Suppl 2, pp. 622–625, Mar. 2020, doi: 10.1016/j.enfcli.2019.07.175.
[6890]	M. E. Bates and J. A. Simmons, “Perception of echo delay is disrupted by small temporal misalignment of echo harmonics in bat sonar,” J. Exp. Biol., vol. 214, no. Pt 3, pp. 394–401, Feb. 2011, doi: 10.1242/jeb.048983.
[6891]	J. Levy, A. Goldstein, and R. Feldman, “Perception of social synchrony induces mother-child gamma coupling in the social brain,” Soc Cogn Affect Neurosci, vol. 12, no. 7, pp. 1036–1046, 01 2017, doi: 10.1093/scan/nsx032.
[6892]	J. Bigelow, S. Berrett, I. Kimuli, and E. Katabira, “Perceptions of epilepsy among first-year medical students at Mulago Hospital in Kampala, Uganda,” Epilepsy Behav, vol. 51, pp. 28–32, Oct. 2015, doi: 10.1016/j.yebeh.2015.06.020.
[6893]	A. Geva, M. Moscovitch, and L. Leach, “Perceptual priming of proper names in young and older normal adults and a patient with prosopanomia,” Neuropsychology, vol. 11, no. 2, pp. 232–242, Apr. 1997, doi: 10.1037//0894-4105.11.2.232.
[6894]	G. A. Thom and K. C. Cheah, “Perforating foreign body reaction to unheated liquid contents of lava lamp,” Pediatr Dermatol, vol. 31, no. 5, pp. 623–624, Oct. 2014, doi: 10.1111/pde.12087.
[6895]	J. Huang and H. Gharavi, “Performance Analysis of Relay-based Two-way D2D Communications with Network Coding,” IEEE Trans Veh Technol, vol. 67, 2018, doi: 10.1109/TVT.2018.2797123.
[6896]	A. Jönsson, S. Jacobsson, S. Foerster, M. J. Cole, and M. Unemo, “Performance characteristics of newer MIC gradient strip tests compared with the Etest for antimicrobial susceptibility testing of Neisseria gonorrhoeae,” APMIS, vol. 126, no. 10, pp. 822–827, Oct. 2018, doi: 10.1111/apm.12887.
[6897]	J. Chen, C. Wu, J. Wang, and J. Ma, “Performance evaluation of biofilters packed with carbon foam and lava for nitric oxide removal,” J. Hazard. Mater., vol. 137, no. 1, pp. 172–177, Sep. 2006, doi: 10.1016/j.jhazmat.2006.01.049.
[6898]	B. Aydenız and E. Yilmaz, “Performance of Different Natural Antioxidant Compounds in Frying Oil,” Food Technol. Biotechnol., vol. 54, no. 1, pp. 21–30, Mar. 2016, doi: 10.17113/ftb.54.01.16.4109.
[6899]	M. S. L. Sey, A. Liu, S. Asfaha, V. Siebring, V. Jairath, and B. Yan, “Performance report cards increase adenoma detection rate,” Endosc Int Open, vol. 5, no. 7, pp. E675–E682, Jul. 2017, doi: 10.1055/s-0043-110568.
[6900]	M. Rozenman, N. Amir, and V. R. Weersing, “Performance-based interpretation bias in clinically anxious youths: relationships with attention, anxiety, and negative cognition,” Behav Ther, vol. 45, no. 5, pp. 594–605, Sep. 2014, doi: 10.1016/j.beth.2014.03.009.
[6901]	C. A. Solid, R. N. Foley, D. T. Gilbertson, and A. J. Collins, “Perihospitalization hemoglobin-epoetin associations in U.S. hemodialysis patients, 1998 to 2003,” Hemodial Int, vol. 11, no. 4, pp. 442–447, Oct. 2007, doi: 10.1111/j.1542-4758.2007.00215.x.
[6902]	F. Fouhy et al., “Perinatal factors affect the gut microbiota up to four years after birth,” Nat Commun, vol. 10, no. 1, p. 1517, 03 2019, doi: 10.1038/s41467-019-09252-4.
[6903]	P. Rzehak et al., “Period-specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years,” Eur. J. Epidemiol., vol. 24, no. 8, pp. 449–467, 2009, doi: 10.1007/s10654-009-9356-5.
[6904]	D. Lauritano, F. Cura, V. Candotto, R. M. Gaudio, D. Mucchi, and F. Carinci, “PERIODONTAL POCKETS AS A RESERVOIR OF HELICOBACTER PYLORI CAUSING RELAPSE OF GASTRIC ULCER: A REVIEW OF THE LITERATURE,” J. Biol. Regul. Homeost. Agents, vol. 29, no. 3 Suppl 1, pp. 123–126, Sep. 2015.
[6905]	J. Litvin, S. Zhu, R. Norris, and R. Markwald, “Periostin family of proteins: therapeutic targets for heart disease,” Anat Rec A Discov Mol Cell Evol Biol, vol. 287, no. 2, pp. 1205–1212, Dec. 2005, doi: 10.1002/ar.a.20237.
[6906]	M. E. Modi et al., “Peripheral Administration of a Long-Acting Peptide Oxytocin Receptor Agonist Inhibits Fear-Induced Freezing,” J. Pharmacol. Exp. Ther., vol. 358, no. 2, pp. 164–172, 2016, doi: 10.1124/jpet.116.232702.
[6907]	B. Tian et al., “Peripheral and spinal 5-HT receptors participate in cholestatic itch and antinociception induced by bile duct ligation in rats,” Sci Rep, vol. 6, p. 36286, 08 2016, doi: 10.1038/srep36286.
[6908]	A. C. Fanaroff et al., “Peripheral Artery Disease and Transcatheter Aortic Valve Replacement Outcomes: A Report From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Therapy Registry,” Circ Cardiovasc Interv, vol. 10, no. 10, Oct. 2017, doi: 10.1161/CIRCINTERVENTIONS.117.005456.
[6909]	M. Rezk-Hanna et al., “Peripheral Blood Flow Changes to Cutaneous and Muscular Beds in Response to Acute Hookah Smoking,” Am. J. Cardiol., vol. 125, no. 11, pp. 1725–1731, 01 2020, doi: 10.1016/j.amjcard.2020.02.042.
[6910]	W. Cao and H. Zheng, “Peripheral immune system in aging and Alzheimer’s disease,” Mol Neurodegener, vol. 13, no. 1, p. 51, 03 2018, doi: 10.1186/s13024-018-0284-2.
[6911]	K. Turżańska, S. Zaborek, A. Posturzyńska, J. Niezbecka, A. Zarębska, and M. Jabłoński, “[Peripheral nerves alcoholization in the spasticity managament],” Wiad. Lek., vol. 69, no. 4, pp. 631–636, 2016.
[6912]	M. W. Brightman and M. Kaya, “Permeable endothelium and the interstitial space of brain,” Cell. Mol. Neurobiol., vol. 20, no. 2, pp. 111–130, Apr. 2000, doi: 10.1023/a:1006944203934.
[6913]	T. D. Jones, P. J. Walsh, and E. A. Zeighami, “Permissible concentrations of chemicals in air and water derived from RTECS entries: a ‘rash’ chemical scoring system,” Toxicol Ind Health, vol. 1, no. 4, pp. 213–234, Dec. 1985, doi: 10.1177/074823378500100414.
[6914]	R. S. Narins, F. S. Brandt, S. H. Dayan, and C. S. Hornfeldt, “Persistence of nasolabial fold correction with a hyaluronic acid dermal filler with retreatment: results of an 18-month extension study,” Dermatol Surg, vol. 37, no. 5, pp. 644–650, May 2011, doi: 10.1111/j.1524-4725.2010.01863.x.
[6915]	D. Merecz and A. Andysz, “Person-organization fit and organizational identification as predictors of positive and negative work-home interactions,” Int J Occup Med Environ Health, vol. 27, no. 1, pp. 16–27, Jan. 2014, doi: 10.2478/s13382-014-0221-8.
[6916]	C. Robitschek, A. Yang, R. Villalba Ii, and Y. Shigemoto, “Personal growth Initiative: A robust and malleable predictor of treatment outcome for depressed partial hospital patients,” J Affect Disord, vol. 246, pp. 548–555, 01 2019, doi: 10.1016/j.jad.2018.12.121.
[6917]	T. Ferns, A. Cork, and M. Rew, “Personal safety in the accident and emergency department,” Br J Nurs, vol. 14, no. 13, pp. 725–730, Jul. 2005, doi: 10.12968/bjon.2005.14.13.18458.
[6918]	P. Brown and J. Yantis, “Personal space intrusion and PTSD,” J Psychosoc Nurs Ment Health Serv, vol. 34, no. 7, pp. 23–28, Jul. 1996.
[6919]	C. R. Cloninger and A. H. Zohar, “Personality and the perception of health and happiness,” J Affect Disord, vol. 128, no. 1–2, pp. 24–32, Jan. 2011, doi: 10.1016/j.jad.2010.06.012.
[6920]	G. Persson, “Personality dimensions in a 70-year-old urban population. Norms for the MNT scales and sex and age relations,” Acta Psychiatr Scand, vol. 62, no. 5, pp. 476–485, Nov. 1980, doi: 10.1111/j.1600-0447.1980.tb00636.x.
[6921]	D. Tomeček et al., “Personality reflection in the brain’s intrinsic functional architecture remains elusive,” PLoS ONE, vol. 15, no. 6, p. e0232570, 2020, doi: 10.1371/journal.pone.0232570.
[6922]	G. H. Lyman and N. M. Kuderer, “Personalized cancer supportive care in COVID-19 era,” Ann. Oncol., vol. 31, no. 7, pp. 835–837, 2020, doi: 10.1016/j.annonc.2020.05.003.
[6923]	X. Hou, W. Zhao, J.-M. Beauregard, and A. Celler, “Personalized kidney dosimetry in 177Lu-octreotate treatment of neuroendocrine tumours: a comparison of kidney dosimetry estimates based on a whole organ and small volume segmentations,” Phys Med Biol, vol. 64, no. 17, p. 175004, 28 2019, doi: 10.1088/1361-6560/ab32a1.
[6924]	E. S. Nash, “Perspectives on anxiety,” S. Afr. Med. J., vol. Suppl, pp. 5–7, Oct. 1985.
[6925]	D. E. Bradway, “Perspectives on interactions with QA--the regulatory perspective,” Qual Assur, vol. 3, no. 4, pp. 328–331, Dec. 1994.
[6926]	S.-H. Yang et al., “Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer,” World J. Gastroenterol., vol. 22, no. 32, pp. 7275–7288, Aug. 2016, doi: 10.3748/wjg.v22.i32.7275.
[6927]	U. E. Reinhardt, “Perspectives on the pharmaceutical industry,” Health Aff (Millwood), vol. 20, no. 5, pp. 136–149, Oct. 2001, doi: 10.1377/hlthaff.20.5.136.
[6928]	“Pertussis vaccines: WHO position paper - September 2015,” Wkly. Epidemiol. Rec., vol. 90, no. 35, pp. 433–458, Aug. 2015.
[6929]	D. E. Turner, J. Woodburn, P. S. Helliwell, M. W. Cornwall, and P. Emery, “Pes planovalgus in RA: a descriptive and analytical study of foot function determined by gait analysis,” Musculoskeletal Care, vol. 1, no. 1, pp. 21–33, Mar. 2003, doi: 10.1002/msc.36.
[6930]	K. M. Kälkner et al., “PET with hydroxytryptophan as tracer in hormone-refractory prostatic adenocarcinoma: evaluation of decarboxylation in vivo,” In Vivo, vol. 11, no. 5, pp. 377–381, Oct. 1997.
[6931]	A. Pratama et al., “Petrology and geochemistry dataset of lava from the Ijen Crater and Mount Blau, Banyuwangi, East Java, Indonesia,” Data Brief, vol. 27, p. 104765, Dec. 2019, doi: 10.1016/j.dib.2019.104765.
[6932]	M.-A. Deprez, E. Eskes, T. Wilms, P. Ludovico, and J. Winderickx, “pH homeostasis links the nutrient sensing PKA/TORC1/Sch9 ménage-à-trois to stress tolerance and longevity,” Microb Cell, vol. 5, no. 3, pp. 119–136, Jan. 2018, doi: 10.15698/mic2018.03.618.
[6933]	K. M. Tyo et al., “pH-responsive delivery of Griffithsin from electrospun fibers,” Eur J Pharm Biopharm, vol. 138, pp. 64–74, May 2019, doi: 10.1016/j.ejpb.2018.04.013.
[6934]	K. Asif and S. V. Kothiwale, “Phagocytic activity of peripheral blood and crevicular phagocytes in health and periodontal disease,” J Indian Soc Periodontol, vol. 14, no. 1, pp. 8–11, Jan. 2010, doi: 10.4103/0972-124X.65427.
[6935]	N. N. Ginsburg and T. N. Maslova, “[PHAGOCYTOSIS CAPACITY IN CELLULAR ELEMENTS OF MACROPHAGE CULTURES IN VITRO. II],” Zh. Mikrobiol. Epidemiol. Immunobiol., vol. 40, pp. 62–66, Apr. 1963.
[6936]	M. Kenneally and V. Walshe, “Pharmaceutical cost-containment policies and sustainability: recent Irish experience,” Value Health, vol. 15, no. 2, pp. 389–393, Apr. 2012, doi: 10.1016/j.jval.2011.10.007.
[6937]	Y. Shen et al., “Pharmaceutical exposure changed antibiotic resistance genes and bacterial communities in soil-surface- and overhead-irrigated greenhouse lettuce,” Environ Int, vol. 131, p. 105031, 2019, doi: 10.1016/j.envint.2019.105031.
[6938]	G. Bobrowicz, “Pharmaceutical GMPs,” Qual Assur, vol. 3, no. 2, pp. 138–148, Jun. 1994.
[6939]	G. O. Delwel and M. J. W. Sprenger, “[Pharmaco-economic evaluations of new drugs: potential key to a more efficient allocation of the health care budget],” Ned Tijdschr Geneeskd, vol. 146, no. 23, pp. 1068–1071, Jun. 2002.
[6940]	P. D. Lister, “Pharmacodynamics of gatifloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model: impact of area under the curve/MIC ratios on eradication,” Antimicrob. Agents Chemother., vol. 46, no. 1, pp. 69–74, Jan. 2002, doi: 10.1128/aac.46.1.69-74.2002.
[6941]	A. S. Al-Jazairi, N. S. Al-Qadheeb, and A. Ajlan, “Pharmacoeconomic analysis in Saudi Arabia: an overdue agenda item for action,” Ann Saudi Med, vol. 31, no. 4, pp. 335–341, Aug. 2011, doi: 10.4103/0256-4947.83201.
[6942]	M. Shiragami, “[Pharmacoeconomics],” Yakugaku Zasshi, vol. 123, no. 3, pp. 133–142, Mar. 2003, doi: 10.1248/yakushi.123.133.
[6943]	H. Shionoiri, “Pharmacokinetic drug interactions with ACE inhibitors,” Clin Pharmacokinet, vol. 25, no. 1, pp. 20–58, Jul. 1993, doi: 10.2165/00003088-199325010-00003.
[6944]	M. Burnier and J. Biollaz, “Pharmacokinetic optimisation of angiotensin converting enzyme (ACE) inhibitor therapy,” Clin Pharmacokinet, vol. 22, no. 5, pp. 375–384, May 1992, doi: 10.2165/00003088-199222050-00004.
[6945]	G. P. Zara, A. Bargoni, R. Cavalli, A. Fundarò, D. Vighetto, and M. R. Gasco, “Pharmacokinetics and tissue distribution of idarubicin-loaded solid lipid nanoparticles after duodenal administration to rats,” J Pharm Sci, vol. 91, no. 5, pp. 1324–1333, May 2002, doi: 10.1002/jps.10129.
[6946]	G. L. Chan et al., “Pharmacokinetics of 6-thiouric acid and 6-mercaptopurine in renal allograft recipients after oral administration of azathioprine,” Eur. J. Clin. Pharmacol., vol. 36, no. 3, pp. 265–271, 1989, doi: 10.1007/BF00558158.
[6947]	E. Miller, A. Morel, J. Redlicka, I. Miller, and J. Saluk, “Pharmacological and Non-pharmacological Therapies of Cognitive Impairment in Multiple Sclerosis,” Curr Neuropharmacol, vol. 16, no. 4, pp. 475–483, 2018, doi: 10.2174/1570159X15666171109132650.
[6948]	A. R. Knight et al., “Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors,” Naunyn Schmiedebergs Arch. Pharmacol., vol. 370, no. 2, pp. 114–123, Aug. 2004, doi: 10.1007/s00210-004-0951-4.
[6949]	J. Mialet, I. Berque-Bestel, S. Sicsic, M. Langlois, R. Fischmeister, and F. Lezoualc’h, “Pharmacological characterization of the human 5-HT(4(d)) receptor splice variant stably expressed in Chinese hamster ovary cells,” Br. J. Pharmacol., vol. 131, no. 4, pp. 827–835, Oct. 2000, doi: 10.1038/sj.bjp.0703641.
[6950]	C. Schindler, T. Chavakis, V. Lamounier-Zepter, and S. R. Bornstein, “[Pharmacological concepts for the treatment of obesity - a therapeutic meander?],” Dtsch. Med. Wochenschr., vol. 136, no. 31–32, pp. 1570–1573, Aug. 2011, doi: 10.1055/s-0031-1281554.
[6951]	G. Sakalauskienė, G. Civinskienė, A. Antuševas, and P. Civinskas, “[Pharmacological Properties of Loop Diuretics and Their Clinical Effects],” Kardiologiia, no. 1, pp. 72–83, Jan. 2018, doi: 10.18087/cardio.2018.1.10084.
[6952]	B. de Toffol et al., “Pharmacotherapy in patients with epilepsy and psychosis,” Epilepsy Behav, vol. 88, pp. 54–60, 2018, doi: 10.1016/j.yebeh.2018.09.001.
[6953]	J. R. Nash and D. J. Nutt, “Pharmacotherapy of anxiety,” Handb Exp Pharmacol, no. 169, pp. 469–501, 2005, doi: 10.1007/3-540-28082-0_17.
[6954]	V. Schusdziarra and J. Erdmann, “[Pharmacotherapy of obesity],” Pharm Unserer Zeit, vol. 35, no. 6, pp. 500–504, 2006, doi: 10.1002/pauz.200600195.
[6955]	M. G. Rezk and J. Foroozesh, “Phase behavior and fluid interactions of a CO2-Light oil system at high pressures and temperatures,” Heliyon, vol. 5, no. 7, p. e02057, Jul. 2019, doi: 10.1016/j.heliyon.2019.e02057.
[6956]	E. G. Rondanelli, “[Phase contrast microcinematography of the phenomenon of emission of bubbles in mitosis of cells cultured in vitro],” Haematologica, vol. 40, pp. 217–224, 1955.
[6957]	J. L. Canton, M. R. Smith, H.-S. Choi, and C. I. Eastman, “Phase delaying the human circadian clock with a single light pulse and moderate delay of the sleep/dark episode: no influence of iris color,” J Circadian Rhythms, vol. 7, p. 8, Jul. 2009, doi: 10.1186/1740-3391-7-8.
[6958]	M. Chaturvedi et al., “Phase lag index and spectral power as QEEG features for identification of patients with mild cognitive impairment in Parkinson’s disease,” Clin Neurophysiol, vol. 130, no. 10, pp. 1937–1944, 2019, doi: 10.1016/j.clinph.2019.07.017.
[6959]	Y. Pang et al., “Phenotype of mesenchymal stem cells from patients with myelodyplastic syndrome maybe partly modulated by decitabine,” Oncol Lett, vol. 18, no. 5, pp. 4457–4466, Nov. 2019, doi: 10.3892/ol.2019.10788.
[6960]	S. Akhavan, M. Luciani, S. Lavoretano, and P. M. Mannucci, “Phenotypic and genetic analysis of a compound heterozygote for dys- and hypoprothrombinaemia,” Br. J. Haematol., vol. 120, no. 1, pp. 142–144, Jan. 2003, doi: 10.1046/j.1365-2141.2003.03986.x.
[6961]	H. Matsui, K. Shimatani, Y. Ikemoto, T. Sasaki, and Y. Matsuo, “Phonon-assisted proton tunneling in the hydrogen-bonded dimeric selenates of Cs3H(SeO4)2,” J Chem Phys, vol. 152, no. 15, p. 154502, Apr. 2020, doi: 10.1063/1.5145108.
[6962]	N. C. Rath, A. Gupta, R. Liyanage, and J. O. Lay, “Phorbol 12-Myristate 13-Acetate-Induced Changes in Chicken Enterocytes,” Proteomics Insights, vol. 10, p. 1178641819840369, 2019, doi: 10.1177/1178641819840369.
[6963]	J. Pratt, A.-M. Boisson, E. Gout, R. Bligny, R. Douce, and S. Aubert, “Phosphate (Pi) starvation effect on the cytosolic Pi concentration and Pi exchanges across the tonoplast in plant cells: an in vivo 31P-nuclear magnetic resonance study using methylphosphonate as a Pi analog,” Plant Physiol., vol. 151, no. 3, pp. 1646–1657, Nov. 2009, doi: 10.1104/pp.109.144626.
[6964]	M. Barac-Nieto, M. Alfred, and A. Spitzer, “Phosphate depletion in opossum kidney cells: apical but not basolateral or transepithelial adaptions of Pi transport,” Exp. Nephrol., vol. 9, no. 4, pp. 258–264, 2001, doi: 10.1159/000052620.
[6965]	W. Ruan, M. Guo, P. Wu, and K. Yi, “Phosphate starvation induced OsPHR4 mediates Pi-signaling and homeostasis in rice,” Plant Mol. Biol., vol. 93, no. 3, pp. 327–340, Feb. 2017, doi: 10.1007/s11103-016-0564-6.
[6966]	J. M. Shillingford, D. T. Calvert, R. B. Beechey, and D. B. Shennan, “Phosphate transport via Na+ -Pi cotransport and anion exchange in lactating rat mammary tissue,” Exp. Physiol., vol. 81, no. 2, pp. 273–284, Mar. 1996, doi: 10.1113/expphysiol.1996.sp003931.
[6967]	R. D. Arroyo-Olarte and N. Gupta, “Phosphatidylthreonine: An exclusive phospholipid regulating calcium homeostasis and virulence in a parasitic protest,” Microb Cell, vol. 3, no. 5, pp. 189–190, May 2016, doi: 10.15698/mic2016.05.496.
[6968]	M. J. Stachowski, R. J. Holewinski, E. Grote, V. Venkatraman, J. E. Van Eyk, and J. A. Kirk, “Phospho-Proteomic Analysis of Cardiac Dyssynchrony and Resynchronization Therapy,” Proteomics, vol. 18, no. 19, p. e1800079, 2018, doi: 10.1002/pmic.201800079.
[6969]	C. Plassard, A. Becquer, and K. Garcia, “Phosphorus Transport in Mycorrhiza: How Far Are We?,” Trends Plant Sci., vol. 24, no. 9, pp. 794–801, 2019, doi: 10.1016/j.tplants.2019.06.004.
[6970]	N. M. Kanaan et al., “Phosphorylation in the amino terminus of tau prevents inhibition of anterograde axonal transport,” Neurobiol. Aging, vol. 33, no. 4, p. 826.e15–30, Apr. 2012, doi: 10.1016/j.neurobiolaging.2011.06.006.
[6971]	L. Fischer, D. Szellas, O. Rådmark, D. Steinhilber, and O. Werz, “Phosphorylation- and stimulus-dependent inhibition of cellular 5-lipoxygenase activity by nonredox-type inhibitors,” FASEB J., vol. 17, no. 8, pp. 949–951, May 2003, doi: 10.1096/fj.02-0815fje.
[6972]	L. Wang, H. Yang, and B. Li, “Photodynamic therapy for prostate cancer: a systematic review and meta-analysis,” Prostate Int, vol. 7, no. 3, pp. 83–90, Sep. 2019, doi: 10.1016/j.prnil.2018.12.002.
[6973]	R. M. May, J. P. Denefle, and B. Courtey, “[PHOTOMETRIC VARIATIONS OF ACETYLCHOLINESTERASES IN SPINAL CORD FRAGMENTS CULTIVATED ‘IN VITRO’ IN THE CHICK EMBRYO],” Arch Sci Physiol (Paris), vol. 17, pp. 421–432, 1963.
[6974]	E. Jiménez, B. Lanza, M. Antiñolo, and J. Albaladejo, “Photooxidation of leaf-wound oxygenated compounds, 1-penten-3-ol, (Z)-3-hexen-1-ol, and 1-penten-3-one, initiated by OH radicals and sunlight,” Environ. Sci. Technol., vol. 43, no. 6, pp. 1831–1837, Mar. 2009, doi: 10.1021/es8027814.
[6975]	P. M. Shih, “Photosynthesis and early Earth,” Curr. Biol., vol. 25, no. 19, pp. R855-859, Oct. 2015, doi: 10.1016/j.cub.2015.04.046.
[6976]	E. Selvaag, H. Anholt, J. Moan, and P. Thune, “Phototoxicity to sulphonamide derived oral antidiabetics and diuretics. Comparative in vitro and in vivo investigations,” In Vivo, vol. 11, no. 1, pp. 103–107, Feb. 1997.
[6977]	J. R. Johnson, P. Delavari, M. Kuskowski, and A. L. Stell, “Phylogenetic distribution of extraintestinal virulence-associated traits in Escherichia coli,” J. Infect. Dis., vol. 183, no. 1, pp. 78–88, Jan. 2001, doi: 10.1086/317656.
[6978]	D. Bian et al., “Phylogenetic relationships of Limacodidae and insights into the higher phylogeny of Lepidoptera,” Int. J. Biol. Macromol., vol. 159, pp. 356–363, Sep. 2020, doi: 10.1016/j.ijbiomac.2020.05.023.
[6979]	B. M. Brumpton et al., “Physical activity and lung function decline in adults with asthma: The HUNT Study,” Respirology, vol. 22, no. 2, pp. 278–283, 2017, doi: 10.1111/resp.12884.
[6980]	M. A. M. Peluso and L. H. S. Guerra de Andrade, “Physical activity and mental health: the association between exercise and mood,” Clinics (Sao Paulo), vol. 60, no. 1, pp. 61–70, Feb. 2005, doi: 10.1590/s1807-59322005000100012.
[6981]	G. M. Frederick, E. R. Williams, I. M. Castillo-Hernández, and E. M. Evans, “Physical activity and perceived benefits, but not barriers, to exercise differ by sex and school year among college students,” J Am Coll Health, pp. 1–8, Aug. 2020, doi: 10.1080/07448481.2020.1800711.
[6982]	N. T. Lautenschlager, K. L. Cox, and K. A. Ellis, “Physical activity for cognitive health: what advice can we give to older adults with subjective cognitive decline and mild cognitive impairment?,” Dialogues Clin Neurosci, vol. 21, no. 1, pp. 61–68, 2019.
[6983]	A. Pouliot-Laforte, L.-N. Veilleux, F. Rauch, and M. Lemay, “Physical activity in youth with osteogenesis imperfecta type I,” J Musculoskelet Neuronal Interact, vol. 15, no. 2, pp. 171–176, Jun. 2015.
[6984]	M. M. Pebole and K. S. Hall, “Physical activity promotion in women with PTSD: What we need for progress,” Psychol Sport Exerc, vol. 41, pp. 127–129, Mar. 2019.
[6985]	G. M. A. S. Tedrus, G. S. Sterca, and R. B. Pereira, “Physical activity, stigma, and quality of life in patients with epilepsy,” Epilepsy Behav, vol. 77, pp. 96–98, 2017, doi: 10.1016/j.yebeh.2017.07.039.
[6986]	H. Tian, F. Imani, and M. J. Soloski, “Physical and molecular genetic analysis of Qa-2 antigen expression: multiple factors controlling cell surface levels,” Mol. Immunol., vol. 28, no. 8, pp. 845–854, Aug. 1991, doi: 10.1016/0161-5890(91)90048-o.
[6987]	K. E. Waddell-Smith et al., “Physical and Psychological Consequences of Left Cardiac Sympathetic Denervation in Long-QT Syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia,” Circ Arrhythm Electrophysiol, vol. 8, no. 5, pp. 1151–1158, Oct. 2015, doi: 10.1161/CIRCEP.115.003159.
[6988]	J. I. Lunine, “Physical conditions on the early Earth,” Philos. Trans. R. Soc. Lond., B, Biol. Sci., vol. 361, no. 1474, pp. 1721–1731, Oct. 2006, doi: 10.1098/rstb.2006.1900.
[6989]	T. Koch, B. Wendling, and N. E. Wilson, “Physician Market Structure, Patient Outcomes, and Spending: An Examination of Medicare Beneficiaries,” Health Serv Res, vol. 53, no. 5, pp. 3549–3568, 2018, doi: 10.1111/1475-6773.12825.
[6990]	A. Zou, J. Bosco, T. Protopsaltis, and J. Slover, “Physician-Specific Variability in Spine Fusion Patients,” Int J Spine Surg, vol. 12, no. 1, pp. 37–42, Jan. 2018, doi: 10.14444/5007.
[6991]	B. Saloner, M. Bachhuber, and C. L. Barry, “Physicians as a Source of Medications for Nonmedical Use: Comparison of Opioid Analgesic, Stimulant, and Sedative Use in a National Sample,” Psychiatr Serv, vol. 68, no. 1, pp. 56–62, 01 2017, doi: 10.1176/appi.ps.201500245.
[6992]	K. Weineck et al., “Physiological Changes as a Measure of Crustacean Welfare under Different Standardized Stunning Techniques: Cooling and Electroshock,” Animals (Basel), vol. 8, no. 9, Sep. 2018, doi: 10.3390/ani8090158.
[6993]	A. Spagnolo et al., “Physiological changes in green stems of Vitis vinifera L. cv. Chardonnay in response to esca proper and apoplexy revealed by proteomic and transcriptomic analyses,” J. Proteome Res., vol. 11, no. 1, pp. 461–475, Jan. 2012, doi: 10.1021/pr200892g.
[6994]	M. Hasanuzzaman, K. Nahar, M. M. Alam, R. Roychowdhury, and M. Fujita, “Physiological, biochemical, and molecular mechanisms of heat stress tolerance in plants,” Int J Mol Sci, vol. 14, no. 5, pp. 9643–9684, May 2013, doi: 10.3390/ijms14059643.
[6995]	A. Grosberg and M. Gharib, “Physiology in phylogeny: modeling of mechanical driving forces in cardiac development,” Heart Fail Clin, vol. 4, no. 3, pp. 247–259, Jul. 2008, doi: 10.1016/j.hfc.2008.02.010.
[6996]	K. S. Maseyk, T. Lin, E. Rotenberg, J. M. Grünzweig, A. Schwartz, and D. Yakir, “Physiology-phenology interactions in a productive semi-arid pine forest,” New Phytol., vol. 178, no. 3, pp. 603–616, 2008, doi: 10.1111/j.1469-8137.2008.02391.x.
[6997]	W. F. Martin, M. C. Weiss, S. Neukirchen, S. Nelson-Sathi, and F. L. Sousa, “Physiology, phylogeny, and LUCA,” Microb Cell, vol. 3, no. 12, pp. 582–587, Nov. 2016, doi: 10.15698/mic2016.12.545.
[6998]	L. Caouette-Laberge, C. Laberge, E. P. Egerszegi, and C. Stanciu, “Physiolysis for correction of clinodactyly in children,” J Hand Surg Am, vol. 27, no. 4, pp. 659–665, Jul. 2002, doi: 10.1053/jhsu.2002.33702.
[6999]	M. Desai, M. Haigh, and H. Walkington, “Phytoremediation: Metal decontamination of soils after the sequential forestation of former opencast coal land,” Sci. Total Environ., vol. 656, pp. 670–680, Mar. 2019, doi: 10.1016/j.scitotenv.2018.11.327.
[7000]	K. R. Rajashankar and S. Ramakumar, “Pi-turns in proteins and peptides: Classification, conformation, occurrence, hydration and sequence,” Protein Sci., vol. 5, no. 5, pp. 932–946, May 1996, doi: 10.1002/pro.5560050515.
[7001]	I. M. Sebetan, “PI*E Tripoli: a new allele in the alpha-1-antitrypsin system,” Hum. Hered., vol. 42, no. 3, pp. 206–208, 1992, doi: 10.1159/000154070.
[7002]	H. Kanaizumi et al., “PI3K/Akt/mTOR signalling pathway activation in patients with ER-positive, metachronous, contralateral breast cancer treated with hormone therapy,” Oncol Lett, vol. 17, no. 2, pp. 1962–1968, Feb. 2019, doi: 10.3892/ol.2018.9759.
[7003]	O. Ganor, A. H. Taghinia, D. A. Diamond, and E. R. Boskey, “Piloting a Genital Affirmation Surgical Priorities Scale for Trans Masculine Patients,” Transgend Health, vol. 4, no. 1, pp. 270–276, 2019, doi: 10.1089/trgh.2019.0038.
[7004]	A. N. Kirschner et al., “PIM kinase inhibitor AZD1208 for treatment of MYC-driven prostate cancer,” J. Natl. Cancer Inst., vol. 107, no. 2, Feb. 2015, doi: 10.1093/jnci/dju407.
[7005]	J. Song, “Pineal gland dysfunction in Alzheimer’s disease: relationship with the immune-pineal axis, sleep disturbance, and neurogenesis,” Mol Neurodegener, vol. 14, no. 1, p. 28, 11 2019, doi: 10.1186/s13024-019-0330-8.
[7006]	P. Ge, V. L. Dawson, and T. M. Dawson, “PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson’s disease,” Mol Neurodegener, vol. 15, no. 1, p. 20, 13 2020, doi: 10.1186/s13024-020-00367-7.
[7007]	D. Whitehead and S. Watts, “Pinnaplasty: the correction of the prominent, protruding or lop ear,” Br J Hosp Med (Lond), vol. 67, no. 11, pp. 574–577, Nov. 2006, doi: 10.12968/hmed.2006.67.11.22224.
[7008]	L. C. Kelly, C. S. Cockell, T. Thorsteinsson, V. Marteinsson, and J. Stevenson, “Pioneer microbial communities of the Fimmvörðuháls lava flow, Eyjafjallajökull, Iceland,” Microb. Ecol., vol. 68, no. 3, pp. 504–518, Oct. 2014, doi: 10.1007/s00248-014-0432-3.
[7009]	U. Wollina, “[Pityriasis rubra pilaris],” Hautarzt, vol. 63, no. 8, pp. 655–661; quiz 662, Aug. 2012, doi: 10.1007/s00105-012-2424-x.
[7010]	S. Hori, “[PK/PD analysis and proper dosage of antimicrobial agents for effective and safe treatment of infectious diseases],” Yakugaku Zasshi, vol. 127, no. 6, pp. 931–937, Jun. 2007, doi: 10.1248/yakushi.127.931.
[7011]	F. J. Espinar-Marchena, R. Babiano, and J. Cruz, “Placeholder factors in ribosome biogenesis: please, pave my way,” Microb Cell, vol. 4, no. 5, pp. 144–168, Apr. 2017, doi: 10.15698/mic2017.05.572.
[7012]	J. K. Owens and L. H. Nicoll, “Plagiarism in Predatory Publications: A Comparative Study of Three Nursing Journals,” J Nurs Scholarsh, vol. 51, no. 3, pp. 356–363, 2019, doi: 10.1111/jnu.12475.
[7013]	B. Joob and V. Wiwanitkit, “Plagiarism, Self-Plagiarism, and Text Recycling: Ethical Problem in Academic Publication,” Headache, vol. 59, no. 1, p. 107, 2019, doi: 10.1111/head.13458.
[7014]	“Plague around the world, 2010–2015,” Wkly. Epidemiol. Rec., vol. 91, no. 8, pp. 89–93, Feb. 2016.
[7015]	E. G. Bertherat, “Plague in Madagascar:overview of the 2014-2015 epidemic season,” Wkly. Epidemiol. Rec., vol. 90, no. 20, pp. 250–252, May 2015.
[7016]	D. J. Schaeffer, “Planarians as a model system for in vivo teratogenesis studies,” Qual Assur, vol. 2, no. 3, pp. 265–318, Sep. 1993.
[7017]	S. Franck, A. Block, W. von Bloh, C. Bounama, I. Garrido, and H. J. Schellnhuber, “Planetary habitability: is Earth commonplace in the Milky Way?,” Naturwissenschaften, vol. 88, no. 10, pp. 416–426, Oct. 2001, doi: 10.1007/s001140100257.
[7018]	A. Pradyumna, “Planetary health and food systems: insights from global SDGs,” Lancet Planet Health, vol. 2, no. 10, pp. e417–e418, 2018, doi: 10.1016/S2542-5196(18)30202-X.
[7019]	R. W. Carlson, “Planetary science: Earth’s building blocks,” Nature, vol. 541, no. 7638, pp. 468–470, 25 2017, doi: 10.1038/541468a.
[7020]	L. Charton, A. Plett, and N. Linka, “Plant peroxisomal solute transporter proteins,” J Integr Plant Biol, vol. 61, no. 7, pp. 817–835, Jul. 2019, doi: 10.1111/jipb.12790.
[7021]	H.-Y. Yan, H.-G. Guo, Y.-C. Sun, and F. Ge, “Plant phenolics mediated bottom-up effects of elevated CO2 on Acyrthosiphon pisum and its parasitoid Aphidius avenae,” Insect Sci., vol. 27, no. 1, pp. 170–184, Feb. 2020, doi: 10.1111/1744-7917.12627.
[7022]	“Plant Posters,” In Vitro Cell. Dev. Biol. Anim., vol. 53, no. Suppl 1, pp. 47–57, Jun. 2017, doi: 10.1007/s11626-017-0156-z.
[7023]	K. Sundaram et al., “Plant-Derived Exosomal Nanoparticles Inhibit Pathogenicity of Porphyromonas gingivalis,” iScience, vol. 21, pp. 308–327, Nov. 2019, doi: 10.1016/j.isci.2019.10.032.
[7024]	W. Mączka, K. Wińska, M. Grabarczyk, and R. Galek, “Plant-Mediated Enantioselective Transformation of Indan-1-one and Indan-1-ol. Part 2,” Molecules, vol. 24, no. 23, Nov. 2019, doi: 10.3390/molecules24234342.
[7025]	Y. T. Cheng, L. Zhang, and S. Y. He, “Plant-Microbe Interactions Facing Environmental Challenge,” Cell Host Microbe, vol. 26, no. 2, pp. 183–192, 14 2019, doi: 10.1016/j.chom.2019.07.009.
[7026]	A. C. Velásquez, C. D. M. Castroverde, and S. Y. He, “Plant-Pathogen Warfare under Changing Climate Conditions,” Curr. Biol., vol. 28, no. 10, pp. R619–R634, 21 2018, doi: 10.1016/j.cub.2018.03.054.
[7027]	J. Ruther and S. Kleier, “Plant-plant signaling: ethylene synergizes volatile emission in Zea mays induced by exposure to (Z)-3-hexen-1-ol,” J. Chem. Ecol., vol. 31, no. 9, pp. 2217–2222, Sep. 2005, doi: 10.1007/s10886-005-6413-8.
[7028]	K. Chooluck, R. P. Singh, K. Sathirakul, and H. Derendorf, “Plasma and dermal pharmacokinetics of terpinen-4-ol in rats following intravenous administration,” Pharmazie, vol. 68, no. 2, pp. 135–140, Feb. 2013.
[7029]	M. O. Olivo and M. A. Gliozzi, “[Plasma and embryonal extract in the migration of fibroblasts in vitro],” Boll. Soc. Ital. Biol. Sper., vol. 36, pp. 349–352, Apr. 1960.
[7030]	S. Gentile, R. Marmo, M. Persico, P. Bronzino, and M. Coltorti, “Plasma clearance of nicotinic acid and rifamycin-SV, and their interaction in Gilbert’s syndrome: application of a compartmental model,” Hepatogastroenterology, vol. 31, no. 2, pp. 72–75, Apr. 1984.
[7031]	N. Draper et al., “Plasma cortisol concentrations and perceived anxiety in response to on-sight rock climbing,” Int J Sports Med, vol. 33, no. 1, pp. 13–17, Jan. 2012, doi: 10.1055/s-0031-1284348.
[7032]	C. Zhong et al., “Plasma Homocysteine and Prognosis of Acute Ischemic Stroke: a Gender-Specific Analysis From CATIS Randomized Clinical Trial,” Mol. Neurobiol., vol. 54, no. 3, pp. 2022–2030, 2017, doi: 10.1007/s12035-016-9799-0.
[7033]	U. Tröhler, J. P. Bonjour, and H. Fleisch, “Plasma level and renal handling of Pi: effect of overnight fasting with and without Pi supply,” Am. J. Physiol., vol. 241, no. 5, pp. F509-516, Nov. 1981, doi: 10.1152/ajprenal.1981.241.5.F509.
[7034]	U. K. Rima, A. S. M. Bari, M. Z. Hossain, and M. A. H. Khan, “Plasmid DNA vaccine coding eight repeats of gonadotrophin-releasing hormone induced atrophy of prostate in male mice,” Prostate Int, vol. 6, no. 4, pp. 151–156, Dec. 2018, doi: 10.1016/j.prnil.2018.01.001.
[7035]	C. Morabito, “Plastic Maps: The New Brain Cartographies of the 21th-Century Neurosciences,” Nuncius, vol. 32, no. 2, pp. 472–500, 2017.
[7036]	R. J. Rohrich, “Plastic surgery journals: a meeting of minds in Berlin,” Plast. Reconstr. Surg., vol. 120, no. 7, pp. 2101–2105, Dec. 2007, doi: 10.1097/01.prs.0000288362.75328.95.
[7037]	N. Han and Y. Mu, “Plasticity of 150-loop in influenza neuraminidase explored by Hamiltonian replica exchange molecular dynamics simulations,” PLoS ONE, vol. 8, no. 4, p. e60995, 2013, doi: 10.1371/journal.pone.0060995.
[7038]	J. Hartmann, “Plate tectonics, carbon, and climate,” Science, vol. 364, no. 6436, pp. 126–127, 12 2019, doi: 10.1126/science.aax1657.
[7039]	X. Zheng et al., “Platelet counts affect the prognostic value of homocysteine in acute ischemic stroke patients,” Atherosclerosis, vol. 285, pp. 163–169, 2019, doi: 10.1016/j.atherosclerosis.2019.04.203.
[7040]	X. Ren, D. Boriero, L. Chaiswing, S. Bondada, D. K. St Clair, and D. A. Butterfield, “Plausible biochemical mechanisms of chemotherapy-induced cognitive impairment (‘chemobrain’), a condition that significantly impairs the quality of life of many cancer survivors,” Biochim Biophys Acta Mol Basis Dis, vol. 1865, no. 6, pp. 1088–1097, 01 2019, doi: 10.1016/j.bbadis.2019.02.007.
[7041]	H. Lee, S. J. Lee, G.-H. Kim, I. Yeo, and J.-K. Han, “PLD1 regulates Xenopus convergent extension movements by mediating Frizzled7 endocytosis for Wnt/PCP signal activation,” Dev. Biol., vol. 411, no. 1, pp. 38–49, Mar. 2016, doi: 10.1016/j.ydbio.2016.01.013.
[7042]	M. Kamel, Y. Terasaki, P. S. Adusumilli, and B. M. Stiles, “Plenary presentations and public citations from The American Association for Thoracic Surgery,” J. Thorac. Cardiovasc. Surg., vol. 151, no. 1, pp. 30–34, Jan. 2016, doi: 10.1016/j.jtcvs.2015.08.103.
[7043]	“Pneumococcal meningitis outbreaks in sub-Saharan Africa,” Wkly. Epidemiol. Rec., vol. 91, no. 23, pp. 298–302, Jun. 2016.
[7044]	K. Dunleavy, A. Taylor, J. Gow, B. Cullen, and K. Roy, “Police officer anxiety after occupational blood and body fluid exposure,” Occup Med (Lond), vol. 62, no. 5, pp. 382–384, Jul. 2012, doi: 10.1093/occmed/kqs078.
[7045]	P. Moïse and E. Docteur, “[Policies concerning pharmaceutical prices and reimbursement in Mexico, Organization for Co-operation and Economic Development. 2007],” Salud Publica Mex, vol. 50 Suppl 4, pp. S504-510, 2008.
[7046]	Y.-E. Chen and B. K. Goodwin, “Policy Design of Multi-Year Crop Insurance Contracts with Partial Payments,” PLoS ONE, vol. 10, no. 12, p. e0145384, 2015, doi: 10.1371/journal.pone.0145384.
[7047]	“Polio vaccines: WHO position paper – March, 2016,” Wkly. Epidemiol. Rec., vol. 91, no. 12, pp. 145–168, Mar. 2016.
[7048]	“Polio vaccines: WHO position paper, January 2014,” Wkly. Epidemiol. Rec., vol. 89, no. 9, pp. 73–92, Feb. 2014.
[7049]	K. Partin-Agarwal, R. J. Terwilliger, W. Lien, J. P. Jessup, N. C. Motyka, and K. S. Vandewalle, “Polish retention of ceramic-polymer CAD/CAM materials,” Gen Dent, vol. 66, no. 6, pp. 65–70, Dec. 2018.
[7050]	X. Wu et al., “Pollution characteristics of polycyclic aromatic hydrocarbons in common used mineral oils and their transformation during oil regeneration,” J Environ Sci (China), vol. 56, pp. 247–253, Jun. 2017, doi: 10.1016/j.jes.2016.06.036.
[7051]	W. Hou, R. Russnak, and T. Platt, “Poly(A) site selection in the yeast Ty retroelement requires an upstream region and sequence-specific titratable factor(s) in vitro,” EMBO J., vol. 13, no. 2, pp. 446–452, Jan. 1994.
[7052]	R. Pelton, “Poly(N-isopropylacrylamide) (PNIPAM) is never hydrophobic,” J Colloid Interface Sci, vol. 348, no. 2, pp. 673–674, Aug. 2010, doi: 10.1016/j.jcis.2010.05.034.
[7053]	S. Tewarson, Z. Zaleska-Rutczynska, F. Figueroa, and J. Klein, “Polymorphism of Qa and Tla loci of the mouse,” Tissue Antigens, vol. 22, no. 3, pp. 204–212, Sep. 1983, doi: 10.1111/j.1399-0039.1983.tb01193.x.
[7054]	J.-Q. He et al., “Polymorphisms of the GM-CSF genes and the development of atopic diseases in at-risk children,” Chest, vol. 123, no. 3 Suppl, p. 438S, Mar. 2003, doi: 10.1378/chest.123.3_suppl.438s.
[7055]	K. Habel, “Polyoma tumor antigen in cells transformed in vitro by polyoma virus,” Virology, vol. 18, pp. 553–558, Dec. 1962, doi: 10.1016/0042-6822(62)90056-9.
[7056]	D. W. Cockburn and N. M. Koropatkin, “Polysaccharide Degradation by the Intestinal Microbiota and Its Influence on Human Health and Disease,” J. Mol. Biol., vol. 428, no. 16, pp. 3230–3252, 14 2016, doi: 10.1016/j.jmb.2016.06.021.
[7057]	B. J. Philips, R. Dhir, J. Hutzley, M. Sen, and U. P. Kelavkar, “Polyunsaturated fatty acid metabolizing 15-Lipoxygenase-1 (15-LO-1) expression in normal and tumorigenic human bladder tissues,” Appl. Immunohistochem. Mol. Morphol., vol. 16, no. 2, pp. 159–164, Mar. 2008, doi: 10.1097/PAI.0b013e31805baa41.
[7058]	D. Kralik, “Poodle skirts, lava lamps and hot pants...is chronic condition self-management another fad?,” J Adv Nurs, vol. 62, no. 1, p. 2, Apr. 2008, doi: 10.1111/j.1365-2648.2008.04595.x.
[7059]	L. Norsa, B. Pietro, A. Indriolo, C. Valle, S. Aurelio, and S. Sironi, “Poor outcome of intestinal ischemic manifestations of COVID 19,” Gastroenterology, Jun. 2020, doi: 10.1053/j.gastro.2020.06.041.
[7060]	R. Fuhrer and K. M. Keyes, “Population Mental Health in the 21st Century: Aspirations and Experiences,” Am J Public Health, vol. 109, no. S3, pp. S150–S151, 2019, doi: 10.2105/AJPH.2019.305187.
[7061]	R. Fuhrer and K. M. Keyes, “Population Mental Health in the 21st Century: Time to Act,” Am J Public Health, vol. 109, no. S3, pp. S152–S153, 2019, doi: 10.2105/AJPH.2019.305200.
[7062]	R. Fuhrer and K. M. Keyes, “Population Mental Health Today: Confronting the Challenge,” Am J Public Health, vol. 109, no. S3, p. S149, 2019, doi: 10.2105/AJPH.2019.305188.
[7063]	L. Dong, R. Li, J. Zhang, and Z. Di, “Population-weighted efficiency in transportation networks,” Sci Rep, vol. 6, p. 26377, 27 2016, doi: 10.1038/srep26377.
[7064]	J. Zhao and D. Wen, “Pore-scale simulation of wettability and interfacial tension effects on flooding process for enhanced oil recovery,” RSC Adv, vol. 7, no. 66, pp. 41391–41398, Aug. 2017, doi: 10.1039/c7ra07325a.
[7065]	M. Saito et al., “Pork Loin Treated with High Hydrostatic Pressure as a Food Processing Technology: Subacute Toxicity of the Freeze-Dried Powder and Cytotoxicity of the Methanol Extracts,” Food Saf (Tokyo), vol. 5, no. 3, pp. 98–109, Sep. 2017, doi: 10.14252/foodsafetyfscj.2016030.
[7066]	X. Fan et al., “Porous FeO x /carbon nanocomposites with different iron oxidation degree for building high-performance lithium ion batteries,” Nanotechnology, vol. 31, no. 28, p. 285403, Apr. 2020, doi: 10.1088/1361-6528/ab86e9.
[7067]	A. Holmlund, M. Hedin, P. J. Pussinen, U. H. Lerner, and L. Lind, “Porphyromonas gingivalis (Pg) a possible link between impaired oral health and acute myocardial infarction,” Int. J. Cardiol., vol. 148, no. 2, pp. 148–153, Apr. 2011, doi: 10.1016/j.ijcard.2009.10.034.
[7068]	R. Srisuwantha et al., “Porphyromonas Gingivalis Elevated High-Mobility Group Box 1 Levels After Myocardial Infarction in Mice,” Int Heart J, vol. 58, no. 5, pp. 762–768, Oct. 2017, doi: 10.1536/ihj.16-500.
[7069]	J. H. Kim et al., “Portal Vein Thrombosis in Patients with Hepatocellular Carcinoma: Diagnostic Accuracy of Gadoxetic Acid-enhanced MR Imaging,” Radiology, vol. 279, no. 3, pp. 773–783, Jun. 2016, doi: 10.1148/radiol.2015150124.
[7070]	P. C. Ferrajão and R. Aragão Oliveira, “Portuguese War Veterans: Moral Injury and Factors Related to Recovery From PTSD,” Qual Health Res, vol. 26, no. 2, pp. 204–214, Jan. 2016, doi: 10.1177/1049732315573012.
[7071]	H. Celepci and E. Brenner, “Position of valves within the subclavian and axillary veins,” J. Vasc. Surg., vol. 54, no. 6 Suppl, pp. 70S–6S, Dec. 2011, doi: 10.1016/j.jvs.2011.06.083.
[7072]	W. M. Budde, C. Y. Mardin, and G. O. Naumann, “[Positive family anamnesis in patients in the "DFG (German Research Group) Glaucoma Clinical Research Group],” Klin Monbl Augenheilkd, vol. 207, no. 5, pp. 292–294, Nov. 1995, doi: 10.1055/s-2008-1035381.
[7073]	C. B. Young and R. Nusslock, “Positive mood enhances reward-related neural activity,” Soc Cogn Affect Neurosci, vol. 11, no. 6, pp. 934–944, 2016, doi: 10.1093/scan/nsw012.
[7074]	D. Helge, “Positively channeling workplace anger and anxiety. Part I,” AAOHN J, vol. 49, no. 9, pp. 445–452; quiz 453–454, Sep. 2001.
[7075]	S. A. Bachneff, “Positron emission tomography and magnetic resonance imaging: a review and a local circuit neurons hypo(dys)function hypothesis of schizophrenia,” Biol. Psychiatry, vol. 30, no. 9, pp. 857–886, Nov. 1991, doi: 10.1016/0006-3223(91)90002-4.
[7076]	W. Kaczmarek, K. Pietrzak, and A. Pucher, “[Possibilities of leg length equalization in total hip replacement],” Chir Narzadow Ruchu Ortop Pol, vol. 76, no. 3, pp. 169–174, Jun. 2011.
[7077]	S. Barni and E. Scherini, “Possible patterns of nuclear rotation in binucleate hepatocytes in vivo: static examination with fluorescence and electron microscopy,” In Vivo, vol. 5, no. 2, pp. 167–170, Apr. 1991.
[7078]	L. W. Fitzgerald et al., “Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine,” Mol. Pharmacol., vol. 57, no. 1, pp. 75–81, Jan. 2000.
[7079]	A. A. Bahrani et al., “Post-acquisition processing confounds in brain volumetric quantification of white matter hyperintensities,” J. Neurosci. Methods, vol. 327, p. 108391, 01 2019, doi: 10.1016/j.jneumeth.2019.108391.
[7080]	I. C. Kos-Braun and M. Koš, “Post-transcriptional regulation of ribosome biogenesis in yeast,” Microb Cell, vol. 4, no. 5, pp. 179–181, May 2017, doi: 10.15698/mic2017.05.575.
[7081]	S. Hariharan, M. A. McBride, W. S. Cherikh, C. B. Tolleris, B. A. Bresnahan, and C. P. Johnson, “Post-transplant renal function in the first year predicts long-term kidney transplant survival,” Kidney Int., vol. 62, no. 1, pp. 311–318, Jul. 2002, doi: 10.1046/j.1523-1755.2002.00424.x.
[7082]	Y. Auxéméry, “Post-traumatic psychiatric disorders: PTSD is not the only diagnosis,” Presse Med, vol. 47, no. 5, pp. 423–430, May 2018, doi: 10.1016/j.lpm.2017.12.006.
[7083]	C. G. Ballard, A. K. Stanley, and I. F. Brockington, “Post-traumatic stress disorder (PTSD) after childbirth,” Br J Psychiatry, vol. 166, no. 4, pp. 525–528, Apr. 1995, doi: 10.1192/bjp.166.4.525.
[7084]	E. Flouri, “Post-traumatic stress disorder (PTSD): what we have learned and what we still have not found out,” J Interpers Violence, vol. 20, no. 4, pp. 373–379, Apr. 2005, doi: 10.1177/0886260504267549.
[7085]	A. Moyer, “Post-traumatic Stress Disorder and Magnetic Resonance Imaging,” Radiol Technol, vol. 87, no. 6, pp. 649–667, Jul. 2016.
[7086]	J. A. Cohen and M. S. Scheeringa, “Post-traumatic stress disorder diagnosis in children: challenges and promises,” Dialogues Clin Neurosci, vol. 11, no. 1, pp. 91–99, 2009.
[7087]	C. L. Donnelly and L. Amaya-Jackson, “Post-traumatic stress disorder in children and adolescents: epidemiology, diagnosis and treatment options,” Paediatr Drugs, vol. 4, no. 3, pp. 159–170, 2002, doi: 10.2165/00128072-200204030-00003.
[7088]	G. Schelling, “Post-traumatic stress disorder in somatic disease: lessons from critically ill patients,” Prog. Brain Res., vol. 167, pp. 229–237, 2008, doi: 10.1016/S0079-6123(07)67016-2.
[7089]	E. Charles, L. Garand, F. Ducrocq, and J.-P. Clément, “[post-traumatic stress disorder in the elderly],” Psychol Neuropsychiatr Vieil, vol. 3, no. 4, pp. 291–300, Dec. 2005.
[7090]	S. Seedat, D. J. Stein, and P. D. Carey, “Post-traumatic stress disorder in women: epidemiological and treatment issues,” CNS Drugs, vol. 19, no. 5, pp. 411–427, 2005, doi: 10.2165/00023210-200519050-00004.
[7091]	U. Frommberger, J. Angenendt, and M. Berger, “Post-traumatic stress disorder--a diagnostic and therapeutic challenge,” Dtsch Arztebl Int, vol. 111, no. 5, pp. 59–65, Jan. 2014, doi: 10.3238/arztebl.2014.0059.
[7092]	H. A. Kirkpatrick and G. M. Heller, “Post-traumatic stress disorder: theory and treatment update,” Int J Psychiatry Med, vol. 47, no. 4, pp. 337–346, 2014, doi: 10.2190/PM.47.4.h.
[7093]	V. Majtán and L. Majtánová, “Postantibiotic effects and postantibiotic sub-MIC effects of ciprofloxacin, pefloxacin and amikacin on the biological properties of Salmonella strains,” Folia Microbiol. (Praha), vol. 42, no. 4, pp. 327–332, 1997, doi: 10.1007/BF02816944.
[7094]	R. S. Adams, M. J. Larson, E. L. Meerwijk, T. V. Williams, and A. H. S. Harris, “Postdeployment Polytrauma Diagnoses Among Soldiers and Veterans Using the Veterans Health Affairs Polytrauma System of Care and Receipt of Opioids, Nonpharmacologic, and Mental Health Treatments,” J Head Trauma Rehabil, vol. 34, no. 3, pp. 167–175, Jun. 2019, doi: 10.1097/HTR.0000000000000481.
[7095]	L. Drever and G. Salomons, “Poster - Thur Eve - 29: Detecting changes in IMRT QA using statistical process control,” Med Phys, vol. 39, no. 7Part3, p. 4630, Jul. 2012, doi: 10.1118/1.4740137.
[7096]	G. P. Milani, M. G. Bianchetti, and S. A. G. Lava, “Posterior reversible encephalopathy syndrome in immunoglobulin A-associated vasculitis,” Neurol. Neurochir. Pol., vol. 52, no. 5, pp. 634–635, Oct. 2018, doi: 10.1016/j.pjnns.2018.08.009.
[7097]	R. G. Chaytors, G. R. Spooner, D. G. Moores, and S. C. Woodhead-Lyons, “Postgraduate training positions. Follow-up survey of third-year residents in family medicine,” Can Fam Physician, vol. 45, pp. 88–91, Jan. 1999.
[7098]	A. Habbout et al., “Postnatal overfeeding causes early shifts in gene expression in the heart and long-term alterations in cardiometabolic and oxidative parameters,” PLoS ONE, vol. 8, no. 2, p. e56981, 2013, doi: 10.1371/journal.pone.0056981.
[7099]	U. Freo, G. Zara, M. Furnari, and C. Ori, “Postoperative Bilateral Brachial Plexopathy in a Diabetic Patient,” Pain Med, vol. 17, no. 10, pp. 1962–1965, 2016, doi: 10.1093/pm/pnw047.
[7100]	P. K. Yu et al., “Postoperative care in an intermediate-level medical unit after head and neck microvascular free flap reconstruction,” Laryngoscope Investig Otolaryngol, vol. 4, no. 1, pp. 39–42, Feb. 2019, doi: 10.1002/lio2.221.
[7101]	Y. Park, Y.-W. Kim, Y.-J. Park, and D.-I. Kim, “Postoperative hemodynamic changes after endovenous laser ablation and phlebectomy in varicose vein surgery,” J Vasc Surg Venous Lymphat Disord, vol. 3, no. 1, pp. 54–57, Jan. 2015, doi: 10.1016/j.jvsv.2014.07.009.
[7102]	T. Peri, Z. Nitzan, B. Kaplan, and Z. Ben Rafael, “[Postpartum depression],” Harefuah, vol. 136, no. 2, pp. 153–158, Jan. 1999.
[7103]	W. Glauser, “Postsecondary campuses responding to record anxiety and depression levels,” CMAJ, vol. 189, no. 48, pp. E1501–E1502, Dec. 2017, doi: 10.1503/cmaj.109-5512.
[7104]	E. Sexton, N. A. Merriman, N.-A. Donnelly, M.-A. Wren, A. Hickey, and K. E. Bennett, “Poststroke Cognitive Impairment in Model-Based Economic Evaluation: A Systematic Review,” Dement Geriatr Cogn Disord, vol. 48, no. 5–6, pp. 234–240, 2019, doi: 10.1159/000506283.
[7105]	R. G. Robinson, “Poststroke depression: prevalence, diagnosis, treatment, and disease progression,” Biol. Psychiatry, vol. 54, no. 3, pp. 376–387, Aug. 2003, doi: 10.1016/s0006-3223(03)00423-2.
[7106]	M. J. Friedman, “Posttraumatic stress disorder,” J Clin Psychiatry, vol. 58 Suppl 9, pp. 33–36, 1997.
[7107]	G. Hornor, “Posttraumatic stress disorder,” J Pediatr Health Care, vol. 27, no. 3, pp. e29-38, Jun. 2013, doi: 10.1016/j.pedhc.2012.07.020.
[7108]	R. E. Jorge, “Posttraumatic stress disorder,” Continuum (Minneap Minn), vol. 21, no. 3 Behavioral Neurology and Neuropsychiatry, pp. 789–805, Jun. 2015, doi: 10.1212/01.CON.0000466667.20403.b1.
[7109]	H. A. MacDonald, V. Colotla, S. Flamer, and H. Karlinsky, “Posttraumatic stress disorder (PTSD) in the workplace: a descriptive study of workers experiencing PTSD resulting from work injury,” J Occup Rehabil, vol. 13, no. 2, pp. 63–77, Jun. 2003, doi: 10.1023/a:1022563930482.
[7110]	C. G. Watson, P. E. Anderson, and L. P. Gearhart, “Posttraumatic stress disorder (PTSD) symptoms in PTSD patients’ families of origin,” J. Nerv. Ment. Dis., vol. 183, no. 10, pp. 633–638, Oct. 1995, doi: 10.1097/00005053-199510000-00004.
[7111]	M. Jakovljević, “Posttraumatic stress disorder (PTSD): a tailor-made diagnosis for an age of disenchantment and disillusionment?,” Psychiatr Danub, vol. 24, no. 3, pp. 238–240, Sep. 2012.
[7112]	F. Martényi, “[Posttraumatic stress disorder (PTSD)],” Orv Hetil, vol. 145, no. 46, pp. 2315–2322, Nov. 2004.
[7113]	S. S. Nayak, A. T. Kamath, K. Gupta, A. Roy, S. Roy, and A. Chatterjee, “Posttraumatic stress disorder among patients with oral and maxillofacial trauma in a South Indian population,” Spec Care Dentist, May 2019, doi: 10.1111/scd.12383.
[7114]	H. R. Khouzam, “Posttraumatic stress disorder and aging,” Postgrad Med, vol. 120, no. 3, pp. 122–129, Sep. 2008, doi: 10.3810/pgm.2008.09.1913.
[7115]	S. J. Blizzard, J. Kemppainen, and J. Taylor, “Posttraumatic stress disorder and community violence: An update for nurse practitioners,” J Am Acad Nurse Pract, vol. 21, no. 10, pp. 535–541, Oct. 2009, doi: 10.1111/j.1745-7599.2009.00442.x.
[7116]	T. A. Grieger et al., “Posttraumatic stress disorder and depression in battle-injured soldiers,” Am J Psychiatry, vol. 163, no. 10, pp. 1777–1783; quiz 1860, Oct. 2006, doi: 10.1176/ajp.2006.163.10.1777.
[7117]	R. A. Bryant, “Posttraumatic stress disorder and mild brain injury: controversies, causes and consequences,” J Clin Exp Neuropsychol, vol. 23, no. 6, pp. 718–728, Dec. 2001, doi: 10.1076/jcen.23.6.718.1024.
[7118]	M. Kangas, J. L. Henry, and R. A. Bryant, “Posttraumatic stress disorder following cancer. A conceptual and empirical review,” Clin Psychol Rev, vol. 22, no. 4, pp. 499–524, May 2002, doi: 10.1016/s0272-7358(01)00118-0.
[7119]	J. Sareen, “Posttraumatic stress disorder in adults: impact, comorbidity, risk factors, and treatment,” Can J Psychiatry, vol. 59, no. 9, pp. 460–467, Sep. 2014, doi: 10.1177/070674371405900902.
[7120]	C. J. Lonigan, B. M. Phillips, and J. A. Richey, “Posttraumatic stress disorder in children: diagnosis, assessment, and associated features,” Child Adolesc Psychiatr Clin N Am, vol. 12, no. 2, pp. 171–194, Apr. 2003, doi: 10.1016/s1056-4993(02)00105-0.
[7121]	M. Böttche, P. Kuwert, and C. Knaevelsrud, “Posttraumatic stress disorder in older adults: an overview of characteristics and treatment approaches,” Int J Geriatr Psychiatry, vol. 27, no. 3, pp. 230–239, Mar. 2012, doi: 10.1002/gps.2725.
[7122]	D. M. Christiansen, “Posttraumatic stress disorder in parents following infant death: A systematic review,” Clin Psychol Rev, vol. 51, pp. 60–74, 2017, doi: 10.1016/j.cpr.2016.10.007.
[7123]	B. H. Yu and J. E. Dimsdale, “Posttraumatic stress disorder in patients with burn injuries,” J Burn Care Rehabil, vol. 20, no. 5, pp. 426–433; discussion 422-425, Oct. 1999, doi: 10.1097/00004630-199909000-00017.
[7124]	R. J. Jakel, “Posttraumatic Stress Disorder in the Elderly,” Psychiatr. Clin. North Am., vol. 41, no. 1, pp. 165–175, 2018, doi: 10.1016/j.psc.2017.10.013.
[7125]	D. Weintraub and P. E. Ruskin, “Posttraumatic stress disorder in the elderly: a review,” Harv Rev Psychiatry, vol. 7, no. 3, pp. 144–152, Oct. 1999.
[7126]	E. Compean and M. Hamner, “Posttraumatic stress disorder with secondary psychotic features (PTSD-SP): Diagnostic and treatment challenges,” Prog. Neuropsychopharmacol. Biol. Psychiatry, vol. 88, pp. 265–275, 10 2019, doi: 10.1016/j.pnpbp.2018.08.001.
[7127]	L. Sher, M. D. Braquehais, and M. Casas, “Posttraumatic stress disorder, depression, and suicide in veterans,” Cleve Clin J Med, vol. 79, no. 2, pp. 92–97, Feb. 2012, doi: 10.3949/ccjm.79a.11069.
[7128]	J. C. Roberts, T. A. deRoon-Cassini, and K. J. Brasel, “Posttraumatic stress disorder: a primer for trauma surgeons,” J Trauma, vol. 69, no. 1, pp. 231–237, Jul. 2010, doi: 10.1097/TA.0b013e3181e16e2a.
[7129]	J. R. T. Davidson, D. J. Stein, A. Y. Shalev, and R. Yehuda, “Posttraumatic stress disorder: acquisition, recognition, course, and treatment,” J Neuropsychiatry Clin Neurosci, vol. 16, no. 2, pp. 135–147, 2004, doi: 10.1176/jnp.16.2.135.
[7130]	G. M. Rosen and S. O. Lilienfeld, “Posttraumatic stress disorder: an empirical evaluation of core assumptions,” Clin Psychol Rev, vol. 28, no. 5, pp. 837–868, Jun. 2008, doi: 10.1016/j.cpr.2007.12.002.
[7131]	W. V. R. Vieweg, D. A. Julius, A. Fernandez, M. Beatty-Brooks, J. M. Hettema, and A. K. Pandurangi, “Posttraumatic stress disorder: clinical features, pathophysiology, and treatment,” Am. J. Med., vol. 119, no. 5, pp. 383–390, May 2006, doi: 10.1016/j.amjmed.2005.09.027.
[7132]	A. Lok, J. L. Frijling, and M. van Zuiden, “[Posttraumatic stress disorder: current insights in diagnostics, treatment and prevention],” Ned Tijdschr Geneeskd, vol. 161, p. D1905, 2018.
[7133]	N. Brunello et al., “Posttraumatic stress disorder: diagnosis and epidemiology, comorbidity and social consequences, biology and treatment,” Neuropsychobiology, vol. 43, no. 3, pp. 150–162, 2001, doi: 10.1159/000054884.
[7134]	A. A. Contractor, C. Armour, D. Forbes, and J. D. Elhai, “Posttraumatic Stress Disorder’s Underlying Dimensions and Their Relation With Impulsivity Facets,” J. Nerv. Ment. Dis., vol. 204, no. 1, pp. 20–25, Jan. 2016, doi: 10.1097/NMD.0000000000000417.
[7135]	M. Jakovljević, L. Brajković, M. Lončar, and A. Cima, “Posttraumatic stress disorders (PTSD) between fallacy and facts: what we know and what we don’t know?,” Psychiatr Danub, vol. 24, no. 3, pp. 241–245, Sep. 2012.
[7136]	D. L. Aaron, P. D. Fadale, C. J. Harrington, and C. T. Born, “Posttraumatic stress disorders in civilian orthopaedics,” J Am Acad Orthop Surg, vol. 19, no. 5, pp. 245–250, May 2011, doi: 10.5435/00124635-201105000-00001.
[7137]	J. Moye and S. J. Rouse, “Posttraumatic stress in older adults: when medical diagnoses or treatments cause traumatic stress,” Clin. Geriatr. Med., vol. 30, no. 3, pp. 577–589, Aug. 2014, doi: 10.1016/j.cger.2014.04.006.
[7138]	H. Yamamoto, C.-Y. Chen, K. Kubota, K. Matsumoto, and R. Hagiwara, “Potassium Single Cation Ionic Liquid Electrolyte for Potassium-Ion Batteries,” J Phys Chem B, vol. 124, no. 29, pp. 6341–6347, Jul. 2020, doi: 10.1021/acs.jpcb.0c03272.
[7139]	M.-G. Sun and L.-C. Ma, “Potassium-rich brine deposit in Lop Nor basin, Xinjiang, China,” Sci Rep, vol. 8, no. 1, p. 7676, May 2018, doi: 10.1038/s41598-018-25993-6.
[7140]	Y. Kanematsu-Yamaki et al., “Potent Body Weight-Lowering Effect of a Neuromedin U Receptor 2-selective PEGylated Peptide,” J. Med. Chem., vol. 60, no. 14, pp. 6089–6097, 27 2017, doi: 10.1021/acs.jmedchem.7b00330.
[7141]	J. Zhang, H. Gao, and Q. Xue, “Potential applications of microbial enhanced oil recovery to heavy oil,” Crit. Rev. Biotechnol., vol. 40, no. 4, pp. 459–474, Jun. 2020, doi: 10.1080/07388551.2020.1739618.
[7142]	J. L. Grenfell et al., “Potential biosignatures in super-Earth atmospheres II. Photochemical responses,” Astrobiology, vol. 13, no. 5, pp. 415–438, May 2013, doi: 10.1089/ast.2012.0926.
[7143]	J. H. E. Yong et al., “Potential Cost-Effectiveness of Ambulatory Cardiac Rhythm Monitoring After Cryptogenic Stroke,” Stroke, vol. 47, no. 9, pp. 2380–2385, 2016, doi: 10.1161/STROKEAHA.115.011979.
[7144]	V. V. Giau, E. Bagyinszky, and S. S. A. An, “Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment,” Int J Mol Sci, vol. 20, no. 17, Aug. 2019, doi: 10.3390/ijms20174149.
[7145]	M. Barrett, V. Caponera, C. McNair, S. O’Donnell, and D. R. Marenda, “Potential for Use of Erythritol as a Socially Transferrable Ingested Insecticide for Ants (Hymenoptera: Formicidae),” J. Econ. Entomol., vol. 113, no. 3, pp. 1382–1388, Jun. 2020, doi: 10.1093/jee/toaa019.
[7146]	K. Kawamoto, “Potential formation of PCDD/Fs and related bromine-substituted compounds from heating processes for ashes,” J. Hazard. Mater., vol. 168, no. 2–3, pp. 641–648, Sep. 2009, doi: 10.1016/j.jhazmat.2009.02.068.
[7147]	Z. Liu, N. Pal, and B. C. Bonning, “Potential ligands of DmP29, a putative juvenile hormone esterase binding protein of Drosophila melanogaster,” Insect Biochem. Mol. Biol., vol. 37, no. 8, pp. 838–846, Aug. 2007, doi: 10.1016/j.ibmb.2007.04.005.
[7148]	G. Fillion, “Potential of 5-HT-moduline as a drug target for affective disorders,” Curr Opin Investig Drugs, vol. 1, no. 1, pp. 104–109, Sep. 2000.
[7149]	A. García-Blanco, M. Baquero, M. Vento, E. Gil, L. Bataller, and C. Cháfer-Pericás, “Potential oxidative stress biomarkers of mild cognitive impairment due to Alzheimer disease,” J. Neurol. Sci., vol. 373, pp. 295–302, Feb. 2017, doi: 10.1016/j.jns.2017.01.020.
[7150]	S. Hervías-Parejo et al., “Potential role of lava lizards as pollinators across the Galápagos Islands,” Integr Zool, vol. 15, no. 2, pp. 144–148, Mar. 2020, doi: 10.1111/1749-4877.12386.
[7151]	J. R. Votano, J. Altman, M. Wilchek, M. Gorecki, and A. Rich, “Potential use of biaromatic L-phenylalanyl derivatives as therapeutic agents in the treatment of sickle cell disease,” Proc. Natl. Acad. Sci. U.S.A., vol. 81, no. 10, pp. 3190–3194, May 1984, doi: 10.1073/pnas.81.10.3190.
[7152]	H. T. T. Nguyen, D. H. Cho, S. H. Jang, S. K. Han, and S. J. Park, “Potentiation of the glycine response by serotonin on the substantia gelatinosa neurons of the trigeminal subnucleus caudalis in mice,” Korean J. Physiol. Pharmacol., vol. 23, no. 4, pp. 271–279, Jul. 2019, doi: 10.4196/kjpp.2019.23.4.271.
[7153]	J. L. Jankowsky and H. Zheng, “Practical considerations for choosing a mouse model of Alzheimer’s disease,” Mol Neurodegener, vol. 12, no. 1, p. 89, 22 2017, doi: 10.1186/s13024-017-0231-7.
[7154]	N. Fontseré et al., “Practical utility of on-line clearance and blood temperature monitors as noninvasive techniques to measure hemodialysis blood access flow,” Blood Purif., vol. 31, no. 1–3, pp. 1–8, 2011, doi: 10.1159/000321364.
[7155]	N. Josman, N. W. S. Tee, M. Maiwald, L. H. Loo, and C. K. M. Ho, “Pragmatic and evidence-based approach to paediatric cerebrospinal fluid reference limits for white cell count and concentrations of total protein and glucose,” J. Clin. Pathol., vol. 71, no. 10, pp. 932–935, Oct. 2018, doi: 10.1136/jclinpath-2018-205090.
[7156]	N. Haddjeri and P. Blier, “Pre- and post-synaptic effects of the 5-HT3 agonist 2-methyl-5-HT on the 5-HT system in the rat brain,” Synapse, vol. 20, no. 1, pp. 54–67, May 1995, doi: 10.1002/syn.890200109.
[7157]	C. W. Michael and B. Davidson, “Pre-analytical issues in effusion cytology,” Pleura Peritoneum, vol. 1, no. 1, pp. 45–56, Mar. 2016, doi: 10.1515/pp-2016-0001.
[7158]	E. Sariali, N. Gaujac, Q. Grimal, and S. Klouche, “Pre-operative bone mineral density is a predictive factor for excellent early patient-reported outcome measures in cementless total hip arthroplasty using a proximally fixed anatomic stem. A prospective study at two year minimum follow-up,” Int Orthop, Jun. 2020, doi: 10.1007/s00264-020-04683-x.
[7159]	L. McCabe, R. A. Britton, and N. Parameswaran, “Prebiotic and Probiotic Regulation of Bone Health: Role of the Intestine and its Microbiome,” Curr Osteoporos Rep, vol. 13, no. 6, pp. 363–371, Dec. 2015, doi: 10.1007/s11914-015-0292-x.
[7160]	J. K. Hammitt, J. B. Wiener, B. Swedlow, D. Kall, and Z. Zhou, “Precautionary regulation in Europe and the United States: a quantitative comparison,” Risk Anal., vol. 25, no. 5, pp. 1215–1228, Oct. 2005, doi: 10.1111/j.1539-6924.2005.00662.x.
[7161]	M. S. Wolfe, “Precautions with oral live typhoid (Ty 21a) vaccine,” Lancet, vol. 336, no. 8715, pp. 631–632, Sep. 1990, doi: 10.1016/0140-6736(90)93429-s.
[7162]	G. F. Striedter, “Précis of principles of brain evolution,” Behav Brain Sci, vol. 29, no. 1, pp. 1–12; discussion 12-36, Feb. 2006, doi: 10.1017/S0140525X06009010.
[7163]	H. T. Hassan and H. R. Maurer, “Preclinical screening of in vivo interactions between myelopoietic growth factors and antitumour drugs for therapy of myeloid leukaemia patients (review),” In Vivo, vol. 5, no. 4, pp. 307–311, Aug. 1991.
[7164]	L. M. Mikhaĭlova et al., “[Preclinical toxicological study of theraphthal-Lio and binary catalytic system ‘theraphthal-Lio+ascorbic acid’],” Vopr Onkol, vol. 47, no. 6, pp. 695–700, 2001.
[7165]	A. Tan, H. Tanaka, T. Tamura, and T. Shiotsuki, “Precocious metamorphosis in transgenic silkworms overexpressing juvenile hormone esterase,” Proc. Natl. Acad. Sci. U.S.A., vol. 102, no. 33, pp. 11751–11756, Aug. 2005, doi: 10.1073/pnas.0500954102.
[7166]	S. Li, J. Zhang, A. Krol, C. R. Schmidtlein, D. Feiglin, and Y. Xu, “Preconditioned alternating projection algorithm for solving the penalized-likelihood SPECT reconstruction problem,” Phys Med, vol. 38, pp. 23–35, Jun. 2017, doi: 10.1016/j.ejmp.2017.05.001.
[7167]	M. Sener, C. D. Davulcu, M. Tahta, and I. Gunal, “Predatory journal preference in the field of Orthopaedics and Traumatology in Turkey,” Acta Orthop Traumatol Turc, vol. 53, no. 5, pp. 390–393, Sep. 2019, doi: 10.1016/j.aott.2019.05.003.
[7168]	M. P. Bertoglia A and A. Águila A, “[Predatory journals: a new threat to scientific publications],” Rev Med Chil, vol. 146, no. 2, pp. 206–212, Feb. 2018, doi: 10.4067/s0034-98872018000200206.
[7169]	J. R. Yan et al., “Predatory Publishing in Orthopaedic Research,” J Bone Joint Surg Am, vol. 100, no. 21, p. e138, Nov. 2018, doi: 10.2106/JBJS.17.01569.
[7170]	F. O’Kelly, N. Fernandez, and M. A. Koyle, “Predatory publishing or a lack of peer review transparency?-a contemporary analysis of indexed open and non-open access articles in paediatric urology,” J Pediatr Urol, vol. 15, no. 2, p. 159.e1-159.e7, Apr. 2019, doi: 10.1016/j.jpurol.2018.08.019.
[7171]	H. B. Harvey and D. F. Weinstein, “Predatory Publishing: An Emerging Threat to the Medical Literature,” Acad Med, vol. 92, no. 2, pp. 150–151, 2017, doi: 10.1097/ACM.0000000000001521.
[7172]	M. H. Kearney and INANE Predatory Publishing Practices Collaborative, “Predatory publishing: what authors need to know,” Res Nurs Health, vol. 38, no. 1, pp. 1–3, Feb. 2015, doi: 10.1002/nur.21640.
[7173]	M. Rohde, L. C. J. van Dam, and M. O. Ernst, “Predictability is necessary for closed-loop visual feedback delay adaptation,” J Vis, vol. 14, no. 3, p. 4, Mar. 2014, doi: 10.1167/14.3.4.
[7174]	K. Lelamali, P. Papirachanat, and T. Puavilai, “Predicting arterio-venous fistula failure by urea method-derived access blood flow in chronic hemodialysis patients,” J Vasc Access, p. 1129729820920115, May 2020, doi: 10.1177/1129729820920115.
[7175]	R. Leonard, “Predicting aspiration risk in patients with dysphagia: Evidence from fluoroscopy,” Laryngoscope Investig Otolaryngol, vol. 4, no. 1, pp. 83–88, Feb. 2019, doi: 10.1002/lio2.226.
[7176]	J. V. Moseley and W. Linden, “Predicting blood pressure and heart rate change with cardiovascular reactivity and recovery: results from 3-year and 10-year follow up,” Psychosom Med, vol. 68, no. 6, pp. 833–843, Dec. 2006, doi: 10.1097/01.psy.0000238453.11324.d5.
[7177]	H. I. Zeliger, Y. Pan, and W. J. Rea, “Predicting co-morbidities in chemically sensitive individuals from exhaled breath analysis,” Interdiscip Toxicol, vol. 5, no. 3, pp. 123–126, Sep. 2012, doi: 10.2478/v10102-012-0020-7.
[7178]	 null Roff and  null Fairbairn, “Predicting correlated responses in natural populations: changes in JHE activity in the bermuda population of the sand cricket, gryllus firmus,” Heredity (Edinb), vol. 83, no. # (Pt 4), pp. 440–450, Oct. 1999, doi: 10.1038/sj.hdy.6886010.
[7179]	I. Hameed, I. Waris, and M. Amin Ul Haq, “Predicting eco-conscious consumer behavior using theory of planned behavior in Pakistan,” Environ Sci Pollut Res Int, vol. 26, no. 15, pp. 15535–15547, May 2019, doi: 10.1007/s11356-019-04967-9.
[7180]	M. Xu, L. Yu, B. Wan, L. Yu, and Q. Huang, “Predicting inactive conformations of protein kinases using active structures: conformational selection of type-II inhibitors,” PLoS ONE, vol. 6, no. 7, p. e22644, 2011, doi: 10.1371/journal.pone.0022644.
[7181]	M. G. Roth, Z. A. Noel, J. Wang, F. Warner, A. M. Byrne, and M. I. Chilvers, “Predicting Soybean Yield and Sudden Death Syndrome Development Using At-Planting Risk Factors,” Phytopathology, vol. 109, no. 10, pp. 1710–1719, Oct. 2019, doi: 10.1094/PHYTO-02-19-0040-R.
[7182]	S. Fouladvand et al., “Predicting Substance Use Disorder in ADHD Patients using Long-Short Term Memory Model,” 2018 IEEE Int Conf Healthc Inform Workshop (2018), vol. 2018, pp. 49–50, Jun. 2018, doi: 10.1109/ICHI-W.2018.00014.
[7183]	G. Goodman and R. Wilson, “Predicting the carcinogenicity of chemicals in humans from rodent bioassay data,” Environ. Health Perspect., vol. 94, pp. 195–218, Aug. 1991, doi: 10.1289/ehp.94-1567942.
[7184]	M. L. Ybarra and R. E. Thompson, “Predicting the Emergence of Sexual Violence in Adolescence,” Prev Sci, vol. 19, no. 4, pp. 403–415, 2018, doi: 10.1007/s11121-017-0810-4.
[7185]	K. Tomita, N. Hata, N. Kobayashi, T. Shinada, and A. Shirakabe, “Predicting the occurrence of oxygenation impairment in patients with type-B acute aortic dissection,” Int. J. Angiol., vol. 23, no. 1, pp. 53–60, Mar. 2014, doi: 10.1055/s-0033-1349398.
[7186]	I. Fyfe, “Predicting treatment response in post-TBI cognitive impairment,” Nat Rev Neurol, vol. 15, no. 9, pp. 492–493, Sep. 2019, doi: 10.1038/s41582-019-0234-9.
[7187]	K. M. Sanfilippo et al., “Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score,” Am. J. Hematol., vol. 94, no. 11, pp. 1176–1184, 2019, doi: 10.1002/ajh.25603.
[7188]	S. U. Shin et al., “Prediction of esophageal varices in patients with cirrhosis: usefulness of three-dimensional MR elastography with echo-planar imaging technique,” Radiology, vol. 272, no. 1, pp. 143–153, Jul. 2014, doi: 10.1148/radiol.14130916.
[7189]	A. Takayanagi et al., “[Predictive Factor of Urinary Continence after Robot-Assisted Laparoscopic Radical Prostatectomy],” Hinyokika Kiyo, vol. 65, no. 11, pp. 451–454, Nov. 2019, doi: 10.14989/ActaUrolJap_65_11_451.
[7190]	N. Bloksma, M. Kubicka-Muranyi, H. C. Schuppe, E. Gleichmann, and H. Gleichmann, “Predictive immunotoxicological test systems: suitability of the popliteal lymph node assay in mice and rats,” Crit. Rev. Toxicol., vol. 25, no. 5, pp. 369–396, 1995, doi: 10.3109/10408449509049338.
[7191]	R. Pieters, J. Ezendam, R. Bleumink, M. Bol, and S. Nierkens, “Predictive testing for autoimmunity,” Toxicol. Lett., vol. 127, no. 1–3, pp. 83–91, Feb. 2002, doi: 10.1016/s0378-4274(01)00487-8.
[7192]	J. Smith, T. Eadie, P. Levickis, L. Bretherton, and S. Goldfeld, “Predictive validity of verbal and non-verbal communication and mother-child turn-taking at 12 months on language outcomes at 24 and 36 months in a cohort of infants experiencing adversity: a preliminary study,” Int J Lang Commun Disord, vol. 53, no. 5, pp. 969–980, 2018, doi: 10.1111/1460-6984.12408.
[7193]	M. J. Kupersmith, S. Anderson, and R. Kardon, “Predictive value of 1 month retinal nerve fiber layer thinning for deficits at 6 months after acute optic neuritis,” Mult. Scler., vol. 19, no. 13, pp. 1743–1748, Nov. 2013, doi: 10.1177/1352458513485149.
[7194]	P. J. Hensley et al., “Predictive value of phenotypic signatures of bladder cancer response to cisplatin-based neoadjuvant chemotherapy,” Urol. Oncol., vol. 37, no. 9, p. 572.e1-572.e11, 2019, doi: 10.1016/j.urolonc.2019.06.020.
[7195]	S. Cao and L. Wei, “Predictive value of serum CRH/5-HT ratio for postpartum depression,” Int J Gynaecol Obstet, Aug. 2020, doi: 10.1002/ijgo.13351.
[7196]	H. Lazaratou et al., “Predictors and characteristics of anxiety among adolescent students: a Greek sample,” Psychiatriki, vol. 24, no. 1, pp. 27–36, Mar. 2013.
[7197]	K. Holte et al., “Predictors for expired CO2 in neonatal bag-mask ventilation at birth: observational study,” BMJ Paediatr Open, vol. 3, no. 1, p. e000544, 2019, doi: 10.1136/bmjpo-2019-000544.
[7198]	L. Rew, K. L. Arheart, S. Thompson, and K. Johnson, “Predictors of adolescents’ health-promoting behaviors guided by primary socialization theory,” J Spec Pediatr Nurs, vol. 18, no. 4, pp. 277–288, Oct. 2013, doi: 10.1111/jspn.12036.
[7199]	S. L. Brown, L. Hope-Stone, H. Heimann, B. Damato, and P. Salmon, “Predictors of anxiety and depression 2 years following treatment in uveal melanoma survivors,” Psychooncology, vol. 27, no. 7, pp. 1727–1734, 2018, doi: 10.1002/pon.4715.
[7200]	C. S. Oravec et al., “Predictors of Citations in Neurosurgical Research,” World Neurosurg, vol. 130, pp. e82–e89, Oct. 2019, doi: 10.1016/j.wneu.2019.05.226.
[7201]	K.-Y. Park, H.-K. Park, J.-H. Kim, and H.-S. Hwang, “[Predictors of clinical practice examination scores of fourth year medical students after core clinical clerkships],” Korean J Med Educ, vol. 27, no. 4, pp. 275–282, Dec. 2015, doi: 10.3946/kjme.2015.27.4.275.
[7202]	M. Hatakeyama et al., “Predictors of cognitive impairment in multiple system atrophy,” J. Neurol. Sci., vol. 388, pp. 128–132, 15 2018, doi: 10.1016/j.jns.2018.03.017.
[7203]	A. Nikonova, H. R. Guirguis, R. Buckstein, and M. C. Cheung, “Predictors of delay in diagnosis and treatment in diffuse large B-cell lymphoma and impact on survival,” Br. J. Haematol., vol. 168, no. 4, pp. 492–500, Feb. 2015, doi: 10.1111/bjh.13150.
[7204]	C. Wojnarowski, N. Firth, M. Finegan, and J. Delgadillo, “Predictors of depression relapse and recurrence after cognitive behavioural therapy: a systematic review and meta-analysis,” Behav Cogn Psychother, vol. 47, no. 5, pp. 514–529, Sep. 2019, doi: 10.1017/S1352465819000080.
[7205]	J. Ali, K. A. Ahmadi, and J. I. Williams, “Predictors of laparotomy and mortality in polytrauma patients with pelvic fractures,” Can J Surg, vol. 52, no. 4, pp. 271–276, Aug. 2009.
[7206]	I. Linfante et al., “Predictors of Mortality in Acute Ischemic Stroke Intervention: Analysis of the North American Solitaire Acute Stroke Registry,” Stroke, vol. 46, no. 8, pp. 2305–2308, Aug. 2015, doi: 10.1161/STROKEAHA.115.009530.
[7207]	A. R. Sepahdari, M. Bahl, A. Harari, H. J. Kim, M. W. Yeh, and J. K. Hoang, “Predictors of Multigland Disease in Primary Hyperparathyroidism: A Scoring System with 4D-CT Imaging and Biochemical Markers,” AJNR Am J Neuroradiol, vol. 36, no. 5, pp. 987–992, May 2015, doi: 10.3174/ajnr.A4213.
[7208]	S. E. Ullman and H. H. Filipas, “Predictors of PTSD symptom severity and social reactions in sexual assault victims,” J Trauma Stress, vol. 14, no. 2, pp. 369–389, Apr. 2001, doi: 10.1023/A:1011125220522.
[7209]	M. P. Olmsted, D. E. MacDonald, T. McFarlane, K. Trottier, and P. Colton, “Predictors of rapid relapse in bulimia nervosa,” Int J Eat Disord, vol. 48, no. 3, pp. 337–340, Apr. 2015, doi: 10.1002/eat.22380.
[7210]	S.-H. Park et al., “Predictors of Rebleeding in Upper Gastrointestinal Dieulafoy Lesions,” Clin Endosc, vol. 48, no. 5, pp. 385–391, Sep. 2015, doi: 10.5946/ce.2015.48.5.385.
[7211]	S. Dabla, I. Puri, D. Dash, P. M. Vasantha, and M. Tripathi, “Predictors of Seizure-Related Injuries in an Epilepsy Cohort from North India,” J Epilepsy Res, vol. 8, no. 1, pp. 27–32, Jun. 2018, doi: 10.14581/jer.18005.
[7212]	A. T. Agoston et al., “Predictors Of Treatment Failure After Radiofrequency Ablation For Intramucosal Adenocarcinoma in Barrett Esophagus: A Multi-institutional Retrospective Cohort Study,” Am. J. Surg. Pathol., vol. 40, no. 4, pp. 554–562, Apr. 2016, doi: 10.1097/PAS.0000000000000566.
[7213]	A. Gimelli et al., “Predictors of ventricular ablation’s success: Viability, innervation, or mismatch?,” J Nucl Cardiol, Jan. 2019, doi: 10.1007/s12350-018-01575-x.
[7214]	J.-P. Armand and L. Ju, “Preface,” Chin Clin Oncol, vol. 4, no. 4, p. E2, Dec. 2015, doi: 10.3978/j.issn.2304-3865.2015.12.09.
[7215]	K. K. Reynolds and R. Valdes, “Preface,” Clin. Lab. Med., vol. 36, no. 3, pp. xi–xiii, 2016, doi: 10.1016/j.cll.2016.06.001.
[7216]	S. Leucht and J. van Os, “Preface: treatment optimization in schizophrenia through active patient management - proceedings from two European consensus meetings,” Acta Psychiatr Scand Suppl, no. 438, pp. 5–6, 2009, doi: 10.1111/j.1600-0447.2008.01307.x.
[7217]	D. P. Yimgang and J. R. Shapiro, “Pregnancy outcomes in women with osteogenesis imperfecta,” J. Matern. Fetal. Neonatal. Med., vol. 29, no. 14, pp. 2358–2362, 2016, doi: 10.3109/14767058.2015.1085965.
[7218]	J. Ruiter-Ligeti, N. Czuzoj-Shulman, A. R. Spence, T. Tulandi, and H. A. Abenhaim, “Pregnancy outcomes in women with osteogenesis imperfecta: a retrospective cohort study,” J Perinatol, vol. 36, no. 10, pp. 828–831, 2016, doi: 10.1038/jp.2016.111.
[7219]	Y. P. Lai et al., “[Pregnancy-related anxiety associated with small-for-gestational-age infants],” Zhonghua Liu Xing Bing Xue Za Zhi, vol. 39, no. 10, pp. 1329–1332, Oct. 2018, doi: 10.3760/cma.j.issn.0254-6450.2018.10.008.
[7220]	V. Ardeleanu, S. Chicoş, D. Tutunaru, and C. Georgescu, “Prehepatocholedochal proper hepatic artery. Rare anatomical variant. Surgical considerations. Case report,” Chirurgia (Bucur), vol. 109, no. 2, pp. 263–266, Apr. 2014.
[7221]	F. M. Köhn, “[Premature orgasm in the male],” MMW Fortschr Med, vol. 145, no. 46, pp. 29–30, 33, Nov. 2003.
[7222]	Z. M. Patel, H. L. Shah, P. F. Madon, and L. M. Ambani, “Prenatal diagnosis of lethal osteogenesis imperfecta (OI) by ultrasonography,” Prenat. Diagn., vol. 3, no. 3, pp. 261–263, Jul. 1983, doi: 10.1002/pd.1970030314.
[7223]	D. M. Stamenkovic et al., “Preoperative anxiety and implications on postoperative recovery: what can we do to change our history,” Minerva Anestesiol, vol. 84, no. 11, pp. 1307–1317, 2018, doi: 10.23736/S0375-9393.18.12520-X.
[7224]	M. I. Ahmed, M. A. Farrell, K. Parrish, and A. Karla, “Preoperative anxiety in children risk factors and non-pharmacological management,” Middle East J Anaesthesiol, vol. 21, no. 2, pp. 153–164, Jun. 2011.
[7225]	A. Perks, S. Chakravarti, and P. Manninen, “Preoperative anxiety in neurosurgical patients,” J Neurosurg Anesthesiol, vol. 21, no. 2, pp. 127–130, Apr. 2009, doi: 10.1097/ANA.0b013e31819a6ca3.
[7226]	A. T. Matthias and D. N. Samarasekera, “Preoperative anxiety in surgical patients - experience of a single unit,” Acta Anaesthesiol Taiwan, vol. 50, no. 1, pp. 3–6, Mar. 2012, doi: 10.1016/j.aat.2012.02.004.
[7227]	J. Lee et al., “Preoperative Breast MRI: Surgeons’ Patient Selection Patterns and Potential Bias in Outcomes Analyses,” AJR Am J Roentgenol, vol. 208, no. 4, pp. 923–932, Apr. 2017, doi: 10.2214/AJR.16.17038.
[7228]	A. Abedinia, F. Ariffin, N. Huda, and A. Mohammadi Nafchi, “Preparation and characterization of a novel biocomposite based on duck feet gelatin as alternative to bovine gelatin,” Int. J. Biol. Macromol., vol. 109, pp. 855–862, Apr. 2018, doi: 10.1016/j.ijbiomac.2017.11.051.
[7229]	T. Davidek, A. Marabi, O. Mauroux, I. Bauwens, and K. Kraehenbuehl, “Preparation of activated flavor precursor DFG, N-(1-deoxy-1-fructosylglycine) by combination of vacuum evaporation and closed system heating steps,” Food Chem, vol. 244, pp. 177–183, Apr. 2018, doi: 10.1016/j.foodchem.2017.10.013.
[7230]	H. Ding, Y. Han, A. Huang, Y. Meng, H. Hu, and X. Li, “[Preparation, identification and application of monoclonal antibody against urease subuint B of Helicobacter pylori],” Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, vol. 30, no. 12, pp. 1278–1281, Dec. 2014.
[7231]	S. Daoud, F. U. Afifi, A. G. Al-Bakri, V. Kasabri, and I. I. Hamdan, “Preparation, Physicochemical Characterization and Biological Evaluation of some Hesperidin Metal Complexes,” Iran J Pharm Res, vol. 13, no. 3, pp. 909–918, 2014.
[7232]	R. A. Blackmer, “Preparing for an FDA preapproval inspection,” Qual Assur, vol. 3, no. 4, pp. 389–403, Dec. 1994.
[7233]	K. T. Rew, “Prescription Drug and Alcohol Use Disorders: Foreword,” FP Essent, vol. 478, p. 2, Mar. 2019.
[7234]	Food and Drug Administration, HHS, “Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures; delay of effective date. Final rule; delay of effective date,” Fed Regist, vol. 69, no. 35, pp. 8105–8107, Feb. 2004.
[7235]	S. B. Murthy et al., “Presence of haptoglobin-2 allele is associated with worse functional outcomes after spontaneous intracerebral hemorrhage,” World Neurosurg, vol. 83, no. 4, pp. 583–587, Apr. 2015, doi: 10.1016/j.wneu.2014.12.013.
[7236]	A. M. Seekatz et al., “Presence of multiple Clostridium difficile strains at primary infection is associated with development of recurrent disease,” Anaerobe, vol. 53, pp. 74–81, Oct. 2018, doi: 10.1016/j.anaerobe.2018.05.017.
[7237]	K. Pryce et al., “Presence of Octopamine and an Octopamine Receptor in Crassostrea virginica,” In Vivo (Brooklyn), vol. 37, no. 1, pp. 16–24, 2015.
[7238]	P. Evenden, A. Roche, B. Karo, S. Balasegaram, and C. S. Anderson, “Presentation and healthcare delays among people with tuberculosis in London, and the impact on treatment outcome,” BMJ Open Respir Res, vol. 6, no. 1, p. e000468, 2019, doi: 10.1136/bmjresp-2019-000468.
[7239]	E. Proctor and R. Parker, “Preservation of isolated heart for 72 hours,” Br Med J, vol. 4, no. 5626, pp. 296–298, Nov. 1968, doi: 10.1136/bmj.4.5626.296.
[7240]	B. S. M. Mahmoud, K. Yamazaki, K. Miyashita, Y. Kawai, I.-S. Shin, and T. Suzuki, “Preservative effect of combined treatment with electrolyzed NaCl solutions and essential oil compounds on carp fillets during convectional air-drying,” Int. J. Food Microbiol., vol. 106, no. 3, pp. 331–337, Feb. 2006, doi: 10.1016/j.ijfoodmicro.2005.09.010.
[7241]	C. J. Yucus and D. Tranel, “Preserved proper naming following left anterior temporal lobectomy is associated with early age of seizure onset,” Epilepsia, vol. 48, no. 12, pp. 2241–2252, Dec. 2007, doi: 10.1111/j.1528-1167.2007.01211.x.
[7242]	C. Velican, G. Latis, M. Popa, and G. Popa, “[Presilicotic hypersilicemia],” Arch Mal Prof, vol. 19, no. 3, pp. 270–273, Jun. 1958.
[7243]	M. Göthert et al., “Presynaptic 5-HT auto- and heteroreceptors in the human central and peripheral nervous system,” Behav. Brain Res., vol. 73, no. 1–2, pp. 89–92, 1996, doi: 10.1016/0166-4328(96)00076-9.
[7244]	S. Navailles and P. De Deurwaerdère, “Presynaptic control of serotonin on striatal dopamine function,” Psychopharmacology (Berl.), vol. 213, no. 2–3, pp. 213–242, Feb. 2011, doi: 10.1007/s00213-010-2029-y.
[7245]	M. Moriyama et al., “Presynaptic modulation by neuromedin U of sensory synaptic transmission in rat spinal dorsal horn neurones,” J. Physiol. (Lond.), vol. 559, no. Pt 3, pp. 707–713, Sep. 2004, doi: 10.1113/jphysiol.2004.070110.
[7246]	M. Jentzsch et al., “Pretreatment CD34+/CD38- Cell Burden as Prognostic Factor in Myelodysplastic Syndrome Patients Receiving Allogeneic Stem Cell Transplantation,” Biol. Blood Marrow Transplant., vol. 25, no. 8, pp. 1560–1566, 2019, doi: 10.1016/j.bbmt.2019.03.022.
[7247]	A. M. Cohn et al., “Pretreatment clinical and risk correlates of substance use disorder patients with primary depression,” J Stud Alcohol Drugs, vol. 72, no. 1, pp. 151–157, Jan. 2011, doi: 10.15288/jsad.2011.72.151.
[7248]	U. A. Kumar and M. M. Jayaram, “Prevalence and audiological characteristics in individuals with auditory neuropathy/auditory dys-synchrony,” Int J Audiol, vol. 45, no. 6, pp. 360–366, Jun. 2006, doi: 10.1080/14992020600624893.
[7249]	L. Ruano et al., “Prevalence and Causes of Cognitive Impairment and Dementia in a Population-Based Cohort From Northern Portugal,” Am J Alzheimers Dis Other Demen, vol. 34, no. 1, pp. 49–56, 2019, doi: 10.1177/1533317518813550.
[7250]	B. Muschalla and M. Jöbges, “Prevalence and Characteristics of Work Anxiety in Medical Rehabilitation Patients: A Cross-Sectional Observation Study,” Arch Phys Med Rehabil, vol. 99, no. 1, pp. 57–64, 2018, doi: 10.1016/j.apmr.2017.06.017.
[7251]	S. V. Faraone, J. Hess, and T. Wilens, “Prevalence and Consequences of the Nonmedical Use of Amphetamine Among Persons Calling Poison Control Centers,” J Atten Disord, vol. 23, no. 11, pp. 1219–1228, Sep. 2019, doi: 10.1177/1087054719843182.
[7252]	B. Cullen et al., “Prevalence and correlates of cognitive impairment in euthymic adults with bipolar disorder: A systematic review,” J Affect Disord, vol. 205, pp. 165–181, Nov. 2016, doi: 10.1016/j.jad.2016.06.063.
[7253]	E. Tilki, E. Zeytun, and S. Doğan, “Prevalence and Density of Demodex folliculorum and Demodex brevis (Acari: Demodicidae) in Erzincan Province,” Turkiye Parazitol Derg, vol. 41, no. 2, pp. 80–86, Jun. 2017, doi: 10.5152/tpd.2017.5156.
[7254]	P. Roux et al., “Prevalence and determinants of cognitive impairment in the euthymic phase of bipolar disorders: results from the FACE-BD cohort,” Psychol Med, vol. 49, no. 3, pp. 519–527, 2019, doi: 10.1017/S0033291718001186.
[7255]	S. Das, M. Basu, A. Mandal, N. Roy, S. Chatterjee, and A. Dasgupta, “Prevalence and determinants of delay in diagnosis of pulmonary tuberculosis in Darjeeling district of West Bengal,” J Family Med Prim Care, vol. 6, no. 3, pp. 627–635, Sep. 2017, doi: 10.4103/2249-4863.214432.
[7256]	M. R. Moghddam, Z. Davoudmanesh, N. Azizi, V. Rakhshan, and M. Shariati, “Prevalence and Length of the Anterior Loop of the Inferior Alveolar Nerve in Iranians,” J Oral Implantol, vol. 43, no. 5, pp. 333–336, Oct. 2017, doi: 10.1563/aaid-joi-D-16-00212.
[7257]	A. van Zwieten et al., “Prevalence and patterns of cognitive impairment in adult hemodialysis patients: the COGNITIVE-HD study,” Nephrol. Dial. Transplant., vol. 33, no. 7, pp. 1197–1206, 01 2018, doi: 10.1093/ndt/gfx314.
[7258]	C. Wang et al., “Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study,” Lancet, vol. 391, no. 10131, pp. 1706–1717, 28 2018, doi: 10.1016/S0140-6736(18)30841-9.
[7259]	H.-J. Wang et al., “Prevalence and risk factors of depression and anxiety among patients with convulsive epilepsy in rural West China,” Acta Neurol. Scand., vol. 138, no. 6, pp. 541–547, Dec. 2018, doi: 10.1111/ane.13016.
[7260]	W. W. M. Hack, K. Sijstermans, J. van Dijk, L. M. van der Voort-Doedens, M. E. de Kok, and M. J. Hobbelt-Stoker, “Prevalence of acquired undescended testis in 6-year, 9-year and 13-year-old Dutch schoolboys,” Arch. Dis. Child., vol. 92, no. 1, pp. 17–20, Jan. 2007, doi: 10.1136/adc.2005.076208.
[7261]	C. Martin et al., “Prevalence of anti-GAD and IA2 autoantibodies in a French cohort of patients with diabetes eligible for bariatric surgery,” Diabetes Metab., Dec. 2019, doi: 10.1016/j.diabet.2019.12.004.
[7262]	M. S. Wiglusz, J. Landowski, and W. J. Cubała, “Prevalence of anxiety disorders in epilepsy,” Epilepsy Behav, vol. 79, pp. 1–3, 2018, doi: 10.1016/j.yebeh.2017.11.025.
[7263]	Z. Radunovic and K. Steine, “Prevalence of Cardiovascular Disease and Cardiac Symptoms: Left and Right Ventricular Function in Adults With Osteogenesis Imperfecta,” Can J Cardiol, vol. 31, no. 11, pp. 1386–1392, Nov. 2015, doi: 10.1016/j.cjca.2015.04.016.
[7264]	R. Gupta et al., “Prevalence of Chromosome 7 Abnormalities in Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Single Center Study and Brief Literature Review,” Indian J Hematol Blood Transfus, vol. 34, no. 4, pp. 602–611, Oct. 2018, doi: 10.1007/s12288-018-0941-1.
[7265]	T. T. Hshieh et al., “Prevalence of Cognitive Impairment and Association With Survival Among Older Patients With Hematologic Cancers,” JAMA Oncol, vol. 4, no. 5, pp. 686–693, 01 2018, doi: 10.1001/jamaoncol.2017.5674.
[7266]	M. L. Phillips and A. C. Johnson, “Prevalence of dry methods in granite countertop fabrication in Oklahoma,” J Occup Environ Hyg, vol. 9, no. 7, pp. 437–442, 2012, doi: 10.1080/15459624.2012.684549.
[7267]	M. Agin, I. Batun, S. Ozdemir, F. Doran, and G. Tumgor, “Prevalence of Helicobacter pylori in Turkish children with celiac disease and its effect on clinical, histopathological, and laboratory parameters,” Arch Med Sci, vol. 15, no. 6, pp. 1475–1481, Oct. 2019, doi: 10.5114/aoms.2019.83699.
[7268]	M. Magwalivha, J.-P. Kabue, A. N. Traore, and N. Potgieter, “Prevalence of Human Sapovirus in Low and Middle Income Countries,” Adv Virol, vol. 2018, p. 5986549, 2018, doi: 10.1155/2018/5986549.
[7269]	E. Coghlan, L. B. Quero, M. Schwab, D. Pellegrini, and H. Trimarchi, “[Prevalence of hypertension in an Indian community in the North of Argentina],” Medicina (B Aires), vol. 65, no. 2, pp. 108–112, 2005.
[7270]	M. Schiefer et al., “Prevalence of hypothyroidism in patients with frozen shoulder,” J Shoulder Elbow Surg, vol. 26, no. 1, pp. 49–55, Jan. 2017, doi: 10.1016/j.jse.2016.04.026.
[7271]	L. E. Austdal, M. C. Strand, V. Vindenes, and S. T. Bogstrand, “[Prevalence of injuries associated with the «russ» celebration in Norway],” Tidsskr. Nor. Laegeforen., vol. 135, no. 7, pp. 648–652, Apr. 2015, doi: 10.4045/tidsskr.14.0238.
[7272]	J. Burtner, M. Behling, T. Cassidy, and S. F. Butler, “Prevalence of nonmedical use and routes of administration for prescription stimulant medications among adults in a substance abuse treatment population,” J Addict Dis, vol. 37, no. 1–2, pp. 34–45, Jun. 2018, doi: 10.1080/10550887.2018.1512825.
[7273]	J. Häggblom, K. Kettunen, J. Karjalainen, M. Heliövaara, P. Jousilahti, and S. Saarelainen, “Prevalence of PI*Z and PI*S alleles of alpha-1-antitrypsin deficiency in Finland,” Eur Clin Respir J, vol. 2, p. 28829, 2015, doi: 10.3402/ecrj.v2.28829.
[7274]	S. Kuladee et al., “Prevalence of psychiatric disorders in Thai patients with epilepsy,” Epilepsy Behav, vol. 90, pp. 20–24, 2019, doi: 10.1016/j.yebeh.2018.11.004.
[7275]	M. Bahl, M. Muzaffar, G. Vij, J. A. Sosa, K. R. Choudhury, and J. K. Hoang, “Prevalence of the polar vessel sign in parathyroid adenomas on the arterial phase of 4D CT,” AJNR Am J Neuroradiol, vol. 35, no. 3, pp. 578–581, Mar. 2014, doi: 10.3174/ajnr.A3715.
[7276]	R. Mostaedi, D. E. Lackey, S. H. Adams, S. A. Dada, Z. A. Hoda, and M. R. Ali, “Prevalence of undiagnosed and inadequately treated type 2 diabetes mellitus, hypertension, and dyslipidemia in morbidly obese patients who present for bariatric surgery,” Obes Surg, vol. 24, no. 6, pp. 927–935, Jun. 2014, doi: 10.1007/s11695-014-1196-z.
[7277]	D. Kondziella, M. H. Olsen, and J. P. Dreier, “Prevalence of visual snow syndrome in the UK,” Eur. J. Neurol., vol. 27, no. 5, pp. 764–772, May 2020, doi: 10.1111/ene.14150.
[7278]	F. J. de Serres and I. Blanco, “Prevalence of α1-antitrypsin deficiency alleles PI*S and PI*Z worldwide and effective screening for each of the five phenotypic classes PI*MS, PI*MZ, PI*SS, PI*SZ, and PI*ZZ: a comprehensive review,” Ther Adv Respir Dis, vol. 6, no. 5, pp. 277–295, Oct. 2012, doi: 10.1177/1753465812457113.
[7279]	W. M. McDonald, I. H. Richard, and M. R. DeLong, “Prevalence, etiology, and treatment of depression in Parkinson’s disease,” Biol. Psychiatry, vol. 54, no. 3, pp. 363–375, Aug. 2003, doi: 10.1016/s0006-3223(03)00530-4.
[7280]	J. H. Byeon, G. H. Kim, and B. L. Eun, “Prevalence, Incidence, and Recurrence of Febrile Seizures in Korean Children Based on National Registry Data,” J Clin Neurol, vol. 14, no. 1, pp. 43–47, Jan. 2018, doi: 10.3988/jcn.2018.14.1.43.
[7281]	K. P. J. Braun, “Preventing cognitive impairment in children with epilepsy,” Curr. Opin. Neurol., vol. 30, no. 2, pp. 140–147, 2017, doi: 10.1097/WCO.0000000000000424.
[7282]	N. W. Boris, A. C. Ou, and R. Singh, “Preventing post-traumatic stress disorder after mass exposure to violence,” Biosecur Bioterror, vol. 3, no. 2, pp. 154–163; discussion 164-165, 2005, doi: 10.1089/bsp.2005.3.154.
[7283]	International Commission on Occupational Health (ICOH), “Preventing tuberculosis among silica dust exposed workers,” Occup Environ Med, vol. 75, no. 11, pp. 765–766, 2018, doi: 10.1136/oemed-2018-105315.
[7284]	P. Gottesfeld, J. Murray, S. S. Chadha, and D. Rees, “Preventing tuberculosis with silica dust controls,” Int. J. Tuberc. Lung Dis., vol. 15, no. 6, pp. 713–714, Jun. 2011, doi: 10.5588/ijtld.10.0727.
[7285]	D. S. Riggs and D. Sermanian, “Prevention and care of combat-related PTSD: directions for future explorations,” Mil Med, vol. 177, no. 8 Suppl, pp. 14–20, Aug. 2012, doi: 10.7205/milmed-d-12-00140.
[7286]	F. Formiga and J. A. López Trigo, “[Prevention and management of cognitive impairment],” Rev Esp Geriatr Gerontol, vol. 51 Suppl 1, pp. 1–2, Jun. 2016, doi: 10.1016/S0211-139X(16)30135-4.
[7287]	P. Bramlage, C. Schindler, M. Thoenes, C. P. Bramlage, W. Böcking, and W. Kirch, “[Prevention of cardiovascular disease by blocking the endocannabinoid system],” Herz, vol. 32, no. 7, pp. 560–567, Oct. 2007, doi: 10.1007/s00059-007-3021-0.
[7288]	B. E. Sims, E. Nottelmann, D. Koretz, and J. Pearson, “Prevention of depression in children and adolescents,” Am J Prev Med, vol. 31, no. 6 Suppl 1, pp. S99-103, Dec. 2006, doi: 10.1016/j.amepre.2006.07.014.
[7289]	E. Allart-van Dam, C. M. H. Hosman, C. a. L. Hoogduin, and C. P. D. R. Schaap, “Prevention of depression in subclinically depressed adults: follow-up effects on the ‘Coping with Depression’ course,” J Affect Disord, vol. 97, no. 1–3, pp. 219–228, Jan. 2007, doi: 10.1016/j.jad.2006.06.020.
[7290]	S. Porru, D. Placidi, A. Carta, and L. Alessio, “Prevention of injuries at work: the role of the occupational physician,” Int Arch Occup Environ Health, vol. 79, no. 3, pp. 177–192, Mar. 2006, doi: 10.1007/s00420-005-0023-1.
[7291]	Y. Kim, J. W. Strehl, M. Gorschlüter, C. Ziske, and I. G. H. Schmidt-Wolf, “Prevention of lethal tumor growth and generation of long-lasting immunity in vivo using CD137L and interleukin-12 gene transfer,” In Vivo, vol. 22, no. 3, pp. 337–343, Jun. 2008.
[7292]	W. Qi, M. Gevonden, and A. Shalev, “Prevention of Post-Traumatic Stress Disorder After Trauma: Current Evidence and Future Directions,” Curr Psychiatry Rep, vol. 18, no. 2, p. 20, Feb. 2016, doi: 10.1007/s11920-015-0655-0.
[7293]	“[Prevention of risks due to the use of crystallized silica in dental prosthesis laboratories],” Rev Fr Prothes Dent, no. 67, pp. 57–65, Nov. 1985.
[7294]	K. H. Ohman, “Prevention of silica exposure and elimination of silicosis,” Am Ind Hyg Assoc J, vol. 39, no. 11, pp. 847–859, Nov. 1978, doi: 10.1080/0002889778507874.
[7295]	G. Ertl, P. Gaudron, S. Neubauer, and B. Bauer, “[Prevention with angiotensin-converting enzyme (ACE) inhibitors],” Z Kardiol, vol. 81 Suppl 4, pp. 205–210, 1992.
[7296]	“Preventive chemotherapy: planning, requesting medicines, and reporting,” Wkly. Epidemiol. Rec., vol. 89, no. 8, pp. 61–71, Feb. 2014.
[7297]	Y. Almora-Pinedo et al., “Preventive effect of Oenothera rosea on N-methyl-N-nitrosourea-(NMU) induced gastric cancer in rats,” Clin Exp Gastroenterol, vol. 10, pp. 327–332, 2017, doi: 10.2147/CEG.S142515.
[7298]	B. J. H. Yarborough, N. A. Perrin, S. P. Stumbo, J. Muench, and C. A. Green, “Preventive Service Use Among People With and Without Serious Mental Illnesses,” Am J Prev Med, vol. 54, no. 1, pp. 1–9, Jan. 2018, doi: 10.1016/j.amepre.2017.08.020.
[7299]	S. Simoens, “Pricing and reimbursement of orphan drugs: the need for more transparency,” Orphanet J Rare Dis, vol. 6, p. 42, Jun. 2011, doi: 10.1186/1750-1172-6-42.
[7300]	K. T. Rew and M. Jimbo, “Primary care urology. Preface,” Prim. Care, vol. 37, no. 3, pp. xv–xvi, Sep. 2010, doi: 10.1016/j.pop.2010.05.004.
[7301]	T. C. Hsu and D. S. Kellogg, “Primary cultivation and continuous propagation in vitro of tissues from small biopsy specimens,” J. Natl. Cancer Inst., vol. 25, pp. 221–235, Aug. 1960.
[7302]	A. Papa, F. Bononi, S. Sciubba, S. Ursella, and N. Gentiloni-Silveri, “Primary hyperparathyroidism: acute paranoid psychosis,” Am J Emerg Med, vol. 21, no. 3, pp. 250–251, May 2003, doi: 10.1016/s0735-6757(03)00022-6.
[7303]	D. S. Curragh et al., “Primary replacement for the management of exposed orbital implant,” Orbit, vol. 38, no. 6, pp. 461–467, Dec. 2019, doi: 10.1080/01676830.2019.1573262.
[7304]	R. S. Heffner, “Primate hearing from a mammalian perspective,” Anat Rec A Discov Mol Cell Evol Biol, vol. 281, no. 1, pp. 1111–1122, Nov. 2004, doi: 10.1002/ar.a.20117.
[7305]	T. Koch, “Prince Kropotkin: public health’s patron saint,” Int J Epidemiol, vol. 43, no. 6, pp. 1681–1685, Dec. 2014, doi: 10.1093/ije/dyu206.
[7306]	J. Bodrogi and Z. Kaló, “Principles of pharmacoeconomics and their impact on strategic imperatives of pharmaceutical research and development,” Br. J. Pharmacol., vol. 159, no. 7, pp. 1367–1373, Apr. 2010, doi: 10.1111/j.1476-5381.2009.00550.x.
[7307]	A. Anell, “Priority setting for pharmaceuticals. The use of health economic evidence by reimbursement and clinical guidance committees,” Eur J Health Econ, vol. 5, no. 1, pp. 28–35, Feb. 2004, doi: 10.1007/s10198-003-0195-0.
[7308]	H. L. Lim, E.-H. Huh, D.-A. Huh, J.-R. Sohn, and K. W. Moon, “Priority Setting for the Management of Chemicals Using the Globally Harmonized System and Multivariate Analysis: Use of the Mahalanobis-Taguchi System,” Int J Environ Res Public Health, vol. 16, no. 17, 27 2019, doi: 10.3390/ijerph16173119.
[7309]	X. H. Yu et al., “Pro-nociceptive effects of neuromedin U in rat,” Neuroscience, vol. 120, no. 2, pp. 467–474, 2003, doi: 10.1016/s0306-4522(03)00300-2.
[7310]	M. A. Alqazzaz and S. C. R. Lummis, “Probing residues in the pore-forming (M2) domain of the Cys-loop receptor homologue GLIC reveals some unusual features,” Mol. Membr. Biol., vol. 32, no. 1, pp. 26–31, 2015, doi: 10.3109/09687688.2015.1023377.
[7311]	Q. Liu et al., “Probiotic culture supernatant improves metabolic function through FGF21-adiponectin pathway in mice,” J. Nutr. Biochem., vol. 75, p. 108256, 2020, doi: 10.1016/j.jnutbio.2019.108256.
[7312]	N. Kuroki, “Problems in diagnosing and deciding on compensation for PTSD in Japan,” Seishin Shinkeigaku Zasshi, vol. 104, no. 12, pp. 1198–1206, 2002.
[7313]	N. Asukai, “[Problems in diagnostic standards for PTSD],” Seishin Shinkeigaku Zasshi, vol. 108, no. 5, pp. 466–469, 2006.
[7314]	“Proceedings of the 15th Annual UT-KBRIN Bioinformatics Summit 2016 : Cadiz, KY, USA. 8-10 April 2016,” BMC Bioinformatics, vol. 17, no. Suppl 10, p. 297, Aug. 2016, doi: 10.1186/s12859-016-1154-y.
[7315]	H. B. Waynforth and P. N. Magee, “Proceedings: Immunosuppressive activity of N-nitroso-N-methylurea (NMU) and dimethylnitrosamine (DMN),” Br. J. Cancer, vol. 29, no. 1, p. 92, Jan. 1974, doi: 10.1038/bjc.1974.14.
[7316]	M. K. Hunt et al., “Process evaluation of an integrated health promotion/occupational health model in WellWorks-2,” Health Educ Behav, vol. 32, no. 1, pp. 10–26, Feb. 2005, doi: 10.1177/1090198104264216.
[7317]	M. Båga, M. Göransson, S. Normark, and B. E. Uhlin, “Processed mRNA with differential stability in the regulation of E. coli pilin gene expression,” Cell, vol. 52, no. 2, pp. 197–206, Jan. 1988, doi: 10.1016/0092-8674(88)90508-9.
[7318]	M. Gerngross, “Processing of samples,” Qual Assur, vol. 3, no. 3, pp. 268–274, Sep. 1994.
[7319]	R. Pierini, P. A. Kroon, S. Guyot, K. Ivory, I. T. Johnson, and N. J. Belshaw, “Procyanidin effects on oesophageal adenocarcinoma cells strongly depend on flavan-3-ol degree of polymerization,” Mol Nutr Food Res, vol. 52, no. 12, pp. 1399–1407, Dec. 2008, doi: 10.1002/mnfr.200700513.
[7320]	H. Lefebvre et al., “Production and metabolism of serotonin (5-HT) by the human adrenal cortex: paracrine stimulation of aldosterone secretion by 5-HT,” J. Clin. Endocrinol. Metab., vol. 86, no. 10, pp. 5001–5007, Oct. 2001, doi: 10.1210/jcem.86.10.7917.
[7321]	N. R. Burns, J. E. Gilmour, S. M. Kingsman, A. J. Kingsman, and S. E. Adams, “Production and Purification of Hybrid Ty-VLPs,” Methods Mol. Biol., vol. 8, pp. 277–285, 1992, doi: 10.1385/0-89603-191-8:277.
[7322]	G. Barski, S. Sorieul, and F. Cornefert, “[Production of cells of a ‘hybrid’ nature in culturs in vitro of 2 cellular strains in combination],” C. R. Hebd. Seances Acad. Sci., vol. 251, pp. 1825–1827, Oct. 1960.
[7323]	B. Mohammadi Nargesi, N. Trachtmann, G. A. Sprenger, and J.-W. Youn, “Production of p-amino-L-phenylalanine (L-PAPA) from glycerol by metabolic grafting of Escherichia coli,” Microb. Cell Fact., vol. 17, no. 1, p. 149, Sep. 2018, doi: 10.1186/s12934-018-0996-6.
[7324]	D. van Dissel, J. Willemse, B. Zacchetti, D. Claessen, G. B. Pier, and G. P. van Wezel, “Production of poly-β-1,6-N-acetylglucosamine by MatAB is required for hyphal aggregation and hydrophilic surface adhesion by Streptomyces,” Microb Cell, vol. 5, no. 6, pp. 269–279, Feb. 2018, doi: 10.15698/mic2018.06.635.
[7325]	R. S. Rew, “Production-based control of parasitic nematodes of cattle,” Int. J. Parasitol., vol. 29, no. 1, pp. 177–182; discussion 183-184, Jan. 1999, doi: 10.1016/s0020-7519(98)00197-0.
[7326]	S. Xu et al., “Professional medical associations and the opportunity to promote breakthrough biomedical innovation,” Drug Discov. Today, vol. 23, no. 8, pp. 1453–1456, 2018, doi: 10.1016/j.drudis.2018.01.044.
[7327]	S. Koga et al., “Profile of cognitive impairment and underlying pathology in multiple system atrophy,” Mov. Disord., vol. 32, no. 3, pp. 405–413, 2017, doi: 10.1002/mds.26874.
[7328]	W. C. Van Voorhis, R. Hooft van Huijsduijnen, and T. N. C. Wells, “Profile of William C. Campbell, Satoshi Ōmura, and Youyou Tu, 2015 Nobel Laureates in Physiology or Medicine,” Proc. Natl. Acad. Sci. U.S.A., vol. 112, no. 52, pp. 15773–15776, Dec. 2015, doi: 10.1073/pnas.1520952112.
[7329]	R. Luukkainen et al., “Prognosis of 5-year radiographic erosions of the wrist according to early, late, and persistent wrist swelling or tenderness in patients with early rheumatoid arthritis,” J. Rheumatol., vol. 34, no. 1, pp. 50–53, Jan. 2007.
[7330]	H.-B. Cai, Y.-B. Li, H. Zhao, S.-M. Zhou, and X.-D. Zhao, “[Prognostic analysis of children with Henoch-Schonlein purpura treated by Helicobacter pylori eradication therapy],” Zhongguo Dang Dai Er Ke Za Zhi, vol. 16, no. 3, pp. 234–237, Mar. 2014.
[7331]	M. E. May et al., “Prognostic factors and selection criteria in the retreatment of head and neck cancers,” Oral Oncol., vol. 88, pp. 85–90, 2019, doi: 10.1016/j.oraloncology.2018.11.024.
[7332]	E. Pavlidou and C. Panteliadis, “Prognostic factors for subsequent epilepsy in children with febrile seizures,” Epilepsia, vol. 54, no. 12, pp. 2101–2107, Dec. 2013, doi: 10.1111/epi.12429.
[7333]	M. Vaage-Nilsen et al., “Prognostic implications of ventricular ectopy one week, one month, and sixteen months after an acute myocardial infarction. Danish Study Group on Verapamil in Myocardial Infarction,” Clin Cardiol, vol. 21, no. 12, pp. 905–911, Dec. 1998, doi: 10.1002/clc.4960211209.
[7334]	N. Ida, K. Nakamura, M. Saijo, T. Kusumoto, and H. Masuyama, “Prognostic nutritional index as a predictor of survival in patients with recurrent cervical cancer,” Mol Clin Oncol, vol. 8, no. 2, pp. 257–263, Feb. 2018, doi: 10.3892/mco.2017.1508.
[7335]	X. Zhang and J. Wu, “Prognostic role of microRNA-145 in prostate cancer: A systems review and meta-analysis,” Prostate Int, vol. 3, no. 3, pp. 71–74, Sep. 2015, doi: 10.1016/j.prnil.2014.09.001.
[7336]	P. Ferrero, A. Iacovoni, E. D’Elia, M. Vaduganathan, A. Gavazzi, and M. Senni, “Prognostic scores in heart failure - Critical appraisal and practical use,” Int. J. Cardiol., vol. 188, pp. 1–9, Jun. 2015, doi: 10.1016/j.ijcard.2015.03.154.
[7337]	Y.-C. Wu, X.-M. Zhang, Y.-D. Zhu, and W. Wu, “Prognostic significance of monosomal karyotype in myelodysplastic syndrome: a meta-analysis,” Hematology, vol. 24, no. 1, pp. 60–69, Dec. 2019, doi: 10.1080/10245332.2018.1510067.
[7338]	F. Marchi et al., “Prognostic Significance of Peripheral T-Cell Subsets in Laryngeal Squamous Cell Carcinoma,” Laryngoscope Investig Otolaryngol, vol. 4, no. 5, pp. 513–519, Oct. 2019, doi: 10.1002/lio2.304.
[7339]	Z. Zhu et al., “Prognostic significance of serum cystatin C in acute ischemic stroke patients according to lipid component levels,” Atherosclerosis, vol. 274, pp. 146–151, 2018, doi: 10.1016/j.atherosclerosis.2018.05.015.
[7340]	B. Jelavic, M. Grgić, H. Cupić, M. Kordić, M. Vasilj, and T. Baudoin, “Prognostic value of Helicobacter pylori sinonasal colonization for efficacy of endoscopic sinus surgery,” Eur Arch Otorhinolaryngol, vol. 269, no. 10, pp. 2197–2202, Oct. 2012, doi: 10.1007/s00405-012-1923-9.
[7341]	L. Han et al., “Prognostic value of lipoprotein-associated phospholipase A2 mass for all-cause mortality and vascular events within one year after acute ischemic stroke,” Atherosclerosis, vol. 266, pp. 1–7, Nov. 2017, doi: 10.1016/j.atherosclerosis.2017.09.013.
[7342]	I. Bozovic-Spasojevic et al., “Prognostic, predictive abilities and concordance of BCL2 and TP53 protein expression in primary breast cancers and axillary lymph-nodes: a retrospective analysis of the Belgian three arm study evaluating anthracycline vs CMF adjuvant chemotherapy,” Breast, vol. 23, no. 4, pp. 473–481, Aug. 2014, doi: 10.1016/j.breast.2014.03.012.
[7343]	L. Hopson, L. Regan, M. A. Gisondi, J. A. Cranford, and J. Branzetti, “Program Director Opinion on the Ideal Length of Residency Training in Emergency Medicine,” Acad Emerg Med, vol. 23, no. 7, pp. 823–827, 2016, doi: 10.1111/acem.12968.
[7344]	R. E. Parchment, “Programmed cell death (apoptosis) in murine blastocysts: extracellular free-radicals, polyamines, and other cytotoxic agents,” In Vivo, vol. 5, no. 5, pp. 493–500, Oct. 1991.
[7345]	F. Larouche et al., “Progress and Status of Hydrometallurgical and Direct Recycling of Li-Ion Batteries and Beyond,” Materials (Basel), vol. 13, no. 3, Feb. 2020, doi: 10.3390/ma13030801.
[7346]	V. Chandra-Mouli et al., “Progress in adolescent sexual and reproductive health and rights globally between 1990 and 2016: what progress has been made, what contributed to this, and what are the implications for the future?,” Sex Reprod Health Matters, vol. 28, no. 1, p. 1741495, Dec. 2020, doi: 10.1080/26410397.2020.1741495.
[7347]	Z. Huang, P. S. Ning, P. X. Cheng, and G. Q. Hu, “[Progress in research of mobile health intervention],” Zhonghua Liu Xing Bing Xue Za Zhi, vol. 37, no. 10, pp. 1430–1434, Oct. 2016, doi: 10.3760/cma.j.issn.0254-6450.2016.10.022.
[7348]	K. Yoshida, “[Progress in research of the pathogenesis of childhood MDS/MPN],” Rinsho Ketsueki, vol. 59, no. 10, pp. 2284–2289, 2018, doi: 10.11406/rinketsu.59.2284.
[7349]	“Progress in rubella and congenital rubella syndrome control and elimination – worldwide, 2000–2016,” Wkly. Epidemiol. Rec., vol. 92, no. 46, pp. 707–715, 17 2017.
[7350]	J. Nakayama, “Progress in searching for the febrile seizure susceptibility genes,” Brain Dev., vol. 31, no. 5, pp. 359–365, May 2009, doi: 10.1016/j.braindev.2008.11.014.
[7351]	K. Kayser, “Progress in telepathology,” In Vivo, vol. 7, no. 4, pp. 331–333, Aug. 1993.
[7352]	Y. Nannya, “Progress in the diagnosis of and therapy for MDS,” Rinsho Ketsueki, vol. 57, no. 10, pp. 1980–1990, 2016, doi: 10.11406/rinketsu.57.1980.
[7353]	B. A. Sparling and E. F. DiMauro, “Progress in the discovery of small molecule modulators of the Cys-loop superfamily receptors,” Bioorg. Med. Chem. Lett., vol. 27, no. 15, pp. 3207–3218, 01 2017, doi: 10.1016/j.bmcl.2017.04.073.
[7354]	S. Devadatta et al., “Progress in the second and third years of patients with quiescent pulmonary tuberculosis after a year of chemotherapy at home or in sanatorium, and influence of further chemotherapy on the relapse rate,” Bull. World Health Organ., vol. 24, pp. 149–175, 1961.
[7355]	S. Velu et al., “Progress in the second year of patients with quiescent pulmonary tuberculosis after a year of chemotherapy at home or in sanatorium, and influence of further chemotherapy on the relapse rate,” Bull. World Health Organ., vol. 23, pp. 511–533, 1960.
[7356]	S. Velu et al., “Progress in the second year of patients with quiescent pulmonary tuberculosis after a year of domiciliary chemotherapy, and influence of further chemotherapy on the relapse rate,” Bull. World Health Organ., vol. 25, pp. 409–429, 1961.
[7357]	G. F. Striedter, “Progress in the study of brain evolution: from speculative theories to testable hypotheses,” Anat. Rec., vol. 253, no. 4, pp. 105–112, 1998, doi: 10.1002/(SICI)1097-0185(199808)253:4<105::AID-AR5>3.0.CO;2-S.
[7358]	S. Tu and H. Yang, “[Progress in the treatment of Helicobacter pylori infection],” Zhong Nan Da Xue Xue Bao Yi Xue Ban, vol. 39, no. 9, pp. 981–988, Sep. 2014, doi: 10.11817/j.issn.1672-7347.2014.09.020.
[7359]	“Progress report on the elimination of human onchocerciasis, 2015-2016,” Wkly. Epidemiol. Rec., vol. 91, no. 43, pp. 505–514, Oct. 2016.
[7360]	“Progress toward eliminating onchocerciasis in the WHO Region of the Americas: verification of elimination of transmission in Mexico,” Wkly. Epidemiol. Rec., vol. 90, no. 43, pp. 577–581, Oct. 2015.
[7361]	“Progress towards eliminating onchocerciasis in the WHO Region of the Americas: elimination of transmission in the north-east focus of the Bolivarian Republic of Venezuela,” Wkly. Epidemiol. Rec., vol. 92, no. 41, pp. 617–623, 13 2017.
[7362]	“Progress towards eliminating onchocerciasis in the WHO Region of the Americas: verification of elimination of transmission in Guatemala,” Wkly. Epidemiol. Rec., vol. 91, no. 43, pp. 501–505, Oct. 2016.
[7363]	“Progress towards measles  elimination, Philippines,  1998–2014,” Wkly. Epidemiol. Rec., vol. 90, no. 15, pp. 149–159, Apr. 2015.
[7364]	“Progress towards measles elimination – African Region, 2013–2016,” Wkly. Epidemiol. Rec., vol. 92, no. 18, pp. 229–239, 05 2017.
[7365]	“Progress towards measles elimination in Bangladesh, 2000–2016,” Wkly. Epidemiol. Rec., vol. 92, no. 29–30, pp. 405–412, 21 2017.
[7366]	“Progress towards measles elimination in Nepal, 2007–2014,” Wkly. Epidemiol. Rec., vol. 91, no. 9, pp. 105–112, Mar. 2016.
[7367]	“Progress towards polio eradication worldwide, 2015–2016,” Wkly. Epidemiol. Rec., vol. 91, no. 19, pp. 250–256, May 2016.
[7368]	“Progress towards poliomyelitis eradication: Nigeria, January–December 2017,” Wkly. Epidemiol. Rec., vol. 93, no. 9, pp. 97–104, Mar. 2018.
[7369]	“Progress towards poliomyelitis eradication: Pakistan, January 2016–September 2017,” Wkly. Epidemiol. Rec., vol. 92, no. 47, pp. 717–724, 24 2017.
[7370]	“Progress towards regional measles elimination – worldwide, 2000–2015,” Wkly. Epidemiol. Rec., vol. 91, no. 45, pp. 525–535, Nov. 2016.
[7371]	“Progress towards regional measles elimination – worldwide, 2000–2016,” Wkly. Epidemiol. Rec., vol. 92, no. 43, pp. 649–659, 27 2017.
[7372]	“Progress towards regional measles elimination, worldwide, 2000–2014,” Wkly. Epidemiol. Rec., vol. 90, no. 46, pp. 623–631, Nov. 2015.
[7373]	“Progress with the implementation of rotavirus surveillance and vaccines in countries of the WHO African Region, 2007–2016,” Wkly. Epidemiol. Rec., vol. 92, no. 44, pp. 673–680, 03 2017.
[7374]	Y. Ishikawa, J. Ishikawa, S. Ishikawa, K. Kario, E. Kajii, and Jichi Medical School Cohort Investigators Group, “Progression from prehypertension to hypertension and risk of cardiovascular disease,” J Epidemiol, vol. 27, no. 1, pp. 8–13, Jan. 2017, doi: 10.1016/j.je.2016.08.001.
[7375]	X. Zhang et al., “Progression in Vascular Cognitive Impairment: Pathogenesis, Neuroimaging Evaluation, and Treatment,” Cell Transplant, vol. 28, no. 1, pp. 18–25, 2019, doi: 10.1177/0963689718815820.
[7376]	S. K. Holden, T. Finseth, S. H. Sillau, and B. D. Berman, “Progression of MDS-UPDRS Scores Over Five Years in De Novo Parkinson Disease from the Parkinson’s Progression Markers Initiative Cohort,” Mov Disord Clin Pract, vol. 5, no. 1, pp. 47–53, Feb. 2018, doi: 10.1002/mdc3.12553.
[7377]	R. B. Singer, “Progression of mean age and mean expected mortality rate by duration of follow up in cohorts with a wide range of age,” J Insur Med, vol. 38, no. 3, pp. 181–191, 2006.
[7378]	A. Saghazadeh, M. Gharedaghi, A. Meysamie, S. Bauer, and N. Rezaei, “Proinflammatory and anti-inflammatory cytokines in febrile seizures and epilepsy: systematic review and meta-analysis,” Rev Neurosci, vol. 25, no. 2, pp. 281–305, 2014, doi: 10.1515/revneuro-2013-0045.
[7379]	S. Sarris, G. I. Swyer, H. H. McGarrigle, D. M. Lawrence, V. Little, and G. C. Lachelin, “Prolactin and luteal insufficiency,” Clin. Endocrinol. (Oxf), vol. 9, no. 6, pp. 543–547, Dec. 1978, doi: 10.1111/j.1365-2265.1978.tb01512.x.
[7380]	N. Kanda, S. Shibata, Y. Tada, K. Nashiro, K. Tamaki, and S. Watanabe, “Prolactin enhances basal and IL-17-induced CCL20 production by human keratinocytes,” Eur. J. Immunol., vol. 39, no. 4, pp. 996–1006, Apr. 2009, doi: 10.1002/eji.200838852.
[7381]	N. Kanda and S. Watanabe, “Prolactin enhances interferon-gamma-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes,” Endocrinology, vol. 148, no. 5, pp. 2317–2325, May 2007, doi: 10.1210/en.2006-1639.
[7382]	H. Van Herck, A. P. Hesp, A. Versluis, P. Zwart, and L. F. Van Zutphen, “Prolapsus vaginae in the IIIVO/JU rabbit,” Lab. Anim., vol. 23, no. 4, pp. 333–336, Oct. 1989, doi: 10.1258/002367789780746097.
[7383]	N. J. Palpant and C. E. Murry, “Proliferation at the heart of preadolescence,” Cell, vol. 157, no. 4, pp. 765–767, May 2014, doi: 10.1016/j.cell.2014.04.025.
[7384]	S. G. C. Mestrum, N. C. J. de Wit, R. J. M. Drent, A. H. N. Hopman, F. C. S. Ramaekers, and M. P. G. Leers, “Proliferative activity is disturbed in myeloproliferative neoplasms (MPN), myelodysplastic syndrome (MDS), and MDS/MPN diseases. Differences between MDS and MDS/MPN,” Cytometry B Clin Cytom, Aug. 2020, doi: 10.1002/cyto.b.21946.
[7385]	Y. Mukai et al., “Proline metabolism regulates replicative lifespan in the yeast Saccharomyces cerevisiae,” Microb Cell, vol. 6, no. 10, pp. 482–490, Sep. 2019, doi: 10.15698/mic2019.10.694.
[7386]	C. P. McLean and E. B. Foa, “Prolonged exposure therapy for post-traumatic stress disorder: a review of evidence and dissemination,” Expert Rev Neurother, vol. 11, no. 8, pp. 1151–1163, Aug. 2011, doi: 10.1586/ern.11.94.
[7387]	U. Min, “[PROLONGED PRESERVATION OF CELL STRAINS IN VITRO IN THE DEEPLY FROZEN STATE],” Tsitologiia, vol. 5, no. 6, pp. 639–645, Dec. 1963.
[7388]	K. Morimoto et al., “Promoting GMP implementation: developing training materials for the international audience,” Qual Assur, vol. 10, no. 1, pp. 11–27, 2003, doi: 10.1080/10529410390198864.
[7389]	G. G. Noja, M. Cristea, N. Sirghi, C.-D. Hategan, and P. D’Anselmi, “Promoting Good Public Governance and Environmental Support for Sustainable Economic Development,” Int J Environ Res Public Health, vol. 16, no. 24, 06 2019, doi: 10.3390/ijerph16244940.
[7390]	R. H. Beaglehole and R. Beaglehole, “Promoting radical action for global oral health: integration or independence?,” Lancet, vol. 394, no. 10194, pp. 196–198, 20 2019, doi: 10.1016/S0140-6736(19)31610-1.
[7391]	N. Ernstmann, T. D. Gloede, and H. Pfaff, “[Promotion of Young Scientists in Health Services Research - Evaluation of the Third Early Career Investigators Workshop in Health Services Research of the German Research Foundation (DFG)],” Gesundheitswesen, vol. 77, no. 8–9, pp. 586–589, Sep. 2015, doi: 10.1055/s-0035-1559610.
[7392]	B. R. Edwards, A. Belousov, and M. Belousova, “Propagation style controls lava-snow interactions,” Nat Commun, vol. 5, p. 5666, Dec. 2014, doi: 10.1038/ncomms6666.
[7393]	A. Paladino and R. Zangi, “Propensities for loop structures of RNA & DNA backbones,” Biophys. Chem., vol. 180–181, pp. 110–118, Nov. 2013, doi: 10.1016/j.bpc.2013.07.003.
[7394]	T. I. Sørensen et al., “[Proper advice on nutrition. Recommendations concerning the conduct of the nutritional news],” Ugeskr. Laeg., vol. 162, no. 14, pp. 2046–2050, Apr. 2000.
[7395]	I. P. Martins and L. Farrajota, “Proper and common names: a double dissociation,” Neuropsychologia, vol. 45, no. 8, pp. 1744–1756, Apr. 2007, doi: 10.1016/j.neuropsychologia.2006.12.016.
[7396]	Y. Cui, I. W. Bulik, C. A. Jiménez-Hoyos, T. M. Henderson, and G. E. Scuseria, “Proper and improper zero energy modes in Hartree-Fock theory and their relevance for symmetry breaking and restoration,” J Chem Phys, vol. 139, no. 15, p. 154107, Oct. 2013, doi: 10.1063/1.4824905.
[7397]	H.-T. Xia, T. Yang, Y. Liu, B. Liang, J. Wang, and J.-H. Dong, “Proper bile duct flow, rather than radical excision, is the most critical factor determining treatment outcomes of bile duct cysts,” BMC Gastroenterol, vol. 18, no. 1, p. 129, Aug. 2018, doi: 10.1186/s12876-018-0862-3.
[7398]	D. Young, “Proper cleansing for the face,” Cutis, vol. 39, no. 6, p. 543, Jun. 1987.
[7399]	K. M. Athern, S. A. Linnebur, and G. Fabisiak, “Proper Disposal of Unused Household Medications: The Role of the Pharmacist,” Consult Pharm, vol. 31, no. 5, pp. 261–266, May 2016, doi: 10.4140/TCP.n.2016.261.
[7400]	Z.-G. Yu, X.-W. Zhan, G.-S. Han, R. W. Wang, V. Anh, and K. H. Chu, “Proper distance metrics for phylogenetic analysis using complete genomes without sequence alignment,” Int J Mol Sci, vol. 11, no. 3, pp. 1141–1154, Mar. 2010, doi: 10.3390/ijms11031141.
[7401]	H. Matsueda and D. Ozaki, “Proper encoding for snapshot-entropy scaling in two-dimensional classical spin models,” Phys Rev E Stat Nonlin Soft Matter Phys, vol. 92, no. 4, p. 042167, Oct. 2015, doi: 10.1103/PhysRevE.92.042167.
[7402]	E. R. Burke, “Proper fit of the bicycle,” Clin Sports Med, vol. 13, no. 1, pp. 1–14, Jan. 1994.
[7403]	D. K. Flood, “Proper Fitting and Use of Crutches,” Phys Sportsmed, vol. 11, no. 3, pp. 75–78, Mar. 1983, doi: 10.1080/00913847.1983.11708482.
[7404]	M. Sasanpour, A. Azadbakht, P. Mollaei, and S. N. S. Reihani, “Proper measurement of pure dielectrophoresis force acting on a RBC using optical tweezers,” Biomed Opt Express, vol. 10, no. 11, pp. 5639–5649, Nov. 2019, doi: 10.1364/BOE.10.005639.
[7405]	Y. Horikawa et al., “Proper muscle layer damage affects ulcer healing after gastric endoscopic submucosal dissection,” Dig Endosc, vol. 27, no. 7, pp. 747–753, Nov. 2015, doi: 10.1111/den.12501.
[7406]	F. Lucchelli and E. De Renzi, “Proper name anomia,” Cortex, vol. 28, no. 2, pp. 221–230, Jun. 1992, doi: 10.1016/s0010-9452(13)80050-0.
[7407]	R. Fukatsu, T. Fujii, T. Tsukiura, A. Yamadori, and T. Otsuki, “Proper name anomia after left temporal lobectomy: a patient study,” Neurology, vol. 52, no. 5, pp. 1096–1099, Mar. 1999, doi: 10.1212/wnl.52.5.1096.
[7408]	C. Geukes and H. M. Müller, “Proper name anomia after right-hemispheric lesion: a case study,” Neurocase, vol. 21, no. 4, pp. 520–528, 2015, doi: 10.1080/13554794.2014.945462.
[7409]	J. R. Hanley and J. Kay, “Proper name anomia and anomia for the names of people: functionally dissociable impairments?,” Cortex, vol. 34, no. 1, pp. 155–158, Feb. 1998, doi: 10.1016/s0010-9452(08)70745-7.
[7410]	P. Vitali et al., “Proper name anomia in poststroke aphasics: evidence from a multiple-case study,” Neurocase, vol. 21, no. 5, pp. 563–572, 2015, doi: 10.1080/13554794.2014.959974.
[7411]	T. Busigny, X. de Boissezon, M. Puel, J.-L. Nespoulous, and E. J. Barbeau, “Proper name anomia with preserved lexical and semantic knowledge after left anterior temporal lesion: a two-way convergence defect,” Cortex, vol. 65, pp. 1–18, Apr. 2015, doi: 10.1016/j.cortex.2014.12.008.
[7412]	C. Papagno and E. Capitani, “Proper name anomia: a case with sparing of the first-letter knowledge,” Neuropsychologia, vol. 36, no. 7, pp. 669–679, Jul. 1998, doi: 10.1016/s0028-3932(97)00142-5.
[7413]	L. Mottron, S. Belleville, and E. Stip, “Proper name hypermnesia in an autistic subject,” Brain Lang, vol. 53, no. 3, pp. 326–350, Jun. 1996, doi: 10.1006/brln.1996.0052.
[7414]	V. Kljajevic and A. Erramuzpe, “Proper name retrieval and structural integrity of cerebral cortex in midlife: A cross-sectional study,” Brain Cogn, vol. 120, pp. 26–33, 2018, doi: 10.1016/j.bandc.2017.11.003.
[7415]	M. La Palme Reyes, J. Macnamara, G. E. Reyes, and H. Zolfaghari, “Proper names and how they are learned,” Memory, vol. 1, no. 4, pp. 433–455, Dec. 1993, doi: 10.1080/09658219308258247.
[7416]	T. H. Gollan, R. I. Montoya, and M. P. Bonanni, “Proper names get stuck on bilingual and monolingual speakers’ tip of the tongue equally often,” Neuropsychology, vol. 19, no. 3, pp. 278–287, May 2005, doi: 10.1037/0894-4105.19.3.278.
[7417]	C. Semenza, S. Mondini, F. Borgo, M. Pasini, and M. T. Sgaramella, “Proper names in patients with early Alzheimer’s disease,” Neurocase, vol. 9, no. 1, pp. 63–69, 2003, doi: 10.1076/neur.9.1.63.14370.
[7418]	C. Semenza, F. Borgo, S. Mondini, M. Pasini, and T. Sgaramella, “Proper names in the early stages of Alzheimer’s disease,” Brain Cogn, vol. 43, no. 1–3, pp. 384–387, Aug. 2000.
[7419]	D. R. Ramponi and A. Callahan, “Proper Placement of Tubes on Chest Radiographs,” Adv Emerg Nurs J, vol. 42, no. 3, pp. 170–175, Sep. 2020, doi: 10.1097/TME.0000000000000308.
[7420]	K. S. Berbaum, D. D. Dorfman, E. A. Franken, and R. T. Caldwell, “Proper ROC analysis and joint ROC analysis of the satisfaction of search effect in chest radiology,” Acad Radiol, vol. 7, no. 11, pp. 945–958, Nov. 2000, doi: 10.1016/s1076-6332(00)80176-2.
[7421]	S. B. Cherry and M. Vasko, “Proper Surgical Dressing Removal Technique in Obstetrics and Gynecology,” Obstet Gynecol, vol. 134, no. 4, pp. 753–755, 2019, doi: 10.1097/AOG.0000000000003469.
[7422]	J. Y. Wick and G. R. Zanni, “Proper use of multidose vials,” Consult Pharm, vol. 21, no. 12, pp. 1005–1008, Dec. 2006, doi: 10.4140/tcp.n.2006.1005.
[7423]	R. Lechowski et al., “Proper use of quinolones for canine colitis ambulatory treatment: literature review and REQUEST guidelines,” Pol J Vet Sci, vol. 16, no. 1, pp. 193–197, 2013, doi: 10.2478/pjvs-2013-0028.
[7424]	E. Kazemi, H. Hassani, M. Grossglauser, and H. Pezeshgi Modarres, “PROPER: global protein interaction network alignment through percolation matching,” BMC Bioinformatics, vol. 17, no. 1, p. 527, Dec. 2016, doi: 10.1186/s12859-016-1395-9.
[7425]	 null Metz and  null Pan, “‘Proper’ Binormal ROC Curves: Theory and Maximum-Likelihood Estimation,” J Math Psychol, vol. 43, no. 1, pp. 1–33, Mar. 1999, doi: 10.1006/jmps.1998.1218.
[7426]	T. A. Livengood et al., “Properties of an Earth-like planet orbiting a Sun-like star: Earth observed by the EPOXI mission,” Astrobiology, vol. 11, no. 9, pp. 907–930, Nov. 2011, doi: 10.1089/ast.2011.0614.
[7427]	U. Zarzecka et al., “Properties of the HtrA Protease From Bacterium Helicobacter pylori Whose Activity Is Indispensable for Growth Under Stress Conditions,” Front Microbiol, vol. 10, p. 961, 2019, doi: 10.3389/fmicb.2019.00961.
[7428]	A. Ferrant et al., “Prophylaxis of graft-versus-host disease in identical sibling donor bone marrow transplant by anti-IL-2 receptor monoclonal antibody LO-Tact-1,” Bone Marrow Transplant., vol. 16, no. 4, pp. 577–581, Oct. 1995.
[7429]	M. T. Khayyal, D. H. Abdel-Naby, and M. A. El-Ghazaly, “Propolis extract protects against radiation-induced intestinal mucositis through anti-apoptotic mechanisms,” Environ Sci Pollut Res Int, vol. 26, no. 24, pp. 24672–24682, Aug. 2019, doi: 10.1007/s11356-019-05782-y.
[7430]	J. P. Gagnon and J. T. Osterhaus, “Proposed drug-drug cost effectiveness methodology,” Ann Pharmacother, vol. 40, no. 3, pp. 524–528, Mar. 2006, doi: 10.1345/aph.140010.
[7431]	J. Leroux, A. B. Davey, and A. Paillard, “Proposed standard methodology for the evaluation of silicosis hazards,” Am Ind Hyg Assoc J, vol. 34, no. 9, pp. 409–417, Sep. 1973, doi: 10.1080/0002889738506871.
[7432]	M. Goumenou and A. Tsatsakis, “Proposing new approaches for the risk characterisation of single chemicals and chemical mixtures: The source related Hazard Quotient (HQS) and Hazard Index (HIS) and the adversity specific Hazard Index (HIA),” Toxicol Rep, vol. 6, pp. 632–636, 2019, doi: 10.1016/j.toxrep.2019.06.010.
[7433]	L. van der Wagen et al., “Prospective evaluation of sequential treatment of sclerotic chronic graft versus host disease with rituximab and nilotinib,” Bone Marrow Transplant., vol. 53, no. 10, pp. 1255–1262, 2018, doi: 10.1038/s41409-018-0158-9.
[7434]	M. Faillot et al., “Prospective Follow-up of Intramedullary Slitlike Cavities: A Consecutive Series of 48 Patients,” Front Neurol, vol. 11, p. 495, 2020, doi: 10.3389/fneur.2020.00495.
[7435]	S. H. Park et al., “Prospective randomized trial of six-month versus nine-month therapy for intestinal tuberculosis,” Antimicrob. Agents Chemother., vol. 53, no. 10, pp. 4167–4171, Oct. 2009, doi: 10.1128/AAC.00874-09.
[7436]	B. J. McGuinness, S. Memon, and J. K. Hope, “Prospective Study of Early MRI Appearances following Flow-Diverting Stent Placement for Intracranial Aneurysms,” AJNR Am J Neuroradiol, vol. 36, no. 5, pp. 943–948, May 2015, doi: 10.3174/ajnr.A4335.
[7437]	S. Sho et al., “Prospective Validation of Two 4D-CT-Based Scoring Systems for Prediction of Multigland Disease in Primary Hyperparathyroidism,” AJNR Am J Neuroradiol, vol. 37, no. 12, pp. 2323–2327, Dec. 2016, doi: 10.3174/ajnr.A4948.
[7438]	S. L. Silvers, J. A. Eviatar, M. I. Echavez, and A. L. Pappas, “Prospective, open-label, 18-month trial of calcium hydroxylapatite (Radiesse) for facial soft-tissue augmentation in patients with human immunodeficiency virus-associated lipoatrophy: one-year durability,” Plast. Reconstr. Surg., vol. 118, no. 3 Suppl, pp. 34S-45S, Sep. 2006, doi: 10.1097/01.prs.0000234847.36020.52.
[7439]	N. Kanda, T. Ishikawa, and S. Watanabe, “Prostaglandin D2 induces the production of human beta-defensin-3 in human keratinocytes,” Biochem. Pharmacol., vol. 79, no. 7, pp. 982–989, Apr. 2010, doi: 10.1016/j.bcp.2009.11.012.
[7440]	N. Kanda, H. Mitsui, and S. Watanabe, “Prostaglandin E(2) suppresses CCL27 production through EP2 and EP3 receptors in human keratinocytes,” J. Allergy Clin. Immunol., vol. 114, no. 6, pp. 1403–1409, Dec. 2004, doi: 10.1016/j.jaci.2004.08.041.
[7441]	N. Kanda, S. Koike, and S. Watanabe, “Prostaglandin E2 enhances neurotrophin-4 production via EP3 receptor in human keratinocytes,” J. Pharmacol. Exp. Ther., vol. 315, no. 2, pp. 796–804, Nov. 2005, doi: 10.1124/jpet.105.091645.
[7442]	S. McGrath et al., “Prostate cancer biomarkers: Are we hitting the mark?,” Prostate Int, vol. 4, no. 4, pp. 130–135, Dec. 2016, doi: 10.1016/j.prnil.2016.07.002.
[7443]	Y. Liu et al., “Prostate cancer in Asia: design of a patient registry to inform real-world treatments, outcomes, and quality of life,” Prostate Int, vol. 7, no. 3, pp. 108–113, Sep. 2019, doi: 10.1016/j.prnil.2018.12.001.
[7444]	S. Cabarkapa, M. Perera, S. McGrath, and N. Lawrentschuk, “Prostate cancer screening with prostate-specific antigen: A guide to the guidelines,” Prostate Int, vol. 4, no. 4, pp. 125–129, Dec. 2016, doi: 10.1016/j.prnil.2016.09.002.
[7445]	T. Feutren and F. G. Herrera, “Prostate irradiation with focal dose escalation to the intraprostatic dominant nodule: a systematic review,” Prostate Int, vol. 6, no. 3, pp. 75–87, Sep. 2018, doi: 10.1016/j.prnil.2018.03.005.
[7446]	B. S. Kim, Y. H. Ko, P. H. Song, T.-H. Kim, K. H. Kim, and B. H. Kim, “Prostatic urethral length as a predictive factor for surgical treatment of benign prostatic hyperplasia: a prospective, multiinstitutional study,” Prostate Int, vol. 7, no. 1, pp. 30–34, Mar. 2019, doi: 10.1016/j.prnil.2018.06.002.
[7447]	C. Garcia, P. Chin, P. Rashid, and H. H. Woo, “Prostatic urethral lift: A minimally invasive treatment for benign prostatic hyperplasia,” Prostate Int, vol. 3, no. 1, pp. 1–5, Mar. 2015, doi: 10.1016/j.prnil.2015.02.002.
[7448]	L. Rew and K. Bowman, “Protecting youth from early and abusive sexual experiences,” Pediatr Nurs, vol. 34, no. 1, pp. 19–25, Feb. 2008.
[7449]	S. Jain, D. Keys, S. Martin, C. L. Edelstein, and A. Jani, “Protection From Apoptotic Cell Death During Cold Storage Followed by Rewarming in 13-Lined Ground Squirrel Tubular Cells: The Role of Prosurvival Factors X-Linked Inhibitor of Apoptosis and PhosphoAkt,” Transplantation, vol. 100, no. 3, pp. 538–545, Mar. 2016, doi: 10.1097/TP.0000000000000937.
[7450]	J. Arroyo-Acevedo, O. Herrera-Calderón, R. Chávez-Asmat, A. Anampa-Guzmán, V. Chumpitaz-Cerrate, and E. Enciso-Roca, “Protective effect of Chuquiraga spinosa extract on N-methyl-nitrosourea (NMU) induced prostate cancer in rats,” Prostate Int, vol. 5, no. 2, pp. 47–52, Jun. 2017, doi: 10.1016/j.prnil.2017.01.005.
[7451]	K. Amimoto et al., “Protective effects of clostridium sordellii LT and HT toxoids against challenge with spores in guinea pigs,” J. Vet. Med. Sci., vol. 63, no. 8, pp. 879–883, Aug. 2001, doi: 10.1292/jvms.63.879.
[7452]	T. A. Shelkovnikova et al., “Protective paraspeckle hyper-assembly downstream of TDP-43 loss of function in amyotrophic lateral sclerosis,” Mol Neurodegener, vol. 13, no. 1, p. 30, 01 2018, doi: 10.1186/s13024-018-0263-7.
[7453]	M. I. Yousef, “Protective role of ascorbic acid to enhance reproductive performance of male rabbits treated with stannous chloride,” Toxicology, vol. 207, no. 1, pp. 81–89, Feb. 2005, doi: 10.1016/j.tox.2004.08.017.
[7454]	Y.-R. Kim and C.-S. Yang, “Protective roles of ginseng against bacterial infection,” Microb Cell, vol. 5, no. 11, pp. 472–481, Sep. 2018, doi: 10.15698/mic2018.11.654.
[7455]	N. Thanki et al., “Protein engineering with monomeric triosephosphate isomerase (monoTIM): the modelling and structure verification of a seven-residue loop,” Protein Eng., vol. 10, no. 2, pp. 159–167, Feb. 1997, doi: 10.1093/protein/10.2.159.
[7456]	Y.-H. Peng et al., “Protein kinase inhibitor design by targeting the Asp-Phe-Gly (DFG) motif: the role of the DFG motif in the design of epidermal growth factor receptor inhibitors,” J. Med. Chem., vol. 56, no. 10, pp. 3889–3903, May 2013, doi: 10.1021/jm400072p.
[7457]	H. Park, G. R. Lee, L. Heo, and C. Seok, “Protein loop modeling using a new hybrid energy function and its application to modeling in inaccurate structural environments,” PLoS ONE, vol. 9, no. 11, p. e113811, 2014, doi: 10.1371/journal.pone.0113811.
[7458]	G. Bieri, K. M. Lucin, C. E. O’Brien, H. Zhang, S. A. Villeda, and T. Wyss-Coray, “Proteolytic cleavage of Beclin 1 exacerbates neurodegeneration,” Mol Neurodegener, vol. 13, no. 1, p. 68, 29 2018, doi: 10.1186/s13024-018-0302-4.
[7459]	M. Kamelgarn et al., “Proteomic analysis of FUS interacting proteins provides insights into FUS function and its role in ALS,” Biochim. Biophys. Acta, vol. 1862, no. 10, pp. 2004–2014, 2016, doi: 10.1016/j.bbadis.2016.07.015.
[7460]	Y. Hou, M.-C. Le Bihan, D. Vega-Avelaira, and G. R. Coulton, “Proteomic changes in hearts of kyphoscoliosis (ky) mutant mice in the absence of structural pathology: implication for the analysis of early human heart disease,” Proteomics, vol. 6, no. 10, pp. 3096–3108, May 2006, doi: 10.1002/pmic.200500475.
[7461]	R. Ghosh, B. Choi, Y. S. Kwon, T. Bashir, D.-W. Bae, and H. Bae, “Proteomic Changes in the Sound Vibration-Treated Arabidopsis thaliana Facilitates Defense Response during Botrytis cinerea Infection,” Plant Pathol. J., vol. 35, no. 6, pp. 609–622, Dec. 2019, doi: 10.5423/PPJ.OA.11.2018.0248.
[7462]	K. Sadtler et al., “Proteomic composition and immunomodulatory properties of urinary bladder matrix scaffolds in homeostasis and injury,” Semin. Immunol., vol. 29, pp. 14–23, 2017, doi: 10.1016/j.smim.2017.05.002.
[7463]	H. L. T. Mobley, “Proteus mirabilis Overview,” Methods Mol. Biol., vol. 2021, pp. 1–4, 2019, doi: 10.1007/978-1-4939-9601-8_1.
[7464]	S. Brisebois, A. Merati, and J. P. Giliberto, “Proton pump inhibitors: Review of reported risks and controversies,” Laryngoscope Investig Otolaryngol, vol. 3, no. 6, pp. 457–462, Dec. 2018, doi: 10.1002/lio2.187.
[7465]	T. Nakamura, “[Proton pump inhibitors: Tenatoprazole (TU-199)],” Nippon Rinsho, vol. 60 Suppl 2, pp. 650–654, Feb. 2002.
[7466]	S. Papa, F. Guerrieri, M. Lorusso, and S. Simone, “Proton translocation and energy transduction in mitochondria,” Biochimie, vol. 55, no. 6, pp. 703–716, 1973, doi: 10.1016/s0300-9084(73)80024-0.
[7467]	J. Chen et al., “Proton-Coupled Electron Transfer of Plastoquinone Redox Reactions in Photosystem II: A Pump-Probe Ultraviolet Resonance Raman Study,” J Phys Chem Lett, vol. 10, no. 12, pp. 3240–3247, Jun. 2019, doi: 10.1021/acs.jpclett.9b00959.
[7468]	A. Berghaus, “[Protruding ears - cosmetic surgery with a sense of proportion],” MMW Fortschr Med, vol. 158, no. 16, pp. 51–53, 2016, doi: 10.1007/s15006-016-8725-8.
[7469]	R. Stephenson, N. Metheny, A. Sharma, S. Sullivan, and E. Riley, “Providing Home-Based HIV Testing and Counseling for Transgender Youth (Project Moxie): Protocol for a Pilot Randomized Controlled Trial,” JMIR Res Protoc, vol. 6, no. 11, p. e237, Nov. 2017, doi: 10.2196/resprot.8562.
[7470]	M. Yousofshahi, S. Manteiga, C. Wu, K. Lee, and S. Hassoun, “PROXIMAL: a method for Prediction of Xenobiotic Metabolism,” BMC Syst Biol, vol. 9, p. 94, Dec. 2015, doi: 10.1186/s12918-015-0241-4.
[7471]	G. M. Rosen and S. Taylor, “Pseudo-PTSD,” J Anxiety Disord, vol. 21, no. 2, pp. 201–210, 2007, doi: 10.1016/j.janxdis.2006.09.011.
[7472]	T. Müller, P. Lentzsch, U. Behrendt, D. Barkusky, and M. E. H. Müller, “Pseudomonas simiae effects on the mycotoxin formation by fusaria and alternaria in vitro and in a wheat field,” Mycotoxin Res, vol. 36, no. 2, pp. 147–158, May 2020, doi: 10.1007/s12550-019-00379-3.
[7473]	A. Rohr, C. Riedel, G. Reimann, K. Alfke, J. Hedderich, and O. Jansen, “[Pseudotumor cerebri: quantitative in-vivo measurements of markers of intracranial hypertension],” Rofo, vol. 180, no. 10, pp. 884–890, Oct. 2008, doi: 10.1055/s-2008-1027627.
[7474]	U. Wollina, “[Psoriasis and the general practitioner],” MMW Fortschr Med, vol. 158 Spec No 1, pp. 40–45, Apr. 2016, doi: 10.1007/s15006-016-7648-8.
[7475]	H. Iwasa, R. Hosaka, and S. Kaneko, “[Psychiatric and Psychological Comorbidities in Epilepsy: Clinical Features and Psychiatric Management],” Brain Nerve, vol. 70, no. 9, pp. 1005–1016, Sep. 2018, doi: 10.11477/mf.1416201120.
[7476]	A. Bermeo-Ovalle, “Psychiatric comorbidities go untreated in patients with epilepsy: Ignorance or denial?,” Epilepsy Behav, vol. 98, no. Pt B, pp. 306–308, 2019, doi: 10.1016/j.yebeh.2018.11.028.
[7477]	A. M. Kanner, “Psychiatric comorbidities in epilepsy: Should they be considered in the classification of epileptic disorders?,” Epilepsy Behav, vol. 64, no. Pt B, pp. 306–308, 2016, doi: 10.1016/j.yebeh.2016.06.040.
[7478]	A. M. Kanner, “Psychiatric comorbidities in new onset epilepsy: Should they be always investigated?,” Seizure, vol. 49, pp. 79–82, Jul. 2017, doi: 10.1016/j.seizure.2017.04.007.
[7479]	A. M. Kanner, “Psychiatric issues in epilepsy: the complex relation of mood, anxiety disorders, and epilepsy,” Epilepsy Behav, vol. 15, no. 1, pp. 83–87, May 2009, doi: 10.1016/j.yebeh.2009.02.034.
[7480]	E. Zara, B. R. Gelli, and U. Rini, “[Psycho-sociological considerations on adolescent prostitution],” Osp Psichiatr, vol. 33, no. 1, pp. 41–116, Jun. 1965.
[7481]	L. Cohen, C. Warneke, R. T. Fouladi, M. A. Rodriguez, and A. Chaoul-Reich, “Psychological adjustment and sleep quality in a randomized trial of the effects of a Tibetan yoga intervention in patients with lymphoma,” Cancer, vol. 100, no. 10, pp. 2253–2260, May 2004, doi: 10.1002/cncr.20236.
[7482]	D. K. Moser et al., “Psychological Aspects of Heart Failure,” Curr Cardiol Rep, vol. 18, no. 12, p. 119, 2016, doi: 10.1007/s11886-016-0799-5.
[7483]	C. Merriman, P. Norman, and J. Barton, “Psychological correlates of PTSD symptoms following stroke,” Psychol Health Med, vol. 12, no. 5, pp. 592–602, Oct. 2007, doi: 10.1080/13548500601162747.
[7484]	E. B. Foa, “Psychological processes related to recovery from a trauma and an effective treatment for PTSD,” Ann. N. Y. Acad. Sci., vol. 821, pp. 410–424, Jun. 1997, doi: 10.1111/j.1749-6632.1997.tb48295.x.
[7485]	B. L. Malivoire, C. J. Hare, and T. L. Hart, “Psychological symptoms and perceived cognitive impairment in multiple sclerosis: The role of rumination,” Rehabil Psychol, vol. 63, no. 2, pp. 286–294, 2018, doi: 10.1037/rep0000180.
[7486]	J. D. Ford, J. Hawke, S. Alessi, D. Ledgerwood, and N. Petry, “Psychological trauma and PTSD symptoms as predictors of substance dependence treatment outcomes,” Behav Res Ther, vol. 45, no. 10, pp. 2417–2431, Oct. 2007, doi: 10.1016/j.brat.2007.04.001.
[7487]	P. Cuijpers, S. Quero, C. Dowrick, and B. Arroll, “Psychological Treatment of Depression in Primary Care: Recent Developments,” Curr Psychiatry Rep, vol. 21, no. 12, p. 129, 23 2019, doi: 10.1007/s11920-019-1117-x.
[7488]	P. Cuijpers, G. Andersson, T. Donker, and A. van Straten, “Psychological treatment of depression: results of a series of meta-analyses,” Nord J Psychiatry, vol. 65, no. 6, pp. 354–364, Dec. 2011, doi: 10.3109/08039488.2011.596570.
[7489]	E. Hougaard and M. B. Jørgensen, “[Psychological treatment of depression],” Ugeskr. Laeg., vol. 169, no. 16, pp. 1444–1447, Apr. 2007.
[7490]	M. A. Forti-Buratti, R. Saikia, E. L. Wilkinson, and P. G. Ramchandani, “Psychological treatments for depression in pre-adolescent children (12 years and younger): systematic review and meta-analysis of randomised controlled trials,” Eur Child Adolesc Psychiatry, vol. 25, no. 10, pp. 1045–1054, Oct. 2016, doi: 10.1007/s00787-016-0834-5.
[7491]	M. Robertson, L. Humphreys, and R. Ray, “Psychological treatments for posttraumatic stress disorder: recommendations for the clinician based on a review of the literature,” J Psychiatr Pract, vol. 10, no. 2, pp. 106–118, Mar. 2004, doi: 10.1097/00131746-200403000-00005.
[7492]	Y.-P. Wang and C. Gorenstein, “Psychometric properties of the Beck Depression Inventory-II: a comprehensive review,” Braz J Psychiatry, vol. 35, no. 4, pp. 416–431, Dec. 2013, doi: 10.1590/1516-4446-2012-1048.
[7493]	M. S. Wiglusz, J. Landowski, and W. J. Cubała, “Psychometric properties of the Polish version of the Hamilton Anxiety Rating Scale in patients with epilepsy with and without comorbid anxiety disorder,” Epilepsy Behav, vol. 94, pp. 9–13, 2019, doi: 10.1016/j.yebeh.2019.02.017.
[7494]	J. S. Buyukdura, S. M. McClintock, and P. E. Croarkin, “Psychomotor retardation in depression: biological underpinnings, measurement, and treatment,” Prog. Neuropsychopharmacol. Biol. Psychiatry, vol. 35, no. 2, pp. 395–409, Mar. 2011, doi: 10.1016/j.pnpbp.2010.10.019.
[7495]	L. Vigoré et al., “Psychoneuroendocrine modulation of regulatory T lymphocyte system: in vivo and in vitro effects of the pineal immunomodulating hormone melatonin,” In Vivo, vol. 24, no. 5, pp. 787–789, Oct. 2010.
[7496]	N. C. Bernardy and M. J. Friedman, “Psychopharmacological strategies in the management of posttraumatic stress disorder (PTSD): what have we learned?,” Curr Psychiatry Rep, vol. 17, no. 4, p. 564, Apr. 2015, doi: 10.1007/s11920-015-0564-2.
[7497]	J. Tawa and S. Murphy, “Psychopharmacological treatment for military posttraumatic stress disorder: an integrative review,” J Am Assoc Nurse Pract, vol. 25, no. 8, pp. 419–423, Aug. 2013, doi: 10.1111/1745-7599.12016.
[7498]	A. M. Freedman, “Psychopharmacology and psychotherapy in the treatment of anxiety,” Pharmakopsychiatr Neuropsychopharmakol, vol. 13, no. 5, pp. 277–289, Sep. 1980, doi: 10.1055/s-2007-1019646.
[7499]	P. J. Cowen, “Psychopharmacology of 5-HT(1A) receptors,” Nucl. Med. Biol., vol. 27, no. 5, pp. 437–439, Jul. 2000, doi: 10.1016/s0969-8051(00)00108-6.
[7500]	C. L. Donnelly, L. Amaya-Jackson, and J. S. March, “Psychopharmacology of pediatric posttraumatic stress disorder,” J Child Adolesc Psychopharmacol, vol. 9, no. 3, pp. 203–220, 1999, doi: 10.1089/cap.1999.9.203.
[7501]	S. P. Orr and W. T. Roth, “Psychophysiological assessment: clinical applications for PTSD,” J Affect Disord, vol. 61, no. 3, pp. 225–240, Dec. 2000, doi: 10.1016/s0165-0327(00)00340-2.
[7502]	C. Bergström, M. Persson, and I. Mogren, “Psychosocial and behavioural characteristics in women with pregnancy-related lumbopelvic pain 12 years postpartum,” Chiropr Man Therap, vol. 27, p. 34, 2019, doi: 10.1186/s12998-019-0257-8.
[7503]	I. J. Gill, S. Mullin, and J. Simpson, “Psychosocial and psychological factors associated with post-traumatic stress disorder following traumatic brain injury in adult civilian populations: a systematic review,” Brain Inj, vol. 28, no. 1, pp. 1–14, 2014, doi: 10.3109/02699052.2013.851416.
[7504]	M. Böttche and C. Knaevelsrud, “[Psychotherapy for posttraumatic stress disorder in older adults],” Nervenarzt, vol. 88, no. 11, pp. 1234–1239, Nov. 2017, doi: 10.1007/s00115-017-0409-9.
[7505]	C. T. McQuillan, “[Psychotherapy of the child and adolescent with depression],” Bol Asoc Med P R, vol. 95, no. 3, pp. 21–28, 33–41, Jun. 2003.
[7506]	K. T. Rew, “Psychotic and Bipolar Disorders: Foreword,” FP Essent, vol. 455, p. 2, Apr. 2017.
[7507]	K. Kanemoto, Y. Tadokoro, and T. Oshima, “Psychotic illness in patients with epilepsy,” Ther Adv Neurol Disord, vol. 5, no. 6, pp. 321–334, Nov. 2012, doi: 10.1177/1756285612454180.
[7508]	A. Maercker and M. Augsburger, “[Psychotraumatology : Differentiation, extension and public discourse],” Nervenarzt, vol. 88, no. 9, pp. 967–973, Sep. 2017, doi: 10.1007/s00115-017-0363-6.
[7509]	Y. Onishi, S. Hinotsu, T. A. Furukawa, and K. Kawakami, “Psychotropic prescription patterns among patients diagnosed with depressive disorder based on claims database in Japan,” Clin Drug Investig, vol. 33, no. 8, pp. 597–605, Aug. 2013, doi: 10.1007/s40261-013-0104-y.
[7510]	A. Naguy and B. Alamiri, “PTSD - Inevitable or preventable?,” Australas Psychiatry, vol. 26, no. 6, p. 670, 2018, doi: 10.1177/1039856218783853.
[7511]	D. Warden, I. Reider-Groswasser, J. Grafman, and A. Salazar, “PTSD and hippocampal volume,” Am J Psychiatry, vol. 153, no. 12, pp. 1657; author reply 1658-1659, Dec. 1996.
[7512]	L. Mevissen and A. de Jongh, “PTSD and its treatment in people with intellectual disabilities: a review of the literature,” Clin Psychol Rev, vol. 30, no. 3, pp. 308–316, Apr. 2010, doi: 10.1016/j.cpr.2009.12.005.
[7513]	R. Yehuda, A. Lehrner, and T. Y. Rosenbaum, “PTSD and Sexual Dysfunction in Men and Women,” J Sex Med, vol. 12, no. 5, pp. 1107–1119, May 2015, doi: 10.1111/jsm.12856.
[7514]	T. C. Buckley, “PTSD and Vietnam Veterans,” Science, vol. 315, no. 5809, pp. 184–187; author reply 184-187, Jan. 2007.
[7515]	J. Heitzman, “[PTSD as a result of a natural disaster],” Psychiatr. Pol., vol. 32, no. 1, pp. 5–13, Feb. 1998.
[7516]	M. J. Friedman, “PTSD diagnosis and treatment for mental health clinicians,” Community Ment Health J, vol. 32, no. 2, pp. 173–189; discussion 191-193, Apr. 1996, doi: 10.1007/BF02249755.
[7517]	G. J. G. Asmundson and S. Taylor, “PTSD diagnostic criteria: understanding etiology and treatment,” Am J Psychiatry, vol. 166, no. 6, pp. 726; author reply 727, Jun. 2009, doi: 10.1176/appi.ajp.2009.08121799.
[7518]	C. S. Paredes Molina, S. Berry, A. Nielsen, and R. Winfield, “PTSD in civilian populations after hospitalization following traumatic injury: A comprehensive review,” Am. J. Surg., vol. 216, no. 4, pp. 745–753, 2018, doi: 10.1016/j.amjsurg.2018.07.035.
[7519]	G. Young, “PTSD in Court II: Risk factors, endophenotypes, and biological underpinnings in PTSD,” Int J Law Psychiatry, vol. 51, pp. 1–21, Apr. 2017, doi: 10.1016/j.ijlp.2017.02.002.
[7520]	I. V. Carlier, R. D. Lamberts, A. J. Fouwels, and B. P. Gersons, “PTSD in relation to dissociation in traumatized police officers,” Am J Psychiatry, vol. 153, no. 10, pp. 1325–1328, Oct. 1996, doi: 10.1176/ajp.153.10.1325.
[7521]	T. Krauseneck, H.-B. Rothenhäusler, G. Schelling, and H.-P. Kapfhammer, “[PTSD in somatic disease],” Fortschr Neurol Psychiatr, vol. 73, no. 4, pp. 206–217, Apr. 2005, doi: 10.1055/s-2004-830108.
[7522]	L. K. Lapp, C. Agbokou, and F. Ferreri, “PTSD in the elderly: the interaction between trauma and aging,” Int Psychogeriatr, vol. 23, no. 6, pp. 858–868, Aug. 2011, doi: 10.1017/S1041610211000366.
[7523]	R. Theroux, “PTSD in the postpartum period: a cause or an effect?,” Nurs Womens Health, vol. 13, no. 5, pp. 437–440, Oct. 2009, doi: 10.1111/j.1751-486X.2009.01464.x.
[7524]	G. R. Greer, C. S. Grob, and A. L. Halberstadt, “PTSD symptom reports of patients evaluated for the New Mexico Medical Cannabis Program,” J Psychoactive Drugs, vol. 46, no. 1, pp. 73–77, Mar. 2014, doi: 10.1080/02791072.2013.873843.
[7525]	N. Noor, C. Pao, M. Dragomir-Davis, J. Tran, and C. Arbona, “PTSD symptoms and suicidal ideation in US female firefighters,” Occup Med (Lond), May 2019, doi: 10.1093/occmed/kqz057.
[7526]	K. Berry, S. Ford, L. Jellicoe-Jones, and G. Haddock, “PTSD symptoms associated with the experiences of psychosis and hospitalisation: a review of the literature,” Clin Psychol Rev, vol. 33, no. 4, pp. 526–538, Jun. 2013, doi: 10.1016/j.cpr.2013.01.011.
[7527]	A. Bokszczanin, “PTSD symptoms in children and adolescents 28 months after a flood: age and gender differences,” J Trauma Stress, vol. 20, no. 3, pp. 347–351, Jun. 2007, doi: 10.1002/jts.20220.
[7528]	R. Fielding and W. W. T. Lam, “PTSD--more complicated on second look,” Nat Rev Clin Oncol, vol. 10, no. 8, Aug. 2013, doi: 10.1038/nrclinonc.2013.49-c1.
[7529]	D. Murphy and W. Busuttil, “PTSD, stigma and barriers to help-seeking within the UK Armed Forces,” J R Army Med Corps, vol. 161, no. 4, pp. 322–326, Dec. 2015, doi: 10.1136/jramc-2014-000344.
[7530]	J. C. Corvalan and D. Klein, “PTSD: diagnosis, evolution, and treatment of combat-related psychological/psychiatric injury,” Mo Med, vol. 108, no. 4, pp. 296–303, Aug. 2011.
[7531]	J. E. Meyer, “PTSD: how to recognize the many faces of this hidden disorder,” JAAPA, vol. 22, no. 9, pp. 46–50, Sep. 2009, doi: 10.1097/01720610-200909000-00009.
[7532]	B. A. Moore, “PTSD: past, present, and future,” CNS Spectr, vol. 18, no. 2, pp. 71–72, Apr. 2013, doi: 10.1017/S1092852913000187.
[7533]	G. H. Wynn and D. M. Benedek, “PTSD: Towards a Patient-Level Understanding of a Complex Disorder,” J. Nerv. Ment. Dis., vol. 205, no. 2, pp. 75–76, 2017, doi: 10.1097/NMD.0000000000000662.
[7534]	W. Bu, Y. Ni, Q. Guo, J. Zheng, and S. Uchida, “Pu isotopes in soils collected downwind from Lop Nor: regional fallout vs. global fallout,” Sci Rep, vol. 5, p. 12262, Jul. 2015, doi: 10.1038/srep12262.
[7535]	J. Rustenhoven et al., “PU.1 regulates Alzheimer’s disease-associated genes in primary human microglia,” Mol Neurodegener, vol. 13, no. 1, p. 44, 20 2018, doi: 10.1186/s13024-018-0277-1.
[7536]	R. Gamache, H. Kharrazi, and J. P. Weiner, “Public and Population Health Informatics: The Bridging of Big Data to Benefit Communities,” Yearb Med Inform, vol. 27, no. 1, pp. 199–206, Aug. 2018, doi: 10.1055/s-0038-1667081.
[7537]	C. Nagamori, K. Hara, Y. Hirose, K. Ohta, M. Akaza, and Y. Sumi, “Public awareness and experiences associated with epilepsy in Japan, 2013-2017,” Epilepsy Behav, vol. 86, pp. 138–144, 2018, doi: 10.1016/j.yebeh.2018.05.007.
[7538]	A. Moore, “Public bioethics and public engagement: the politics of ‘proper talk,’” Public Underst Sci, vol. 19, no. 2, pp. 197–211, Mar. 2010, doi: 10.1177/0963662508096781.
[7539]	B. Walker, “Public health in a managed care environment,” J Health Care Poor Underserved, vol. 8, no. 3, pp. 345–350; discussion 350-351, Aug. 1997, doi: 10.1353/hpu.2010.0637.
[7540]	“Public health round-up,” Bull. World Health Organ., vol. 95, no. 4, pp. 244–245, Apr. 2017, doi: 10.2471/BLT.17.010417.
[7541]	M. E. Kruk and G. Mbaruku, “Public health successes and frail health systems in Tanzania,” Lancet Glob Health, vol. 3, no. 7, pp. e348-349, Jul. 2015, doi: 10.1016/S2214-109X(15)00036-4.
[7542]	E. C. Jarillo-Soto and O. López-Arellano, “[Public health: knowledge, practice and training],” Rev Salud Publica (Bogota), vol. 9, no. 1, pp. 140–154, Mar. 2007, doi: 10.1590/s0124-00642007000100014.
[7543]	B. Castle, M. Wendel, J. Kerr, D. Brooms, and A. Rollins, “Public Health’s Approach to Systemic Racism: a Systematic Literature Review,” J Racial Ethn Health Disparities, vol. 6, no. 1, pp. 27–36, 2019, doi: 10.1007/s40615-018-0494-x.
[7544]	P. F. Waller, “Public health’s contribution to motor vehicle injury prevention,” Am J Prev Med, vol. 21, no. 4 Suppl, pp. 3–4, Nov. 2001, doi: 10.1016/s0749-3797(01)00386-5.
[7545]	D. U. Himmelstein and S. Woolhandler, “Public Health’s Falling Share of US Health Spending,” Am J Public Health, vol. 106, no. 1, pp. 56–57, Jan. 2016, doi: 10.2105/AJPH.2015.302908.
[7546]	K. Kiser, “Public health’s head cheerleader,” Minn Med, vol. 93, no. 6, pp. 10–12, Jun. 2010.
[7547]	E. Majestic, “Public health’s inconvenient truth: the need to create partnerships with the business sector,” Prev Chronic Dis, vol. 6, no. 2, p. A39, Apr. 2009.
[7548]	I. S. Shannon, “Public health’s promise for the future: 1989 presidential address,” Am J Public Health, vol. 80, no. 8, pp. 909–912, Aug. 1990, doi: 10.2105/ajph.80.8.909.
[7549]	D. Bishai, J. P. Leider, and B. Resnick, “Public Health’s Share of US Health Spending,” Am J Public Health, vol. 106, no. 7, p. e11, 2016, doi: 10.2105/AJPH.2016.303213.
[7550]	J. Matthes, M. Giesler, M. Wagner-Menghin, M. Himmelbauer, I. Preusche, and K. Schüttpelz-Brauns, “Publication activity in medical education research: A descriptive analysis of submissions to the GMS Zeitschrift für Medizinische Ausbildung in 2007-2015,” GMS J Med Educ, vol. 34, no. 3, p. Doc32, 2017, doi: 10.3205/zma001109.
[7551]	R. Britton, “Publication anxiety: conflict between communication and affiliation,” Int J Psychoanal, vol. 75 ( Pt 5–6), pp. 1213–1224, Dec. 1994.
[7552]	J. M. Cowell, “Publication Ethics,” J Sch Nurs, vol. 33, no. 1, p. 7, Feb. 2017, doi: 10.1177/1059840516685797.
[7553]	M. Rees, “Publication ethics,” Maturitas, vol. 71, no. 3, p. 199, Mar. 2012, doi: 10.1016/j.maturitas.2012.01.003.
[7554]	S. Sengupta and S. G. Honavar, “Publication ethics,” Indian J Ophthalmol, vol. 65, no. 6, pp. 429–432, Jun. 2017, doi: 10.4103/ijo.IJO_483_17.
[7555]	R. A. Black, “Publication ethics: redundancy in publication,” Med Eng Phys, vol. 35, no. 4, p. 421, Apr. 2013, doi: 10.1016/j.medengphy.2013.02.004.
[7556]	A. Fabre, “[Publication of pediatric medical dissertations in France],” Arch Pediatr, vol. 22, no. 8, pp. 802–806, Aug. 2015, doi: 10.1016/j.arcped.2015.03.013.
[7557]	B. R. Williams, L. M. MacCormick, D. L. McCreary, A. J. Dugarte, and B. P. Cunningham, “Publication of Podium Presentations at the Orthopaedic Trauma Association Annual Meetings: 2008-2012,” J Orthop Trauma, vol. 32, no. 5, pp. e166–e170, 2018, doi: 10.1097/BOT.0000000000001045.
[7558]	K. W. Hinchcliff and S. P. DiBartola, “Publication of the Journal of Veterinary Internal Medicine,” J. Vet. Intern. Med., vol. 22, no. 1, p. 1, Feb. 2008, doi: 10.1111/j.1939-1676.2008.0056.x.
[7559]	L. Baudoin, V. Akiki, A. Magnan, and P. Devos, “[Publication output of French university hospitals during 2006-2015: Trends and position in the national health research landscape],” Presse Med, vol. 47, no. 11-12 Pt 1, pp. e175–e186, Dec. 2018, doi: 10.1016/j.lpm.2018.06.016.
[7560]	A. Basilious, A. M. Benavides Vargas, and Y. M. Buys, “Publication rate of abstracts presented at the 2010 Canadian Ophthalmological Society Annual Meeting,” Can. J. Ophthalmol., vol. 52, no. 4, pp. 343–348, Aug. 2017, doi: 10.1016/j.jcjo.2016.11.033.
[7561]	J. Boldt and W. Maleck, “[Publication rate of Deutsche Forschungsgemeinschaft (DFG)-supported research projects. An analysis of the ‘fate’ of DFG-support methods in anesthesia, surgery and internal medicine],” Dtsch. Med. Wochenschr., vol. 125, no. 38, pp. 1142–1146, Sep. 2000, doi: 10.1055/s-2000-7578.
[7562]	H. Dobson and S. Wall, “Publication Rates of Studies Presented at the International Society of Craniofacial Surgery Congress,” J Craniofac Surg, vol. 27, no. 8, pp. 1943–1945, Nov. 2016, doi: 10.1097/SCS.0000000000003016.
[7563]	C. Johnson, “Publication, publication, publication...,” Ann R Coll Surg Engl, vol. 96, no. 1, p. 1, Jan. 2014, doi: 10.1308/rcsann.2014.96.8.e1.
[7564]	U. S. Neill, “Publish or perish, but at what cost?,” J. Clin. Invest., vol. 118, no. 7, p. 2368, Jul. 2008, doi: 10.1172/JCI36371.
[7565]	J. M. Collier, N. Vig, and D. Hammond, “Publish or perish? A survey of abstracts accepted for meetings of the British Association of Oral and Maxillofacial Surgeons, and subsequently published,” Br J Oral Maxillofac Surg, vol. 48, no. 7, pp. 540–543, Oct. 2010, doi: 10.1016/j.bjoms.2009.08.037.
[7566]	M. G. Siegel, J. C. Brand, M. J. Rossi, and J. H. Lubowitz, “‘Publish or Perish’ Promotes Medical Literature Quantity Over Quality,” Arthroscopy, vol. 34, no. 11, pp. 2941–2942, 2018, doi: 10.1016/j.arthro.2018.08.029.
[7567]	S. Mori, A. H. Pang, N. T. Chandrika, S. Garneau-Tsodikova, and O. V. Tsodikov, “Publisher Correction: Unusual substrate and halide versatility of phenolic halogenase PltM,” Nat Commun, vol. 10, no. 1, p. 2053, Apr. 2019, doi: 10.1038/s41467-019-09731-8.
[7568]	W. Y. Takahashi and A. T. Tu, “Puff adder snakebite,” JAMA, vol. 211, no. 11, p. 1857, Mar. 1970.
[7569]	H. Koneru et al., “Pulmonary Artery Pseudoaneurysm: A Rare Cause of Fatal Massive Hemoptysis,” Case Rep Pulmonol, vol. 2018, p. 8251967, 2018, doi: 10.1155/2018/8251967.
[7570]	R. Pálföldi et al., “Pulmonary epithelioid haemangioendothelioma studies in vitro and in vivo: new diagnostic and treatment methods,” In Vivo, vol. 27, no. 2, pp. 221–225, Apr. 2013.
[7571]	N. Y. Gabrail and B. Y. Zara, “Pulmonary hamartoma syndrome,” Chest, vol. 97, no. 4, pp. 962–965, Apr. 1990, doi: 10.1378/chest.97.4.962.
[7572]	R. M. Abel, J. Brown, B. Moreland, and D. Parikh, “Pulmonary metastasectomy for pediatric solid tumors,” Pediatr. Surg. Int., vol. 20, no. 8, pp. 630–632, Aug. 2004, doi: 10.1007/s00383-002-0927-8.
[7573]	G. Dreyfus, M. Zara, and C. Betourne, “[Pulmonary pachydermo-periostosis],” Sem Hop, vol. 27, no. 57–58, pp. 2397–2400, Aug. 1951.
[7574]	 null Gilbert-Dreyfus, M. Zara, and C. Betourne, “[Pulmonary pachydermoperiostosis],” Bull Mem Soc Med Hop Paris, vol. 66, no. 17–18, pp. 909–912, May 1950.
[7575]	N. N. Ngangro et al., “Pulmonary tuberculosis diagnostic delays in Chad: a multicenter, hospital-based survey in Ndjamena and Moundou,” BMC Public Health, vol. 12, p. 513, Jul. 2012, doi: 10.1186/1471-2458-12-513.
[7576]	J. Ben Amar et al., “Pulmonary tuberculosis: Diagnostic delay in Tunisia,” Med Mal Infect, vol. 46, no. 2, pp. 79–86, Mar. 2016, doi: 10.1016/j.medmal.2015.11.012.
[7577]	M. C. Cartolano, H. N. Gancel, J. Lonthair, C. M. Wood, and M. D. McDonald, “Pulsatile urea excretion in Gulf toadfish: the role of circulating serotonin and additional 5-HT receptor subtypes,” J. Comp. Physiol. B, Biochem. Syst. Environ. Physiol., vol. 189, no. 5, pp. 537–548, 2019, doi: 10.1007/s00360-019-01223-x.
[7578]	S. Angermann et al., “Pulse wave velocity is associated with cognitive impairment in hemodialysis patients,” Clin. Sci., vol. 131, no. 13, pp. 1483–1493, Jul. 2017, doi: 10.1042/CS20170087.
[7579]	S. Maleki and S. H. Razavi, “Pulses’ germination and fermentation: Two bioprocessing against hypertension by releasing ACE inhibitory peptides,” Crit Rev Food Sci Nutr, pp. 1–18, Jul. 2020, doi: 10.1080/10408398.2020.1789551.
[7580]	A. J. Zera, T. Sanger, J. Hanes, and L. Harshman, “Purification and characterization of hemolymph juvenile hormone esterase from the cricket, Gryllus assimilis,” Arch. Insect Biochem. Physiol., vol. 49, no. 1, pp. 41–55, Jan. 2002, doi: 10.1002/arch.10004.
[7581]	K. Maruyama, H. Kaiya, M. Miyazato, N. Murakami, K. Nakahara, and K. Matsuda, “Purification and identification of native forms of goldfish neuromedin U from brain and gut,” Biochem. Biophys. Res. Commun., vol. 517, no. 3, pp. 433–438, 24 2019, doi: 10.1016/j.bbrc.2019.07.108.
[7582]	P. M. Campbell, J. G. Oakeshott, and M. J. Healy, “Purification and kinetic characterisation of juvenile hormone esterase from Drosophila melanogaster,” Insect Biochem. Mol. Biol., vol. 28, no. 7, pp. 501–515, Jul. 1998, doi: 10.1016/s0965-1748(98)00037-x.
[7583]	 null Keller,  null Wage,  null Hohaus,  null Hölzer,  null Eichhorn, and  null van Pée KH, “Purification and Partial Characterization of Tryptophan 7-Halogenase (PrnA) from Pseudomonas fluorescens This work was supported by the Deutsche Forschungsgemeinschaft (DFG) through the Graduiertenkolleg ‘Struktur-Eigenschafts-Beziehungen bei Heterocyclen’, the Environment and Climate Research and Technology Development Programme of the European Union, the Sächsische Staatsministerium für Umwelt und Landesentwicklung, the Max-Buchner-Stiftung, and the Fonds der Chemischen Industrie. Samples of P. fluorescens BL915DeltaORF1-4 with pPEH14(prnA) and pPEH14(prnC) were obtained from Dr. J. M. Ligon, Novartis Agribusiness Biotechnology Research, Inc., Research Triangle, NC (USA) and NADH oxidase (from Thermus thermiphilus) from Prof. Helmut Erdmann, Fachhochschule Flensburg (Germany),” Angew. Chem. Int. Ed. Engl., vol. 39, no. 13, pp. 2300–2302, Jul. 2000, doi: 10.1002/1521-3773(20000703)39:13<2300::aid-anie2300>3.0.co;2-i.
[7584]	E. Krasowska, J. Róg, A. Sinadinos, C. N. J. Young, D. C. Górecki, and K. Zabłocki, “Purinergic receptors in skeletal muscles in health and in muscular dystrophy,” Postepy Biochem., vol. 60, no. 4, pp. 483–489, 2014.
[7585]	B. Hayden and J. A. Prahlow, “Purulent pericarditis,” Forensic Sci Med Pathol, vol. 13, no. 1, pp. 96–98, Mar. 2017, doi: 10.1007/s12024-016-9829-2.
[7586]	B. B. Gorzalka and M. N. Hill, “Putative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants,” Prog. Neuropsychopharmacol. Biol. Psychiatry, vol. 35, no. 7, pp. 1575–1585, Aug. 2011, doi: 10.1016/j.pnpbp.2010.11.021.
[7587]	M. Braun-Falco, O. Kovnerystyy, P. Lohse, and T. Ruzicka, “Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)--a new autoinflammatory syndrome distinct from PAPA syndrome,” J. Am. Acad. Dermatol., vol. 66, no. 3, pp. 409–415, Mar. 2012, doi: 10.1016/j.jaad.2010.12.025.
[7588]	C. N. Renn, A. Helmer, and M. Megahed, “[Pyogenic arthritis, pyoderma gangrenosum and acne syndrome (PAPA syndrome)],” Hautarzt, vol. 58, no. 5, pp. 383–384, May 2007, doi: 10.1007/s00105-007-1331-z.
[7589]	W. Löffler, P. Lohse, T. Weihmayr, and W. Widenmayer, “Pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome: differential diagnosis of septic arthritis by regular detection of exceedingly high synovial cell counts,” Infection, vol. 45, no. 4, pp. 395–402, Aug. 2017, doi: 10.1007/s15010-017-0996-1.
[7590]	A. F. Edrees, D. L. Kaplan, and N. I. Abdou, “Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome) associated with hypogammaglobulinemia and elevated serum tumor necrosis factor-alpha levels,” J Clin Rheumatol, vol. 8, no. 5, pp. 273–275, Oct. 2002, doi: 10.1097/00124743-200210000-00009.
[7591]	S.-Y. Park, C.-H. Park, W.-S. Lee, H.-S. Kim, S.-K. Choi, and J.-S. Rew, “Pyogenic granuloma of the duodenum treated successfully by endoscopic mucosal resection,” Gut Liver, vol. 3, no. 1, pp. 48–51, Mar. 2009, doi: 10.5009/gnl.2009.3.1.48.
[7592]	J. Li et al., “Pyrolysis kinetics and reaction mechanism of the electrode materials during the spent LiCoO2 batteries recovery process,” J. Hazard. Mater., vol. 398, p. 122955, Nov. 2020, doi: 10.1016/j.jhazmat.2020.122955.
[7593]	Y. Xia, Y. Liu, M. Deng, and R. Xi, “Pysim-sv: a package for simulating structural variation data with GC-biases,” BMC Bioinformatics, vol. 18, no. Suppl 3, p. 53, Mar. 2017, doi: 10.1186/s12859-017-1464-8.
[7594]	M. A. Lynes, S. Tonkonogy, and L. Flaherty, “Qa-1 and Qa-2 expression on CFU-s,” J. Immunol., vol. 129, no. 3, pp. 928–930, Sep. 1982.
[7595]	L. J. Nell, R. G. Cook, and R. R. Rich, “Qa-1-associated antigens. IV. Evidence for additional Qa-1 polymorphism defined biochemically and by cytotoxic T lymphocyte recognition,” Transplantation, vol. 34, no. 1, pp. 54–59, Jul. 1982.
[7596]	M. Oudshoorn-Snoek and P. Demant, “Qa-12--a novel determinant of activated T and B lymphocytes,” J. Immunogenet., vol. 16, no. 4–5, pp. 263–272, Oct. 1989, doi: 10.1111/j.1744-313x.1989.tb00472.x.
[7597]	J. K. Hammit, “QALYs versus WTP,” Risk Anal., vol. 22, no. 5, pp. 985–1001, Oct. 2002, doi: 10.1111/1539-6924.00265.
[7598]	P. Ferrero, I. Piazza, A. Grosu, P. Brambilla, S. Sironi, and M. Senni, “QRS fragmentation as possible new marker of fibrosis in patients with myocarditis. Preliminary validation with cardiac magnetic resonance,” Eur. J. Heart Fail., vol. 21, no. 9, pp. 1160–1161, Sep. 2019, doi: 10.1002/ejhf.1413.
[7599]	J. A. Kors, G. van Herpen, and J. H. van Bemmel, “QT dispersion as an attribute of T-loop morphology,” Circulation, vol. 99, no. 11, pp. 1458–1463, Mar. 1999, doi: 10.1161/01.cir.99.11.1458.
[7600]	Y. He, Y. Fu, D. Hu, D. Wei, and W. Qian, “QTL Mapping of Seed Glucosinolate Content Responsible for Environment in Brassica napus,” Front Plant Sci, vol. 9, p. 891, 2018, doi: 10.3389/fpls.2018.00891.
[7601]	R. W. Cross et al., “Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and death,” J. Clin. Invest., vol. 130, no. 1, pp. 539–551, 02 2020, doi: 10.1172/JCI131958.
[7602]	W. C. Stewart, P. G. Chaney, J. A. Stewart, B. Kruft, and L. A. Nelson, “Qualitative factors underlying the successful investment in new ophthalmic pharmaceutical products in the United States,” Acta Ophthalmol, vol. 91, no. 6, pp. e496-497, Sep. 2013, doi: 10.1111/aos.12041.
[7603]	S. S. Collard and P. Regmi, “Qualitative insights into the feelings, knowledge, and impact of SUDEP: A narrative synthesis,” Epilepsy Behav, vol. 94, pp. 20–28, 2019, doi: 10.1016/j.yebeh.2019.02.015.
[7604]	G. Hu, Z. Wu, C. J. Oldfield, C. Wang, and L. Kurgan, “Quality assessment for the putative intrinsic disorder in proteins,” Bioinformatics, vol. 35, no. 10, pp. 1692–1700, 15 2019, doi: 10.1093/bioinformatics/bty881.
[7605]	A. E. Shamoo, “Quality assurance,” Qual Assur, vol. 1, no. 1, pp. 4–9, Oct. 1991.
[7606]	R. E. Fredekind, E. J. Cuny, and N. A. Nadershahi, “Quality assurance and risk management: a survey of dental schools and recommendations for integrated program management,” J Dent Educ, vol. 66, no. 4, pp. 556–563, Apr. 2002.
[7607]	K. A. Garnett and A. L. Reigel, “Quality Assurance Computer System,” Qual Assur, vol. 3, no. 4, pp. 332–348, Dec. 1994.
[7608]	C. C. Glüer, K. G. Faulkner, M. J. Estilo, K. Engelke, J. Rosin, and H. K. Genant, “Quality assurance for bone densitometry research studies: concept and impact,” Osteoporos Int, vol. 3, no. 5, pp. 227–235, Sep. 1993, doi: 10.1007/BF01623825.
[7609]	W. Abubaker and M. Abdulrahman, “Quality assurance guides health reform in Jordan,” QA Brief, vol. 5, no. 1, pp. 19–21, 1996.
[7610]	G. Hoff, “Quality assurance in gastroenterology: QA in research, and research in QA,” Best Pract Res Clin Gastroenterol, vol. 25, no. 3, pp. 427–434, Jun. 2011, doi: 10.1016/j.bpg.2011.05.006.
[7611]	W. Lu, K. Dong, D. Cui, Q. Jiao, and J. Qiu, “Quality assurance of human functional magnetic resonance imaging: a literature review,” Quant Imaging Med Surg, vol. 9, no. 6, pp. 1147–1162, Jun. 2019, doi: 10.21037/qims.2019.04.18.
[7612]	V. Sarkar, L. Lin, C. Shi, and N. Papanikolaou, “Quality assurance of the multileaf collimator with helical tomotherapy: design and implementation,” Med Phys, vol. 34, no. 7, pp. 2949–2956, Jul. 2007, doi: 10.1118/1.2748105.
[7613]	F. M. Pattillo, P. H. Carver, and M. A. Brewster, “Quality auditing of chromatographic data,” Qual Assur, vol. 4, no. 4, pp. 358–360, Dec. 1995.
[7614]	S. Ohman, “Quality control for the clinical chemistry laboratory,” Qual Assur, vol. 5, no. 2, pp. 79–93, Jun. 1997.
[7615]	Y. S. Erozan, “Quality control in cytopathology,” Clin. Lab. Med., vol. 6, no. 4, pp. 707–713, Dec. 1986.
[7616]	V. N. Luzikov, “Quality control: from molecules to organelles,” FEBS Lett., vol. 448, no. 2–3, pp. 201–205, Apr. 1999, doi: 10.1016/s0014-5793(99)00344-0.
[7617]	E. Brähler and S. Riedel-Heller, “[Quality instead of quantity--DFG paradigm change],” Psychother Psychosom Med Psychol, vol. 60, no. 7, pp. 241–242, Jul. 2010, doi: 10.1055/s-0030-1248505.
[7618]	J. Kinnunen and A. Laitinen, “[Quality of health care and costs],” Sairaanhoitaja, no. 4, pp. 13–15, 1993.
[7619]	L. Westermann et al., “Quality of life and functional outcomes after surgery for spinal metastases: Results of a cohort study,” Technol Health Care, vol. 28, no. 3, pp. 303–314, 2020, doi: 10.3233/THC-191727.
[7620]	W. Boling, M. Means, and A. Fletcher, “Quality of Life and Stigma in Epilepsy, Perspectives from Selected Regions of Asia and Sub-Saharan Africa,” Brain Sci, vol. 8, no. 4, Apr. 2018, doi: 10.3390/brainsci8040059.
[7621]	T. H. Nageeti, H. R. Elzahrany, A. O. Gabra, A. A. Obaid, and R. A. Jastania, “Quality of life assessment of breast cancer patients in Saudi Arabia,” J Family Community Med, vol. 26, no. 2, pp. 98–102, Aug. 2019, doi: 10.4103/jfcm.JFCM_4_18.
[7622]	F. Tomao, A. Papa, and S. Tomao, “Quality of Life Effects of Ovarian Suppression in the Suppression of Ovarian Function Trial,” J. Clin. Oncol., vol. 34, no. 34, p. 4188, 2016, doi: 10.1200/JCO.2016.68.8218.
[7623]	S. Pedras, E. Vilhena, R. Carvalho, and M. G. Pereira, “Quality of Life Following a Lower Limb Amputation in Diabetic Patients: A Longitudinal and Multicenter Study,” Psychiatry, vol. 83, no. 1, pp. 47–57, 2020, doi: 10.1080/00332747.2019.1672438.
[7624]	A. Saadi, B. Patenaude, and F. J. Mateen, “Quality of life in epilepsy-31 inventory (QOLIE-31) scores: A global comparison,” Epilepsy Behav, vol. 65, pp. 13–17, 2016, doi: 10.1016/j.yebeh.2016.09.032.
[7625]	N. Dahan-Oliel, S. Oliel, A. Tsimicalis, K. Montpetit, F. Rauch, and M. J. Dogba, “Quality of life in osteogenesis imperfecta: A mixed-methods systematic review,” Am. J. Med. Genet. A, vol. 170A, no. 1, pp. 62–76, Jan. 2016, doi: 10.1002/ajmg.a.37377.
[7626]	S. Ventegodt, N. J. Andersen, and J. Merrick, “Quality of life philosophy IV. The brain and consciousness,” ScientificWorldJournal, vol. 3, pp. 1199–1209, Dec. 2003, doi: 10.1100/tsw.2003.104.
[7627]	B. Jönsson, “Quality of life--economic aspects,” Scand J Prim Health Care Suppl, vol. 1, pp. 93–96, 1990.
[7628]	M. Szklo, “Quality of scientific articles,” Rev Saude Publica, vol. 40 Spec no., pp. 30–35, Aug. 2006, doi: 10.1590/s0034-89102006000400005.
[7629]	T. Salthammer, “Quality or quantity? Historic and current trends in scientific publishing,” Indoor Air, vol. 26, no. 3, pp. 347–349, 2016, doi: 10.1111/ina.12287.
[7630]	T. J. Hughes, “Quality science and quality assurance: observations of an environmental scientist,” Qual Assur, vol. 7, no. 4, pp. 225–235, Dec. 1999, doi: 10.1080/105294199750061344.
[7631]	U. H. Ehling, “[Quantification of chemical genetic risk],” Naturwissenschaften, vol. 76, no. 5, pp. 194–199, May 1989, doi: 10.1007/BF00627685.
[7632]	N. Rolf et al., “Quantification of fetal myocardial function in pregnant women with diabetic diseases and in normal controls using speckle tracking echocardiography (STE),” J Perinat Med, vol. 47, no. 1, pp. 68–76, Dec. 2018, doi: 10.1515/jpm-2018-0031.
[7633]	J. Shimamura et al., “Quantification of interventricular dyssynchrony during continuous-flow left ventricular assist device support,” J Artif Organs, vol. 22, no. 4, pp. 269–275, Dec. 2019, doi: 10.1007/s10047-019-01109-3.
[7634]	P. J. Brandvik, C. Storey, E. J. Davies, and F. Leirvik, “Quantification of oil droplets under high pressure laboratory experiments simulating deep water oil releases and subsea dispersants injection (SSDI),” Mar. Pollut. Bull., vol. 138, pp. 520–525, Jan. 2019, doi: 10.1016/j.marpolbul.2018.11.020.
[7635]	H. Tatebe et al., “Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and down syndrome,” Mol Neurodegener, vol. 12, no. 1, p. 63, 04 2017, doi: 10.1186/s13024-017-0206-8.
[7636]	X. Meng, X. Wang, and Y. Wang, “Quantifying correlations of metal ionic characters with ecological soil screening levels (Eco-SSLs) of metals using QICAR models,” Chemosphere, vol. 228, pp. 451–459, Aug. 2019, doi: 10.1016/j.chemosphere.2019.04.183.
[7637]	S. B. Pointing, N. Fierer, G. J. D. Smith, P. D. Steinberg, and M. Wiedmann, “Quantifying human impact on Earth’s microbiome,” Nat Microbiol, vol. 1, no. 9, p. 16145, 26 2016, doi: 10.1038/nmicrobiol.2016.145.
[7638]	J. H. Rasmussen, C. T. Herbst, and C. P. H. Elemans, “Quantifying syringeal dynamics in vitro using electroglottography,” J. Exp. Biol., vol. 221, no. Pt 16, 23 2018, doi: 10.1242/jeb.172247.
[7639]	J. A. Schofield, K. Miller, and L. Blume, “Quantifying uncertainty: calculating interval estimates using quality control results,” Qual Assur, vol. 9, no. 3–4, pp. 229–237, Dec. 2001, doi: 10.1080/713844031.
[7640]	A. T. Maynard and C. D. Roberts, “Quantifying, Visualizing, and Monitoring Lead Optimization,” J. Med. Chem., vol. 59, no. 9, pp. 4189–4201, 12 2016, doi: 10.1021/acs.jmedchem.5b00948.
[7641]	M. Wang et al., “Quantitative Analyses of the Interfacial Properties of Current Collectors at the Mesoscopic Level in Lithium Ion Batteries by Using Hierarchical Graphene,” Nano Lett., vol. 20, no. 3, pp. 2175–2182, Mar. 2020, doi: 10.1021/acs.nanolett.0c00348.
[7642]	J. B. Bateman, O. A. Chadwick, and P. M. Vitousek, “Quantitative Analysis of Pedogenic Thresholds and Domains in Volcanic Soils,” Ecosystems (N. Y., Print), vol. 22, no. 7, pp. 1633–1649, Nov. 2019, doi: 10.1007/s10021-019-00361-1.
[7643]	M. G. Swanson et al., “Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy,” Magn Reson Med, vol. 55, no. 6, pp. 1257–1264, Jun. 2006, doi: 10.1002/mrm.20909.
[7644]	G. Janiga, “Quantitative assessment of 4D hemodynamics in cerebral aneurysms using proper orthogonal decomposition,” J Biomech, vol. 82, pp. 80–86, 03 2019, doi: 10.1016/j.jbiomech.2018.10.014.
[7645]	W. Wang and J. P. Lynch, “Quantitative assessment of compress-type osseointegrated prosthetic implants in human bone using electromechanical impedance spectroscopic methods,” Biomed Eng Lett, vol. 10, no. 1, pp. 129–147, Feb. 2020, doi: 10.1007/s13534-019-00139-3.
[7646]	M. S. Gnatiuk, “[Quantitative assessment of different parts of the heart in young and old white rats],” Arkh Anat Gistol Embriol, vol. 84, no. 5, pp. 33–36, May 1983.
[7647]	G. Tamura, K. So, H. Miyoshi, T. Honda, S. Nishizuka, and T. Motoyama, “Quantitative assessment of gene methylation in neoplastic and non-neoplastic gastric epithelia using methylation-specific DNA microarray,” Pathol. Int., vol. 59, no. 12, pp. 895–899, Dec. 2009, doi: 10.1111/j.1440-1827.2009.02458.x.
[7648]	J. H. Yoon et al., “Quantitative Assessment of Liver Function by Using Gadoxetic Acid-enhanced MRI: Hepatocyte Uptake Ratio,” Radiology, vol. 290, no. 1, pp. 125–133, 2019, doi: 10.1148/radiol.2018180753.
[7649]	T. Nogaki, N. Keskin, T. Azuma, M. M. Paparella, J. B. Nadol, and S. Cureoglu, “Quantitative assessment of vestibular otopathology in granulomatosis with polyangitis: A temporal bone study,” Laryngoscope Investig Otolaryngol, vol. 3, no. 6, pp. 473–477, Dec. 2018, doi: 10.1002/lio2.182.
[7650]	Z. Heidari, H. Mahmoudzadeh-Sagheb, and M. Narouei, “Quantitative changes of gastric mucosa during carcinogenesis using stereological methods,” J BUON, vol. 22, no. 4, pp. 905–910, Aug. 2017.
[7651]	E. W. Lake et al., “Quantitative conformational profiling of kinase inhibitors reveals origins of selectivity for Aurora kinase activation states,” Proc. Natl. Acad. Sci. U.S.A., vol. 115, no. 51, pp. E11894–E11903, 18 2018, doi: 10.1073/pnas.1811158115.
[7652]	M. L. Trew, B. J. Caldwell, and B. H. Smaill, “Quantitative descriptions of extended volume cardiac tissue architecture from multiple large hearts,” Conf Proc IEEE Eng Med Biol Soc, vol. 2018, pp. 616–619, 2018, doi: 10.1109/EMBC.2018.8512309.
[7653]	J. H. Yoon, J. M. Lee, E. Kim, T. Okuaki, and J. K. Han, “Quantitative Liver Function Analysis: Volumetric T1 Mapping with Fast Multisection B1 Inhomogeneity Correction in Hepatocyte-specific Contrast-enhanced Liver MR Imaging,” Radiology, vol. 282, no. 2, pp. 408–417, Feb. 2017, doi: 10.1148/radiol.2016152800.
[7654]	T. E. H. Allen, J. M. Goodman, S. Gutsell, and P. J. Russell, “Quantitative Predictions for Molecular Initiating Events Using Three-Dimensional Quantitative Structure-Activity Relationships,” Chem. Res. Toxicol., vol. 33, no. 2, pp. 324–332, 17 2020, doi: 10.1021/acs.chemrestox.9b00136.
[7655]	A. Martinez et al., “Quantitative proteomic analysis of Parkin substrates in Drosophila neurons,” Mol Neurodegener, vol. 12, no. 1, p. 29, 11 2017, doi: 10.1186/s13024-017-0170-3.
[7656]	S. Rangaraju et al., “Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer’s disease-related proteins,” Mol Neurodegener, vol. 13, no. 1, p. 34, 28 2018, doi: 10.1186/s13024-018-0266-4.
[7657]	F. A. Hanefeld, K. Brockmann, P. J. W. Pouwels, B. Wilken, J. Frahm, and P. Dechent, “Quantitative proton MRS of Pelizaeus-Merzbacher disease: evidence of dys- and hypomyelination,” Neurology, vol. 65, no. 5, pp. 701–706, Sep. 2005, doi: 10.1212/01.wnl.0000174642.32187.20.
[7658]	O. A. Khan, “Quantitative proton MRS of Pelizaeus-Merzbacher disease: evidence of dys- and hypomyelination,” Neurology, vol. 66, no. 7, pp. 1131–1132; author reply 1131-1132, Apr. 2006, doi: 10.1212/01.wnl.0000220159.27255.35.
[7659]	Y. Liang, R. Xiong, S. I. Sandler, and D. M. Di Toro, “Quantum Chemically Estimated Abraham Solute Parameters Using Multiple Solvent-Water Partition Coefficients and Molecular Polarizability,” Environ. Sci. Technol., vol. 51, no. 17, pp. 9887–9898, Sep. 2017, doi: 10.1021/acs.est.7b01737.
[7660]	M. Gazouli et al., “Quantum dots-bevacizumab complexes for in vivo imaging of tumors,” In Vivo, vol. 28, no. 6, pp. 1091–1095, Dec. 2014.
[7661]	M. Zych, F. Costa, I. Pikovski, and Č. Brukner, “Quantum interferometric visibility as a witness of general relativistic proper time,” Nat Commun, vol. 2, p. 505, Oct. 2011, doi: 10.1038/ncomms1498.
[7662]	G. K. Wang, R. Simon, and S. Y. Wang, “Quaternary ammonium compounds as structural probes of single batrachotoxin-activated Na+ channels,” J. Gen. Physiol., vol. 98, no. 5, pp. 1005–1024, Nov. 1991, doi: 10.1085/jgp.98.5.1005.
[7663]	N. N. Barotto, C. B. López, A. R. Eynard, M. E. Fernández Zapico, and M. A. Valentich, “Quercetin enhances pretumorous lesions in the NMU model of rat pancreatic carcinogenesis,” Cancer Lett., vol. 129, no. 1, pp. 1–6, Jul. 1998, doi: 10.1016/s0304-3835(98)00033-0.
[7664]	J. E. Kim et al., “Quercetin promotes gastrointestinal motility and mucin secretion in loperamide-induced constipation of SD rats through regulation of the mAChRs downstream signal,” Pharm Biol, vol. 56, no. 1, pp. 309–317, Dec. 2018, doi: 10.1080/13880209.2018.1474932.
[7665]	A. Witze, “Quest to drill into Earth’s mantle restarts,” Nature, vol. 528, no. 7580, pp. 16–17, Dec. 2015, doi: 10.1038/528016a.
[7666]	M. Patak and B. Reynolds, “Question-based assessments of delay discounting: do respondents spontaneously incorporate uncertainty into their valuations for delayed rewards?,” Addict Behav, vol. 32, no. 2, pp. 351–357, Feb. 2007, doi: 10.1016/j.addbeh.2006.03.034.
[7667]	“QuickStats: Percentage Distribution of Gestational Age in Weeks for Infants Who Survived to Age 1 Year and Infants Who Died Before Age 1 Year - National Vital Statistics System, United States, 2014,” MMWR Morb. Mortal. Wkly. Rep., vol. 66, no. 14, p. 392, Apr. 2017, doi: 10.15585/mmwr.mm6614a5.
[7668]	R. G. Tavares et al., “Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes,” Neurochem. Int., vol. 40, no. 7, pp. 621–627, Jun. 2002, doi: 10.1016/s0197-0186(01)00133-4.
[7669]	H. Huss and R. Hutchison, “Quo vademus? A review of the regulatory environment,” Qual Assur, vol. 4, no. 3, pp. 181–186, Sep. 1995.
[7670]	H. E. Kaiser, V. Bodey, S. E. Siegel, and B. Bodey, “Racial differences in childhood tumors,” In Vivo, vol. 16, no. 6, pp. 417–422, Dec. 2002.
[7671]	G. M. Woodwell, “Radiation and the patterns of nature. BNL 924 (T-381),” Tech Rep Brookhaven Natl Lab, pp. 1–15, 1965.
[7672]	A. Chowdhary, A. M. Spence, L. Sales, R. C. Rostomily, J. K. Rockhill, and D. L. Silbergeld, “Radiation associated tumors following therapeutic cranial radiation,” Surg Neurol Int, vol. 3, p. 48, 2012, doi: 10.4103/2152-7806.96068.
[7673]	M. Soret et al., “Radiation dose of nuclear medicine technicians performing PET/MR,” J Radiol Prot, vol. 40, no. 3, pp. 861–866, Jun. 2020, doi: 10.1088/1361-6498/aba082.
[7674]	T. Yasuda et al., “Radiation-induced brain cell death can be observed in living medaka embryos,” J. Radiat. Res., vol. 47, no. 3–4, pp. 295–303, Nov. 2006, doi: 10.1269/jrr.0617.
[7675]	G. D. Cilliers, I. S. Harper, and A. Lochner, “Radiation-induced changes in the ultrastructure and mechanical function of the rat heart,” Radiother Oncol, vol. 16, no. 4, pp. 311–326, Dec. 1989, doi: 10.1016/0167-8140(89)90044-3.
[7676]	A. N. Stroud, A. M. Brues, and B. R. Svoboda, “RADIATION-INDUCED CHROMOSOMAL ABERRATIONS AND VARIANT CLONES IN MAMMALIAN CELLS CULTIVATED IN VITRO. ANL-6723,” ANL Rep, pp. 223–236, May 1963.
[7677]	 null Gilbert-Dreyfus and M. Zara, “[Radio-active iodine and the thyroid],” Hopital, vol. 39, no. 600, pp. 212–215, Jul. 1951.
[7678]	Y. Wang, G. Li, W. Li, X. He, and L. Xu, “Radiofrequency ablation of advanced lung tumors: imaging features, local control, and follow-up protocol,” Int J Clin Exp Med, vol. 8, no. 10, pp. 18137–18143, 2015.
[7679]	D. H. Lee et al., “Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis,” Radiology, vol. 270, no. 3, pp. 900–909, Mar. 2014, doi: 10.1148/radiol.13130940.
[7680]	M. H. Yu et al., “Radiofrequency Ablation with an Internally Cooled Monopolar Directional Electrode: Ex Vivo and in Vivo Experimental Studies in the Liver,” Radiology, vol. 278, no. 2, pp. 395–404, Feb. 2016, doi: 10.1148/radiol.2015142269.
[7681]	A. Renaud et al., “Radiographic features of osteogenesis imperfecta,” Insights Imaging, vol. 4, no. 4, pp. 417–429, Aug. 2013, doi: 10.1007/s13244-013-0258-4.
[7682]	E. Gokce and M. Beyhan, “Radiological imaging findings of scheuermann disease,” World J Radiol, vol. 8, no. 11, pp. 895–901, Nov. 2016, doi: 10.4329/wjr.v8.i11.895.
[7683]	P. J. Lewis, J. Y. Chen, D. J. Lin, and N. J. McNulty, “Radiology ExamWeb: development and implementation of a national web-based examination system for medical students in radiology,” Acad Radiol, vol. 20, no. 3, pp. 290–296, Mar. 2013, doi: 10.1016/j.acra.2012.09.023.
[7684]	A. T. Grady, J. A. Sosa, T. P. Tanpitukpongse, K. R. Choudhury, R. T. Gupta, and J. K. Hoang, “Radiology reports for incidental thyroid nodules on CT and MRI: high variability across subspecialties,” AJNR Am J Neuroradiol, vol. 36, no. 2, pp. 397–402, Feb. 2015, doi: 10.3174/ajnr.A4089.
[7685]	F. Nobili et al., “Radionuclide brain imaging correlates of cognitive impairment in Parkinson’s disease (PD),” J. Neurol. Sci., vol. 310, no. 1–2, pp. 31–35, Nov. 2011, doi: 10.1016/j.jns.2011.06.053.
[7686]	Y.-Y. Shen, T.-M. Dai, H.-L. Liu, W. Wu, and J.-L. Tu, “Ramsay Hunt Syndrome Complicated by Brainstem Encephalitis in Varicella-zoster Virus Infection,” Chin. Med. J., vol. 128, no. 23, pp. 3258–3259, Dec. 2015, doi: 10.4103/0366-6999.170275.
[7687]	P. Chys and P. Chacón, “Random Coordinate Descent with Spinor-matrices and Geometric Filters for Efficient Loop Closure,” J Chem Theory Comput, vol. 9, no. 3, pp. 1821–1829, Mar. 2013, doi: 10.1021/ct300977f.
[7688]	W. L. Law, K. W. Chu, and H. K. Choi, “Randomized clinical trial comparing loop ileostomy and loop transverse colostomy for faecal diversion following total mesorectal excision,” Br J Surg, vol. 89, no. 6, pp. 704–708, Jun. 2002, doi: 10.1046/j.1365-2168.2002.02082.x.
[7689]	M. E. Gleave et al., “Randomized comparative study of 3 versus 8-month neoadjuvant hormonal therapy before radical prostatectomy: biochemical and pathological effects,” J. Urol., vol. 166, no. 2, pp. 500–506; discussion 506-507, Aug. 2001.
[7690]	I. Sailer, S. Mühlemann, V. Fehmer, C. H. F. Hämmerle, and G. I. Benic, “Randomized controlled clinical trial of digital and conventional workflows for the fabrication of zirconia-ceramic fixed partial dentures. Part I: Time efficiency of complete-arch digital scans versus conventional impressions,” J Prosthet Dent, vol. 121, no. 1, pp. 69–75, Jan. 2019, doi: 10.1016/j.prosdent.2018.04.021.
[7691]	G. I. Benic, I. Sailer, M. Zeltner, J. N. Gütermann, M. Özcan, and S. Mühlemann, “Randomized controlled clinical trial of digital and conventional workflows for the fabrication of zirconia-ceramic fixed partial dentures. Part III: Marginal and internal fit,” J Prosthet Dent, vol. 121, no. 3, pp. 426–431, Mar. 2019, doi: 10.1016/j.prosdent.2018.05.014.
[7692]	K. Kimura et al., “Randomized controlled trial of TY-51924, a novel hydrophilic NHE inhibitor, in acute myocardial infarction,” J Cardiol, vol. 67, no. 4, pp. 307–313, Apr. 2016, doi: 10.1016/j.jjcc.2015.07.017.
[7693]	G. I. Benic, S. Mühlemann, V. Fehmer, C. H. F. Hämmerle, and I. Sailer, “Randomized controlled within-subject evaluation of digital and conventional workflows for the fabrication of lithium disilicate single crowns. Part I: digital versus conventional unilateral impressions,” J Prosthet Dent, vol. 116, no. 5, pp. 777–782, Nov. 2016, doi: 10.1016/j.prosdent.2016.05.007.
[7694]	I. Pearce et al., “Ranibizumab 0.5 mg for Diabetic Macular Edema with Bimonthly Monitoring after a Phase of Initial Treatment: 18-Month, Multicenter, Phase IIIB RELIGHT Study,” Ophthalmology, vol. 122, no. 9, pp. 1811–1819, Sep. 2015, doi: 10.1016/j.ophtha.2015.05.038.
[7695]	W. Zhu, X. Wang, and L. Chen, “Rapid detection of peanut oil adulteration using low-field nuclear magnetic resonance and chemometrics,” Food Chem, vol. 216, pp. 268–274, Feb. 2017, doi: 10.1016/j.foodchem.2016.08.051.
[7696]	S. M. Doyle et al., “Rapid Formation of Microbe-Oil Aggregates and Changes in Community Composition in Coastal Surface Water Following Exposure to Oil and the Dispersant Corexit,” Front Microbiol, vol. 9, p. 689, 2018, doi: 10.3389/fmicb.2018.00689.
[7697]	M. P. Sárria, J. Soares, M. N. Vieira, L. F. C. Castro, M. M. Santos, and N. M. Monteiro, “Rapid-behaviour responses as a reliable indicator of estrogenic chemical toxicity in zebrafish juveniles,” Chemosphere, vol. 85, no. 10, pp. 1543–1547, Nov. 2011, doi: 10.1016/j.chemosphere.2011.07.048.
[7698]	E. Cho et al., “Rare case of obstructive duodenal phytobezoar caused by two lipomas,” J Dig Dis, vol. 19, no. 1, pp. 48–51, Jan. 2018, doi: 10.1111/1751-2980.12508.
[7699]	T. A. Thompson, J. D. Haag, and M. N. Gould, “ras gene mutations are absent in NMU-induced mammary carcinomas from aging rats,” Carcinogenesis, vol. 21, no. 10, pp. 1917–1922, Oct. 2000, doi: 10.1093/carcin/21.10.1917.
[7700]	D. R. Pentland, E. Piper-Brown, F. A. Mühlschlegel, and C. W. Gourlay, “Ras signalling in pathogenic yeasts,” Microb Cell, vol. 5, no. 2, pp. 63–73, Dec. 2017, doi: 10.15698/mic2018.02.612.
[7701]	B. Di Micco, G. Colonna, R. Porta, and S. Metafora, “Rat protein SV-IV (seminal vesicle protein No. 4) accelerates human blood coagulation in vitro by selective inhibition of antithrombin III,” Biochem. Pharmacol., vol. 48, no. 2, pp. 345–352, Jul. 1994, doi: 10.1016/0006-2952(94)90106-6.
[7702]	M. Gulcek, F. Inci, E. Ceyhan, U. Gurhan, Y. Kahve, and A. Ucaner, “Rate of conversion of reports presented at the Turkish Society of Sports Traumatology, Arthroscopy and Knee Surgery Congress into publication,” Acta Orthop Traumatol Turc, vol. 52, no. 6, pp. 447–451, Nov. 2018, doi: 10.1016/j.aott.2018.08.002.
[7703]	D. Vukadinović, A. N. Vukadinović, D. Lavall, U. Laufs, S. Wagenpfeil, and M. Böhm, “Rate of Cough During Treatment With Angiotensin-Converting Enzyme Inhibitors: A Meta-Analysis of Randomized Placebo-Controlled Trials,” Clin. Pharmacol. Ther., vol. 105, no. 3, pp. 652–660, 2019, doi: 10.1002/cpt.1018.
[7704]	Y.-E. Ju, L. Larson-Prior, and S. Duntley, “RBD and antidepressants,” Sleep Med., vol. 13, no. 2, pp. 211–212, Feb. 2012, doi: 10.1016/j.sleep.2011.05.001.
[7705]	M. H. Witte and M. J. Bernas, “RE-REDISCOVERY OF THE BRAIN’S LYMPHATIC SYSTEM,” Lymphology, vol. 48, no. 4, pp. 161–162, Dec. 2015.
[7706]	S.-M. Tu and A. H. Chen, “Re:  Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastases,” Can J Urol, vol. 19, no. 3, p. 6268, Jun. 2012.
[7707]	L. B. Barnett, J. E. Springer, and R. M. Worthing, “Re: Aerobic Exercise Combined with Noninvasive Positive Pressure Ventilation Increases Serum Brain-Derived Neurotrophic Factor in Healthy Males by Kawazu et al,” PM R, vol. 10, no. 9, p. 988, 2018, doi: 10.1016/j.pmrj.2018.03.011.
[7708]	P. Striano, S. Striano, and F. Zara, “Re: Fame 3: a novel form of progressive myoclonus and epilepsy,” Neurology, vol. 70, no. 1, pp. 85; author reply 85-86, Jan. 2008, doi: 10.1212/01.wnl.0000295707.90283.e6.
[7709]	L. Zhu, H. Liu, C. J. Pickard, G. Zou, and Y. Ma, “Reactions of xenon with iron and nickel are predicted in the Earth’s inner core,” Nat Chem, vol. 6, no. 7, pp. 644–648, Jul. 2014, doi: 10.1038/nchem.1925.
[7710]	F. Roelants, S. Potier, J. L. Souciet, and J. de Montigny, “Reactivation of the ATCase domain of the URA2 gene complex: a positive selection method for Ty insertions and chromosomal rearrangements in Saccharomyces cerevisiae,” Mol. Gen. Genet., vol. 246, no. 6, pp. 767–773, Mar. 1995, doi: 10.1007/BF00290725.
[7711]	H. Fan et al., “Reactive astrocytes undergo M1 microglia/macrohpages-induced necroptosis in spinal cord injury,” Mol Neurodegener, vol. 11, p. 14, Feb. 2016, doi: 10.1186/s13024-016-0081-8.
[7712]	S. Papa and V. P. Skulachev, “Reactive oxygen species, mitochondria, apoptosis and aging,” Mol. Cell. Biochem., vol. 174, no. 1–2, pp. 305–319, Sep. 1997.
[7713]	R. Nouchi, Y. Taki, H. Takeuchi, T. Nozawa, A. Sekiguchi, and R. Kawashima, “Reading Aloud and Solving Simple Arithmetic Calculation Intervention (Learning Therapy) Improves Inhibition, Verbal Episodic Memory, Focus Attention and Processing Speed in Healthy Elderly People: Evidence from a Randomized Controlled Trial,” Front Hum Neurosci, vol. 10, p. 217, 2016, doi: 10.3389/fnhum.2016.00217.
[7714]	L. Korn, D. Rüschen, N. Zander, S. Leonhardt, and M. Walter, “Real-Time ECG Simulation for Hybrid Mock Circulatory Loops,” Artif Organs, vol. 42, no. 2, pp. 131–140, Feb. 2018, doi: 10.1111/aor.13000.
[7715]	“Real-time monitoring of vaccination campaign performance using mobile phones – Nepal, 2016,” Wkly. Epidemiol. Rec., vol. 91, no. 40, pp. 461–468, Oct. 2016.
[7716]	A. F. Ozaki et al., “Real-World Adherence and Persistence to Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis,” Circ Cardiovasc Qual Outcomes, vol. 13, no. 3, p. e005969, 2020, doi: 10.1161/CIRCOUTCOMES.119.005969.
[7717]	A. J. Camm et al., “Real-world vs. randomized trial outcomes in similar populations of rivaroxaban-treated patients with non-valvular atrial fibrillation in ROCKET AF and XANTUS,” Europace, vol. 21, no. 3, pp. 421–427, Mar. 2019, doi: 10.1093/europace/euy160.
[7718]	R. F. Geever, T. Murayama, M. E. Case, and N. H. Giles, “Rearrangement mutations on the 5’ side of the qa-2 gene of Neurospora implicate two regions of qa-1F activator-protein interaction,” Proc. Natl. Acad. Sci. U.S.A., vol. 83, no. 11, pp. 3944–3948, Jun. 1986, doi: 10.1073/pnas.83.11.3944.
[7719]	D. Tu, “[Reasons for drug-resistant tuberculosis emergence],” Zhonghua Jie He He Hu Xi Za Zhi, vol. 30, no. 6, pp. 403–405, Jun. 2007.
[7720]	A. Bhagyalaxmi, S. Jain, P. Patel, and D. Barot, “Reasons for the delay in the initiation of treatment and initial default among drug-resistant tuberculosis patients in Ahmedabad corporation area,” Indian J Public Health, vol. 63, no. 4, pp. 377–379, Dec. 2019, doi: 10.4103/ijph.IJPH_26_19.
[7721]	V. Weisbecker and A. Goswami, “Reassessing the relationship between brain size, life history, and metabolism at the marsupial/placental dichotomy,” Zool. Sci., vol. 31, no. 9, pp. 608–612, Sep. 2014, doi: 10.2108/zs140022.
[7722]	Z. Taylor and K. Miller, “Reassessment of brain elasticity for analysis of biomechanisms of hydrocephalus,” J Biomech, vol. 37, no. 8, pp. 1263–1269, Aug. 2004, doi: 10.1016/j.jbiomech.2003.11.027.
[7723]	Y. Shao and W. Le, “Recent advances and perspectives of metabolomics-based investigations in Parkinson’s disease,” Mol Neurodegener, vol. 14, no. 1, p. 3, 11 2019, doi: 10.1186/s13024-018-0304-2.
[7724]	J. Yu, G. Gu, and S. Ju, “Recent advances in clinical applications of circulating cell-free DNA integrity,” Lab Med, vol. 45, no. 1, pp. 6–11, 2014, doi: 10.1309/lmkkox6ujzqgw0ea.
[7725]	A. B. Dixit, J. Banerjee, P. S. Chandra, and M. Tripathi, “Recent advances in Epilepsy Research in India,” Neurol India, vol. 65, no. Supplement, pp. S83–S92, 2017, doi: 10.4103/neuroindia.NI_1070_16.
[7726]	G. Romano, P. P. Claudio, H. E. Kaiser, and A. Giordano, “Recent advances, prospects and problems in designing new strategies for oligonucleotide and gene delivery in therapy,” In Vivo, vol. 12, no. 1, pp. 59–67, Feb. 1998.
[7727]	J. L. Shaker, C. Albert, J. Fritz, and G. Harris, “Recent developments in osteogenesis imperfecta,” F1000Res, vol. 4, no. F1000 Faculty Rev, p. 681, 2015, doi: 10.12688/f1000research.6398.1.
[7728]	J. C. Becerra, L. S. Bildstein, and J. S. Gach, “Recent Insights into the HIV/AIDS Pandemic,” Microb Cell, vol. 3, no. 9, pp. 451–475, Sep. 2016, doi: 10.15698/mic2016.09.529.
[7729]	X. Zhao and S.-G. Yan, “Recent progress in osteogenesis imperfecta,” Orthop Surg, vol. 3, no. 2, pp. 127–130, May 2011, doi: 10.1111/j.1757-7861.2011.00128.x.
[7730]	P. Moore, Q. Zhang, and A. Alothman, “Recent results on modelling the spatial and temporal structure of the Earth’s gravity field,” Philos Trans A Math Phys Eng Sci, vol. 364, no. 1841, pp. 1009–1026, Apr. 2006, doi: 10.1098/rsta.2006.1751.
[7731]	B. S. Hong and T. Y. Ahn, “Recent trends in the treatment of testosterone deficiency syndrome,” Int. J. Urol., vol. 14, no. 11, pp. 981–985, Nov. 2007, doi: 10.1111/j.1442-2042.2007.01882.x.
[7732]	K. E. Kolaczynska, D. Luethi, D. Trachsel, M. C. Hoener, and M. E. Liechti, “Receptor Interaction Profiles of 4-Alkoxy-Substituted 2,5-Dimethoxyphenethylamines and Related Amphetamines,” Front Pharmacol, vol. 10, p. 1423, 2019, doi: 10.3389/fphar.2019.01423.
[7733]	U. Hellström, P. Perlmann, E. S. Robertsson, and S. Hammarström, “Receptors for Helix pomatia A haemagglutinin (HP) on a subpopulation of human B cells,” Scand. J. Immunol., vol. 7, no. 3, pp. 191–197, Mar. 1978, doi: 10.1111/j.1365-3083.1978.tb00443.x.
[7734]	M. Rohrbach and C. Giunta, “Recessive osteogenesis imperfecta: clinical, radiological, and molecular findings,” Am J Med Genet C Semin Med Genet, vol. 160C, no. 3, pp. 175–189, Aug. 2012, doi: 10.1002/ajmg.c.31334.
[7735]	X. Yang et al., “Recharge and groundwater use in the North China Plain for six irrigated crops for an eleven year period,” PLoS ONE, vol. 10, no. 1, p. e0115269, 2015, doi: 10.1371/journal.pone.0115269.
[7736]	C. Li and L.-K. Ju, “Reclamation of wastewater organics via two-stage growth of bacteria-then-oleaginous phagotrophic algae,” Bioprocess Biosyst Eng, vol. 41, no. 12, pp. 1757–1766, Dec. 2018, doi: 10.1007/s00449-018-1998-9.
[7737]	G. Pappas, P. Panagopoulou, and N. Akritidis, “Reclassifying bioterrorism risk: are we preparing for the proper pathogens?,” J Infect Public Health, vol. 2, no. 2, pp. 55–61, 2009, doi: 10.1016/j.jiph.2009.03.002.
[7738]	L. M. Martin, K. C. Fleming, and J. M. Evans, “Recognition and management of anxiety and depression in elderly patients,” Mayo Clin. Proc., vol. 70, no. 10, pp. 999–1006, Oct. 1995, doi: 10.4065/70.10.999.
[7739]	H. Wang et al., “Recognizing Brain States Using Deep Sparse Recurrent Neural Network,” IEEE Trans Med Imaging, vol. 38, no. 4, pp. 1058–1068, 2019, doi: 10.1109/TMI.2018.2877576.
[7740]	E. A. Bruckbauer, “Recognizing poststroke depression,” Rehabil Nurs, vol. 16, no. 1, pp. 34–36, Feb. 1991, doi: 10.1002/j.2048-7940.1991.tb01170.x.
[7741]	A. Parket, O. Inbar, and M. Kupiec, “Recombination of Ty elements in yeast can be induced by a double-strand break,” Genetics, vol. 140, no. 1, pp. 67–77, May 1995.
[7742]	M. Fabra, A. Stevens, and T. Merten, “[Recommendations for independent medical examinations of PTSD claimants],” Versicherungsmedizin, vol. 61, no. 3, pp. 111–117, Sep. 2009.
[7743]	“Recommended composition of influenza virus vaccines for use in the 2016–2017 northern hemisphere influenza season,” Wkly. Epidemiol. Rec., vol. 91, no. 10, pp. 121–132, Mar. 2016.
[7744]	“Recommended composition of influenza virus vaccines for use in the 2017 southern hemisphere influenza season,” Wkly. Epidemiol. Rec., vol. 91, no. 41, pp. 469–484, Oct. 2016.
[7745]	“Recommended composition of influenza virus vaccines for use in the 2017–2018 northern hemisphere influenza season,” Wkly. Epidemiol. Rec., vol. 92, no. 11, pp. 117–128, 17 2017.
[7746]	“Recommended composition of influenza virus vaccines for use in the 2018 southern hemisphere influenza season,” Wkly. Epidemiol. Rec., vol. 92, no. 42, pp. 625–633, 20 2017.
[7747]	“Recommended composition of influenza virus vaccines for use in the 2018–2019 northern hemisphere influenza season,” Wkly. Epidemiol. Rec., vol. 93, no. 12, pp. 133–141, Mar. 2018.
[7748]	H. Olbrich, C. Slabik, and R. Stripecke, “Reconstructing the immune system with lentiviral vectors,” Virus Genes, vol. 53, no. 5, pp. 723–732, Oct. 2017, doi: 10.1007/s11262-017-1495-2.
[7749]	P. Chanchay, W. Vongsangnak, A. Thancharoen, and A. Sriboonlert, “Reconstruction of insect hormone pathways in an aquatic firefly, Sclerotia aquatilis (Coleoptera: Lampyridae), using RNA-seq,” PeerJ, vol. 7, p. e7428, 2019, doi: 10.7717/peerj.7428.
[7750]	C. Chen, P. Tang, and X. Zhang, “Reconstruction of proper digital nerve defects in the thumb using a pedicle nerve graft,” Plast. Reconstr. Surg., vol. 130, no. 5, pp. 1089–1097, Nov. 2012, doi: 10.1097/PRS.0b013e318267d56b.
[7751]	A. Paré, A. Bossard, B. Laure, P. Weiss, O. Gauthier, and P. Corre, “Reconstruction of segmental mandibular defects: Current procedures and perspectives,” Laryngoscope Investig Otolaryngol, vol. 4, no. 6, pp. 587–596, Dec. 2019, doi: 10.1002/lio2.325.
[7752]	N. Jovanovic, A. L. Carniciu, W. W. Russell, A. Jarocki, and A. Kahana, “Reconstruction of the Orbit and Anophthalmic Socket Using the Dermis Fat Graft: A Major Review,” Ophthalmic Plast Reconstr Surg, Mar. 2020, doi: 10.1097/IOP.0000000000001610.
[7753]	N. Goyal, D. G. Deschler, and K. S. Emerick, “Reconstruction of total parotidectomy defects with a de-epithelialized submental flap,” Laryngoscope Investig Otolaryngol, vol. 4, no. 2, pp. 222–226, Apr. 2019, doi: 10.1002/lio2.258.
[7754]	M. Miller-Perusse, K. J. Horvath, T. Chavanduka, and R. Stephenson, “Recruitment and Enrollment of a National Sample of Transgender Youth via Social Media: Experiences from Project Moxie,” Transgend Health, vol. 4, no. 1, pp. 157–161, 2019, doi: 10.1089/trgh.2018.0062.
[7755]	P. G. Signorile, M. Campioni, B. Vincenzi, A. D’Avino, and A. Baldi, “Rectovaginal septum endometriosis: an immunohistochemical analysis of 62 cases,” In Vivo, vol. 23, no. 3, pp. 459–464, Jun. 2009.
[7756]	E. C. Dickerson et al., “Recurrence of Colonic Diverticulitis: Identifying Predictive CT Findings-Retrospective Cohort Study,” Radiology, vol. 285, no. 3, pp. 850–858, 2017, doi: 10.1148/radiol.2017161374.
[7757]	P. Kin Cho Goon, L.-U. Scholtz, and H. Sudhoff, “Recurrent respiratory papillomatosis (RRP)-time for a reckoning?,” Laryngoscope Investig Otolaryngol, vol. 2, no. 4, pp. 184–186, 2017, doi: 10.1002/lio2.80.
[7758]	A. Eliseyev et al., “Recursive Exponentially Weighted N-way Partial Least Squares Regression with Recursive-Validation of Hyper-Parameters in Brain-Computer Interface Applications,” Sci Rep, vol. 7, no. 1, p. 16281, 24 2017, doi: 10.1038/s41598-017-16579-9.
[7759]	P. Yadav, C. J. Jie, S. Tan, and M. Srinivasan, “Recycling of cathode from spent lithium iron phosphate batteries,” J. Hazard. Mater., vol. 399, p. 123068, May 2020, doi: 10.1016/j.jhazmat.2020.123068.
[7760]	A. P. George, C. E. Gaby, and R. A. Broughton, “Red chromonychia in Kawasaki disease,” Pediatr. Infect. Dis. J., vol. 34, no. 6, pp. 675–676, Jun. 2015, doi: 10.1097/INF.0000000000000689.
[7761]	A. Casadevall, L. Enquist, M. J. Imperiale, P. Keim, M. T. Osterholm, and D. A. Relman, “Redaction of sensitive data in the publication of dual use research of concern,” mBio, vol. 5, no. 1, pp. e00991-00913, Dec. 2013, doi: 10.1128/mBio.00991-13.
[7762]	D. Iacono, M. Geraci-Erck, H. Peng, M. L. Rabin, and R. Kurlan, “Reduced Number of Pigmented Neurons in the Substantia Nigra of Dystonia Patients? Findings from Extensive Neuropathologic, Immunohistochemistry, and Quantitative Analyses,” Tremor Other Hyperkinet Mov (N Y), vol. 5, 2015, doi: 10.7916/D8T72G9G.
[7763]	H. Noels et al., “Reduced post-operative DPP4 activity associated with worse patient outcome after cardiac surgery,” Sci Rep, vol. 8, no. 1, p. 11820, 07 2018, doi: 10.1038/s41598-018-30235-w.
[7764]	S. L. Andersen, B. Sweigart, P. Sebastiani, J. Drury, S. Sidlowski, and T. T. Perls, “Reduced Prevalence and Incidence of Cognitive Impairment Among Centenarian Offspring,” J. Gerontol. A Biol. Sci. Med. Sci., vol. 74, no. 1, pp. 108–113, 01 2019, doi: 10.1093/gerona/gly141.
[7765]	E. M. Fine, D. C. Delis, B. M. Paul, and J. V. Filoteo, “Reduced verbal fluency for proper names in nondemented patients with Parkinson’s disease: a quantitative and qualitative analysis,” J Clin Exp Neuropsychol, vol. 33, no. 2, pp. 226–233, Feb. 2011, doi: 10.1080/13803395.2010.507185.
[7766]	P. Gottesfeld, S. Tirima, S. M. Anka, A. Fotso, and M. M. Nota, “Reducing Lead and Silica Dust Exposures in Small-Scale Mining in Northern Nigeria,” Ann Work Expo Health, vol. 63, no. 1, pp. 1–8, 07 2019, doi: 10.1093/annweh/wxy095.
[7767]	B. Symon, M. Bammann, G. Crichton, C. Lowings, and J. Tucsok, “Reducing postnatal depression, anxiety and stress using an infant sleep intervention,” BMJ Open, vol. 2, no. 5, 2012, doi: 10.1136/bmjopen-2012-001662.
[7768]	S. Zirn, J. Angermeier, S. Arndt, A. Aschendorff, and T. Wesarg, “Reducing the Device Delay Mismatch Can Improve Sound Localization in Bimodal Cochlear Implant/Hearing-Aid Users,” Trends Hear, vol. 23, p. 2331216519843876, Dec. 2019, doi: 10.1177/2331216519843876.
[7769]	J. K. Hoang et al., “Reduction in Thyroid Nodule Biopsies and Improved Accuracy with American College of Radiology Thyroid Imaging Reporting and Data System,” Radiology, vol. 287, no. 1, pp. 185–193, Apr. 2018, doi: 10.1148/radiol.2018172572.
[7770]	C. F. Martino, L. Portelli, K. McCabe, M. Hernandez, and F. Barnes, “Reduction of the Earth’s magnetic field inhibits growth rates of model cancer cell lines,” Bioelectromagnetics, vol. 31, no. 8, pp. 649–655, Dec. 2010, doi: 10.1002/bem.20606.
[7771]	M. Baranowska-Kuczko et al., “Reduction of the serotonin 5-HT1B and 5-HT2A receptor-mediated contraction of human pulmonary artery by the combined 5-HT1B receptor antagonist and serotonin transporter inhibitor LY393558,” Pharmacol Rep, vol. 72, no. 3, pp. 756–762, Jun. 2020, doi: 10.1007/s43440-020-00105-2.
[7772]	X. Li, Y. Sun, X. Zhang, and J. Wang, “Reductions in gut microbiota‑derived metabolite trimethylamine N‑oxide in the circulation may ameliorate myocardial infarction‑induced heart failure in rats, possibly by inhibiting interleukin‑8 secretion,” Mol Med Rep, vol. 20, no. 1, pp. 779–786, Jul. 2019, doi: 10.3892/mmr.2019.10297.
[7773]	J. Honeyman-Buck, “Redundant Publication-How to Avoid Duplication,” J Digit Imaging, vol. 29, no. 1, pp. 1–2, Feb. 2016, doi: 10.1007/s10278-015-9851-z.
[7774]	J. A. Amado Señarís, “[Redundant publication: everyone against],” Acta Otorrinolaringol Esp, vol. 59, no. 2, pp. 45–46, Feb. 2008.
[7775]	M. S. Wiglusz, J. Landowski, L. Michalak, and W. J. Cubała, “Reevaluating the prevalence and diagnostic subtypes of depressive disorders in epilepsy,” Epilepsy Behav, vol. 53, pp. 15–19, Dec. 2015, doi: 10.1016/j.yebeh.2015.09.029.
[7776]	A. M. Schoenthaler, “Reexamining medication adherence in black patients with hypertension through the lens of the social determinants of health,” J Clin Hypertens (Greenwich), vol. 19, no. 10, pp. 1025–1027, 2017, doi: 10.1111/jch.13071.
[7777]	M. F. Armstrong, J. H. Conduff, J. E. Fenton, and D. H. Coelho, “Reference Errors in Otolaryngology-Head and Neck Surgery Literature,” Otolaryngol Head Neck Surg, vol. 159, no. 2, pp. 249–253, 2018, doi: 10.1177/0194599818772521.
[7778]	R. J. Leo, C. Sherry, and A. W. Jones, “Referral patterns and recognition of depression among African-American and Caucasian patients,” Gen Hosp Psychiatry, vol. 20, no. 3, pp. 175–182, May 1998, doi: 10.1016/s0163-8343(98)00019-x.
[7779]	M. Bachl, “[Reflection of increasing economizing],” Krankenpfl Soins Infirm, vol. 102, no. 8, pp. 14–17, 2009.
[7780]	D. M. Raymaker, “Reflections of a community-based participatory researcher from the intersection of disability advocacy, engineering, and the academy,” Action Res (Lond), vol. 15, no. 3, pp. 258–275, Sep. 2017, doi: 10.1177/1476750316636669.
[7781]	D. H. Molyneux and S. A. Ward, “Reflections on the Nobel Prize for Medicine 2015--The Public Health Legacy and Impact of Avermectin and Artemisinin,” Trends Parasitol., vol. 31, no. 12, pp. 605–607, Dec. 2015, doi: 10.1016/j.pt.2015.10.008.
[7782]	F. R. Cassee, “Reflections on the scope and the future of Particle and Fibre Toxicology,” Part Fibre Toxicol, vol. 8, p. 13, Apr. 2011, doi: 10.1186/1743-8977-8-13.
[7783]	A. J. Formicola, “Reflections on the three-year program,” J Dent Educ, vol. 42, no. 10, pp. 572–575, Oct. 1978.
[7784]	M. M. Patnaik and A. Tefferi, “Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis (RARS-T): 2017 update on diagnosis, risk-stratification, and management,” Am. J. Hematol., vol. 92, no. 3, pp. 297–310, Mar. 2017, doi: 10.1002/ajh.24637.
[7785]	M. M. Patnaik and A. Tefferi, “Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis: ‘2019 Update on Diagnosis, Risk-stratification, and Management,’” Am. J. Hematol., vol. 94, no. 4, pp. 475–488, 2019, doi: 10.1002/ajh.25397.
[7786]	P. Striano, S. Striano, C. Minetti, and F. Zara, “Refractory, life-threatening status epilepticus in a 3-year-old girl,” Lancet Neurol, vol. 7, no. 3, pp. 278–284, Mar. 2008, doi: 10.1016/S1474-4422(08)70043-7.
[7787]	F. Ogata and N. Kawasaki, “Regeneration of Waste Edible Oil by the Use of Virgin and Calcined Magnesium Hydroxide as Adsorbents,” J Oleo Sci, vol. 65, no. 11, pp. 941–948, 2016, doi: 10.5650/jos.ess16040.
[7788]	T. A. Harrison, K. M. Perry, and D. B. Hoover, “Regional cardiac ganglia projections in the guinea pig heart studied by postmortem DiI tracing,” Anat Rec A Discov Mol Cell Evol Biol, vol. 285, no. 2, pp. 758–770, Aug. 2005, doi: 10.1002/ar.a.20213.
[7789]	K. Lilja, A. Prevodnik, J. Gardeström, T. Elfwing, M. Tedengren, and T. Bollner, “Regional differences in mRNA responses in blue mussels within the Baltic proper,” Comp. Biochem. Physiol. C Toxicol. Pharmacol., vol. 148, no. 2, pp. 101–106, Aug. 2008, doi: 10.1016/j.cbpc.2008.04.001.
[7790]	S.-Y. Wang, X. Yang, and C.-F. Shi, “[Regional eco-economic resilience of Changzhi city],” Ying Yong Sheng Tai Xue Bao, vol. 20, no. 7, pp. 1608–1612, Jul. 2009.
[7791]	Z. Yao, L. Wang, Q. Lu, H. Liu, and G. Teng, “Regional homogeneity in depression and its relationship with separate depressive symptom clusters: a resting-state fMRI study,” J Affect Disord, vol. 115, no. 3, pp. 430–438, Jun. 2009, doi: 10.1016/j.jad.2008.10.013.
[7792]	J. V. Tu et al., “Regional variations in ambulatory care and incidence of cardiovascular events,” CMAJ, vol. 189, no. 13, pp. E494–E501, Apr. 2017, doi: 10.1503/cmaj.160823.
[7793]	H. E. Zimmerman and T. Novak, “Regioselectivity of the tri-pi-methane rearrangement: mechanistic and exploratory organic photochemistry,” J. Org. Chem., vol. 68, no. 13, pp. 5056–5066, Jun. 2003, doi: 10.1021/jo034189j.
[7794]	R. E. Giunta et al., “[Registry Research Funding of the German Society of Plastic, Reconstructive and Aesthetic Surgeons (DGPRÄC) and Research Funding Report 2017/2018],” Handchir Mikrochir Plast Chir, vol. 50, no. 6, pp. 414–421, Dec. 2018, doi: 10.1055/a-0770-3485.
[7795]	O. Costerousse, J. Allegrini, H. Huang, J. Bounhik, and F. Alhenc-Gelas, “Regulation of ACE gene expression and plasma levels during rat postnatal development,” Am. J. Physiol., vol. 267, no. 5 Pt 1, pp. E745-753, Nov. 1994, doi: 10.1152/ajpendo.1994.267.5.E745.
[7796]	R. C. Gillis, B. J. Daley, B. L. Enderson, D. P. Kestler, and M. D. Karlstad, “Regulation of apoptosis in eicosapentaenoic acid-treated HL-60 cells,” J. Surg. Res., vol. 137, no. 1, pp. 141–150, Jan. 2007, doi: 10.1016/j.jss.2006.08.012.
[7797]	J. E. Kim et al., “Regulation of gastrointestinal hormones during laxative activity of gallotannin-enriched extract isolated from Galla Rhois in loperamide-induced constipation of SD rats,” Lab Anim Res, vol. 34, no. 4, pp. 223–231, Dec. 2018, doi: 10.5625/lar.2018.34.4.223.
[7798]	Y. Fukue et al., “Regulation of gonadotropin secretion and puberty onset by neuromedin U,” FEBS Lett., vol. 580, no. 14, pp. 3485–3488, Jun. 2006, doi: 10.1016/j.febslet.2006.05.025.
[7799]	L. Pengfei et al., “Regulation of Hormone-Related Genes in Ericerus pela (Hemiptera: Coccidae) for Dimorphic Metamorphosis,” J. Insect Sci., vol. 19, no. 5, Sep. 2019, doi: 10.1093/jisesa/iez092.
[7800]	V. J. Wroblewski, L. G. Harshman, T. N. Hanzlik, and B. D. Hammock, “Regulation of juvenile hormone esterase gene expression in the tobacco budworm (Heliothis virescens),” Arch. Biochem. Biophys., vol. 278, no. 2, pp. 461–466, May 1990, doi: 10.1016/0003-9861(90)90285-7.
[7801]	J. T. Kim et al., “Regulation of Ketogenic Enzyme HMGCS2 by Wnt/β-catenin/PPARγ Pathway in Intestinal Cells,” Cells, vol. 8, no. 9, 19 2019, doi: 10.3390/cells8091106.
[7802]	T. Lischetti and J. Nilsson, “Regulation of mitotic progression by the spindle assembly checkpoint,” Mol Cell Oncol, vol. 2, no. 1, p. e970484, Mar. 2015, doi: 10.4161/23723548.2014.970484.
[7803]	D. L. McCue, J. M. Kasper, and J. D. Hommel, “Regulation of motivation for food by neuromedin U in the paraventricular nucleus and the dorsal raphe nucleus,” Int J Obes (Lond), vol. 41, no. 1, pp. 120–128, 2017, doi: 10.1038/ijo.2016.178.
[7804]	N. Kanda and S. Watanabe, “Regulatory roles of adenylate cyclase and cyclic nucleotide phosphodiesterases 1 and 4 in interleukin-13 production by activated human T cells,” Biochem. Pharmacol., vol. 62, no. 4, pp. 495–507, Aug. 2001, doi: 10.1016/s0006-2952(01)00688-8.
[7805]	N. Kanda and S. Watanabe, “Regulatory roles of sex hormones in cutaneous biology and immunology,” J. Dermatol. Sci., vol. 38, no. 1, pp. 1–7, Apr. 2005, doi: 10.1016/j.jdermsci.2004.10.011.
[7806]	J. K. Haselkorn et al., “Rehabilitation in multiple sclerosis: Commentary on the recent AAN systematic review,” Neurol Clin Pract, vol. 7, no. 3, pp. 189–190, Jun. 2017, doi: 10.1212/01.CPJ.0000520916.56328.f5.
[7807]	A. Anell and U. Persson, “Reimbursement and clinical guidance for pharmaceuticals in Sweden: do health-economic evaluations support decision making?,” Eur J Health Econ, vol. 6, no. 3, pp. 274–279, Sep. 2005, doi: 10.1007/s10198-005-0301-6.
[7808]	M. E. Kelley, D. C. Lerman, W. W. Fisher, H. S. Roane, and A. N. Zangrillo, “Reinforcement delay fading during differential reinforcement of communication: the effects of signals on response maintenance,” J Exp Anal Behav, vol. 96, no. 1, pp. 107–122, Jul. 2011, doi: 10.1901/jeab.2011.96-107.
[7809]	J. Black, J. D. Belluzzi, and L. Stein, “Reinforcement delay of one second severely impairs acquisition of brain self-stimulation,” Brain Res., vol. 359, no. 1–2, pp. 113–119, Dec. 1985, doi: 10.1016/0006-8993(85)91418-0.
[7810]	T. Lahmer et al., “Relapsing polychondritis: An autoimmune disease with many faces,” Autoimmun Rev, vol. 9, no. 8, pp. 540–546, Jun. 2010, doi: 10.1016/j.autrev.2010.02.016.
[7811]	K. M. Tyo et al., “Relating Advanced Electrospun Fiber Architectures to the Temporal Release of Active Agents to Meet the Needs of Next-Generation Intravaginal Delivery Applications,” Pharmaceutics, vol. 11, no. 4, Apr. 2019, doi: 10.3390/pharmaceutics11040160.
[7812]	M. Al-Ghonaim, B. J. Manns, D. J. Hirsch, Z. Gao, M. Tonelli, and Alberta Kidney Disease Network, “Relation between access blood flow and mortality in chronic hemodialysis patients,” Clin J Am Soc Nephrol, vol. 3, no. 2, pp. 387–391, Mar. 2008, doi: 10.2215/CJN.03000707.
[7813]	J. L. Hébert, Y. Lecarpentier, K. Zamani, C. Coirault, G. Daccache, and D. Chemla, “Relation between aortic dicrotic notch pressure and mean aortic pressure in adults,” Am. J. Cardiol., vol. 76, no. 4, pp. 301–306, Aug. 1995, doi: 10.1016/s0002-9149(99)80086-1.
[7814]	M. Thyrault, J. L. Teboul, C. Richard, C. Coirault, Y. Lecarpentier, and D. Chemla, “Relation between dicrotic notch and mean pulmonary artery pressure studied by using a Swan-Ganz catheter in critically ill patients,” Intensive Care Med, vol. 24, no. 1, pp. 77–80, Jan. 1998, doi: 10.1007/s001340050519.
[7815]	D. Pang, S. C. Fu, and G. C. Yang, “Relation between exposure to respirable silica dust and silicosis in a tungsten mine in China,” Br J Ind Med, vol. 49, no. 1, pp. 38–40, Jan. 1992, doi: 10.1136/oem.49.1.38.
[7816]	F. Borda et al., “[Relation between preoperative prognostic Onodera’s Index and postsurgery complications in the R0 gastric carcinoma resection],” An Sist Sanit Navar, vol. 40, no. 1, pp. 67–75, Apr. 2017, doi: 10.23938/ASSN.0007.
[7817]	R. Bassleer, “[RELATION BETWEEN TOTAL DRY WEIGHT AND DESOXYRIBONUCLEIC ACID CONTENT IN THE NUCLEI OF NORMAL FIBROBLASTS CULTIVATED IN VITRO],” C. R. Seances Soc. Biol. Fil., vol. 157, pp. 2340–2342, 1963.
[7818]	H. H. Schmidt, S. Hill, E. V. Makariou, I. M. Feuerstein, K. A. Dugi, and J. M. Hoeg, “Relation of cholesterol-year score to severity of calcific atherosclerosis and tissue deposition in homozygous familial hypercholesterolemia,” Am. J. Cardiol., vol. 77, no. 8, pp. 575–580, Mar. 1996, doi: 10.1016/s0002-9149(97)89309-5.
[7819]	Z.-W. Hong et al., “Relation of size of seminal vesicles on ultrasound to premature ejaculation,” Asian J. Androl., vol. 19, no. 5, pp. 554–560, Oct. 2017, doi: 10.4103/1008-682X.186187.
[7820]	T. Tomoto, T. Imai, S. Ogoh, S. Maeda, and J. Sugawara, “Relationship between Aortic Compliance and Impact of Cerebral Blood Flow Fluctuation to Dynamic Orthostatic Challenge in Endurance Athletes,” Front Physiol, vol. 9, p. 25, 2018, doi: 10.3389/fphys.2018.00025.
[7821]	D. Bhutani et al., “Relationship between clostridium difficile infection and gastrointestinal graft versus host disease in recipients of allogeneic stem cell transplantation,” Bone Marrow Transplant., vol. 54, no. 1, pp. 164–167, 2019, doi: 10.1038/s41409-018-0270-x.
[7822]	M. G. Cardoso, M. Diniz-Freitas, P. Vázquez, S. Cerqueiro, P. Diz, and J. Limeres, “Relationship between functional masticatory units and cognitive impairment in elderly persons,” J Oral Rehabil, vol. 46, no. 5, pp. 417–423, May 2019, doi: 10.1111/joor.12763.
[7823]	E. Gavalas et al., “Relationship between Helicobacter pylori infection and multiple sclerosis,” Ann Gastroenterol, vol. 28, no. 3, pp. 353–356, Sep. 2015.
[7824]	A. Tuten et al., “Relationship between LPA SNPs and inflammatory burden in patients with preeclampsia to address future cardiovascular risk,” J. Matern. Fetal. Neonatal. Med., pp. 1–9, May 2019, doi: 10.1080/14767058.2019.1622667.
[7825]	H. Nagasawa, R. Konishi, T. Naito, S. Ohmiya, and T. Mori, “Relationship between mammary tumourigenesis and uterine adenomyosis in four strains of mice,” In Vivo, vol. 1, no. 4, pp. 237–240, Aug. 1987.
[7826]	S. V. Dangudubiyyam and O. J. Ginther, “Relationship between more follicles in right than left ovary in recently born calves and right ovary propensity for ovulation in cattle,” Reprod Biol, vol. 19, no. 4, pp. 363–367, Dec. 2019, doi: 10.1016/j.repbio.2019.09.005.
[7827]	R. P. Łysek et al., “Relationship between past myocardial infarction, periodontal disease and Porphyromonas gingivalis serum antibodies: A case-control study,” Cardiol J, vol. 25, no. 3, pp. 386–392, 2018, doi: 10.5603/CJ.a2017.0015.
[7828]	J. Zeni, F. Pozzi, S. Abujaber, and L. Miller, “Relationship between physical impairments and movement patterns during gait in patients with end-stage hip osteoarthritis,” J. Orthop. Res., vol. 33, no. 3, pp. 382–389, Mar. 2015, doi: 10.1002/jor.22772.
[7829]	H. Yoshihara, K. Hasegawa, M. Okamoto, S. Hatsushikano, and K. Watanabe, “Relationship between sagittal radiographic parameters and disability in patients with spinal disease using 3D standing analysis,” Orthop Traumatol Surg Res, vol. 104, no. 7, pp. 1017–1023, 2018, doi: 10.1016/j.otsr.2018.07.009.
[7830]	M. C. Petriello et al., “Relationship between serum trimethylamine N-oxide and exposure to dioxin-like pollutants,” Environ. Res., vol. 162, pp. 211–218, 2018, doi: 10.1016/j.envres.2018.01.007.
[7831]	S. Kudo, Y. Sakurai, T. Miwa, and Y. Matsuda, “Relationship between shoulder roll and hand propulsion in the front crawl stroke,” J Sports Sci, vol. 35, no. 10, pp. 945–952, May 2017, doi: 10.1080/02640414.2016.1206208.
[7832]	H. Sakamoto, T. Yajima, M. Nagata, T. Okumura, K. Suzuki, and Y. Ogawa, “Relationship between testicular size by ultrasonography and testicular function: measurement of testicular length, width, and depth in patients with infertility,” Int. J. Urol., vol. 15, no. 6, pp. 529–533, Jun. 2008, doi: 10.1111/j.1442-2042.2008.02071.x.
[7833]	K. Ito, B. Bayaraa, and S. Imafuku, “Relationship between the efficacy of biologics and clinical plaque psoriasis subtypes in Japanese patients: A single-center pilot study,” J. Dermatol., vol. 46, no. 12, pp. 1160–1165, Dec. 2019, doi: 10.1111/1346-8138.15089.
[7834]	W. Ishii, S. Komine-Aizawa, C. Takano, Y. Fujita, I. Morioka, and S. Hayakawa, “Relationship Between the Fecal Microbiota and Depression and Anxiety in Pediatric Patients With Orthostatic Intolerance,” Prim Care Companion CNS Disord, vol. 21, no. 2, Apr. 2019, doi: 10.4088/PCC.18m02401.
[7835]	I. C. S. Ribeiro, L. F. Kubrusly, P. A. N. Nassif, P. F. S. Ribeiro, R. de O. Veras, and A. Neppel, “RELATIONSHIP BETWEEN THE PRESENCE OF HELICOBACTER PYLORI WITH INFLAMMATORY ENDOSCOPIC CHANGES IN GASTRODUODENAL MUCOSA,” Arq Bras Cir Dig, vol. 29, no. 3, pp. 142–145, Sep. 2016, doi: 10.1590/0102-6720201600030004.
[7836]	H. Zou, G. Wu, J. Lv, and G. Xu, “Relationship of angiotensin I-converting enzyme (ACE) and bradykinin B2 receptor (BDKRB2) polymorphism with diabetic nephropathy,” Biochim Biophys Acta Mol Basis Dis, vol. 1863, no. 6, pp. 1264–1272, 2017, doi: 10.1016/j.bbadis.2017.04.002.
[7837]	J. J. Popma et al., “Relationship of Annular Sizing Using Multidetector Computed Tomographic Imaging and Clinical Outcomes After Self-Expanding CoreValve Transcatheter Aortic Valve Replacement,” Circ Cardiovasc Interv, vol. 9, no. 7, 2016, doi: 10.1161/CIRCINTERVENTIONS.115.003282.
[7838]	A. Frances et al., “Relationship of anxiety and depression,” Psychopharmacology (Berl.), vol. 106 Suppl, pp. S82-86, 1992, doi: 10.1007/BF02246243.
[7839]	R. G. Kathol and F. Petty, “Relationship of depression to medical illness. A critical review,” J Affect Disord, vol. 3, no. 2, pp. 111–121, Jun. 1981, doi: 10.1016/0165-0327(81)90036-7.
[7840]	J. R. Sharkey, C. M. Johnson, and W. R. Dean, “Relationship of household food insecurity to health-related quality of life in a large sample of rural and urban women,” Women Health, vol. 51, no. 5, pp. 442–460, Jul. 2011, doi: 10.1080/03630242.2011.584367.
[7841]	K. J. Meador, A. Boyd, and D. W. Loring, “Relationship of Reaction Time to Perception of a Stimulus and Volitionally Delayed Response,” Cogn Behav Neurol, vol. 30, no. 2, pp. 57–61, 2017, doi: 10.1097/WNN.0000000000000121.
[7842]	T.-Y. Han, Z.-L. Li, and H.-M. Ye, “[Relationship of the disease severity with ACE gene polymorphism and serum ACE activity in preterm infants],” Zhongguo Dang Dai Er Ke Za Zhi, vol. 10, no. 6, pp. 693–696, Dec. 2008.
[7843]	C. Mussolin, R. Martin, and C. Schiltz, “Relationships between number and space processing in adults with and without dyscalculia,” Acta Psychol (Amst), vol. 138, no. 1, pp. 193–203, Sep. 2011, doi: 10.1016/j.actpsy.2011.06.004.
[7844]	D. Huang and H. Guo, “Relationships between odor properties and determination of odor concentration limits in odor impact criteria for poultry and dairy barns,” Sci. Total Environ., vol. 630, pp. 1484–1491, Jul. 2018, doi: 10.1016/j.scitotenv.2018.02.318.
[7845]	S. Krisdapong, P. Prasertsom, K. Rattanarangsima, and A. Sheiham, “Relationships between oral diseases and impacts on Thai schoolchildren’s quality of life: evidence from a Thai national oral health survey of 12- and 15-year-olds,” Community Dent Oral Epidemiol, vol. 40, no. 6, pp. 550–559, Dec. 2012, doi: 10.1111/j.1600-0528.2012.00705.x.
[7846]	K. Suzuki et al., “Relationships of serum haptoglobin concentration with HbA1c and glycated albumin concentrations in Japanese type 2 diabetic patients,” Clin. Chem. Lab. Med., vol. 47, no. 1, pp. 70–74, 2009, doi: 10.1515/CCLM.2009.022.
[7847]	F. Sayol, L. Lefebvre, and D. Sol, “Relative Brain Size and Its Relation with the Associative Pallium in Birds,” Brain Behav. Evol., vol. 87, no. 2, pp. 69–77, 2016, doi: 10.1159/000444670.
[7848]	E. Armstrong, “Relative brain size in monkeys and prosimians,” Am. J. Phys. Anthropol., vol. 66, no. 3, pp. 263–273, Mar. 1985, doi: 10.1002/ajpa.1330660303.
[7849]	E. Nakamura et al., “Relative contributions of 5-hydroxytryptamine (5-HT) receptor subtypes in 5-HT-induced vasoconstriction of the distended human saphenous vein as a coronary artery bypass graft,” Biol. Pharm. Bull., vol. 34, no. 1, pp. 82–86, 2011, doi: 10.1248/bpb.34.82.
[7850]	P. J. Conn and E. Sanders-Bush, “Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT-2 and 5-HT-1c) receptors,” J. Pharmacol. Exp. Ther., vol. 242, no. 2, pp. 552–557, Aug. 1987.
[7851]	M. Ito and M. Oyama, “Relative sensitivity to reinforcer amount and delay in a self-control choice situation,” J Exp Anal Behav, vol. 66, no. 2, pp. 219–229, Sep. 1996, doi: 10.1901/jeab.1996.66-219.
[7852]	I. J. General and H. Meirovitch, “Relative stability of the open and closed conformations of the active site loop of streptavidin,” J Chem Phys, vol. 134, no. 2, p. 025104, Jan. 2011, doi: 10.1063/1.3521267.
[7853]	C. Ross Schmidtlein et al., “Relaxed ordered subset preconditioned alternating projection algorithm for PET reconstruction with automated penalty weight selection,” Med Phys, vol. 44, no. 8, pp. 4083–4097, Aug. 2017, doi: 10.1002/mp.12292.
[7854]	A. H. Criss, C. Salomão, K. J. Malmberg, W. Aue, A. Kılıç, and M. Claridge, “Release from output interference in recognition memory: A test of the attention hypothesis,” Q J Exp Psychol (Hove), vol. 71, no. 5, pp. 1081–1089, May 2018, doi: 10.1080/17470218.2017.1310265.
[7855]	M. Zarà et al., “Release of Prometastatic Platelet-Derived Microparticles Induced by Breast Cancer Cells: A Novel Positive Feedback Mechanism for Metastasis,” TH Open, vol. 1, no. 2, pp. e155–e163, Jul. 2017, doi: 10.1055/s-0037-1613674.
[7856]	S.-Y. Park et al., “Relevance of Colonic Gas Analysis and Transit Study in Patients With Chronic Constipation,” J Neurogastroenterol Motil, vol. 21, no. 3, pp. 433–439, Jul. 2015, doi: 10.5056/jnm14109.
[7857]	M. G. Kiuchi et al., “Relevance of Targeting the Distal Renal Artery and Branches with Radiofrequency Renal Denervation Approaches-A Secondary Analysis from a Hypertensive CKD Patient Cohort,” J Clin Med, vol. 8, no. 5, Apr. 2019, doi: 10.3390/jcm8050581.
[7858]	N. E. Carlozzi and P. J. Long, “Reliability and validity of the SCL-90-R PTSD subscale,” J Interpers Violence, vol. 23, no. 9, pp. 1162–1176, Sep. 2008, doi: 10.1177/0886260508314295.
[7859]	M. Bednar, “Reliability of the Etest in light of the correlation between an antibiotic’s critical concentration (Cc) and MIC values,” Pol. J. Microbiol., vol. 56, no. 3, pp. 165–168, 2007.
[7860]	K. A. King, A. Topalian, and R. A. Vidourek, “Religiosity and Adolescent Major Depressive Episodes Among 12-17-Year-Olds,” J Relig Health, Jan. 2019, doi: 10.1007/s10943-019-00766-1.
[7861]	N. Tsilimparis, A. Dayama, and J. J. Ricotta, “Remodeling of aortic aneurysm and aortic neck on follow-up after endovascular repair with suprarenal fixation,” J. Vasc. Surg., vol. 61, no. 1, pp. 28–34, Jan. 2015, doi: 10.1016/j.jvs.2014.06.104.
[7862]	J. Zhang, H. Zhao, H. Cao, H. Li, and Z. Li, “Removal of Cd2+ from water by Friedel’s salt (FS: 3CaO x A12O3 x CaCI2 x 10H2O): sorption characteristics and mechanisms,” J Environ Sci (China), vol. 25, no. 9, pp. 1719–1725, Sep. 2013, doi: 10.1016/s1001-0742(12)60287-3.
[7863]	M.-W. Shen, C.-Y. Yan, H.-C. Chen, and S.-T. Chen, “Removal of heavy oil using rhinoceros beetle, Oryctes rhinoceros,” J. Environ. Manage., vol. 249, p. 109418, Nov. 2019, doi: 10.1016/j.jenvman.2019.109418.
[7864]	J. Ma, J. Zhang, and D. Li, “Removal of methylene blue by lava adsorption and catalysis oxidation,” Environ Technol, vol. 31, no. 3, pp. 267–276, Mar. 2010, doi: 10.1080/09593330903453244.
[7865]	M.-B. Chang, Y.-C. Hsu, and S.-H. Chang, “Removal of PCDD/Fs, PCP and mercury from sediments: Thermal oxidation versus pyrolysis,” Chemosphere, vol. 207, pp. 10–17, Sep. 2018, doi: 10.1016/j.chemosphere.2018.05.037.
[7866]	S. Mizuiri et al., “Renal ACE immunohistochemical localization in NIDDM patients with nephropathy,” Am. J. Kidney Dis., vol. 31, no. 2, pp. 301–307, Feb. 1998, doi: 10.1053/ajkd.1998.v31.pm9469501.
[7867]	W. Kong, T. N. Haschler, B. Nürnberg, S. Krämer, M. Gollasch, and L. Markó, “Renal Fibrosis, Immune Cell Infiltration and Changes of TRPC Channel Expression after Unilateral Ureteral Obstruction in Trpc6-/- Mice,” Cell. Physiol. Biochem., vol. 52, no. 6, pp. 1484–1502, 2019, doi: 10.33594/000000103.
[7868]	J. Wallace, H. White, J. Eastman, S. Augsburger, X. Ma, and J. Walker, “Reoccurrence rate in Ponseti treated clubfeet: A meta-regression,” Foot (Edinb), vol. 40, pp. 59–63, Sep. 2019, doi: 10.1016/j.foot.2019.03.002.
[7869]	H. Wang et al., “[Repair of digital volar complex soft tissue defect with heterodigital antegrade digital artery island flap innervated by digital nerve],” Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, vol. 33, no. 11, pp. 1429–1432, Nov. 2019, doi: 10.7507/1002-1892.201903001.
[7870]	E. S. De Lustig and F. Sacerdote, “[Repair of wounds in tissues cultivated in different media in vitro],” Publ B Aires Cent Investig, vol. 18, pp. 241–247, 1955 1954.
[7871]	P. Saranjampour and K. Armbrust, “Repeatability of n-octanol/water partition coefficient values between liquid chromatography measurement methods,” Environ Sci Pollut Res Int, vol. 25, no. 15, pp. 15111–15119, May 2018, doi: 10.1007/s11356-018-1729-4.
[7872]	M. Szlachta et al., “Repeated Clozapine Increases the Level of Serotonin 5-HT1AR Heterodimerization with 5-HT2A or Dopamine D2 Receptors in the Mouse Cortex,” Front Mol Neurosci, vol. 11, p. 40, 2018, doi: 10.3389/fnmol.2018.00040.
[7873]	S.-C. P. Sun, J. Garcia, and J. A. Hayden, “Repeating Critical Hematology and Coagulation Values Wastes Resources, Lengthens Turnaround Time, and Delays Clinical Action,” Am. J. Clin. Pathol., vol. 149, no. 3, pp. 247–252, Feb. 2018, doi: 10.1093/ajcp/aqx156.
[7874]	C. Johnson, “Repetitive, duplicate, and redundant publications: a review for authors and readers,” J Manipulative Physiol Ther, vol. 29, no. 7, pp. 505–509, Sep. 2006, doi: 10.1016/j.jmpt.2006.07.001.
[7875]	B. Marcic, P. A. Deddish, R. A. Skidgel, E. G. Erdös, R. D. Minshall, and F. Tan, “Replacement of the transmembrane anchor in angiotensin I-converting enzyme (ACE) with a glycosylphosphatidylinositol tail affects activation of the B2 bradykinin receptor by ACE inhibitors,” J. Biol. Chem., vol. 275, no. 21, pp. 16110–16118, May 2000, doi: 10.1074/jbc.M909490199.
[7876]	J. A. Lyon and V. S. Hinshaw, “Replication of influenza A viruses in an avian macrophage cell line,” J. Gen. Virol., vol. 72 ( Pt 8), pp. 2011–2013, Aug. 1991, doi: 10.1099/0022-1317-72-8-2011.
[7877]	K. C. Welch, “Reply (by Kevin Welch) to Zara Patel Correspondence,” Int Forum Allergy Rhinol, vol. 10, no. 5, pp. 589–590, May 2020, doi: 10.1002/alr.22584.
[7878]	Y.-E. S. Ju and D. M. Holtzman, “Reply to ‘obstructive sleep apnea treatment and amyloid-β in cerebrospinal fluid,’” Ann. Neurol., vol. 85, no. 3, pp. 460–461, 2019, doi: 10.1002/ana.25424.
[7879]	N. Del Papa et al., “Reply to J. Magalon et al,” Cell Transplant, vol. 24, no. 12, pp. 2669–2670, 2015, doi: 10.3727/096368915X688218.
[7880]	A. Brucato et al., “Reply to: ‘Effusive-constrictive pericarditis successfully treated with anakinra’ G. Lazaros et al. Interleukin-1β receptor antagonist and pericardial constriction,” Clin. Exp. Rheumatol., vol. 33, no. 6, p. 946, Dec. 2015.
[7881]	B. Lojanapiwat et al., “Report of the third Asian Prostate Cancer study meeting,” Prostate Int, vol. 7, no. 2, pp. 60–67, Jun. 2019, doi: 10.1016/j.prnil.2018.06.001.
[7882]	S. Cabarkapa, M. Perera, K. Sikaris, J. S. O’Brien, D. M. Bolton, and N. Lawrentschuk, “Reporting and ideal testosterone levels in men undergoing androgen deprivation for prostate cancer-time for a rethink?,” Prostate Int, vol. 6, no. 1, pp. 1–6, Mar. 2018, doi: 10.1016/j.prnil.2017.05.003.
[7883]	N. Nikolov, V. Grancharov, G. Stoyanova, T. Pavlov, and O. Mekenyan, “Representation of chemical information in OASIS centralized 3D database for existing chemicals,” J Chem Inf Model, vol. 46, no. 6, pp. 2537–2551, Dec. 2006, doi: 10.1021/ci060142y.
[7884]	J. Hirt, C. Buhtz, B. Mersdorf, and G. Meyer, “Representation of Nursing Scientists from German-speaking countries in High Impact Journals. A bibliometric publication analysis,” Pflege, vol. 31, no. 1, pp. 31–39, 2018, doi: 10.1024/1012-5302/a000593.
[7885]	U. Borate, B. A. Norris, A. Statler, R. Fu, T. Bucy, and M. A. Sekeres, “Representation of therapy-related myelodysplastic syndrome in clinical trials over the past 20 years,” Blood Adv, vol. 3, no. 18, pp. 2738–2747, 24 2019, doi: 10.1182/bloodadvances.2019000293.
[7886]	L. Zhytnik, K. Simm, A. Salumets, M. Peters, A. Märtson, and K. Maasalu, “Reproductive options for families at risk of Osteogenesis Imperfecta: a review,” Orphanet J Rare Dis, vol. 15, no. 1, p. 128, May 2020, doi: 10.1186/s13023-020-01404-w.
[7887]	C. M. O. Kapel, P. R. Torgerson, R. C. A. Thompson, and P. Deplazes, “Reproductive potential of Echinococcus multilocularis in experimentally infected foxes, dogs, raccoon dogs and cats,” Int. J. Parasitol., vol. 36, no. 1, pp. 79–86, Jan. 2006, doi: 10.1016/j.ijpara.2005.08.012.
[7888]	K. Chonabayashi, Y. Yoshida, and A. Takaori-Kondo, “Reprogramming technology reveals genetic and functional diversity of subclones in myelodysplastic syndromes,” Rinsho Ketsueki, vol. 58, no. 7, pp. 787–791, 2017, doi: 10.11406/rinketsu.58.787.
[7889]	Z. Wu et al., “Repurposing of Fruit Peel Waste as a Green Reductant for Recycling of Spent Lithium-Ion Batteries,” Environ. Sci. Technol., vol. 54, no. 15, pp. 9681–9692, Aug. 2020, doi: 10.1021/acs.est.0c02873.
[7890]	E. M. Bordewijk, F. Mol, F. van der Veen, and M. Van Wely, “Required amount of rFSH, HP-hMG and HP-FSH to reach a live birth: a systematic review and meta-analysis,” Hum Reprod Open, vol. 2019, no. 3, p. hoz008, 2019, doi: 10.1093/hropen/hoz008.
[7891]	E. Turner and J. Bolton, “Required steps for the validation of a Laboratory Information Management System,” Qual Assur, vol. 9, no. 3–4, pp. 217–224, Dec. 2001, doi: 10.1080/713844028.
[7892]	E. K. Covan, “Research about mental health issues,” Health Care Women Int, vol. 31, no. 2, p. 99, Feb. 2010, doi: 10.1080/07399330903543465.
[7893]	C. Y. May and K. Nesaretnam, “Research advancements in palm oil nutrition,” Eur J Lipid Sci Technol, vol. 116, no. 10, pp. 1301–1315, Oct. 2014, doi: 10.1002/ejlt.201400076.
[7894]	Y. Diao and T. Pei, “[Research advances in dynamic mechanism and its simulation of eco-hydrological process in forest catchment],” Ying Yong Sheng Tai Xue Bao, vol. 15, no. 12, pp. 2369–2376, Dec. 2004.
[7895]	F. Liu, H.-H. Teng, B.-X. Ren, and S.-Y. Shi, “[Research advances in eco-toxicological diagnosis of soil pollution],” Ying Yong Sheng Tai Xue Bao, vol. 25, no. 9, pp. 2733–2744, Sep. 2014.
[7896]	F. Wissing and L. Bruckner-Tuderman, “[Research funding for rare diseases in Germany],” Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, vol. 60, no. 5, pp. 550–555, May 2017, doi: 10.1007/s00103-017-2532-y.
[7897]	G. Adler and J. von dem Knesebeck, “[Research funding of university medicine by the BMBF, DFG, and EU],” Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, vol. 52, no. 9, pp. 917–924, Sep. 2009, doi: 10.1007/s00103-009-0925-2.
[7898]	G. Abbatiello, G. Abbilello, and P. Rosenfeld, “Research on cognitive impairment in community and home settings,” Home Healthc Nurse, vol. 31, no. 2, pp. 104–110, Feb. 2013, doi: 10.1097/NHH.0b013e31827f4635.
[7899]	A. Ghisellini, “[RESEARCH ON THE DEVELOPMENT OF THE BONES OF MOUSE EXTREMITIES. STUDY IN VIVO AND IN ORGAN-TYPE CULTURE IN VITRO],” Arch Anat Microsc Morphol Exp, vol. 53, pp. 1–28, Mar. 1964.
[7900]	Z. Tang, G. Sun, M. Fu, C. Wen, and A. Plenković-Moraj, “Research on the Industrial Energy Eco-Efficiency Evolution Characteristics of the Yangtze River Economic Belt in the Temporal and Spatial Dimension, China,” Int J Environ Res Public Health, vol. 17, no. 1, 30 2019, doi: 10.3390/ijerph17010268.
[7901]	L. Talamo and P. Maceraudi, “[Research on the possibility of the use of non-silica sand in a foundry to prevent silicosis],” Med Lav, vol. 58, no. 5, pp. 345–363, May 1967.
[7902]	Y. Zhang and C.-K. Chang, “[Research progress in MDS mouse model- review],” Zhongguo Shi Yan Xue Ye Xue Za Zhi, vol. 20, no. 5, pp. 1272–1279, Oct. 2012.
[7903]	Y. Li, W. Zeng, and Q. Zhou, “[Research progress in water eco-functional regionalization],” Ying Yong Sheng Tai Xue Bao, vol. 20, no. 12, pp. 3101–3108, Dec. 2009.
[7904]	J. Wang and H. Gu, “[Research progress on genotyping of Helicobacter pylori],” Zhejiang Da Xue Xue Bao Yi Xue Ban, vol. 47, no. 1, pp. 97–103, Jan. 2018.
[7905]	L.-L. Wang, C. Gao, and B.-A. Chen, “[Research progress on mechanism of MDS transformation into AML],” Zhongguo Shi Yan Xue Ye Xue Za Zhi, vol. 19, no. 1, pp. 254–259, Feb. 2011.
[7906]	Y.-M. Hu, S. Cui, and L.-H. Ji, “[Research Progress on Role of Gene Mutations in Prognostic Evaluation of Patients with Myelodysplastic Syndrome after Stem-Cell Transplantation--Review],” Zhongguo Shi Yan Xue Ye Xue Za Zhi, vol. 27, no. 4, pp. 1330–1333, Aug. 2019, doi: 10.19746/j.cnki.issn.1009-2137.2019.04.056.
[7907]	Z. Wang, Y. Xu, and B. Suman, “Research status and development trend of ultrasonic oil production technique in China,” Ultrason Sonochem, vol. 26, pp. 1–8, Sep. 2015, doi: 10.1016/j.ultsonch.2015.01.014.
[7908]	T. S. Riall et al., “Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up,” Surgery, vol. 140, no. 5, pp. 764–772, Nov. 2006, doi: 10.1016/j.surg.2006.04.006.
[7909]	Y. Yasuda, P. N. Larsen, T. Ishibashi, K. Yamashita, and H. Toei, “Resection of hilar cholangiocarcinoma with left hepatectomy after pre-operative embolization of the proper hepatic artery,” HPB (Oxford), vol. 12, no. 2, pp. 147–152, Mar. 2010, doi: 10.1111/j.1477-2574.2009.00152.x.
[7910]	A. While, “Reset for health creation,” Br J Community Nurs, vol. 24, no. 9, p. 458, Sep. 2019, doi: 10.12968/bjcn.2019.24.9.458.
[7911]	T. R. Wanke, J. L. Brock, R. Basile, B. Merk, and J. Azizi, “Residual bioburden after standard cleaning of the reusable orthopedic depth gauge,” Am J Infect Control, vol. 46, no. 3, p. 362, Mar. 2018, doi: 10.1016/j.ajic.2017.10.022.
[7912]	A. Ilyas, K. M. Persson, and M. Persson, “Residual organic matter and microbial respiration in bottom ash: Effects on metal leaching and eco-toxicity,” Waste Manag Res, vol. 33, no. 9, pp. 805–811, Sep. 2015, doi: 10.1177/0734242X15585343.
[7913]	C. L. Olinger, R. D. Schmitt, and E. Zager, “Residue chemistry guidelines,” Qual Assur, vol. 2, no. 1–2, pp. 127–133, Jun. 1993.
[7914]	B. Ky, “Resiliency and Our Cardio-Oncology Community,” JACC CardioOncol, vol. 2, no. 2, pp. 343–344, Jun. 2020, doi: 10.1016/j.jaccao.2020.05.003.
[7915]	V. G. Martinez et al., “Resistance to HER2-targeted anti-cancer drugs is associated with immune evasion in cancer cells and their derived extracellular vesicles,” Oncoimmunology, vol. 6, no. 12, p. e1362530, 2017, doi: 10.1080/2162402X.2017.1362530.
[7916]	L. S. Nagamatsu, T. C. Handy, C. L. Hsu, M. Voss, and T. Liu-Ambrose, “Resistance training promotes cognitive and functional brain plasticity in seniors with probable mild cognitive impairment,” Arch. Intern. Med., vol. 172, no. 8, pp. 666–668, Apr. 2012, doi: 10.1001/archinternmed.2012.379.
[7917]	J. Sarkis, V. Vié, S. J. Winder, A. Renault, E. Le Rumeur, and J.-F. Hubert, “Resisting sarcolemmal rupture: dystrophin repeats increase membrane-actin stiffness,” FASEB J., vol. 27, no. 1, pp. 359–367, Jan. 2013, doi: 10.1096/fj.12-208967.
[7918]	M. S. Cappell, D. Singh, R. Sage, and M. B. Amin, “Resolution of Isolated, Aspergillus Colonization in a Deep Esophageal Ulcer in an Immunocompetent Patient with Ulcer Healing Without Specific Antifungal Therapy,” Dig. Dis. Sci., vol. 61, no. 8, pp. 2445–2450, 2016, doi: 10.1007/s10620-016-4101-x.
[7919]	A. Brucato, A. Valenti, A. Assolari, A. Calabrese, M. Imazio, and A. Martini, “Resolution of pericardial constriction with anakinra; possible role of C reactive protein,” Int. J. Cardiol., vol. 234, p. 150, 01 2017, doi: 10.1016/j.ijcard.2016.11.312.
[7920]	L. M. Petta, “Resonance Frequency Breathing Biofeedback to Reduce Symptoms of Subthreshold PTSD with an Air Force Special Tactics Operator: A Case Study,” Appl Psychophysiol Biofeedback, vol. 42, no. 2, pp. 139–146, Jun. 2017, doi: 10.1007/s10484-017-9356-2.
[7921]	K. Fitch, K. Iwasaki, and K. F. Villa, “Resource utilization and cost in a commercially insured population with schizophrenia,” Am Health Drug Benefits, vol. 7, no. 1, pp. 18–26, Jan. 2014.
[7922]	W. Ibn Saied et al., “Respective impact of implementation of prevention strategies, colonization with multiresistant bacteria and antimicrobial use on the risk of early- and late-onset VAP: An analysis of the OUTCOMEREA network,” PLoS ONE, vol. 12, no. 11, p. e0187791, 2017, doi: 10.1371/journal.pone.0187791.
[7923]	K. A. Mundt et al., “Respirable crystalline silica exposure-response evaluation of silicosis morbidity and lung cancer mortality in the German porcelain industry cohort,” J. Occup. Environ. Med., vol. 53, no. 3, pp. 282–289, Mar. 2011, doi: 10.1097/JOM.0b013e31820c2bff.
[7924]	K. T. Rew, “Respiratory Conditions Update: Foreword,” FP Essent, vol. 448, p. 2, Sep. 2016.
[7925]	G. H. Mills et al., “Respiratory muscle strength in Cushing’s syndrome,” Am. J. Respir. Crit. Care Med., vol. 160, no. 5 Pt 1, pp. 1762–1765, Nov. 1999, doi: 10.1164/ajrccm.160.5.9810028.
[7926]	M. Jevnikar et al., “Respiratory muscle training with enzyme replacement therapy improves muscle strength in late - onset Pompe disease,” Mol Genet Metab Rep, vol. 5, pp. 67–71, 2015, doi: 10.1016/j.ymgmr.2015.09.007.
[7927]	D. W. Schaal and M. N. Branch, “Responding of pigeons under variable-interval schedules of signaled-delayed reinforcement: effects of delay-signal duration,” J Exp Anal Behav, vol. 53, no. 1, pp. 103–121, Jan. 1990, doi: 10.1901/jeab.1990.53-103.
[7928]	N. D. Shah, V. M. Montori, H. M. Krumholz, K. Tu, G. C. Alexander, and C. A. Jackevicius, “Responding to an FDA warning--geographic variation in the use of rosiglitazone,” N. Engl. J. Med., vol. 363, no. 22, pp. 2081–2084, Nov. 2010, doi: 10.1056/NEJMp1011042.
[7929]	K. A. Murach, C. M. Dungan, C. A. Peterson, and J. J. McCarthy, “Response,” Exerc Sport Sci Rev, vol. 47, no. 4, p. 260, 2019, doi: 10.1249/JES.0000000000000197.
[7930]	P. Fenaux, “Response assessments in low-risk and high-risk myelodysplastic syndromes (MDS),” Semin. Oncol., vol. 32, no. 4 Suppl 5, pp. S11-15, Aug. 2005, doi: 10.1053/j.seminoncol.2005.06.016.
[7931]	M. C. Diamond, “Response of the brain to enrichment,” An. Acad. Bras. Cienc., vol. 73, no. 2, pp. 211–220, Jun. 2001, doi: 10.1590/s0001-37652001000200006.
[7932]	D. Zhao et al., “Response of the Trilaminar Retinal Vessel Network to Intraocular Pressure Elevation in Rat Eyes,” Invest. Ophthalmol. Vis. Sci., vol. 61, no. 2, p. 2, 07 2020, doi: 10.1167/iovs.61.2.2.
[7933]	J. Hollander-Rodriguez and J. E. DeVoe, “Response to ‘“Family Medicine’s Task in Population Health: Defining It and Owning It” Begins With the Community’ and ‘Family Medicine and Social Determinants,’” Fam Med, vol. 51, no. 5, pp. 446–447, 2019, doi: 10.22454/FamMed.2019.780575.
[7934]	M. Bradley Calobrace, “Response to ‘Textured Breast Implants and Spherical Capsular Contracture,’” Aesthet Surg J, vol. 38, no. 11, pp. NP180–NP181, 15 2018, doi: 10.1093/asj/sjy182.
[7935]	C. E. Collins et al., “Response to belimumab among patients with systemic lupus erythematosus in clinical practice settings: 24-month results from the OBSErve study in the USA,” Lupus Sci Med, vol. 3, no. 1, p. e000118, 2016, doi: 10.1136/lupus-2015-000118.
[7936]	P. Striano, F. Zara, and S. Striano, “Response to: ‘Cortical tremor or cortical pseudotremor?,’” Acta Neurol. Scand., vol. 112, no. 3, p. 204, Sep. 2005, doi: 10.1111/j.1600-0404.2005.00460.x.
[7937]	H. Wang et al., “Responses of detoxification enzymes in the midgut of Bombyx mori after exposure to low-dose of acetamiprid,” Chemosphere, vol. 251, p. 126438, Jul. 2020, doi: 10.1016/j.chemosphere.2020.126438.
[7938]	R. Pokrzywinski, A. M. Soliman, J. Chen, M. C. Snabes, H. S. Taylor, and K. S. Coyne, “Responsiveness Evaluation and Recommendation for Responder Thresholds for Endometriosis Health Profile-30: Analysis of Two Phase III Clinical Trials,” J Womens Health (Larchmt), vol. 29, no. 2, pp. 253–261, 2020, doi: 10.1089/jwh.2019.7788.
[7939]	S. Vahdat et al., “Resting-state brain and spinal cord networks in humans are functionally integrated,” PLoS Biol., vol. 18, no. 7, p. e3000789, 2020, doi: 10.1371/journal.pbio.3000789.
[7940]	J. Jeon, S. U. Lim, C.-H. Park, C.-H. Jun, S.-Y. Park, and J.-S. Rew, “Restoration of common bile duct diameter within 2 weeks after endoscopic stone retraction is a preventive factor for stone recurrence,” HBPD INT, vol. 17, no. 3, pp. 251–256, Jun. 2018, doi: 10.1016/j.hbpd.2018.03.014.
[7941]	J. Meng, N. P. Sweeney, B. Doreste, F. Muntoni, M. McClure, and J. Morgan, “Restoration of Functional Full-Length Dystrophin After Intramuscular Transplantation of Foamy Virus-Transduced Myoblasts,” Hum. Gene Ther., vol. 31, no. 3–4, pp. 241–252, 2020, doi: 10.1089/hum.2019.224.
[7942]	N. Madan and K. Pannu, “Restoration of maxillary anterior esthetics using lava all-ceramic fixed dental prostheses,” Int J Comput Dent, vol. 14, no. 1, pp. 47–53, 2011.
[7943]	K. D. P. Barnfather and P. A. Brunton, “Restoration of the upper dental arch using Lava all-ceramic crown and bridgework,” Br Dent J, vol. 202, no. 12, pp. 731–735, Jun. 2007, doi: 10.1038/BDJ.2007.534.
[7944]	W. J. Lynk, “Restraint of trade through hospital exclusive contracts: an economic appraisal of the legal theory,” J Health Polit Policy Law, vol. 9, no. 2, pp. 269–279, 1984, doi: 10.1215/03616878-9-2-269.
[7945]	D. Kaszeta, “Restrict use of riot-control chemicals,” Nature, vol. 573, no. 7772, pp. 27–29, 2019, doi: 10.1038/d41586-019-02594-5.
[7946]	C. Duan, N. C. do Nascimento, S. Calve, A. Cox, and M. P. Sivasankar, “Restricted Water Intake Adversely Affects Rat Vocal Fold Biology,” Laryngoscope, Jul. 2020, doi: 10.1002/lary.28881.
[7947]	“Results at 5 years of a controlled comparison of a 6-month and a standard 18-month regimen of chemotherapy for pulmonary tuberculosis,” Am. Rev. Respir. Dis., vol. 116, no. 1, pp. 3–8, Jul. 1977, doi: 10.1164/arrd.1977.116.1.3.
[7948]	S. R. Craig, H. L. Smith, and M. W. Short, “Results from a transitional-year program director survey: identifying crucial issues and concerns,” J Grad Med Educ, vol. 4, no. 1, pp. 28–33, Mar. 2012, doi: 10.4300/JGME-D-11-00172.1.
[7949]	H. Gerding, V. Loukopoulos, J. Riese, L. Hefner, and M. Timmermann, “Results of flexible ranibizumab treatment in age-related macular degeneration and search for parameters with impact on outcome,” Graefes Arch. Clin. Exp. Ophthalmol., vol. 249, no. 5, pp. 653–662, May 2011, doi: 10.1007/s00417-011-1636-6.
[7950]	B. E. Yuh et al., “Results of Phase 1 study on cytoreductive radical prostatectomy in men with newly diagnosed metastatic prostate cancer,” Prostate Int, vol. 7, no. 3, pp. 102–107, Sep. 2019, doi: 10.1016/j.prnil.2018.10.002.
[7951]	K. Okamoto et al., “Resuscitation and evaluation of non-beating hearts obtained from asphyxiated dogs via autoperfusing heart-lung circuit,” Ann Thorac Cardiovasc Surg, vol. 7, no. 6, pp. 341–345, Dec. 2001.
[7952]	J. K. Hansen and K. L. Rasmussen, “[Retained fetal bones in uterus],” Ugeskr. Laeg., vol. 165, no. 7, pp. 695–696, Feb. 2003.
[7953]	J. Yang, G. Deol, and N. Myangar, “Retention of o-cymen-5-ol and zinc on reconstructed human gingival tissue from a toothpaste formulation,” Int Dent J, vol. 61 Suppl 3, pp. 41–45, Aug. 2011, doi: 10.1111/j.1875-595X.2011.00048.x.
[7954]	J. McKimm and M. McLean, “Rethinking health professions’ education leadership: Developing ‘eco-ethical’ leaders for a more sustainable world and future,” Med Teach, vol. 42, no. 8, pp. 855–860, Aug. 2020, doi: 10.1080/0142159X.2020.1748877.
[7955]	F. M. Knaul, A. Langer, R. Atun, D. Rodin, J. Frenk, and R. Bonita, “Rethinking maternal health,” Lancet Glob Health, vol. 4, no. 4, pp. e227-228, Apr. 2016, doi: 10.1016/S2214-109X(16)00044-9.
[7956]	S. K. Abe, Y. Murakami, D. Morgan, and K. Shibuya, “Rethinking the global tracking system on development assistance to reproductive, maternal, newborn, and child health,” Lancet Glob Health, vol. 3, no. 7, pp. e350-351, Jul. 2015, doi: 10.1016/S2214-109X(15)00043-1.
[7957]	G. L. Romano et al., “Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7,” Sci Rep, vol. 10, no. 1, p. 3972, 04 2020, doi: 10.1038/s41598-020-60931-5.
[7958]	K. O’Reilly, S. J. Bailey, and M. A. Lane, “Retinoid-mediated regulation of mood: possible cellular mechanisms,” Exp. Biol. Med. (Maywood), vol. 233, no. 3, pp. 251–258, Mar. 2008, doi: 10.3181/0706-MR-158.
[7959]	K. Hwang and X. Wu, “Retracted or Withdrawn Publications in Journals Relating to Plastic Surgery,” J Craniofac Surg, vol. 29, no. 5, pp. 1114–1116, Jul. 2018, doi: 10.1097/SCS.0000000000004326.
[7960]	J. C. Samp, G. T. Schumock, and A. S. Pickard, “Retracted publications in the drug literature,” Pharmacotherapy, vol. 32, no. 7, pp. 586–595, Jul. 2012, doi: 10.1002/j.1875-9114.2012.01100.x.
[7961]	S. Kriss, G. Bertocci, M. Currie, A. Thompson, and V. Kriss, “Retraction Note to: Radiographic characteristics that delineate abusive from accidental skull fractures, including the significance of fracture extension to sutures,” Pediatr Radiol, vol. 50, no. 1, p. 150, 2020, doi: 10.1007/s00247-019-04581-4.
[7962]	P. Pratheeshkumar, Y.-O. Son, S. P. Divya, L. Wang, Z. Zhang, and X. Shi, “Retraction Note: Oncogenic transformation of human lung bronchial epithelial cells induced by arsenic involves ROS-dependent activation of STAT3-miR-21-PDCD4 mechanism,” Sci Rep, vol. 9, no. 1, p. 17001, 15 2019, doi: 10.1038/s41598-019-53858-z.
[7963]	J. Wang, J. C. Ku, N. M. Alotaibi, and J. T. Rutka, “Retraction of Neurosurgical Publications: A Systematic Review,” World Neurosurg, vol. 103, pp. 809-814.e1, Jul. 2017, doi: 10.1016/j.wneu.2017.04.014.
[7964]	“Retraction: Chan, M.-f.,Wong, F. K.Y., Chang, K., Chow, S.,   Chung, L., Lee,W.-m. and Lee, R. (2009), Identifying   patient readmission subtypes from unplanned readmissions   to hospitals in Hong Kong:A cluster analysis. Nursing &   Health Sciences. 11: 37–44,” Nurs Health Sci, vol. 16, no. 3, p. 411, Sep. 2014, doi: 10.1111/nhs.12164.
[7965]	K. Schock, R. Rosner, M. Wenk-Ansohn, and C. Knaevelsrud, “[Retraumatization--a conceptional approach],” Psychother Psychosom Med Psychol, vol. 60, no. 7, pp. 243–249, Jul. 2010, doi: 10.1055/s-0030-1248268.
[7966]	C. Semenza, “Retrieval pathways for common and proper names,” Cortex, vol. 42, no. 6, pp. 884–891, Aug. 2006, doi: 10.1016/s0010-9452(08)70432-5.
[7967]	L. Zhang et al., “Retrospective analysis of factors associated with quetiapine dosage in the acute and subsequent six-month maintenance treatment of bipolar disorders,” Neuropsychiatr Dis Treat, vol. 9, pp. 575–580, 2013, doi: 10.2147/NDT.S42473.
[7968]	S. Chan, G. N. Glickman, K. F. Woodmansey, and J. He, “Retrospective Analysis of Root-end Microsurgery Outcomes in a Postgraduate Program in Endodontics Using Calcium Silicate-based Cements as Root-end Filling Materials,” J Endod, vol. 46, no. 3, pp. 345–351, Mar. 2020, doi: 10.1016/j.joen.2019.11.010.
[7969]	R. J. Rando, P. M. Vacek, R. E. Glenn, C. W. Kwon, and J. E. Parker, “Retrospective Assessment of Respirable Quartz Exposure for a Silicosis Study of the Industrial Sand Industry,” Ann Work Expo Health, vol. 62, no. 8, pp. 1021–1032, 15 2018, doi: 10.1093/annweh/wxy064.
[7970]	J. P. Harris, N. K. Parnell, E. H. Griffith, and K. E. Saker, “Retrospective evaluation of the impact of early enteral nutrition on clinical outcomes in dogs with pancreatitis: 34 cases (2010-2013),” J Vet Emerg Crit Care (San Antonio), vol. 27, no. 4, pp. 425–433, Jul. 2017, doi: 10.1111/vec.12612.
[7971]	Y.-C. Chen, G. Ramachandran, B. H. Alexander, and J. H. Mandel, “Retrospective exposure assessment in a chemical research and development facility,” Environ Int, vol. 39, no. 1, pp. 111–121, Feb. 2012, doi: 10.1016/j.envint.2011.10.008.
[7972]	P. Lesbats and V. Parissi, “Retroviral integration site selection: a running Gag?,” Microb Cell, vol. 5, no. 12, pp. 569–571, Nov. 2018, doi: 10.15698/mic2018.12.663.
[7973]	J. Handschel, N.-C. Gellrich, A. Bremerich, and G. Krüskemper, “Return to work and quality of life after therapy and rehabilitation in oral cancer,” In Vivo, vol. 27, no. 3, pp. 401–407, Jun. 2013.
[7974]	M. V. Pauly, “Returns on equity for not-for-profit hospitals,” Health Serv Res, vol. 21, no. 1, pp. 1–28, Apr. 1986.
[7975]	T. Funato, T. Ishii, M. Kanbe, K. J. Scanlon, and T. Sasaki, “Reversal of cisplatin resistance in vivo by an anti-fos ribozyme,” In Vivo, vol. 11, no. 3, pp. 217–220, Jun. 1997.
[7976]	E. W. Pommerenke and M. Volm, “Reversal of doxorubicin-resistance in solid tumors by clomipramine,” In Vivo, vol. 9, no. 2, pp. 99–101, Apr. 1995.
[7977]	Y. Sakarya, R. Sakarya, and S. Kara, “Reversal of sensation of conjunctival autograft after pterygium surgery,” Eur J Ophthalmol, vol. 22 Suppl 7, pp. S11-16, 2012, doi: 10.5301/ejo.5000082.
[7978]	J. Mellor et al., “Reverse transcriptase activity and Ty RNA are associated with virus-like particles in yeast,” Nature, vol. 318, no. 6046, pp. 583–586, Dec. 1985, doi: 10.1038/318583a0.
[7979]	G. Palencia, F. Teixeira, A. Ortiz, R. Perez, and J. Sotelo, “Reversibility of the alterations induced by chronic alcoholism and malnutrition in rats after alcohol withdrawal and proper nutrition,” J. Stud. Alcohol, vol. 56, no. 2, pp. 140–146, Mar. 1995, doi: 10.15288/jsa.1995.56.140.
[7980]	I. Vass, S. Styring, T. Hundal, A. Koivuniemi, E. Aro, and B. Andersson, “Reversible and irreversible intermediates during photoinhibition of photosystem II: stable reduced QA species promote chlorophyll triplet formation,” Proc. Natl. Acad. Sci. U.S.A., vol. 89, no. 4, pp. 1408–1412, Feb. 1992, doi: 10.1073/pnas.89.4.1408.
[7981]	T. Gerling and H. Dietz, “Reversible Covalent Stabilization of Stacking Contacts in DNA Assemblies,” Angew. Chem. Int. Ed. Engl., vol. 58, no. 9, pp. 2680–2684, 25 2019, doi: 10.1002/anie.201812463.
[7982]	T. Li et al., “Review and publication of protocol submissions to Trials - what have we learned in 10 years?,” Trials, vol. 18, no. 1, p. 34, 16 2016, doi: 10.1186/s13063-016-1743-0.
[7983]	M. F. Fingas and B. P. Hollebone, “Review of behaviour of oil in freezing environments,” Mar. Pollut. Bull., vol. 47, no. 9–12, pp. 333–340, 2003, doi: 10.1016/S0025-326X(03)00210-8.
[7984]	“Review of global influenza activity, October 2016–October 2017,” Wkly. Epidemiol. Rec., vol. 92, no. 50, pp. 761–779, Dec. 2017.
[7985]	M. Fingas and C. Brown, “Review of oil spill remote sensing,” Mar. Pollut. Bull., vol. 83, no. 1, pp. 9–23, Jun. 2014, doi: 10.1016/j.marpolbul.2014.03.059.
[7986]	“Review of the 2013–2014 winter influenza season, northern hemisphere,” Wkly. Epidemiol. Rec., vol. 89, no. 23, pp. 245–256, Jun. 2014.
[7987]	“Review of the 2014  influenza season in the  southern hemisphere,” Wkly. Epidemiol. Rec., vol. 89, no. 48, pp. 529–541, Nov. 2014.
[7988]	“Review of the 2014-2015 influenza season in the northern hemisphere,” Wkly. Epidemiol. Rec., vol. 90, no. 23, pp. 281–296, Jun. 2015.
[7989]	“Review of the 2015 influenza season in the southern hemisphere,” Wkly. Epidemiol. Rec., vol. 90, no. 48, pp. 645–660, Nov. 2015.
[7990]	Z. J. Liao and C. Huang, “[Review on enterprises’eco-innovation],” Ying Yong Sheng Tai Xue Bao, vol. 28, no. 12, pp. 4150–4156, Dec. 2017, doi: 10.13287/j.1001-9332.201712.031.
[7991]	C. Nabzdyk, L. Pradhan, J. Molina, E. Perin, D. Paniagua, and D. Rosenstrauch, “Review: auricular chondrocytes - from benchwork to clinical applications,” In Vivo, vol. 23, no. 3, pp. 369–380, Jun. 2009.
[7992]	V. Yagublu, Z. Ahmadova, M. Hafner, and M. Keese, “Review: Fluorescent protein-based tumor models,” In Vivo, vol. 26, no. 4, pp. 599–607, Aug. 2012.
[7993]	C. Xiong, L. Jiang, and L. Ju, “[Review: influenza A and its vaccine],” Zhonghua Yu Fang Yi Xue Za Zhi, vol. 46, no. 10, pp. 871–875, Oct. 2012.
[7994]	M. Halje, M. Nordin, D. Bergman, and W. Engström, “Review: The effect of insulin-like growth factor II in the regulation of tumour cell growth in vitro and tumourigenesis in vivo,” In Vivo, vol. 26, no. 4, pp. 519–526, Aug. 2012.
[7995]	D. Levêque, M. C. M. Carvalho, and F. Maloisel, “Review. Clinical pharmacokinetics of bortezomib,” In Vivo, vol. 21, no. 2, pp. 273–278, Apr. 2007.
[7996]	G. Baronzio, A. Gramaglia, and G. Fiorentini, “Review. Current role and future perspectives of hyperthermia for prostate cancer treatment,” In Vivo, vol. 23, no. 1, pp. 143–146, Feb. 2009.
[7997]	Y. Chen and S.-H. Tseng, “Review. Pro- and anti-angiogenesis effects of resveratrol,” In Vivo, vol. 21, no. 2, pp. 365–370, Apr. 2007.
[7998]	“Revised guidance on the choice of pertussis vaccines: July 2014,” Wkly. Epidemiol. Rec., vol. 89, no. 30, pp. 337–340, Jul. 2014.
[7999]	B. E. Sample, W. N. Beyer, and R. Wentsel, “Revisiting the Avian Eco-SSL for Lead: Recommendations for Revision,” Integr Environ Assess Manag, vol. 15, no. 5, pp. 739–749, Sep. 2019, doi: 10.1002/ieam.4157.
[8000]	D. J. Larkin, R. J. Buck, J. Fieberg, and S. M. Galatowitsch, “Revisiting the benefits of active approaches for restoring damaged ecosystems. A Comment on Jones HP et al. 2018 Restoration and repair of Earth’s damaged ecosystems,” Proc. Biol. Sci., vol. 286, no. 1907, p. 20182928, 24 2019, doi: 10.1098/rspb.2018.2928.
[8001]	C. Michel et al., “Revisiting the Road Map of Medullary Thymic Epithelial Cell Differentiation,” J. Immunol., vol. 199, no. 10, pp. 3488–3503, 15 2017, doi: 10.4049/jimmunol.1700203.
[8002]	P. Gorphe et al., “Revisiting vascular contraindications for transoral robotic surgery for oropharyngeal cancer,” Laryngoscope Investig Otolaryngol, vol. 3, no. 2, pp. 121–126, Apr. 2018, doi: 10.1002/lio2.152.
[8003]	“Revitalizing control efforts for cholera,” Wkly. Epidemiol. Rec., vol. 90, no. 40, pp. 530–534, Oct. 2015.
[8004]	K. Barber, “Revolution-"Speak With Your Pens" / Prenez la plume pour participer à une révolution,” J Cutan Med Surg, vol. 22, no. 2, pp. 125–128, Apr. 2018, doi: 10.1177/1203475418762108.
[8005]	C. Krebs, “[Rew egg yolk auxiliary to radiotherapy of osteogenic sarcoma in children (patients under 18 Years) 1950-52],” Ugeskr. Laeg., vol. 115, no. 29, pp. 1107–1132, Jul. 1953.
[8006]	G. O’Callaghan and A. Stringaris, “Reward Processing in Adolescent Depression Across Neuroimaging Modalities,” Z Kinder Jugendpsychiatr Psychother, vol. 47, no. 6, pp. 535–541, Nov. 2019, doi: 10.1024/1422-4917/a000663.
[8007]	P. Dieudé, “Rheumatic diseases: environment and genetics,” Joint Bone Spine, vol. 76, no. 6, pp. 602–607, Dec. 2009, doi: 10.1016/j.jbspin.2009.10.002.
[8008]	Z. Sebestyen et al., “RhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell Receptor,” Cell Rep, vol. 15, no. 9, pp. 1973–1985, 31 2016, doi: 10.1016/j.celrep.2016.04.081.
[8009]	S. Landolfo, R. Chessa, G. Zara, S. Zara, M. Budroni, and I. Mannazzu, “Rhodotorula mucilaginosa C2.5t1 Modulates Carotenoid Content and CAR Genes Transcript Levels to Counteract the Pro-Oxidant Effect of Hydrogen Peroxide,” Microorganisms, vol. 7, no. 9, Sep. 2019, doi: 10.3390/microorganisms7090316.
[8010]	A. LoMauro et al., “Rib cage deformities alter respiratory muscle action and chest wall function in patients with severe osteogenesis imperfecta,” PLoS ONE, vol. 7, no. 4, p. e35965, 2012, doi: 10.1371/journal.pone.0035965.
[8011]	S. M. Hoy, “Rifamycin SV MMX®: A Review in the Treatment of Traveller’s Diarrhoea,” Clin Drug Investig, vol. 39, no. 7, pp. 691–697, Jul. 2019, doi: 10.1007/s40261-019-00808-2.
[8012]	P. Omdahl, M. D. Eggen, M. D. Bonner, P. A. Iaizzo, and K. Wika, “Right Ventricular Anatomy Can Accommodate Multiple Micra Transcatheter Pacemakers,” Pacing Clin Electrophysiol, vol. 39, no. 4, pp. 393–397, Apr. 2016, doi: 10.1111/pace.12804.
[8013]	P.-N. Jone, M. Schäfer, Z. Pan, and D. D. Ivy, “Right Ventricular-Arterial Coupling Ratio Derived From 3-Dimensional Echocardiography Predicts Outcomes in Pediatric Pulmonary Hypertension,” Circ Cardiovasc Imaging, vol. 12, no. 1, p. e008176, 2019, doi: 10.1161/CIRCIMAGING.118.008176.
[8014]	M. S. Mitchell and C. M. Koen, “Rightful Discharge: Making ‘Termination’ Mean It’s REALLY Over Part 2-Proper Documentation,” Health Care Manag (Frederick), vol. 35, no. 2, pp. 113–117, Jun. 2016, doi: 10.1097/HCM.0000000000000103.
[8015]	Z. Peng, M. Takeshita, N. Shibata, H. Tada, Y. Tanaka, and J. Kaneko, “Rim domain loops of staphylococcal β-pore forming bi-component toxin S-components recognize target human erythrocytes in a coordinated manner,” J. Biochem., vol. 164, no. 2, pp. 93–102, Aug. 2018, doi: 10.1093/jb/mvy030.
[8016]	C. Ju, R. Spiegel, R. Radecki, and A. K. Swaminathan, “Rimegepant in the Treatment of Migraine Headache: The Importance of Comparator Treatments: November 2019 Annals of Emergency Medicine Journal Club,” Ann Emerg Med, vol. 74, no. 5, pp. 721–723, 2019, doi: 10.1016/j.annemergmed.2019.09.014.
[8017]	P. Goldwasser, A. I. Kaldas, and R. H. Barth, “Rise in serum albumin and creatinine in the first half year on hemodialysis,” Kidney Int., vol. 56, no. 6, pp. 2260–2268, Dec. 1999, doi: 10.1046/j.1523-1755.1999.00768.x.
[8018]	Y.-S. Chao, C.-J. Wu, and T.-S. Chen, “Risk adjustment and observation time: comparison between cross-sectional and 2-year panel data from the Medical Expenditure Panel Survey (MEPS),” Health Inf Sci Syst, vol. 2, p. 5, 2014, doi: 10.1186/2047-2501-2-5.
[8019]	A. M. Brunner et al., “Risk and timing of cardiovascular death among patients with myelodysplastic syndromes,” Blood Adv, vol. 1, no. 23, pp. 2032–2040, Oct. 2017, doi: 10.1182/bloodadvances.2017010165.
[8020]	M. H. Whittaker, “Risk Assessment and Alternatives Assessment: Comparing Two Methodologies,” Risk Anal., vol. 35, no. 12, pp. 2129–2136, Dec. 2015, doi: 10.1111/risa.12549.
[8021]	“Risk communication – A moving target in the fight against infectious hazards and epidemics,” Wkly. Epidemiol. Rec., vol. 91, no. 7, pp. 82–87, Feb. 2016.
[8022]	C. H. Jun et al., “Risk factors and clinical outcomes for spontaneous rupture of pyogenic liver abscess,” J Dig Dis, vol. 16, no. 1, pp. 31–36, Jan. 2015, doi: 10.1111/1751-2980.12209.
[8023]	D. H. Kim et al., “Risk Factors and On-site Rescue Treatments for Endoscopic Variceal Ligation Failure,” Korean J Gastroenterol, vol. 72, no. 4, pp. 188–196, Oct. 2018, doi: 10.4166/kjg.2018.72.4.188.
[8024]	S. J. Weinreb, A. J. Pianelli, S. R. Tanga, I. A. Parness, and R. U. Shenoy, “Risk factors for development of obesity in an ethnically diverse CHD population,” Cardiol Young, vol. 29, no. 2, pp. 123–127, Feb. 2019, doi: 10.1017/S1047951118001889.
[8025]	A. Thorne, T. Luo, N. K. Durairajan, K. S. Kaye, and B. Foxman, “Risk factors for endemic Acinetobacter Baumannii colonization: A case-case study,” Am J Infect Control, vol. 47, no. 11, pp. 1294–1297, 2019, doi: 10.1016/j.ajic.2019.04.179.
[8026]	J. He et al., “Risk Factors for Heart Failure in Patients With Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study,” J Am Heart Assoc, vol. 6, no. 5, May 2017, doi: 10.1161/JAHA.116.005336.
[8027]	J. D. Bundy et al., “Risk factors for progression of coronary artery calcification in patients with chronic kidney disease: The CRIC study,” Atherosclerosis, vol. 271, pp. 53–60, 2018, doi: 10.1016/j.atherosclerosis.2018.02.009.
[8028]	S. Ding et al., “Risk factors for suicidal tendency in adult patients with epilepsy in China,” Epilepsy Behav, vol. 97, pp. 118–122, 2019, doi: 10.1016/j.yebeh.2019.06.006.
[8029]	N. L. Campbell, F. Unverzagt, M. A. LaMantia, B. A. Khan, and M. A. Boustani, “Risk factors for the progression of mild cognitive impairment to dementia,” Clin. Geriatr. Med., vol. 29, no. 4, pp. 873–893, Nov. 2013, doi: 10.1016/j.cger.2013.07.009.
[8030]	F. G. Benavides, E. Q. Ahonen, and C. Bosch, “[Risk of occupational injury in foreign workers in Spain [2003 and 2004]],” Gac Sanit, vol. 22, no. 1, pp. 44–47, Feb. 2008, doi: 10.1157/13115110.
[8031]	M. R. Jorgenson et al., “Risk of opportunistic infection in kidney transplant recipients with cytomegalovirus infection and associated outcomes,” Transpl Infect Dis, vol. 21, no. 3, p. e13080, Jun. 2019, doi: 10.1111/tid.13080.
[8032]	K. Kreiss and B. Zhen, “Risk of silicosis in a Colorado mining community,” Am. J. Ind. Med., vol. 30, no. 5, pp. 529–539, Nov. 1996, doi: 10.1002/(SICI)1097-0274(199611)30:5<529::AID-AJIM2>3.0.CO;2-O.
[8033]	W. Chen et al., “Risk of silicosis in cohorts of Chinese tin and tungsten miners, and pottery workers (I): an epidemiological study,” Am. J. Ind. Med., vol. 48, no. 1, pp. 1–9, Jul. 2005, doi: 10.1002/ajim.20174.
[8034]	M. Taylor-Seehafer and L. Rew, “Risky sexual behavior among adolescent women,” J Soc Pediatr Nurs, vol. 5, no. 1, pp. 15–25, Mar. 2000, doi: 10.1111/j.1744-6155.2000.tb00082.x.
[8035]	G. Avallone and A. Zara, “[Ritalin in peroperative hiccup during operations on the stomach],” Minerva Anestesiol, vol. 29, pp. 50–51, Feb. 1963.
[8036]	C. Briani, G. Zara, R. Zambello, L. Trentin, M. Rana, and F. Zaja, “Rituximab-responsive CIDP,” Eur. J. Neurol., vol. 11, no. 11, p. 788, Nov. 2004, doi: 10.1111/j.1468-1331.2004.00911.x.
[8037]	S. Reardon, “Rival theories face off over brain’s source of consciousness,” Science, vol. 366, no. 6463, p. 293, 18 2019, doi: 10.1126/science.366.6463.293.
[8038]	A. A. Khorana et al., “Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial. Rationale and Design of the CASSINI Trial,” Thromb. Haemost., vol. 117, no. 11, pp. 2135–2145, 01 2017, doi: 10.1160/TH17-03-0171.
[8039]	A. A. Khorana et al., “Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer,” N. Engl. J. Med., vol. 380, no. 8, pp. 720–728, 21 2019, doi: 10.1056/NEJMoa1814630.
[8040]	M. Vatanparast, M. Kazzazi, A. Mirzaie-Asl, and V. Hosseininaveh, “RNA interference-mediated knockdown of some genes involved in digestion and development of Helicoverpa armigera,” Bull. Entomol. Res., vol. 107, no. 6, pp. 777–790, Dec. 2017, doi: 10.1017/S0007485317000293.
[8041]	A.-M. Yu, C. Jian, A. H. Yu, and M.-J. Tu, “RNA therapy: Are we using the right molecules?,” Pharmacol. Ther., vol. 196, pp. 91–104, 2019, doi: 10.1016/j.pharmthera.2018.11.011.
[8042]	J. H. Chariker et al., “RNA-seq data of soleus muscle tissue after spinal cord injury under conditions of inactivity and applied exercise,” Data Brief, vol. 28, p. 105056, Feb. 2020, doi: 10.1016/j.dib.2019.105056.
[8043]	T. Yin, S.-J. Cho, and X. Chen, “RNPC1, an RNA-binding protein and a p53 target, regulates macrophage inhibitory cytokine-1 (MIC-1) expression through mRNA stability,” J. Biol. Chem., vol. 288, no. 33, pp. 23680–23686, Aug. 2013, doi: 10.1074/jbc.M113.480186.
[8044]	D. Tanner and J. Perry, “Road effects on abundance and fitness of Galápagos lava lizards (Microlophus albemarlensis),” J. Environ. Manage., vol. 85, no. 2, pp. 270–278, Oct. 2007, doi: 10.1016/j.jenvman.2006.08.022.
[8045]	“Roadmap to elimination standard measles and rubella surveillance,” Wkly. Epidemiol. Rec., vol. 92, no. 9–10, pp. 97–105, 03 2017.
[8046]	C. De Taeye, M. Bodart, G. Caullet, and S. Collin, “Roasting conditions for preserving cocoa flavan-3-ol monomers and oligomers: interesting behaviour of Criollo clones,” J. Sci. Food Agric., vol. 97, no. 12, pp. 4001–4008, Sep. 2017, doi: 10.1002/jsfa.8265.
[8047]	M. Troullinaki et al., “Robo4-mediated pancreatic endothelial integrity decreases inflammation and islet destruction in autoimmune diabetes,” FASEB J., vol. 34, no. 2, pp. 3336–3346, Feb. 2020, doi: 10.1096/fj.201900125RR.
[8048]	J.-H. Egberts, M. Schlemminger, C. Hauser, and T. Becker, “Robot-Assisted McKeown Procedure via a Cervical Mediastinoscopy Avoiding an Abdominal and Thoracic Incision,” Thorac Cardiovasc Surg, vol. 67, no. 7, pp. 610–614, Oct. 2019, doi: 10.1055/s-0039-1685471.
[8049]	P.-L. Liu, “Robust absolute stability criteria for uncertain Lurie interval time-varying delay systems of neutral type,” ISA Trans, vol. 60, pp. 2–11, Jan. 2016, doi: 10.1016/j.isatra.2015.10.019.
[8050]	R. Kowalski et al., “Robust and practical non-invasive estimation of local arterial wave speed and mean blood velocity waveforms,” Physiol Meas, vol. 38, no. 11, pp. 2081–2099, Nov. 2017, doi: 10.1088/1361-6579/aa8de3.
[8051]	A. Valente, D. Iribarren, J.-L. Gálvez-Martos, and J. Dufour, “Robust eco-efficiency assessment of hydrogen from biomass gasification as an alternative to conventional hydrogen: A life-cycle study with and without external costs,” Sci. Total Environ., vol. 650, no. Pt 1, pp. 1465–1475, Feb. 2019, doi: 10.1016/j.scitotenv.2018.09.089.
[8052]	H. Jiao, L. Zhang, Q. Shen, J. Zhu, and P. Shi, “Robust Gene Circuit Control Design for Time-Delayed Genetic Regulatory Networks Without SUM Regulatory Logic,” IEEE/ACM Trans Comput Biol Bioinform, vol. 15, no. 6, pp. 2086–2093, Dec. 2018, doi: 10.1109/TCBB.2018.2825445.
[8053]	W. Bowen, L. Batra, A. R. Pulsifer, E. S. Yolcu, M. B. Lawrenz, and H. Shirwan, “Robust Th1 cellular and humoral responses generated by the Yersinia pestis rF1-V subunit vaccine formulated to contain an agonist of the CD137 pathway do not translate into increased protection against pneumonic plague,” Vaccine, vol. 37, no. 38, pp. 5708–5716, 10 2019, doi: 10.1016/j.vaccine.2019.07.103.
[8054]	Q. Wang, H. Tang, S. Qiu, X. Yuan, and J. Zuo, “Robustness of eco-industrial symbiosis network: a case study of China,” Environ Sci Pollut Res Int, vol. 25, no. 27, pp. 27203–27213, Sep. 2018, doi: 10.1007/s11356-018-2764-x.
[8055]	O. Onwujekwe et al., “Role and use of evidence in policymaking: an analysis of case studies from the health sector in Nigeria,” Health Res Policy Syst, vol. 13, p. 46, Oct. 2015, doi: 10.1186/s12961-015-0049-0.
[8056]	Y. Cao and P. Yan, “Role of atomic spin-mechanical coupling in the problem of a magnetic biocompass,” Phys Rev E, vol. 97, no. 4–1, p. 042409, Apr. 2018, doi: 10.1103/PhysRevE.97.042409.
[8057]	B. Wahlang, C. McClain, S. Barve, and L. Gobejishvili, “Role of cAMP and phosphodiesterase signaling in liver health and disease,” Cell. Signal., vol. 49, pp. 105–115, Sep. 2018, doi: 10.1016/j.cellsig.2018.06.005.
[8058]	J. A. Martinez, M. Larion, M. S. Conejo, C. M. Porter, and B. G. Miller, “Role of connecting loop I in catalysis and allosteric regulation of human glucokinase,” Protein Sci., vol. 23, no. 7, pp. 915–922, Jul. 2014, doi: 10.1002/pro.2473.
[8059]	J. Krusche, S. Basse, and B. Schaub, “Role of early life immune regulation in asthma development,” Semin Immunopathol, vol. 42, no. 1, pp. 29–42, 2020, doi: 10.1007/s00281-019-00774-z.
[8060]	X.-Y. Zheng, J. Liang, Y.-S. Li, and M. Tu, “Role of Fat-Soluble Vitamins in Osteoarthritis Management,” J Clin Rheumatol, vol. 24, no. 3, pp. 132–137, Apr. 2018, doi: 10.1097/RHU.0000000000000587.
[8061]	F. Basolo, C. Ugolini, A. Proietti, P. Iacconi, P. Berti, and P. Miccoli, “Role of frozen section associated with intraoperative cytology in comparison to FNA and FS alone in the management of thyroid nodules,” Eur J Surg Oncol, vol. 33, no. 6, pp. 769–775, Aug. 2007, doi: 10.1016/j.ejso.2006.12.004.
[8062]	J. C. Barrett, D. G. Thomassen, and T. W. Hesterberg, “Role of gene and chromosomal mutations in cell transformation,” Ann. N. Y. Acad. Sci., vol. 407, pp. 291–300, 1983, doi: 10.1111/j.1749-6632.1983.tb47834.x.
[8063]	M. Y. Liu and L. J. Zhang, “[Role of Ginkgo biloba extract in regulating 5-hydroxytrytamine and its receptor in heart failure mice],” Zhonghua Yi Xue Za Zhi, vol. 98, no. 25, pp. 2024–2029, Jul. 2018, doi: 10.3760/cma.j.issn.0376-2491.2018.25.012.
[8064]	Y. Hayashi, “[Role of HIF1A in the development of myelodysplastic syndromes],” Rinsho Ketsueki, vol. 60, no. 7, pp. 818–823, 2019, doi: 10.11406/rinketsu.60.818.
[8065]	S. Aggarwal, A. A. van de Loosdrecht, C. Alhan, G. J. Ossenkoppele, T. M. Westers, and H. J. Bontkes, “Role of immune responses in the pathogenesis of low-risk MDS and high-risk MDS: implications for immunotherapy,” Br. J. Haematol., vol. 153, no. 5, pp. 568–581, Jun. 2011, doi: 10.1111/j.1365-2141.2011.08683.x.
[8066]	M. Somlói, E. Toldy-Schedel, Z. Nényei, R. Böszörményi, and J. Tomcsányi, “[Role of implantable loop recorder in the clinical diagnosis of syncope: results of the introduction of an effective diagnostic tool],” Orv Hetil, vol. 156, no. 15, pp. 609–613, Apr. 2015, doi: 10.1556/OH.2015.30124.
[8067]	M. L. Cunningham, “Role of increased DNA replication in the carcinogenic risk of nonmutagenic chemical carcinogens,” Mutat. Res., vol. 365, no. 1–3, pp. 59–69, Sep. 1996, doi: 10.1016/s0165-1110(96)90012-3.
[8068]	Z. U. Chaudhry, “Role of JCPSP in Advancement of Medical Journals in Pakistan: Raising the Standards through Quality Publication,” J Coll Physicians Surg Pak, vol. 28, no. 1, pp. 1–2, Jan. 2018, doi: 10.29271/jcpsp.2018.01.1.
[8069]	S. B. Ramaswamy et al., “Role of juvenile hormone-esterase in mating-stimulated egg development in the moth Heliothis virescens,” Insect Biochem. Mol. Biol., vol. 30, no. 8–9, pp. 785–791, Sep. 2000, doi: 10.1016/s0965-1748(00)00050-3.
[8070]	R. Natarajan and J. Nadler, “Role of lipoxygenases in breast cancer,” Front. Biosci., vol. 3, pp. E81-88, Jun. 1998, doi: 10.2741/a369.
[8071]	H. Teranishi et al., “Role of neuromedin U in accelerating of non-alcoholic steatohepatitis in mice,” Peptides, vol. 99, pp. 134–141, 2018, doi: 10.1016/j.peptides.2017.09.011.
[8072]	Z. Posalaky, I. Toro, and T. Barka, “[Role of nucleic acid in growth of liver tissue in vitro],” Kiserl Orvostud, vol. 5, no. 6, pp. 401–410, Nov. 1953.
[8073]	F. Ye and N. Li, “Role of p15(INK4B) Methylation in Patients With Myelodysplastic Syndromes: A Systematic Meta-Analysis,” Clin Lymphoma Myeloma Leuk, vol. 19, no. 6, pp. e259–e265, 2019, doi: 10.1016/j.clml.2019.03.013.
[8074]	B. Godínez-Chaparro, P. Barragán-Iglesias, G. Castañeda-Corral, H. I. Rocha-González, and V. Granados-Soto, “Role of peripheral 5-HT(4), 5-HT(6), and 5-HT(7) receptors in development and maintenance of secondary mechanical allodynia and hyperalgesia,” Pain, vol. 152, no. 3, pp. 687–697, Mar. 2011, doi: 10.1016/j.pain.2010.12.020.
[8075]	T. Seike and C. Shimoda, “Role of pheromone recognition systems in creating new species of fission yeast,” Microb Cell, vol. 6, no. 4, pp. 209–211, Mar. 2019, doi: 10.15698/mic2019.04.675.
[8076]	S. Chande and C. Bergwitz, “Role of phosphate sensing in bone and mineral metabolism,” Nat Rev Endocrinol, vol. 14, no. 11, pp. 637–655, 2018, doi: 10.1038/s41574-018-0076-3.
[8077]	J. B. Allendorfer and R. M. Arida, “Role of Physical Activity and Exercise in Alleviating Cognitive Impairment in People With Epilepsy,” Clin Ther, vol. 40, no. 1, pp. 26–34, 2018, doi: 10.1016/j.clinthera.2017.12.004.
[8078]	L. A. Glasgow and K. Habel, “Role of polyoma virus and interferon in a herpes simplex virus infection in vitro,” Virology, vol. 19, pp. 328–339, Mar. 1963, doi: 10.1016/0042-6822(63)90072-2.
[8079]	P. Jenjitranant and K. A. Touijer, “Role of surgery in oligometastatic prostate cancer,” Prostate Int, vol. 7, no. 4, pp. 125–130, Dec. 2019, doi: 10.1016/j.prnil.2019.10.001.
[8080]	A. M. Shaw, C. Brown, J. Irvine, D. C. Bunton, and A. MacDonald, “Role of the 5-HT(2A)receptor and alpha(1)-adrenoceptor in the contractile response of rat pulmonary artery to 5-HT in the presence and absence of nitric oxide,” Pulm Pharmacol Ther, vol. 13, no. 6, pp. 277–285, 2000, doi: 10.1006/pupt.2000.0255.
[8081]	F.-Y. Liu, G.-G. Xing, X.-X. Qu, I. S. Xu, J.-S. Han, and Y. Wan, “Roles of 5-hydroxytryptamine (5-HT) receptor subtypes in the inhibitory effects of 5-HT on C-fiber responses of spinal wide dynamic range neurons in rats,” J. Pharmacol. Exp. Ther., vol. 321, no. 3, pp. 1046–1053, Jun. 2007, doi: 10.1124/jpet.106.115204.
[8082]	K. Suzuki, S. Maeda, and K. Morokuma, “Roles of Closed- and Open-Loop Conformations in Large-Scale Structural Transitions of l-Lactate Dehydrogenase,” ACS Omega, vol. 4, no. 1, pp. 1178–1184, Jan. 2019, doi: 10.1021/acsomega.8b02813.
[8083]	Y. Mori, M. A. Borgan, M. Takayama, N. Ito, M. Sugiyama, and N. Minamoto, “Roles of outer capsid proteins as determinants of pathogenicity and host range restriction of avian rotaviruses in a suckling mouse model,” Virology, vol. 316, no. 1, pp. 126–134, Nov. 2003, doi: 10.1016/j.virol.2003.08.006.
[8084]	N. Inohara, “Route Connection: Mouth to Intestine in Colitis,” Cell Host Microbe, vol. 22, no. 6, pp. 730–731, 13 2017, doi: 10.1016/j.chom.2017.11.012.
[8085]	N. J. Walsh, B. T. Sullivan, W. S. Duke, and D. J. Terris, “Routine bilateral neck exploration and four-gland dissection remains unnecessary in modern parathyroid surgery,” Laryngoscope Investig Otolaryngol, vol. 4, no. 1, pp. 188–192, Feb. 2019, doi: 10.1002/lio2.223.
[8086]	A. Papa and C. Lefton, “Rub a dub dub: best practices for stretcher cleaning,” J Emerg Nurs, vol. 40, no. 6, pp. 619–620, Nov. 2014, doi: 10.1016/j.jen.2014.08.001.
[8087]	A. Papa, G. Gioula, A. Antoniadis, and V. Kyriazopoulou-Dalaina, “Rubella epidemic strain, Greece, 1999,” Emerging Infect. Dis., vol. 10, no. 9, pp. 1696–1697, Sep. 2004, doi: 10.3201/eid1009.040117.
[8088]	“Rubella virus nomenclature update: 2013,” Wkly. Epidemiol. Rec., vol. 88, no. 32, pp. 337–343, Aug. 2013.
[8089]	N. Kallscheuer et al., “Rubinisphaera italica sp. nov. isolated from a hydrothermal area in the Tyrrhenian Sea close to the volcanic island Panarea,” Antonie Van Leeuwenhoek, Nov. 2019, doi: 10.1007/s10482-019-01329-w.
[8090]	B. Fisak, A. Kissinger-Knox, and E. Cibrian, “Rumination and the mood-as-input hypothesis: Does congruence matter?,” J Behav Ther Exp Psychiatry, vol. 61, pp. 51–59, 2018, doi: 10.1016/j.jbtep.2018.06.004.
[8091]	L. Kovács, F. L. Kézér, F. Ruff, and O. Szenci, “Rumination time and reticuloruminal temperature as possible predictors of dystocia in dairy cows,” J. Dairy Sci., vol. 100, no. 2, pp. 1568–1579, Feb. 2017, doi: 10.3168/jds.2016-11884.
[8092]	A. Larson, “Rural health’s demographic destiny,” Rural Remote Health, vol. 6, no. 2, p. 551, Jun. 2006.
[8093]	M. Fischer-Gödde et al., “Ruthenium isotope vestige of Earth’s pre-late-veneer mantle preserved in Archaean rocks,” Nature, vol. 579, no. 7798, pp. 240–244, 2020, doi: 10.1038/s41586-020-2069-3.
[8094]	J. S. M. Samec and J.-E. Bäckvall, “Ruthenium-catalyzed transfer hydrogenation of imines by propan-2-ol in benzene,” Chemistry, vol. 8, no. 13, pp. 2955–2961, Jul. 2002, doi: 10.1002/1521-3765(20020703)8:13<2955::AID-CHEM2955>3.0.CO;2-Q.
[8095]	J. Hayles, “S. pombe placed on the prion map,” Microb Cell, vol. 4, no. 2, pp. 35–37, Feb. 2017, doi: 10.15698/mic2017.02.555.
[8096]	A. Kandil, A. Chutipongtanate, R. E. Wood, and M. Mahmoud, “Saber-sheath Tracheal Deformity,” Anesthesiology, vol. 129, no. 4, p. 811, 2018, doi: 10.1097/ALN.0000000000002268.
[8097]	J. D. Boeke, C. A. Styles, and G. R. Fink, “Saccharomyces cerevisiae SPT3 gene is required for transposition and transpositional recombination of chromosomal Ty elements,” Mol. Cell. Biol., vol. 6, no. 11, pp. 3575–3581, Nov. 1986, doi: 10.1128/mcb.6.11.3575.
[8098]	S. F. Emami and F. Farahani, “Saccular dysfunction in children with sensorineural hearing loss and auditory neuropathy/auditory dys-synchrony,” Acta Otolaryngol., vol. 135, no. 12, pp. 1298–1303, 2015, doi: 10.3109/00016489.2015.1076169.
[8099]	A. Esteban-Fernández et al., “Sacubitril/Valsartan is useful and safe in elderly people with heart failure and reduced ejection fraction. Data from a real-word cohort,” Rev Esp Geriatr Gerontol, vol. 55, no. 2, pp. 65–69, Apr. 2020, doi: 10.1016/j.regg.2019.10.002.
[8100]	A. M. Leventhal, “Sadness, depression, and avoidance behavior,” Behav Modif, vol. 32, no. 6, pp. 759–779, Nov. 2008, doi: 10.1177/0145445508317167.
[8101]	M. F. Fathalla, “Safe abortion: The public health rationale,” Best Pract Res Clin Obstet Gynaecol, vol. 63, pp. 2–12, Feb. 2020, doi: 10.1016/j.bpobgyn.2019.03.010.
[8102]	N. Kaempf and T. Maritzen, “Safeguards of Neurotransmission: Endocytic Adaptors as Regulators of Synaptic Vesicle Composition and Function,” Front Cell Neurosci, vol. 11, p. 320, 2017, doi: 10.3389/fncel.2017.00320.
[8103]	K. B. Chambers and L. Rew, “Safer sexual decision making in adolescent women: perspectives from the conflict theory of decision-making,” Issues Compr Pediatr Nurs, vol. 26, no. 3, pp. 129–143, Sep. 2003, doi: 10.1080/01460860390223853.
[8104]	M. L. Elizaga et al., “Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trial,” PLoS ONE, vol. 13, no. 9, p. e0202753, 2018, doi: 10.1371/journal.pone.0202753.
[8105]	J.-L. Marendaz, K. Friedrich, and T. Meyer, “Safety management and risk assessment in chemical laboratories,” Chimia (Aarau), vol. 65, no. 9, pp. 734–737, 2011, doi: 10.2533/chimia.2011.734.
[8106]	A. H. Hall, M. Cavallini, L. Mathieu, and H. I. Maibach, “Safety of dermal diphoterine application: an active decontamination solution for chemical splash injuries,” Cutan Ocul Toxicol, vol. 28, no. 4, pp. 149–156, 2009, doi: 10.3109/15569520903269122.
[8107]	J. Moon et al., “Safety of tianeptine use in patients with epilepsy,” Epilepsy Behav, vol. 34, pp. 116–119, May 2014, doi: 10.1016/j.yebeh.2014.03.021.
[8108]	I. Jandric et al., “Salutary effect of gastric pentadecapeptide BPC 157 in two different stress urinary incontinence models in female rats,” Med Sci Monit Basic Res, vol. 19, pp. 93–102, Mar. 2013, doi: 10.12659/MSMBR.883828.
[8109]	D. K. Yadav et al., “Salvage Liver Transplant versus Primary Liver Transplant for Patients with Hepatocellular Carcinoma,” Ann. Transplant., vol. 23, pp. 524–545, 03 2018, doi: 10.12659/AOT.908623.
[8110]	Q. Cao et al., “Sap flow of Amorpha fruticosa: implications of water use strategy in a semiarid system with secondary salinization,” Sci Rep, vol. 10, no. 1, p. 13504, Aug. 2020, doi: 10.1038/s41598-020-70511-2.
[8111]	H. Y. Hwang and K.-B. Kim, “Saphenous vein as a composite graft from the internal thoracic artery,” Ann Cardiothorac Surg, vol. 7, no. 5, pp. 686–689, Sep. 2018, doi: 10.21037/acs.2018.06.08.
[8112]	E. Martin, S. Radomski, and E. Harley, “Sarcomas of the paranasal sinuses: An analysis of the SEER database,” Laryngoscope Investig Otolaryngol, vol. 4, no. 1, pp. 70–75, Feb. 2019, doi: 10.1002/lio2.245.
[8113]	A. Ohtaka et al., “Sarcopenia is a poor prognostic factor of castration-resistant prostate cancer treated with docetaxel therapy,” Prostate Int, vol. 7, no. 1, pp. 9–14, Mar. 2019, doi: 10.1016/j.prnil.2018.04.002.
[8114]	M. Sturek, K. Kunda, and Q. Hu, “Sarcoplasmic reticulum buffering of myoplasmic calcium in bovine coronary artery smooth muscle,” J. Physiol. (Lond.), vol. 451, pp. 25–48, 1992, doi: 10.1113/jphysiol.1992.sp019152.
[8115]	G. Kundu, S. De, S. Tothadi, A. Das, D. Koley, and S. S. Sen, “Saturated N-Heterocyclic Carbene Based Thiele’s Hydrocarbon with a Tetrafluorophenylene Linker,” Chemistry, Oct. 2019, doi: 10.1002/chem.201904421.
[8116]	C. L. Martins, H. Ribeiro, A. T. Alvarenga, and J. da R. Carvalheiro, “Saúde e Sociedade Journal: partnership and openness to new approaches,” Cien Saude Colet, vol. 20, no. 7, pp. 2069–2080, Jul. 2015, doi: 10.1590/1413-81232015207.06042015.
[8117]	M. A. Garlick, “Save the earth,” Sci. Am., vol. 284, no. 6, p. 24D, Jun. 2001, doi: 10.1038/scientificamerican0601-24da.
[8118]	W. J. Ripple, E. Meijaard, and T. Newsome, “Saving the World with Satire: A Response to Chapron et al,” Trends Ecol. Evol. (Amst.), vol. 33, no. 7, pp. 483–484, 2018, doi: 10.1016/j.tree.2018.04.011.
[8119]	P. Milis and R. Renard, “[Say: Papa],” Arch Belg, vol. 43, no. 5–8, pp. 289–295, 1985.
[8120]	C. D. Cassilly et al., “SB-224289 Antagonizes the Antifungal Mechanism of the Marine Depsipeptide Papuamide A,” PLoS ONE, vol. 11, no. 5, p. e0154932, 2016, doi: 10.1371/journal.pone.0154932.
[8121]	R. Konar et al., “Scalable Synthesis of Few-Layered 2D Tungsten Diselenide (2H-WSe2) Nanosheets Directly Grown on Tungsten (W) Foil Using Ambient-Pressure Chemical Vapor Deposition for Reversible Li-Ion Storage,” ACS Omega, vol. 5, no. 31, pp. 19409–19421, Aug. 2020, doi: 10.1021/acsomega.0c01155.
[8122]	L. Jäncke, F. Liem, and S. Merillat, “Scaling of brain compartments to brain size,” Neuroreport, vol. 30, no. 8, pp. 573–579, 22 2019, doi: 10.1097/WNR.0000000000001249.
[8123]	K. M. Burnett, L. A. Solterbeck, and C. M. Strapp, “Scent and mood state following an anxiety-provoking task,” Psychol Rep, vol. 95, no. 2, pp. 707–722, Oct. 2004, doi: 10.2466/pr0.95.2.707-722.
[8124]	C. M. Isherwood, E. D. Chinoy, A. S. Murphy, J. H. Kim, W. Wang, and J. F. Duffy, “Scheduled afternoon-evening sleep leads to better night shift performance in older adults,” Occup Environ Med, vol. 77, no. 3, pp. 179–184, 2020, doi: 10.1136/oemed-2019-105916.
[8125]	A. D. Sircar, P. N. M. Mwinzi, I. O. Onkanga, R. E. Wiegand, S. P. Montgomery, and W. E. Secor, “Schistosoma mansoni Mass Drug Administration Regimens and Their Effect on Morbidity among Schoolchildren over a 5-Year Period-Kenya, 2010-2015,” Am. J. Trop. Med. Hyg., vol. 99, no. 2, pp. 362–369, 2018, doi: 10.4269/ajtmh.18-0067.
[8126]	“Schistosomiasis and soil-transmitted helminthiases: number of people treated in 2015,” Wkly. Epidemiol. Rec., vol. 91, no. 49–50, pp. 585–595, 09 2016.
[8127]	“Schistosomiasis and soil-transmitted helminthiases: number of people treated in 2016,” Wkly. Epidemiol. Rec., vol. 92, no. 49, pp. 749–760, Dec. 2017.
[8128]	“Schistosomiasis: number  of people treated worldwide  in 2013,” Wkly. Epidemiol. Rec., vol. 90, no. 5, pp. 25–32, Jan. 2015.
[8129]	“Schistosomiasis: number of people treated worldwide in 2014,” Wkly. Epidemiol. Rec., vol. 91, no. 5, pp. 53–60, Feb. 2016.
[8130]	H. Desombre, P. Fourneret, O. Revol, and R. de Villard, “[School refusal anxiety],” Arch Pediatr, vol. 6, no. 1, pp. 97–101, Jan. 1999, doi: 10.1016/s0929-693x(99)80082-7.
[8131]	M. Schiltz, “Science Without Publication Paywalls: cOAlition S for the Realisation of Full and Immediate Open Access,” PLoS Med., vol. 15, no. 9, p. e1002663, 2018, doi: 10.1371/journal.pmed.1002663.
[8132]	M. Schiltz, “Science without publication paywalls: cOAlition S for the realisation of full and immediate Open Access,” PLoS Biol., vol. 16, no. 9, p. e3000031, 2018, doi: 10.1371/journal.pbio.3000031.
[8133]	D. A. Rew, “ScienceDirect: our next step in electronic publishing,” Eur J Surg Oncol, vol. 28, no. 8, p. 811, Dec. 2002, doi: 10.1053/ejso.2002.1342.
[8134]	C. J. F. Waaijer, B. W. C. Ommering, L. J. van der Wurff, T. N. van Leeuwen, F. W. Dekker, and NVMO Special Interest Group on Scientific Education, “Scientific activity by medical students: the relationship between academic publishing during medical school and publication careers after graduation,” Perspect Med Educ, vol. 8, no. 4, pp. 223–229, 2019, doi: 10.1007/s40037-019-0524-3.
[8135]	B. van Steensel, “Scientific honesty and publicly shared lab notebooks: Sharing lab notebooks along with publication would increase transparency and help to improve honesty when reporting results,” EMBO Rep., vol. 19, no. 10, 2018, doi: 10.15252/embr.201846866.
[8136]	Ó. García-Algar and O. Vall Combelles, “Scientific publications: present and future,” Arch. Bronconeumol., vol. 49, no. 12, pp. 503–504, Dec. 2013, doi: 10.1016/j.arbres.2013.04.008.
[8137]	A. W. Wilhite and E. A. Fong, “Scientific publications. Coercive citation in academic publishing,” Science, vol. 335, no. 6068, pp. 542–543, Feb. 2012, doi: 10.1126/science.1212540.
[8138]	R. M. Barría P, “Scientific Rigor,Ethics of Publications,and the Temptation of Predatory Journals,” Invest Educ Enferm, vol. 36, no. 3, 2018, doi: 10.17533/udea.iee.v36n3e01.
[8139]	U. Baschant, H. Henneicke, L. C. Hofbauer, and M. Rauner, “Sclerostin Blockade-A Dual Mode of Action After All?,” J. Bone Miner. Res., vol. 31, no. 10, pp. 1787–1790, 2016, doi: 10.1002/jbmr.2988.
[8140]	A. Papa and A. Mannelli, “[Sclerotizing evolution of breast cancer],” Arch De Vecchi Anat Patol, vol. 15, no. 1, pp. 365–386, Jul. 1950.
[8141]	R. Bronheim, S. Khan, E. Carter, R. A. Sandhaus, and C. Raggio, “Scoliosis and Cardiopulmonary Outcomes in Osteogenesis Imperfecta Patients,” Spine, vol. 44, no. 15, pp. 1057–1063, Aug. 2019, doi: 10.1097/BRS.0000000000003012.
[8142]	A. Sato, J. Ouellet, T. Muneta, F. H. Glorieux, and F. Rauch, “Scoliosis in osteogenesis imperfecta caused by COL1A1/COL1A2 mutations - genotype-phenotype correlations and effect of bisphosphonate treatment,” Bone, vol. 86, pp. 53–57, May 2016, doi: 10.1016/j.bone.2016.02.018.
[8143]	R. Stromberg, E. Wernering, A. Aberg-Wistedt, A.-K. Furhoff, S.-E. Johansson, and L. G. Backlund, “Screening and diagnosing depression in women visiting GPs’ drop in clinic in Primary Health Care,” BMC Fam Pract, vol. 9, p. 34, Jun. 2008, doi: 10.1186/1471-2296-9-34.
[8144]	Y. Le, “Screening and identification of key candidate genes and pathways in myelodysplastic syndrome by bioinformatic analysis,” PeerJ, vol. 7, p. e8162, 2019, doi: 10.7717/peerj.8162.
[8145]	M. R. Schwarzman et al., “Screening for Chemical Contributions to Breast Cancer Risk: A Case Study for Chemical Safety Evaluation,” Environ. Health Perspect., vol. 123, no. 12, pp. 1255–1264, Dec. 2015, doi: 10.1289/ehp.1408337.
[8146]	Z. Wang and B. Dong, “Screening for Cognitive Impairment in Geriatrics,” Clin. Geriatr. Med., vol. 34, no. 4, pp. 515–536, 2018, doi: 10.1016/j.cger.2018.06.004.
[8147]	D. L. Musselman, J. S. McDaniel, M. R. Porter, and C. B. Nemeroff, “Screening for depression,” J Med Assoc Ga, vol. 88, no. 1, pp. 47–53, Feb. 1999.
[8148]	M. Kafman, N. Alon, and D. Hermoni, “[Screening for depression in primary care clinics in Israel--how wide is the gap?],” Harefuah, vol. 142, no. 12, pp. 815–819, 880, 879, Dec. 2003.
[8149]	F. Tong et al., “[Screening for hereditary tyrosinemia and genotype analysis in newborns],” Zhejiang Da Xue Xue Bao Yi Xue Ban, vol. 48, no. 4, pp. 459–464, Jun. 2019.
[8150]	M. A. Sutherland, H. C. Fantasia, and M. K. Hutchinson, “Screening for Intimate Partner and Sexual Violence in College Women: Missed Opportunities,” Womens Health Issues, vol. 26, no. 2, pp. 217–224, Apr. 2016, doi: 10.1016/j.whi.2015.07.008.
[8151]	C. Kokorelis, B. Slomine, P. C. Rowe, and S. Suskauer, “Screening for Orthostatic Intolerance in Symptomatic Children Presenting for Concussion Care,” Clin Pediatr (Phila), vol. 59, no. 1, pp. 75–82, 2020, doi: 10.1177/0009922819885656.
[8152]	C. L. Franklin, T. Sheeran, and M. Zimmerman, “Screening for trauma histories, posttraumatic stress disorder (PTSD), and subthreshold PTSD in psychiatric outpatients,” Psychol Assess, vol. 14, no. 4, pp. 467–471, Dec. 2002, doi: 10.1037//1040-3590.14.4.467.
[8153]	D. Espinosa-Pesqueira, A. X. Roig-Sagués, and M. M. Hernández-Herrero, “Screening Method to Evaluate Amino Acid-Decarboxylase Activity of Bacteria Present in Spanish Artisanal Ripened Cheeses,” Foods, vol. 7, no. 11, Nov. 2018, doi: 10.3390/foods7110182.
[8154]	S. Gur-Ozmen, A. Leibetseder, H. R. Cock, N. Agrawal, and T. J. von Oertzen, “Screening of anxiety and quality of life in people with epilepsy,” Seizure, vol. 45, pp. 107–113, Feb. 2017, doi: 10.1016/j.seizure.2016.11.026.
[8155]	A. San, B. Hiremagalur, W. Muircroft, and L. Grealish, “Screening of Cognitive Impairment in the Dialysis Population: A Scoping Review,” Dement Geriatr Cogn Disord, vol. 44, no. 3–4, pp. 182–195, 2017, doi: 10.1159/000479679.
[8156]	P. Cuijpers, P. Boluijt, and A. van Straten, “Screening of depression in adolescents through the Internet : sensitivity and specificity of two screening questionnaires,” Eur Child Adolesc Psychiatry, vol. 17, no. 1, pp. 32–38, Feb. 2008, doi: 10.1007/s00787-007-0631-2.
[8157]	J. Greenberg, A. A. Tesfazion, and C. S. Robinson, “Screening, diagnosis, and treatment of depression,” Mil Med, vol. 177, no. 8 Suppl, pp. 60–66, Aug. 2012, doi: 10.7205/milmed-d-12-00102.
[8158]	Y. Watanabe et al., “Scrotal disorders: evaluation of testicular enhancement patterns at dynamic contrast-enhanced subtraction MR imaging,” Radiology, vol. 217, no. 1, pp. 219–227, Oct. 2000, doi: 10.1148/radiology.217.1.r00oc41219.
[8159]	M. V. Johnston, A. Nishimura, K. Harum, J. Pekar, and M. E. Blue, “Sculpting the developing brain,” Adv Pediatr, vol. 48, pp. 1–38, 2001.
[8160]	M. Gurnis, “Sculpting the earth from inside out,” Sci. Am., vol. 284, no. 3, pp. 40–47, Mar. 2001, doi: 10.1038/scientificamerican0301-40.
[8161]	A. T. Tu and G. Fulde, “Sea snake bites,” Clin. Dermatol., vol. 5, no. 3, pp. 118–126, Sep. 1987, doi: 10.1016/s0738-081x(87)80018-4.
[8162]	M. E. Brown, W. H. Swiggart, C. M. Dewey, and M. V. Ghulyan, “Searching for answers: proper prescribing of controlled prescription drugs,” J Psychoactive Drugs, vol. 44, no. 1, pp. 79–85, Mar. 2012, doi: 10.1080/02791072.2012.662081.
[8163]	N. Uchida, L. Jerabek, and I. L. Weissman, “Searching for hematopoietic stem cells. II. The heterogeneity of Thy-1.1(lo)Lin(-/lo)Sca-1+ mouse hematopoietic stem cells separated by counterflow centrifugal elutriation,” Exp. Hematol., vol. 24, no. 5, pp. 649–659, Apr. 1996.
[8164]	H. Zhao, G. Jia, H. Wang, A. Zhang, and X. Xu, “Seasonal and interannual variations in carbon fluxes in East Asia semi-arid grasslands,” Sci. Total Environ., vol. 668, pp. 1128–1138, Jun. 2019, doi: 10.1016/j.scitotenv.2019.02.378.
[8165]	T. Zitko and E. Merdić, “Seasonal and spatial oviposition activity of Aedes albopictus (Diptera: Culicidae) in Adriatic Croatia,” J. Med. Entomol., vol. 51, no. 4, pp. 760–768, Jul. 2014, doi: 10.1603/me13071.
[8166]	A. Pakalnis and G. L. Heyer, “Seasonal Variation in Emergency Department Visits Among Pediatric Headache Patients,” Headache, vol. 56, no. 8, pp. 1344–1347, Sep. 2016, doi: 10.1111/head.12888.
[8167]	N. Rathore, D. Thakur, and A. Chawla, “Seasonal variations coupled with elevation gradient drives significant changes in eco-physiological and biogeochemical traits of a high altitude evergreen broadleaf shrub, Rhododendron anthopogon,” Plant Physiol. Biochem., vol. 132, pp. 708–719, Nov. 2018, doi: 10.1016/j.plaphy.2018.08.009.
[8168]	Q. Ju and L.-Q. Xia, “[Sebaceous glands and acne],” Zhongguo Yi Xue Ke Xue Yuan Xue Bao, vol. 29, no. 2, pp. 272–274, Apr. 2007.
[8169]	M. D’Attilio, D. Rodolfino, A. Filippakos, M. Saccucci, F. Festa, and D. Tripodi, “Second Class Resolver: a retrospective analysis,” Eur J Paediatr Dent, vol. 15, no. 1, pp. 72–74, Mar. 2014.
[8170]	L. Rew, D. Koniak-Griffin, M. A. Lewis, M. Miles, and A. O’sullivan, “Secondary data analysis: new perspective for adolescent research,” Nurs Outlook, vol. 48, no. 5, pp. 223–229, Oct. 2000, doi: 10.1067/mno.2000.104901.
[8171]	J. Nehme et al., “Secondary intraocular lens implantation with absence of capsular support: Scleral versus iris fixation,” J Fr Ophtalmol, vol. 41, no. 7, pp. 630–636, Sep. 2018, doi: 10.1016/j.jfo.2017.11.029.
[8172]	B. A. B. Blackwell et al., “Sedimentary Dosimetry for the Saradj-Chuko Grotto: A Cave in a Lava Tube in the North-Central Caucasus, Russia,” Methods Protoc, vol. 3, no. 1, Feb. 2020, doi: 10.3390/mps3010020.
[8173]	Z.-Y. Hu et al., “Seed structure characteristics to form ultrahigh oil content in rapeseed,” PLoS ONE, vol. 8, no. 4, p. e62099, 2013, doi: 10.1371/journal.pone.0062099.
[8174]	L. Gu, X. Yang, L. M. W. Li, X. Zhou, and D.-G. Gao, “Seeing the big picture: Broadening attention relieves sadness and depressed mood,” Scand J Psychol, vol. 58, no. 4, pp. 324–332, Aug. 2017, doi: 10.1111/sjop.12376.
[8175]	S. Rivier et al., “Segmented grown Yb:KY(WO(4))(2)/KY(WO(4))2(2) for use in continuous-wave and mode-locked lasers,” Opt Express, vol. 15, no. 24, pp. 16279–16284, Nov. 2007, doi: 10.1364/oe.15.016279.
[8176]	S. Kumar, S. C. Sarangi, M. Tripathi, B. Ramanujam, and Y. K. Gupta, “Seizure recurrence risk in persons with epilepsy undergoing antiepileptic drug tapering,” Acta Neurol. Scand., vol. 141, no. 1, pp. 65–76, Jan. 2020, doi: 10.1111/ane.13183.
[8177]	J. Saengsuwan et al., “Seizure-related vehicular crashes and falls with injuries for people with epilepsy (PWE) in northeastern Thailand,” Epilepsy Behav, vol. 32, pp. 49–54, Mar. 2014, doi: 10.1016/j.yebeh.2013.12.021.
[8178]	R. Weishaar, R. Wellmann, A. Camarinha-Silva, M. Rodehutscord, and J. Bennewitz, “Selecting the hologenome to breed for an improved feed efficiency in pigs-A novel selection index,” J. Anim. Breed. Genet., vol. 137, no. 1, pp. 14–22, Jan. 2020, doi: 10.1111/jbg.12447.
[8179]	T. Lebret et al., “Selection criteria for initiation and renewal of luteinizing hormone-releasing hormone agonist therapy in patients with prostate cancer: a French prospective observational study,” Ther Adv Urol, vol. 6, no. 6, pp. 205–214, Dec. 2014, doi: 10.1177/1756287214542418.
[8180]	V. J. Aloyo, K. D. Dave, T. Rahman, and J. A. Harvey, “Selective and divergent regulation of cortical 5-HT(2A) receptors in rabbit,” J. Pharmacol. Exp. Ther., vol. 299, no. 3, pp. 1066–1072, Dec. 2001.
[8181]	E. Bojnik et al., “Selective and high affinity labeling of neuronal and recombinant nociceptin receptors with the hexapeptide radioprobe [(3)H]Ac-RYYRIK-ol,” Neurochem. Int., vol. 55, no. 7, pp. 458–466, Dec. 2009, doi: 10.1016/j.neuint.2009.04.014.
[8182]	D. Parbat and U. Manna, “Selective Cooperation with Liquids for Environmentally Friendly and Comprehensive Oil-Water Separation,” ChemSusChem, vol. 10, no. 24, pp. 4839–4844, 22 2017, doi: 10.1002/cssc.201701791.
[8183]	Z. Zhou, Y. Yuan, S. Zhou, K. Ding, F. Zheng, and C.-G. Zhan, “Selective inhibitors of human mPGES-1 from structure-based computational screening,” Bioorg. Med. Chem. Lett., vol. 27, no. 16, pp. 3739–3743, 15 2017, doi: 10.1016/j.bmcl.2017.06.075.
[8184]	J. O. Jansen and Torso Trauma Working Group, “Selective non-operative management of abdominal injury in the military setting,” J R Army Med Corps, vol. 157, no. 3, pp. 237–242, Sep. 2011, doi: 10.1136/jramc-157-03-10.
[8185]	S. Clegg, F. Sirois, and M. Reuber, “Self-compassion and adjustment in epilepsy and psychogenic nonepileptic seizures,” Epilepsy Behav, vol. 100, no. Pt A, p. 106490, 2019, doi: 10.1016/j.yebeh.2019.106490.
[8186]	D. A. Baker, H. L. Caswell, and F. J. R. Eccles, “Self-compassion and depression, anxiety, and resilience in adults with epilepsy,” Epilepsy Behav, vol. 90, pp. 154–161, 2019, doi: 10.1016/j.yebeh.2018.11.025.
[8187]	S. P. Ragotzy, E. Blakely, and A. Poling, “Self-control in mentally retarded adolescents: choice as a function of amount and delay of reinforcement,” J Exp Anal Behav, vol. 49, no. 2, pp. 191–199, Mar. 1988, doi: 10.1901/jeab.1988.49-191.
[8188]	C. Roberts et al., “Self-defense,” Science, vol. 173, no. 3994, p. 281, Jul. 1971, doi: 10.1126/science.173.3994.281.
[8189]	J. Song et al., “Self-driven one-step oil removal from oil spill on water via selective-wettability steel mesh,” ACS Appl Mater Interfaces, vol. 6, no. 22, pp. 19858–19865, Nov. 2014, doi: 10.1021/am505254j.
[8190]	E. Cho, C. H. Park, C. H. Jun, H. S. Kim, S. K. Choi, and J. S. Rew, “Self-expandable metal stents for the extraction of common bile duct stones in patients receiving dual antiplatelet agents: a pilot study,” Surg Endosc, vol. 32, no. 2, pp. 1077–1081, 2018, doi: 10.1007/s00464-017-5743-2.
[8191]	D. K. Pandey et al., “Self-management skills and behaviors, self-efficacy, and quality of life in people with epilepsy from underserved populations,” Epilepsy Behav, vol. 98, no. Pt A, pp. 258–265, 2019, doi: 10.1016/j.yebeh.2019.07.042.
[8192]	M. A. de Souza and D. Salvalaio, “[Self-owned versus accredited network: comparative cost analysis in a Brazilian health insurance provider],” Rev. Panam. Salud Publica, vol. 28, no. 4, pp. 305–310, Oct. 2010, doi: 10.1590/s1020-49892010001000010.
[8193]	H. H. Siqueira et al., “Self-reported adherence among people with epilepsy in Brazil,” Epilepsy Behav, vol. 103, no. Pt A, p. 106498, 2020, doi: 10.1016/j.yebeh.2019.106498.
[8194]	Y. Otto, K. Kolmorgen, A. Andreas, C. Köppe, K. von Klitzing, and A. M. Klein, “[Self-reported Anxiety and Regulation Strategies in Primary School-age Children],” Prax Kinderpsychol Kinderpsychiatr, vol. 64, no. 5, pp. 351–367, 2015, doi: 10.13109/prkk.2015.64.5.351.
[8195]	I. R. Bell, L. Warg-Damiani, C. M. Baldwin, M. E. Walsh, and G. E. Schwartz, “Self-reported chemical sensitivity and wartime chemical exposures in Gulf War veterans with and without decreased global health ratings,” Mil Med, vol. 163, no. 11, pp. 725–732, Nov. 1998.
[8196]	C. Hausteiner, S. Bornschein, J. Hansen, T. Zilker, and H. Förstl, “Self-reported chemical sensitivity in Germany: a population-based survey,” Int J Hyg Environ Health, vol. 208, no. 4, pp. 271–278, 2005, doi: 10.1016/j.ijheh.2005.03.006.
[8197]	I. Magiati, K. Ponniah, Y. P. Ooi, Y. H. Chan, D. Fung, and B. Woo, “Self-reported depression and anxiety symptoms in school-aged Singaporean children,” Asia Pac Psychiatry, vol. 7, no. 1, pp. 91–104, Mar. 2015, doi: 10.1111/appy.12099.
[8198]	U. C. Wieshmann and G. A. Baker, “Self-reported feelings of anger and aggression towards others in patients on levetiracetam: data from the UK antiepileptic drug register,” BMJ Open, vol. 3, no. 3, Mar. 2013, doi: 10.1136/bmjopen-2013-002564.
[8199]	J. D. Bundy et al., “Self-Reported Tobacco, Alcohol, and Illicit Drug Use and Progression of Chronic Kidney Disease,” Clin J Am Soc Nephrol, vol. 13, no. 7, pp. 993–1001, 06 2018, doi: 10.2215/CJN.11121017.
[8200]	D. G. Hall, “Semantic constraints on word learning: proper names and adjectives,” Child Dev, vol. 65, no. 5, pp. 1299–1317, Oct. 1994, doi: 10.1111/j.1467-8624.1994.tb00818.x.
[8201]	J. M. J. Vonk et al., “Semantic loss marks early Alzheimer’s disease-related neurodegeneration in older adults without dementia,” Alzheimers Dement (Amst), vol. 12, no. 1, p. e12066, 2020, doi: 10.1002/dad2.12066.
[8202]	J. E. Cilek et al., “Semi-field evaluation of several novel alkenol analogs of 1-octen-3-ol as attractants to adult Aedes albopictus and Culex quinquefasciatus,” J. Am. Mosq. Control Assoc., vol. 27, no. 3, pp. 256–262, Sep. 2011, doi: 10.2987/10-6097.1.
[8203]	Y. Ma et al., “Semiconductor-based plasmonic interferometers for ultrasensitive sensing in a terahertz regime,” Opt Lett, vol. 42, no. 12, pp. 2338–2341, Jun. 2017, doi: 10.1364/OL.42.002338.
[8204]	M. A. Garcia Bento, L. S. López Greco, and F. J. Zara, “Seminal fluid production and sperm packaging in dromiid crabs (Brachyura, Podotremata),” Zoology (Jena), vol. 132, pp. 17–30, 2019, doi: 10.1016/j.zool.2018.09.001.
[8205]	F. Lotti et al., “Seminal vesicles ultrasound features in a cohort of infertility patients,” Hum. Reprod., vol. 27, no. 4, pp. 974–982, Apr. 2012, doi: 10.1093/humrep/des032.
[8206]	D. G. E. Thiem et al., “Semiquantifiable angiogenesis parameters in association with the malignant transformation of oral leukoplakia,” J. Oral Pathol. Med., vol. 46, no. 9, pp. 710–716, Oct. 2017, doi: 10.1111/jop.12544.
[8207]	S. Watanabe, M. Kanatsu-Shinohara, and T. Shinohara, “Sendai virus-mediated transduction of mammalian spermatogonial stem cells†,” Biol. Reprod., vol. 100, no. 2, pp. 523–534, 01 2019, doi: 10.1093/biolre/ioy192.
[8208]	O. H. Jeon et al., “Senescence cell-associated extracellular vesicles serve as osteoarthritis disease and therapeutic markers,” JCI Insight, vol. 4, no. 7, 04 2019, doi: 10.1172/jci.insight.125019.
[8209]	O. H. Jeon, N. David, J. Campisi, and J. H. Elisseeff, “Senescent cells and osteoarthritis: a painful connection,” J. Clin. Invest., vol. 128, no. 4, pp. 1229–1237, 02 2018, doi: 10.1172/JCI95147.
[8210]	Y.-B. Pang, W.-W. Li, J.-M. Luo, J. Ji, and X. Du, “[Senescent Mesenchymal Stem Cells Contribute to Progression of Myelodysplastic Syndromes-Review],” Zhongguo Shi Yan Xue Ye Xue Za Zhi, vol. 26, no. 3, pp. 942–946, Jun. 2018, doi: 10.7534/j.issn.1009-2137.2018.03.053.
[8211]	M. T. Keddis et al., “Senior internal medicine residents’ confidence with essential topics in evidence-based medicine taught during internship,” J Grad Med Educ, vol. 3, no. 4, pp. 490–496, Dec. 2011, doi: 10.4300/JGME-D-10-00172.1.
[8212]	X. Lou, “Sensing Exocytosis and Triggering Endocytosis at Synapses: Synaptic Vesicle Exocytosis-Endocytosis Coupling,” Front Cell Neurosci, vol. 12, p. 66, 2018, doi: 10.3389/fncel.2018.00066.
[8213]	C. Spalthoff and M. C. Göpfert, “Sensing pH with TMCs,” Neuron, vol. 91, no. 1, pp. 6–8, 06 2016, doi: 10.1016/j.neuron.2016.06.026.
[8214]	W. T. Clough, S. O. Canapp, L. D. Taboada, D. L. Dycus, and C. S. Leasure, “Sensitivity and Specificity of a Weight Distribution Platform for the Detection of Objective Lameness and Orthopaedic Disease,” Vet Comp Orthop Traumatol, vol. 31, no. 6, pp. 391–395, Nov. 2018, doi: 10.1055/s-0038-1667063.
[8215]	D. French-McCay, D. Crowley, and L. McStay, “Sensitivity of modeled oil fate and exposure from a subsea blowout to oil droplet sizes, depth, dispersant use, and degradation rates,” Mar. Pollut. Bull., vol. 146, pp. 779–793, Sep. 2019, doi: 10.1016/j.marpolbul.2019.07.038.
[8216]	C. M. Novak, M. Zhang, and J. A. Levine, “Sensitivity of the hypothalamic paraventricular nucleus to the locomotor-activating effects of neuromedin U in obesity,” Brain Res., vol. 1169, pp. 57–68, Sep. 2007, doi: 10.1016/j.brainres.2007.06.055.
[8217]	C. Moret and M. Briley, “Sensitivity of the response of 5-HT autoreceptors to drugs modifying synaptic availability of 5-HT,” Neuropharmacology, vol. 27, no. 1, pp. 43–49, Jan. 1988, doi: 10.1016/0028-3908(88)90199-2.
[8218]	G. Tripp and B. Alsop, “Sensitivity to reward delay in children with attention deficit hyperactivity disorder (ADHD),” J Child Psychol Psychiatry, vol. 42, no. 5, pp. 691–698, Jul. 2001.
[8219]	A. Sargolzaei, M. Abdelghani, K. K. Yen, and S. Sargolzaei, “Sensorimotor control: computing the immediate future from the delayed present,” BMC Bioinformatics, vol. 17 Suppl 7, p. 245, Jul. 2016, doi: 10.1186/s12859-016-1098-2.
[8220]	D. C. Steffens, “Separating mood disturbance from mild cognitive impairment in geriatric depression,” Int Rev Psychiatry, vol. 20, no. 4, pp. 374–381, Aug. 2008, doi: 10.1080/09540260802094589.
[8221]	L. Brandt, J. Borjeson, A. Norden, and I. Olsson, “Separation of lymphocytes from peripheral blood by means of a glass wool column. A method for in vitro culture of lymphocytes,” Acta Med Scand, vol. 172, pp. 459–462, Oct. 1962, doi: 10.1111/j.0954-6820.1962.tb07179.x.
[8222]	M. E. Starr and H. Saito, “Sepsis in old age: review of human and animal studies,” Aging Dis, vol. 5, no. 2, pp. 126–136, Apr. 2014, doi: 10.14336/AD.2014.0500126.
[8223]	S. R. Qayyum, S. Webb, R. H. Anderson, F. J. Verbeek, N. A. Brown, and M. K. Richardson, “Septation and valvar formation in the outflow tract of the embryonic chick heart,” Anat. Rec., vol. 264, no. 3, pp. 273–283, 01 2001, doi: 10.1002/ar.1162.
[8224]	D. Tamborrini and S. Piatti, “Septin clearance from the division site triggers cytokinesis in budding yeast,” Microb Cell, vol. 6, no. 6, pp. 295–298, May 2019, doi: 10.15698/mic2019.06.681.
[8225]	A. Kosiński, M. Zajączkowski, W. Kuta, D. Kozłowski, M. Szpinda, and M. Grzybiak, “Septomarginal trabecula and anterior papillary muscle in primate hearts: developmental issues,” Folia Morphol. (Warsz), vol. 72, no. 3, pp. 202–209, Aug. 2013, doi: 10.5603/fm.2013.0034.
[8226]	P. Badrinarayan and G. N. Sastry, “Sequence, structure, and active site analyses of p38 MAP kinase: exploiting DFG-out conformation as a strategy to design new type II leads,” J Chem Inf Model, vol. 51, no. 1, pp. 115–129, Jan. 2011, doi: 10.1021/ci100340w.
[8227]	S. A. G. Lava, V. Elie, P. T. V. Ha, and E. Jacqz-Aigrain, “Sequential analysis in neonatal research-systematic review,” Eur. J. Pediatr., vol. 177, no. 5, pp. 733–740, May 2018, doi: 10.1007/s00431-018-3110-5.
[8228]	Q. Ji et al., “Sequential Saphenous Vein Coronary Bypass Grafting,” Int Heart J, vol. 59, no. 6, pp. 1211–1218, Nov. 2018, doi: 10.1536/ihj.17-639.
[8229]	A. C. Cook et al., “Sequential segmental analysis of the crocodilian heart,” J. Anat., vol. 231, no. 4, pp. 484–499, Oct. 2017, doi: 10.1111/joa.12661.
[8230]	J. Ariño, D. Velázquez, and A. Casamayor, “Ser/Thr protein phosphatases in fungi: structure, regulation and function,” Microb Cell, vol. 6, no. 5, pp. 217–256, Apr. 2019, doi: 10.15698/mic2019.05.677.
[8231]	J. C. Marini, M. B. Lewis, Q. Wang, K. J. Chen, and B. M. Orrison, “Serine for glycine substitutions in type I collagen in two cases of type IV osteogenesis imperfecta (OI). Additional evidence for a regional model of OI pathophysiology,” J. Biol. Chem., vol. 268, no. 4, pp. 2667–2673, Feb. 1993.
[8232]	H. Y. Meltzer, “Serotonergic mechanisms as targets for existing and novel antipsychotics,” Handb Exp Pharmacol, no. 212, pp. 87–124, 2012, doi: 10.1007/978-3-642-25761-2_4.
[8233]	D. Sung, X. Dong, M. Ernberg, U. Kumar, and B. E. Cairns, “Serotonin (5-HT) excites rat masticatory muscle afferent fibers through activation of peripheral 5-HT3 receptors,” Pain, vol. 134, no. 1–2, pp. 41–50, Jan. 2008, doi: 10.1016/j.pain.2007.03.034.
[8234]	C. Nieto et al., “Serotonin (5-HT) Shapes the Macrophage Gene Profile through the 5-HT2B-Dependent Activation of the Aryl Hydrocarbon Receptor,” J. Immunol., vol. 204, no. 10, pp. 2808–2817, May 2020, doi: 10.4049/jimmunol.1901531.
[8235]	R. Liu, T. Jolas, and G. Aghajanian, “Serotonin 5-HT(2) receptors activate local GABA inhibitory inputs to serotonergic neurons of the dorsal raphe nucleus,” Brain Res., vol. 873, no. 1, pp. 34–45, Aug. 2000, doi: 10.1016/s0006-8993(00)02468-9.
[8236]	S. N. Sudweeks, J. A. van Hooft, and J. L. Yakel, “Serotonin 5-HT(3) receptors in rat CA1 hippocampal interneurons: functional and molecular characterization,” J. Physiol. (Lond.), vol. 544, no. 3, pp. 715–726, 01 2002, doi: 10.1113/jphysiol.2002.029736.
[8237]	S. Doly et al., “Serotonin 5-HT2B receptors are required for 3,4-methylenedioxymethamphetamine-induced hyperlocomotion and 5-HT release in vivo and in vitro,” J. Neurosci., vol. 28, no. 11, pp. 2933–2940, Mar. 2008, doi: 10.1523/JNEUROSCI.5723-07.2008.
[8238]	J. J. Curtis, N. T. K. Vo, C. B. Seymour, and C. E. Mothersill, “Serotonin and 5-HT3 receptors sensitize human skin cells to direct irradiation cell death but not to soluble radiation-induced bystander signals,” Environ. Res., vol. 180, p. 108807, 2020, doi: 10.1016/j.envres.2019.108807.
[8239]	G. Bagdy, V. Kecskemeti, P. Riba, and R. Jakus, “Serotonin and epilepsy,” J. Neurochem., vol. 100, no. 4, pp. 857–873, Feb. 2007, doi: 10.1111/j.1471-4159.2006.04277.x.
[8240]	J. a. J. Schmitt, M. Wingen, J. G. Ramaekers, E. a. T. Evers, and W. J. Riedel, “Serotonin and human cognitive performance,” Curr. Pharm. Des., vol. 12, no. 20, pp. 2473–2486, 2006, doi: 10.2174/138161206777698909.
[8241]	A. Panconesi, “Serotonin and migraine: a reconsideration of the central theory,” J Headache Pain, vol. 9, no. 5, pp. 267–276, Oct. 2008, doi: 10.1007/s10194-008-0058-2.
[8242]	A. M. Marshall, L. L. Hernandez, and N. D. Horseman, “Serotonin and serotonin transport in the regulation of lactation,” J Mammary Gland Biol Neoplasia, vol. 19, no. 1, pp. 139–146, Mar. 2014, doi: 10.1007/s10911-013-9304-6.
[8243]	J. M. Monti, “Serotonin control of sleep-wake behavior,” Sleep Med Rev, vol. 15, no. 4, pp. 269–281, Aug. 2011, doi: 10.1016/j.smrv.2010.11.003.
[8244]	M. Göthert, H. Bönisch, B. Malinowska, and E. Schlicker, “Serotonin discovery and stepwise disclosure of 5-HT receptor complexity over four decades. Part II. Some contributions of Manfred Göthert,” Pharmacol Rep, vol. 72, no. 2, pp. 271–284, Apr. 2020, doi: 10.1007/s43440-019-00047-4.
[8245]	L. Bardin, J. Lavarenne, and A. Eschalier, “Serotonin receptor subtypes involved in the spinal antinociceptive effect of 5-HT in rats,” Pain, vol. 86, no. 1–2, pp. 11–18, May 2000, doi: 10.1016/s0304-3959(99)00307-3.
[8246]	F. Artigas, “Serotonin receptors involved in antidepressant effects,” Pharmacol. Ther., vol. 137, no. 1, pp. 119–131, Jan. 2013, doi: 10.1016/j.pharmthera.2012.09.006.
[8247]	J. Y. Cheng, “Serotonin Reuptake Inhibitors in Obstructive Sleep Apnea: Associations in People with and without Epilepsy,” Neurol Res Int, vol. 2018, p. 7247605, 2018, doi: 10.1155/2018/7247605.
[8248]	M. Wan, L. Ding, D. Wang, J. Han, and P. Gao, “Serotonin: A Potent Immune Cell Modulator in Autoimmune Diseases,” Front Immunol, vol. 11, p. 186, 2020, doi: 10.3389/fimmu.2020.00186.
[8249]	D. M. Lovinger, “Serotonin’s role in alcohol’s effects on the brain,” Alcohol Health Res World, vol. 21, no. 2, pp. 114–120, 1997.
[8250]	T. Xu et al., “Serum 25-hydroxyvitamin D deficiency predicts long-term poor prognosis among ischemic stroke patients without hyperglycaemia,” Clin. Chim. Acta, vol. 471, pp. 81–85, Aug. 2017, doi: 10.1016/j.cca.2017.05.020.
[8251]	J. Vafaeimanesh, A. Heidari, M. Effatpanah, and M. Parham, “Serum adiponectin level in diabetic patients with and without Helicobacter pylori infection: is there any difference?,” ScientificWorldJournal, vol. 2014, p. 402685, 2014, doi: 10.1155/2014/402685.
[8252]	J. C. Thompson et al., “Serum amyloid A3 is pro-atherogenic,” Atherosclerosis, vol. 268, pp. 32–35, 2018, doi: 10.1016/j.atherosclerosis.2017.11.011.
[8253]	S. P. Alsemgeest, F. H. Jonker, M. A. Taverne, H. C. Kalsbeek, T. Wensing, and E. Gruys, “Serum amyloid-A (SAA) and haptoglobin (Hp) plasma concentrations in newborn calves,” Theriogenology, vol. 43, no. 2, pp. 381–387, Jan. 1995, doi: 10.1016/0093-691x(94)00031-o.
[8254]	M. A. Al-Humaidi, “Serum cytokines levels in Graves’ disease,” Saudi Med J, vol. 21, no. 7, pp. 639–644, Jul. 2000.
[8255]	A. Wang et al., “Serum Galectin-3 and Poor Outcomes Among Patients With Acute Ischemic Stroke,” Stroke, vol. 49, no. 1, pp. 211–214, 2018, doi: 10.1161/STROKEAHA.117.019084.
[8256]	C. Chiellini et al., “Serum haptoglobin: a novel marker of adiposity in humans,” J. Clin. Endocrinol. Metab., vol. 89, no. 6, pp. 2678–2683, Jun. 2004, doi: 10.1210/jc.2003-031965.
[8257]	Z. Zhu et al., “Serum Hepatocyte Growth Factor Is Probably Associated With 3-Month Prognosis of Acute Ischemic Stroke,” Stroke, vol. 49, no. 2, pp. 377–383, 2018, doi: 10.1161/STROKEAHA.117.019476.
[8258]	C. Zhong et al., “Serum Matrix Metalloproteinase-9 and Cognitive Impairment After Acute Ischemic Stroke,” J Am Heart Assoc, vol. 7, no. 1, 06 2018, doi: 10.1161/JAHA.117.007776.
[8259]	C. Zhong et al., “Serum matrix metalloproteinase-9 levels and prognosis of acute ischemic stroke,” Neurology, vol. 89, no. 8, pp. 805–812, Aug. 2017, doi: 10.1212/WNL.0000000000004257.
[8260]	H. Proenca, C. Ferreira, M. Miranda, A. Castanheira-Dinis, and M. Monteiro-Grillo, “Serum prolactin levels in HLA-B27-associated uveitis,” Eur J Ophthalmol, vol. 18, no. 6, pp. 929–933, Dec. 2008, doi: 10.1177/112067210801800612.
[8261]	Z. Zhu et al., “Serum Rheumatoid Factor Levels at Acute Phase of Ischemic Stroke are Associated with Poststroke Cognitive Impairment,” J Stroke Cerebrovasc Dis, vol. 28, no. 4, pp. 1133–1140, Apr. 2019, doi: 10.1016/j.jstrokecerebrovasdis.2018.12.049.
[8262]	R. Kocijan et al., “Serum sclerostin levels are decreased in adult patients with different types of osteogenesis imperfecta,” J. Clin. Endocrinol. Metab., vol. 99, no. 2, pp. E311-319, Feb. 2014, doi: 10.1210/jc.2013-2244.
[8263]	D. Navarro et al., “Set of interviews,” Wkly. Epidemiol. Rec., vol. 90, no. 20, pp. 218–235, May 2015.
[8264]	D. L. Conine, B. D. Naumann, and L. H. Hecker, “Setting health-based residue limits for contaminants in pharmaceuticals and medical devices,” Qual Assur, vol. 1, no. 3, pp. 171–180, Jun. 1992.
[8265]	B. Dowd, R. Feldman, J. Nyman, and B. Town, “Setting physicians’ prices in FFS medicare: an economic perspective,” Health Care Financ Rev, vol. 28, no. 2, pp. 97–111, 2006.
[8266]	K. Fulcher and H. Gibb, “Setting the research agenda on the health effects of chemicals,” Int J Environ Res Public Health, vol. 11, no. 1, pp. 1049–1057, Jan. 2014, doi: 10.3390/ijerph110101049.
[8267]	A. M. Gila, M. A. Bejaoui, G. Beltrán, and A. Jiménez, “Settling of virgin olive oil from horizontal screw solid bowl in static conditions,” J Food Sci Technol, vol. 54, no. 9, pp. 2989–2996, Aug. 2017, doi: 10.1007/s13197-017-2738-x.
[8268]	G. Mall, M. Hubig, A. Büttner, J. Kuznik, R. Penning, and M. Graw, “Sex determination and estimation of stature from the long bones of the arm,” Forensic Sci. Int., vol. 117, no. 1–2, pp. 23–30, Mar. 2001, doi: 10.1016/s0379-0738(00)00445-x.
[8269]	V. Osborne, C. W. Striley, S. J. Nixon, A. G. Winterstein, and L. B. Cottler, “Sex differences in patterns of prescription opioid non-medical use among 10-18 year olds in the US,” Addict Behav, vol. 89, pp. 163–171, 2019, doi: 10.1016/j.addbeh.2018.10.009.
[8270]	V. Osborne, C. W. Striley, S. J. Nixon, A. G. Winterstein, and L. B. Cottler, “Sex differences in peer and parental risk factors for non-medical use of prescription opioids in youth,” Am J Drug Alcohol Abuse, vol. 46, no. 2, pp. 203–215, 2020, doi: 10.1080/00952990.2019.1671436.
[8271]	S. Murphy, A. Elklit, Y. Y. Chen, S. R. Ghazali, and M. Shevlin, “Sex differences in PTSD symptoms: A differential item functioning approach,” Psychol Trauma, vol. 11, no. 3, pp. 319–327, Mar. 2019, doi: 10.1037/tra0000355.
[8272]	J. Repple, U. Habel, L. Wagels, C. M. Pawliczek, F. Schneider, and N. Kohn, “Sex differences in the neural correlates of aggression,” Brain Struct Funct, vol. 223, no. 9, pp. 4115–4124, Dec. 2018, doi: 10.1007/s00429-018-1739-5.
[8273]	M. Palmiero, R. Nori, C. Rogolino, S. D’amico, and L. Piccardi, “Sex differences in visuospatial and navigational working memory: the role of mood induced by background music,” Exp Brain Res, vol. 234, no. 8, pp. 2381–2389, 2016, doi: 10.1007/s00221-016-4643-3.
[8274]	L. Andréen, S. Nyberg, S. Turkmen, G. van Wingen, G. Fernández, and T. Bäckström, “Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABAA modulators,” Psychoneuroendocrinology, vol. 34, no. 8, pp. 1121–1132, Sep. 2009, doi: 10.1016/j.psyneuen.2009.02.003.
[8275]	E. D. Luczak and L. A. Leinwand, “Sex-based cardiac physiology,” Annu. Rev. Physiol., vol. 71, pp. 1–18, 2009, doi: 10.1146/annurev.physiol.010908.163156.
[8276]	H. Zhang et al., “Sex-Based Differences in Gut Microbiota Composition in Response to Tuna Oil and Algae Oil Supplementation in a D-galactose-Induced Aging Mouse Model,” Front Aging Neurosci, vol. 10, p. 187, 2018, doi: 10.3389/fnagi.2018.00187.
[8277]	C. P. McDowell, M. J. Campbell, and M. P. Herring, “Sex-Related Differences in Mood Responses to Acute Aerobic Exercise,” Med Sci Sports Exerc, vol. 48, no. 9, pp. 1798–1802, 2016, doi: 10.1249/MSS.0000000000000969.
[8278]	H. Rakov et al., “Sex-specific phenotypes of hyperthyroidism and hypothyroidism in aged mice,” Biol Sex Differ, vol. 8, no. 1, p. 38, 22 2017, doi: 10.1186/s13293-017-0159-1.
[8279]	M. J. Traa, J. De Vries, J. A. Roukema, and B. L. Den Oudsten, “Sexual (dys)function and the quality of sexual life in patients with colorectal cancer: a systematic review,” Ann. Oncol., vol. 23, no. 1, pp. 19–27, Jan. 2012, doi: 10.1093/annonc/mdr133.
[8280]	I. Askew et al., “Sexual and reproductive health and rights in emergencies,” Bull. World Health Organ., vol. 94, no. 5, p. 311, May 2016, doi: 10.2471/BLT.16.173567.
[8281]	C. P. Miles and A. S. Koons, “Sexual dimorphism of rat cells in vitro,” Science, vol. 131, no. 3402, p. 740, Mar. 1960, doi: 10.1126/science.131.3402.740.
[8282]	C. Rathore, O. J. Henning, G. Luef, and K. Radhakrishnan, “Sexual dysfunction in people with epilepsy,” Epilepsy Behav, vol. 100, no. Pt A, p. 106495, 2019, doi: 10.1016/j.yebeh.2019.106495.
[8283]	L. Rew, “Sexual Health in Children and Adolescents,” Compr Child Adolesc Nurs, vol. 40, no. 3, pp. 142–143, Sep. 2017, doi: 10.1080/24694193.2017.1333878.
[8284]	L. Rew, “Sexual health of adolescents with chronic health conditions,” Adolesc Med State Art Rev, vol. 18, no. 3, pp. 519–529, vii, Dec. 2007.
[8285]	L. Rew, “Sexual health practices of homeless youth: a model for intervention,” Issues Compr Pediatr Nurs, vol. 24, no. 1, pp. 1–18, Mar. 2001.
[8286]	L. Rew, “Sexual health promotion in adolescents with chronic health conditions,” Fam Community Health, vol. 29, no. 1 Suppl, pp. 61S–9S, Mar. 2006, doi: 10.1097/00003727-200601001-00010.
[8287]	L. Ouellette, M. Wingelaar, T. Peterson, M. Emery, and J. Jones, “Sexual history documentation in adolescents with lower abdominal pain or genitourinary complaints,” Am J Emerg Med, vol. 36, no. 4, pp. 728–729, Apr. 2018, doi: 10.1016/j.ajem.2017.08.041.
[8288]	U. Boehmer, A. Ozonoff, and J. Potter, “Sexual Minority Women’s Health Behaviors and Outcomes After Breast Cancer,” LGBT Health, vol. 2, no. 3, pp. 221–227, Sep. 2015, doi: 10.1089/lgbt.2014.0105.
[8289]	J. A. Blayney, M. Scalco, S. Radomski, C. Colder, and J. P. Read, “Sexual victimization histories and substance use trajectories during the transition out of college,” Psychol Addict Behav, vol. 33, no. 6, pp. 529–539, Sep. 2019, doi: 10.1037/adb0000489.
[8290]	A. Bonomi, E. Nichols, R. Kammes, and T. Green, “Sexual Violence and Intimate Partner Violence in College Women with a Mental Health and/or Behavior Disability,” J Womens Health (Larchmt), vol. 27, no. 3, pp. 359–368, 2018, doi: 10.1089/jwh.2016.6279.
[8291]	K. von Sydow and M. Ullmeyer, “[Sexuality in pregnancy: survey of the DFG project ‘Parenthood, couple relations and sexuality’ and first preliminary findings],” Zentralbl Gynakol, vol. 121 Suppl 1, pp. 35–40, 1999.
[8292]	T. B. Kashdan, F. R. Goodman, M. Stiksma, C. R. Milius, and P. E. McKnight, “Sexuality leads to boosts in mood and meaning in life with no evidence for the reverse direction: A daily diary investigation,” Emotion, vol. 18, no. 4, pp. 563–576, 2018, doi: 10.1037/emo0000324.
[8293]	D. Carmona-Gutierrez, K. Kainz, and F. Madeo, “Sexually transmitted infections: old foes on the rise,” Microb Cell, vol. 3, no. 9, pp. 361–362, Sep. 2016, doi: 10.15698/mic2016.09.522.
[8294]	M. Schürmann and C. Olms, “Shade Stability of Polymer Infiltrated and Resin Nano Ceramic Crowns after Dynamic Chewing Simulation,” Eur J Prosthodont Restor Dent, vol. 26, no. 4, pp. 174–183, Nov. 2018, doi: 10.1922/EJPRD_01807Schurmann10.
[8295]	M. G. Schürmann and C. Olms, “Shade Stability of Polymer-Infiltrated and Resin Nano Ceramics,” Open Dent J, vol. 12, pp. 791–800, 2018, doi: 10.2174/1745017901814010791.
[8296]	F. Martin, M. Holtmann, and T. Legenbauer, “[Shame and Compassion: Potential Mechanisms Behind Bullying and Depressive Symptoms],” Prax Kinderpsychol Kinderpsychiatr, vol. 68, no. 7, pp. 639–653, Nov. 2019, doi: 10.13109/prkk.2019.68.7.639.
[8297]	A. Viol, F. Palhano-Fontes, H. Onias, D. B. de Araujo, and G. M. Viswanathan, “Shannon entropy of brain functional complex networks under the influence of the psychedelic Ayahuasca,” Sci Rep, vol. 7, no. 1, p. 7388, 07 2017, doi: 10.1038/s41598-017-06854-0.
[8298]	E. Robotti, “Shaping the nasal dorsum,” HNO, vol. 66, no. 2, pp. 92–102, Feb. 2018, doi: 10.1007/s00106-017-0425-x.
[8299]	L. Sargent et al., “Shared biological pathways for frailty and cognitive impairment: A systematic review,” Ageing Res. Rev., vol. 47, pp. 149–158, 2018, doi: 10.1016/j.arr.2018.08.001.
[8300]	H.-Z. Xu, Y.-M. Chu, and W.-M. Qian, “Sharp bounds for the Sándor-Yang means in terms of arithmetic and contra-harmonic means,” J Inequal Appl, vol. 2018, no. 1, p. 127, 2018, doi: 10.1186/s13660-018-1719-6.
[8301]	D. H. Lee et al., “Shear-Wave Dispersion Slope from US Shear-Wave Elastography: Detection of Allograft Damage after Liver Transplantation,” Radiology, vol. 293, no. 2, pp. 327–333, 2019, doi: 10.1148/radiol.2019190064.
[8302]	M. Faisal, M. Purbayu, M. A. Shavalier, T. L. Marsh, and T. P. Loch, “Shedding of the Salmonid Herpesvirus-3 by Infected Lake Trout (Salvelinus namaycush),” Viruses, vol. 11, no. 7, 26 2019, doi: 10.3390/v11070580.
[8303]	G. A. Fontana, J. K. Reinert, N. H. Thomä, and U. Rass, “Shepherding DNA ends: Rif1 protects telomeres and chromosome breaks,” Microb Cell, vol. 5, no. 7, pp. 327–343, May 2018, doi: 10.15698/mic2018.07.639.
[8304]	Y. Qiu et al., “Shifts in the Composition and Activities of Denitrifiers Dominate CO2 Stimulation of N2O Emissions,” Environ. Sci. Technol., vol. 53, no. 19, pp. 11204–11213, Oct. 2019, doi: 10.1021/acs.est.9b02983.
[8305]	C. Barba, M. Valeriani, G. Colicchio, and F. Mauguière, “Short and middle-latency Median Nerve (MN) SEPs recorded by depth electrodes in human pre-SMA and SMA-proper,” Clin Neurophysiol, vol. 116, no. 11, pp. 2664–2674, Nov. 2005, doi: 10.1016/j.clinph.2005.07.022.
[8306]	G. Migliardi et al., “Short- and long-term effects on prolactin of risperidone and olanzapine treatments in children and adolescents,” Prog. Neuropsychopharmacol. Biol. Psychiatry, vol. 33, no. 8, pp. 1496–1501, Nov. 2009, doi: 10.1016/j.pnpbp.2009.08.009.
[8307]	M. Elliott, C. Watson, E. Wilkinson, A. W. Musk, and F. R. Lake, “Short- and long-term hospital and community exercise programmes for patients with chronic obstructive pulmonary disease,” Respirology, vol. 9, no. 3, pp. 345–351, Aug. 2004, doi: 10.1111/j.1440-1843.2004.00595.x.
[8308]	I. Tendolkar, G. van Wingen, M. Urner, R. J. Verkes, and G. Fernández, “Short-term duloxetine administration affects neural correlates of mood-congruent memory,” Neuropsychopharmacology, vol. 36, no. 11, pp. 2266–2275, Oct. 2011, doi: 10.1038/npp.2011.114.
[8309]	C. Steinert, H. Schauenburg, U. Dinger, and F. Leichsenring, “[Short-Term Psychodynamic Therapy in Depression - An Evidence-Based Unified Protocol],” Psychother Psychosom Med Psychol, vol. 66, no. 1, pp. 9–20, Jan. 2016, doi: 10.1055/s-0035-1559612.
[8310]	H. Hamid and A. M. Kanner, “Should antidepressant drugs of the selective serotonin reuptake inhibitor family be tested as antiepileptic drugs?,” Epilepsy Behav, vol. 26, no. 3, pp. 261–265, Mar. 2013, doi: 10.1016/j.yebeh.2012.10.009.
[8311]	M. Di Napoli and F. Papa, “Should neurologists measure fibrinogen concentrations?,” J. Neurol. Sci., vol. 246, no. 1–2, pp. 5–9, Jul. 2006, doi: 10.1016/j.jns.2006.03.005.
[8312]	R. Seides, “Should the current DSM-IV-TR definition for PTSD be expanded to include serial and multiple microtraumas as aetiologies?,” J Psychiatr Ment Health Nurs, vol. 17, no. 8, pp. 725–731, Oct. 2010, doi: 10.1111/j.1365-2850.2010.01591.x.
[8313]	E. Erkul and M. B. Gillespie, “Sialendoscopy for non-stone disorders: The current evidence,” Laryngoscope Investig Otolaryngol, vol. 1, no. 5, pp. 140–145, 2016, doi: 10.1002/lio2.33.
[8314]	L. Gugglberger, E. Flaschberger, and F. Teutsch, “‘Side effects’ of health promotion: an example from Austrian schools,” Health Promot Int, vol. 32, no. 1, pp. 157–166, 01 2017, doi: 10.1093/heapro/dau054.
[8315]	J. L. Yaek, C. J. Andrecovich, J. M. Cavanaugh, and S. W. Rouhana, “Side Impact Assessment and Comparison of Appropriate Size and Age Equivalent Porcine Surrogates to Scaled Human Side Impact Response Biofidelity Corridors,” Stapp Car Crash J, vol. 62, pp. 359–377, Nov. 2018.
[8316]	S. S. Atamanalp, E. Disci, and R. S. Atamanalp, “Sigmoid volvulus: Comorbidity with sigmoid gangrene,” Pak J Med Sci, vol. 35, no. 1, pp. 288–290, Feb. 2019, doi: 10.12669/pjms.35.1.295.
[8317]	J. J. Heinisch and R. Brandt, “Signaling pathways and posttranslational modifications of tau in Alzheimer’s disease: the humanization of yeast cells,” Microb Cell, vol. 3, no. 4, pp. 135–146, Mar. 2016, doi: 10.15698/mic2016.04.489.
[8318]	D. A. Rew, “Significance of aneuploidy,” Br J Surg, vol. 81, no. 10, pp. 1416–1422, Oct. 1994, doi: 10.1002/bjs.1800811005.
[8319]	M. R. Mohanka et al., “Significance of Best Spirometry in the First Year after Bilateral Lung Transplantation: Association with 3-Year Outcomes,” Transplantation, Nov. 2019, doi: 10.1097/TP.0000000000003046.
[8320]	B. Xia et al., “Significance of CD34(-) and CD34(+) cell apoptosis and proliferation in bone marrow of patients with MDS and their impact on survival,” Zhongguo Shi Yan Xue Ye Xue Za Zhi, vol. 20, no. 6, pp. 1392–1397, Dec. 2012.
[8321]	Z. Chlap and Z. Porwit-Bobr, “[Significance of human tumor tissue culture in vitro in virusology],” Postepy Hig Med Dosw, vol. 10, no. 3, pp. 299–315, 1956.
[8322]	K. Kitamura et al., “Significant association between urethral length measured by magnetic resonance imaging and urinary continence recovery after robot-assisted radical prostatectomy,” Prostate Int, vol. 7, no. 2, pp. 54–59, Jun. 2019, doi: 10.1016/j.prnil.2018.06.003.
[8323]	G. Palmiero et al., “Significant functional mitral regurgitation affects left atrial function in heart failure patients: haemodynamic correlations and prognostic implications,” Eur Heart J Cardiovasc Imaging, vol. 20, no. 9, pp. 1012–1019, Sep. 2019, doi: 10.1093/ehjci/jez036.
[8324]	S. S.-S. Chen, “Significant predictive factors for subfertility in patients with subclinical varicocele,” Andrologia, vol. 49, no. 10, Dec. 2017, doi: 10.1111/and.12781.
[8325]	Y. P. Malyshkov and S. Y. Malyshkov, “[Signs of the Impact of the Earth’s core on the Planet’s Population],” Biofizika, vol. 60, no. 3, pp. 589–624, Jun. 2015.
[8326]	V. Phani, V. S. Somvanshi, and U. Rao, “Silencing of a Meloidogyne incognita selenium-binding protein alters the cuticular adhesion of Pasteuria penetrans endospores,” Gene, vol. 677, pp. 289–298, Nov. 2018, doi: 10.1016/j.gene.2018.08.058.
[8327]	N. J. Simcox, D. Lofgren, J. Leons, and J. Camp, “Silica exposure during granite countertop fabrication,” Appl Occup Environ Hyg, vol. 14, no. 9, pp. 577–582, Sep. 1999, doi: 10.1080/104732299302350.
[8328]	J. R. Deslauriers and C. A. Redlich, “Silica Exposure, Silicosis, and the New Occupational Safety and Health Administration Silica Standard. What Pulmonologists Need to Know,” Ann Am Thorac Soc, vol. 15, no. 12, pp. 1391–1392, 2018, doi: 10.1513/AnnalsATS.201809-589ED.
[8329]	P. Gottesfeld, D. Andrew, and J. Dalhoff, “Silica Exposures in Artisanal Small-Scale Gold Mining in Tanzania and Implications for Tuberculosis Prevention,” J Occup Environ Hyg, vol. 12, no. 9, pp. 647–653, 2015, doi: 10.1080/15459624.2015.1029617.
[8330]	H. Barnes, N. S. L. Goh, T. L. Leong, and R. Hoy, “Silica-associated lung disease: An old-world exposure in modern industries,” Respirology, vol. 24, no. 12, pp. 1165–1175, 2019, doi: 10.1111/resp.13695.
[8331]	N. H. de Klerk and A. W. Musk, “Silica, compensated silicosis, and lung cancer in Western Australian goldminers,” Occup Environ Med, vol. 55, no. 4, pp. 243–248, Apr. 1998, doi: 10.1136/oem.55.4.243.
[8332]	T. Partanen, J. Jaakkola, and A. Tossavainen, “Silica, silicosis and cancer in Finland,” Scand J Work Environ Health, vol. 21 Suppl 2, pp. 84–86, 1995.
[8333]	M. Manno, L. Levy, G. Johanson, and P. Cocco, “Silica, silicosis and lung cancer: what level of exposure is acceptable?,” Med Lav, vol. 109, no. 6, pp. 478–480, Dec. 2018, doi: 10.23749/mdl.v109i6.7928.
[8334]	D. Rees and J. Murray, “Silica, silicosis and tuberculosis,” Int. J. Tuberc. Lung Dis., vol. 11, no. 5, pp. 474–484, May 2007.
[8335]	M. M. Finkelstein, “Silica, silicosis, and lung cancer: a risk assessment,” Am. J. Ind. Med., vol. 38, no. 1, pp. 8–18, Jul. 2000, doi: 10.1002/1097-0274(200007)38:1<8::aid-ajim2>3.0.co;2-#.
[8336]	K. Steenland and E. Ward, “Silica: a lung carcinogen,” CA Cancer J Clin, vol. 64, no. 1, pp. 63–69, Feb. 2014, doi: 10.3322/caac.21214.
[8337]	Y. Yang et al., “Silicon-nanoparticle-based composites for advanced lithium-ion battery anodes,” Nanoscale, vol. 12, no. 14, pp. 7461–7484, Apr. 2020, doi: 10.1039/c9nr10652a.
[8338]	A. Kampik and A. Gandorfer, “Silicone oil removal strategies,” Semin Ophthalmol, vol. 15, no. 2, pp. 88–91, Jun. 2000, doi: 10.3109/08820530009039998.
[8339]	C. C. Leung, I. T. S. Yu, and W. Chen, “Silicosis,” Lancet, vol. 379, no. 9830, pp. 2008–2018, May 2012, doi: 10.1016/S0140-6736(12)60235-9.
[8340]	E. M. De Capitani, “Silicosis (still) among us,” J Bras Pneumol, vol. 32, no. 6, pp. xxxiii–xxxv, Dec. 2006, doi: 10.1590/s1806-37132006000600003.
[8341]	Centers for Disease Control (CDC), “Silicosis among pottery workers--New Jersey,” MMWR Morb. Mortal. Wkly. Rep., vol. 41, no. 23, pp. 405–406, 411, Jun. 1992.
[8342]	N. Kurihara and O. Wada, “Silicosis and smoking strongly increase lung cancer risk in silica-exposed workers,” Ind Health, vol. 42, no. 3, pp. 303–314, Jul. 2004, doi: 10.2486/indhealth.42.303.
[8343]	N. H. De Klerk, G. L. Ambrosini, S. C. Pang, and A. W. Musk, “Silicosis compensation in Western Australian gold miners since the introduction of an occupational exposure standard for crystalline silica,” Ann Occup Hyg, vol. 46, no. 8, pp. 687–692, Nov. 2002, doi: 10.1093/annhyg/mef088.
[8344]	M. Zhang et al., “Silicosis in automobile foundry workers: a 29-year cohort study,” Biomed. Environ. Sci., vol. 23, no. 2, pp. 121–129, Apr. 2010, doi: 10.1016/S0895-3988(10)60041-4.
[8345]	C. Wen, X. Wen, R. Li, S. Su, and H. Xu, “Silicosis in rhinestone-manufacturing workers in South China,” Occup Med (Lond), vol. 69, no. 7, pp. 475–481, Dec. 2019, doi: 10.1093/occmed/kqz107.
[8346]	V. Marochini and M. Kuis, “[Silicosis in the silica sand quarry Saulaga near Pula],” Arh Hig Rada, vol. 6, no. 1, pp. 11–22, 1955.
[8347]	K. M. Bang et al., “Silicosis mortality trends and new exposures to respirable crystalline silica - United States, 2001-2010,” MMWR Morb. Mortal. Wkly. Rep., vol. 64, no. 5, pp. 117–120, Feb. 2015.
[8348]	M. M. Finkelstein, “Silicosis surveillance in Ontario from 1979 to 1992,” Scand J Work Environ Health, vol. 21 Suppl 2, pp. 55–57, 1995.
[8349]	M. I. Greenberg, J. Waksman, and J. Curtis, “Silicosis: a review,” Dis Mon, vol. 53, no. 8, pp. 394–416, Aug. 2007, doi: 10.1016/j.disamonth.2007.09.020.
[8350]	R. Teipel et al., “Siltuximab for Multicentric Castleman Disease-Letter,” Clin. Cancer Res., vol. 21, no. 20, p. 4740, Oct. 2015, doi: 10.1158/1078-0432.CCR-15-1310.
[8351]	G. Maass, “[Simian virus (SV) 40],” Ergeb Mikrobiol Immunitatsforsch Exp Ther, vol. 39, pp. 146–193, 1966, doi: 10.1007/978-3-662-38353-7_6.
[8352]	P. Striano, A. Bianchi, M. Pezzella, and F. Zara, “Similar but not identical: clinical implications for molecular studies in monozygotic discordant twins with epilepsy,” Epilepsy Behav, vol. 20, no. 2, p. 419, Feb. 2011, doi: 10.1016/j.yebeh.2010.12.007.
[8353]	J. P. Gleeson et al., “Similar overall survival with reduced vs. standard dose bevacizumab monotherapy in progressive glioblastoma,” Cancer Med, vol. 9, no. 2, pp. 469–475, 2020, doi: 10.1002/cam4.2616.
[8354]	J. M. Bae and H. J. Ju, “Simple cross-polarized photography using a smartphone,” J. Am. Acad. Dermatol., vol. 82, no. 6, pp. e185–e186, Jun. 2020, doi: 10.1016/j.jaad.2019.08.025.
[8355]	G. Elshimy, P. Techathaveewat, M. Alsayed, S. Jyothinagaram, and R. Correa, “Simple Reason for Hypoglycemia: ACE Inhibitor-induced Severe Recurrent Hypoglycemia in a Nondiabetic Patient,” Cureus, vol. 11, no. 8, p. e5449, Aug. 2019, doi: 10.7759/cureus.5449.
[8356]	S. Taylor, G. J. G. Asmundson, and R. N. Carleton, “Simple versus complex PTSD: a cluster analytic investigation,” J Anxiety Disord, vol. 20, no. 4, pp. 459–472, 2006, doi: 10.1016/j.janxdis.2005.04.003.
[8357]	R. R. Liu, K. L. Prado, and M. T. Gillin, “Simplified ‘on-couch’ daily quality assurance procedure for CT simulators,” J Appl Clin Med Phys, vol. 10, no. 3, p. 2844, Jun. 2009, doi: 10.1120/jacmp.v10i3.2844.
[8358]	R. A. Yokel et al., “Simulated biological fluid exposure changes nanoceria’s surface properties but not its biological response,” Eur J Pharm Biopharm, vol. 144, pp. 252–265, Nov. 2019, doi: 10.1016/j.ejpb.2019.09.023.
[8359]	A. R. Memon, J. Andresen, M. Habib, and M. Jaffar, “Simulated sugar factory wastewater remediation kinetics using algal-bacterial raceway reactor promoted by polyacrylate polyalcohol,” Bioresour. Technol., vol. 157, pp. 37–43, Apr. 2014, doi: 10.1016/j.biortech.2014.01.047.
[8360]	M. Zarbin, M. Tsuboi, L. F. Hill, and I. Stoilov, “Simulating an Anti-Vascular Endothelial Growth Factor Switch in Neovascular Age-Related Macular Degeneration: A HARBOR Subanalysis,” Ophthalmology, vol. 126, no. 6, pp. 849–855, 2019, doi: 10.1016/j.ophtha.2019.01.003.
[8361]	S. M. Danilov, I. V. Balyasnikova, R. F. Albrecht, and O. A. Kost, “Simultaneous determination of ACE activity with 2 substrates provides information on the status of somatic ACE and allows detection of inhibitors in human blood,” J. Cardiovasc. Pharmacol., vol. 52, no. 1, pp. 90–103, Jul. 2008, doi: 10.1097/FJC.0b013e31817fd3bc.
[8362]	E. Perkins, M. Rooth, M. Dillon, and K. Brown, “Simultaneous labyrinthectomy and cochlear implantation in unilateral meniere’s disease,” Laryngoscope Investig Otolaryngol, vol. 3, no. 3, pp. 225–230, Jun. 2018, doi: 10.1002/lio2.163.
[8363]	C. M. O’Connell et al., “Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis,” Microb Cell, vol. 6, no. 3, pp. 177–183, Jan. 2019, doi: 10.15698/mic2019.03.672.
[8364]	L. He et al., “Simultaneous Quantification of Nucleosides and Nucleotides from Biological Samples,” J. Am. Soc. Mass Spectrom., vol. 30, no. 6, pp. 987–1000, Jun. 2019, doi: 10.1007/s13361-019-02140-7.
[8365]	L. He et al., “Simultaneous quantification of straight-chain and branched-chain short chain fatty acids by gas chromatography mass spectrometry,” J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., vol. 1092, pp. 359–367, Aug. 2018, doi: 10.1016/j.jchromb.2018.06.028.
[8366]	M. R. Cowie, “Simultaneous treatment of hypertension and dyslipidaemia may help to reduce overall cardiovascular risk: focus on amlodipine/atorvastatin single-pill therapy,” Int. J. Clin. Pract., vol. 59, no. 7, pp. 839–846, Jul. 2005, doi: 10.1111/j.1368-5031.2005.00601.x.
[8367]	S. Biswas, H. Naskar, S. Pradhan, Y. Wang, R. Bandyopadhyay, and P. Pramanik, “Simultaneous voltammetric determination of Adrenaline and Tyrosine in real samples by neodymium oxide nanoparticles grafted graphene,” Talanta, vol. 206, p. 120176, Jan. 2020, doi: 10.1016/j.talanta.2019.120176.
[8368]	T. Chen et al., “Simvastatin Enhances Activity and Trafficking of α7 Nicotinic Acetylcholine Receptor in Hippocampal Neurons Through PKC and CaMKII Signaling Pathways,” Front Pharmacol, vol. 9, p. 362, 2018, doi: 10.3389/fphar.2018.00362.
[8369]	X. Zheng, W. Zhang, and Z. Wang, “Simvastatin preparations promote PDGF-BB secretion to repair LPS-induced endothelial injury through the PDGFRβ/PI3K/Akt/IQGAP1 signalling pathway,” J. Cell. Mol. Med., vol. 23, no. 12, pp. 8314–8327, 2019, doi: 10.1111/jcmm.14709.
[8370]	G. I. Harisa, A. H. Alomrani, and M. M. Badran, “Simvastatin-loaded nanostructured lipid carriers attenuate the atherogenic risk of erythrocytes in hyperlipidemic rats,” Eur J Pharm Sci, vol. 96, pp. 62–71, Jan. 2017, doi: 10.1016/j.ejps.2016.09.004.
[8371]	S. Korrapati et al., “Single Cell and Single Nucleus RNA-Seq Reveal Cellular Heterogeneity and Homeostatic Regulatory Networks in Adult Mouse Stria Vascularis,” Front Mol Neurosci, vol. 12, p. 316, 2019, doi: 10.3389/fnmol.2019.00316.
[8372]	H. Fan, C. Wang, and Z. Guo, “Single nucleotide polymorphisms in the mitochondrial displacement loop and age at onset of non-Hodgkin lymphoma,” Onco Targets Ther, vol. 6, pp. 1041–1045, 2013, doi: 10.2147/OTT.S49597.
[8373]	G. Swapna, E. Y. Yu, and N. F. Lue, “Single telomere length analysis in Ustilago maydis, a high-resolution tool for examining fungal telomere length distribution and C-strand 5’-end processing,” Microb Cell, vol. 5, no. 9, pp. 393–403, Aug. 2018, doi: 10.15698/mic2018.09.645.
[8374]	K. Midtvedt et al., “Single transplanted kidneys from a 90-year-old deceased donor perform acceptably at 1 year,” Transplant. Proc., vol. 43, no. 5, pp. 2107–2109, Jun. 2011, doi: 10.1016/j.transproceed.2011.01.192.
[8375]	M. Hori et al., “Single-breath-hold thin-slice gadoxetic acid-enhanced hepatobiliary MR imaging using a newly developed three-dimensional fast spoiled gradient-echo sequence,” Magn Reson Imaging, vol. 34, no. 4, pp. 545–551, May 2016, doi: 10.1016/j.mri.2015.11.014.
[8376]	J. M. Criado, A. de la Fuente, M. Heredia, A. S. Riolobos, and J. Yajeya, “Single-cell recordings: a method for investigating the brain’s activation pattern during exercise,” Methods, vol. 45, no. 4, pp. 262–270, Aug. 2008, doi: 10.1016/j.ymeth.2008.05.007.
[8377]	J. H. Erasmus et al., “Single-dose replicating RNA vaccine induces neutralizing antibodies against SARS-CoV-2 in nonhuman primates,” bioRxiv, May 2020, doi: 10.1101/2020.05.28.121640.
[8378]	D. A. Carlton, D. David Beahm, and A. G. Chiu, “Sinonasal malignancies: Endoscopic treatment outcomes,” Laryngoscope Investig Otolaryngol, vol. 4, no. 2, pp. 259–263, Apr. 2019, doi: 10.1002/lio2.249.
[8379]	I. Gengler, J. C. Wang, M. M. Speth, and A. R. Sedaghat, “Sinonasal pathophysiology of SARS-CoV-2 and COVID-19: A systematic review of the current evidence,” Laryngoscope Investig Otolaryngol, vol. 5, no. 3, pp. 354–359, Jun. 2020, doi: 10.1002/lio2.384.
[8380]	M. Palmiero, R. Nori, C. Rogolino, S. D’Amico, and L. Piccardi, “Situated navigational working memory: the role of positive mood,” Cogn Process, vol. 16 Suppl 1, pp. 327–330, Sep. 2015, doi: 10.1007/s10339-015-0670-4.
[8381]	A. Moritz et al., “Six-year follow-up after heart valve replacement with the Edwards Duromedics bileaflet prosthesis,” Eur J Cardiothorac Surg, vol. 7, no. 2, pp. 84–90, 1993, doi: 10.1016/1010-7940(93)90186-f.
[8382]	B. Szyszymar, “[Skin changes in dys-and paraproteinemias],” Przegl Dermatol, vol. 54, no. 5, pp. 591–596, Oct. 1967.
[8383]	M. Promkatkaew, D. Gleeson, S. Hannongbua, and M. P. Gleeson, “Skin sensitization prediction using quantum chemical calculations: a theoretical model for the S(N)Ar domain,” Chem. Res. Toxicol., vol. 27, no. 1, pp. 51–60, Jan. 2014, doi: 10.1021/tx400323e.
[8384]	A. G. Harvey, C. Jones, and D. A. Schmidt, “Sleep and posttraumatic stress disorder: a review,” Clin Psychol Rev, vol. 23, no. 3, pp. 377–407, May 2003, doi: 10.1016/s0272-7358(03)00032-1.
[8385]	P. Pérez Sales, M. Graell Berna, A. Pérez Jiménez, J. P. Pérez Jiménez, J. J. López Castillo, and J. Santodomingo Carrasco, “[Sleep deprivation and its effect on mood and performance of residents],” Rev Clin Esp, vol. 193, no. 7, pp. 383–386, Nov. 1993.
[8386]	K. T. Rew, “Sleep Disorders: Foreword,” FP Essent, vol. 460, p. 2, Sep. 2017.
[8387]	M. A. Komolafe et al., “Sleep disturbances among patients with epilepsy in Nigeria,” Ann Afr Med, vol. 14, no. 2, pp. 103–108, Jun. 2015, doi: 10.4103/1596-3519.149880.
[8388]	J. Watling, B. Pawlik, K. Scott, S. Booth, and M. A. Short, “Sleep Loss and Affective Functioning: More Than Just Mood,” Behav Sleep Med, vol. 15, no. 5, pp. 394–409, Oct. 2017, doi: 10.1080/15402002.2016.1141770.
[8389]	R. Robbins et al., “Sleep myths: an expert-led study to identify false beliefs about sleep that impinge upon population sleep health practices,” Sleep Health, vol. 5, no. 4, pp. 409–417, 2019, doi: 10.1016/j.sleh.2019.02.002.
[8390]	A. E. Çilliler and B. Güven, “Sleep quality and related clinical features in patients with epilepsy: A preliminary report,” Epilepsy Behav, vol. 102, p. 106661, 2020, doi: 10.1016/j.yebeh.2019.106661.
[8391]	B. Izci, M. Vennelle, W. A. Liston, K. C. Dundas, A. A. Calder, and N. J. Douglas, “Sleep-disordered breathing and upper airway size in pregnancy and post-partum,” Eur. Respir. J., vol. 27, no. 2, pp. 321–327, Feb. 2006, doi: 10.1183/09031936.06.00148204.
[8392]	S. J. Choi, E. Y. Joo, and S. B. Hong, “Sleep-wake pattern, chronotype and seizures in patients with epilepsy,” Epilepsy Res., vol. 120, pp. 19–24, Feb. 2016, doi: 10.1016/j.eplepsyres.2015.11.010.
[8393]	M. H. Yu et al., “Small (≤1-cm) hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid-enhanced MR imaging,” Radiology, vol. 271, no. 3, pp. 748–760, Jun. 2014, doi: 10.1148/radiol.14131996.
[8394]	N. Wu et al., “Small Heterodimer Partner (NR0B2) Coordinates Nutrient Signaling and the Circadian Clock in Mice,” Mol. Endocrinol., vol. 30, no. 9, pp. 988–995, Sep. 2016, doi: 10.1210/me.2015-1295.
[8395]	S. HervÍas-Parejo et al., “Small size does not restrain frugivory and seed dispersal across the evolutionary radiation of Galápagos lava lizards,” Curr Zool, vol. 65, no. 4, pp. 353–361, Aug. 2019, doi: 10.1093/cz/zoy066.
[8396]	“Smallpox in the post eradication era,” Wkly. Epidemiol. Rec., vol. 91, no. 20, pp. 257–264, May 2016.
[8397]	L. Velayudhan, F. Wilson-Morkeh, E. Penney, A. J. M. Jesu, S. Baillon, and T. Brugha, “Smell identification function in early-onset Alzheimer’s disease and mild cognitive impairment,” Int Psychogeriatr, pp. 1–6, Oct. 2018, doi: 10.1017/S1041610218001503.
[8398]	Y. Du, J. Fryzek, M. A. Sekeres, and E. Taioli, “Smoking and alcohol intake as risk factors for myelodysplastic syndromes (MDS),” Leuk. Res., vol. 34, no. 1, pp. 1–5, Jan. 2010, doi: 10.1016/j.leukres.2009.08.006.
[8399]	L. S. Covey, I. Berlin, M.-C. Hu, and J. K. Hakes, “Smoking and suicidal behaviours in a sample of US adults with low mood: a retrospective analysis of longitudinal data,” BMJ Open, vol. 2, no. 3, 2012, doi: 10.1136/bmjopen-2012-000876.
[8400]	F. Gloria-Bottini and E. Bottini, “Smoking and the correlation between birth weight and placental weight. Evidence of interaction with maternal haptoglobin phenotype,” Eur. J. Obstet. Gynecol. Reprod. Biol., vol. 185, pp. 136–139, Feb. 2015, doi: 10.1016/j.ejogrb.2014.12.019.
[8401]	K. A. Perkins, G. E. Giedgowd, J. L. Karelitz, C. A. Conklin, and C. Lerman, “Smoking in response to negative mood in men versus women as a function of distress tolerance,” Nicotine Tob. Res., vol. 14, no. 12, pp. 1418–1425, Dec. 2012, doi: 10.1093/ntr/nts075.
[8402]	C. J. Berg et al., “Smoking patterns, attitudes and motives: unique characteristics among 2-year versus 4-year college students,” Health Educ Res, vol. 26, no. 4, pp. 614–623, Aug. 2011, doi: 10.1093/her/cyr017.
[8403]	K. Miyagawa et al., “Smooth Muscle Contact Drives Endothelial Regeneration by BMPR2-Notch1-Mediated Metabolic and Epigenetic Changes,” Circ. Res., vol. 124, no. 2, pp. 211–224, 18 2019, doi: 10.1161/CIRCRESAHA.118.313374.
[8404]	S. D. Willis et al., “Snf1 cooperates with the CWI MAPK pathway to mediate the degradation of Med13 following oxidative stress,” Microb Cell, vol. 5, no. 8, pp. 357–370, Jun. 2018, doi: 10.15698/mic2018.08.641.
[8405]	Q. N. Tran, I. T. Kim, S. Park, H. W. Choi, and S. J. Park, “SnO2 Nanoflower-Nanocrystalline Cellulose Composites as Anode Materials for Lithium-Ion Batteries,” Materials (Basel), vol. 13, no. 14, Jul. 2020, doi: 10.3390/ma13143165.
[8406]	A. Papa, “So much to gain for nurses who ease the pain,” Nurs Manage, vol. 45, no. 12, pp. 21–22, Dec. 2014, doi: 10.1097/01.NUMA.0000457135.64967.fd.
[8407]	J. S. Alpert, “So, You Have to Give a Lecture-Are You Anxious?,” Am. J. Med., vol. 132, no. 5, pp. 545–546, 2019, doi: 10.1016/j.amjmed.2018.11.024.
[8408]	M. S. Roberto, K. Mearns, and S. A. Silva, “Social and moral norm differences among Portuguese 1st and 6th year medical students towards their intention to comply with hand hygiene,” Psychol Health Med, vol. 17, no. 4, pp. 408–416, 2012, doi: 10.1080/13548506.2011.626431.
[8409]	R. E. Bueno, S. T. Moysés, P. A. R. Bueno, and S. J. Moysés, “[Social determinants and adult oral health in Brazilian state capitals],” Rev. Panam. Salud Publica, vol. 36, no. 1, pp. 17–23, Jul. 2014.
[8410]	H. Graham and P. C. L. White, “Social determinants and lifestyles: integrating environmental and public health perspectives,” Public Health, vol. 141, pp. 270–278, Dec. 2016, doi: 10.1016/j.puhe.2016.09.019.
[8411]	G. Macgregor, “Social determinants of health practices,” Am J Public Health Nations Health, vol. 51, pp. 1709–1714, Nov. 1961, doi: 10.2105/ajph.51.11.1709.
[8412]	J. Namasasu, S. Chivers, and L. Costello, “Social determinants of health: Social forces that shape women and men’s knowledge of reproductive health in a resource-limited setting,” Health Care Women Int, vol. 37, no. 10, pp. 1138–1155, 2016, doi: 10.1080/07399332.2016.1158261.
[8413]	A. K. Cadogan, D. A. Kendall, H. Fink, and C. A. Marsden, “Social interaction increases 5-HT release and cAMP efflux in the rat ventral hippocampus in vivo,” Behav Pharmacol, vol. 5, no. 3, pp. 299–305, Jun. 1994, doi: 10.1097/00008877-199406000-00007.
[8414]	A. Kapilashrami et al., “Social movements and public health advocacy in action: the UK people’s health movement,” J Public Health (Oxf), vol. 38, no. 3, pp. 413–416, 2016, doi: 10.1093/pubmed/fdv085.
[8415]	H. B. Shakya, C. J. Fariss, C. Ojeda, A. Raj, and E. Reed, “Social Network Clustering of Sexual Violence Experienced by Adolescent Girls,” Am. J. Epidemiol., vol. 186, no. 7, pp. 796–804, Oct. 2017, doi: 10.1093/aje/kwx154.
[8416]	X. Tong et al., “Social support for people with epilepsy in China,” Epilepsy Behav, vol. 64, no. Pt A, pp. 224–232, 2016, doi: 10.1016/j.yebeh.2016.08.010.
[8417]	S. L. Asher, K. V. Iserson, L. H. Merck, and Society for Academic Emergency Medicine Ethics Committee (Aasim I. Padela, MD, MS, Chair), “Society for Academic Emergency Medicine Statement on Plagiarism,” Acad Emerg Med, vol. 24, no. 10, pp. 1290–1292, 2017, doi: 10.1111/acem.13241.
[8418]	D. Brodish, M. Bandoli, and R. Smith, “Society of Quality Assurance demographic and salary survey,” Qual Assur, vol. 5, no. 2, pp. 115–124, Jun. 1997.
[8419]	K. M. Robinson, K. B. Christensen, B. Ottesen, and A. Krasnik, “Socio-demographic factors, comorbidity and diagnostic delay among women diagnosed with cervical, endometrial or ovarian cancer,” Eur J Cancer Care (Engl), vol. 20, no. 5, pp. 653–661, Sep. 2011, doi: 10.1111/j.1365-2354.2011.01259.x.
[8420]	S. N. Goh et al., “Sociodemographic, home environment and parental influences on total and device-specific screen viewing in children aged 2 years and below: an observational study,” BMJ Open, vol. 6, no. 1, p. e009113, Jan. 2016, doi: 10.1136/bmjopen-2015-009113.
[8421]	M. Y. Chan, J. Na, P. F. Agres, N. K. Savalia, D. C. Park, and G. S. Wig, “Socioeconomic status moderates age-related differences in the brain’s functional network organization and anatomy across the adult lifespan,” Proc. Natl. Acad. Sci. U.S.A., vol. 115, no. 22, pp. E5144–E5153, 29 2018, doi: 10.1073/pnas.1714021115.
[8422]	S. A. G. Lava, M. G. Bianchetti, C. Agostoni, and G. P. Milani, “Sodium monitoring in infants < 100 days of life,” Eur. J. Pediatr., vol. 179, no. 7, pp. 1167–1168, 2020, doi: 10.1007/s00431-019-03471-z.
[8423]	Y. Liu, M. Shi, J. Dolan, and J. He, “Sodium sensitivity of blood pressure in Chinese populations,” J Hum Hypertens, vol. 34, no. 2, pp. 94–107, Feb. 2020, doi: 10.1038/s41371-018-0152-0.
[8424]	“Soil-transmitted helminthiases:  number of children treated in  2013,” Wkly. Epidemiol. Rec., vol. 90, no. 10, pp. 89–94, Mar. 2015.
[8425]	J. J. Lembrechts et al., “SoilTemp: A global database of near-surface temperature,” Glob Chang Biol, Apr. 2020, doi: 10.1111/gcb.15123.
[8426]	H. Otani, M. Kaya, A. Tamaki, Y. Hosokawa, and J. K. W. Lee, “Solar radiation and the validity of infrared tympanic temperature during exercise in the heat,” Int J Biometeorol, vol. 64, no. 1, pp. 39–45, Jan. 2020, doi: 10.1007/s00484-019-01791-1.
[8427]	A. Bargoni, R. Cavalli, O. Caputo, A. Fundarò, M. R. Gasco, and G. P. Zara, “Solid lipid nanoparticles in lymph and plasma after duodenal administration to rats,” Pharm. Res., vol. 15, no. 5, pp. 745–750, May 1998, doi: 10.1023/a:1011975120776.
[8428]	N. Berger et al., “Solvent-Enhanced Conformational Flexibility of Cyclic Tetrapeptides,” Chemphyschem, vol. 20, no. 13, pp. 1664–1670, 02 2019, doi: 10.1002/cphc.201900345.
[8429]	E. Gennaro et al., “Somatic and germline mosaicisms in severe myoclonic epilepsy of infancy,” Biochem. Biophys. Res. Commun., vol. 341, no. 2, pp. 489–493, Mar. 2006, doi: 10.1016/j.bbrc.2005.12.209.
[8430]	V. I. Shumakov, N. K. Zimin,  null Kormer AYa, and L. P. Tsyganov, “Some aspects of experimental heart transplantation,” Cor Vasa, vol. 28, no. 5, pp. 384–391, 1986.
[8431]	D. Stiller, F. W. Path, and H. E. Kaiser, “Some characteristics of the mesenchymal stem cell of soft tissue tumors,” In Vivo, vol. 6, no. 4, pp. 477–480, Aug. 1992.
[8432]	A. W. Siegel, “Some doubts about in vitro eugenics as a human enhancement technology,” J Med Ethics, vol. 40, no. 11, p. 732, Nov. 2014, doi: 10.1136/medethics-2013-101511.
[8433]	P.-H. Castel, “[Some Drops of Logic in the Fog of Depression],” Rev Colomb Psiquiatr, vol. 45, no. 2, pp. 137–144, Jun. 2016, doi: 10.1016/j.rcp.2015.10.001.
[8434]	S. Xiang, J. He, C. Liu, W. Jia, and Y. Yang, “Some further results on the stability of Ky Fan’s points,” J Inequal Appl, vol. 2017, no. 1, p. 289, 2017, doi: 10.1186/s13660-017-1562-1.
[8435]	F. Diamond, “Some Health Insurance Plans Groan About Not Making It on Exchanges,” Manag Care, vol. 25, no. 3, pp. 34–35, Mar. 2016.
[8436]	H. Rein, Y. Fujii, and D. S. Spiegel, “Some inconvenient truths about biosignatures involving two chemical species on Earth-like exoplanets,” Proc. Natl. Acad. Sci. U.S.A., vol. 111, no. 19, pp. 6871–6875, May 2014, doi: 10.1073/pnas.1401816111.
[8437]	T. Yonezawa and M. Hasegawa, “Some problems in proving the existence of the universal common ancestor of life on Earth,” ScientificWorldJournal, vol. 2012, p. 479824, 2012, doi: 10.1100/2012/479824.
[8438]	A. F. Zakharov, “[SOME PROBLEMS OF CULTIVATION IN VITRO IN CONNECTION WITH THE DEVELOPMENT OF GENETICS OF SOMATIC CELLS OF MAMMALS AND MAN],” Usp Sovrem Biol, vol. 56, pp. 228–248, Oct. 1963.
[8439]	T. S. Duffy, “Some recent advances in understanding the mineralogy of Earth’s deep mantle,” Philos Trans A Math Phys Eng Sci, vol. 366, no. 1883, pp. 4273–4293, Nov. 2008, doi: 10.1098/rsta.2008.0172.
[8440]	J. Smith, S. J. Wisniewski, M. K. Wempe, B. W. Landry, and J. L. Sellon, “Sonographically guided obturator internus injections: techniques and validation,” J Ultrasound Med, vol. 31, no. 10, pp. 1597–1608, Oct. 2012, doi: 10.7863/jum.2012.31.10.1597.
[8441]	M. R. Boyett, H. Dobrzynski, M. K. Lancaster, S. A. Jones, H. Honjo, and I. Kodama, “Sophisticated architecture is required for the sinoatrial node to perform its normal pacemaker function,” J. Cardiovasc. Electrophysiol., vol. 14, no. 1, pp. 104–106, Jan. 2003, doi: 10.1046/j.1540-8167.2003.02307.x.
[8442]	H. W. Elani, C. Bedos, and P. J. Allison, “Sources of stress in Canadian dental students: a prospective mixed methods study,” J Dent Educ, vol. 77, no. 11, pp. 1488–1497, Nov. 2013.
[8443]	L.-J. Chew et al., “Sox17 Regulates a Program of Oligodendrocyte Progenitor Cell Expansion and Differentiation during Development and Repair,” Cell Rep, vol. 29, no. 10, pp. 3173-3186.e7, 03 2019, doi: 10.1016/j.celrep.2019.10.121.
[8444]	I. D. Fisk and D. A. Gray, “Soybean (Glycine max) oil bodies and their associated phytochemicals,” J. Food Sci., vol. 76, no. 9, pp. C1349-1354, Dec. 2011, doi: 10.1111/j.1750-3841.2011.02428.x.
[8445]	N. Srivastava, J. Grover, and P. Panthri, “Space Maintenance with an Innovative ‘Tube and Loop’ Space Maintainer (Nikhil Appliance),” Int J Clin Pediatr Dent, vol. 9, no. 1, pp. 86–89, Mar. 2016, doi: 10.5005/jp-journals-10005-1340.
[8446]	W. H. Thompson and P. Fransson, “Spatial confluence of psychological and anatomical network constructs in the human brain revealed by a mass meta-analysis of fMRI activation,” Sci Rep, vol. 7, p. 44259, 13 2017, doi: 10.1038/srep44259.
[8447]	T. Z. Osborne, G. L. Bruland, S. Newman, K. R. Reddy, and S. Grunwald, “Spatial distributions and eco-partitioning of soil biogeochemical properties in the Everglades National Park,” Environ Monit Assess, vol. 183, no. 1–4, pp. 395–408, Dec. 2011, doi: 10.1007/s10661-011-1928-7.
[8448]	J. Tan, P. Zhang, J. Li, and S. Liu, “[Spatial-temporal evolution characteristic of coordination between urbanization and eco-environment in Jilin Province, Northeast China],” Ying Yong Sheng Tai Xue Bao, vol. 26, no. 12, pp. 3827–3834, Dec. 2015.
[8449]	O. Lib and Y. Bromberg, “Spatially entangled Airy photons,” Opt Lett, vol. 45, no. 6, pp. 1399–1402, Mar. 2020, doi: 10.1364/OL.388692.
[8450]	G. Northoff, “Spatiotemporal psychopathology I: No rest for the brain’s resting state activity in depression? Spatiotemporal psychopathology of depressive symptoms,” J Affect Disord, vol. 190, pp. 854–866, Jan. 2016, doi: 10.1016/j.jad.2015.05.007.
[8451]	A. Papa, “Special Needs Patients,” J Emerg Nurs, vol. 42, no. 1, pp. 71–74, Jan. 2016, doi: 10.1016/j.jen.2015.10.018.
[8452]	W. Lijinsky, “Species differences in carcinogenesis,” In Vivo, vol. 7, no. 1, pp. 65–72, Feb. 1993.
[8453]	T. Shibamoto, Y. Kato, R. Nagao, T. Yamazaki, T. Tomo, and T. Watanabe, “Species-dependence of the redox potential of the primary quinone electron acceptor QA in photosystem II verified by spectroelectrochemistry,” FEBS Lett., vol. 584, no. 8, pp. 1526–1530, Apr. 2010, doi: 10.1016/j.febslet.2010.03.002.
[8454]	F. Ramos-León, S. Arévalo, V. Mariscal, and E. Flores, “Specific mutations in the permease domain of septal protein SepJ differentially affect functions related to multicellularity in the filamentous cyanobacterium Anabaena,” Microb Cell, vol. 5, no. 12, pp. 555–565, Oct. 2018, doi: 10.15698/mic2018.12.661.
[8455]	M.-H. Bardel and F. Colombel, “[Specific trait and state anxiety’s roles in emergence and maintenance of attentional biases associated with anxiety: Inventories and investigation tracks],” Encephale, vol. 35, no. 5, pp. 409–416, Oct. 2009, doi: 10.1016/j.encep.2008.08.004.
[8456]	N. Teraphongphom, C. S. Kong, J. M. Warram, and E. L. Rosenthal, “Specimen mapping in head and neck cancer using fluorescence imaging,” Laryngoscope Investig Otolaryngol, vol. 2, no. 6, pp. 447–452, 2017, doi: 10.1002/lio2.84.
[8457]	Y. Peng et al., “[Spectral reflectance characteristics of dominant plant species at different eco-restoring stages in the semi-arid grassland],” Guang Pu Xue Yu Guang Pu Fen Xi, vol. 34, no. 11, pp. 3090–3094, Nov. 2014.
[8458]	F. Maderspacher, “Spectres of the Anthropocene,” Curr. Biol., vol. 29, no. 19, pp. R942–R946, 07 2019, doi: 10.1016/j.cub.2019.09.020.
[8459]	S. R. Grobler, R. Hayward, S. Wiese, M. H. Moola, and T. J. van W Kotze, “Spectrophotometric assessment of the effectiveness of Opalescence PF 10%: a 14-month clinical study,” J Dent, vol. 38, no. 2, pp. 113–117, Feb. 2010, doi: 10.1016/j.jdent.2009.09.009.
[8460]	P. Allard, M. Burton, and F. Muré, “Spectroscopic evidence for a lava fountain driven by previously accumulated magmatic gas,” Nature, vol. 433, no. 7024, pp. 407–410, Jan. 2005, doi: 10.1038/nature03246.
[8461]	G. Rance and E. J. Barker, “Speech and language outcomes in children with auditory neuropathy/dys-synchrony managed with either cochlear implants or hearing aids,” Int J Audiol, vol. 48, no. 6, pp. 313–320, 2009, doi: 10.1080/14992020802665959.
[8462]	P. Prabhu, V. Avilala, and A. Barman, “Speech perception abilities for spectrally modified signals in individuals with auditory dys-synchrony,” Int J Audiol, vol. 50, no. 5, pp. 349–352, May 2011, doi: 10.3109/14992027.2010.549516.
[8463]	U. A. Kumar and M. Jayaram, “Speech perception in individuals with auditory dys-synchrony,” J Laryngol Otol, vol. 125, no. 3, pp. 236–245, Mar. 2011, doi: 10.1017/S0022215110001854.
[8464]	U. A. Kumar and M. Jayaram, “Speech perception in individuals with auditory dys-synchrony: effect of lengthening of voice onset time and burst duration of speech segments,” J Laryngol Otol, vol. 127, no. 7, pp. 656–665, Jul. 2013, doi: 10.1017/S0022215113001278.
[8465]	S. H. Speldewinde and C. M. Grant, “Spermidine cures yeast of prions,” Microb Cell, vol. 3, no. 1, pp. 46–48, Dec. 2015, doi: 10.15698/mic2016.01.474.
[8466]	S. Yun et al., “Spexin-Based Galanin Receptor Type 2 Agonist for Comorbid Mood Disorders and Abnormal Body Weight,” Front Neurosci, vol. 13, p. 391, 2019, doi: 10.3389/fnins.2019.00391.
[8467]	P. Spincemaille, B. P. Cammue, and K. Thevissen, “Sphingolipids and mitochondrial function, lessons learned from yeast,” Microb Cell, vol. 1, no. 7, pp. 210–224, Jun. 2014, doi: 10.15698/mic2014.07.156.
[8468]	J. E. Kim, J. Go, H. S. Lee, J. T. Hong, and D. Y. Hwang, “Spicatoside A in red Liriope platyphylla displays a laxative effect in a constipation rat model via regulating mAChRs and ER stress signaling,” Int. J. Mol. Med., vol. 43, no. 1, pp. 185–198, Jan. 2019, doi: 10.3892/ijmm.2018.3960.
[8469]	“Spin cycle,” Nature, vol. 516, no. 7531, pp. 287–288, Dec. 2014, doi: 10.1038/516287b.
[8470]	G. Ju, J. Wang, Y. Wang, and X. Zhao, “Spinal cord contusion,” Neural Regen Res, vol. 9, no. 8, pp. 789–794, Apr. 2014, doi: 10.4103/1673-5374.131591.
[8471]	A. Amelot, C. Cretolle, T. de Saint Denis, S. Sarnacki, M. Catala, and M. Zerah, “Spinal dysraphism as a new entity in V.A.C.TE.R.L syndrome, resulting in a novel acronym V.A.C.TE.R.L.S,” Eur. J. Pediatr., vol. 179, no. 7, pp. 1121–1129, Jul. 2020, doi: 10.1007/s00431-020-03609-4.
[8472]	S. K. Mukherji, “Spinal infections,” Neuroimaging Clin. N. Am., vol. 25, no. 2, p. xiii, May 2015, doi: 10.1016/j.nic.2015.02.002.
[8473]	Y. Su, Q. Liang, G. Su, N. Wang, C. Baudouin, and A. Labbé, “Spontaneous Eye Blink Patterns in Dry Eye: Clinical Correlations,” Invest. Ophthalmol. Vis. Sci., vol. 59, no. 12, pp. 5149–5156, 01 2018, doi: 10.1167/iovs.18-24690.
[8474]	E. P. Spugnini et al., “Spontaneous intestinal melanoma in dogs,” In Vivo, vol. 19, no. 6, pp. 1051–1054, Dec. 2005.
[8475]	Q. Wang, J. Cheng, W. Zhang, and Y. Ju, “Spontaneous massive intracystic hemorrhage due to cystic hemangioblastoma in a pediatric patient,” Br J Neurosurg, pp. 1–2, Jul. 2019, doi: 10.1080/02688697.2019.1639618.
[8476]	N. Maqani, R. D. Fine, M. Shahid, M. Li, E. Enriquez-Hesles, and J. S. Smith, “Spontaneous mutations in CYC8 and MIG1 suppress the short chronological lifespan of budding yeast lacking SNF1/AMPK,” Microb Cell, vol. 5, no. 5, pp. 233–248, Feb. 2018, doi: 10.15698/mic2018.05.630.
[8477]	G. Capoferri, G. P. Milani, G. P. Ramelli, A. Ferrarini, M. G. Bianchetti, and S. A. G. Lava, “Sporadic acute benign calf myositis: Systematic literature review,” Neuromuscul. Disord., vol. 28, no. 5, pp. 443–449, 2018, doi: 10.1016/j.nmd.2018.02.005.
[8478]	J. R. Freedy and C. D. Brock, “Spotting-and treating-PTSD in primary care,” J Fam Pract, vol. 59, no. 2, pp. 75–80, Feb. 2010.
[8479]	Y.-T. Yang, C.-T. Chen, J.-C. Yang, and T. Tsai, “Spray-dried microparticles containing polymeric micelles encapsulating hematoporphyrin,” AAPS J, vol. 12, no. 2, pp. 138–146, Jun. 2010, doi: 10.1208/s12248-009-9172-6.
[8480]	C. H. Lineweaver, “Spreading the power: comment on ‘Life, hierarchy, and the thermodynamic machinery of planet Earth’ by A. Kleidon,” Phys Life Rev, vol. 7, no. 4, pp. 463–464; discussion 473-476, Dec. 2010, doi: 10.1016/j.plrev.2010.10.004.
[8481]	N. Ludwig et al., “Spring is in the air: seasonal profiles indicate vernal change of miRNA activity,” RNA Biol, vol. 16, no. 8, pp. 1034–1043, 2019, doi: 10.1080/15476286.2019.1612217.
[8482]	“Sputum-smear-negative pulmonary tuberculosis: controlled trial of 3-month and 2-month regimens of chemotherapy,” Lancet, vol. 1, no. 8131, pp. 1361–1363, Jun. 1979.
[8483]	B. D. Lovin and P. W. Gidley, “Squamous cell carcinoma of the temporal bone: A current review,” Laryngoscope Investig Otolaryngol, vol. 4, no. 6, pp. 684–692, Dec. 2019, doi: 10.1002/lio2.330.
[8484]	J. Sun, P. Tu, and Y. Wang, “sQUIZ your knowledge: Rheumatoid nodules in progressive rheumatoid arthritis,” Eur J Dermatol, vol. 29, no. 2, pp. 245–246, Apr. 2019, doi: 10.1684/ejd.2019.3567.
[8485]	Z. Lian, Y. He, C.-K. Zhang, and M. Wu, “Stability and Stabilization of T-S Fuzzy Systems With Time-Varying Delays via Delay-Product-Type Functional Method,” IEEE Trans Cybern, vol. 50, no. 6, pp. 2580–2589, Jun. 2020, doi: 10.1109/TCYB.2018.2890425.
[8486]	S. S. Teh and S. H. Mah, “Stability Evaluations of Different Types of Vegetable Oil-based Emulsions,” J Oleo Sci, vol. 67, no. 11, pp. 1381–1387, 2018, doi: 10.5650/jos.ess18067.
[8487]	I. Berasategi, B. Barriuso, D. Ansorena, and I. Astiasarán, “Stability of avocado oil during heating: comparative study to olive oil,” Food Chem, vol. 132, no. 1, pp. 439–446, May 2012, doi: 10.1016/j.foodchem.2011.11.018.
[8488]	A. Loh, R. Shankar, S. Y. Ha, J. G. An, and U. H. Yim, “Stability of mechanically and chemically dispersed oil: Effect of particle types on oil dispersion,” Sci. Total Environ., vol. 716, p. 135343, May 2020, doi: 10.1016/j.scitotenv.2019.135343.
[8489]	H. Asghar, W. Wei, P. Kumar, E. Sooudi, and J. G. McInerney, “Stabilization of self-mode-locked quantum dash lasers by symmetric dual-loop optical feedback,” Opt Express, vol. 26, no. 4, pp. 4581–4592, Feb. 2018, doi: 10.1364/OE.26.004581.
[8490]	E. Sadeghi, A. Mahtabani, A. Etminan, and F. Karami, “Stabilization of soybean oil during accelerated storage by essential oil of ferulago angulata boiss,” J Food Sci Technol, vol. 53, no. 2, pp. 1199–1204, Feb. 2016, doi: 10.1007/s13197-015-2078-7.
[8491]	B. Yoldemir, B. Ng, and R. Abugharbieh, “Stable Overlapping Replicator Dynamics for Brain Community Detection,” IEEE Trans Med Imaging, vol. 35, no. 2, pp. 529–538, Feb. 2016, doi: 10.1109/TMI.2015.2480864.
[8492]	H. Guo and Y. Kim, “Stacked multi-electrode design of microbial electrolysis cells for rapid and low-sludge treatment of municipal wastewater,” Biotechnol Biofuels, vol. 12, p. 23, 2019, doi: 10.1186/s13068-019-1368-0.
[8493]	 null Stoltzman,  null Stocker,  null Borst, and  null Stay, “Stage-specific production and release of juvenile hormone esterase from the ovary of Diploptera punctata,” J. Insect Physiol., vol. 46, no. 5, pp. 771–782, May 2000, doi: 10.1016/s0022-1910(99)00166-3.
[8494]	X. Xu et al., “Stage-specific regulation of oligodendrocyte development by Hedgehog signaling in the spinal cord,” Glia, vol. 68, no. 2, pp. 422–434, 2020, doi: 10.1002/glia.23729.
[8495]	C.-W. Wu et al., “Staged Thyroidectomy: A Single Institution Perspective,” Laryngoscope Investig Otolaryngol, vol. 3, no. 4, pp. 326–332, Aug. 2018, doi: 10.1002/lio2.171.
[8496]	A. Papa and C. Lefton, “Stand Up and Make a Difference!,” J Emerg Nurs, vol. 41, no. 6, pp. 518–520, Nov. 2015, doi: 10.1016/j.jen.2015.07.008.
[8497]	K. R. Kaufman and N. D. Kaufman, “Stand up for epilepsy San Diego photo-shoot: a personal odyssey,” Epileptic Disord, vol. 15, no. 2, pp. 211–215, Jun. 2013, doi: 10.1684/epd.2013.0579.
[8498]	V. Isaman and R. Thelin, “Standard operating procedures (SOPs): reason for, types of, adequacy, approval, and deviations from and revisions to,” Qual Assur, vol. 4, no. 3, pp. 167–171, Sep. 1995.
[8499]	F. Schneider, R. C. Gur, R. E. Gur, and L. R. Muenz, “Standardized mood induction with happy and sad facial expressions,” Psychiatry Res, vol. 51, no. 1, pp. 19–31, Jan. 1994, doi: 10.1016/0165-1781(94)90044-2.
[8500]	S. K. Nath, “Stapled Haemorrhoidectomy-Experience With Modified Anoscope,” Indian J Surg, vol. 77, no. Suppl 3, pp. 1438–1440, Dec. 2015, doi: 10.1007/s12262-014-1131-5.
[8501]	D. Waltham, “Star Masses and Star-Planet Distances for Earth-like Habitability,” Astrobiology, vol. 17, no. 1, pp. 61–77, 2017, doi: 10.1089/ast.2016.1518.
[8502]	R. J. Dohmen, “Starting with a degron: N-terminal formyl-methionine of nascent bacterial proteins contributes to their proteolytic control,” Microb Cell, vol. 2, no. 10, pp. 356–359, Oct. 2015, doi: 10.15698/mic2015.10.235.
[8503]	R. W. Booth and M. Peker, “State anxiety impairs attentional control when other sources of control are minimal,” Cogn Emot, vol. 31, no. 5, pp. 1004–1011, 2017, doi: 10.1080/02699931.2016.1172474.
[8504]	N. D. Anderson, “State of the science on mild cognitive impairment (MCI),” CNS Spectr, vol. 24, no. 1, pp. 78–87, 2019, doi: 10.1017/S1092852918001347.
[8505]	L. Rew and E. M. Barrow, “State of the science: intuition in nursing, a generation of studying the phenomenon,” ANS Adv Nurs Sci, vol. 30, no. 1, pp. E15-25, Mar. 2007, doi: 10.1097/00012272-200701000-00011.
[8506]	A. K. Madl et al., “State-of-the-science review of the occupational health hazards of crystalline silica in abrasive blasting operations and related requirements for respiratory protection,” J Toxicol Environ Health B Crit Rev, vol. 11, no. 7, pp. 548–608, Aug. 2008, doi: 10.1080/10937400801909135.
[8507]	D. Knorr, K.-H. Engel, R. Vogel, B. Kochte-Clemens, G. Eisenbrand, and Senate Commission on Food Safety (SKLM) of the German Research Foundation (DFG), “Statement on the treatment of food using a pulsed electric field. Opinion of the Senate Commission on Food Safety (SKLM) of the German Research Foundation (DFG),” Mol Nutr Food Res, vol. 52, no. 12, pp. 1539–1542, Dec. 2008, doi: 10.1002/mnfr.200800391.
[8508]	O. Eyal et al., “Static and dynamic characteristics of an InAs/InP quantum-dot optical amplifier operating at high temperatures,” Opt Express, vol. 25, no. 22, pp. 27262–27269, Oct. 2017, doi: 10.1364/OE.25.027262.
[8509]	D. R. Christman, “Static gas counters for inimical gases,” Tech Rep Brookhaven Natl Lab, pp. 1–6, May 1966.
[8510]	L. M. Spergel, J. E. Holland, S. Z. Fadem, C. J. McAllister, and E. J. Peacock, “Static intra-access pressure ratio does not correlate with access blood flow,” Kidney Int., vol. 66, no. 4, pp. 1512–1516, Oct. 2004, doi: 10.1111/j.1523-1755.2004.00946.x.
[8511]	M. S. von Itzstein et al., “Statin Intolerance, Anti-HMGCR Antibodies, and Immune Checkpoint Inhibitor-Associated Myositis: A ‘Two-Hit’ Autoimmune Toxicity or Clinical Predisposition?,” Oncologist, May 2020, doi: 10.1634/theoncologist.2019-0911.
[8512]	T. Sanghangthum, S. Suriyapee, S. Srisatit, and T. Pawlicki, “Statistical process control analysis for patient-specific IMRT and VMAT QA,” J. Radiat. Res., vol. 54, no. 3, pp. 546–552, May 2013, doi: 10.1093/jrr/rrs112.
[8513]	“Status of new vaccine introduction – worldwide, September 2016,” Wkly. Epidemiol. Rec., vol. 92, no. 1, pp. 1–8, 06 2017.
[8514]	A. Bhanushali et al., “Status of TMPRSS2-ERG fusion in prostate cancer patients from India: correlation with clinico-pathological details and TMPRSS2 Met160Val polymorphism,” Prostate Int, vol. 6, no. 4, pp. 145–150, Dec. 2018, doi: 10.1016/j.prnil.2018.03.004.
[8515]	J. Breton, “Steady-state FTIR spectra of the photoreduction of QA and QB in Rhodobacter sphaeroides reaction centers provide evidence against the presence of a proposed transient electron acceptor X between the two quinones,” Biochemistry, vol. 46, no. 15, pp. 4459–4465, Apr. 2007, doi: 10.1021/bi700297b.
[8516]	B. Adams and T. Shwayder, “Steatocystoma multiplex suppurativum,” Int. J. Dermatol., vol. 47, no. 11, pp. 1155–1156, Nov. 2008, doi: 10.1111/j.1365-4632.2008.03698.x.
[8517]	T. Douglas, “Stem cell-derived gametes, iterated in vitro reproduction, and genetic parenthood,” J Med Ethics, vol. 40, no. 11, pp. 723–724, Nov. 2014, doi: 10.1136/medethics-2014-102521.
[8518]	C. L. Tommaso, “Stents following rotablator for flow limiting dissections: device synergy or dys-synergy,” Cathet Cardiovasc Diagn, vol. 37, no. 3, pp. 305–306, Mar. 1996, doi: 10.1002/(SICI)1097-0304(199603)37:3<305::AID-CCD19>3.0.CO;2-G.
[8519]	T. Hayashi, G. Kehr, K. Bergander, and R. Gilmour, “Stereospecific α-Sialylation by Site-Selective Fluorination,” Angew. Chem. Int. Ed. Engl., vol. 58, no. 12, pp. 3814–3818, 18 2019, doi: 10.1002/anie.201812963.
[8520]	C. H. Kim et al., “Stereotactic body radiotherapy in the treatment of pancreatic adenocarcinoma in elderly patients,” Radiat Oncol, vol. 8, p. 240, Oct. 2013, doi: 10.1186/1748-717X-8-240.
[8521]	J. W. Wright and M. D. Kern, “Stereotaxic atlas of the brain of Octodon degus,” J. Morphol., vol. 214, no. 3, pp. 299–320, Dec. 1992, doi: 10.1002/jmor.1052140306.
[8522]	N. J. Mercuro, R. M. Kenney, L. Samuel, R. J. Tibbetts, G. J. Alangaden, and S. L. Davis, “Stewardship opportunities in viral pneumonia: Why not the immunocompromised?,” Transpl Infect Dis, vol. 20, no. 2, p. e12854, Apr. 2018, doi: 10.1111/tid.12854.
[8523]	M. W. Ben Hassan, L. Andersson, and P. W. Lucas, “Stiffness characteristics of splints for fixation of traumatized teeth,” Dent Traumatol, vol. 32, no. 2, pp. 140–145, Apr. 2016, doi: 10.1111/edt.12234.
[8524]	Y.-J. Lim, S.-Y. Chan, and Y. Ko, “Stigma and health-related quality of life in Asian adults with epilepsy,” Epilepsy Res., vol. 87, no. 2–3, pp. 107–119, Dec. 2009, doi: 10.1016/j.eplepsyres.2009.08.014.
[8525]	M. Nagarathnam, B. Vengamma, B. Shalini, and S. Latheef, “Stigma and Polytherapy: Predictors of Quality of Life in Patients with Epilepsy from South India,” Ann Indian Acad Neurol, vol. 20, no. 3, pp. 233–241, Sep. 2017, doi: 10.4103/aian.AIAN_36_17.
[8526]	T. Obeid, “Stigma. An aspect of epilepsy not to be ignored,” Saudi Med J, vol. 29, no. 4, pp. 489–497, Apr. 2008.
[8527]	C. M. Hedrich, C. Günther, and M. Aringer, “[Still’s disease in children and adults],” Hautarzt, vol. 68, no. 6, pp. 497–511, Jun. 2017, doi: 10.1007/s00105-017-3983-7.
[8528]	E. Kukiełka and A. I. Cederbaum, “Stimulation of NADH-dependent microsomal DNA strand cleavage by rifamycin SV,” Biochem. J., vol. 307 ( Pt 2), pp. 361–367, Apr. 1995, doi: 10.1042/bj3070361.
[8529]	N. V. Aleksandrova, M. A. Shkolnikova, V. V. Dlin, and M. T. Yugay, “[Stimulation of Research in Biomedicine. Role of Effective Contract],” Vestn. Akad. Med. Nauk SSSR, vol. 71, no. 5, pp. 397–405, 2016, doi: 10.15690/vramn705.
[8530]	I. Teixeira, “[STIMULATORY ACTION EXERCISED BY THE CHICK EMBRYO THYMUS ON THE FEMUR ASSOCIATED IN CULTURE IN VITRO],” C. R. Seances Soc. Biol. Fil., vol. 157, pp. 1332–1333, Nov. 1963.
[8531]	C.-C. Hsu, T. Ruan, L.-Y. Lee, and Y. S. Lin, “Stimulatory Effect of 5-Hydroxytryptamine (5-HT) on Rat Capsaicin-Sensitive Lung Vagal Sensory Neurons via Activation of 5-HT3 Receptors,” Front Physiol, vol. 10, p. 642, 2019, doi: 10.3389/fphys.2019.00642.
[8532]	W. F. Bottke, R. J. Walker, J. M. D. Day, D. Nesvorny, and L. Elkins-Tanton, “Stochastic late accretion to Earth, the Moon, and Mars,” Science, vol. 330, no. 6010, pp. 1527–1530, Dec. 2010, doi: 10.1126/science.1196874.
[8533]	B. Chugh and K. Dhawan, “Storage studies on mustard oil blends,” J Food Sci Technol, vol. 51, no. 4, pp. 762–767, Apr. 2014, doi: 10.1007/s13197-011-0540-8.
[8534]	J. Lee and M. Lee, “Stormwater runoff treatment filtration system and backwashing system,” Water Sci. Technol., vol. 79, no. 4, pp. 771–778, Feb. 2019, doi: 10.2166/wst.2019.097.
[8535]	J. D. Catalano, “Strabismus,” Pediatr Ann, vol. 19, no. 5, pp. 289, 292–297, May 1990, doi: 10.3928/0090-4481-19900501-05.
[8536]	R. Curran, “Straight to the heart. By understanding the heart’s anatomy, you can understand cardiac disorders and terminology,” EMS Mag, vol. 36, no. 11, pp. 72–75, Nov. 2007.
[8537]	M.-C. V. Drop et al., “Strain and dyssynchrony in fetuses with congenital heart disease compared to normal controls using speckle tracking echocardiography (STE),” J Perinat Med, vol. 47, no. 6, pp. 598–604, Aug. 2019, doi: 10.1515/jpm-2019-0073.
[8538]	A. de Voogt, “Strategic interactions: Games of the Ju|’hoan,” Learn Behav, vol. 45, no. 4, pp. 406–413, 2017, doi: 10.3758/s13420-017-0281-2.
[8539]	N. Momtahan, S. Sukavaneshvar, B. L. Roeder, and A. D. Cook, “Strategies and processes to decellularize and recellularize hearts to generate functional organs and reduce the risk of thrombosis,” Tissue Eng Part B Rev, vol. 21, no. 1, pp. 115–132, Feb. 2015, doi: 10.1089/ten.TEB.2014.0192.
[8540]	L. L. Davis and B. G. Dodd, “Strategies for controlling item exposure in computerized adaptive testing with the partial credit model,” J Appl Meas, vol. 9, no. 1, pp. 1–17, 2008.
[8541]	L. Culpepper, “Strategies for Managing Patients With Depression Who Are Experiencing Cognitive Impairment,” J Clin Psychiatry, vol. 78, no. 9, p. e1432, Dec. 2017, doi: 10.4088/JCP.tk16043tx3c.
[8542]	J. Ferwerda, I. S. Deleanu, and B. Unger, “Strategies to avoid blacklisting: The case of statistics on money laundering,” PLoS ONE, vol. 14, no. 6, p. e0218532, 2019, doi: 10.1371/journal.pone.0218532.
[8543]	V. Bari et al., “Strength and Latency of the HP-SAP Closed Loop Variability Interactions in Subjects Prone to Develop Postural Syncope,” Conf Proc IEEE Eng Med Biol Soc, vol. 2019, pp. 2003–2006, 2019, doi: 10.1109/EMBC.2019.8856288.
[8544]	H. W. Jann, L. E. Stein, and J. K. Good, “Strength characteristics and failure modes of locking-loop and three-loop pulley suture patterns in equine tendons,” Vet Surg, vol. 19, no. 1, pp. 28–33, Feb. 1990, doi: 10.1111/j.1532-950x.1990.tb01139.x.
[8545]	I. Litvan, K. Kieburtz, A. I. Tröster, and D. Aarsland, “Strengths and challenges in conducting clinical trials in Parkinson’s disease mild cognitive impairment,” Mov. Disord., vol. 33, no. 4, pp. 520–527, 2018, doi: 10.1002/mds.27345.
[8546]	N. Damé-Teixeira, D. Deng, and T. Do, “Streptococcus mutans transcriptome in the presence of sodium fluoride and sucrose,” Arch. Oral Biol., vol. 102, pp. 186–192, Jun. 2019, doi: 10.1016/j.archoralbio.2019.04.020.
[8547]	C. Cheng et al., “Streptomyces xinjiangensis sp. nov., an actinomycete isolated from Lop Nur region,” Arch. Microbiol., vol. 198, no. 8, pp. 785–791, Oct. 2016, doi: 10.1007/s00203-016-1234-4.
[8548]	M. Tokur, M. Y. Jin, B. W. Sheldon, and H. Akbulut, “Stress Bearing Mechanism of Reduced Graphene Oxide in Silicon-Based Composite Anodes for Lithium Ion Batteries,” ACS Appl Mater Interfaces, vol. 12, no. 30, pp. 33855–33869, Jul. 2020, doi: 10.1021/acsami.0c10064.
[8549]	I. Krejci and R. Daher, “Stress distribution difference between Lava Ultimate full crowns and IPS e.max CAD full crowns on a natural tooth and on tooth-shaped implant abutments,” Odontology, vol. 105, no. 2, pp. 254–256, Apr. 2017, doi: 10.1007/s10266-016-0276-z.
[8550]	R. Albers, A. van der Pijl, M. Bol, W. Seinen, and R. Pieters, “Stress proteins (HSP) and chemical-induced autoimmunity,” Toxicol. Appl. Pharmacol., vol. 140, no. 1, pp. 70–76, Sep. 1996, doi: 10.1006/taap.1996.0198.
[8551]	I. Kotwas, A. McGonigal, M. Bastien-Toniazzo, F. Bartolomei, and J.-A. Micoulaud-Franchi, “Stress regulation in drug-resistant epilepsy,” Epilepsy Behav, vol. 71, no. Pt A, pp. 39–50, 2017, doi: 10.1016/j.yebeh.2017.01.025.
[8552]	C. Bordier et al., “Stress response in honeybees is associated with changes in task-related physiology and energetic metabolism,” J. Insect Physiol., vol. 98, pp. 47–54, 2017, doi: 10.1016/j.jinsphys.2016.11.013.
[8553]	B. Xue et al., “Stress-induced sensitization of angiotensin II hypertension is reversed by blockade of angiotensin-converting enzyme or tumor necrosis factor-α,” Am. J. Hypertens., May 2019, doi: 10.1093/ajh/hpz075.
[8554]	H. Anisman and K. Matheson, “Stress, depression, and anhedonia: caveats concerning animal models,” Neurosci Biobehav Rev, vol. 29, no. 4–5, pp. 525–546, 2005, doi: 10.1016/j.neubiorev.2005.03.007.
[8555]	E. M. Millon, H. Y. M. Chang, and T. J. Shors, “Stressful Life Memories Relate to Ruminative Thoughts in Women With Sexual Violence History, Irrespective of PTSD,” Front Psychiatry, vol. 9, p. 311, 2018, doi: 10.3389/fpsyt.2018.00311.
[8556]	A. Klaus, H. Planert, J. J. J. Hjorth, J. D. Berke, G. Silberberg, and J. H. Kotaleski, “Striatal fast-spiking interneurons: from firing patterns to postsynaptic impact,” Front Syst Neurosci, vol. 5, p. 57, 2011, doi: 10.3389/fnsys.2011.00057.
[8557]	A. Kochar et al., “Stroke and Cardiovascular Outcomes in Patients With Carotid Disease Undergoing Transcatheter Aortic Valve Replacement,” Circ Cardiovasc Interv, vol. 11, no. 6, p. e006322, 2018, doi: 10.1161/CIRCINTERVENTIONS.117.006322.
[8558]	G. Xu, F. Hao, M. Weng, J. Hong, F. Pan, and D. Fang, “Strong influence of strain gradient on lithium diffusion: flexo-diffusion effect,” Nanoscale, vol. 12, no. 28, pp. 15175–15184, Jul. 2020, doi: 10.1039/d0nr03746j.
[8559]	T. Zhou et al., “Structural analysis of DFG-in and DFG-out dual Src-Abl inhibitors sharing a common vinyl purine template,” Chem Biol Drug Des, vol. 75, no. 1, pp. 18–28, Jan. 2010, doi: 10.1111/j.1747-0285.2009.00905.x.
[8560]	F. Wang, Q. He, K. Su, T. Wei, S. Xu, and L. Gu, “Structural and biochemical characterization of the catalytic domains of GdpP reveals a unified hydrolysis mechanism for the DHH/DHHA1 phosphodiesterase,” Biochem. J., vol. 475, no. 1, pp. 191–205, 05 2018, doi: 10.1042/BCJ20170739.
[8561]	T. Klein et al., “Structural and dynamic insights into the energetics of activation loop rearrangement in FGFR1 kinase,” Nat Commun, vol. 6, p. 7877, Jul. 2015, doi: 10.1038/ncomms8877.
[8562]	S. G, R. M. L, B. Ch, and J. C K, “Structural and luminescent properties of KY(1-x)DyxBO3 phosphors,” Spectrochim Acta A Mol Biomol Spectrosc, vol. 170, pp. 206–213, Jan. 2017, doi: 10.1016/j.saa.2016.06.054.
[8563]	L. Linsenmeier et al., “Structural and mechanistic aspects influencing the ADAM10-mediated shedding of the prion protein,” Mol Neurodegener, vol. 13, no. 1, p. 18, 06 2018, doi: 10.1186/s13024-018-0248-6.
[8564]	L. Marty, A. Vigouroux, M. Aumont-Nicaise, Y. Dessaux, D. Faure, and S. Moréra, “Structural Basis for High Specificity of Amadori Compound and Mannopine Opine Binding in Bacterial Pathogens,” J. Biol. Chem., vol. 291, no. 43, pp. 22638–22649, Oct. 2016, doi: 10.1074/jbc.M116.745562.
[8565]	M. B. Stein, C. Hanna, C. Koverola, M. Torchia, and B. McClarty, “Structural brain changes in PTSD. Does trauma alter neuroanatomy?,” Ann. N. Y. Acad. Sci., vol. 821, pp. 76–82, Jun. 1997, doi: 10.1111/j.1749-6632.1997.tb48270.x.
[8566]	M. Lövdén, E. Wenger, J. Mårtensson, U. Lindenberger, and L. Bäckman, “Structural brain plasticity in adult learning and development,” Neurosci Biobehav Rev, vol. 37, no. 9 Pt B, pp. 2296–2310, Nov. 2013, doi: 10.1016/j.neubiorev.2013.02.014.
[8567]	N. R. Lakkaniga, M. Balasubramaniam, S. Zhang, B. Frett, and H.-Y. Li, “Structural Characterization of the Aurora Kinase B ‘DFG-flip’ Using Metadynamics,” AAPS J, vol. 22, no. 1, p. 14, 18 2019, doi: 10.1208/s12248-019-0399-6.
[8568]	L. I. Brueggemann, L. L. Cribbs, and K. L. Byron, “Structural Determinants of Kv7.5 Potassium Channels That Confer Changes in Phosphatidylinositol 4,5-Bisphosphate (PIP2) Affinity and Signaling Sensitivities in Smooth Muscle Cells,” Mol. Pharmacol., vol. 97, no. 3, pp. 145–158, 2020, doi: 10.1124/mol.119.117192.
[8569]	Q. Huang et al., “Structural differences in interictal migraine attack after epilepsy: A diffusion tensor imaging analysis,” Epilepsy Behav, vol. 77, pp. 8–12, 2017, doi: 10.1016/j.yebeh.2017.09.002.
[8570]	A. Messoussi, L. Peyronnet, C. Feneyrolles, G. Chevé, K. Bougrin, and A. Yasri, “Structural elucidation of the DFG-Asp in and DFG-Asp out states of TAM kinases and insight into the selectivity of their inhibitors,” Molecules, vol. 19, no. 10, pp. 16223–16239, Oct. 2014, doi: 10.3390/molecules191016223.
[8571]	M. J. van Dongen et al., “Structural features of the DNA hairpin d(ATCCTA-GTTA-TAGGAT): formation of a G-A base pair in the loop,” Nucleic Acids Res., vol. 25, no. 8, pp. 1537–1547, Apr. 1997, doi: 10.1093/nar/25.8.1537.
[8572]	A. Karki, H. K. Namballa, I. Alberts, and W. W. Harding, “Structural manipulation of aporphines via C10 nitrogenation leads to the identification of new 5-HT7AR ligands,” Bioorg. Med. Chem., vol. 28, no. 15, p. 115578, Aug. 2020, doi: 10.1016/j.bmc.2020.115578.
[8573]	S. Rumney and E. T. Kool, “Structural Optimization of Non-Nucleotide Loop Replacements for Duplex and Triplex DNAs,” J. Am. Chem. Soc., vol. 117, pp. 5635–5646, 1995, doi: 10.1021/ja00126a004.
[8574]	M. Hakeberg, C. Hägglin, U. Berggren, and S. G. Carlsson, “Structural relationships of dental anxiety, mood, and general anxiety,” Acta Odontol. Scand., vol. 59, no. 2, pp. 99–103, Apr. 2001, doi: 10.1080/000163501750157252.
[8575]	M. Wogulis et al., “Structural studies of a potent insect maturation inhibitor bound to the juvenile hormone esterase of Manduca sexta,” Biochemistry, vol. 45, no. 13, pp. 4045–4057, Apr. 2006, doi: 10.1021/bi0521644.
[8576]	M. A. Holmes, P. Li, E. W. Petersdorf, and R. K. Strong, “Structural studies of allelic diversity of the MHC class I homolog MIC-B, a stress-inducible ligand for the activating immunoreceptor NKG2D,” J. Immunol., vol. 169, no. 3, pp. 1395–1400, Aug. 2002, doi: 10.4049/jimmunol.169.3.1395.
[8577]	L. A. Favorito, K. M. Anderson, S. F. Costa, W. S. Costa, and F. J. Sampaio, “Structural study of the cremaster muscle in patients with retractile testis,” J. Pediatr. Surg., vol. 53, no. 4, pp. 780–783, Apr. 2018, doi: 10.1016/j.jpedsurg.2017.04.013.
[8578]	P. Guan and W.-K. Sung, “Structural variation detection using next-generation sequencing data: A comparative technical review,” Methods, vol. 102, pp. 36–49, 01 2016, doi: 10.1016/j.ymeth.2016.01.020.
[8579]	E. Rothenberg and D. Triglia, “Structure and expression of glycoproteins controlled by the Qa-1a allele,” Immunogenetics, vol. 14, no. 6, pp. 455–468, Dec. 1981, doi: 10.1007/BF00350118.
[8580]	B. Jensen, A. F. M. Moorman, and T. Wang, “Structure and function of the hearts of lizards and snakes,” Biol Rev Camb Philos Soc, vol. 89, no. 2, pp. 302–336, May 2014, doi: 10.1111/brv.12056.
[8581]	J. Hu, W. Huang, L. Yang, and F. Pan, “Structure and performance of the LiFePO4 cathode material: from the bulk to the surface,” Nanoscale, vol. 12, no. 28, pp. 15036–15044, Jul. 2020, doi: 10.1039/d0nr03776a.
[8582]	D. S. Spiegel, J. J. Fortney, and C. Sotin, “Structure of exoplanets,” Proc. Natl. Acad. Sci. U.S.A., vol. 111, no. 35, pp. 12622–12627, Sep. 2014, doi: 10.1073/pnas.1304206111.
[8583]	J. J. Jaffe, G. A. Fischer, and A. D. Welch, “STRUCTURE-ACTION RELATIONSHIPS OF CORTICOSTEROID COMPOUNDS AS INHIBITORS OF LEUKEMIC L5187Y CELL REPRODUCTION IN VIVO AND IN VITRO,” Biochem. Pharmacol., vol. 12, pp. 1081–1090, Oct. 1963, doi: 10.1016/0006-2952(63)90083-2.
[8584]	J. P. Doucet, A. Doucet-Panaye, and J. Devillers, “Structure-activity relationship study of trifluoromethylketones: inhibitors of insect juvenile hormone esterase,” SAR QSAR Environ Res, vol. 24, no. 6, pp. 481–499, 2013, doi: 10.1080/1062936X.2013.792499.
[8585]	M. H. Karol, C. Graham, R. Gealy, O. T. Macina, N. Sussman, and H. S. Rosenkranz, “Structure-activity relationships and computer-assisted analysis of respiratory sensitization potential,” Toxicol. Lett., vol. 86, no. 2–3, pp. 187–191, Aug. 1996, doi: 10.1016/0378-4274(96)03689-2.
[8586]	T. Hashimoto, K. Kurosawa, and N. Sakura, “Structure-activity relationships of neuromedin U. II. Highly potent analogs substituted or modified at the N-terminus of neuromedin U-8,” Chem. Pharm. Bull., vol. 43, no. 7, pp. 1154–1157, Jul. 1995, doi: 10.1248/cpb.43.1154.
[8587]	N. Sakura, S. Ohta, Y. Uchida, K. Kurosawa, K. Okimura, and T. Hashimoto, “Structure-activity relationships of rat neuromedin U for smooth muscle contraction,” Chem. Pharm. Bull., vol. 39, no. 8, pp. 2016–2020, Aug. 1991, doi: 10.1248/cpb.39.2016.
[8588]	I. Botos, L. Scapozza, J. D. Shannon, J. W. Fox, and E. F. Meyer, “Structure-based analysis of inhibitor binding to Ht-d,” Acta Crystallogr. D Biol. Crystallogr., vol. 51, no. Pt 4, pp. 597–604, Jul. 1995, doi: 10.1107/S0907444995001910.
[8589]	D. Dufour, M. de la Peña, S. Gago, R. Flores, and J. Gallego, “Structure-function analysis of the ribozymes of chrysanthemum chlorotic mottle viroid: a loop-loop interaction motif conserved in most natural hammerheads,” Nucleic Acids Res., vol. 37, no. 2, pp. 368–381, Feb. 2009, doi: 10.1093/nar/gkn918.
[8590]	G. Jones, V. Venkataraman, B. Ridley, P. O’Mahony, and H. Turner, “Structure, expression and gene sequence of a juvenile hormone esterase-related protein from metamorphosing larvae of Trichoplusia ni,” Biochem. J., vol. 302 ( Pt 3), pp. 827–835, Sep. 1994, doi: 10.1042/bj3020827.
[8591]	E. A. Coon et al., “Structured handoff checklists improve clinical measures in patients discharged from the neurointensive care unit,” Neurol Clin Pract, vol. 5, no. 1, pp. 42–49, Feb. 2015, doi: 10.1212/CPJ.0000000000000094.
[8592]	F. V. Ribeiro, B. A. P. da Gama, and R. C. Pereira, “Structuring effects of chemicals from the sea fan Phyllogorgia dilatata on benthic communities,” PeerJ, vol. 5, p. e3186, 2017, doi: 10.7717/peerj.3186.
[8593]	J. Cornwall, T. M. Davies, and D. Lees, “Student injuries in the dissecting room,” Anat Sci Educ, vol. 6, no. 6, pp. 404–409, Dec. 2013, doi: 10.1002/ase.1363.
[8594]	L. J. Frick, J. L. Frick, R. E. Coffman, and S. Dey, “Student stress in a three-year doctor of pharmacy program using a mastery learning educational model,” Am J Pharm Educ, vol. 75, no. 4, p. 64, May 2011, doi: 10.5688/ajpe75464.
[8595]	S. Suurmaa, “STUDIES IN THE IMMUNE RESPONSE IN VITRO. 3. MORPHOLOGICAL CHANGES IN LYMPH NODE CELL POPULATION DURING IMMUNE REPONSE IN ORGAN CULTURE,” Ann Med Exp Biol Fenn, vol. 43, pp. 53–56, 1965.
[8596]	O. Maekelae, S. Suurmaa, and T. Vainio, “STUDIES IN THE IMMUNE RESPONSE IN VITRO. I. A METHOD FOR ANTIBODY PRODUCTION IN ORGAN CULTURE,” Ann Med Exp Biol Fenn, vol. 42, pp. 57–60, 1964.
[8597]	J. Poirier-Bisson, P. Roberge, A. Marchand, and R. Grégoire, “[Studies of cost/effectiveness of pharmacological and psychological treatment of anxiety disorders: a literature review],” Sante Ment Que, vol. 35, no. 1, pp. 129–152, 2010, doi: 10.7202/044801ar.
[8598]	W. E. Castle and S. C. Reed, “Studies of Inheritance in Lop-Eared Rabbits,” Genetics, vol. 21, no. 4, pp. 297–309, Jul. 1936.
[8599]	S. Ma et al., “Studies of N(9)-arenthenyl purines as novel DFG-in and DFG-out dual Src/Abl inhibitors using 3D-QSAR, docking and molecular dynamics simulations,” Mol Biosyst, vol. 11, no. 2, pp. 394–406, Feb. 2015, doi: 10.1039/c4mb00350k.
[8600]	G. A. Fischer, “Studies of the culture of leukemic cells in vitro,” Ann. N. Y. Acad. Sci., vol. 76, no. 3, pp. 673–680, Dec. 1958, doi: 10.1111/j.1749-6632.1958.tb54884.x.
[8601]	F. Bernard, V. Daële, A. Mellouki, and H. Sidebottom, “Studies of the gas phase reactions of linalool, 6-methyl-5-hepten-2-ol and 3-methyl-1-penten-3-ol with O3 and OH radicals,” J Phys Chem A, vol. 116, no. 24, pp. 6113–6126, Jun. 2012, doi: 10.1021/jp211355d.
[8602]	M. F. La Via, S. A. Uriu, and L. A. Ferguson, “Studies on antibody production by spleen explants maintained in vitro,” J. Immunol., vol. 84, pp. 48–53, Jan. 1960.
[8603]	Y. Kuroda, “STUDIES ON CARTILAGE CELLS IN VITRO. I. MORPHOLOGY AND GROWTH OF CARTILAGE CELLS IN MONOLAYER CULTURES,” Exp. Cell Res., vol. 35, pp. 326–336, Jul. 1964, doi: 10.1016/0014-4827(64)90099-0.
[8604]	Y. Kuroda, “STUDIES ON CARTILAGE CELLS IN VITRO. II. CHANGES IN AGGREGATION AND IN CARTILAGE-FORMING ACTIVITY OF CELLS MAINTAINED IN MONOLAYER CULTURES,” Exp. Cell Res., vol. 35, pp. 337–348, Jul. 1964, doi: 10.1016/0014-4827(64)90100-4.
[8605]	H. Sato, K. Utagawa, and T. Ebina, “STUDIES ON IN VITRO CULTURE OF A SMALL NUMBER OF YOSHIDA SARCOMA CELLS,” Acta Unio Int Contra Cancrum, vol. 20, pp. 1320–1322, 1964.
[8606]	A. Schleich, “Studies on radioprotection of various compounds in vitro and in vivo,” Ann. N. Y. Acad. Sci., vol. 95, pp. 1009–1020, Nov. 1961, doi: 10.1111/j.1749-6632.1961.tb50096.x.
[8607]	G. Szabo, “Studies on the cultivation of teeth in vitro,” J. Anat., vol. 88, no. 1, pp. 31–44, Jan. 1954.
[8608]	I. D. Bassukas, W. Deubel, W. Schlereth, and R. Metz, “Studies on the effect of aurintricarboxylic acid (ATA) on cell proliferation of renewable epithelial tissues in the mouse,” In Vivo, vol. 9, no. 3, pp. 219–223, Jun. 1995.
[8609]	X. Lan et al., “Studies on the Interaction between Angiotensin-Converting Enzyme (ACE) and ACE Inhibitory Peptide from Saurida elongata,” J. Agric. Food Chem., vol. 66, no. 51, pp. 13414–13422, Dec. 2018, doi: 10.1021/acs.jafc.8b04303.
[8610]	C. Thomas and R. Bollmann, “[Studies on the organotropism of the carcinogenic effect of N-nitroso-N-methylurea (NMU) in rats],” Experientia, vol. 25, no. 1, pp. 50–51, Jan. 1969, doi: 10.1007/BF01903889.
[8611]	M. Rozynek and W. Krawczyk, “[STUDIES ON THE PROCESS OF FIBRILLOGENESIS IN THE GROWTH ZONE OF CULTURES OF JENSEN AND WALKER SARCOMA IN VITRO],” Patol Pol, vol. 16, pp. 1–9, Mar. 1965.
[8612]	E. Klein, “Studies on the substrate-induced arginase synthesis in animal cell strains cultured in vitro,” Exp. Cell Res., vol. 22, pp. 226–232, Jan. 1961, doi: 10.1016/0014-4827(61)90100-8.
[8613]	M. Fingas and B. Fieldhouse, “Studies on water-in-oil products from crude oils and petroleum products,” Mar. Pollut. Bull., vol. 64, no. 2, pp. 272–283, Feb. 2012, doi: 10.1016/j.marpolbul.2011.11.019.
[8614]	Q. Zhang et al., “Study of a composite solid electrolyte made from a new pyrrolidone-containing polymer and LLZTO,” J Colloid Interface Sci, vol. 580, pp. 389–398, Jul. 2020, doi: 10.1016/j.jcis.2020.07.024.
[8615]	I. Utkin, M. V. Avdzhian, I. P. Butnev, and G. G. Kuznetsova, “[Study of cell division in corneal epithelium by the method of incubation of the eye in vitro],” Tsitologiia, vol. 3, pp. 668–674, Dec. 1961.
[8616]	D. Simon and E. Wolff, “[Study of circulation in chick embryo explanted in vitro after resection of various parts],” C. R. Seances Soc. Biol. Fil., vol. 150, no. 1, pp. 11–15, May 1956.
[8617]	A. Hajduk, M. Korzonek, K. Przybycień, S. Ertmański, and J. Stolarek, “[Study of depressiveness with Beck Depression Inventory in patients with cardiac arrhythmias],” Ann Acad Med Stetin, vol. 57, no. 1, pp. 45–48, 2011.
[8618]	M. C. Cuerda Compés et al., “[Study of energy expenditure in anorexia nervosa: agreement between indirect calorimatry and several equations],” Nutr Hosp, vol. 20, no. 6, pp. 371–377, Dec. 2005.
[8619]	J. Duan, W. Liu, X. Zhao, Y. Han, S. E. O’Reilly, and D. Zhao, “Study of residual oil in Bay Jimmy sediment 5 years after the Deepwater Horizon oil spill: Persistence of sediment retained oil hydrocarbons and effect of dispersants on desorption,” Sci. Total Environ., vol. 618, pp. 1244–1253, Mar. 2018, doi: 10.1016/j.scitotenv.2017.09.234.
[8620]	I. L. Ang et al., “Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach,” J. Proteome Res., vol. 5, no. 10, pp. 2691–2700, Oct. 2006, doi: 10.1021/pr060109r.
[8621]	M. Yamazaki, E. Yamada, S. Kudou, and M. Higashida, “[Study of temperature rise in RF irradiation during MR imaging: measurement of local temperature using a loop phantom],” Nihon Hoshasen Gijutsu Gakkai Zasshi, vol. 61, no. 8, pp. 1125–1132, Aug. 2005, doi: 10.6009/jjrt.kj00003943073.
[8622]	U. Farooq, I. C. Taban, and P. S. Daling, “Study of the oil interaction towards oil spill recovery skimmer material: Effect of the oil weathering and emulsification properties,” Mar. Pollut. Bull., vol. 135, pp. 119–128, Oct. 2018, doi: 10.1016/j.marpolbul.2018.06.017.
[8623]	W. Ji, D. Cheng, and L. Yang, “[Study on biomarkers of silicosis and silica-exposed group],” Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, vol. 23, no. 3, pp. 217–218, Jun. 2005.
[8624]	Y. Fan, B. Bai, Q. Qiao, P. Kang, Y. Zhang, and J. Guo, “Study on eco-efficiency of industrial parks in China based on data envelopment analysis,” J. Environ. Manage., vol. 192, pp. 107–115, May 2017, doi: 10.1016/j.jenvman.2017.01.048.
[8625]	B. Li, D. Zhang, and Y. Shen, “Study on terahertz spectrum analysis and recognition modeling of common agricultural diseases,” Spectrochim Acta A Mol Biomol Spectrosc, vol. 243, p. 118820, Aug. 2020, doi: 10.1016/j.saa.2020.118820.
[8626]	H. Z. Li, H. X. Jia, D. Liang, T. T. Deng, L. T. Niu, and J. H. Han, “[Study on the contribution rate of follow-up formula to the nutrient intake of infants and young children aged 7-24 months in China],” Zhonghua Yu Fang Yi Xue Za Zhi, vol. 51, no. 1, pp. 65–69, Jan. 2017, doi: 10.3760/cma.j.issn.0253-9624.2017.01.013.
[8627]	M. Yawata, M. Iwahashi, R. Hori, H. Shiramasa, and N. Totani, “Study on the effect of polydimethylsiloxane from the viewpoint of oxygen content in oil,” J Oleo Sci, vol. 63, no. 10, pp. 987–994, 2014, doi: 10.5650/jos.ess14085.
[8628]	M. Wu, “[Study on the first translated obstetrics book Tai chan ju yao (Essentials in Obstetrics)],” Zhonghua Yi Shi Za Zhi, vol. 48, no. 1, pp. 37–42, Jan. 2018, doi: 10.3760/cma.j.issn.0255-7053.2018.01.009.
[8629]	Y. Zheng et al., “SU-E-T-202: Comprehensive Quality Assurance Procedures for Uniform Scanning Proton Therapy Machines,” Med Phys, vol. 39, no. 6Part12, p. 3749, Jun. 2012, doi: 10.1118/1.4735262.
[8630]	M. R. Lahaniatis et al., “Sub-working group ‘air analysis’ of the Senate Commission on the Investigation of Health Hazards of Chemical Compounds in the Work Area of the Deutsche Forschungsgemeinschaft (DFG),” J Occup Environ Hyg, vol. 1, no. 10, pp. D112-116, Oct. 2004, doi: 10.1080/15459620490500811.
[8631]	K. Fink, J. Zentner, and M. Göthert, “Subclassification of presynaptic 5-HT autoreceptors in the human cerebral cortex as 5-HT1D receptors,” Naunyn Schmiedebergs Arch. Pharmacol., vol. 352, no. 4, pp. 451–454, Oct. 1995, doi: 10.1007/BF00172785.
[8632]	P. Cuijpers and F. Smit, “[Subclinical depression: a clinically relevant condition?],” Tijdschr Psychiatr, vol. 50, no. 8, pp. 519–528, 2008.
[8633]	P. E. Watson and B. W. McDonald, “Subcutaneous body fat in pregnant New Zealand women: association with wheeze in their infants at 18 months,” Matern Child Health J, vol. 17, no. 5, pp. 959–967, Jul. 2013, doi: 10.1007/s10995-012-1124-6.
[8634]	T. Plank and C. E. Manning, “Subducting carbon,” Nature, vol. 574, no. 7778, pp. 343–352, 2019, doi: 10.1038/s41586-019-1643-z.
[8635]	N. L. Hill et al., “Subjective cognitive impairment and quality of life: a systematic review,” Int Psychogeriatr, vol. 29, no. 12, pp. 1965–1977, 2017, doi: 10.1017/S1041610217001636.
[8636]	Q. Wu, “Subjective cognitive impairment of older adults: a comparison between the US and China,” Int J Methods Psychiatr Res, vol. 25, no. 1, pp. 68–75, Mar. 2016, doi: 10.1002/mpr.1499.
[8637]	S. Garcia-Ptacek, M. Eriksdotter, V. Jelic, J. Porta-Etessam, I. Kåreholt, and S. Manzano Palomo, “Subjective cognitive impairment: Towards early identification of Alzheimer disease,” Neurologia, vol. 31, no. 8, pp. 562–571, Oct. 2016, doi: 10.1016/j.nrl.2013.02.007.
[8638]	M. Wyczesany, J. Kaiser, and A. M. M. L. Coenen, “Subjective mood estimation co-varies with spectral power EEG characteristics,” Acta Neurobiol Exp (Wars), vol. 68, no. 2, pp. 180–192, 2008.
[8639]	S.-Y. Park et al., “Subjective taste to polyethylene glycol is associated with efficacy of right colon preparation,” Scand. J. Gastroenterol., vol. 52, no. 4, pp. 373–376, Apr. 2017, doi: 10.1080/00365521.2016.1250158.
[8640]	A. M. Noor, “Subnational benchmarking of health systems performance in Africa using health outcome and coverage indicators,” BMC Med, vol. 13, p. 299, Dec. 2015, doi: 10.1186/s12916-015-0541-y.
[8641]	S. Simmons and L. Suárez, “Substance Abuse and Trauma,” Child Adolesc Psychiatr Clin N Am, vol. 25, no. 4, pp. 723–734, Oct. 2016, doi: 10.1016/j.chc.2016.05.006.
[8642]	N. Kanda and S. Watanabe, “Substance P enhances the production of interferon-induced protein of 10 kDa by human keratinocytes in synergy with interferon-gamma,” J. Invest. Dermatol., vol. 119, no. 6, pp. 1290–1297, Dec. 2002, doi: 10.1046/j.1523-1747.2002.19626.x.
[8643]	P. J. Brown, R. L. Stout, and J. Gannon-Rowley, “Substance use disorder-PTSD comorbidity. Patients’ perceptions of symptom interplay and treatment issues,” J Subst Abuse Treat, vol. 15, no. 5, pp. 445–448, Oct. 1998, doi: 10.1016/s0740-5472(97)00286-9.
[8644]	F. Sacher et al., “Substrate mapping and ablation for ventricular tachycardia: the LAVA approach,” J. Cardiovasc. Electrophysiol., vol. 26, no. 4, pp. 464–471, Apr. 2015, doi: 10.1111/jce.12565.
[8645]	R. J. Ascuitto and N. T. Ross-Ascuitto, “Substrate metabolism in the developing heart,” Semin. Perinatol., vol. 20, no. 6, pp. 542–563, Dec. 1996, doi: 10.1016/s0146-0005(96)80068-1.
[8646]	M. Bauer, T. Glenn, P. Grof, R. Schmid, A. Pfennig, and P. C. Whybrow, “Subsyndromal mood symptoms: a useful concept for maintenance studies of bipolar disorder?,” Psychopathology, vol. 43, no. 1, pp. 1–7, 2010, doi: 10.1159/000255957.
[8647]	N. Sadek and J. Bona, “Subsyndromal symptomatic depression: a new concept,” Depress Anxiety, vol. 12, no. 1, pp. 30–39, 2000, doi: 10.1002/1520-6394(2000)12:1<30::AID-DA4>3.0.CO;2-P.
[8648]	M. Moss, J. Radack, and M. S. Rockett, “Subtalar arthrodesis,” Clin Podiatr Med Surg, vol. 21, no. 2, pp. 179–201, Apr. 2004, doi: 10.1016/j.cpm.2004.01.001.
[8649]	R. Wesselhoeft, M. J. Sørensen, E. R. Heiervang, and N. Bilenberg, “Subthreshold depression in children and adolescents - a systematic review,” J Affect Disord, vol. 151, no. 1, pp. 7–22, Oct. 2013, doi: 10.1016/j.jad.2013.06.010.
[8650]	B. Geiselmann and M. Bauer, “Subthreshold depression in the elderly: qualitative or quantitative distinction?,” Compr Psychiatry, vol. 41, no. 2 Suppl 1, pp. 32–38, Apr. 2000, doi: 10.1016/s0010-440x(00)80006-1.
[8651]	D. S. Fink et al., “Subthreshold PTSD and PTSD in a prospective-longitudinal cohort of military personnel: Potential targets for preventive interventions,” Depress Anxiety, vol. 35, no. 11, pp. 1048–1055, 2018, doi: 10.1002/da.22819.
[8652]	M. Zimmerman, J. H. Martinez, K. Dalrymple, I. Chelminski, and D. Young, “‘Subthreshold’ depression: is the distinction between depressive disorder not otherwise specified and adjustment disorder valid?,” J Clin Psychiatry, vol. 74, no. 5, pp. 470–476, May 2013, doi: 10.4088/JCP.12m08053.
[8653]	K. L. Price, Y. Hirayama, and S. C. R. Lummis, “Subtle Differences among 5-HT3AC, 5-HT3AD, and 5-HT3AE Receptors Are Revealed by Partial Agonists,” ACS Chem Neurosci, vol. 8, no. 5, pp. 1085–1091, 17 2017, doi: 10.1021/acschemneuro.6b00416.
[8654]	J. Park et al., “Subunit-specific mass spectrometry method identifies haptoglobin subunit alpha as a diagnostic marker in non-small cell lung cancer,” J Proteomics, vol. 94, pp. 302–310, Dec. 2013, doi: 10.1016/j.jprot.2013.09.019.
[8655]	S. Alsford, “Subverting lysosomal function in Trypanosoma brucei,” Microb Cell, vol. 2, no. 8, pp. 259–261, Aug. 2015, doi: 10.15698/mic2015.08.222.
[8656]	A. Di Giorgio et al., “Successful management of acute liver failure in Italian children: A 16-year experience at a referral centre for paediatric liver transplantation,” Dig Liver Dis, vol. 49, no. 10, pp. 1139–1145, Oct. 2017, doi: 10.1016/j.dld.2017.05.026.
[8657]	R. A. Audisio, R. A. Stahel, M. S. Aapro, A. Costa, M. Pandey, and N. Pavlidis, “Successful publishing: how to get your paper accepted,” Surg Oncol, vol. 18, no. 4, pp. 350–356, Dec. 2009, doi: 10.1016/j.suronc.2008.09.001.
[8658]	T. Ju, L. Rivas, and B. Sarani, “Successful Surgical Stabilization of Rib Fractures Despite Candida Colonization of the Mediastinum,” Ann. Thorac. Surg., vol. 106, no. 3, pp. e121–e123, 2018, doi: 10.1016/j.athoracsur.2018.03.009.
[8659]	P. Striano, E. D’Amato, M. Pezzella, P. Mainardi, F. Zara, and S. Striano, “Sudden death in Unverricht-Lundborg patients: is serotonin the key?,” Neurol. Sci., vol. 31, no. 1, pp. 115–116, Feb. 2010, doi: 10.1007/s10072-009-0193-9.
[8660]	K. Pretorius and L. Rew, “Sudden Infant Death Syndrome: A Global Public Health Issue and Nursing’s Response,” Compr Child Adolesc Nurs, vol. 42, no. 2, pp. 151–160, Jun. 2019, doi: 10.1080/24694193.2018.1451569.
[8661]	D. C. Hesdorffer, L. A. Crandall, D. Friedman, and O. Devinsky, “Sudden unexplained death in childhood: A comparison of cases with and without a febrile seizure history,” Epilepsia, vol. 56, no. 8, pp. 1294–1300, Aug. 2015, doi: 10.1111/epi.13066.
[8662]	J.-G. Seo et al., “Suicidality and Its Risk Factors in Korean People with Epilepsy: A MEPSY Study,” J Clin Neurol, vol. 11, no. 1, pp. 32–41, Jan. 2015, doi: 10.3988/jcn.2015.11.1.32.
[8663]	J. Fawcett, “Suicide and anxiety in DSM-5,” Depress Anxiety, vol. 30, no. 10, pp. 898–901, Oct. 2013, doi: 10.1002/da.22058.
[8664]	L. Rew, C. Young, A. Brown, and S. Rancour, “Suicide Ideation and Life Events in a Sample of Rural Adolescents,” Arch Psychiatr Nurs, vol. 30, no. 2, pp. 198–203, Apr. 2016, doi: 10.1016/j.apnu.2015.08.012.
[8665]	R. M. Hill, D. Castellanos, and J. W. Pettit, “Suicide-related behaviors and anxiety in children and adolescents: a review,” Clin Psychol Rev, vol. 31, no. 7, pp. 1133–1144, Nov. 2011, doi: 10.1016/j.cpr.2011.07.008.
[8666]	P. Striano, F. Zara, and C. Minetti, “Suicide-related events in patients treated with antiepileptic drugs,” N. Engl. J. Med., vol. 363, no. 19, pp. 1873–1874; author reply 1874, 04 2010, doi: 10.1056/NEJMc1010020.
[8667]	F. Gadal, J. Bastias, M. X. Wei, and M. Crépin, “‘Suicide’ gene therapy of breast cancer cells is only cytostatic in vitro but anti-tumoral in vivo on breast MCF7-ras tumor,” In Vivo, vol. 18, no. 6, pp. 813–818, Dec. 2004.
[8668]	H. E. Lee, S. J. Yoon, J.-R. Sohn, D.-A. Huh, S.-W. Jang, and K. W. Moon, “Suitability Assessment of Legal Regulation of Chemical Concentrations According to Vapor Pressure and Damage Radius,” Int J Environ Res Public Health, vol. 16, no. 3, 26 2019, doi: 10.3390/ijerph16030347.
[8669]	A. M. Selleck, J. E. Moore, A. L. Rutt, A. Hu, and R. T. Sataloff, “Sulcus Vocalis (Type III): Prevalence and Strobovideolaryngoscopy Characteristics,” J Voice, vol. 29, no. 4, pp. 507–511, Jul. 2015, doi: 10.1016/j.jvoice.2014.09.015.
[8670]	M. Awang and G. M. Seng, “Sulfonation of phenols extracted from the pyrolysis oil of oil palm shells for enhanced oil recovery,” ChemSusChem, vol. 1, no. 3, pp. 210–214, 2008, doi: 10.1002/cssc.200700083.
[8671]	Y. Li et al., “Sulforaphane protects against ethanol-induced apoptosis in neural crest cells through restoring epithelial-mesenchymal transition by epigenetically modulating the expression of Snail1,” Biochim Biophys Acta Mol Basis Dis, vol. 1865, no. 10, pp. 2586–2594, 01 2019, doi: 10.1016/j.bbadis.2019.07.002.
[8672]	E. García-Ríos and J. M. Guillamón, “Sulfur dioxide resistance in Saccharomyces cerevisiae: beyond SSU1,” Microb Cell, vol. 6, no. 12, pp. 527–530, Nov. 2019, doi: 10.15698/mic2019.12.699.
[8673]	“Summary of global update on preventive chemotherapy implementation in 2016: crossing the billion,” Wkly. Epidemiol. Rec., vol. 92, no. 40, pp. 589–593, 06 2017.
[8674]	L. V. Allen, “Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 1: Physical and Chemical Testing,” Int J Pharm Compd, vol. 23, no. 3, pp. 211–216, Jun. 2019.
[8675]	Z. Song, “[Sun Simiao’s voyage to Chu and Shu regions],” Zhonghua Yi Shi Za Zhi, vol. 44, no. 4, pp. 232–238, Jul. 2014.
[8676]	E. Callaway, “Supercomputer scours fossil record for Earth’s hidden extinctions,” Nature, vol. 577, no. 7791, pp. 458–459, 2020, doi: 10.1038/d41586-020-00117-1.
[8677]	R. Heller and J. Armstrong, “Superhabitable worlds,” Astrobiology, vol. 14, no. 1, pp. 50–66, Jan. 2014, doi: 10.1089/ast.2013.1088.
[8678]	S. Fu et al., “Superhydrophilic, Underwater Directional Oil-Transport Fabrics with a Novel Oil Trapping Function,” ACS Appl Mater Interfaces, vol. 11, no. 30, pp. 27402–27409, Jul. 2019, doi: 10.1021/acsami.9b06533.
[8679]	B. C. Bonning, P. W. Roelvink, J. M. Vlak, R. D. Possee, and B. D. Hammock, “Superior expression of juvenile hormone esterase and beta-galactosidase from the basic protein promoter of Autographa californica nuclear polyhedrosis virus compared to the p10 protein and polyhedrin promoters,” J. Gen. Virol., vol. 75 ( Pt 7), pp. 1551–1556, Jul. 1994, doi: 10.1099/0022-1317-75-7-1551.
[8680]	V. K. Dhillon, “Superior laryngeal nerve block for neurogenic cough: A case series,” Laryngoscope Investig Otolaryngol, vol. 4, no. 4, pp. 410–413, Aug. 2019, doi: 10.1002/lio2.292.
[8681]	E. Hayden, A. Cone, and S. Ju, “Supersaturated proteins in ALS,” Proc. Natl. Acad. Sci. U.S.A., vol. 114, no. 20, pp. 5065–5066, 16 2017, doi: 10.1073/pnas.1704885114.
[8682]	K. Lee et al., “Superwetting of TiO2 by light-induced water-layer growth via delocalized surface electrons,” Proc. Natl. Acad. Sci. U.S.A., vol. 111, no. 16, pp. 5784–5789, Apr. 2014, doi: 10.1073/pnas.1319001111.
[8683]	M. Osborne, A. Aryasomayajula, A. Shakeri, P. R. Selvaganapathy, and T. F. Didar, “Suppression of Biofouling on a Permeable Membrane for Dissolved Oxygen Sensing Using a Lubricant-Infused Coating,” ACS Sens, vol. 4, no. 3, pp. 687–693, 22 2019, doi: 10.1021/acssensors.8b01541.
[8684]	T. Kanoh, K. Matsunaga, K. Saito, and T. Fujii, “Suppression of in vivo tumor-induced angiogenesis by the protein-bound polysaccharide PSK,” In Vivo, vol. 8, no. 2, pp. 247–250, Apr. 1994.
[8685]	N. Kanda and S. Watanabe, “Suppressive effects of antimycotics on tumor necrosis factor-alpha-induced CCL27, CCL2, and CCL5 production in human keratinocytes,” Biochem. Pharmacol., vol. 72, no. 4, pp. 463–473, Aug. 2006, doi: 10.1016/j.bcp.2006.05.001.
[8686]	A. F. El-Kott and M. M. Bin-Meferij, “Suppressive effects of capsaicin against N-nitrosomethylurea-induced mammary tumorigenesis in rats,” Biomed. Pharmacother., vol. 98, pp. 673–679, Feb. 2018, doi: 10.1016/j.biopha.2017.12.036.
[8687]	H. Zheng et al., “Surface Effect on Oil Transportation in Nanochannel: a Molecular Dynamics Study,” Nanoscale Res Lett, vol. 12, no. 1, p. 413, Dec. 2017, doi: 10.1186/s11671-017-2161-2.
[8688]	M. A. I. Prodhan, X. Yin, S. Kim, C. McClain, and X. Zhang, “Surface fitting for calculating the second dimension retention index in comprehensive two-dimensional gas chromatography mass spectrometry,” J Chromatogr A, vol. 1539, pp. 62–70, Mar. 2018, doi: 10.1016/j.chroma.2018.01.049.
[8689]	N. Luan, R. Wang, W. Lv, Y. Lu, and J. Yao, “Surface plasmon resonance temperature sensor based on photonic crystal fibers randomly filled with silver nanowires,” Sensors (Basel), vol. 14, no. 9, pp. 16035–16045, Aug. 2014, doi: 10.3390/s140916035.
[8690]	C. Tiengwe, K. A. Muratore, and J. D. Bangs, “Surface proteins, ERAD and antigenic variation in Trypanosoma brucei,” Cell. Microbiol., vol. 18, no. 11, pp. 1673–1688, Nov. 2016, doi: 10.1111/cmi.12605.
[8691]	L. Heinke and C. Wöll, “Surface-Mounted Metal-Organic Frameworks: Crystalline and Porous Molecular Assemblies for Fundamental Insights and Advanced Applications,” Adv. Mater. Weinheim, vol. 31, no. 26, p. e1806324, Jun. 2019, doi: 10.1002/adma.201806324.
[8692]	B. Abramczyk, “[Surgery for lop ears],” Otolaryngol Pol, vol. 28, no. 3, pp. 307–309, 1974.
[8693]	B. Goldenberg and N. Barrile, “[Surgery of lop ears],” Dia Med, vol. 25, no. 17, pp. 411–412, Apr. 1953.
[8694]	I. I. Berishvili, M. N. Vakhromeeva, T. M. Lebedeva, and F. R. Ragimov, “[Surgical anatomy of subaortic conus of the normal heart],” Arkh Anat Gistol Embriol, vol. 100, no. 4, pp. 44–53, Apr. 1991.
[8695]	V. Dayan, L. Cura, S. Cubas, and G. Carriquiry, “Surgical anatomy of the saphenous nerve,” Ann. Thorac. Surg., vol. 85, no. 3, pp. 896–900, Mar. 2008, doi: 10.1016/j.athoracsur.2007.11.032.
[8696]	M. Vaiman, I. Bekerman, J. Basel, and M. Peer, “Surgical approach to the intrathoracic goiter,” Laryngoscope Investig Otolaryngol, vol. 3, no. 2, pp. 127–132, Apr. 2018, doi: 10.1002/lio2.146.
[8697]	L. D’Antiga and M. Colledan, “Surgical gene therapy by domino auxiliary liver transplantation,” Liver Transpl., vol. 21, no. 11, pp. 1338–1339, Nov. 2015, doi: 10.1002/lt.24326.
[8698]	A. Afaneh, M. Yang, A. Hamza, E. Schervish, and R. Berri, “Surgical Management of a Giant Pheochromocytoma,” In Vivo, vol. 32, no. 3, pp. 703–706, Jun. 2018, doi: 10.21873/invivo.11297.
[8699]	I. Dina, C. Voiculet, D. Georgescu, A. L. Gurghean, A. Pleșa, and O. D. Zară, “Surgical management of urothelial cancer in a cirrhotic patient after partial splenic embolisation,” Prz Gastroenterol, vol. 14, no. 4, pp. 298–301, 2019, doi: 10.5114/pg.2019.90256.
[8700]	J. W. T. Byrd, K. S. Jones, and C. R. Freeman, “Surgical Outcome of Pincer Femoroacetabular Impingement With and Without Labral Ossification,” Arthroscopy, vol. 32, no. 6, pp. 1022–1029, 2016, doi: 10.1016/j.arthro.2015.12.042.
[8701]	B. C. Lobo, M. M. Baumanis, and R. F. Nelson, “Surgical repair of spontaneous cerebrospinal fluid (CSF) leaks: A systematic review,” Laryngoscope Investig Otolaryngol, vol. 2, no. 5, pp. 215–224, 2017, doi: 10.1002/lio2.75.
[8702]	K. W. Kwak, M. S. Kim, C. H. Chang, S. W. Kim, and S. H. Kim, “Surgical results of selective median neurotomy for wrist and finger spasticity,” J Korean Neurosurg Soc, vol. 50, no. 2, pp. 95–98, Aug. 2011, doi: 10.3340/jkns.2011.50.2.95.
[8703]	M. Arslan et al., “Surgical view of the lumbar arteries and their branches: an anatomical study,” Neurosurgery, vol. 68, no. 1 Suppl Operative, pp. 16–22; discussion 22, Mar. 2011, doi: 10.1227/NEU.0b013e318205e307.
[8704]	“Surveillance systems to track progress towards polio eradication worldwide, 2015–2016,” Wkly. Epidemiol. Rec., vol. 92, no. 14, pp. 165–175, 07 2017.
[8705]	T. J. Wannemuehler et al., “Survey of endoscopic skull base surgery practice patterns among otolaryngologists,” Laryngoscope Investig Otolaryngol, vol. 3, no. 3, pp. 143–155, Jun. 2018, doi: 10.1002/lio2.149.
[8706]	J. Cline, D. P. Duncan, C. Molloy, and O. S. Zuberi, “Survey of Intern Year Experiences for Those Going into Interventional Radiology: Comparing Surgery, Medicine and Transitional Year Internships,” Acad Radiol, vol. 26, no. 11, pp. 1555–1561, 2019, doi: 10.1016/j.acra.2019.03.016.
[8707]	M. Wang and J. Wang, “[Survey of studies on correlation between Helicobacter pylori and cerebral infarction],” Zhongguo Zhen Jiu, vol. 27, no. 7, pp. 549–551, Jul. 2007.
[8708]	Y. Wang et al., “Survival Impact of Delaying Postoperative Radiotherapy in Patients with Esophageal Cancer,” Transl Oncol, vol. 11, no. 6, pp. 1358–1363, Dec. 2018, doi: 10.1016/j.tranon.2018.08.007.
[8709]	M. Pivetta Rippe et al., “Survival rate and load to failure of premolars restored with inlays: An evaluation of different inlay fabrication methods,” J Prosthet Dent, vol. 121, no. 2, pp. 292–297, Feb. 2019, doi: 10.1016/j.prosdent.2018.03.019.
[8710]	B. K. T. Vijayaragavan and N. Ramakrishnan, “Survivorship and (QALY)ty: In Pursuit of a Mirage?,” Indian J Crit Care Med, vol. 23, no. 3, pp. 111–112, Mar. 2019, doi: 10.5005/jp-journals-10071-23130.
[8711]	J. C. Lo et al., “Sustained benefits of delaying school start time on adolescent sleep and well-being,” Sleep, vol. 41, no. 6, 01 2018, doi: 10.1093/sleep/zsy052.
[8712]	J. Z. He, S. Dorion, M. Lacroix, and J. Rivoal, “Sustained substrate cycles between hexose phosphates and free sugars in phosphate-deficient potato (Solanum tuberosum) cell cultures,” Planta, vol. 249, no. 5, pp. 1319–1336, May 2019, doi: 10.1007/s00425-019-03088-4.
[8713]	P. M. H. Kroneck and M. E. Sosa Torres, “Sustaining Life on Planet Earth:Metalloenzymes Mastering Dioxygen and Other Chewy Gases,” Met Ions Life Sci, vol. 15, pp. vii–ix, 2015.
[8714]	R. W. Kates, “Sustaining life on the earth,” Sci. Am., vol. 271, no. 4, pp. 114–122, Oct. 1994, doi: 10.1038/scientificamerican1094-114.
[8715]	W. Y. Leung et al., “SV-AUTOPILOT: optimized, automated construction of structural variation discovery and benchmarking pipelines,” BMC Genomics, vol. 16, p. 238, Mar. 2015, doi: 10.1186/s12864-015-1376-9.
[8716]	Y. Xia, Y. Liu, M. Deng, and R. Xi, “SVmine improves structural variation detection by integrative mining of predictions from multiple algorithms,” Bioinformatics, vol. 33, no. 21, pp. 3348–3354, Nov. 2017, doi: 10.1093/bioinformatics/btx455.
[8717]	E. Kioko, A. M. Musyoki, A. Luanga, M. D. Kioko, E. W. Mwangi, and L. Monda, “Swallowtail butterflies (Lepidoptera: Papilionidae) species diversity and distribution in Africa: The Papilionidae collection at the National Museums of Kenya, Nairobi, Kenya,” Biodivers Data J, vol. 8, p. e50664, 2020, doi: 10.3897/BDJ.8.e50664.
[8718]	C. M. Papa and A. M. Kligman, “Sweat pore patterns,” J. Invest. Dermatol., vol. 46, no. 2, pp. 193–197, Feb. 1966.
[8719]	H. Reichmann, B. Herting, A. Mïller, and U. Sommer, “Switching and combining dopamine agonists,” J Neural Transm (Vienna), vol. 110, no. 12, pp. 1393–1400, Dec. 2003, doi: 10.1007/s00702-003-0081-z.
[8720]	G. Gratze, H. Mayer, and F. Skrabal, “Sympathetic reserve, serum potassium, and orthostatic intolerance after endurance exercise and implications for neurocardiogenic syncope,” Eur. Heart J., vol. 29, no. 12, pp. 1531–1541, Jun. 2008, doi: 10.1093/eurheartj/ehn193.
[8721]	L. G. Park et al., “Symptom Diary Use and Improved Survival for Patients With Heart Failure,” Circ Heart Fail, vol. 10, no. 11, Nov. 2017, doi: 10.1161/CIRCHEARTFAILURE.117.003874.
[8722]	R. D. Chiaie et al., “Symptomatic subsyndromal depression in hospitalized hypertensive patients,” J Affect Disord, vol. 135, no. 1–3, pp. 168–176, Dec. 2011, doi: 10.1016/j.jad.2011.07.008.
[8723]	A. Thompson-Harvey and T. C. Hain, “Symptoms in cervical vertigo,” Laryngoscope Investig Otolaryngol, vol. 4, no. 1, pp. 109–115, Feb. 2019, doi: 10.1002/lio2.227.
[8724]	E. Acquarone et al., “Synaptic and memory dysfunction induced by tau oligomers is rescued by up-regulation of the nitric oxide cascade,” Mol Neurodegener, vol. 14, no. 1, p. 26, 27 2019, doi: 10.1186/s13024-019-0326-4.
[8725]	J. J. Harris, R. Jolivet, and D. Attwell, “Synaptic energy use and supply,” Neuron, vol. 75, no. 5, pp. 762–777, Sep. 2012, doi: 10.1016/j.neuron.2012.08.019.
[8726]	T. G. Smart and P. Paoletti, “Synaptic neurotransmitter-gated receptors,” Cold Spring Harb Perspect Biol, vol. 4, no. 3, Mar. 2012, doi: 10.1101/cshperspect.a009662.
[8727]	M. He et al., “Synaptic Plasticity in PTSD and associated Comorbidities: The Function and Mechanism for Diagnostics and Therapy,” Curr. Pharm. Des., vol. 24, no. 34, pp. 4051–4059, 2018, doi: 10.2174/1381612824666181120094749.
[8728]	G. Esposito, F. Ana Clara, and P. Verstreken, “Synaptic vesicle trafficking and Parkinson’s disease,” Dev Neurobiol, vol. 72, no. 1, pp. 134–144, Jan. 2012, doi: 10.1002/dneu.20916.
[8729]	B. Jiang, J. Lu, J. Lou, and J. Qiu, “Synchronization in an array of coupled neural networks with delayed impulses: Average impulsive delay method,” Neural Netw, vol. 121, pp. 452–460, Jan. 2020, doi: 10.1016/j.neunet.2019.09.019.
[8730]	Z. Xu, D. Peng, and X. Li, “Synchronization of chaotic neural networks with time delay via distributed delayed impulsive control,” Neural Netw, vol. 118, pp. 332–337, Oct. 2019, doi: 10.1016/j.neunet.2019.07.002.
[8731]	Z. Xu, X. Li, and P. Duan, “Synchronization of complex networks with time-varying delay of unknown bound via delayed impulsive control,” Neural Netw, vol. 125, pp. 224–232, May 2020, doi: 10.1016/j.neunet.2020.02.003.
[8732]	D. D’Abbicco, S. Praino, M. Amoruso, A. Notarnicola, and A. Margari, “‘Syndrome in syndrome’: Wernicke syndrome due to afferent loop syndrome. Case report and review of the literature,” G Chir, vol. 32, no. 11–12, pp. 479–482, Dec. 2011.
[8733]	H. Plotkin, “Syndromes with congenital brittle bones,” BMC Pediatr, vol. 4, p. 16, Aug. 2004, doi: 10.1186/1471-2431-4-16.
[8734]	J. E. Kim et al., “Synergic Laxative Effects of an Herbal Mixture of Liriope platyphylla, Glycyrrhiza uralensis, and Cinnamomum cassia in Loperamide-Induced Constipation of Sprague Dawley Rats,” J Med Food, vol. 22, no. 3, pp. 294–304, Mar. 2019, doi: 10.1089/jmf.2018.4234.
[8735]	M. L. Ackland, S. van de Waarsenburg, and R. Jones, “Synergistic antiproliferative action of the flavonols quercetin and kaempferol in cultured human cancer cell lines,” In Vivo, vol. 19, no. 1, pp. 69–76, Feb. 2005.
[8736]	K. Xia et al., “Synergistic effect of receptor-interacting protein 140 and simvastatin on the inhibition of proliferation and survival of hepatocellular carcinoma cells,” Oncol Lett, vol. 15, no. 4, pp. 4344–4350, Apr. 2018, doi: 10.3892/ol.2018.7831.
[8737]	M. Kertész, R. Aszalós, A. Lengyel, and G. Ónodi, “Synergistic effects of the components of global change: Increased vegetation dynamics in open, forest-steppe grasslands driven by wildfires and year-to-year precipitation differences,” PLoS ONE, vol. 12, no. 11, p. e0188260, 2017, doi: 10.1371/journal.pone.0188260.
[8738]	D. De Padova, M. Mossa, M. Adamo, G. De Carolis, and G. Pasquariello, “Synergistic use of an oil drift model and remote sensing observations for oil spill monitoring,” Environ Sci Pollut Res Int, vol. 24, no. 6, pp. 5530–5543, Feb. 2017, doi: 10.1007/s11356-016-8214-8.
[8739]	L. Flaherty, M. Karl, and C. L. Reinisch, “Syngeneic tumor immunizations produce Qa antibodies. Discovery of a new Qa antigen, Qa-6,” Immunogenetics, vol. 16, no. 4, pp. 329–337, 1982, doi: 10.1007/BF00372304.
[8740]	T. Abiko and Y. Takamura, “Syntheses of two neuromedin U (NMU) analogues and their comparative reducing food intake effect in rats,” Amino Acids, vol. 25, no. 1, pp. 107–110, Jul. 2003, doi: 10.1007/s00726-002-0351-3.
[8741]	Y. Shikichi, S. Shankar, J. Y. Yew, and K. Mori, “Synthesis and bioassay of the eight analogues of the CH503 male pheromone (3-acetoxy-11,19-octacosadien-1-ol) of the Drosophila melanogaster fruit fly,” Biosci. Biotechnol. Biochem., vol. 77, no. 9, pp. 1931–1938, 2013, doi: 10.1271/bbb.130383.
[8742]	P. Kaviani, D. Shahbazi-Gahrouei, and A. A. Saray, “Synthesis and characterisation of LiB3O5 nanophosphor as a TL dosimeter,” IET Nanobiotechnol, vol. 14, no. 4, pp. 300–307, Jun. 2020, doi: 10.1049/iet-nbt.2019.0381.
[8743]	H. C. Geiger, P. L. Zick, W. R. Roberts, and D. K. Geiger, “Synthesis and characterization of a novel long-alkyl-chain ester-substituted benzimidazole gelator and its octan-1-ol solvate,” Acta Crystallogr C Struct Chem, vol. 73, no. Pt 4, pp. 350–356, Apr. 2017, doi: 10.1107/S2053229617004314.
[8744]	S. Sharma et al., “Synthesis and Characterization of Li-C Nanocomposite for Easy and Safe Handling,” Nanomaterials (Basel), vol. 10, no. 8, Jul. 2020, doi: 10.3390/nano10081483.
[8745]	T. Zhang et al., “Synthesis and Electrochemical Properties of Bi2MoO6/Carbon Anode for Lithium-Ion Battery Application,” Materials (Basel), vol. 13, no. 5, Mar. 2020, doi: 10.3390/ma13051132.
[8746]	X. Chen et al., “Synthesis and Electrochemical Property of FeOOH/Graphene Oxide Composites,” Front Chem, vol. 8, p. 328, 2020, doi: 10.3389/fchem.2020.00328.
[8747]	L. S. Dalbøge et al., “Synthesis and evaluation of novel lipidated neuromedin U analogs with increased stability and effects on food intake,” J. Pept. Sci., vol. 21, no. 2, pp. 85–94, Feb. 2015, doi: 10.1002/psc.2727.
[8748]	A. De Prins et al., “Synthesis and in Vitro Evaluation of Stabilized and Selective Neuromedin U-1 Receptor Agonists,” ACS Med Chem Lett, vol. 9, no. 5, pp. 496–501, May 2018, doi: 10.1021/acsmedchemlett.8b00105.
[8749]	M. Rapp, I. Giraud, J.-C. Maurizis, M.-J. Galmier, and J.-C. Madelmont, “Synthesis and in vivo biodisposition of [14C]-quaternary ammonium-melphalan conjugate, a potential cartilage-targeted alkylating drug,” Bioconjug. Chem., vol. 14, no. 2, pp. 500–506, Apr. 2003, doi: 10.1021/bc020031e.
[8750]	Z. Zhao et al., “Synthesis of a novel Fe-Mn binary oxide-modified lava adsorbent and its effect on ammonium removal from aqueous solutions,” Water Environ. Res., vol. 92, no. 6, pp. 850–864, Jun. 2020, doi: 10.1002/wer.1277.
[8751]	E. Şahin, “Synthesis of enantiopure (S)-6-chlorochroman-4-ol using whole-cell Lactobacillus paracasei biotransformation,” Chirality, vol. 32, no. 3, pp. 400–406, 2020, doi: 10.1002/chir.23177.
[8752]	S. Nandini et al., “Synthesis of one-dimensional gold nanostructures and the electrochemical application of the nanohybrid containing functionalized graphene oxide for cholesterol biosensing,” Bioelectrochemistry, vol. 110, pp. 79–90, Aug. 2016, doi: 10.1016/j.bioelechem.2016.03.006.
[8753]	T. Abiko and Y. Takamura, “Synthesis of two neuromedin U (NMU) analogues and their comparative effect of reducing food intake in rats,” Prep. Biochem. Biotechnol., vol. 32, no. 1, pp. 79–86, Feb. 2002, doi: 10.1081/PB-120013163.
[8754]	C. D. Raposo, K. T. Petrova, M. T. Barros, R. C. Calhelha, M. Sokovic, and I. C. F. R. Ferreira, “Synthesis, Characterization, Antimicrobial and Antitumor Activities of Sucrose Octa(N-ethyl)carbamate,” Med Chem, vol. 12, no. 1, pp. 22–29, 2016, doi: 10.2174/1573406410666150807111029.
[8755]	D. Sun et al., “Synthesis, in Vitro Covalent Binding Evaluation, and Metabolism of (14)C-Labeled Inhibitors of 11β-HSD1,” ACS Med Chem Lett, vol. 5, no. 11, pp. 1245–1250, Nov. 2014, doi: 10.1021/ml500331y.
[8756]	M. Zara and A. Cohen, “[Synthetic hypoglycemics],” Rev Fr Endocrinol Clin, vol. 2, pp. 489–500, Oct. 1961.
[8757]	K. Sanderson, “Synthetic Lava Brings Eruption into the Lab,” ACS Cent Sci, vol. 4, no. 9, pp. 1074–1077, Sep. 2018, doi: 10.1021/acscentsci.8b00615.
[8758]	N. M. Kumar, B. Fritz, S. E. Stern, J. B. M. Warntjes, Y. M. Lisa Chuah, and J. Fritz, “Synthetic MRI of the Knee: Phantom Validation and Comparison with Conventional MRI,” Radiology, vol. 289, no. 2, pp. 465–477, 2018, doi: 10.1148/radiol.2018173007.
[8759]	L. V. Stamm, “Syphilis: Re-emergence of an old foe,” Microb Cell, vol. 3, no. 9, pp. 363–370, Jun. 2016, doi: 10.15698/mic2016.09.523.
[8760]	Y. Sun et al., “Systematic expression profiling analysis mines dys-regulated modules in active tuberculosis based on re-weighted protein-protein interaction network and attract algorithm,” Microb. Pathog., vol. 107, pp. 48–53, Jun. 2017, doi: 10.1016/j.micpath.2017.03.013.
[8761]	H. Ding et al., “Systematic review and meta-analysis of application of fibrin sealant after liver resection,” Curr Med Res Opin, vol. 29, no. 4, pp. 387–394, Apr. 2013, doi: 10.1185/03007995.2013.768216.
[8762]	B. V. Dasari, H. Mergental, J. R. Isaac, P. Muiesan, D. F. Mirza, and T. Perera, “Systematic review and meta-analysis of liver transplantation using grafts from deceased donors aged over 70 years,” Clin Transplant, vol. 31, no. 12, Dec. 2017, doi: 10.1111/ctr.13139.
[8763]	A. E. Adegbosin, H. Zhou, S. Wang, B. Stantic, and J. Sun, “Systematic review and meta-analysis of the association between dimensions of inequality and a selection of indicators of Reproductive, Maternal, Newborn and Child Health (RMNCH),” J Glob Health, vol. 9, no. 1, p. 010429, Jun. 2019, doi: 10.7189/jogh.09.010429.
[8764]	G. Uchida et al., “Systematic review and meta-analysis of the diagnostic and therapeutic yield of small bowel endoscopy in patients with overt small bowel bleeding,” Dig Endosc, Mar. 2020, doi: 10.1111/den.13669.
[8765]	L. Rew, M. Kaur, A. McMillan, M. Mackert, and D. Bonevac, “Systematic review of psychosocial benefits and harms of genetic testing,” Issues Ment Health Nurs, vol. 31, no. 10, pp. 631–645, Oct. 2010, doi: 10.3109/01612840.2010.510618.
[8766]	C. R. Brewin, “Systematic review of screening instruments for adults at risk of PTSD,” J Trauma Stress, vol. 18, no. 1, pp. 53–62, Feb. 2005, doi: 10.1002/jts.20007.
[8767]	S. L. van Egmond, I. Stegeman, F. A. Pameijer, J. J. Bluemink, C. H. Terhaard, and L. M. Janssen, “Systematic review of the diagnostic value of magnetic resonance imaging for early glottic carcinoma,” Laryngoscope Investig Otolaryngol, vol. 3, no. 1, pp. 49–55, 2018, doi: 10.1002/lio2.138.
[8768]	M. Mahendran, K. N. Speechley, and E. Widjaja, “Systematic review of unmet healthcare needs in patients with epilepsy,” Epilepsy Behav, vol. 75, pp. 102–109, 2017, doi: 10.1016/j.yebeh.2017.02.034.
[8769]	S. V. Faraone, A. L. Rostain, C. B. Montano, O. Mason, K. M. Antshel, and J. H. Newcorn, “Systematic Review: Nonmedical Use of Prescription Stimulants: Risk Factors, Outcomes, and Risk Reduction Strategies,” J Am Acad Child Adolesc Psychiatry, vol. 59, no. 1, pp. 100–112, 2020, doi: 10.1016/j.jaac.2019.06.012.
[8770]	B. Howard, J. T. Scott, M. Blubaugh, B. Roepke, C. Scheckel, and M. Vassar, “Systematic review: Outcome reporting bias is a problem in high impact factor neurology journals,” PLoS ONE, vol. 12, no. 7, p. e0180986, 2017, doi: 10.1371/journal.pone.0180986.
[8771]	M. Kotowski, O. Naggara, T. E. Darsaut, and J. Raymond, “Systematic reviews of the literature on clipping and coiling of unruptured intracranial aneurysms,” Neurochirurgie, vol. 58, no. 2–3, pp. 125–139, Jun. 2012, doi: 10.1016/j.neuchi.2012.02.021.
[8772]	C. D. Lucas, N. Amft, and P. T. Reid, “Systemic lupus erythematosus complicating simple silicosis,” Occup Med (Lond), vol. 64, no. 5, pp. 387–390, Jul. 2014, doi: 10.1093/occmed/kqu060.
[8773]	G. S. Thakur et al., “Systems biology approach to understanding post-traumatic stress disorder,” Mol Biosyst, vol. 11, no. 4, pp. 980–993, Apr. 2015, doi: 10.1039/c4mb00404c.
[8774]	X. Tang et al., “Systems biology of the qa gene cluster in Neurospora crassa,” PLoS ONE, vol. 6, no. 6, p. e20671, 2011, doi: 10.1371/journal.pone.0020671.
[8775]	D. J. Spurgeon, O. A. H. Jones, J.-L. C. M. Dorne, C. Svendsen, S. Swain, and S. R. Stürzenbaum, “Systems toxicology approaches for understanding the joint effects of environmental chemical mixtures,” Sci. Total Environ., vol. 408, no. 18, pp. 3725–3734, Aug. 2010, doi: 10.1016/j.scitotenv.2010.02.038.
[8776]	L. van Garsse et al., “Systolic papillary muscle dyssynchrony predicts recurrence of mitral regurgitation in patients with ischemic cardiomyopathy (ICM) undergoing mitral valve repair,” Echocardiography, vol. 29, no. 10, pp. 1191–1200, Nov. 2012, doi: 10.1111/j.1540-8175.2012.01789.x.
[8777]	J. V. Cramer, C. Benakis, and A. Liesz, “T cells in the post-ischemic brain: Troopers or paramedics?,” J. Neuroimmunol., vol. 326, pp. 33–37, 15 2019, doi: 10.1016/j.jneuroim.2018.11.006.
[8778]	C. M. Gill et al., “T2 Candida versus beta-D-glucan to facilitate antifungal discontinuation in the intensive care unit,” Diagn. Microbiol. Infect. Dis., vol. 95, no. 2, pp. 162–165, Oct. 2019, doi: 10.1016/j.diagmicrobio.2019.04.016.
[8779]	G. Schyns, A. Roefs, and A. Jansen, “Tackling sabotaging cognitive processes to reduce overeating; expectancy violation during food cue exposure,” Physiol. Behav., vol. 222, p. 112924, Aug. 2020, doi: 10.1016/j.physbeh.2020.112924.
[8780]	V. Schmidt et al., “Taenia solium cysticercosis and taeniasis in urban settings: Epidemiological evidence from a health-center based study among people with epilepsy in Dar es Salaam, Tanzania,” PLoS Negl Trop Dis, vol. 13, no. 12, p. e0007751, 2019, doi: 10.1371/journal.pntd.0007751.
[8781]	M. Donadeu, M. W. Lightowlers, A. S. Fahrion, J. Kessels, and B. Abela-Ridder, “Taenia solium: WHO endemicity map update,” Wkly. Epidemiol. Rec., vol. 91, no. 49–50, pp. 595–599, 09 2016.
[8782]	C. C. Wang et al., “Taiwanese medical and nursing student interest levels in and attitudes towards geriatrics,” Ann Acad Med Singap, vol. 38, no. 3, pp. 230–236, Mar. 2009.
[8783]	S. George, L. Z. Dixon, E. Carrasco, O. Romo, L. Vides, and H. Balcazar, “Talk to PAPA: A Systematic Review of Patient/Participant (PAPA) Feedback on Interactions With Community Health Workers Using a Depth Analysis Approach,” J Ambul Care Manage, vol. 43, no. 1, pp. 55–70, Mar. 2020, doi: 10.1097/JAC.0000000000000309.
[8784]	T. Shien et al., “Tamoxifen plus tegafur-uracil (TUFT) versus tamoxifen plus Adriamycin (doxorubicin) and cyclophosphamide (ACT) as adjuvant therapy to treat node-positive premenopausal breast cancer (PreMBC): results of Japan Clinical Oncology Group Study 9404,” Cancer Chemother. Pharmacol., vol. 74, no. 3, pp. 603–609, Sep. 2014, doi: 10.1007/s00280-014-2545-2.
[8785]	A. Bhatia, B. Singh, K. Raza, S. Wadhwa, and O. P. Katare, “Tamoxifen-loaded lecithin organogel (LO) for topical application: Development, optimization and characterization,” Int J Pharm, vol. 444, no. 1–2, pp. 47–59, Feb. 2013, doi: 10.1016/j.ijpharm.2013.01.029.
[8786]	C. Y. J. Chang and N. C. Stellwagen, “Tandem GA residues on opposite sides of the loop in molecular beacon-like DNA hairpins compact the loop and increase hairpin stability,” Biochemistry, vol. 50, no. 42, pp. 9148–9157, Oct. 2011, doi: 10.1021/bi201263n.
[8787]	P. W. Winwood et al., “Tapering Practices of Strongman Athletes,” J Strength Cond Res, vol. 32, no. 5, pp. 1181–1196, May 2018, doi: 10.1519/JSC.0000000000002453.
[8788]	E. Landhuis, “Tapping into the brain’s star power,” Nature, vol. 563, no. 7729, pp. 141–143, 2018, doi: 10.1038/d41586-018-07197-0.
[8789]	M. Soejima and Y. Koda, “TaqMan-based real-time PCR for genotyping common polymorphisms of haptoglobin (HP1 and HP2),” Clin. Chem., vol. 54, no. 11, pp. 1908–1913, Nov. 2008, doi: 10.1373/clinchem.2008.113126.
[8790]	S. Palakurthi, J. Wilson, S. A. McQuarrie, M. R. Suresh, J. R. Mercer, and G. G. Miller, “Target specificity of 188Re-labeled B27.1 monoclonal antibodies to ovarian cancer cells in vivo,” In Vivo, vol. 22, no. 3, pp. 321–326, Jun. 2008.
[8791]	J. Hellmann, I. Heuser, and G. Kronenberg, “[Targeted prevention of posttraumatic stress disorder],” Nervenarzt, vol. 82, no. 7, pp. 834–841, Jul. 2011, doi: 10.1007/s00115-010-3064-y.
[8792]	K. Meschenmoser et al., “Targeting cancer with a bi-functional peptide: in vitro and in vivo results,” In Vivo, vol. 27, no. 4, pp. 431–442, Aug. 2013.
[8793]	S.-J. Li et al., “Targeting delivery of simvastatin using ICAM-1 antibody-conjugated nanostructured lipid carriers for acute lung injury therapy,” Drug Deliv, vol. 24, no. 1, pp. 402–413, Nov. 2017, doi: 10.1080/10717544.2016.1259369.
[8794]	E. Quansah, W. Peelaerts, J. W. Langston, D. K. Simon, J. Colca, and P. Brundin, “Targeting energy metabolism via the mitochondrial pyruvate carrier as a novel approach to attenuate neurodegeneration,” Mol Neurodegener, vol. 13, no. 1, p. 28, 24 2018, doi: 10.1186/s13024-018-0260-x.
[8795]	A. Zimmermann et al., “Targeting GATA transcription factors - a novel strategy for anti-aging interventions?,” Microb Cell, vol. 6, no. 5, pp. 212–216, May 2019, doi: 10.15698/mic2019.05.676.
[8796]	J. Schneiderhan, T. Master-Hunter, and A. Locke, “Targeting gut flora to treat and prevent disease,” J Fam Pract, vol. 65, no. 1, pp. 34–38, Jan. 2016.
[8797]	A. G. Rabchevsky, S. P. Patel, and P. G. Sullivan, “Targeting mitoNEET with pioglitazone for therapeutic neuroprotection after spinal cord injury,” Neural Regen Res, vol. 12, no. 11, pp. 1807–1808, Nov. 2017, doi: 10.4103/1673-5374.219040.
[8798]	N. Lypova et al., “Targeting Palbociclib-Resistant Estrogen Receptor-Positive Breast Cancer Cells via Oncolytic Virotherapy,” Cancers (Basel), vol. 11, no. 5, May 2019, doi: 10.3390/cancers11050684.
[8799]	G. Gallardo et al., “Targeting tauopathy with engineered tau-degrading intrabodies,” Mol Neurodegener, vol. 14, no. 1, p. 38, 22 2019, doi: 10.1186/s13024-019-0340-6.
[8800]	D. Hoyer, H. Professorial Fellow, and  null Adjunct, “Targeting the 5-HT system: Potential side effects,” Neuropharmacology, vol. 179, p. 108233, Aug. 2020, doi: 10.1016/j.neuropharm.2020.108233.
[8801]	P. Teodorescu, S. Pasca, D. Dima, C. Tomuleasa, and G. Ghiaur, “Targeting the Microenvironment in MDS: The Final Frontier,” Front Pharmacol, vol. 11, p. 1044, 2020, doi: 10.3389/fphar.2020.01044.
[8802]	Y. Kim, M. Schmidt, T. Endo, D. Lu, D. Carson, and I. G. H. Schmidt-Wolf, “Targeting the Wnt/beta-catenin pathway with the antifungal agent ciclopirox olamine in a murine myeloma model,” In Vivo, vol. 25, no. 6, pp. 887–893, Dec. 2011.
[8803]	E. A. Schmidt, M. W. Scerbo, G. Kapur, and A. R. Heyl, “Task sequencing effects for open and closed loop laparoscopic skills,” Stud Health Technol Inform, vol. 125, pp. 412–417, 2007.
[8804]	R. M. Carey, N. D. Adappa, J. N. Palmer, R. J. Lee, and N. A. Cohen, “Taste Receptors: Regulators of Sinonasal Innate Immunity,” Laryngoscope Investig Otolaryngol, vol. 1, no. 4, pp. 88–95, Aug. 2016, doi: 10.1002/lio2.26.
[8805]	M. Chiasseu et al., “Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer’s disease,” Mol Neurodegener, vol. 12, no. 1, p. 58, 03 2017, doi: 10.1186/s13024-017-0199-3.
[8806]	J. E. Gerson et al., “Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy,” Mol Neurodegener, vol. 13, no. 1, p. 13, 15 2018, doi: 10.1186/s13024-018-0245-9.
[8807]	L. Saint-Aubert, L. Lemoine, K. Chiotis, A. Leuzy, E. Rodriguez-Vieitez, and A. Nordberg, “Tau PET imaging: present and future directions,” Mol Neurodegener, vol. 12, no. 1, p. 19, 20 2017, doi: 10.1186/s13024-017-0162-3.
[8808]	L. Sagwan-Barkdoll and A. M. Anterola, “Taxadiene-5α-ol is a minor product of CYP725A4 when expressed in Escherichia coli,” Biotechnol. Appl. Biochem., vol. 65, no. 3, pp. 294–305, May 2018, doi: 10.1002/bab.1606.
[8809]	B. E. Compas, S. Ey, and K. E. Grant, “Taxonomy, assessment, and diagnosis of depression during adolescence,” Psychol Bull, vol. 114, no. 2, pp. 323–344, Sep. 1993, doi: 10.1037/0033-2909.114.2.323.
[8810]	G.-S. Cho, D.-S. Park, S.-C. Choi, and J.-K. Han, “Tbx2 regulates anterior neural specification by repressing FGF signaling pathway,” Dev. Biol., vol. 421, no. 2, pp. 183–193, Jan. 2017, doi: 10.1016/j.ydbio.2016.11.020.
[8811]	A. E. Layne, G. A. Bernstein, and J. S. March, “Teacher awareness of anxiety symptoms in children,” Child Psychiatry Hum Dev, vol. 36, no. 4, pp. 383–392, 2006, doi: 10.1007/s10578-006-0009-6.
[8812]	J. W. Halle, D. M. Baer, and J. E. Spradlin, “Teachers’ generalized use of delay as a stimulus control procedure to increase language use in handicapped children,” J Appl Behav Anal, vol. 14, no. 4, pp. 389–409, 1981, doi: 10.1901/jaba.1981.14-389.
[8813]	I. Bou Akl et al., “Teaching clinical pharmacology using team-based learning: a comparison between third- and fourth-year medical students,” J Clin Pharmacol, vol. 52, no. 12, pp. 1806–1814, Dec. 2012, doi: 10.1177/0091270011428986.
[8814]	L. Latham, A. MacDonald, A. B. Kimball, and R. G. Langley, “Teaching empathy to undergraduate medical students using a temporary tattoo simulating psoriasis,” J. Am. Acad. Dermatol., vol. 67, no. 1, pp. 93–99, Jul. 2012, doi: 10.1016/j.jaad.2011.07.023.
[8815]	D. R. Hill, R. M. Ainsworth, and U. Partap, “Teaching global public health in the undergraduate liberal arts: a survey of 50 colleges,” Am. J. Trop. Med. Hyg., vol. 87, no. 1, pp. 11–15, Jul. 2012, doi: 10.4269/ajtmh.2012.11-0571.
[8816]	A. Marušić, M. Malički, D. Sambunjak, A. Jerončić, and M. Marušić, “Teaching science throughout the six-year medical curriculum: two-year experience from the University of Split School of Medicine, Split, Croatia,” Acta Med Acad, vol. 43, no. 1, pp. 50–62, 2014, doi: 10.5644/ama2006-124.100.
[8817]	L. Hu et al., “Tear menisci and corneal subbasal nerve density in patients after laser in situ keratomileusis,” Eye Contact Lens, vol. 41, no. 1, pp. 51–57, Jan. 2015, doi: 10.1097/ICL.0000000000000062.
[8818]	Y. M. Shaaban and T. A. F. Badran, “Tear meniscus evaluation after microkeratome laser in situ keratomileusis, femtosecond laser and femtosmile laser techniques using anterior segment optical coherence tomography,” Clin Ophthalmol, vol. 12, pp. 1337–1345, 2018, doi: 10.2147/OPTH.S169091.
[8819]	D. Badawi, “TearCare® system extension study: evaluation of the safety, effectiveness, and durability through 12 months of a second TearCare® treatment on subjects with dry eye disease,” Clin Ophthalmol, vol. 13, pp. 189–198, 2019, doi: 10.2147/OPTH.S191588.
[8820]	R. Sivelli, A. M. Farinon, M. Sianesi, M. Percudani, G. Ugolotti, and B. Calbiani, “Technetium-99m HIDA hepatobiliary scanning in evaluation of afferent loop syndrome,” Am. J. Surg., vol. 148, no. 2, pp. 262–265, Aug. 1984, doi: 10.1016/0002-9610(84)90234-4.
[8821]	A. Millan, “[Technic of electron microscopic observation of in vitro tissue cultures],” Neurocirugia, vol. 10, p. No. 11, 1-5, 1954.
[8822]	C. Saw, M. Ferenci, and H. Wanger, “Technical aspects of quality assurance in radiation oncology,” Biomed Imaging Interv J, vol. 4, no. 3, p. e48, Jul. 2008, doi: 10.2349/biij.4.3.e48.
[8823]	J. M. Converse and D. Wood-Smith, “Technical details in the surgical correction of the lop ear deformity,” Plast. Reconstr. Surg., vol. 31, pp. 118–128, Feb. 1963, doi: 10.1097/00006534-196302000-00002.
[8824]	S.-A. Park, D.-S. Kwak, and H.-J. Cho, “Technical variation of trans-articular sacroiliac joint (SIJ) fusion using three screws considering the effects of sacral dysplasia in patients with non-traumatic SIJ pain,” BMC Musculoskelet Disord, vol. 20, no. 1, p. 386, Aug. 2019, doi: 10.1186/s12891-019-2771-1.
[8825]	N. I. Elsahy, “Technique for correction of lop ear,” Plast. Reconstr. Surg., vol. 85, no. 4, pp. 615–620, Apr. 1990, doi: 10.1097/00006534-199004000-00021.
[8826]	Q. Song, M. Peng, Y. Chu, and S. Huang, “Techniques for detecting chromosomal aberrations in myelodysplastic syndromes,” Oncotarget, vol. 8, no. 37, pp. 62716–62729, Sep. 2017, doi: 10.18632/oncotarget.17698.
[8827]	Y. Ono et al., “Techniques for splenic vein reconstruction after pancreaticoduodenectomy with portal vein resection for pancreatic cancer,” HPB (Oxford), vol. 21, no. 10, pp. 1288–1294, 2019, doi: 10.1016/j.hpb.2019.01.017.
[8828]	L. Knopfová, P. Bouchal, and J. Smarda, “[Techniques to study transendothelial migration in vitro],” Klin Onkol, vol. 27 Suppl 1, pp. S28-33, 2014, doi: 10.14735/amko20141s28.
[8829]	C. A. Caceres and A. Zara, “Technology and dollars,” Clin Eng News, vol. 4, no. 6, pp. 3–4, Nov. 1976.
[8830]	T. Straetemans et al., “TEG001 Insert Integrity from Vector Producer Cells until Medicinal Product,” Mol. Ther., vol. 28, no. 2, pp. 561–571, 05 2020, doi: 10.1016/j.ymthe.2019.11.030.
[8831]	C. Plathow et al., “[Teleradiology: economic research analysis of CT investigations in a small hospital],” Rofo, vol. 177, no. 7, pp. 1016–1026, Jul. 2005, doi: 10.1055/s-2005-858265.
[8832]	K. Ohyashiki et al., “Telomere dynamics in myelodysplastic syndromes and acute leukemic transformation,” Leuk. Lymphoma, vol. 42, no. 3, pp. 291–299, Jul. 2001, doi: 10.3109/10428190109064585.
[8833]	V. Paavonen, K. Luoto, A. Koivukangas, A. Lassila, E. Leinonen, and O. Kampman, “Temperament and character profiles associated with depression and treatment response in patients with or without comorbid substance abuse,” Psychiatry Res, vol. 245, pp. 250–258, 30 2016, doi: 10.1016/j.psychres.2016.08.043.
[8834]	A. Fraga, M. C. Carreira, A. Gonzalez-Izquierdo, C. Diéguez, M. López, and E. Gutiérrez, “Temperature but not leptin prevents semi-starvation induced hyperactivity in rats: implications for anorexia nervosa treatment,” Sci Rep, vol. 10, no. 1, p. 5300, 24 2020, doi: 10.1038/s41598-020-62147-z.
[8835]	S. Wang, H. Hwang, S. Yoon, and E. Choe, “Temperature dependence of autoxidation of perilla oil and tocopherol degradation,” J. Food Sci., vol. 75, no. 6, pp. C498-505, Aug. 2010, doi: 10.1111/j.1750-3841.2010.01681.x.
[8836]	A. Cano-Martínez, A. Vargas-González, and V. Guarner-Lans, “Temperature effect on contractile activity of the Ambystoma dumerilii heart previously treated with isoproterenol,” Comp. Biochem. Physiol., Part A Mol. Integr. Physiol., vol. 147, no. 3, pp. 743–749, Jul. 2007, doi: 10.1016/j.cbpa.2006.10.030.
[8837]	C. E. Paquin and V. M. Williamson, “Temperature effects on the rate of ty transposition,” Science, vol. 226, no. 4670, pp. 53–55, Oct. 1984, doi: 10.1126/science.226.4670.53.
[8838]	M. Krafft and J. Keller, “Temperature measurements in carbonatite lava lakes and flows from oldoinyo lengai, Tanzania,” Science, vol. 245, no. 4914, pp. 168–170, Jul. 1989, doi: 10.1126/science.245.4914.168.
[8839]	F. J. Kim et al., “Temperature safety profile of laparoscopic devices: Harmonic ACE (ACE), Ligasure V (LV), and plasma trisector (PT),” Surg Endosc, vol. 22, no. 6, pp. 1464–1469, Jun. 2008, doi: 10.1007/s00464-007-9650-9.
[8840]	I. K. Jordan and J. F. McDonald, “Tempo and mode of Ty element evolution in Saccharomyces cerevisiae,” Genetics, vol. 151, no. 4, pp. 1341–1351, Apr. 1999.
[8841]	L. Basmaciyan, L. Berry, J. Gros, N. Azas, and M. Casanova, “Temporal analysis of the autophagic and apoptotic phenotypes in Leishmania parasites,” Microb Cell, vol. 5, no. 9, pp. 404–417, Aug. 2018, doi: 10.15698/mic2018.09.646.
[8842]	F. Santos and J. B. Nadol, “Temporal bone histopathology of furosemide ototoxicity,” Laryngoscope Investig Otolaryngol, vol. 2, no. 5, pp. 204–207, 2017, doi: 10.1002/lio2.108.
[8843]	O. J. Ungar, J. B. Nadol, and F. Santos, “Temporal Bone Histopathology of X-linked Inherited Alport Syndrome,” Laryngoscope Investig Otolaryngol, vol. 3, no. 4, pp. 311–314, Aug. 2018, doi: 10.1002/lio2.177.
[8844]	B. M. Lin, K. Reinshagen, J. Nadol, and A. M. Quesnel, “Temporal bone histopathology: Superior semicircular canal dehiscence,” Laryngoscope Investig Otolaryngol, vol. 5, no. 1, pp. 117–121, Feb. 2020, doi: 10.1002/lio2.332.
[8845]	P. Striano, F. Zara, and C. Minetti, “Temporal lobe abnormalities on brain MRI in healthy volunteers: a prospective case-control study,” Neurology, vol. 75, no. 4, pp. 377–378; author reply 378, Jul. 2010, doi: 10.1212/WNL.0b013e3181e79389.
[8846]	J.-L. Feng et al., “Temporal Trends in Sudden Cardiac Death From 1997 to 2010: A Data Linkage Study,” Heart Lung Circ, vol. 26, no. 8, pp. 808–816, Aug. 2017, doi: 10.1016/j.hlc.2016.11.021.
[8847]	R. D. Burghardt and J. E. Herzenberg, “Temporary hemiepiphysiodesis with the eight-Plate for angular deformities: mid-term results,” J Orthop Sci, vol. 15, no. 5, pp. 699–704, Sep. 2010, doi: 10.1007/s00776-010-1514-9.
[8848]	G. Zara, I. Ponza, V. Citton, and R. Manara, “Temporo-sylvian arachnoidal cyst and an extreme pneumatization of the cranial sinuses: a case report,” Clin Neurol Neurosurg, vol. 112, no. 9, pp. 821–823, Nov. 2010, doi: 10.1016/j.clineuro.2010.06.015.
[8849]	K. H. Bendixen et al., “Temporomandibular disorders and psychosocial status in osteogenesis imperfecta - a cross-sectional study,” BMC Oral Health, vol. 18, no. 1, p. 35, 07 2018, doi: 10.1186/s12903-018-0497-3.
[8850]	A. Bernard, “Ten ways for provider units to weather this economic downturn,” J Contin Educ Nurs, vol. 40, no. 5, pp. 196–197, May 2009.
[8851]	“Tenatoprazole. Benatoprazole, TU 199,” Drugs R D, vol. 3, no. 4, pp. 276–277, 2002, doi: 10.2165/00126839-200203040-00009.
[8852]	M. J. Mienaltowski, S. M. Adams, and D. E. Birk, “Tendon proper- and peritenon-derived progenitor cells have unique tenogenic properties,” Stem Cell Res Ther, vol. 5, no. 4, p. 86, Jul. 2014, doi: 10.1186/scrt475.
[8853]	Y. Chen, Z. Li, and L. A. Ju, “Tensile and compressive force regulation on cell mechanosensing,” Biophys Rev, vol. 11, no. 3, pp. 311–318, Jun. 2019, doi: 10.1007/s12551-019-00536-z.
[8854]	M. Woerner et al., “Terahertz Driven Amplification of Coherent Optical Phonons in GaAs Coupled to a Metasurface,” Phys. Rev. Lett., vol. 122, no. 10, p. 107402, Mar. 2019, doi: 10.1103/PhysRevLett.122.107402.
[8855]	B. Toth, “Teratogenic hydrazines: a review,” In Vivo, vol. 7, no. 1, pp. 101–110, Feb. 1993.
[8856]	H. Holst, E. Muhari-Stark, and S. A. Lava, “Teratogenicity of systemic isotretinoin,” Minerva Pediatr., vol. 70, no. 1, pp. 107–109, 2018, doi: 10.23736/S0026-4946.16.04778-2.
[8857]	W. J. Rea, C. Restrepo, and Y. Pan, “Terpenes and terpenoids in chemical sensitivity,” Altern Ther Health Med, vol. 21, no. 4, pp. 12–17, Aug. 2015.
[8858]	S. K. Bose, M. Chauhan, N. Dhingra, S. Chhibber, and K. Harjai, “Terpinen-4-ol attenuates quorum sensing regulated virulence factors and biofilm formation in Pseudomonas aeruginosa,” Future Microbiol, vol. 15, pp. 127–142, 2020, doi: 10.2217/fmb-2019-0204.
[8859]	Z. Li et al., “Terpinen-4-ol Enhances Disease Resistance of Postharvest Strawberry Fruit More Effectively than Tea Tree Oil by Activating the Phenylpropanoid Metabolism Pathway,” J. Agric. Food Chem., vol. 68, no. 24, pp. 6739–6747, Jun. 2020, doi: 10.1021/acs.jafc.0c01840.
[8860]	C.-S. Wu et al., “Terpinen-4-ol Induces Apoptosis in Human Nonsmall Cell Lung Cancer In Vitro and In Vivo,” Evid Based Complement Alternat Med, vol. 2012, p. 818261, 2012, doi: 10.1155/2012/818261.
[8861]	S. Tighe, Y.-Y. Gao, and S. C. G. Tseng, “Terpinen-4-ol is the Most Active Ingredient of Tea Tree Oil to Kill Demodex Mites,” Transl Vis Sci Technol, vol. 2, no. 7, p. 2, Nov. 2013, doi: 10.1167/tvst.2.7.2.
[8862]	S. Shapira, S. Pleban, D. Kazanov, P. Tirosh, and N. Arber, “Terpinen-4-ol: A Novel and Promising Therapeutic Agent for Human Gastrointestinal Cancers,” PLoS ONE, vol. 11, no. 6, p. e0156540, 2016, doi: 10.1371/journal.pone.0156540.
[8863]	H. Hahn, P. Kropp, T. Kirschstein, G. Rücker, and B. Müller-Hilke, “Test anxiety in medical school is unrelated to academic performance but correlates with an effort/reward imbalance,” PLoS ONE, vol. 12, no. 2, p. e0171220, 2017, doi: 10.1371/journal.pone.0171220.
[8864]	D. D. Szafranski, T. L. Barrera, and P. J. Norton, “Test anxiety inventory: 30 years later,” Anxiety Stress Coping, vol. 25, no. 6, pp. 667–677, Nov. 2012, doi: 10.1080/10615806.2012.663490.
[8865]	J. Bodas and T. H. Ollendick, “Test anxiety: a cross-cultural perspective,” Clin Child Fam Psychol Rev, vol. 8, no. 1, pp. 65–88, Mar. 2005, doi: 10.1007/s10567-005-2342-x.
[8866]	A. Papaioannou et al., “Testing a theoretical model of imminent fracture risk in elderly women: an observational cohort analysis of the Canadian Multicentre Osteoporosis Study,” Osteoporos Int, vol. 31, no. 6, pp. 1145–1153, Jun. 2020, doi: 10.1007/s00198-020-05330-2.
[8867]	S. A. G. Lava, M. G. Bianchetti, and G. P. Milani, “Testing Na+ in blood,” Clin Kidney J, vol. 10, no. 2, pp. 147–148, Apr. 2017, doi: 10.1093/ckj/sfw103.
[8868]	F. Domaneschi, M. Vignolo, and S. Di Paola, “Testing the causal theory of reference,” Cognition, vol. 161, pp. 1–9, 2017, doi: 10.1016/j.cognition.2016.12.014.
[8869]	S. A. Duke, B. W. R. Balzer, and K. S. Steinbeck, “Testosterone and its effects on human male adolescent mood and behavior: a systematic review,” J Adolesc Health, vol. 55, no. 3, pp. 315–322, Sep. 2014, doi: 10.1016/j.jadohealth.2014.05.007.
[8870]	G. Hackett, N. Cole, A. Saghir, P. Jones, R. C. Strange, and S. Ramachandran, “Testosterone replacement therapy: improved sexual desire and erectile function in men with type 2 diabetes following a 30-week randomized placebo-controlled study,” Andrology, vol. 5, no. 5, pp. 905–913, Sep. 2017, doi: 10.1111/andr.12399.
[8871]	J. J. Chillarón et al., “Testosterone undecanoate improves lipid profile in patients with type 1 diabetes and hypogonadotrophic hypogonadism,” Endocr. J., vol. 63, no. 9, pp. 849–855, Sep. 2016, doi: 10.1507/endocrj.EJ16-0195.
[8872]	G. Hackett, N. Cole, A. Saghir, P. Jones, R. C. Strange, and S. Ramachandran, “Testosterone undecanoate improves sexual function in men with type 2 diabetes and severe hypogonadism: results from a 30-week randomized placebo-controlled study,” BJU Int., vol. 118, no. 5, pp. 804–813, Nov. 2016, doi: 10.1111/bju.13516.
[8873]	D. Edelstein and S. Basaria, “Testosterone undecanoate in the treatment of male hypogonadism,” Expert Opin Pharmacother, vol. 11, no. 12, pp. 2095–2106, Aug. 2010, doi: 10.1517/14656566.2010.505920.
[8874]	Y.-W. Chen et al., “Testosterone undecanoate supplementation together with human chorionic gonadotropin does not impair spermatogenesis in males with isolated hypogonadotropic hypogonadism: a retrospective study,” Asian J. Androl., vol. 21, no. 4, pp. 413–418, Aug. 2019, doi: 10.4103/aja.aja_107_18.
[8875]	T. L. McKerchar and J. E. Mazur, “Tests of an indifference rule in variable-delay and double-reward choice procedures with humans,” J Exp Anal Behav, vol. 111, no. 3, pp. 387–404, 2019, doi: 10.1002/jeab.521.
[8876]	M. P. Kefer, “Tetanus,” Am J Emerg Med, vol. 10, no. 5, pp. 445–448, Sep. 1992, doi: 10.1016/0735-6757(92)90073-7.
[8877]	“Tetanus vaccines: WHO position paper – February 2017,” Wkly. Epidemiol. Rec., vol. 92, no. 6, pp. 53–76, 10 2017.
[8878]	A. Ali, C. Hambrock, and M. J. Aslam, “Tetraquark interpretation of the BELLE data on the anomalous Upsilon(1S)pi+ pi- and Upsilon(2S)pi+ pi- production near the Upsilon(5S) resonance,” Phys. Rev. Lett., vol. 104, no. 16, p. 162001, Apr. 2010, doi: 10.1103/PhysRevLett.104.162001.
[8879]	T. Yagi, D. Ito, and N. Suzuki, “TFG-Related Neurologic Disorders: New Insights Into Relationships Between Endoplasmic Reticulum and Neurodegeneration,” J. Neuropathol. Exp. Neurol., vol. 75, no. 4, pp. 299–305, Apr. 2016, doi: 10.1093/jnen/nlw009.
[8880]	J. I. Rojas et al., “Thalamus volume change and cognitive impairment in early relapsing-remitting multiple sclerosis patients,” Neuroradiol J, vol. 31, no. 4, pp. 350–355, Aug. 2018, doi: 10.1177/1971400918781977.
[8881]	G. Zara, M. Ermani, R. Rondinone, S. Arienti, and A. Doria, “Thalidomide and sensory neurotoxicity: a neurophysiological study,” J. Neurol. Neurosurg. Psychiatry, vol. 79, no. 11, pp. 1258–1261, Nov. 2008, doi: 10.1136/jnnp.2008.147892.
[8882]	G. Cavaletti et al., “Thalidomide sensory neurotoxicity: a clinical and neurophysiologic study,” Neurology, vol. 62, no. 12, pp. 2291–2293, Jun. 2004, doi: 10.1212/wnl.62.12.2291.
[8883]	A. A. Davenport, T. R. Williams, and D. T. Myers, “The ‘shaggy esophagus,’” Abdom Radiol (NY), vol. 44, no. 1, pp. 385–386, 2019, doi: 10.1007/s00261-018-1729-3.
[8884]	A. González-Hernández et al., “The 5-HT(1) receptors inhibiting the rat vasodepressor sensory CGRPergic outflow: further involvement of 5-HT(1F), but not 5-HT(1A) or 5-HT(1D), subtypes,” Eur. J. Pharmacol., vol. 659, no. 2–3, pp. 233–243, Jun. 2011, doi: 10.1016/j.ejphar.2011.03.035.
[8885]	B. M. Ruf and Z. Bhagwagar, “The 5-HT1B receptor: a novel target for the pathophysiology of depression,” Curr Drug Targets, vol. 10, no. 11, pp. 1118–1138, Nov. 2009, doi: 10.2174/138945009789735192.
[8886]	S. Isaza-Jaramillo, L. V. Salazar-Velásquez, M. Portillo-Benjumea, and J. Carrizosa-Moog, “The abbreviation ‘PWE’ may carry a negative connotation compared with the labels ‘person with epilepsy’ and ‘epileptic,’” Seizure, vol. 76, pp. 167–172, Feb. 2020, doi: 10.1016/j.seizure.2020.02.010.
[8887]	H. Möbitz, “The ABC of protein kinase conformations,” Biochim. Biophys. Acta, vol. 1854, no. 10 Pt B, pp. 1555–1566, Oct. 2015, doi: 10.1016/j.bbapap.2015.03.009.
[8888]	S. Crawford, K. Davis, C. Saddler, J. Joseph, E. J. Catapane, and M. A. Carroll, “The Ability of PAS, Acetylsalicylic Acid and Calcium Disodium EDTA to Protect Against the Toxic Effects of Manganese on Mitochondrial Respiration in Gill of Crassostrea virginica,” In Vivo (Brooklyn), vol. 33, no. 1, pp. 7–14, 2011.
[8889]	O. Amir et al., “The ACE deletion allele is associated with Israeli elite endurance athletes,” Exp. Physiol., vol. 92, no. 5, pp. 881–886, Sep. 2007, doi: 10.1113/expphysiol.2007.038711.
[8890]	C. D. Johnson, J. B. Rand, R. K. Herman, B. D. Stern, and R. L. Russell, “The acetylcholinesterase genes of C. elegans: identification of a third gene (ace-3) and mosaic mapping of a synthetic lethal phenotype,” Neuron, vol. 1, no. 2, pp. 165–173, Apr. 1988, doi: 10.1016/0896-6273(88)90201-2.
[8891]	M. S. Murray, A. Neal-Barnett, J. L. Demmings, and R. E. Stadulis, “The acting White accusation, racial identity, and anxiety in African American adolescents,” J Anxiety Disord, vol. 26, no. 4, pp. 526–531, May 2012, doi: 10.1016/j.janxdis.2012.02.006.
[8892]	R. W. Gillette, “The action of desoxypyrodoxine on chick fibroblasts in vitro,” Exp. Cell Res., vol. 9, no. 3, pp. 589–592, Dec. 1955, doi: 10.1016/0014-4827(55)90091-4.
[8893]	G. Miccolis, “[The action of the inflammatory exudate in rheumatic seroitis on the growth of cultures in vitro],” Minerva Med., vol. 53, pp. 2662–2667, Sep. 1962.
[8894]	A. Adibi et al., “The Acute COPD Exacerbation Prediction Tool (ACCEPT): a modelling study,” Lancet Respir Med, Mar. 2020, doi: 10.1016/S2213-2600(19)30397-2.
[8895]	G. Zara et al., “The administration of L-cysteine and L-arginine inhibits biofilm formation in wild-type biofilm-forming yeast by modulating FLO11 gene expression,” Appl. Microbiol. Biotechnol., vol. 103, no. 18, pp. 7675–7685, Sep. 2019, doi: 10.1007/s00253-019-09996-5.
[8896]	P. A. Nickerson, “The adrenal cortex in spontaneously hypertensive rats. A quantitative ultrastructural study,” Am. J. Pathol., vol. 84, no. 3, pp. 545–560, Sep. 1976.
[8897]	D. L. Faden, K. Chang Sing Pang, and D. M. Hildrew, “The age of telemedicine is upon us,” Laryngoscope Investig Otolaryngol, vol. 5, no. 3, pp. 584–585, Jun. 2020, doi: 10.1002/lio2.391.
[8898]	H. Creasey and S. I. Rapoport, “The aging human brain,” Ann. Neurol., vol. 17, no. 1, pp. 2–10, Jan. 1985, doi: 10.1002/ana.410170103.
[8899]	E. Soref, “[The aging of the population and late-life depression--implications for the medical sciences and presentation of one therapeutic modality],” Harefuah, vol. 146, no. 1, pp. 38–41, 78, Jan. 2007.
[8900]	G. Staneva, N. Puff, S. Stanimirov, T. Tochev, M. I. Angelova, and M. Seigneuret, “The Alzheimer’s disease amyloid-β peptide affects the size-dynamics of raft-mimicking Lo domains in GM1-containing lipid bilayers,” Soft Matter, vol. 14, no. 47, pp. 9609–9618, Dec. 2018, doi: 10.1039/c8sm01636d.
[8901]	H. Rachlin, K. B. Arfer, V. Safin, and M. Yen, “The amount effect and marginal value,” J Exp Anal Behav, vol. 104, no. 1, pp. 1–6, Jul. 2015, doi: 10.1002/jeab.158.
[8902]	J. C. Boucaut, T. Darribere, D. L. Shi, J. F. Riou, M. Delarue, and K. E. Johnson, “The amphibian embryo: an experimental model for the in vivo analysis of interactions between embryonic cells and extracellular matrix molecules,” In Vivo, vol. 5, no. 5, pp. 473–481, Oct. 1991.
[8903]	C. Goga and U. Türe, “The anatomy of Meyer’s loop revisited: changing the anatomical paradigm of the temporal loop based on evidence from fiber microdissection,” J. Neurosurg., vol. 122, no. 6, pp. 1253–1262, Jun. 2015, doi: 10.3171/2014.12.JNS14281.
[8904]	H. Stopfkuchen, D. Weitzel, and E. Stofft, “The anatomy of the heart in the sonogram. A comparison between anatomic and ultrasonic cross-section,” Pediatr Radiol, vol. 6, no. 2, pp. 68–73, Sep. 1977, doi: 10.1007/BF00973525.
[8905]	F. Cambien, “The angiotensin-converting enzyme (ACE) genetic polymorphism: its relationship with plasma ACE level and myocardial infarction,” Clin. Genet., vol. 46, no. 1 Spec No, pp. 94–101, Jul. 1994, doi: 10.1111/j.1399-0004.1994.tb04210.x.
[8906]	D. Vallöf, J. Vestlund, J. A. Engel, and E. Jerlhag, “The Anorexigenic Peptide Neuromedin U (NMU) Attenuates Amphetamine-Induced Locomotor Stimulation, Accumbal Dopamine Release and Expression of Conditioned Place Preference in Mice,” PLoS ONE, vol. 11, no. 5, p. e0154477, 2016, doi: 10.1371/journal.pone.0154477.
[8907]	W. F. Laurance, “The Anthropocene,” Curr. Biol., vol. 29, no. 19, pp. R953–R954, 07 2019, doi: 10.1016/j.cub.2019.07.055.
[8908]	N. Kanda, R. Kano, T. Ishikawa, and S. Watanabe, “The antimycotic drugs itraconazole and terbinafine hydrochloride induce the production of human β-defensin-3 in human keratinocytes,” Immunobiology, vol. 216, no. 4, pp. 497–504, Apr. 2011, doi: 10.1016/j.imbio.2010.08.008.
[8909]	A. Peier et al., “The antiobesity effects of centrally administered neuromedin U and neuromedin S are mediated predominantly by the neuromedin U receptor 2 (NMUR2),” Endocrinology, vol. 150, no. 7, pp. 3101–3109, Jul. 2009, doi: 10.1210/en.2008-1772.
[8910]	K. Pommerehne, J. Walisko, A. Ebersbach, and R. Krull, “The antitumor antibiotic rebeccamycin-challenges and advanced approaches in production processes,” Appl. Microbiol. Biotechnol., vol. 103, no. 9, pp. 3627–3636, May 2019, doi: 10.1007/s00253-019-09741-y.
[8911]	V. K. Neychev and V. I. Mitev, “The aphrodisiac herb Tribulus terrestris does not influence the androgen production in young men,” J Ethnopharmacol, vol. 101, no. 1–3, pp. 319–323, Oct. 2005, doi: 10.1016/j.jep.2005.05.017.
[8912]	W. Phuttharak, K. Sawanyawisuth, A. Kawiwungsanon, and S. Tiamkao, “The appropriate neuroimaging study in persons with epilepsy,” Neurol. Sci., vol. 32, no. 5, pp. 969–971, Oct. 2011, doi: 10.1007/s10072-011-0640-2.
[8913]	C. F. Sharpley, V. Bitsika, E. Jesulola, K. Fitzpatrick, and L. L. Agnew, “The association between aspects of psychological resilience and subtypes of depression: implications for focussed clinical treatment models,” Int J Psychiatry Clin Pract, vol. 20, no. 3, pp. 151–156, Sep. 2016, doi: 10.1080/13651501.2016.1199810.
[8914]	O. J. Ungar, A. Brenner-Ullman, O. Cavel, Y. Oron, O. Wasserzug, and O. Handzel, “The association between auditory nerve neurovascular conflict and sudden unilateral sensorineural hearing loss,” Laryngoscope Investig Otolaryngol, vol. 3, no. 5, pp. 384–387, Oct. 2018, doi: 10.1002/lio2.209.
[8915]	S. J. Kim, M. J. Windon, and S. Y. Lin, “The association between diabetes and olfactory impairment in adults: A systematic review and meta-analysis,” Laryngoscope Investig Otolaryngol, vol. 4, no. 5, pp. 465–475, Oct. 2019, doi: 10.1002/lio2.291.
[8916]	A. Arab, S. Mehrabani, S. Moradi, and R. Amani, “The association between diet and mood: A systematic review of current literature,” Psychiatry Res, vol. 271, pp. 428–437, 2019, doi: 10.1016/j.psychres.2018.12.014.
[8917]	A. Göbel, L. Y. Stuhrmann, S. Harder, M. Schulte-Markwort, and S. Mudra, “The association between maternal-fetal bonding and prenatal anxiety: An explanatory analysis and systematic review,” J Affect Disord, vol. 239, pp. 313–327, 15 2018, doi: 10.1016/j.jad.2018.07.024.
[8918]	J. C. Tanner, C. W. Rogers, and E. C. Firth, “The association of 2-year-old training milestones with career length and racing success in a sample of Thoroughbred horses in New Zealand,” Equine Vet. J., vol. 45, no. 1, pp. 20–24, Jan. 2013, doi: 10.1111/j.2042-3306.2011.00534.x.
[8919]	A. Shami, M. Brennan, P. S. Marie, P. K. Lindenauer, and M. S. Stefan, “The association of cognitive impairment as screened by the Mini-Cog with long term post-hospitalization outcomes,” Arch Gerontol Geriatr, vol. 85, p. 103916, Dec. 2019, doi: 10.1016/j.archger.2019.103916.
[8920]	D. Rodic, A. H. Meyer, R. Lieb, and G. Meinlschmidt, “The Association of Sensory Responsiveness with Somatic Symptoms and Illness Anxiety,” Int J Behav Med, vol. 23, no. 1, pp. 39–48, Feb. 2016, doi: 10.1007/s12529-015-9483-1.
[8921]	K. R. Anderson and J. G. Murphy, “The atrio-ventricular node artery in the human heart,” Angiology, vol. 34, no. 11, pp. 711–716, Nov. 1983, doi: 10.1177/000331978303401104.
[8922]	J. M. Icardo and E. Colvee, “The atrioventricular region of the teleost heart. A distinct heart segment,” Anat Rec (Hoboken), vol. 294, no. 2, pp. 236–242, Feb. 2011, doi: 10.1002/ar.21320.
[8923]	H. Baxter, S. P. Singh, P. Standen, and C. Duggan, “The attitudes of ‘tomorrow’s doctors’ towards mental illness and psychiatry: changes during the final undergraduate year,” Med Educ, vol. 35, no. 4, pp. 381–383, Apr. 2001, doi: 10.1046/j.1365-2923.2001.00902.x.
[8924]	B. Ky and J. Upshaw, “The Authors Reply,” JACC Cardiovasc Imaging, vol. 13, no. 6, pp. 1455–1456, Jun. 2020, doi: 10.1016/j.jcmg.2020.03.018.
[8925]	G. B. Huffnagle and R. P. Dickson, “The bacterial microbiota in inflammatory lung diseases,” Clin. Immunol., vol. 159, no. 2, pp. 177–182, Aug. 2015, doi: 10.1016/j.clim.2015.05.022.
[8926]	C. M. Papa and A. M. Kligman, “The behavior of melanocytes in inflammation,” J. Invest. Dermatol., vol. 45, no. 6, pp. 465–473, Dec. 1965.
[8927]	E. Wolff and E. Wolff, “[The behavior, in culture in vitro, of human cancers combined with explants of chick embryo kidney],” C. R. Seances Soc. Biol. Fil., vol. 155, pp. 441–443, 1961.
[8928]	M. Dose and H. W. Lange, “The benzamide tiapride: treatment of extrapyramidal motor and other clinical syndromes,” Pharmacopsychiatry, vol. 33, no. 1, pp. 19–27, Jan. 2000, doi: 10.1055/s-2000-7964.
[8929]	S. Córdoba and C. Estella, “The bHLH-PAS transcription factor dysfusion regulates tarsal joint formation in response to Notch activity during drosophila leg development,” PLoS Genet., vol. 10, no. 10, p. e1004621, Oct. 2014, doi: 10.1371/journal.pgen.1004621.
[8930]	J. W. Lichtman and W. Denk, “The big and the small: challenges of imaging the brain’s circuits,” Science, vol. 334, no. 6056, pp. 618–623, Nov. 2011, doi: 10.1126/science.1209168.
[8931]	A. P. Asimakopoulou, A. D. Theocharis, G. N. Tzanakakis, and N. K. Karamanos, “The biological role of chondroitin sulfate in cancer and chondroitin-based anticancer agents,” In Vivo, vol. 22, no. 3, pp. 385–389, Jun. 2008.
[8932]	D. J. Garfinkel, M. J. Curcio, S. D. Youngren, and N. J. Sanders, “The biology and exploitation of the retrotransposon Ty in Saccharomyces cerevisiae,” Genome, vol. 31, no. 2, pp. 909–919, 1989, doi: 10.1139/g89-162.
[8933]	H. J. Curtis, “THE BIOLOGY OF AGING. BNL 854 (T-340),” Tech Rep Brookhaven Natl Lab, vol. 34, pp. 1–11, Mar. 1964.
[8934]	M. T. Ringel and T. Brüser, “The biosynthesis of pyoverdines,” Microb Cell, vol. 5, no. 10, pp. 424–437, Aug. 2018, doi: 10.15698/mic2018.10.649.
[8935]	A. R. Pati, B. Swain, and S. S. Mohapatra, “The Boiling Phenomena and their Proper Identification and Discrimination Methodology,” Sci Rep, vol. 10, no. 1, p. 8381, May 2020, doi: 10.1038/s41598-020-65342-0.
[8936]	K. Scheffler, R. Heule, M. G. Báez-Yánez, B. Kardatzki, and G. Lohmann, “The BOLD sensitivity of rapid steady-state sequences,” Magn Reson Med, vol. 81, no. 4, pp. 2526–2535, 2019, doi: 10.1002/mrm.27585.
[8937]	G. Northoff, N. W. Duncan, and D. J. Hayes, “The brain and its resting state activity--experimental and methodological implications,” Prog. Neurobiol., vol. 92, no. 4, pp. 593–600, Dec. 2010, doi: 10.1016/j.pneurobio.2010.09.002.
[8938]	G. Kjelvik et al., “The brain structural and cognitive basis of odor identification deficits in mild cognitive impairment and Alzheimer’s disease,” BMC Neurol, vol. 14, p. 168, Aug. 2014, doi: 10.1186/s12883-014-0168-1.
[8939]	B. P. Zeigler, “The brain-machine disanalogy revisited,” BioSystems, vol. 64, no. 1–3, pp. 127–140, Jan. 2002, doi: 10.1016/s0303-2647(01)00181-2.
[8940]	M. E. Raichle, “The brain’s dark energy,” Sci. Am., vol. 302, no. 3, pp. 44–49, Mar. 2010, doi: 10.1038/scientificamerican0310-44.
[8941]	M. E. Raichle, “The brain’s default mode network,” Annu. Rev. Neurosci., vol. 38, pp. 433–447, Jul. 2015, doi: 10.1146/annurev-neuro-071013-014030.
[8942]	E. Giugni, R. Vadalà, C. De Vincentiis, C. Colica, and S. Bastianello, “The brain’s default mode network: a mind ‘sentinel’ role?,” Funct. Neurol., vol. 25, no. 4, pp. 189–190, Dec. 2010.
[8943]	R. L. Buckner, J. R. Andrews-Hanna, and D. L. Schacter, “The brain’s default network: anatomy, function, and relevance to disease,” Ann. N. Y. Acad. Sci., vol. 1124, pp. 1–38, Mar. 2008, doi: 10.1196/annals.1440.011.
[8944]	N. Mandairon and A. Didier, “The brain’s fight against aging,” Proc. Natl. Acad. Sci. U.S.A., vol. 107, no. 35, pp. 15316–15317, Aug. 2010, doi: 10.1073/pnas.1010574107.
[8945]	K. Izuma and R. Adolphs, “The brain’s rose-colored glasses,” Nat. Neurosci., vol. 14, no. 11, pp. 1355–1356, Oct. 2011, doi: 10.1038/nn.2960.
[8946]	G. Northoff, “The brain’s spontaneous activity and its psychopathological symptoms - ‘Spatiotemporal binding and integration,’” Prog. Neuropsychopharmacol. Biol. Psychiatry, vol. 80, no. Pt B, pp. 81–90, Jan. 2018, doi: 10.1016/j.pnpbp.2017.03.019.
[8947]	W. J. Gardner, “The brain’s third circulation,” Arch. Neurol., vol. 34, no. 3, p. 200, Mar. 1977, doi: 10.1001/archneur.1977.00500150086021.
[8948]	S. Makin, “The Brain’s Whorl,” Sci. Am., vol. 314, no. 1, p. 22, Jan. 2016, doi: 10.1038/scientificamerican0116-22.
[8949]	A. G. Gross, “The brains in Brain: the coevolution of localization and its images,” J Hist Neurosci, vol. 17, no. 3, pp. 380–392, 2008, doi: 10.1080/09647040701423705.
[8950]	M. F. de Almeida, M. Goldbaum, and J. da R. Carvalheiro, “The Brazilian Journal of Epidemiology: 18 years of contributing to knowledge dissemination,” Cien Saude Colet, vol. 20, no. 7, pp. 2031–2039, Jul. 2015, doi: 10.1590/1413-81232015207.06012015.
[8951]	C. Beron, A. G. Vidal-Gadea, J. Cohn, A. Parikh, G. Hwang, and J. T. Pierce-Shimomura, “The burrowing behavior of the nematode Caenorhabditis elegans: a new assay for the study of neuromuscular disorders,” Genes Brain Behav., vol. 14, no. 4, pp. 357–368, Apr. 2015, doi: 10.1111/gbb.12217.
[8952]	J. E. Gambone, S. S. Dusaban, R. Loperena, Y. Nakata, and S. E. Shetzline, “The c-Myb target gene neuromedin U functions as a novel cofactor during the early stages of erythropoiesis,” Blood, vol. 117, no. 21, pp. 5733–5743, May 2011, doi: 10.1182/blood-2009-09-242131.
[8953]	J. Paul, “The cancer cell in vitro: a review,” Cancer Res., vol. 22, pp. 431–440, May 1962.
[8954]	S. M. Papa, “The cannabinoid system in Parkinson’s disease: multiple targets to motor effects,” Exp. Neurol., vol. 211, no. 2, pp. 334–338, Jun. 2008, doi: 10.1016/j.expneurol.2008.03.009.
[8955]	M. M. Grady and I. Wright, “The carbon cycle on early Earth--and on Mars?,” Philos. Trans. R. Soc. Lond., B, Biol. Sci., vol. 361, no. 1474, pp. 1703–1713, Oct. 2006, doi: 10.1098/rstb.2006.1898.
[8956]	J. Sasamori et al., “The cardioprotective effects of novel Na+/H+ exchanger inhibitor TY-51924 on ischemia/reperfusion injury,” J. Cardiovasc. Pharmacol., vol. 63, no. 4, pp. 351–359, Apr. 2014, doi: 10.1097/FJC.0000000000000055.
[8957]	O. Bucher, “[The caryogramm in different growth intensity of connective tissue culture in vitro],” Anat Anz, vol. 106, no. 11–16, pp. 271–284, May 1959.
[8958]	P. E. Orzechowski, “The Case for a Private Healthcare Insurance Monopoly,” Appl Health Econ Health Policy, vol. 16, no. 4, pp. 433–443, 2018, doi: 10.1007/s40258-018-0381-y.
[8959]	S. Sarkar et al., “The CD38low natural killer cell line KHYG1 transiently expressing CD16F158V in combination with daratumumab targets multiple myeloma cells with minimal effector NK cell fratricide,” Cancer Immunol. Immunother., vol. 69, no. 3, pp. 421–434, Mar. 2020, doi: 10.1007/s00262-019-02477-8.
[8960]	J. A. Beto, C. M. Champagne, C. C. Dennett, and J. E. Harris, “The Challenge of Connecting Dietary Changes to Improved Disease Outcomes: The Balance between Positive, Neutral, and Negative Publication Results,” J Acad Nutr Diet, vol. 116, no. 6, pp. 917–920, 2016, doi: 10.1016/j.jand.2016.02.019.
[8961]	D. Rew, “The challenges of success,” Eur J Surg Oncol, vol. 35, no. 1, pp. 1–2, Jan. 2009, doi: 10.1016/j.ejso.2008.11.001.
[8962]	K. M. Chung et al., “[The changes in incidence of Crohn’s disease and intestinal tuberculosis in Korea],” Korean J Gastroenterol, vol. 52, no. 6, pp. 351–358, Dec. 2008.
[8963]	R. T. McNamar, “The changing economic environment,” J Med Educ, vol. 58, no. 2, pp. 87–92, Feb. 1983, doi: 10.1097/00001888-198302000-00001.
[8964]	M. K. Stowe, T. C. Turlings, J. H. Loughrin, W. J. Lewis, and J. H. Tumlinson, “The chemistry of eavesdropping, alarm, and deceit,” Proc. Natl. Acad. Sci. U.S.A., vol. 92, no. 1, pp. 23–28, Jan. 1995, doi: 10.1073/pnas.92.1.23.
[8965]	K.-Y. Moon, “The chemopreventive effect of retinoids on cellular NF-kappaB activity induced by NMU and NEU in human malignant keratinocytes,” Cancer Res Treat, vol. 39, no. 2, pp. 82–87, Jun. 2007, doi: 10.4143/crt.2007.39.2.82.
[8966]	P. R. Wolf and R. G. Cook, “The class I-b molecule Qa-1 forms heterodimers with H-2Ld and a novel 50-kD glycoprotein encoded centromeric to I-E beta,” J. Exp. Med., vol. 181, no. 2, pp. 657–668, Feb. 1995, doi: 10.1084/jem.181.2.657.
[8967]	K. Nie et al., “The clinical characteristics and cognitive features of mild cognitive impairment in Parkinson’s disease and the analysis of relevant factors,” J Clin Neurosci, vol. 63, pp. 142–148, May 2019, doi: 10.1016/j.jocn.2019.01.021.
[8968]	X.-J. Xu et al., “THE CLINICAL CHARACTERISTICS AND EFFICACY OF BISPHOSPHONATES IN AUDLT PATIENTS WITH OSTEOGENESIS IMPERGECTA,” Endocr Pract, vol. 22, no. 11, pp. 1267–1276, 2016, doi: 10.4158/EP151184.OR.
[8969]	Y. Xiao et al., “The clinical characteristics and related factors of tremor in patients with epilepsy,” Seizure, vol. 66, pp. 70–75, Mar. 2019, doi: 10.1016/j.seizure.2019.02.002.
[8970]	M. Charkhandeh, M. A. Talib, and C. J. Hunt, “The clinical effectiveness of cognitive behavior therapy and an alternative medicine approach in reducing symptoms of depression in adolescents,” Psychiatry Res, vol. 239, pp. 325–330, 30 2016, doi: 10.1016/j.psychres.2016.03.044.
[8971]	H. D. Binh et al., “The clinical features of osteogenesis imperfecta in Vietnam,” Int Orthop, vol. 41, no. 1, pp. 21–29, Jan. 2017, doi: 10.1007/s00264-016-3315-z.
[8972]	J. M. Lyness et al., “The clinical significance of subsyndromal depression in older primary care patients,” Am J Geriatr Psychiatry, vol. 15, no. 3, pp. 214–223, Mar. 2007, doi: 10.1097/01.JGP.0000235763.50230.83.
[8973]	A. Pilotto et al., “The clinical usefulness of serum pepsinogens, specific IgG anti-HP antibodies and gastrin for monitoring Helicobacter pylori treatment in older people,” J Am Geriatr Soc, vol. 44, no. 6, pp. 665–670, Jun. 1996, doi: 10.1111/j.1532-5415.1996.tb01829.x.
[8974]	J. Chang, I. O. Kim, J. S. Ahn, J. S. Kwon, S. H. Jeon, and S. H. Kim, “The CNS midline cells coordinate proper cell cycle progression and identity determination of the Drosophila ventral neuroectoderm,” Dev. Biol., vol. 227, no. 2, pp. 307–323, Nov. 2000, doi: 10.1006/dbio.2000.9905.
[8975]	S. Brédart, “The cognitive psychology and neuroscience of naming people,” Neurosci Biobehav Rev, vol. 83, pp. 145–154, Dec. 2017, doi: 10.1016/j.neubiorev.2017.10.008.
[8976]	D. B. Kenyon, M. Buffalo, J. Heinzmann, M. Seiber, D. Castille, and A. Elliott, “The Collaborative Research Center for American Indian Health’s Partnership River of Life: Special Issue Introduction,” Am Indian Alsk Native Ment Health Res, vol. 26, no. 2, pp. 1–14, 2019, doi: 10.5820/aian.2602.2019.1.
[8977]	S. H. Jang and D. K. Yang, “The combination of Cassia obtusifolia L. and Foeniculum vulgare M. exhibits a laxative effect on loperamide-induced constipation of rats,” PLoS ONE, vol. 13, no. 4, p. e0195624, 2018, doi: 10.1371/journal.pone.0195624.
[8978]	T. A. Fergus, L. P. Kelley, and J. O. Griggs, “The combination of health anxiety and somatic symptoms: Specificity to anxiety sensitivity cognitive concerns among patients in primary care,” Psychiatry Res, vol. 239, pp. 117–121, May 2016, doi: 10.1016/j.psychres.2016.02.067.
[8979]	K. Tao and X. Wang, “The comorbidity of epilepsy and depression: diagnosis and treatment,” Expert Rev Neurother, vol. 16, no. 11, pp. 1321–1333, 2016, doi: 10.1080/14737175.2016.1204233.
[8980]	J. Pudło, M. Wierdak, K. Macioł, K. Gumul, and J. Lelakowski, “[The comparison of 4th, 5th and 6th year medical students knowledge of rules and practical skills in the interpretation of electrocardiograms at Jagiellonian University],” Prz. Lek., vol. 69, no. 4, pp. 143–148, 2012.
[8981]	L. Bardin, “The complex role of serotonin and 5-HT receptors in chronic pain,” Behav Pharmacol, vol. 22, no. 5–6, pp. 390–404, Sep. 2011, doi: 10.1097/FBP.0b013e328349aae4.
[8982]	E. Lopez-Medina and A. Y. Koh, “The complexities of bacterial-fungal interactions in the mammalian gastrointestinal tract,” Microb Cell, vol. 3, no. 5, pp. 191–195, Mar. 2016, doi: 10.15698/mic2016.05.497.
[8983]	H. Han and A. Ju, “The complexity of mentoring observed through engagement with programmatic assessment,” Med Educ, vol. 53, no. 6, pp. 542–544, 2019, doi: 10.1111/medu.13906.
[8984]	R. Frost, P. Hyland, A. McCarthy, R. Halpin, M. Shevlin, and J. Murphy, “The complexity of trauma exposure and response: Profiling PTSD and CPTSD among a refugee sample,” Psychol Trauma, vol. 11, no. 2, pp. 165–175, Feb. 2019, doi: 10.1037/tra0000408.
[8985]	B. Schöne-Seifert, J.-O. Reichardt, D. R. Friedrich, and P. Hucklenbroich, “[The concept of complementary and alternative medicine from the perspective of the philosophy of science and bioethics],” Z Evid Fortbild Qual Gesundhwes, vol. 109, no. 3, pp. 236–244, 2015, doi: 10.1016/j.zefq.2015.01.015.
[8986]	W. F. Helsen, N. Medic, J. L. Starkes, and A. M. Williams, “The Constituent Year Effect in European Track and Field Masters Athletes: Evidence of Participation and Performance Advantages,” J Aging Phys Act, vol. 28, no. 1, pp. 63–72, 01 2020, doi: 10.1123/japa.2018-0439.
[8987]	R. C. Tanzer, “The constricted (cup and lop) ear,” Plast. Reconstr. Surg., vol. 55, no. 4, pp. 406–415, Apr. 1975.
[8988]	A. F. Berger and H. W. Knirk, “The continuing threat of tax-exempt competition,” Mod Vet Pract, vol. 63, no. 5, pp. 421–422, May 1982.
[8989]	G. L. Flett, K. Vredenburg, and L. Krames, “The continuity of depression in clinical and nonclinical samples,” Psychol Bull, vol. 121, no. 3, pp. 395–416, May 1997, doi: 10.1037/0033-2909.121.3.395.
[8990]	B. J. Cox, M. W. Enns, and D. K. Larsen, “The continuity of depression symptoms: use of cluster analysis for profile identification in patient and student samples,” J Affect Disord, vol. 65, no. 1, pp. 67–73, Jun. 2001, doi: 10.1016/s0165-0327(00)00253-6.
[8991]	A. Katz, “The Copyright Issue,” Oncol Nurs Forum, vol. 46, no. 3, pp. 267–268, 01 2019, doi: 10.1188/19.ONF.267-268.
[8992]	S. Lahiri, C. Levenstein, D. I. Nelson, and B. J. Rosenberg, “The cost effectiveness of occupational health interventions: prevention of silicosis,” Am. J. Ind. Med., vol. 48, no. 6, pp. 503–514, Dec. 2005, doi: 10.1002/ajim.20222.
[8993]	A. I. Godfrey, “The cost of school dental care--some thoughts on economic analysis,” Aust Dent J, vol. 25, no. 1, pp. 20–24, Feb. 1980, doi: 10.1111/j.1834-7819.1980.tb03658.x.
[8994]	D. C. Blaikie and R. N. Weidenhofer, “The cost of school dental care: a preliminary economic analysis,” Aust Dent J, vol. 23, no. 2, pp. 146–151, Apr. 1978, doi: 10.1111/j.1834-7819.1978.tb02901.x.
[8995]	J. García-Martínez, R. D. Maldonado, N. M. Guzmán, and F. J. M. Mojica, “The CRISPR conundrum: evolve and maybe die, or survive and risk stagnation,” Microb Cell, vol. 5, no. 6, pp. 262–268, May 2018, doi: 10.15698/mic2018.06.634.
[8996]	M. Vallejo, M. F. San Román, I. Ortiz, and A. Irabien, “The critical role of the operating conditions on the Fenton oxidation of 2-chlorophenol: assessment of PCDD/Fs formation,” J. Hazard. Mater., vol. 279, pp. 579–585, Aug. 2014, doi: 10.1016/j.jhazmat.2014.07.020.
[8997]	A. K. Powell, “The cultivation in vitro of mouse ascites tumour cells; the morphology and behaviour of the tumour cells in pure cultures,” Br. J. Cancer, vol. 11, no. 2, pp. 280–286, Jun. 1957, doi: 10.1038/bjc.1957.36.
[8998]	A. K. Powell, “The cultivation in vitro of mouse ascites tumour cells; the relation between density of cell population, viability and mitosis in pure cultures,” Br. J. Cancer, vol. 11, no. 2, pp. 274–279, Jun. 1957, doi: 10.1038/bjc.1957.35.
[8999]	C. L. Foote and F. M. Foote, “The culture in vitro of urogenital organs of Pleurodeles waltii,” J Embryol Exp Morphol, vol. 10, pp. 465–470, Dec. 1962.
[9000]	K. W. Jones and T. R. Elsdale, “The culture of small aggregates of amphibian embryonic cells in vitro,” J Embryol Exp Morphol, vol. 11, pp. 135–154, Mar. 1963.
[9001]	A. Karnkowska and V. Hampl, “The curious case of vanishing mitochondria,” Microb Cell, vol. 3, no. 10, pp. 491–494, Sep. 2016, doi: 10.15698/mic2016.10.531.
[9002]	D. Hasegawa, “The current perspective of low-grade myelodysplastic syndrome in children,” Int. J. Hematol., vol. 103, no. 4, pp. 360–364, Apr. 2016, doi: 10.1007/s12185-016-1965-7.
[9003]	J. Jawien and R. Korbut, “The current view on the role of leukotrienes in atherogenesis,” J. Physiol. Pharmacol., vol. 61, no. 6, pp. 647–650, Dec. 2010.
[9004]	C. M. Papa, “The cutaneous safety of topical tretinoin,” Acta Derm Venereol Suppl (Stockh), vol. 74, pp. 128–132, Jan. 1975.
[9005]	N. Perakis and R. Cocconi, “The decision-making process in interdisciplinary treatment: digital versus conventional approach. A case presentation,” Int J Esthet Dent, vol. 14, no. 2, pp. 212–224, 2019.
[9006]	G. Coatantiec, “[The defense and illustration of proper nouns in cardiology],” Presse Med, vol. 33, no. 9 Pt 1, pp. 587–589, May 2004, doi: 10.1016/s0755-4982(04)98681-2.
[9007]	R. Adar and M. Z. Papa, “The definition of Buerger’s disease,” World J Surg, vol. 8, no. 3, pp. 423–424, Jun. 1984, doi: 10.1007/BF01655096.
[9008]	K. J. Thuesen et al., “The dental perspective on osteogenesis imperfecta in a Danish adult population,” BMC Oral Health, vol. 18, no. 1, p. 175, 24 2018, doi: 10.1186/s12903-018-0639-7.
[9009]	C. M. van der Feltz-Cornelis, “[The depression epidemic does not exist],” Ned Tijdschr Geneeskd, vol. 153, p. A494, 2009.
[9010]	C. Ransom, G. Zamora, and L. Jones, “The development and implementation of a quality assurance Master Audit Plan,” Qual Assur, vol. 4, no. 1, pp. 80–82, Mar. 1995.
[9011]	D. D. Blake et al., “The development of a Clinician-Administered PTSD Scale,” J Trauma Stress, vol. 8, no. 1, pp. 75–90, Jan. 1995, doi: 10.1007/BF02105408.
[9012]	M. K. Kließ, A. Ernst, J. Wagner, and P. Mittmann, “The development of active middle ear implants: A historical perspective and clinical outcomes,” Laryngoscope Investig Otolaryngol, vol. 3, no. 5, pp. 394–404, Oct. 2018, doi: 10.1002/lio2.215.
[9013]	K. M. Langa and D. A. Levine, “The diagnosis and management of mild cognitive impairment: a clinical review,” JAMA, vol. 312, no. 23, pp. 2551–2561, Dec. 2014, doi: 10.1001/jama.2014.13806.
[9014]	B. L. Dow, J. A. Kenardy, R. M. Le Brocque, and D. A. Long, “The diagnosis of posttraumatic stress disorder in school-aged children and adolescents following pediatric intensive care unit admission,” J Child Adolesc Psychopharmacol, vol. 23, no. 9, pp. 614–619, Nov. 2013, doi: 10.1089/cap.2013.0044.
[9015]	R. J. Bateman et al., “The DIAN-TU Next Generation Alzheimer’s prevention trial: Adaptive design and disease progression model,” Alzheimers Dement, vol. 13, no. 1, pp. 8–19, 2017, doi: 10.1016/j.jalz.2016.07.005.
[9016]	J. B. Finkelstein, J. P. Van Batavia, and J. S. Rosoff, “The Difference a Year Can Make: Academic Productivity of Residents in 5 vs 6-Year Urology Programs,” Urology, vol. 86, no. 2, pp. 220–222, Aug. 2015, doi: 10.1016/j.urology.2015.03.057.
[9017]	S. Lovera, L. Sutto, R. Boubeva, L. Scapozza, N. Dölker, and F. L. Gervasio, “The different flexibility of c-Src and c-Abl kinases regulates the accessibility of a druggable inactive conformation,” J. Am. Chem. Soc., vol. 134, no. 5, pp. 2496–2499, Feb. 2012, doi: 10.1021/ja210751t.
[9018]	I. Conti, M. Garavelli, and G. Orlandi, “The different photoisomerization efficiency of azobenzene in the lowest n pi* and pi pi* singlets: the role of a phantom state,” J. Am. Chem. Soc., vol. 130, no. 15, pp. 5216–5230, Apr. 2008, doi: 10.1021/ja710275e.
[9019]	M. N Laska, K. E. Pasch, K. Lust, M. Story, and E. Ehlinger, “The differential prevalence of obesity and related behaviors in two- vs. four-year colleges,” Obesity (Silver Spring), vol. 19, no. 2, pp. 453–456, Feb. 2011, doi: 10.1038/oby.2010.262.
[9020]	G. Singh et al., “The dilemma of arranged marriages in people with epilepsy. An expert group appraisal,” Epilepsy Behav, vol. 61, pp. 242–247, 2016, doi: 10.1016/j.yebeh.2016.05.034.
[9021]	E. C. Shattuck, “The dilemma of immune stimulation and suppression during depression: One step closer to a solution?,” Brain Behav. Immun., vol. 54, pp. 15–16, May 2016, doi: 10.1016/j.bbi.2016.02.004.
[9022]	M. L. J. Apuzzo, “The dimension of time and the unification of the planet Earth,” World Neurosurg, vol. 81, no. 1, p. 1, Jan. 2014, doi: 10.1016/j.wneu.2013.12.001.
[9023]	H. Feldman et al., “The disability assessment for dementia scale: a 12-month study of functional ability in mild to moderate severity Alzheimer disease,” Alzheimer Dis Assoc Disord, vol. 15, no. 2, pp. 89–95, Jun. 2001, doi: 10.1097/00002093-200104000-00008.
[9024]	X.-Z. Su and L. H. Miller, “The discovery of artemisinin and the Nobel Prize  in Physiology or Medicine,” Sci China Life Sci, vol. 58, no. 11, pp. 1175–1179, Nov. 2015, doi: 10.1007/s11427-015-4948-7.
[9025]	G. Aumüller, “[The Discovery of the Cardiac Atrioventricular Node by Sunao Tawara and Ludwig Aschoff],” Dtsch. Med. Wochenschr., vol. 144, no. 25, pp. 1771–1777, 2019, doi: 10.1055/a-0819-7328.
[9026]	S. A. Finkler, “The distinction between cost and charges,” Ann. Intern. Med., vol. 96, no. 1, pp. 102–109, Jan. 1982, doi: 10.7326/0003-4819-96-1-102.
[9027]	A. Smith et al., “The diverse cardiac morphology seen in hearts with isomerism of the atrial appendages with reference to the disposition of the specialised conduction system,” Cardiol Young, vol. 16, no. 5, pp. 437–454, Oct. 2006, doi: 10.1017/S1047951106000382.
[9028]	R. Revilla-I-Domingo and O. Simakov, “The Diversification of Early Emerging Metazoans: A Window into the Evolution of Animal Multicellularity,” Bioessays, vol. 40, no. 5, p. e1800029, 2018, doi: 10.1002/bies.201800029.
[9029]	Y. Gao, D. Xu, L. Zhao, and Y. Sun, “The DNA damage response of C. elegans affected by gravity sensing and radiosensitivity during the Shenzhou-8 spaceflight,” Mutat. Res., vol. 795, pp. 15–26, 2017, doi: 10.1016/j.mrfmmm.2017.01.001.
[9030]	D. A. Rew, “The DNA deluge,” Eur J Surg Oncol, vol. 28, no. 6, pp. 567–568, Sep. 2002, doi: 10.1053/ejso.2002.1333.
[9031]	J. Biddlestone, M. Samuel, T. Creagh, and T. Ahmad, “The double loop mattress suture,” Wound Repair Regen, vol. 22, no. 3, pp. 415–423, Jun. 2014, doi: 10.1111/wrr.12159.
[9032]	L. Yue et al., “The Double-Edged Sword of Urbanization and Its Nexus with Eco-Efficiency in China,” Int J Environ Res Public Health, vol. 17, no. 2, 09 2020, doi: 10.3390/ijerph17020446.
[9033]	S. Wilker, T. Elbert, and I.-T. Kolassa, “The downside of strong emotional memories: how human memory-related genes influence the risk for posttraumatic stress disorder--a selective review,” Neurobiol Learn Mem, vol. 112, pp. 75–86, Jul. 2014, doi: 10.1016/j.nlm.2013.08.015.
[9034]	A. Linhananta, H. Zhou, and Y. Zhou, “The dual role of a loop with low loop contact distance in folding and domain swapping,” Protein Sci., vol. 11, no. 7, pp. 1695–1701, Jul. 2002, doi: 10.1110/ps.0205002.
[9035]	R. Strich and K. F. Cooper, “The dual role of cyclin C connects stress regulated gene expression to mitochondrial dynamics,” Microb Cell, vol. 1, no. 10, pp. 318–324, Sep. 2014, doi: 10.15698/mic2014.10.169.
[9036]	A. Tate and B. J. Rimel, “The duality of option-listing in cancer care,” Patient Educ Couns, vol. 103, no. 1, pp. 71–76, 2020, doi: 10.1016/j.pec.2019.07.025.
[9037]	J. J. DeGeorge, L. L. Meyers, M. Takahashi, and J. F. Contrera, “The duration of non-rodent toxicity studies for pharmaceuticals. International Conference on Harmonication (ICH),” Toxicol. Sci., vol. 49, no. 2, pp. 143–155, Jun. 1999, doi: 10.1093/toxsci/49.2.143.
[9038]	H. Li et al., “The early alteration of left ventricular strain and dys-synchrony index in breast cancer patients undergoing anthracycline therapy using layer-specific strain analysis,” Echocardiography, vol. 36, no. 9, pp. 1675–1681, 2019, doi: 10.1111/echo.14460.
[9039]	S. A. Bowring and T. Housh, “The Earth’s early evolution,” Science, vol. 269, no. 5230, pp. 1535–1540, Sep. 1995, doi: 10.1126/science.7667634.
[9040]	D. March and E. Susser, “The eco- in eco-epidemiology,” Int J Epidemiol, vol. 35, no. 6, pp. 1379–1383, Dec. 2006, doi: 10.1093/ije/dyl249.
[9041]	R. Kronborg, “The economic aspects of hospital administration in Australia,” World Hosp, vol. 14, no. 1, pp. 45–47, Feb. 1978.
[9042]	A. Papa and V. Papa, “The Economic Burden of Diverticular Disease,” J. Clin. Gastroenterol., vol. 50 Suppl 1, pp. S2-3, 2016, doi: 10.1097/MCG.0000000000000598.
[9043]	T. Bramley, V. Antao, O. Lunacsek, K. Hennenfent, and A. Masaquel, “The economic burden of end-of-life care in metastatic breast cancer,” J Med Econ, vol. 19, no. 11, pp. 1075–1080, Nov. 2016, doi: 10.1080/13696998.2016.1197130.
[9044]	D. C. White, “The economic valuation of improved process plant decision support technology,” ISA Trans, vol. 46, no. 3, pp. 437–442, Jun. 2007, doi: 10.1016/j.isatra.2007.01.003.
[9045]	J. K. Hammitt and M. E. Ibarrarán, “The economic value of fatal and non-fatal occupational risks in Mexico City using actuarial- and perceived-risk estimates,” Health Econ, vol. 15, no. 12, pp. 1329–1335, Dec. 2006, doi: 10.1002/hec.1137.
[9046]	D. Fok, T. G. Mong, and D. Chua, “The economics of breastfeeding in Singapore,” Breastfeed Rev, vol. 6, no. 2, pp. 5–9, Aug. 1998.
[9047]	D. E. Hosking and K. J. Anstey, “The Economics of Cognitive Impairment: Volunteering and Cognitive Function in the HILDA Survey,” Gerontology, vol. 62, no. 5, pp. 536–540, 2016, doi: 10.1159/000444416.
[9048]	K. J. Wrobel, “The economics of health insurance plan design,” Manag Care Q, vol. 9, no. 3, pp. 66–73, 2001.
[9049]	W. Widmer, “[The Economization of Medicine],” Praxis (Bern 1994), vol. 109, no. 3, p. 159, 2020, doi: 10.1024/1661-8157/a003410.
[9050]	M. J. Funt, “The economy, the markets and volatility,” Pa Dent J (Harrisb), vol. 75, no. 2, pp. 29–30, Apr. 2008.
[9051]	M. P. Bucci, C. L. Gerard, and E. Bui-Quoc, “The effect of a cognitive task on the postural control of dyslexic children,” Res Dev Disabil, vol. 34, no. 11, pp. 3727–3735, Nov. 2013, doi: 10.1016/j.ridd.2013.07.032.
[9052]	N. Allen, A. M. Nevill, J. H. M. Brooks, Y. Koutedakis, and M. A. Wyon, “The effect of a comprehensive injury audit program on injury incidence in ballet: a 3-year prospective study,” Clin J Sport Med, vol. 23, no. 5, pp. 373–378, Sep. 2013, doi: 10.1097/JSM.0b013e3182887f32.
[9053]	J. J. Pérez Fontán, G. P. Heldt, and G. A. Gregory, “The effect of a gas leak around the endotracheal tube on the mean tracheal pressure during mechanical ventilation,” Am. Rev. Respir. Dis., vol. 132, no. 2, pp. 339–342, Aug. 1985, doi: 10.1164/arrd.1985.132.2.339.
[9054]	P. Hyytiä, “[The effect of abused drugs on the developing brain during childhood and adolescence],” Duodecim, vol. 131, no. 10, pp. 933–939, 2015.
[9055]	F. Gharagozloo et al., “The effect of amino acid L-glutamate on the extended preservation ex vivo of the heart for transplantation,” Circulation, vol. 76, no. 5 Pt 2, pp. V65-70, Nov. 1987.
[9056]	C. M. Papa, D. M. Carter, and A. M. Kligman, “The effect of autotransplantation on the progression or reversibility of aging in human skin,” J. Invest. Dermatol., vol. 54, no. 3, pp. 200–212, Mar. 1970, doi: 10.1111/1523-1747.ep12280258.
[9057]	R. E. Friedrich, H. A. Scheuer, and W. Höltje, “The effect of bisphosphonate medication on orthodontics and orthognathic surgery in patients with osteogenesis imperfecta,” GMS Interdiscip Plast Reconstr Surg DGPW, vol. 8, p. Doc06, 2019, doi: 10.3205/iprs000132.
[9058]	Y. N. El Hadidi, M. Seif, H. Sleem, K. A. Mohsen, and M. El Kassaby, “The Effect of Bone Marrow Aspirate Concentrate Application on Distracted Bone Biomechanical Properties,” J Craniofac Surg, vol. 30, no. 8, pp. 2650–2655, Dec. 2019, doi: 10.1097/SCS.0000000000005998.
[9059]	E. Vogazianos, P. Vogazianos, J. Fiala, D. Janecek, and I. Slapák, “The effect of breastfeeding and its duration on acute otitis media in children in Brno, Czech Republic,” Cent. Eur. J. Public Health, vol. 15, no. 4, pp. 143–146, Dec. 2007.
[9060]	R. R. Shah, J. J. Suen, I. P. Cellum, J. B. Spitzer, and A. K. Lalwani, “The effect of brief subway station noise exposure on commuter hearing,” Laryngoscope Investig Otolaryngol, vol. 3, no. 6, pp. 486–491, Dec. 2018, doi: 10.1002/lio2.216.
[9061]	T. Satou, N. Sato, H. Kato, M. Kawamura, S. Watanabe, and K. Koike, “The Effect of Camellia Seed Oil Intake on Lipid Metabolism in Mice,” Nat Prod Commun, vol. 11, no. 4, pp. 511–513, Apr. 2016.
[9062]	G. Lee et al., “The effect of change in fasting glucose on the risk of myocardial infarction, stroke, and all-cause mortality: a nationwide cohort study,” Cardiovasc Diabetol, vol. 17, no. 1, p. 51, 07 2018, doi: 10.1186/s12933-018-0694-z.
[9063]	E. Van den Bussche, M. Alves, Y. P. J. Murray, and G. Hughes, “The effect of cognitive effort on the sense of agency,” PLoS ONE, vol. 15, no. 8, p. e0236809, Aug. 2020, doi: 10.1371/journal.pone.0236809.
[9064]	A. Akpalu, B. N. Calys-Tagoe, and R. N. Kwei-Nsoro, “The Effect of Cognitive Impairment on the Health-Related Quality of Life Among Stroke Survivors at a Major Referral Hospital in Ghana,” West Afr J Med, vol. 35, no. 3, pp. 199–203, Dec. 2018.
[9065]	R. A. Sherer and P. S. Price, “The effect of cooking processes on PCB levels in edible fish tissue,” Qual Assur, vol. 2, no. 4, pp. 396–407, Dec. 1993.
[9066]	A. M. Weatherholt, W. R. Vanwye, J. Lohmann, and J. G. Owens, “The Effect of Cuff Width for Determining Limb Occlusion Pressure: A Comparison of Blood Flow Restriction Devices,” Int J Exerc Sci, vol. 12, no. 3, pp. 136–143, 2019.
[9067]	P. Schaper and T. Grundgeiger, “The effect of different distractions on remembering delayed intentions,” Memory, vol. 26, no. 2, pp. 154–170, 2018, doi: 10.1080/09658211.2017.1339090.
[9068]	I. Hromadnikova et al., “The effect of DYS-14 copy number variations on extracellular fetal DNA quantification in maternal circulation,” DNA Cell Biol., vol. 28, no. 7, pp. 351–358, Jul. 2009, doi: 10.1089/dna.2009.0855.
[9069]	J. Kim, J. Chey, S.-E. Kim, and H. Kim, “The effect of education on regional brain metabolism and its functional connectivity in an aged population utilizing positron emission tomography,” Neurosci. Res., vol. 94, pp. 50–61, May 2015, doi: 10.1016/j.neures.2014.12.009.
[9070]	S. Smith, “The effect of EMDR on the pathophysiology of PTSD,” Int J Emerg Ment Health, vol. 5, no. 2, pp. 85–91, 2003.
[9071]	A. Byrne and D. G. Byrne, “The effect of exercise on depression, anxiety and other mood states: a review,” J Psychosom Res, vol. 37, no. 6, pp. 565–574, Sep. 1993, doi: 10.1016/0022-3999(93)90050-p.
[9072]	P. Castañeda, L. Moscona, and K. Masrouha, “The effect of femoral shortening in the treatment of developmental dysplasia of the hip after walking age,” J Child Orthop, vol. 13, no. 4, pp. 371–376, Aug. 2019, doi: 10.1302/1863-2548.13.190029.
[9073]	L. Fang, M. Baertschi, and M. Mozaffarieh, “The effect of flammer-syndrome on retinal venous pressure,” BMC Ophthalmol, vol. 14, p. 121, Oct. 2014, doi: 10.1186/1471-2415-14-121.
[9074]	P. G. Schnabel, W. Bagchus, H. Lass, T. Thomsen, and T. B. P. Geurts, “The effect of food composition on serum testosterone levels after oral administration of Andriol Testocaps,” Clin. Endocrinol. (Oxf), vol. 66, no. 4, pp. 579–585, Apr. 2007, doi: 10.1111/j.1365-2265.2007.02781.x.
[9075]	N. Tekçe, S. Fidan, S. Tuncer, D. Kara, and M. Demirci, “The effect of glazing and aging on the surface properties of CAD/CAM resin blocks,” J Adv Prosthodont, vol. 10, no. 1, pp. 50–57, Feb. 2018, doi: 10.4047/jap.2018.10.1.50.
[9076]	G. Chevalier, “The effect of grounding the human body on mood,” Psychol Rep, vol. 116, no. 2, pp. 534–542, Apr. 2015, doi: 10.2466/06.PR0.116k21w5.
[9077]	Y. Ogawa and H. Nittono, “The effect of induced mood on word imagery processing: An ERP study,” Int J Psychophysiol, vol. 142, pp. 17–24, 2019, doi: 10.1016/j.ijpsycho.2019.05.010.
[9078]	A. Kelly, E. B. Elliott, R. Matsuda, N. Kaneko, G. L. Smith, and C. M. Loughrey, “The effect of K201 on isolated working rabbit heart mechanical function during pharmacologically induced Ca2+ overload,” Br. J. Pharmacol., vol. 165, no. 4b, pp. 1068–1083, Feb. 2012, doi: 10.1111/j.1476-5381.2011.01531.x.
[9079]	W.-Q. Li et al., “The effect of lime-dried sewage sludge on the heat-resistance of eco-cement,” Water Sci. Technol., vol. 74, no. 1, pp. 212–219, 2016, doi: 10.2166/wst.2016.196.
[9080]	S. Ergün, U. Akgün, and M. Karahan, “The effect of loop size on loop security and elongation of a knot,” Orthop Traumatol Surg Res, vol. 106, no. 1, pp. 35–38, Feb. 2020, doi: 10.1016/j.otsr.2019.10.008.
[9081]	M. F. Mason and M. Bar, “The effect of mental progression on mood,” J Exp Psychol Gen, vol. 141, no. 2, pp. 217–221, May 2012, doi: 10.1037/a0025035.
[9082]	E. Harris et al., “The effect of multivitamin supplementation on mood and stress in healthy older men,” Hum Psychopharmacol, vol. 26, no. 8, pp. 560–567, Dec. 2011, doi: 10.1002/hup.1245.
[9083]	F. S. Sheikh and R. R. Iyer, “The effect of oil pulling with rice bran oil, sesame oil, and chlorhexidine mouth rinsing on halitosis among pregnant women: A comparative interventional study,” Indian J Dent Res, vol. 27, no. 5, pp. 508–512, Oct. 2016, doi: 10.4103/0970-9290.195638.
[9084]	S. Chen, K. J. Malmberg, M. Prince, S. Peckoo, and A. H. Criss, “The effect of perceptual information on output interference,” Psychon Bull Rev, vol. 26, no. 1, pp. 269–278, Feb. 2019, doi: 10.3758/s13423-018-1521-y.
[9085]	B. Ceccarelli, R. Fesce, F. Grohovaz, and C. Haimann, “The effect of potassium on exocytosis of transmitter at the frog neuromuscular junction,” J. Physiol. (Lond.), vol. 401, pp. 163–183, Jul. 1988, doi: 10.1113/jphysiol.1988.sp017156.
[9086]	S. S. Cakir, E. C. Polat, L. Ozcan, H. Besiroglu, A. Ötunctemur, and E. Ozbek, “The effect of prostatic inflammation on clinical outcomes in patients with benign prostate hyperplasia,” Prostate Int, vol. 6, no. 2, pp. 71–74, Jun. 2018, doi: 10.1016/j.prnil.2017.12.003.
[9087]	N. Boumparis, E. Karyotaki, A. Kleiboer, S. G. Hofmann, and P. Cuijpers, “The effect of psychotherapeutic interventions on positive and negative affect in depression: A systematic review and meta-analysis,” J Affect Disord, vol. 202, pp. 153–162, Sep. 2016, doi: 10.1016/j.jad.2016.05.019.
[9088]	M. B. Jørgensen, O. H. Dam, and T. G. Bolwig, “[The effect of psychotherapy on depression],” Ugeskr. Laeg., vol. 164, no. 26, pp. 3435–3439, Jun. 2002.
[9089]	M. Y. A. Tan, R. C. B. Hutten, R. G. F. Visser, and H. J. van Eck, “The effect of pyramiding Phytophthora infestans resistance genes R Pi-mcd1 and R Pi-ber in potato,” Theor. Appl. Genet., vol. 121, no. 1, pp. 117–125, Jun. 2010, doi: 10.1007/s00122-010-1295-8.
[9090]	R. Patel, K. P. Connaghan, and P. J. Campellone, “The effect of rate reduction on signaling prosodic contrasts in dysarthria,” Folia Phoniatr Logop, vol. 65, no. 3, pp. 109–116, 2013, doi: 10.1159/000354422.
[9091]	T. H. Mansouri, A. K. Crandall, and J. L. Temple, “The effect of repeated episodic future thinking on the relative reinforcing value of snack food,” J Health Psychol, p. 1359105320914060, Apr. 2020, doi: 10.1177/1359105320914060.
[9092]	C. Roberts, L. Allen, C. J. Langmead, J. J. Hagan, D. N. Middlemiss, and G. W. Price, “The effect of SB-269970, a 5-HT(7) receptor antagonist, on 5-HT release from serotonergic terminals and cell bodies,” Br. J. Pharmacol., vol. 132, no. 7, pp. 1574–1580, Apr. 2001, doi: 10.1038/sj.bjp.0703979.
[9093]	R. Yang, E. L. Tracy, F. B. Jensen, Y. Jiang, and L. Linder, “The Effect of Screen Viewing Duration and Self-Efficacy in Limiting Screen Viewing on Loneliness in Adolescent-Parent Dyads: An Application of the Actor-Partner Interdependence Model,” J Pediatr Nurs, vol. 47, pp. 106–113, Aug. 2019, doi: 10.1016/j.pedn.2019.05.007.
[9094]	B. T. Nezami et al., “The Effect of Self-Efficacy on Behavior and Weight in a Behavioral Weight-Loss Intervention,” Health Psychol, May 2016, doi: 10.1037/hea0000378.
[9095]	M. Matos, J. Pinto-Gouveia, and P. Gilbert, “The effect of shame and shame memories on paranoid ideation and social anxiety,” Clin Psychol Psychother, vol. 20, no. 4, pp. 334–349, Aug. 2013, doi: 10.1002/cpp.1766.
[9096]	G. S. Travlos, R. E. Wilson, J. A. Murrell, C. F. Chignell, and G. A. Boorman, “The effect of short intermittent light exposures on the melatonin circadian rhythm and NMU-induced breast cancer in female F344/N rats,” Toxicol Pathol, vol. 29, no. 1, pp. 126–136, Feb. 2001, doi: 10.1080/019262301301418937.
[9097]	R. J. Kennedy, W. W. Crozier, and M. Allen, “The effect of stocking with 0+ year age-class Atlantic salmon Salmo salar fry: a case study from the River Bush, Northern Ireland,” J. Fish Biol., vol. 81, no. 5, pp. 1730–1746, Oct. 2012, doi: 10.1111/j.1095-8649.2012.03445.x.
[9098]	S. Kurtulmus-Yilmaz, E. Cengiz, S. Ongun, and I. Karakaya, “The Effect of Surface Treatments on the Mechanical and Optical Behaviors of CAD/CAM Restorative Materials,” J Prosthodont, vol. 28, no. 2, pp. e496–e503, Feb. 2019, doi: 10.1111/jopr.12749.
[9099]	E.-H. Bedri, A. Worku, and M. Redleaf, “The effect of surgeon experience on tympanic membrane closure,” Laryngoscope Investig Otolaryngol, vol. 4, no. 5, pp. 526–531, Oct. 2019, doi: 10.1002/lio2.296.
[9100]	V. Hazan, S. Messaoud-Galusi, and S. Rosen, “The effect of talker and intonation variability on speech perception in noise in children with dyslexia,” J. Speech Lang. Hear. Res., vol. 56, no. 1, pp. 44–62, Feb. 2013, doi: 10.1044/1092-4388(2012/10-0107).
[9101]	H. A. Loáiciga, “The effect of the earth’s rotation on ground water motion,” Ground Water, vol. 45, no. 1, pp. 98–100, Feb. 2007, doi: 10.1111/j.1745-6584.2006.00241.x.
[9102]	J. A. Henderson, “The effect of the economic recession on the hospital market,” Med Mark Media, vol. 15, no. 3, pp. 19–25, Mar. 1980.
[9103]	R. Porteous, D. J. Moreau, and C. J. Doolan, “The effect of the incoming boundary layer thickness on the aeroacoustics of finite wall-mounted square cylinders,” J. Acoust. Soc. Am., vol. 146, no. 3, p. 1808, Sep. 2019, doi: 10.1121/1.5126693.
[9104]	M. Landén Ludvigsson, G. Peterson, and A. Peolsson, “The effect of three exercise approaches on health-related quality of life, and factors associated with its improvement in chronic whiplash-associated disorders: analysis of a randomized controlled trial,” Qual Life Res, vol. 28, no. 2, pp. 357–368, Feb. 2019, doi: 10.1007/s11136-018-2004-3.
[9105]	C. A. Bauer, J. L. Berry, and T. J. Brozoski, “The effect of tinnitus retraining therapy on chronic tinnitus: A controlled trial,” Laryngoscope Investig Otolaryngol, vol. 2, no. 4, pp. 166–177, 2017, doi: 10.1002/lio2.76.
[9106]	N. C. Rouse and H. I. Maibach, “The effect of volatility on percutaneous absorption,” J Dermatolog Treat, vol. 27, no. 1, pp. 5–10, 2016, doi: 10.3109/09546634.2015.1044491.
[9107]	R. Sianturi, B. Anna Keliat, and I. Yulia Wardani, “The effectiveness of acceptance and commitment therapy on anxiety in clients with stroke,” Enferm Clin, vol. 28 Suppl 1, pp. 94–97, Feb. 2018, doi: 10.1016/S1130-8621(18)30045-7.
[9108]	S. Çırakoğlu, B. Baddal, and A. İslam, “The Effectiveness of Laser-Activated Irrigation on the Apical Microleakage Qualities of MTA Repair HP and NeoMTA Plus in Simulated Immature Teeth: A Comparative Study,” Materials (Basel), vol. 13, no. 15, Jul. 2020, doi: 10.3390/ma13153287.
[9109]	F. Karakuş, A. Yılmaz, B. Hakan, K. Stormo, and H. Ulker, “The effectiveness of recombinant OL fusion protein (ovalbumin-LHRH-7) in suppressing reproductive functions when injected in single-dose vaccination protocols with different adjuvants,” Anim. Reprod. Sci., vol. 138, no. 3–4, pp. 228–232, May 2013, doi: 10.1016/j.anireprosci.2013.02.014.
[9110]	J. E. Jesseph, W. H. Moore, V. P. Bond, and S. W. Lippincott, “The effects of 2.0 BeV protons in mice. BNL 7343 (SM-44/23),” Tech Rep Brookhaven Natl Lab, pp. 1–15, 1965.
[9111]	T. Hu et al., “The Effects of a Low-Carbohydrate Diet vs. a Low-Fat Diet on Novel Cardiovascular Risk Factors: A Randomized Controlled Trial,” Nutrients, vol. 7, no. 9, pp. 7978–7994, Sep. 2015, doi: 10.3390/nu7095377.
[9112]	S. Nakagawa, R. J. M. Etheredge, T. M. Foster, C. E. Sumpter, and W. Temple, “The effects of changes in consequences on hens’ performance in delayed-matching-to-sample tasks,” Behav. Processes, vol. 67, no. 3, pp. 441–451, Nov. 2004, doi: 10.1016/j.beproc.2004.07.005.
[9113]	B. Oc, O. Arun, S. B. Taylan, M. Oc, H. Bariskaner, and A. Duman, “The effects of dexmedetomidine on human internal mammary artery and saphenous vein grafts under hypothermia and normothermia,” Bratisl Lek Listy, vol. 120, no. 5, pp. 380–385, 2019, doi: 10.4149/BLL_2019_062.
[9114]	R. Bechter and J. F. Brouillard, “The effects of different chemical forms of a test compound on embryotoxicity, distribution and metabolism in vitro,” Toxicol In Vitro, vol. 2, no. 3, pp. 181–188, 1988, doi: 10.1016/0887-2333(88)90006-9.
[9115]	G. C. Lasiuk and K. M. Hegadoren, “The effects of estradiol on central serotonergic systems and its relationship to mood in women,” Biol Res Nurs, vol. 9, no. 2, pp. 147–160, Oct. 2007, doi: 10.1177/1099800407305600.
[9116]	A. H. Mesiwala, L. Farrell, P. Santiago, S. Ghatan, and D. L. Silbergeld, “The effects of hydrogen peroxide on brain and brain tumors,” Surg Neurol, vol. 59, no. 5, pp. 398–407; discussion 407, May 2003, doi: 10.1016/s0090-3019(03)00029-6.
[9117]	S. N. Stehr et al., “The effects of lipid infusion on myocardial function and bioenergetics in l-bupivacaine toxicity in the isolated rat heart,” Anesth. Analg., vol. 104, no. 1, pp. 186–192, Jan. 2007, doi: 10.1213/01.ane.0000248220.01320.58.
[9118]	J.-M. P. Yuann, W.-H. Tseng, H.-Y. Lin, and M.-H. Hou, “The effects of loop size on Sac7d-hairpin DNA interactions,” Biochim. Biophys. Acta, vol. 1824, no. 9, pp. 1009–1015, Sep. 2012, doi: 10.1016/j.bbapap.2012.05.011.
[9119]	R. Hung, S. Lee, and J. W. Bennett, “The effects of low concentrations of the enantiomers of mushroom alcohol (1-octen-3-ol) on Arabidopsis thaliana,” Mycology, vol. 5, no. 2, pp. 73–80, Jun. 2014, doi: 10.1080/21501203.2014.902401.
[9120]	A. D. Bachstetter et al., “The effects of mild closed head injuries on tauopathy and cognitive deficits in rodents: Primary results in wild type and rTg4510 mice, and a systematic review,” Exp. Neurol., vol. 326, p. 113180, Apr. 2020, doi: 10.1016/j.expneurol.2020.113180.
[9121]	R. S. Thomson et al., “The effects of nasal closure on quality of life in patients with hereditary hemorrhagic telangiectasia,” Laryngoscope Investig Otolaryngol, vol. 3, no. 3, pp. 178–181, Jun. 2018, doi: 10.1002/lio2.157.
[9122]	V. Cardi, J. Leppanen, and J. Treasure, “The effects of negative and positive mood induction on eating behaviour: A meta-analysis of laboratory studies in the healthy population and eating and weight disorders,” Neurosci Biobehav Rev, vol. 57, pp. 299–309, Oct. 2015, doi: 10.1016/j.neubiorev.2015.08.011.
[9123]	T. Shimono, S. Matsunaga, E. Fukada, T. Hattori, and Y. Shikinami, “The effects of piezoelectric poly-L-lactic acid films in promoting ossification in vivo,” In Vivo, vol. 10, no. 5, pp. 471–476, Oct. 1996.
[9124]	M. O’Brien, C. Shields, S. Crowell, O. Theou, P. McGrath, and J. Fowles, “The effects of previous educational training on physical activity counselling and exercise prescription practices among physicians across Nova Scotia: a cross-sectional study,” Can Med Educ J, vol. 9, no. 4, pp. e35–e45, Nov. 2018.
[9125]	M. J. Ilett, T. Rantalainen, M. A. Keske, A. K. May, and S. A. Warmington, “The Effects of Restriction Pressures on the Acute Responses to Blood Flow Restriction Exercise,” Front Physiol, vol. 10, p. 1018, 2019, doi: 10.3389/fphys.2019.01018.
[9126]	B. S. Obeidat et al., “The effects of Saccharomyces cerevisiae supplementation on intake, nutrient digestibility, and rumen fluid pH in Awassi female lambs,” Vet World, vol. 11, no. 7, pp. 1015–1020, Jul. 2018, doi: 10.14202/vetworld.2018.1015-1020.
[9127]	L. De Groote, B. Olivier, and H. G. M. Westenberg, “The effects of selective serotonin reuptake inhibitors on extracellular 5-HT levels in the hippocampus of 5-HT(1B) receptor knockout mice,” Eur. J. Pharmacol., vol. 439, no. 1–3, pp. 93–100, Mar. 2002, doi: 10.1016/s0014-2999(02)01417-6.
[9128]	W. B. DeHart and A. L. Odum, “The effects of the framing of time on delay discounting,” J Exp Anal Behav, vol. 103, no. 1, pp. 10–21, Jan. 2015, doi: 10.1002/jeab.125.
[9129]	T. Whitmarsh, G. M. Treece, A. H. Gee, and K. E. S. Poole, “The Effects on the Femoral Cortex of a 24 Month Treatment Compared to an 18 Month Treatment with Teriparatide: A Multi-Trial Retrospective Analysis,” PLoS ONE, vol. 11, no. 2, p. e0147722, 2016, doi: 10.1371/journal.pone.0147722.
[9130]	S. D. Hollon, “The efficacy and acceptability of psychological interventions for depression: where we are now and where we are going,” Epidemiol Psychiatr Sci, vol. 25, no. 4, pp. 295–300, Aug. 2016, doi: 10.1017/S2045796015000748.
[9131]	K. Pavelka et al., “The efficacy and safety of diacerein in the treatment of painful osteoarthritis of the knee: a randomized, multicenter, double-blind, placebo-controlled study with primary end points at two months after the end of a three-month treatment period,” Arthritis Rheum., vol. 56, no. 12, pp. 4055–4064, Dec. 2007, doi: 10.1002/art.23056.
[9132]	D. G. Moon et al., “The efficacy and safety of testosterone undecanoate (Nebido(®)) in testosterone deficiency syndrome in Korean: a multicenter prospective study,” J Sex Med, vol. 7, no. 6, pp. 2253–2260, Jun. 2010, doi: 10.1111/j.1743-6109.2010.01765.x.
[9133]	H. C. Yang, E. K. Jung, S. H. Yoon, and H.-H. Cho, “The efficacy of drug induced sleep endoscopy using multimodality monitoring system,” PLoS ONE, vol. 13, no. 12, p. e0209775, 2018, doi: 10.1371/journal.pone.0209775.
[9134]	M. Wotman, J. Levinger, L. Leung, A. Kallush, E. Mauer, and A. Kacker, “The Efficacy of Lavender Aromatherapy in Reducing Preoperative Anxiety in Ambulatory Surgery Patients Undergoing Procedures in General Otolaryngology,” Laryngoscope Investig Otolaryngol, vol. 2, no. 6, pp. 437–441, 2017, doi: 10.1002/lio2.121.
[9135]	S. Nagao et al., “The Efficacy of Low-Dose Paclitaxel Added to Combination Chemotherapy of Carboplatin and Gemcitabine or Pegylated Liposomal Doxorubicin,” Int. J. Gynecol. Cancer, vol. 26, no. 3, pp. 443–448, Mar. 2016, doi: 10.1097/IGC.0000000000000630.
[9136]	C. Evans, M. J. Banissy, and R. A. Charlton, “The efficacy of transcranial random noise stimulation (tRNS) on mood may depend on individual differences including age and trait mood,” Clin Neurophysiol, vol. 129, no. 6, pp. 1201–1208, 2018, doi: 10.1016/j.clinph.2018.03.012.
[9137]	M. Toyono, K. Harada, M. Tamura, K. Yasuoka, T. Oyama, and G. Takada, “The efficacy of using pulmonary vein wedge pressure for the estimation of pulmonary artery pressure in children with congenital heart disease,” Catheter Cardiovasc Interv, vol. 58, no. 2, pp. 232–237, Feb. 2003, doi: 10.1002/ccd.10365.
[9138]	T. Lomas, “The Elements of Eco-Connection: A Cross-Cultural Lexical Enquiry,” Int J Environ Res Public Health, vol. 16, no. 24, 14 2019, doi: 10.3390/ijerph16245120.
[9139]	F. Zannad, “The emerging role of ACE inhibitors in the treatment of cardiovascular disease,” J. Cardiovasc. Pharmacol., vol. 15 Suppl 2, pp. S1-5, 1990, doi: 10.1097/00005344-199000152-00002.
[9140]	Y. Yaniv and E. G. Lakatta, “The end effector of circadian heart rate variation: the sinoatrial node pacemaker cell,” BMB Rep, vol. 48, no. 12, pp. 677–684, Dec. 2015, doi: 10.5483/bmbrep.2015.48.12.061.
[9141]	J. Shen, N. Chan, and B. B. Wrobel, “The endoscopic modified lothrop procedure: Review of single institution experience and long-term outcomes,” Laryngoscope Investig Otolaryngol, vol. 3, no. 2, pp. 105–109, Apr. 2018, doi: 10.1002/lio2.145.
[9142]	P. Gupta et al., “The environmental pollutant, polychlorinated biphenyls, and cardiovascular disease: a potential target for antioxidant nanotherapeutics,” Drug Deliv Transl Res, vol. 8, no. 3, pp. 740–759, 2018, doi: 10.1007/s13346-017-0429-9.
[9143]	A. Peracino and S. Pecorelli, “The Epidemiology of Cognitive Impairment in the Aging Population: Implications for Hearing Loss,” Audiol. Neurootol., vol. 21 Suppl 1, pp. 3–9, 2016, doi: 10.1159/000448346.
[9144]	P. K. Patel et al., “The epidemiology of hospital-acquired urinary tract-related bloodstream infection in veterans,” Am J Infect Control, vol. 46, no. 7, pp. 747–750, 2018, doi: 10.1016/j.ajic.2018.01.016.
[9145]	R. A. E. Clayton and C. M. Court-Brown, “The epidemiology of musculoskeletal tendinous and ligamentous injuries,” Injury, vol. 39, no. 12, pp. 1338–1344, Dec. 2008, doi: 10.1016/j.injury.2008.06.021.
[9146]	S. J. Steele et al., “The epidemiology of rape and sexual violence in the platinum mining district of Rustenburg, South Africa: Prevalence, and factors associated with sexual violence,” PLoS ONE, vol. 14, no. 7, p. e0216449, 2019, doi: 10.1371/journal.pone.0216449.
[9147]	O. Wong, “The epidemiology of silica, silicosis and lung cancer: some recent findings and future challenges,” Ann Epidemiol, vol. 12, no. 5, pp. 285–287, Jul. 2002, doi: 10.1016/s1047-2797(02)00263-6.
[9148]	G. M. Leggio et al., “The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans,” Mol. Psychiatry, Sep. 2019, doi: 10.1038/s41380-019-0511-4.
[9149]	F. Bienvenu, “The Equivocal Mean Age of Parents in a Cohort,” Am. Nat., vol. 194, no. 2, pp. 276–284, 2019, doi: 10.1086/704110.
[9150]	D. L. Lin, T. Inoue, Y.-J. Chen, A. Chang, B. Tsai, and A. W. Tai, “The ER Membrane Protein Complex Promotes Biogenesis of Dengue and Zika Virus Non-structural Multi-pass Transmembrane Proteins to Support Infection,” Cell Rep, vol. 27, no. 6, pp. 1666-1674.e4, 07 2019, doi: 10.1016/j.celrep.2019.04.051.
[9151]	I. S. Tsimmerman, “[The ethiology, pathogenesis, and treatment of Helicobacter pylori-associated peptic ulcer: the status of the problem and the prospects],” Klin Med (Mosk), vol. 84, no. 3, pp. 9–19, 2006.
[9152]	M. C. Chibucos, D. A. Siegele, J. C. Hu, and M. Giglio, “The Evidence and Conclusion Ontology (ECO): Supporting GO Annotations,” Methods Mol. Biol., vol. 1446, pp. 245–259, 2017, doi: 10.1007/978-1-4939-3743-1_18.
[9153]	S. J. Gould, “The evolution of life on the earth,” Sci. Am., vol. 271, no. 4, pp. 84–91, Oct. 1994, doi: 10.1038/scientificamerican1094-84.
[9154]	L. D. Prybil, F. D. Scutchfield, and R. E. Dixon, “The Evolution of Public Health-Hospital Collaboration in the United States,” Public Health Rep, vol. 131, no. 4, pp. 522–525, Aug. 2016, doi: 10.1177/0033354916662208.
[9155]	G. S. Dotson, C.-P. Chen, B. Gadagbui, A. Maier, H. W. Ahlers, and T. J. Lentz, “The evolution of skin notations for occupational risk assessment: a new NIOSH strategy,” Regul. Toxicol. Pharmacol., vol. 61, no. 1, pp. 53–62, Oct. 2011, doi: 10.1016/j.yrtph.2011.06.002.
[9156]	D. A. Roff, G. Stirling, and D. J. Fairbairn, “THE EVOLUTION OF THRESHOLD TRAITS: A QUANTITATIVE GENETIC ANALYSIS OF THE PHYSIOLOGICAL AND LIFE-HISTORY CORRELATES OF WING DIMORPHISM IN THE SAND CRICKET,” Evolution, vol. 51, no. 6, pp. 1910–1919, Dec. 1997, doi: 10.1111/j.1558-5646.1997.tb05113.x.
[9157]	J. Masin-Spasovska et al., “The evolution of untreated borderline and subclinical rejections at first month kidney allograft biopsy in comparison with histological changes at 6 months protocol biopsies,” Prilozi, vol. 26, no. 1, pp. 25–33, Aug. 2005.
[9158]	D. Nettle and M. Bateson, “The evolutionary origins of mood and its disorders,” Curr. Biol., vol. 22, no. 17, pp. R712-721, Sep. 2012, doi: 10.1016/j.cub.2012.06.020.
[9159]	A. L. Strome, X. Zhang, and S. E. Strome, “The evolving role of immuno-oncology for the treatment of head and neck cancer,” Laryngoscope Investig Otolaryngol, vol. 4, no. 1, pp. 62–69, Feb. 2019, doi: 10.1002/lio2.235.
[9160]	M. D. Mattes, “The Evolving Role of Regional Radiation Oncology Societies in Resident Education,” J Cancer Educ, vol. 30, no. 3, pp. 428–431, Sep. 2015, doi: 10.1007/s13187-014-0682-2.
[9161]	M. Stolina et al., “The evolving systemic biomarker milieu in obese ZSF1 rat model of human cardiometabolic syndrome: Characterization of the model and cardioprotective effect of GDF15,” PLoS ONE, vol. 15, no. 8, p. e0231234, Aug. 2020, doi: 10.1371/journal.pone.0231234.
[9162]	H. Sharif Nia, A. Ebadi, R. H. Lehto, and H. Peyrovi, “The experience of death anxiety in Iranian war veterans: a phenomenology study,” Death Stud, vol. 39, no. 1–5, pp. 281–287, Jun. 2015, doi: 10.1080/07481187.2014.991956.
[9163]	S. E. Adams, K. M. Dawson, K. Gull, S. M. Kingsman, and A. J. Kingsman, “The expression of hybrid HIV:Ty virus-like particles in yeast,” Nature, vol. 329, no. 6134, pp. 68–70, Sep. 1987, doi: 10.1038/329068a0.
[9164]	D. Vital, K. Ikenberg, H. Moch, M. Roessle, and G. F. Huber, “The expression of the cancer testis antigen MAGE A4: A favorable prognostic biomarker in salivary gland carcinomas related to low tumor grading,” Laryngoscope Investig Otolaryngol, vol. 3, no. 3, pp. 182–190, Jun. 2018, doi: 10.1002/lio2.160.
[9165]	P. Chakraborty and A. Kumar, “The extracellular matrix of mycobacterial biofilms: could we shorten the treatment of mycobacterial infections?,” Microb Cell, vol. 6, no. 2, pp. 105–122, Jan. 2019, doi: 10.15698/mic2019.02.667.
[9166]	R. Lasala and R. Rizzello, “The facility between certification and accreditation,” Qual Assur, vol. 6, no. 3, pp. 137–148, Sep. 1998, doi: 10.1080/105294199277815.
[9167]	I. Elman and D. Borsook, “The Failing Cascade: Comorbid Post Traumatic- and Opioid Use Disorders,” Neurosci Biobehav Rev, May 2019, doi: 10.1016/j.neubiorev.2019.04.023.
[9168]	J. Ko, D. Lee, H. Park, E. A. Coutsias, J. Lee, and C. Seok, “The FALC-Loop web server for protein loop modeling,” Nucleic Acids Res., vol. 39, no. Web Server issue, pp. W210-214, Jul. 2011, doi: 10.1093/nar/gkr352.
[9169]	J. Michl and J. Svobodova, “THE FATE OF LABELED GROWTH-PROMOTING ALPHA-GLOBULIN IN CELL CULTURE IN VITRO,” Exp. Cell Res., vol. 37, pp. 685–687, Mar. 1965, doi: 10.1016/0014-4827(65)90217-x.
[9170]	M. Kivipelto et al., “The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): study design and progress,” Alzheimers Dement, vol. 9, no. 6, pp. 657–665, Nov. 2013, doi: 10.1016/j.jalz.2012.09.012.
[9171]	K. Marchetti, T. Lee, D. A. Bloom, and J. Wan, “The first female authors of the Journal of Urology,” J Med Biogr, vol. 27, no. 3, pp. 136–143, Aug. 2019, doi: 10.1177/0967772017729563.
[9172]	J. Boehm, R. Cordier, Y. Thomas, B. Tanner, and K. Salata, “The first year experience of occupational therapy students at an Australian regional university: Promoting student retention and developing a regional and remote workforce,” Aust J Rural Health, vol. 25, no. 1, pp. 22–27, Feb. 2017, doi: 10.1111/ajr.12252.
[9173]	L. A. Snyder, V. Rismondo, and N. R. Miller, “The Fisher variant of Guillain-Barré syndrome (Fisher syndrome),” J Neuroophthalmol, vol. 29, no. 4, pp. 312–324, Dec. 2009, doi: 10.1097/WNO.0b013e3181c2514b.
[9174]	A. Papa, “The flame of the future is in your hands,” J Emerg Nurs, vol. 37, no. 2, p. 121, Mar. 2011, doi: 10.1016/j.jen.2011.02.001.
[9175]	T. Esch, G. Jose, C. Gimpel, C. von Scheidt, and A. Michalsen, “[The Flourishing Scale (FS) by Diener et al. is now available in an authorized German version (FS-D): application in mind-body medicine],” Forsch Komplementmed, vol. 20, no. 4, pp. 267–275, 2013, doi: 10.1159/000354414.
[9176]	T. J. Meyer et al., “The Flow of the Gibbon LAVA Element Is Facilitated by the LINE-1 Retrotransposition Machinery,” Genome Biol Evol, vol. 8, no. 10, pp. 3209–3225, 30 2016, doi: 10.1093/gbe/evw224.
[9177]	X. Li, G. Bu, and X. Guo, “[The flow-limiting segment (FS) of the nasal airway],” Zhonghua Er Bi Yan Hou Ke Za Zhi, vol. 29, no. 1, pp. 48–49, 1994.
[9178]	A. J. McAdam, “The Focus on Quality Publications in Journal of Clinical Microbiology,” J. Clin. Microbiol., vol. 54, no. 9, p. 2218, 2016, doi: 10.1128/JCM.01370-16.
[9179]	R. Heidari, “The footprints of mitochondrial impairment and cellular energy crisis in the pathogenesis of xenobiotics-induced nephrotoxicity, serum electrolytes imbalance, and Fanconi’s syndrome: A comprehensive review,” Toxicology, vol. 423, pp. 1–31, 01 2019, doi: 10.1016/j.tox.2019.05.002.
[9180]	S. L. Miller, “The formation of organic compounds on the primitive earth,” Ann. N. Y. Acad. Sci., vol. 69, no. 2, pp. 260–275, Aug. 1957, doi: 10.1111/j.1749-6632.1957.tb49662.x.
[9181]	A. Walling and A. Merando, “The fourth year of medical education: a literature review,” Acad Med, vol. 85, no. 11, pp. 1698–1704, Nov. 2010, doi: 10.1097/ACM.0b013e3181f52dc6.
[9182]	B. Zeng et al., “The FOXO transcription factor controls insect growth and development by regulating juvenile hormone degradation in the silkworm, Bombyx mori,” J. Biol. Chem., vol. 292, no. 28, pp. 11659–11669, 14 2017, doi: 10.1074/jbc.M117.777797.
[9183]	C. A. Chastenet et al., “The French eco-neighbourhood evaluation model: Contributions to sustainable city making and to the evolution of urban practices,” J. Environ. Manage., vol. 176, pp. 69–78, Jul. 2016, doi: 10.1016/j.jenvman.2016.03.036.
[9184]	G. Jones et al., “The French human Salmonella surveillance system: evaluation of timeliness of laboratory reporting and factors associated with delays, 2007 to 2011,” Euro Surveill., vol. 19, no. 1, Jan. 2014, doi: 10.2807/1560-7917.es2014.19.1.20664.
[9185]	F. Song et al., “The frontline of immune response in peripheral blood,” PLoS ONE, vol. 12, no. 8, p. e0182294, 2017, doi: 10.1371/journal.pone.0182294.
[9186]	P. Costa-Mallen et al., “The functional polymorphism of the hemoglobin-binding protein haptoglobin influences susceptibility to idiopathic Parkinson’s disease,” Am. J. Med. Genet. B Neuropsychiatr. Genet., vol. 147B, no. 2, pp. 216–222, Mar. 2008, doi: 10.1002/ajmg.b.30593.
[9187]	G. L. Birbeck and E. M. N. Kalichi, “The functional status of people with epilepsy in rural sub-Saharan Africa,” J. Neurol. Sci., vol. 209, no. 1–2, pp. 65–68, May 2003, doi: 10.1016/s0022-510x(02)00467-7.
[9188]	S. E. Adams et al., “The functions and relationships of Ty-VLP proteins in yeast reflect those of mammalian retroviral proteins,” Cell, vol. 49, no. 1, pp. 111–119, Apr. 1987, doi: 10.1016/0092-8674(87)90761-6.
[9189]	S. I. Hwang and H. J. Lee, “The future perspectives in transrectal prostate ultrasound guided biopsy,” Prostate Int, vol. 2, no. 4, pp. 153–160, Dec. 2014, doi: 10.12954/PI.14062.
[9190]	D. D. Vanslyke, “THE GASES OF THE BLOOD. NO. 41, BNL 898 (T-366),” Tech Rep Brookhaven Natl Lab, vol. 59, pp. 1–16, Nov. 1964.
[9191]	A. Corl et al., “The Genetic Basis of Adaptation following Plastic Changes in Coloration in a Novel Environment,” Curr. Biol., vol. 28, no. 18, pp. 2970-2977.e7, 24 2018, doi: 10.1016/j.cub.2018.06.075.
[9192]	G. Liu et al., “The genetic implication of scoliosis in osteogenesis imperfecta: a review,” J Spine Surg, vol. 3, no. 4, pp. 666–678, Dec. 2017, doi: 10.21037/jss.2017.10.01.
[9193]	A. J. Kingsman et al., “The genetic organization of the yeast Ty element,” J. Cell Sci. Suppl., vol. 7, pp. 155–167, 1987, doi: 10.1242/jcs.1987.supplement_7.12.
[9194]	S. Hirose, R. P. Mohney, M. Okada, S. Kaneko, and A. Mitsudome, “The genetics of febrile seizures and related epilepsy syndromes,” Brain Dev., vol. 25, no. 5, pp. 304–312, Aug. 2003, doi: 10.1016/s0387-7604(03)00026-3.
[9195]	A. Rodríguez-Verdugo, J. Buckley, and J. Stapley, “The genomic basis of eco-evolutionary dynamics,” Mol. Ecol., vol. 26, no. 6, pp. 1456–1464, Mar. 2017, doi: 10.1111/mec.14045.
[9196]	A. L. Zerkle and S. Mikhail, “The geobiological nitrogen cycle: From microbes to the mantle,” Geobiology, vol. 15, no. 3, pp. 343–352, 2017, doi: 10.1111/gbi.12228.
[9197]	Y. B. Saab, P. R. Gard, and A. D. J. Overall, “The geographic distribution of the ACE II genotype: a novel finding,” Genet. Res., vol. 89, no. 4, pp. 259–267, Aug. 2007, doi: 10.1017/S0016672307009019.
[9198]	E. M. Engels, G. Lotter, and S. Schicktanz, “The German Research Society (DFG) research project: new perspectives in transplantation medicine: the biological, medical, and ethical aspects of xenotransplantation and the derivation of organs from embryonic stem cells,” Biomed Ethics, vol. 4, no. 3, pp. 74–76, 1999.
[9199]	B. A. Dye, “The Global Burden of Oral Disease: Research and Public Health Significance,” J. Dent. Res., vol. 96, no. 4, pp. 361–363, 2017, doi: 10.1177/0022034517693567.
[9200]	M. Moore, M. McKee, B. Borisch, and W. Ricciardi, “The Global Charter for the Public’s Health,” Eur J Public Health, vol. 26, no. 2, p. 207, Apr. 2016, doi: 10.1093/eurpub/ckw013.
[9201]	K. T. Mills, A. Stefanescu, and J. He, “The global epidemiology of hypertension,” Nat Rev Nephrol, vol. 16, no. 4, pp. 223–237, 2020, doi: 10.1038/s41581-019-0244-2.
[9202]	L. Muszkieta et al., “The Glycosylphosphatidylinositol-Anchored DFG Family Is Essential for the Insertion of Galactomannan into the β-(1,3)-Glucan-Chitin Core of the Cell Wall of Aspergillus fumigatus,” mSphere, vol. 4, no. 4, 31 2019, doi: 10.1128/mSphere.00397-19.
[9203]	D. Centurión, A. Sánchez-López, P. De Vries, P. R. Saxena, and C. M. Villalón, “The GR127935-sensitive 5-HT(1) receptors mediating canine internal carotid vasoconstriction: resemblance to the 5-HT(1B), but not to the 5-HT(1D) or 5-ht(1F), receptor subtype,” Br. J. Pharmacol., vol. 132, no. 5, pp. 991–998, Mar. 2001, doi: 10.1038/sj.bjp.0703913.
[9204]	A. Mirza and Y. Mao-Draayer, “The gut microbiome and microbial translocation in multiple sclerosis,” Clin. Immunol., vol. 183, pp. 213–224, 2017, doi: 10.1016/j.clim.2017.03.001.
[9205]	S. J. Evans et al., “The gut microbiome composition associates with bipolar disorder and illness severity,” J Psychiatr Res, vol. 87, pp. 23–29, 2017, doi: 10.1016/j.jpsychires.2016.12.007.
[9206]	K. Nakahara et al., “The gut-brain peptide neuromedin U is involved in the mammalian circadian oscillator system,” Biochem. Biophys. Res. Commun., vol. 318, no. 1, pp. 156–161, May 2004, doi: 10.1016/j.bbrc.2004.04.014.
[9207]	S. Papa, F. Capuano, M. Markert, and N. Altamura, “The H+/O stoicheiometry of mitochondrial respiration,” FEBS Lett., vol. 111, no. 1, pp. 243–248, Feb. 1980, doi: 10.1016/0014-5793(80)80803-9.
[9208]	N. H. Sleep, “The Hadean-Archaean environment,” Cold Spring Harb Perspect Biol, vol. 2, no. 6, p. a002527, Jun. 2010, doi: 10.1101/cshperspect.a002527.
[9209]	R. Speeckaert, M. M. Speeckaert, E. Padalko, L. R. Claeys, and J. R. Delanghe, “The haptoglobin phenotype is associated with the Epstein-Barr virus antibody titer,” Clin. Chem. Lab. Med., vol. 47, no. 7, pp. 826–828, 2009, doi: 10.1515/CCLM.2009.193.
[9210]	M. Soejima, K. Teye, and Y. Koda, “The haptoglobin promoter polymorphism rs5471 is the most definitive genetic determinant of serum haptoglobin level in a Ghanaian population,” Clin. Chim. Acta, vol. 483, pp. 303–307, Aug. 2018, doi: 10.1016/j.cca.2018.05.029.
[9211]	A. D. Kraft, S. A. Quimbo, O. Solon, R. Shimkhada, J. Florentino, and J. W. Peabody, “The health and cost impact of care delay and the experimental impact of insurance on reducing delays,” J. Pediatr., vol. 155, no. 2, pp. 281-285.e1, Aug. 2009, doi: 10.1016/j.jpeds.2009.02.035.
[9212]	V. N. Houk, “The health effects of dioxin on humans,” Qual Assur, vol. 1, no. 2, pp. 97–103, Feb. 1992.
[9213]	P. A. Anderson, “The heart and development,” Semin. Perinatol., vol. 20, no. 6, pp. 482–509, Dec. 1996, doi: 10.1016/s0146-0005(96)80064-4.
[9214]	K. E. Brack, “The heart’s ‘little brain’ controlling cardiac function in the rabbit,” Exp. Physiol., vol. 100, no. 4, pp. 348–353, Apr. 2015, doi: 10.1113/expphysiol.2014.080168.
[9215]	A. Faucherre and C. Jopling, “The heart’s content-renewable resources,” Int. J. Cardiol., vol. 167, no. 4, pp. 1141–1146, Aug. 2013, doi: 10.1016/j.ijcard.2012.09.051.
[9216]	B. G. Bruneau and B. L. Black, “The heart’s Da Vinci code: a Renaissance at Keystone,” Development, vol. 134, no. 9, pp. 1631–1633, May 2007, doi: 10.1242/dev.002014.
[9217]	R. San Gil, L. Ooi, J. J. Yerbury, and H. Ecroyd, “The heat shock response in neurons and astroglia and its role in neurodegenerative diseases,” Mol Neurodegener, vol. 12, no. 1, p. 65, 18 2017, doi: 10.1186/s13024-017-0208-6.
[9218]	I. Calderon, S. R. Lobos, and G. C. Mora, “The hemolytic effect of Salmonella typhi Ty 2 porins,” Eur. J. Biochem., vol. 141, no. 3, pp. 579–583, Jun. 1984, doi: 10.1111/j.1432-1033.1984.tb08232.x.
[9219]	X. Li, N. Qiao, D. Reynaud, M. Abdelhaleem, and C. R. Pace-Asciak, “The hepoxilin analog, PBT-3, inhibits growth of K-562 CML solid tumours in vivo in nude mice,” In Vivo, vol. 19, no. 1, pp. 185–189, Feb. 2005.
[9220]	P. Coit and A. H. Sawalha, “The human microbiome in rheumatic autoimmune diseases: A comprehensive review,” Clin. Immunol., vol. 170, pp. 70–79, Sep. 2016, doi: 10.1016/j.clim.2016.07.026.
[9221]	M. J. Dobson et al., “The identification and high level expression of a protein encoded by the yeast Ty element,” EMBO J., vol. 3, no. 5, pp. 1115–1119, May 1984.
[9222]	A. J. Masot, L. Gomez, C. Gomez-Tejedor, S. Martinez, and E. Redondo, “The immunologic response to experimental infection with bovine respiratory syncytial virus in lambs,” Zentralblatt Veterinarmedizin Reihe B, vol. 40, no. 9–10, pp. 659–666, Dec. 1993, doi: 10.1111/j.1439-0450.1993.tb00189.x.
[9223]	D. T. L. Shek and L. Yu, “The impact of 3-year and 4-year undergraduate programs on university students: the case of Hong Kong,” Int J Adolesc Med Health, vol. 29, no. 1, pp. 49–55, Feb. 2017, doi: 10.1515/ijamh-2017-3007.
[9224]	J. R. Payne et al., “The impact of ACE genotype on serum ACE activity in a black South African male population,” Ann. Hum. Genet., vol. 71, no. Pt 1, pp. 1–7, Jan. 2007, doi: 10.1111/j.1469-1809.2006.00300.x.
[9225]	L. Xi, F. Cao, W. Xiong, F. He, and L. Zhang, “[The impact of allergic rhinitis on state-trait anxiety],” Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, vol. 49, no. 10, pp. 828–831, Oct. 2014.
[9226]	A.-M. De Cock, S. Perkisas, V. Verhoeven, M. Vandewoude, E. Fransen, and R. Remmen, “The impact of cognitive impairment on the physical ageing process,” Aging Clin Exp Res, vol. 30, no. 11, pp. 1297–1306, Nov. 2018, doi: 10.1007/s40520-018-1016-8.
[9227]	M. G. Figueiro et al., “The impact of daytime light exposures on sleep and mood in office workers,” Sleep Health, vol. 3, no. 3, pp. 204–215, 2017, doi: 10.1016/j.sleh.2017.03.005.
[9228]	K. L. Lavoie and R. P. Fleet, “The impact of depression on the course and outcome of coronary artery disease: review for cardiologists,” Can J Cardiol, vol. 16, no. 5, pp. 653–662, May 2000.
[9229]	J. C. Strickland, W. W. Stoops, M. A. Kincer, and C. R. Rush, “The impact of financial strain on medication non-adherence: Influence of psychiatric medication use,” Psychiatry Res, vol. 271, pp. 389–395, 2019, doi: 10.1016/j.psychres.2018.11.055.
[9230]	F. Zara and A. Bianchi, “The impact of genetics on the classification of epilepsy syndromes,” Epilepsia, vol. 50 Suppl 5, pp. 11–14, May 2009, doi: 10.1111/j.1528-1167.2009.02113.x.
[9231]	J. Hou, Y. An, H. Song, and J. Chen, “The Impact of Haze Pollution on Regional Eco-Economic Treatment Efficiency in China: An Environmental Regulation Perspective,” Int J Environ Res Public Health, vol. 16, no. 21, 23 2019, doi: 10.3390/ijerph16214059.
[9232]	R. Tunder, “[The impact of health economics: a status report],” Urologe A, vol. 50, no. 12, pp. 1543–1549, Dec. 2011, doi: 10.1007/s00120-011-2729-x.
[9233]	W. Van Biesen, C. Dequidt, R. Vanholder, and N. Lameire, “The impact of healthy start peritoneal dialysis on the evolution of residual renal function and nutrition parameters,” Adv Perit Dial, vol. 18, pp. 44–48, 2002.
[9234]	S. R. M. Pereira, M. T. E. Puts, M. C. Portela, and M. A. Sayeg, “The impact of hip fracture (HF) on the functional status (FS) of older persons in Rio de Janeiro, Brazil: results of a prospective cohort study,” Arch Gerontol Geriatr, vol. 51, no. 1, pp. e28-35, Aug. 2010, doi: 10.1016/j.archger.2009.08.007.
[9235]	M. Benns, M. Ruther, N. Nash, M. Bozeman, B. Harbrecht, and K. Miller, “The impact of historical racism on modern gun violence: Redlining in the city of Louisville, KY,” Injury, Jun. 2020, doi: 10.1016/j.injury.2020.06.042.
[9236]	Y. Yang, Z. Tang, T. An, and L. Zhao, “The impact of iron chelation therapy on patients with lower/intermediate IPSS MDS and the prognostic role of elevated serum ferritin in patients with MDS and AML: A meta-analysis,” Medicine (Baltimore), vol. 98, no. 40, p. e17406, Oct. 2019, doi: 10.1097/MD.0000000000017406.
[9237]	J. S. Robertson, “THE IMPACT OF ISOTOPIC TRACERS ON PHYSIOLOGICAL CONCEPTS. BNL 857 (T-341),” Tech Rep Brookhaven Natl Lab, vol. 23, pp. 1–13, Feb. 1964.
[9238]	L. Granek and O. Nakash, “The Impact of Militarism, Patriarchy, and Culture on Israeli Women’s Reproductive Health and Well-Being,” Int J Behav Med, vol. 24, no. 6, pp. 893–900, 2017, doi: 10.1007/s12529-017-9650-7.
[9239]	I. Kahramanoglu, M. Baktiroglu, K. Hamzaoglu, O. Kahramanoglu, F. F. Verit, and O. Yucel, “The impact of mode of delivery on the sexual function of primiparous women: a prospective study,” Arch. Gynecol. Obstet., vol. 295, no. 4, pp. 907–916, Apr. 2017, doi: 10.1007/s00404-017-4299-7.
[9240]	X. Li, X. Meng, H. Li, J. Yang, and J. Yuan, “The impact of mood on empathy for pain: Evidence from an EEG study,” Psychophysiology, vol. 54, no. 9, pp. 1311–1322, Sep. 2017, doi: 10.1111/psyp.12882.
[9241]	D. Parikesit, C. A. Mochtar, R. Umbas, and A. R. A. H. Hamid, “The impact of obesity towards prostate diseases,” Prostate Int, vol. 4, no. 1, pp. 1–6, Mar. 2016, doi: 10.1016/j.prnil.2015.08.001.
[9242]	A. A. G. Oka, G. W. K. Duarsa, P. A. Novianti, T. G. B. Mahadewa, and C. Ryalino, “The impact of prostate-transurethral resection on erectile dysfunction in benign prostatic hyperplasia,” Res Rep Urol, vol. 11, pp. 91–96, 2019, doi: 10.2147/RRU.S189414.
[9243]	A. N. Barczyk, S. J. Thompson, and L. Rew, “The impact of psychosocial factors on subjective well-being among homeless young adults,” Health Soc Work, vol. 39, no. 3, pp. 172–180, Aug. 2014, doi: 10.1093/hsw/hlu020.
[9244]	A. Tranoulis, A. Laios, G. Theophilou, K. Bramis, and S. Kehoe, “The Impact of Saphenous Vein Sparing During Inguinal Lymphadenectomy on Postoperative Morbidity in Women With Vulval Cancer: An Updated Per-Groin Meta-analysis of Short-term Outcomes,” Int. J. Gynecol. Cancer, vol. 28, no. 6, pp. 1232–1238, 2018, doi: 10.1097/IGC.0000000000001283.
[9245]	M. J. Dogba et al., “The impact of severe osteogenesis imperfecta on the lives of young patients and their parents - a qualitative analysis,” BMC Pediatr, vol. 13, p. 153, Sep. 2013, doi: 10.1186/1471-2431-13-153.
[9246]	J. C. Zurko, R. C. Wade, and A. Mehta, “The impact of structural factors on diagnostic delay in diffuse large B-cell lymphoma,” Cancer Med, vol. 8, no. 4, pp. 1416–1422, 2019, doi: 10.1002/cam4.2009.
[9247]	M. Miyake et al., “The impact of the definition of biochemical recurrence following salvage radiotherapy on outcomes and prognostication in patients with recurrent prostate cancer after radical prostatectomy: a comparative study of three definitions,” Prostate Int, vol. 7, no. 2, pp. 47–53, Jun. 2019, doi: 10.1016/j.prnil.2018.04.005.
[9248]	B. Vollmer et al., “The impact of very short transition times on switching from Natalizumab to Fingolimod on imaging and clinical effectiveness outcomes in multiple sclerosis,” J. Neurol. Sci., vol. 390, pp. 89–93, 15 2018, doi: 10.1016/j.jns.2018.04.021.
[9249]	K.-U. Hanusch and C. W. Janssen, “The impact of whole-body hyperthermia interventions on mood and depression - are we ready for recommendations for clinical application?,” Int J Hyperthermia, vol. 36, no. 1, pp. 573–581, 2019, doi: 10.1080/02656736.2019.1612103.
[9250]	K. A. E. Rodenhizer and K. M. Edwards, “The Impacts of Sexual Media Exposure on Adolescent and Emerging Adults’ Dating and Sexual Violence Attitudes and Behaviors: A Critical Review of the Literature,” Trauma Violence Abuse, vol. 20, no. 4, pp. 439–452, 2019, doi: 10.1177/1524838017717745.
[9251]	C. Munsch, J. F. Williams, and F. L. Rosenfeldt, “The impaired tolerance of the recently infarcted rat heart to cardioplegic arrest: the protective effect of orotic acid,” J. Mol. Cell. Cardiol., vol. 21, no. 8, pp. 751–754, Aug. 1989, doi: 10.1016/0022-2828(89)90713-x.
[9252]	E. Cohen, G. Zerach, and Z. Solomon, “The implication of combat-induced stress reaction, PTSD, and attachment in parenting among war veterans,” J Fam Psychol, vol. 25, no. 5, pp. 688–698, Oct. 2011, doi: 10.1037/a0024065.
[9253]	D. J. Murphy, “The implications of the declining energy return on investment of oil production,” Philos Trans A Math Phys Eng Sci, vol. 372, no. 2006, p. 20130126, Jan. 2014, doi: 10.1098/rsta.2013.0126.
[9254]	W. H. Ponder, “The importance of a successful Quality Assurance (QA) program from a research manager’s perspective,” Qual Assur, vol. 9, no. 3–4, pp. 173–178, Dec. 2001, doi: 10.1080/713844023.
[9255]	F. S. Goes, “The importance of anxiety states in bipolar disorder,” Curr Psychiatry Rep, vol. 17, no. 2, p. 3, Feb. 2015, doi: 10.1007/s11920-014-0540-2.
[9256]	R. Bonacina, V. Martini, P. Schiavone, U. Mariani, and A. Rambaldi, “The importance of differential diagnosis between Bronj and hematologic diseases,” Ann Stomatol (Roma), vol. 4, no. Suppl 2, pp. 27–28, 2013.
[9257]	B. P. O’Connell, J. B. Hunter, and G. B. Wanna, “The importance of electrode location in cochlear implantation,” Laryngoscope Investig Otolaryngol, vol. 1, no. 6, pp. 169–174, 2016, doi: 10.1002/lio2.42.
[9258]	S. Wyke, A. Peña-Fernández, N. Brooke, and R. Duarte-Davidson, “The importance of evaluating the physicochemical and toxicological properties of a contaminant for remediating environments affected by chemical incidents,” Environ Int, vol. 72, pp. 109–118, Nov. 2014, doi: 10.1016/j.envint.2014.05.002.
[9259]	K. Tigen et al., “The importance of papillary muscle dyssynchrony in predicting the severity of functional mitral regurgitation in patients with non-ischaemic dilated cardiomyopathy: a two-dimensional speckle-tracking echocardiography study,” Eur J Echocardiogr, vol. 11, no. 8, pp. 671–676, Sep. 2010, doi: 10.1093/ejechocard/jeq040.
[9260]	M. S. Eberhardt and E. R. Pamuk, “The importance of place of residence: examining health in rural and nonrural areas,” Am J Public Health, vol. 94, no. 10, pp. 1682–1686, Oct. 2004, doi: 10.2105/ajph.94.10.1682.
[9261]	R. Bejar and O. Abdel-Wahab, “The importance of subclonal genetic events in MDS,” Blood, vol. 122, no. 22, pp. 3550–3551, Nov. 2013, doi: 10.1182/blood-2013-09-527655.
[9262]	L. F. Canêo and R. Neirotti, “The Importance of the Proper Definition of Adulthood: What is and What is Not Included in a Scientific Publication,” Braz J Cardiovasc Surg, vol. 32, no. 1, p. 60, Feb. 2017, doi: 10.21470/1678-9741-2016-0049.
[9263]	K. Priftis, S. Di Salvo, and D. Zara, “The importance of time limits in detecting signs of left visual peripersonal neglect: a multiple single-case, pilot study,” Neurocase, vol. 25, no. 5, pp. 209–215, 2019, doi: 10.1080/13554794.2019.1658788.
[9264]	Z. Chen and H. Li, “The improved anode performance enabled by Ni2P@C embedded in echinus-like porous carbon for lithium-ion battery,” Nanotechnology, vol. 31, no. 21, p. 215405, May 2020, doi: 10.1088/1361-6528/ab71b7.
[9265]	A. R. Seaman, “The in vitro cultivation of the prostate gland of the adult mouse in alkaline fluid medium,” Exp. Cell Res., vol. 11, no. 2, pp. 283–288, Aug. 1956, doi: 10.1016/0014-4827(56)90103-3.
[9266]	S. H. Madin, P. C. Andriese, and N. B. Darby, “The in vitro cultivation of tissues of domestic and laboratory animals,” Am. J. Vet. Res., vol. 18, no. 69, pp. 932–941, Oct. 1957.
[9267]	G. Li et al., “The in vivo DNA aneuploidization during expansion of conventional renal cell carcinoma,” In Vivo, vol. 16, no. 5, pp. 341–344, Oct. 2002.
[9268]	V. Gebbia, S. Palmeri, R. Valenza, L. Rausa, and P. Citarrella, “The in vivo effects of recombinant human erythropoietin on cisdiamminodichloroplatinum-induced anemia in golden Syrian hamsters,” In Vivo, vol. 5, no. 2, pp. 149–152, Apr. 1991.
[9269]	J. B. Zhang et al., “The incidence of orthostatic intolerance after bariatric surgery,” Obes Sci Pract, vol. 6, no. 1, pp. 76–83, Feb. 2020, doi: 10.1002/osp4.383.
[9270]	A. McGrogan, C. F. M. Franssen, and C. S. de Vries, “The incidence of primary glomerulonephritis worldwide: a systematic review of the literature,” Nephrol. Dial. Transplant., vol. 26, no. 2, pp. 414–430, Feb. 2011, doi: 10.1093/ndt/gfq665.
[9271]	S. Hassanipour, M. Fathalipour, and H. Salehiniya, “The incidence of prostate cancer in Iran: a systematic review and meta-analysis,” Prostate Int, vol. 6, no. 2, pp. 41–45, Jun. 2018, doi: 10.1016/j.prnil.2017.11.003.
[9272]	N. A. Kovalkova, D. V. Denisova, Y. V. Polonskaya, and E. V. Kashtanova, “[The incidence of respiratory symptoms and their associations with serum cotinine levels as a marker of tobacco smoking in 25-45-year-old Novosibirsk dwellers],” Ter. Arkh., vol. 88, no. 1, pp. 70–74, 2016, doi: 10.17116/terarkh201688170-74.
[9273]	B. Ha Chung, S. Horie, and E. Chiong, “The incidence, mortality, and risk factors of prostate cancer in Asian men,” Prostate Int, vol. 7, no. 1, pp. 1–8, Mar. 2019, doi: 10.1016/j.prnil.2018.11.001.
[9274]	L. Crivelli and P. Salari, “The inequity of the Swiss Health Care system financing from a federal state perspective,” Int J Equity Health, vol. 13, p. 17, Feb. 2014, doi: 10.1186/1475-9276-13-17.
[9275]	L. Yang, Y. Qian, E. Eksioglu, P. K. Epling-Burnette, and S. Wei, “The inflammatory microenvironment in MDS,” Cell. Mol. Life Sci., vol. 72, no. 10, pp. 1959–1966, May 2015, doi: 10.1007/s00018-015-1846-x.
[9276]	D. N. Edwards and G. J. Bix, “The Inflammatory Response After Ischemic Stroke: Targeting β2 and β1 Integrins,” Front Neurosci, vol. 13, p. 540, 2019, doi: 10.3389/fnins.2019.00540.
[9277]	R. E. Beyer and J. E. Fattore, “The influence of age and endurance exercise on the myoglobin concentration of skeletal muscle of the rat,” J Gerontol, vol. 39, no. 5, pp. 525–530, Sep. 1984, doi: 10.1093/geronj/39.5.525.
[9278]	V. J. Harvey, M. L. Slevin, M. R. Dilloway, P. I. Clark, A. Johnston, and A. F. Lant, “The influence of cimetidine on the pharmacokinetics of 5-fluorouracil,” Br J Clin Pharmacol, vol. 18, no. 3, pp. 421–430, Sep. 1984, doi: 10.1111/j.1365-2125.1984.tb02484.x.
[9279]	L. Rew, “The influence of culture on nursing practice and research,” J Spec Pediatr Nurs, vol. 19, no. 1, pp. 1–2, Jan. 2014, doi: 10.1111/jspn.12058.
[9280]	V. D. Guajardo et al., “The influence of depressive symptoms on quality of life after stroke: a prospective study,” J Stroke Cerebrovasc Dis, vol. 24, no. 1, pp. 201–209, Jan. 2015, doi: 10.1016/j.jstrokecerebrovasdis.2014.08.020.
[9281]	L. Dell’Osso et al., “The influence of gender on social anxiety spectrum symptoms in a sample of university students,” Riv Psichiatr, vol. 50, no. 6, pp. 295–301, Dec. 2015, doi: 10.1708/2098.22688.
[9282]	B. Piech et al., “[The influence of living conditions and lifestyle on the anxiety level in women in the postpartum period-questionnaire study],” Prz. Lek., vol. 74, no. 3, pp. 101–105, 2017.
[9283]	R. E. Durand, “The influence of microenvironmental factors during cancer therapy,” In Vivo, vol. 8, no. 5, pp. 691–702, Dec. 1994.
[9284]	R. Uma, J. S. Forsyth, A. D. Struthers, C. G. Fraser, and D. J. Murphy, “The influence of mode of delivery and ACE genotype on serum angiotensin converting enzyme (ACE) activity in the mother and infant at term,” Eur. J. Obstet. Gynecol. Reprod. Biol., vol. 134, no. 2, pp. 179–183, Oct. 2007, doi: 10.1016/j.ejogrb.2006.10.009.
[9285]	Y. R. Avramova, D. A. Stapel, and D. Lerouge, “The influence of mood on attribution,” Pers Soc Psychol Bull, vol. 36, no. 10, pp. 1360–1371, Oct. 2010, doi: 10.1177/0146167210381083.
[9286]	J. B. Knight, G. A. Brewer, B. H. Ball, M. R. DeWitt, and R. L. Marsh, “The influence of mood on the process and content of encoding future intentions,” Q J Exp Psychol (Hove), vol. 68, no. 6, pp. 1082–1100, 2015, doi: 10.1080/17470218.2014.975729.
[9287]	C. M. Growney and T. M. Hess, “The influence of mood versus relevant self-perceptions in older adults’ interest in negative health-related information,” Psychol Aging, vol. 34, no. 3, pp. 348–361, May 2019, doi: 10.1037/pag0000333.
[9288]	S. Hu, C. Xiao, X. Liang, Y. Cao, X. Wang, and M. Li, “The influence of oil shale in situ mining on groundwater environment: A water-rock interaction study,” Chemosphere, vol. 228, pp. 384–389, Aug. 2019, doi: 10.1016/j.chemosphere.2019.04.142.
[9289]	M. A. McDevitt, J. M. Pisklak, M. Spetch, and R. Dunn, “The influence of outcome delay on suboptimal choice,” Behav. Processes, vol. 157, pp. 279–285, Dec. 2018, doi: 10.1016/j.beproc.2018.10.008.
[9290]	N. A. Samoylova, G. G. Shkilnyuk, Z. A. Goncharova, and I. D. Stolyarov, “[The influence of solar and geomagnetic activity on the risk of multiple sclerosis (results of correlation and regression analysis)],” Zh Nevrol Psikhiatr Im S S Korsakova, vol. 117, no. 2. Vyp. 2, pp. 42–49, 2017, doi: 10.17116/jnevro20171172242-49.
[9291]	A. J. Bojarski et al., “The influence of substitution at aromatic part of 1,2,3,4-tetrahydroisoquinoline on in vitro and in vivo 5-HT(1A)/5-HT(2A) receptor activities of its 1-adamantoyloaminoalkyl derivatives,” Bioorg. Med. Chem., vol. 10, no. 1, pp. 87–95, Jan. 2002, doi: 10.1016/s0968-0896(01)00236-x.
[9292]	T. N. Tibbs, L. R. Lopez, and J. C. Arthur, “The influence of the microbiota on immune development, chronic inflammation, and cancer in the context of aging,” Microb Cell, vol. 6, no. 8, pp. 324–334, May 2019, doi: 10.15698/mic2019.08.685.
[9293]	G. C. Critchfield and S. T. Bennett, “The influence of the reference mean prothrombin time on the international normalized ratio,” Am. J. Clin. Pathol., vol. 102, no. 6, pp. 806–811, Dec. 1994, doi: 10.1093/ajcp/102.6.806.
[9294]	X. Li, Y. Lin, G. Yao, and Y. Wang, “The Influence of Vaccine on Febrile Seizure,” Curr Neuropharmacol, vol. 16, no. 1, pp. 59–65, 2018, doi: 10.2174/1570159X15666170726115639.
[9295]	S. Gilpin, “The influence of vapor pressure of chemicals on dermal penetration,” Rev Environ Health, vol. 29, no. 3, pp. 181–184, 2014, doi: 10.1515/reveh-2014-0056.
[9296]	G. Sorek et al., “The integrated functions of the cardiac autonomic and vestibular/oculomotor systems in adolescents following severe traumatic brain injury and typically developing controls,” Brain Inj, pp. 1–9, Aug. 2020, doi: 10.1080/02699052.2020.1807055.
[9297]	S. D. L. Postnikoff, J. E. Johnson, and J. K. Tyler, “The integrated stress response in budding yeast lifespan extension,” Microb Cell, vol. 4, no. 11, pp. 368–375, Oct. 2017, doi: 10.15698/mic2017.11.597.
[9298]	B. J. Blaauboer, “The integration of data on physico-chemical properties, in vitro-derived toxicity data and physiologically based kinetic and dynamic as modelling a tool in hazard and risk assessment. A commentary,” Toxicol. Lett., vol. 138, no. 1–2, pp. 161–171, Feb. 2003, doi: 10.1016/s0378-4274(02)00367-3.
[9299]	C. Steingröver, N. Wattie, J. Baker, W. F. Helsen, and J. Schorer, “The interaction between constituent year and within-1-year effects in elite German youth basketball,” Scand J Med Sci Sports, vol. 27, no. 6, pp. 627–633, Jun. 2017, doi: 10.1111/sms.12672.
[9300]	M. B. Lewis, “The interactions between botulinum-toxin-based facial treatments and embodied emotions,” Sci Rep, vol. 8, no. 1, p. 14720, 03 2018, doi: 10.1038/s41598-018-33119-1.
[9301]	F. Seligman and C. B. Nemeroff, “The interface of depression and cardiovascular disease: therapeutic implications,” Ann. N. Y. Acad. Sci., vol. 1345, pp. 25–35, May 2015, doi: 10.1111/nyas.12738.
[9302]	“The International Health Regulations (IHR) – 10 years of global public health  security,” Wkly. Epidemiol. Rec., vol. 92, no. 23, pp. 321–323, 09 2017.
[9303]	H. Hasle et al., “The International Prognostic Scoring System (IPSS) for childhood myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML),” Leukemia, vol. 18, no. 12, pp. 2008–2014, Dec. 2004, doi: 10.1038/sj.leu.2403489.
[9304]	S. Das, D. Sarkar, and B. Das, “The interplay between transcription and mRNA degradation in Saccharomyces cerevisiae,” Microb Cell, vol. 4, no. 7, pp. 212–228, Jul. 2017, doi: 10.15698/mic2017.07.580.
[9305]	I. Zusman and D. Beniashvili, “The interspecies sensitivity to transplacental effects of carcinogens,” In Vivo, vol. 15, no. 1, pp. 93–99, Feb. 2001.
[9306]	E. P. Allain, L. H. Boudreau, N. Flamand, and M. E. Surette, “The Intracellular Localisation and Phosphorylation Profile of the Human 5-Lipoxygenase Δ13 Isoform Differs from That of Its Full Length Counterpart,” PLoS ONE, vol. 10, no. 7, p. e0132607, 2015, doi: 10.1371/journal.pone.0132607.
[9307]	G. Langlhofer and C. Villmann, “The Intracellular Loop of the Glycine Receptor: It’s not all about the Size,” Front Mol Neurosci, vol. 9, p. 41, 2016, doi: 10.3389/fnmol.2016.00041.
[9308]	J. Y. Kresh, M. A. Cobanoglu, and S. K. Brockman, “The intramyocardial pressure: a parameter of heart contractility,” J Heart Transplant, vol. 4, no. 2, pp. 241–246, Feb. 1985.
[9309]	Z. Chen, R.-L. Li, and S.-H. Tu, “[The investigation and progress of the cellular and molecular biological mechanisms of Tripterygium wilfordii in treating rheumatoid arthritis],” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 29, no. 2, pp. 183–186, Feb. 2009.
[9310]	B. Brunetto et al., “The ISS Sensitizing Agents Data Bank (BDS),” Ann. Ist. Super. Sanita, vol. 44, no. 1, pp. 64–74, 2008.
[9311]	G. Bortoluzzi and A. Palese, “The Italian economic crisis and its impact on nursing services and education: hard and challenging times,” J Nurs Manag, vol. 18, no. 5, pp. 515–519, Jul. 2010, doi: 10.1111/j.1365-2834.2010.01128.x.
[9312]	O. R. Herber, S. Wilm, A. Fiege, N. Ernstmann, H. Pfaff, and A. Icks, “[The Junior Research Academy 2017 of the German Research Foundation (DFG) - Promotion of Young Researchers in Health Services],” Gesundheitswesen, Feb. 2020, doi: 10.1055/a-1082-0966.
[9313]	K. Yada et al., “The Kampo medicine ‘Daikenchuto (TU-100)’ prevents bacterial translocation and hepatic fibrosis in a rat model of biliary atresia,” Surgery, vol. 159, no. 6, pp. 1600–1611, 2016, doi: 10.1016/j.surg.2016.02.002.
[9314]	J. R. Phelps, S. V. Siemers, and R. S. El-Mallakh, “The ketogenic diet for type II bipolar disorder,” Neurocase, vol. 19, no. 5, pp. 423–426, 2013, doi: 10.1080/13554794.2012.690421.
[9315]	M. Yu, G. S. Chasson, M. Wang, Y. Zhu, Q. Xu, and J. Wang, “The latent profile analysis of Chinese adolescents’ anxiety: Examination and validation,” J Anxiety Disord, vol. 59, pp. 74–81, 2018, doi: 10.1016/j.janxdis.2018.09.005.
[9316]	A. Y. Fan, “The legendary life of Dr. Gim Shek Ju, the founding father of the education of acupuncture and Chinese medicine in the United States,” J Integr Med, vol. 14, no. 3, pp. 159–164, May 2016, doi: 10.1016/S2095-4964(16)60260-1.
[9317]	L. Zhou, A. J. van Heel, and O. P. Kuipers, “The length of a lantibiotic hinge region has profound influence on antimicrobial activity and host specificity,” Front Microbiol, vol. 6, p. 11, 2015, doi: 10.3389/fmicb.2015.00011.
[9318]	R. Amini, K. H. Chee, J. Swan, M. Mendieta, and T. Williams, “The Level of Cognitive Impairment and Likelihood of Frequent Hospital Admissions,” J Aging Health, vol. 31, no. 6, pp. 967–988, 2019, doi: 10.1177/0898264317747078.
[9319]	S. Grossberg, “The link between brain learning, attention, and consciousness,” Conscious Cogn, vol. 8, no. 1, pp. 1–44, Mar. 1999, doi: 10.1006/ccog.1998.0372.
[9320]	P. Cocco, “The long and winding road from silica exposure to silicosis and other health effects,” Occup Environ Med, vol. 60, no. 3, pp. 157–158, Mar. 2003, doi: 10.1136/oem.60.3.157.
[9321]	X. Wang et al., “The Long Noncoding RNA, LINC01555, Promotes Invasion and Metastasis of Colorectal Cancer by Activating the Neuropeptide, Neuromedin U,” Med. Sci. Monit., vol. 25, pp. 4014–4024, May 2019, doi: 10.12659/MSM.916508.
[9322]	D. Rosner, “The long struggle to protect workers’ lungs against silicosis,” Milbank Q, vol. 92, no. 2, pp. 191–194, Jun. 2014, doi: 10.1111/1468-0009.12051.
[9323]	A. Dallas and P. B. Moore, “The loop E-loop D region of Escherichia coli 5S rRNA: the solution structure reveals an unusual loop that may be important for binding ribosomal proteins,” Structure, vol. 5, no. 12, pp. 1639–1653, Dec. 1997, doi: 10.1016/s0969-2126(97)00311-0.
[9324]	D. Wood-Smith and J. M. Converse, “The lop ear deformity,” Surg. Clin. North Am., vol. 51, no. 2, pp. 417–427, Apr. 1971, doi: 10.1016/s0039-6109(16)39386-0.
[9325]	R. Southworth, S. C. Blackburn, K. a. B. Davey, G. K. Sharland, and P. B. Garlick, “The low oxygen-carrying capacity of Krebs buffer causes a doubling in ventricular wall thickness in the isolated heart,” Can. J. Physiol. Pharmacol., vol. 83, no. 2, pp. 174–182, Feb. 2005, doi: 10.1139/y04-138.
[9326]	C. W. Lee et al., “The lysosomal protein cathepsin L is a progranulin protease,” Mol Neurodegener, vol. 12, no. 1, p. 55, 25 2017, doi: 10.1186/s13024-017-0196-6.
[9327]	P. A. Lio, “The many faces of eczema and its treatments,” Ann. Allergy Asthma Immunol., vol. 120, no. 6, pp. 553–554, 2018, doi: 10.1016/j.anai.2018.04.018.
[9328]	C. Claussin and M. Chang, “The many facets of homologous recombination at telomeres,” Microb Cell, vol. 2, no. 9, pp. 308–321, Jul. 2015, doi: 10.15698/mic2015.09.224.
[9329]	D. A. Fair et al., “The maturing architecture of the brain’s default network,” Proc. Natl. Acad. Sci. U.S.A., vol. 105, no. 10, pp. 4028–4032, Mar. 2008, doi: 10.1073/pnas.0800376105.
[9330]	S. L. Hartmaier, P. D. Sloane, H. A. Guess, and G. G. Koch, “The MDS Cognition Scale: a valid instrument for identifying and staging nursing home residents with dementia using the minimum data set,” J Am Geriatr Soc, vol. 42, no. 11, pp. 1173–1179, Nov. 1994, doi: 10.1111/j.1532-5415.1994.tb06984.x.
[9331]	C. A. Figueroa et al., “The measurement of cognitive reactivity to sad mood in patients remitted from major depressive disorder,” Br J Clin Psychol, vol. 57, no. 3, pp. 313–327, Sep. 2018, doi: 10.1111/bjc.12175.
[9332]	R. Leib, A. Karniel, and F. A. Mussa-Ivaldi, “The Mechanical Representation of Temporal Delays,” Sci Rep, vol. 7, no. 1, p. 7669, 09 2017, doi: 10.1038/s41598-017-07289-3.
[9333]	H. Schjönsby, “The mechanism of vitamin B 12  malabsorption in blind-loop syndrome,” Scand. J. Gastroenterol., vol. 8, no. 2, pp. 97–99, 1973.
[9334]	S. Mehrabian, F. Letendre, and C. B. Cameron, “The mechanisms of filter feeding on oil droplets: Theoretical considerations,” Mar. Environ. Res., vol. 135, pp. 29–42, Apr. 2018, doi: 10.1016/j.marenvres.2018.01.006.
[9335]	N. Sutin, “The mechanisms of oxidation-reduction reactions in solution. BNL 50070 (T-469),” Tech Rep Brookhaven Natl Lab, vol. 67, pp. 1–8, Jun. 1967.
[9336]	I. McLaughlin, J. A. Dani, and M. De Biasi, “The medial habenula and interpeduncular nucleus circuitry is critical in addiction, anxiety, and mood regulation,” J. Neurochem., vol. 142 Suppl 2, pp. 130–143, 2017, doi: 10.1111/jnc.14008.
[9337]	A. C. Wenink, “The medial papillary complex,” Br Heart J, vol. 39, no. 9, pp. 1012–1018, Sep. 1977, doi: 10.1136/hrt.39.9.1012.
[9338]	R. Edwards, “The Medicaid trap,” Hosp Health Netw, vol. 84, no. 1, pp. 18–21, 1, Jan. 2010.
[9339]	G. Zara, F. Freilone, S. Veggi, E. Biondi, D. Ceccarelli, and S. Gino, “The medicolegal, psycho-criminological, and epidemiological reality of intimate partner and non-intimate partner femicide in North-West Italy: looking backwards to see forwards,” Int. J. Legal Med., vol. 133, no. 4, pp. 1295–1307, Jul. 2019, doi: 10.1007/s00414-019-02061-w.
[9340]	P. J. Meier-Abt, “The Meikirch Model of Health fits well into the concept of ‘personalized health,’” J Public Health Policy, vol. 35, no. 3, pp. 420–421, Aug. 2014, doi: 10.1057/jphp.2014.27.
[9341]	M. Bürgy, “[The melancholic-delusional depression as a disturbance of the drive],” Fortschr Neurol Psychiatr, vol. 88, no. 3, pp. 170–178, Mar. 2020, doi: 10.1055/a-0957-3226.
[9342]	Y. J. Huang and J. J. LiPuma, “The Microbiome in Cystic Fibrosis,” Clin. Chest Med., vol. 37, no. 1, pp. 59–67, Mar. 2016, doi: 10.1016/j.ccm.2015.10.003.
[9343]	D. P. Buxhoeveden and M. F. Casanova, “The minicolumn and evolution of the brain,” Brain Behav. Evol., vol. 60, no. 3, pp. 125–151, 2002, doi: 10.1159/000065935.
[9344]	M. Calabria et al., “The missing link between faces and names: evidence from Alzheimer’s disease patients,” Brain Cogn, vol. 80, no. 2, pp. 250–256, Nov. 2012, doi: 10.1016/j.bandc.2012.07.002.
[9345]	L. Capobianco, A. Ferramosca, and V. Zara, “The mitochondrial tricarboxylate carrier of silver eel: dimeric structure and cytosolic exposure of both N- and C-termini,” J. Protein Chem., vol. 21, no. 8, pp. 515–521, Nov. 2002, doi: 10.1023/a:1022473504904.
[9346]	Y. Xu et al., “The modulation effect of non-invasive brain stimulation on cognitive function in patients with mild cognitive impairment: a systematic review and meta-analysis of randomized controlled trials,” BMC Neurosci, vol. 20, no. 1, p. 2, Jan. 2019, doi: 10.1186/s12868-018-0484-2.
[9347]	C. Sun and B. Zhou, “The molecular and cellular action properties of artemisinins: what has yeast told us?,” Microb Cell, vol. 3, no. 5, pp. 196–205, Apr. 2016, doi: 10.15698/mic2016.05.498.
[9348]	D. H. Hopkins et al., “The molecular basis for the neofunctionalization of the juvenile hormone esterase duplication in Drosophila,” Insect Biochem. Mol. Biol., vol. 106, pp. 10–18, 2019, doi: 10.1016/j.ibmb.2019.01.001.
[9349]	L. Fischer et al., “The molecular mechanism of the inhibition by licofelone of the biosynthesis of 5-lipoxygenase products,” Br. J. Pharmacol., vol. 152, no. 4, pp. 471–480, Oct. 2007, doi: 10.1038/sj.bjp.0707416.
[9350]	E. Ginzberg, “The monetarization of medical care,” N. Engl. J. Med., vol. 310, no. 18, pp. 1162–1165, May 1984, doi: 10.1056/NEJM198405033101806.
[9351]	E. Borland, K. Nägga, P. M. Nilsson, L. Minthon, E. D. Nilsson, and S. Palmqvist, “The Montreal Cognitive Assessment: Normative Data from a Large Swedish Population-Based Cohort,” J. Alzheimers Dis., vol. 59, no. 3, pp. 893–901, 2017, doi: 10.3233/JAD-170203.
[9352]	N. Traub and D. Lichtstein, “The mood cycle hypothesis: possible involvement of steroid hormones in mood regulation by means of Na+, K+-ATPase inhibition,” J Basic Clin Physiol Pharmacol, vol. 11, no. 4, pp. 375–394, 2000, doi: 10.1515/jbcpp.2000.11.4.375.
[9353]	S. T. Liechty, D. C. Barnhart, J. T. Huber, S. Zobell, and M. D. Rollins, “The morbidity of a divided stoma compared to a loop colostomy in patients with anorectal malformation,” J. Pediatr. Surg., vol. 51, no. 1, pp. 107–110, Jan. 2016, doi: 10.1016/j.jpedsurg.2015.10.025.
[9354]	F. Chen and M. Stuart, “The morbidity of defunctioning stomata,” Aust N Z J Surg, vol. 66, no. 4, pp. 218–221, Apr. 1996, doi: 10.1111/j.1445-2197.1996.tb01168.x.
[9355]	M. A. Benito-Orfila, J. Domin, K. A. Nandha, and S. R. Bloom, “The motor effect of neuromedin U on rat stomach in vitro,” Eur. J. Pharmacol., vol. 193, no. 3, pp. 329–333, Feb. 1991, doi: 10.1016/0014-2999(91)90147-i.
[9356]	S. Jankowski et al., “The multi PAM2 protein Upa2 functions as novel core component of endosomal mRNA transport,” EMBO Rep., vol. 20, no. 9, p. e47381, 2019, doi: 10.15252/embr.201847381.
[9357]	J. N. Bugalhão and L. J. Mota, “The multiple functions of the numerous Chlamydia trachomatis secreted proteins: the tip of the iceberg,” Microb Cell, vol. 6, no. 9, pp. 414–449, Aug. 2019, doi: 10.15698/mic2019.09.691.
[9358]	A. E. Barrett and C. Robbins, “The multiple sources of women’s aging anxiety and their relationship with psychological distress,” J Aging Health, vol. 20, no. 1, pp. 32–65, Feb. 2008, doi: 10.1177/0898264307309932.
[9359]	E. Zimmerman and A. Lahav, “The multisensory brain and its ability to learn music,” Ann. N. Y. Acad. Sci., vol. 1252, pp. 179–184, Apr. 2012, doi: 10.1111/j.1749-6632.2012.06455.x.
[9360]	M. Lader, “The nature of anxiety,” Br J Psychiatry, vol. 121, no. 564, pp. 481–491, Nov. 1972.
[9361]	T. A. Brown, “The nature of generalized anxiety disorder and pathological worry: current evidence and conceptual models,” Can J Psychiatry, vol. 42, no. 8, pp. 817–825, Oct. 1997, doi: 10.1177/070674379704200803.
[9362]	A. C. Enthoven, “The need for fundamental reform through competition and rational economic incentives,” Issues Health Care, vol. 2, no. 1, pp. 2–7, 1981.
[9363]	D. Antai-Otong, “The neurobiology of anxiety disorders: implications for psychiatric nursing practice,” Issues Ment Health Nurs, vol. 21, no. 1, pp. 71–89, Feb. 2000, doi: 10.1080/016128400248275.
[9364]	M. A. DeTure and D. W. Dickson, “The neuropathological diagnosis of Alzheimer’s disease,” Mol Neurodegener, vol. 14, no. 1, p. 32, 02 2019, doi: 10.1186/s13024-019-0333-5.
[9365]	M. Moriyama et al., “The neuropeptide neuromedin U activates eosinophils and is involved in allergen-induced eosinophilia,” Am. J. Physiol. Lung Cell Mol. Physiol., vol. 290, no. 5, pp. L971-977, May 2006, doi: 10.1152/ajplung.00345.2005.
[9366]	S. M. Rao et al., “The neuropeptide neuromedin U promotes autoantibody-mediated arthritis,” Arthritis Res. Ther., vol. 14, no. 1, p. R29, Feb. 2012, doi: 10.1186/ar3732.
[9367]	M. Moriyama et al., “The neuropeptide neuromedin U promotes IL-6 production from macrophages and endotoxin shock,” Biochem. Biophys. Res. Commun., vol. 341, no. 4, pp. 1149–1154, Mar. 2006, doi: 10.1016/j.bbrc.2006.01.075.
[9368]	M. Moriyama et al., “The neuropeptide neuromedin U promotes inflammation by direct activation of mast cells,” J. Exp. Med., vol. 202, no. 2, pp. 217–224, Jul. 2005, doi: 10.1084/jem.20050248.
[9369]	J. A. Gray and N. McNaughton, “The neuropsychology of anxiety: reprise,” Nebr Symp Motiv, vol. 43, pp. 61–134, 1996.
[9370]	J. Banks, “The neurotechnological revolution: unlocking the brain’s secrets to develop innovative technologies as well as treatments for neurological diseases,” IEEE Pulse, vol. 6, no. 2, pp. 10–15, Apr. 2015, doi: 10.1109/MPUL.2014.2387031.
[9371]	J. Laskaris and K. Regan, “The new break-even analysis,” Healthc Financ Manage, vol. 67, no. 12, pp. 88–95, Dec. 2013.
[9372]	N. Sachs-Ericsson and D. G. Blazer, “The new DSM-5 diagnosis of mild neurocognitive disorder and its relation to research in mild cognitive impairment,” Aging Ment Health, vol. 19, no. 1, pp. 2–12, Jan. 2015, doi: 10.1080/13607863.2014.920303.
[9373]	A. N. Boyko et al., “[The new pegylated interferon beta-1a (sampeginterferon beta-1a, BCD-054) in the treatment of remitting multiple sclerosis],” Zh Nevrol Psikhiatr Im S S Korsakova, vol. 119, no. 10. Vyp. 2, pp. 100–109, 2019, doi: 10.17116/jnevro201911910100.
[9374]	M. Hummel, “[The new S3-guideline gestational diabetes],” MMW Fortschr Med, vol. 160, no. 19, pp. 64–66, 2018, doi: 10.1007/s15006-018-1091-y.
[9375]	M. Saresella et al., “The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease,” Mol Neurodegener, vol. 11, p. 23, Mar. 2016, doi: 10.1186/s13024-016-0088-1.
[9376]	H. Długońska, “The Nobel Prize 2015 in physiology or medicine for highly effective antiparasitic drugs,” Ann Parasitol, vol. 61, no. 4, pp. 299–301, 2015, doi: 10.17420/ap6104.23.
[9377]	Z. Belabess, M. Peterschmitt, M. Granier, A. Tahiri, A. Blenzar, and C. Urbino, “The non-canonical tomato yellow leaf curl virus recombinant that displaced its parental viruses in southern Morocco exhibits a high selective advantage in experimental conditions,” J. Gen. Virol., vol. 97, no. 12, pp. 3433–3445, Dec. 2016, doi: 10.1099/jgv.0.000633.
[9378]	Y.-R. Lee, S. Kwon, and B. J. Sung, “The non-classical kinetics and the mutual information of polymer loop formation,” J Chem Phys, vol. 152, no. 18, p. 184905, May 2020, doi: 10.1063/5.0005453.
[9379]	S. Xia, Y. Xu, R. Hoy, J. Zhang, L. Qin, and X. Li, “The Notorious Soilborne Pathogenic Fungus Sclerotinia sclerotiorum: An Update on Genes Studied with Mutant Analysis,” Pathogens, vol. 9, no. 1, Dec. 2019, doi: 10.3390/pathogens9010027.
[9380]	M. Herrero Fernandez et al., “The Off-Label Use of Antineoplastics in Oncology Is Limited But Has Notable Scientific Support in a University Hospital Setting,” Front Pharmacol, vol. 10, p. 1210, 2019, doi: 10.3389/fphar.2019.01210.
[9381]	R. P. Thompson et al., “The oldest, toughest cells in the heart,” Novartis Found. Symp., vol. 250, pp. 157–174; discussion 174-176, 276–279, 2003.
[9382]	J. Kido, N. Nishi, and T. Matsumoto, “The Oral Provocation Test for Raw Egg in Patients with Hen Egg Allergy,” Int. Arch. Allergy Immunol., vol. 177, no. 1, pp. 40–44, 2018, doi: 10.1159/000489098.
[9383]	A. M. Fulton, S. E. Adams, J. Mellor, S. M. Kingsman, and A. J. Kingsman, “The organization and expression of the yeast retrotransposon, Ty,” Microbiol. Sci., vol. 4, no. 6, pp. 180–185, Jun. 1987.
[9384]	K. Tsolov, “[The organization of, and achievements in the control of quartz dust and silicosis in the People’s Republic of Bulgaria],” Gig Tr Prof Zabol, vol. 11, no. 8, pp. 8–11, Aug. 1967.
[9385]	A. Mitchinson, “The origin of blue diamonds,” Nature, vol. 560, no. 7716, p. 35, 2018, doi: 10.1038/d41586-018-05830-6.
[9386]	M. Calvin, “The origin of life on earth and elsewhere,” Perspect. Biol. Med., vol. 5, pp. 399–422, 1962, doi: 10.1353/pbm.1962.0025.
[9387]	C. G. Hales, “The origins of the brain’s endogenous electromagnetic field and its relationship to provision of consciousness,” J. Integr. Neurosci., vol. 13, no. 2, pp. 313–361, Jun. 2014, doi: 10.1142/S0219635214400056.
[9388]	J. E. Rothhardt, C. Kröger, S. P. Broadley, and T. M. Fuchs, “The orphan regulator ReiD of Salmonella enterica is essential for myo-inositol utilization,” Mol. Microbiol., vol. 94, no. 3, pp. 700–712, Nov. 2014, doi: 10.1111/mmi.12788.
[9389]	D. Trail, E. B. Watson, and N. D. Tailby, “The oxidation state of Hadean magmas and implications for early Earth’s atmosphere,” Nature, vol. 480, no. 7375, pp. 79–82, Nov. 2011, doi: 10.1038/nature10655.
[9390]	A. R. Jones and C. Murcott, “The oxidative metabolism of alpha-chlorohydrin and the chemical induction of spermatocoeles,” Experientia, vol. 32, no. 9, pp. 1135–1136, Sep. 1976, doi: 10.1007/BF01927587.
[9391]	S. Papa et al., “The oxidative phosphorylation system in mammalian mitochondria,” Adv. Exp. Med. Biol., vol. 942, pp. 3–37, 2012, doi: 10.1007/978-94-007-2869-1_1.
[9392]	S. Leucht, W. Kissling, and J. M. Davis, “The PANSS should be rescaled,” Schizophr Bull, vol. 36, no. 3, pp. 461–462, May 2010, doi: 10.1093/schbul/sbq016.
[9393]	K. Wissemann, J. Y. Gorday, and A. Meyer, “The Parent Sensitivity to Child Anxiety Index,” Child Psychiatry Hum Dev, vol. 49, no. 5, pp. 814–821, 2018, doi: 10.1007/s10578-018-0797-5.
[9394]	A. Wolfovitz, A. B. Grobman, T. A. Babcock, and S. I. Angeli, “The pattern of hearing outcome following surgery of the semicircular canals,” Laryngoscope Investig Otolaryngol, vol. 4, no. 1, pp. 132–137, Feb. 2019, doi: 10.1002/lio2.239.
[9395]	G. Farrer-Brown and M. H. Tarbit, “The pattern of intramural veins of the left ventricle of the human heart,” Br Heart J, vol. 37, no. 1, pp. 85–93, Jan. 1975, doi: 10.1136/hrt.37.1.85.
[9396]	E. Pofeldt, “The payer merger effect: What it means for physicians,” Med Econ, vol. 92, no. 22, pp. 46–49, Nov. 2015.
[9397]	A. Vergnenègre, “[The payer, the T2A pathway, the physician, the patient: the exemple of thoracic oncology],” Rev Mal Respir, vol. 24, no. 8 Pt 2, pp. 6S216-221, Oct. 2007.
[9398]	F. Weitendorf and K. K. Reynolds, “The Pharmacist’s Perspective on Pharmacogenetics Implementation,” Clin. Lab. Med., vol. 36, no. 3, pp. 543–556, Sep. 2016, doi: 10.1016/j.cll.2016.05.009.
[9399]	G. W. Mihaly, R. G. Moore, J. Thomas, E. J. Triggs, D. Thomas, and C. A. Shanks, “The pharmacokinetics and metabolism of the anilide local anaesthetics in neonates. I. Lignocaine,” Eur. J. Clin. Pharmacol., vol. 13, no. 2, pp. 143–152, May 1978, doi: 10.1007/BF00609759.
[9400]	D. J. Nutt, “The pharmacology of human anxiety,” Pharmacol. Ther., vol. 47, no. 2, pp. 233–266, 1990, doi: 10.1016/0163-7258(90)90089-k.
[9401]	J. G. Gunderson and A. N. Sabo, “The phenomenological and conceptual interface between borderline personality disorder and PTSD,” Am J Psychiatry, vol. 150, no. 1, pp. 19–27, Jan. 1993, doi: 10.1176/ajp.150.1.19.
[9402]	K. Kroenke, T. W. Strine, R. L. Spitzer, J. B. W. Williams, J. T. Berry, and A. H. Mokdad, “The PHQ-8 as a measure of current depression in the general population,” J Affect Disord, vol. 114, no. 1–3, pp. 163–173, Apr. 2009, doi: 10.1016/j.jad.2008.06.026.
[9403]	G. Angelini, D. Ganora, G. Francesetti, and A. Meluzzi, “[The physiognomic semeiotics of anxiety. A critical review],” Minerva Med., vol. 82, no. 4, pp. 217–219, Apr. 1991.
[9404]	B. R. K. Roller and T. M. Schmidt, “The physiology and ecological implications of efficient growth,” ISME J, vol. 9, no. 7, pp. 1481–1487, Jul. 2015, doi: 10.1038/ismej.2014.235.
[9405]	T. Severin and D. L. Erdner, “The Phytoplankton Taxon-Dependent Oil Response and Its Microbiome: Correlation but Not Causation,” Front Microbiol, vol. 10, p. 385, 2019, doi: 10.3389/fmicb.2019.00385.
[9406]	C. Graf, “The Pillars of Publication Ethics and Research Integrity: Spread the Word,” Chin. Med. J., vol. 130, no. 12, pp. 1502–1504, Jun. 2017, doi: 10.4103/0366-6999.207483.
[9407]	V. Gente and G. Pattanaro, “The place of eco-innovation in the current sustainability debate,” Waste Manag, vol. 88, pp. 96–101, Apr. 2019, doi: 10.1016/j.wasman.2019.03.026.
[9408]	M. Semis, G. B. Gugiu, E. A. Bernstein, K. E. Bernstein, and M. Kalkum, “The Plethora of Angiotensin-Converting Enzyme-Processed Peptides in Mouse Plasma,” Anal. Chem., vol. 91, no. 10, pp. 6440–6453, 21 2019, doi: 10.1021/acs.analchem.8b03828.
[9409]	V. Martinovich, “[The political dimension of open access: knowledge as a public good or as a commodity?],” Salud Colect, vol. 11, no. 3, pp. 297–300, Sep. 2015, doi: 10.1590/S1851-82652015000300001.
[9410]	C. M. Wilke, E. Maimer, and J. Adams, “The population biology and evolutionary significance of Ty elements in Saccharomyces cerevisiae,” Genetica, vol. 86, no. 1–3, pp. 155–173, 1992, doi: 10.1007/BF00133718.
[9411]	C. Coutts, A. Forkink, and J. Weiner, “The portrayal of natural environment in the evolution of the ecological public health paradigm,” Int J Environ Res Public Health, vol. 11, no. 1, pp. 1005–1019, Jan. 2014, doi: 10.3390/ijerph110101005.
[9412]	M. Olff, “[The post-traumatic stress disorder],” Ned Tijdschr Geneeskd, vol. 157, no. 26, p. A5818, 2013.
[9413]	V. Fallon, J. C. G. Halford, K. M. Bennett, and J. A. Harrold, “The Postpartum Specific Anxiety Scale: development and preliminary validation,” Arch Womens Ment Health, vol. 19, no. 6, pp. 1079–1090, 2016, doi: 10.1007/s00737-016-0658-9.
[9414]	J. A. Lyons, J. M. Caddell, R. L. Pittman, R. Rawls, and S. Perrin, “The potential for faking on the Mississippi Scale for Combat-Related PTSD,” J Trauma Stress, vol. 7, no. 3, pp. 441–445, Jul. 1994, doi: 10.1007/BF02102788.
[9415]	G. Eisenbrand and Senate Commission on Food Safety (SKLM) of the German Research Foundation (DFG), “The potential involvement of glutamate ingestion in chronic neurodegenerative diseases. Opinion of the Senate Commission on Food Safety (SKLM) of the German Research Foundation (DFG)-(shortened version),” Mol Nutr Food Res, vol. 50, no. 12, pp. 1239–1243, Dec. 2006, doi: 10.1002/mnfr.200600205.
[9416]	B. Shibulal, S. N. Al-Bahry, Y. M. Al-Wahaibi, A. E. Elshafie, A. S. Al-Bemani, and S. J. Joshi, “The potential of indigenous Paenibacillus ehimensis BS1 for recovering heavy crude oil by biotransformation to light fractions,” PLoS ONE, vol. 12, no. 2, p. e0171432, 2017, doi: 10.1371/journal.pone.0171432.
[9417]	M. Boland, J. K. Rielage, and T. Hoyt, “The power of negative mood in predicting posttraumatic stress disorder and alcohol abuse comorbidity,” Psychol Trauma, vol. 10, no. 5, pp. 572–575, Sep. 2018, doi: 10.1037/tra0000322.
[9418]	D. P. Kumar et al., “The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease,” Sci Rep, vol. 10, no. 1, p. 9330, Jun. 2020, doi: 10.1038/s41598-020-66458-z.
[9419]	A. Nomura and T. Takahashi, “The practical aspects of quality assurance in Good Laboratory Practice studies in an emergency situation,” Qual Assur, vol. 4, no. 4, pp. 366–373, Dec. 1995.
[9420]	E. K. Covan, “The precarious state of mental health,” Health Care Women Int, vol. 30, no. 7, p. 571, Jul. 2009, doi: 10.1080/07399330903028970.
[9421]	I. T. Cousins, R. Vestergren, Z. Wang, M. Scheringer, and M. S. McLachlan, “The precautionary principle and chemicals management: The example of perfluoroalkyl acids in groundwater,” Environ Int, vol. 94, pp. 331–340, Sep. 2016, doi: 10.1016/j.envint.2016.04.044.
[9422]	W. Pfaller, P. Prieto, W. Dekant, P. Jennings, and B. J. Blaauboer, “The Predict-IV project: Towards predictive toxicology using in vitro techniques,” Toxicol In Vitro, vol. 30, no. 1 Pt A, pp. 1–3, Dec. 2015, doi: 10.1016/j.tiv.2015.10.006.
[9423]	C.-Y. Chang et al., “The Predictor of Mortality within Six-Months in Patients with Spontaneous Cerebellar Hemorrhage: A Retrospective Study,” PLoS ONE, vol. 10, no. 7, p. e0132975, 2015, doi: 10.1371/journal.pone.0132975.
[9424]	D. J. Keating, H. Peiris, M. Kyloh, S. J. H. Brookes, and N. J. Spencer, “The presence of 5-HT in myenteric varicosities is not due to uptake of 5-HT released from the mucosa during dissection: use of a novel method for quantifying 5-HT immunoreactivity in myenteric ganglia,” Neurogastroenterol. Motil., vol. 25, no. 10, pp. 849–853, Oct. 2013, doi: 10.1111/nmo.12189.
[9425]	J. Harrison et al., “The Presence of Histamine and a Histamine Receptor in the Bivalve Mollusc, Crassostrea virginica,” In Vivo (Brooklyn), vol. 36, no. 3, pp. 123–130, 2015.
[9426]	W. R. Klein, V. P. Rutten, P. A. Steerenberg, and E. J. Ruitenberg, “The present status of BCG treatment in the veterinary practice,” In Vivo, vol. 5, no. 6, pp. 605–608, Dec. 1991.
[9427]	A. C. McFarlane, “The prevalence and longitudinal course of PTSD. Implications for the neurobiological models of PTSD,” Ann. N. Y. Acad. Sci., vol. 821, pp. 10–23, Jun. 1997, doi: 10.1111/j.1749-6632.1997.tb48265.x.
[9428]	A. Payne, A. Kralj, J. Young, and R. Meiser-Stedman, “The prevalence of intrusive memories in adult depression: A meta-analysis,” J Affect Disord, vol. 253, pp. 193–202, Apr. 2019, doi: 10.1016/j.jad.2019.04.055.
[9429]	H. Greenberg, S. U. Raymond, and S. R. Leeder, “The Prevention of Global Chronic Disease: Academic Public Health’s New Frontier,” Am J Public Health, vol. 101, no. 8, pp. 1386–1390, Aug. 2011, doi: 10.2105/AJPH.2011.300147.
[9430]	S. Bjerkestrand, “[The price of greediness],” Tidsskr. Nor. Laegeforen., vol. 131, no. 15, p. 1411, Aug. 2011, doi: 10.4045/tidsskr.11.15E1.
[9431]	A. S. Santos, A. A. Guerra-Junior, K. V. M. de S. Noronha, M. V. Andrade, and C. M. Ruas, “The Price of Substitute Technologies,” Value Health Reg Issues, vol. 20, pp. 154–158, Dec. 2019, doi: 10.1016/j.vhri.2019.08.474.
[9432]	E. Caspari, “The problem of development. BNL 976 (T-411),” Tech Rep Brookhaven Natl Lab, pp. 1–12, Apr. 1964.
[9433]	L. Bowleg, “The problem with the phrase women and minorities: intersectionality-an important theoretical framework for public health,” Am J Public Health, vol. 102, no. 7, pp. 1267–1273, Jul. 2012, doi: 10.2105/AJPH.2012.300750.
[9434]	M. Vaughan, “The production and release of glycerol by adipose tissue incubated in vitro,” J. Biol. Chem., vol. 237, pp. 3354–3358, Nov. 1962.
[9435]	M. H. Malim, S. E. Adams, K. Gull, A. J. Kingsman, and S. M. Kingsman, “The production of hybrid Ty:IFN virus-like particles in yeast,” Nucleic Acids Res., vol. 15, no. 18, pp. 7571–7580, Sep. 1987, doi: 10.1093/nar/15.18.7571.
[9436]	C. Haug, “[The profit roundabout],” Tidsskr. Nor. Laegeforen., vol. 127, no. 9, p. 1173, May 2007.
[9437]	Q. Li et al., “The prognostic value of neuromedin U in patients with hepatocellular carcinoma,” BMC Cancer, vol. 20, no. 1, p. 95, Feb. 2020, doi: 10.1186/s12885-020-6532-1.
[9438]	K. Y. Park, W. T. Kim, and E. Y. Kim, “The proper localization of RESPONSIVE TO DESICCATION 20 in lipid droplets depends on their biogenesis induced by STRESS-RELATED PROTEINS in vegetative tissues,” Biochem. Biophys. Res. Commun., vol. 495, no. 2, pp. 1885–1889, 08 2018, doi: 10.1016/j.bbrc.2017.12.068.
[9439]	S. Fujiwara, K. Takemine, H. Kakiuchi, S. Tsujimoto, and C. Tashiro, “[The proper size of bronchial tube for pediatric differential lung ventilation using laryngeal mask airway],” Masui, vol. 53, no. 2, pp. 137–142, Feb. 2004.
[9440]	J. Ning, L. Xu, Q. Zhao, Y.-Y. Zhang, and C.-Q. Shen, “The Protective Effects of Terpinen-4-ol on LPS-Induced Acute Lung Injury via Activating PPAR-γ,” Inflammation, vol. 41, no. 6, pp. 2012–2017, Dec. 2018, doi: 10.1007/s10753-018-0844-1.
[9441]	S. Marlan, “The psychologist who is not a psychologist: a deconstructive reading of Wolfgang Giegerich’s idea of psychology proper,” J Anal Psychol, vol. 61, no. 2, pp. 223–238, Apr. 2016, doi: 10.1111/1468-5922.12212.
[9442]	R. G. Cook, R. R. Rich, and L. Flaherty, “The Qa-1 alloantigens. I. Identification and molecular weight characterization of glycoproteins controlled by the Qa-1a and Qa-1b alleles,” J. Immunol., vol. 127, no. 5, pp. 1894–1898, Nov. 1981.
[9443]	R. G. Cook, R. N. Jenkins, L. Flaherty, and R. R. Rich, “The Qa-1 alloantigens. II. Evidence for the expression of two Qa-1 molecules by the Qa-1d genotype and for cross-reactivity between Qa-1 and H-2K,” J. Immunol., vol. 130, no. 3, pp. 1293–1299, Mar. 1983.
[9444]	N. F. Landolfi, R. R. Rich, and R. G. Cook, “The Qa-1 alloantigens. III. Biochemical analysis of the structure and extent of polymorphism of the Qa-1 allelic products,” J. Immunol., vol. 135, no. 2, pp. 1264–1270, Aug. 1985.
[9445]	T. H. Stanton et al., “The Qa-1 antigenic system. Relation of Qa-1 phenotypes to lymphocyte sets, mitogen responses, and immune functions,” J. Exp. Med., vol. 148, no. 4, pp. 963–973, Oct. 1978, doi: 10.1084/jem.148.4.963.
[9446]	J. Forman, J. Trial, S. Tonkonogy, and L. Flaherty, “The Qa2 subregion controls the expression of two antigens recognized by H-2-unrestricted cytotoxic T cells,” J. Exp. Med., vol. 155, no. 3, pp. 749–767, Mar. 1982, doi: 10.1084/jem.155.3.749.
[9447]	C. A. Elith, S. E. Dempsey, F. Cao, A. Farshadi, and H. M. Warren-Forward, “The quality assurance of volumetric modulated arc therapy (VMAT) plans for early stage prostate cancer: a technical note,” J Med Radiat Sci, vol. 61, no. 4, pp. 261–266, Dec. 2014, doi: 10.1002/jmrs.78.
[9448]	S. Anderson, W. Qiu, and S. J. Wheeler, “THE QUALITY OF FATHER-CHILD ROUGH-AND-TUMBLE PLAY AND TODDLERS’ AGGRESSIVE BEHAVIOR IN CHINA,” Infant Ment Health J, vol. 38, no. 6, pp. 726–742, 2017, doi: 10.1002/imhj.21675.
[9449]	O. Goh, G. Lai, T. M. Tu, and K. E. Lee, “The quest to prevent stroke in atrial fibrillation: fighting the fluttering heart in Singapore,” Neurology, vol. 82, no. 22, pp. 2034–2036, Jun. 2014, doi: 10.1212/WNL.0000000000000466.
[9450]	M. V. Pauly, “The Questionable Economic Case for Value-Based Drug Pricing in Market Health Systems,” Value Health, vol. 20, no. 2, pp. 278–282, 2017, doi: 10.1016/j.jval.2016.11.017.
[9451]	T. Stigbrand, “The rapidly changing landscape of scientific publishing,” Tumour Biol., vol. 39, no. 1, p. 1010428316687894, Jan. 2017, doi: 10.1177/1010428316687894.
[9452]	J. W. Gratama, M. Keeney, D. R. Sutherland, and S. Papa, “The real CD34+ events: simplicity versus accuracy and flexibility,” Exp. Hematol., vol. 27, no. 6, pp. 975–977, Jun. 1999, doi: 10.1016/s0301-472x(99)00047-8.
[9453]	S. N. Shapovalov, “[The reasons for the «space» of gerontology: the impact of the movements of the Earth and Moon on the performance of the human environment],” Adv Gerontol, vol. 29, no. 1, pp. 11–22, 2016.
[9454]	R. Rechtman, “The rebirth of PTSD: the rise of a new paradigm in psychiatry,” Soc Psychiatry Psychiatr Epidemiol, vol. 39, no. 11, pp. 913–915, Nov. 2004, doi: 10.1007/s00127-004-0874-x.
[9455]	Y. Saruhashi, Y. Matsusue, and M. Fujimiya, “The recovery of 5-HT transporter and 5-HT immunoreactivity in injured rat spinal cord,” Arch Orthop Trauma Surg, vol. 129, no. 9, pp. 1279–1285, Sep. 2009, doi: 10.1007/s00402-008-0754-z.
[9456]	M. Devitt and N. Porot, “The Reference of Proper Names: Testing Usage and Intuitions,” Cogn Sci, Apr. 2018, doi: 10.1111/cogs.12609.
[9457]	Y. Kaneda and A. Fujii, “The relation between anxiety and depressive symptoms in normal subjects and patients with anxiety and/or mood disorders,” J. Med. Invest., vol. 47, no. 1–2, pp. 14–18, Feb. 2000.
[9458]	D. Topal, V. Göral, F. Yilmaz, and I. H. Kara, “The relation of Helicobacter pylori with intestinal metaplasia, gastric atrophy and BCL-2,” Turk J Gastroenterol, vol. 15, no. 3, pp. 149–155, Sep. 2004.
[9459]	S. Marcus, L. T. Roland, J. M. DelGaudio, and S. K. Wise, “The relationship between allergy and chronic rhinosinusitis,” Laryngoscope Investig Otolaryngol, vol. 4, no. 1, pp. 13–17, Feb. 2019, doi: 10.1002/lio2.236.
[9460]	S. Pandeya and R. M. Lindsay, “The relationship between cardiac output and access flow during hemodialysis,” ASAIO J., vol. 45, no. 3, pp. 135–138, Jun. 1999, doi: 10.1097/00002480-199905000-00006.
[9461]	O. Ekinci, G. K. Ugurlu, Y. Albayrak, M. Arslan, and A. Caykoylu, “The relationship between cognitive insight, clinical insight, and depression in patients with schizophrenia,” Compr Psychiatry, vol. 53, no. 2, pp. 195–200, Feb. 2012, doi: 10.1016/j.comppsych.2011.02.010.
[9462]	D. J. Kerr and H. E. Smart, “The relationship between cytotoxic drug exposure and tumour cell kill, in vitro and in vivo,” In Vivo, vol. 5, no. 4, pp. 385–388, Aug. 1991.
[9463]	I. M. Aderka, C. Beard, J. Lee, R. B. Weiss, and T. Björgvinsson, “The relationship between depression and generalized anxiety during intensive psychological and pharmacological treatment,” J Affect Disord, vol. 184, pp. 261–268, Sep. 2015, doi: 10.1016/j.jad.2015.05.054.
[9464]	C. Hingray, A. McGonigal, I. Kotwas, and J.-A. Micoulaud-Franchi, “The Relationship Between Epilepsy and Anxiety Disorders,” Curr Psychiatry Rep, vol. 21, no. 6, p. 40, 29 2019, doi: 10.1007/s11920-019-1029-9.
[9465]	E. S. Tung, M. G. Tung, E. M. Altenburger, D. L. Pauls, and N. J. Keuthen, “The relationship between hair pulling style and quality of life,” Ann Clin Psychiatry, vol. 26, no. 3, pp. 193–198, Aug. 2014.
[9466]	H. Hou, H. Meng, W. Hu, and J. Wang, “[The relationship between Helicobacter pylori in oral cavity and the Hp infection in stomach],” Zhonghua Kou Qiang Yi Xue Za Zhi, vol. 38, no. 5, pp. 327–329, Sep. 2003.
[9467]	I. K. Choi, H. J. Sung, J.-H. Lee, J. S. Kim, and J. H. Seo, “The relationship between Helicobacter pylori infection and the effects of chemotherapy in patients with advanced or metastatic gastric cancer,” Cancer Chemother. Pharmacol., vol. 70, no. 4, pp. 555–558, Oct. 2012, doi: 10.1007/s00280-012-1944-5.
[9468]	M. Agin, Y. Kayar, and R. Dertli, “The relationship between mean platelet volume and platelet levels of children with Helicobacter pylori and gastritis,” Prz Gastroenterol, vol. 14, no. 3, pp. 198–201, 2019, doi: 10.5114/pg.2019.88169.
[9469]	M. Claycomb et al., “The relationship between negative expressivity, anger, and PTSD symptom clusters,” Psychiatry Res, vol. 243, pp. 1–4, Sep. 2016, doi: 10.1016/j.psychres.2016.06.012.
[9470]	S. Senan, R. M. Msetfi, M. El Keshky, and Y. Halbrook, “The relationship between perception of control and mood: The intervening effect of cultural values in a Saudi Arabian sample,” PLoS ONE, vol. 14, no. 8, p. e0220509, 2019, doi: 10.1371/journal.pone.0220509.
[9471]	I. Alat, “The relationship between Raynaud’s phenomenon and Helicobacter pylori,” Bratisl Lek Listy, vol. 120, no. 11, pp. 827–831, 2019, doi: 10.4149/BLL_2019_137.
[9472]	A. Gigantesco et al., “The Relationship Between Satisfaction With Life and Depression Symptoms by Gender,” Front Psychiatry, vol. 10, p. 419, 2019, doi: 10.3389/fpsyt.2019.00419.
[9473]	Y. Bulbul, S. Ayik, F. Oztuna, T. Ozlu, and S. Sahin, “The relationship between socio-demographic characteristics of patients and diagnostic delay in acute pulmonary thromboembolism,” Ups. J. Med. Sci., vol. 116, no. 1, pp. 72–76, Mar. 2011, doi: 10.3109/03009734.2010.530701.
[9474]	S. M. Bayram, G. Gürsoy, A. Araz Güngör, F. Güngör, and E. Atalay, “The relationship of mean platelet volume with microalbuminuriain type 2 diabetic patients,” Turk J Med Sci, vol. 46, no. 2, pp. 251–258, Feb. 2016, doi: 10.3906/sag-1410-94.
[9475]	T. Krieger, T. Berger, and M. G. Holtforth, “The relationship of self-compassion and depression: Cross-lagged panel analyses in depressed patients after outpatient therapy,” J Affect Disord, vol. 202, pp. 39–45, Sep. 2016, doi: 10.1016/j.jad.2016.05.032.
[9476]	Y. Wang et al., “The release and trans-synaptic transmission of Tau via exosomes,” Mol Neurodegener, vol. 12, no. 1, p. 5, 13 2017, doi: 10.1186/s13024-016-0143-y.
[9477]	T. V. Smulders, “The relevance of brain evolution for the biomedical sciences,” Biol. Lett., vol. 5, no. 1, pp. 138–140, Feb. 2009, doi: 10.1098/rsbl.2008.0521.
[9478]	F. Coulston, “The relevance to humans of animal models for inhalation studies of cancer in the nose and upper airways,” Qual Assur, vol. 2, no. 3, pp. 211–212, Sep. 1993.
[9479]	O. P. Zakharova, V. A. Kubyshkin, and G. G. Karmazanovskiĭ, “[The requirement for the CT-scan protocol for the proper assessment of pancreatic tumors resectability],” Khirurgiia (Mosk), no. 8, pp. 44–50, 2012.
[9480]	G. B. Huffnagle, R. P. Dickson, and N. W. Lukacs, “The respiratory tract microbiome and lung inflammation: a two-way street,” Mucosal Immunol, vol. 10, no. 2, pp. 299–306, 2017, doi: 10.1038/mi.2016.108.
[9481]	Y. Dong, Z. Wang, H. Sun, W. Yang, and H. Xu, “The Response Patterns of Arbuscular Mycorrhizal and Ectomycorrhizal Symbionts Under Elevated CO2: A Meta-Analysis,” Front Microbiol, vol. 9, p. 1248, 2018, doi: 10.3389/fmicb.2018.01248.
[9482]	J. L. Leslie and V. B. Young, “The rest of the story: the microbiome and gastrointestinal infections,” Curr. Opin. Microbiol., vol. 23, pp. 121–125, Feb. 2015, doi: 10.1016/j.mib.2014.11.010.
[9483]	M. E. Raichle, “The restless brain,” Brain Connect, vol. 1, no. 1, pp. 3–12, 2011, doi: 10.1089/brain.2011.0019.
[9484]	P. Léger, “[The Revue becomes Journal of Stomatology Oral and Maxillofacial Surgery],” Rev Stomatol Chir Maxillofac Chir Orale, vol. 117, no. 5, pp. 303–305, Nov. 2016, doi: 10.1016/j.revsto.2016.10.001.
[9485]	A. Soutschek, M. Moisa, C. C. Ruff, and P. N. Tobler, “The right temporoparietal junction enables delay of gratification by allowing decision makers to focus on future events,” PLoS Biol., vol. 18, no. 8, p. e3000800, Aug. 2020, doi: 10.1371/journal.pbio.3000800.
[9486]	N. Tessitore, V. Bedogna, G. Verlato, and A. Poli, “The rise and fall of access blood flow surveillance in arteriovenous fistulas,” Semin Dial, vol. 27, no. 2, pp. 108–118, Mar. 2014, doi: 10.1111/sdi.12187.
[9487]	G. A. Beller, “The rising cost of health care in the United States: is it making the United States globally noncompetitive?,” J Nucl Cardiol, vol. 15, no. 4, pp. 481–482, Aug. 2008, doi: 10.1016/j.nuclcard.2008.06.001.
[9488]	P. L. Lu, M. Moore-Clingenpeel, D. Yacob, C. Di Lorenzo, and H. M. Mousa, “The rising cost of hospital care for children with gastroparesis: 2004-2013,” Neurogastroenterol. Motil., vol. 28, no. 11, pp. 1698–1704, Nov. 2016, doi: 10.1111/nmo.12869.
[9489]	N. Chokr, R. Patel, K. Wattamwar, and S. Chokr, “The Rising Era of Immune Checkpoint Inhibitors in Myelodysplastic Syndromes,” Adv Hematol, vol. 2018, p. 2458679, 2018, doi: 10.1155/2018/2458679.
[9490]	C. Moret, B. Grimaldi, O. Massot, and G. Fillion, “The role and therapeutic potential of 5-HT-moduline in psychiatry,” Semin Clin Neuropsychiatry, vol. 8, no. 2, pp. 137–146, Apr. 2003, doi: 10.1053/scnp.2003.50013.
[9491]	C. L. Qu, F. Q. Huo, F. S. Huang, Y. Q. Li, J. S. Tang, and H. Jia, “The role of 5-HT receptor subtypes in the ventrolateral orbital cortex of 5-HT-induced antinociception in the rat,” Neuroscience, vol. 152, no. 2, pp. 487–494, Mar. 2008, doi: 10.1016/j.neuroscience.2007.09.036.
[9492]	S. O. Ogren et al., “The role of 5-HT(1A) receptors in learning and memory,” Behav. Brain Res., vol. 195, no. 1, pp. 54–77, Dec. 2008, doi: 10.1016/j.bbr.2008.02.023.
[9493]	K. Krebs-Thomson and M. A. Geyer, “The role of 5-HT(1A) receptors in the locomotor-suppressant effects of LSD: WAY-100635 studies of 8-OH-DPAT, DOI and LSD in rats,” Behav Pharmacol, vol. 7, no. 6, pp. 551–559, Nov. 1996.
[9494]	P. K. Eide and K. Hole, “The role of 5-hydroxytryptamine (5-HT) receptor subtypes and plasticity in the 5-HT systems in the regulation of nociceptive sensitivity,” Cephalalgia, vol. 13, no. 2, pp. 75–85, Apr. 1993, doi: 10.1046/j.1468-2982.1993.1302075.x.
[9495]	J. Zhou, I. Sargiannidou, and G. P. Tuszynski, “The role of adhesive proteins in the hematogenous spread of cancer,” In Vivo, vol. 14, no. 1, pp. 199–208, Feb. 2000.
[9496]	I. Brook, “The role of antibiotics in pediatric chronic rhinosinusitis,” Laryngoscope Investig Otolaryngol, vol. 2, no. 3, pp. 104–108, 2017, doi: 10.1002/lio2.67.
[9497]	K. Götze, C. Müller-Thomas, and C. Peschel, “The role of azacitidine in the management of myelodysplastic syndromes (MDS),” Cancer Manag Res, vol. 1, pp. 119–130, Oct. 2009, doi: 10.2147/cmr.s4721.
[9498]	M. A. Z. Knoll, “The role of behavioral economics and behavioral decision making in Americans’ retirement savings decisions,” Soc Secur Bull, vol. 70, no. 4, pp. 1–23, 2010.
[9499]	E. Asselmann, H.-U. Wittchen, R. Lieb, M. Höfler, and K. Beesdo-Baum, “The role of behavioral inhibition and parenting for an unfavorable emotional trauma response and PTSD,” Acta Psychiatr Scand, vol. 131, no. 4, pp. 279–289, Apr. 2015, doi: 10.1111/acps.12316.
[9500]	U. Heemann and O. Viklicky, “The role of belataceptin transplantation: results and implications of clinical trials in the context of other new biological immunosuppressant agents,” Clin Transplant, vol. 27, no. 1, pp. E3-11, Feb. 2013, doi: 10.1111/ctr.12044.
[9501]	J. Elisseeff, A. Ferran, S. Hwang, S. Varghese, and Z. Zhang, “The role of biomaterials in stem cell differentiation: applications in the musculoskeletal system,” Stem Cells Dev., vol. 15, no. 3, pp. 295–303, Jun. 2006, doi: 10.1089/scd.2006.15.295.
[9502]	A. J. Steward, D. J. Kelly, and D. R. Wagner, “The role of calcium signalling in the chondrogenic response of mesenchymal stem cells to hydrostatic pressure,” Eur Cell Mater, vol. 28, pp. 358–371, Oct. 2014, doi: 10.22203/ecm.v028a25.
[9503]	J. Zara and R. K. Naz, “The role of carbohydrates in mammalian sperm-egg interactions: how important are carbohydrate epitopes?,” Front. Biosci., vol. 3, pp. D1028-1038, Oct. 1998, doi: 10.2741/a343.
[9504]	A. G. Ramage, “The role of central 5-hydroxytryptamine (5-HT, serotonin) receptors in the control of micturition,” Br. J. Pharmacol., vol. 147 Suppl 2, pp. S120-131, Feb. 2006, doi: 10.1038/sj.bjp.0706504.
[9505]	S. B. Pruett, D. K. Ensley, and P. L. Crittenden, “The role of chemical-induced stress responses in immunosuppression: a review of quantitative associations and cause-effect relationships between chemical-induced stress responses and immunosuppression,” J Toxicol Environ Health, vol. 39, no. 2, pp. 163–192, Jun. 1993, doi: 10.1080/15287399309531744.
[9506]	T. J. Songer, “The role of cost-effectiveness analysis and health insurance in diabetes care,” Diabetes Res. Clin. Pract., vol. 54 Suppl 1, pp. S7-11, Nov. 2001, doi: 10.1016/s0168-8227(01)00303-5.
[9507]	A. F. G. Leentjens, “The role of dopamine agonists in the treatment of depression in patients with Parkinson’s disease: a systematic review,” Drugs, vol. 71, no. 3, pp. 273–286, Feb. 2011, doi: 10.2165/11585380-000000000-00000.
[9508]	S. Fethi and A. Rahuma, “The role of eco-innovation on CO2 emission reduction in an extended version of the environmental Kuznets curve: evidence from the top 20 refined oil exporting countries,” Environ Sci Pollut Res Int, vol. 26, no. 29, pp. 30145–30153, Oct. 2019, doi: 10.1007/s11356-019-05951-z.
[9509]	A. Rocchi, D. Menon, S. Verma, and E. Miller, “The role of economic evidence in Canadian oncology reimbursement decision-making: to lambda and beyond,” Value Health, vol. 11, no. 4, pp. 771–783, Aug. 2008, doi: 10.1111/j.1524-4733.2007.00298.x.
[9510]	M. J. Power and C. Fyvie, “The role of emotion in PTSD: two preliminary studies,” Behav Cogn Psychother, vol. 41, no. 2, pp. 162–172, Mar. 2013, doi: 10.1017/S1352465812000148.
[9511]	A. R. Polak, A. B. Witteveen, J. B. Reitsma, and M. Olff, “The role of executive function in posttraumatic stress disorder: a systematic review,” J Affect Disord, vol. 141, no. 1, pp. 11–21, Dec. 2012, doi: 10.1016/j.jad.2012.01.001.
[9512]	“The role of extended and whole genome sequencing for tracking transmission of measles and rubella viruses: report from the Global Measles and Rubella Laboratory Network meeting, 2017,” Wkly. Epidemiol. Rec., vol. 93, no. 6, pp. 55–59, Feb. 2018.
[9513]	D. R. Claycomb, “The role of field auditing in environmental quality assurance management,” Qual Assur, vol. 8, no. 3–4, pp. 189–194, Dec. 2000, doi: 10.1080/10529410052852349.
[9514]	M. Yemisen, B. Mete, A. Kanbay, I. I. Balkan, and R. Ozaras, “The Role of Helicobacter pylori in Upper Respiratory System Infections: Is it More Than Colonization?,” Curr Infect Dis Rep, vol. 14, no. 2, pp. 128–136, Apr. 2012, doi: 10.1007/s11908-012-0237-9.
[9515]	B. Roizman, “The role of hormones in viral infection. II. Acceleration of viral adsorption and penetration into cells treated with thyroid hormone in vitro,” Proc. Natl. Acad. Sci. U.S.A., vol. 48, pp. 973–977, Jun. 1962, doi: 10.1073/pnas.48.6.973.
[9516]	Y. Xiao and M. Rosen, “The role of Imaging and Radiation Oncology Core for precision medicine era of clinical trial,” Transl Lung Cancer Res, vol. 6, no. 6, pp. 621–624, Dec. 2017, doi: 10.21037/tlcr.2017.09.06.
[9517]	K. L. Bradley, K. Shachmut, S. Viswanathan, B. Griffin, and D. Vielehr, “The Role of Incentives in Health - Closing the Gap,” Mil Med, vol. 183, no. suppl_3, pp. 208–212, 01 2018, doi: 10.1093/milmed/usy216.
[9518]	Y. Zhou, Y. Kong, J. Sha, and H. Wang, “The role of industrial structure upgrades in eco-efficiency evolution: Spatial correlation and spillover effects,” Sci. Total Environ., vol. 687, pp. 1327–1336, Oct. 2019, doi: 10.1016/j.scitotenv.2019.06.182.
[9519]	M. B. Barshak and M. L. Durand, “The role of infection and antibiotics in chronic rhinosinusitis,” Laryngoscope Investig Otolaryngol, vol. 2, no. 1, pp. 36–42, 2017, doi: 10.1002/lio2.61.
[9520]	Y. Liu, J. Yu, Y.-C. Shi, Y. Zhang, and S. Lin, “The role of inflammation and endoplasmic reticulum stress in obesity-related cognitive impairment,” Life Sci., vol. 233, p. 116707, Sep. 2019, doi: 10.1016/j.lfs.2019.116707.
[9521]	E. De Nardin, “The role of inflammatory and immunological mediators in periodontitis and cardiovascular disease,” Ann. Periodontol., vol. 6, no. 1, pp. 30–40, Dec. 2001, doi: 10.1902/annals.2001.6.1.30.
[9522]	M. G. Arend and T. Franke, “The Role of Interaction Patterns with Hybrid Electric Vehicle Eco-Features for Drivers’ Eco-Driving Performance,” Hum Factors, vol. 59, no. 2, pp. 314–327, 2017, doi: 10.1177/0018720816670819.
[9523]	I. Zangl, I.-J. Pap, C. Aspöck, and C. Schüller, “The role of Lactobacillus species in the control of Candida via biotrophic interactions,” Microb Cell, vol. 7, no. 1, pp. 1–14, Nov. 2019, doi: 10.15698/mic2020.01.702.
[9524]	J. J. Dobias and T. V. Papathomas, “The role of linear perspective cues on the perceived depth magnitude of the surfaces they are painted on: proper-, reverse-, and flat-perspective paintings,” Perception, vol. 43, no. 9, pp. 989–1000, 2014, doi: 10.1068/p7705.
[9525]	E. Lotan et al., “The Role of Liver Segment-to-Spleen Volume Ratio in the Staging of Hepatic Fibrosis in Patients with Hepatitis C Virus Infection,” Isr. Med. Assoc. J., vol. 19, no. 4, pp. 251–256, Apr. 2017.
[9526]	V. A. Giagulli et al., “The role of long-acting parenteral testosterone undecanoate compound in the induction of secondary sexual characteristics in males with hypogonadotropic hypogonadism,” J Sex Med, vol. 8, no. 12, pp. 3471–3478, Dec. 2011, doi: 10.1111/j.1743-6109.2011.02497.x.
[9527]	M. H. Browder, L. J. D’Amico, and H. F. Nijhout, “The role of low levels of juvenile hormone esterase in the metamorphosis of Manduca sexta,” J. Insect Sci., vol. 1, p. 11, 2001.
[9528]	B. I. Jelen, D. Giovannelli, and P. G. Falkowski, “The Role of Microbial Electron Transfer in the Coevolution of the Biosphere and Geosphere,” Annu. Rev. Microbiol., vol. 70, pp. 45–62, 08 2016, doi: 10.1146/annurev-micro-102215-095521.
[9529]	P. Piomboni, R. Focarelli, A. Stendardi, A. Ferramosca, and V. Zara, “The role of mitochondria in energy production for human sperm motility,” Int. J. Androl., vol. 35, no. 2, pp. 109–124, Apr. 2012, doi: 10.1111/j.1365-2605.2011.01218.x.
[9530]	F. Conti and R. A. Van Gorder, “The role of network structure and time delay in a metapopulation Wilson--Cowan model,” J. Theor. Biol., vol. 477, pp. 1–13, 21 2019, doi: 10.1016/j.jtbi.2019.05.010.
[9531]	A. Didonna and P. Opal, “The role of neurofilament aggregation in neurodegeneration: lessons from rare inherited neurological disorders,” Mol Neurodegener, vol. 14, no. 1, p. 19, 16 2019, doi: 10.1186/s13024-019-0318-4.
[9532]	T. Kono et al., “The role of neuromedin U during inflammatory response in the common carp,” Fish Shellfish Immunol., vol. 32, no. 1, pp. 151–160, Jan. 2012, doi: 10.1016/j.fsi.2011.11.004.
[9533]	T. Barka, I. Toro, and Z. Posalaky, “The role of nucleic acids in the growth in vitro of liver tissues,” Acta Morphol Acad Sci Hung, vol. 3, no. 4, pp. 437–448, 1953.
[9534]	Y. Jiao, M. Hasegawa, and N. Inohara, “The Role of Oral Pathobionts in Dysbiosis during Periodontitis Development,” J. Dent. Res., vol. 93, no. 6, pp. 539–546, Jun. 2014, doi: 10.1177/0022034514528212.
[9535]	N. Jakšić, L. Brajković, E. Ivezić, R. Topić, and M. Jakovljević, “The role of personality traits in posttraumatic stress disorder (PTSD),” Psychiatr Danub, vol. 24, no. 3, pp. 256–266, Sep. 2012.
[9536]	A. Sebastianelli et al., “The role of prostate-specific antigen density in men with low-risk prostate cancer suitable for active surveillance: results of a prospective observational study,” Prostate Int, vol. 7, no. 4, pp. 139–142, Dec. 2019, doi: 10.1016/j.prnil.2019.02.001.
[9537]	R. D. Heilman, L. Jones, L. V. Kapili, and G. Zamora, “The role of QC/QA in ‘paper’ NDA submissions,” Qual Assur, vol. 4, no. 2, pp. 151–153, Jun. 1995.
[9538]	B. H. Chung, “The role of radical prostatectomy in high-risk prostate cancer,” Prostate Int, vol. 1, no. 3, pp. 95–101, 2013, doi: 10.12954/PI.13018.
[9539]	G. V. Carr and I. Lucki, “The role of serotonin receptor subtypes in treating depression: a review of animal studies,” Psychopharmacology (Berl.), vol. 213, no. 2–3, pp. 265–287, Feb. 2011, doi: 10.1007/s00213-010-2097-z.
[9540]	N. Tessitore, V. Bedogna, and A. Poli, “The role of surveillance in mature arteriovenous fistula management,” J Vasc Access, vol. 5, no. 2, pp. 57–61, Jun. 2004, doi: 10.1177/112972980400500203.
[9541]	J. P. York, R. Klump, J. J. Smith, and J. R. Drago, “The role of the adrenal in the rat varicocele model,” In Vivo, vol. 4, no. 2, pp. 145–147, Apr. 1990.
[9542]	R. S. Subbarayan, L. Arnold, J. P. Gomez, and S. M. Thomas, “The role of the innate and adaptive immune response in HPV-associated oropharyngeal squamous cell carcinoma,” Laryngoscope Investig Otolaryngol, vol. 4, no. 5, pp. 508–512, Oct. 2019, doi: 10.1002/lio2.300.
[9543]	J. Libertucci and V. B. Young, “The role of the microbiota in infectious diseases,” Nat Microbiol, vol. 4, no. 1, pp. 35–45, 2019, doi: 10.1038/s41564-018-0278-4.
[9544]	L. Sobkowiak et al., “The Role of the P1BS Element Containing Promoter-Driven Genes in Pi Transport and Homeostasis in Plants,” Front Plant Sci, vol. 3, p. 58, 2012, doi: 10.3389/fpls.2012.00058.
[9545]	E. Kohno, “[The role of the pharmacist in the proper use of antibacterial drugs],” Rinsho Byori, vol. 61, no. 2, pp. 118–126, Feb. 2013.
[9546]	N. Borel, A. Pospischil, A. P. Hudson, J. Rupp, and R. V. Schoborg, “The role of viable but non-infectious developmental forms in chlamydial biology,” Front Cell Infect Microbiol, vol. 4, p. 97, 2014, doi: 10.3389/fcimb.2014.00097.
[9547]	A. W. C. Man, N. Xia, A. Daiber, and H. Li, “The roles of gut microbiota and circadian rhythm in the cardiovascular protective effects of polyphenols,” Br. J. Pharmacol., vol. 177, no. 6, pp. 1278–1293, Mar. 2020, doi: 10.1111/bph.14850.
[9548]	E. A. G. van der Vossen et al., “The Rpi-blb2 gene from Solanum bulbocastanum is an Mi-1 gene homolog conferring broad-spectrum late blight resistance in potato,” Plant J., vol. 44, no. 2, pp. 208–222, Oct. 2005, doi: 10.1111/j.1365-313X.2005.02527.x.
[9549]	L. B. E. Shields, T. A. Gertz, K. C. Wilson, G. L. Figg, S. T. Hester, and J. T. Honaker, “The S-curve discontinuity theory predicts the path towards a ‘well’ society and increased longevity,” Med. Hypotheses, vol. 121, pp. 99–102, Dec. 2018, doi: 10.1016/j.mehy.2018.09.006.
[9550]	J. S. Fassler, W. Gray, J. P. Lee, G. Y. Yu, and G. Gingerich, “The Saccharomyces cerevisiae SPT14 gene is essential for normal expression of the yeast transposon, Ty, as well as for expression of the HIS4 gene and several genes in the mating pathway,” Mol. Gen. Genet., vol. 230, no. 1–2, pp. 310–320, Nov. 1991, doi: 10.1007/BF00290682.
[9551]	S. Picologlou, M. E. Dicig, P. Kovarik, and S. W. Liebman, “The same configuration of Ty elements promotes different types and frequencies of rearrangements in different yeast strains,” Mol. Gen. Genet., vol. 211, no. 2, pp. 272–281, Feb. 1988, doi: 10.1007/BF00330604.
[9552]	K. Sadtler, B. W. Allen, K. Estrellas, F. Housseau, D. M. Pardoll, and J. H. Elisseeff, “The Scaffold Immune Microenvironment: Biomaterial-Mediated Immune Polarization in Traumatic and Nontraumatic Applications<sup/>,” Tissue Eng Part A, vol. 23, no. 19–20, pp. 1044–1053, 2017, doi: 10.1089/ten.TEA.2016.0304.
[9553]	R. Lo, “The Schimmelbusch mask,” Hong Kong Med J, vol. 20, no. 6, pp. 560–561, Dec. 2014.
[9554]	B. L. Blas, M. I. Rosales, I. L. Lipayon, K. Yasuraoka, H. Matsuda, and M. Hayashi, “The schistosomiasis problem in the Philippines: a review,” Parasitol. Int., vol. 53, no. 2, pp. 127–134, Jun. 2004, doi: 10.1016/j.parint.2004.01.003.
[9555]	Y. Sakurai, “The search for cell assemblies in the working brain,” Behav. Brain Res., vol. 91, no. 1–2, pp. 1–13, Mar. 1998, doi: 10.1016/s0166-4328(97)00106-x.
[9556]	R. Heller and R. E. Pudritz, “The Search for Extraterrestrial Intelligence in Earth’s Solar Transit Zone,” Astrobiology, vol. 16, no. 4, pp. 259–270, Apr. 2016, doi: 10.1089/ast.2015.1358.
[9557]	A. A. Jensen et al., “The selective 5-HT2A receptor agonist 25CN-NBOH: Structure-activity relationship, in vivo pharmacology, and in vitro and ex vivo binding characteristics of [3H]25CN-NBOH,” Biochem. Pharmacol., vol. 177, p. 113979, Jul. 2020, doi: 10.1016/j.bcp.2020.113979.
[9558]	K. S. Hardin, K. N. Leasia, J. Haenel, E. E. Moore, C. C. Burlew, and F. M. Pieracci, “The Sequential Clinical Assessment of Respiratory Function (SCARF) score: A dynamic pulmonary physiologic score that predicts adverse outcomes in critically ill rib fracture patients,” J Trauma Acute Care Surg, vol. 87, no. 6, pp. 1260–1268, 2019, doi: 10.1097/TA.0000000000002480.
[9559]	R. L. Buckner, “The serendipitous discovery of the brain’s default network,” Neuroimage, vol. 62, no. 2, pp. 1137–1145, Aug. 2012, doi: 10.1016/j.neuroimage.2011.10.035.
[9560]	T. J. Feuerstein, A. Lupp, and G. Hertting, “The serotonin (5-HT) autoreceptor in the hippocampus of the rabbit: role of 5-HT biophase concentration,” Neuropharmacology, vol. 26, no. 8, pp. 1071–1080, Aug. 1987, doi: 10.1016/0028-3908(87)90250-4.
[9561]	H. Xicoy, B. Wieringa, and G. J. M. Martens, “The SH-SY5Y cell line in Parkinson’s disease research: a systematic review,” Mol Neurodegener, vol. 12, no. 1, p. 10, 24 2017, doi: 10.1186/s13024-017-0149-0.
[9562]	C. Mirasano, “[The significance of ‘Health for All’ and the primary health care approach],” Imbonezamuryango, no. 1, pp. 33–40, 1984.
[9563]	K. M. Pendleton, G. B. Huffnagle, and R. P. Dickson, “The significance of Candida in the human respiratory tract: our evolving understanding,” Pathog Dis, vol. 75, no. 3, Apr. 2017, doi: 10.1093/femspd/ftx029.
[9564]	R. E. Cilley and V. K. Brighton, “The significance of Helicobacter pylori colonization of the stomach,” Semin. Pediatr. Surg., vol. 4, no. 4, pp. 221–227, Nov. 1995.
[9565]	T. Opthof, R. Coronel, and M. J. Janse, “The significance of the peer review process against the background of bias: priority ratings of reviewers and editors and the prediction of citation, the role of geographical bias,” Cardiovasc. Res., vol. 56, no. 3, pp. 339–346, Dec. 2002, doi: 10.1016/s0008-6363(02)00712-5.
[9566]	D. C. Stewart and P. L. Kirk, “The simultaneous measurement of several parameters of embryo heart explant growth in vitro,” J Cell Comp Physiol, vol. 40, no. 2, pp. 183–198, Oct. 1952, doi: 10.1002/jcp.1030400203.
[9567]	T. Yasui et al., “The single-knot method with Lapra-Ty clips is useful for training surgeons in vesicourethral anastomosis during laparoscopic radical prostatectomy,” Int Urol Nephrol, vol. 41, no. 2, pp. 281–285, 2009, doi: 10.1007/s11255-008-9414-z.
[9568]	J. M. Ellenbogen, “The sleeping brain’s influence on memory,” Sleep, vol. 31, no. 2, pp. 163–164, Feb. 2008, doi: 10.1093/sleep/31.2.163.
[9569]	A. M. Happel, M. S. Swanson, and F. Winston, “The SNF2, SNF5 and SNF6 genes are required for Ty transcription in Saccharomyces cerevisiae,” Genetics, vol. 128, no. 1, pp. 69–77, May 1991.
[9570]	S.-L. Chiu, M.-J. Gee, C.-H. Muo, C.-L. Chu, S.-J. Lan, and C.-L. Chen, “The sociocultural effects on orthopedic surgeries in Taiwan,” PLoS ONE, vol. 13, no. 3, p. e0195183, 2018, doi: 10.1371/journal.pone.0195183.
[9571]	G. López-Casasnovas and M. Soley-Bori, “The socioeconomic determinants of health: economic growth and health in the OECD countries during the last three decades,” Int J Environ Res Public Health, vol. 11, no. 1, pp. 815–829, Jan. 2014, doi: 10.3390/ijerph110100815.
[9572]	A. J. Lee and D. M. Crothers, “The solution structure of an RNA loop-loop complex: the ColE1 inverted loop sequence,” Structure, vol. 6, no. 8, pp. 993–1005, Aug. 1998, doi: 10.1016/s0969-2126(98)00101-4.
[9573]	S. Hulme, D. Bright, and S. Nielsen, “The source and diversion of pharmaceutical drugs for non-medical use: A systematic review and meta-analysis,” Drug Alcohol Depend, vol. 186, pp. 242–256, May 2018, doi: 10.1016/j.drugalcdep.2018.02.010.
[9574]	Y. Zhou, Y. Kong, and T. Zhang, “The spatial and temporal evolution of provincial eco-efficiency in China based on SBM modified three-stage data envelopment analysis,” Environ Sci Pollut Res Int, vol. 27, no. 8, pp. 8557–8569, Mar. 2020, doi: 10.1007/s11356-019-07515-7.
[9575]	W. G. Schmitt, W. Hofmann, and B. L. Andermann, “[The specific gravity of the excitation formation and conduction system of the heart compared to the working myocardium as an indication of differences in structure and composition (author’s transl)],” Virchows Arch A Pathol Anat Histol, vol. 370, no. 3, pp. 267–272, Jun. 1976, doi: 10.1007/BF00427587.
[9576]	F. Winston, K. J. Durbin, and G. R. Fink, “The SPT3 gene is required for normal transcription of Ty elements in S. cerevisiae,” Cell, vol. 39, no. 3 Pt 2, pp. 675–682, Dec. 1984, doi: 10.1016/0092-8674(84)90474-4.
[9577]	S. R. Hilfer, “The stability of embryonic chick thyroid cells in vitro as judged by morphological and physiological criteria,” Dev. Biol., vol. 4, pp. 1–21, Feb. 1962, doi: 10.1016/0012-1606(62)90030-1.
[9578]	H. Riasi, A. Rajabpour Sanati, and K. Ghaemi, “The stigma of epilepsy and its effects on marital status,” Springerplus, vol. 3, p. 762, 2014, doi: 10.1186/2193-1801-3-762.
[9579]	R. J. Pinto, S. P. Henriques, I. Jongenelen, C. Carvalho, and Â. C. Maia, “The Strongest Correlates of PTSD for Firefighters: Number, Recency, Frequency, or Perceived Threat of Traumatic Events?,” J Trauma Stress, vol. 28, no. 5, pp. 434–440, Oct. 2015, doi: 10.1002/jts.22035.
[9580]	S. C. Stallings and P. B. Moore, “The structure of an essential splicing element: stem loop IIa from yeast U2 snRNA,” Structure, vol. 5, no. 9, pp. 1173–1185, Sep. 1997, doi: 10.1016/s0969-2126(97)00268-2.
[9581]	K. Y. Chang and I. Tinoco, “The structure of an RNA ‘kissing’ hairpin complex of the HIV TAR hairpin loop and its complement,” J. Mol. Biol., vol. 269, no. 1, pp. 52–66, May 1997, doi: 10.1006/jmbi.1997.1021.
[9582]	M. Cyniak-Cieciura, K. Staniaszek, A. Popiel, E. Pragłowska, and B. Zawadzki, “The structure of PTSD symptoms according to DSM-5 and IDC-11 proposal: A multi-sample analysis,” Eur. Psychiatry, vol. 44, pp. 179–186, 2017, doi: 10.1016/j.eurpsy.2017.02.491.
[9583]	J. M. Monti, “The structure of the dorsal raphe nucleus and its relevance to the regulation of sleep and wakefulness,” Sleep Med Rev, vol. 14, no. 5, pp. 307–317, Oct. 2010, doi: 10.1016/j.smrv.2009.11.004.
[9584]	G. G. Aminova, “[The structure of the esophageal glands proper in the individuals of elderly and senile age],” Morfologiia, vol. 146, no. 4, pp. 37–42, 2014.
[9585]	S. Camagni et al., “The successful management of a Bronchoesophageal fistula after lung transplantation: a case report,” Transpl. Int., vol. 28, no. 7, pp. 884–887, Jul. 2015, doi: 10.1111/tri.12561.
[9586]	T. Hongo, N. Komune, R. Shimamoto, and T. Nakagawa, “The surgical anatomy of soft tissue layers in the mastoid region,” Laryngoscope Investig Otolaryngol, vol. 4, no. 3, pp. 359–364, Jun. 2019, doi: 10.1002/lio2.271.
[9587]	D. Aerden et al., “The surgical history of the amputated limb according to the indication for revascularization: diabetic foot, acute ischaemia, aneurysmal disease, chronic arterial occlusive disease,” Acta Chir. Belg., vol. 111, no. 6, pp. 384–388, Dec. 2011, doi: 10.1080/00015458.2011.11680778.
[9588]	M. A. Talamini, C. L. Stanfield, D. C. Chang, and A. W. Wu, “The Surgical Recovery Index,” Surg Endosc, vol. 18, no. 4, pp. 596–600, Apr. 2004, doi: 10.1007/s00464-002-8962-z.
[9589]	M. H. Foley, D. W. Cockburn, and N. M. Koropatkin, “The Sus operon: a model system for starch uptake by the human gut Bacteroidetes,” Cell. Mol. Life Sci., vol. 73, no. 14, pp. 2603–2617, 2016, doi: 10.1007/s00018-016-2242-x.
[9590]	I. Karakaya, B. Ağaoğlu, A. Coşkun, S. G. Sişmanlar, and O. Yildiz Oc, “[The symptoms of PTSD, depression and anxiety in adolescent students three and a half years after the Marmara earthquake],” Turk Psikiyatri Derg, vol. 15, no. 4, pp. 257–263, 2004.
[9591]	R. M. Billow, “The therapist’s anxiety and resistance to group therapy,” Int J Group Psychother, vol. 51, no. 2, pp. 225–242, Apr. 2001, doi: 10.1521/ijgp.51.2.225.49856.
[9592]	P. R. Wolf and R. G. Cook, “The TL region gene 37 encodes a Qa-1 antigen,” J. Exp. Med., vol. 172, no. 6, pp. 1795–1804, Dec. 1990, doi: 10.1084/jem.172.6.1795.
[9593]	O. M. de Ilarduya, A. E. Moore, and I. Kaloshian, “The tomato Rme1 locus is required for Mi-1-mediated resistance to root-knot nematodes and the potato aphid,” Plant J., vol. 27, no. 5, pp. 417–425, Sep. 2001, doi: 10.1046/j.1365-313x.2001.01112.x.
[9594]	M. G. Verlaan et al., “The Tomato Yellow Leaf Curl Virus resistance genes Ty-1 and Ty-3 are allelic and code for DFDGD-class RNA-dependent RNA polymerases,” PLoS Genet., vol. 9, no. 3, p. e1003399, Mar. 2013, doi: 10.1371/journal.pgen.1003399.
[9595]	K. E. Campbell, L. Dennerstein, M. Tacey, and C. E. Szoeke, “The trajectory of negative mood and depressive symptoms over two decades,” Maturitas, vol. 95, pp. 36–41, Jan. 2017, doi: 10.1016/j.maturitas.2016.10.011.
[9596]	T. Mezher, “The transformation of Lebanese firms from ISO 9000 certified to TQM,” Qual Assur, vol. 8, no. 1, pp. 37–56, Mar. 2000, doi: 10.1080/105294100753209183.
[9597]	B. Narayan et al., “The transition between active and inactive conformations of Abl kinase studied by rock climbing and Milestoning,” Biochim Biophys Acta Gen Subj, vol. 1864, no. 4, p. 129508, 2020, doi: 10.1016/j.bbagen.2019.129508.
[9598]	J. M. Harris and R. Hemnani, “The transition to emerging revenue models,” Healthc Financ Manage, vol. 67, no. 4, pp. 54–63, Apr. 2013.
[9599]	B. Jojic, S. Amodeo, and T. Ochsenreiter, “The translationally controlled tumor protein TCTP is involved in cell cycle progression and heat stress response in the bloodstream form of Trypanosoma brucei,” Microb Cell, vol. 5, no. 10, pp. 460–468, Aug. 2018, doi: 10.15698/mic2018.10.652.
[9600]	G.-H. Lo, “The Transplantation of Fecal Microbiota for Cirrhotic Patients,” Gastroenterology, vol. 157, no. 3, p. 902, 2019, doi: 10.1053/j.gastro.2019.06.040.
[9601]	A. M. Kanner, “The treatment of depressive disorders in epilepsy: what all neurologists should know,” Epilepsia, vol. 54 Suppl 1, pp. 3–12, Mar. 2013, doi: 10.1111/epi.12100.
[9602]	I. Hackert, R. Aschoff, and G. Sebastian, “[The treatment of keloids],” Hautarzt, vol. 54, no. 10, pp. 1003–1015; quiz 1016–1017, Oct. 2003, doi: 10.1007/s00105-003-0573-7.
[9603]	X. Xiang et al., “The Trem2 R47H Alzheimer’s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans,” Mol Neurodegener, vol. 13, no. 1, p. 49, 06 2018, doi: 10.1186/s13024-018-0280-6.
[9604]	P. J. Cheng-Hathaway et al., “The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer’s disease,” Mol Neurodegener, vol. 13, no. 1, p. 29, 01 2018, doi: 10.1186/s13024-018-0262-8.
[9605]	S. S. Ivanov, “The tug-of-war over MTOR in Legionella infections,” Microb Cell, vol. 4, no. 2, pp. 67–68, Jan. 2017, doi: 10.15698/mic2017.02.559.
[9606]	C. Park, “The tumbling concha-cartilage flap for correction of lop ear,” Plast. Reconstr. Surg., vol. 106, no. 2, pp. 259–265, Aug. 2000, doi: 10.1097/00006534-200008000-00002.
[9607]	S. B. Osiro, D. Cunningham, M. M. Shoja, R. S. Tubbs, J. Gielecki, and M. Loukas, “The twisted colon: a review of sigmoid volvulus,” Am Surg, vol. 78, no. 3, pp. 271–279, Mar. 2012.
[9608]	C. C. Carman and J. Evans, “The two earths of Eratosthenes,” Isis, vol. 106, no. 1, pp. 1–16, Mar. 2015, doi: 10.1086/681034.
[9609]	H. C. Comijs et al., “The two-year course of late-life depression; results from the Netherlands study of depression in older persons,” BMC Psychiatry, vol. 15, p. 20, Feb. 2015, doi: 10.1186/s12888-015-0401-5.
[9610]	J. Mellor et al., “The Ty transposon of Saccharomyces cerevisiae determines the synthesis of at least three proteins,” Nucleic Acids Res., vol. 13, no. 17, pp. 6249–6263, Sep. 1985, doi: 10.1093/nar/13.17.6249.
[9611]	J. Mlíkovský, “The type specimens, type localities and nomenclature of Sarcoramphus vultures (Aves: Cathartidae), with a note on their speciation,” Zootaxa, vol. 3918, no. 4, pp. 579–586, Feb. 2015, doi: 10.11646/zootaxa.3918.4.7.
[9612]	A. Vaccari, “The tyramine binding site in the central nervous system: an overview,” Neurochem. Res., vol. 18, no. 8, pp. 861–868, Aug. 1993, doi: 10.1007/BF00998269.
[9613]	M. A. Kedda, G. Stevens, P. Manga, C. Viljoen, T. Jenkins, and M. Ramsay, “The tyrosinase-positive oculocutaneous albinism gene shows locus homogeneity on chromosome 15q11-q13 and evidence of multiple mutations in southern African negroids,” Am. J. Hum. Genet., vol. 54, no. 6, pp. 1078–1084, Jun. 1994.
[9614]	N. Modi, J. Ellis, and M. Marsh, “The UK Royal College of Paediatrics and Child Health’s Policy on Funding From Commercial Organizations,” JAMA Pediatr, vol. 171, no. 10, pp. 1016–1017, 01 2017, doi: 10.1001/jamapediatrics.2017.2470.
[9615]	J. McKigney, “The uniqueness of human milk. Economic aspects,” Am. J. Clin. Nutr., vol. 24, no. 8, pp. 1005–1012, Aug. 1971, doi: 10.1093/ajcn/24.8.1005.
[9616]	J. Breton, J. Lavergne, M. C. Wakeham, E. Nabedryk, and M. R. Jones, “The unusually strong hydrogen bond between the carbonyl of Q(A) and His M219 in the Rhodobacter sphaeroides reaction center is not essential for efficient electron transfer from Q(A)(-) to Q(B),” Biochemistry, vol. 46, no. 22, pp. 6468–6476, Jun. 2007, doi: 10.1021/bi700057f.
[9617]	K. K. Scarsi and D. C. Bjornson, “The use of ACE inhibitors as renoprotective agents in Medicaid patients with diabetes,” Ann Pharmacother, vol. 34, no. 9, pp. 1002–1006, Sep. 2000, doi: 10.1345/aph.19346.
[9618]	E. Richelson, “The use of cultured cells in the study of mood-normalizing drugs,” Pharmacol. Toxicol., vol. 66 Suppl 3, pp. 69–75, 1990, doi: 10.1111/j.1600-0773.1990.tb02074.x.
[9619]	G. Svendal, M. Berk, J. A. Pasco, F. N. Jacka, A. Lund, and L. J. Williams, “The use of hormonal contraceptive agents and mood disorders in women,” J Affect Disord, vol. 140, no. 1, pp. 92–96, Sep. 2012, doi: 10.1016/j.jad.2012.03.030.
[9620]	J. L. Moreau et al., “The Use of Telemental Health to Meet the Mental Health Needs of Women Using Department of Veterans Affairs Services,” Womens Health Issues, vol. 28, no. 2, pp. 181–187, Apr. 2018, doi: 10.1016/j.whi.2017.12.005.
[9621]	M. Rew, H. Lake, and K. Brownlee-Moore, “The use of Tiemann tip catheters for male intermittent self-catheterisation,” Br J Nurs, vol. 27, no. 9, pp. S18–S25, May 2018, doi: 10.12968/bjon.2018.27.9.S18.
[9622]	H. Cheng and F. Hu, “[The value of Helicobacter pylori stool antigen ImmunoCard STAT in diagnosis of HP infection and assessing of eradication of HP],” Zhonghua Yi Xue Za Zhi, vol. 84, no. 14, pp. 1166–1170, Jul. 2004.
[9623]	L.-G. Faksness, P. J. Brandvik, P. S. Daling, I. Singsaas, and S. E. Sørstrøm, “The value of offshore field experiments in oil spill technology development for Norwegian waters,” Mar. Pollut. Bull., vol. 111, no. 1–2, pp. 402–410, Oct. 2016, doi: 10.1016/j.marpolbul.2016.07.035.
[9624]	R. N. Khurana, L. K. Chang, L. F. Hill, A. Ghanekar, and I. Stoilov, “The Value of Prior Response to Anti-Vascular Endothelial Growth Factor for Age-Related Macular Degeneration: A HARBOR Subanalysis,” Ophthalmol Retina, vol. 4, no. 1, pp. 13–18, 2020, doi: 10.1016/j.oret.2019.06.008.
[9625]	S. R. Baker, G. S. Tilak, C. Geannette, M. J. Romero, A. Patel, and L. Pan, “The value of the internship year for radiologists: a retrospective analysis as assessed by current residents and fellows,” Acad Radiol, vol. 15, no. 9, pp. 1205–1210, Sep. 2008, doi: 10.1016/j.acra.2008.04.015.
[9626]	M. Capece and C. Imbimbo, “[The varicocele: the proper therapy for the proper patient],” Urologia, vol. 81, no. 3, pp. 165–168, Sep. 2014, doi: 10.5301/uro.5000078.
[9627]	J. T. O’Malley-James and L. Kaltenegger, “The Vegetation Red Edge Biosignature Through Time on Earth and Exoplanets,” Astrobiology, vol. 18, no. 9, pp. 1123–1136, 2018, doi: 10.1089/ast.2017.1798.
[9628]	S. N. Bleich, J. C. Jones-Smith, H. J. Walters, and L. Rutkow, “The Voices for Healthy Kids and State Legislation to Prevent Childhood Obesity: An Update,” Am J Prev Med, vol. 54, no. 6, pp. 821–824, 2018, doi: 10.1016/j.amepre.2018.01.041.
[9629]	M. M. Krem et al., “The VR-DCEP regimen rescues mobilization failures and controls refractory disease in multiple myeloma,” Bone Marrow Transplant., vol. 55, no. 7, pp. 1451–1453, Jul. 2020, doi: 10.1038/s41409-019-0735-6.
[9630]	W. K. Morgan, “The Walrus and the Carpenter or the Silica Criteria Standard,” J Occup Med, vol. 17, no. 12, pp. 782–783, Dec. 1975.
[9631]	Q. Wu et al., “The way forward confronting eco-environmental challenges during land-use practices: a bibliometric analysis,” Environ Sci Pollut Res Int, vol. 25, no. 28, pp. 28296–28311, Oct. 2018, doi: 10.1007/s11356-018-2866-5.
[9632]	N. H. Giles, R. F. Geever, D. K. Asch, J. Avalos, and M. E. Case, “The Wilhelmine E. Key 1989 invitational lecture. Organization and regulation of the qa (quinic acid) genes in Neurospora crassa and other fungi,” J. Hered., vol. 82, no. 1, pp. 1–7, Feb. 1991, doi: 10.1093/jhered/82.1.1.
[9633]	A. Papa, “The wonder of you…,” J Emerg Nurs, vol. 37, no. 4, pp. 305–306, Jul. 2011, doi: 10.1016/j.jen.2011.05.009.
[9634]	M. Max-Neef, “The world on a collision course and the need for a new economy,” Ambio, vol. 39, no. 3, pp. 200–210, May 2010, doi: 10.1007/s13280-010-0028-1.
[9635]	W. Yoo et al., “The YAP1-NMU Axis Is Associated with Pancreatic Cancer Progression and Poor Outcome: Identification of a Novel Diagnostic Biomarker and Therapeutic Target,” Cancers (Basel), vol. 11, no. 10, Sep. 2019, doi: 10.3390/cancers11101477.
[9636]	P. D. Rathjen, A. J. Kingsman, and S. M. Kingsman, “The yeast ROAM mutation--identification of the sequences mediating host gene activation and cell-type control in the yeast retrotransposon, Ty,” Nucleic Acids Res., vol. 15, no. 18, pp. 7309–7324, Sep. 1987, doi: 10.1093/nar/15.18.7309.
[9637]	H. Rampelt and M. van der Laan, “The Yin & Yang of Mitochondrial Architecture - Interplay of MICOS and F1Fo-ATP synthase in cristae formation,” Microb Cell, vol. 4, no. 8, pp. 236–239, Aug. 2017, doi: 10.15698/mic2017.08.583.
[9638]	J. Huang and M. Kertesz, “Theoretical analysis of intermolecular covalent pi-pi bonding and magnetic properties of phenalenyl and spiro-biphenalenyl radical pi-dimers,” J Phys Chem A, vol. 111, no. 28, pp. 6304–6315, Jul. 2007, doi: 10.1021/jp072086p.
[9639]	P. Veylon, M. Rochoy, S. Gautier, B. Wallaert, and C. Berkhout, “[Theoretical and practical assessment of Lille general practice and pharmacy students’ knowledge about use of inhaler devices for asthma control],” Rev Pneumol Clin, vol. 74, no. 2, pp. 67–75, Apr. 2018, doi: 10.1016/j.pneumo.2018.02.003.
[9640]	E. Walter and S. Zehetmayr, “[Theoretical implications of health economic evaluations in an Austrian context],” Wien Med Wochenschr, vol. 156, no. 23–24, pp. 622–627, Dec. 2006, doi: 10.1007/s10354-006-0359-5.
[9641]	J. Hu, Y. Liu, N. Liu, J. Li, and C. Ouyang, “Theoretical prediction of T-graphene as a promising alkali-ion battery anode offering ultrahigh capacity,” Phys Chem Chem Phys, vol. 22, no. 6, pp. 3281–3289, Feb. 2020, doi: 10.1039/c9cp06099e.
[9642]	R. Hammersley and M. Reid, “Theorising transient mood after ingestion,” Neurosci Biobehav Rev, vol. 33, no. 3, pp. 213–222, Mar. 2009, doi: 10.1016/j.neubiorev.2008.07.010.
[9643]	C. Ma, S. R. Meyers, and B. B. Sageman, “Theory of chaotic orbital variations confirmed by Cretaceous geological evidence,” Nature, vol. 542, no. 7642, pp. 468–470, 22 2017, doi: 10.1038/nature21402.
[9644]	M. Demerec, “Theory of the gene,” Tech Rep Brookhaven Natl Lab, pp. 1–13, Oct. 1961.
[9645]	M. Kirsch, T. Santarius, P. M. Black, and G. Schackert, “Therapeutic anti-angiogenesis for malignant brain tumors,” Onkologie, vol. 24, no. 5, pp. 423–430, Oct. 2001, doi: 10.1159/000055122.
[9646]	L. M. Bryant, K. E. Daniels, D. M. Cognetti, P. Tassone, A. J. Luginbuhl, and J. M. Curry, “Therapeutic Cannabis and Endocannabinoid Signaling System Modulator Use in Otolaryngology Patients,” Laryngoscope Investig Otolaryngol, vol. 3, no. 3, pp. 169–177, Jun. 2018, doi: 10.1002/lio2.154.
[9647]	S. A. Torrisi, G. M. Leggio, F. Drago, and S. Salomone, “Therapeutic Challenges of Post-traumatic Stress Disorder: Focus on the Dopaminergic System,” Front Pharmacol, vol. 10, p. 404, 2019, doi: 10.3389/fphar.2019.00404.
[9648]	T. E. Moors et al., “Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease,” Mol Neurodegener, vol. 12, no. 1, p. 11, 25 2017, doi: 10.1186/s13024-017-0154-3.
[9649]	J. Tu and L.-P. Wang, “Therapeutic potential of extracellular ATP and P2 receptors in nervous system diseases,” Neurosci Bull, vol. 25, no. 1, pp. 27–32, Feb. 2009, doi: 10.1007/s12264-009-1020-2.
[9650]	E. Scalzulli, S. Pepe, G. Colafigli, and M. Breccia, “Therapeutic strategies in low and high-risk MDS: What does the future have to offer?,” Blood Rev., p. 100689, Mar. 2020, doi: 10.1016/j.blre.2020.100689.
[9651]	G. V. Papatheodoridis, S. Manolakopoulos, G. Dusheiko, and A. J. Archimandritis, “Therapeutic strategies in the management of patients with chronic hepatitis B virus infection,” Lancet Infect Dis, vol. 8, no. 3, pp. 167–178, Mar. 2008, doi: 10.1016/S1473-3099(07)70264-5.
[9652]	A. K. Gupta and L. Q. Tu, “Therapies for onychomycosis: a review,” Dermatol Clin, vol. 24, no. 3, pp. 375–379, Jul. 2006, doi: 10.1016/j.det.2006.03.010.
[9653]	G. Papa, F. R. Mauro, and F. Mandelli, “Therapy-related acute non-lymphoid leukemia,” Haematologica, vol. 72, no. 6 Suppl, pp. 130–131, Dec. 1987.
[9654]	A. Abou Zahr, A. M. Kavi, S. Mukherjee, and A. M. Zeidan, “Therapy-related myelodysplastic syndromes, or are they?,” Blood Rev., vol. 31, no. 3, pp. 119–128, 2017, doi: 10.1016/j.blre.2016.11.002.
[9655]	A. E. Hassan, H. Kotta, U. Shariff, L. Preston, W. Tekle, and A. Qureshi, “There Is No Association Between the Number of Stent Retriever Passes and the Incidence of Hemorrhagic Transformation for Patients Undergoing Mechanical Thrombectomy,” Front Neurol, vol. 10, p. 818, 2019, doi: 10.3389/fneur.2019.00818.
[9656]	C. J. C. Jabbour, D. Jugend, A. B. L. de S. Jabbour, K. Govindan, D. Kannan, and W. Leal Filho, “‘There is no carnival without samba’: Revealing barriers hampering biodiversity-based R&D and eco-design in Brazil,” J. Environ. Manage., vol. 206, pp. 236–245, Jan. 2018, doi: 10.1016/j.jenvman.2017.10.019.
[9657]	D. H. Lee, J. M. Lee, J. H. Yoon, Y. J. Kim, and J. K. Han, “Thermal Injury-induced Hepatic Parenchymal Hypoperfusion: Risk of Hepatocellular Carcinoma Recurrence after Radiofrequency Ablation,” Radiology, vol. 282, no. 3, pp. 880–891, 2017, doi: 10.1148/radiol.2016152322.
[9658]	S. Guth, M. Habermeyer, M. Baum, P. Steinberg, A. Lampen, and G. Eisenbrand, “Thermally induced process-related contaminants: the example of acrolein and the comparison with acrylamide: opinion of the Senate Commission on Food Safety (SKLM) of the German Research Foundation (DFG),” Mol Nutr Food Res, vol. 57, no. 12, pp. 2269–2282, Dec. 2013, doi: 10.1002/mnfr.201300418.
[9659]	M. W. Haenel, S. Oevers, K. Angermund, W. C. Kaska, H.-J. Fan, and M. B. Hall, “Thermally Stable Homogeneous Catalysts for Alkane Dehydrogenation S.O. thanks the German Academic Exchange Service (DAAD) for financing a research stay with W.C.K. in the USA. This work was supported by the National Science Foundation (CHE 9800184 to M.B.H.), by the University of California Energy Institute and University of California Santa Barbara (to W.C.K.), and by the German Research Association (DFG, to M.W.H). We thank Dr. R. Mynott and Mrs. C. Wirtz, MPI für Kohlenforschung, for NMR spectroscopic investigations.,” Angew. Chem. Int. Ed. Engl., vol. 40, no. 19, pp. 3596–3600, Oct. 2001, doi: 10.1002/1521-3773(20011001)40:19<3596::aid-anie3596>3.0.co;2-c.
[9660]	A. Sanan, N. Hjelm, P. Tassone, H. Krein, and R. N. Heffelfinger, “Thermistor-controlled subdermal skin tightening for the aging face: Clinical outcomes and efficacy,” Laryngoscope Investig Otolaryngol, vol. 4, no. 1, pp. 18–23, Feb. 2019, doi: 10.1002/lio2.228.
[9661]	T. Kamisawa, Y. Tu, N. Egawa, A. Okamoto, and T. Sasaki, “[Thermo-chemo-radiotherapy for advanced biliary carcinoma],” Nippon Rinsho, vol. 64 Suppl 1, pp. 543–546, Jan. 2006.
[9662]	H. Elloumi, R. Bouarrouj, A. Chadli Debbiche, A. Mrabet, and C. Dziri, “Theses defended at Tunis Faculty of Medecine from 2004 to 2005: Scientific become and predictive factors of publications,” Tunis Med, vol. 95, no. 4, pp. 236–241, Apr. 2017.
[9663]	B. Beermann, “Thiazides and loop-diuretics therapeutic aspects,” Acta Med. Scand. Suppl., vol. 707, pp. 75–78, 1986, doi: 10.1111/j.0954-6820.1986.tb18119.x.
[9664]	A. Cortegiani and S. L. Shafer, “‘Think. Check. Submit.’ to avoid predatory publishing,” Crit Care, vol. 22, no. 1, p. 300, Nov. 2018, doi: 10.1186/s13054-018-2244-1.
[9665]	T. A. Jan, A. K. Remenschneider, C. Halpin, M. Seton, M. J. McKenna, and A. M. Quesnel, “Third-generation bisphosphonates for cochlear otosclerosis stabilizes sensorineural hearing loss in long-term follow-up,” Laryngoscope Investig Otolaryngol, vol. 2, no. 5, pp. 262–268, 2017, doi: 10.1002/lio2.91.
[9666]	G. B. Jena and S. P. Bhunya, “Thirty day genotoxicity study of an organophosphate insecticide, monocrotophos, in a chick in vivo test system,” In Vivo, vol. 6, no. 5, pp. 527–530, Oct. 1992.
[9667]	B. Li et al., “Thirty-day hospital revisits after prostate brachytherapy: who is at risk?,” Prostate Int, vol. 7, no. 2, pp. 68–72, Jun. 2019, doi: 10.1016/j.prnil.2018.03.003.
[9668]	C. Pierson, R. Woods, R. Nekkanti, H. Arastu, R. Corns, and A. W. Ju, “Thoracic Radiation Therapy in Patients With Entirely Intracardiac Leadless Cardiovascular Implantable Electronic Devices: 2 Case Reports and a Review of the Literature,” Pract Radiat Oncol, vol. 9, no. 6, pp. e620–e624, Nov. 2019, doi: 10.1016/j.prro.2019.06.013.
[9669]	N. Lassau et al., “Three artificial intelligence data challenges based on CT and MRI,” Diagn Interv Imaging, Mar. 2020, doi: 10.1016/j.diii.2020.03.006.
[9670]	E. M. Gordon et al., “Three Distinct Sets of Connector Hubs Integrate Human Brain Function,” Cell Rep, vol. 24, no. 7, pp. 1687-1695.e4, 14 2018, doi: 10.1016/j.celrep.2018.07.050.
[9671]	F. Winston et al., “Three genes are required for trans-activation of Ty transcription in yeast,” Genetics, vol. 115, no. 4, pp. 649–656, Apr. 1987.
[9672]	T. V. Borchert et al., “Three new crystal structures of point mutation variants of monoTIM: conformational flexibility of loop-1, loop-4 and loop-8,” Structure, vol. 3, no. 7, pp. 669–679, Jul. 1995, doi: 10.1016/s0969-2126(01)00202-7.
[9673]	Z. Yao, G. M. Kioko, E. N. Kioko, and S. Li, “Three new species of the spider family Pholcidae (Arachnida: Araneae) from Taita-Taveta, Kenya,” Zootaxa, vol. 4651, no. 1, p. zootaxa.4651.1.7, Aug. 2019, doi: 10.11646/zootaxa.4651.1.7.
[9674]	L. M. Bidaut et al., “Three- to five-dimensional biomedical multisensor imaging for the assessment of neurological (dys) function,” J Digit Imaging, vol. 9, no. 4, pp. 185–198, Nov. 1996, doi: 10.1007/BF03168617.
[9675]	X. Jia, J. Wang, H. Hu, and Y.-F. Song, “Three-Dimensional Carbon Framework Anchored Polyoxometalate as a High-Performance Anode for Lithium-Ion Batteries,” Chemistry, vol. 26, no. 23, pp. 5257–5263, Apr. 2020, doi: 10.1002/chem.201905764.
[9676]	M. Zimmermann, A. Valcanaia, G. Neiva, A. Mehl, and D. Fasbinder, “Three-Dimensional Digital Evaluation of the Fit of Endocrowns Fabricated from Different CAD/CAM Materials,” J Prosthodont, vol. 28, no. 2, pp. e504–e509, Feb. 2019, doi: 10.1111/jopr.12770.
[9677]	S.-I. Chitose et al., “Three-dimensional imaging of upper esophageal sphincter resting pressure,” Laryngoscope Investig Otolaryngol, vol. 4, no. 6, pp. 645–652, Dec. 2019, doi: 10.1002/lio2.324.
[9678]	K. Ohsawa, M. Uchida, and S. Aiyama, “Three-dimensional observation of blood vessels supplying the gland proper and capsule of the mouse submandibular gland,” Ann. Anat., vol. 188, no. 1, pp. 61–67, Jan. 2006, doi: 10.1016/j.aanat.2005.07.008.
[9679]	P.-Y. Tsai, C.-H. Chang, C.-H. Yu, Y.-C. Cheng, and F.-M. Chang, “Three-dimensional ultrasound in the prenatal diagnosis of osteogenesis imperfecta,” Taiwan J Obstet Gynecol, vol. 51, no. 3, pp. 387–392, Sep. 2012, doi: 10.1016/j.tjog.2012.07.012.
[9680]	E. Iofina et al., “Three-year follow-up after intracoronary beta-radiation therapy for in-stent restenosis,” Catheter Cardiovasc Interv, vol. 67, no. 4, pp. 600–606, Apr. 2006, doi: 10.1002/ccd.20667.
[9681]	M. Krüger, “Three-Year-Olds Solved a Mental Rotation Task Above Chance Level, but No Linear Relation Concerning Reaction Time and Angular Disparity Presented Itself,” Front Psychol, vol. 9, p. 1796, 2018, doi: 10.3389/fpsyg.2018.01796.
[9682]	D. H. Rothman, “Thresholds of catastrophe in the Earth system,” Sci Adv, vol. 3, no. 9, p. e1700906, 2017, doi: 10.1126/sciadv.1700906.
[9683]	M. Gross et al., “Thresholds of toxicological concern for endocrine active substances in the aquatic environment,” Integr Environ Assess Manag, vol. 6, no. 1, pp. 2–11, Jan. 2010, doi: 10.1897/IEAM_2008-092.1.
[9684]	R. M. M. K. Namal Rathnayaka, P. E. A. Nishanthi Ranathunga, and S. A. M. Kularatne, “Thrombotic Microangiopathy Following Hypnale zara (Hump-Nosed Pit Viper) Envenoming: The First Known Case Report from Sri Lanka,” Wilderness Environ Med, vol. 31, no. 1, pp. 71–77, Mar. 2020, doi: 10.1016/j.wem.2019.08.009.
[9685]	L. A. Lanterna et al., “Thyroid Autoantibodies and the Clinical Presentation of Moyamoya Disease: A Prospective Study,” J Stroke Cerebrovasc Dis, vol. 27, no. 5, pp. 1194–1199, May 2018, doi: 10.1016/j.jstrokecerebrovasdis.2017.11.037.
[9686]	M. Bahl, J. A. Sosa, R. C. Nelson, H. A. Hobbs, N. M. Wnuk, and J. K. Hoang, “Thyroid cancers incidentally detected at imaging in a 10-year period: how many cancers would be missed with use of the recommendations from the Society of Radiologists in Ultrasound?,” Radiology, vol. 271, no. 3, pp. 888–894, Jun. 2014, doi: 10.1148/radiol.13132002.
[9687]	A. Pingitore and G. Iervasi, “[Thyroid function and heart failure: from the new clinical evidences to the potential therapeutical implications],” Recenti Prog Med, vol. 96, no. 11, pp. 535–541, Nov. 2005.
[9688]	R. M. McClain, “Thyroid gland neoplasia: non-genotoxic mechanisms,” Toxicol. Lett., vol. 64-65 Spec No, pp. 397–408, Dec. 1992, doi: 10.1016/0378-4274(92)90213-4.
[9689]	N. Tsuzuki, K. Wasano, T. Kawasaki, S.-I. Sasaki, and K. Ogawa, “Thyroid lobe size predicts risk of postoperative temporary recurrent laryngeal nerve paralysis,” Laryngoscope Investig Otolaryngol, vol. 4, no. 6, pp. 708–713, Dec. 2019, doi: 10.1002/lio2.321.
[9690]	A. S. Martins and A. J. Tincani, “Thyroidectomy and hypoparathyroidism in patients with pharyngoesophageal tumors,” Head Neck, vol. 28, no. 2, pp. 135–141, Feb. 2006, doi: 10.1002/hed.20318.
[9691]	M. Xia et al., “Ti3C2T                     x                  MXene Nanosheets as a Robust and Conductive Tight on Si Anodes Significantly Enhance Electrochemical Lithium Storage Performance,” ACS Nano, vol. 14, no. 4, pp. 5111–5120, Apr. 2020, doi: 10.1021/acsnano.0c01976.
[9692]	A. Meneses, “Tianeptine: 5-HT uptake sites and 5-HT(1-7) receptors modulate memory formation in an autoshaping Pavlovian/instrumental task,” Neurosci Biobehav Rev, vol. 26, no. 3, pp. 309–319, May 2002, doi: 10.1016/s0149-7634(02)00005-2.
[9693]	R. Mehta and U. Mahajan, “Tibial-tubercle avulsion and patellar-tendon rupture in pre-pubertal child with osteogenesis imperfecta(OI): Case report and review of current treatment in OI,” J Clin Orthop Trauma, vol. 11, no. 2, pp. 339–343, Apr. 2020, doi: 10.1016/j.jcot.2020.01.013.
[9694]	M. Ćuk, D. P. Hamilton, S. J. Lock, and S. T. Stewart, “Tidal evolution of the Moon from a high-obliquity, high-angular-momentum Earth,” Nature, vol. 539, no. 7629, pp. 402–406, 17 2016, doi: 10.1038/nature19846.
[9695]	W. Li et al., “[Tight junction protein expression of gastric mucosa and its significance in children with Helicobacter pylori infection],” Zhonghua Er Ke Za Zhi, vol. 53, no. 7, pp. 510–515, Jul. 2015.
[9696]	H. Bastaki, J. Carter, L. Marston, J. Cassell, and G. Rait, “Time delays in the diagnosis and treatment of malaria in non-endemic countries: A systematic review,” Travel Med Infect Dis, vol. 21, pp. 21–27, Feb. 2018, doi: 10.1016/j.tmaid.2017.12.002.
[9697]	M. Asaad, A. Rajesh, J. Banuelos, K. S. Vyas, and N. V. Tran, “Time from submission to publication in plastic surgery journals: The story of accepted manuscripts,” J Plast Reconstr Aesthet Surg, vol. 73, no. 2, pp. 383–390, Feb. 2020, doi: 10.1016/j.bjps.2019.09.029.
[9698]	K. Wilk and U. Hegerl, “Time of mood switches in ultra-rapid cycling disorder: a brief review,” Psychiatry Res, vol. 180, no. 1, pp. 1–4, Nov. 2010, doi: 10.1016/j.psychres.2009.08.011.
[9699]	B. Crabtree-Ramírez et al., “Time to HAART Initiation after Diagnosis and Treatment of Opportunistic Infections in Patients with AIDS in Latin America,” PLoS ONE, vol. 11, no. 6, p. e0153921, 2016, doi: 10.1371/journal.pone.0153921.
[9700]	I. Villarroya-Marquina, J. Sancho, L. Lorente-Poch, L. Gallego-Otaegui, and A. Sitges-Serra, “Time to parathyroid function recovery in patients with protracted hypoparathyroidism after total thyroidectomy,” Eur. J. Endocrinol., vol. 178, no. 1, pp. 103–111, Jan. 2018, doi: 10.1530/EJE-17-0589.
[9701]	S. D. Sommerfeld and J. H. Elisseeff, “Time to Relax: Mechanical Stress Release Guides Stem Cell Responses,” Cell Stem Cell, vol. 18, no. 2, pp. 166–167, Feb. 2016, doi: 10.1016/j.stem.2016.01.020.
[9702]	L. E. S. da Silva and R. M. Claro, “[Time trends in the consumption of fruits and vegetables among adults in Brazilian state capitals and the Federal District, 2008-2016],” Cad Saude Publica, vol. 35, no. 5, p. e00023618, 20 2019, doi: 10.1590/0102-311X00023618.
[9703]	T. Gouin and F. Wania, “Time trends of Arctic contamination in relation to emission history and chemical persistence and partitioning properties,” Environ. Sci. Technol., vol. 41, no. 17, pp. 5986–5992, Sep. 2007, doi: 10.1021/es0709730.
[9704]	D. F. Heitjan and S. Kunselman, “Time until first significant difference in in vivo tumor growth experiments,” In Vivo, vol. 9, no. 1, pp. 7–9, Feb. 1995.
[9705]	H. T. Khosroshahi, R. Oskui, M. M. Shoja, R. S. Tubbs, and M. R. Ardalan, “Time-dependent variations in urine output after renal transplantation,” Transplant. Proc., vol. 39, no. 4, pp. 932–933, May 2007, doi: 10.1016/j.transproceed.2007.04.006.
[9706]	M. H. Davidson, J. E. Tomassini, E. Jensen, D. Neff, A. B. Polis, and A. M. Tershakovec, “Time-related trends in variability of cIMT changes in statin trials,” Data Brief, vol. 6, pp. 530–541, Mar. 2016, doi: 10.1016/j.dib.2015.12.029.
[9707]	J. Gerstmeier, C. Weinigel, S. Rummler, O. Rådmark, O. Werz, and U. Garscha, “Time-resolved in situ assembly of the leukotriene-synthetic 5-lipoxygenase/5-lipoxygenase-activating protein complex in blood leukocytes,” FASEB J., vol. 30, no. 1, pp. 276–285, Jan. 2016, doi: 10.1096/fj.15-278010.
[9708]	Y. Nakasone, K. Kikukawa, S. Masuda, and M. Terazima, “Time-Resolved Study of Interprotein Signaling Process of a Blue Light Sensor PapB-PapA Complex,” J Phys Chem B, vol. 123, no. 15, pp. 3210–3218, 18 2019, doi: 10.1021/acs.jpcb.9b00196.
[9709]	S. Aouichat, M. Chayah, S. Bouguerra-Aouichat, and A. Agil, “Time-Restricted Feeding Improves Body Weight Gain, Lipid Profiles, and Atherogenic Indices in Cafeteria-Diet-Fed Rats: Role of Browning of Inguinal White Adipose Tissue,” Nutrients, vol. 12, no. 8, Jul. 2020, doi: 10.3390/nu12082185.
[9710]	P. Richard, L. P. Koziris, M. Charbonneau, C. Naulleau, J. Tremblay, and F. Billaut, “Time-Trial Performance in World-Class Speed Skaters After Chronic Nitrate Ingestion,” Int J Sports Physiol Perform, vol. 13, no. 10, pp. 1317–1323, Nov. 2018, doi: 10.1123/ijspp.2017-0724.
[9711]	F. J. Gonzalez-Barcala et al., “Timeliness of care and prognosis in patients with lung cancer,” Ir J Med Sci, vol. 183, no. 3, pp. 383–390, Sep. 2014, doi: 10.1007/s11845-013-1025-8.
[9712]	A.-C. Bailly et al., “Timeliness of vaccination in infants followed by primary-care pediatricians in France,” Hum Vaccin Immunother, vol. 14, no. 4, pp. 1018–1023, 03 2018, doi: 10.1080/21645515.2017.1409318.
[9713]	B. Noë, L. D. Turner, D. E. J. Linden, S. M. Allen, G. R. Maio, and R. M. Whitaker, “Timing rather than user traits mediates mood sampling on smartphones,” BMC Res Notes, vol. 10, no. 1, p. 481, Sep. 2017, doi: 10.1186/s13104-017-2808-1.
[9714]	R. Shy, “Tinea corporis and tinea capitis,” Pediatr Rev, vol. 28, no. 5, pp. 164–174, May 2007, doi: 10.1542/pir.28-5-164.
[9715]	C. Y. J. Chang and S. W. Cheung, “Tinnitus modulation by stapedectomy,” Otol. Neurotol., vol. 35, no. 6, pp. 1065–1069, Jul. 2014, doi: 10.1097/MAO.0000000000000370.
[9716]	A. Grund et al., “TIP30 counteracts cardiac hypertrophy and failure by inhibiting translational elongation,” EMBO Mol Med, vol. 11, no. 10, p. e10018, 2019, doi: 10.15252/emmm.201810018.
[9717]	S. M. Danilov, R. Metzger, E. Klieser, K. Sotlar, I. N. Trakht, and J. G. N. Garcia, “Tissue ACE phenotyping in lung cancer,” PLoS ONE, vol. 14, no. 12, p. e0226553, 2019, doi: 10.1371/journal.pone.0226553.
[9718]	S. M. Danilov et al., “Tissue ACE phenotyping in prostate cancer,” Oncotarget, vol. 10, no. 59, pp. 6349–6361, Oct. 2019, doi: 10.18632/oncotarget.27276.
[9719]	A. Anand, E. J. Crone, and A. J. Zera, “Tissue and stage-specific juvenile hormone esterase (JHE) and epoxide hydrolase (JHEH) enzyme activities and Jhe transcript abundance in lines of the cricket Gryllus assimilis artificially selected for plasma JHE activity: implications for JHE microevolution,” J. Insect Physiol., vol. 54, no. 9, pp. 1323–1331, Sep. 2008, doi: 10.1016/j.jinsphys.2008.06.006.
[9720]	T. Hayek et al., “Tissue angiotensin-converting-enzyme (ACE) deficiency leads to a reduction in oxidative stress and in atherosclerosis: studies in ACE-knockout mice type 2,” Arterioscler. Thromb. Vasc. Biol., vol. 23, no. 11, pp. 2090–2096, Nov. 2003, doi: 10.1161/01.ATV.0000098653.74209.C6.
[9721]	G. Lenti and E. Tortarolo, “[Tissue culture in vitro in oncology: critical review],” Minerva Med., vol. 46, no. 1–2, pp. 25–34, Jan. 1955.
[9722]	A. Mohr et al., “Tissue Infiltrating LTi-Like Group 3 Innate Lymphoid Cells and T Follicular Helper Cells in Graves’ and Hashimoto’s Thyroiditis,” Front Immunol, vol. 11, p. 601, 2020, doi: 10.3389/fimmu.2020.00601.
[9723]	C. Zhong et al., “Tissue inhibitor metalloproteinase-1 and clinical outcomes after acute ischemic stroke,” Neurology, vol. 93, no. 18, pp. e1675–e1685, 29 2019, doi: 10.1212/WNL.0000000000008389.
[9724]	J. Kim et al., “Tissue-based markers of right ventricular dysfunction in ischemic mitral regurgitation assessed via stress cardiac magnetic resonance and three-dimensional echocardiography,” Int J Cardiovasc Imaging, vol. 35, no. 4, pp. 683–693, Apr. 2019, doi: 10.1007/s10554-018-1500-4.
[9725]	H. Yin et al., “Tissue-Derived Biological Particles Restore Cornea Properties in an Enzyme-Mediated Corneal Ectatic Model,” Bioengineering (Basel), vol. 6, no. 4, Sep. 2019, doi: 10.3390/bioengineering6040090.
[9726]	H. Yin et al., “Tissue-derived microparticles reduce inflammation and fibrosis in cornea wounds,” Acta Biomater, vol. 85, pp. 192–202, 2019, doi: 10.1016/j.actbio.2018.12.027.
[9727]	I. Zubiri et al., “Tissue-enhanced plasma proteomic analysis for disease stratification in amyotrophic lateral sclerosis,” Mol Neurodegener, vol. 13, no. 1, p. 60, 07 2018, doi: 10.1186/s13024-018-0292-2.
[9728]	S. Chattopadhyay, S. P. Kessler, J. A. Colucci, M. Yamashita, P. deS Senanayake, and G. C. Sen, “Tissue-specific expression of transgenic secreted ACE in vasculature can restore normal kidney functions, but not blood pressure, of Ace-/- mice,” PLoS ONE, vol. 9, no. 1, p. e87484, 2014, doi: 10.1371/journal.pone.0087484.
[9729]	M. Kamimura, M. Takahashi, K. Kikuchi, A. M. S. Reza, and M. Kiuchi, “Tissue-specific regulation of juvenile hormone esterase gene expression by 20-hydroxyecdysone and juvenile hormone in Bombyx mori,” Arch. Insect Biochem. Physiol., vol. 65, no. 3, pp. 143–151, Jul. 2007, doi: 10.1002/arch.20186.
[9730]	K. R. Michels, N. W. Lukacs, and W. Fonseca, “TLR Activation and Allergic Disease: Early Life Microbiome and Treatment,” Curr Allergy Asthma Rep, vol. 18, no. 11, p. 61, 26 2018, doi: 10.1007/s11882-018-0815-5.
[9731]	Y. Ren et al., “TMEM106B haplotypes have distinct gene expression patterns in aged brain,” Mol Neurodegener, vol. 13, no. 1, p. 35, 03 2018, doi: 10.1186/s13024-018-0268-2.
[9732]	N. Jyoti and S. Kaur, “To analyze the Impact of Serial Prescription Audits with Active Feedback on Quality of Prescription Behaviour,” J Clin Diagn Res, vol. 7, no. 4, pp. 680–683, Apr. 2013, doi: 10.7860/JCDR/2013/5441.2880.
[9733]	A. M. Zeidan and E. A. Griffiths, “To chelate or not to chelate in MDS: That is the question!,” Blood Rev., vol. 32, no. 5, pp. 368–377, 2018, doi: 10.1016/j.blre.2018.03.002.
[9734]	L. Danielsson, M. Hansson Scherman, and S. Rosberg, “To sense and make sense of anxiety: physiotherapists’ perceptions of their treatment for patients with generalized anxiety,” Physiother Theory Pract, vol. 29, no. 8, pp. 604–615, Nov. 2013, doi: 10.3109/09593985.2013.778382.
[9735]	R. Bendon and S. Potenziani-Pradella, “To the Editor,” Pediatr. Dev. Pathol., vol. 18, no. 5, p. 426, Oct. 2015, doi: 10.2350/15-03-1618-LET.1.
[9736]	R. Nicolai and S. Nicolai, “TO THE EDITOR,” Isis, vol. 107, no. 1, pp. 130–131, Mar. 2016, doi: 10.1086/686178.
[9737]	K. A. Oinonen and D. Mazmanian, “To what extent do oral contraceptives influence mood and affect?,” J Affect Disord, vol. 70, no. 3, pp. 229–240, Aug. 2002, doi: 10.1016/s0165-0327(01)00356-1.
[9738]	G. Ward-Fear, M. J. Greenlees, and R. Shine, “Toads on Lava: Spatial Ecology and Habitat Use of Invasive Cane Toads (Rhinella marina) in Hawai’i,” PLoS ONE, vol. 11, no. 3, p. e0151700, 2016, doi: 10.1371/journal.pone.0151700.
[9739]	H. Singhavi et al., “Tobacco carcinogen research to aid understanding of cancer risk and influence policy,” Laryngoscope Investig Otolaryngol, vol. 3, no. 5, pp. 372–376, Oct. 2018, doi: 10.1002/lio2.204.
[9740]	M. A. Stone and B. C. J. Moore, “Tolerable hearing aid delays. III. Effects on speech production and perception of across-frequency variation in delay,” Ear Hear, vol. 24, no. 2, pp. 175–183, Apr. 2003, doi: 10.1097/01.AUD.0000058106.68049.9C.
[9741]	B. Murali, M. C. Korrapati, A. Warbritton, J. R. Latendresse, and H. M. Mehendale, “Tolerance of aged Fischer 344 rats against chlordecone-amplified carbon tetrachloride toxicity,” Mech. Ageing Dev., vol. 125, no. 6, pp. 421–435, Jun. 2004, doi: 10.1016/j.mad.2004.03.005.
[9742]	J. Fagnani, G. Barrera, F. Carballo, and M. Bentosela, “Tolerance to delayed reward tasks in social and non-social contexts,” Behav. Processes, vol. 130, pp. 19–30, Sep. 2016, doi: 10.1016/j.beproc.2016.06.011.
[9743]	Y. Wang et al., “Toluene diisocyanate based phase-selective supramolecular oil gelator for effective removal of oil spills from polluted water,” Chemosphere, vol. 153, pp. 485–493, Jun. 2016, doi: 10.1016/j.chemosphere.2016.03.036.
[9744]	Y. Bai et al., “Tomato defense to Oidium neolycopersici: dominant Ol genes confer isolate-dependent resistance via a different mechanism than recessive ol-2,” Mol. Plant Microbe Interact., vol. 18, no. 4, pp. 354–362, Apr. 2005, doi: 10.1094/MPMI-18-0354.
[9745]	P. Butterbach et al., “Tomato yellow leaf curl virus resistance by Ty-1 involves increased cytosine methylation of viral genomes and is compromised by cucumber mosaic virus infection,” Proc. Natl. Acad. Sci. U.S.A., vol. 111, no. 35, pp. 12942–12947, Sep. 2014, doi: 10.1073/pnas.1400894111.
[9746]	B. Malmgren et al., “Tooth agenesis in osteogenesis imperfecta related to mutations in the collagen type I genes,” Oral Dis, vol. 23, no. 1, pp. 42–49, Jan. 2017, doi: 10.1111/odi.12568.
[9747]	A. R. Anderson and Centers for Disease Control and Prevention (CDC), “Top five chemicals resulting in injuries from acute chemical incidents—Hazardous Substances Emergency Events Surveillance, nine states, 1999-2008,” MMWR supplements, vol. 64, no. 2, pp. 39–46, Apr. 2015.
[9748]	D. A. Bluemke, “Top Publications in Radiology, 2018,” Radiology, vol. 290, no. 3, pp. 581–582, 2019, doi: 10.1148/radiol.2019194003.
[9749]	G. Ellis, “Top-down effects in the brain,” Phys Life Rev, vol. 31, pp. 11–27, 2019, doi: 10.1016/j.plrev.2018.05.006.
[9750]	D. G. Klein and P. O’Malley, “Topical injury from chemical agents: initial treatment,” Heart Lung, vol. 16, no. 1, pp. 49–54, Jan. 1987.
[9751]	D. de Ortueta and S. Arba Mosquera, “Topographic stability after hyperopic LASIK,” J Refract Surg, vol. 26, no. 8, pp. 547–554, Aug. 2010, doi: 10.3928/1081597X-20100225-01.
[9752]	K. Blouhos, K. A. Boulas, I. I. Salpigktidis, A. Konstantinidou, K. Ioannidis, and A. Hatzigeorgiadis, “Total Reconstruction of the Afferent Loop for Treatment of Radiation-Induced Afferent Loop Obstruction with Segmental Involvement after Pancreaticoduodenectomy with Roux-en-Y Reconstruction,” Case Rep Oncol, vol. 6, no. 2, pp. 424–429, 2013, doi: 10.1159/000354576.
[9753]	P. Garnett, “Total systemic failure?,” Sci. Total Environ., vol. 626, pp. 684–688, Jun. 2018, doi: 10.1016/j.scitotenv.2018.01.075.
[9754]	B. Tuncali, H. Boya, Z. Kayhan, and S. Arac, “Tourniquet pressure settings based on limb occlusion pressure determination or arterial occlusion pressure estimation in total knee arthroplasty? A prospective, randomized, double blind trial,” Acta Orthop Traumatol Turc, vol. 52, no. 4, pp. 256–260, Jul. 2018, doi: 10.1016/j.aott.2018.04.001.
[9755]	S. Seager, W. Bains, and J. J. Petkowski, “Toward a List of Molecules as Potential Biosignature Gases for the Search for Life on Exoplanets and Applications to Terrestrial Biochemistry,” Astrobiology, vol. 16, no. 6, pp. 465–485, 2016, doi: 10.1089/ast.2015.1404.
[9756]	G. J. Madden, E. E. Ewan, and C. H. Lagorio, “Toward an animal model of gambling: delay discounting and the allure of unpredictable outcomes,” J Gambl Stud, vol. 23, no. 1, pp. 63–83, Mar. 2007, doi: 10.1007/s10899-006-9041-5.
[9757]	C. Sun and P. Medvedev, “Toward fast and accurate SNP genotyping from whole genome sequencing data for bedside diagnostics,” Bioinformatics, vol. 35, no. 3, pp. 415–420, 01 2019, doi: 10.1093/bioinformatics/bty641.
[9758]	H.-G. Steinrück, C. Cao, G. M. Veith, and M. F. Toney, “Toward quantifying capacity losses due to solid electrolyte interphase evolution in silicon thin film batteries,” J Chem Phys, vol. 152, no. 8, p. 084702, Feb. 2020, doi: 10.1063/1.5142643.
[9759]	B. Hemmer and H.-P. Hartung, “Toward the development of rational therapies in multiple sclerosis: what is on the horizon?,” Ann. Neurol., vol. 62, no. 4, pp. 314–326, Oct. 2007, doi: 10.1002/ana.21289.
[9760]	C. S. North, A. M. Suris, M. Davis, and R. P. Smith, “Toward validation of the diagnosis of posttraumatic stress disorder,” Am J Psychiatry, vol. 166, no. 1, pp. 34–41, Jan. 2009, doi: 10.1176/appi.ajp.2008.08050644.
[9761]	M. Saggar et al., “Towards a new approach to reveal dynamical organization of the brain using topological data analysis,” Nat Commun, vol. 9, no. 1, p. 1399, 11 2018, doi: 10.1038/s41467-018-03664-4.
[9762]	N. S. Ward and R. S. J. Frackowiak, “Towards a new mapping of brain cortex function,” Cerebrovasc. Dis., vol. 17 Suppl 3, pp. 35–38, 2004, doi: 10.1159/000075303.
[9763]	R. P. Dickson, J. R. Erb-Downward, and G. B. Huffnagle, “Towards an ecology of the lung: new conceptual models of pulmonary microbiology and pneumonia pathogenesis,” Lancet Respir Med, vol. 2, no. 3, pp. 238–246, Mar. 2014, doi: 10.1016/S2213-2600(14)70028-1.
[9764]	E. S. Edward, A. Z. Kouzani, and S. J. Tye, “Towards miniaturized closed-loop optogenetic stimulation devices,” J Neural Eng, vol. 15, no. 2, p. 021002, 2018, doi: 10.1088/1741-2552/aa7d62.
[9765]	H. J. Hwang, “Towards Modern Depressive Disorder: Professional Understanding of Depression in Interwar Britain,” Uisahak, vol. 28, no. 3, pp. 787–820, 2019, doi: 10.13081/kjmh.2019.28.787.
[9766]	V. K. Jirsa, O. Sporns, M. Breakspear, G. Deco, and A. R. McIntosh, “Towards the virtual brain: network modeling of the intact and the damaged brain,” Arch Ital Biol, vol. 148, no. 3, pp. 189–205, Sep. 2010.
[9767]	P. Spornraft-Ragaller, M. Ragaller, and M. Meurer, “[Toxic epidermal necrolysis induced by NSAID],” Z Rheumatol, vol. 62, no. 5, pp. 474–475, Oct. 2003, doi: 10.1007/s00393-003-0535-6.
[9768]	H. Greim, D. Bury, H. J. Klimisch, M. Oeben-Negele, and K. Ziegler-Skylakakis, “Toxicity of aliphatic amines: structure-activity relationship,” Chemosphere, vol. 36, no. 2, pp. 271–295, Jan. 1998, doi: 10.1016/s0045-6535(97)00365-2.
[9769]	S. A. Nutile and M. E. Solan, “Toxicity testing of ‘eco-friendly’ de-icing formulations using Chironomus dilutus,” Environ. Pollut., vol. 246, pp. 408–413, Mar. 2019, doi: 10.1016/j.envpol.2018.12.033.
[9770]	F. N. Jaffery, V. Misra, and P. N. Viswanathan, “Toxicological considerations in environmental audit studies,” Qual Assur, vol. 5, no. 1, pp. 19–26, Mar. 1997.
[9771]	V. J. Feron, J. P. Groten, D. Jonker, F. R. Cassee, and P. J. van Bladeren, “Toxicology of chemical mixtures: challenges for today and the future,” Toxicology, vol. 105, no. 2–3, pp. 415–427, Dec. 1995, doi: 10.1016/0300-483x(95)03239-c.
[9772]	I. El Meouche and J. Peltier, “Toxin release mediated by the novel autolysin Cwp19 in Clostridium difficile,” Microb Cell, vol. 5, no. 9, pp. 421–423, Aug. 2018, doi: 10.15698/mic2018.09.648.
[9773]	H.-S. Joo and M. Otto, “Toxin-mediated gene regulatory mechanism in Staphylococcus aureus,” Microb Cell, vol. 4, no. 1, pp. 29–31, Dec. 2016, doi: 10.15698/mic2017.01.553.
[9774]	G. C. Cotzias, “TRACE METALS: ESSENTIAL OR DETRIMENTAL TO LIFE. BNL 828 (T-323),” Tech Rep Brookhaven Natl Lab, vol. 26, pp. 1–14, Apr. 1964.
[9775]	S. Sazzed, J. Song, J. A. Kovacs, W. Wriggers, M. Auer, and J. He, “Tracing Actin Filament Bundles in Three-Dimensional Electron Tomography Density Maps of Hair Cell Stereocilia,” Molecules, vol. 23, no. 4, Apr. 2018, doi: 10.3390/molecules23040882.
[9776]	C. Pitt, C. Grollman, M. Martinez-Alvarez, L. Arregoces, and J. Borghi, “Tracking aid for global health goals: a systematic comparison of four approaches applied to reproductive, maternal, newborn, and child health,” Lancet Glob Health, vol. 6, no. 8, pp. e859–e874, 2018, doi: 10.1016/S2214-109X(18)30276-6.
[9777]	S. N. Rao, “Tracking binding modes of 1,2,4-trisubstituted imidazolinone P38 MAP kinase and ERK-2 inhibitors,” J. Mol. Graph. Model., vol. 76, pp. 161–171, 2017, doi: 10.1016/j.jmgm.2017.07.001.
[9778]	M. Hoshi, “Tracking down a missing trigger for Alzheimer’s disease by mass spectrometric imaging based on brain network analysis,” Prog Mol Biol Transl Sci, vol. 168, pp. 25–55, 2019, doi: 10.1016/bs.pmbts.2019.05.011.
[9779]	H. Xue, D. Song, B. Shi, Y. Li, and J. Li, “Tracking of green fluorescent protein labeled Escherichia coli confirms bacterial translocation in blind loop rat,” J. Surg. Res., vol. 143, no. 2, pp. 206–210, Dec. 2007, doi: 10.1016/j.jss.2006.03.030.
[9780]	F. Farahpour, M. Saeedghalati, V. S. Brauer, and D. Hoffmann, “Trade-off shapes diversity in eco-evolutionary dynamics,” Elife, vol. 7, 17 2018, doi: 10.7554/eLife.36273.
[9781]	Y. Zhang, J. Liu, J. Wang, and Q. He, “Traditional Chinese Medicine for treatment of cerebral palsy in children: a systematic review of randomized clinical trials,” J Altern Complement Med, vol. 16, no. 4, pp. 375–395, Apr. 2010, doi: 10.1089/acm.2009.0609.
[9782]	L. Wadley, G. Trower, L. Backwell, and F. d’Errico, “Traditional Glue, Adhesive and Poison Used for Composite Weapons by Ju/’hoan San in Nyae Nyae, Namibia. Implications for the Evolution of Hunting Equipment in Prehistory,” PLoS ONE, vol. 10, no. 10, p. e0140269, 2015, doi: 10.1371/journal.pone.0140269.
[9783]	A. Dare, N. Fancourt, E. Robinson, T. Wilkinson, and W. Bagg, “Training the intern: The value of a pre-intern year in preparing students for practice,” Med Teach, vol. 31, no. 8, pp. e345-350, Aug. 2009, doi: 10.1080/01421590903127669.
[9784]	P. J. Ward, A. N. Herrity, S. J. Harkema, and C. H. Hubscher, “Training-Induced Functional Gains following SCI,” Neural Plast., vol. 2016, p. 4307694, 2016, doi: 10.1155/2016/4307694.
[9785]	L. Henry, C. Farmer, S. S. Manwaring, L. Swineford, and A. Thurm, “Trajectories of cognitive development in toddlers with language delays,” Res Dev Disabil, vol. 81, pp. 65–72, Oct. 2018, doi: 10.1016/j.ridd.2018.04.005.
[9786]	J.-F. Huang et al., “Trajectory of depression symptoms and related factors in later life--a population based study,” J Affect Disord, vol. 133, no. 3, pp. 499–508, Oct. 2011, doi: 10.1016/j.jad.2011.04.048.
[9787]	L. Leger, M. Zara, and C. Proux, “[Trans-parieto-hepatic cholangiography],” Presse Med, vol. 61, no. 48, p. Atlas de radiol clin, 3-4, Jul. 1953.
[9788]	H. G. de Oliveira et al., “Transbronchoscopic pulmonary emphysema treatment: 1-month to 24-month endoscopic follow-up,” Chest, vol. 130, no. 1, pp. 190–199, Jul. 2006, doi: 10.1378/chest.130.1.190.
[9789]	J. P. Vavalle, T. L. Kiefer, C. A. Milano, J. K. Harrison, and G. C. Hughes, “Transcatheter aortic valve replacement performed via left ventricular assist device inflow cannula,” Circ Heart Fail, vol. 7, no. 3, pp. 544–546, May 2014, doi: 10.1161/CIRCHEARTFAILURE.114.001232.
[9790]	D. H. Adams et al., “Transcatheter aortic-valve replacement with a self-expanding prosthesis,” N. Engl. J. Med., vol. 370, no. 19, pp. 1790–1798, May 2014, doi: 10.1056/NEJMoa1400590.
[9791]	G. Diallinas, “Transceptors as a functional link of transporters and receptors,” Microb Cell, vol. 4, no. 3, pp. 69–73, Mar. 2017, doi: 10.15698/mic2017.03.560.
[9792]	P. Cirillo et al., “Transcranial magnetic stimulation in anxiety and trauma-related disorders: A systematic review and meta-analysis,” Brain Behav, p. e01284, May 2019, doi: 10.1002/brb3.1284.
[9793]	U. Raaz et al., “Transcription Factor Runx2 Promotes Aortic Fibrosis and Stiffness in Type 2 Diabetes Mellitus,” Circ. Res., vol. 117, no. 6, pp. 513–524, Aug. 2015, doi: 10.1161/CIRCRESAHA.115.306341.
[9794]	T. E. Howard, S. Y. Shai, K. G. Langford, B. M. Martin, and K. E. Bernstein, “Transcription of testicular angiotensin-converting enzyme (ACE) is initiated within the 12th intron of the somatic ACE gene,” Mol. Cell. Biol., vol. 10, no. 8, pp. 4294–4302, Aug. 1990, doi: 10.1128/mcb.10.8.4294.
[9795]	M. Båga, M. Göransson, S. Normark, and B. E. Uhlin, “Transcriptional activation of a pap pilus virulence operon from uropathogenic Escherichia coli,” EMBO J., vol. 4, no. 13B, pp. 3887–3893, Dec. 1985.
[9796]	Y. Nevo-Caspi and M. Kupiec, “Transcriptional induction of Ty recombination in yeast,” Proc. Natl. Acad. Sci. U.S.A., vol. 91, no. 26, pp. 12711–12715, Dec. 1994, doi: 10.1073/pnas.91.26.12711.
[9797]	C. Liu, D. Xu, J. Sjöberg, P. Forsell, M. Björkholm, and H.-E. Claesson, “Transcriptional regulation of 15-lipoxygenase expression by promoter methylation,” Exp. Cell Res., vol. 297, no. 1, pp. 61–67, Jul. 2004, doi: 10.1016/j.yexcr.2004.02.014.
[9798]	E. J. Jokl, G. L. Hughes, T. Cracknell, M. E. Pownall, and G. Blanco, “Transcriptional upregulation of Bag3, a chaperone-assisted selective autophagy factor, in animal models of KY-deficient hereditary myopathy,” Dis Model Mech, vol. 11, no. 7, 06 2018, doi: 10.1242/dmm.033225.
[9799]	M. J. Mienaltowski et al., “Transcriptome profiles of isolated murine Achilles tendon proper- and peritenon-derived progenitor cells,” J. Orthop. Res., vol. 37, no. 6, pp. 1409–1418, 2019, doi: 10.1002/jor.24076.
[9800]	Y. Huang et al., “Transcriptome profiling reveals differential gene expression of detoxification enzymes in Sitophilus zeamais responding to terpinen-4-ol fumigation,” Pestic Biochem Physiol, vol. 149, pp. 44–53, Jul. 2018, doi: 10.1016/j.pestbp.2018.05.008.
[9801]	H. M. Nguyen et al., “Transcriptomic analysis of Arabidopsis thaliana plants treated with the Ky-9 and Ky-72 histone deacetylase inhibitors,” Plant Signal Behav, vol. 13, no. 3, p. e1448333, 04 2018, doi: 10.1080/15592324.2018.1448333.
[9802]	P. Lage, B. Sampaio-Marques, P. Ludovico, N. P. Mira, and A. Mendes-Ferreira, “Transcriptomic and chemogenomic analyses unveil the essential role of Com2-regulon in response and tolerance of Saccharomyces cerevisiae to stress induced by sulfur dioxide,” Microb Cell, vol. 6, no. 11, pp. 509–523, Sep. 2019, doi: 10.15698/mic2019.11.697.
[9803]	K. Solanki et al., “Transcutaneous absorption of topically massaged oil in neonates,” Indian Pediatr, vol. 42, no. 10, pp. 998–1005, Oct. 2005.
[9804]	P. B. Sharp, G. A. Miller, and W. Heller, “Transdiagnostic dimensions of anxiety: Neural mechanisms, executive functions, and new directions,” Int J Psychophysiol, vol. 98, no. 2 Pt 2, pp. 365–377, Nov. 2015, doi: 10.1016/j.ijpsycho.2015.07.001.
[9805]	S. Hiss-Pesch, F. Daniel, S. Dunkelberg-Denk, M. Mielenz, and H. Sauerwein, “Transfer of maternal haptoglobin to suckling piglets,” Vet. Immunol. Immunopathol., vol. 144, no. 1–2, pp. 104–110, Nov. 2011, doi: 10.1016/j.vetimm.2011.07.015.
[9806]	Q. Li, Z. Liu, J. Lu, W. Shao, and X. Feng, “[Transferring the ulnaris proper digital nerve of index finger and its dorsal branch to repair the thumb nerve avulsion],” Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, vol. 31, no. 8, pp. 992–995, 15 2017, doi: 10.7507/1002-1892.201612105.
[9807]	E. J. Matthews, J. W. Spalding, and R. W. Tennant, “Transformation of BALB/c-3T3 cells: IV. Rank-ordered potency of 24 chemical responses detected in a sensitive new assay procedure,” Environ. Health Perspect., vol. 101 Suppl 2, pp. 319–345, Jul. 1993, doi: 10.1289/ehp.93101s2319.
[9808]	M. Eichinger, “Transformational change in the Anthropocene epoch,” Lancet Planet Health, vol. 3, no. 3, pp. e116–e117, 2019, doi: 10.1016/S2542-5196(18)30280-8.
[9809]	R. A. Kell, C. M. Hedin, G. H. Kassakhian, and E. S. Reynolds, “Transforming an EPA QA/R-2 quality management plan into an ISO 9002 quality management system,” Qual Assur, vol. 9, no. 3–4, pp. 199–207, Dec. 2001, doi: 10.1080/713844026.
[9810]	M. E. Pueyo et al., “Transforming growth factor-beta 1 production is correlated with genetically determined ACE expression in congenic rats: a possible link between ACE genotype and diabetic nephropathy,” Diabetes, vol. 53, no. 4, pp. 1111–1118, Apr. 2004, doi: 10.2337/diabetes.53.4.1111.
[9811]	A. Daugherty, Z. Chen, H. Sawada, D. L. Rateri, and M. B. Sheppard, “Transforming Growth Factor-β in Thoracic Aortic Aneurysms: Good, Bad, or Irrelevant?,” J Am Heart Assoc, vol. 6, no. 1, 24 2017, doi: 10.1161/JAHA.116.005221.
[9812]	S. Schrager, “Transforming your presentation into a publication,” Fam Med, vol. 42, no. 4, pp. 268–272, Apr. 2010.
[9813]	P. Moor, D. Rew, M. J. Midwinter, and H. Doughty, “Transfusion for trauma: civilian lessons from the battlefield?,” Anaesthesia, vol. 64, no. 5, pp. 469–472, May 2009, doi: 10.1111/j.1365-2044.2008.05829.x.
[9814]	M. V. Jali and P. S. Shankar, “Transient diabetes following chicken pox,” J Assoc Physicians India, vol. 38, no. 9, pp. 663–664, Sep. 1990.
[9815]	P. Striano, F. Zara, and S. Striano, “Transient epileptic amnesia: a new epileptic syndrome in development?,” Ann. Neurol., vol. 67, no. 3, p. 416, Mar. 2010, doi: 10.1002/ana.21286.
[9816]	K. Tsuchiya et al., “Transient receptor potential ankyrin 1 agonists improve intestinal transit in a murine model of postoperative ileus,” Neurogastroenterol. Motil., vol. 28, no. 12, pp. 1792–1805, Dec. 2016, doi: 10.1111/nmo.12877.
[9817]	T. Graen, R. Klement, A. Grupi, E. Haas, and H. Grubmüller, “Transient Secondary and Tertiary Structure Formation Kinetics in the Intrinsically Disordered State of α-Synuclein from Atomistic Simulations,” Chemphyschem, vol. 19, no. 19, pp. 2507–2511, 05 2018, doi: 10.1002/cphc.201800504.
[9818]	V. Rossi and G. Pourtois, “Transient state-dependent fluctuations in anxiety measured using STAI, POMS, PANAS or VAS: a comparative review,” Anxiety Stress Coping, vol. 25, no. 6, pp. 603–645, Nov. 2012, doi: 10.1080/10615806.2011.582948.
[9819]	M. Driessen, J. M. Fegert, H. J. Freyberger, A. Karow, and T. Banaschewski, “[Transition Psychiatry - a Contemporary Challenge],” Psychiatr Prax, vol. 46, no. 3, pp. 125–127, 2019, doi: 10.1055/a-0860-4844.
[9820]	C. M. Laurencot, W. Dean, M. L. Borek, and N. M. Klein, “Transitioning trauma research: Navigating the regulatory requirements for medical product development,” J Trauma Acute Care Surg, vol. 81, no. 5 Suppl 2 Proceedings of the 2015 Military Health System Research Symposium, pp. S81–S86, 2016, doi: 10.1097/TA.0000000000001247.
[9821]	E. T. Chuck, K. Meyers, D. France, T. L. Creazzo, and G. E. Morley, “Transitions in ventricular activation revealed by two-dimensional optical mapping,” Anat Rec A Discov Mol Cell Evol Biol, vol. 280, no. 2, pp. 990–1000, Oct. 2004, doi: 10.1002/ar.a.20083.
[9822]	M. Polymenis and R. Aramayo, “Translate to divide: сontrol of the cell cycle by protein synthesis,” Microb Cell, vol. 2, no. 4, pp. 94–104, Mar. 2015, doi: 10.15698/mic2015.04.198.
[9823]	Z. Sebestyen, I. Prinz, J. Déchanet-Merville, B. Silva-Santos, and J. Kuball, “Translating gammadelta (γδ) T cells and their receptors into cancer cell therapies,” Nat Rev Drug Discov, vol. 19, no. 3, pp. 169–184, 2020, doi: 10.1038/s41573-019-0038-z.
[9824]	J. DePierro, L. Lepow, A. Feder, and R. Yehuda, “Translating Molecular and Neuroendocrine Findings in Posttraumatic Stress Disorder and Resilience to Novel Therapies,” Biol. Psychiatry, vol. 86, no. 6, pp. 454–463, 15 2019, doi: 10.1016/j.biopsych.2019.07.009.
[9825]	O. Turque, T. Tsao, T. Li, and M. Zhang, “Translational Repression in Malaria Sporozoites,” Microb Cell, vol. 3, no. 5, pp. 227–229, Apr. 2016, doi: 10.15698/mic2016.05.502.
[9826]	T. Toyo-Oka et al., “Translocation and cleavage of myocardial dystrophin as a common pathway to advanced heart failure: a scheme for the progression of cardiac dysfunction,” Proc. Natl. Acad. Sci. U.S.A., vol. 101, no. 19, pp. 7381–7385, May 2004, doi: 10.1073/pnas.0401944101.
[9827]	T. D. Church, J. P. Jessup, V. L. Guillory, and K. S. Vandewalle, “Translucency and strength of high-translucency monolithic zirconium oxide materials,” Gen Dent, vol. 65, no. 1, pp. 48–52, Feb. 2017.
[9828]	K. Walczak et al., “Translucency of Zirconia Ceramics before and after Artificial Aging,” J Prosthodont, vol. 28, no. 1, pp. e319–e324, Jan. 2019, doi: 10.1111/jopr.12771.
[9829]	F. Palmieri et al., “Transmembrane topology, genes, and biogenesis of the mitochondrial phosphate and oxoglutarate carriers,” J. Bioenerg. Biomembr., vol. 25, no. 5, pp. 493–501, Oct. 1993, doi: 10.1007/BF01108406.
[9830]	W. R. Beardslee, T. R. G. Gladstone, and E. E. O’Connor, “Transmission and prevention of mood disorders among children of affectively ill parents: a review,” J Am Acad Child Adolesc Psychiatry, vol. 50, no. 11, pp. 1098–1109, Nov. 2011, doi: 10.1016/j.jaac.2011.07.020.
[9831]	A. Liebermann et al., “Transmittance of visible and blue light through zirconia,” Dent Mater J, vol. 37, no. 5, pp. 812–817, Sep. 2018, doi: 10.4012/dmj.2016-287.
[9832]	K. Inami, J. Shiino, S. Hagiwara, K. Takeda, and M. Mochizuki, “Transnitrosation of non-mutagenic N-nitrosoproline forms mutagenic N-nitroso-N-methylurea,” Bioorg. Med. Chem., vol. 23, no. 13, pp. 3297–3302, Jul. 2015, doi: 10.1016/j.bmc.2015.04.058.
[9833]	B. Badr et al., “Transonic, thermodilution, or ionic dialysance to manage vascular access: which method is best?,” Hemodial Int, vol. 18, no. 1, pp. 127–135, Jan. 2014, doi: 10.1111/hdi.12092.
[9834]	K. M. Van Abel et al., “Transoral robotic surgery using the thulium:YAG laser: a prospective study,” Arch. Otolaryngol. Head Neck Surg., vol. 138, no. 2, pp. 158–166, Feb. 2012, doi: 10.1001/archoto.2011.1199.
[9835]	P. T. Brooks et al., “Transplanted human fecal microbiota enhanced Guillain Barré syndrome autoantibody responses after Campylobacter jejuni infection in C57BL/6 mice,” Microbiome, vol. 5, no. 1, p. 92, 08 2017, doi: 10.1186/s40168-017-0284-4.
[9836]	A. M. Vahabzadeh-Hagh, A. N. Goel, J. W. Frederick, G. S. Berke, and J. L. Long, “Transplanted human multipotent stromal cells reduce acute tongue fibrosis in rats,” Laryngoscope Investig Otolaryngol, vol. 3, no. 6, pp. 450–456, Dec. 2018, doi: 10.1002/lio2.202.
[9837]	G. S. Roeder, A. B. Rose, and R. E. Pearlman, “Transposable element sequences involved in the enhancement of yeast gene expression,” Proc. Natl. Acad. Sci. U.S.A., vol. 82, no. 16, pp. 5428–5432, Aug. 1985, doi: 10.1073/pnas.82.16.5428.
[9838]	M. J. Curcio, N. J. Sanders, and D. J. Garfinkel, “Transpositional competence and transcription of endogenous Ty elements in Saccharomyces cerevisiae: implications for regulation of transposition,” Mol. Cell. Biol., vol. 8, no. 9, pp. 3571–3581, Sep. 1988, doi: 10.1128/mcb.8.9.3571.
[9839]	D. J. Garfinkel, M. F. Mastrangelo, N. J. Sanders, B. K. Shafer, and J. N. Strathern, “Transposon tagging using Ty elements in yeast,” Genetics, vol. 120, no. 1, pp. 95–108, Sep. 1988.
[9840]	Z. Haider, G. Condous, S. Ahmed, E. Kirk, and T. Bourne, “Transvaginal sonographic diagnosis of appendicitis in acute pelvic pain,” J Ultrasound Med, vol. 25, no. 9, pp. 1243–1244, Sep. 2006, doi: 10.7863/jum.2006.25.9.1243.
[9841]	K. Ratanasopa, S. Chakane, M. Ilyas, C. Nantasenamat, and L. Bulow, “Trapping of human hemoglobin by haptoglobin: molecular mechanisms and clinical applications,” Antioxid. Redox Signal., vol. 18, no. 17, pp. 2364–2374, Jun. 2013, doi: 10.1089/ars.2012.4878.
[9842]	M. J. J. Lommen and K. Restifo, “Trauma and posttraumatic stress disorder (PTSD) in patients with schizophrenia or schizoaffective disorder,” Community Ment Health J, vol. 45, no. 6, pp. 485–496, Dec. 2009, doi: 10.1007/s10597-009-9248-x.
[9843]	W. M. Vanderheyden, G. R. Poe, and I. Liberzon, “Trauma exposure and sleep: using a rodent model to understand sleep function in PTSD,” Exp Brain Res, vol. 232, no. 5, pp. 1575–1584, May 2014, doi: 10.1007/s00221-014-3890-4.
[9844]	R. J. Herringa, “Trauma, PTSD, and the Developing Brain,” Curr Psychiatry Rep, vol. 19, no. 10, p. 69, Aug. 2017, doi: 10.1007/s11920-017-0825-3.
[9845]	J. J. Vasterling, S. N. Jacob, and A. Rasmusson, “Traumatic Brain Injury and Posttraumatic Stress Disorder: Conceptual, Diagnostic, and Therapeutic Considerations in the Context of Co-Occurrence,” J Neuropsychiatry Clin Neurosci, vol. 30, no. 2, pp. 91–100, 2018, doi: 10.1176/appi.neuropsych.17090180.
[9846]	A. Lazarus, “Traumatized by practice: PTSD in physicians,” J Med Pract Manage, vol. 30, no. 2, pp. 131–134, Oct. 2014.
[9847]	B. Silvestrini, “Trazodone: from the mental pain to the ‘dys-stress’ hypothesis of depression,” Clin Neuropharmacol, vol. 12 Suppl 1, pp. S4-10, 1989, doi: 10.1097/00002826-198901001-00002.
[9848]	F. Rouillon and M. Leboyer, “Treating depression: Diagnosing and treating circadian abnormalities in depression: current antidepressants,” Eur Neuropsychopharmacol, vol. 21 Suppl 4, pp. S669-670, Sep. 2011, doi: 10.1016/j.euroneuro.2011.07.017.
[9849]	C. Staehelin, L. Elzi, R. Weber, and H. Furrer, “[Treatment and prevention of opportunistic infections],” Ther Umsch, vol. 71, no. 8, pp. 475–482, Aug. 2014, doi: 10.1024/0040-5930/a000540.
[9850]	A. Hussen, S. Biadgilign, F. Tessema, S. Mohammed, K. Deribe, and A. Deribew, “Treatment delay among pulmonary tuberculosis patients in pastoralist communities in Bale Zone, Southeast Ethiopia,” BMC Res Notes, vol. 5, p. 320, Jun. 2012, doi: 10.1186/1756-0500-5-320.
[9851]	Y. Morita, “[Treatment for low-risk myelodysplastic syndromes],” Rinsho Ketsueki, vol. 59, no. 10, pp. 2050–2057, 2018, doi: 10.11406/rinketsu.59.2050.
[9852]	R. Sousa, P. Cortes, M. Harries, and S. Papa, “Treatment for metastatic melanoma: a new and evolving era,” Int. J. Clin. Pract., vol. 69, no. 3, pp. 273–280, Mar. 2015, doi: 10.1111/ijcp.12583.
[9853]	M. Cyr and M. K. Farrar, “Treatment for posttraumatic stress disorder,” Ann Pharmacother, vol. 34, no. 3, pp. 366–376, Mar. 2000, doi: 10.1345/aph.19120.
[9854]	M. Bjørn, B. Stausbøl-Grøn, A. Braae Olesen, and L. Hedelund, “Treatment of acne scars with fractional CO2 laser at 1-month versus 3-month intervals: an intra-individual randomized controlled trial,” Lasers Surg Med, vol. 46, no. 2, pp. 89–93, Feb. 2014, doi: 10.1002/lsm.22165.
[9855]	C. Gasca-Salas, “Treatment of cognitive impairment in Parkinson disease,” Med Clin (Barc), vol. 148, no. 5, pp. 232–237, 03 2017, doi: 10.1016/j.medcli.2016.10.027.
[9856]	C. F. Reynolds, “Treatment of depression in late life,” Am. J. Med., vol. 97, no. 6A, pp. 39S-46S, Dec. 1994, doi: 10.1016/0002-9343(94)90362-x.
[9857]	P. Lingor et al., “[Treatment of end-of-dose fluctuations: the need for an individualized approach],” Fortschr Neurol Psychiatr, vol. 86, no. S 01, pp. S59–S62, 2018, doi: 10.1055/a-0583-8460.
[9858]	X.-A.-D. Chang, S. Dai, Z.-Z. Ye, and Q.-H. Song, “[Treatment of Facial Acne Vulgaris by Chinese Medicine Combined Western Medicine],” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 37, no. 2, pp. 160–164, Feb. 2017.
[9859]	M. P. Dutro, T. D. Gerthoffer, E. D. Peterson, S. S. K. Tang, and G. A. Goldberg, “Treatment of hypertension and dyslipidemia or their combination among US managed-care patients,” J Clin Hypertens (Greenwich), vol. 9, no. 9, pp. 684–691, Sep. 2007, doi: 10.1111/j.1524-6175.2007.07146.x.
[9860]	X. Wang, X. Song, Y. Liu, W. Zhang, W. An, and Y. Tu, “Treatment of membranous nephropathy with mizoribine: A control trial,” Life Sci., vol. 154, pp. 75–78, Jun. 2016, doi: 10.1016/j.lfs.2016.04.012.
[9861]	J. H. Tu, J. A. Udkoff, and L. F. Eichenfield, “Treatment of Pediatric Treadmill Burn Contractures With Ablative Fractional Laser and Topical Triamcinolone Suspension,” Dermatol Surg, vol. 44, no. 12, pp. 1656–1659, 2018, doi: 10.1097/DSS.0000000000001553.
[9862]	I. Minkina, J. G. Ojemann, T. J. Grabowski, J. P. Silkes, V. Phatak, and D. L. Kendall, “Treatment of proper name retrieval deficits in an individual with temporal lobe epilepsy,” Am J Speech Lang Pathol, vol. 22, no. 2, pp. S250-255, May 2013, doi: 10.1044/1058-0360(2012/12-0048).
[9863]	A. A. Yassin and F. Saad, “Treatment of sexual dysfunction of hypogonadal patients with long-acting testosterone undecanoate (Nebido),” World J Urol, vol. 24, no. 6, pp. 639–644, Dec. 2006, doi: 10.1007/s00345-006-0120-0.
[9864]	B. Jeremic, F. B. Zimmermann, M. Bamberg, and M. Molls, “Treatment of small cell lung cancer in the elderly,” Hematol. Oncol. Clin. North Am., vol. 18, no. 2, pp. 433–443, Apr. 2004, doi: 10.1016/j.hoc.2003.12.003.
[9865]	M. Hayashi, H. Kobayashi, H. Kawano, Y. Handa, and S. Hirose, “Treatment of systemic hypertension and intracranial hypertension in cases of brain hemorrhage,” Stroke, vol. 19, no. 3, pp. 314–321, Mar. 1988, doi: 10.1161/01.str.19.3.314.
[9866]	Q. Du, H. Cong, Y. Shi, H. Jiang, and H. Sui, “[Treatment of tibial traumatic osteomyelitis with vacuum sealing drainage combined with open bone graft],” Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, vol. 28, no. 5, pp. 562–565, May 2014.
[9867]	P. A. Richardson et al., “Treatment Patterns in Veterans with Laryngeal and Oropharyngeal Cancer and Impact on Survival,” Laryngoscope Investig Otolaryngol, vol. 3, no. 4, pp. 275–282, Aug. 2018, doi: 10.1002/lio2.170.
[9868]	A. K. Singh, A. Rai, M. Kushwaha, P. S. Chauhan, V. Pandey, and N. Singh, “Tree growth rate regulate the influence of elevated CO2 on soil biochemical responses under tropical condition,” J. Environ. Manage., vol. 231, pp. 1211–1221, Feb. 2019, doi: 10.1016/j.jenvman.2018.11.025.
[9869]	R. L. Vicente, L. Spina, J. P. L. Gómez, S. Dejean, J.-L. Parrou, and J. M. François, “Trehalose-6-phosphate promotes fermentation and glucose repression in Saccharomyces cerevisiae,” Microb Cell, vol. 5, no. 10, pp. 444–459, Oct. 2018, doi: 10.15698/mic2018.10.651.
[9870]	T. R. Jay, V. E. von Saucken, and G. E. Landreth, “TREM2 in Neurodegenerative Diseases,” Mol Neurodegener, vol. 12, no. 1, p. 56, 02 2017, doi: 10.1186/s13024-017-0197-5.
[9871]	A. O. Ceballos-Baumann and H. Boecker, “[Tremor--new therapy options],” Internist (Berl), vol. 41, no. 12, pp. 1353–1362, Dec. 2000.
[9872]	J. F. Scalo and K. L. Rascati, “Trends and issues in oncology costs,” Expert Rev Pharmacoecon Outcomes Res, vol. 14, no. 1, pp. 35–44, Feb. 2014, doi: 10.1586/14737167.2014.864561.
[9873]	N. Amankwah, M. Park, A. Gu, and B. G. Choi, “Trends in Authorship Demographics for Manuscripts Published in The American Journal of Cardiology,” Am. J. Cardiol., vol. 122, no. 7, pp. 1255–1259, 01 2018, doi: 10.1016/j.amjcard.2018.06.026.
[9874]	H. Blažun Vošner, D. Železnik, P. Kokol, J. Vošner, and J. Završnik, “Trends in nursing ethics research: Mapping the literature production,” Nurs Ethics, vol. 24, no. 8, pp. 892–907, Dec. 2017, doi: 10.1177/0969733016654314.
[9875]	M. Rodríguez Giménez, M. Ubalde-Lopez, C. Cornelio, M. López-Ruiz, and F. G. Benavides, “[TRENDS IN OCCUPATIONAL INJURY AND DISEASE IN ARGENTINA, 1997-2015],” Arch Prev Riesgos Labor, vol. 22, no. 1, pp. 18–24, Mar. 2019, doi: 10.12961/aprl.2019.22.01.4.
[9876]	G. O. Ogunbayo et al., “Trends, Management Patterns, and Predictors of Leaving Against Medical Advice among Patients with Documented Noncompliance Admitted for Acute Myocardial Infarction,” J Gen Intern Med, vol. 34, no. 4, pp. 486–488, 2019, doi: 10.1007/s11606-018-4671-8.
[9877]	M. So and M. A. Rendón, “Tribal warfare: Commensal Neisseria kill pathogen Neisseria gonorrhoeae using its DNA,” Microb Cell, vol. 6, no. 12, pp. 544–546, Oct. 2019, doi: 10.15698/mic2019.12.701.
[9878]	H. Wu, G. Spatafora, C. Fenno, and K. Mintz, “Tribute,” Mol Oral Microbiol, vol. 30, no. 4, pp. 253–254, Aug. 2015, doi: 10.1111/omi.12105.
[9879]	C. B. Menezes, A. P. Frasson, and T. Tasca, “Trichomoniasis - are we giving the deserved attention to the most common non-viral sexually transmitted disease worldwide?,” Microb Cell, vol. 3, no. 9, pp. 404–419, Jun. 2016, doi: 10.15698/mic2016.09.526.
[9880]	K. Kamm, H.-J. Osigus, P. F. Stadler, R. DeSalle, and B. Schierwater, “Trichoplax genomes reveal profound admixture and suggest stable wild populations without bisexual reproduction,” Sci Rep, vol. 8, no. 1, p. 11168, 24 2018, doi: 10.1038/s41598-018-29400-y.
[9881]	J. Estany, R. Ros-Freixedes, M. Tor, and R. N. Pena, “TRIENNIAL GROWTH AND DEVELOPMENT SYMPOSIUM: Genetics and breeding for intramuscular fat and oleic acid content in pigs,” J. Anim. Sci., vol. 95, no. 5, pp. 2261–2271, May 2017, doi: 10.2527/jas.2016.1108.
[9882]	H. Kettenmann, “Triggering the brain’s pathology sensor,” Nat. Neurosci., vol. 9, no. 12, pp. 1463–1464, Dec. 2006, doi: 10.1038/nn1206-1463.
[9883]	A. Salamon and J. P. Kent, “Triple-yolked eggs in domestic ducks: a rare occurrence,” Poult. Sci., vol. 95, no. 5, pp. 1179–1181, May 2016, doi: 10.3382/ps/pew004.
[9884]	R. Root-Bernstein, Y. Kim, A. Sanjay, and Z. F. Burton, “tRNA evolution from the proto-tRNA minihelix world,” Transcription, vol. 7, no. 5, pp. 153–163, 19 2016, doi: 10.1080/21541264.2016.1235527.
[9885]	D. Pak, R. Root-Bernstein, and Z. F. Burton, “tRNA structure and evolution and standardization to the three nucleotide genetic code,” Transcription, vol. 8, no. 4, pp. 205–219, 08 2017, doi: 10.1080/21541264.2017.1318811.
[9886]	B. Bozeman and J. Youtie, “Trouble in Paradise: Problems in Academic Research Co-authoring,” Sci Eng Ethics, vol. 22, no. 6, pp. 1717–1743, 2016, doi: 10.1007/s11948-015-9722-5.
[9887]	M. Rew and S. Woodward, “Troubleshooting common problems associated with long-term catheters,” Br J Nurs, vol. 10, no. 12, pp. 764–774, Jul. 2001, doi: 10.12968/bjon.2001.10.12.5302.
[9888]	P. A. Rosental, “Truncating a disease. The reduction of silica hazards to silicosis at the 1930 international labor office conference on silicosis in Johannesburg,” Am. J. Ind. Med., vol. 58 Suppl 1, pp. S6-14, Nov. 2015, doi: 10.1002/ajim.22517.
[9889]	L. E. Michaelson and Y. Munakata, “Trust matters: Seeing how an adult treats another person influences preschoolers’ willingness to delay gratification,” Dev Sci, vol. 19, no. 6, pp. 1011–1019, 2016, doi: 10.1111/desc.12388.
[9890]	J. R. Bean, “Truth or Consequences: The Growing Trend of Publication Retraction,” World Neurosurg, vol. 103, pp. 917–918, 2017, doi: 10.1016/j.wneu.2017.04.086.
[9891]	B. D. Lundholm, J. Storz, and D. G. McKERCHER, “Trypanosoma theileri as a contaminant of tissue origin in cultures of fetal bovine kidney cells in vitro,” Virology, vol. 8, no. 3, pp. 394–396, Jul. 1959, doi: 10.1016/0042-6822(59)90042-x.
[9892]	X. Zhai, Q. Wang, and M. Li, “Tu Youyou’s Nobel Prize and the academic evaluation system in China,” Lancet, vol. 387, no. 10029, p. 1722, Apr. 2016, doi: 10.1016/S0140-6736(16)30261-6.
[9893]	T. Hamaguchi, A. Takahashi, A. Manaka, M. Sato, and H. Osada, “TU-572, a potent and selective CD45 inhibitor, suppresses IgE-mediated anaphylaxis and murine contact hypersensitivity reactions,” Int. Arch. Allergy Immunol., vol. 126, no. 4, pp. 318–324, Dec. 2001, doi: 10.1159/000049529.
[9894]	Z. Mor, H. Kolb, M. Lidji, G. Migliori, and A. Leventhal, “Tuberculosis diagnostic delay and therapy outcomes of non-national migrants in Tel Aviv, 1998-2008,” Euro Surveill., vol. 18, no. 12, Mar. 2013.
[9895]	A. K. Dutt, D. Moers, and W. W. Stead, “Tuberculous pleural effusion: 6-month therapy with isoniazid and rifampin,” Am. Rev. Respir. Dis., vol. 145, no. 6, pp. 1429–1432, Jun. 1992, doi: 10.1164/ajrccm/145.6.1429.
[9896]	J. H. Song, A. F. Koreishi, and D. A. Goldstein, “Tuberculous Uveitis Presenting with a Bullous Exudative Retinal Detachment: A Case Report and Systematic Literature Review,” Ocul. Immunol. Inflamm., vol. 27, no. 6, pp. 998–1009, 2019, doi: 10.1080/09273948.2018.1485958.
[9897]	M. M. Sigel, T. M. Scotti, M. A. Wryk, and M. Dorsey, “Tubule formation in rat brains by monkey kidney cells previously grown in vitro,” Nature, vol. 182, no. 4641, pp. 1034–1035, Oct. 1958, doi: 10.1038/1821034a0.
[9898]	W. A. Weber, R. Haubner, E. Vabuliene, B. Kuhnast, H. J. Wester, and M. Schwaiger, “Tumor angiogenesis targeting using imaging agents,” Q J Nucl Med, vol. 45, no. 2, pp. 179–182, Jun. 2001.
[9899]	M. Diament, S. Klein, E. Rodriguez Paradisi, I. D. Elia, and Y. P. De Bonaparte, “Tumor cells cultured in vivo in diffusion chambers induce hematological alterations,” In Vivo, vol. 9, no. 3, pp. 203–206, Jun. 1995.
[9900]	A. Schartl and M. Schartl, “Tumor induction and tumor regression in Xiphophorus,” In Vivo, vol. 10, no. 2, pp. 179–184, Apr. 1996.
[9901]	R. Miskin, “‘Tumor target organs and rate of survival in long-living transgenic mice and their parental wild-type counterparts exposed to the carcinogen dimethylbenz(alpha)anthracene’, by Kossoy George, Herzl Ben-Hur, Ruth Miskin and Isthak Zusman. In vivo 20: 543-548, 2006,” In Vivo, vol. 20, no. 6B, pp. 911–912, Dec. 2006.
[9902]	D. Lüftner et al., “Tumor type M2 pyruvate kinase expression in advanced breast cancer,” Anticancer Res., vol. 20, no. 6D, pp. 5077–5082, Dec. 2000.
[9903]	D. A. Rew, “Tumour biology, chaos and non-linear dynamics,” Eur J Surg Oncol, vol. 25, no. 1, pp. 86–89, Feb. 1999, doi: 10.1053/ejso.1998.0606.
[9904]	A. Galindo-Ferreiro, D. AlEssa, S. M. Elkhamary, D. P. Edward, A. Galvez-Ruiz, and S. Schellini, “Tungiasis infestation of dermis fat graft in an anophthalmic socket,” Saudi J Ophthalmol, vol. 33, no. 1, pp. 102–104, Mar. 2019, doi: 10.1016/j.sjopt.2018.06.005.
[9905]	J. Wu et al., “Tunicamycin specifically aggravates ER stress and overcomes chemoresistance in multidrug-resistant gastric cancer cells by inhibiting N-glycosylation,” J. Exp. Clin. Cancer Res., vol. 37, no. 1, p. 272, Nov. 2018, doi: 10.1186/s13046-018-0935-8.
[9906]	S. Haldar, D. Kaleeswaran, D. Rase, K. Roy, S. Ogale, and R. Vaidhyanathan, “Tuning the electronic energy level of covalent organic frameworks for crafting high-rate Na-ion battery anode,” Nanoscale Horiz, vol. 5, no. 8, pp. 1264–1273, Aug. 2020, doi: 10.1039/d0nh00187b.
[9907]	H. Pars, R. Akın, N. E. Sahin, S. Cinar, F. Aslan, and S. Duygulu, “Turkish health field periodical editors’ Views on publication process and ethical problems,” Niger J Clin Pract, vol. 21, no. 3, pp. 264–270, Mar. 2018, doi: 10.4103/njcp.njcp_49_17.
[9908]	M. T. Tanoue et al., “Tweeting the Meeting,” Circ Cardiovasc Qual Outcomes, vol. 11, no. 11, p. e005018, 2018, doi: 10.1161/CIRCOUTCOMES.118.005018.
[9909]	M. L. Giannì, O. Picciolini, C. Vegni, L. Gardon, M. Fumagalli, and F. Mosca, “Twelve-month neurofunctional assessment and cognitive performance at 36 months of age in extremely low birth weight infants,” Pediatrics, vol. 120, no. 5, pp. 1012–1019, Nov. 2007, doi: 10.1542/peds.2006-3364.
[9910]	G. J. Magovern, G. A. Liebler, S. B. Park, J. A. Burkholder, T. Sakert, and K. A. Simpson, “Twenty-five-year review of the Magovern-Cromie sutureless aortic valve,” Ann. Thorac. Surg., vol. 48, no. 3 Suppl, pp. S33-34, Sep. 1989, doi: 10.1016/0003-4975(89)90629-2.
[9911]	W. N. Wicomb, D. K. Cooper, and C. N. Barnard, “Twenty-four-hour preservation of the pig heart by a portable hypothermic perfusion system,” Transplantation, vol. 34, no. 5, pp. 246–250, Nov. 1982, doi: 10.1097/00007890-198211000-00002.
[9912]	C. Bartlett and R. Wurtz, “Twitter and public health,” J Public Health Manag Pract, vol. 21, no. 4, pp. 375–383, Aug. 2015, doi: 10.1097/PHH.0000000000000041.
[9913]	A. Yasuda, H. Imamoto, H. Furukawa, M. Imano, T. Yasuda, and K. Okuno, “[Two cases of afferent loop syndrome caused by obstruction at the jejuno-jejunostomy site in the Roux-en-Y loop that were successfully treated by endoscopic balloon dilatation],” Gan To Kagaku Ryoho, vol. 41, no. 12, pp. 2322–2325, Nov. 2014.
[9914]	Y. Mohammad, L. Haffar, A. Adib, Z. Hamdan, and B. Dubaybo, “[Two cases of endobronchial tuberculosis],” Rev Pneumol Clin, vol. 72, no. 2, pp. 155–160, Apr. 2016, doi: 10.1016/j.pneumo.2015.08.001.
[9915]	W. H. Koppenol and H. Sies, “Two centuries since discovery of dawn-of-life molecule,” Nature, vol. 559, no. 7713, p. 181, 2018, doi: 10.1038/d41586-018-05674-0.
[9916]	O. Nazareth et al., “Two controlled studies of the efficacy of isoniazid alone in preventing relapse in patients with bacteriologically quiescent pulmonary tuberculosis at the end of one year of chemotherapy,” Bull. World Health Organ., vol. 45, no. 5, pp. 603–615, 1971.
[9917]	S. Castanheira, J. J. Cestero, F. García-del Portillo, and M. G. Pucciarelli, “Two distinct penicillin binding proteins promote cell division in different Salmonella lifestyles,” Microb Cell, vol. 5, no. 3, pp. 165–168, 17 2018, doi: 10.15698/mic2018.03.622.
[9918]	J. Witecka et al., “Two novel COL1A1 mutations in patients with osteogenesis imperfecta (OI) affect the stability of the collagen type I triple-helix,” J. Appl. Genet., vol. 49, no. 3, pp. 283–295, 2008, doi: 10.1007/BF03195625.
[9919]	H. Mafakheri, S. M. Taghavi, J. Puławska, P. de Lajudie, F. Lassalle, and E. Osdaghi, “Two Novel Genomospecies in the Agrobacterium tumefaciens Species Complex Associated with Rose Crown Gall,” Phytopathology, vol. 109, no. 11, pp. 1859–1868, Nov. 2019, doi: 10.1094/PHYTO-05-19-0178-R.
[9920]	H. Wang, C. Xie, P. Zhu, N.-Y. Zhou, and Z. Lu, “Two Novel Sets of Genes Essential for Nicotine Degradation by Sphingomonas melonis TY,” Front Microbiol, vol. 7, p. 2060, 2016, doi: 10.3389/fmicb.2016.02060.
[9921]	F. Batioğlu, E. Ozmert, N. Parmak, and S. Celik, “Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema,” Int Ophthalmol, vol. 27, no. 5, pp. 299–306, Oct. 2007, doi: 10.1007/s10792-007-9072-7.
[9922]	D. J. Garfinkel, J. D. Boeke, and G. R. Fink, “Ty element transposition: reverse transcriptase and virus-like particles,” Cell, vol. 42, no. 2, pp. 507–517, Sep. 1985, doi: 10.1016/0092-8674(85)90108-4.
[9923]	J. D. Boeke, D. J. Garfinkel, C. A. Styles, and G. R. Fink, “Ty elements transpose through an RNA intermediate,” Cell, vol. 40, no. 3, pp. 491–500, Mar. 1985, doi: 10.1016/0092-8674(85)90197-7.
[9924]	C. E. Paquin and V. M. Williamson, “Ty insertions at two loci account for most of the spontaneous antimycin A resistance mutations during growth at 15 degrees C of Saccharomyces cerevisiae strains lacking ADH1,” Mol. Cell. Biol., vol. 6, no. 1, pp. 70–79, Jan. 1986, doi: 10.1128/mcb.6.1.70.
[9925]	G. E. Chisholm and T. G. Cooper, “Ty insertions upstream and downstream of native DUR1,2 promoter elements generate different patterns of DUR1,2 expression in Saccharomyces cerevisiae,” J. Bacteriol., vol. 174, no. 8, pp. 2548–2559, Apr. 1992, doi: 10.1128/jb.174.8.2548-2559.1992.
[9926]	L. J. Capsey, D. H. Williamson, and G. R. Banks, “Ty virus-like particles in the Saccharomyces cerevisiae strain NCYC74,” Curr. Genet., vol. 18, no. 6, pp. 485–491, Dec. 1990, doi: 10.1007/BF00327018.
[9927]	C. M. Voorburg, Z. Yan, M. Bergua-Vidal, A.-M. A. Wolters, Y. Bai, and R. Kormelink, “Ty-1, a universal resistance gene against geminiviruses that is compromised by co-replication of a betasatellite,” Mol. Plant Pathol., vol. 21, no. 2, pp. 160–172, 2020, doi: 10.1111/mpp.12885.
[9928]	U. Gill et al., “Ty-6, a major begomovirus resistance gene on chromosome 10, is effective against Tomato yellow leaf curl virus and Tomato mottle virus,” Theor. Appl. Genet., vol. 132, no. 5, pp. 1543–1554, May 2019, doi: 10.1007/s00122-019-03298-0.
[9929]	K. Aihara et al., “TY-12533, a novel Na(+)/H(+) exchange inhibitor, prevents myocardial stunning in dogs,” Eur. J. Pharmacol., vol. 419, no. 1, pp. 93–97, May 2001, doi: 10.1016/s0014-2999(01)00952-9.
[9930]	G. Simchen, F. Winston, C. A. Styles, and G. R. Fink, “Ty-mediated gene expression of the LYS2 and HIS4 genes of Saccharomyces cerevisiae is controlled by the same SPT genes,” Proc. Natl. Acad. Sci. U.S.A., vol. 81, no. 8, pp. 2431–2434, Apr. 1984, doi: 10.1073/pnas.81.8.2431.
[9931]	G. A. M. Govaert and S. van Helden, “Ty-raps in trauma: a novel closing technique of extremity fasciotomy wounds,” J Trauma, vol. 69, no. 4, pp. 972–975, Oct. 2010, doi: 10.1097/TA.0b013e3181f2d9d3.
[9932]	R. Stucka, H. Lochmüller, and H. Feldmann, “Ty4, a novel low-copy number element in Saccharomyces cerevisiae: one copy is located in a cluster of Ty elements and tRNA genes,” Nucleic Acids Res., vol. 17, no. 13, pp. 4993–5001, Jul. 1989, doi: 10.1093/nar/17.13.4993.
[9933]	S. Sachs, A. J. Ghio, and S. L. Young, “Tyloxapol confers durable protection against hyperoxic lung injury in the rat,” Exp. Lung Res., vol. 25, no. 6, pp. 543–559, Sep. 1999, doi: 10.1080/019021499270123.
[9934]	D. S. Roberts, A. Yamasaki, A. R. Sedaghat, D. J. Lee, and E. Reardon, “Tympanic Plexus Neurectomy for Intractable Otalgia,” Laryngoscope Investig Otolaryngol, vol. 1, no. 5, pp. 135–139, 2016, doi: 10.1002/lio2.31.
[9935]	M. M. Mancardi et al., “Type 1 diabetes and epilepsy: more than a casual association?,” Epilepsia, vol. 51, no. 2, pp. 320–321, Feb. 2010, doi: 10.1111/j.1528-1167.2009.02380.x.
[9936]	X. Chen et al., “[Type C2 proximal humeral fracture fixation using locking-plate with an intramedullary fibular allograft],” Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, vol. 28, no. 2, pp. 201–204, Feb. 2014.
[9937]	L. T. Alexander et al., “Type II Inhibitors Targeting CDK2,” ACS Chem. Biol., vol. 10, no. 9, pp. 2116–2125, Sep. 2015, doi: 10.1021/acschembio.5b00398.
[9938]	Y. Shen, H. Huang, L. Zhu, M. Luo, and D. Chen, “Type II thioesterase gene (ECO-orf27) from Amycolatopsis orientalis influences production of the polyketide antibiotic, ECO-0501 (LW01),” Biotechnol. Lett., vol. 34, no. 11, pp. 2087–2091, Nov. 2012, doi: 10.1007/s10529-012-1010-8.
[9939]	M. T. Mata et al., “Type II-Metacaspases are involved in cell stress but not in cell death in the unicellular green alga Dunaliella tertiolecta,” Microb Cell, vol. 6, no. 11, pp. 494–508, Oct. 2019, doi: 10.15698/mic2019.11.696.
[9940]	A. Reich et al., “Type V OI primary osteoblasts display increased mineralization despite decreased COL1A1 expression,” J. Clin. Endocrinol. Metab., vol. 100, no. 2, pp. E325-332, Feb. 2015, doi: 10.1210/jc.2014-3082.
[9941]	G. Lelli and M. Bondi, “[Typical and atypical mitosis in cultures in vitro; studies of normal kidney cells of the Rhesus monkey],” Rend Ist Sup Sanit, vol. 20, no. 12, pp. 1126–1130, 1957.
[9942]	Y. Shi et al., “Tyrosinase-doped bioink for 3D bioprinting of living skin constructs,” Biomed Mater, vol. 13, no. 3, p. 035008, 06 2018, doi: 10.1088/1748-605X/aaa5b6.
[9943]	L. van der Wagen et al., “Tyrosine kinase inhibitor levels matter in treating chronic GVHD,” Bone Marrow Transplant., vol. 54, no. 7, pp. 1141–1144, 2019, doi: 10.1038/s41409-018-0429-5.
[9944]	M. Caboral-Stevens, M. V. Whetsell, L. S. Evangelista, B. Cypress, and D. Nickitas, “U.S.A.B.I.L.I.T.Y. Framework for Older Adults,” Res Gerontol Nurs, vol. 8, no. 6, pp. 300–306, Dec. 2015, doi: 10.3928/19404921-20150522-02.
[9945]	E. U. Zorn, T. R. Walter, J. B. Johnson, and R. Mania, “UAS-based tracking of the Santiaguito Lava Dome, Guatemala,” Sci Rep, vol. 10, no. 1, p. 8644, May 2020, doi: 10.1038/s41598-020-65386-2.
[9946]	J. Wang, Z. Qiu, and Y. Wu, “Ubiquitin Regulation: The Histone Modifying Enzyme’s Story,” Cells, vol. 7, no. 9, Aug. 2018, doi: 10.3390/cells7090118.
[9947]	“UEG Research Committee: Encouraging innovation and excellence in research on digestive health,” United European Gastroenterol J, vol. 7, no. 8, pp. 1139–1140, 2019, doi: 10.1177/2050640619877604.
[9948]	C. M. Papa, “Ugly as sun,” N J Med, vol. 91, no. 5, p. 311, May 1994.
[9949]	C.-I. Shin et al., “Ultra-low peak voltage CT colonography: effect of iterative reconstruction algorithms on performance of radiologists who use anthropomorphic colonic phantoms,” Radiology, vol. 273, no. 3, pp. 759–771, Dec. 2014, doi: 10.1148/radiol.14140192.
[9950]	Y. Liu et al., “Ultrafast and Stable Lithium Storage Enabled by the Electric Field Effect in Layer-Structured Tablet-Like NH4TiOF3 Mesocrystals,” ACS Appl Mater Interfaces, vol. 12, no. 18, pp. 20404–20413, May 2020, doi: 10.1021/acsami.0c01795.
[9951]	W. Wang et al., “Ultrafine antimony (Sb) nanoparticles encapsulated into a carbon microfiber framework as an excellent LIB anode with a superlong life of more than 5000 cycles,” Nanotechnology, vol. 31, no. 21, p. 215403, May 2020, doi: 10.1088/1361-6528/ab73b8.
[9952]	A. A. Rigler, A. Vizjak, D. Ferluga, A. Kandus, and J. Buturović-Ponikvar, “Ultrasonography parameters and histopathology findings in transplanted kidney,” Transplant. Proc., vol. 45, no. 4, pp. 1630–1634, May 2013, doi: 10.1016/j.transproceed.2013.01.034.
[9953]	N. J. Petterson, L. S. Fixsen, M. C. M. Rutten, N. H. J. Pijls, F. N. van de Vosse, and R. G. P. Lopata, “Ultrasound functional imaging in an ex vivo beating porcine heart platform,” Phys Med Biol, vol. 62, no. 23, pp. 9112–9126, Nov. 2017, doi: 10.1088/1361-6560/aa9515.
[9954]	J. Alexander et al., “Ultrasound-guided femoral arterial access in pediatric cardiac catheterizations: A prospective evaluation of the prevalence, risk factors, and mechanism for acute loss of arterial pulse,” Catheter Cardiovasc Interv, vol. 88, no. 7, pp. 1098–1107, Dec. 2016, doi: 10.1002/ccd.26702.
[9955]	S. C. Lee, D. Rha, H.-J. Kim, H. Yang, S.-H. Lee, and D. Koh, “Ultrasound-guided injection of the intrapelvic portion of the obturator internus in a cadaver model,” Reg Anesth Pain Med, vol. 39, no. 4, pp. 347–350, Aug. 2014, doi: 10.1097/AAP.0000000000000093.
[9956]	N. Al Rifai et al., “Ultrasound-triggered delivery of paclitaxel encapsulated in an emulsion at low acoustic pressures,” J Mater Chem B, vol. 8, no. 8, pp. 1640–1648, 26 2020, doi: 10.1039/c9tb02493j.
[9957]	A. C. Gelijns, J. G. Zivin, and R. R. Nelson, “Uncertainty and technological change in medicine,” J Health Polit Policy Law, vol. 26, no. 5, pp. 913–924, Oct. 2001, doi: 10.1215/03616878-26-5-913.
[9958]	K. J. Arrow, “Uncertainty and the welfare economics of medical care. 1963,” J Health Polit Policy Law, vol. 26, no. 5, pp. 851–883, Oct. 2001, doi: 10.1215/03616878-26-5-851.
[9959]	R. C. Lindsley, “Uncoding the genetic heterogeneity of myelodysplastic syndrome,” Hematology Am Soc Hematol Educ Program, vol. 2017, no. 1, pp. 447–452, 08 2017, doi: 10.1182/asheducation-2017.1.447.
[9960]	J.-B. Hong, H. Prucha, B. Melnik, M. Ziai, J. Ring, and W. Chen, “[Uncommon acne-associated syndromes and their significance in understanding the pathogenesis of acne],” Hautarzt, vol. 64, no. 4, pp. 274–279, Apr. 2013, doi: 10.1007/s00105-012-2460-6.
[9961]	M. Rodriguez Celin, S. Moosa, and V. Fano, “Uncommon IFITM5 mutation associated with severe skeletal deformity in osteogenesis imperfecta,” Ann. Hum. Genet., vol. 82, no. 6, pp. 477–481, 2018, doi: 10.1111/ahg.12275.
[9962]	I. Rustenbeck, “[Unconventional antidiabetic agents],” Med Monatsschr Pharm, vol. 30, no. 4, pp. 131–137, Apr. 2007.
[9963]	G. P. Haag and J. A. Adamski, “Uncovering preoperative anxiety,” AANA J, vol. 46, no. 6, pp. 615–621, Dec. 1978.
[9964]	M. A. Flores-Valdez, “Uncovering the hidden: complexity and strategies for diagnosing latent tuberculosis,” Microb Cell, vol. 4, no. 11, pp. 365–367, Oct. 2017, doi: 10.15698/mic2017.11.596.
[9965]	D. S. Cui, J. M. Lipchock, D. Brookner, and J. P. Loria, “Uncovering the Molecular Interactions in the Catalytic Loop That Modulate the Conformational Dynamics in Protein Tyrosine Phosphatase 1B,” J. Am. Chem. Soc., vol. 141, no. 32, pp. 12634–12647, 14 2019, doi: 10.1021/jacs.9b04470.
[9966]	G. J. Bix et al., “Uncovering the Rosetta Stone: Report from the First Annual Conference on Key Elements in Translating Stroke Therapeutics from Pre-Clinical to Clinical,” Transl Stroke Res, vol. 9, no. 3, pp. 258–266, 2018, doi: 10.1007/s12975-018-0628-9.
[9967]	L. R. Webster, “Uncritical Publication of a Biased Study Leads to Misleading Media Reports,” Pain Med, vol. 20, no. 7, pp. 1274–1276, 01 2019, doi: 10.1093/pm/pny234.
[9968]	G. Nicolet and J. Gallera, “[Under what conditions will the amnion of the chick embryo develop in culture in vitro?],” Experientia, vol. 19, pp. 165–166, Mar. 1963, doi: 10.1007/BF02171616.
[9969]	L. Heslop, M. McIntyre, and G. Ives, “Undergraduate student nurses’ expectations and their self-reported preparedness for the graduate year role,” J Adv Nurs, vol. 36, no. 5, pp. 626–634, Dec. 2001, doi: 10.1046/j.1365-2648.2001.02022.x.
[9970]	C. W. Higgins, “Undermining the hospital industry through nonprice competition,” Hosp Top, vol. 67, no. 3, pp. 18–21, Jun. 1989, doi: 10.1080/00185868.1989.10543653.
[9971]	F. L. Cavallaro et al., “Understanding ‘missed appointments’ for pills and injectables: a mixed methods study in Senegal,” BMJ Glob Health, vol. 3, no. 6, p. e000975, 2018, doi: 10.1136/bmjgh-2018-000975.
[9972]	P. Tucker and R. Trautman, “Understanding and treating PTSD: past, present, and future,” Bull Menninger Clin, vol. 64, no. 3 Suppl A, pp. A37-51, 2000.
[9973]	K. J. Saleh, A. Gafni, W. B. Macaulay, A. Miric, L. Saleh, and J. Schatzker, “Understanding economic evaluations: a review of the knee arthroplasty literature,” Am J Knee Surg, vol. 12, no. 3, pp. 155–160, 1999.
[9974]	R. C. Wester and H. I. Maibach, “Understanding percutaneous absorption for occupational health and safety,” Int J Occup Environ Health, vol. 6, no. 2, pp. 86–92, Jun. 2000, doi: 10.1179/oeh.2000.6.2.86.
[9975]	S. R. Horn and A. Feder, “Understanding Resilience and Preventing and Treating PTSD,” Harv Rev Psychiatry, vol. 26, no. 3, pp. 158–174, Jun. 2018, doi: 10.1097/HRP.0000000000000194.
[9976]	J. T. Barnett and N. M. Kad, “Understanding the coupling between DNA damage detection and UvrA’s ATPase using bulk and single molecule kinetics,” FASEB J., vol. 33, no. 1, pp. 763–769, 2019, doi: 10.1096/fj.201800899R.
[9977]	D. O. Carpenter, K. Arcaro, and D. C. Spink, “Understanding the human health effects of chemical mixtures,” Environ. Health Perspect., vol. 110 Suppl 1, pp. 25–42, Feb. 2002, doi: 10.1289/ehp.02110s125.
[9978]	Q. M. Bautista-de Los Santos, K. A. Chavarria, and K. L. Nelson, “Understanding the impacts of intermittent supply on the drinking water microbiome,” Curr. Opin. Biotechnol., vol. 57, pp. 167–174, 2019, doi: 10.1016/j.copbio.2019.04.003.
[9979]	V. Y. Kong, C. Aldous, and D. L. Clarke, “Understanding the reasons for delay to definitive surgical care of patients with acute appendicitis in rural South Africa,” S Afr J Surg, vol. 52, no. 1, pp. 2–5, Feb. 2014.
[9980]	Y. Zhao, S. Wang, and C. Zhou, “Understanding the relation between urbanization and the eco-environment in China’s Yangtze River Delta using an improved EKC model and coupling analysis,” Sci. Total Environ., vol. 571, pp. 862–875, Nov. 2016, doi: 10.1016/j.scitotenv.2016.07.067.
[9981]	B. Ashby, R. Iritani, A. Best, A. White, and M. Boots, “Understanding the role of eco-evolutionary feedbacks in host-parasite coevolution,” J. Theor. Biol., vol. 464, pp. 115–125, 07 2019, doi: 10.1016/j.jtbi.2018.12.031.
[9982]	B. Maresca et al., “Understanding the role of haptoglobin in psoriasis: effects of ultraviolet B,” Clin. Exp. Dermatol., vol. 41, no. 1, pp. 74–80, Jan. 2016, doi: 10.1111/ced.12667.
[9983]	Y. Han, G. F. John, and T. P. Clement, “Understanding the thermal degradation patterns of hopane biomarker compounds present in crude oil,” Sci. Total Environ., vol. 667, pp. 792–798, Jun. 2019, doi: 10.1016/j.scitotenv.2019.02.445.
[9984]	D. Torgerson and M. Campbell, “Unequal randomisation can improve the economic efficiency of clinical trials,” J Health Serv Res Policy, vol. 2, no. 2, pp. 81–85, Apr. 1997, doi: 10.1177/135581969700200205.
[9985]	S. C. Lucan, A. R. Maroko, J. L. Seitchik, D. H. Yoon, L. E. Sperry, and C. B. Schechter, “Unexpected Neighborhood Sources of Food and Drink: Implications for Research and Community Health,” Am J Prev Med, vol. 55, no. 2, pp. e29–e38, 2018, doi: 10.1016/j.amepre.2018.04.011.
[9986]	P. Striano, M. Pagliuca, V. Andreone, F. Zara, A. Coppola, and S. Striano, “Unfavourable outcome of Hashimoto encephalopathy due to status epilepticus. One autopsy case,” J. Neurol., vol. 253, no. 2, pp. 248–249, Feb. 2006, doi: 10.1007/s00415-005-0925-6.
[9987]	S. C. Lucan, A. R. Maroko, O. C. Sanon, and C. B. Schechter, “Unhealthful Food-and-Beverage Advertising in Subway Stations: Targeted Marketing, Vulnerable Groups, Dietary Intake, and Poor Health,” J Urban Health, vol. 94, no. 2, pp. 220–232, 2017, doi: 10.1007/s11524-016-0127-9.
[9988]	G. Panattoni, C. Crescenzi, R. Della Bona, and L. Calò, “Unicuique suum: the proper discipline for the proper athlete,” Eur J Prev Cardiol, vol. 26, no. 14, pp. 1545–1548, 2019, doi: 10.1177/2047487319861230.
[9989]	B. Kim et al., “Unified stress tensor of the hydration water layer,” Phys. Rev. Lett., vol. 111, no. 24, p. 246102, Dec. 2013, doi: 10.1103/PhysRevLett.111.246102.
[9990]	H. Chen, P. Tang, Y. Zhao, Y. Gao, and Y. Wang, “Unilateral versus bilateral balloon kyphoplasty in the treatment of osteoporotic vertebral compression fractures,” Orthopedics, vol. 37, no. 9, pp. e828-835, Sep. 2014, doi: 10.3928/01477447-20140825-61.
[9991]	B. R. Keeton et al., “Univentricular heart of right ventricular type with double or common inlet,” Circulation, vol. 59, no. 2, pp. 403–411, Feb. 1979, doi: 10.1161/01.cir.59.2.403.
[9992]	F. Bustreo and C. Doebbler, “Universal Health Coverage: Are We Losing Our Way on Women’s and Children’s Health?,” Health Hum Rights, vol. 21, no. 2, pp. 229–234, 2019.
[9993]	G. Schehr and S. N. Majumdar, “Universal order statistics of random walks,” Phys. Rev. Lett., vol. 108, no. 4, p. 040601, Jan. 2012, doi: 10.1103/PhysRevLett.108.040601.
[9994]	N. Nilsson and T. Minssen, “Unlocking the full potential of open innovation in the life sciences through a classification system,” Drug Discov. Today, vol. 23, no. 4, pp. 771–775, 2018, doi: 10.1016/j.drudis.2018.01.002.
[9995]	A. N. Chamseddine, E. Jabbour, H. M. Kantarjian, Z. S. Bohannan, and G. Garcia-Manero, “Unraveling Myelodysplastic Syndromes: Current Knowledge and Future Directions,” Curr Oncol Rep, vol. 18, no. 1, p. 4, Jan. 2016, doi: 10.1007/s11912-015-0489-2.
[9996]	D. A. Sallman, T. Cluzeau, A. A. Basiorka, and A. List, “Unraveling the Pathogenesis of MDS: The NLRP3 Inflammasome and Pyroptosis Drive the MDS Phenotype,” Front Oncol, vol. 6, p. 151, 2016, doi: 10.3389/fonc.2016.00151.
[9997]	S. Taddei and L. Bortolotto, “Unraveling the Pivotal Role of Bradykinin in ACE Inhibitor Activity,” Am J Cardiovasc Drugs, vol. 16, no. 5, pp. 309–321, Oct. 2016, doi: 10.1007/s40256-016-0173-4.
[9998]	M. Sciotto, A. Cannata, M. Prestifilippo, S. Scollo, D. Fee, and E. Privitera, “Unravelling the links between seismo-acoustic signals and eruptive parameters: Etna lava fountain case study,” Sci Rep, vol. 9, no. 1, p. 16417, Nov. 2019, doi: 10.1038/s41598-019-52576-w.
[9999]	G. V. Beitler, “Unrecognized health effects of chemicals,” AAOHN J, vol. 58, no. 5, pp. 207–211; quiz 212, May 2010, doi: 10.3928/08910162-20100416-02.
[10000]	T. Straetemans et al., “Untouched GMP-Ready Purified Engineered Immune Cells to Treat Cancer,” Clin. Cancer Res., vol. 21, no. 17, pp. 3957–3968, Sep. 2015, doi: 10.1158/1078-0432.CCR-14-2860.
[10001]	H. F. Bianchi, C. A. Vargas, and N. E. Ottone, “Unusual ending of the second dorsal metacarpal artery as proper palmar digital arteries,” Folia Morphol. (Warsz), vol. 77, no. 2, pp. 393–396, 2018, doi: 10.5603/FM.a2017.0084.
[10002]	C.-D. Han and W.-S. Ge, “Up-Regulation of Angiotensin-Converting Enzyme (ACE) Enhances Cell Proliferation and Predicts Poor Prognosis in Laryngeal Cancer,” Med. Sci. Monit., vol. 22, pp. 4132–4138, Nov. 2016, doi: 10.12659/msm.896933.
[10003]	B. Chertin, V. Solari, D. J. Reen, A. Farkas, and P. Puri, “Up-regulation of angiotensin-converting enzyme (ACE) gene expression induces tubulointerstitial injury in reflux nephropathy,” Pediatr. Surg. Int., vol. 18, no. 7, pp. 635–639, Oct. 2002, doi: 10.1007/s00383-002-0857-5.
[10004]	Y. Morova, M. Tonelli, V. Petrov, and A. Sennaroglu, “Upconversion pumping of a 2.3  µm Tm3+:KY3F10 laser with a 1064  nm ytterbium fiber laser,” Opt Lett, vol. 45, no. 4, pp. 931–934, Feb. 2020, doi: 10.1364/OL.384284.
[10005]	S. Guth, M. Habermeyer, D. Schrenk, and G. Eisenbrand, “Update of the toxicological assessment of furanocoumarins in foodstuffs (Update of the SKLM statement of 23/24 September 2004)--Opinion of the Senate Commission on Food Safety (SKLM) of the German Research Foundation (DFG),” Mol Nutr Food Res, vol. 55, no. 5, pp. 807–810, May 2011, doi: 10.1002/mnfr.201100011.
[10006]	N. Attiullah and M. Zimmerman, “Update on the diagnosis and treatment of depression,” Med Health R I, vol. 86, no. 10, pp. 310–314, Oct. 2003.
[10007]	J. M. Stewart, “Update on the theory and management of orthostatic intolerance and related syndromes in adolescents and children,” Expert Rev Cardiovasc Ther, vol. 10, no. 11, pp. 1387–1399, Nov. 2012, doi: 10.1586/erc.12.139.
[10008]	“Update on vaccine-derived polioviruses worldwide, January 2015–May 2016,” Wkly. Epidemiol. Rec., vol. 91, no. 31, pp. 365–375, Aug. 2016.
[10009]	“Update on vaccine-derived polioviruses worldwide, January 2016–June 2017,” Wkly. Epidemiol. Rec., vol. 92, no. 44, pp. 661–672, 03 2017.
[10010]	T. Van Heest, B. Ebert, B. B. Roby, and J. Sidman, “Upper airway obstruction in neonates: Does sleep exacerbate symptoms?,” Laryngoscope Investig Otolaryngol, vol. 3, no. 2, pp. 78–81, Apr. 2018, doi: 10.1002/lio2.137.
[10011]	M. Elifranji, T. Abbas, S. Vallasciani, B. Leslie, A. Elkadhi, and J. L. Pippi Salle, “Upper lib graft (ULG) for redo urethroplasties in children. A step by step video,” J Pediatr Urol, Jul. 2020, doi: 10.1016/j.jpurol.2020.06.029.
[10012]	T. Saito et al., “Upregulation of Human Endogenous Retrovirus-K Is Linked to Immunity and Inflammation in Pulmonary Arterial Hypertension,” Circulation, vol. 136, no. 20, pp. 1920–1935, Nov. 2017, doi: 10.1161/CIRCULATIONAHA.117.027589.
[10013]	A. M. Fulton, P. D. Rathjen, S. M. Kingsman, and A. J. Kingsman, “Upstream and downstream transcriptional control signals in the yeast retrotransposon, TY,” Nucleic Acids Res., vol. 16, no. 12, pp. 5439–5458, Jun. 1988, doi: 10.1093/nar/16.12.5439.
[10014]	J. Vearey, I. Luginaah, N. F. Magitta, D. J. Shilla, and T. Oni, “Urban health in Africa: a critical global public health priority,” BMC Public Health, vol. 19, no. 1, p. 340, Mar. 2019, doi: 10.1186/s12889-019-6674-8.
[10015]	J. Yang, W. G. Liu, Z. Y. Xia, and X. F. Hui, “[Uremic Toxins in Cognitive Impairment],” Zhongguo Yi Xue Ke Xue Yuan Xue Bao, vol. 42, no. 1, pp. 124–127, Feb. 2020, doi: 10.3881/j.issn.1000-503X.10989.
[10016]	J. E. Kim et al., “Uridine stimulate laxative effect in the loperamide-induced constipation of SD rats through regulation of the mAChRs signaling pathway and mucin secretion,” BMC Gastroenterol, vol. 17, no. 1, p. 21, Jan. 2017, doi: 10.1186/s12876-017-0576-y.
[10017]	M. Yamashita et al., “Urinary Cross-linked N-terminal Telopeptide of Type I Collagen Levels of Infants with Osteogenesis Imperfecta and Healthy Infants,” Acta Med. Okayama, vol. 70, no. 6, pp. 435–439, Dec. 2016, doi: 10.18926/AMO/54805.
[10018]	K. S. Coyne, M. Kvasz, A. M. Ireland, I. Milsom, Z. S. Kopp, and C. R. Chapple, “Urinary incontinence and its relationship to mental health and health-related quality of life in men and women in Sweden, the United Kingdom, and the United States,” Eur. Urol., vol. 61, no. 1, pp. 88–95, Jan. 2012, doi: 10.1016/j.eururo.2011.07.049.
[10019]	M. N. E. Tuong, N. A. Patel, J. M. Zillioux, and D. E. Rapp, “Urinary Incontinence Research: Compliance With Research Standards for Clinical Studies,” Urology, vol. 137, pp. 55–59, Mar. 2020, doi: 10.1016/j.urology.2019.11.032.
[10020]	J. He et al., “Urinary Sodium and Potassium Excretion and CKD Progression,” J. Am. Soc. Nephrol., vol. 27, no. 4, pp. 1202–1212, Apr. 2016, doi: 10.1681/ASN.2015010022.
[10021]	A. G. W. Norden, M. Lapsley, and R. J. Unwin, “Urine retinol-binding protein 4: a functional biomarker of the proximal renal tubule,” Adv Clin Chem, vol. 63, pp. 85–122, 2014, doi: 10.1016/b978-0-12-800094-6.00003-0.
[10022]	K. T. Rew, “Urologic Conditions in Infants and Children: Foreword,” FP Essent, vol. 488, p. 2, 2020.
[10023]	K. T. Rew, “Urology and nephrology update: foreword,” FP Essent, vol. 416, p. 2, Jan. 2014.
[10024]	R. B. Gold and A. M. Starrs, “US reproductive health and rights: beyond the global gag rule,” Lancet Public Health, vol. 2, no. 3, pp. e122–e123, 2017, doi: 10.1016/S2468-2667(17)30035-X.
[10025]	I. Goldstein, “US State Department Memo Proposes to Ban the Word ‘Sex,’” Sex Med Rev, vol. 7, no. 1, p. 1, 2019, doi: 10.1016/j.sxmr.2018.11.004.
[10026]	A. Y. X. Yu et al., “Use and Utility of Administrative Health Data for Stroke Research and Surveillance,” Stroke, vol. 47, no. 7, pp. 1946–1952, 2016, doi: 10.1161/STROKEAHA.116.012390.
[10027]	R. B. Singer, “Use of a mean entry age underestimates expected mean mortality rate,” J Insur Med, vol. 38, no. 2, pp. 94–104, 2006.
[10028]	J. G. Gums, “Use of ACE inhibitors in the treatment of cardiovascular disease,” Am Pharm, vol. NS32, no. 6, pp. 62–70, Jun. 1992, doi: 10.1016/s0160-3450(15)31098-9.
[10029]	R. Gradzki, R. K. Dhingra, F. K. Port, E. Roys, W. F. Weitzel, and J. M. Messana, “Use of ACE inhibitors is associated with prolonged survival of arteriovenous grafts,” Am. J. Kidney Dis., vol. 38, no. 6, pp. 1240–1244, Dec. 2001, doi: 10.1053/ajkd.2001.29220.
[10030]	J. H. Beckmann, J.-N. Kersebaum, W. von Schönfels, T. Becker, C. Schafmayer, and J. H. Egberts, “Use of barbed sutures in robotic bariatric bypass surgery: a single-center case series,” BMC Surg, vol. 19, no. 1, p. 97, Jul. 2019, doi: 10.1186/s12893-019-0563-z.
[10031]	M. Rew, “Use of catheter maintenance solutions for long-term catheters,” Br J Nurs, vol. 8, no. 11, pp. 708–710, 712, 714–715, Jun. 1999, doi: 10.12968/bjon.1999.8.11.6585.
[10032]	M. Bosak and A. Słowik, “Use of complementary and alternative medicine among adults with epilepsy in a university epilepsy clinic in Poland,” Epilepsy Behav, vol. 98, no. Pt A, pp. 40–44, 2019, doi: 10.1016/j.yebeh.2019.06.004.
[10033]	D. Todescato et al., “Use of cork granules as an effective sustainable material to clean-up spills of crude oil and derivatives,” Environ Sci Pollut Res Int, vol. 27, no. 1, pp. 366–378, Jan. 2020, doi: 10.1007/s11356-019-06743-1.
[10034]	M. H. Afzal, V. Renaudin, and G. Lachapelle, “Use of Earth’s magnetic field for mitigating gyroscope errors regardless of magnetic perturbation,” Sensors (Basel), vol. 11, no. 12, pp. 11390–11414, 2011, doi: 10.3390/s111211390.
[10035]	M. E. Case, R. F. Geever, and D. K. Asch, “Use of gene replacement transformation to elucidate gene function in the qa gene cluster of Neurospora crassa,” Genetics, vol. 130, no. 4, pp. 729–736, Apr. 1992.
[10036]	J. W. Worley, T. M. Bass, and P. F. Vendrell, “Use of geotextile tubes with chemical amendments to dewater dairy lagoon solids,” Bioresour. Technol., vol. 99, no. 10, pp. 4451–4459, Jul. 2008, doi: 10.1016/j.biortech.2007.08.080.
[10037]	E. G. Abramowitz and O. Bonne, “[Use of hypnosis in the treatment of combat post traumatic stress disorder (PTSD)],” Harefuah, vol. 152, no. 8, pp. 490–493, 497, Aug. 2013.
[10038]	B. C. Bonning and B. D. Hammock, “Use of juvenile hormone esterase as a novel reporter enzyme in the baculovirus expression system,” J. Virol. Methods, vol. 51, no. 1, pp. 103–113, Jan. 1995, doi: 10.1016/0166-0934(94)00095-x.
[10039]	C. Napoleone, R. Giovannelli, E. Capoccetti, L. Zara, and R. Franchi, “Use of keloid cutis as reconstructive flap of the auricle after keloid excision,” Plast. Reconstr. Surg., vol. 111, no. 1, pp. 518–519, Jan. 2003, doi: 10.1097/00006534-200301000-00123.
[10040]	S. Woodward, “Use of lubricant in female urethral catheterization,” Br J Nurs, vol. 14, no. 19, pp. 1022–1023, Nov. 2005, doi: 10.12968/bjon.2005.14.19.19945.
[10041]	C. Nikolova and T. Gutierrez, “Use of Microorganisms in the Recovery of Oil From Recalcitrant Oil Reservoirs: Current State of Knowledge, Technological Advances and Future Perspectives,” Front Microbiol, vol. 10, p. 2996, 2019, doi: 10.3389/fmicb.2019.02996.
[10042]	M. R. Joshi et al., “Use of percutaneous thread loop to hold the vermiform appendix during laparoscopic appendectomy,” Kathmandu Univ Med J (KUMJ), vol. 5, no. 1, pp. 63–67, Mar. 2007.
[10043]	J. H. Tu and J. M. C. Teng, “Use of topical sirolimus in the management of multiple familial trichoepitheliomas,” Dermatol Ther, vol. 30, no. 2, Mar. 2017, doi: 10.1111/dth.12458.
[10044]	A. Tateo, S. Tateo, C. Bernasconi, and C. Zara, “Use of V-Y flap for vulvar reconstruction,” Gynecol. Oncol., vol. 62, no. 2, pp. 203–207, Aug. 1996, doi: 10.1006/gyno.1996.0216.
[10045]	H. Klaus, J. Goebel, R. E. Woods, M. Castles, and G. Zimny, “Use-effectiveness and analysis of satisfaction levels with the Billings Ovulation Method: two-year pilot study,” Fertil. Steril., vol. 28, no. 10, pp. 1038–1043, Oct. 1977.
[10046]	E. A. Badings et al., “Use, timing and outcome of coronary angiography in patients with high-risk non-ST-segment elevation acute coronary syndrome in daily clinical practice: insights from a ‘real world’ prospective registry,” Neth Heart J, vol. 27, no. 2, pp. 73–80, Feb. 2019, doi: 10.1007/s12471-018-1212-3.
[10047]	W. K. Bae, J. S. Lee, N. H. Kim, K. A. Kim, Y. S. Moon, and M. K. Oh, “[Usefulness of DeltaMELD/month for prediction of the mortality in the first episode of variceal bleeding patients with liver cirrhosis: comparison with CTP, MELD score and DeltaCTP/month],” Korean J Hepatol, vol. 13, no. 1, pp. 51–60, Mar. 2007.
[10048]	E. Chisadza, C. C. Maponga, and H. Nazerali, “User fees and drug pricing policies: a study at Harare Central Hospital, Zimbabwe,” Health Policy Plan, vol. 10, no. 3, pp. 319–326, Sep. 1995, doi: 10.1093/heapol/10.3.319.
[10049]	V. Mahtani-Chugani and E. J. Sanz, “Users perception of risk and benefits of mood modifying drugs,” Curr Clin Pharmacol, vol. 6, no. 2, pp. 108–114, May 2011, doi: 10.2174/157488411796151183.
[10050]	L. L. Needham, D. G. Patterson, D. B. Barr, J. Grainger, and A. M. Calafat, “Uses of speciation techniques in biomonitoring for assessing human exposure to organic environmental chemicals,” Anal Bioanal Chem, vol. 381, no. 2, pp. 397–404, Jan. 2005, doi: 10.1007/s00216-004-2975-5.
[10051]	B. Wildman-Tobriner et al., “Using Artificial Intelligence to Revise ACR TI-RADS Risk Stratification of Thyroid Nodules: Diagnostic Accuracy and Utility,” Radiology, vol. 292, no. 1, pp. 112–119, 2019, doi: 10.1148/radiol.2019182128.
[10052]	T. Hershey and J. W. Mink, “Using functional neuroimaging to study the brain’s response to deep brain stimulation,” Neurology, vol. 66, no. 8, pp. 1142–1143, Apr. 2006, doi: 10.1212/01.wnl.0000216425.34178.dd.
[10053]	M. L. Avery, M. E. McDevitt-Murphy, and R. J. Zakarian, “Using Latent Variable Mixture Modeling to Understand Trauma-Related Outcomes in Undergraduate Women,” J Sex Marital Ther, vol. 45, no. 8, pp. 673–687, 2019, doi: 10.1080/0092623X.2019.1610120.
[10054]	M. Mauthe and F. Reggiori, “Using microbes as a key tool to unravel the mechanism of autophagy and the functions of the ATG proteins,” Microb Cell, vol. 4, no. 1, pp. 1–5, Dec. 2016, doi: 10.15698/mic2017.01.550.
[10055]	R. LaFollette, K. Hojnowski, J. Norton, J. DiRocco, D. Carney, and G. Nieman, “Using pressure-volume curves to set proper PEEP in acute lung injury,” Nurs Crit Care, vol. 12, no. 5, pp. 231–241, Oct. 2007, doi: 10.1111/j.1478-5153.2007.00224.x.
[10056]	Y. He et al., “Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity,” Nat Commun, vol. 11, no. 1, p. 1996, 24 2020, doi: 10.1038/s41467-020-15838-0.
[10057]	C. R. Carpenter, D. C. Cone, and C. C. Sarli, “Using publication metrics to highlight academic productivity and research impact,” Acad Emerg Med, vol. 21, no. 10, pp. 1160–1172, Oct. 2014, doi: 10.1111/acem.12482.
[10058]	V. J. Miller, N. L. Fields, G. Adorno, and A. Smith-Osborne, “Using the Eco-Map and Ecosystems Perspective to Guide Skilled Nursing Facility Discharge Planning,” J Gerontol Soc Work, vol. 60, no. 6–7, pp. 504–518, Oct. 2017, doi: 10.1080/01634372.2017.1324548.
[10059]	L. Savic, I. Mrdovic, M. Asanin, S. Stankovic, G. Krljanac, and R. Lasica, “Using the RISK-PCI Score in the Long-Term Prediction of Major Adverse Cardiovascular Events and Mortality after Primary Percutaneous Coronary Intervention,” J Interv Cardiol, vol. 2019, p. 2679791, 2019, doi: 10.1155/2019/2679791.
[10060]	B.-S. Lin, C.-C. Chang, Y.-H. Tseng, J.-R. Li, Y.-S. Peng, and Y.-K. Huang, “Using Wireless Near-Infrared Spectroscopy to Predict Wound Prognosis in Diabetic Foot Ulcers,” Adv Skin Wound Care, vol. 33, no. 1, pp. 1–12, Jan. 2020, doi: 10.1097/01.ASW.0000613552.50065.d5.
[10061]	Q. Yu, G. Gabriel, M. Hoffman, S. Sanampudi, T. Jassim, and D. Raissi, “Uterine-sparing management of pyomyoma after uterine fibroid embolization,” Radiol Case Rep, vol. 14, no. 8, pp. 1031–1035, Aug. 2019, doi: 10.1016/j.radcr.2019.05.009.
[10062]	M. Nadeau-Vallée et al., “Uterotonic Neuromedin U Receptor 2 and Its Ligands Are Upregulated by Inflammation in Mice and Humans, and Elicit Preterm Birth,” Biol. Reprod., vol. 95, no. 3, p. 72, Sep. 2016, doi: 10.1095/biolreprod.116.140905.
[10063]	K. Bravo-Rodriguez et al., “Utilities for Mass Spectrometry Analysis of Proteins (UMSAP): Fast post-processing of mass spectrometry data,” Rapid Commun. Mass Spectrom., vol. 32, no. 19, pp. 1659–1667, Oct. 2018, doi: 10.1002/rcm.8243.
[10064]	R. Gupta, K. Rahman, M. K. Singh, S. Kumari, G. Yadav, and S. Nityanand, “Utility of a Single-Tube, Six-Color Flow Cytometry Panel for the Diagnosis of Myelodysplastic Syndrome: Experience of a Tertiary Care Centre in India,” Int J Hematol Oncol Stem Cell Res, vol. 12, no. 1, pp. 29–34, Jan. 2018.
[10065]	B.-S. Kim et al., “Utility of baseline impedance level measurement in patients with gastroesophageal reflux symptoms,” Scand. J. Gastroenterol., vol. 51, no. 1, pp. 1–7, Jan. 2016, doi: 10.3109/00365521.2015.1042031.
[10066]	E. Mateos Torres, S. Collado Nieto, H. Cao Baduell, M. Lacambra Peñart, A. Velescu, and A. Clará Velasco, “Utility of doppler ultrasound in the preoperative evaluation of the first vascular access for haemodialysis,” Nefrologia, vol. 39, no. 5, pp. 539–544, Oct. 2019, doi: 10.1016/j.nefro.2019.02.012.
[10067]	C. Wu et al., “Utility of intraoperative frozen section in the diagnosis of periprosthetic joint infection,” PLoS ONE, vol. 9, no. 7, p. e102346, 2014, doi: 10.1371/journal.pone.0102346.
[10068]	H. H. Rashidi et al., “Utility of peripheral blood flow cytometry in differentiating low grade versus high grade myelodysplastic syndromes (MDS) and in the evaluation of cytopenias,” Int J Clin Exp Pathol, vol. 5, no. 3, pp. 224–230, 2012.
[10069]	S. Ichikawa et al., “Utility of Stack-of-stars Acquisition for Hepatobiliary Phase Imaging without Breath-holding,” Magn Reson Med Sci, vol. 19, no. 2, pp. 99–107, May 2020, doi: 10.2463/mrms.mp.2019-0030.
[10070]	S. Chenji, D. Mah, W. Johnston, R. Camicioli, N. Fisher, and S. Kalra, “Utility of the Addenbrooke’s Cognitive Examination in Amyotrophic Lateral Sclerosis,” Can J Neurol Sci, vol. 45, no. 5, pp. 527–532, 2018, doi: 10.1017/cjn.2018.68.
[10071]	I. Sergides, Z. Hussain, S. Naik, C. Good, K. Miles, and G. Critchley, “Utilization of dynamic CT perfusion in the study of intracranial meningiomas and their surrounding tissue,” Neurol. Res., vol. 31, no. 1, pp. 84–89, Feb. 2009, doi: 10.1179/174313208X331563.
[10072]	Y. Lin, S. Zhou, F. Li, and Y. Lin, “Utilization of municipal sewage sludge as additives for the production of eco-cement,” J. Hazard. Mater., vol. 213–214, pp. 457–465, Apr. 2012, doi: 10.1016/j.jhazmat.2012.02.020.
[10073]	H. Y. Gebrechristos and W. Chen, “Utilization of potato peel as eco-friendly products: A review,” Food Sci Nutr, vol. 6, no. 6, pp. 1352–1356, Sep. 2018, doi: 10.1002/fsn3.691.
[10074]	“VA economizes,” Conn State Med J, vol. 16, no. 8, pp. 627–628, Aug. 1952.
[10075]	K. Yaddanapudi, C. Li, and J. W. Eaton, “Vaccination with induced pluripotent stem cells confers protection against cancer,” Stem Cell Investig, vol. 5, p. 23, 2018, doi: 10.21037/sci.2018.07.03.
[10076]	B. Rogers, K. Dennison, N. Adepoju, S. Dowd, and K. Uedoi, “Vaccine cold chain: part 1. proper handling and storage of vaccine,” AAOHN J, vol. 58, no. 8, pp. 337–334; quiz 345–346, Aug. 2010, doi: 10.3928/08910162-20100801-03.
[10077]	“Vaccine-derived polioviruses outbreaks and events in 3 provinces of Democratic Republic of the Congo, 2017,” Wkly. Epidemiol. Rec., vol. 93, no. 11, pp. 117–125, Mar. 2018.
[10078]	“Vaccines against influenza WHO position paper – November 2012,” Wkly. Epidemiol. Rec., vol. 87, no. 47, pp. 461–476, Nov. 2012.
[10079]	N. Principi and S. Esposito, “Vaccines and febrile seizures,” Expert Rev Vaccines, vol. 12, no. 8, pp. 885–892, Aug. 2013, doi: 10.1586/14760584.2013.814781.
[10080]	U. H. Gondolf, I. Tetens, A. P. Hills, K. F. Michaelsen, and E. Trolle, “Validation of a pre-coded food record for infants and young children,” Eur J Clin Nutr, vol. 66, no. 1, pp. 91–96, Jan. 2012, doi: 10.1038/ejcn.2011.133.
[10081]	A. M. Mukhtar et al., “Validation of electrical velocimetry in resuscitation of patients undergoing liver transplantation. Observational study,” J Clin Monit Comput, vol. 34, no. 2, pp. 271–276, Apr. 2020, doi: 10.1007/s10877-019-00313-z.
[10082]	“Validation of maternal and neonatal tetanus elimination in Equatorial Guinea, 2016,” Wkly. Epidemiol. Rec., vol. 92, no. 24, pp. 333–344, 16 2017.
[10083]	J. Lin et al., “Validation of the Chinese version of the Hamilton Rating Scale for Depression in adults with epilepsy,” Epilepsy Behav, vol. 89, pp. 148–152, Dec. 2018, doi: 10.1016/j.yebeh.2018.10.009.
[10084]	X. Li et al., “Validation of the Chinese version of the Scale for Suicide Ideation-Worst in adult patients with epilepsy,” Epilepsy Behav, vol. 101, no. Pt A, p. 106586, 2019, doi: 10.1016/j.yebeh.2019.106586.
[10085]	M. van Duinen, J. Rickelt, and E. Griez, “Validation of the electronic Visual Analogue Scale of Anxiety,” Prog. Neuropsychopharmacol. Biol. Psychiatry, vol. 32, no. 4, pp. 1045–1047, May 2008, doi: 10.1016/j.pnpbp.2008.02.002.
[10086]	K. Horvath et al., “[VALIDATION OF THE HUNGARIAN MDS-UPDRS: WHY DO WE NEED A NEW PARKINSON SCALE?],” Ideggyogy Sz, vol. 67, no. 3–4, pp. 129–134, Mar. 2014.
[10087]	H. Rashid, J. Katyal, M. Tripathi, M. Sood, and Y. K. Gupta, “Validation of the Indian version of Neurological Disorders Depression Inventory for Epilepsy (NDDI-E),” Epilepsy Behav, vol. 95, pp. 75–78, 2019, doi: 10.1016/j.yebeh.2019.03.048.
[10088]	K. Sato, “Validation study of the new criteria for sensitizer using German sensitizers of Deutschen forschungsgemeinschaft (DFG),” Int J Immunopathol Pharmacol, vol. 24, no. 1 Suppl, pp. 17S-21S, Mar. 2011.
[10089]	C. Yucel, L. Taskin, and L. K. Low, “Validity and reliability of the Turkish version of the Optimality Index-US (OI-US) to assess maternity care outcomes,” Midwifery, vol. 31, no. 12, pp. 1135–1142, Dec. 2015, doi: 10.1016/j.midw.2015.08.003.
[10090]	B. Getnet and A. Alem, “Validity of the Center for Epidemiologic Studies Depression Scale (CES-D) in Eritrean refugees living in Ethiopia,” BMJ Open, vol. 9, no. 5, p. e026129, May 2019, doi: 10.1136/bmjopen-2018-026129.
[10091]	O.-Y. Kwon and S.-P. Park, “Validity of the Liverpool Adverse Events Profile as a Screening Tool for Detecting Comorbid Depression or Anxiety Disorder in People with Epilepsy,” J Epilepsy Res, vol. 8, no. 2, pp. 74–80, Dec. 2018, doi: 10.14581/jer.18012.
[10092]	W. F. Stewart, R. B. Lipton, K. B. Kolodner, J. Sawyer, C. Lee, and J. N. Liberman, “Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers,” Pain, vol. 88, no. 1, pp. 41–52, Oct. 2000, doi: 10.1016/s0304-3959(00)00305-5.
[10093]	F. Sebera, J. R. N. Vissoci, J. Umwiringirwa, D. E. Teuwen, P. E. Boon, and P. Dedeken, “Validity, reliability and cut-offs of the Patient Health Questionnaire-9 as a screening tool for depression among patients living with epilepsy in Rwanda,” PLoS ONE, vol. 15, no. 6, p. e0234095, 2020, doi: 10.1371/journal.pone.0234095.
[10094]	N. Takpho, D. Watanabe, and H. Takagi, “Valine biosynthesis in Saccharomyces cerevisiae is regulated by the mitochondrial branched-chain amino acid aminotransferase Bat1,” Microb Cell, vol. 5, no. 6, pp. 293–299, Mar. 2018, doi: 10.15698/mic2018.06.637.
[10095]	J. Pagés-Díaz and C. Huiliñir, “Valorization of the liquid fraction of co-hydrothermal carbonization of mixed biomass by anaerobic digestion: Effect of the substrate to inoculum ratio and hydrochar addition,” Bioresour. Technol., vol. 317, p. 123989, Aug. 2020, doi: 10.1016/j.biortech.2020.123989.
[10096]	A. B. Ünal, L. Steg, and M. Gorsira, “Values Versus Environmental Knowledge as Triggers of a Process of Activation of Personal Norms for Eco-Driving,” Environ Behav, vol. 50, no. 10, pp. 1092–1118, Dec. 2018, doi: 10.1177/0013916517728991.
[10097]	A. Lamanna, T. Fayers, S. Clarke, and W. Parsonage, “Valvular and aortic diseases in osteogenesis imperfecta,” Heart Lung Circ, vol. 22, no. 10, pp. 801–810, Oct. 2013, doi: 10.1016/j.hlc.2013.05.640.
[10098]	M. Ji et al., “Vancomycin AUC24 /MIC Ratio in Patients with Methicillin-Resistant Staphylococcus aureus Pneumonia,” J. Clin. Lab. Anal., vol. 30, no. 5, pp. 485–489, Sep. 2016, doi: 10.1002/jcla.21883.
[10099]	A. Husain, V. Rawat,  null Umesh, M. Kumar, and P. K. Verma, “Vancomycin, linezolid and daptomycin susceptibility pattern among clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) from Sub- Himalyan Center,” J Lab Physicians, vol. 10, no. 2, pp. 145–148, Jun. 2018, doi: 10.4103/JLP.JLP_92_17.
[10100]	W. C. Harrill, “Vaping during the COVID-19 pandemic: NOT GOOD!!,” Laryngoscope Investig Otolaryngol, vol. 5, no. 3, pp. 399–400, Jun. 2020, doi: 10.1002/lio2.386.
[10101]	P. Ladzinski and M. Maliszewski, “Variability of the division of the cortical branches of the posterior cerebral artery,” Anat Rec A Discov Mol Cell Evol Biol, vol. 282, no. 1, pp. 74–82, Jan. 2005, doi: 10.1002/ar.a.20100.
[10102]	R. A. Harris, M. S. Sandrin, V. R. Sutton, P. M. Hogarth, I. F. McKenzie, and D. G. Penington, “Variable expression of Qa-m7, Qa-m8, and Qa-m9 antigenic determinants on primitive hemopoietic precursor cells,” J. Cell. Physiol., vol. 123, no. 3, pp. 451–458, Jun. 1985, doi: 10.1002/jcp.1041230324.
[10103]	F. Veltri and K. Poppe, “Variables Contributing to Thyroid (Dys)Function in Pregnant Women: More than Thyroid Antibodies?,” Eur Thyroid J, vol. 7, no. 3, pp. 120–128, Jun. 2018, doi: 10.1159/000488279.
[10104]	A. M. Fulton et al., “Variants within the yeast Ty sequence family encode a class of structurally conserved proteins,” Nucleic Acids Res., vol. 13, no. 11, pp. 4097–4112, Jun. 1985, doi: 10.1093/nar/13.11.4097.
[10105]	R. B. Perich, B. Jackson, and C. I. Johnston, “Variation in angiotensin-converting enzyme (ACE) inhibitor affinity at two binding sites on rat pulmonary ACE: influence on bradykinin hydrolysis,” Clin. Exp. Pharmacol. Physiol., vol. 19, no. 5, pp. 353–357, May 1992, doi: 10.1111/j.1440-1681.1992.tb00470.x.
[10106]	M. C. Jackson and M. Arlegui-Prieto, “Variation in normal mood state influences sensitivity to dynamic changes in emotional expression,” Emotion, vol. 16, no. 2, pp. 145–149, Mar. 2016, doi: 10.1037/emo0000126.
[10107]	A. B. Jessop, J. K. Hom, and M. Burke, “Variation in the Viral Hepatitis and HIV Policies and Practices of Methadone Maintenance Programs,” J Addict Med, vol. 11, no. 3, pp. 191–196, Jun. 2017, doi: 10.1097/ADM.0000000000000296.
[10108]	S. L. Anders, P. A. Frazier, and S. B. Frankfurt, “Variations in Criterion A and PTSD rates in a community sample of women,” J Anxiety Disord, vol. 25, no. 2, pp. 176–184, Mar. 2011, doi: 10.1016/j.janxdis.2010.08.018.
[10109]	W.-J. Kee et al., “Various applications of endoscopic scissors in difficult endoscopic interventions,” Endoscopy, vol. 46, no. 5, pp. 432–434, May 2014, doi: 10.1055/s-0034-1364957.
[10110]	M. U. Farooq and P. B. Gorelick, “Vascular cognitive impairment,” Curr Atheroscler Rep, vol. 15, no. 6, p. 330, Jun. 2013, doi: 10.1007/s11883-013-0330-z.
[10111]	J. Graff-Radford, “Vascular Cognitive Impairment,” Continuum (Minneap Minn), vol. 25, no. 1, pp. 147–164, 2019, doi: 10.1212/CON.0000000000000684.
[10112]	“Vascular cognitive impairment,” Nat Rev Dis Primers, vol. 4, p. 18004, Feb. 2018, doi: 10.1038/nrdp.2018.4.
[10113]	P. B. Gorelick, S. E. Counts, and D. Nyenhuis, “Vascular cognitive impairment and dementia,” Biochim. Biophys. Acta, vol. 1862, no. 5, pp. 860–868, 2016, doi: 10.1016/j.bbadis.2015.12.015.
[10114]	M. R. Azarpazhooh and V. Hachinski, “Vascular cognitive impairment: A preventable component of dementia,” Handb Clin Neurol, vol. 167, pp. 377–391, 2019, doi: 10.1016/B978-0-12-804766-8.00020-0.
[10115]	S. P. Kessler, P. deS Senanayake, C. Gaughan, and G. C. Sen, “Vascular expression of germinal ACE fails to maintain normal blood pressure in ACE-/- mice,” FASEB J., vol. 21, no. 1, pp. 156–166, Jan. 2007, doi: 10.1096/fj.06-6678com.
[10116]	B. Ditto and C. R. France, “Vasovagal symptoms mediate the relationship between predonation anxiety and subsequent blood donation in female volunteers,” Transfusion, vol. 46, no. 6, pp. 1006–1010, Jun. 2006, doi: 10.1111/j.1537-2995.2006.00835.x.
[10117]	Y. Nakaya et al., “Vector U loop in normal and hypertensive subjects,” J Electrocardiol, vol. 17, no. 2, pp. 161–168, Apr. 1984, doi: 10.1016/s0022-0736(84)81091-2.
[10118]	R. Vullings and M. Mischi, “Vectorcardiographic loop alignment for fetal movement detection using the expectation-maximization algorithm and support vector machines,” Conf Proc IEEE Eng Med Biol Soc, vol. 2013, pp. 2915–2918, 2013, doi: 10.1109/EMBC.2013.6610150.
[10119]	M. G. Pereira, S. M. Mudge, and J. Latchford, “Vegetable oil spills on salt marsh sediments; comparison between sunflower and linseed oils,” Mar. Environ. Res., vol. 56, no. 3, pp. 367–385, Sep. 2003, doi: 10.1016/S0141-1136(02)00309-4.
[10120]	A. Høye, “Vehicle registration year, age, and weight - Untangling the effects on crash risk,” Accid Anal Prev, vol. 123, pp. 1–11, Feb. 2019, doi: 10.1016/j.aap.2018.11.002.
[10121]	B. H. Bijnens, M. Cikes, P. Claus, and G. R. Sutherland, “Velocity and deformation imaging for the assessment of myocardial dysfunction,” Eur J Echocardiogr, vol. 10, no. 2, pp. 216–226, Mar. 2009, doi: 10.1093/ejechocard/jen323.
[10122]	O. M. Olivo and M. A. Gliozzi, “[Velocity of the in vitro growth of cultures in hanging drop and their yield using various technics],” Biol Lat, vol. 14, pp. 17–33, Feb. 1961.
[10123]	R. M. M. K. Namal Rathnayaka, P. E. A. N. Ranathunga, and S. a. M. Kularatne, “Venom-Induced Consumption Coagulopathy Following Hump-Nosed Pit Viper (Genus: Hypnale) Envenoming in Sri Lanka: Uncertain Efficacy of Fresh Frozen Plasma,” Wilderness Environ Med, vol. 31, no. 2, pp. 131–143, Jun. 2020, doi: 10.1016/j.wem.2019.12.006.
[10124]	N. Patel et al., “Ventricular Dysfunction Is a Critical Determinant of Mortality in Congenital Diaphragmatic Hernia,” Am. J. Respir. Crit. Care Med., vol. 200, no. 12, pp. 1522–1530, 15 2019, doi: 10.1164/rccm.201904-0731OC.
[10125]	R. H. Anderson et al., “Ventricular morphology in the univentricular heart,” Herz, vol. 4, no. 2, pp. 184–197, Apr. 1979.
[10126]	G. Pelamatti, M. Pascotto, and C. Semenza, “Verbal free recall in high altitude: proper names vs common names,” Cortex, vol. 39, no. 1, pp. 97–103, Feb. 2003, doi: 10.1016/s0010-9452(08)70077-7.
[10127]	T. Grunwald, K. Lehnertz, H. J. Heinze, C. Helmstaedter, and C. E. Elger, “Verbal novelty detection within the human hippocampus proper,” Proc. Natl. Acad. Sci. U.S.A., vol. 95, no. 6, pp. 3193–3197, Mar. 1998, doi: 10.1073/pnas.95.6.3193.
[10128]	E. Chiang et al., “Verrucomicrobia are prevalent in north-temperate freshwater lakes and display class-level preferences between lake habitats,” PLoS ONE, vol. 13, no. 3, p. e0195112, 2018, doi: 10.1371/journal.pone.0195112.
[10129]	A. M. Sepúlveda, C. V. Terrazas, J. Sáez, and M. L. Reyes, “[Vertebral fractures in children with Type I Osteogenesis imperfecta],” Rev Chil Pediatr, vol. 88, no. 3, pp. 348–353, Jun. 2017, doi: 10.4067/S0370-41062017000300006.
[10130]	H. J. Auman and D. Yelon, “Vertebrate organogenesis: getting the heart into shape,” Curr. Biol., vol. 14, no. 4, pp. R152-153, Feb. 2004.
[10131]	L. Patanè et al., “Vertical transmission of coronavirus disease 2019: severe acute respiratory syndrome coronavirus 2 RNA on the fetal side of the placenta in pregnancies with coronavirus disease 2019-positive mothers and neonates at birth,” Am J Obstet Gynecol MFM, vol. 2, no. 3, p. 100145, Aug. 2020, doi: 10.1016/j.ajogmf.2020.100145.
[10132]	L. R. Buschle et al., “Vessel radius mapping in an extended model of transverse relaxation,” MAGMA, vol. 31, no. 4, pp. 531–551, Aug. 2018, doi: 10.1007/s10334-018-0677-9.
[10133]	S. H. Yoon and C. M. Waters, “Vibrio cholerae,” Trends Microbiol., vol. 27, no. 9, pp. 806–807, 2019, doi: 10.1016/j.tim.2019.03.005.
[10134]	D. Gonzalez et al., “Video-assisted thoracic surgery lobectomy: 3-year initial experience with 200 cases,” Eur J Cardiothorac Surg, vol. 40, no. 1, pp. e21-28, Jul. 2011, doi: 10.1016/j.ejcts.2011.02.051.
[10135]	M. Humphreys et al., “Video-rate terahertz digital holographic imaging system,” Opt Express, vol. 26, no. 20, pp. 25805–25813, Oct. 2018, doi: 10.1364/OE.26.025805.
[10136]	K. Takahashi, T. Nin, M. Akano, Y. Hasuike, H. Iijima, and K. Suzuki, “Views of Japanese medical students on the work-life balance of female physicians,” Int J Med Educ, vol. 8, pp. 165–169, May 2017, doi: 10.5116/ijme.5907.0d44.
[10137]	A. R. McKinlay and L. L. Ridsdale, “Views of People With Epilepsy About Web-Based Self-Presentation: A Qualitative Study,” Interact J Med Res, vol. 7, no. 2, p. e10349, Dec. 2018, doi: 10.2196/10349.
[10138]	J. R. Bail and W. Demark-Wahnefried, “Vigorous physical activity and mental health-Associations suggest a link among childhood cancer survivors,” Cancer, vol. 125, no. 17, pp. 2923–2925, 01 2019, doi: 10.1002/cncr.32171.
[10139]	A. Acharjya, P. Pachfule, J. Roeser, F.-J. Schmitt, and A. Thomas, “Vinylene-Linked Covalent Organic Frameworks by Base-Catalyzed Aldol Condensation,” Angew. Chem. Int. Ed. Engl., vol. 58, no. 42, pp. 14865–14870, Oct. 2019, doi: 10.1002/anie.201905886.
[10140]	J. Gao, S. Chau, and M. D. Meneghini, “Viral attenuation by Endonuclease G during yeast gametogenesis: insights into ancestral roles of programmed cell death?,” Microb Cell, vol. 7, no. 2, pp. 32–35, Dec. 2019, doi: 10.15698/mic2020.02.705.
[10141]	“Virologic monitoring of poliovirus type 2 after OPV2 withdrawal in April 2016: an important advance in eradicating poliomyelitis and eliminating live oral poliovirus vaccines worldwide, 2016–2017,” Wkly. Epidemiol. Rec., vol. 92, no. 21, pp. 293–300, 26 2017.
[10142]	V. A. Shchukin et al., “Virtual cavity in distributed Bragg reflectors,” Opt Express, vol. 26, no. 19, pp. 25280–25292, Sep. 2018, doi: 10.1364/OE.26.025280.
[10143]	C. Féria, J. Machado, J. D. Correia, J. Gonçalves, and W. Gaastra, “Virulence genes and P fimbriae PapA subunit diversity in canine and feline uropathogenic Escherichia coli,” Vet. Microbiol., vol. 82, no. 1, pp. 81–89, Sep. 2001, doi: 10.1016/s0378-1135(01)00375-3.
[10144]	A. C. M. Santos et al., “Virulence Potential of a Multidrug-Resistant Escherichia coli Strain Belonging to the Emerging Clonal Group ST101-B1 Isolated from Bloodstream Infection,” Microorganisms, vol. 8, no. 6, May 2020, doi: 10.3390/microorganisms8060827.
[10145]	T. Tu and S. Urban, “Virus entry and its inhibition to prevent and treat hepatitis B and hepatitis D virus infections,” Curr Opin Virol, vol. 30, pp. 68–79, 2018, doi: 10.1016/j.coviro.2018.04.004.
[10146]	P. E. Phillips, “Viruses in the pathogenesis of systemic lupus erythematosus,” In Vivo, vol. 2, no. 1, pp. 15–18, Feb. 1988.
[10147]	L. D. Saravolatz and J. Pawlak, “VISA-Daptomycin non-susceptible Staphylococcus aureus frequently demonstrate non-susceptibility to Telavancin,” Diagn. Microbiol. Infect. Dis., vol. 93, no. 2, pp. 159–161, Feb. 2019, doi: 10.1016/j.diagmicrobio.2018.09.003.
[10148]	R. Costantini, G. Affaitati, U. Wesselmann, P. Czakanski, and M. A. Giamberardino, “Visceral pain as a triggering factor for fibromyalgia symptoms in comorbid patients,” Pain, vol. 158, no. 10, pp. 1925–1937, Oct. 2017, doi: 10.1097/j.pain.0000000000000992.
[10149]	M. A. Giamberardino et al., “Viscero-visceral hyperalgesia: characterization in different clinical models,” Pain, vol. 151, no. 2, pp. 307–322, Nov. 2010, doi: 10.1016/j.pain.2010.06.023.
[10150]	N. Kanda, C. S. Hau, Y. Tada, A. Tatsuta, S. Sato, and S. Watanabe, “Visfatin enhances CXCL8, CXCL10, and CCL20 production in human keratinocytes,” Endocrinology, vol. 152, no. 8, pp. 3155–3164, Aug. 2011, doi: 10.1210/en.2010-1481.
[10151]	M. J. Ju, C. Huang, D. J. Wahl, Y. Jian, and M. V. Sarunic, “Visible light sensorless adaptive optics for retinal structure and fluorescence imaging,” Opt Lett, vol. 43, no. 20, pp. 5162–5165, Oct. 2018, doi: 10.1364/OL.43.005162.
[10152]	U. Strassen, M. Bas, and A. Knopf, “[Visit at the dentist with consequences],” HNO, vol. 59, no. 11, pp. 1125–1128, Nov. 2011, doi: 10.1007/s00106-011-2290-3.
[10153]	K. L. Haley, J. L. Womack, T. G. Harmon, and S. W. Williams, “Visual analog rating of mood by people with aphasia,” Top Stroke Rehabil, vol. 22, no. 4, pp. 239–245, Aug. 2015, doi: 10.1179/1074935714Z.0000000009.
[10154]	R. A. Barton, “Visual specialization and brain evolution in primates,” Proc. Biol. Sci., vol. 265, no. 1409, pp. 1933–1937, Oct. 1998, doi: 10.1098/rspb.1998.0523.
[10155]	T. Zhou et al., “Visualization of crystal plane selectivity for irreversible phase transition in MnO@C anode,” Chem. Commun. (Camb.), vol. 56, no. 26, pp. 3753–3756, Apr. 2020, doi: 10.1039/d0cc00373e.
[10156]	C. P. Hess and P. Mukherjee, “Visualizing white matter pathways in the living human brain: diffusion tensor imaging and beyond,” Neuroimaging Clin. N. Am., vol. 17, no. 4, pp. 407–426, vii, Nov. 2007, doi: 10.1016/j.nic.2007.07.002.
[10157]	M. Zara, “[Vitamin B4 therapy of toxic agranulocytosis],” Presse Med, vol. 65, no. 64, pp. 1437–1438, Sep. 1957.
[10158]	M. Kodama and T. Kodama, “Vitamin C and the genesis of autoimmune disease and allergy (review),” In Vivo, vol. 9, no. 3, pp. 231–238, Jun. 1995.
[10159]	J. R. Delanghe et al., “Vitamin C deficiency: more than just a nutritional disorder,” Genes Nutr, vol. 6, no. 4, pp. 341–346, Nov. 2011, doi: 10.1007/s12263-011-0237-7.
[10160]	M. I. Yousef, “Vitamin E modulates reproductive toxicity of pyrethroid lambda-cyhalothrin in male rabbits,” Food Chem. Toxicol., vol. 48, no. 5, pp. 1152–1159, May 2010, doi: 10.1016/j.fct.2010.02.002.
[10161]	N. Getoff, “Vitamin free radicals and their anticancer action. Review,” In Vivo, vol. 23, no. 4, pp. 599–611, Aug. 2009.
[10162]	N. Kellermann, M. Maier, and N. Feucht, “[Vitreous metastasis of malignant cutaneous melanoma during treatment with ipilimumab],” Ophthalmologe, vol. 114, no. 2, pp. 163–166, Feb. 2017, doi: 10.1007/s00347-016-0271-3.
[10163]	H. Zhou et al., “Vitrified collagen-based conjunctival equivalent for ocular surface reconstruction,” Biomaterials, vol. 35, no. 26, pp. 7398–7406, Aug. 2014, doi: 10.1016/j.biomaterials.2014.05.024.
[10164]	M. M. Hassan, E. Yumoto, Y. Kumai, T. Sanuki, and N. Kodama, “Vocal outcome after arytenoid adduction and ansa cervicalis transfer,” Arch. Otolaryngol. Head Neck Surg., vol. 138, no. 1, pp. 60–65, Jan. 2012, doi: 10.1001/archoto.2011.228.
[10165]	P. Shirooye, R. Mokaberinejad, L. Ara, and M. Hamzeloo-Moghadam, “VOLATILE CONSTITUENTS OF GINGER OIL PREPARED ACCORDING TO IRANIAN TRADITIONAL MEDICINE AND CONVENTIONAL METHOD: A COMPARATIVE STUDY,” Afr J Tradit Complement Altern Med, vol. 13, no. 6, pp. 68–73, 2016, doi: 10.21010/ajtcam.v13i6.11.
[10166]	C. R. Cousins and I. A. Crawford, “Volcano-ice interaction as a microbial habitat on Earth and Mars,” Astrobiology, vol. 11, no. 7, pp. 695–710, Sep. 2011, doi: 10.1089/ast.2010.0550.
[10167]	R. D’Alessandro et al., “Volcanoes in Italy and the role of muon radiography,” Philos Trans A Math Phys Eng Sci, vol. 377, no. 2137, 10 2018, doi: 10.1098/rsta.2018.0050.
[10168]	M. Welniak-Kaminska et al., “Volumes of brain structures in captive wild-type and laboratory rats: 7T magnetic resonance in vivo automatic atlas-based study,” PLoS ONE, vol. 14, no. 4, p. e0215348, 2019, doi: 10.1371/journal.pone.0215348.
[10169]	J. Varelius, “Voluntary euthanasia, physician-assisted suicide, and the goals of medicine,” J Med Philos, vol. 31, no. 2, pp. 121–137, Apr. 2006, doi: 10.1080/03605310600588665.
[10170]	S. Mahajan et al., “VX-509 (decernotinib) is a potent and selective janus kinase 3 inhibitor that attenuates inflammation in animal models of autoimmune disease,” J. Pharmacol. Exp. Ther., vol. 353, no. 2, pp. 405–414, May 2015, doi: 10.1124/jpet.114.221176.
[10171]	T. P. Nguyen and I. T. Kim, “W2C/WS2 Alloy Nanoflowers as Anode Materials for Lithium-Ion Storage,” Nanomaterials (Basel), vol. 10, no. 7, Jul. 2020, doi: 10.3390/nano10071336.
[10172]	K. E. Sivick and H. L. T. Mobley, “Waging war against uropathogenic Escherichia coli: winning back the urinary tract,” Infect. Immun., vol. 78, no. 2, pp. 568–585, Feb. 2010, doi: 10.1128/IAI.01000-09.
[10173]	A. S. Rahman, S. Shi, P. K. Meza, J. L. Jia, D. Svec, and L. Shieh, “Waiting it out: consultation delays prolong in-patient length of stay,” Postgrad Med J, vol. 95, no. 1119, pp. 1–5, Jan. 2019, doi: 10.1136/postgradmedj-2018-136269.
[10174]	F. Sow, M. Nyonda, A.-L. Bienvenu, and S. Picot, “Wanted Plasmodium falciparum, dead or alive,” Microb Cell, vol. 2, no. 7, pp. 219–224, Jul. 2015, doi: 10.15698/mic2015.07.211.
[10175]	D. Schulze-Makuch and I. A. Crawford, “Was There an Early Habitability Window for Earth’s Moon?,” Astrobiology, vol. 18, no. 8, pp. 985–988, 2018, doi: 10.1089/ast.2018.1844.
[10176]	J. Li, Y. Lu, T. Yang, D. Ge, D. L. Wood, and Z. Li, “Water-Based Electrode Manufacturing and Direct Recycling of Lithium-Ion Battery Electrodes-A Green and Sustainable Manufacturing System,” iScience, vol. 23, no. 5, p. 101081, May 2020, doi: 10.1016/j.isci.2020.101081.
[10177]	N. Aguiló-Aguayo, D. Hubmann, F. U. Khan, S. Arzbacher, and T. Bechtold, “Water-based slurries for high-energy LiFePO4 batteries using embroidered current collectors,” Sci Rep, vol. 10, no. 1, p. 5565, Mar. 2020, doi: 10.1038/s41598-020-62553-3.
[10178]	R. K. Upadhyay, P. Roy, C. Venkataraman, and A. Madzvamuse, “Wave of chaos in a spatial eco-epidemiological system: Generating realistic patterns of patchiness in rabbit-lynx dynamics,” Math Biosci, vol. 281, pp. 98–119, 2016, doi: 10.1016/j.mbs.2016.08.014.
[10179]	D. Dausch, S. Dausch, and E. Schröder, “Wavefront-supported photorefractive keratectomy: 12-month follow-up,” J Refract Surg, vol. 19, no. 4, pp. 405–411, Aug. 2003.
[10180]	J. S. Kim, C.-R. Lee, K. W. Seol, and D. K. Oh, “Wavelength shift of InP-based InAs quantum dot lasers above room temperature,” J Nanosci Nanotechnol, vol. 7, no. 12, pp. 4443–4446, Dec. 2007, doi: 10.1166/jnn.2007.878.
[10181]	V. A. Shchukin, N. N. Ledentsov, and A. Y. Egorov, “Wavelength-stabilized near-field laser,” Opt Express, vol. 27, no. 22, pp. 32019–32036, Oct. 2019, doi: 10.1364/OE.27.032019.
[10182]	Z. Li, E. W. C. Tam, A. F. T. Mak, and R. Y. C. Lau, “Wavelet analysis of the effects of static magnetic field on skin blood flowmotion: investigation using an in vivo rat model,” In Vivo, vol. 21, no. 1, pp. 61–68, Feb. 2007.
[10183]	C. Ham, “We cannot lop off our leaders,” Health Serv J, vol. 121, no. 6243, p. 16, Feb. 2011.
[10184]	Y. Kamide, “We reside in the sun’s atmosphere,” Biomed. Pharmacother., vol. 59 Suppl 1, pp. S1-4, Oct. 2005, doi: 10.1016/s0753-3322(05)80001-0.
[10185]	H. Young and D. Benton, “We should be using nonlinear indices when relating heart-rate dynamics to cognition and mood,” Sci Rep, vol. 5, p. 16619, Nov. 2015, doi: 10.1038/srep16619.
[10186]	F. S. Ludovichetti, F. Z. Trindade, A. Werner, C. J. Kleverlaan, and R. G. Fonseca, “Wear resistance and abrasiveness of CAD-CAM monolithic materials,” J Prosthet Dent, vol. 120, no. 2, p. 318.e1-318.e8, Aug. 2018, doi: 10.1016/j.prosdent.2018.05.011.
[10187]	E. Bruno et al., “Wearable technology in epilepsy: The views of patients, caregivers, and healthcare professionals,” Epilepsy Behav, vol. 85, pp. 141–149, 2018, doi: 10.1016/j.yebeh.2018.05.044.
[10188]	A. Papa and C. Lefton, “Welcome new nurses to the wonderful world of emergency nursing!,” J Emerg Nurs, vol. 41, no. 3, pp. 245–248, May 2015, doi: 10.1016/j.jen.2015.01.019.
[10189]	A. Aftab and D. V. Jeste, “Well-being in dementia and mild cognitive impairment,” Int Psychogeriatr, vol. 31, no. 5, pp. 603–606, 2019, doi: 10.1017/S1041610219000590.
[10190]	A. Papa, “West Nile virus infections in humans--focus on Greece,” J. Clin. Virol., vol. 58, no. 2, pp. 351–353, Oct. 2013, doi: 10.1016/j.jcv.2013.02.020.
[10191]	P. Striano et al., “West syndrome associated with 14q12 duplications harboring FOXG1,” Neurology, vol. 76, no. 18, pp. 1600–1602, May 2011, doi: 10.1212/WNL.0b013e3182194bbf.
[10192]	M. Mohammed and T. Babadagli, “Wettability alteration: A comprehensive review of materials/methods and testing the selected ones on heavy-oil containing oil-wet systems,” Adv Colloid Interface Sci, vol. 220, pp. 54–77, Jun. 2015, doi: 10.1016/j.cis.2015.02.006.
[10193]	S. P. Rallison, “What are Journals for?,” Ann R Coll Surg Engl, vol. 97, no. 2, pp. 89–91, Mar. 2015, doi: 10.1308/003588414X14055925061397.
[10194]	S. G. Gabram, J. Hoenig, J. W. Schroeder, A. Mansour, and R. Gamelli, “What are the primary concerns of recently graduated surgeons and how do they differ from those of the residency training years?,” Arch Surg, vol. 136, no. 10, pp. 1109–1114, Oct. 2001, doi: 10.1001/archsurg.136.10.1109.
[10195]	B. A. Pellman and J. J. Kim, “What Can Ethobehavioral Studies Tell Us about the Brain’s Fear System?,” Trends Neurosci., vol. 39, no. 6, pp. 420–431, 2016, doi: 10.1016/j.tins.2016.04.001.
[10196]	I. Heinonen, O. Sorop, V. J. de Beer, D. J. Duncker, and D. Merkus, “What can we learn about treating heart failure from the heart’s response to acute exercise? Focus on the coronary microcirculation,” J. Appl. Physiol., vol. 119, no. 8, pp. 934–943, Oct. 2015, doi: 10.1152/japplphysiol.00053.2015.
[10197]	T. Templin and E. Bendavid, “What counts as development assistance for reproductive, maternal, newborn, and child health?,” Lancet Glob Health, vol. 8, no. 3, pp. e312–e313, 2020, doi: 10.1016/S2214-109X(20)30042-5.
[10198]	R. C. McIlroy and N. A. Stanton, “What do people know about eco-driving?,” Ergonomics, vol. 60, no. 6, pp. 754–769, Jun. 2017, doi: 10.1080/00140139.2016.1227092.
[10199]	S. Lochner, “[What do you do if an injection of insulin causes allergic reactions?],” Med Monatsschr Pharm, vol. 34, no. 7, pp. 257–258, Jul. 2011.
[10200]	P. Corsi, “What do you mean by a periodical? Forms and functions,” Notes Rec R Soc Lond, vol. 70, no. 4, pp. 325–341, Dec. 2016, doi: 10.1098/rsnr.2016.0028.
[10201]	M. G. Pepin and P. H. Byers, “What every clinical geneticist should know about testing for osteogenesis imperfecta in suspected child abuse cases,” Am J Med Genet C Semin Med Genet, vol. 169, no. 4, pp. 307–313, Dec. 2015, doi: 10.1002/ajmg.c.31459.
[10202]	G. Boudon, H. Balcone-Boissard, B. Villemant, and D. J. Morgan, “What factors control superficial lava dome explosivity?,” Sci Rep, vol. 5, p. 14551, Sep. 2015, doi: 10.1038/srep14551.
[10203]	A. C. Ju, “What I Learned From the Antivaccine Movement,” Pediatrics, vol. 144, no. 4, 2019, doi: 10.1542/peds.2019-2384.
[10204]	A. Alban, B. Danneskiold-Samsøe, and K. M. Pedersen, “[What is cost effectiveness analysis?],” Ugeskr. Laeg., vol. 152, no. 2, pp. 81–86, Jan. 1990.
[10205]	D. D. Mccarthy, “What is leprosy? Leprosy, zara’eth, ngerengere, Hansen’s disease,” N. Z. Med. J., vol. 62, pp. 74–76, Feb. 1963.
[10206]	J. E. Clark, S. Watson, and K. J. Friston, “What is mood? A computational perspective,” Psychol Med, vol. 48, no. 14, pp. 2277–2284, 2018, doi: 10.1017/S0033291718000430.
[10207]	E. R. Valadares, T. B. Carneiro, P. M. Santos, A. C. Oliveira, and B. Zabel, “What is new in genetics and osteogenesis imperfecta classification?,” J Pediatr (Rio J), vol. 90, no. 6, pp. 536–541, Dec. 2014, doi: 10.1016/j.jped.2014.05.003.
[10208]	A. Westgaard, “[What is not a double publication?],” Tidsskr. Nor. Laegeforen., vol. 127, no. 6, pp. 765–766, Mar. 2007.
[10209]	G. P. Monaco and P. Goldschmidt, “What is proper cancer care in the era of managed care?,” Oncology (Williston Park, N.Y.), vol. 11, no. 1, pp. 65–71; discussion 72, 78, Jan. 1997.
[10210]	M. J. McCue and J. S. Peterman, “What is the hospital industry’s exposure from the ARS collapse?,” Healthc Financ Manage, vol. 63, no. 10, pp. 80–84, 86, Oct. 2009.
[10211]	M. Scharplatz, M. A. Puhan, J. Steurer, and L. M. Bachmann, “What is the impact of the ACE gene insertion/deletion (I/D) polymorphism on the clinical effectiveness and adverse events of ACE inhibitors?--Protocol of a systematic review,” BMC Med. Genet., vol. 5, p. 23, Sep. 2004, doi: 10.1186/1471-2350-5-23.
[10212]	R. V. Cohen, A. Luque, S. Junqueira, R. A. Ribeiro, and C. W. Le Roux, “What is the impact on the healthcare system if access to bariatric surgery is delayed?,” Surg Obes Relat Dis, vol. 13, no. 9, pp. 1619–1627, Sep. 2017, doi: 10.1016/j.soard.2017.03.025.
[10213]	K. D. Rosenman, A. Hogan, and M. J. Reilly, “What is the most cost-effective way to identify silica problem worksites?,” Am. J. Ind. Med., vol. 39, no. 6, pp. 629–635, Jun. 2001, doi: 10.1002/ajim.1062.
[10214]	J. A. Yates, L. Clare, R. T. Woods, and Cognitive Function and Ageing Study: Wales, “What is the Relationship between Health, Mood, and Mild Cognitive Impairment?,” J. Alzheimers Dis., vol. 55, no. 3, pp. 1183–1193, 2017, doi: 10.3233/JAD-160611.
[10215]	V. M. White, S. J. Durkin, K. Coomber, and M. A. Wakefield, “What is the role of tobacco control advertising intensity and duration in reducing adolescent smoking prevalence? Findings from 16 years of tobacco control mass media advertising in Australia,” Tob Control, vol. 24, no. 2, pp. 198–204, Mar. 2015, doi: 10.1136/tobaccocontrol-2012-050945.
[10216]	E. Dolgin, “What lava lamps and vinaigrette can teach us about cell biology,” Nature, vol. 555, no. 7696, pp. 300–302, Mar. 2018, doi: 10.1038/d41586-018-03070-2.
[10217]	P. E. Keck, S. L. McElroy, N. Richtand, and M. Tohen, “What makes a drug a primary mood stabilizer?,” Mol. Psychiatry, vol. 7 Suppl 1, pp. S8-14, 2002, doi: 10.1038/sj.mp.4001013.
[10218]	C. Baggott et al., “What matters most to patients when choosing treatment for mild-moderate asthma? Results from a discrete choice experiment,” Thorax, Jul. 2020, doi: 10.1136/thoraxjnl-2019-214343.
[10219]	J. M. Harik, R. A. Matteo, B. A. Hermann, and J. L. Hamblen, “What people with PTSD symptoms do (and do not) know about PTSD: A national survey,” Depress Anxiety, vol. 34, no. 4, pp. 374–382, 2017, doi: 10.1002/da.22558.
[10220]	A. Carstairs-McCarthy, “What proper names, and their absence, do not demonstrate,” Behav Brain Sci, vol. 26, no. 3, pp. 288–289, Jun. 2003, doi: 10.1017/S0140525X03280079.
[10221]	A. B. Ohman, H. B. Pride, and C. A. Papa, “What syndrome is this? Killian-Teschler-Nicola syndrome,” Pediatr Dermatol, vol. 17, no. 2, pp. 151–153, Apr. 2000, doi: 10.1046/j.1525-1470.2000.01737.x.
[10222]	G. Northoff, “What the brain’s intrinsic activity can tell us about consciousness? A tri-dimensional view,” Neurosci Biobehav Rev, vol. 37, no. 4, pp. 726–738, May 2013, doi: 10.1016/j.neubiorev.2012.12.004.
[10223]	A. Spura et al., “What understanding of economics do medical students have?,” GMS J Med Educ, vol. 36, no. 4, p. Doc41, 2019, doi: 10.3205/zma001249.
[10224]	S.-A. Lee, “What we confront with employment of people with epilepsy in Korea,” Epilepsia, vol. 46 Suppl 1, pp. 57–58, 2005, doi: 10.1111/j.0013-9580.2005.461018.x.
[10225]	M. Tomlinson et al., “What will it take for children and adolescents to thrive? The Global Strategy for Women’s, Children’s, and Adolescents’ Health,” Lancet Child Adolesc Health, vol. 3, no. 4, pp. 208–209, 2019, doi: 10.1016/S2352-4642(19)30004-5.
[10226]	E. B. O’Shea, “What’s another year? A qualitative evaluation of extension of general practice training in the West of Ireland,” Educ Prim Care, vol. 20, no. 3, pp. 159–166, May 2009, doi: 10.1080/14739879.2009.11493787.
[10227]	“What’s in a Discussion section? Exploiting 2-dimensionality in the online world…,” Bioessays, vol. 38, no. 12, p. 1185, 2016, doi: 10.1002/bies.201600242.
[10228]	A. Gruber, “What’s in a name? How organelles of endosymbiotic origin can be distinguished from endosymbionts,” Microb Cell, vol. 6, no. 2, pp. 123–133, Jan. 2019, doi: 10.15698/mic2019.02.668.
[10229]	A. Barnard, “What’s next for the Ju/’hoansi?,” Science, vol. 356, no. 6345, p. 1340, Jun. 2017, doi: 10.1126/science.aan6309.
[10230]	J. Cole and S. Bickersteth, “What’s planetary about health? An analysis of topics covered in The Lancet Planetary Health’s first year,” Lancet Planet Health, vol. 2, no. 7, pp. e283–e284, 2018, doi: 10.1016/S2542-5196(18)30143-8.
[10231]	L. Rew, “What’s so special about adolescence?,” Issues Ment Health Nurs, vol. 28, no. 1, pp. 3–5, Jan. 2007, doi: 10.1080/01612840600996109.
[10232]	L. Nohales and N. Prieto, “[What’s the post-traumatic stress disorder (PTSD)?],” Rev Prat, vol. 68, no. 1, pp. 92–96, Jan. 2018.
[10233]	A. D. Harries, F. Gausi, and F. M. Salaniponi, “When are follow-up sputum smears actually examined in patients treated for new smear-positive pulmonary tuberculosis?,” Int. J. Tuberc. Lung Dis., vol. 8, no. 4, pp. 440–444, Apr. 2004.
[10234]	A. E. Mirrakhimov, M. E. Jesinger, T. Ayach, and A. Gray, “When does S aureus bacteremia require transesophageal echocardiography?,” Cleve Clin J Med, vol. 85, no. 7, pp. 517–520, Jul. 2018, doi: 10.3949/ccjm.85a.16095.
[10235]	C. Koeberl, “When Earth got pummeled,” Science, vol. 363, no. 6424, pp. 224–225, 18 2019, doi: 10.1126/science.aav8480.
[10236]	C. Arnold, “When earth was a snowball,” Sci. Am., vol. 304, no. 2, p. 32, Feb. 2011, doi: 10.1038/scientificamerican0211-32a.
[10237]	M. K. McCarty, N. E. Iannone, E. E. Jones, and J. R. Kelly, “When inclusion hurts: The role of valence in moderating the effects of being in the loop,” J Soc Psychol, vol. 158, no. 1, pp. 93–108, 2018, doi: 10.1080/00224545.2017.1314247.
[10238]	H. L. Schacter and G. Margolin, “When it feels good to give: Depressive symptoms, daily prosocial behavior, and adolescent mood,” Emotion, vol. 19, no. 5, pp. 923–927, Aug. 2019, doi: 10.1037/emo0000494.
[10239]	M. Manga, “When it rains, lava pours,” Nature, vol. 580, no. 7804, pp. 457–458, 2020, doi: 10.1038/d41586-020-01091-4.
[10240]	A. Zimmermann, M. A. Bauer, G. Kroemer, F. Madeo, and D. Carmona-Gutierrez, “When less is more: hormesis against stress and disease,” Microb Cell, vol. 1, no. 5, pp. 150–153, May 2014, doi: 10.15698/mic2014.05.148.
[10241]	H. Kulaksizoglu, G. Toktas, I. B. Kulaksizoglu, E. Aglamis, and E. Unlüer, “When should quality of life be measured after radical cystectomy?,” Eur. Urol., vol. 42, no. 4, pp. 350–355, Oct. 2002, doi: 10.1016/s0302-2838(02)00351-2.
[10242]	A. P. Pinheiro, M. Schwartze, F. Gutierrez, and S. A. Kotz, “When temporal prediction errs: ERP responses to delayed action-feedback onset,” Neuropsychologia, vol. 134, p. 107200, 2019, doi: 10.1016/j.neuropsychologia.2019.107200.
[10243]	C. Barroso, K. C. Gautam, and IAP Members, “Where is the accountability to adolescents?,” Lancet, vol. 390, no. 10101, pp. 1474–1475, Sep. 2017, doi: 10.1016/S0140-6736(17)32482-0.
[10244]	L. Rew, “Where is the evidence for holistic nursing care?,” J Holist Nurs, vol. 22, no. 4, pp. 295–297, Dec. 2004, doi: 10.1177/0898010104269310.
[10245]	H. Graham, “Where is the future in public health?,” Milbank Q, vol. 88, no. 2, pp. 149–168, Jun. 2010, doi: 10.1111/j.1468-0009.2010.00594.x.
[10246]	Y. Chamata, K. A. Watson, and P. Jauregi, “Whey-Derived Peptides Interactions with ACE by Molecular Docking as a Potential Predictive Tool of Natural ACE Inhibitors,” Int J Mol Sci, vol. 21, no. 3, Jan. 2020, doi: 10.3390/ijms21030864.
[10247]	J. A. Cantrill, P. Dewis, D. M. Large, M. Newman, and D. C. Anderson, “Which testosterone replacement therapy?,” Clin. Endocrinol. (Oxf), vol. 21, no. 2, pp. 97–107, Aug. 1984, doi: 10.1111/j.1365-2265.1984.tb03448.x.
[10248]	O. M. Al-Janabi et al., “White Matter Hyperintensity Regression: Comparison of Brain Atrophy and Cognitive Profiles with Progression and Stable Groups,” Brain Sci, vol. 9, no. 7, Jul. 2019, doi: 10.3390/brainsci9070170.
[10249]	R. Biancheri et al., “White matter involvement in a family with a novel PDGFB mutation,” Neurol Genet, vol. 2, no. 3, p. e77, Jun. 2016, doi: 10.1212/NXG.0000000000000077.
[10250]	A. Papa and C. Lefton, “Whiteboardology,” J Emerg Nurs, vol. 42, no. 2, pp. 167–169, Mar. 2016, doi: 10.1016/j.jen.2016.02.009.
[10251]	J. L. Brewster, T. J. Finn, M. A. Ramirez, and W. M. Patrick, “Whither life? Conjectures on the future evolution of biochemistry,” Biol. Lett., vol. 12, no. 8, 2016, doi: 10.1098/rsbl.2016.0269.
[10252]	“WHO Alliance for the Global Elimination of Trachoma by 2020: progress report on elimination of trachoma, 2014–2016,” Wkly. Epidemiol. Rec., vol. 92, no. 26, pp. 359–368, 30 2017.
[10253]	H. Liu, “Who first created the Chinese term for psychology-Xin Li Xue?,” Hist Psychol, vol. 22, no. 2, pp. 216–217, May 2019, doi: 10.1037/hop0000119.
[10254]	P. Sörqvist et al., “Who needs cream and sugar when there is eco-labeling? Taste and willingness to pay for ‘eco-friendly’ coffee,” PLoS ONE, vol. 8, no. 12, p. e80719, 2013, doi: 10.1371/journal.pone.0080719.
[10255]	“WHO procedures for certification of malaria elimination,” Wkly. Epidemiol. Rec., vol. 89, no. 29, pp. 321–325, Jul. 2014.
[10256]	G. H. Kwon, M. J. Kwon, J. E. Park, and Y. H. Kim, “Whole genome sequence of a freshwater agar-degrading bacterium Cellvibrio sp. KY-GH-1,” Biotechnol Rep (Amst), vol. 23, p. e00346, Sep. 2019, doi: 10.1016/j.btre.2019.e00346.
[10257]	N. M. McKeown et al., “Whole grains and health: from theory to practice--highlights of The Grains for Health Foundation’s Whole Grains Summit 2012,” J. Nutr., vol. 143, no. 5, pp. 744S-758S, May 2013, doi: 10.3945/jn.112.172536.
[10258]	H. W. Paschold and A. V. Sergeev, “Whole-body vibration knowledge survey of U.S. occupational safety and health professionals,” J Safety Res, vol. 40, no. 3, pp. 171–176, 2009, doi: 10.1016/j.jsr.2009.02.008.
[10259]	V. Rew et al., “Whole-genome sequencing revealed concurrent outbreaks of shigellosis in the English Orthodox Jewish Community caused by multiple importations of Shigella sonnei from Israel,” Microb Genom, vol. 4, no. 3, 2018, doi: 10.1099/mgen.0.000170.
[10260]	Z. Zhang and Q. Ren, “Why are essential genes essential? - The essentiality of Saccharomyces genes,” Microb Cell, vol. 2, no. 8, pp. 280–287, Jul. 2015, doi: 10.15698/mic2015.08.218.
[10261]	J.-A. Hwang, Y. Park, and Y. Kim, “Why do consumers respond to eco-labels? The case of Korea,” Springerplus, vol. 5, no. 1, p. 1915, 2016, doi: 10.1186/s40064-016-3550-1.
[10262]	J. A. Biello and T. Dimofte, “Why do Earth’s equatorial waves head east?,” Science, vol. 358, no. 6366, pp. 990–991, 24 2017, doi: 10.1126/science.aaq0469.
[10263]	L. Tite and S. Schroter, “Why do peer reviewers decline to review? A survey,” J Epidemiol Community Health, vol. 61, no. 1, pp. 9–12, Jan. 2007, doi: 10.1136/jech.2006.049817.
[10264]	S. Yuan, Y. Dou, W. Wu, Y. Hu, and J. Zhao, “Why does trans-azobenzene have a smaller isomerization yield for pi pi* excitation than for n pi* excitation?,” J Phys Chem A, vol. 112, no. 51, pp. 13326–13334, Dec. 2008, doi: 10.1021/jp806227x.
[10265]	L. Rew, “Why don’t consumers seek our advice?,” J Holist Nurs, vol. 19, no. 1, pp. 3–4, Mar. 2001, doi: 10.1177/089801010101900101.
[10266]	N. Ikegami, M. Drummond, S. Fukuhara, S. Nishimura, G. W. Torrance, and F. Schubert, “Why has the use of health economic evaluation in Japan lagged behind that in other developed countries?,” Pharmacoeconomics, vol. 20 Suppl 2, pp. 1–7, 2002, doi: 10.2165/00019053-200220002-00001.
[10267]	I. T. Cousins, C. A. Ng, Z. Wang, and M. Scheringer, “Why is high persistence alone a major cause of concern?,” Environ Sci Process Impacts, vol. 21, no. 5, pp. 781–792, May 2019, doi: 10.1039/c8em00515j.
[10268]	F. Andersson, “Why is the pharmaceutical industry investing increasing amounts in health economic evaluations?,” Int J Technol Assess Health Care, vol. 11, no. 4, pp. 750–761, 1995, doi: 10.1017/s0266462300009181.
[10269]	E. Diener, S. Kanazawa, E. M. Suh, and S. Oishi, “Why People Are in a Generally Good Mood,” Pers Soc Psychol Rev, vol. 19, no. 3, pp. 235–256, Aug. 2015, doi: 10.1177/1088868314544467.
[10270]	R. Karniol et al., “Why superman can wait: cognitive self-transformation in the delay of gratification paradigm,” J Clin Child Adolesc Psychol, vol. 40, no. 2, pp. 307–317, 2011, doi: 10.1080/15374416.2011.546040.
[10271]	A. Mundra, P. Kothekar, P. R. Deshmukh, and A. Dongre, “Why tuberculosis patients under revised national tuberculosis control programme delay in health-care seeking? A mixed-methods research from Wardha District, Maharashtra,” Indian J Public Health, vol. 63, no. 2, pp. 94–100, Jun. 2019, doi: 10.4103/ijph.IJPH_138_18.
[10272]	E. M. Jenoh et al., “Wide Ranging Insect Infestation of the Pioneer Mangrove Sonneratia alba by Two Insect Species along the Kenyan Coast,” PLoS ONE, vol. 11, no. 5, p. e0154849, 2016, doi: 10.1371/journal.pone.0154849.
[10273]	V. Niven, L. B. Cabot, and J. E. Gallagher, “Widening participation - a comparison of the characteristics of successful UK applicants to the five-year and four-year dental programmes in 2007 and 2008,” Br Dent J, vol. 214, no. 3, pp. 117–122, Feb. 2013, doi: 10.1038/sj.bdj.2013.107.
[10274]	S. Marchi et al., “Widespread mixing and burial of Earth’s Hadean crust by asteroid impacts,” Nature, vol. 511, no. 7511, pp. 578–582, Jul. 2014, doi: 10.1038/nature13539.
[10275]	A. Porta, V. Bari, A. Marchi, B. De Maria, and S. Cerutti, “Wiener-Granger causality in QT-HP variability interactions,” Conf Proc IEEE Eng Med Biol Soc, vol. 2015, pp. 1781–1784, Aug. 2015, doi: 10.1109/EMBC.2015.7318724.
[10276]	B. W. McCrindle, P. N. Tyrrell, and R.-E. W. Kavey, “Will obesity increase the proportion of children and adolescents recommended for a statin?,” Circulation, vol. 128, no. 19, pp. 2162–2165, Nov. 2013, doi: 10.1161/CIRCULATIONAHA.113.002411.
[10277]	E. Bayen et al., “Will participation restrictions related to the COVID-19 lockdown boost inclusivity?,” Ann Phys Rehabil Med, vol. 63, no. 4, p. 383, 2020, doi: 10.1016/j.rehab.2020.04.004.
[10278]	D. M. Seliger, “[Will work disability due to PTSD soon no longer be an option?],” Versicherungsmedizin, vol. 67, no. 2, pp. 90–91, Jun. 2015.
[10279]	P. Striano, F. Zara, and C. Minetti, “Willful modulation of brain activity in disorders of consciousness,” N. Engl. J. Med., vol. 362, no. 20, pp. 1937; author reply 1937-1938, May 2010.
[10280]	C. M. Papa, “Winter itch, dry skin,” J Med Soc N J, vol. 77, no. 12, pp. 817–819, Nov. 1980.
[10281]	M. Stolarski, K. S. Jankowski, G. Matthews, and J. Kawalerczyk, “Wise ‘birds’ follow their clock: The role of emotional intelligence and morningness-eveningness in diurnal regulation of mood,” Chronobiol. Int., vol. 33, no. 1, pp. 51–63, 2016, doi: 10.3109/07420528.2015.1115413.
[10282]	M. L. To, C. D. Fisher, N. M. Ashkanasy, and P. A. Rowe, “Within-person relationships between mood and creativity,” J Appl Psychol, vol. 97, no. 3, pp. 599–612, May 2012, doi: 10.1037/a0026097.
[10283]	L. Rew, M. Taylor-Seehafer, and N. Thomas, “Without parental consent: conducting research with homeless adolescents,” J Soc Pediatr Nurs, vol. 5, no. 3, pp. 131–138, Sep. 2000, doi: 10.1111/j.1744-6155.2000.tb00098.x.
[10284]	P. Schröttner, W. W. Rudolph, U. Damme, C. Lotz, E. Jacobs, and F. Gunzer, “Wohlfahrtiimonas chitiniclastica: current insights into an emerging human pathogen,” Epidemiol. Infect., vol. 145, no. 7, pp. 1292–1303, May 2017, doi: 10.1017/S0950268816003411.
[10285]	J. V. Carter et al., “Women in surgery: A longer term follow-up,” Am. J. Surg., vol. 216, no. 2, pp. 189–193, 2018, doi: 10.1016/j.amjsurg.2017.05.002.
[10286]	F. Bustreo, F. M. Knaul, A. Bhadelia, J. Beard, and I. Araujo de Carvalho, “Women’s health beyond reproduction: meeting the challenges,” Bull. World Health Organ., vol. 90, no. 7, pp. 478-478A, Jul. 2012, doi: 10.2471/BLT.12.103549.
[10287]	B. Muschalla, M. Linden, and M. Jöbges, “Work-Anxiety and Sickness Absence After a Short Inpatient Cognitive Behavioral Group Intervention in Comparison to a Recreational Group Meeting,” J. Occup. Environ. Med., vol. 58, no. 4, pp. 398–406, Apr. 2016, doi: 10.1097/JOM.0000000000000678.
[10288]	B. D. Aggarwal, “Worker education level is a factor in self-compliance with dust-preventive methods among small-scale agate industrial workers,” J Occup Health, vol. 55, no. 4, pp. 312–317, 2013, doi: 10.1539/joh.12-0167-oa.
[10289]	M. I. Dow, “Worker exposure studies,” Qual Assur, vol. 3, no. 3, pp. 275–278, Sep. 1994.
[10290]	R. S. Judson et al., “Workflow for defining reference chemicals for assessing performance of in vitro assays,” ALTEX, vol. 36, no. 2, pp. 261–276, 2019, doi: 10.14573/altex.1809281.
[10291]	J. K. Holodinsky, N. Kamal, A. T. Wilson, M. D. Hill, and M. Goyal, “Workflow in Acute Stroke: What Is the 90th Percentile?,” Stroke, vol. 48, no. 3, pp. 808–812, 2017, doi: 10.1161/STROKEAHA.116.015951.
[10292]	M. H. Ashcraft and J. A. Krause, “Working memory, math performance, and math anxiety,” Psychon Bull Rev, vol. 14, no. 2, pp. 243–248, Apr. 2007, doi: 10.3758/bf03194059.
[10293]	T. Sen Gupta, R. Hays, T. Woolley, G. Kelly, and H. Jacobs, “Workplace immersion in the final year of an undergraduate medicine course: the views of final year students and recent graduates,” Med Teach, vol. 36, no. 6, pp. 518–526, Jun. 2014, doi: 10.3109/0142159X.2014.907878.
[10294]	M. Linden and B. Muschalla, “[Workplace related anxiety and phobia],” Nervenarzt, vol. 78, no. 1, pp. 39–44, Jan. 2007, doi: 10.1007/s00115-006-2196-6.
[10295]	K. Fuchs and B. Müller, “World Stress Map of the Earth: a key to tectonic processes and technological applications,” Naturwissenschaften, vol. 88, no. 9, pp. 357–371, Sep. 2001, doi: 10.1007/s001140100253.
[10296]	T. Sasaki, K. Hashiguchi, K. Yoshimoto, A. Nakamizo, M. Mizoguchi, and Neurosurgical Staff of Kyushu University, “Worldwide academic contributions of Japanese neurosurgeons,” Neurol. Med. Chir. (Tokyo), vol. 51, no. 6, pp. 405–414, 2011, doi: 10.2176/nmc.51.405.
[10297]	A. Ricci et al., “Worry and anger rumination in fibromyalgia syndrome,” Reumatismo, vol. 68, no. 4, pp. 195–198, Dec. 2016, doi: 10.4081/reumatismo.2016.896.
[10298]	R. I. Shader, “Worry dissected,” J Clin Psychopharmacol, vol. 35, no. 3, pp. 215–216, Jun. 2015, doi: 10.1097/JCP.0000000000000322.
[10299]	R. A. Norman and M. Bock, “Wound care in geriatrics,” Dermatol Ther, vol. 16, no. 3, pp. 224–230, 2003, doi: 10.1046/j.1529-8019.2003.01632.x.
[10300]	E. S. De Lustig and F. Sacerdote, “[Wound healing in tissues cultured in different media in vitro],” Rev Soc Argent Biol, vol. 30, no. 4–5, pp. 117–122, Aug. 1954.
[10301]	W.-C. Yeap, F.-C. Lee, D. K. Shabari Shan, H. Musa, D. R. Appleton, and H. Kulaveerasingam, “WRI1-1, ABI5, NF-YA3 and NF-YC2 increase oil biosynthesis in coordination with hormonal signaling during fruit development in oil palm,” Plant J., vol. 91, no. 1, pp. 97–113, Jul. 2017, doi: 10.1111/tpj.13549.
[10302]	C. A. Perfetti and L.-H. Tan, “Write to read: the brain’s universal reading and writing network,” Trends Cogn. Sci. (Regul. Ed.), vol. 17, no. 2, pp. 56–57, Feb. 2013, doi: 10.1016/j.tics.2012.12.008.
[10303]	S. L. Siedlecki, M. Montague, and J. Schultz, “Writing for publication: avoiding common ethical pitfalls,” J Wound Ostomy Continence Nurs, vol. 35, no. 2, pp. 147–150, Apr. 2008, doi: 10.1097/01.WON.0000313636.83881.22.
[10304]	D. A. Rew, “Writing for readers,” Eur J Surg Oncol, vol. 29, no. 8, p. 633, Oct. 2003, doi: 10.1016/s0748-7983(03)00144-6.
[10305]	Y. Y. Chen, “Written emotional expression and religion: effects on PTSD symptoms,” Int J Psychiatry Med, vol. 35, no. 3, pp. 273–286, 2005, doi: 10.2190/2X0U-0CTB-Y877-5DRQ.
[10306]	M. Pauly, “Wussinomics: the state of competitive efficiency in private health insurance,” Int J Health Care Finance Econ, vol. 12, no. 3, pp. 235–245, Sep. 2012, doi: 10.1007/s10754-012-9111-4.
[10307]	R. P. Meyer et al., “Xenobiotics in the limbic system--affecting brain’s network function,” Vitam. Horm., vol. 82, pp. 87–106, 2010, doi: 10.1016/S0083-6729(10)82005-9.
[10308]	C. Rodrigues-Pousada et al., “Yeast AP-1 like transcription factors (Yap) and stress response: a current overview,” Microb Cell, vol. 6, no. 6, pp. 267–285, May 2019, doi: 10.15698/mic2019.06.679.
[10309]	E. Herrero and R. E. Wellinger, “Yeast as a model system to study metabolic impact of selenium compounds,” Microb Cell, vol. 2, no. 5, pp. 139–149, Apr. 2015, doi: 10.15698/mic2015.05.200.
[10310]	P. Polčic, P. Jaká, and M. Mentel, “Yeast as a tool for studying proteins of the Bcl-2 family,” Microb Cell, vol. 2, no. 3, pp. 74–87, Mar. 2015, doi: 10.15698/mic2015.03.193.
[10311]	H. Pereira, C. S. F. Oliveira, L. Castro, A. Preto, S. R. Chaves, and M. Côrte-Real, “Yeast as a tool to explore cathepsin D function,” Microb Cell, vol. 2, no. 7, pp. 225–234, Jul. 2015, doi: 10.15698/mic2015.07.212.
[10312]	G. Zara, M. Budroni, I. Mannazzu, F. Fancello, and S. Zara, “Yeast biofilm in food realms: occurrence and control,” World J. Microbiol. Biotechnol., vol. 36, no. 9, p. 134, Aug. 2020, doi: 10.1007/s11274-020-02911-5.
[10313]	J. Natarajan, A. Moitra, S. Zabel, N. Singh, S. Wagner, and D. Rapaport, “Yeast can express and assemble bacterial secretins in the mitochondrial outer membrane,” Microb Cell, vol. 7, no. 1, pp. 15–27, Nov. 2019, doi: 10.15698/mic2020.01.703.
[10314]	R. Y. Zhao, “Yeast for virus research,” Microb Cell, vol. 4, no. 10, pp. 311–330, Sep. 2017, doi: 10.15698/mic2017.10.592.
[10315]	I. Mannazzu et al., “Yeast killer toxins: from ecological significance to application,” Crit. Rev. Biotechnol., vol. 39, no. 5, pp. 603–617, Aug. 2019, doi: 10.1080/07388551.2019.1601679.
[10316]	V. Zara et al., “Yeast mitochondria lacking the phosphate carrier/p32 are blocked in phosphate transport but can import preproteins after regeneration of a membrane potential,” Mol. Cell. Biol., vol. 16, no. 11, pp. 6524–6531, Nov. 1996, doi: 10.1128/mcb.16.11.6524.
[10317]	T. Amen and D. Kaganovich, “Yeast screening platform identifies FDA-approved drugs that reduce Aβ oligomerization,” Microb Cell, vol. 3, no. 3, pp. 97–100, Mar. 2016, doi: 10.15698/mic2016.03.482.
[10318]	M. Ghoneum, L. Wang, S. Agrawal, and S. Gollapudi, “Yeast therapy for the treatment of breast cancer: a nude mice model study,” In Vivo, vol. 21, no. 2, pp. 251–258, Apr. 2007.
[10319]	J. L. Gonzalez-Pimentel, A. Z. Miller, V. Jurado, L. Laiz, M. F. C. Pereira, and C. Saiz-Jimenez, “Yellow coloured mats from lava tubes of La Palma (Canary Islands, Spain) are dominated by metabolically active Actinobacteria,” Sci Rep, vol. 8, no. 1, p. 1944, 31 2018, doi: 10.1038/s41598-018-20393-2.
[10320]	“Yellow fever in Africa and  South America, 2015,” Wkly. Epidemiol. Rec., vol. 91, no. 32, pp. 381–388, Aug. 2016.
[10321]	“Yellow fever in Africa and South America, 2013,” Wkly. Epidemiol. Rec., vol. 89, no. 27, pp. 297–306, Jul. 2014.
[10322]	“Yellow fever in Africa and the Americas, 2014,” Wkly. Epidemiol. Rec., vol. 90, no. 26, pp. 323–334, Jun. 2015.
[10323]	“Yellow fever in Africa and the Americas, 2016,” Wkly. Epidemiol. Rec., vol. 92, no. 32, pp. 442–452, 11 2017.
[10324]	“Yellow fever urban outbreak in Angola and the risk of extension,” Wkly. Epidemiol. Rec., vol. 91, no. 14, pp. 186–192, Apr. 2016.
[10325]	“Yellow fever vaccine: WHO position on the use of fractional doses – June 2017,” Wkly. Epidemiol. Rec., vol. 92, no. 25, pp. 345–350, 23 2017.
[10326]	A. Origi et al., “Yet another job for the bacterial ribosome,” Microb Cell, vol. 6, no. 11, pp. 524–526, Oct. 2019, doi: 10.15698/mic2019.11.698.
[10327]	F. Llorens et al., “YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias,” Mol Neurodegener, vol. 12, no. 1, p. 83, Nov. 2017, doi: 10.1186/s13024-017-0226-4.
[10328]	Z. Mabaso, T. Erogbogbo, and K. Toure, “Young people’s contribution to the Global strategy for women’s, children’s and adolescents’ health (2016-2030),” Bull. World Health Organ., vol. 94, no. 5, p. 312, May 2016, doi: 10.2471/BLT.16.174714.
[10329]	K. M. Cardarelli, M. Paul, B. May, M. Dunfee, S. Browning, and N. Schoenberg, “‘Youth Are More Aware and Intelligent than Imagined’: The Mountain Air Youth Photovoice Project,” Int J Environ Res Public Health, vol. 16, no. 20, 11 2019, doi: 10.3390/ijerph16203829.
[10330]	L. Rew and S. D. Horner, “Youth Resilience Framework for reducing health-risk behaviors in adolescents,” J Pediatr Nurs, vol. 18, no. 6, pp. 379–388, Dec. 2003, doi: 10.1016/s0882-5963(03)00162-3.
[10331]	X. Zhang, “Youyou Tu honored by the Lasker award,” Protein Cell, vol. 2, no. 10, p. 773, Oct. 2011, doi: 10.1007/s13238-011-1111-5.
[10332]	D. Mazier and M. Thellier, “[Youyou Tu, from Mao Zedong to the Nobel Prize],” Med Sci (Paris), vol. 32, no. 1, pp. 106–109, Jan. 2016, doi: 10.1051/medsci/20163201017.
[10333]	N. Rochow et al., “Z-score differences based on cross-sectional growth charts do not reflect the growth rate of very low birth weight infants,” PLoS ONE, vol. 14, no. 5, p. e0216048, 2019, doi: 10.1371/journal.pone.0216048.
[10334]	H. M. Rowe, J. H. Withey, and M. N. Neely, “Zebrafish as a model for zoonotic aquatic pathogens,” Dev. Comp. Immunol., vol. 46, no. 1, pp. 96–107, Sep. 2014, doi: 10.1016/j.dci.2014.02.014.
[10335]	“Zika virus infection: global update on epidemiology and potentially associated clinical manifestations,” Wkly. Epidemiol. Rec., vol. 91, no. 7, pp. 73–81, Feb. 2016.
[10336]	“Zika virus outbreaks in the Americas,” Wkly. Epidemiol. Rec., vol. 90, no. 45, pp. 609–610, Nov. 2015.
[10337]	“Zika virus: an epidemiological update,” Wkly. Epidemiol. Rec., vol. 92, no. 15, pp. 188–192, 14 2017.
[10338]	W. Alker and H. Haase, “Zinc and Sepsis,” Nutrients, vol. 10, no. 8, Jul. 2018, doi: 10.3390/nu10080976.
[10339]	H.-T. Yu, J. Zhen, J.-Y. Leng, L. Cai, H.-L. Ji, and B. B. Keller, “Zinc as a countermeasure for cadmium toxicity,” Acta Pharmacol. Sin., Apr. 2020, doi: 10.1038/s41401-020-0396-4.
[10340]	N. Tanaka, M. Kawachi, T. Fujiwara, and M. Maeshima, “Zinc-binding and structural properties of the histidine-rich loop of Arabidopsis thaliana vacuolar membrane zinc transporter MTP1,” FEBS Open Bio, vol. 3, pp. 218–224, 2013, doi: 10.1016/j.fob.2013.04.004.
[10341]	S. Zara et al., “Zoledronic acid at subtoxic dose extends osteoblastic stage span of primary human osteoblasts,” Clin Oral Investig, vol. 19, no. 3, pp. 601–611, Apr. 2015, doi: 10.1007/s00784-014-1280-8.
[10342]	G. A. Otaify, M. S. Aglan, M. M. Ibrahim, M. Elnashar, R. a. S. El Banna, and S. A. Temtamy, “Zoledronic acid in children with osteogenesis imperfecta and Bruck syndrome: a 2-year prospective observational study,” Osteoporos Int, vol. 27, no. 1, pp. 81–92, Jan. 2016, doi: 10.1007/s00198-015-3216-9.
[10343]	“Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness,” Wkly. Epidemiol. Rec., vol. 92, no. 12, pp. 129–144, 24 2017.
[10344]	S. P. Yun et al., “α-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism,” Mol Neurodegener, vol. 13, no. 1, p. 1, 08 2018, doi: 10.1186/s13024-017-0233-5.
[10345]	A. Janssen et al., “γδ T-cell Receptors Derived from Breast Cancer-Infiltrating T Lymphocytes Mediate Antitumor Reactivity,” Cancer Immunol Res, vol. 8, no. 4, pp. 530–543, 2020, doi: 10.1158/2326-6066.CIR-19-0513.
